PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moore, N; Blouin, B; Razuri, H; Casapia, M; Gyorkos, TW				Moore, Nora; Blouin, Brittany; Razuri, Hugo; Casapia, Martin; Gyorkos, Theresa W.			Determinants of first trimester attendance at antenatal care clinics in the Amazon region of Peru: A case-control study	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; DEVELOPING-COUNTRIES; ANEMIA	Objective To identify determinants which influence the timing of the first antenatal care (ANC) visit in pregnant women. Design Retrospective matched nested case-control study. Setting Two health centres, Belen and 6 de Octubre, in the Peruvian Amazon. Population All pregnant women who had attended ANC during the years 2010, 2011, and 2012. Methods All cases (819 women initiating ANC in their first trimester) were selected from ANC registries from 2010 to 2012. A random sample of controls (819 women initiating ANC in their second or third trimester) was matched 1: 1 to cases on health centre and date of first ANC visit. Data were obtained from ANC registries. Conditional logistic regression analyses were performed. Main outcome measure Case-control status of each woman determined by the gestational age at first ANC visit. Results Cases had higher odds of: 1) being married or cohabiting (aOR = 1.69; 95% CI: 1.19, 2.41); 2) completing secondary school or attending post-secondary school (aOR = 1.45; 95% CI: 1.02, 2.06); 3) living in an urban environment (aOR = 1.79; 95% CI: 1.04, 3.10) and 4) having had a previous miscarriage (aOR = 1.56; 95% CI: 1.13, 2.15), compared to controls. No statistically significant difference in odds was found for parity (aOR = 1.08; 95% CI: 0.85, 1.36). Conclusions This study provides empirical evidence of determinants of first ANC attendance. These findings are crucial to the planning and timing of local interventions, like deworming, aimed at pregnant women so that they can access and benefit fully from all government-provided ANC services.	[Moore, Nora; Blouin, Brittany; Gyorkos, Theresa W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Moore, Nora; Blouin, Brittany; Razuri, Hugo; Gyorkos, Theresa W.] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru	McGill University; McGill University	Gyorkos, TW (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Gyorkos, TW (corresponding author), McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada.	theresa.gyorkos@mcgill.ca	Razuri, Hugo/C-1542-2013	Razuri, Hugo/0000-0003-4571-5520; Blouin, Brittany/0000-0001-7447-7467; Casapia Morales, Wilfredo Martin/0000-0002-5972-0948	National Institutes of Health (NIH) grant [1P50A1098574-01]	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health (NIH) grant [Grant # 1P50A1098574-01, to M.C. and T.W.G.); https:// grants.nih.gov/funding/index.htm. Additional support includes: travel awards from McGill University Faculty of Medicine and the Axe de recherche en sante mondiale of the Reseau de recherche en sante des populations du Quebec (to N.M.). URLs: http//www.mcgill.calmedresearch/students-postdocs/graduate-funding/graduate mobility-award-2016-2017; http://www.santepop. qc.ca/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Ayala LSH, 2013, MATERN CHILD HLTH J, V17, P1112, DOI 10.1007/s10995-012-1113-9; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Casapia Martin, 2007, Int J Equity Health, V6, P6, DOI 10.1186/1475-9276-6-6; Crompton D, 2006, PREVENTATIVE CHEMOTH; Habibov NN, 2011, HEALTH ECON POLICY L, V6, P175, DOI 10.1017/S1744133110000174; Hawley NL, 2014, MATERN CHILD HLTH J, V18, P2284, DOI 10.1007/s10995-013-1368-9; Instituto Nacional de Estadistica E Informatica, 2013, POBL EST GRUP ED SEG; Instituto Nacional de Estadistica E Informatica, 2013, PER ENC DEM SAL FAM; Jewell RT, 2009, APPL ECON, V41, P10; Kasiulevicius V, 2006, GERONTOLOGIJA, V7, P6; Larocque R, 2005, AM J TROP MED HYG, V73, P783, DOI 10.4269/ajtmh.2005.73.783; Larocque R, 2006, TROP MED INT HEALTH, V11, P1485, DOI 10.1111/j.1365-3156.2006.01706.x; Larocque R, 2006, CAN J PUBLIC HEALTH, V97, P222, DOI 10.1007/BF03405590; Mishra SCK, 2014, NATL GUIDELINES DEWO; Munoz DC, 2015, COST EFFECT RESOUR A, V13, DOI 10.1186/s12962-015-0042-z; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Ryan JA, 2009, INT J GYNECOL OBSTET, V107, P162, DOI 10.1016/j.ijgo.2009.06.014; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Villar J, 2002, WHO ANTENATAL CARE R; WHO, 2005, 3 GLOB M PARTN PAR C	24	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171136	10.1371/journal.pone.0171136	http://dx.doi.org/10.1371/journal.pone.0171136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207749	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500016
J	Park, JY; Chung, TW; Jeong, YJ; Kwak, CH; Ha, SH; Kwon, KM; Abekura, F; Cho, SH; Lee, YC; Ha, KT; Magae, J; Chang, YC; Kim, CH				Park, Jun-Young; Chung, Tae-Wook; Jeong, Yun-Jeong; Kwak, Choong-Hwan; Ha, Sun-Hyung; Kwon, Kyung-Min; Abekura, Fukushi; Cho, Seung-Hak; Lee, Young-Choon; Ha, Ki-Tae; Magae, Junji; Chang, Young-Chae; Kim, Cheorl-Ho			Ascofuranone inhibits Iipopolysaccharide-induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-alpha, IL-6 and IL-1 beta in RAW 264.7 macrophages	PLOS ONE			English	Article							SIGNALING PATHWAY; NITRIC-OXIDE; MAPK ACTIVATION; DOWN-REGULATION; CELLS; SUPPRESSES; CYCLOOXYGENASE-2; EXPRESSION; INDUCTION; DIFFERENTIATION	The natural fungal compound ascofuranone (5-chloro-3-[(2E,6E)-7-[(2S)-5,5-dimethyl-4-oxo-tetrahydrofuran-2-yl]-3-methyl-octa-2,6-dienyl]-2,4-dihydroxy-6-methyl-benzaldehyde, MW 420.93) (AF) isolated from Ascochyta viciae has been known to promote cell cycle arrest and inhibit invasion of tumor cells. We have previously studied a structurally similar compound ascochlorin (ASC; MW 404.93) with regard to its anti-inflammatory activity in LPS-stimulated RAW 264.7 macrophages. In order to examine the relationship between the anti-inflammatory activities and the molecular differences between AF and ASC, the activity of AF is herein studied, because ASC has a unique trimethyl oxocyclohexyl structure, while AF has a unique dimethyl-oxo-tetrahydrofuran structure. AF dose-dependently inhibited the production of NO and iNOS and the COX-2 mRNA and protein levels in RAW 264.7 cells. In addition, AF suppressed mRNA expression levels of inflammatory cytokines such as TNF-alpha, IL-6, and IL-1 beta, as assessed by RT-PCR. AF (30-50 mu g/ml) treatment clearly inhibited the nuclear translocation of NF-kappa B, AP-1 (p-c-Jun) from the cytosolic space. Phosphorylation of I kappa B, which functions to maintain the activity of NF-kappa B, was decreased by AF treatment. Moreover, AF suppressed the binding of NF-kappa B (p65). Inhibition of I kappa Ba phosphorylation and degradation inhibits nuclear translocation of p65. Immunofluorescence con focal microscopy analysis also revealed that translocation of NF-kappa B and AP-1 (p-c-Jun) was decreased upon AF treatment. AF specifically decreased the expression level of p-ERK, but not the expression level of p-p38 or p-JNK. Given these results, we suggest that AF suppresses the inflammatory response by targeting p-ERK. This indicates that AF is a negative regulator of LPS-stimulated nuclear translocation of NF-kappa B and AP-1 (p-c-Jun) in RAW 264.7 macrophages, and specifically it targets p-ERK. Therefore, AF and ASC exert their effects in different ways, most probably because their structural differences allow for specific recognition and inhibition of their target MAPKs. Our results further suggest that AF could be a natural bioactive compound useful for treating inflammation -mediated pathological diseases.	[Park, Jun-Young; Kwak, Choong-Hwan; Ha, Sun-Hyung; Kwon, Kyung-Min; Abekura, Fukushi; Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Seoburo 2066, Suwon, Gyunggi Do, South Korea; [Chung, Tae-Wook; Ha, Ki-Tae] Pusan Natl Univ, Korean Med Res Ctr, Sch Korean Med & Hlth Aging, Yangsan, Gyeongsangnam D, South Korea; [Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu, South Korea; [Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu, South Korea; [Cho, Seung-Hak] Korea Natl Inst Hlth, Ctr Infect Dis Res, Div Enter Dis, Cheongju, South Korea; [Lee, Young-Choon] Dong A Univ, Fac Med Biotechnol, Busan, South Korea; [Magae, Junji] Magae Biosci Inst, 49-4 Fujimidai, Tsukuba, Ibaraki, Japan; [Kim, Cheorl-Ho] Sungkyunkwan Univ, SAIHST, Seoul, South Korea	Sungkyunkwan University (SKKU); Pusan National University; Catholic University of Daegu; Catholic University of Daegu; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Dong A University; Sungkyunkwan University (SKKU)	Kim, CH (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Seoburo 2066, Suwon, Gyunggi Do, South Korea.; Chang, YC (corresponding author), Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu, South Korea.; Chang, YC (corresponding author), Catholic Univ Daegu, Sch Med, Dept Med, Daegu, South Korea.; Kim, CH (corresponding author), Sungkyunkwan Univ, SAIHST, Seoul, South Korea.	ycchang@cu.ac.kr; chkimbio@skku.edu	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714; Park, Junyoung/0000-0003-3197-3908; Chung, Tae-Wook/0000-0001-5243-5020	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2014R1A2A1A 11050776]; Basic Science Research Program - Ministry of Education, Science and Technology (MEST) of Korea [NRF-2015R1D1A1A01057153]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2014R1A2A1A 11050776, NRF-2015R1D1A1A01057153]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Basic Science Research Program - Ministry of Education, Science and Technology (MEST) of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This study has in part been supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2014R1A2A1A 11050776 to Young-Chae Chang and the Basic Science Research Program funded by the Ministry of Education, Science and Technology (MEST) of Korea through NRF-2015R1D1A1A01057153 to Cheorl-Ho Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has in part supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2014R1A2A1A 11050776 to Young-Chae Chang and NRF-2015R1D1A1A01057153 to Cheorl-Ho Kim).	ab Yabu Y, PARASITOL INT, V52, P155; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Cho EJ, 2011, J CELL BIOCHEM, V112, P3648, DOI 10.1002/jcb.23294; Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217; Cho HJ, 2009, J CELL BIOCHEM, V107, P335, DOI 10.1002/jcb.22130; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Hsieh IN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-28; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035922; Jeong JH, 2010, MOL CANCER THER, V9, P2102, DOI 10.1158/1535-7163.MCT-09-1159; Jeong YJ, 2013, TOXICOL APPL PHARM, V273, P542, DOI 10.1016/j.taap.2013.09.027; Jin X, 2016, MOL MED REP; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim SJ, 2014, INT J BIOCHEM CELL B, V46, P32, DOI 10.1016/j.biocel.2013.09.015; Lee SH, 2016, J CELL BIOCHEM, V117, P978, DOI 10.1002/jcb.25383; Ma Y, 2016, INFLAMMATION; MAGAE J, 1986, CANCER RES, V46, P1073; MAGAE J, 1988, J ANTIBIOT, V41, P959, DOI 10.7164/antibiotics.41.959; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; MITCHELL JA, 1995, BIOCHEM PHARMACOL, V50, P1535, DOI 10.1016/0006-2952(95)00212-X; Morris KR, 2003, INFECT IMMUN, V71, P1442, DOI 10.1128/IAI.71.3.1442-1452.2003; Pourgholaminejad A, 2016, CYTOKINE, V85, P51, DOI 10.1016/j.cyto.2016.06.003; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Safdari Y, 2015, PHARMACOL RES, V93, P1, DOI 10.1016/j.phrs.2014.12.004; SASAKI H, 1973, J ANTIBIOT, V26, P676, DOI 10.7164/antibiotics.26.676; Suh SJ, 2007, ARCH BIOCHEM BIOPHYS, V467, P227, DOI 10.1016/j.abb.2007.08.025; Suh SJ, 2012, INFLAMMATION, V35, P736, DOI 10.1007/s10753-011-9369-6; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wang Z, 2016, ONCOL REP; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yu Q, 2016, INT IMMUNOPHARMACOL, V38, P104, DOI 10.1016/j.intimp.2016.05.010	32	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171322	10.1371/journal.pone.0171322	http://dx.doi.org/10.1371/journal.pone.0171322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207754	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500023
J	Wang, R; Edrington, TC; Storrs, SB; Crowley, KS; Ward, JM; Lee, TC; Liu, ZL; Li, B; Glenn, KC				Wang, Rong; Edrington, Thomas C.; Storrs, S. Bradley; Crowley, Kathleen S.; Ward, Jason M.; Lee, Thomas C.; Liu, Zi L.; Li, Bin; Glenn, Kevin C.			Analyzing pepsin degradation assay conditions used for allergenicity assessments to ensure that pepsin susceptible and pepsin resistant dietary proteins are distinguishable	PLOS ONE			English	Article							LIPID-TRANSFER PROTEINS; HORSERADISH-PEROXIDASE; FOOD ALLERGENS; WHEY PROTEINS; ACTIVE-SITE; STABILITY; DIGESTION; DIGESTIBILITY; PH	The susceptibility of a dietary protein to proteolytic degradation by digestive enzymes, such as gastric pepsin, provides information on the likelihood of systemic exposure to a structurally intact and biologically active macromolecule, thus informing on the safety of proteins for human and animal consumption. Therefore, the purpose of standardized in vitro degradation studies that are performed during protein safety assessments is to distinguish whether proteins of interest are susceptible or resistant to pepsin degradation via a study design that enables study-to-study comparison. Attempting to assess pepsin degradation under a wide range of possible physiological conditions poses a problem because of the lack of robust and consistent data collected under a large-range of sub-optimal conditions, which undermines the needs to harmonize in vitro degradation conditions. This report systematically compares the effects of pH, incubation time, and pepsin-to-substrate protein ratio on the relative degradation of five dietary proteins: three pepsin susceptible proteins [ribulose 1,5-bisphosphate carboxylase-oxygenase (Rubisco), horseradish peroxidase (HRP), hemoglobin (Hb)], and two pepsin resistant proteins [lipid transfer protein (LTP) and soybean trypsin inhibitor (STI)]. The results indicate that proteins susceptible to pepsin degradation are readily distinguishable from pepsin-resistant proteins when the reaction conditions are within the well-characterized optima for pepsin. The current standardized in vitro pepsin resistant assay with low pH and high pepsin-to-substrate ratio fits this purpose. Using non-optimal pH and/or pepsin-to-substrate protein ratios resulted in susceptible proteins no longer being reliably degraded by this stomach enzyme, which compromises the ability of this in vitro assay to distinguish between resistant and susceptible proteins and, therefore, no longer providing useful data to an overall weight-of-evidence approach to assessing safety of proteins.	[Wang, Rong; Edrington, Thomas C.; Storrs, S. Bradley; Crowley, Kathleen S.; Ward, Jason M.; Lee, Thomas C.; Liu, Zi L.; Li, Bin; Glenn, Kevin C.] Monsanto Co, St Louis, MO 63141 USA; [Crowley, Kathleen S.] Tioma Therapeut, St Louis, MO USA; [Ward, Jason M.] Royal Canin, St Charles, MO USA	Monsanto	Wang, R (corresponding author), Monsanto Co, St Louis, MO 63141 USA.	rong.wang@monsanto.com		Wang, Rong/0000-0002-7198-7784	Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, however Monsanto Company provided managerial guidance during the study and final approval to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; ANTONOV VK, 1974, FEBS LETT, V46, P29, DOI 10.1016/0014-5793(74)80327-3; Bannon G, 2003, ENVIRON HEALTH PERSP, V111, P1122; Bannon GA, 2004, CURR ALLERGY ASTHM R, V4, P43, DOI 10.1007/s11882-004-0042-0; Bogh KL, 2016, CRIT REV FOOD SCI, V56, P1545, DOI 10.1080/10408398.2013.779569; Campos LA, 2003, FEBS LETT, V538, P89, DOI 10.1016/S0014-5793(03)00152-2; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; Chen EP, 2008, PHARM RES, V25, P123, DOI 10.1007/s11095-007-9358-5; Codex Alimentarius, 2009, FOODS DER MOD BIOT; Eriksen EK, 2010, BRIT J NUTR, V104, P374, DOI 10.1017/S0007114510000577; FAO/WHO, 2001, EV ALL GEN MOD FOODS; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Foster ES, 2013, TOXICOLOGY, V309, P30, DOI 10.1016/j.tox.2013.04.011; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; GARDNER MLG, 1988, ANNU REV NUTR, V8, P329, DOI 10.1146/annurev.nu.08.070188.001553; Gu X, 2017, J AGR FOOD IN PRESS; Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041; Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KATZ DS, 1994, J MOL BIOL, V244, P541, DOI 10.1006/jmbi.1994.1751; Lang GH, 2015, FOOD CHEM, V168, P606, DOI 10.1016/j.foodchem.2014.07.089; LIN YZ, 1992, J BIOL CHEM, V267, P18413; Marcus Y, 2003, J BACTERIOL, V185, P1509, DOI 10.1128/JB.185.5.1509-1517.2003; McConnell EL, 2008, INT J PHARMACEUT, V364, P213, DOI 10.1016/j.ijpharm.2008.05.012; Mills ENC, 2013, EFSA J, P1; MINEKUS M, 1995, ATLA-ALTERN LAB ANIM, V23, P197; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Naegeli H, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4862; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ofori-Anti AO, 2008, REGUL TOXICOL PHARM, V52, P94, DOI 10.1016/j.yrtph.2008.06.006; PIPER DW, 1965, GUT, V6, P506, DOI 10.1136/gut.6.5.506; Roychaudhuri R, 2004, BBA-PROTEINS PROTEOM, V1699, P207, DOI 10.1016/j.bbapap.2004.02.014; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001; SCHMIDT DG, 1995, CLIN EXP ALLERGY, V25, P1007, DOI 10.1111/j.1365-2222.1995.tb00404.x; Smeller L, 2003, BIOCHEMISTRY-US, V42, P553, DOI 10.1021/bi026192n; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; TOMIMATSU Y, 1981, PLANT PHYSIOL, V68, P808, DOI 10.1104/pp.68.4.808; Untersmayr E, 2007, J ALLERGY CLIN IMMUN, V119, P711, DOI 10.1016/j.jaci.2006.10.039; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Yagami T, 2000, J ALLERGY CLIN IMMUN, V106, P752, DOI 10.1067/mai.2000.109171; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349	44	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171926	10.1371/journal.pone.0171926	http://dx.doi.org/10.1371/journal.pone.0171926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207780	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500060
J	Balandraud, N; Texier, G; Massy, E; Muis-Pistor, O; Martin, M; Auger, I; Guzian, MC; Guis, S; Pham, T; Roudier, J				Balandraud, Nathalie; Texier, Gaetan; Massy, Emmanuel; Muis-Pistor, Olivier; Martin, Marielle; Auger, Isabelle; Guzian, Marie-Caroline; Guis, Sandrine; Pham, Thao; Roudier, Jean			Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; T-CELL-ACTIVATION; PERIPHERAL-BLOOD; CLINICAL-TRIAL; DOUBLE-BLIND; METHOTREXATE; INHIBITION; LYMPHOMAS; BLOCKADE; RISK	Background Epstein-Barr Virus (EBV) is a widely disseminated lymphotropic herpes virus implicated in benign and malignant disorders. In transplant patients, immunosuppressive drugs (cyclosporine) diminish control of EBV replication, potentially leading to lymphoproliferative disorders (LPD). Rheumatoid arthritis (RA) patients have impaired control of EBV infection and have EBV load ten times higher than controls. As post transplant patients, patients with RA have increased risk of developing lymphomas. Immunosuppressive drugs used to treat RA (conventional disease modifying drugs cDMARDs or biologics bDMARDs) could enhance the risk of developing LPD in RA patients. We have previously shown that long term treatment with Methotrexate and/or TNF alpha antagonists does not increase EBV load in RA. Our objective was to monitor the Epstein-Barr Virus load in RA patients treated with Abatacept (CTLA4 Ig), a T cell coactivation inhibitor, and Tocilizumab, an anti IL6 receptor antibody. Methods EBV load in the peripheral blood mononuclear cells (PBMCs) of 55 patients under Abatacept (in 34% associated with Methotrexate) and 35 patients under Tocilizumab (in 37% associated with Methotrexate) was monitored for durations ranging from 6 months to 3 years by real time PCR. The influences of treatment duration and disease activity score 28 (DAS28) index on EBV load were analyzed. Results Abatacept did not significantly modify EBV load over time. Tocilizumab significantly diminished EBV load over time. No patient (of 90) developed EBV associated lymphoma. Conclusion Long term treatment with Abatacept or Tocilizumab does not increase EBV load in the PBMNCs of patients with RA.	[Balandraud, Nathalie; Massy, Emmanuel; Muis-Pistor, Olivier; Guzian, Marie-Caroline; Guis, Sandrine; Pham, Thao; Roudier, Jean] AP HM, IML, Rheumatol 1 2, 270 Blvd St Marguerite, Marseilles, France; [Balandraud, Nathalie; Martin, Marielle; Auger, Isabelle; Roudier, Jean] Aix Marseille Univ, INSERM UMRs 1097, 163 Ave Luminy, Aix En Provence, France; [Texier, Gaetan] Ctr Epidemiol & Sante Pbl Armees, CESPA, Marseilles, France; [Texier, Gaetan] Aix Marseille Univ, INSERM, SESSTIM, IRD, Marseilles, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Balandraud, N (corresponding author), AP HM, IML, Rheumatol 1 2, 270 Blvd St Marguerite, Marseilles, France.; Balandraud, N (corresponding author), Aix Marseille Univ, INSERM UMRs 1097, 163 Ave Luminy, Aix En Provence, France.	nathalie.balandraud@ap-hm.fr	roudier, jean/A-8654-2011; AUGER, ISABELLE/P-6294-2016; Balandraud, Nathalie/ABD-6012-2020; Pham, Thao/GYA-5092-2022	roudier, jean/0000-0001-5435-8567; AUGER, ISABELLE/0000-0002-1414-8095; Balandraud, Nathalie/0000-0002-3839-0185; 	Assistance Publique des Hopitaux de Marseille AP-HM (AORC); INSERM; ROCHE-CHUGAI	Assistance Publique des Hopitaux de Marseille AP-HM (AORC); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ROCHE-CHUGAI(Roche Holding)	This work has been supported by Assistance Publique des Hopitaux de Marseille AP-HM (AORC 2009), INSERM and ROCHE-CHUGAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1981, J CLIN INVEST, V67, P1134, DOI 10.1172/JCI110127; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baecklund E, 2004, CURR OPIN RHEUMATOL, V16, P254, DOI 10.1097/00002281-200405000-00014; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Baecklund E, 2006, ARTHRITIS RHEUM-US, V54, P3774, DOI 10.1002/art.22277; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; Balandraud N, 2007, ARTHRIT RHEUM-ARTHR, V57, P762, DOI 10.1002/art.22783; Baldanti F, 2000, J CLIN MICROBIOL, V38, P613, DOI 10.1128/JCM.38.2.613-619.2000; Bassil N, 2014, EXP CLIN TRANSPLANT, V12, P212, DOI 10.6002/ect.2013.0252; Emery P, 2003, EXPERT OPIN INV DRUG, V12, P673, DOI 10.1517/eoid.12.4.673.23757; Erre GL, 2015, VIRAL IMMUNOL, V28, P385, DOI 10.1089/vim.2015.0035; Fujieda M, 2016, MOD RHEUMATOL JPN RH, P1; Gartner B, 2010, J CLIN VIROL, V48, P82, DOI 10.1016/j.jcv.2010.03.016; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gridelli B, 2000, Transpl Int, V13 Suppl 1, pS399, DOI 10.1111/j.1432-2277.2000.tb02069.x; Harigai M, 2016, MOD RHEUMATOL, V26, P1; Hsu FJ, 2002, J IMMUNOTHER, V25, P455, DOI 10.1097/00002371-200211000-00002; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Lahaye C, 2016, RHEUMATOL OXF ENQL; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Mariette X, 2011, RHEUMATOLOGY, V50, P222, DOI 10.1093/rheumatology/keq368; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mourgues C, 2016, JOINT BONE SPINE, V83, P412, DOI 10.1016/j.jbspin.2015.07.009; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; Ogawa J, 2006, ANN RHEUM DIS, V65, P1667, DOI 10.1136/ard.2006.054197; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Ruf S, 2012, J CLIN VIROL, V53, P186, DOI 10.1016/j.jcv.2011.11.010; San Juan R., 2015, CLIN MICROBIOL INFEC, V2015, pe1; San-Juan R, 2014, CLIN MICROBIOL INFEC, V20, P109, DOI 10.1111/1469-0691.12534; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; SMOLEN JS, 1995, ARTHRITIS RHEUM, V38, P38, DOI 10.1002/art.1780380106; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; TOSATO G, 1984, J CLIN INVEST, V73, P1789, DOI 10.1172/JCI111388; Toussirot E, 2000, ANN RHEUM DIS, V59, P533, DOI 10.1136/ard.59.7.533; Weinblatt ME, 2013, J RHEUMATOL, V40, P787, DOI 10.3899/jrheum.120906; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J, 2004, STAT MED, V23, P879, DOI 10.1002/sim.1736	45	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171623	10.1371/journal.pone.0171623	http://dx.doi.org/10.1371/journal.pone.0171623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199343	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400036
J	Koo, ES; Kim, MS; Choi, YS; Park, KS; Jeong, YS				Koo, Eung Seo; Kim, Man Su; Choi, Yong Seon; Park, Kwon-Sam; Jeong, Yong Seok			Occurrence of novel GII. 17 and GII. 21 norovirus variants in the coastal environment of South Korea in 2015	PLOS ONE			English	Article							HERD-IMMUNITY; EVOLUTION; GASTROENTERITIS; RECOMBINATION; EMERGENCE; INFECTION; STRAINS; WATERS; DIVERSITY; ESCAPE	Human norovirus (HNoV), a positive-sense RNA virus, is the main causative agent of acute viral gastroenteritis. Multiple pandemic variants of the genogroup II genotype 4 (GII. 4) of NoV have attracted great attention from researchers worldwide. However, novel variants of GII. 17 have been overtaking those pandemic variants in some areas of East Asia. To investigate the environmental occurrence of GII in South Korea, we collected water samples from coastal streams and a neighboring waste water treatment plant in North Jeolla province (in March, July, and December of 2015). Based on capsid gene region C analysis, four different genotypes (GII. 4, GII. 13, GII. 17, and GII. 21) were detected, with much higher prevalence of GII. 17 than of GII. 4. Additional sequence analyses of the ORF1-ORF2 junction and ORF2 from the water samples revealed that the GII. 17 sequences in this study were closely related to the novel strains of GII. P17-GII. 17, the main causative variants of the 2014-2015 HNoV outbreak in China and Japan. In addition, the GII. P21-GII. 21 variants were identified in this study and they had new amino acid sequence variations in the blockade epitopes of the P2 domain. From these results, we present two important findings: 1) the novel GII. P17-GII. 17 variants appeared to be predominant in the study area, and 2) new GII. 21 variants have emerged in South Korea.	[Koo, Eung Seo; Kim, Man Su; Choi, Yong Seon; Jeong, Yong Seok] Kyung Hee Univ, Coll Sci, Dept Biol, Seoul, South Korea; [Park, Kwon-Sam] Kunsan Natl Univ, Dept Food Sci & Biotechnol, Gunsan, South Korea	Kyung Hee University; Kunsan National University	Jeong, YS (corresponding author), Kyung Hee Univ, Coll Sci, Dept Biol, Seoul, South Korea.	ysjeong@khu.ac.kr	Jeong, Yong Seok/AAK-4353-2020	Koo, Eung Seo/0000-0002-4413-3716; KIM, Man Su/0000-0002-3584-6589	Ministry of Korean Food and Drug Administration [14162-973]	Ministry of Korean Food and Drug Administration	The funds for water sampling of ESK were provided by the Ministry of Korean Food and Drug Administration, http://www.mfds.go.kr/index.do, Project Number 14162-973. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EURO SURVEILL; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Aw TG, 2009, APPL ENVIRON MICROB, V75, P4984, DOI 10.1128/AEM.00489-09; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Campos CJA, 2014, APPL ENVIRON MICROB, V80, P3552, DOI 10.1128/AEM.04188-13; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fout G, 2010, 1615 US EPA NAT EXP; Fu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21157; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Green K., 2013, FIELDS VIROLOGY, V1, P583; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Ham Hee-Jin, 2015, Journal of Bacteriology and Virology, V45, P376, DOI 10.4167/jbv.2015.45.4.376; Han JK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0370-9; Thanh HD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154284; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Kim MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163800; Kim M, 2010, VIRUS RES, V147, P1, DOI 10.1016/j.virusres.2009.08.013; Koo ES, 2012, J MICROBIOL, V50, P726, DOI 10.1007/s12275-012-2279-y; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lee SG, 2015, BMB REP, V48, P61, DOI 10.5483/BMBRep.2015.48.2.254; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Liu W, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005025; Lu J, 2015, EMERG INFECT DIS, V21, P1240, DOI 10.3201/eid2107.150226; Mans J, 2016, EPIDEMIOL INFECT, V144, P907, DOI 10.1017/S0950268815002150; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Nataraju SM, 2011, INT J MOL EPIDEMIOL, V2, P130; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Said MA, 2008, CLIN INFECT DIS, V47, P1202, DOI 10.1086/592299; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Ueki Y, 2005, WATER RES, V39, P4271, DOI 10.1016/j.watres.2005.06.035; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Won YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085063	49	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172237	10.1371/journal.pone.0172237	http://dx.doi.org/10.1371/journal.pone.0172237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199388	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400083
J	Naidoo, P; Dunbar, R; Caldwell, J; Lombard, C; Beyers, N				Naidoo, Pren; Dunbar, Rory; Caldwell, Judy; Lombard, Carl; Beyers, Nulda			Has universal screening with Xpert (R) MTB/RIF increased the proportion of multidrugresistant tuberculosis cases diagnosed in a routine operational setting?	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; SPUTUM SMEAR MICROSCOPY; PULMONARY TUBERCULOSIS; SOUTH-AFRICA; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; RISK-FACTORS; GENDER; SENSITIVITY; ALGORITHMS	Setting Primary health services in Cape Town, South Africa where the introduction of Xpert MTB/RIF (Xpert) enabled simultaneous screening for tuberculosis (TB) and drug susceptibility in all presumptive cases. Study aim To compare the proportion of TB cases with drug susceptibility tests undertaken and multi drug-resistant tuberculosis (MDR-TB) diagnosed pre-treatment and during the course of 1st line treatment in the previous smear/culture and the newly introduced Xpert-based algorithms. Methods TB cases identified in a previous stepped-wedge study of TB yield in five sub-districts over seven one-month time-points prior to, during and after the introduction of the Xpert-based algorithm were analysed. We used a combination of patient identifiers to identify all drug susceptibility tests undertaken from electronic laboratory records. Differences in the proportions of DST undertaken and MDR-TB cases diagnosed between algorithms were estimated using a binomial regression model. Results Pre-treatment, the probability of having a DST undertaken (RR = 1.82)(p<0.001) and being diagnosed with MDR-TB (RR =1.42)(p<0.001) was higher in the Xpert-based algorithm than in the smear/culture-based algorithm. For cases evaluated during the course of 1st-line TB treatment, there was no significant difference in the proportion with DST undertaken (RR = 1.02)(p = 0.848) or MDR-TB diagnosed (RR = 1.12)(p = 0.678) between algorithms. Conclusion Universal screening for drug susceptibility in all presumptive TB cases in the Xpert-based algorithm resulted in a higher overall proportion of MDR-TB cases being diagnosed and is an important strategy in reducing transmission. The previous strategy of only screening new TB cases when 1st line treatment failed did not compensate for cases missed pretreatment.	[Naidoo, Pren; Dunbar, Rory; Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Stellenbosch, South Africa; [Caldwell, Judy] City Hlth Directorate, Cape Town, South Africa; [Lombard, Carl] South African Med Res Council, Biostat Unit, Cape Town, South Africa	Stellenbosch University; South African Medical Research Council	Naidoo, P (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Stellenbosch, South Africa.	pnaidoo@icon.co.za		Lombard, Carl/0000-0002-2136-6533	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB)(United States Agency for International Development (USAID))	This research was partially supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Caulfield Adam J, 2016, J Clin Tuberc Other Mycobact Dis, V4, P33, DOI 10.1016/j.jctube.2016.05.005; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox HS, PLOS MED, V11; du Toit E, 2015, INT J TUBERC LUNG D, V19, P960, DOI 10.5588/ijtld.14.0703; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Furin JJ, 2000, EUR J CLIN MICROBIOL, V19, P132, DOI 10.1007/s100960050445; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hof Susan V, 2010, SYSTEMATIC REV ROLE; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Naidoo P, 2016, INT J TUBERC LUNG D, V20, P1377, DOI 10.5588/ijtld.16.0081; Naidoo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150487; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; National Institute for Communicable Diseases, 2016, S AFR TUB DRUG RES S; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Schnippel K, 2015, INT J INFECT DIS, V39, P89, DOI 10.1016/j.ijid.2015.09.002; Seddon JA, 2012, EMERG INFECT DIS, V18, P1342, DOI 10.3201/eid1808.111650; Smith A, 2016, INT J TUBERC LUNG D, V20, P350, DOI 10.5588/ijtld.15.0312; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, MTB RIF ASSAY PULMON; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2015, GLOB TUB REP 2015	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172143	10.1371/journal.pone.0172143	http://dx.doi.org/10.1371/journal.pone.0172143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199375	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400076
J	Nkuipou-Kenfack, E; Schanstra, JP; Bajwa, S; Pejchinovski, M; Vinel, C; Dray, C; Valet, P; Bascands, JL; Vlahou, A; Koeck, T; Borries, M; Busch, H; Bechtel-Walz, W; Huber, TB; Rudolph, KL; Pich, A; Mischak, H; Zurbig, P				Nkuipou-Kenfack, Esther; Schanstra, Joost P.; Bajwa, Seerat; Pejchinovski, Martin; Vinel, Claire; Dray, Cedric; Valet, Philippe; Bascands, Jean-Loup; Vlahou, Antonia; Koeck, Thomas; Borries, Melanie; Busch, Hauke; Bechtel-Walz, Wibke; Huber, Tobias B.; Rudolph, Karl L.; Pich, Andreas; Mischak, Harald; Zuerbig, Petra			The use of urinary proteomics in the assessment of suitability of mouse models for ageing	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; COLLAGEN; KIDNEY; SKIN; BIOMARKERS; CANCER; AGE	Ageing is a complex process characterised by a systemic and progressive deterioration of biological functions. As ageing is associated with an increased prevalence of age related chronic disorders, understanding its underlying molecular mechanisms can pave the way for therapeutic interventions and managing complications. Animal models such as mice are commonly used in ageing research as they have a shorter lifespan in comparison to humans and are also genetically close to humans. To assess the translatability of mouse ageing to human ageing, the urinary proteome in 89 wild-type (C57BL/6) mice aged between 8-96 weeks was investigated using capillary electrophoresis coupled to mass spectrometry (CE-MS). Using age as a continuous variable, 295 peptides significantly correlated with age in mice were identified. To investigate the relevance of using mouse models in human ageing studies, a comparison was performed with a previous correlation analysis using 1227 healthy subjects. In mice and humans, a decrease in urinary excretion of fibrillar collagens and an increase of uromodulin fragments was observed with advanced age. Of the 295 peptides correlating with age, 49 had a strong homology to the respective human age-related peptides. These ortholog peptides including several collagen (N = 44) and uromodulin (N = 5) fragments were used to generate an ageing classifier that was able to discriminate the age among both wild-type mice and healthy subjects. Additionally, the ageing classifier depicted that telomerase knock-out mice were older than their chronological age. Hence, with a focus on ortholog urinary peptides mouse ageing can be translated to human ageing.	[Nkuipou-Kenfack, Esther; Borries, Melanie; Zuerbig, Petra] Mosa Diagnost GmbH, Hannover, Germany; [Bajwa, Seerat; Valet, Philippe; Koeck, Thomas] Hannover Med Sch, Core Facil Prote, Hannover, Germany; [Pejchinovski, Martin; Bascands, Jean-Loup; Borries, Melanie] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Vinel, Claire; Koeck, Thomas; Huber, Tobias B.; Rudolph, Karl L.] Univ Toulouse III Paul Sabatier, Toulouse, France; [Schanstra, Joost P.; Vinel, Claire; Bascands, Jean-Loup; Koeck, Thomas] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Bajwa, Seerat; Bechtel-Walz, Wibke; Pich, Andreas] Plateforme CYROI, Diabet Atherothrombose Thrapies Re Union Oce Indi, Inserm UMR, St Clotilde, Reunion, France; [Pejchinovski, Martin; Valet, Philippe] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Bajwa, Seerat; Bascands, Jean-Loup; Bechtel-Walz, Wibke; Mischak, Harald] Albert Ludwigs Univ, Inst Mol Med & Cell Res, Cellular Microenvironment Grp, Syst Biol, Freiburg Im Breisgau, Germany; [Vinel, Claire; Vlahou, Antonia; Bechtel-Walz, Wibke; Rudolph, Karl L.] Freiburg & German Canc Res Ctr DKFZ, German Canc Consortium DKTK, Heidelberg, Germany; [Bajwa, Seerat; Bechtel-Walz, Wibke; Pich, Andreas] Univ Hosp Freiburg, Freiburg, Germany; [Bajwa, Seerat; Bascands, Jean-Loup; Borries, Melanie; Busch, Hauke] Univ Freiburg, Dept Med 4, Med Ctr, Fac Med, Freiburg, Germany; [Bajwa, Seerat; Borries, Melanie; Rudolph, Karl L.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Bajwa, Seerat; Valet, Philippe; Koeck, Thomas; Bechtel-Walz, Wibke] Albert Ludwigs Univ Freiburg, Ctr Syst Biol ZBSA, Freiburg, Germany; [Dray, Cedric; Koeck, Thomas; Bechtel-Walz, Wibke] Albert Ludwigs Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany; [Schanstra, Joost P.; Vinel, Claire; Borries, Melanie; Rudolph, Karl L.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Modular Open Systems Approach (MOSA) Solutions; Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Institut National de la Sante et de la Recherche Medicale (Inserm); Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Glasgow	Zurbig, P (corresponding author), Mosa Diagnost GmbH, Hannover, Germany.	zuerbig@mosaiques-diagnostics.com	Busch, Hauke/R-6452-2016; Schanstra, Joost P/X-7724-2018; Valet, Philippe/N-7472-2017; dray, cedric/N-7440-2017	Busch, Hauke/0000-0003-4763-4521; Schanstra, Joost P/0000-0002-7471-372X; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X; Bascands, Jean-loup/0000-0002-1667-5913; Bechtel-Walz, Wibke/0000-0001-6032-3627; Vinel, Claire/0000-0003-3329-321X; Zurbig, Petra/0000-0003-3465-2173; Mischak, Harald/0000-0003-0323-0306; Vlahou, Antonia/0000-0003-3284-5713; Huber, Tobias B./0000-0001-7175-5062	FP7-PEOPLE-ITN program [GA 31354]; BMBF Gerontosys II project (NephAge) [031 5896A]; Marie Curie EU grant [293568]; Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg); Mathilde-Wagner-Habilitationspreis; German Research Foundation (DFG) [CRC 992]; Heisenberg program; European Research Council-ERC grant [616891]; BMBF-STOP-FSGS [01GM1518C]; Excellence Initiative of the German Federal and State Governments [EXC294, BIOSS II]	FP7-PEOPLE-ITN program; BMBF Gerontosys II project (NephAge)(Federal Ministry of Education & Research (BMBF)); Marie Curie EU grant(European Commission); Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg); Mathilde-Wagner-Habilitationspreis; German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program(German Research Foundation (DFG)); European Research Council-ERC grant(European Research Council (ERC)); BMBF-STOP-FSGS; Excellence Initiative of the German Federal and State Governments	The project was partly funded by grant GA 31354 (CodeAge) FP7-PEOPLE-2011-ITN program (to HM and ENK), BMBF Gerontosys II project (NephAge, 031 5896A) (to PZ, MB, WBW and TBH), by a Marie Curie EU grant (CIG 293568) (to WBW), by the Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg) (to WBW), by the Mathilde-Wagner-Habilitationspreis (to WBW), by the German Research Foundation (DFG): CRC 992 (to TBH) and Heisenberg program (to TBH), by the European Research Council-ERC grant 616891 (to TBH); by the BMBF-STOP-FSGS 01GM1518C (to TBH), and by the Excellence Initiative of the German Federal and State Governments (EXC294, BIOSS II to TBH). The funders provided support in the form of salaries for authors [ENK, SB, MP, TK, MB, WBW, TBH, KLR, HM and PZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arab S, 2006, J AM COLL CARDIOL, V48, P1733, DOI 10.1016/j.jacc.2006.06.063; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Burkhardt AM, 2013, CELL MOL IMMUNOL, V10, P373, DOI 10.1038/cmi.2013.19; Dissard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076703; Ganceviciene R, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22804; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Gu YM, 2014, NEPHROL DIAL TRANSPL; HAMLIN CR, 1972, EXP GERONTOL, V7, P377, DOI 10.1016/0531-5565(72)90061-7; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Klein J, 2016, URINARY PEPTIDOMICS; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Nkuipou-Kenfack E, 2015, ONCOTARGET; Nkuipou-Kenfack E, 2014, AGEING RES REV, V18, P74, DOI 10.1016/j.arr.2014.09.002; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; R Core Team, 2018, R LANG ENV STAT COMP; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rodriguez-Feo JA, 2005, CURR PHARM DESIGN, V11, P2501, DOI 10.2174/1381612054367544; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schanstra JP, 2015, J AM SOC NEPHROL; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Stevenson K, 2006, MOL CELL BIOCHEM, V283, P107, DOI 10.1007/s11010-006-2388-1; Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2009, PROTEOMICS, V9, P2108, DOI 10.1002/pmic.200800560	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0166875	10.1371/journal.pone.0166875	http://dx.doi.org/10.1371/journal.pone.0166875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199320	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000394424400002
J	Chewchuk, S; Guo, BQ; Parissenti, AM				Chewchuk, Simon; Guo, Baoqing; Parissenti, Amadeo Mark			Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells	PLOS ONE			English	Article							ALDO-KETO REDUCTASES; CANCER-CELLS; ENDOCRINE THERAPY; RECEPTOR-ALPHA; MCF-7 CELLS; NEOADJUVANT CHEMOTHERAPY; DOXORUBICIN RESISTANCE; DRUG-RESISTANCE; GROWTH-FACTORS; ER-ALPHA	Intrinsic or acquired drug resistance is a major impediment to the successful treatment of women with breast cancer using chemotherapy. We have observed that MCF-7 breast tumor cells selected for resistance to doxorubicin or epirubicin (MCF-7(DOX2) and MCF-(7EPI) cells, respectively) exhibited increased expression of several members of the aldo-keto reductase (AKR) gene family (in particular AKR1C3 and AKR1B10) relative to control MCF-7(CC) cells selected by propagation in the absence of drug. Normal cellular roles for the AKRs include the promotion of estrogen (E2) synthesis from estrone (E1) and the hydroxylation and detoxification of exogenous xenobiotics such as anthracycline chemotherapy drugs. While hydroxylation of anthracyclines strongly attenuates their cytotoxicity, it is unclear whether the enhanced AKR expression in the above anthracycline-resistant cells promotes E2 synthesis and/or alterations in E2 signalling pathways and whether such changes contribute to enhanced survival and anthracycline resistance. To determine the role of AKRs and E2 pathways in doxorubicin resistance, we examined changes in the expression of E2 related genes and proteins upon acquisition of doxorubicin resistance. We also assessed the effects of AKR overexpression or downregulation or the effects of activators or inhibitors of E2-dependent pathways on previously acquired resistance to doxorubicin. In this study we observed that the enhanced AKR expression upon acquisition of anthracycline resistance was, in fact, associated with enhanced E2 production. However, the expression of estrogen receptor alpha (ER alpha) was reduced by 2- to 5-fold at the gene transcript level and 2-to 20-fold at the protein level upon acquisition of anthracycline resistance. This was accompanied by an even stronger reduction in ERa phosphorylation and activity, including highly suppressed expression of two proteins under E2-dependent control (Bcl-2 and cyclin D1). The diminished Bcl-2 and cyclin D1 expression would be expected to reduce the growth rate of the cells, a hypothesis which was confirmed in subsequent cell proliferation experiments. AKR1C3 or AKR1B10overexpression alone had no effect on doxorubicin sensitivity in MCF-7(CC) cells, while siRNA-mediated knockdown of AKR1C3 and/or AKR1B10 expression had no significant effect on sensitivity to doxorubicin in MCF-7(DOX2) or MCF-7(EPI) cells. This suggested that enhanced or reduced AKR expression/activity is insufficient to conferanthracycline resistance or sensitivity to breast tumor cells, respectively. Rather, it would appear that AKR overexpression acts in concert with other proteins to confer anthracycline resistance, including reduced E2-dependent expression of both an important apoptosis inhibitor (Bcl-2) and a key protein associated with activation of cell cycle-dependent kinases (cyclin D1).	[Chewchuk, Simon; Parissenti, Amadeo Mark] Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada; [Guo, Baoqing; Parissenti, Amadeo Mark] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Parissenti, Amadeo Mark] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [Parissenti, Amadeo Mark] Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada	Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Northern Ontario School of Medicine; University of Ottawa	Guo, BQ (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.	aparissenti@amric.ca			Canadian Institutes of Health Research [MOP-89993]; Northern Cancer Foundation of Sudbury	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern Cancer Foundation of Sudbury	This study was supported, in part, by a grant from the Canadian Institutes of Health Research (MOP-89993). Core funding to support this work is also acknowledged from the Northern Cancer Foundation of Sudbury.	Almeida M, 2006, ENDOCRINOLOGY, V147, P1986, DOI 10.1210/en.2005-1314; Arendt LM, 2015, J MAMMARY GLAND BIOL, V20, P9, DOI 10.1007/s10911-015-9337-0; Barnadas A, 2008, ANTI-CANCER DRUG, V19, P339, DOI 10.1097/CAD.0b013e3282f97f75; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Bartlett JMS, 2011, J CLIN ONCOL, V29, P1531, DOI 10.1200/JCO.2010.30.3677; BONNEY RC, 1983, CLIN ENDOCRINOL, V19, P727, DOI 10.1111/j.1365-2265.1983.tb00051.x; Burow ME, 2001, J STEROID BIOCHEM, V78, P409, DOI 10.1016/S0960-0760(01)00117-0; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Chantzi MI, 2013, J CANCER RES CLIN, V139, P1489, DOI 10.1007/s00432-013-1467-4; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; DARBRE P, 1983, CANCER RES, V43, P349; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Gaui MDD, 2007, AM J CLIN ONCOL-CANC, V30, P78, DOI 10.1097/01.coc.0000245475.41324.6d; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Guo LY, 2015, EXP THER MED, V9, P2147, DOI 10.3892/etm.2015.2380; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Heibein AD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-381; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; Hembruff SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-318; Herold CI, 2008, CLIN BREAST CANCER, V8, P50, DOI 10.3816/CBC.2008.n.003; Hirata T, 2009, BRIT J CANCER, V101, P1529, DOI 10.1038/sj.bjc.6605360; Hofman J, 2014, TOXICOL APPL PHARM, V278, P238, DOI 10.1016/j.taap.2014.04.027; Ishizuna Kazuo, 2013, BMC Res Notes, V6, P254, DOI 10.1186/1756-0500-6-254; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; KOMIYAMA T, 1983, BIOCHIM BIOPHYS ACTA, V740, P80, DOI 10.1016/0167-4781(83)90124-0; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Leung LK, 1999, BRIT J CANCER, V81, P387, DOI 10.1038/sj.bjc.6690706; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li YW, 2011, J CELL BIOCHEM, V112, P217, DOI 10.1002/jcb.22922; Matsunaga T, 2014, ANTI-CANCER DRUG, V25, P868, DOI 10.1097/CAD.0000000000000112; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; O'Driscoll L, 2006, CHEMOTHERAPY, V52, P125, DOI 10.1159/000092540; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pennery E, 2008, EUR J ONCOL NURS, V12, P233, DOI 10.1016/j.ejon.2008.01.007; Penning TM, 2001, MOL CELL ENDOCRINOL, V171, P137, DOI 10.1016/S0303-7207(00)00426-3; POMMERENKE E, 1994, J CANCER RES CLIN, V120, P422, DOI 10.1007/BF01240142; Ram PT, 1998, MOL CELL ENDOCRINOL, V141, P53, DOI 10.1016/S0303-7207(98)00095-1; Rastogi P, 2013, AM SOC CLIN ONCOL ED, V33, P73; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rizner TL, 2006, MOL CELL ENDOCRINOL, V248, P126, DOI 10.1016/j.mce.2005.10.009; Rochefort H, 1995, CIBA F SYMP, V191, P254; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Sasano H, 2008, J STEROID BIOCHEM, V108, P181, DOI 10.1016/j.jsbmb.2007.09.012; Savatier J, 2012, LEUKEMIA RES, V36, P791, DOI 10.1016/j.leukres.2012.02.017; Schiavon G, 2013, HEMATOL ONCOL CLIN N, V27, P715, DOI 10.1016/j.hoc.2013.05.004; Shields-Botella J, 2005, J STEROID BIOCHEM, V93, P1, DOI 10.1016/j.jsbmb.2004.11.004; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Sundar SN, 2008, CARCINOGENESIS, V29, P2252, DOI 10.1093/carcin/bgn214; Tanos T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3166; Toldo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058421; Turner N, 2015, LANCET ONCOL, V16, pE362, DOI 10.1016/S1470-2045(15)00079-0; Veitch ZW, 2009, PHARMACOGENET GENOM, V19, P477, DOI 10.1097/FPC.0b013e32832c484b; Vihko P, 2001, MOL CELL ENDOCRINOL, V171, P71, DOI 10.1016/S0303-7207(00)00389-0; WILSON RG, 1981, CHEM-BIOL INTERACT, V37, P351, DOI 10.1016/0009-2797(81)90120-4; Zhong T, 2015, BIOMED PHARMACOTHER, V69, P317, DOI 10.1016/j.biopha.2014.12.022	61	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172244	10.1371/journal.pone.0172244	http://dx.doi.org/10.1371/journal.pone.0172244			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196134	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900064
J	Moran-Ramos, S; He, X; Chin, EL; Tovar, AR; Torres, N; Slupsky, CM; Raybould, HE				Moran-Ramos, Sofia; He, Xuan; Chin, Elizabeth L.; Tovar, Armando R.; Torres, Nimbe; Slupsky, Carolyn M.; Raybould, Helen E.			Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OPUNTIA-FICUS-INDICA; GUT MICROBIOTA; OXIDATIVE STRESS; BETAINE; LIVER; MICE; MECHANISM; INSULIN; GLUCOSE	Nopal is a cactus plant widely consumed in Mexico that has been used in traditional medicine to aid in the treatment of type-2 diabetes. We previously showed that chronic consumption of dehydrated nopal ameliorated hepatic steatosis in obese (fa/fa) rats; however, description of the effects on other tissues is sparse. The aim of the present study was to investigate the effects of nopal cladode consumption on intestinal physiology, microbial community structure, adipose tissue, and serum biochemistry in diet-induced obese rats. Rats were fed either a normal fat (NF) diet or a HF diet containing 4% of dietary fiber from either nopal or cellulose for 6 weeks. Consumption of nopal counteracted HF-induced adiposity and adipocyte hypertrophy, and induced profound changes in intestinal physiology. Nopal consumption reduced biomarkers of intestinal inflammation (mRNA expression of IL-6) and oxidative stress (ROS), modfied gut microbiota composition, increasing microbial diversity and cecal fermentation (SCFA), and altered the serum metabolome. Interestingly, metabolomic analysis of dehydrated nopal revealed a high choline content, which appeared to generate high levels of serum betaine, that correlated negatively with hepatic triglyceride (TAG) levels. A parallel decrease in some of the taxa associated with the production of trimethylamine, suggest an increase in choline absorption and bioavailability with transformation to betaine. The latter may partially explain the previously observed effect of nopal on the development of hepatic steatosis. In conclusion, this study provides new evidence on the effects of nopal consumption on normal and HF-diet induced changes in the intestine, the liver and systemic metabolism.	[Moran-Ramos, Sofia; Tovar, Armando R.; Torres, Nimbe] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico; [Moran-Ramos, Sofia] Inst Nacl Med Genom, Unidad Genom Poblac, Conacyt, Mexico City, DF, Mexico; [He, Xuan; Chin, Elizabeth L.; Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, One Shields Ave, Davis, CA 95616 USA; [He, Xuan; Slupsky, Carolyn M.] Univ Calif Davis, Dept Nutr, One Shields Ave, Davis, CA 95616 USA; [Raybould, Helen E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, One Shields Ave, Davis, CA 95616 USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Medicina Genomica; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Raybould, HE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, One Shields Ave, Davis, CA 95616 USA.	heraybould@ucdavis.edu	Torres, Nimbe/AAY-8821-2020; Moran, Sofia/AAK-8815-2021; Torres, Nimbe/AAI-4340-2020	Torres, Nimbe/0000-0002-1741-0984; Chin, Elizabeth/0000-0003-1395-1836	National Institute of Health [DK41004]; USDA National Institute of Food and Agriculture Hatch Project [1005945]; Conacyt Scholarship Mexico	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture Hatch Project; Conacyt Scholarship Mexico	This work was supported by the National Institute of Health DK41004 (HR); USDA National Institute of Food and Agriculture Hatch Project 1005945 (CS); Conacyt Scholarship Mexico (S M-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Aguilar FJ, 2003, P W PHARMACOL SOC, V46, P139; Bielohuby M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1059, DOI 10.1152/ajpendo.00208.2013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen HC, 2002, J LIPID RES, V43, P986; Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Erdelyi I, 2009, J NUTR, V139, P2072, DOI 10.3945/jn.108.104125; Feugang JM, 2006, FRONT BIOSCI-LANDMRK, V11, P2574, DOI 10.2741/1992; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRATIMUNARI AC, 1983, ARCH INVEST MED, V14, P117; FRATIMUNARI AC, 1983, ARCH INVEST MED, V14, P269; Guevara-Cruz M, 2012, J NUTR, V142, P64, DOI 10.3945/jn.111.147447; He X, 2014, J PROTEOME RES, V13, P5281, DOI 10.1021/pr500629t; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kim A, 2015, J CLIN GASTROENTEROL, V49, pS20, DOI 10.1097/MCG.0000000000000356; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Luo CA, 2010, CHEM BIODIVERS, V7, P2869, DOI 10.1002/cbdv.201000077; Matsuzawa Toshiaki, 1997, Journal of Toxicological Sciences, V22, P25; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Neyrinck AM, 2009, INT IMMUNOPHARMACOL, V9, P767, DOI 10.1016/j.intimp.2009.02.015; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806; Orozco-Ibarra M, 2007, TOXICOLOGY, V229, P123, DOI 10.1016/j.tox.2006.10.008; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao Y, 2013, APPL MICROBIOL BIOT, V97, P1689, DOI 10.1007/s00253-012-4323-6; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Torres N, 2015, ARCH MED RES, V46, P408, DOI 10.1016/j.arcmed.2015.05.010; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Wang LJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-34; Wang ZG, 2010, AM J PHYSIOL-GASTR L, V298, pG634, DOI 10.1152/ajpgi.00249.2009; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	60	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171672	10.1371/journal.pone.0171672	http://dx.doi.org/10.1371/journal.pone.0171672			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196086	Green Published, gold			2022-12-27	WOS:000394423900028
J	Tanaka, KR; Belknap, SL; Homola, JJ; Chen, Y				Tanaka, Kisei R.; Belknap, Samuel L.; Homola, Jared J.; Chen, Yong			A statistical model for monitoring shell disease in inshore lobster fisheries: A case study in Long Island Sound	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SQUID OMMASTREPHES-BARTRAMII; WINTER-SPRING COHORT; SOUTHERN NEW-ENGLAND; AMERICAN LOBSTER; HOMARUS-AMERICANUS; SPATIOTEMPORAL VARIABILITY; SPATIAL-DISTRIBUTION; SPECIES ABUNDANCE; COASTAL WATERS	The expansion of shell disease is an emerging threat to the inshore lobster fisheries in the northeastern United States. The development of models to improve the efficiency and precision of existing monitoring programs is advocated as an important step in mitigating its harmful effects. The objective of this study is to construct a statistical model that could enhance the existing monitoring effort through (1) identification of potential disease-associated abiotic and biotic factors, and (2) estimation of spatial variation in disease prevalence in the lobster fishery. A delta-generalized additive modeling (GAM) approach was applied using bottom trawl survey data collected from 2001 - 2013 in Long Island Sound, a tidal estuary between New York and Connecticut states. Spatial distribution of shell disease prevalence was found to be strongly influenced by the interactive effects of latitude and longitude, possibly indicative of a geographic origin of shell disease. Bottom temperature, bottom salinity, and depth were also important factors affecting the spatial variability in shell disease prevalence. The delta-GAM projected high disease prevalence in non-surveyed locations. Additionally, a potential spatial discrepancy was found between modeled disease hotspots and survey-based gravity centers of disease prevalence. This study provides a modeling framework to enhance research, monitoring and management of emerging and continuing marine disease threats.	[Tanaka, Kisei R.; Chen, Yong] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Tanaka, Kisei R.; Belknap, Samuel L.; Homola, Jared J.; Chen, Yong] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Belknap, Samuel L.] Univ Maine, Dept Anthropol, Orono, ME USA; [Homola, Jared J.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Tanaka, KR (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.; Tanaka, KR (corresponding author), Univ Maine, Climate Change Inst, Orono, ME 04469 USA.	kisei.tanaka@maine.edu		Tanaka, Kisei/0000-0002-1901-6972	National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program [1144423]; National Science Foundation Coastal Science, Engineering and Education for Sustainability program [1325369]; Maine Sea Grant College Program	National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program; National Science Foundation Coastal Science, Engineering and Education for Sustainability program; Maine Sea Grant College Program	Financial support for this study was provided by National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program (grant number 1144423, URL http://www.igert.org/projects/297), National Science Foundation Coastal Science, Engineering and Education for Sustainability program (grant number 1325369, URL http://www.nsf.gov/awardsearch/showAward?AWD_ID=1325369, and Maine Sea Grant College Program.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2010, MAPPING SPECIES DIST; Atlantic States Marine Fisheries Commision (ASMFC), 2012, ADD 17 SO NEW ENGL M; Atlantic States Marine Fisheries Commission American Lobster Stock Assessment Review Panel, 2015, AM LOBST STOCK ASS R; Atlantic States Marine Fisheries Commission American Lobster Stock Assessment Subcommittee, 2009, 0901 ATL STAT MAR FI, V1; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Benson J, 2013, THE DAY; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Cao J, 2009, MAR ECOL PROG SER, V381, P119, DOI 10.3354/meps07969; Castro K., 2005, AQUATIC FORUM SERIES; Castro KM, 2006, J CRUSTACEAN BIOL, V26, P646, DOI 10.1651/S-2761a.1; Castro KM, 2012, J SHELLFISH RES, V31, P423, DOI 10.2983/035.031.0202; Chang J-H, 2010, SPATIAL TEMPORAL COH, P2010; Chang JH, 2010, MAR ECOL PROG SER, V420, P145, DOI 10.3354/meps08849; Chen C., 2006, OCEANOGRAPHY, V19, P78, DOI [DOI 10.5670/OCEANOG.2006.92, 10.5670/oceanog.2006.92]; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Cobb J. S., 2006, SHELL DIS LOBSTERS S; Connecticut Department of Energy and Environmental Protection, 2013, STUD MAR RECR FISH C; Crossin GT, 1998, J EXP BIOL, V201, P365; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Glenn RP, 2006, J CRUSTACEAN BIOL, V26, P639, DOI 10.1651/S-2754.1; Gottschall K, 2013, STUDY MARINE RECREAT; Gottschall K, 2013, LONG ISLAND SOUND TR; Groner ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0364; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Harding GC, 1992, AM LOBSTER HOMARUS A, P49; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hess E., 1937, Journal of the Biological Board of Canada, V3, P358; Horodysky AZ, 2015, REV FISH BIOL FISHER, V25, P425, DOI 10.1007/s11160-015-9393-y; Howell P, 2012, J SHELLFISH RES, V31, P573, DOI 10.2983/035.031.0217; Jacobs M, 2012, J SHELLFISH RES, V31, P563, DOI 10.2983/035.031.0216; Jensen OP, 2005, MAR ECOL PROG SER, V299, P239, DOI 10.3354/meps299239; JURY SH, 1994, J EXP MAR BIOL ECOL, V180, P23, DOI 10.1016/0022-0981(94)90076-0; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lacurci J, 2014, NATURE WORLD NE 0908; Landers D.F, 2005, AQUATIC FORUM SERIES, P94; Laufer H, 2013, CAN J FISH AQUAT SCI, V70, P1588, DOI 10.1139/cjfas-2013-0148; Laufer H, 2012, J SHELLFISH RES, V31, P555, DOI 10.2983/035.031.0215; Lee YJ, 2008, ESTUAR COAST SHELF S, V76, P187, DOI 10.1016/j.ecss.2007.07.001; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li B, 2015, N AM J FISH MANAGE, V35, P942, DOI 10.1080/02755947.2015.1074961; Loots C, 2010, ICES J MAR SCI, V67, P244, DOI 10.1093/icesjms/fsp238; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maynard J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0208; McCreesh Nicky, 2015, Parasites & Vectors, V8, P4, DOI 10.1186/s13071-014-0617-0; Mercaldo- Allen R., 1994, NMFSNE105 NOAA; Meres NJ, 2012, J SHELLFISH RES, V31, P463, DOI 10.2983/035.031.0206; National Marine Fisheries Service (NMFS), ANN COMM LAND STAT; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pedersen Ulrik B., 2014, Geospatial Health, V8, P335; Poppe LJ, 2000, 00304 US GEOL SURV; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; RICHARDS LJ, 1986, CAN J FISH AQUAT SCI, V43, P1214, DOI 10.1139/f86-151; Robohm RA, 2005, J SHELLFISH RES, V24, P773; Rooper CN, 2016, MAR ECOL PROG SER, V551, P117, DOI 10.3354/meps11703; Rooper CN, 2014, MAR ECOL PROG SER, V503, P157, DOI 10.3354/meps10710; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Shelton AO, 2014, CAN J FISH AQUAT SCI, V71, P1655, DOI 10.1139/cjfas-2013-0508; Shields JD, 2013, CAN J FISH AQUAT SCI, V70, P1576, DOI 10.1139/cjfas-2013-0050; Sissenwine M.P., 1978, INTERNATIONAL COMMISSION FOR THE NORTHWEST ATLANTIC FISHERIES RESEARCH BULLETIN, P81; SMOLOWITZ RM, 1992, BIOL BULL, V183, P99, DOI 10.2307/1542411; Stevens BG, 2009, DIS AQUAT ORGAN, V78, P249; Tanaka K, 2016, FISH RES, V177, P137, DOI 10.1016/j.fishres.2016.01.010; Tanaka K, 2015, J SHELLFISH RES, V34, P531, DOI 10.2983/035.034.0238; Tlusty MF, 2007, J AQUAT ANIM HEALTH, V19, P215, DOI 10.1577/H06-014.1; Tlusty MF, 2008, DIS AQUAT ORGAN, V78, P249, DOI 10.3354/dao01867; Tlusty MF, 2012, J SHELLFISH RES, V31, P533, DOI 10.2983/035.031.0213; Truesdell S., 2013, MODELING JUVENILE AT; Tseng CT, 2011, ICES J MAR SCI, V68, P1105, DOI 10.1093/icesjms/fsr070; Winton MV, 2014, CAN J FISH AQUAT SCI, V71, P1279, DOI 10.1139/cjfas-2013-0617; Wood S., 2011, GAMS R GEN ADDITIVE; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Yasuda T, 2014, MAR ECOL PROG SER, V501, P239, DOI 10.3354/meps10679; Zhang H, 2015, J APPL ICHTHYOL, V31, P646, DOI 10.1111/jai.12765; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1; [No title captured]	81	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172123	10.1371/journal.pone.0172123	http://dx.doi.org/10.1371/journal.pone.0172123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196150	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900052
J	Zielke, C; Kosik, O; Ainalem, ML; Lovegrove, A; Stradner, A; Nilsson, L				Zielke, Claudia; Kosik, Ondrej; Ainalem, Marie-Louise; Lovegrove, Alison; Stradner, Anna; Nilsson, Lars			Characterization of cereal beta-glucan extracts from oat and barley and quantification of proteinaceous matter	PLOS ONE			English	Article							FIELD-FLOW FRACTIONATION; MOLECULAR-WEIGHT; PHYSICOCHEMICAL PROPERTIES; PHYSICAL-PROPERTIES; SOLUTION BEHAVIOR; MOLAR-MASS; PART I.; WATER; MACROMOLECULES; SOLUBILITY	An extraction method for mixed-linkage beta-glucan from oat and barley was developed in order to minimize the effect of extraction on the beta-glucan structure. beta-Glucan were characterized in terms of molecular size and molar mass distributions using asymmetric flow field flow fractionation (AF4) coupled to multiangle light scattering (MALS), differential refractive index (dRI) and fluorescence (FL) detection. The carbohydrate composition of the extracts was analysed using polysaccharide analysis by carbohydrate gel electrophoresis (PACE) and high-performance anion-exchange chromatography (HPAEC). Whether there were any proteinaceous moieties linked to beta-glucan was also examined. Purified extracts contained 65% and 53% 6-glucan for oats and barley, respectively. The main impurities were degradation products of starch. The extracts contained high molecular weight beta-glucan (10(5)-10(8) g/ mol) and large sizes (root-mean-square radii from 20 to 140 nm). No proteins covalently bound to beta-glucan were detected; therefore, any suggested functionality of proteins regarding the health benefits of beta-glucan can be discounted.	[Zielke, Claudia; Nilsson, Lars] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Kosik, Ondrej; Lovegrove, Alison] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Ainalem, Marie-Louise] European Spallat Source ESS AB, Lund, Sweden; [Stradner, Anna] Lund Univ, Dept Phys Chem, Lund, Sweden	Lund University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; European Spallation Source (ESS); Lund University	Zielke, C (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden.	claudia.zielke@food.lth.se	Zielke, Claudia/I-5864-2019; Kosik, Ondrej/AAR-1206-2021; Stradner, Anna/B-5195-2015	Kosik, Ondrej/0000-0003-3117-0224; Stradner, Anna/0000-0003-3310-3412; Zielke, Claudia/0000-0003-4654-4903	Swedish research council (VR), Stockholm, Sweden; Biotechnology and Biological Sciences Research Council of the United Kingdom; European Spallation Source ESS AB; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005206] Funding Source: researchfish; BBSRC [BBS/E/C/000I0250, BB/J019380/1, BBS/E/C/00005206, BB/I00582X/1] Funding Source: UKRI	Swedish research council (VR), Stockholm, Sweden(Swedish Research Council); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Spallation Source ESS AB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support was provided by the Swedish research council (VR), Stockholm, Sweden and from the Biotechnology and Biological Sciences Research Council of the United Kingdom. The sponsors had no influence on study design, collection, analysis and interpretation of data, nor in writing the manuscript and neither in the decision to submit the article for publication. European Spallation Source ESS AB, provided support in the form of salaries for author MLA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER L., 1955, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung, V100, P180, DOI 10.1007/BF01713465; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P304, DOI 10.1016/j.ijbiomac.2010.01.002; Ajayi AO, 2007, AFR J BIOTECHNOL, V6, P1181; Alftren J, 2012, FOOD HYDROCOLLOID, V26, P54, DOI 10.1016/j.foodhyd.2011.04.008; Alves LA, 2007, J CHEM ENG DATA, V52, P2166, DOI 10.1021/je700177n; Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Andersson M, 2001, ANAL CHEM, V73, P4852, DOI 10.1021/ac0104734; AUTIO K, 1992, FOOD HYDROCOLLOID, V5, P513, DOI 10.1016/S0268-005X(09)80121-5; Beer MU, 1997, CEREAL CHEM, V74, P476, DOI 10.1094/CCHEM.1997.74.4.476; BERRY GC, 1966, J CHEM PHYS, V44, P4550, DOI 10.1063/1.1726673; CALDWELL KD, 1979, SEPAR SCI TECHNOL, V14, P935, DOI 10.1080/01496397908058103; Cui SW, 2009, STRUCT CHEM, V20, P291, DOI 10.1007/s11224-009-9441-0; DAWKINS NL, 1993, J FOOD SCI, V58, P562, DOI 10.1111/j.1365-2621.1993.tb04324.x; Food and Drug Administration S, 2008, FED REGISTER, V73, P47828; FORREST IS, 1977, J I BREWING, V83, P279, DOI 10.1002/j.2050-0416.1977.tb03809.x; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Gomez C, 1997, CARBOHYD POLYM, V34, P141, DOI 10.1016/S0144-8617(97)00134-3; Gong XC, 2012, J CHEM ENG DATA, V57, P3264, DOI 10.1021/je300885g; Goubet F, 2009, PLANT J, V60, P527, DOI 10.1111/j.1365-313X.2009.03977.x; Hakansson A, 2012, J CHROMATOGR A, V1253, P120, DOI 10.1016/j.chroma.2012.07.029; Hakansson A, 2012, CARBOHYD POLYM, V87, P518, DOI 10.1016/j.carbpol.2011.08.014; Immerstrand T, 2009, CEREAL CHEM, V86, P601, DOI 10.1094/CCHEM-86-6-0601; Izydorczyk MS, 2008, FOOD RES INT, V41, P850, DOI 10.1016/j.foodres.2008.04.001; JOHANSEN HN, 1993, J AGR FOOD CHEM, V41, P2347, DOI 10.1021/jf00036a025; Kim S, 2006, J FOOD COMPOS ANAL, V19, P466, DOI 10.1016/j.jfca.2005.11.006; Kosik O, 2012, METHOD ENZYMOL, V510, P51, DOI 10.1016/B978-0-12-415931-0.00004-5; Lazaridou A, 2007, J CEREAL SCI, V46, P101, DOI 10.1016/j.jcs.2007.05.003; Li W, 2011, FOOD HYDROCOLLOID, V25, P189, DOI 10.1016/j.foodhyd.2010.02.005; Nilsson L, 2013, FOOD HYDROCOLLOID, V30, P1, DOI 10.1016/j.foodhyd.2012.04.007; Papageorgiou M, 2005, J CEREAL SCI, V42, P213, DOI 10.1016/j.jcs.2005.03.002; Perez-Rea D, 2015, ANAL BIOANAL CHEM, V407, P4315, DOI 10.1007/s00216-015-8611-8; Robyt JF, 2009, FOOD SCI TECH-INT SE, P237, DOI 10.1016/B978-0-12-746275-2.00007-0; Tugel I, 2015, J I BREWING, V121, P44, DOI 10.1002/jib.195; U.S. Food and Drug Administration, 1992, FED REGISTER, V62, P15343; Ulmius M, 2012, FOOD CHEM, V130, P536, DOI 10.1016/j.foodchem.2011.07.066; Ulmius M, 2012, FOOD HYDROCOLLOID, V26, P175, DOI 10.1016/j.foodhyd.2011.05.004; VARUM KM, 1988, CARBOHYD POLYM, V9, P103, DOI 10.1016/0144-8617(88)90008-2; WAHLUND KG, 1987, ANAL CHEM, V59, P1332, DOI 10.1021/ac00136a016; Webster F. H., 2011, OATS CHEM TECHNOLOGY; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; Wood PJ, 2004, TRENDS FOOD SCI TECH, V15, P313, DOI 10.1016/j.tifs.2003.03.001; WOOD PJ, 1977, CEREAL CHEM, V54, P524; Zhou MX, 2000, J SCI FOOD AGR, V80, P1486, DOI 10.1002/1097-0010(200008)80:10<1486::AID-JSFA668>3.3.CO;2-R	44	23	25	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172034	10.1371/journal.pone.0172034	http://dx.doi.org/10.1371/journal.pone.0172034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196092	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900046
J	Farias-Curtidor, N; Barragan-Barrera, DC; Chavez-Carreno, PA; Jimenez-Pinedo, C; Palacios, DM; Caicedo, D; Trujillo, F; Caballero, S				Farias-Curtidor, Nohelia; Barragan-Barrera, Dalia C.; Alejandra Chavez-Carreno, Paula; Jimenez-Pinedo, Cristina; Palacios, Daniel M.; Caicedo, Dalila; Trujillo, Fernando; Caballero, Susana			Range extension for the common dolphin (Delphinus sp.) to the Colombian Caribbean, with taxonomic implications from genetic barcoding and phylogenetic analyses	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; POPULATION-STRUCTURE; SOUTHERN AUSTRALIA; ATLANTIC-OCEAN; MITOCHONDRIAL; NUCLEAR; DNA; SURVEILLANCE; SYSTEMATICS; CETACEANS	The nearest known population of common dolphins (Delphinus sp.) to the Colombian Caribbean occurs in a fairly restricted range in eastern Venezuela. These dolphins have not been previously reported in the Colombian Caribbean, likely because of a lack of study of the local cetacean fauna. We collected cetacean observations in waters of the Guajira Department, northern Colombia (similar to 11 degrees N, 73 degrees W) during two separate efforts: (a) a seismic vessel survey (December 2009 D March 2010), and (b) three coastal surveys from small boats ( May-July 2012, May 2013, and May 2014). Here we document ten sightings of common dolphins collected during these surveys, which extend the known range of the species by similar to 1000 km into the southwestern Caribbean. We also collected nine skin biopsies in 2013 and 2014. In order to determine the taxonomic identity of the specimens, we conducted genetic barcoding and phylogenetic analyses using two mitochondrial markers, the Control Region (mtDNA) and Cytochrome b (Cytb). Results indicate that these specimens are genetically closer to the short-beaked common dolphin (Delphinus delphis) even though morphologically they resemble a long-beaked form (Delphinus sp.). However, the specific taxonomic status of common dolphins in the Caribbean and in the Western Atlantic remains unresolved. It is also unclear whether the distribution of the species between northern Colombia and eastern Venezuela is continuous or disjoined, or whether they can be considered part of the same stock.	[Farias-Curtidor, Nohelia] Conjunto Caeli Reservado, Cajica, Colombia; [Barragan-Barrera, Dalia C.; Alejandra Chavez-Carreno, Paula; Caballero, Susana] Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia; [Barragan-Barrera, Dalia C.] Fdn Macuat Colombia, Medellin, Colombia; [Alejandra Chavez-Carreno, Paula] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jimenez-Pinedo, Cristina] Zona Rural Piedras Coloradas S-N, Las Grutas, Rio Negro, Argentina; [Palacios, Daniel M.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Caicedo, Dalila; Trujillo, Fernando] Fdn Omacha, Bogota, Colombia	Universidad de los Andes (Colombia); Duke University; Oregon State University	Caballero, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, LEMVA, Lab J 202, Bogota, Colombia.	sj.caballero26@uniandes.edu.co	Barragán-Barrera, Dalia C./ABA-2913-2020; Palacios, Daniel M./B-9180-2008	Barragán-Barrera, Dalia C./0000-0003-4023-9908; Palacios, Daniel M./0000-0001-7069-7913	Society for Marine Mammalogy; Universidad de los Andes [1821]; Universidad de los Andes	Society for Marine Mammalogy; Universidad de los Andes; Universidad de los Andes	This study was supported by the Society for Marine Mammalogy (DB, 2014); the "Proyecto Semilla - 2013-2 Call for Funding of Research Category: Master and Doctoral students, project 'Genetic structure and diversity of bottlenose dolphins Tursiops truncatus (Montagu,1821) (Cetacea:Delphinidae) in La Guajira, Colombian Caribbean'" from Universidad de los Andes (DB, 2014); and the "Proyecto Semilla - 2015-1 Call for Funding of Research Category: Master and Doctoral students, project 'Occurrence, distribution and preliminary genetic status of delphinids in La Guajira, Colombian Caribbean'" from Universidad de los Andes (DB, 2015).	Aguayo CG, 1954, CIRCULARES MUSEO BIB, V13, P1125; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; AMOS B, 1991, P99; Andrade CA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001549; Andrade CA, 2005, CONTINENTAL SHELF RE, V25; [Anonymous], 2002, NCBI HDB; Baker CS, 2003, TRENDS ECOL EVOL, V18, P271, DOI 10.1016/S0169-5347(03)00101-0; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Bell Catherine H., 2002, Australian Mammalogy, V24, P1; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Burmeister H., 1866, Annals & Magazine of Natural History, Vxviii, P99; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Casinos A., 1984, ACTA ZOOL FENN, V172, P141; CORREDOR JE, 1979, DEEP-SEA RES, V26, P731, DOI 10.1016/0198-0149(79)90010-4; Cunha HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140251; Cuni LA, 1918, MEMORIAS SOC CUBANA, P83; CURL H, 1960, DEEP-SEA RES, V7, P183, DOI 10.1016/0146-6313(60)90024-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2009, GENEIOUS PROV4 8 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2012, REMOVE REDUNDANT TAX; Esteves Maria Alejandra, 2007, Aquatic Mammals, V33, P229, DOI 10.1578/AM.33.2.2007.229; EVANS W.E., 1982, DISTRIBUTION AND DIF, VIV, P45; Gilson A, 1998, CALIF FISH GAME, V84, P159; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; *IWC, 2007, J CETACEAN RES MAN S, V9, P297; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jefferson TA, 2002, MAR MAMMAL SCI, V18, P787, DOI 10.1111/j.1748-7692.2002.tb01074.x; Jefferson TA, 2009, MAR BIOL, V156, P1109, DOI 10.1007/s00227-009-1152-y; Juri Eduardo, 2012, Marine Biodiversity Records, V5, P1; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Lonin SA, 2010, J GEOPHYS RES, V115, P1; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; Murphy S, 2006, MAR MAMMAL SCI, V22, P573, DOI 10.1111/j.1748-7692.2006.00037.x; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Oviedo L, J MARINE BIOL ASS UK; Paramo J, 2011, REV BIOL MAR OCEANOG, V46, P421, DOI 10.4067/S0718-19572011000300011; Perrin W. F., 2004, WORKSH SHORTC CET TA, P26; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinela AM, 2011, J ZOOL, V284, P239, DOI 10.1111/j.1469-7998.2011.00798.x; Querouil S, 2010, MAR BIOL, V157, P2567, DOI 10.1007/s00227-010-1519-0; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2014, TREEANNOTATOR V1 8 2; Ramirez Carroz Sonsiree, 2004, Boletin del Centro de Investigaciones Biologicas Universidad del Zulia, V38, P140; ROSEL PE, 1994, MAR BIOL, V119, P159, DOI 10.1007/BF00349552; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Segura-Garcia I, 2011, THESIS; Stockin KA, 2014, MAR MAMMAL SCI, V30, P44, DOI 10.1111/mms.12027; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Tezanos-Pinto G, 2011, NEW ZEAL J MAR FRESH, V1, P1; Tzika AC, 2010, CONSERV GENET, V11, P2207, DOI 10.1007/s10592-010-0106-8; Viricel A, 2012, MAR MAMMAL SCI, V28, P37, DOI 10.1111/j.1748-7692.2010.00460.x; Whitt Amy D., 2011, Latin American Journal of Aquatic Mammals, V9, P65	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171000	10.1371/journal.pone.0171000	http://dx.doi.org/10.1371/journal.pone.0171000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192446	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800014
J	Sacco, NJ; Bonetto, MC; Corton, E				Sacco, Natalia J.; Celina Bonetto, M.; Corton, Eduardo			Isolation and Characterization of a Novel Electrogenic Bacterium, Dietzia sp RNV-4	PLOS ONE			English	Article							MICROBIAL FUEL-CELL; BIOFILMS; IDENTIFICATION; CANTHAXANTHIN; COMMUNITY; POWER; BIOELECTRICITY; VOLTAMMETRY; GENERATION; TRANSPORT	Electrogenic bacteria are organisms that can transfer electrons to extracellular electron acceptors and have the potential to be used in devices such as bioelectrochemical systems (BES). In this study, Dietzia sp. RNV-4 bacterium has been isolated and identified based on its biochemical, physiological and morphological characteristics, as well as by its 16S rRNA sequence analysis. Furthermore, the current density production and electron transfer mechanisms were investigated using bioelectrochemical methods. The chronoamperometric data showed that the biofilm of Dietzia sp. RNV-4 grew as the current increased with time, reaching a maximum of 176.6 +/- 66.1 mA/m(2) at the end of the experiment (7 d); this highly suggests that the current was generated by the biofilm. The main electron transfer mechanism, indicated by the cyclic voltammograms, was due to secreted redox mediators. By high performance liquid chromatography, canthaxanthin was identified as the main compound involved in charge transfer between the bacteria and the solid electrodes. Dietzia sp. RNV-4 was used as biological material in a microbial fuel cell (MFC) and the current density production was 299.4 +/- 40.2 mA/m(2). This is the first time that Dietzia sp. RNV-4 has been electrochemically characterized and identified as a new electrogenic strain.	[Sacco, Natalia J.] Univ Buenos Aires, Dept Quim Biol, Lab Biosensors & Bioanal LABB, Fac Ciencias Exactas & Nat, Ciudad Univ, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Ciudad Univ, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Sacco, NJ (corresponding author), Univ Buenos Aires, Dept Quim Biol, Lab Biosensors & Bioanal LABB, Fac Ciencias Exactas & Nat, Ciudad Univ, Buenos Aires, DF, Argentina.	nsacco@qb.fcen.uba.ar	, EduardoCorton/AAE-6023-2019	Sacco, Natalia/0000-0003-3556-7018	Consejo Nacional de Investigaciones Cientfficas y Tecnicas [PIP 112-200801-00502]; Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID) [PICT 2013-0033, PICT 20140402]; EC; University of Buenos Aires; National Council for Scientific and Technological Research (CONICET) [PIP 112-200801-00502]; ANPCyT (Prestamo BID) [PICT 2013-0033, PICT 2014-0402]	Consejo Nacional de Investigaciones Cientfficas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID); EC(European CommissionEuropean Commission Joint Research Centre); University of Buenos Aires(University of Buenos Aires); National Council for Scientific and Technological Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT (Prestamo BID)(ANPCyT)	This work was supported by the Consejo Nacional de Investigaciones Cientfficas y Tecnicas (PIP 112-200801-00502), and The Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID, PICT 2013-0033 and PICT 20140402). Funding was received by EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Buenos Aires, the National Council for Scientific and Technological Research (CONICET, PIP 112-200801-00502), and the ANPCyT (Prestamo BID, PICT 2013-0033 and PICT 2014-0402). We also want to thank to Lic. Fabian Tricarico for his help with SEM photography, to Dr. Laura J. Raiger Iustman for her contribution in this section of bioinformatics and phylogenetic analysis, and to Lic. Silvia Rodriguez, for editing our manuscript.	Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P591, DOI 10.1016/j.bios.2014.04.053; Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P580, DOI 10.1016/j.bios.2014.04.034; Asker D, 1999, J BIOSCI BIOENG, V88, P617, DOI 10.1016/S1389-1723(00)87089-9; Bard A. J., 2001, ELECTROCHEMICAL METH; Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Bhosale P, 2005, APPL MICROBIOL BIOT, V68, P445, DOI 10.1007/s00253-005-0032-8; Bodtker G, 2009, ANTON LEEUW INT J G, V96, P459, DOI 10.1007/s10482-009-9359-y; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Esfahani-Mashhour M, 2009, ASIAN AUSTRAL J ANIM, V22, P254, DOI 10.5713/ajas.2009.80202; GABY WL, 1957, J BACTERIOL, V74, P356, DOI 10.1128/JB.74.3.356-358.1957; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Harnisch F, 2012, CHEM-ASIAN J, V7, P466, DOI 10.1002/asia.201100740; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Jain A, 2012, BIOELECTROCHEMISTRY, V87, P28, DOI 10.1016/j.bioelechem.2011.12.012; Jayashree C, 2016, J ENVIRON MANAGE, V180, P351, DOI 10.1016/j.jenvman.2016.05.050; Khodaiyan F, 2007, J MICROBIOL BIOTECHN, V17, P195; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Kumar R, 2016, RENEW SUST ENERG REV, V56, P1322, DOI 10.1016/j.rser.2015.12.029; Kumar R, 2015, INT J ENERG RES, V39, P1048, DOI 10.1002/er.3305; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labelle E., 2009, INTEGRATED ENV TECHN; Lanthier M, 2008, FEMS MICROBIOL LETT, V278, P29, DOI 10.1111/j.1574-6968.2007.00964.x; Liu DZ, 2000, J ELECTROANAL CHEM, V488, P140, DOI 10.1016/S0022-0728(00)00205-9; Liu YM, 2014, ENV MICROBIOL REP, V6, P776, DOI 10.1111/1758-2229.12204; Logan B. E., 2008, MICROBIAL FUEL CELLS, P44; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Mahon CR, 2014, TXB DIAGNOSTIC MICRO; Malvankar NS, 2014, NAT NANOTECHNOL, V9, P1012, DOI [10.1038/nnano.2014.236, 10.1038/NNANO.2014.236]; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Merchant IA, 1969, VET BACTERIOLOGY VIR; NELIS HJ, 1991, J APPL BACTERIOL, V70, P181, DOI 10.1111/j.1365-2672.1991.tb02922.x; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Sacco NJ, 2012, BIORESOURCE TECHNOL, V126, P328, DOI 10.1016/j.biortech.2012.09.060; Samsudeen N, 2015, BIORESOURCE TECHNOL, V195, P242, DOI 10.1016/j.biortech.2015.07.023; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; von der Weid I, 2007, SYST APPL MICROBIOL, V30, P331, DOI 10.1016/j.syapm.2006.11.001; Wang VB, 2014, ELECTROCHEM COMMUN, V41, P55, DOI 10.1016/j.elecom.2014.01.025; Watson VJ, 2010, BIOTECHNOL BIOENG, V105, P489, DOI 10.1002/bit.22556; Yumoto I, 2002, INT J SYST EVOL MICR, V52, P85, DOI 10.1099/00207713-52-1-85	51	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0169955	10.1371/journal.pone.0169955	http://dx.doi.org/10.1371/journal.pone.0169955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192491	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800007
J	Hradilova, N; Sadilkova, L; Palata, O; Mysikova, D; Mrazkova, H; Lischke, R; Spisek, R; Adkins, I				Hradilova, Nada; Sadilkova, Lenka; Palata, Ondrej; Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert; Spisek, Radek; Adkins, Irena			Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; TUMOR-CELLS; IMMUNE-RESPONSES; CLINICAL-TRIAL; PHASE-I; PEPTIDE; IMMUNIZATION; DEATH; THERAPY; GENES	High hydrostatic pressure (HHP) induces immunogenic death of tumor cells which confer protective anti-tumor immunity in vivo. Moreover, DC pulsed with HHP-treated tumor cells induced therapeutic effect in mouse cancer model. In this study, we tested the immunogenicity, stability and T cell stimulatory activity of human monocyte-derived dendritic cell (DC)based HHP lung cancer vaccine generated in GMP compliant serum free medium using HHP 250 MPa. DC pulsed with HHP-killed lung cancer cells and poly(I:C) enhanced DC maturation, chemotactic migration and production of pro-inflammatory cytokines after 24h. Moreover, DC-based HHP lung cancer vaccine showed functional plasticity after transfer into serum-containing media and stimulation with LPS or CD40L after additional 24h. LPS and CD40L stimulation further differentially enhanced the expression of costimulatory molecules and production of IL-12p70. DC-based HHP lung cancer vaccine decreased the number of CD4(+) CD25(+) Foxp3(+) T regulatory cells and stimulated IFN-gamma-producing tumor antigenspecific CD4(+) and CD8(+) T cells from non-small cell lung cancer (NSCLC) patients. Tumor antigen specific CD8(+) and CD4(+) T cell responses were detected in NSCLC patient's against a selected tumor antigens expressed by lung cancer cell lines used for the vaccine generation. We also showed for the first time that protein antigen from HHP-killed lung cancer cells is processed and presented by DC to CD8(+) T cells. Our results represent important preclinical data for ongoing NSCLC Phase I/II clinical trial using DC-based active cellular immunotherapy (DCVAC/LuCa) in combination with chemotherapy and immune enhancers.	[Hradilova, Nada; Sadilkova, Lenka; Palata, Ondrej; Spisek, Radek; Adkins, Irena] SOTIO, Prague, Czech Republic; [Hradilova, Nada; Palata, Ondrej; Spisek, Radek; Adkins, Irena] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic; [Hradilova, Nada; Palata, Ondrej; Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert; Spisek, Radek; Adkins, Irena] Univ Hosp Motol, Prague, Czech Republic; [Mysikova, Dagmar; Mrazkova, Hana; Lischke, Robert] Charles Univ Prague, Fac Med 1, Dept Surg 3, Thorac & Lung Transplantat Div, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague	Adkins, I (corresponding author), SOTIO, Prague, Czech Republic.; Adkins, I (corresponding author), Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic.; Adkins, I (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	adkins@sotio.com	Palata, Ondřej/N-2764-2017; Faltova, Hana/D-6279-2017; Lischke, Robert/E-6087-2017; Mysikova, Dagmar/D-7011-2017	Palata, Ondřej/0000-0003-3264-9384; Faltova, Hana/0000-0003-2221-4950; Lischke, Robert/0000-0002-0578-1833; Mysikova, Dagmar/0000-0002-0400-6253	Charles Universityin Prague, Czech Republic, project GAUK [458216]	Charles Universityin Prague, Czech Republic, project GAUK	The authors declare that this study was supported by Sotio a.s. This study was further supported by the Charles Universityin Prague, Czech Republic, project GAUK No.458216 granted to OP. This does not alterouradherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Adkins I, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968434; Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Atanackovic D, 2004, J IMMUNOL, V172, P3289, DOI 10.4049/jimmunol.172.5.3289; Babatz J, 2006, CANCER IMMUNOL IMMUN, V55, P268, DOI 10.1007/s00262-005-0021-x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Brunsvig PF, 2011, CLIN CANCER RES, V17, P6847, DOI 10.1158/1078-0432.CCR-11-1385; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang GC, 2005, CANCER-AM CANCER SOC, V103, P763, DOI 10.1002/cncr.20843; Coulie PG, 2005, CURR OPIN IMMUNOL, V17, P320, DOI 10.1016/j.coi.2005.03.002; Datta Jashodeep, 2014, Yale Journal of Biology and Medicine, V87, P491; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Engell-Noerregaard L, 2013, CANCER IMMUNOL IMMUN, V62, P17, DOI 10.1007/s00262-012-1306-5; Fucikova J, 2014, INT J CANCER, V135, P1165, DOI 10.1002/ijc.28766; Fucikova J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-223; Grunwald C, 2006, INT J CANCER, V118, P2522, DOI 10.1002/ijc.21669; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Hirschowitz EA, 2004, J CLIN ONCOL, V22, P2808, DOI 10.1200/JCO.2004.01.074; Hirschowitz EA, 2007, LUNG CANCER, V57, P365, DOI 10.1016/j.lungcan.2007.04.002; Hirschowitz EA, 2011, J THORAC ONCOL, V6, P169, DOI 10.1097/JTO.0b013e3181fb5c22; Karanikas V, 2008, CANCER BIOL THER, V7, P345, DOI 10.4161/cbt.7.3.5424; Kontani K, 2003, INT J MOL MED, V12, P493; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mellstedt H, 2011, LUNG CANCER, V73, P11, DOI 10.1016/j.lungcan.2011.02.023; Mikyskova R, 2016, INT J ONCOL, V48, P953, DOI 10.3892/ijo.2015.3314; Morse MA, 2005, CLIN CANCER RES, V11, P3017, DOI 10.1158/1078-0432.CCR-04-2172; MUKHERJI B, 1995, P NATL ACAD SCI USA, V92, P8078, DOI 10.1073/pnas.92.17.8078; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Perroud MW, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-65; Rouas R, 2004, INT IMMUNOL, V16, P767, DOI 10.1093/intimm/dxh077; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Skachkova O. V., 2013, Experimental Oncology, V35, P109; Tajima K, 2003, LUNG CANCER-J IASLC, V42, P23, DOI 10.1016/S0169-5002(03)00244-7; Takahashi H, 2013, EUR J CANCER, V49, P852, DOI 10.1016/j.ejca.2012.11.005; Takahashi N, 2012, CANCER SCI, V103, P150, DOI 10.1111/j.1349-7006.2011.02106.x; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Truxova I, 2014, IMMUNOL LETT, V160, P39, DOI 10.1016/j.imlet.2014.03.010; Ueda Y, 2004, INT J ONCOL, V24, P909; Um SJ, 2010, LUNG CANCER, V70, P188, DOI 10.1016/j.lungcan.2010.02.006; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yannelli JR, 2005, LUNG CANCER, V47, P337, DOI 10.1016/j.lungcan.2004.08.008	45	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171539	10.1371/journal.pone.0171539	http://dx.doi.org/10.1371/journal.pone.0171539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187172	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300028
J	Thompson, C; Rahim, S; Arnold, J; Hielscher, A				Thompson, Christopher; Rahim, Sahar; Arnold, Jeremiah; Hielscher, Abigail			Loss of caveolin-1 alters extracellular matrix protein expression and ductal architecture in murine mammary glands	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; INVASIVE BREAST-CANCER; TUMOR-SUPPRESSOR GENE; MAMMOGRAPHIC DENSITY; TENASCIN-C; FIBRONECTIN EXPRESSION; PROSTATE-CANCER; COLLAGEN; PROGRESSION; CELLS	The extracellular matrix (ECM) is abnormal in breast tumors and has been reported to contribute to breast tumor progression. One factor, which may drive ongoing matrix synthesis in breast tumors, is the loss of stromal caveolin-1 (cav-1), a scaffolding protein of caveolae, which has been linked to breast tumor aggressiveness. To determine whether loss of cav-1 results in the abnormal expression of matrix proteins, mammary glands from cav-1-/- and cav-1 +/+ mice were investigated for differences in expression of several ECM proteins. In addition, the presence of myofibroblasts, changes in the vessel density, and differences in duct number and size were assessed in the mammary glands of both animal models. Using immunohistochemistry, expression of fibronectin, tenascin-C, collagens and alpha SMA were significantly increased in the mammary glands of cav-1-/- mice. Second harmonic generation revealed more organized collagen fibers in cav-1-/- glands and supported immunohistochemical analyses of increased collagen abundance in the glands of cav-1-/- mice. Analysis of the ductal structure demonstrated a significant increase in the number of proliferating ducts in addition to significant increases in the duct circumference and area in cav1 -/- glands compared to cav-1 +/+ glands. Differences in microvessel density weren't apparent between the animal models. In summary, we found that the loss of cav-1 resulted in increased ECM and alpha-SMA protein expression in murine mammary glands. Furthermore, we found that an abnormal ductal architecture accompanied the loss of cav-1. These data support a role for cav-1 in maintaining mammary gland structure.	[Thompson, Christopher; Rahim, Sahar; Arnold, Jeremiah; Hielscher, Abigail] Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA		Hielscher, A (corresponding author), Georgia Philadelphia Coll Osteopath Med, Dept Biomed Sci, Suwanee, GA 30024 USA.	abigailhi@pcom.edu	Thompson, Christopher/GZH-1662-2022	Thompson, Christopher/0000-0002-6284-1919	Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging	Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging	Support was provided by the Philadelphia College of Osteopathic Medicine Centers for Chronic Disorders of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Bae YK, 2013, HUM PATHOL, V44, P2028, DOI 10.1016/j.humpath.2013.03.006; Balanis N, 2013, J BIOL CHEM, V288, P17954, DOI 10.1074/jbc.M113.475277; Barcus CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116891; Belanger MM, 2004, CHEST, V125, p106S, DOI 10.1378/chest.125.5_suppl.106S; Boyd N F, 2001, Curr Oncol Rep, V3, P314, DOI 10.1007/s11912-001-0083-7; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Brownfield DG, 2013, CURR BIOL, V23, P703, DOI 10.1016/j.cub.2013.03.032; Castello-Cros R, 2011, CELL CYCLE, V10, P2140, DOI 10.4161/cc.10.13.16227; Chan EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149799; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cloos PAC, 2003, BREAST CANCER RES, V5, pR103, DOI 10.1186/bcr607; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Guttery DS, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2618; Han QQ, 2014, J MED BIOL ENG, V34, P130, DOI 10.5405/jmbe.1445; Hielscher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147600; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Hino M, 2003, SURG TODAY, V33, P486, DOI 10.1007/s10595-002-2538-4; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kobayashi Y, 2016, MOL VIS, V22, P436; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Pontiggia O, 2012, BREAST CANCER RES TR, V133, P459, DOI 10.1007/s10549-011-1766-x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Pucci M, 2015, CANCER GENOM PROTEOM, V12, P143; Qian N, 2011, CANCER SCI, V102, P1590, DOI 10.1111/j.1349-7006.2011.01985.x; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Witkiewicz AK, 2009, CELL CYCLE, V8, P1654, DOI 10.4161/cc.8.11.8544; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5	64	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172067	10.1371/journal.pone.0172067	http://dx.doi.org/10.1371/journal.pone.0172067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187162	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300078
J	Bezerra, IWL; Oliveira, AG; Pinheiro, LGB; Morais, CMM; Sampaio, LMB				Leal Bezerra, Ingrid W.; Oliveira, Antonio Gouveia; Pinheiro, Liana G. B.; Morais, Celia M. M.; Sampaio, Luciano M. B.			Evaluation of the nutritional status of workers of transformation industries adherent to the Brazilian Workers' Food Program. A comparative study	PLOS ONE			English	Article								The objective of this study was to assess whether the Brazilian Workers' Food Program (WFP) is associated with changes in the nutritional status of workers in the transformation industry. We conducted a cross-sectional, observational, comparative study, based on prospectively collected data from a combined stratified and two-stage probability sample of workers from 26 small and medium size companies, 13 adherent and 13 non-adherent to the WFP, in the food, mining and textile sectors. Study variables were body mass index (BMI), waist circumference (WC), and dietary intake at lunch obtained by 24-hour dietary recall. Data were analyzed with nested mixed effects linear regression with adjustment by subject variables. Sampling weights were applied in computing population parameters. The final sample consisted of 1069 workers, 541 from WFP-adherent and 528 from WFP non-adherent companies. The groups were different only in education level, income and in-house training. Workers in WFP-adherent companies have greater BMI (27.0 kg/m(2) vs. 26.0 kg/m(2), p = 0.002) and WC (87.9 cm vs. 86.5, p = 0.04), higher prevalence of excessive weight (62.6% vs. 55.5%, p<0.001) and of increased WC (49.1% vs. 39.9%). Workers of WFP companies have lower intake of saturated fat (-1.34 g, p<0.01) and sodium (-0.3 g, p<0.01) at lunch. In conclusion, this study showed that workers of companies adherent to the Brazilian WFP have greater rates of excessive weight and increased cardiovascular risk-a negative finding -as well as lower intake of sodium and saturated fat -a positive finding. Therefore, the WFP needs to be revisited and its aims redefined according to the current epidemiological status of the target population of the program.	[Leal Bezerra, Ingrid W.; Pinheiro, Liana G. B.; Morais, Celia M. M.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Nutr, Natal, RN, Brazil; [Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Pharm, Natal, RN, Brazil; [Sampaio, Luciano M. B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Adm Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Bezerra, IWL (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Nutr, Natal, RN, Brazil.	ingrid@ufrnet.br	Sampaio, Luciano/AAL-6220-2020	Sampaio, Luciano/0000-0003-1632-3149				Afrc GL, 1978, NUTR B, V12, P138; [Anonymous], 2011, TAB BRAS COMP AL TAC; Burlandy L, 2001, Cad Saude Publica, V17, P1457, DOI 10.1590/S0102-311X2001000600029; CAISAN-Camara Interministerial de Seguranca Alimentar e Nutricional, 2011, PLAN NACL SEG AL NUT; Fildes A, 2015, AM J PUBLIC HEALTH, V105, pE54, DOI 10.2105/AJPH.2015.302773; Geraldo APG, 2008, REV PANAM SALUD PUBL, V23, P19, DOI 10.1590/S1020-49892008000100003; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kleinert S, 2015, LANCET, V385, P2410; Marchioni DML, 2012, MANUAL AVALIACAO CON; Ministerio da Saude, 2008, GUIA AL POP BRAS PRO; Ministerio da saude, 2006, POL NAC PROM SAUD; Ministerio da Saude, 2011, EST INF SAUD G; Ministerio da Saude. Secretaria de Poloticas de Saude, 2002, SECR POL SAUD POL NA; Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica-IBGE. Diretoria de Pesquisas, 2011, COORD TRAB REND PESQ; Ministerio do Trabalho e Emprego, 2015, INSP TRAB PROGR AL T; OLIVEIRA AG, 2013, BIOSTATISTICS DECODE; ParkerDR EvangelouE, CONT CLIN TRIALS, V26, P260, DOI [10.1016/j.cct.2005.01.002, DOI 10.1016/J.CCT.2005.01.002]; Philippi ST, 2018, FOOD COMPOSITION TAB, V6th; Rohryova L, 2014, THESIS; Sarno Flávio, 2008, Rev. bras. epidemiol., V11, P453, DOI 10.1590/S1415-790X2008000300012; Savio KEO, 2005, REV SAUDE PUBL, V39, P148, DOI 10.1590/S0034-89102005000200002; Searle SR., 1992, VARIANCE COMPONENTS; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Veloso IS, 2007, REV SAUDE PUBL, V41, P769, DOI 10.1590/S0034-89102007000500011; Veloso Iracema Santos, 2002, Rev Panam Salud Publica, V11, P24, DOI 10.1590/S1020-49892002000100004; Wanjek C, 2005, FOOD WORK WORKPLACE; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2004, GLOB STRAT DIET PHYS	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171821	10.1371/journal.pone.0171821	http://dx.doi.org/10.1371/journal.pone.0171821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182763	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800121
J	Nagarajan, B; Sankaranarayanan, NV; Patel, BB; Desai, UR				Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Patel, Bhaumik B.; Desai, Umesh R.			A molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CANCER STEM-CELLS; 2-O-SULFO-ALPHA-L-IDURONIC ACID; ALLOSTERIC INHIBITION; STRUCTURAL BIOLOGY; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; HIGH-SPECIFICITY; HEPARAN-SULFATE; NON-SACCHARIDE	Glycosaminoglycans (GAGs) are key natural biopolymers that exhibit a range of biological functions including growth and differentiation. Despite this multiplicity of function, natural GAG sequences have not yielded drugs because of problems of heterogeneity and synthesis. Recently, several homogenous non-saccharide glycosaminoglycan mimetics (NSGMs) have been reported as agents displaying major therapeutic promise. Yet, it remains unclear whether sulfated NSGMs structurally mimic sulfated GAGs. To address this, we developed a three-step molecular dynamics (MD)-based algorithm to compare sulfated NSGMs with GAGs. In the first step of this algorithm, parameters related to the range of conformations sampled by the two highly sulfated molecules as free entities in water were compared. The second step compared identity of binding site geometries and the final step evaluated comparable dynamics and interactions in the protein-bound state. Using a test case of interactions with fibroblast growth factor-related proteins, we show that this three-step algorithm effectively predicts the GAG structure mimicking property of NSGMs. Specifically, we show that two unique dimeric NSGMs mimic hexameric GAG sequences in the protein-bound state. In contrast, closely related monomeric and trimeric NSGMs do not mimic GAG in either the free or bound states. These results correspond well with the functional properties of NSGMs. The results show for the first time that appropriately designed sulfated NSGMs can be good structural mimetics of GAGs and the incorporation of a MD-based strategy at the NSGM library screening stage can identify promising mimetics of targeted GAG sequences.	[Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23284 USA; [Nagarajan, Balaji; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Patel, Bhaumik B.] Hunter Holmes Muire VA Med Ctr, Richmond, VA USA; [Patel, Bhaumik B.] Virginia Commonwealth Univ, Dept Internal Med, Div Hematol Oncol & Palliat Care, Richmond, VA USA; [Patel, Bhaumik B.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23284 USA.; Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	urdesai@vcu.edu	Nagarajan, Balaji/K-6924-2019; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Nagarajan, Balaji/0000-0003-3892-6178; Sankaranarayanan, Nehru Viji/0000-0002-2870-9164	NIH [HL107152, HL090586, HL128639]; VCU	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU	This work was supported by grants from the NIH, including HL107152, HL090586 and HL128639, and internal funds from VCU.; We thank Prof. Glen Kellogg and Prof. Neel Scarsdale of VCU for computational support. We also thank the availability of research resources from National Center for Research Resources (S10 RR027411) to VCU. This work was supported in part by grants from the NIH including HL107152, HL090586 and HL128639.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Horani RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160189; Al-Horani RA, 2015, THROMB RES, V136, P379, DOI 10.1016/j.thromres.2015.04.017; Al-Horani RA, 2015, MOLECULES, V20, P608, DOI 10.3390/molecules20010608; Al-Horani RA, 2013, J MED CHEM, V56, P867, DOI 10.1021/jm301338q; Argade MD, 2014, J MED CHEM, V57, P3559, DOI 10.1021/jm5002698; Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018; Munoz-Garcia JC, 2013, GLYCOBIOLOGY, V23, P1220, DOI 10.1093/glycob/cwt058; Case D.A., 2022, AMBER; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER, V13; Coombe Deirdre R, 2012, Handb Exp Pharmacol, P361, DOI 10.1007/978-3-642-23056-1_16; Desai UR, 2013, FUTURE MED CHEM, V5, P1363, DOI 10.4155/fmc.13.117; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Gandhi NS, 2010, CARBOHYD RES, V345, P689, DOI 10.1016/j.carres.2009.12.020; Gunnarsson GT, 2002, J MED CHEM, V45, P1233, DOI 10.1021/jm020012q; Gunnarsson GT, 2002, J MED CHEM, V45, P4460, DOI 10.1021/jm020132y; Haley EM, 2014, CANCER LETT, V346, P1, DOI 10.1016/j.canlet.2013.12.003; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karuturi R, 2013, J MED CHEM, V56, P2415, DOI 10.1021/jm301757v; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Mehta AY, 2014, J MED CHEM, V57, P3030, DOI 10.1021/jm4020026; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mizuno S, 2013, INT J MOL SCI, V14, P888, DOI 10.3390/ijms14010888; Moshtagh N., 2006, COMPUTES MINIMUM VOL; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2016, PHARMACOL REV, V68, P76, DOI 10.1124/pr.115.011247; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patel NJ, 2014, ACS CHEM BIOL, V9, P1826, DOI 10.1021/cb500402f; Patel NJ, 2016, ONCOTARGET; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016; Pomin VH, 2015, CURR OPIN STRUC BIOL, V34, P17, DOI 10.1016/j.sbi.2015.05.007; Presta M., 2008, ANGIOGENESIS INTEGRA, P77, DOI DOI 10.1111/WRR.12195; Raman K, 2012, BIOORG MED CHEM LETT, V22, P4467, DOI 10.1016/j.bmcl.2012.04.014; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047; Sankaranarayanan NV, 2014, GLYCOBIOLOGY, V24, P1323, DOI 10.1093/glycob/cwu077; Sankaranarayanan NV, 2015, METHODS MOL BIOL, V1229, P289, DOI 10.1007/978-1-4939-1714-3_24; Sattelle BM, 2013, BIOMACROMOLECULES, V14, P1149, DOI 10.1021/bm400067g; Sattelle BM, 2010, J AM CHEM SOC, V132, P13132, DOI 10.1021/ja1054143; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sidhu PS, 2013, J MED CHEM, V56, P5059, DOI 10.1021/jm400369q; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; TVAROSKA I, 1989, ADV CARBOHYD CHEM BI, V47, P45; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Woods RJ, 2010, CURR OPIN STRUC BIOL, V20, P575, DOI 10.1016/j.sbi.2010.07.005; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	66	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171619	10.1371/journal.pone.0171619	http://dx.doi.org/10.1371/journal.pone.0171619			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182755	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800080
J	Wu, CY; Lu, YY; Lu, CC; Su, YF; Tsai, TH; Wu, CH				Wu, Ching-Ying; Lu, Ying-Yi; Lu, Chun-Ching; Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin			Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; VITAMIN-D; CARDIOVASCULAR-DISEASES; HIP FRACTURE; RISK; TAIWAN; WOMEN; ASSOCIATION	The aim of this study was to investigate osteoporosis risk in atopic dermatitis (AD) patients. This study included patients in the Taiwan National Health Insurance Research dataset. The population-based study included all patients aged 20-49 years who had been diagnosed with AD during 1996-2010. In total, 35,229 age and gender-matched patients without AD in a 1:1 ratio were randomly selected as the non-AD group. Cox proportional-hazards regression and Kaplan-Meier analyses were used to measure the hazard ratios and the cumulative incidences of osteoporosis, respectively. During the follow-up period, 360 (1.02%) AD patients and 127(0.36%) non-AD patients developed osteoporosis. The overall incidence of osteoporosis was4.72-fold greater in the AD patients compared to the non-AD patients (1.82 vs. 0.24 per 1,000 person-years, respectively) after adjusting for potential confounding factors. Osteoporosis risk factors included female gender, age, advanced Charlson Comorbidity Index, depression and use of corticosteroids. The dataset analysis showed that AD was significantly associated with subsequent risk of osteoporosis.	[Wu, Ching-Ying] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Wu, Ching-Ying; Lu, Ying-Yi; Wu, Chieh-Hsin] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan; [Lu, Chun-Ching] Taipei Vet Gen Hosp, Dept Orthoped, Taipei, Taiwan; [Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wu, CH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan.	wujoeys@gmail.com		Wu, Ching-Ying/0000-0002-3645-5117; Su, Yu-feng/0000-0003-0355-3981				AaltoKorte K, 1997, BRIT J DERMATOL, V136, P172; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Boyanov M, 2003, CLIN RHEUMATOL, V22, P318, DOI 10.1007/s10067-003-0743-0; Chen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002086; Cheng CM, 2015, J AFFECT DISORDERS, V178, P60, DOI 10.1016/j.jad.2015.02.025; Chow SN, 1997, J FORMOS MED ASSOC, V96, P806; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Finlay AY, 2001, J AM ACAD DERMATOL, V45, pS64, DOI 10.1067/mjd.2001.117010; Guttman-Yassky E, 2013, EXPERT OPIN BIOL TH, V13, P549, DOI 10.1517/14712598.2013.758708; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Haeck IM, 2009, BRIT J DERMATOL, V161, P1248, DOI 10.1111/j.1365-2133.2009.09327.x; Hashiro M, 1997, J DERMATOL SCI, V14, P63, DOI 10.1016/S0923-1811(96)00553-1; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Hwang CY, 2013, J PEDIATR-US, V163, P811, DOI 10.1016/j.jpeds.2013.03.068; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Keller JJ, 2013, OSTEOPOROSIS INT, V24, P1835, DOI 10.1007/s00198-012-2185-5; Lai SW, 2013, J EPIDEMIOL, V23, P109, DOI 10.2188/jea.JE20120071; Lin CH, 2016, BRIT J DERMATOL, V174, P88, DOI 10.1111/bjd.14166; Lin CH, 2015, BONE, V72, P9, DOI 10.1016/j.bone.2014.11.007; Lippuner K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13624; Lodder MC, 2004, ANN RHEUM DIS, V63, P1576, DOI 10.1136/ard.2003.016253; Mutgi K, 2013, PEDIATR DERMATOL, V30, P303, DOI 10.1111/j.1525-1470.2012.01850.x; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oren E, 2008, J ALLERGY CLIN IMMUN, V121, P533, DOI 10.1016/j.jaci.2007.11.005; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Pedreira CC, 2007, PEDIATR DERMATOL, V24, P613, DOI 10.1111/j.1525-1470.2007.00549.x; Peterlik M, 2009, INT J ENV RES PUB HE, V6, P2585, DOI 10.3390/ijerph6102585; Ramsey-Goldman R, 1999, ARTHRITIS RHEUM, V42, P882, DOI 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C; Schmitt J, 2013, J ALLERGY CLIN IMMUN, V132, P1337, DOI 10.1016/j.jaci.2013.07.008; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Silverberg JI, 2015, ALLERGY; Silverberg JI, 2015, J ALLERGY CLIN IMMUN, V135, P721, DOI 10.1016/j.jaci.2014.11.023; Silverberg JI, 2015, PEDIAT ALLERG IMM-UK, V26, P54, DOI 10.1111/pai.12315; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Tsai MS, 2015, INT J CLIN PRACT, V69, P235, DOI 10.1111/ijcp.12526; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; van Velsen SGA, 2010, J AM ACAD DERMATOL, V63, P824, DOI 10.1016/j.jaad.2009.12.015; Wang TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132447; Weller MSD, 2013, CLIN EXP ALLERGY, V43, P279, DOI 10.1111/cea.12030; Wu Q, 2009, OSTEOPOROSIS INT, V20, P1309, DOI 10.1007/s00198-009-0918-x; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009; Zhang A, 2015, J AM ACAD DERMATOL, V72, P606, DOI 10.1016/j.jaad.2014.12.013	45	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171667	10.1371/journal.pone.0171667	http://dx.doi.org/10.1371/journal.pone.0171667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207767	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500044
J	Chabalko, MJ; Shahmohammadi, M; Sample, AP				Chabalko, Matthew J.; Shahmohammadi, Mohsen; Sample, Alanson P.			Quasistatic Cavity Resonance for Ubiquitous Wireless Power Transfer	PLOS ONE			English	Article							EFFICIENCY; FIELD	Wireless power delivery has the potential to seamlessly power our electrical devices as easily as data is transmitted through the air. However, existing solutions are limited to near contact distances and do not provide the geometric freedom to enable automatic and un-aided charging. We introduce quasistatic cavity resonance (QSCR), which can enable purposebuilt structures, such as cabinets, rooms, and warehouses, to generate quasistatic magnetic fields that safely deliver kilowatts of power to mobile receivers contained nearly anywhere within. A theoretical model of a quasistatic cavity resonator is derived, and field distributions along with power transfer efficiency are validated against measured results. An experimental demonstration shows that a 54 m(3) QSCR room can deliver power to small coil receivers in nearly any position with 40% to 95% efficiency. Finally, a detailed safety analysis shows that up to 1900 watts can be transmitted to a coil receiver enabling safe and ubiquitous wireless power.	[Chabalko, Matthew J.; Shahmohammadi, Mohsen; Sample, Alanson P.] Disney Res, 4720 Forbes Ave,Lower Level,Suite 110, Pittsburgh, PA 15213 USA		Sample, AP (corresponding author), Disney Res, 4720 Forbes Ave,Lower Level,Suite 110, Pittsburgh, PA 15213 USA.	alanson.sample@disneyresearch.com		Chabalko, Matthew/0000-0002-9618-0522; Sample, Alanson/0000-0002-8046-0538	Disney Research	Disney Research	Disney Research provided support in the form of salaries for authors MC, MS, and AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdolkhani A, 2013, IEEE IND ELEC, P1416, DOI 10.1109/IECON.2013.6699340; Chabalko M, 2014, IEEE ANTENNAS PROP, P645, DOI 10.1109/APS.2014.6904653; Chabalko MJ, 2015, IEEE T POWER ELECTR, V30, P6163, DOI 10.1109/TPEL.2015.2440914; Chabalko MJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904344; Cheng DK, 2014, FUNDAMENTALS ENG ELE; Choi J, 2012, EUR MICROW CONF, P916; Christ A, 2013, IEEE T ELECTROMAGN C, V55, P265, DOI 10.1109/TEMC.2012.2219870; Deyle T, 2008, IEEE INT CONF ROBOT, P1036, DOI 10.1109/ROBOT.2008.4543341; Finkenzeller K., 1999, RFID HDB RADIO FREQU; Ghotbi I, 2015, IRAN CONF ELECTR ENG, P1249, DOI 10.1109/IranianCEE.2015.7146407; Hans S, 1964, Patent No. [US3143697 A, 3143697]; Hoang H, 2012, IEEE T CONSUM ELECTR, V58, P327, DOI 10.1109/TCE.2012.6227430; Institute of Electrical and Electronics Engineers (IEEE), 1992, SCC28 IEEE; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Jang Y. J., 2012, P IEEE INT EL VEH C, P1, DOI DOI 10.1109/1EVC.2012.6183294; KAJFEZ D, 1984, IEEE T MICROW THEORY, V32, P666, DOI 10.1109/TMTT.1984.1132751; Kuo R. C., 2015, P 2015 IEEE WIR POW, P1; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Li PF, 2007, IEEE T CIRCUITS-II, V54, P912, DOI 10.1109/TCSII.2007.901613; Mitsuhashi N, 2009, NUCLEIC ACIDS RES, V37, pD782, DOI 10.1093/nar/gkn613; Ng WM, 2014, IEEE T POWER ELECTR, V29, P4470, DOI 10.1109/TPEL.2014.2300866; Parks AN, 2013, IEEE TOPIC CONF BIOM, P154, DOI 10.1109/BioWireleSS.2013.6613706; Ricketts DS, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788748; Sample AP, 2011, IEEE T IND ELECTRON, V58, P544, DOI 10.1109/TIE.2010.2046002; Schauer DA, 2009, RADIOLOGY, V253, P293, DOI 10.1148/radiol.2532090494; Scheible G, 2002, IEEE IND ELEC, P1358, DOI 10.1109/IECON.2002.1185473; Tesla N., 1914, U.S. Patent, Patent No. 1119732; Waters BH, 2014, IEEE INT SYMP CIRC S, P2045, DOI 10.1109/ISCAS.2014.6865567; Waters BH, 2012, P IEEE, V100, P138, DOI 10.1109/JPROC.2011.2165309; Zargham M, 2012, IEEE T BIOMED CIRC S, V6, P228, DOI 10.1109/TBCAS.2011.2174794	30	31	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169045	10.1371/journal.pone.0169045	http://dx.doi.org/10.1371/journal.pone.0169045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199321	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400004
J	Fu, CH; Tseng, HJ; Huang, CC; Chang, PH; Chen, YW; Lee, TJ				Fu, Chia-Hsiang; Tseng, Hsiao-Jung; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen			Nasal nitric oxide in unilateral sinus disease	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; SINONASAL DISEASE	Unilateral sinus disease (USD) can sometimes be difficult to accurately diagnose before surgery. The application of nasal nitric oxide (nNO) for USD diagnosis and its surgical outcome in USD has not been reported in the literature. We prospectively enrolled sixty-six USD patients who underwent endoscopic sinus surgery for fungal rhinosinusitis (n = 19), chronic rhinosinusitis (CRS) without nasal polyps (n = 13), CRS with nasal polyps (n = 12) and sinonasal mass lesions (n = 22). nNO levels were measured preoperatively and at three and six months postoperatively. Correlations between nNO levels and potential clinical parameters, type of disease, disease severity, and disease-related quality of life (QOL) were assessed. Unlike bilateral CRS, in USD, nNO levels did not correlate with disease severity or postoperative QOL improvements. Except for fungus group, there were no differences in nNO levels between lesion and non-lesion sides in all the other groups. nNO levels on both sides were significantly elevated six months postoperatively in all groups. Fungal rhinosinusitis patients had the lowest preoperative nNO levels, and a cutoff of 239.3 ppb had the best sensitivity (79.0%) and specificity (87.2%) for preoperative diagnosis. While preoperative nNO levels cannot serve as an alternative marker for disease severity of USD, they were lower in fungal rhinosinusitis patients than in other USD patients and may be useful for more accurate diagnosis prior to surgery.	[Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tseng, Hsiao-Jung] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lee, TJ (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan.; Lee, TJ (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.	entlee@adm.cgmh.org.tw	Chen, Yi/HIR-2608-2022	Lee, Ta-Jen/0000-0003-0508-1359	Chang Gung Memorial Hospital [CMRPG3E1671, CMRPG3A1003]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital (CMRPG3E1671 and CMRPG3A1003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Collette JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096203; Deroee AF, 2009, AM J RHINOL ALLERGY, V23, P159, DOI 10.2500/ajra.2009.23.3289; EICHEL BS, 1977, LARYNGOSCOPE, V87, P737, DOI 10.1002/lary.5540870509; Ferguson BJ, 2000, OTOLARYNG CLIN N AM, V33, P389, DOI 10.1016/S0030-6665(00)80013-4; Ferreiro JA, 1997, HEAD NECK-J SCI SPEC, V19, P481, DOI 10.1002/(SICI)1097-0347(199709)19:6&lt;481::AID-HED4&gt;3.0.CO;2-V; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fu CH, 2015, AM J RHINOL ALLERGY, V29, pE187, DOI 10.2500/ajra.2015.29.4249; Ikeda K, 1997, ARCH OTOLARYNGOL, V123, P198; JAIN B, 1993, BIOCHEM BIOPH RES CO, V191, P83, DOI 10.1006/bbrc.1993.1187; Jeong JH, 2014, AM J RHINOL ALLERGY, V28, pE11, DOI 10.2500/ajra.2014.28.3984; Li DD, 2016, INDIAN J MICROBIOL, V56, P214, DOI 10.1007/s12088-016-0580-x; Phillips PS, 2011, OTOLARYNG HEAD NECK, V144, P159, DOI 10.1177/0194599810392667; Ragab SM, 2006, ALLERGY, V61, P717, DOI 10.1111/j.1398-9995.2006.01044.x; Sidhu R, 2014, GCSMC J MED SCI, V3, P42; Silva MP, 2015, INT FORUM ALLERGY RH, V5, P590, DOI 10.1002/alr.21526; Soler ZM, 2010, OTOLARYNG HEAD NECK, V143, P621, DOI 10.1016/j.otohns.2010.07.014; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wodehouse T, 2003, EUR RESPIR J, V21, P43, DOI 10.1183/09031936.03.00305503; Yoon JH, 1999, AM J NEURORADIOL, V20, P571	20	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171965	10.1371/journal.pone.0171965	http://dx.doi.org/10.1371/journal.pone.0171965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199369	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400061
J	Zhang, X; Zhou, ZL; Cheng, D				Zhang, Xi; Zhou, Zhili; Cheng, Dong			Efficient path routing strategy for flows with multiple priorities on scale-free networks	PLOS ONE			English	Article							TRAFFIC FLOW; COMPLEX; CONGESTION; TRANSITION; DYNAMICS	In real networks, traffic flows are different in amount as well as their priorities. However, the latter priority has rarely been examined in routing strategy studies. In this paper, a novel routing algorithm, which is based on the efficient path routing strategy (EP), is proposed to overcome network congestion problem caused by large amount of traffic flows with different priorities. In this scheme, traffic flows with different priorities are transmitted through different routing paths, which are based on EP with different parameters. Simulation results show that the traffic capacity for flows with different priorities can be enhanced by 12% with this method, compared with EP. In addition, the new method contributes to more balanced network traffic load distribution and reduces average transmission jump and delay of packets.	[Zhang, Xi; Zhou, Zhili; Cheng, Dong] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China	Xi'an Jiaotong University	Zhang, X (corresponding author), Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China.	xjtu_zhangxi@163.com						Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen SY, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/732698; Chen ZY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036107; Danila B, 2007, CHAOS, V17, DOI 10.1063/1.2731718; Danila B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046106; Danila B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066116; De Martino D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/08/P08023; De Martino D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.015101; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; Echenique P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056105; Echenique P, 2005, EUROPHYS LETT, V71, P325, DOI 10.1209/epl/i2005-10080-8; Ericsson M, 2002, J COMB OPTIM, V6, P299, DOI 10.1023/A:1014852026591; Fortz B, 2002, IEEE J SEL AREA COMM, V20, P756, DOI 10.1109/JSAC.2002.1003042; Guan ZH, 2011, PHYSICA A, V390, P1131, DOI 10.1016/j.physa.2010.10.002; Guimera R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026704; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Huang W, 2010, CHAOS, V20, DOI 10.1063/1.3490745; Huang W, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/01/P01016; Jiang Z, 2013, PLOS ONE; Jiang ZY, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500167; Kawamoto H, 2012, PHYSICA A, V391, P895, DOI 10.1016/j.physa.2011.08.064; Kim K, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/58002; Li K, 2011, INT J MOD PHYS B, V25, P1419, DOI 10.1142/S0217979211100655; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Ling X, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066110; Liu Z, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.037101; Low SH, 2002, IEEE CONTROL SYSTEMS, V22; Ohira T, 1998, PHYS REV E, V58, P193, DOI 10.1103/PhysRevE.58.193; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Tan F, 2013, PHYSICA A, V392, P4146, DOI 10.1016/j.physa.2013.04.032; Wang K, 2011, PHYSICA A, V390, P2593, DOI 10.1016/j.physa.2011.01.026; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016101; Wang WX, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026111; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xia YX, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58004; Xia YX, 2006, IEEE INT SYMP CIRC S, P2625; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Yin CY, 2006, PHYS LETT A, V351, P220, DOI 10.1016/j.physleta.2005.10.104; Yu Y, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/48004; Zhang GQ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.017101; Zhang H, 2007, PHYS LETT A, V364, P177, DOI 10.1016/j.physleta.2006.12.009; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125; Zhou SY, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/8/080501	45	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172035	10.1371/journal.pone.0172035	http://dx.doi.org/10.1371/journal.pone.0172035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199382	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400068
J	Dehbandi, B; Barachant, A; Smeragliuolo, AH; Long, JD; Bumanlag, SJ; He, V; Lampe, A; Putrino, D				Dehbandi, Behdad; Barachant, Alexandre; Smeragliuolo, Anna H.; Long, John Davis; Bumanlag, Silverio Joseph; He, Victor; Lampe, Anna; Putrino, David			Using data from the Microsoft Kinect 2 to determine postural stability in healthy subjects: A feasibility trail	PLOS ONE			English	Article							BERG BALANCE SCALE; XBOX ONE KINECT; CONCURRENT VALIDITY; CLINICAL-ASSESSMENT; RELIABILITY; REHABILITATION; CLASSIFICATION; UTILITY; PEOPLE; CAMERA	The objective of this study was to determine whether kinematic data collected by the Microsoft Kinect 2 (MK2) could be used to quantify postural stability in healthy subjects. Twelve subjects were recruited for the project, and were instructed to perform a sequence of simple postural stability tasks. The movement sequence was performed as subjects were seated on top of a force platform, and the MK2 was positioned in front of them. This sequence of tasks was performed by each subject under three different postural conditions: "both feet on the ground" (1), "One foot off the ground" (2), and "both feet off the ground" (3). We compared force platform and MK2 data to quantify the degree to which the MK2 was returning reliable data across subjects. We then applied a novel machine-learning paradigm to the MK2 data in order to determine the extent to which data from the MK2 could be used to reliably classify different postural conditions. Our initial comparison of force plate and MK2 data showed a strong agreement between the two devices, with strong Pearson correlations between the trunk centroids "Spine_Mid" (0.85 +/- 0.06), "Neck" (0.86 +/- 0.07) and "Head" (0.87 +/- 0.07), and the center of pressure centroid inferred by the force platform. Mean accuracy for the machine learning classifier from MK2 was 97.0%, with a specific classification accuracy breakdown of 90.9%, 100%, and 100% for conditions 1 through 3, respectively. Mean accuracy for the machine learning classifier derived from the force platform data was lower at 84.4%. We conclude that data from the MK2 has sufficient information content to allow us to classify sequences of tasks being performed under different levels of postural stability. Future studies will focus on validating this protocol on large populations of individuals with actual balance impairments in order to create a toolkit that is clinically validated and available to the medical community.	[Dehbandi, Behdad; Smeragliuolo, Anna H.; Lampe, Anna; Putrino, David] Burke Med Res Inst, Dept Telemed & Virtual Rehabil, White Plains, NY 10605 USA; [Dehbandi, Behdad; Smeragliuolo, Anna H.; Putrino, David] Weill Cornell Med Coll, Dept Rehabil Med, New York, NY 10065 USA; [Barachant, Alexandre] Burke Med Res Inst, Clin Lab Early Brain Injury Recovery, White Plains, NY USA; [Long, John Davis] NYU, Langone Sch Med, New York, NY USA; [Bumanlag, Silverio Joseph; He, Victor] Mercy Coll, Dept Phys Therapy, Dobbs Ferry, NY 10522 USA	Cornell University; New York University; NYU Langone Medical Center	Putrino, D (corresponding author), Burke Med Res Inst, Dept Telemed & Virtual Rehabil, White Plains, NY 10605 USA.; Putrino, D (corresponding author), Weill Cornell Med Coll, Dept Rehabil Med, New York, NY 10065 USA.	dap3002@med.cornell.edu		Putrino, David/0000-0002-2232-3324	Burke Medical Research Institute	Burke Medical Research Institute	This research was funded by the Burke Medical Research Institute.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Burke Medical Research Institute for their generous support of this research.	Adlerton Anna-Karin, 2003, Physiother Res Int, V8, P187, DOI 10.1002/pri.289; [Anonymous], 2003, J PHYS THERAPY SCI, DOI [10.1589/jpts.15.93, DOI 10.1589/JPTS.15.93]; Arnaudon M, 2013, IEEE J-STSP, V7, P595, DOI 10.1109/JSTSP.2013.2261798; Baldewijns G, 2014, IEEE ENG MED BIO, P5920, DOI 10.1109/EMBC.2014.6944976; Barachant A, 2013, NEUROCOMPUTING, V112, P172, DOI 10.1016/j.neucom.2012.12.039; Barachant A, 2012, IEEE T BIO-MED ENG, V59, P920, DOI 10.1109/TBME.2011.2172210; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Bonnechere B, 2014, GAIT POSTURE, V39, P593, DOI 10.1016/j.gaitpost.2013.09.018; Chan C. L., 2012, 2012 Second International Conference on Digital Information and Communication Technology and it's Applications (DICTAP), P159, DOI 10.1109/DICTAP.2012.6215343; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Congedo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121423; Datta S, 2012, ARCH PHYS MED REHAB, V93, P1565, DOI 10.1016/j.apmr.2012.01.026; Eroglu S., 2012, SAUDI MED J, P3; Forstner W, 2003, AMETRIE COVARIANCE M; Frykberg GE, 2007, J REHABIL MED, V39, P448, DOI 10.2340/16501977-0071; Funaya H, 2013, INT SYM MED INFORM, P213, DOI 10.1109/ISMICT.2013.6521731; Harel NY, 2013, J SPINAL CORD MED, V36, P127, DOI 10.1179/2045772312Y.0000000053; Hebert-Losier K, 2014, J STRENGTH COND RES, V28, P1849, DOI 10.1519/JSC.0000000000000343; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Howland Jonathan, 2015, Inj Epidemiol, V2, P25; Hussein Mohamed E, 2013, 23 INT JOINT C ART I; Jbabdi Myriam, 2008, BMC Geriatr, V8, P8, DOI 10.1186/1471-2318-8-8; Kumar M. S. N., 2012, P 8 IND C COMP VIS G, P1; Li WB, 2010, 2010 THE 3RD INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND INDUSTRIAL APPLICATION (PACIIA2010), VOL I, P9, DOI 10.1109/cvprw.2010.5543273; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Moakher M, 2005, SIAM J MATRIX ANAL A, V26, P735, DOI 10.1137/S0895479803436937; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Putrino D, 2014, CURR OPIN NEUROL, V27, P631, DOI 10.1097/WCO.0000000000000152; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stone E, 2011, J AMB INTEL SMART EN, V3, P349, DOI 10.3233/AIS-2011-0124; Suma EA, 2011, P IEEE VIRT REAL ANN, P247, DOI 10.1109/VR.2011.5759491; Tao D, 2013, IEEE T IND INFORM, V10, P1; Tao Dapeng, 2014, IEEE T NEURAL NETWOR, P1; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Vernadakis N, 2014, PHYS THER SPORT, V15, P148, DOI 10.1016/j.ptsp.2013.08.004; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Yang Y, 2016, LATENT MAX MARGIN MU, P1; Yang Y, 2014, IEEE SENS J, V14, P1633, DOI 10.1109/JSEN.2013.2296509; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	44	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170890	10.1371/journal.pone.0170890	http://dx.doi.org/10.1371/journal.pone.0170890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196139	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900007
J	Rovira, S; Puertas, E; Igual, L				Rovira, Sergi; Puertas, Eloi; Igual, Laura			Data-driven system to predict academic grades and dropout	PLOS ONE			English	Article							MODEL	Nowadays, the role of a tutor is more important than ever to prevent students dropout and improve their academic performance. This work proposes a data-driven system to extract relevant information hidden in the student academic data and, thus, help tutors to offer their pupils a more proactive personal guidance. In particular, our system, based on machine learning techniques, makes predictions of dropout intention and courses grades of students, as well as personalized course recommendations. Moreover, we present different visualizations which help in the interpretation of the results. In the experimental validation, we show that the system obtains promising results with data from the degree studies in Law, Computer Science and Mathematics of the Universitat de Barcelona.	[Rovira, Sergi; Puertas, Eloi; Igual, Laura] Univ Barcelona, Dept Matemat & Informat, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain	University of Barcelona	Igual, L (corresponding author), Univ Barcelona, Dept Matemat & Informat, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain.	ligual@ub.edu	Igual, Laura/H-5606-2015; Puertas, Eloi/F-9425-2016	Igual, Laura/0000-0002-7225-7441; Puertas, Eloi/0000-0001-6292-6448; Rovira Cisterna, Sergi/0000-0001-8440-9345	Spanish Ministry of Science and Innovation [TIN2013-43478-P, TIN2015-66951-C2-1-R]; Catalan Government award [SGR-1219, SGR-561]; Universitat de Barcelona (INDOMAIN Innovation and Teaching Group) [2014PID-UB/068, REDICE-1602]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government award; Universitat de Barcelona (INDOMAIN Innovation and Teaching Group)	This work was supported by Spanish Ministry of Science and Innovation (Grant TIN2013-43478-P and Grant TIN2015-66951-C2-1-R), by Catalan Government award 2014 SGR-1219 and SGR-561 and by Universitat de Barcelona (Grant 2014PID-UB/068 and Grant REDICE-1602 of the INDOMAIN Innovation and Teaching Group).	[Anonymous], 2016, INDICATORS ED DEV AN; [Anonymous], 2013, ED GLANC OECD IND; Belloc F, 2010, J APPL STAT, P1; Bernardo-Gutierrez AB, 2016, REV FUENTES; Casaravilla A., 2014, REV PENSAMLENTO MATE, V4, P7; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Davila N, 2015, RIE-REV INVESTIG EDU, V33, P27, DOI 10.6018/rie.33.1.178481; de Wit H., 2007, EUROPEAN INTEGRATION, P461; Duque LC, 2014, TOTAL QUAL MANAG BUS, V25, P1, DOI 10.1080/14783363.2013.807677; Esteban G. M., 2016, AULA ABIERTA, V44, P1, DOI [10.1016/j.aula.2015.04.001, DOI 10.1016/J.AULA.2015.04.001]; Gairin J, 2014, QUAL HIGH EDUC, V20, P165, DOI 10.1080/13538322.2014.925230; Goldenhersh H., 2011, REV ARGENTINA ED SUP, V3, P96; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Huberth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137001; Iba W, 1992, P 10 C ART INT, P223; KNIGHT WR, 1966, J AM STAT ASSOC, V61, P436, DOI 10.2307/2282833; Learning J., 2013, ED STUDIES, V39, P261, DOI [10.1080/03055698.2012.724353, DOI 10.1080/03055698.2012.724353]; Lemaitre G., 2016, CORR; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Montmarquette C, 2001, ECON EDUC REV, V20, P475, DOI 10.1016/S0272-7757(00)00029-7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rennie J., 2003, P 20 INT C MACH LEAR, ppp; Rodriguez-Gomez D, 2015, STUD HIGH EDUC, V40, P690, DOI 10.1080/03075079.2013.842966; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shani G, 2011, RECOMMENDER SYSTEMS HANDBOOK, P257, DOI 10.1007/978-0-387-85820-3_8; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tekin A, 2014, EURASIAN J EDUC RES, P207, DOI 10.14689/ejer.2014.54.12; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Tinto V, 2006, J COLL STUD RETENT-R, V8, P1; Van Soom C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112489; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	34	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171207	10.1371/journal.pone.0171207	http://dx.doi.org/10.1371/journal.pone.0171207			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196078	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900013
J	Greer, JMH; Hamilton, C; McMullon, MEG; Riby, DM; Riby, LM				Greer, Joanna M. H.; Hamilton, Colin; McMullon, Mhairi E. G.; Riby, Deborah M.; Riby, Leigh M.			An event related potential study of ihibitory and attentional control in Williams syndrome adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LONG-TERM-MEMORY; DOWN-SYNDROME; EXECUTIVE FUNCTIONS; RESPONSE-INHIBITION; GENETIC INFLUENCES; COGNITIVE CONTROL; STIMULUS NOVELTY; VISUAL-STIMULI; TASK	The primary aim of the current study was to employ event-related potentials (ERPs) methodology to disentangle the mechanisms related to inhibitory control in older adults with Williams syndrome (WS). Eleven older adults with WS (mean age 42), 16 typically developing adults (mean age 42) and 13 typically developing children (mean age 12) participated in the study. ERPs were recorded during a three-stimulus visual oddball task, during which participants were required to make a response to a rare target stimulus embedded in a train of frequent non-target stimuli. A task -irrelevant infrequent stimulus was also present at randomised intervals during the session. The P3a latency data response related to task -irrelevant stimulus processing was delayed in WS. In addition, the early perceptual N2 amplitude was attenuated. These data are indicative of compromised early monitoring of perceptual input, accompanied by appropriate orientation of responses to task -irrelevant stimuli. However, the P3a delay suggests inefficient evaluation of the task -irrelevant stimuli. These data are discussed in terms of deficits in the disengagement of attentional processes, and the regulation of monitoring processes required for successful inhibition.	[Greer, Joanna M. H.; Hamilton, Colin; McMullon, Mhairi E. G.; Riby, Leigh M.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Riby, Deborah M.] Univ Durham, Dept Psychol, Durham, England	Northumbria University; Durham University	Riby, LM (corresponding author), Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England.	leigh.riby@northumbria.ac.uk	Riby, Deborah M/G-8474-2013	Riby, Deborah M/0000-0001-5747-8441	Psychology department at Northumbria University	Psychology department at Northumbria University	The research was conducted as part of a PhD thesis, therefore there was no source of external or internal funding apart from the student's travel expenses supplied by the Psychology department at Northumbria University.	Atkinson J, 2011, PROG BRAIN RES, V189, P261, DOI 10.1016/B978-0-444-53884-0.00029-4; Bachiller A, 2015, SCHIZOPHR RES, V169, P318, DOI 10.1016/j.schres.2015.09.028; Barron E., 2011, PSYCHOL SCI; Barry RJ, 2009, INT J PSYCHOPHYSIOL, V71, P124, DOI 10.1016/j.ijpsycho.2008.09.009; Brinkman MJR, 2007, CLIN NEUROPHYSIOL, V118, P1517, DOI 10.1016/j.clinph.2007.04.002; Brock J, 2007, DEV PSYCHOPATHOL, V19, P97, DOI 10.1017/S095457940707006X; Brown JH, 2003, NEUROPSYCHOLOGIA, V41, P1037, DOI 10.1016/S0028-3932(02)00299-3; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Clery H, 2013, PSYCHOPHYSIOLOGY, V50, P240, DOI 10.1111/psyp.12006; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Cornish K, 2007, CORTEX, V43, P672, DOI 10.1016/S0010-9452(08)70497-0; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Daffner KR, 2015, BIOL PSYCHOL; del Re EC, 2015, PSYCHIAT RES-NEUROIM, V231, P126, DOI 10.1016/j.pscychresns.2014.11.012; Donchin E., 1978, EVENT RELAT BRAIN PO, V349, P411; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frigerio E, 2006, NEUROPSYCHOLOGIA, V44, P254, DOI 10.1016/j.neuropsychologia.2005.05.008; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Greer J, 2013, RES DEV DISABIL, V34, P4170, DOI 10.1016/j.ridd.2013.08.041; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P456, DOI 10.1016/j.neuropsychologia.2009.10.003; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Karmiloff-Smith A, 2013, Q J EXP PSYCHOL, V66, P1, DOI 10.1080/17470218.2012.744424; Key APF, 2011, J NEURODEV DISORD, V3, P28, DOI 10.1007/s11689-010-9064-1; Key AP, 2015, SOCIAL NEUROSCIENCE; Kim H, 2014, HUM BRAIN MAPP, V35, P2265, DOI 10.1002/hbm.22326; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Landau B, 2006, COGNITION, V100, P483, DOI 10.1016/j.cognition.2005.06.005; Lincoln A, 2002, NEUROCASE, V8, P226, DOI 10.1093/neucas/8.3.226; Little K, 2013, RES DEV DISABIL, V34, P959, DOI 10.1016/j.ridd.2012.11.020; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Mills DL, 2013, DEV NEUROPSYCHOL, V38, P613, DOI 10.1080/87565641.2013.825617; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osborne A, 2016, RES PSYCHOL BEHAV SC, V4, P1, DOI DOI 10.12691/rpbs-4-1-1; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J., 2003, THEORETICAL OVERVIEW; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Riby DM, 2014, J INTELL DISABIL RES, V58, P572, DOI 10.1111/jir.12055; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2011, J AUTISM DEV DISORD, V41, P1228, DOI 10.1007/s10803-010-1141-5; Riby LM, 2013, BRAIN COGNITION, V81, P215, DOI 10.1016/j.bandc.2012.10.011; Riby LM, 2013, EXPT PSYCHOL; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Scerif G, 2004, DEVELOPMENTAL SCI, V7, P116, DOI 10.1111/j.1467-7687.2004.00327.x; Searcy YM, 2004, AM J MENT RETARD, V109, P231, DOI 10.1352/0895-8017(2004)109<231:TRBAAI>2.0.CO;2; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smit DJA, 2007, TWIN RES HUM GENET, V10, P335, DOI 10.1375/twin.10.2.335; Smith AD, 2009, PERCEPTION, V38, P694, DOI 10.1068/p6050; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Sokhadze E, 2009, APPL PSYCHOPHYS BIOF, V34, P37, DOI 10.1007/s10484-009-9074-5; St- Louis- Deschenes M, 2015, PEDIAT THERAPEUT, V5, P2161, DOI DOI 10.4172/2161-0665.1000238; Steiner GZ, 2013, PSYCHOPHYSIOLOGY, V50, P187, DOI 10.1111/j.1469-8986.2012.01491.x; Stige S, 2007, DEV NEUROPSYCHOL, V32, P563, DOI 10.1080/87565640701361096; Thomas KM, 1996, ELECTROEN CLIN NEURO, V98, P294, DOI 10.1016/0013-4694(95)00280-4; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P720, DOI 10.1016/j.clinph.2011.08.023; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Wetzel N, 2013, PSYCHOPHYSIOLOGY, V50, P920, DOI 10.1111/psyp.12072	87	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170180	10.1371/journal.pone.0170180	http://dx.doi.org/10.1371/journal.pone.0170180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187205	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000394244300005
J	Lin, SC; Wang, SY; Pasquale, LR; Singh, K; Lin, SC				Lin, Shuai-Chun; Wang, Sophia Y.; Pasquale, Louis R.; Singh, Kuldev; Lin, Shan C.			The relation between exercise and glaucoma in a South Korean population-based sample	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR BLOOD-FLOW; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE CHANGES; NUTRITION EXAMINATION SURVEY; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; AUTONOMIC DYSFUNCTION; VARIABILITY ANALYSIS	Purpose To investigate the association between exercise and glaucoma in a South Korean population-based sample. Design Population-based, cross-sectional study. Participants A total of 11,246 subjects, 40 years and older who underwent health care assessment as part of the 2008-2011 Korean National Health and Nutrition Examination Survey. Methods Variables regarding the duration (total minutes per week), frequency (days per week), and intensity of exercise (vigorous, moderate exercise and walking) as well as glaucoma prevalence were ascertained for 11,246 survey participants. Demographic, comorbidity, and health-related behavior information was obtained via interview. Multivariable logistic regression analyses were performed to determine the association between the exercise-related parameters and odds of a glaucoma diagnosis. Main outcome measure(s) Glaucoma defined by International Society for Geographical and Epidemiological Ophthalmology criteria. Results Overall, 336 (2.7%) subjects met diagnostic criteria for glaucomatous disease. After adjustment for potential confounding variables, subjects engaged in vigorous exercise 7 days per week had higher odds of having glaucoma compared with those exercising 3 days per week (Odds Ratio [OR] 3.33, 95% confidence interval [Cl] 1.16-9.54). High intensity of exercise, as categorized by the guidelines of the American College of Sports Medicine (ACSM), was also associated with greater glaucoma prevalence compared with moderate intensity of exercise (OR 1.55, 95% Cl 1.03-2.33). There was no association between other exercise parameters including frequency of moderate exercise, walking, muscle strength exercise, flexibility training, or total minutes of exercise per week, and the prevalence of glaucoma. In sub-analyses stratifying by gender, the association between frequency of vigorous exercise 7 days per week and glaucoma diagnosis remained significant in men (OR 6.05, 95% Cl 1.67-21.94) but not in women (OR 0.96 95% Cl: 0.23-3.97). A U-shaped association between exercise intensity and glaucoma prevalence was noted in men (OR 1.71, 95% Cl 1.09-2.69 for low intensity versus moderate intensity; OR 2.19, 95% Cl 1.25-3.85 for high intensity versus moderate intensity). Conclusion In a South Korean population sample, daily vigorous exercise was associated with higher glaucoma prevalence. In addition, the intensity of exercise was positively associated with glaucoma diagnosis in men but not women.	[Lin, Shuai-Chun; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Lin, Shuai-Chun] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan; [Wang, Sophia Y.] Univ Michigan, Kellogg Eye Inst, Ann Arbor, MI 48109 USA; [Pasquale, Louis R.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Glaucoma Serv, Boston, MA USA; [Pasquale, Louis R.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Singh, Kuldev] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; National Yang Ming Chiao Tung University; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	LinS@vision.ucsf.edu		Wang, Sophia/0000-0003-0916-9403	National Eye Institute P30 Core Grant For Vision Research; Man May See, Inc; Research to Prevent Blindness Unrestricted Grant; Harvard Glaucoma Center of Excellence;  [EY015473]	National Eye Institute P30 Core Grant For Vision Research; Man May See, Inc; Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; 	This study was supported by the National Eye Institute P30 Core Grant For Vision Research (Dr. ShanC. Lin); by That Man May See, Inc (Dr. Shan C. Lin); by Research to Prevent Blindness Unrestricted Grant (Dr. Shan C. Lin); by the Harvard Glaucoma Center of Excellence and by EY015473 (Dr. Louis R. Pasquale).None of the sponsors or funding organizations had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, orapproval of the manuscript; and decision to submit the manuscript for publication.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson DR, 1999, SURV OPHTHALMOL, V43, pS5, DOI 10.1016/S0039-6257(99)00046-6; [Anonymous], 2010, ACSMS GUIDELINES EXE; ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80; Baskaran M, 2006, OPHTHALMOLOGY, V113, P1327, DOI 10.1016/j.ophtha.2006.02.063; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Boltz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082351; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Chrysostomou V., 2016, AGING CELL; Chrysostomou V, 2014, NEUROBIOL AGING, V35, P1722, DOI 10.1016/j.neurobiolaging.2014.01.019; CRUICKSHANKS KJ, 1995, OPHTHALMOLOGY, V102, P1177, DOI 10.1016/S0161-6420(95)30893-7; Dickerman RD, 1999, NEUROL RES, V21, P243, DOI 10.1080/01616412.1999.11740925; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Evans DW, 1999, BRIT J OPHTHALMOL, V83, P809, DOI 10.1136/bjo.83.7.809; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Galambos P, 2006, OPHTHALMOLOGY, V113, P1832, DOI 10.1016/j.ophtha.2006.05.030; Gale J, 2009, SURV OPHTHALMOL, V54, P349, DOI 10.1016/j.survophthal.2009.02.005; GRUNWALD JE, 1984, OPHTHALMOLOGY, V91, P1690; Gugleta K, 2003, INVEST OPHTH VIS SCI, V44, P1573, DOI 10.1167/iovs.02-0521; HAYNES WL, 1992, OPHTHALMOLOGY, V99, P1096; Iester M, 2007, OPHTHALMOLOGICA, V221, P180, DOI 10.1159/000099298; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kang HK, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002089; Khan JC, 2002, BRIT J OPHTHALMOL, V86, P1089, DOI 10.1136/bjo.86.10.1089; Kim YK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE.]; Knudtson MD, 2006, BRIT J OPHTHALMOL, V90, P1461, DOI 10.1136/bjo.2006.103796; KRISKA AM, 1991, J CLIN EPIDEMIOL, V44, P1207, DOI 10.1016/0895-4356(91)90153-Z; Kruk J, 2016, MINI-REV MED CHEM, V16, P241, DOI 10.2174/1389557516666151120114605; LANIGAN LP, 1989, EYE, V3, P39, DOI 10.1038/eye.1989.6; LANIGAN LP, 1988, EYE, V2, P412, DOI 10.1038/eye.1988.75; Lee HT, 2015, CORONARY ARTERY DIS, V26, P66, DOI 10.1097/MCA.0000000000000165; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148412; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Lovasik JV, 2003, INVEST OPHTH VIS SCI, V44, P2126, DOI 10.1167/iovs.02-0825; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Morgan AJ, 2007, BRIT J OPHTHALMOL, V91, P385, DOI 10.1136/bjo.2006.098574; Movaffaghy A, 1998, EXP EYE RES, V67, P561, DOI 10.1006/exer.1998.0556; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; Okuno T, 2004, EYE, V18, P697, DOI 10.1038/sj.eye.6700749; PASSO MS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1096, DOI 10.1001/archopht.1991.01080080056027; Pournaras CJ, 2004, EUR J OPHTHALMOL, V14, P226, DOI 10.1177/112067210401400307; Ramulu PY, 2012, OPHTHALMOLOGY, V119, P1159, DOI 10.1016/j.ophtha.2012.01.013; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; Risner D, 2009, J GLAUCOMA, V18, P429, DOI 10.1097/IJG.0b013e31818fa5f3; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; ROSEN DA, 1959, ARCH OPHTHALMOL-CHIC, V62, P810; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Schuman JS, 2000, OPHTHALMOLOGY, V107, P127, DOI 10.1016/S0161-6420(99)00015-9; Terry AL, 2010, OPHTHAL EPIDEMIOL, V17, P411, DOI 10.3109/09286586.2010.528575; Ulrich A, 1996, OPHTHALMIC SURG LAS, V27, P746; van Landingham SW, 2012, OPHTHALMOLOGY, V119, P2486, DOI 10.1016/j.ophtha.2012.06.034; Vieira GM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1251, DOI 10.1001/archopht.124.9.1251; Wierzbowska J, 2012, BRIT J OPHTHALMOL, V96, P624, DOI 10.1136/bjophthalmol-2011-300945; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zeyen T, 2005, Bull Soc Belge Ophtalmol, P53; Zwierko T, 2010, EUR J OPHTHALMOL, V20, P381, DOI 10.1177/112067211002000219	64	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171441	10.1371/journal.pone.0171441	http://dx.doi.org/10.1371/journal.pone.0171441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187143	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300023
J	Halvarsson, C; Eliasson, P; Jonsson, JI				Halvarsson, Camilla; Eliasson, Pernilla; Jonsson, Jan-Ingvar			Pyruvate dehydrogenase kinase 1 is essential for transplantable mouse bone marrow hematopoietic stem cell and progenitor function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HYPOXIC NICHE; MULTIPOTENT PROGENITORS; LINEAGE COMMITMENT; HIF-1-ALPHA; GROWTH; DIFFERENTIATION; IDENTIFICATION; ACTIVATION; ADAPTATION	Background Accumulating evidence suggests that hypoxic areas in the bone marrow are crucial for maintenance of hematopoietic stem cells (HSCs) by supporting a quiescent state of cell cycle and regulating the transplantation capacity of long-term (LT)-HSCs. In addition, HSCs seem to express a metabolic profile of energy production away from mitochondrial oxidative phosphorylation in favor of glycolysis. At oxygen deprivation, hypoxia inducible factor 1 alpha (HIF-1 alpha) is known to induce glycolytic enzymes as well as suppressing mitochondrial energy production by inducing pyruvate dehydrogenase kinase 1 (Pdk1) in most cell types. It has not been established whether PDK1 is essential for HSC function and mediates hypoxia-adapting functions in HSCs. While the Pdk gene family contains four members (Pdk1-4), it was recently shown that Pdk2 and Pdk4 have an important role in regulating LT-HSCs. Principle findings Here we demonstrate that PDK1 activity is crucial for transplantable HSC function. Whereas Pdkl, Pdk2, and Pdk3 transcripts were expressed at higher levels in different subtypes of HSCs compared to differentiated cells, we could not detect any major differences in expression between LT-HSCs and more short-term HSCs and multipotent progenitors. When studying HIF-1 alpha-mediated regulation of Pdk activity in vitro, Pdk1 was the most robust target regulated by hypoxia, whereas Pdk2, Pdk3, and Pdk4 were not affected. Contrary, genetic ablation in a cre-inducible Hif-1 alpha knockout mouse did not support a link between HIF-1 alpha and Pdk1. Silencing of Pdk1 by shRNA lentiviral gene transfer partially impaired progenitor colony formation in vitro and had a strong negative effect on both long-term and short-term engraftment in mice. Conclusions Our study demonstrates that PDK1 has broad effects in hematopoiesis and is a critical factor for engraftment of both HSCs and multipotent progenitors upon transplantation to recipient mice. While Pdk1 was a robust hypoxia-inducible gene mediated by HIF-1 alpha in vitro, we could not find evidence of any in vivo links between Pdk1 and HIF-1 alpha.	[Halvarsson, Camilla; Eliasson, Pernilla; Jonsson, Jan-Ingvar] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Halvarsson, Camilla; Jonsson, Jan-Ingvar] Linkoping Univ, Linkoping Integrat Regenerat Med Ctr, Linkoping, Sweden	Linkoping University; Linkoping University	Jonsson, JI (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Jonsson, JI (corresponding author), Linkoping Univ, Linkoping Integrat Regenerat Med Ctr, Linkoping, Sweden.	jan-ingvar.jonsson@liu.se		Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; County Council of Ostergotland; Faculty of Medicine at Linkoping University; Ollie and Elof Ericssons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); County Council of Ostergotland; Faculty of Medicine at Linkoping University; Ollie and Elof Ericssons Foundation(Ericsson)	This work was supported by grants from: Swedish Research Council, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Swedish Cancer Society, https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society; Swedish Childhood Cancer Foundation, https://www.barncancerfonden.se/in-english/; County Council of Ostergotland, http://www.regionostergotland.se/Forskning-och-innovation/Samverkan-kring-forskning/Organisation-och-beslutsvagar/FoU-gruppen/; Faculty of Medicine at Linkoping University, https://liu.se/medfak/?l=en; and Ollie and Elof Ericssons Foundation, http://oestiftelse.se/ansokan.html.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Klimmeck D, 2012, MOL CELL PROTEOMICS, V11, P286, DOI 10.1074/mcp.M111.016790; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kondo M, 2010, IMMUNOL REV, V238, P37, DOI 10.1111/j.1600-065X.2010.00963.x; Krock BL, 2015, BLOOD, V125, P3263, DOI 10.1182/blood-2014-10-607267; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Morikawa T, 2015, PFLUGERS ARCH EUROPE; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Ryan HE, 2000, CANCER RES, V60, P4010; Shima H, 2009, BIOCHEM BIOPH RES CO, V378, P467, DOI 10.1016/j.bbrc.2008.11.056; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tang Y, 2012, EXP HEMATOL, V40, P879, DOI 10.1016/j.exphem.2012.07.005; Vukovic M, 2016, BLOOD, V127, P2841, DOI 10.1182/blood-2015-10-677138; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	37	13	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171714	10.1371/journal.pone.0171714	http://dx.doi.org/10.1371/journal.pone.0171714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182733	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800095
J	Nkwouano, V; Witkowski, S; Rehberg, N; Kalscheuer, R; Nausch, N; Mayatepek, E; Jacobsen, M				Nkwouano, Vanesa; Witkowski, Sven; Rehberg, Nidja; Kalscheuer, Rainer; Nausch, Norman; Mayatepek, Ertan; Jacobsen, Marc			A novel mycobacterial In Vitro infection assay identifies differences of induced macrophage apoptosis between CD4(+) and CD8(+) T cells	PLOS ONE			English	Article							IFN-GAMMA; TUBERCULOSIS; IMMUNITY; GROWTH; REQUIREMENT; INHIBITION	Macrophages are natural host cells for pathogenic mycobacteria, like Mycobacterium tuberculosis (M.tb). Immune surveillance by T cells and interaction with M.tb infected macrophages is crucial for protection against M.tb reactivation and development of active tuberculosis. Several factors play a role in the control of M.tb infection but reliable biomarkers remain elusive. One major obstacle is the absence of functional in vitro assays which allow concomitant determination of i) mycobacterial eradication; ii) cytotoxic effects on host macrophages; and iii) effector T-cell functions. We established a novel functional in vitro assay based on flow cytometry analysis of monocyte-derived macrophages (MDM) infected with a Mycobacterium bovis BCG strain containing a tetracycline inducible live/dead reporter plasmid (LD-BCG). MDM of healthy human donors were generated in vitro and infected with defined LD-BCG numbers. After short-term MDM/LD-BCG co-incubation with autologous effector T cells or in the presence of antibiotics, proportions of MDM containing live or dead LD-BCG were determined by flow cytometry. Concomitant measure of defined numbers of added beads allowed comparison of absolute MDM numbers between samples. Differential effects of T-cell subpopulations on anti-mycobacterial cytotoxicity and on MDM apoptosis were determined. Flow cytometry measure of MDM/LD-BCG treated with rifampicin correlated well with mycobacterial colony forming units and fluorescence microscopy results. Co culture with pre-activated effector T cells reduced viability of both, LD-BCG and MDM, in a concentration-dependent manner. M.tb protein specific CD4(+) and CD8(+) T-cells contributed similarly to anti-mycobacterial cytotoxicity but CD4(+) T cells induced higher levels of apoptosis in infected MDMs. This novel assay enables rapid quantification of anti-mycobacterial cytotoxicity and characterization of effector functions. Our functional in vitro assay has the potential to contribute to the identification of biomarkers for protective T-cell responses against tuberculosis.	[Nkwouano, Vanesa; Witkowski, Sven; Nausch, Norman; Mayatepek, Ertan; Jacobsen, Marc] Heinrich Heine Univ, Dept Gen Pediat Neonatol & Pediat Cardiol, Univ Childrens Hosp, Dusseldorf, Germany; [Rehberg, Nidja; Kalscheuer, Rainer] Heinrich Heine Univ, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf	Jacobsen, M (corresponding author), Heinrich Heine Univ, Dept Gen Pediat Neonatol & Pediat Cardiol, Univ Childrens Hosp, Dusseldorf, Germany.	marc.jacobsen@med.uni-duesseldorf.de	Kalscheuer, Rainer/AAF-1381-2020; Kalscheuer, Rainer/A-2852-2015; Nausch, Norman/L-9276-2013; Nausch, Norman/M-4526-2019	Kalscheuer, Rainer/0000-0002-3378-2067; Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Jacobsen, Marc/0000-0002-4703-5652; Witkowski, Sven/0000-0001-5398-7572	Jurgen Manchot Foundation; Graduate School 'Molecules of Infection II'	Jurgen Manchot Foundation; Graduate School 'Molecules of Infection II'	This study was supported by the Jurgen Manchot Foundation and the Graduate School 'Molecules of Infection II' project 13 to V. Nkwouano and M. Jacobsen. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Attiyah R, 2006, CLIN EXP IMMUNOL, V145, P520, DOI 10.1111/j.1365-2249.2006.03133.x; Bonecini-Almeida MG, 1998, J IMMUNOL, V160, P4490; Boselli D, 2007, EUR J IMMUNOL, V37, P2196, DOI 10.1002/eji.200636541; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Brookes RH, 2003, EUR J IMMUNOL, V33, P3293, DOI 10.1002/eji.200324109; Fletcher HA, 2013, CLIN VACCINE IMMUNOL, V20, P1683, DOI 10.1128/CVI.00427-13; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Newton S, 2011, JOVE-J VIS EXP, DOI 10.3791/3332; Oddo M, 1998, J IMMUNOL, V160, P5448; Santucci MB, 2000, J INFECT DIS, V181, P1506, DOI 10.1086/315371; Silver RF, 1998, J IMMUNOL, V160, P2408; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Worku S, 2000, CLIN INFECT DIS, V30, pS257, DOI 10.1086/313887; World Health Organization, 2015, GLOB TUB REP 2015	23	4	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171817	10.1371/journal.pone.0171817	http://dx.doi.org/10.1371/journal.pone.0171817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199374	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400051
J	Poli, D; Fabbri, E; Goffredo, S; Airi, V; Franzellitti, S				Poli, Davide; Fabbri, Elena; Goffredo, Stefano; Airi, Valentina; Franzellitti, Silvia			Physiological plasticity related to zonation affects hsp70 expression in the reef-building coral Pocillopora verrucosa	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GENE-EXPRESSION; MOLECULAR CHAPERONES; RAPID ACCLIMATION; TRANSCRIPTOME; TEMPERATURE; RESILIENCE; MECHANISMS; RESISTANCE; ACIDIFICATION	This study investigates for the first time the transcriptional regulation of a stress-inducible 70-kDa heat shock protein (hsp70) in the scleractinian coral Pocillopora verrucosa sampled at three locations and two depths (3 m and 12 m) in Bangka Island waters (North Sulawesi, Indonesia). Percentage of coral cover indicated reduced habitat suitability with depth and at the Tanjung Husi (TA) site, which also displayed relatively higher seawater temperatures. Expression of the P. verrucosa hsp70 transcript evaluated under field conditions followed a depth-related profile, with relatively higher expression levels in 3-m collected nubbins compared to the 12-m ones. Expression levels of metabolism-related transcripts ATP synthase and NADH dehydrogenase indicated metabolic activation of nubbins to cope with habitat conditions of the TA site at 3 m. After a 14-day acclimatization to common and fixed temperature conditions in the laboratory, corals were subjected for 7 days to an altered thermal regime, where temperature was elevated at 31 degrees C during the light phase and returned to 28 C during the dark phase. Nubbins collected at 12 m were relatively more sensitive to thermal stress, as they significantly over-expressed the selected transcripts. Corals collected at 3 m appeared more resilient, as they showed unaffected mRNA expressions. The results indicated that local habitat conditions may influence transcription of stress-related genes in P. verrucosa. Corals exhibiting higher basal hsp70 levels may display enhanced tolerance towards environmental stressors.	[Poli, Davide; Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Dept Biol Geol & Environm Sci, Via S Alberto, Ravenna, Italy; [Poli, Davide; Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Interdept Ctr Environm Sci Res, Via S Alberto, Ravenna, Italy; [Goffredo, Stefano; Airi, Valentina] Univ Bologna, Marine Sci Grp, Dept Biol Geol & Environm Sci, Via F Selmi 3, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Franzellitti, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Via S Alberto, Ravenna, Italy.; Franzellitti, S (corresponding author), Univ Bologna, Interdept Ctr Environm Sci Res, Via S Alberto, Ravenna, Italy.	silvia.franzellitti@unibo.it		Airi, Valentina/0000-0002-6118-7441; Franzellitti, Silvia/0000-0001-6104-7812; FABBRI, Elena/0000-0002-9957-8202; goffredo, stefano/0000-0002-5022-9503	Italian Ministry of University and Research [MIUR RF02013]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Support was provided by the Italian Ministry of University and Research (MIUR RF02013) to EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelman HE, 2016, ECOL EVOL; Al-Sofyani AA, 2013, OCEANOLOGIA, V55, P917, DOI 10.5697/oc.55-4.917; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anestis A, 2008, J EXP BIOL, V211, P2889, DOI 10.1242/jeb.016782; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bay Line K., 2013, PLoS ONE, V8, P1; Bay RA, 2015, GENOME BIOL EVOL, V7, P1602, DOI 10.1093/gbe/evv085; Bedulina DS, 2010, COMP BIOCHEM PHYS B, V155, P413, DOI 10.1016/j.cbpb.2010.01.004; Bellantuono AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050685; Bhattacharya D, 2016, ELIFE, V5, DOI 10.7554/eLife.13288; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Brown T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067246; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224; Dong YW, 2010, BIOL BULL-US, V218, P87, DOI 10.1086/BBLv218n1p87; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fabbri E., 2008, ISJ, V5, P135; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fantazzini P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8785; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244; Franzellitti S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16966; Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010; Freeman LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128875; Gates RD, 1999, AM ZOOL, V39, P30; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Goffredo S, 2014, NAT CLIM CHANGE, V4, P593, DOI [10.1038/nclimate2241, 10.1038/NCLIMATE2241]; Granados-Cifuentes C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-228; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoeksema BW, 2014, IUCN RED LIST THREAT; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jovanovic B, 2014, ENVIRON TOXICOL CHEM, V33, P1346, DOI 10.1002/etc.2560; Kegler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142744; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Levin RA, 2016, MOL BIOL EVOL, V33, P2201, DOI 10.1093/molbev/msw119; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Levy O, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3025; Maor-Landaw K, 2014, GLOBAL CHANGE BIOL, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; Morris JP, 2013, MOL ECOL, V22, P1494, DOI 10.1111/mec.12216; Moya A, 2015, MOL ECOL, V24, P438, DOI 10.1111/mec.13021; Moya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2355-x; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Piano A, 2005, GENE, V361, P119, DOI 10.1016/j.gene.2005.06.034; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Pratlong M, 2015, MOL ECOL RESOUR, V15, P1205, DOI 10.1111/1755-0998.12383; Richier S, 2008, J EXP MAR BIOL ECOL, V357, P48, DOI 10.1016/j.jembe.2007.12.026; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Sawall Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08940; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Seneca FO, 2015, MOL ECOL, V24, P1467, DOI 10.1111/mec.13125; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Tambutte E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8368; Tomanek L, 2002, J EXP BIOL, V205, P677; Turak E, 2013, RAP B BIOL ASSESSMEN, P78; Venn AA, 2009, AQUAT TOXICOL, V93, P188, DOI 10.1016/j.aquatox.2009.05.003; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wilkinson CR, 2003, P 7 INT COR REEF S G, V1, P11; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004; Ziegler M, 2014, CORAL REEFS; Ziegler M, 2015, MAR ECOL PROG SER, V533, P149, DOI 10.3354/meps11365	83	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171456	10.1371/journal.pone.0171456	http://dx.doi.org/10.1371/journal.pone.0171456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199351	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400031
J	Riehl, BD; Lee, JS; Ha, L; Kwon, IK; Lim, JY				Riehl, Brandon D.; Lee, Jeong Soon; Ha, Ligyeom; Kwon, Il Keun; Lim, Jung Yul			Flowtaxis of osteoblast migration under fluid shear and the effect of RhoA kinase silencing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BONE-CELLS; MC3T3-E1 OSTEOBLASTS; FLOW; PROLIFERATION; CYTOSKELETON; ROCK; DIFFERENTIATION; REGENERATION; RECRUITMENT	Despite the important role of mechanical signals in bone remodeling, relatively little is known about how fluid shear affects osteoblastic cell migration behavior. Here we demonstrated that MC3T3-E1 osteoblast migration could be activated by physiologically-relevant levels of fluid shear in a shear stress-dependent manner. Interestingly, shear-sensitive osteoblast migration behavior was prominent only during the initial period after the onset of the steady flow (for about 30 min), exhibiting shear stress-dependent migration speed, displacement, arrest coefficient, and motility coefficient. For example, cell speed at 1 min was 0.28, 0.47, 0.51, and 0.84 pm min(-1) for static, 2, 15, and 25 dyne cm(-2) shear stress, respectively. Arrest coefficient (measuring how often cells are paused during migration) assessed for the first 30 min was 0.40, 0.26, 0.24, and 0.12 respectively for static, 2, 15, and 25 dyne cm(-2). After this initial period, osteoblasts under steady flow showed decreased migration capacity and diminished shear stress dependency. Molecular interference of RhoA kinase (ROCK), a regulator of cytoskeletal tension signaling, was found to increase the shear-sensitive window beyond the initial period. Cells with ROCK-shRNA had increased migration in the flow direction and continued shear sensitivity, resulting in greater root mean square displacement at the end of 120 min of measurement. It is notable that the transient osteoblast migration behavior was in sharp contrast to mesenchymal stem cells that exhibited sustained shear sensitivity (as we recently reported, J. R. Soc. Interface. 2015; 12:20141351). The study of fluid shear as a driving force for cell migration, i.e., "flowtaxis", and investigation of molecular mechanosensors governing such behavior (e.g., ROCK as tested in this study) may provide new and improved insights into the fundamental understanding of cell migration-based homeostasis.	[Riehl, Brandon D.; Lee, Jeong Soon; Ha, Ligyeom; Kwon, Il Keun; Lim, Jung Yul] Univ Nebraska, Coll Engn, Dept Mech & Mat Engn, Lincoln, NE USA; [Kwon, Il Keun; Lim, Jung Yul] Kyung Hee Univ, Grad Sch Dent, Seoul, South Korea	University of Nebraska System; University of Nebraska Lincoln; Kyung Hee University	Lim, JY (corresponding author), Univ Nebraska, Coll Engn, Dept Mech & Mat Engn, Lincoln, NE USA.; Lim, JY (corresponding author), Kyung Hee Univ, Grad Sch Dent, Seoul, South Korea.	jlim4@unl.edu		Kwon, Il Keun/0000-0001-9649-3003	National Science Foundation CAREER Award [1351570]; Nebraska Tobacco Settlement Biomedical Research Seed Grant; Layman New Directions Award; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115458] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Nebraska Tobacco Settlement Biomedical Research Seed Grant; Layman New Directions Award; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation CAREER Award (1351570) to JYL (http://www.nsf.gov/); Nebraska Tobacco Settlement Biomedical Research Seed Grant to JYL; Layman New Directions Award to JYL; Nebraska Research Initiative to JYL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalib MN, 2013, ACTA BIOMATER, V9, P7737, DOI 10.1016/j.actbio.2013.04.013; Bacabac RG, 2005, ANN BIOMED ENG, V33, P104, DOI 10.1007/s10439-005-8968-5; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047; Fritton K, 2012, TISSUE ENG PT A, V18, P2559, DOI [10.1089/ten.tea.2012.0086, 10.1089/ten.TEA.2012.0086]; Gardinier JD, 2009, CELL MOL BIOENG, V2, P133, DOI 10.1007/s12195-008-0038-2; Gildner CD, 2014, MATRIX BIOL, V34, P33, DOI 10.1016/j.matbio.2014.01.017; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Jackson WM, 2008, AM J PHYSIOL-CELL PH, V295, pC1007, DOI 10.1152/ajpcell.00509.2007; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Karadag A, 2006, J BONE MINER RES, V21, P1627, DOI 10.1359/JBMR.060710; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Lai XH, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.9; Li P, 2012, MOL CELL BIOCHEM, V364, P321, DOI 10.1007/s11010-012-1233-y; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020; Lim JY, 2005, J R SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019; Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19; Liu LY, 2012, BIOMECH MODEL MECHAN, V11, P391, DOI 10.1007/s10237-011-0319-x; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Orr DE, 2008, ANN BIOMED ENG, V36, P1228, DOI 10.1007/s10439-008-9505-0; Pan J, 2010, CELL MOL BIOENG, V3, P376, DOI 10.1007/s12195-010-0132-0; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; Proksch S, 2015, STEM CELLS, V33, P3114, DOI 10.1002/stem.2119; Prowse PDH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058898; Riehl BD, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1351; Riehl Brandon D, 2012, Cells, V1, P1225, DOI 10.3390/cells1041225; Salvi JD, 2010, J BIOMECH, V43, P3058, DOI 10.1016/j.jbiomech.2010.07.015; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Tian YS, 2009, BIOCHEM BIOPH RES CO, V386, P499, DOI 10.1016/j.bbrc.2009.06.087; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Worton LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074205; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Zhang XJ, 2011, CELL MOL BIOL LETT, V16, P279, DOI 10.2478/s11658-011-0006-z	42	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171857	10.1371/journal.pone.0171857	http://dx.doi.org/10.1371/journal.pone.0171857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199362	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400053
J	Alsous, M; Alhalaiqa, F; Abu Farha, R; Jalil, MA; McElnay, J; Horne, R				Alsous, Mervat; Alhalaiqa, Fadwa; Abu Farha, Rana; Jalil, Mariam Abdel; McElnay, James; Horne, Robert			Reliability and validity of Arabic translation of Medication Adherence Report Scale (MARS) and Beliefs about Medication Questionnaire (BMQ)-specific for use in children and their parents	PLOS ONE			English	Article							ILLNESS PERCEPTIONS; ASTHMA; MEDICINES; DISEASES; THERAPY	Objectives to evaluate the reliability and discriminant validity of Arabic translation of the Medication Adherence Report Scale (MARS) and the Beliefs about Medication Questionnaire-specific (BMQ-specific). Methods Having developed Arabic translations of the study instruments, a cross-sectional study was carried out between March and October 2015 in two multidisciplinary governmental hospitals in Jordan. An expert panel monitored the forward and backward translation of the MARS and BMQ. Standard Arabic was used (with no specific dialect inclusion) to allow greater generalisability across Arabic speaking countries. Once the Arabic translations of the questionnaires were developed they were tested for consistency, validity and reliability on a group of children with chronic diseases and their parents. Results A total of 258 parents and 208 children were included in the study. The median age of participated children and parents was 15 years and 42 years respectively. Principle component analysis of all questionnaires indicated that all had good construct validity as they clearly measured one construct. The questionnaires were deemed reliable based on the results of Cronbach alpha coefficient. Furthermore, reliability of the questionnaires was demonstrated by test-retest intraclass correlation coefficients (ICC) which ranged from good to excellent for all scales (ICC>0.706). The Pearson correlation coefficient ranged from 0.546-0.805 for the entire sample which indicated a significant moderate to strong positive correlation between MARS and BMQ items at time 1 and 2. Reported adherence was greater than 59% using MARS-children and MARS-parents scales, and was correlated with beliefs in necessity and independent of the concerns regarding medications. Conclusion The Arabic translations of both BMQ and MARS for use in children and their parents have good internal consistency and proved to be valid and reliable tools that can be used by researchers in clinical practice to measure adherence and beliefs about medications in Arabic speaking patient populations.	[Alsous, Mervat; Abu Farha, Rana] Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Amman, Jordan; [Alhalaiqa, Fadwa] Philadelphia Univ, Fac Nursing, Amman, Jordan; [Jalil, Mariam Abdel] Univ Jordan, Fac Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [McElnay, James] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland; [Horne, Robert] UCL, UCL Sch Pharm, Ctr Behav Med, London, England	Philadelphia University Jordan; University of Jordan; Queens University Belfast; University of London; University College London; University of London School of Pharmacy	Alsous, M (corresponding author), Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Amman, Jordan.	m_alsous@asu.edu.jo	Alsous, Mervat/AAF-2470-2019; Al-Halaiqa, Fadwa/AGK-3501-2022; Hamoury, Mariam/Q-8423-2019; Abu-Farha, Rana/AAA-6119-2019	Hamoury, Mariam/0000-0002-3976-5444; Abu-Farha, Rana/0000-0001-8298-4071; Alsous, Mervat/0000-0002-6678-670X	Applied Science Private University, Amman, Jordan [DRGS-2014-2015-139]; National Institute for Health Research [NF-SI-0510-10197] Funding Source: researchfish	Applied Science Private University, Amman, Jordan; National Institute for Health Research(National Institute for Health Research (NIHR))	Thanks are due to those people, who did the translation process of Medication Adherence Report Scale (MARS) and Beliefs About Medication Questionnaire (BMQ)-specific, from Arabic to English and vice versa. The authors are grateful to the Applied Science Private University, Amman, Jordan, for the financial support granted to perform this research project (Grant NO. DRGS-2014-2015-139).	Al Qasem A, 2011, ADHERENCE MED CHRONI; Al-Hajje A, 2015, PHARM PRACTICE, V13; Al-Nsour M, 2012, PREV CHRONIC DIS, V9, pE25, DOI DOI 10.5888/PCD9.110077; Alhalaiqa F, 2012, J HUM HYPERTENS, V26, P117, DOI 10.1038/jhh.2010.133; Alhalaiqa F, 2015, CLIN NURS RES, V24, P539, DOI 10.1177/1054773814545383; Alhalaiqa F, 2013, J CLIN NURS, V22, P2039, DOI 10.1111/j.1365-2702.2012.04321.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Brown DW, 2009, PREV CHRONIC DIS, V6; Bucks RS, 2009, J PEDIATR PSYCHOL, V34, P893, DOI 10.1093/jpepsy/jsn135; Byer B, 2000, PSYCHOL HEALTH MED, V5, P389, DOI [DOI 10.1080/713690213, 10.1080/713690213]; Cohen JL, 2009, ANN ALLERG ASTHMA IM, V103, P325, DOI 10.1016/S1081-1206(10)60532-7; Gardiner P, 2006, AM FAM PHYSICIAN, V74, P793; George D.M., 2003, SPSS WINDOWS STEP BY, V7th; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 2002, PSYCHOL HEALTH, V17, P17, DOI 10.1080/08870440290001502; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2000, HDB DRUG RES METHODO, P299; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Jensen MP, 2003, CLIN J PAIN, V19, P345, DOI 10.1097/00002508-200311000-00002; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; [MOH Research DoISa], 2008, HASH KINGD JORDAN200; Mora PA, 2011, PSYCHOL HEALTH, V26, P713, DOI 10.1080/08870446.2010.490585; Morrison A, 2000, FORMULARY, V35, P234; Nunes V, 2009, CLIN GUIDELINES EVID, P364; Osamor PE, 2011, J HLTH POPULATION NU, P619; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Rezaee ME, 2015, PEER REV MULTIPLE CH, P12; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Salt E, 2012, J NURS MEAS, V20, P59, DOI 10.1891/1061-3749.20.1.59; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; Thier Sara L, 2008, Manag Care, V17, P48; Van Steenis MNA, 2014, PATIENT PREFER ADHER, V8, P83, DOI 10.2147/PPA.S44185; Winnick S, 2005, PEDIATRICS, V115, pE718, DOI 10.1542/peds.2004-1133; World Health Organization, 2003, ADH LONG TERM THER; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; Zylke JW, 2007, JAMA-J AM MED ASSOC, V297, P2765, DOI 10.1001/jama.297.24.2765	38	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171863	10.1371/journal.pone.0171863	http://dx.doi.org/10.1371/journal.pone.0171863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192467	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800046
J	Carrieri, MP; Marcellin, F; Fressard, L; Preau, M; Sagaon-Teyssier, L; Suzan-Monti, M; Guagliardo, V; Mora, M; Roux, P; Dray-Spira, R; Spire, B				Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Preau, Marie; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Dray-Spira, Rosemary; Spire, Bruno		ANRS VESPA2 Study Grp	Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey)	PLOS ONE			English	Article							HEPATITIS-C; COMPLETED SUICIDE; USE DISORDERS; ALCOHOL-USE; SMOKING; IDEATION; AIDS; ASSOCIATION; INFECTION; BEHAVIOR	Background Suicide risk is high among people living with HIV (PLHIV). This study aimed to identify major correlates of suicide risk in a representative sample of PLHIV in France, in order to help target individuals who would benefit from suicide risk screening and psychiatric care. Methods The ANRS VESPA2 cross-sectional survey (April 2011-January 2012) collected sociodemographic, medical and behavioral data from 3,022 PLHIV recruited in 73 French HIV hospital departments. The study sample comprised the 2,973 participants with available self-reported data on suicide risk (defined as having either thought about and planned to commit suicide during the previous 12 months or attempted suicide during the same period of time) and medical data on comorbidities. Weighted Poisson models adjusted for HCV co infection and significant clinical variables were used to estimate the relationship between suicide risk and HIV transmission groups, experience with HIV disease and other psychosocial factors. Results Suicide risk was reported by 6.3% of PLHIV in the study sample. After adjustment for HIV immunological status and HCV co-infection, women (IRR [95%Cl]:1.93 [1.17; 3.19]) and men who have sex with men (MSM) (1.97 [1.22; 3.19]) had a higher suicide risk than the rest of the sample. Moreover, the number of discrimination-related social contexts reported (1.39 [1.19; 1.61]), homelessness (4.87 [1.82; 13.02]), and reporting a feeling of loneliness (4.62 [3.06; 6.97]) were major predictors of suicide risk. Conclusions Reducing the burden of precarious social conditions and discrimination is an important lever for preventing suicide risk among PLHIV in France. Comprehensive care models involving peer/community social interventions targeted at women and MSM need to be implemented to lower the risk of suicide in these specific subgroups of PLHIV.	[Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Preau, Marie; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Spire, Bruno] Aix Marseille Univ, INSERM, Sci Econ & Sociales Sante & Traitement Informat M, IRD,SESSTIM, Marseille, France; [Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Spire, Bruno; ANRS VESPA2 Study Grp] ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France; [Preau, Marie] Univ Lyon 2, Inst Psychol, GREPS, 5 Ave Pierre Mendes France, Bron, France; [Dray-Spira, Rosemary] INSERM, UMR S1136, Pierre Louis Inst Epidemiol & Publ Hlth, Team Res Social Epidemiol, Paris, France; [Dray-Spira, Rosemary] UPMC Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth, Team Res Social Epidemiol,UMR S1136, Paris, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Marcellin, F; Fressard, L (corresponding author), Aix Marseille Univ, INSERM, Sci Econ & Sociales Sante & Traitement Informat M, IRD,SESSTIM, Marseille, France.; Marcellin, F; Fressard, L (corresponding author), ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France.	fabienne.marcellin@inserm.fr; lisa.fressard@inserm.fr	Marcellin, Fabienne/H-7911-2019; Spire, Bruno/F-5546-2013	Marcellin, Fabienne/0000-0001-8853-3829; Spire, Bruno/0000-0002-3546-8020; Alvarez, Mario Moises/0000-0002-9131-5344; DENES, Eric/0000-0001-5321-3171; Lelievre, Jean-Daniel/0000-0002-8182-3628; Carrieri, Patrizia/0000-0002-6794-4837; Sagaon-Teyssier, Luis/0000-0001-7318-6596; Dray-Spira, Rosemary/0000-0001-7646-3667	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The ANRS-VESPA2 survey was sponsored and funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The grants were paid to the research units of the co-authors. htfplivevevenrs.fre.	Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Balbuena L, 2015, PSYCHIAT SERV, V66, P186, DOI 10.1176/appi.ps.201300509; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Carrieri MP, 2015, AIDS IMPACT; Cazein F., 2015, Bulletin Epidemiologique Hebdomadaire, P152; Cooperman NA, 2005, J BEHAV MED, V28, P149, DOI 10.1007/s10865-005-3664-3; Daskalopoulou M, 2014, LANCET HIV; Douab T, 2014, AIDS CARE, V26, pS29, DOI 10.1080/09540121.2014.906553; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P321; Grassi L, 2001, J AFFECT DISORDERS, V64, P195, DOI 10.1016/S0165-0327(00)00244-5; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Kalichman SC, 2000, PSYCHIATR SERV, V51, P903, DOI 10.1176/appi.ps.51.7.903; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; Kennedy MC, 2015, DRUG ALCOHOL DEPEN, V151, P272, DOI 10.1016/j.drugalcdep.2015.03.006; Komiti A, 2001, AUST NZ J PSYCHIAT, V35, P747, DOI 10.1046/j.1440-1614.2001.00943.x; Krueger C, 2011, J VIRAL HEPATITIS, V18, pE284, DOI 10.1111/j.1365-2893.2010.01408.x; Kuramoto SJ, 2013, SUICIDE LIFE-THREAT, V43, P366, DOI 10.1111/sltb.12023; Lucas M, 2013, J AFFECT DISORDERS, V151, P1053, DOI 10.1016/j.jad.2013.08.033; Marcellin F, 2014, SEX TRANSM INFECT; Marcellin F., 2016, DRUG ALCOHOL REV; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Marsicano E, 2014, AIDS CARE, P1; MCKEGNEY FP, 1992, AM J PSYCHIAT, V149, P396; McManus H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089089; Michel L, 2015, COMPR PSYCHIAT, V62, P123, DOI 10.1016/j.comppsych.2015.07.004; Mino A, 1999, Crisis, V20, P28, DOI 10.1027//0227-5910.20.1.28; Modabbernia A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8340; Nostlinger C, 2014, AIDS PATIENT CARE ST, V28, P155, DOI 10.1089/apc.2013.0247; ODOWD MA, 1993, PSYCHOSOMATICS, V34, P33; Paul JP, 2002, AM J PUBLIC HEALTH, V92, P1338, DOI 10.2105/AJPH.92.8.1338; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Preau M, 2008, AIDS CARE, V20, P917, DOI 10.1080/09540120701777249; Roux P., 2013, Bulletin Epidemiologique Hebdomadaire, P314; Schwartz R. C., 2004, COUNSELING PSYCHOL Q, V17, P89, DOI DOI 10.1080/09515070410001665712; Sherr L, 1995, AIDS CARE, V7, pS109; Sockalingam S, 2011, J VIRAL HEPATITIS, V18, P153, DOI 10.1111/j.1365-2893.2010.01393.x; Stutterheim SE, 2009, AIDS, V23, P2353, DOI 10.1097/QAD.0b013e3283320dce; Suzan-Monti M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20095; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003	43	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171645	10.1371/journal.pone.0171645	http://dx.doi.org/10.1371/journal.pone.0171645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192455	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800034
J	Gernsbacher, MA; Stevenson, JL; Dern, S				Gernsbacher, Morton Ann; Stevenson, Jennifer L.; Dern, Sebastian			Specificity, contexts, and reference groups matter when assessing autistic traits	PLOS ONE			English	Article							QUALITY-OF-LIFE; SPECTRUM QUOTIENT AQ; PERVASIVE DEVELOPMENTAL DISORDERS; SOCIAL-RESPONSIVENESS-SCALE; BROAD AUTISM; INTERGENERATIONAL TRANSMISSION; PERSONALITY-TRAITS; PSYCHONEUROTIC INVENTORY; PHENOTYPE QUESTIONNAIRE; INFORMANT AGREEMENT	Many of the personality and behavioral traits (e.g., social imperviousness, directness in conversation, lack of imagination, affinity for solitude, difficulty displaying emotions) that are known to be sensitive to context (with whom?) and reference group (according to whom?) also appear in questionnaire-based assessments of autistic traits. Therefore, two experiments investigated the effects of specifying contexts and reference groups when assessing autistic traits in autistic and non-autistic participants. Experiment 1 (124 autistic and 124 non-autistic participants) demonstrated that context matters when assessing autistic traits (F(1,244) = 267.5, p <.001,1), eta(2)(p) =.523). When the context of the Broad Autism Phenotype Questionnaire was specified as the participants' out-group (e.g., "I like being around non autistic people" or "I like being around autistic people"), both autistic and non-autistic participants self-reported having more autistic traits; when the context was specified as the participants' in-group, participants reported having fewer autistic traits. Experiment 2 (82 autistic and 82 non-autistic participants) demonstrated that reference group matters when assessing autistic traits (F(2,160) = 94.38, p <.001,eta(2)(p) =.541). When the reference group on the Social Responsiveness Scale was specified as the participants' out-group (e.g., "According to non-autistic people, I have unusual eye contact"), autistic participants reported having more autistic traits; when the reference group was their in-group, autistic participants reported having fewer autistic traits. Non-autistic participants appeared insensitive to reference group on the Social Responsiveness Scale. Exploratory analyses suggested that when neither the context nor the reference group is specified (for assessing autistic traits on the Autism-Spectrum Quotient), both autistic and non-autistic participants use the majority ("non-autistic people") as the implied context and reference group.	[Gernsbacher, Morton Ann] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Stevenson, Jennifer L.] Ursinus Coll, Dept Psychol, Collegeville, PA 19426 USA; [Dern, Sebastian] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands	University of Wisconsin System; University of Wisconsin Madison; Maastricht University	Gernsbacher, MA (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	MAGernsb@wisc.edu	; Frymiare, Jennifer L./O-4812-2016	Gernsbacher, Morton Ann/0000-0003-0397-3329; Frymiare, Jennifer L./0000-0002-3896-461X	Vilas Trust, University of Wisconsin-Madison	Vilas Trust, University of Wisconsin-Madison	This work was supported by the Vilas Trust, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; Adams RE, 2014, J AUTISM DEV DISORD, V44, P861, DOI 10.1007/s10803-013-1938-0; Albaum G, 2010, J MARKET THEORY PRAC, V18, P285, DOI 10.2753/MTP1069-6679180306; Andersen PN, 2015, J AUTISM DEV DISORD, V45, P2497, DOI 10.1007/s10803-015-2415-8; ANDERSON J, 1993, SOC PSYCH PSYCH EPID, V28, P134, DOI 10.1007/BF00801744; Arnaud C, 2008, PEDIATRICS, V121, P54, DOI 10.1542/peds.2007-0854; Aust F, 2013, BEHAV RES METHODS, V45, P527, DOI 10.3758/s13428-012-0265-2; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Barry D T, 2001, J Immigr Health, V3, P193, DOI 10.1023/A:1012227611547; Bennett T, 2012, J CHILD PSYCHOL PSYC, V53, P89, DOI 10.1111/j.1469-7610.2011.02451.x; Bitsika V, 2015, J DEV PHYS DISABIL, V27, P467, DOI 10.1007/s10882-015-9431-7; Bradburn NM., 2004, ASKING QUESTIONS DEF, VRev. edn; Brownlow C, 2006, MENT RETARD, V44, P315, DOI 10.1352/0047-6765(2006)44[315:CAAIAV]2.0.CO;2; Bruckmuller S, 2010, PERS SOC PSYCHOL B, V36, P1424, DOI 10.1177/0146167210383581; Cameron L, 2006, J SOC ISSUES, V62, P469, DOI 10.1111/j.1540-4560.2006.00469.x; Carlson EN, 2011, J PERS SOC PSYCHOL, V101, P831, DOI 10.1037/a0024297; Carlson EN, 2009, PSYCHOL SCI, V20, P1033, DOI 10.1111/j.1467-9280.2009.02409.x; Carroll L. J., 1996, COMMUNICATION REPORT, V9, P185, DOI [10.1080/08934219609367650, DOI 10.1080/08934219609367650]; Cast AD, 1999, SOC PSYCHOL QUART, V62, P68, DOI 10.2307/2695826; Cederlund M, 2010, RES DEV DISABIL, V31, P287, DOI 10.1016/j.ridd.2009.09.006; Chandler S, 2016, CHILD CARE HLTH DEV, V42, P486, DOI 10.1111/cch.12346; Christ SE, 2010, NEUROPSYCHOLOGY, V24, P590, DOI 10.1037/a0019176; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Clifton A, 2004, PERS INDIV DIFFER, V36, P1499, DOI 10.1016/j.paid.2003.06.002; Cohen L.H., 1988, LIFE EVENTS PSYCHOL, P11; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Crede M, 2010, J PERS ASSESS, V92, P390, DOI 10.1080/00223891.2010.497393; Cuellar I, HISP J BEHAV SCI, P199; De Alwis D, 2014, J STUD ALCOHOL DRUGS, V75, P211, DOI 10.15288/jsad.2014.75.211; De la Marche W, 2015, EUR CHILD ADOLES PSY, V24, P385, DOI 10.1007/s00787-014-0586-z; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Dunn DS, 2015, AM PSYCHOL, V70, P255, DOI 10.1037/a0038636; Eisenberg P, 1941, J EDUC PSYCHOL, V32, P321, DOI 10.1037/h0060946; Eisenberg P, 1941, J GEN PSYCHOL, V25, P19, DOI 10.1080/00221309.1941.10544702; Ekstrom R., 1976, MANUAL KIT FACTOR RE; ELLIS A, 1946, PSYCHOL BULL, V43, P385, DOI 10.1037/h0055483; Faja S, 2015, AUTISM, V19, P91, DOI 10.1177/1362361313512424; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Garrett MT, 2000, J COUNS DEV, V78, P3, DOI 10.1002/j.1556-6676.2000.tb02554.x; Gernsbacher MA, J CHILD PSY IN PRESS; Gernsbacher MA, 2012, METAPHOR SYMBOL, V27, P93, DOI 10.1080/10926488.2012.656255; Gernsbacher Morton Ann, 2005, J Dev Learn Disord, V9, P3; GIBBONS FX, 1983, J PERS, V51, P517, DOI 10.1111/j.1467-6494.1983.tb00343.x; Guimond S, 2006, J PERS SOC PSYCHOL, V90, P221, DOI 10.1037/0022-3514.90.2.221; Hampton P, 1941, J EDUC PSYCHOL, V32, P471, DOI 10.1037/h0060603; Hegarty P, 2004, GROUP PROCESS INTERG, V7, P119, DOI 10.1177/1368430204041399; Heine SJ, 2002, J PERS SOC PSYCHOL, V82, P903, DOI 10.1037//0022-3514.82.6.903; Heine SJ, 2008, PSYCHOL SCI, V19, P309, DOI 10.1111/j.1467-9280.2008.02085.x; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hurley RSE, 2007, J AUTISM DEV DISORD, V37, P1679, DOI 10.1007/s10803-006-0299-3; Hurst RM, 2007, PERS INDIV DIFFER, V43, P1938, DOI 10.1016/j.paid.2007.06.012; Hus V, 2013, J CHILD PSYCHOL PSYC, V54, P216, DOI 10.1111/j.1469-7610.2012.02589.x; Hyman H., 1942, PSYCHOL BULL, V39, P473; Ingersoll B, 2011, J AUTISM DEV DISORD, V41, P1646, DOI 10.1007/s10803-011-1192-2; INGWELL RH, 1967, J SOC PSYCHOL, V72, P107, DOI 10.1080/00224545.1967.9922304; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; JOHN OP, 1993, J PERS, V61, P521, DOI 10.1111/j.1467-6494.1993.tb00781.x; Joinson AN, 2007, COMPUT HUM BEHAV, V23, P275, DOI 10.1016/j.chb.2004.10.012; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; KATZ I, 1960, J ABNORM SOC PSYCH, V61, P448, DOI 10.1037/h0043665; Kelley H. H., 1960, PSYCHOL RES REHABILI, P172; Kenny L, 2016, AUTISM, V20, P442, DOI 10.1177/1362361315588200; Klonoff EA, 2000, J BLACK PSYCHOL, V26, P235, DOI DOI 10.1177/0095798400026002007; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Leung RC, 2016, CHILD NEUROPSYCHOL, V22, P336, DOI 10.1080/09297049.2015.1005066; Lundberg V, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-33; Maxwell CR, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-25; McCallion MJ, 2007, BLACKWELL ENCY SOCIO, P2238; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILLER DT, 1991, J PERS SOC PSYCHOL, V61, P5, DOI 10.1037/0022-3514.61.1.5; Moreno-De-Luca A, 2015, JAMA PSYCHIAT, V72, P119, DOI 10.1001/jamapsychiatry.2014.2147; Moricke E, 2016, J AUTISM DEV DISORD, V46, P164, DOI 10.1007/s10803-015-2562-y; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nishiyama T, 2014, J AUTISM DEV DISORD, V44, P2079, DOI 10.1007/s10803-014-2077-y; Nishiyama T, 2014, J AUTISM DEV DISORD, V44, P993, DOI 10.1007/s10803-013-2020-7; Parsons SK, 1999, INT J CANCER, P46; Piven J, 2014, J AUTISM DEV DISORD, V44, P2077, DOI 10.1007/s10803-014-2076-z; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Rescorla LA, 2013, J CLIN CHILD ADOLESC, V42, P262, DOI 10.1080/15374416.2012.717870; Reszka SS, 2014, J AUTISM DEV DISORD, V44, P466, DOI 10.1007/s10803-013-1879-7; Robins R.W., 1997, HDB PERSONALITY PSYC, P649, DOI [10.1016/B978-012134645-4/50026-3, DOI 10.1016/B978-012134645-4/50026-3]; ROGERS EM, 1970, PUBLIC OPIN QUART, V34, P523, DOI 10.1086/267838; Ruta L, 2012, J AUTISM DEV DISORD, V42, P625, DOI 10.1007/s10803-011-1290-1; Sasson NJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-11; Saudino KJ, 2004, J PERS SOC PSYCHOL, V87, P698, DOI 10.1037/0022-3514.87.5.698; Schanding GT, 2012, J AUTISM DEV DISORD, V42, P1705, DOI 10.1007/s10803-011-1412-9; Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202; Schwarz N., 1997, J OFF STAT, V13, P159; Selfhout M, 2010, J PERS, V78, P509, DOI 10.1111/j.1467-6494.2010.00625.x; SELLTIZ C, 1965, J PERS SOC PSYCHOL, V2, P408, DOI 10.1037/h0022381; Sinclair J., 1999, WHY I DISLIKE PERSON; Stratis EA, 2015, J AUTISM DEV DISORD, V45, P1026, DOI 10.1007/s10803-014-2258-8; SZATMARI P, 1994, J AUTISM DEV DISORD, V24, P703, DOI 10.1007/BF02172281; Taylor LJ, 2015, RES AUTISM SPECT DIS, V11, P56, DOI 10.1016/j.rasd.2014.12.003; Tsai JL, 2000, J CROSS CULT PSYCHOL, V31, P302, DOI 10.1177/0022022100031003002; Uzark K, 2012, PEDIATRICS, V130, pE1559, DOI 10.1542/peds.2012-0858; Van de Gaer E, 2012, J CROSS CULT PSYCHOL, V43, P1205, DOI 10.1177/0022022111428083; van Dijk J, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-65; Vazire S, 2010, SOC PERSONAL PSYCHOL, V4, P605, DOI 10.1111/j.1751-9004.2010.00280.x; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908; Verkuyten M, 2002, EUR J SOC PSYCHOL, V32, P781, DOI 10.1002/ejsp.121; Wainer AL, 2011, J PSYCHOPATHOL BEHAV, V33, P459, DOI 10.1007/s10862-011-9259-0; Warren Z, 2012, AUTISM RES, V5, P31, DOI 10.1002/aur.230; White SW, 2015, BEHAV THER, V46, P40, DOI 10.1016/j.beth.2014.05.005; White SW, 2011, AUTISM, V15, P683, DOI 10.1177/1362361310393363; White SW, 2014, FOCUS AUTISM OTHER D, V30, P3; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; Wood AM, 2012, J PERS, V80, P1275, DOI 10.1111/j.1467-6494.2012.00763.x; WOOD W, 1994, PSYCHOL BULL, V115, P323, DOI 10.1037/0033-2909.115.3.323; Wood W, 1996, J PERS SOC PSYCHOL, V71, P1181, DOI 10.1037/0022-3514.71.6.1181	113	32	32	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171931	10.1371/journal.pone.0171931	http://dx.doi.org/10.1371/journal.pone.0171931			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192464	Green Published, gold			2022-12-27	WOS:000394423800052
J	Higashiyama, T; Nishida, Y; Ohji, M				Higashiyama, Tomoaki; Nishida, Yasuhiro; Ohji, Masahito			Optical coherence tomography angiography in eyes with good visual acuity recovery after treatment for optic neuritis	PLOS ONE			English	Article							NERVE-FIBER LAYER; CHOROIDAL NEOVASCULARIZATION; AXONAL LOSS	Objective To evaluate the retinal perfusion using optical coherence tomography (OCT) angiography in eyes with good visual acuity recovery after treatment for optic neuritis (ON). Methods Seven eyes of seven patients with good visual acuity recovery after treatment for monocular ON and seven eyes of each fellow eye used as controls were studied. Retinal perfusion around the disc and at the macula was evaluated using OCT angiography. The retinal nerve fiber layer thickness was measured around the disc. The ganglion cell layer complex thickness or the ganglion cell layer plus the inner plexiform layer thickness were measured at the macula. Results The retinal perfusions in all eyes with ON decreased around the disc and at the macula compared with those of the fellow eyes, as shown by OCT angiography (disc, P= 0.003; macula, P= 0.001). The retinal thicknesses in all eyes with ON also decreased around the disc and at the macula compared with those of the fellow eyes (disc, P< 0.001; macula, P= 0.003). Conclusions Optic neuritis may cause not only retinal structural damage but also decreased retinal perfusion, even after the visual acuity recovered well after treatment.	[Higashiyama, Tomoaki; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan; [Nishida, Yasuhiro] Shiga Univ Med Sci, Clin Med Educ Ctr, Otsu, Shiga, Japan	Shiga University of Medical Science	Higashiyama, T (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan.	higashi@belle.shiga-med.ac.jp						BECK RW, 1994, OPHTHALMOLOGY, V101, P1771; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Costello F, 2015, J NEUROL NEUROSUR PS, V86, P1369, DOI 10.1136/jnnp-2014-309704; de Carlo TE, 2015, OSLI RETINA, V46, P611, DOI 10.3928/23258160-20150610-03; GUY J, 1992, OPHTHALMOLOGY, V99, P720; Higashiyama T, 2016, NEURO-OPHTHALMOLOGY, V40, P146, DOI 10.3109/01658107.2016.1162174; Higashiyama T, 2016, OSLI RETINA, V47, P724, DOI 10.3928/23258160-20160808-05; Huang-Link YM, 2015, NEUROL SCI, V36, P617, DOI 10.1007/s10072-014-1982-3; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Pro MJ, 2006, J NEUROL SCI, V250, P114, DOI 10.1016/j.jns.2006.08.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spaide RF, 2015, AM J OPHTHALMOL, V160, P6, DOI 10.1016/j.ajo.2015.04.012; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437	22	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172168	10.1371/journal.pone.0172168	http://dx.doi.org/10.1371/journal.pone.0172168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192497	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800081
J	Jabbari, A; Mousavian, M; Seyedi, SM; Bakavoli, M; Sadeghian, H				Jabbari, Atena; Mousavian, Mina; Seyedi, Seyed Mohamad; Bakavoli, Mehdi; Sadeghian, Hamid			O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors	PLOS ONE			English	Article							POTENT 15-LIPOXYGENASE INHIBITORS; ARACHIDONATE 15-LIPOXYGENASE; HUMAN EOSINOPHILS; PURIFICATION; ACID; LIPOXYGENASES; RETICULOCYTE; LEUKOCYTES; EXPRESSION; MECHANISM	Allyloxy, Isopentenyloxy, geranyloxy and farnesyloxy derivatives of 3-carboxycoumarin, at position 5, 6, 7, and 8, were synthesized and their inhibitory potency against human 15-lipoxygenase-1 (human 15-LOX-1) were determined. Among the synthetic coumarins, O-allyl and O-isopentenyl derivatives demonstrated no considerable lipoxygenase inhibition while O-geranyl and O-farnesyl derivatives demonstrated potent inhibitory activity. 5-farnesyloxy-3-carboxycoumarin demonstrated the most potent inhibitory activity by IC50 = 0.74 mu M while 6-farnesyloxy-3-carboxycoumarin was the weakest inhibitor among farnesyl analogs (IC50 = 10.4 mu M). Bonding affinity of the designed molecular structures toward 15-LOX-1 3D structure complexed with RS75091, as potent 15-LOX-1 inhibitor, was studied by utilizing docking analysis. There was a direct relationship between lipoxygenase inhibitory potency and prenyl length chain. The ability of the prenyl portion to fill the lipophilic pocket which is formed by Ile663, Ala404, Arg403, Ile400, Ile173 and Phe167 side chains can explain the observed relationship. Similarity rate between the docked models and complexed form of RS75091, from point of view of configuration and conformation, could explain inhibitory potency variation between each prenyloxy substitution of 3-carboxycoumarins.	[Jabbari, Atena; Seyedi, Seyed Mohamad; Bakavoli, Mehdi] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Iran; [Mousavian, Mina] Payame Noor Univ, Dept Biol, Mashhad, Iran; [Sadeghian, Hamid] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sadeghian, Hamid] Mashhad Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Mashhad, Iran	Ferdowsi University Mashhad; Payame Noor University; Mashhad University Medical Science; Mashhad University Medical Science	Sadeghian, H (corresponding author), Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran.; Sadeghian, H (corresponding author), Mashhad Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Mashhad, Iran.	sadeghianh@mums.ac.ir		Sadeghian, Hamid/0000-0001-7894-5002				Berhenke LF, 1944, U.S. Patent., Patent No. [2:338,569, 2338569]; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Creaven BS, 2006, INORG CHIM ACTA, V359, P3976, DOI 10.1016/j.ica.2006.04.006; Eleftheriadis N, 2015, EUR J MED CHEM, V94, P265, DOI 10.1016/j.ejmech.2015.03.007; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Heidelbaugh TM, 2011, Coumarin compounds as receptor modulator with therapeutic utility, Patent No. [WO/2011/050054, 2011050054]; Iranshahi M, 2012, EUR J MED CHEM, V57, P134, DOI 10.1016/j.ejmech.2012.09.006; Jabbari A, 2012, BIOORGAN MED CHEM, V20, P5518, DOI 10.1016/j.bmc.2012.07.025; Kelavkar UP, 2000, CARCINOGENESIS, V21, P1777; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mytilineou C, 2002, PARKINSONISM RELAT D, V8, P385, DOI 10.1016/S1353-8020(02)00018-4; NADEL JA, 1991, J CLIN INVEST, V87, P1139, DOI 10.1172/JCI115110; Nadendla R.R., 2005, PRINCIPLES ORGANIC M; Nikpour M, 2013, MED CHEM RES, V22, P5036, DOI 10.1007/s00044-013-0506-7; Sadeghian H, 2016, EXPERT OPIN THER PAT, V26, P65, DOI 10.1517/13543776.2016.1113259; Sadeghian H, 2009, BIOORGAN MED CHEM, V17, P2327, DOI 10.1016/j.bmc.2009.02.009; Samoszuk M, 2006, AM J HEMATOL, V81, P552, DOI 10.1002/ajh.20551; Shah RC, 1938, J CHEM SOC, P1828, DOI 10.1039/jr9380001828; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V150, P376, DOI 10.1016/0006-291X(88)90531-1; Spindler SA, 1997, BIOCHEM BIOPH RES CO, V239, P775, DOI 10.1006/bbrc.1997.7471; Suardiaz R, 2016, J CHEM THEO IN PRESS; Toledo L, 2010, J PHYS CHEM B, V114, P7037, DOI 10.1021/jp912120n; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9	29	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171789	10.1371/journal.pone.0171789	http://dx.doi.org/10.1371/journal.pone.0171789			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182779	Green Published, gold			2022-12-27	WOS:000394231800112
J	Kaida, K; Itaguchi, Y; Iwaki, S				Kaida, Kosuke; Itaguchi, Yoshihiro; Iwaki, Sunao			Interactive effects of visuomotor perturbation and an afternoon nap on performance and the flow experience	PLOS ONE			English	Article							MOTOR SEQUENCE; SLEEP; MEMORY; ADAPTATION; CONSOLIDATION; IMPLICIT; STRIATUM; IMAGERY; STATES; SPORT	The present study was designed (1) to clarify the relationship between the flow experience and improvements in visuomotor skills, (2) to examine the effects of rotating the axis of a computer mouse on visuomotor skills, and (3) to investigate the effects of sleep for improving visuomotor skills. Participants (N = 18) responded to Perturbation and nap (PER+Nap), No-perturbation and nap (NoPER+Nap) and Perturbation and rest (PER+Rest) conditions. In the PER+Nap condition, participants conducted a visuomotor tracking task using a computer mouse, which was accompanied by perturbation caused by rotating the axis of their mouse. After the task, they took a 90 min nap. In NoPER+Nap condition, they conducted the same visuomotor task without any perturbation and took a nap. In the PER+Rest condition, participants conducted the task with the perturbation and took a 90 min break spent reading magazines instead of taking a nap. Results indicated (1) the flow experience did not occur when participants' skills and the degree of the visuomotor challenge were matching, (2) improvements of visuomotor skills occurred regardless of the perturbation, (3) improvements of visuomotor skills occurred unrelated to the flow experience, or to mood states, and (4) improvements of visuomotor performance occurred regardless of sleep. These findings suggest that improvements of visuomotor skills occur regardless of mood status and occur independently of perturbations by axis rotation. The study also suggests that the acquisition of skills is related to merely the time elapsed since learning, rather than to sleep.	[Kaida, Kosuke; Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, Inst Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan; [Itaguchi, Yoshihiro] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Keio University	Kaida, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Informat Technol & Human Factors, Tsukuba, Ibaraki, Japan.	kaida.kosuke@aist.go.jp	Itaguchi, Yoshihiro/AAK-7239-2020; Iwaki, Sunao/B-1079-2011	Itaguchi, Yoshihiro/0000-0002-2033-2171; Iwaki, Sunao/0000-0002-7123-7203	JSPS KAKENHI [16K13511]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI Grant No. 16K13511	Albouy G, 2013, PLOS ONE, V8; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2013, J SLEEP RES, V22, P144, DOI 10.1111/j.1365-2869.2012.01059.x; Asakawa K, 2010, J HAPPINESS STUD, V11, P205, DOI 10.1007/s10902-008-9132-3; Backhaus W, 2016, NEUROBIOL LEARN MEM, V131, P147, DOI 10.1016/j.nlm.2016.03.017; Bakker AB, 2011, PSYCHOL SPORT EXERC, V12, P442, DOI 10.1016/j.psychsport.2011.02.003; Bedard P, 2014, NEUROIMAGE, V101, P225, DOI 10.1016/j.neuroimage.2014.07.009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Csikszentmihalyi M, 1997, FINDING FLOW; de Manzano O, 2010, EMOTION, V10, P301, DOI 10.1037/a0018432; de Manzano O, 2013, NEUROIMAGE, V67, P1, DOI 10.1016/j.neuroimage.2012.10.072; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Debarnot U, 2009, SLEEP, V32, P1559, DOI 10.1093/sleep/32.12.1559; Dinges DF, 1997, SLEEP, V20, P267; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Iber C., 2007, AASM MANUAL SCORING; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2012, CEREBELLUM, V11, P325, DOI 10.1007/s12311-010-0241-2; Ishimura I, 2008, THESIS; Jackson SA, 1998, J SPORT EXERCISE PSY, V20, P358, DOI 10.1123/jsep.20.4.358; Kaida K, 2014, JIDOUSYAGIZYUTSU, V68, P59; Kaida K, 2012, ERGONOMICS, V55, P1340, DOI 10.1080/00140139.2012.715681; Kaida K, 2012, IND HEALTH, V50, P189; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Landsness EC, 2009, SLEEP, V32, P1273; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Morita Y, 2012, SLEEP BIOL RHYTHMS, V10, P302, DOI 10.1111/j.1479-8425.2012.00576.x; Payne JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00108; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rieth CA, 2010, BEHAV BRAIN RES, V214, P470, DOI 10.1016/j.bbr.2010.05.052; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Swann C, 2012, PSYCHOL SPORT EXERC, V13, P807, DOI 10.1016/j.psychsport.2012.05.006; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; van der Helm E, 2011, SLEEP MED CLIN, V6, P31, DOI 10.1016/j.jsmc.2010.12.010; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171907	10.1371/journal.pone.0171907	http://dx.doi.org/10.1371/journal.pone.0171907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182742	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800132
J	Kubota, C; Meng, C; Son, YJ; Lewis, M; Spalholz, H; Tronstad, R				Kubota, Chieri; Meng, Chao; Son, Young-Jun; Lewis, Myles; Spalholz, Hans; Tronstad, Russell			Horticultural, systems-engineering and economic evaluations of short-term plant storage techniques as a labor management tool for vegetable grafting nurseries	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; LED-LOW LIGHT; ROOT TEMPERATURE; CUCUMBER CULTIVARS; FIGLEAF GOURD; SIMULATION; PRESERVATION; INTENSITY; SEEDLINGS; QUALITY	This transdisciplinary study has a three-fold systems approach in evaluating a horticultural technology: 1) horticultural evaluations, 2) economic and resource analyses, and 3) systems engineering analyses, using low temperature storage as an example technology. Vegetable grafting is a technique to produce value-added seedlings but requires labor intensive nursery operations. Low temperature storage of seedlings for a short period of time can reduce peak production, but has not been evaluated at the extent demonstrated in this paper. Seedlings of 22 genotypes of Cucurbitaceae (cucurbit family) and Solanaceae (nightshade family) were evaluated for storability under selected temperatures and photosynthetic photon flux. Storability of Cucurbitaceous seedlings varied between 2 to 4 weeks at 12 degrees C and 13 mu mol m(-2) s(-1). Solanaceous seedlings were generally storable for 4 weeks at 12 degrees C and 13 mu mol m(-2) s(-1), but tomato seedlings could be stored for 4 weeks at 10 degrees C and 5 mu mol m(-2) s(-1). Capital and weekly operational costs of a low temperature storage system with a design that meets environmental requirements were estimated as $671 to $708 per m(2) footprint and $0.79 to $2.21 per m(2) footprint per week, respectively. Electricity costs per plant was less than 0.1 cents for 2 to 4 weeks of storage. Using a schedule-optimization heuristic and a logistics simulator previously developed for grafting nursery operations, six production scenarios consisting of two crops (tomato or watermelon) and three production peak patterns were examined to evaluate the impact of including low temperature storage. While the overall average costs of grafting labor were not significantly different, maximum labor demand and grafting labor cost during the peak production week were reduced by 31% to 50% and 14% to 30% by using storage, respectively. Therefore, low temperature storage can be an effective means to address the issue of labor management in grafting nurseries.	[Kubota, Chieri; Lewis, Myles; Spalholz, Hans] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Meng, Chao; Son, Young-Jun] Univ Arizona, Dept Syst & Ind Engn, Tucson, AZ 85721 USA; [Tronstad, Russell] Univ Arizona, Dept Agr & Resource Econ, Tucson, AZ 85721 USA; [Meng, Chao] Valdosta State Univ, Dept Mkt & Int Business, Valdosta, GA USA	University of Arizona; University of Arizona; University of Arizona; University System of Georgia; Valdosta State University	Kubota, C (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	ckubota@email.arizona.edu		Lewis, Myles/0000-0002-9812-5156				Ahn SJ, 1999, SCI HORTIC-AMSTERDAM, V81, P397, DOI 10.1016/S0304-4238(99)00042-4; Augusto V, 2015, P 2015 WINT SIM C DE, P1503; Calvin L., 2010, ERR106 US DEP AGR EC; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; Ding M, 2011, HORTSCIENCE, V46, P993, DOI 10.21273/HORTSCI.46.7.993; Fujiwara K, 2005, HORTTECHNOLOGY, V15, P781, DOI 10.21273/HORTTECH.15.4.0781; Heins RD, 1995, ACTA HORTIC, P285, DOI 10.17660/ActaHortic.1995.396.34; Justus I, 2010, SCI HORTIC-AMSTERDAM, V125, P47, DOI 10.1016/j.scienta.2010.02.020; Khan A, 2004, EXPANDED PRODUCTION, P35; Kubota C, 1995, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.1995.393.11; Kubota C, 2002, SCI HORTIC-AMSTERDAM, V94, P13, DOI 10.1016/S0304-4238(01)00382-X; LEE JM, 1994, HORTSCIENCE, V29, P235, DOI 10.21273/HORTSCI.29.4.235; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Lee S, 2004, J EXP BOT, V56, P955; Lewis M, 2014, HORTSCIENCE, V49, P917, DOI 10.21273/HORTSCI.49.7.917; Liu CI, 2002, IEEE T INTELL TRANSP, V3, P12, DOI 10.1109/6979.994792; Louws FJ, 2010, SCI HORTIC-AMSTERDAM, V127, P127, DOI 10.1016/j.scienta.2010.09.023; Mawlana M, 2015, AUTOMAT CONSTR, V60, P25, DOI 10.1016/j.autcon.2015.09.005; Meng C, 2014, COMPUT ELECTRON AGR, V102, P73, DOI 10.1016/j.compag.2014.01.007; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Ohyama K., 1998, Journal of Society of High Technology in Agriculture, V10, P96; Park JS, 2009, EUR J HORTIC SCI, V74, P21; Rivard CL, 2010, HORTTECHNOLOGY, V20, P794, DOI 10.21273/HORTTECH.20.4.794; Rusnock CF, 2013, IIE 2013 ANN C P JAN, P2485; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Son YJ, 2003, COMPUT IND ENG, V45, P141, DOI 10.1016/S0360-8352(03)00023-8; Spalholz H., 2013, THESIS U ARIZONA; TACHIBANA S, 1987, J JPN SOC HORTIC SCI, V55, P461, DOI 10.2503/jjshs.55.461; TACHIBANA S, 1982, J JPN SOC HORTIC SCI, V51, P299, DOI 10.2503/jjshs.51.299; Zhang ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13094	30	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170614	10.1371/journal.pone.0170614	http://dx.doi.org/10.1371/journal.pone.0170614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182757	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800015
J	Li, YH; Yu, SF; Gu, GZ; Chen, GS; Zheng, YX; Jiao, J; Zhou, WH; Wu, H; Zhang, ZR; Zhang, HL; He, LH; Yang, QY; Xu, XR				Li, Yanhong; Yu, Shanfa; Gu, Guizhen; Chen, Guoshun; Zheng, Yuxin; Jiao, Jie; Zhou, Wenhui; Wu, Hui; Zhang, Zengrui; Zhang, Huanling; He, Lihua; Yang, Qiuyue; Xu, Xiangrong			Polymorphisms of heat shock protein 70 genes (HSPA1A, HSPA1B and HSPA1L) and susceptibility of noise-induced hearing loss in a Chinese population: A case-control study	PLOS ONE			English	Article							HSP70 GENES; ASSOCIATION; WORKERS; EXPOSURE; SMOKING; RISK; SOD2; CAT	Noise-induced hearing loss (NIHL) is the second-most frequent form of sensorineural hearing loss. When exposed to the same noise, some workers develop NIHL while others do not, suggesting that NIHL may be associated with genetic factors. To explore the relationship between single nucleotide polymorphisms (SNPs) in heat shock protein 70 (HSP70) genes (HSPA1A, HSPA1B and HSPA1L) and susceptibility to NIHL in Han Chinese workers exposed to noise, a case-control association study was carried out with 286 hearing loss cases and 286 matched with gender, age, type of work, and exposure time, drawn from a population of 3790 noise-exposed workers. Four SNPs were selected and genotyped. Subsequently, the effects of the alleles and genotypes of the three HSP70 genes (HSPA1A, HSPA1B and HSPA1L) on NIHL were analyzed by using a conditional logistic regression. A generalized multiple dimensionality reduction (GMDR) was applied to further detect an interaction between the four SNPs. Compared with the combined genotypes CC/TC, carriers of the TT genotype of rs2763979 appeared to show greater susceptibility to NIHL (P = 0.042, adjusted OR = 1.731, 95% CI 1.021-2.935). A significant interaction between rs2763979 and CNE was found (P = 0.029), and a significant association was found between TT of s2763979 and NIHL (P = 0.024, adjusted OR = 5.694, 95% CI 1.256-25.817) in the 96 dB (A) <= CNE < 101 dB (A) group. The results suggest that the rs2763979 locus of the HSP70 genes may be associated with susceptibility to NIHL in Chinese individuals, and other HSP70 genes may also be susceptibility genes for NIHL, but the results must be further replicated in additional independent sample sets.	[Li, Yanhong; Yu, Shanfa; Gu, Guizhen; Jiao, Jie; Zhou, Wenhui; Wu, Hui; Zhang, Zengrui] Henan Prov Inst Occupat Hlth, Zhengzhou, Peoples R China; [Chen, Guoshun; Zhang, Huanling] Wugang Inst Occupat Hlth, Wugang, Peoples R China; [Zheng, Yuxin] Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [He, Lihua; Yang, Qiuyue; Xu, Xiangrong] Peking Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Peking University	Yu, SF (corresponding author), Henan Prov Inst Occupat Hlth, Zhengzhou, Peoples R China.	yu-shanfa@163.com	zhang, zengrui/HGB-6209-2022		National Natural Science Foundation of the People's Republic of China [81372940]; National Science and Technology Infrastructure Program of the People's Republic of China [2014BAI12B03]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Infrastructure Program of the People's Republic of China	This study was supported by the National Natural Science Foundation of the People's Republic of China (81372940) and the Research Fund from the National Science and Technology Infrastructure Program of the People's Republic of China (2014BAI12B03).	Abreu-Silva RS, 2011, ANN HUM BIOL, V38, P210, DOI 10.3109/03014460.2010.513774; Carlsson PI, 2005, HEARING RES, V202, P87, DOI 10.1016/j.heares.2004.09.005; Chang NC, 2007, OTOLARYNG HEAD NECK, V137, P603, DOI 10.1016/j.otohns.2007.04.022; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Chang NC, 2009, AM J OTOLARYNG, V30, P396, DOI 10.1016/j.amjoto.2008.08.001; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; LIM DJ, 1986, AM J OTOLARYNG, V7, P73, DOI 10.1016/S0196-0709(86)80037-0; Liu JP, 2007, CLIN CHIM ACTA, V384, P64, DOI 10.1016/j.cca.2007.05.021; Liu YM, 2010, DIS MARKERS, V28, P137, DOI [10.1155/2010/753073, 10.3233/DMA-2010-0693]; Liu YM, 2010, ACTA OTO-LARYNGOL, V130, P477, DOI 10.3109/00016480903253587; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ni CH, 2007, CHINESE MED J-PEKING, V120, P1309, DOI 10.1097/00029330-200708010-00003; Rachiotis G, 2006, AURIS NASUS LARYNX, V33, P381, DOI 10.1016/j.anl.2006.03.008; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shen HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089662; Sliwinska-Kowalska M, 2008, AM J HUM BIOL, V20, P481, DOI 10.1002/ajhb.20744; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Sulkowski Wieslaw J, 2004, Otolaryngol Pol, V58, P233; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P48, DOI 10.1136/ard.61.1.48; Wang SL, 2014, BIOMED ENVIRON SCI, V27, P965, DOI 10.3967/bes2014.131; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Xie HW, 2015, EAR HEAR; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1; Zhou F, 2005, CELL STRESS CHAPERON, V10, P349, DOI 10.1379/CSC-156.1	33	9	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171722	10.1371/journal.pone.0171722	http://dx.doi.org/10.1371/journal.pone.0171722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182740	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800096
J	Rzewuska, M; de Azevedo-Marques, JM; Coxon, D; Zanetti, ML; Zanetti, ACG; Franco, LJ; Santos, JLF				Rzewuska, Magdalena; de Azevedo-Marques, Joao Mazzoncini; Coxon, Domenica; Zanetti, Maria Lucia; Guidorizzi Zanetti, Ana Carolina; Franco, Laercio Joel; Ferreira Santos, Jair Licio			Epidemiology of multimorbidity within the Brazilian adult general population: Evidence from the 2013 National Health Survey (PNS 2013)	PLOS ONE			English	Article							PRIMARY-CARE; CHRONIC DISEASES; CONSULTATION; DEPRESSION; PREVALENCE; PATTERNS; DESIGN; GENDER; INCOME	Middle-income countries are facing a growing challenge of adequate health care provision for people with multimorbidity. The objectives of this study were to explore the distribution of multimorbidity and to identify patterns of multimorbidity in the Brazilian general adult population. Data from 60202 adults, aged >= 18 years that completed the individual questionnaire of the National Health Survey 2013 (Portuguese: Pesquisa Nacional de SaudePNS) was used. We defined multimorbidity as the presence of two or more chronic conditions, including self-reported diagnoses and responses to the 9-item Patient Health Questionnaire for depression. Multivariate Poisson regression analyses were used to explore relationship between multimorbidity and demographic factors. Exploratory tetrachoric factor analysis was performed to identify multimorbidity patterns. 24.2% (95% CI 23.524.9) of the study population were multimorbid, with prevalence rate ratios being significantly higher in women, older people and those with lowest educational level. Multimorbidity occurred earlier in women than in men, with half of the women and men aged 5559 years and 6569 years, respectively, were multimorbid. The absolute number of people with multimorbidity was approximately 2.5-fold higher in people younger than 65 years than older counterparts (9920 vs 3945). Prevalence rate ratios of any mental health disorder significantly increased with the number of physical conditions. 46.7% of the persons were assigned to at least one of three identified patterns of multimorbidity, including: "cardio-metabolic", "musculoskeletal-mental" and "respiratory" disorders. Multimorbidity in Brazil is as common as in more affluent countries. Women in Brazil develop diseases at younger ages than men. Our findings can inform a national action plan to prevent multimorbidity, reduce its burden and align health-care services more closely with patients' needs.	[Rzewuska, Magdalena] Univ Sao Paulo, Ribeirao Preto Sch Med, Community Hlth Postgrad Program, Ribeirao Preto, SP, Brazil; [de Azevedo-Marques, Joao Mazzoncini; Franco, Laercio Joel; Ferreira Santos, Jair Licio] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Social Med, Ribeirao Preto, SP, Brazil; [Coxon, Domenica] Univ Edinburgh, Ctr Populat Hlth Sci, Lothian, Scotland; [Zanetti, Maria Lucia; Guidorizzi Zanetti, Ana Carolina] Univ Sao Paulo, Ribeirao Preto Coll Nursing, WHO Collaborating Ctr Nursing Res Dev, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Edinburgh; Universidade de Sao Paulo; World Health Organization	Rzewuska, M (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Community Hlth Postgrad Program, Ribeirao Preto, SP, Brazil.	magda.rzewuska@yahoo.co.uk	de azevedo-marques, joao mazzoncini/J-3172-2014; Zanetti, Ana Carolina G./H-6954-2013; de azevedo marques, joão mazzoncini/AAQ-8464-2020	de azevedo-marques, joao mazzoncini/0000-0002-3100-3883; Zanetti, Ana Carolina G./0000-0003-0011-4510; Rzewuska, Magdalena/0000-0003-4642-1196	Brazilian Ministry of Health [328 159]; Science without Borders Programme for "Young Talent Attraction" (CAPES) [CSF-PAJT - 88887.090476/2014-00]	Brazilian Ministry of Health; Science without Borders Programme for "Young Talent Attraction" (CAPES)	The survey data used in the study was financed by the Brazilian Ministry of Health (no. 328 159, 26 June 2013). Magdalena Rzewuska is funded by the Science without Borders Programme for Young Talent Attraction (CAPES, grant number: CSF-PAJT - 88887.090476/2014-00). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andrade LH, 2010, BRAZ J MED BIOL RES, V43, P483, DOI 10.1590/S0100-879X2010007500024; [Anonymous], 2005, PREV CHRON DIS VIT I; Ballester Dinarte Alexandre, 2005, Sao Paulo Med. J., V123, P72, DOI 10.1590/S1516-31802005000200008; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Lima AFBD, 2011, REV BRAS PSIQUIATR, V33, P245, DOI 10.1590/S1516-44462011000300007; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Brazil Health Ministry D Health Care Secretary, 2012, NAT PROGR ACC QUAL I; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Capilheira MF, 2006, REV SAUDE PUBL, V40, P436, DOI 10.1590/S0034-89102006000300011; dos Santos Palazzo L, 2001, Aten Primaria, V28, P543; Elhayany, 1995, BMC PUBLIC HEALTH, V24, P167; Field A., 2013, DISCOVERING STAT USI; Fortin M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-686; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Goncalves DA, 2013, GEN HOSP PSYCHIAT, V35, P304, DOI 10.1016/j.genhosppsych.2013.01.003; Gregorio G, 2012, REV BRAS PSIQUIATR, V34, P434, DOI 10.1016/j.rbp.2012.05.006; Gross R, 1996, Public Health Rev, V24, P167; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Leite ID, 2015, CAD SAUDE PUBLICA, V31, P1551, DOI 10.1590/0102-311X00111614; Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P3, DOI 10.1590/1980-5497201500060002; Mercer S., 2014, ABC MULTIMORBIDITY; Moffat K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0344-4; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Munhoz TN, 2016, J AFFECT DISORDERS, V192, P226, DOI 10.1016/j.jad.2015.12.038; Nunes BP, 2016, INT J PUBLIC HEALTH, P1; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Rao CR, 2006, HDB STAT; Rasmussen B, 2015, EC COSTS ABSENTEEISM; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]; Machado VDS, 2012, MENOPAUSE, V19, P569, DOI 10.1097/gme.0b013e3182455963; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Valentini W, 2004, REV SAUDE PUBL, V38, P522, DOI 10.1590/S0034-89102004000400007; Vegda K, 2009, BMC HEALTH SERV RES, V9, P1; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; WHO, 2008, PHARMAFORUM 0121; Willadsen TG, 2016, SCAND J PRIM HEALTH, V34, P112, DOI 10.3109/02813432.2016.1153242; Wilson P, 2008, PSYCHOLOGIST, V21, P866; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, 2013, GLOB ACT PLAN PREV C; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	59	37	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171813	10.1371/journal.pone.0171813	http://dx.doi.org/10.1371/journal.pone.0171813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182778	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800118
J	Sprenger, N; Lee, LY; De Castro, CA; Steenhout, P; Thakkar, SK				Sprenger, Norbert; Lee, Le Ye; De Castro, Carlos Antonio; Steenhout, Philippe; Thakkar, Sagar K.			Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study	PLOS ONE			English	Article							BREAST-FED INFANTS; GROUP-DEPENDENT OLIGOSACCHARIDES; NEUTRAL OLIGOSACCHARIDES; LACTATION; POPULATION; PROTECTION; NUTRITION; EVOLUTION; COLOSTRUM; CHILDREN	Background: Human milk is the recommended and sole nutrient source for newborns. One of the largest components of human milk is oligosaccharides (HMOs) with major constituents determined by the mother genotype for the fucosyltransferase 2 (FUT2, secretor) gene. HMO variation has been related with infant microbiota establishment, diarrhea incidence, morbidity and mortality, IgE associated eczema and body composition. Objectives: We investigated the (i) dependence of several major representative HMOs on the FUT2 status assessed through breast milk 2'Fucosyllactose (2'FL) and (ii) the relation of the 2'FL status with infant growth up to 4 months of life. Design: From an open observatory, single center, longitudinal cohort study with quantitative human milk collection at 30, 60, and 120 days postpartum from 50 mothers, who gave birth to 25 female and 25 male singleton infants, we collected a representative sample of human milk. We quantified the following 5 representative HMOs: 2'FL, Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'Sialyllactose (3'SL) and 6'Sialyllactose (6'SL). We grouped the milk samples and corresponding infants according to the measured milk 2'FL concentrations at 30 days of lactation, which clustered around low concentrations (95% CI of mean 12-42 mg/L) and high concentrations (95% CI of mean 1880-2460 mg/L) with the former likely representing Secretor negative mothers. Infant anthropometric measures were recorded at birth, 1, 2 and 4 months of age. Relations among the quantified HMOs and the relation of the high and low 2'FL HMOs groups with infant growth parameters were investigated via linear mixed models. Results: The milk samples with low 2'FL concentration had higher LNT and lower LNnT concentrations compared to the samples with high 2'FL. The milk 3'- and 6'SL concentrations were independent of 2'FL. Over lactation time we observed a drop in the concentration of 2'FL, LNT, LNnT and 6'SL, especially from 1 to 2 months, while 3'SL remained at relatively constant concentration from 1 month onwards. Up to 4 months of age, we did not observe significant differences in body weight, body length, body mass index and head circumference of the infants who consumed breast milk with low or high FUT2 associated HMO concentrations and composition. Conclusions: Our findings on HMO concentrations over time of lactation and clusters based on 2'FL concentrations confirm previous observations and suggest that LNnT and LNT are 'co-regulated' with the FUT2 dependent 2'FL concentration, with LNnT showing a positive and LNT a negative relation. Further, our findings also suggest that the relatively substantial variation in HMOs between the high and low 2'FL clusters do not impact infant growth of either sex up to 4 months of age.	[Sprenger, Norbert; De Castro, Carlos Antonio; Thakkar, Sagar K.] Nestec Ltd, Nestle Res Ctr, Lausanne, Switzerland; [Lee, Le Ye] Khoo Teck Puat Natl Univ, Natl Univ Hosp, Childrens Med Inst, Dept Neonatol, Singapore, Singapore; [Lee, Le Ye] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117548, Singapore; [Steenhout, Philippe] Nestle Nutr, Vevey, Switzerland	Nestle SA; National University of Singapore; National University of Singapore; Nestle SA	Sprenger, N (corresponding author), Nestec Ltd, Nestle Res Ctr, Lausanne, Switzerland.	Norbert.Sprenger@rdls.nestle.com		Sprenger, Norbert/0000-0003-4880-2750	Nestle Nutrition	Nestle Nutrition(Nestle SA)	The study was funded by Nestle Nutrition. NS CADC PS and SKT are employees of Nestec S.A.; LYL received financial support from Nestle Nutrition to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [PS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alderete TL, 2015, AM J CLIN NUTR, V102, P1381, DOI 10.3945/ajcn.115.115451; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Austin S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060346; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; Blank D, 2012, ADV NUTR, V3, p440S, DOI 10.3945/an.111.001446; Bode L, 2012, ADV NUTR, V3, p383S, DOI 10.3945/an.111.001404; Castanys-Munoz E, 2013, NUTR REV, V71, P773, DOI 10.1111/nure.12079; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Emmett PM, 1997, EARLY HUM DEV, V49, pS7, DOI 10.1016/S0378-3782(97)00051-0; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Koda Y, 1996, AM J HUM GENET, V59, P343; Kuhn L, 2015, J NUTR, V145, P66, DOI 10.3945/jn.114.199794; Kunz C, 1999, BRIT J NUTR, V82, P391, DOI 10.1017/S0007114599001798; Kunz C, 2016, J PEDIAT GASTROENTER; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; McClellan HL, 2008, NUTR RES REV, V21, P97, DOI 10.1017/S0954422408100749; Morrow AL, 2004, ADV EXP MED BIOL, V554, P443; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020; Seppo AE, 2016, J ALLERGY CLIN IMMUN; Serpa J, 2004, BIOCHEM J, V383, P469, DOI 10.1042/BJ20040803; Sjogren YM, 2007, PEDIAT ALLERG IMM-UK, V18, P20, DOI 10.1111/j.1399-3038.2006.00486.x; Smilowitz JT, 2013, J NUTR, V143, P1709, DOI 10.3945/jn.113.178772; Smith-Brown P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161211; Soejima M, 2012, TRANSFUSION, V52, P1268, DOI 10.1111/j.1537-2995.2011.03485.x; Sprenger N, 2016, EUR J NUTR; Stahl B, 2001, ADV EXP MED BIOL, V501, P299; Thakkar Sagar K, 2013, Am J Hum Biol, V25, P770, DOI 10.1002/ajhb.22446; Thurl S, 1997, GLYCOCONJUGATE J, V14, P795, DOI 10.1023/A:1018529703106; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g	35	108	115	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171814	10.1371/journal.pone.0171814	http://dx.doi.org/10.1371/journal.pone.0171814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182762	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800119
J	Abdelkader, MM; Aboshanab, KM; El-Ashry, MA; Aboulwafa, MM				Abdelkader, Mona M.; Aboshanab, Khaled M.; El-Ashry, Marwa A.; Aboulwafa, Mohammad M.			Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; EPIDEMIOLOGY; MECHANISMS; CAIRO; SURVEILLANCE	The aim of this study was identifying bacterial pathogens involved in meningitis, studying their antibiotic resistance profiles, investigating the antibiotic resistance genes as well as evaluating the use of various antibiotic combinations. Antibiotic susceptibility tests were evaluated according to CLSI guidelines. Antibiotic combinations were evaluated by calculating the Fractional Inhibitory Concentration (FIC) index. A total of 71 bacterial isolates were recovered from 68 culture positive CSF specimens. Sixty five of these isolates (91.5%) were recovered from single infection specimens, while 6 isolates (8.4%) were recovered from mixed infection specimens. Out of the 71 recovered isolates, 48 (67.6%) were Gram-positive, and 23 (32.4%) were Gram-negative. Thirty one of the Gram positive isolates were S. pneumoniae (64.6%, n = 48). Out of the recovered 71 isolates; 26 (36.6%) were multidrugresistant (MDR) isolates of which, 18 (69.2%) were Gram-negative and 8 (30.8%) were Gram-positive. All MDR isolates (100%) showed resistance to penicillin and ampicillin, however, they showed lower resistance to meropenem (50%), levofloxacin (50%), amikacin (48%), pipercillin-tazobactam (45.8%). Most common antibiotic resistance genes were investigated including: tern (21.1%), shv (15.8%), ctx-m (15.8%) coding for TEM-, SHV, CTX-M extended-spectrum beta-lactamases (ESBLs), respectively; aac(6)-I b(26.3%) coding for aminoglycoside 6'-N-acetyltransferase type lb ciprofloxacin resistant variant; and qnrA (5.3%) gene coding for quinolone resistance. The DNA sequences of the respective resistance genes of some selected isolates were PCR amplified, analyzed and submitted to the GenBank database under the accession numbers, KX214665, KX214664, KX214663, KX214662, respectively. The FIC values for ampicillin/sulbactam plus cefepime showed either additive or synergistic effect against ten tested Gram-negative MDR isolates, while doxycycline plus levofloxacin combination revealed synergism against two MDR Gram-positive isolates. The results indicate high prevalence of antibiotic resistance among MDR isolates. Therefore, new guidelines should be implemented in Egypt to rationalize the use and avoid the misuse and abuse of antimicrobial agents.	[Abdelkader, Mona M.; Aboshanab, Khaled M.; Aboulwafa, Mohammad M.] Ain Shams Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [El-Ashry, Marwa A.] Ain Shams Univ, Fac Med, Dept Clin & Chem Pathol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Aboshanab, KM (corresponding author), Ain Shams Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt.	aboshanab2012@pharma.asu.edu.eg	Aboshanab, Khaled/L-9848-2019; Aboulwafa, Mohammad/V-5498-2018	Aboulwafa, Mohammad/0000-0002-0828-1420; Aboshanab, Khaled/0000-0002-7608-850X				Abdel-Aziz S, 2015, ACTAMICROBIOL, V6; Afifi S, 2007, EUR J CLIN MICROBIOL, V26, P331, DOI 10.1007/s10096-007-0280-x; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; [Anonymous], 2013, CHEMOTHERAPY; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; BERGOGNEBEREZIN E, 1995, J HOSP INFECT, V30, P441, DOI 10.1016/0195-6701(95)90048-9; Boctor W M, 1969, J Egypt Public Health Assoc, V44, P253; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Borg MA, 2009, CLIN MICROBIOL INFEC, V15, P232, DOI 10.1111/j.1469-0691.2008.02651.x; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Carbonnelle E, 2009, MED MALADIES INFECT, V39, P581, DOI 10.1016/j.medmal.2009.02.017; Chandramohan L, 2012, ANTIMICROB AGENTS CH, V56, P4765, DOI 10.1128/AAC.00666-12; CLSI, 2011, M100S20 CLSI, P172; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; El Kholy A, 2003, J ANTIMICROB CHEMOTH, V51, P625, DOI 10.1093/jac/dkg101; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; GIRGIS NI, 1972, J TROP MED HYG, V73, P154; GIRGIS NI, 1993, AM J TROP MED HYG, V48, P97, DOI 10.4269/ajtmh.1993.48.97; GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7; Hamed SM., 2013, BRIT MICROBIOL RES J, V3, P448; Hirsch EB, 2013, J INFECT DIS, V207, P786, DOI 10.1093/infdis/jis766; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Hou XH, 2015, BRAZ J MICROBIOL, V46, P759, DOI 10.1590/S1517-838246320140138; HSIEH MH, 1993, DIAGN MICR INFEC DIS, V16, P343, DOI 10.1016/0732-8893(93)90087-N; Jones Mark E, 2004, Ann Clin Microbiol Antimicrob, V3, P3, DOI 10.1186/1476-0711-3-3; Lewis JS, 2007, ANTIMICROB AGENTS CH, V51, P4015, DOI 10.1128/AAC.00576-07; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; McGettigan SE, 2009, J CLIN MICROBIOL, V47, P2970, DOI 10.1128/JCM.00319-09; MINER WF, 1978, AM J TROP MED HYG, V27, P986, DOI 10.4269/ajtmh.1978.27.986; Ministry of Health and Population Egypt, 2000, ENH SURV COMM DIS AN; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Ostroff SM, 1996, CLIN INFECT DIS, V23, P1069, DOI 10.1093/clinids/23.5.1069; Owusu M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-28; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Pitout JDD, 2004, CLIN INFECT DIS, V38, P1736, DOI 10.1086/421094; Rafi W, 2010, J EMERG MED, V38, P225, DOI 10.1016/j.jemermed.2008.02.053; Rasheed JK, 1997, ANTIMICROB AGENTS CH, V41, P647, DOI 10.1128/AAC.41.3.647; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sader HS, 2005, INT J ANTIMICROB AG, V25, P380, DOI 10.1016/j.ijantimicag.2005.01.011; Sambrook J., 2001, MOL CLONING LAB MANU; Shaban L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-26; Sidjabat HE, 2009, ANTIMICROB AGENTS CH, V53, P4733, DOI 10.1128/AAC.00533-09; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Taha N, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-2; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; Walsh C., 2003, ANTIBIOTICS ACTIONS; Won H, 2012, DIAGN MICR INFEC DIS, V74, P22, DOI 10.1016/j.diagmicrobio.2012.05.015; Youssef FG, 2004, ANN EPIDEMIOL, V14, P44, DOI 10.1016/S1047-2797(03)00075-9; Zhao Chaoli, 2014, Zhonghua Shao Shang Za Zhi, V30, P166	62	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171349	10.1371/journal.pone.0171349	http://dx.doi.org/10.1371/journal.pone.0171349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207768	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500025
J	Baker, WL				Baker, William L.			Restoring and managing low-severity fire in dry-forest landscapes of the western USA	PLOS ONE			English	Article							MIXED-CONIFER FORESTS; SAN-PEDRO-MARTIR; NATIONAL-PARK; SOUTHERN CASCADES; MONTANE FORESTS; PRESCRIBED FIRE; JEFFREY PINE; HISTORY; CALIFORNIA; INTERVAL	Low-severity fires that killed few canopy trees played a significant historical role in dry forests of the western USA and warrant restoration and management, but historical rates of burning remain uncertain. Past reconstructions focused on on dating fire years, not measuring historical rates of burning. Past statistics, including mean composite fire interval (mean CFI) and individual-tree fire interval (mean ITFI) have biases and inaccuracies if used as estimators of rates. In this study, I used regression, with a calibration dataset of 96 cases, to test whether these statistics could accurately predict two equivalent historical rates, population mean fire interval (PMFI) and fire rotation (FR). The best model, using Weibull mean ITFI, had low prediction error and R-2 (adj) = 0.972. I used this model to predict historical PMFI/FR at 252 sites spanning dry forests. Historical PMFI/FR for a pool of 342 calibration and predicted sites had a mean of 39 years and median of 30 years. Short (< 25 years) mean PMFI/FRs were in Arizona and New Mexico and scattered in other states. Long (> 55 years) mean PMFI/FRs were mainly from northern New Mexico to South Dakota. Mountain sites often had a large range in PMFI/FR. Nearly all 342 estimates are for old forests with a history of primarily low-severity fire, found across only about 34% of historical dry-forest area. Frequent fire (PMFI/FR < 25 years) was found across only about 14% of historical dry-forest area, with 86% having multidecadal rates of low-severity fire. Historical fuels (e.g., understory shrubs and small trees) could fully recover between multidecadal fires, allowing some denser forests and some ecosystem processes and wildlife habitat to be less limited by fire. Lower historical rates mean less restoration treatment is needed before beginning managed fire for resource benefits, where feasible. Mimicking patterns of variability in historical low-severity fire regimes would likely benefit biological diversity and ecosystem functioning.	[Baker, William L.] Univ Wyoming, Dept Geog, Program Ecol, Dept 3371,1000 E Univ Ave, Laramie, WY 82071 USA	University of Wyoming	Baker, WL (corresponding author), Univ Wyoming, Dept Geog, Program Ecol, Dept 3371,1000 E Univ Ave, Laramie, WY 82071 USA.	bakerwl@uwyo.edu	Baker, William/A-7008-2008					Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Agee J. K., 1994, FIRE WEATHER DISTURB; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arno S. F., 1983, INT301 USDA FOR SERV; Baker W. L., 2008, Open Forest Science Journal, V1, P1, DOI 10.2174/1874398600801010001; Baker WL, 2015, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00088; Baker WL, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0136147, 10.1080/1554480X.2014.999777]; Baker WL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00046.1; Baker WL, 2013, CAN J FOREST RES, V43, P951, DOI 10.1139/cjfr-2013-0176; Baker WL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00320.1; Baker WL, 2001, CAN J FOREST RES, V31, P1205, DOI 10.1139/cjfr-31-7-1205; Baker WL., 2009, FIRE ECOLOGY ROCKY M; BARRETT SW, 1997, INTGTR370 USDA FOR S; Beaty RM, 2001, J BIOGEOGR, V28, P955, DOI 10.1046/j.1365-2699.2001.00591.x; Brewer PW., 2016, FIRE HIST ANAL EXPLO; BROWN JK, 1994, INT J WILDLAND FIRE, V4, P157, DOI 10.1071/WF9940157; Collins B.M., 2007, FIRE ECOL, V3, P53, DOI [10.4996/fireecology.0302053, DOI 10.4996/FIREEC0L0GY.0302053]; Cooper C. F., 1960, Ecological Monographs, V30, P129, DOI 10.2307/1948549; COVINGTON WW, 1994, J FOREST, V92, P39; Dugan AJ, 2015, J VEG SCI, V26, P697, DOI 10.1111/jvs.12266; Dugan AJ, 2014, INT J WILDLAND FIRE, V23, P58, DOI 10.1071/WF12162; Falk DA, 2002, US FOR SERV RMRS-P, P301; Falk DA, 2007, ECOSYSTEMS, V10, P809, DOI 10.1007/s10021-007-9070-7; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Farris CA, 2013, INT J WILDLAND FIRE, V22, P1021, DOI 10.1071/WF13026; Farris CA, 2010, ECOL APPL, V20, P1598, DOI 10.1890/09-1535.1; Fiegener RP, 2001, THESIS; GOLDBLUM D, 1992, PHYS GEOGR, V13, P133, DOI 10.1080/02723646.1992.10642449; Grissino-Mayer H. D., 1995, THESIS; Grissino-Mayer HD, 1999, INT J WILDLAND FIRE, V9, P37, DOI 10.1071/WF99004; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Jordan GJ, 2005, LANDSCAPE ECOL, V20, P719, DOI 10.1007/s10980-005-0071-7; Kaufmann MR, 1992, RMGTR213 USDA FOR SE; Keeley JE, 2007, INT J WILDLAND FIRE, V16, P96, DOI 10.1071/WF06052; Kolden CA, 2012, FOREST ECOL MANAG, V286, P38, DOI 10.1016/j.foreco.2012.08.020; Kou XJ, 2006, LANDSCAPE ECOL, V21, P735, DOI 10.1007/s10980-005-5325-x; Kou XJ, 2006, INT J WILDLAND FIRE, V15, P489, DOI 10.1071/WF05113; Laughlin DC, 2006, OIKOS, V114, P60, DOI 10.1111/j.0030-1299.2006.14424.x; Leiberg JB, 1902, US GEOLOGICAL SURVEY; Lombardo K. J., 2009, Fire Ecology, V5, P35; LORIMER CG, 1985, CAN J FOREST RES, V15, P200, DOI 10.1139/x85-038; Margolis EQ, 2009, FOREST ECOL MANAG, V258, P2416, DOI 10.1016/j.foreco.2009.08.019; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P27, DOI 10.1007/978-94-007-0301-8_2; Moritz MA, 2009, ENVIRON ECOL STAT, V16, P271, DOI 10.1007/s10651-007-0088-y; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Parsons RA, 2007, CAN J FOREST RES, V37, P1605, DOI 10.1139/X07-013; R Development Core Team, 2007, R LANG ENV STAT COMP; Reynolds R.T., 2013, RMRSGTR310 US DEP AG; Scholl AE, 2010, ECOL APPL, V20, P362, DOI 10.1890/08-2324.1; Shapiro-Miller LB, 2007, CAN J FOREST RES, V37, P1933, DOI 10.1139/X07-054; Show S.B., 1924, ROLE FIRE CALIFORNIA; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Stephens SL, 2012, FOREST ECOL MANAG, V285, P204, DOI 10.1016/j.foreco.2012.08.030; Stephens SL, 2010, CAN J FOREST RES, V40, P1497, DOI 10.1139/X10-083; Stephens SL, 2003, CAN J FOREST RES, V33, P1090, DOI [10.1139/x03-031, 10.1139/X03-031]; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Swetnam T, 2011, ECOL STUD-ANAL SYNTH, V213, P165, DOI 10.1007/978-94-007-0301-8_7; Taylor AH, 1998, FOREST ECOL MANAG, V111, P285, DOI 10.1016/S0378-1127(98)00342-9; Taylor AH, 2000, J BIOGEOGR, V27, P87, DOI 10.1046/j.1365-2699.2000.00353.x; Tiedemann AR, 2000, FOREST ECOL MANAG, V127, P1, DOI 10.1016/S0378-1127(99)00114-0; Van Horne ML, 2006, CAN J FOREST RES, V36, P855, DOI 10.1139/X05-289; van Mantgem PJ, 2016, FOREST ECOL MANAG, V379, P265, DOI 10.1016/j.foreco.2016.07.028; VANKAT JL, 1978, J BIOGEOGR, V5, P377, DOI 10.2307/3038030; Veblen TT, 2002, US FOR SERV RMRS-P, P259; WHITE AS, 1985, ECOLOGY, V66, P589, DOI 10.2307/1940407; Williams MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P831, DOI 10.1111/geb.12152; Williams MA, 2013, LANDSCAPE ECOL, V28, P297, DOI 10.1007/s10980-012-9835-z; Williams MA, 2012, GLOBAL ECOL BIOGEOGR, V21, P1042, DOI 10.1111/j.1466-8238.2011.00750.x; Williams MA, 2011, ECOL MONOGR, V81, P63, DOI 10.1890/10-0256.1	72	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172288	10.1371/journal.pone.0172288	http://dx.doi.org/10.1371/journal.pone.0172288			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199416	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400088
J	Ohara, WM; Mirande, JM; de Lima, FCT				Ohara, Willian Massaharu; Marcos Mirande, Juan; Thadeo de Lima, Flavio Cesar			Phycocharax rasbora, a new genus and species of Brazilian tetra (Characiformes: Characidae) from Serra do Cachimbo, rio Tapajos basin	PLOS ONE			English	Article							PHYLOGENY; TELEOSTEI; REPRODUCTION; HEMIGRAMMUS	A new genus and species of characid fish is described from rio Braco Norte, a tributary of rio Teles Pires, Tapajos basin, Mato Groso, Brazil. The new taxa can be diagnosed from the remaining characids by a unique combination of characters that includes the presence of a single row of relatively compressed premaxillary teeth, large teeth with four to nine cusps on premaxillary and dentary, absence of pseudotympanum, incomplete lateral line with 7-13 pored scales, sexually-dimorphic males with distal margin of anal fin approximately straight, and presence of a nearly triangular and horizontally elongated blotch from the posterior half of the body to caudal peduncle. The most parsimonious phylogenetic hypothesis, using morphological data, recovered the new genus and species in a clade including Paracheirodon axelrodi and Hyphessobrycon elachys.	[Ohara, Willian Massaharu] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Marcos Mirande, Juan] Fdn Miguel Lillo, CONICET, Miguel Lillo, San Miguel De T, Argentina; [Thadeo de Lima, Flavio Cesar] Univ Estadual Campinas Adao Jose Cardoso, Museu Zool, Campinas, SP, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Universidade Estadual de Campinas	Ohara, WM (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil.	willianmohara@gmail.com	Lima, Flávio C.T./B-6218-2013	Lima, Flávio C.T./0000-0002-7636-5431; Mirande, Juan Marcos/0000-0003-4370-3526	South American Characiformes Inventory [FAPESP 2011/502827]; FAPESP [2013/22473-8, 2011/51532-7, 2013/20936-0]; CONICET [PIP-0301]; FONCyT [PICT 2011-0992]	South American Characiformes Inventory; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT)	Part of the type series was collected during an expedition funded by the South American Characiformes Inventory (FAPESP 2011/502827, http//www.projeto-saci.com). The authors are supported by FAPESP (WMO: grant # 2013/22473-8; FCTL: grants # 2011/51532-7 and 2013/20936-0), CONICET (JMM: PIP-0301), and FONCyT (JMM: PICT 2011-0992). A travel by the second author to ZUEC was funded by FAPESP [grant # 2011/51532-7, "Systematics of tetras (genera Hemigrammus, Hyphessobrycon, Thayeria, Parapristella and Bryconella), with emphasis on the species from northern cis-andean South America"]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT A, 1988, ENVIRON BIOL FISH, V22, P15, DOI 10.1007/BF00000541; Eigenmann C.H., 1917, MEM MUS COMP ZOOL, V43, P1; Eigenmann CH, 1915, MEM CARNEGIE MUS, V7, P1, DOI [10.5962/bhl.title.46579, DOI 10.5962/BHL.TITLE.46579]; Eschmeyer W.N., 2016, SPECIES FAMILY SUBFA; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Gery J., 1977, CHARACOIDS WORLD; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; Gonçalves Cristina da Silva, 2013, Acta Limnol. Bras., V25, P398; Kottelat Maurice, 1999, Journal of South Asian Natural History, V4, P49; Lima Flavio C. T., 2016, Aqua, V22, P123; Lima Flavio C. T., 2009, Aqua, V15, P153; Malabarba Luiz R., 1998, P193; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2011, ZOOTAXA, P1; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Netto-Ferreira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052098; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pastana MNL, 2016, ZOOTAXA, V4161, P386, DOI 10.11646/zootaxa.4161.3.6; TAYLOR W R, 1985, Cybium, V9, P107; Teixeira TF, 2013, COPEIA, P612, DOI 10.1643/CI-13-026; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; Weitzman Stanley H., 1998, P161; Zanata Angela M., 2004, Neotrop. ichthyol., V2, P45, DOI 10.1590/S1679-62252004000200001	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170648	10.1371/journal.pone.0170648	http://dx.doi.org/10.1371/journal.pone.0170648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199336	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400018
J	Okino, CH; Mores, MAZ; Trevisol, IM; Coldebella, A; Montassier, HJ; Brentano, L				Okino, Cintia Hiromi; Zanella Mores, Marcos Antonio; Trevisol, Iara Maria; Coldebella, Arlei; Montassier, Helio Jose; Brentano, Liana			Early immune responses and development of pathogenesis of avian infectious bronchitis viruses with different virulence profiles	PLOS ONE			English	Article							TISSUE TROPISM; CHICKENS; GENOTYPE; STRAINS; OVIDUCT; VARIANT; TRANSCRIPTOME; EXPRESSION; EMERGENCE; NEPHRITIS	Avian infectious bronchitis virus (IBV) primarily replicates in epithelial cells of the upper respiratory tract of chickens, inducing both morphological and immune modulatory changes. However, the association between the local immune responses induced by IBV and the mechanisms of pathogenesis has not yet been completely elucidated. This study compared the expression profile of genes related to immune responses in tracheal samples after challenge with two Brazilian field isolates (A and B) of IBV from the same genotype, associating these responses with viral replication and with pathological changes in trachea and kidney. We detected a suppressive effect on the early activation of TLR7 pathway, followed by lower expression levels of inflammatory related genes induced by challenge with the IBV B isolate when compared to the challenge with to the IBV A isolate. Cell-mediated immune (CMI) related genes presented also lower levels of expression in tracheal samples from birds challenged with B isolate at 1dpi. Increased viral load and a higher percentage of birds with relevant lesions were observed in both tracheal and renal samples from chickens exposed to challenge with IBV B isolate. This differential pattern of early immune responses developed after challenge with IBV B isolate, related to the downregulation of TLR7, leading to insufficient pro-inflammatory response and lower CMI responses, seem to have an association with a most severe renal lesion and an enhanced capability of replication of this isolate in chicken.	[Okino, Cintia Hiromi; Zanella Mores, Marcos Antonio; Trevisol, Iara Maria; Coldebella, Arlei; Brentano, Liana] Embrapa Swine & Poultry, Concordia, SC, Brazil; [Montassier, Helio Jose] Univ Estadual Paulista, UNESP, Dept Vet Pathol, Lab Immunol & Virol Imunovir, Jaboticabal, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista	Okino, CH (corresponding author), Embrapa Swine & Poultry, Concordia, SC, Brazil.	cintia.okino@embrapa.br	Okino, Cintia/P-6563-2014; Okino, Cintia/N-9601-2019	Okino, Cintia/0000-0002-3692-3902; Okino, Cintia/0000-0002-3692-3902	Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil	Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil	The whole study was supported by Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil. The funder had role in study design, data collection and analysis, decision to publish and also on the preparation of the manuscript, as most of authors (CHO, MAZM, IMT, AC and LB) work for the funder.	Abdel-Moneim AS, 2012, ARCH VIROL, V157, P2453, DOI 10.1007/s00705-012-1445-1; Asif M, 2007, VIRAL IMMUNOL, V20, P479, DOI 10.1089/vim.2006.0109; Burggraaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014561; Chhabra R, 2016, VIROLOGY, V488, P232, DOI 10.1016/j.virol.2015.11.011; Chhabra R, 2015, VIRAL IMMUNOL, V28, P478, DOI 10.1089/vim.2015.0027; Chhabra R, 2015, CLIN VACCINE IMMUNOL, V22, P1050, DOI 10.1128/CVI.00368-15; Chousalkar KK, 2009, J VIROL METHODS, V155, P67, DOI 10.1016/j.jviromet.2008.09.028; Cong F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-743; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; Fernando FS, 2015, PESQUI VET BRASIL, V35, P216, DOI 10.1590/S0100-736X2015000300002; Fraga AP, 2013, AVIAN DIS, V57, P225, DOI 10.1637/10346-090412-Reg.1; Franca M, 2011, AVIAN DIS, V55, P422, DOI 10.1637/9417-060510-Reg.1; Gelb J, 2013, AVIAN DIS, V57, P65, DOI 10.1637/10313-080212-Reg.1; Guo XH, 2008, VET IMMUNOL IMMUNOP, V121, P332, DOI 10.1016/j.vetimm.2007.09.016; Kameka AM, 2014, VIROLOGY, V450, P114, DOI 10.1016/j.virol.2013.12.001; Kim BY, 2013, AVIAN DIS, V57, P667, DOI 10.1637/10519-022213-ResNote.1; Kotani T, 2000, J VET MED SCI, V62, P397, DOI 10.1292/jvms.62.397; Li H, 2001, AVIAN PATHOL, V30, P535, DOI 10.1080/03079450120078734; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HB, 2012, VIRUS GENES, V44, P19, DOI 10.1007/s11262-011-0657-x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mork AK, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-67; Nii T, 2014, THERIOGENOLOGY, V81, P1129, DOI 10.1016/j.theriogenology.2014.02.002; Okino CH, 2014, VIRAL IMMUNOL, V27, P383, DOI 10.1089/vim.2014.0054; Okino CH, 2013, VIRAL IMMUNOL, V26, P259, DOI 10.1089/vim.2013.0015; OWEN RL, 1991, AVIAN PATHOL, V20, P663, DOI 10.1080/03079459108418805; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rue CA, 2011, J GEN VIROL, V92, P931, DOI 10.1099/vir.0.025486-0; Smith J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0575-6; Vervelde L, 2013, VET IMMUNOL IMMUNOP, V151, P337, DOI 10.1016/j.vetimm.2012.11.012; Wang XQ, 2006, VIRAL IMMUNOL, V19, P768, DOI 10.1089/vim.2006.19.768; Zhong YX, 2012, VIRUSES-BASEL, V4, P980, DOI 10.3390/v4060980	32	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172275	10.1371/journal.pone.0172275	http://dx.doi.org/10.1371/journal.pone.0172275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199419	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424400087
J	Puchner, SE; Funovics, PT; Bohler, C; Kaider, A; Stihsen, C; Hobusch, GM; Panotopoulos, J; Windhager, R				Puchner, Stephan E.; Funovics, Philipp T.; Boehler, Christoph; Kaider, Alexandra; Stihsen, Christoph; Hobusch, Gerhard M.; Panotopoulos, Joannis; Windhager, Reinhard			Oncological and surgical outcome after treatment of pelvic sarcomas	PLOS ONE			English	Article							MALIGNANT-TUMORS; RECONSTRUCTION; RESECTION; COMPLICATIONS; OSTEOSARCOMA; EXPERIENCE; PROSTHESES; SURVIVAL; BONE; LIMB	Background and objectives Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. Methods Between 1980 and 2012, 147 patients underwent surgical treatment for pelvic sarcoma. Histological diagnosis was Chondrosarcoma in 54, Ewing's Sarcoma/PNET in 37, Osterosar-coma in 32 and others in 24 patients. Statistical analysis for the evaluation of oncological and surgical outcome was performed by applying Cox proportional hazards regression and Fine-Gray regression models for competing risk (CR) endpoints. Results The estimated overall survival (OS) to death was 80%, 45% and 37% at 1, 5 and 10 years, respectively. Univariate analyses revealed a statistically significant unadjusted influence of age age (p = 0.038; HR = 1.01), margin (p = 0.043; HR = 0.51) and grade (p = 0.001; HR = 2.27) on OS. Considering the multivariable model, grade (p = 0.005; HR = 3.04) and tumor volume (p = 0.014; HR = 1.18) presented themselves as independent prognostic factors on OS. CR analysis showed a cumulative incidence for major complication of 31% at 5 years. Endoprosthetic reconstruction had a higher risk for experiencing a major complication (p<0.0001) and infection (p = 0.001). Conclusions Pelvic resections are still associated with a high incidence of complications. Patients with pelvic reconstruction and high volume tumors are especially at risk. Consequently, a cautious decision-making process is necessary when indicating pelvic reconstruction, although a restrictive approach to pelvic reconstruction is not necessarily reasonable when the other option is major amputation.	[Puchner, Stephan E.; Funovics, Philipp T.; Boehler, Christoph; Stihsen, Christoph; Hobusch, Gerhard M.; Panotopoulos, Joannis; Windhager, Reinhard] Med Univ Vienna, Dept Orthoped, Waehringer Guertel 18-20, Vienna, Austria; [Kaider, Alexandra] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Waehringer Guertel 18-20, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Puchner, SE (corresponding author), Med Univ Vienna, Dept Orthoped, Waehringer Guertel 18-20, Vienna, Austria.	stephan.puchner@meduniwien.ac.at	Hobusch, Gerhard/AAA-6637-2021	Hobusch, Gerhard M/0000-0002-4123-6680; Windhager, Reinhard/0000-0002-6321-1804				Abudu A, 1997, J BONE JOINT SURG BR, V79B, P773, DOI 10.1302/0301-620X.79B5.6749; Angelini A, 2013, CLIN ORTHOPAEDICS RE; Beadel GP, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000180048.43208.2f; Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO;2-W; CAMPANACCI M, 1991, ORTHOP CLIN N AM, V22, P65; CAPANNA R, 1987, ARCH ORTHOP TRAUM SU, V106, P71, DOI 10.1007/BF00435417; CARTER SR, 1990, J BONE JOINT SURG BR, V72, P490; Cottias P, 2001, J SURG ONCOL, V78, P90, DOI 10.1002/jso.1127; Delloye C, 2007, J BONE JOINT SURG AM, V89A, P579, DOI 10.2106/JBJS.F.00943; EILBER FR, 1979, CANCER, V43, P806, DOI 10.1002/1097-0142(197903)43:3<806::AID-CNCR2820430305>3.0.CO;2-Y; ENNEKING WF, 1978, J BONE JOINT SURG AM, V60, P731, DOI 10.2106/00004623-197860060-00002; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Gebert C, 2011, J SURG ONCOL, V103, P269, DOI 10.1002/jso.21820; Guo W, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31806165d5; Guo W, 2012, J SURG ONCOL, V106, P406, DOI 10.1002/jso.23076; Guo Z, 2010, SURG ONCOL, V19, P95, DOI 10.1016/j.suronc.2009.04.003; Han I, 2010, CLIN ORTHOP SURG, V2, P160, DOI 10.4055/cios.2010.2.3.160; HARRINGTON KD, 1992, J BONE JOINT SURG AM, V74A, P331, DOI 10.2106/00004623-199274030-00003; Hillmann A, 2003, ARCH ORTHOP TRAUM SU, V123, P340, DOI 10.1007/s00402-003-0543-7; Jawad MU, 2011, CANCER-AM CANCER SOC, V117, P1529, DOI 10.1002/cncr.25684; Kohl M, 2015, COMPUT METH PROG BIO, V118, P218, DOI 10.1016/j.cmpb.2014.11.009; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P212, DOI 10.1097/01.blo.0000137241.24906.bf; Mavrogenis AF, 2013, J SURG ONCOL, V108, P19, DOI 10.1002/jso.23351; Mavrogenis AF, 2012, ORTHOPEDICS, V35, pE232, DOI 10.3928/01477447-20120123-40; OConnor MI, 1997, SEMIN SURG ONCOL, V13, P49, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<49::AID-SSU8>3.0.CO;2-4; OCONNOR MI, 1989, J BONE JOINT SURG AM, V71A, P481, DOI 10.2106/00004623-198971040-00002; Ozaki T, 2003, J CLIN ONCOL, V21, P334, DOI 10.1200/JCO.2003.01.142; Ozaki T, 2002, CLIN ORTHOP RELAT R, P197; Ozaki T, 1996, ACTA ORTHOP SCAND, V67, P333, DOI 10.3109/17453679609002326; Pring ME, 2001, J BONE JOINT SURG AM, V83A, P1630, DOI 10.2106/00004623-200111000-00003; Puchner SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135736; Satcher RL, 2003, CLIN ORTHOP RELAT R, P209, DOI 10.1097/01.blo.0000057791.10364.7c; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schuh R, 2015, CLIN ORTHOP RELAT R, V473, P900, DOI 10.1007/s11999-014-3703-x; Schwameis E, 2002, CLIN ORTHOP RELAT R, P220; SHIN KH, 1994, CLIN ORTHOP RELAT R, P207; Sucato DJ, 2000, CLIN ORTHOP RELAT R, P193; Windhager R, 1996, CLIN ORTHOP RELAT R, P265; Wirbel RJ, 2001, CLIN ORTHOP RELAT R, P190; Wirbel RJ, 1999, ACTA ORTHOP SCAND, V70, P348, DOI 10.3109/17453679908997823	40	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172203	10.1371/journal.pone.0172203	http://dx.doi.org/10.1371/journal.pone.0172203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199377	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400081
J	Yun, J; Olkkola, S; Hanninen, ML; Oliviero, C; Heinonen, M				Yun, Jinhyeon; Olkkola, Satu; Hanninen, Marja-Liisa; Oliviero, Claudio; Heinonen, Mari			The effects of amoxicillin treatment of newborn piglets on the prevalence of hernias and abscesses, growth and ampicillin resistance of intestinal coliform bacteria in weaned pigs	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SWINE; ANTIBIOTICS; PERFORMANCE; MICROFLORA; DIVERSITY; IMPACT; FEED	This study investigated the effects of a single amoxicillin treatment of newborn piglets on the prevalence of hernias and abscesses until the age of nine weeks. We also studied whether the treatment was associated with growth and mortality, the need for treatment of other diseases, the proportions of ampicillin resistant coliforms and antimicrobial resistance patterns of intestinal Escherichia coli (E. coli). A total of 7156 piglets, from approximately 480 litters, were divided into two treatment groups: ANT (N = 3661) and CON (N = 3495), where piglets were treated with or without a single intramuscular injection of 75 mg amoxicillin one day after birth, respectively. The umbilical and inguinal areas of weaned pigs were palpated at four and nine weeks of age. At the same time, altogether 124 pigs with hernias or abscesses and 820 non -defective pigs from three pens per batch were weighed individually. Mortality and the need to treat piglets for other diseases were recorded. Piglet faecal samples were collected from three areas of the floors of each pen at four weeks of age. The prevalence of umbilical hernias or abscesses did not differ between the groups at four weeks of age, but it was higher in the CON group than in the ANT group at nine weeks of age (2.3% vs. 0.7%, P<0.05). Numbers of inguinal hernias and abscesses did not differ between the groups at four or nine weeks of age. The ANT group, when it compared with the CON group, increased the weight gain between four and nine weeks of age (LS means SE; 497.5 g/d 5.0 vs. 475.3 g/d 4.9, P< 0.01),and decreased piglet mortality (19.5% 1.0 vs. 6.9% 1.0, P < 0.05) and the need to treat the piglets for leg problems (3.4% 0.3 vs. 1.9% 0.3%, P < 0.01) but not for other diseases by the age of four weeks. The proportion of ampicillin resistant intestinal coliform bacteria and the resistance patterns of the E. coli isolates were not different between the ANT and CON groups. In conclusion, our results showed that the amoxicillin treatment of new-born piglets produced statistically significant effect in some of the parameters studied. However, as these effects were only minor, we did not find grounds to recommend preventive antibiotic treatment. Further, continuous antimicrobial treatment of newborn piglets could negatively influence the development of the normal microbiota of the piglet and promote selection of antimicrobial resistance genes in herds. Therefore we suggest rejection of the use of routine administration of antimicrobial agents at birth.	[Yun, Jinhyeon] Univ Helsinki, Dept Prod Anim Med, Res Ctr Anim Welf, Fac Vet Med, Helsinki, Finland; [Olkkola, Satu] Finnish Food Safety Author Evira, Antibiot Sect, Food & Feed Microbiol Res Unit, Res & Lab Dept, Mustialankatu 3, Helsinki, Finland; [Olkkola, Satu; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland; [Oliviero, Claudio; Heinonen, Mari] Univ Helsinki, Dept Prod Anim Med, Fac Vet Med, Paroninkuja 20, Saarentaus, Finland	University of Helsinki; Finnish Food Authority; University of Helsinki; University of Helsinki	Yun, J (corresponding author), Univ Helsinki, Dept Prod Anim Med, Res Ctr Anim Welf, Fac Vet Med, Helsinki, Finland.	jinhyeon.yun@helsinki.fi	Yun, Jinhyeon/S-3453-2019	Yun, Jinhyeon/0000-0002-0697-0679; Olkkola, Satu/0000-0001-6966-7151; Heinonen, Mari/0000-0002-5732-0692; Oliviero, Claudio/0000-0001-8910-9595	Ministry of Agriculture and Forestry in Finland; Vetcare Ltd	Ministry of Agriculture and Forestry in Finland; Vetcare Ltd	Support was provided by the Ministry of Agriculture and Forestry in Finland and Vetcare Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso H, 1989, J VET PHARMACOL THER, V21, P41; Anderson DE, 2012, ANESTHESIA SURG PROC, P119; ANGUS K, 1972, VET REC, V90, P245; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bibbal D, 2007, APPL ENVIRON MICROB, V73, P4785, DOI 10.1128/AEM.00252-07; Bibbal D, 2009, APPL ENVIRON MICROB, V75, P2999, DOI 10.1128/AEM.02143-08; Callens B, 2015, MICROB DRUG RESIST, V21, P50, DOI 10.1089/mdr.2014.0037; Cavaco L, 2015, PCR PLASMID MEDIATED; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Ding NS, 2009, J ANIM SCI, V87, P2469, DOI 10.2527/jas.2008-1601; Du ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004837; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; GARDNER IA, 1989, J AM VET MED ASSOC, V194, P659; Gibbons JF, 2015, ANTIMICROBIAL RESIST; Grindflek E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-25; Harada K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/180682; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Kluge H, 2006, J ANIM PHYSIOL AN N, V90, P316, DOI 10.1111/j.1439-0396.2005.00604.x; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Literak I, 2009, MICROB DRUG RESIST, V15, P229, DOI 10.1089/mdr.2009.0913; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; MAGEE WT, 1951, J ANIM SCI, V10, P516, DOI 10.2527/jas1951.102516x; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martinez-Larranaga MR, 2004, VET REC, V154, P627, DOI 10.1136/vr.154.20.627; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Reiman J., 2012, Integrating science, welfare, and economics in practice. American Association of Swine Veterinarians 43rd Annual Meeting Proceedings, Denver, Colorado, USA, 10-13 March 2012, P55; Reiman J, 2010, AM ASS SWIN VET ANN; Rutten-Ramos SC, 2006, J SWINE HEALTH PROD, V14, P317; Schmidt Bettina, 2011, PLoS One, V6, pe28284, DOI 10.1371/journal.pone.0028284; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; SEARCYBERNAL R, 1994, J AM VET MED ASSOC, V204, P1660; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Varga C, 2008, CAN J VET RES, V72, P175; Vestergaard K, 2002, 556 VID SVIN; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu SY, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-47; Zoric M., 2016, Porcine Health Management, V2; Zoric M, 2004, J VET MED B, V51, P278, DOI 10.1111/j.1439-0450.2004.00777.x	44	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172150	10.1371/journal.pone.0172150	http://dx.doi.org/10.1371/journal.pone.0172150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199379	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400077
J	Kuo, WC; Kao, MC; Tsou, MY; Ting, CK				Kuo, Wen-Chuan; Kao, Meng-Chun; Tsou, Mei-Yung; Ting, Chien-Kun			In vivo images of the epidural space with two- and three-dimensional optical coherence tomography in a porcine model	PLOS ONE			English	Article							SPONTANEOUS INTRACRANIAL HYPOTENSION; BLIND BLOOD PATCH; CATHETER PLACEMENT; ULTRASOUND; FEASIBILITY; SYSTEM	Background No reports exist concerning in vivo optical coherence tomography visualization of the epidural space and the blood patch process in the epidural space. In this study, we produced real-time two-dimensional and reconstructed three-dimensional images of the epidural space by using optical coherence tomography in a porcine model. We also aimed to produce three-dimensional optical coherence tomography images of the dura puncture and blood patch process. Methods Two-dimensional and three-dimensional optical coherence tomography images were obtained using a swept source optical coherence tomography (SSOCT) system. Four laboratory pigs were intubated and ventilated after the induction of general anesthesia. An 18-gauge Tuohy needle was used as a tunnel for the optical coherence tomography probe to the epidural space. Two-dimensional and three-dimensional reconstruction optical coherence tomography images of the epidural space were acquired in four stages. Results In stage 1, real-time two-dimensional and reconstructed three-dimensional optical coherence tomography of the lumbar and thoracic epidural space were successfully acquired. In stage 2, the epidural catheter in the epidural space was successfully traced in the 3D optical coherence tomography images. In stage 3, water injection and lumbar puncture were successfully monitored in all study animals. In stage 4, 10 mL of fresh blood was injected into the epidural space and two-dimensional and three-dimensional optical coherence tomography images were successfully acquired. Conclusions These animal experiments suggest the potential capability of using an optical coherence tomography-based imaging needle in the directed two-dimensional and three-dimensional visualization of the epidural space. More investigations involving humans are required before optical coherence tomography can be recommended for routine use. However, three-dimensional optical coherence tomography may provide a novel, minimally invasive, and safe way to observe the spinal epidural space, epidural catheter, lumbar puncture hole, and blood patch.	[Kuo, Wen-Chuan; Kao, Meng-Chun] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Kuo, Wen-Chuan] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan; [Tsou, Mei-Yung; Ting, Chien-Kun] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsou, Mei-Yung; Ting, Chien-Kun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Ting, CK (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	ckting@vghtpe.gov.tw	Ting, Chien-Kun/C-1389-2012	Ting, Chien-Kun/0000-0002-3156-8139	Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST [MOST 103-2221-E-075 -004, MOST 104-2221-E-075-002]	Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST	This work was supported by Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST, MOST 103-2221-E-075 -004 and MOST 104-2221-E-075-002 (https://www.most.gov.tw/ch/academic).	Palomero-Rodriguez MA, 2015, SAUDI J ANAESTH, V9, P467, DOI 10.4103/1658-354X.159478; Beamer J, 2000, ANAESTHESIA, V55, P1233, DOI 10.1046/j.1365-2044.2000.01798-33.x; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Chang Pi-Ying, 2010, Acta Anaesthesiol Taiwan, V48, P45, DOI 10.1016/S1875-4597(10)60010-0; Chen YC, 2016, CEPHALALGIA, V36, P225, DOI 10.1177/0333102415585095; Chen Y, 2009, J NEUROSCI METH, V178, P162, DOI 10.1016/j.jneumeth.2008.11.026; Chiang HK, 2011, ANESTHESIOLOGY, V114, P1320, DOI 10.1097/ALN.0b013e31821b5746; Chiu SC, 2012, REGION ANESTH PAIN M, V37, P354, DOI 10.1097/AAP.0b013e31824c0310; Cho KI, 2011, NEUROLOGY, V76, P1139, DOI 10.1212/WNL.0b013e318212ab43; Correia I, 2016, CASE REP MED, V2016, DOI 10.1155/2016/9809017; Ferrante E, 2016, ACTA NEUROL BELG, V116, P503, DOI 10.1007/s13760-016-0617-2; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; HEAVNER J E, 1991, Regional Anesthesia, V16, P85; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jones MR, 2012, AM J NEURORADIOL, V33, P1494, DOI 10.3174/ajnr.A3016; Karraz MA, 2002, ANESTH ANALG, V95, P257, DOI 10.1097/00000539-200207000-00065; Kumar Yogesh, 2015, Conn Med, V79, P547; Kuo WC, 2015, ANESTHESIOLOGY, V122, P585, DOI 10.1097/ALN.0000000000000531; Gutierrez-Chico JL, 2012, EUR HEART J-CARD IMG, V13, P370, DOI 10.1093/ehjci/jes025; Motamed C, 2006, ANESTH ANALG, V103, P1026, DOI 10.1213/01.ane.0000237291.30499.32; Nakai E, 2016, J NEUROSURG, V124, P580, DOI 10.3171/2015.2.JNS142746; Pagani-Estevez GL, 2016, REGION ANESTH PAIN M, V41, P164, DOI 10.1097/AAP.0000000000000352; Shah Manish, 2015, J Anaesthesiol Clin Pharmacol, V31, P560, DOI 10.4103/0970-9185.169091; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Smith KA, 2016, J CLIN NEUROSCI, V25, P10, DOI 10.1016/j.jocn.2015.07.009; Srinivasan KK, 2014, MED ULTRASON, V16, P356; Tsui BCH, 1999, CAN J ANAESTH, V46, P675, DOI 10.1007/BF03013957; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Yeager MP, 2016, ACTA ANAESTH SCAND, V60, P513, DOI 10.1111/aas.12649; Zahid Yaqoob, J BIOMEDICAL OPTICS, V11	30	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172149	10.1371/journal.pone.0172149	http://dx.doi.org/10.1371/journal.pone.0172149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196128	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900056
J	Grzelak, CA; Sigglekow, ND; Tirnitz-Parker, JEE; Hamson, EJ; Warren, A; Maneck, B; Chen, JB; Patkunanathan, B; Boland, J; Cheng, R; Shackel, NA; Seth, D; Bowen, DG; Martelotto, LG; Watkins, DN; McCaughan, GW				Grzelak, Candice Alexandra; Sigglekow, Nicholas David; Tirnitz-Parker, Janina Elke Eleonore; Hamson, Elizabeth Jane; Warren, Alessandra; Maneck, Bharvi; Chen, Jinbiao; Patkunanathan, Bramilla; Boland, Jade; Cheng, Robert; Shackel, Nicholas Adam; Seth, Devanshi; Bowen, David Geoffrey; Martelotto, Luciano Gaston; Watkins, D. Neil; McCaughan, Geoffrey William			Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease	PLOS ONE			English	Article							PRIMARY CILIA; PROGENITOR CELLS; STEM-CELLS; OVAL CELLS; PATHWAY; MICE; FIBROSIS; REGENERATION; DIVERSITY; HEPATITIS	Canonical Hedgehog (Hh) signaling in vertebrate cells occurs following Smoothened activation/translocation into the primary cilia (Pc), followed by a GLI transcriptional response. Nonetheless, GLI activation can occur independently of the canonical Hh pathway. Using a murine model of liver injury, we previously identified the importance of canonical Hh signaling within the Pc+ liver progenitor cell (LPC) population and noted that SMO-independent, GLI-mediated signals were important in multiple Pc-ve GLI2(+) intrahepatic populations. This study extends these observations to human liver tissue, and analyses the effect of GLI inhibition on LPC viability/gene expression. Human donor and cirrhotic liver tissue specimens were evaluated for SHH, GLI2 and Pc expression using immunofluorescence and qRT-PCR. Changes to viability and gene expression in LPCs in vitro were assessed following GLI inhibition. Identification of Pc (as a marker of canonical Hh signaling) in human cirrhosis was predominantly confined to the ductular reaction and LPCs. In contrast, GLI2 was expressed in multiple cell populations including Pc-ve endothelium, hepatocytes, and leukocytes. HSCs/myofibroblasts (>99%) expressed GLI2, with only 1.92% displaying Pc. In vitro GLI signals maintained proliferation/viability within LPCs and GLI inhibition affected the expression of genes related to stemness, hepatocyte/biliary differentiation and Hh/Wnt signaling. At least two mechanisms of GLI signaling (Pc/SMOdependent and Pc/SMO-independent) mediate chronic liver disease pathogenesis. This may have significant ramifications for the choice of Hh inhibitor (anti-SMO or anti-GLI) suitable for clinical trials. We also postulate GLI delivers a pro-survival signal to LPCs whilst maintaining stemness.	[Grzelak, Candice Alexandra; Sigglekow, Nicholas David; Hamson, Elizabeth Jane; Maneck, Bharvi; Chen, Jinbiao; Patkunanathan, Bramilla; Boland, Jade; Cheng, Robert; Shackel, Nicholas Adam; Seth, Devanshi; Bowen, David Geoffrey; McCaughan, Geoffrey William] Centenary Inst, Liver Injury & Canc, Camperdown, NSW, Australia; [Tirnitz-Parker, Janina Elke Eleonore] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Bentley, WA, Australia; [Warren, Alessandra] Univ Sydney, Ageing & Alzheimers Inst, Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Warren, Alessandra] Univ Sydney, ANZAC Res Inst, Concord Hosp, Sydney, NSW, Australia; [Maneck, Bharvi; Shackel, Nicholas Adam; Bowen, David Geoffrey; McCaughan, Geoffrey William] RPAH, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia; [Shackel, Nicholas Adam; McCaughan, Geoffrey William] Univ Sydney, Fac Med, Sydney, NSW, Australia; [Martelotto, Luciano Gaston] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Watkins, D. Neil] Garvan Inst, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia	University of Sydney; Centenary Institute; Curtin University; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; Memorial Sloan Kettering Cancer Center; Garvan Institute of Medical Research	McCaughan, GW (corresponding author), Centenary Inst, Liver Injury & Canc, Camperdown, NSW, Australia.; McCaughan, GW (corresponding author), RPAH, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia.; McCaughan, GW (corresponding author), Univ Sydney, Fac Med, Sydney, NSW, Australia.	g.mccaughan@centenary.org.au	Chen, Jinbiao/N-9905-2019; Chen, Jinbiao/J-5868-2013; Research Institute, ANZAC/CAE-9030-2022; Martelotto, Luciano/D-1946-2015	Chen, Jinbiao/0000-0003-0339-5880; Chen, Jinbiao/0000-0003-0339-5880; Grzelak, Candice/0000-0001-8645-4297; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Martelotto, Luciano/0000-0002-9625-1183; Tirnitz-Parker, Janina/0000-0002-3558-5892; Bowen, David/0000-0002-7965-5581	National Health and Medical Research Council [571408]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council, Program Grant #571408 (GWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Candice AG, 2015, HEPATOLOGY, V61, P1770, DOI 10.1002/hep.27432; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Grzelak CA, 2014, J HEPATOL, V61, P1451, DOI 10.1016/j.jhep.2014.08.019; Grzelak CA, 2014, J HEPATOL, V60, P143, DOI 10.1016/j.jhep.2013.08.012; Guy CD, 2015, HEPATOLOGY, V61, P98, DOI 10.1002/hep.27235; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Kohn-Gaone J, 2016, AM J PHYSIOL-GASTR L, V310, pG143, DOI 10.1152/ajpgi.00215.2015; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Marican NHJ, 2016, STEM CELL REP, V6, P798, DOI 10.1016/j.stemcr.2016.04.004; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sicklick JK, 2016, PHASE IB STUDY SINGL; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Syn WK, 2009, EUR J IMMUNOL, V39, P1879, DOI 10.1002/eji.200838890; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032	39	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171480	10.1371/journal.pone.0171480	http://dx.doi.org/10.1371/journal.pone.0171480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187190	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300024
J	Morris, JK; Vidoni, ED; Johnson, DK; Van Sciver, A; Mahnken, JD; Honea, RA; Wilkins, HM; Brooks, WM; Billinger, SA; Swerdlow, RH; Burns, JM				Morris, Jill K.; Vidoni, Eric D.; Johnson, David K.; Van Sciver, Angela; Mahnken, Jonathan D.; Honea, Robyn A.; Wilkins, Heather M.; Brooks, William M.; Billinger, Sandra A.; Swerdlow, Russell H.; Burns, Jeffrey M.			Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; OLDER-ADULTS; DEMENTIA; WALKING; BRAIN	Background There is increasing interest in the role of physical exercise as a therapeutic strategy for individuals with Alzheimer's disease (AD). We assessed the effect of 26 weeks (6 months) of a supervised aerobic exercise program on memory, executive function, functional ability and depression in early AD. Methods and findings This study was a 26-week randomized controlled trial comparing the effects of 150 minutes per week of aerobic exercise vs. non-aerobic stretching and toning control intervention in individuals with early AD. A total of 76 well-characterized older adults with probable AD (mean age 72.9 [7.7]) were enrolled and 68 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. Neuropsychological tests and surveys were conducted at baseline,13, and 26 weeks to assess memory and executive function composite scores, functional ability (Disability Assessment for Dementia), and depressive symptoms (Cornell Scale for Depression in Dementia). Cardiorespiratory fitness testing and brain MRI was performed at baseline and 26 weeks. Aerobic exercise was associated with a modest gain in functional ability (Disability Assessment for Dementia) compared to individuals in the ST group (X2 = 8.2, p = 0.02). There was no clear effect of intervention on other primary outcome measures of Memory, Executive Function, or depressive symptoms. However, secondary analyses revealed that change in cardiorespiratory fitness was positively correlated with change in memory performance and bilateral hippocampal volume. Conclusions Aerobic exercise in early AD is associated with benefits in functional ability. Exercise-related gains in cardiorespiratory fitness were associated with improved memory performance and reduced hippocampal atrophy, suggesting cardiorespiratory fitness gains may be important in driving brain benefits.	[Morris, Jill K.; Vidoni, Eric D.; Van Sciver, Angela; Honea, Robyn A.; Wilkins, Heather M.; Brooks, William M.; Swerdlow, Russell H.; Burns, Jeffrey M.] Univ Kansas, Alzheimers Dis Ctr, Fairway, KS 66205 USA; [Johnson, David K.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Mahnken, Jonathan D.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Brooks, William M.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA; [Billinger, Sandra A.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Burns, JM (corresponding author), Univ Kansas, Alzheimers Dis Ctr, Fairway, KS 66205 USA.	jburns2@kumc.edu	Brooks, William/AAF-8299-2019	Brooks, William/0000-0001-6227-7636; Burns, Jeffrey/0000-0001-7609-8954; Wilkins, Heather/0000-0003-4563-4544; Johnson, David/0000-0003-3670-8054	National Institutes of Health [R01 AG033673, F32 AG044953, K99 AG050490, P30 AG035982, S10 RR29577, UL1 TR000001, KL2 TR000119, K01 AG035042, K01 HD067318]; Foundation for Physical Therapy New Investigator Fellowship Training Initiative; Hyndman Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000120, KL2TR000119] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033177, M01RR023940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG044953, P30AG035982, R01AG033673, K01AG035042, K99AG050490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Physical Therapy New Investigator Fellowship Training Initiative; Hyndman Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institutes of Health under award numbers R01 AG033673, F32 AG044953, K99 AG050490, P30 AG035982, S10 RR29577, UL1 TR000001, KL2 TR000119, K01 AG035042, and K01 HD067318. Additional support was provided by the Foundation for Physical Therapy New Investigator Fellowship Training Initiative and the Hyndman Foundation. The Hoglund Brain Imaging Center is supported by a generous gift from Forrest and Sally Hoglund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; Billinger S.A., 2016, J AGING PHYS ACT, P1; Billinger SA, 2011, ARCH PHYS MED REHAB, V92, P2000, DOI 10.1016/j.apmr.2011.07.194; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bossers WJR, 2016, J AM GERIATR SOC, V64, P1258, DOI 10.1111/jgs.14160; Burns JM, 2008, NEUROLOGY, V71, P210, DOI 10.1212/01.wnl.0000317094.86209.cb; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Feldman H, 2001, ALZ DIS ASSOC DIS, V15, P89, DOI 10.1097/00002093-200104000-00008; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Gaugler JE, 2003, GERONTOLOGIST, V43, P219, DOI 10.1093/geront/43.2.219; Harry A, 2014, CLIN NEUROPSYCHOL, V28, P486, DOI 10.1080/13854046.2014.892155; Hayes SM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00031; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Jedrziewski MK, 2010, ALZHEIMERS DEMENT, V6, P448, DOI 10.1016/j.jalz.2010.02.004; Johnson DK, 2008, NEUROLOGY, V71, P1783, DOI 10.1212/01.wnl.0000335972.35970.70; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kryscio RJ, 2014, JAMA NEUROL, V71, P947, DOI 10.1001/jamaneurol.2014.1120; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nichol K, 2009, ALZHEIMERS DEMENT, V5, P287, DOI 10.1016/j.jalz.2009.02.006; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; RCore Team, 2020, R LANG ENV STAT COMP; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Schultz SA, 2015, J INT NEUROPSYCH SOC, V21, P841, DOI 10.1017/S1355617715000843; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Tappen RM, 2000, ALZ DIS ASSOC DIS, V14, P196, DOI 10.1097/00002093-200010000-00002; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Tolppanen AM, 2015, ALZHEIMERS DEMENT, V11, P434, DOI 10.1016/j.jalz.2014.01.008; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Vidoni ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131647; Vidoni ED, 2012, CONTEMP CLIN TRIALS, V33, P1105, DOI 10.1016/j.cct.2012.08.002; Vidoni ED, 2012, NEUROBIOL AGING, V33, P1624, DOI 10.1016/j.neurobiolaging.2011.03.016; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008	53	137	142	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170547	10.1371/journal.pone.0170547	http://dx.doi.org/10.1371/journal.pone.0170547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187125	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300006
J	Adebiyi, A; Sorrentino, P; Bohlool, S; Zhang, C; Arditti, M; Goodrich, G; Weiland, JD				Adebiyi, Aminat; Sorrentino, Paige; Bohlool, Shadi; Zhang, Carey; Arditti, Mort; Goodrich, Gregory; Weiland, James D.			Assessment of feedback modalities for wearable visual aids in blind mobility	PLOS ONE			English	Article							DISPLAY; VISION; INFORMATION; TECHNOLOGY; IMPAIRMENT; NAVIGATION; SUS	Sensory substitution devices engage sensory modalities other than vision to communicate information typically obtained through the sense of sight. In this paper, we examine the ability of subjects who are blind to follow simple verbal and vibrotactile commands that allow them to navigate a complex path. A total of eleven visually impaired subjects were enrolled in the study. Prototype systems were developed to deliver verbal and vibrotactile commands to allow an investigator to guide a subject through a course. Using this mode, subjects could follow commands easily and navigate significantly faster than with their cane alone (p < 0.05). The feedback modes were similar with respect to the increased speed for course completion. Subjects rated usability of the feedback systems as "above average" with scores of 76.3 and 90.9 on the system usability scale.	[Adebiyi, Aminat; Bohlool, Shadi; Zhang, Carey; Weiland, James D.] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90033 USA; [Sorrentino, Paige] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90033 USA; [Sorrentino, Paige; Zhang, Carey] Univ Southern Calif, Dept Elect Engn, Los Angeles, CA 90033 USA; [Arditti, Mort] Univ Southern Calif, Inst Eye, Los Angeles, CA 90033 USA; [Goodrich, Gregory] Psychol Serv, Palo Alto, CA USA; [Goodrich, Gregory] Western Blind Rehabil Ctr, Palo Alto, CA USA; [Weiland, James D.] Univ Southern Calif, Dept Ophthalmol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Weiland, JD (corresponding author), Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90033 USA.; Weiland, JD (corresponding author), Univ Southern Calif, Dept Ophthalmol, Los Angeles, CA USA.	weiland@umich.edu	Goodrich, Gregory L./AAF-7184-2019	Weiland, James/0000-0003-3453-9074				Adebiyi A, 2013, MULT EXP WORKSH ICME; Arditi A, 2013, J VISUAL IMPAIR BLIN, V107, P118, DOI 10.1177/0145482X1310700205; Ball E. M., 2008, ELECT TRAVEL AIDS AS, P289, DOI [10.1007/978-1-84628-867-8_9, DOI 10.1007/978-1-84628-867-8_9]; Bangor A, 2009, J USABILITY STUD, V4, P114; Blasch B, 1995, J VISUAL IMPAIRMENT, V89; Brabyn J, 1985, ELECT SPATIAL SENSIN, P13; Brooke J, 2013, J USABILITY STUD, V8, P29; Cholewiak RW, 2003, PERCEPT PSYCHOPHYS, V65, P1058, DOI 10.3758/BF03194834; Cohen J.E., 1988, STAT POWER ANAL BEHA; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Elliott LR, 2010, IEEE T HAPTICS, V3, P78, DOI [10.1109/TOH.2010.3, 10.1109/ToH.2010.3]; Fok D, 2011, WORK, V39, P37, DOI 10.3233/WOR-2011-1149; Giudice N.A., 2008, ENGI HDB SMART TECHN, V8, P479, DOI DOI 10.1002/9780470379424.CH25; Grill T, 2012, SIGACCESS ACCESSIBIL, P12, DOI DOI 10.1145/2388818.2388820; Guth DA, 1997, FDN ORIENTATION MOBI, P9; Havik EM, 2011, J VISUAL IMPAIR BLIN, V105, P624, DOI 10.1177/0145482X1110501009; Jones LA, 2006, ADV ROBOTICS, V20, P1359, DOI 10.1163/156855306778960563; Jordan P.W, 1996, USABILITY EVALUATION, P6, DOI [DOI 10.1201/9781498710411, 10.1201/9781498710411]; Klatzky RL, 2006, J EXP PSYCHOL-APPL, V12, P223, DOI 10.1037/1076-898X.12.4.223; Klatzky RL, 2014, MULTISENS RES, V27, P359, DOI 10.1163/22134808-00002447; LaGrow SJ., 1994, ORIENTATION MOBILITY; Loomis JM, 1998, PRESENCE-TELEOP VIRT, V7, P193, DOI 10.1162/105474698565677; Loomis JM, 2012, SENSORY SUBSTITUTION; Nicolau H, 2009, DESIGNING GUIDES BLI; Parseihian G, 2012, J AUDIO ENG SOC, V60, P409; Phillips B, 1993, Assist Technol, V5, P36; Pradeep V, 2010, IEEE ENG MED BIO, P6233, DOI 10.1109/IEMBS.2010.5627715; Roentgen U.R., 2008, J VIS IMPAIRMENT BLI, V102, P702, DOI DOI 10.1177/0145482X0810201105; SALIVE ME, 1994, J AM GERIATR SOC, V42, P287, DOI 10.1111/j.1532-5415.1994.tb01753.x; Sauro J, 2011, PRACTICAL GUIDE SYST; Shull PB, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0055-z; Soong Grace P, 2000, Clin Exp Optom, V83, P279; Thakoor K, 2013, MULT EXP WORKSH ICME	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170531	10.1371/journal.pone.0170531	http://dx.doi.org/10.1371/journal.pone.0170531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182731	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800013
J	Borysov, SS; Geilhufe, RM; Balatsky, AV				Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.			Organic materials database: An open-access online database for data mining	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; CRYSTALLOGRAPHY OPEN DATABASE; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; HIGH-THROUGHPUT; ULTRASOFT PSEUDOPOTENTIALS; MATERIALS INFORMATICS; CRYSTAL-STRUCTURES; ELECTRON-GAS; BASIS-SET	We present an organic materials database (OMDB) hosting thousands of Kohn-Sham electronic band structures, which is freely accessible online at http://omdb.diracmaterials.org. The OMDB focus lies on electronic structure, density of states and other properties for purely organic and organometallic compounds that are known to date. The electronic band structures are calculated using density functional theory for the crystal structures contained in the Crystallography Open Database. The OMDB web interface allows users to retrieve materials with specified target properties using non-trivial queries about their electronic structure. We illustrate the use of the OMDB and how it can become an organic part of search and prediction of novel functional materials via data mining techniques. As a specific example, we provide data mining results for metals and semiconductors, which are known to be rare in the class of organic materials.	[Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.] KTH Royal Inst Technol, Ctr Quantum Mat, Nordita, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden; [Borysov, Stanislav S.; Geilhufe, R. Matthias; Balatsky, Alexander V.] Stockholm Univ, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden; [Balatsky, Alexander V.] ETH, Inst Theoret Studies, CH-8092 Zurich, Switzerland	Nordic Institute for Theoretical Physics; Royal Institute of Technology; Stockholm University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Borysov, SS (corresponding author), KTH Royal Inst Technol, Ctr Quantum Mat, Nordita, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden.; Borysov, SS (corresponding author), Stockholm Univ, Roslagstullsbacken 23, SE-10691 Stockholm, Sweden.	borysov@kth.se	Geilhufe, Matthias/S-5773-2018; Borysov, Stanislav/O-7465-2017	Geilhufe, Matthias/0000-0001-9285-0165; Borysov, Stanislav/0000-0003-2810-9203	Swedish Research Council [638-2013-9243]; Knut and Alice Wallenberg Foundation; European Research Council under the European Union's Seventh Framework Program FP/2207-2013 [DM-321031]; Villum Foundation through the Villum Center for Dirac Materials; Walter Haefner Foundation; ETH Zurich Foundation; Villum Fonden [00011744] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council under the European Union's Seventh Framework Program FP/2207-2013; Villum Foundation through the Villum Center for Dirac Materials; Walter Haefner Foundation; ETH Zurich Foundation(ETH Zurich); Villum Fonden(Villum Fonden)	This work is supported by the Swedish Research Council, Grant No. 638-2013-9243, http://www.vr.se/; Knut and Alice Wallenberg Foundation, https://www.wallenberg.com/kaw/; European Research Council under the European Union's Seventh Framework Program (FP/2207-2013)/ERC Grant Agreement No. DM-321031, https//erc.europa.eu/; Villum Foundation through the Villum Center for Dirac Materials; Dr. Max Rossler; Walter Haefner Foundation; and ETH Zurich Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104518; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chan MKY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196403; Curtarolo S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.135503; Curtarolo S, 2013, NAT MATER, V12, P191, DOI [10.1038/nmat3568, 10.1038/NMAT3568]; Curtarolo S, 2012, COMP MATER SCI, V58, P218, DOI 10.1016/j.commatsci.2012.02.005; Curtarolo S, 2012, COMP MATER SCI, V58, P227, DOI 10.1016/j.commatsci.2012.02.002; Ebert H, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096501; Geilhufe R. M., ARXIV161104316; Geilhufe RM, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.041103; Gershenson ME, 2006, REV MOD PHYS, V78, P973, DOI 10.1103/RevModPhys.78.973; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; GODBY RW, 1988, PHYS REV B, V37, P10159, DOI 10.1103/PhysRevB.37.10159; Grazulis S, 2012, NUCLEIC ACIDS RES, V40, pD420, DOI 10.1093/nar/gkr900; Grazulis S, 2009, J APPL CRYSTALLOGR, V42, P726, DOI 10.1107/S0021889809016690; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057; HALL SR, 1991, ACTA CRYSTALLOGR A, V47, P655, DOI 10.1107/S010876739101067X; HEDIN L, 1965, PHYS REV, V139, pA796, DOI 10.1103/PhysRev.139.A796; Heyd J, 2005, J CHEM PHYS, V123, DOI [10.1063/1.2085170, 10.1063/1.1760074]; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hoppe H, 2004, J MATER RES, V19, P1924, DOI 10.1557/JMR.2004.0252; Ichimura K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114707; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Jain A, 2011, COMP MATER SCI, V50, P2295, DOI 10.1016/j.commatsci.2011.02.023; Johnson KA, 1998, PHYS REV B, V58, P15548, DOI 10.1103/PhysRevB.58.15548; Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897; Keogh EJ, KDD, P24; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Klintenberg M, 2014, APPL PHYS RES, P6, DOI [10.5539/apr.v6n4p31, DOI 10.5539/APR.V6N4P31]; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; Lejaeghere K, 2016, SCIENCE, V351, DOI 10.1126/science.aad3000; Luders M, 2001, J PHYS-CONDENS MAT, V13, P8587, DOI 10.1088/0953-8984/13/38/305; MacDiarmid AG, 2001, ANGEW CHEM INT EDIT, V40, P2581, DOI 10.1002/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI [10.1103/PhysRevB.13.5188, 10.1103/PhysRevB.16.1746]; Morgan D, 2005, MEAS SCI TECHNOL, V16, P296, DOI 10.1088/0957-0233/16/1/039; Nathan A, 2012, P IEEE, V100, P1486, DOI 10.1109/JPROC.2012.2190168; Nayak SK, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.155105; Ong SP, 2013, COMP MATER SCI, V68, P314, DOI 10.1016/j.commatsci.2012.10.028; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rajan K, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71123-8; Rasmussen FA, 2015, J PHYS CHEM C, V119, P13169, DOI 10.1021/acs.jpcc.5b02950; Rodgers JR, 2006, MRS BULL, V31, P975, DOI 10.1557/mrs2006.223; Sariciftci NS., 2013, ORGANIC PHOTOVOLTAIC, V60; Sarmiento-Perez R, 2015, CHEM MATER, V27, P5957, DOI 10.1021/acs.chemmater.5b02026; Setyawan W, 2011, ACS COMB SCI, V13, P382, DOI 10.1021/co200012w; Tajima N, 2000, J PHYS SOC JPN, V69, P543, DOI 10.1143/JPSJ.69.543; Thiess A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235103; Tikkanen J, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/3/036001; Uji S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/020301; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Vitos L, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.014107; WANG CS, 1983, PHYS REV LETT, V51, P597, DOI 10.1103/PhysRevLett.51.597; Wehling TO, 2014, ADV PHYS, V63, P1, DOI 10.1080/00018732.2014.927109; Xianping Ge, 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P81; Zeller R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/29/294215	61	41	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171501	10.1371/journal.pone.0171501	http://dx.doi.org/10.1371/journal.pone.0171501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182744	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800066
J	Esposito, ER; Choi, HS; Darter, BJ; Wilken, JM				Esposito, Elizabeth Russell; Choi, Harmony S.; Darter, Benjamin J.; Wilken, Jason M.			Can real-time visual feedback during gait retraining reduce metabolic demand for individuals with transtibial amputation?	PLOS ONE			English	Article							ENERGY-COST; TRANSFEMORAL AMPUTEES; PHYSICAL-ACTIVITY; WALKING; PERFORMANCE; EXPENDITURE; AMBULATION; KINETICS; MUSCLES; PEOPLE	The metabolic demand of walking generally increases following lower extremity amputation. This study used real-time visual feedback to modify biomechanical factors linked to an elevated metabolic demand of walking in individuals with transtibial amputation. Eight persons with unilateral, traumatic transtibial amputation and 8 uninjured controls participated. Two separate bouts of real-time visual feedback were provided during a single session of gait retraining to reduce 1) center of mass sway and 2) thigh muscle activation magnitudes and duration. Baseline and post-intervention data were collected. Metabolic rate, heart rate, frontal plane center of mass sway, quadriceps and hamstrings muscle activity, and co-contraction indices were evaluated during steady state walking at a standardized speed. Visual feedback successfully decreased center of mass sway 12% ( p = 0.006) and quadriceps activity 12% ( p = 0.041); however, thigh muscle co-contraction indices were unchanged. Neither condition significantly affected metabolic rate during walking and heart rate increased with center-of-mass feedback. Metabolic rate, center of mass sway, and integrated quadriceps muscle activity were all not significantly different from controls. Attempts to modify gait to decrease metabolic demand may actually adversely increase the physiological effort of walking in individuals with lower extremity amputation who are young, active and approximate metabolic rates of able-bodied adults.	[Esposito, Elizabeth Russell; Choi, Harmony S.; Wilken, Jason M.] US Army, Brooke Army Med Ctr, Ctr Intrepid, JBSA, Ft Sam Houston, TX 78234 USA; [Esposito, Elizabeth Russell; Choi, Harmony S.; Wilken, Jason M.] Extrem Trauma & Amputat Ctr Excellence, Ft Sam Houston, TX 78234 USA; [Darter, Benjamin J.] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; Virginia Commonwealth University	Esposito, ER (corresponding author), US Army, Brooke Army Med Ctr, Ctr Intrepid, JBSA, Ft Sam Houston, TX 78234 USA.; Esposito, ER (corresponding author), Extrem Trauma & Amputat Ctr Excellence, Ft Sam Houston, TX 78234 USA.	erussell.kin@gmail.com	Wilken, Jason/ABA-3309-2021	Wilken, Jason/0000-0002-5556-7667; Russell Esposito, Elizabeth/0000-0001-5321-0333	Telemedicine and Advanced Technology Research Center's AMEDD Advanced Medical Technologies Initiative grant [W911QY-09-D-0043]; National Center for Advancing Translational Sciences grant [KL2TR000057]	Telemedicine and Advanced Technology Research Center's AMEDD Advanced Medical Technologies Initiative grant; National Center for Advancing Translational Sciences grant	Financial support was provided by a Telemedicine and Advanced Technology Research Centers AMEDD Advanced Medical Technologies Initiative grant (W911QY-09-D-0043) and a National Center for Advancing Translational Sciences grant (KL2TR000057). JMW BJD.	ArendtNielsen L, 1996, PAIN, V64, P231, DOI 10.1016/0304-3959(95)00115-8; ARVIDSSON I, 1986, ORTHOPEDICS, V9, P1415; Beurskens R, 2014, J BIOMECH, V47, P1675, DOI 10.1016/j.jbiomech.2014.02.033; Brown MB, 2009, MED SCI SPORT EXER, V41, P1080, DOI 10.1249/MSS.0b013e3181923cee; Burden A, 1999, MED ENG PHYS, V21, P247, DOI 10.1016/S1350-4533(99)00054-5; Bussmann JB, 2008, ARCH PHYS MED REHAB, V89, P430, DOI 10.1016/j.apmr.2007.11.012; Caldwell LK, 2013, CLIN BIOMECH, V28, P649, DOI 10.1016/j.clinbiomech.2013.05.012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darter BJ, 2011, PHYS THER, V91, P1385, DOI 10.2522/ptj.20100360; Darter BJ, 2009, VITUAL REHABILITATIO; Davis BL., 2004, J PROSTHETICS ORTHOT, V16, P49; Dempster WT, 1955, TR55159 WRIGHT PATT; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Esposito ER, 2014, J REHABIL RES DEV, V51, P1287, DOI 10.1682/JRRD.2014.06.0141; Falconer K, 1985, Electromyogr Clin Neurophysiol, V25, P135; Fey NP, 2010, J ELECTROMYOGR KINES, V20, P155, DOI 10.1016/j.jelekin.2009.02.004; GAILEY RS, 1994, PROSTHET ORTHOT INT, V18, P84; GANGULI S, 1973, ERGONOMICS, V16, P797, DOI 10.1080/00140137308924571; Genin JJ, 2008, EUR J APPL PHYSIOL, V103, P655, DOI 10.1007/s00421-008-0764-0; GITTER A, 1995, AM J PHYS MED REHAB, V74, P332, DOI 10.1097/00002060-199509000-00002; Goujon-Pillet H, 2008, ARCH PHYS MED REHAB, V89, P87, DOI 10.1016/j.apmr.2007.08.136; Houdijk H, 2009, GAIT POSTURE, V30, P35, DOI 10.1016/j.gaitpost.2009.02.009; Hsu MJ, 2006, ARCH PHYS MED REHAB, V87, P123, DOI 10.1016/j.apmr.2005.07.310; HUANG CT, 1979, ARCH PHYS MED REHAB, V60, P18; Isakov E, 2001, J REHABIL MED, V33, P196; JAEGERS SMHJ, 1993, ARCH PHYS MED REHAB, V74, P521, DOI 10.1016/0003-9993(93)90117-S; Jaegers SMHJ, 1996, CLIN ORTHOP RELAT R, P119; James U, 1973, Scand J Rehabil Med, V5, P71; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; MOLEN NH, 1973, INT Z ANGEW PHYSIOL, V31, P173; OTIS JC, 1985, J BONE JOINT SURG AM, V67A, P606, DOI 10.2106/00004623-198567040-00016; Pantall A, 2011, CLIN BIOMECH, V26, P760, DOI 10.1016/j.clinbiomech.2011.03.008; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; PINZUR MS, 1992, ORTHOPEDICS, V15, P1033; Powers CM, 1998, GAIT POSTURE, V8, P1, DOI 10.1016/S0966-6362(98)00016-2; Robins K, 2013, NUTR CLIN PRACT, V28, P758, DOI 10.1177/0884533613507605; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Seyedali M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-29; Sheehan RC, 2015, GAIT POSTURE, V41, P795, DOI 10.1016/j.gaitpost.2015.02.008; Silverman AK, 2008, GAIT POSTURE, V28, P602, DOI 10.1016/j.gaitpost.2008.04.005; Takacs J, 2014, OSTEOARTHR CARTILAGE, V22, P203, DOI 10.1016/j.joca.2013.12.003; van Keeken HG, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838028; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; WATERS RL, 1976, J BONE JOINT SURG AM, V58, P42, DOI 10.2106/00004623-197658010-00007; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wezenberg D, 2013, ARCH PHYS MED REHAB, V94, P1714, DOI 10.1016/j.apmr.2013.02.016; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G., 2007, ATTENTION MOTOR SKIL; Yang L, 2012, GAIT POSTURE, V36, P631, DOI 10.1016/j.gaitpost.2012.04.004	51	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171786	10.1371/journal.pone.0171786	http://dx.doi.org/10.1371/journal.pone.0171786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182797	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800111
J	Lackner, A; Ficjan, A; Stradner, MH; Hermann, J; Unger, J; Stamm, T; Stummvoll, G; Dur, M; Graninger, WB; Dejaco, C				Lackner, Angelika; Ficjan, Anja; Stradner, Martin H.; Hermann, Josef; Unger, Julia; Stamm, Tanja; Stummvoll, Georg; Duer, Mona; Graninger, Winfried B.; Dejaco, Christian			It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjogren's Syndrome - A qualitative study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; STANDARD MEASURES; DISEASE-ACTIVITY; REPORTED INDEX; PREVALENCE; VALIDATION; DISABILITY; PEOPLE	Objectives In Primary Sjogren's Syndrome (PSS), there is an apparent lack of data concerning the perspectives of patients, their needs, preferences and difficulties of daily life. This qualitative study was conducted to explore perspectives and needs of patients with PSS that influence health related quality of life (HRQL). Methods We recruited 20 PSS patients fulfilling the American-European consensus classification criteria out of the PSS cohort of the Medical University Graz, Austria. In total, 6 focus group sessions (with three to four patients per group) were performed. A modified meaning condensation procedure was used to analyse the data. Results The interview analysis resulted in 484 meaning units, 254 subconcepts and 86 concepts. The identified concepts were grouped into three dimensions: physical dimension, psychological & emotional challenges and social life & daily living. A dependency between the three categories was identified. The concepts most commonly reported by patients were related to the physical dimension: pain and dryness as well as complaints associated with/provoked by these symptoms. Patients also reported shortness of breath, fatigue und constipation. Conclusions This qualitative study underpins that HRQL in PSS patients is affected by several factors. The problems are not limited to dryness, pain and fatigue while the complaints secondary to these symptoms are important to patients with PSS significantly affecting physical, psychological and social life components of HRQL. A disease-specific patient related outcome measures for clinical practice and trials should be developed considering the different aspects of HRQL in PSS.	[Lackner, Angelika; Ficjan, Anja; Stradner, Martin H.; Hermann, Josef; Graninger, Winfried B.; Dejaco, Christian] Med Univ Graz, Dept Internal Med, Div Rheumatol & Immunol, Graz, Austria; [Unger, Julia] Univ Appl Sci JOANNEUM, Inst Occupat Therapy, Dept Hlth Studies, Bad Gleichenberg, Austria; [Stamm, Tanja; Stummvoll, Georg] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Duer, Mona] IMC Univ Appl Sci Krems, Krems An Der Donau, Austria; [Duer, Mona] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria; [Dejaco, Christian] Hosp Bruneck, South Tyrolean Hlth Trust, Rheumatol Serv, Brunico, Italy	Medical University of Graz; Medical University of Vienna; Medical University of Vienna	Dejaco, C (corresponding author), Med Univ Graz, Dept Internal Med, Div Rheumatol & Immunol, Graz, Austria.; Dejaco, C (corresponding author), Hosp Bruneck, South Tyrolean Hlth Trust, Rheumatol Serv, Brunico, Italy.	christian.dejaco@gmx.net	Graninger, Winfried/AAI-7192-2020; Stradner, Martin H/D-6473-2011; Unger, Julia/AAW-5017-2020	Stradner, Martin H/0000-0002-7884-6626; Graninger, Winfried/0000-0002-3489-3439; Dejaco, Christian/0000-0002-0173-0668				Avis M., 2005, QUAL RES HLTH CARE, P3; Coenen M, 2012, QUAL LIFE RES, V21, P359, DOI 10.1007/s11136-011-9943-2; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Gossec L, 2014, ANN RHEUM DIS, V73, P1012, DOI 10.1136/annrheumdis-2014-205207; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hackett K, 2012, BRIT J OCCUP THER, V75, P247, DOI 10.4276/030802212X13361458480441; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; JACOBSSON LTH, 1989, J AUTOIMMUN, V2, P521, DOI 10.1016/0896-8411(89)90185-6; Kotsis K, 2014, RHEUMATOL INT, V34, P1671, DOI 10.1007/s00296-014-3008-0; Kvale S., 1996, INTERVIEW INTRO QUAL; Lendrem D, 2014, ANN RHEUM DIS, V73, P1362, DOI 10.1136/annrheumdis-2012-202863; Liang Y, 2014, ANN RHEUM DIS, V73, P1151, DOI 10.1136/annrheumdis-2013-203305; McSweeny A J, 1995, Dis Mon, V41, P1; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Ngo DYJ, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0165-4; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Patton M. Q., 1990, QUALITATIVE EVALUATI; Ramos-Casals M, 2005, ANN RHEUM DIS, V64, P347, DOI 10.1136/ard.2004.025676; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Segal BM, 2012, ACTA NEUROL SCAND, V125, P272, DOI 10.1111/j.1600-0404.2011.01530.x; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2013, ARTHRIT CARE RES, V65, P1358, DOI 10.1002/acr.21991; Seror R., 2014, ANN RHEUM DIS; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Stamm T, 2014, MUSCULOSKELET CARE, V12, P22, DOI 10.1002/msc.1047; Stamm TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P1287, DOI 10.1002/art.23013; Stamm TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P487, DOI 10.1002/art.22605; Stamm TA, 2011, ANN RHEUM DIS, V70, P1074, DOI 10.1136/ard.2010.148767; Strombeck B, 2000, SCAND J RHEUMATOL, V29, P20; Sutcliffe N, 1998, J RHEUMATOL, V25, P63; van Leeuwen N, 2016, J CLIN PSYCHOL MED S, V23, P77, DOI 10.1007/s10880-015-9432-9; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; ZHANG NZ, 1995, J RHEUMATOL, V22, P659	36	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172056	10.1371/journal.pone.0172056	http://dx.doi.org/10.1371/journal.pone.0172056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182787	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800147
J	Nakamura, T; Matsumine, A; Matsusaka, M; Mizumoto, K; Mori, M; Yoshizaki, T; Matsubara, T; Asanuma, K; Sudo, A				Nakamura, Tomoki; Matsumine, Akihiko; Matsusaka, Miki; Mizumoto, Keitaro; Mori, Mayuko; Yoshizaki, Tomoya; Matsubara, Takao; Asanuma, Kunihiro; Sudo, Akihiro			Analysis of pulmonary nodules in patients with high-grade soft tissue sarcomas	PLOS ONE			English	Article							LUNG-CANCER; METASTASES; CT	Nowadays, small pulmonary nodules are easily detectable in patients with soft tissue sarcomas (STSs) because of highly improved computed tomography (CT) technologies. The purpose of this study was to determine the frequency and significance of the pulmonary nodules detected by CT in high-grade STS patients. 124 patients with high-grade STS were retrospectively reviewed. There were 72 males (57%) and 52 females (43%). Patients' average age was 61 years (median (quartiles) 66 years (48-75), range 8-94 years). Pulmonary nodules were detected in 49 (39.5%) of 124 patients by CT scanning at first presentation. Of 49 patients with nodules at first presentation, 34 (69.4%) had benign lesions, and 13 (26.5%) had metastatic nodules. One patient (2%) had primary lung cancer and the remaining one with one nodule could not be definitively diagnosed due to a short follow-up time. 30 patients (24.1%) of 124 patients developed pulmonary nodules during their clinical progression. Seven (23.3%) had benign lesions, whereas 21 (70%) had metastatic lesions. Primary lung cancer was detected in two patients (6.7%). The size and timing of detection of a pulmonary nodule significantly affected the final clinical diagnosisby multivariate analysis. We conclude that pulmonary nodules can be detected highly frequently in patients with high-grade STSs because of improved CT technologies. Careful follow-up is needed if nodules are detected after initial treatment or during the clinical course of the disease.	[Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Matsusaka, Miki; Mizumoto, Keitaro; Mori, Mayuko; Yoshizaki, Tomoya] Mie Univ, Sch Med, Tsu, Mie, Japan	Mie University; Mie University	Nakamura, T (corresponding author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	tomoki66@clin.medic.mie-u.ac.jp						Bacci G, 1997, CANCER-AM CANCER SOC, V79, P245; Billingsley KG, 1999, ANN SURG, V229, P602, DOI 10.1097/00000658-199905000-00002; Ferguson PC, 2011, CANCER-AM CANCER SOC, V117, P372, DOI 10.1002/cncr.25418; Fortes DL, 2008, EUR J CARDIO-THORAC, V34, P1223, DOI 10.1016/j.ejcts.2008.09.007; Hanamiya M, 2012, EUR J RADIOL, V81, P152, DOI 10.1016/j.ejrad.2010.08.013; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Iagaru A, 2006, NUCL MED COMMUN, V27, P795, DOI 10.1097/01.mnm.0000237986.31597.86; Kane John M. III, 2002, Sarcoma, V6, P69, DOI 10.1080/1357714021000022168; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.2002.20.3.791; LILLINGTON GA, 1993, CLIN CHEST MED, V14, P111; Nakamura T, 2011, ONCOL LETT, V2, P315, DOI 10.3892/ol.2011.238; Nakamura T, 2009, CLIN EXP METASTAS, V26, P713, DOI 10.1007/s10585-009-9270-y; Pollock RE, 1996, CANCER, V78, P2247, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2247::AID-CNCR29>3.3.CO;2-B; Reinhardt MJ, 2006, EUR J NUCL MED MOL I, V33, P134, DOI 10.1007/s00259-005-1901-1; Rissing S, 2007, CLIN ORTHOP RELAT R, P118, DOI 10.1097/BLO.0b013e31805d8606; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Zagars GK, 2003, CANCER, V97, P2530, DOI 10.1002/cncr.11365	17	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172148	10.1371/journal.pone.0172148	http://dx.doi.org/10.1371/journal.pone.0172148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182790	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800150
J	Gaksch, M; Jorde, R; Grimnes, G; Joakimsen, R; Schirmer, H; Wilsgaard, T; Mathiesen, EB; Njolstad, I; Lochen, ML; Marz, W; Kleber, ME; Tomaschitz, A; Grubler, M; Eiriksdottir, G; Gudmundsson, EF; Harris, TB; Cotch, MF; Aspelund, T; Gudnason, V; Rutters, F; Beulens, JWJ; van't Riet, E; Nijpels, G; Dekker, JM; Grove-Laugesen, D; Rejnmark, L; Busch, MA; Mensink, GBM; Scheidt-Nave, C; Thamm, M; Swart, KMA; Brouwer, IA; Lips, P; van Schoor, NM; Sempos, CT; Durazo-Arvizu, RA; Skrabakova, Z; Dowling, KG; Cashman, KD; Kiely, M; Pilz, S				Gaksch, Martin; Jorde, Rolf; Grimnes, Guri; Joakimsen, Ragnar; Schirmer, Henrik; Wilsgaard, Tom; Mathiesen, Ellisiv B.; Njolstad, Inger; Lochen, Maja-Lisa; Maerz, Winfried; Kleber, Marcus E.; Tomaschitz, Andreas; Gruebler, Martin; Eiriksdottir, Gudny; Gudmundsson, Elias F.; Harris, Tamara B.; Cotch, Mary F.; Aspelund, Thor; Gudnason, Vilmundur; Rutters, Femke; Beulens, Joline W. J.; van't Riet, Esther; Nijpels, Giel; Dekker, Jacqueline M.; Grove-Laugesen, Diana; Rejnmark, Lars; Busch, Markus A.; Mensink, Gert B. M.; Scheidt-Nave, Christa; Thamm, Michael; Swart, Karin M. A.; Brouwer, Ingeborg A.; Lips, Paul; van Schoor, Natasja M.; Sempos, Christopher T.; Durazo-Arvizu, Ramon A.; Skrabakova, Zuzana; Dowling, Kirsten G.; Cashman, Kevin D.; Kiely, Mairead; Pilz, Stefan			Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; D DEFICIENCY; CANCER; HEALTH; PREVENTION; DISEASE; RISK	Background Vitamin D deficiency may be a risk factor for mortality but previous meta-analyses lacked standardization of laboratory methods for 25-hydroxyvitamin D (25[OH]D) concentrations and used aggregate data instead of individual participant data (IPD). We therefore performed an IPD meta-analysis on the association between standardized serum 25(OH)D and mortality. Methods In a European consortium of eight prospective studies, including seven general population cohorts, we used the Vitamin D Standardization Program (VDSP) protocols to standardize 25(OH)D data. Meta-analyses using a one step procedure on IPD were performed to study associations of 25(OH)D with all-cause mortality as the primary outcome, and with cardiovascular and cancer mortality as secondary outcomes. This meta-analysis is registered at ClinicalTrials.gov, number NCT02438488. Findings We analysed 26916 study participants (median age 61.6 years, 58% females) with a median 25(OH) D concentration of 53.8 nmol/L. During a median follow-up time of 10.5 years, 6802 persons died. Compared to participants with 25(OH)D concentrations of 75 to 99.99 nmol/L, the adjusted hazard ratios (with 95% confidence interval) for mortality in the 25(OH)D groups with 40 to 49.99, 30 to 39.99, and <30 nmol/L were 1.15 (1.00 +/- 1.29), 1.33 (1.16 +/- 1.51), and 1.67 (1.44 +/- 1.89), respectively. We observed similar results for cardiovascular mortality, but there was no significant linear association between 25(OH)D and cancer mortality. There was also no significantly increased mortality risk at high 25(OH)D levels up to 125 nmol/L. Interpretation In the first IPD meta-analysis using standardized measurements of 25(OH)D we observed an association between low 25(OH)D and increased risk of all-cause mortality. It is of public health interest to evaluate whether treatment of vitamin D deficiency prevents premature deaths.	[Gaksch, Martin; Gruebler, Martin; Pilz, Stefan] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria; [Jorde, Rolf; Grimnes, Guri; Joakimsen, Ragnar; Mathiesen, Ellisiv B.] Univ Tromso, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway; [Schirmer, Henrik] UiT Arctic Univ Norway, Dept Clin Med, Tromso Cardiovasc Res Grp UNN, Tromso, Norway; [Wilsgaard, Tom; Njolstad, Inger; Lochen, Maja-Lisa] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Maerz, Winfried; Kleber, Marcus E.] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim Med Fac, Mannheim, Germany; [Maerz, Winfried] Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Kleber, Marcus E.] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Tomaschitz, Andreas; Gruebler, Martin] Med Univ Graz, Dept Cardiol, Graz, Austria; [Tomaschitz, Andreas] Specialist Clin Rehabil Bad Aussee, Bad Aussee, Austria; [Tomaschitz, Andreas] Charite, Campus Virchow Klinikum, Dept Internal Med Cardiol, Berlin, Germany; [Gruebler, Martin] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr Bern, Bern, Switzerland; [Eiriksdottir, Gudny; Gudmundsson, Elias F.; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Cotch, Mary F.] NEI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland; [Rutters, Femke; Beulens, Joline W. J.; van't Riet, Esther; Nijpels, Giel; Dekker, Jacqueline M.; Swart, Karin M. A.; van Schoor, Natasja M.; Pilz, Stefan] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Rutters, Femke; Beulens, Joline W. J.; van't Riet, Esther; Nijpels, Giel; Dekker, Jacqueline M.; Swart, Karin M. A.; van Schoor, Natasja M.; Pilz, Stefan] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Beulens, Joline W. J.; Pilz, Stefan] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Grove-Laugesen, Diana; Rejnmark, Lars] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Busch, Markus A.; Mensink, Gert B. M.; Scheidt-Nave, Christa; Thamm, Michael] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Fac Earth & Life Sci, Amsterdam, Netherlands; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Endocrine Sect, Amsterdam, Netherlands; [Sempos, Christopher T.] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA; [Durazo-Arvizu, Ramon A.] Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, 2160 S 1st Ave, Maywood, IL 60153 USA; [Skrabakova, Zuzana; Dowling, Kirsten G.; Cashman, Kevin D.; Kiely, Mairead] Univ Coll Cork, Cork Ctr Vitamin D & Nutr Res, Sch Food & Nutr Sci, Cork, Ireland; [Cashman, Kevin D.] Univ Coll Cork, Dept Med, Cork, Ireland; [Kiely, Mairead] Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res INFANT, Cork, Ireland	Medical University of Graz; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Ruprecht Karls University Heidelberg; SYNLAB Group; Medical University of Graz; Ulm University; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bern; University Hospital of Bern; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Iceland; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Aarhus University; Robert Koch Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; National Institutes of Health (NIH) - USA; Loyola University Chicago; University College Cork; University College Cork; University College Cork	Pilz, S (corresponding author), Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.; Pilz, S (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Pilz, S (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	stefan.pilz@chello.at	Gudnason, Vilmundur/AAE-7126-2019; Mensink, Gert B/B-2447-2009; Kiely, Mairead E/ABA-3235-2020; Njolstad, Inger/X-3784-2019; Aspelund, Thor/K-7022-2019; Aspelund, Thor/C-5983-2008; Kiely, Mairead/I-8269-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Mensink, Gert B/0000-0001-6268-5998; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Kiely, Mairead/0000-0003-0973-808X; Brouwer, Ingeborg/0000-0002-8762-382X; Keppel, Martin/0000-0003-3448-3349; Gudmundsson, Elias Freyr/0000-0002-7661-4872; Beulens, Joline/0000-0002-4181-0937; van Schoor, Natasja/0000-0002-0870-0795; Cotch, Mary Frances/0000-0002-2046-4350; Nijpels, Giel/0000-0002-3679-9710; Lochen, Maja-Lisa/0000-0002-8532-6573; Pilz, Stefan/0000-0002-7959-1311; Busch, Markus/0000-0003-4936-983X; Joakimsen, Ragnar Martin/0000-0002-2125-8081	European Community [613977]; NATIONAL EYE INSTITUTE [ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER	European Community(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 613977 for the ODIN Integrated Project [Food-based solutions for optimal vitamin D nutrition and health through the life cycle http://www.odin-vitd.eu/]. Funding for the individual studies contributing data to this effort can be found in Appendix (S1File), section 11.	Abo-Zaid G, 2013, J CLIN EPIDEMIOL, V66, P865, DOI 10.1016/j.jclinepi.2012.12.017; Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Binkley N, 2014, J BONE MINER RES, V29, P1709, DOI 10.1002/jbmr.2252; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Eliassen AH, 2016, CANCER RES, V76, P5423, DOI 10.1158/0008-5472.CAN-16-0353; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garland CF, 2014, AM J PUBLIC HEALTH, V104, pE43, DOI 10.2105/AJPH.2014.302034; Grant WB, 2016, DERM-ENDOCRINOL, V8, DOI 10.1080/19381980.2016.1187349; Grant WB, 2012, DERM-ENDOCRINOL, V4, P198, DOI 10.4161/derm.20514; Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI [10.4161/derm.3.3.15364, 10.4161/derm.15364]; Harrell FE, 2001, REGRESSION MODELING; Harrell Jr FE, DASPLINE MACRO SAS; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Hicks KA, STANDARDIZED DEFINIT; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kroll MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118108; Kupferschmidt K, 2012, SCIENCE, V337, P1476, DOI 10.1126/science.337.6101.1476; Liu Q, 2009, COMPUT STAT DATA AN, V53, P4157, DOI 10.1016/j.csda.2009.05.001; Pilz S, 2012, SCIENCE, V338, P883, DOI 10.1126/science.338.6109.883-c; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, INT J EPIDEMIOL, V39, P1359, DOI 10.1093/ije/dyq129; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Royston P, 2001, STATA J, V1, P1, DOI 10.1177/1536867X0100100101; Schottker B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048774; SCHOTTKER B, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3656; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Thomas D, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-79; Zhou BQ, 2011, BIOMETRICS, V67, P661, DOI 10.1111/j.1541-0420.2010.01493.x; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	40	171	182	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170791	10.1371/journal.pone.0170791	http://dx.doi.org/10.1371/journal.pone.0170791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207791	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500013
J	Silove, D; Baker, JR; Mohsin, M; Teesson, M; Creamer, M; O'Donnell, M; Forbes, D; Carragher, N; Slade, T; Mills, K; Bryant, R; McFarlane, A; Steel, Z; Felmingham, K; Rees, S				Silove, Derrick; Baker, Jess R.; Mohsin, Mohammed; Teesson, Maree; Creamer, Mark; O'Donnell, Meaghan; Forbes, David; Carragher, Natacha; Slade, Tim; Mills, Katherine; Bryant, Richard; McFarlane, Alexander; Steel, Zachary; Felmingham, Kim; Rees, Susan			The contribution of gender-based violence and network trauma to gender differences in Post-Traumatic Stress Disorder	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH; SEX-DIFFERENCES; PTSD; PREVALENCE; COMORBIDITY; WOMEN; VULNERABILITY; CONSEQUENCES; EPIDEMIOLOGY	Background Posttraumatic stress disorder (PTSD) occurs twice as commonly amongst women as men. Two common domains of trauma, network trauma and gender based violence (GBV), may contribute to this gender difference in PTSD rates. We examined data from a nationally representative sample of the Australian population to clarify the characteristics of these two trauma domains in their contributions to PTSD rates in men and women. Methods We drew on data from the 2007 Australian National Survey of Mental Health and Well-being to assess gender differences across a comprehensive range of trauma domains, including (1) prevalence of lifetime exposure; (2) identification of an index trauma or DSM-IV Criterion A event; and (3) the likelihood of developing full DSM-IV PTSD symptoms once an index trauma was identified. Results Men reported more traumatic events (TEs) overall but women reported twice the prevalence of lifetime PTSD (women, 13.4%; men, 6.3%). Women reported a threefold higher level of exposure to GBV and were seven times more likely to nominate GBV as the index trauma as compared to men. Women were twice more likely than men to identify a network trauma as the index trauma and more likely to meet full PTSD symptoms in relation to that event (women, 20.6%; men, 14.6%). Conclusion Women are more likely to identify GBV and network trauma as an index trauma. Women's far greater exposure to GBV contributes to their higher prevalence of PTSD. Women are markedly more likely to develop PTSD when network trauma is identified as the index trauma. Preventing exposure to GBV and providing timely interventions for acute psychological reactions following network trauma may assist in reducing PTSD rates amongst women.	[Silove, Derrick; Baker, Jess R.; Mohsin, Mohammed; Rees, Susan] Univ New South Wales, Psychiat Res & Teaching Unit, Sydney, NSW, Australia; [Mohsin, Mohammed; Steel, Zachary] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Teesson, Maree; Carragher, Natacha; Slade, Tim; Mills, Katherine] Univ New South Wales, Off Med Educ, Sydney, NSW, Australia; [Creamer, Mark; O'Donnell, Meaghan; Forbes, David] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Bryant, Richard; Felmingham, Kim] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [McFarlane, Alexander] Univ Adelaide, Ctr Traumat Stress Studies, Adelaide, SA, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne; University of New South Wales Sydney; University of Adelaide	Silove, D (corresponding author), Univ New South Wales, Psychiat Res & Teaching Unit, Sydney, NSW, Australia.	D.Silove@unsw.edu.au	Teesson, Maree/AFM-2972-2022; Slade, Tim/O-2031-2019; Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; Mohsin, Mohammed/0000-0003-2483-3798; O'Donnell, Meaghan/0000-0003-4349-0022; Forbes, David/0000-0001-9145-1605; Teesson, Maree Rose/0000-0002-6744-463X; Slade, Tim/0000-0002-1725-9188	National Health and Medical Research Council, Australia [APP1073041]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	DS received funding from the National Health and Medical Research Council, Australia (APP1073041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2014, TRAUMA VIOLENCE ABUS, V15, P265, DOI 10.1177/1524838014521031; ABS, 2014, AUSTR BUR STAT ABS A; American Psychiatric A American Psychiatric A Force DSMT, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Australian Bureau of Statistics A, NAT SURV MENT HLTH W; Ballenger JC, 2000, J CLIN PSYCHIAT; Berntsen D, 2003, APPL COGNITIVE PSYCH, V17, P675, DOI 10.1002/acp.894; Bleiberg KL, 2005, AM J PSYCHIAT, V162, P181, DOI 10.1176/appi.ajp.162.1.181; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Campanini RFB, 2010, DEPRESS ANXIETY, V27, P72, DOI 10.1002/da.20610; Chapman C, 2012, PSYCHOL MED, V42, P1695, DOI 10.1017/S0033291711002856; Cohen-Mansfield J, 2010, J NERV MENT DIS, V198, P586, DOI 10.1097/NMD.0b013e3181e9dc76; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; CONGER RD, 1993, J HEALTH SOC BEHAV, V34, P71, DOI 10.2307/2137305; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; FAVA M, 1990, AM J PSYCHIAT, V147, P867; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gold SD, 2005, J ANXIETY DISORD, V19, P687, DOI 10.1016/j.janxdis.2004.06.002; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hetzel-Riggin MD, 2013, J LOSS TRAUMA, V18, P41, DOI 10.1080/15325024.2012.679119; Iverson KM, 2013, PSYCHOL VIOLENCE, V3, P273, DOI 10.1037/a0030956; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KESSLER RC, 1984, AM SOCIOL REV, V49, P620, DOI 10.2307/2095420; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kirch DG, 2005, ACAD MED, V80, P980, DOI 10.1097/00001888-200511000-00003; Koss M.P., 1994, NO SAFE HAVEN MALE V; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P634, DOI 10.1177/1077801208319283; Mervin MC, 2014, SOC SCI MED, V107, P68, DOI 10.1016/j.socscimed.2014.02.009; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Reich CM, 2014, J INTERPERSONAL VIOL; Seedat S, 2005, CNS DRUGS, V19, P411, DOI 10.2165/00023210-200519050-00004; Slade T, 2007, AUST NZ J PSYCHIAT, V2009, P594, DOI DOI 10.1080/00048670902970882; Spitzer RL, 2007, J ANXIETY DISORD, V21, P233, DOI 10.1016/j.janxdis.2006.09.006; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Tjaden P., 2000, FULL REPORT PREVALEN; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Vickerman KA, 2009, CLIN PSYCHOL REV, V29, P431, DOI 10.1016/j.cpr.2009.04.004; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	49	30	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171879	10.1371/journal.pone.0171879	http://dx.doi.org/10.1371/journal.pone.0171879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207775	Green Published, gold			2022-12-27	WOS:000394424500056
J	Vasta, R; Nicoletti, A; Mostile, G; Dibilio, V; Sciacca, G; Contrafatto, D; Cicero, CE; Raciti, L; Luca, A; Zappia, M				Vasta, Rosario; Nicoletti, Alessandra; Mostile, Giovanni; Dibilio, Valeria; Sciacca, Giorgia; Contrafatto, Donatella; Cicero, Calogero Edoardo; Raciti, Loredana; Luca, Antonina; Zappia, Mario			Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DIAGNOSTIC-CRITERIA; CONSENSUS STATEMENT	Introduction Acute levodopa challenge may be performed to predict levodopa chronic responsiveness. The aim of the study was to investigate frequency of side effects during the acute levodopa challenge in PD and atypical parkinsonisms. Methods We enrolled 34 de novo PD patients and 29 patients affected by atypical parkinsonisms ( Multiple System Atrophy, MSA, n = 10; Progressive Supranuclear Palsy, PSP, n = 12 and Corticobasal Degeneration, CBD, n = 7) who underwent an acute levodopa challenge. Side effects occurring during test were recorded. Results Side effects were more frequent among atypical parkinsonisms as unique group when compared to PD patients ( 64.3% versus 23.5%; p-value 0.002) with an adjusted OR of 4.36 ( 95% CI 1.40-13.5). Each atypical parkinsonisms showed almost double occurrence of side effects ( MSA 90%, PSP 41.7% and CBD 57%). Conclusions Side effects during acute levodopa challenge may be frequent in atypical parkinsonisms. This information could be useful in order to better prepare the patient for the test. Furthermore, it could represent a useful cue in differential diagnosis with PD.	[Vasta, Rosario; Nicoletti, Alessandra; Mostile, Giovanni; Dibilio, Valeria; Sciacca, Giorgia; Contrafatto, Donatella; Cicero, Calogero Edoardo; Raciti, Loredana; Luca, Antonina; Zappia, Mario] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy	University of Catania	Zappia, M (corresponding author), Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy.	m.zappia@unict.it	Vasta, Rosario/AAB-9040-2019; Luca, Antonina/AAA-6614-2022; Zappia, Mario/AAB-7800-2019; Nicoletti, Alessandra/K-4486-2018; Cicero, Calogero Edoardo CE/K-4055-2018; Luca, Antonina/AAA-6605-2022; Mostile, Giovanni/AAA-9014-2022; Sciacca, Giorgia/AAA-6704-2022	Vasta, Rosario/0000-0002-0393-4736; Luca, Antonina/0000-0002-8397-3478; Nicoletti, Alessandra/0000-0001-6757-340X; Cicero, Calogero Edoardo CE/0000-0002-8647-8851; Luca, Antonina/0000-0002-8397-3478; Mostile, Giovanni/0000-0002-3556-7432; Sciacca, Giorgia/0000-0002-1629-1282				Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Estevez S, 2009, INT J NEUROSCI, V119, P2257, DOI 10.3109/00207450903139721; Fahn S., 1987, RECENT DEV PARKINSON, P153; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; HUGHES AJ, 1991, NEUROLOGY, V41, P1723, DOI 10.1212/WNL.41.11.1723; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; QUATTRONE A, 1995, ANN NEUROL, V38, P389, DOI 10.1002/ana.410380308; RAJPUT AH, 1991, CAN J NEUROL SCI, V18, P275, DOI 10.1017/S0317167100031814; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; Zappia M, 1997, MOVEMENT DISORD, V12, P103, DOI 10.1002/mds.870120118	13	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172145	10.1371/journal.pone.0172145	http://dx.doi.org/10.1371/journal.pone.0172145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207803	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500089
J	Joo, MW; Kang, YK; Yoo, CY; Cha, SH; Chung, YG				Joo, Min Wook; Kang, Yong Koo; Yoo, Chang-Young; Cha, Sung Ho; Chung, Yang-Guk			Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts	PLOS ONE			English	Article							MALIGNANT BONE-TUMORS; RESECTION; SURGERY; SARCOMA; RECONSTRUCTION; TEMPERATURE; REPLACEMENT; ALLOGRAFT; FEMUR	Background Among various reconstruction methods after wide excision for osteosarcoma, pasteurized autograft is often preferred. While the whole area of the tumor can be assessed for chemo-therapy-induced necrosis, one of the important prognostic factors, in other reconstructive techniques, only a portion removed from a wide-resection specimen is available when using pasteurized autograft method. The assessment, therefore, may be unreliable. We analyzed the prognostic significance of the chemotherapy-induced necrosis in osteosarcoma patients who underwent reconstruction with pasteurized autografts. Patients and methods We reviewed the records of osteosarcoma patients who underwent treatment in our institution from 1998 to 2013. Cases of reconstruction with pasteurized autografts were defined as the patient group, and the same number of patients who underwent other reconstruction methods served as controls. Chemotherapy-induced necrosis was evaluated for removed extra-osseous and curetted intramedullary tumor tissues. Results A total of 22 patients were identified; the median age was 15.5 years, and there were 12 males. The most common tumor location was the distal femur. The most common histological subtype was osteoblastic. Median size was 8.1 cm. Disease status was stage IIB in 13 patients and IIA in 9. Median follow-up was 76 months. No differences between the patient and control groups were observed in potential prognostic factors, overall survival, metastasis-free survival, or recurrence-free survival. Univariate analyses demonstrated that histological response was a significant prognostic factor for metastasis-free survival and also significant for recurrence-free survival. Conclusion Chemotherapy-induced necrosis grading, using only available tumor tissues, could be a prognostic factor for osteosarcoma patients receiving pasteurized autografts for reconstructive surgery.	[Joo, Min Wook; Kang, Yong Koo; Cha, Sung Ho] Catholic Univ Korea, St Vincents Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea; [Yoo, Chang-Young] Catholic Univ Korea, St Vincents Hosp, Dept Hosp Pathol, Coll Med, Seoul, South Korea; [Chung, Yang-Guk] Catholic Univ Korea, Seoul St Marys Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Chung, YG (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	ygchung@catholic.ac.kr	Joo, Min Wook/AAM-6417-2020	Joo, Min Wook/0000-0003-1348-2187; Chung, Yang-Guk/0000-0001-8153-8205				Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Asada N, 1997, ACTA ORTHOP SCAND, V68, P392, DOI 10.3109/17453679708996184; Berner Kjetil, 2015, Sarcoma, V2015, P516843, DOI 10.1155/2015/516843; Bielack SS, 2004, EXPERT OPIN PHARMACO, V5, P1243, DOI 10.1517/14656566.5.6.1243; Bramer JAM, 2009, EJSO-EUR J SURG ONC, V35, P1030, DOI 10.1016/j.ejso.2009.01.011; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Chen TH, 2005, J BONE JOINT SURG BR, V87B, P704, DOI 10.1302/0301-620X.87B5.15491; Chen WM, 2002, J BONE JOINT SURG BR, V84B, P1156, DOI 10.1302/0301-620X.84B8.13508; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; DAHLIN DC, 1977, AM J SURG PATHOL, V1, P61, DOI 10.1097/00000478-197701010-00007; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Hameed M, 2011, SEMIN DIAGN PATHOL, V28, P86, DOI 10.1053/j.semdp.2011.02.002; INOKUCHI T, 1991, J CRANIO MAXILL SURG, V19, P31, DOI 10.1016/S1010-5182(05)80269-0; ITO T, 1995, CLIN ORTHOP RELAT R, P267; Iwamoto Y, 1997, CLIN ORTHOP RELAT R, P292; Joo MW, 2015, ANN SURG ONCOL, V22, P3557, DOI 10.1245/s10434-015-4414-6; Kawai A, 1998, J BONE JOINT SURG AM, V80A, P636, DOI 10.2106/00004623-199805000-00004; Manabe J, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P255; Manabe J, 2004, CLIN ORTHOP RELAT R, P258, DOI 10.1097/01.blo.0000122665.47154.8f; Mankin HJ, 1996, CLIN ORTHOP RELAT R, P86; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Miwa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071362; Nakanishi K, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P949; Nishida J, 2008, MED SCI MONITOR, V14, pRA107; Ogura Koichi, 2015, Sarcoma, V2015, P861575, DOI 10.1155/2015/861575; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; RONG Y, 1995, CLIN ORTHOP RELAT R, P227; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; Sugiura H, 2003, ARCH ORTHOP TRAUM SU, V123, P514, DOI 10.1007/s00402-003-0556-2; Sugiura H, 2012, ARCH ORTHOP TRAUM SU, V132, P1685, DOI 10.1007/s00402-012-1606-4; Tsuchiya H, 2004, J ORTHOP SCI, V9, P619, DOI 10.1007/s00776-004-0836-x; Umer M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/698461; Yi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094632; Zhu LM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00230	35	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172155	10.1371/journal.pone.0172155	http://dx.doi.org/10.1371/journal.pone.0172155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196121	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900057
J	Nauwelaerts, S; Hobbs, SJ; Back, W				Nauwelaerts, Sandra; Hobbs, Sarah Jane; Back, Willem			A horse's locomotor signature: COP path determined by the individual limb	PLOS ONE			English	Article							HOOF WALL; THOROUGHBRED RACEHORSE; WARMBLOOD HORSES; PRESSURE PLATE; UNEVEN FEET; ASYMMETRY; MORPHOLOGY; FORELIMB; LENGTH; GAIT	Introduction Ground reaction forces in sound horses with asymmetric hooves show systematic differences in the horizontal braking force and relative timing of break-over. The Center Of Pressure (COP) path quantifies the dynamic load distribution under the hoof in a moving horse. The objective was to test whether anatomical asymmetry, quantified by the difference in dorsal wall angle between the left and right forelimbs, correlates with asymmetry in the COP path between these limbs. In addition, repeatability of the COP path was investigated. Methods A larger group (n = 31) visually sound horses with various degree of dorsal hoof wall asymmetry trotted three times over a pressure mat. COP path was determined in a hoof-bound coordinate system. A relationship between correlations between left and right COP paths and degree of asymmetry was investigated. Results Using a hoof-bound coordinate system made the COP path highly repeatable and unique for each limb. The craniocaudal patterns are usually highly correlated between left and right, but the mediolateral patterns are not. Some patterns were found between COP path and dorsal wall angle but asymmetry in dorsal wall angle did not necessarily result in asymmetry in COP path and the same could be stated for symmetry. Conclusion This method is a highly sensitive method to quantify the net result of the interaction between all of the forces and torques that occur in the limb and its inertial properties. We argue that changes in motor control, muscle force, inertial properties, kinematics and kinetics can potentially be picked up at an early stage using this method and could therefore be used as an early detection method for changes in the musculoskeletal apparatus.	[Nauwelaerts, Sandra] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Nauwelaerts, Sandra] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Hobbs, Sarah Jane] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England; [Back, Willem] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesiol Domest Anim, Merelbeke, Belgium	University of Antwerp; University of Central Lancashire; Utrecht University; Ghent University	Nauwelaerts, S (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.; Nauwelaerts, S (corresponding author), Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium.	sandra.nauwelaerts@uantwerpen.be		Hobbs, Sarah Jane/0000-0002-1552-8647	Qualisys grant; FWO-Flanders grant; IOF grant [IOF SBO ID 34424]	Qualisys grant; FWO-Flanders grant; IOF grant	This work was supported by a Qualisys grant to SJH, an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424).; We would like to thank the owners of the patients for their informed consent, Wouter Kuijsten (Kistler), Jempi Wilssens (RsScan) and Maarten Oosterlinck (U Gent) for their technical assistance, and also Qualisys (Sweden) for their kind financial support. This study was supported by an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424).	Bellenzani MCR, 2012, AM J VET RES, V73, P1735, DOI 10.2460/ajvr.73.11.1735; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Clayton HM, 2011, AUST VET J, V89, P305, DOI 10.1111/j.1751-0813.2011.00806.x; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; De Cock A, 2008, GAIT POSTURE, V27, P669, DOI 10.1016/j.gaitpost.2007.08.013; Dyson S, 2016, J EQUINE VET SCI, V38, P1, DOI 10.1016/j.jevs.2015.12.012; Faramarzi B, 2009, AM J VET RES, V70, P1354, DOI 10.2460/ajvr.70.11.1354; Han TR, 1999, GAIT POSTURE, V10, P248, DOI 10.1016/S0966-6362(99)00040-5; Hertsch B, 1996, HOOF PROTECT IT NAIL; Ishihara A, 2009, JAVMA-J AM VET MED A, V234, P644, DOI 10.2460/javma.234.5.644; Kaufman KR, 1996, J PEDIATR ORTHOPED, V16, P144, DOI 10.1097/01241398-199603000-00002; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kroekenstoel AM, 2006, EQUINE VET J, V38, P652, DOI 10.2746/042516406X159089; Kummer M, 2006, VET J, V172, P58, DOI 10.1016/j.tvjl.2005.03.008; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Maupas E, 1999, CLIN BIOMECH, V14, P403, DOI 10.1016/S0268-0033(99)00005-4; Moleman M, 2005, EQUINE VET EDUC, V17, P319, DOI 10.1111/j.2042-3292.2005.tb00401.x; Oosterlinck M, 2013, VET J, V198, pE9, DOI 10.1016/j.tvjl.2013.09.026; Oosterlinck M, 2011, VET J, V190, P71, DOI 10.1016/j.tvjl.2010.08.016; Oosterlinck M, 2010, VET J, V183, P305, DOI 10.1016/j.tvjl.2008.12.012; Parks A.H., 2003, DIAGNOSIS MANAGEMENT, P250; Pearce GP, 2005, AUST VET J, V83, P367, DOI 10.1111/j.1751-0813.2005.tb15636.x; Ross M.W., 2011, DIAGNOSIS MANAGEMENT, V2nd edition, P426, DOI DOI 10.1016/B978-1-4160-6069-7.00002-X; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Seminati E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074134; Stashak TS, 2002, ADAMS LAMENESS HORSE, V6th, P1081; THOMASON JJ, 1992, J EXP BIOL, V166, P145; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; Van Heel MCV, 2006, EQUINE VET J, V38, P258, DOI 10.2746/042516406776866471; Van Heel MCV, 2004, EQUINE VET J, V36, P778, DOI 10.2746/0425164044847993; van Heel MCV, 2005, EQUINE VET J EQUINE, V37, P536; Watson KM, 2003, EQUINE VET J, V35, P712, DOI 10.2746/042516403775696348; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; White JM, 2008, EQUINE VET J, V40, P623, DOI 10.2746/042516408X313625; White SC, 2004, CLIN ORTHOP RELAT R, P287, DOI 10.1097/01.blo.0000119460.33630.6d; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836; Wilson AM, 2001, EQUINE VET J, V33, P159, DOI 10.1111/j.2042-3306.2001.tb00594.x; Wilson GH, 2009, EQUINE VET J, V41, P238, DOI 10.2746/042516409X395561	38	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0167477	10.1371/journal.pone.0167477	http://dx.doi.org/10.1371/journal.pone.0167477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196073	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000394423900002
J	Zhu, CK; Pan, ZJ; Wang, H; Chang, GL; Wu, N; Ding, HY				Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu			De novo assembly, characterization and annotation for the transcriptome of Sarcocheilichthys sinensis	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMPLETE MITOCHONDRIAL GENOME; IMMUNE-RELATED GENES; PROVIDES INSIGHTS; CYPRINIFORMES CYPRINIDAE; POSITIVE SELECTION; PROFILING ANALYSIS; ASIAN CYPRINIDAE; ANALYSIS REVEALS; DUPLICATION	The Chinese lake gudgeon Sarcocheilichthys sinensis is a small cyprinid fish with great aquaculture potential both for its edible and ornamental values. Nevertheless, available genomic and transcriptomic information for this fish is extremely deficient. In this study, a normalized cDNA library was constructed using 13 mixed tissues of an adult male S. sinensis, and was sequenced by the Illumina HiSeq2500 platform. De novo assembly was performed using 38,911,511 obtained clean reads, and a total of 147,282 unigenes with an average length of 900 bp were finally achieved. 96.2% of these unigenes were annotated in 9 public databases, and 16 segments of growth-related genes were identified for future studies. In addition, 28,493 unigenes were assigned to 61 subcategories of Gene Ontology ( GO), and 10,483 unigenes were assigned to 25 categories of Cluster of Orthologous Group ( COG). Moreover, 14,943 unigenes were classified into 225 pathways of the Kyoto Encyclopedia of Genes and Genomes ( KEGG) database. A total of 30,666 microsatellites were detected from 17,627 unigenes with an average distribution density of 1: 2405 bp. This transcriptome data set will be valuable for researches on discovery, expression and evolution on genes of interest. Meanwhile, the identified microsatellites would be useful tools for genetic and genomic studies in S. sinensis.	[Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu] Huaiyin Normal Univ, Jiangsu Engn Lab Breeding Special Aquat Organisms, Huaian, Peoples R China; [Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu] Huaiyin Normal Univ, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Huaian, Peoples R China	Huaiyin Normal University; Huaiyin Normal University	Zhu, CK (corresponding author), Huaiyin Normal Univ, Jiangsu Engn Lab Breeding Special Aquat Organisms, Huaian, Peoples R China.; Zhu, CK (corresponding author), Huaiyin Normal Univ, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Huaian, Peoples R China.	zhuchuankun@hytc.edu.cn	Zhu, Chuankun/AFE-0407-2022		University Natural Science Foundation of Jiangsu Province [15KJB240001]; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection [HSXT307]; Huaiyin Normal University [31ZCK00]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	University Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection; Huaiyin Normal University; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	This study was supported by University Natural Science Foundation of Jiangsu Province (15KJB240001), funds from Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection (HSXT307), the Startup Funds of Scientific Research from Huaiyin Normal University (31ZCK00) and the Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP) .The funders harole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Chen JJ, 2015, THERIOGENOLOGY, V83, P1416, DOI 10.1016/j.theriogenology.2015.01.001; Chen XM, 2016, GENE, V576, P537, DOI 10.1016/j.gene.2015.11.001; Cheng F, 2013, ICHTHYOL RES, V60, P165, DOI 10.1007/s10228-012-0329-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09836; He SP, 2004, SCI CHINA SER C, V47, P130, DOI 10.1360/03yc0034; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117642; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Li CJ, 2015, GENE, V557, P201, DOI 10.1016/j.gene.2014.12.034; Li C, 2016, MITOCHONDRIAL DNA A, V27, P1056, DOI 10.3109/19401736.2014.928865; Li GX, 2015, FISH SHELLFISH IMMUN, V44, P420, DOI 10.1016/j.fsi.2015.03.014; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Ren L, 2014, GENE, V552, P265, DOI 10.1016/j.gene.2014.09.053; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Shi Z., 2015, JIANGZI FISHERY SCI, V2, P21; Song TX, 1994, ZOOLOGICAL RES, V15, P96; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wan QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12946; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang XZ, 2012, SCI CHINA LIFE SCI, V55, P761, DOI 10.1007/s11427-012-4366-z; Wang Y, 2015, GENE, V565, P211, DOI 10.1016/j.gene.2015.04.023; Wang ZJ, 2016, COMP BIOCHEM PHYS D, V19, P120, DOI 10.1016/j.cbd.2016.05.003; Werner GDA, 2013, MAR BIOTECHNOL, V15, P230, DOI 10.1007/s10126-012-9481-0; XiangHui K, 2007, SCI CHINA SER C, V50, P780, DOI 10.1007/s11427-007-0076-3; Xiao J, 2015, FISH SHELLFISH IMMUN, V44, P60, DOI 10.1016/j.fsi.2015.01.022; Xuan Y, 2010, J AQUACULTURE, V11, P35; Yang SB, 2014, MITOCHONDR DNA, V25, P286, DOI 10.3109/19401736.2013.796461; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhao Z., 2015, SCI AQUACULTURE, V10, P68; Zhou ZH, 2015, MITOCHONDR DNA, V26, P141, DOI 10.3109/19401736.2013.815176; Zhu JJ, 2011, CONSERV GENET RESOUR, V3, P239, DOI 10.1007/s12686-010-9331-1; Zhu R, 2016, FISH SHELLFISH IMMUN, V55, P699, DOI 10.1016/j.fsi.2016.06.051; Zou M, 2014, GENE, V547, P267, DOI 10.1016/j.gene.2014.06.056	46	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171966	10.1371/journal.pone.0171966	http://dx.doi.org/10.1371/journal.pone.0171966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196101	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900038
J	Browne, SH; Diaz-Perez, JA; Preziosi, M; King, CC; Jones, GA; Jain, S; Sun, XY; Reid, EG; VandenBerg, S; Wang, HY				Browne, Sara H.; Diaz-Perez, Julio A.; Preziosi, Michael; King, Charles C.; Jones, George A.; Jain, Sonia; Sun, Xiaoying; Reid, Erin G.; VandenBerg, Scott; Wang, Huan-You			mTOR activity in AIDS-related diffuse large B-cell lymphoma	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; ANTIRETROVIRAL THERAPY; TISSUE MICROARRAY; MAMMALIAN TARGET; RAPAMYCIN; EXPRESSION; INHIBITORS; AUTOCRINE; MALIGNANCIES; ACTIVATION	Background Patients infected with HIV have a significantly increased risk of developing non-Hodgkin lymphomas despite the widespread use of HAART. To investigate mTOR pathway activity in acquired immunodeficiency syndrome (AIDS) related diffuse large B-cell lymphoma AR-DLBCL, we used immunohistochemistry to examine the presence of the phosphorylated 70 ribosomal S6 protein-kinase (p70S6K), an extensively studied effector of mTOR Complex 1 (mTORC1) and the phosphorylated phosphatase and tensin homolog (pPTEN), a negative regulator of mTORC1 pathway. Materials and methods We evaluated tissue samples from 126 patients with AR-DLBCL. Among them, 98 samples were from tissue microarrays (TMAs) supplied by the Aids and Cancer Specimen Resource (ACSR), the remaining 28 samples were from cases diagnosed and treated at the University of California, San Diego (UCSD). The presence of p70S6K was evaluated with two antibodies directed against the combined epitopes Ser235/236 and Ser240/244, respectively; and additional monoclonal anti-bodies were used to identify pPTEN and phosphorylated proline-rich Akt substrate of 40kDa (pPRAS40). The degree of intensity and percentage of cells positive for p70S6K and pPTEN were assessed in all the samples. In addition, a subgroup of 28 patients from UCSD was studied to assess the presence of pPRAS40, an insulin-regulated activator of the mTORC1. The expression of each of these markers was correlated with clinical and histopathologic features. Results The majority of the patients evaluated were males (88%); only two cases (1.6%) were older than 65 years of age. We found high levels of both p70S6K-paired epitopes studied, 48% positivity against Ser235/236 (44% in ACSR and 64% in UCSD group), and 86% positivity against Ser240/244 (82% in ACSR and 100% in UCSD group). We observed more positive cells and stronger intensity with epitope Ser 240/244 in comparison to Ser 235/236 (p < 0.0001). The degree of intensity and percentage of cells positive for pPTEN was positively correlated with p70S6K levels (p = 0.016 for 235/236 and p = 0.007 for 240/244). High levels of pPRAS40 were observed in the majority of the cases evaluated (64.3%), but no correlation was found with either pPTEN (p = 0.9) or p70S6K (p = 0.9) levels. Conclusion AR-DLBCL frequently contain p70S6K, a main downstream effector of the mTOR pathway. The presence of p70S6K is positively correlated with pPTEN, an inactive form of PTEN, which makes mTORC1 activated. The presence of p70S6K was independent of HIV viral load or CD4 (+) counts. These results suggest that the mTOR pathway is active in the majority of AR-DLBCL, and p70S6K, particularly the Ser240/244 epitope immunohistochemistry is an excellent surrogate biomarker, which could be used to identify cases expected to be responsive to mTOR inhibitors.	[Browne, Sara H.; Diaz-Perez, Julio A.; Preziosi, Michael] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [King, Charles C.; Jones, George A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Dept Family Med & Publ Hlth, Biostat Res Ctr, La Jolla, CA 92093 USA; [Reid, Erin G.] Univ Calif San Diego, Dept Med, Div Hematol, La Jolla, CA 92093 USA; [VandenBerg, Scott; Wang, Huan-You] Univ Calif San Diego, Dept Pathol, Div Clin Pathol, La Jolla, CA 92093 USA; [VandenBerg, Scott] Univ Calif San Diego, Human Tissue Technol Core, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Browne, SH (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.; Wang, HY (corresponding author), Univ Calif San Diego, Dept Pathol, Div Clin Pathol, La Jolla, CA 92093 USA.	shbrowne@ucsd.edu; hywang2@ucsd.edu	Diaz-Perez, Julio A/L-4057-2013; Diaz-Perez, Julio A./G-7377-2017	Diaz-Perez, Julio A/0000-0001-8166-7314; Diaz-Perez, Julio A./0000-0001-8166-7314; Browne, Sara/0000-0003-0360-3301	UC San Diego Center for AIDS Research; Moores Cancer Center [100893]; World Pathology Foundation	UC San Diego Center for AIDS Research; Moores Cancer Center; World Pathology Foundation	This work is supported by the UC San Diego Center for AIDS Research (http://cfar.ucsd.edu) and Moores Cancer Center Grant No. #100893, which received an NIH supplement to support collaborative studies in HIV-associated malignancies (SH Browne, HY Wang, EG Reid and S VandenBerg), and in part by the World Pathology Foundation.	Barta SK, 2013, BLOOD, V122, P3251, DOI 10.1182/blood-2013-04-498964; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Cesarman E, 2012, HEMATOLOGY, V17, pS83, DOI 10.1179/102453312X13336169155899; Chadburn A, 2009, J CLIN ONCOL, V27, P5039, DOI 10.1200/JCO.2008.20.5450; Chao C, 2012, CLIN CANCER RES, V18, P4702, DOI 10.1158/1078-0432.CCR-11-3169; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; El-Salem M, 2009, AM J PATHOL, V175, P817, DOI 10.2353/ajpath.2009.080451; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hong JY, 2014, ANN ONCOL, V25, P182, DOI 10.1093/annonc/mdt530; Johnston PB, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-45; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Matthews GV, 2000, BLOOD, V96, P2730; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851; Roy D, 2011, AM J PATHOL, V179, P2108, DOI 10.1016/j.ajpath.2011.06.017; Sebestyen A, 2012, MODERN PATHOL, V25, P1623, DOI 10.1038/modpathol.2012.141; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Smith SM, 2012, BEST PRACT RES CL HA, V25, P175, DOI 10.1016/j.beha.2012.04.008; Teachey DT, 2009, BRIT J HAEMATOL, V145, P569, DOI 10.1111/j.1365-2141.2009.07657.x; Vajpayee N, 2012, LEUKEMIA RES, V36, P1403, DOI 10.1016/j.leukres.2012.07.016; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Younes A, 2011, ONCOLOGIST, V16, P730, DOI 10.1634/theoncologist.2010-0318; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zhao MY, 2009, CLIN CANCER RES, V15, P1708, DOI 10.1158/1078-0432.CCR-08-1543	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170771	10.1371/journal.pone.0170771	http://dx.doi.org/10.1371/journal.pone.0170771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192480	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800011
J	Wu, SC; Bergey, EA				Wu, Shelly C.; Bergey, Elizabeth A.			Diatoms on the carapace of common snapping turtles: Luticola spp. dominate despite spatial variation in assemblages	PLOS ONE			English	Article							ALGAL GENUS BASICLADIA; FRESH-WATER TURTLES; CLADOPHORALES; CHLOROPHYTA; BASIN; RIVER	Filamentous algae are often visible on the carapaces of freshwater turtles and these algae are dominated by a few species with varying geographic distributions. Compared to filamentous algae, little is known about the much more speciose microalgae on turtles. Our objectives were to compare the diatom flora on a single turtle species (the common snapping turtle, Chelydra serpentina) across part of its range to examine spatial patterns and determine whether specific diatom taxa were consistently associated with turtles (as occurs in the filamentous alga Basicladia spp.). Using preserved turtle specimens from museums, we systematically sampled diatoms on the carapaces of 25 snapping turtles across five states. The diverse diatom assemblages formed two groups-the southern Oklahoma group and the northern Illinois/ Wisconsin/New York group, with Arkansas not differing from either group. Of the six diatom species found in all five states, four species are widespread, whereas Luticola cf. goeppertiana and L. cf. mutica are undescribed species, known only from turtles in our study. L. cf. goeppertiana comprised 83% of the diatom abundance on Oklahoma turtles and was relatively more abundant on southern turtles (Oklahoma and Arkansas) than on northern turtles (where mean abundance/state was > 10%). L. cf. mutica was the most abundant species (40%) on New York turtles. Some Luticola species are apparently turtle associates and results support a pattern of spatial variation in Luticola species, similar to that in Basicladia. Using museum specimens is an efficient and effective method to study the distribution of micro-epibionts.	[Wu, Shelly C.; Bergey, Elizabeth A.] Oklahoma Biol Survey, Norman, OK 73019 USA; [Wu, Shelly C.; Bergey, Elizabeth A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Wu, Shelly C.] Texas Christian Univ, Andrews Inst, Ft Worth, TX 76129 USA	University of Oklahoma System; University of Oklahoma - Norman; Texas Christian University	Wu, SC (corresponding author), Oklahoma Biol Survey, Norman, OK 73019 USA.; Wu, SC (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.; Wu, SC (corresponding author), Texas Christian Univ, Andrews Inst, Ft Worth, TX 76129 USA.	shelly.wu@tcu.edu			National Science Collections Alliance	National Science Collections Alliance	The Collections-Web Award from the National Science Collections Alliance was granted to the corresponding author (SW). The University of Oklahoma Department of Biology and the Oklahoma Biological Survey provided travel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DIATOMS APPL ENV EAR; BELUSZ LC, 1969, AM MIDL NAT, V81, P598, DOI 10.2307/2423999; Boedeker C, 2012, J PHYCOL, V48, P808, DOI 10.1111/j.1529-8817.2012.01145.x; BOYER DR, 1965, ECOLOGY, V46, P99, DOI 10.2307/1935262; Bury R. Bruce, 2015, Northwestern Naturalist, V96, P150; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colt LC, 1995, CAN FIELD NAT, V109, P454; EDGREN RA, 1953, ECOLOGY, V34, P733, DOI 10.2307/1931336; ERNST CH, 1978, ESTUARIES, V1, P54, DOI 10.2307/1351650; Ernst CH, 2009, TURTLES US CANADA; Ersanli ET, 2014, BANGL J BOT, V43, P157; Garbary DJ, 2007, J FRESHWATER ECOL, V22, P677, DOI 10.1080/02705060.2007.9664828; GOLLADAY SW, 1991, FRESHWATER BIOL, V25, P437, DOI 10.1111/j.1365-2427.1991.tb01387.x; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; HULSE A C, 1976, Journal of Herpetology, V10, P45, DOI 10.2307/1562927; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kramer K., 1986, SUSSWASSERFLORA MITT; LIPSEY LL, 1978, RHODORA, V80, P441; Lowe RL, 2007, SOUTHEAST NAT, V6, P135, DOI 10.1656/1528-7092(2007)6[135:DBADOW]2.0.CO;2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; NEILL WT, 1954, ECOLOGY, V35, P581, DOI 10.2307/1931051; NORMANDIN ROBERT F., 1959, OHIO JOUR SCI, V59, P58; OBBARD ME, 1981, COPEIA, P630; Pavlov A, 2016, DIATOM RES, V31, P85, DOI 10.1080/0269249X.2016.1157376; Peres CK, 2012, CRYPTOGAMIE ALGOL, V33, P329, DOI 10.7872/crya.v33.iss4.2012.329; PLOTKIN PT, 1995, MAR BIOL, V122, P137, DOI 10.1007/BF00349287; PROCTOR VW, 1958, ECOLOGY, V39, P634, DOI 10.2307/1931604; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Round F. E., 1990, DIATOMS BIOL MORPHOL; Skinner S, 2008, TELOPEA, V12, P279, DOI 10.7751/telopea20085817; Smith P. W., 1961, Bulletin of the Illinois Natural History Survey, V28, P1; Souffreau C, 2010, PHYCOLOGIA, V49, P309, DOI 10.2216/09-30.1; Soylu EN, 2006, J FRESHWATER ECOL, V21, P535, DOI 10.1080/02705060.2006.9665033; Spaulding S, 2008, LUTICOLA; Spaulding S. A., 2010, DIATOMS US; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Tumlison R., 1996, P ARKANSAS ACAD SCI, V50, P148; Van De Vijver B, 2008, PHYCOLOGIA, V47, P451, DOI 10.2216/07-67.1; Wetzel CE, 2010, VIE MILIEU, V60, P177; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Williner V, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0071-x; Yoneda Y., 1952, Publications of the Seto Marine Biological Laboratory, V2, P227; Zanelli H. R. R., 2009, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V12, P91; Ziglar CL, 2005, J FRESHWATER ECOL, V20, P389, DOI 10.1080/02705060.2005.9664979	44	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171910	10.1371/journal.pone.0171910	http://dx.doi.org/10.1371/journal.pone.0171910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192469	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800050
J	Chierico, L; Rizzello, L; Guan, LJ; Joseph, AS; Lewis, A; Battaglia, G				Chierico, Luca; Rizzello, Loris; Guan, Lijuan; Joseph, Adrian Steve; Lewis, Andrew; Battaglia, Giuseppe			The role of the two splice variants and extranuclear pathway on Ki-67 regulation in non-cancer and cancer cells	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; MITOTIC CHROMOSOMES; QUALITY-CONTROL; ANTIBODY KI-67; BREAST-CANCER; CHAPERONE BIP; PROLIFERATION; ANTIGEN; CYCLE; KI67	Ki-67 is a nuclear protein that has been used in cancer diagnostic because of its specific cell-cycle dependent expression profile. After quantifying and characterising the expression level of Ki-67, as a function of the cell cycle, we found out that the two main splice variants of the protein (i.e. a and (3) are differently regulated in non-cancerous and cancerous cells both at mRNA and protein level. We were able to correlate the presence of the a variant of the protein with the progression through the interphase of cell cycle. We also observed that the different expression profiles correspond to different degradation pathways for non-cancerous and cancerous cells. Furthermore, Ki-67 is continuously regulated and degraded via proteasome system in both cell types, suggesting an active control of the protein. However we also observed a putative extranuclear elimination pathway of Ki-67 where it is transported to the Golgi apparatus. Our evidence in the different expression of the splice variants may represent a milestone for the development of new targets for cancer diagnostic and prognostic. Additionally, the unexpected extranuclear elimination of Ki-67 strongly suggests that this protein must be looked at also outside of the "nuclear box", as thought to date.	[Chierico, Luca; Rizzello, Loris; Guan, Lijuan; Joseph, Adrian Steve; Battaglia, Giuseppe] UCL, Dept Chem, London, England; [Lewis, Andrew] Biocompatibles UK Ltd, Farnham Business Pk,Weydon Lane, Farnham, Surrey, England	University of London; University College London; Biocompatibles International PLC	Rizzello, L; Battaglia, G (corresponding author), UCL, Dept Chem, London, England.	l.rizzello@ucl.ac.uk; g.battaglia@ucl.ac.uk	Battaglia, Giuseppe/I-2142-2013; Rizzello, Loris/HDM-2610-2022	Battaglia, Giuseppe/0000-0003-3349-6770; Rizzello, Loris/0000-0002-8230-853X	Biocompatibles UK Ltd; BTG/Biocompatibles	Biocompatibles UK Ltd; BTG/Biocompatibles	Biocompatibles UK Ltd provided support in the form of salaries for authors LC and AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors thank Miss Silvia Bianco for the design of the cartoon. L.C. thanks BTG/Biocompatibles for sponsoring his studentship.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boge A, 2012, FASEB J, P26; Booth DG, 2014, KI 67 IS PP1 INTERAC; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Derganc J, 2013, TRENDS BIOCHEM SCI, V38, P576, DOI 10.1016/j.tibs.2013.08.006; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Endl E, 1997, CYTOMETRY, V29, P233, DOI 10.1002/(SICI)1097-0320(19971101)29:3<233::AID-CYTO6>3.0.CO;2-C; Endl E, 2000, J CELL PHYSIOL, V182, P371, DOI 10.1002/(SICI)1097-4652(200003)182:3<371::AID-JCP8>3.0.CO;2-J; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Kill IR, 1996, J CELL SCI, V109, P1253; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Onn A, 2010, NAT STRUCT MOL BIOL, V17, P924, DOI 10.1038/nsmb0810-924; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rustandi RR, 2012, ELECTROPHORESIS, V33, P2790, DOI 10.1002/elps.201200095; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Starborg M, 1996, J CELL SCI, V109, P143; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171815	10.1371/journal.pone.0171815	http://dx.doi.org/10.1371/journal.pone.0171815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187152	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300045
J	Getahun, B; Nkosi, ZZ				Getahun, Belete; Nkosi, Zethu Zerish			Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; CARE; SERVICES; DOTS	Background Directly observed treatment, short course (DOTS) strategy has been a cornerstone for Tuberculosis (TB) control programs in developing countries. However, in Ethiopia satisfaction level of patients' with TB with the this strategy is not well understood. Therefore, the study aimed to assess the satisfaction level of patients with TB with the DOTS. Method Explanatory sequential mixed method design was carried out in Addis Ababa, Ethiopia. Interviewer-administered questionnaire with 601 patients with TB who were on follow-up was employed in the quantitative approach. In the qualitative approach telephonic-interview with 25 persons lost to follow-up and focus group discussions with 23 TB experts were conducted. Result Sixty seven percent of respondent was satisfied with the DOTS. Rural residency (AOR = 3.4, 95% CI 1.6, 7.6), having TB symptoms (AOR = 0.6, 95% CI 0.4, 0.94) and treatment supporter (AOR = 4.3, 95% CI 2.7, 6.8) were associated with satisfaction with DOTS. In qualitative finding, all persons lost to follow-up were dissatisfied while TB experts enlightened lack of evidence to affirm the satisfaction level of patients with DOTS. Explored factors contributing to satisfaction include: on time availability of health care providers, DOTS service delivery process, general condition of health care facilities, nutritional support and transportation. Conclusion DOTS is limited to satisfy patients with TB and lacks a consistent system that determines the satisfaction level of patients with TB. Therefore, DOTS strategy needs to have a system to captures patients' satisfaction level to respond on areas that need progress to improve DOTS service quality.	[Getahun, Belete; Nkosi, Zethu Zerish] Univ South Africa, Dept Hlth Studies, Coll Human Sci, Pretoria, South Africa; [Getahun, Belete] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	University of South Africa; Addis Ababa University	Getahun, B (corresponding author), Univ South Africa, Dept Hlth Studies, Coll Human Sci, Pretoria, South Africa.; Getahun, B (corresponding author), Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia.	bgetahun150@gmail.com	Nkosi, Zethu/AAG-3980-2020					Addis Ababa City Adminstration Finnance and Economic Development Buraueu, 2013, ADD AB POP IM; Addis Ababa City Adminstration Health Buraeu, 2015, ANN ACT REP; Ahmad I, 2010, GOMAL J MED SCI, V9; Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Bahrampour A., 2005, Eastern Mediterranean Health Journal, V11, P905; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Bhattacherjee A., 2012, SOCIAL SCI RES PRINC, V2nd \; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Central Statistical Agency of Ethiopia, 2014, POP PROJ ETH ALL REG; Chimbindi N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-32; Dansereau E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009700; Diacona HA, 2012, SWISS MED WKLY, V142, P1; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, ETH NAT HLTH CAR QUA; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, P 6 NAT TB RES WORKS; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, HLTH HLTH REL IND; Federal Democratic Republic of Ethiopia MoH, 2013, GUID CLIN PROGR MAN, V5; Gebreegziabher S., 2016, J TUBERC RES, V4, P23, DOI DOI 10.4236/JTR.2016.41004; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Gupta S., 2015, J ADV MED DENT SCI R, V3, P34; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Marshall G.B., 2011, DESIGNING QUALITATIV; Nezenega ZS, 2013, BMC HEALTH SERV RES, V13, P1; Onyeonoro UU, 2015, HEALTH SERV INSIGHTS, V8, P25, DOI 10.4137/HSI.S27177; Otu A. A., 2013, Asian Pacific Journal of Tropical Disease, V3, P227, DOI 10.1016/S2222-1808(13)60045-6; Palha PF, 2012, REV ESC ENFERM USP, V46, P342, DOI 10.1590/S0080-62342012000200011; Paulson T., 2013, NATURE; Pefoyo AJ, 2013, BMC RES NOTES, V6, P1; Portela MC, 2014, REV SAUDE PUBL, V48, P497, DOI 10.1590/S0034-8910.2014048004793; Rahmqvist M, 2010, INT J QUALITY H 0203; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sisay Solomon, 2014, BMC Res Notes, V7, P44, DOI 10.1186/1756-0500-7-44; Srivastav S, 2014, ANN TROP MED PUBLIC, V7, P116, DOI 10.4103/1755-6783.146398; van der Eijk M, 2013, PARKINSONISM RELAT D, V19, P923, DOI 10.1016/j.parkreldis.2013.04.022; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB TUB REP 2013; Yin Robert K., 2015, QUALITATIVE RES STAR; Young GJ, 2000, MED CARE, V38, P325, DOI 10.1097/00005650-200003000-00009	40	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171209	10.1371/journal.pone.0171209	http://dx.doi.org/10.1371/journal.pone.0171209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182754	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800045
J	Fletcher, DE; Lindell, AH; Stillings, GK; Blas, SA; McArthur, JV				Fletcher, Dean E.; Lindell, Angela H.; Stillings, Garrett K.; Blas, Susan A.; McArthur, J. Vaun			Trace element accumulation in lotic dragonfly nymphs: Genus matters	PLOS ONE			English	Article							COAL COMBUSTION RESIDUES; METAL CONCENTRATIONS; STABLE-ISOTOPES; TROPHIC STRUCTURE; INTRAGUILD PREDATION; DISSOLVED CADMIUM; AQUATIC DISPOSAL; UNITED-STATES; HEAVY-METALS; RIVER-BASIN	Constituents of coal combustion waste (CCW) expose aquatic organisms to complex mixtures of potentially toxic metals and metalloids. Multi-element trace element analyses were used to distinguish patterns of accumulation among 8 genera of dragonfly nymphs collected from two sites on a CCW contaminated coastal plain stream. Dragonfly nymphs are exceptional for comparing trace element accumulation in syntopic macroinvertebrates that are all predators within the same order (Odonata) and suborder (Anisoptera), but differ vastly in habitat use and body form. Sixteen trace element (Be, V, Cr, Ni, Cu, Zn, As, Se, Sr, Cd, Sb, Cs, Ba, Hg, Tl, and Pb) were analyzed and trophic position and basal carbon sources assessed with stable isotope analyses (C and N). Trophic positions varied within relatively narrow ranges. Size did not appear to influence trophic position. Trophic position rarely influenced trace element accumulation within genera and did not consistently correlate with accumulation among genera. Patterns between delta C-13 and trace element accumulation were generally driven by differences between sites. An increase in trace element accumulation was associated with a divergence of carbon sources between sites in two genera. Higher trace element concentrations tended to accumulate in nymphs from the upstream site, closer to contaminant sources. Influences of factors such as body form and habitat use appeared more influential on trace element accumulation than phylogeny for several elements (Ni, Ba, Sr, V, Be, Cd, and Cr) as higher concentrations accumulated in sprawler and the climber-sprawler genera, irrespective of family. In contrast, As and Se accumulated variably higher in burrowers, but accumulation in sprawlers differed between sites. Greater variation between genera than within genera suggests genus as an acceptable unit of comparison in dragonfly nymphs. Overall, taxonomic differences in trace element accumulation can be substantial, often exceeding variation between sites. Our results underscore the element and taxa specific nature of trace element accumulation, but we provide evidence of accumulation of some trace elements differing among dragonflies that differ in body form and utilize different sub-habitats within a stream reach.	[Fletcher, Dean E.; Lindell, Angela H.; Stillings, Garrett K.; McArthur, J. Vaun] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29808 USA; [Blas, Susan A.] Savannah River Nucl Solut, Area Complet Projects, Aiken, SC USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Fletcher, DE (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29808 USA.	fletcher@srel.uga.edu			Department of Energy; Area Completion Projects group-Savannah River Nuclear Solutions [DE-EM0004391]	Department of Energy(United States Department of Energy (DOE)); Area Completion Projects group-Savannah River Nuclear Solutions	This material is based upon work supported by the Department of Energy and the Area Completion Projects group-Savannah River Nuclear Solutions under Award Number DE-EM0004391 to the University of Georgia Research Foundation. SAB of Area Completion Projects assisted with establishing the project goals and general study design of providing a detailed assessment of contaminant accumulation in biota of Beaver Dam Creek. This work has led to several publications on contaminant accumulations in this system. SAB is a trained fish ecologist with experience on the Savannah River Site where the study was conducted. The funding agency provided support in the form of salaries for authors [DEF, JVM, AHL, GKS] and research materials. The funding agency did not have an additional role in the detailed study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. All final decisions on study design, data interpretation, and presentation in the submitted manuscript were made by DEF and JVM.; This material is based upon work supported by the Department of Energy and the Area Completion Projects group-Savannah River Nuclear Solutions under Award Number DE-EM0004391 to the University of Georgia Research Foundation. We thank David Kling, Cynthia Tant and Beryl Walker for field and lab assistance, Tracye Murphy and John Seaman for trace element analysis, and Tom Maddox for SIA.	Arribere MA, 2010, WATER AIR SOIL POLL, V212, P167, DOI 10.1007/s11270-010-0330-3; BENKE AC, 1978, J ANIM ECOL, V47, P335, DOI 10.2307/3787; Bennett PM, 2009, ENTOMOL SCI, V12, P17, DOI 10.1111/j.1479-8298.2009.00308.x; BLOIS C, 1985, FRESHWATER BIOL, V15, P505, DOI 10.1111/j.1365-2427.1985.tb00220.x; Bo T, 2011, ENTOMOL FENNICA, V22, P255; Buchwalter DB, 2008, P NATL ACAD SCI USA, V105, P8321, DOI 10.1073/pnas.0801686105; Buchwalter DB, 2005, ENVIRON SCI TECHNOL, V39, P498, DOI 10.1021/es0404421; Burcher CL, 2002, AM MIDL NAT, V148, P75, DOI 10.1674/0003-0031(2002)148[0075:HDDCAL]2.0.CO;2; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CAIN DJ, 1992, CAN J FISH AQUAT SCI, V49, P2141, DOI 10.1139/f92-237; Casey RE, 2007, WATER AIR SOIL POLL, V178, P69, DOI 10.1007/s11270-006-9132-z; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherry D.S., 2004, STATE REGULATION COA, P193; CHERRY DS, 1979, HYDROBIOLOGIA, V62, P257, DOI 10.1007/BF00043543; CHERRY DS, 1978, WATER AIR SOIL POLL, V9, P403; Chumchal MM, 2011, ENVIRON TOXICOL CHEM, V30, P1153, DOI 10.1002/etc.477; Clayden MG, 2013, ENVIRON SCI TECHNOL, V47, P12047, DOI 10.1021/es4022975; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbi JJ, 2008, WATER AIR SOIL POLL, V195, P325, DOI 10.1007/s11270-008-9749-1; Corbi JJ, 2011, BRAZ ARCH BIOL TECHN, V54, P613, DOI 10.1590/S1516-89132011000300023; Corbi JJ, 2011, ENVIRON MONIT ASSESS, V177, P545, DOI 10.1007/s10661-010-1655-5; Corbi JJ, 2010, QUIM NOVA, V33, P644, DOI 10.1590/S0100-40422010000300030; Cordoba-Aguilar A, 2008, DRAGONFLIES DAMSELFL; Cremona F, 2014, FRESHW SCI, V33, P885, DOI 10.1086/677540; Crumrine Patrick W., 2008, P21; Crumrine PW, 2003, ECOLOGY, V84, P1588, DOI 10.1890/0012-9658(2003)084[1588:PCORRI]2.0.CO;2; Demirak A, 2006, CHEMOSPHERE, V63, P1451, DOI 10.1016/j.chemosphere.2005.09.033; Donahue WF, 2006, J PALEOLIMNOL, V35, P111, DOI 10.1007/s10933-005-7878-8; Edwards PG, 2014, HUM ECOL RISK ASSESS, V20, P1565, DOI 10.1080/10807039.2013.862107; Evans D.W., 1978, ECOLOGY COAL RESOURC, V2, P782; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Fletcher DE, 2015, SOUTHEAST NAT, V14, P373, DOI 10.1656/058.014.0217; Fletcher DE, 2014, ARCH ENVIRON CON TOX, V66, P341, DOI 10.1007/s00244-013-9984-3; Fletcher DE, 2014, ECOTOX ENVIRON SAFE, V101, P196, DOI 10.1016/j.ecoenv.2013.12.024; Gu B, 1996, J FISH BIOL, V49, P1233, DOI 10.1111/j.1095-8649.1996.tb01792.x; GUTHRIE RK, 1979, WATER RESOUR BULL, V15, P244; Guthrie RK, 1976, WATER RESOUR B, V12, P889; Halverson N.V., 1997, WSRCTR970223, P67; Henderson BL, 2012, ENVIRON TOXICOL CHEM, V31, P870, DOI 10.1002/etc.1760; Herwig BR, 2004, CAN J FISH AQUAT SCI, V61, P12, DOI 10.1139/F03-139; Hicks BJ, 1997, NEW ZEAL J MAR FRESH, V31, P651, DOI 10.1080/00288330.1997.9516796; Hopkins WA, 2001, ENVIRON POLLUT, V115, P1, DOI 10.1016/S0269-7491(01)00098-7; Jardine TD, 2005, J N AM BENTHOL SOC, V24, P290, DOI 10.1899/04-092.1; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Karimi R, 2006, ECOL LETT, V9, P1273, DOI 10.1111/j.1461-0248.2006.00979.x; Karouna-Renier NK, 2001, ENVIRON POLLUT, V112, P183, DOI 10.1016/S0269-7491(00)00119-6; KENNEDY GH, 1950, ECOL MONOGR, V20, P105, DOI 10.2307/1943547; Kilham SS, 2009, INT VER THEOR ANGEW, V30, P749; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Kormondy E. J., 1965, Limnology and Oceanography, V10, P427; Kupfer A, 2006, J TROP ECOL, V22, P469, DOI 10.1017/S0266467406003336; Lavilla I, 2010, J ENVIRON MONITOR, V12, P724, DOI 10.1039/b920379f; Lemly AD, 2012, ENVIRON SCI TECHNOL, V46, P8595, DOI 10.1021/es301467q; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; Luther L., 2010, 75700 CRS, P1; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Merritt R. W., 2008, INTRO AQUATIC INSECT; Metts BS, 2013, ENVIRON SCI TECHNOL, V47, P2846, DOI 10.1021/es303989u; Molina CI, 2011, HYDROBIOLOGIA, V663, P135, DOI 10.1007/s10750-010-0565-4; MORIN PJ, 1984, ECOLOGY, V65, P1866, DOI 10.2307/1937784; Needham J. G., 2014, DRAGONFLIES N AM, V3rd; Nummelin M, 2007, ENVIRON POLLUT, V145, P339, DOI 10.1016/j.envpol.2006.03.002; Overman NC, 2001, CAN J FISH AQUAT SCI, V58, P1253, DOI 10.1139/cjfas-58-6-1253; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Peltier GL, 2009, ECOTOX ENVIRON SAFE, V72, P1384, DOI 10.1016/j.ecoenv.2009.01.011; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Poteat MD, 2013, ENVIRON SCI TECHNOL, V47, P7989, DOI 10.1021/es401368u; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Rowe CL, 2014, SCI TOTAL ENVIRON, V485, P490, DOI 10.1016/j.scitotenv.2014.03.119; Rowe CL, 2002, ENVIRON MONIT ASSESS, V80, P207, DOI 10.1023/A:1021127120575; Rowe CL, 2001, ARCH ENVIRON CON TOX, V40, P399; Roy I, 1999, CAN J FISH AQUAT SCI, V56, P1143, DOI 10.1139/cjfas-56-7-1143; Ruhl L, 2012, ENVIRON SCI TECHNOL, V46, P12226, DOI 10.1021/es303263x; Schaller J, 2015, SCI TOTAL ENVIRON, V530, P430, DOI 10.1016/j.scitotenv.2015.06.015; Scheuhammer AM, 1997, ENVIRON POLLUT, V96, P235, DOI 10.1016/S0269-7491(97)00032-8; SHELTON LR, 1994, 94458 US GEOL SURV; SMOCK LA, 1983, FRESHWATER BIOL, V13, P301, DOI 10.1111/j.1365-2427.1983.tb00682.x; Snodgrass JW, 2003, ENVIRON TOXICOL CHEM, V22, P1597, DOI 10.1002/etc.5620220724; Taylor KG, 2009, J SOIL SEDIMENT, V9, P281, DOI 10.1007/s11368-009-0103-z; THORP JH, 1984, ECOLOGY, V65, P1546, DOI 10.2307/1939134; Tollett VD, 2009, ARCH ENVIRON CON TOX, V56, P77, DOI 10.1007/s00244-008-9170-1; Unrine JM, 2007, ENVIRON POLLUT, V149, P182, DOI 10.1016/j.envpol.2007.01.039; VANBUSKIRK J, 1992, OIKOS, V65, P455, DOI 10.2307/3545563; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI; WALLACE JB, 1987, CAN J ZOOL, V65, P35, DOI 10.1139/z87-006; Wiener J, 2008, GLKN2008VERSION10; Wilkinson L., 1996, DESKTOP DATA ANAL SY; Wilson AL, 2005, AQUAT ECOL, V39, P189, DOI 10.1007/s10452-004-7085-0; WISSINGER S, 1993, ECOLOGY, V74, P207, DOI 10.2307/1939515; Worthen Wade B., 2004, International Journal of Odonatology, V7, P97; Worthen WB, 2002, SOUTHEAST NAT, V1, P205, DOI 10.1656/1528-7092(2002)001[0205:TSOLOA]2.0.CO;2	94	14	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172016	10.1371/journal.pone.0172016	http://dx.doi.org/10.1371/journal.pone.0172016			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207806	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500072
J	Shattock, AJ; Benedikt, C; Bokazhanova, A; Duric, P; Petrenko, I; Ganina, L; Kelly, SL; Stuart, RM; Kerr, CC; Vinichenko, T; Zhang, SF; Hamelmann, C; Manova, M; Masaki, E; Wilson, DP; Gray, RT				Shattock, Andrew J.; Benedikt, Clemens; Bokazhanova, Aliya; Duric, Predrag; Petrenko, Irina; Ganina, Lolita; Kelly, Sherrie L.; Stuart, Robyn M.; Kerr, Cliff C.; Vinichenko, Tatiana; Zhang, Shufang; Hamelmann, Christoph; Manova, Manoela; Masaki, Emiko; Wilson, David P.; Gray, Richard T.			Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies	PLOS ONE			English	Article							DRUG-USERS; PRIORITIZATION; INTERVENTIONS; EPIDEMIC; COVERAGE; PEOPLE; COSTS; RISK	Background Despite a non-decreasing HIV epidemic, international donors are soon expected to withdraw funding from Kazakhstan. Here we analyze how allocative, implementation, and technical efficiencies could strengthen the national HIV response under assumptions of future budget levels. Methodology We used the Optima model to project future scenarios of the HIV epidemic in Kazakhstan that varied in future antiretroviral treatment unit costs and management expenditure D two areas identified for potential cost- reductions. We determined optimal allocations across HIV programs to satisfy either national targets or ambitious targets. For each scenario, we considered two cases of future HIV financing: the 2014 national budget maintained into the future and the 2014 budget without current international investment. Findings Kazakhstan can achieve its national HIV targets with the current budget by (1) optimally reallocating resources across programs and (2) either securing a 35% [30% - 39%] reduction in antiretroviral treatment drug costs or reducing management costs by 44% [36% - 58%] of 2014 levels. Alternatively, a combination of antiretroviral treatment and management cost-reductions could be sufficient. Furthermore, Kazakhstan can achieve ambitious targets of halving new infections and AIDS-related deaths by 2020 compared to 2014 levels by attaining a 67% reduction in antiretroviral treatment costs, a 19% [14% - 27%] reduction in management costs, and allocating resources optimally. Significance With Kazakhstan facing impending donor withdrawal, it is important for the HIV response to achieve more with available resources. This analysis can help to guide HIV response planners in directing available funding to achieve the greatest yield from investments. The key changes recommended were considered realistic by Kazakhstan country representatives.	[Shattock, Andrew J.; Stuart, Robyn M.; Kerr, Cliff C.; Wilson, David P.; Gray, Richard T.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Benedikt, Clemens; Masaki, Emiko] World Bank Grp, Washington, DC USA; [Bokazhanova, Aliya; Manova, Manoela] Joint United Nations Programme HIV AIDS, Geneva, Switzerland; [Duric, Predrag; Hamelmann, Christoph] United Nations Dev Programme, Istanbul Reg Hub, Istanbul, Turkey; [Petrenko, Irina; Ganina, Lolita] Republican Ctr Prevent & Control AIDS, Alma Ata, Kazakhstan; [Kelly, Sherrie L.; Wilson, David P.] Burnet Inst, Melbourne, Australia; [Stuart, Robyn M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [Vinichenko, Tatiana; Zhang, Shufang] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	University of New South Wales Sydney; Kirby Institute; The World Bank; Burnet Institute; University of Copenhagen; University of Sydney	Shattock, AJ (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.	ashattock@kirby.unsw.edu.au	Duric, Predrag/L-9002-2019	Duric, Predrag/0000-0001-5770-7224; Shattock, Andrew/0000-0002-2285-8425; Manova, Manoela/0000-0002-8749-7974; Gray, Richard/0000-0002-2885-0483	World Bank Group; Australian National Health and Medical Research Council [APP1064192, APP1086540]; Australian Government, Department of Health and Ageing	World Bank Group; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This study was funded by the World Bank Group and the Australian National Health and Medical Research Council (APP1064192 and APP1086540, both awarded to DPW). The World Bank Group also provided support in the form of salaries for CB and EM. The Kirby Institute at UNSW Australia is funded by the Australian Government, Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. As members of the study team, CB and EM (employed by the World Bank Group) supported the project by engaging with the Kazakhstan HIV sector and requesting data from the national Ministry of Health. They did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond what is specified in the Author Contributions Statement.	Aceijas CC, 2006, SEX TRANSM INFECT; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Bobkov AF, 2004, AIDS RES HUM RETROV, V20, P1134, DOI 10.1089/aid.2004.20.1134; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bunupuradah T, 2015, J INT AIDS SOC; Carey D., 2014, J INT AIDS SOC S3, V17; Caucasus Research Resource Centers, 2013, LAB MIGR STI HIV RIS; Clayden P, 2016, DRUGS DIAGNOSTICS VA; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Development Continuum Working Group, 2015, EV GLOB FOUND GREAT; Duric P, 2015, MODELLING OPTIMISED; Duric P, 2015, MODELLING OPTIMIZED; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; El-Bassel N, 2014, CURR OPIN HIV AIDS, V9, P150, DOI 10.1097/COH.0000000000000035; El-Bassel N, 2013, AIDS BEHAV, V17, P2490, DOI 10.1007/s10461-013-0484-2; Enserink M, 2014, SCIENCE, V345, P1258, DOI 10.1126/science.345.6202.1258; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, P1; Fraser N, 2015, JAIDS-J ACQ IMM DEF, V68, pS213, DOI 10.1097/QAI.0000000000000456; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Holmes CB, 2012, HEALTH AFFAIR, V31, P1553, DOI 10.1377/hlthaff.2012.0562; Kelly SL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20772; Kerr CC, PLOS ONE IN PRESS; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Medecins Sans Frontieres, 2014, UNT WEB ANT PRIC RED; Ministry of Health of the Republic of Kazakhstan, 2011, EP PROF HIV AIDS KAZ; Organization for Economic Cooperation and Development, 2014, CRED REP SYST; Palmer S, 1999, BRIT MED J, V318, P1136, DOI 10.1136/bmj.318.7191.1136; Panovska-Griffiths J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107066; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Sagaon-Teyssier L, 2016, J INT AIDS SOC, V19; Sandgren E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-295; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The Global Fund to Fight AIDS, 2007, 15 BOARD M GEN; The World Bank, 2015, MATH ED; The World Bank, 2012, UKR HIV PROGR EFF ST; Thorne C, 2010, LANCET INFECT DIS, V10, P479, DOI 10.1016/S1473-3099(10)70118-3; UNAIDS, 2013, EFFICIENT SUSTAINABL; UNAIDS, 2013, AIDS BY THE NUMB; UNDP, 2015, DOM FIN NAT HIV RESP; UNGASS, 2013, COUNTR PROGR REP HIV; UNICEF, 2007, UNICEF PROC HIV AIDS; WHO, 2010, EL MOTH TO CHILD TRA; Wilson DP, 2012, GETTING ZERO HIV PRE; Wirtz AL, 2013, INT J STD AIDS, V24, P18, DOI 10.1177/0956462412472291; World Health Organization, 2015, CONS STRAT INF GUID	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169530	10.1371/journal.pone.0169530	http://dx.doi.org/10.1371/journal.pone.0169530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207809	Green Published, gold			2022-12-27	WOS:000394424500004
J	Ambler, GK; Stimpson, AL; Wardle, BG; Bosanquet, DC; Hanif, UK; Germain, S; Chick, C; Goyal, N; Twine, CP				Ambler, G. K.; Stimpson, A. L.; Wardle, B. G.; Bosanquet, D. C.; Hanif, U. K.; Germain, S.; Chick, C.; Goyal, N.; Twine, C. P.			Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy	PLOS ONE			English	Article							ENDOVASCULAR REVASCULARIZATION; DIABETIC FOOT; ISCHEMIA; DISEASE; METAANALYSIS; INFECTION; SURGERY; THERAPY; BYPASS; TRIAL	Introduction Infra-popliteal angioplasty continues to be widely performed with minimal evidence to guide practice. Endovascular device selection is contentious and there is even uncertainty over which artery to treat for optimum reperfusion. Direct reperfusion (DR) targets the artery supplying the ischaemic tissue. Indirect reperfusion (IR) targets an artery supplying collaterals to the ischaemic area. Our unit practice for the last eight years has been to attempt to open all tibial arteries at the time of angioplasty. When successful, this results in both direct and indirect; or combined reperfusion (CR). The aim was to review the outcomes of CR and compare them with DR or IR alone. Methods An eight year retrospective review from a single unit of all infra-popliteal angioplasties was undertaken. Wound healing, limb salvage, amputation-free and overall survival data as well as re-intervention rates were captured for all patients. Subgroup analysis for diabetics was undertaken. Kaplan Meier curves are presented for survival outcomes. All odds and hazard ratios (HR) and p values were corrected for bias from confounders using multivariate analysis. Results 250 procedures were performed: 22 (9%) were CR; 115 (46%) DR and 113 (45%) IR. Amputation- free survival (HR 0.504, p = 0.039) and re-intervention and amputation-free survival (HR 0.414, p = 0.005) were significantly improved in patients undergoing CR compared to IR. Wound healing was similarly affected by reperfusion strategy (OR = 0.35, p = 0.047). Effects of CR over IR were similar when only diabetic patients were considered. Conclusions Combined revascularisation can only be achieved in approximately 10% of patients. However, when successful, it results in significant improvements in wound healing and amputation- free survival over simple indirect reperfusion techniques.	[Ambler, G. K.; Twine, C. P.] Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd,Heath Pk, Cardiff, S Glam, Wales; [Ambler, G. K.; Stimpson, A. L.; Wardle, B. G.; Bosanquet, D. C.; Hanif, U. K.; Germain, S.; Chick, C.; Goyal, N.; Twine, C. P.] Royal Gwent Hosp, South East Wales Vasc Network, Cardiff Rd, Newport, Gwent, Wales	Cardiff University; Royal Gwent Hospital	Twine, CP (corresponding author), Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd,Heath Pk, Cardiff, S Glam, Wales.; Twine, CP (corresponding author), Royal Gwent Hosp, South East Wales Vasc Network, Cardiff Rd, Newport, Gwent, Wales.	christopher.twine@wales.nhs.uk	Twine, Chris/GLS-2275-2022; Bosanquet, David Charles/AAB-1557-2022	Twine, Chris/0000-0003-0385-5760; Bosanquet, David Charles/0000-0003-2304-0489; Ambler, Graeme/0000-0002-3024-6365				Acin F, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/270539; Aerden D, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/672897; Bosanquet DC, 2014, EUR J VASC ENDOVASC, V48, P88, DOI 10.1016/j.ejvs.2014.04.002; Bradbury AW, 2010, J VASC SURG, V51, p5S, DOI 10.1016/j.jvs.2010.01.073; Conrad MF, 2009, J VASC SURG, V50, P799, DOI 10.1016/j.jvs.2009.05.026; Farber A, 2014, TECH VASC INTERV RAD, V17, P221, DOI 10.1053/j.tvir.2014.08.012; Fossaceca R, 2013, CARDIOVASC INTER RAD, V36, P637, DOI 10.1007/s00270-012-0544-4; Iida O, 2013, EUR J VASC ENDOVASC, V46, P575, DOI 10.1016/j.ejvs.2013.08.002; Jens S, 2014, EUR J VASC ENDOVASC, V47, P536, DOI 10.1016/j.ejvs.2014.02.012; Lejay A, 2014, ANN VASC SURG, V28, P983, DOI 10.1016/j.avsg.2013.08.026; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Peregrin JH, 2010, CARDIOVASC INTER RAD, V33, P720, DOI 10.1007/s00270-010-9881-3; Popplewell MA, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1114-2; Soderstrom M, 2013, J VASC SURG, V57, P427, DOI 10.1016/j.jvs.2012.07.057; Spillerova K, 2015, EUR J VASC ENDOVASC, V49, P412, DOI 10.1016/j.ejvs.2014.12.023; Sumpio BE, 2013, J VASC SURG, V58, P814, DOI 10.1016/j.jvs.2013.06.056; Sun NF, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-32; Tan TW, 2011, INT J ANGIOL, V20, P19, DOI 10.1055/s-0031-1272545; TAYLOR GI, 1992, BRIT J PLAST SURG, V45, P327, DOI 10.1016/0007-1226(92)90063-4; VARTY K, 1995, EUR J VASC ENDOVASC, V9, P341, DOI 10.1016/S1078-5884(05)80141-8	20	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172023	10.1371/journal.pone.0172023	http://dx.doi.org/10.1371/journal.pone.0172023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199363	gold, Green Published, Green Accepted			2022-12-27	WOS:000394424400067
J	Auguste, A; Cortet, M; Dabakuyo-Yonli, TS; Launay, L; Arnould, L; Desmoulins, I; Roignot, P; Darut-Jouve, A; Poillot, ML; Bertaut, A; Arveux, P				Auguste, Aviane; Cortet, Marion; Dabakuyo-Yonli, Tienhan Sandrine; Launay, Ludivine; Arnould, Laurent; Desmoulins, Isabelle; Roignot, Patrick; Darut-Jouve, Ariane; Poillot, Marie-Laure; Bertaut, Aurelie; Arveux, Patrick			Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; ECOLOGICAL DEPRIVATION INDEX; RISK; DISPARITIES; ESTROGEN; EXPRESSION; MUTATIONS; SURVIVAL; FEATURES; BIOLOGY	Context The molecular subtype of breast tumours plays a major role in cancer prognosis and treatment options. Triple negative tumours (TN) carry the worst prognosis and affects most frequently women of low socioeconomic status (SES). Studies have shown that non-biologic factors, such as the socioeconomic status could have an influence on tumour biology. To this date no study has been done investigating this association in French women. The objective is to study the association between the SES and the molecular tumour subtype of breast cancer patients in the French county of Cote d'Or. This study benefits from the population data from the Cote d'Or breast cancer registry known for its strict quality control policy. Methods Invasive breast cancer cases between 2003 and 2013 were extracted from the Breast cancer registry database in Cote d'Or. A multivariate analysis was conducted using a hierarchical polytomous regression for the multinomial outcomes for the cancer subtype with HR +/HER2 as reference category. Results A total of 4553 cases were included in our study. There was no significant association found between SES and tumour subtype in French women at diagnosis. Women older than 75 years were less likely to have a TN and HR+/HER2+ breast cancer (OR = 0.66; CI95% = [0.46-0.94] and OR = 0.51; CI95% = [0.37-0.70] respectively). Women with TN tumour subtype had significantly less lymph node invasion when compared to HR+/HER2-subtype (OR = 0.71; CI95% = [0.54-0.92]). Conclusion No significant association was found between socioeconomic status and molecular subtype. Further studies are needed to clarify the mechanisms associated with developing each tumour subtype.	[Auguste, Aviane; Cortet, Marion; Dabakuyo-Yonli, Tienhan Sandrine; Arnould, Laurent; Desmoulins, Isabelle; Poillot, Marie-Laure; Arveux, Patrick] Georges Francois Leclerc Comprehens Canc Care Ctr, Breast & Gynaecol Canc Registry Cote Or, 1 Rue Prof Marion, Dijon, France; [Auguste, Aviane; Dabakuyo-Yonli, Tienhan Sandrine; Bertaut, Aurelie; Arveux, Patrick] Univ Burgundy, Sch Med, EA 4184, 7 Blvd Jeanne dArc, Dijon, France; [Launay, Ludivine] Franc ois Baclesse Comprehens Canc Care Ctr, U 1086, INSERM Canc & Prevent, Plateforme ERISC, 3 Ave Gen Harris, Caen, France; [Roignot, Patrick] Pathol Ctr, 33 Rue Nicolas Bornier, Dijon, France; [Darut-Jouve, Ariane] Oncol Ctr Pk, 18 Cours Gen De Gaulle, Dijon, France; [Bertaut, Aurelie] Georges Francois Leclerc Comprehens Canc Care Ctr, Biostat Unit, 1 Rue Prof Marion, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc; Universite de Bourgogne; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; UNICANCER; Centre Georges-Francois Leclerc	Arveux, P (corresponding author), Georges Francois Leclerc Comprehens Canc Care Ctr, Breast & Gynaecol Canc Registry Cote Or, 1 Rue Prof Marion, Dijon, France.; Arveux, P (corresponding author), Univ Burgundy, Sch Med, EA 4184, 7 Blvd Jeanne dArc, Dijon, France.	parveux@cgfl.fr	CORTET, Marion/H-4781-2018; Auguste, Aviane/GWC-5806-2022; Desmoulins, Isabelle/AAD-3011-2022; Launay, Ludivine/ABD-8881-2020; Dabakuyo - Yonli, Tienhan Sandrine/Q-2150-2018	CORTET, Marion/0000-0001-6770-7340; Auguste, Aviane/0000-0003-2536-3716; bertaut, Aurelie/0000-0002-7934-9509; Launay, Ludivine/0000-0002-4006-9585; Dabakuyo - Yonli, Tienhan Sandrine/0000-0002-8191-1222	National Cancer Institute (INCA) [2015-027]	National Cancer Institute (INCA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France)	The Breast and Gynaecologic Cancer Registry is funded by the National Cancer Institute (INCA) http://www.e-cancer.fr/. [grant number 2015-027]. This research did not receive any additional grant from funding agencies in the public, commercial, or not-for-profit sectors. The INCA provides financial support for the operation of the Cote d'Or breast cancer registry.	Akinyemiju TF, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1282-2; Ambrosone CB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv172; Ambrosone CB, 2014, CANCER CAUSE CONTROL, V25, P259, DOI 10.1007/s10552-013-0323-9; Andaya AA, 2012, CANCER CAUSE CONTROL, V23, P951, DOI 10.1007/s10552-012-9966-1; Bandera EV, 2015, BREAST CANCER RES TR, V150, P655, DOI 10.1007/s10549-015-3353-z; Banegas MP, 2014, BREAST CANCER RES TR, V144, P625, DOI 10.1007/s10549-014-2882-1; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bertaut A, 2015, EUR J CANCER CARE, V24, P920, DOI 10.1111/ecc.12306; Brown M, 2008, CANCER-AM CANCER SOC, V112, P737, DOI 10.1002/cncr.23243; Crispo A, 2016, CURR RES TRANSL MED, V64, P15, DOI 10.1016/j.retram.2016.01.004; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dossus L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0546-7; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gangi A, 2014, ANN SURG ONCOL, V21, P4098, DOI 10.1245/s10434-014-3989-7; Greenup R, 2013, ANN SURG ONCOL, V20, P3254, DOI 10.1245/s10434-013-3205-1; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Holm-Rasmussen EV, 2015, BREAST CANCER RES TR, V149, P229, DOI 10.1007/s10549-014-3225-y; IARC, GLOB INC MOND CANC S; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Ouedraogo S, 2014, PREV MED, V63, P103, DOI 10.1016/j.ypmed.2013.12.007; Parise C, 2014, CANCER EPIDEMIOL, V38, P556, DOI 10.1016/j.canep.2014.08.001; Parise CA, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/813456; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Redondo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040543; Ritte R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-584; Sineshaw HM, 2014, BREAST CANCER RES TR, V145, P753, DOI 10.1007/s10549-014-2976-9; Sturtz LA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-62; Titloye NA, 2016, PATHOBIOLOGY, V83, P24, DOI 10.1159/000441949; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170069	10.1371/journal.pone.0170069	http://dx.doi.org/10.1371/journal.pone.0170069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199325	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400012
J	Taylor, RP; Martin, TP; Montgomery, RD; Smith, JH; Micolich, AP; Boydston, C; Scannell, BC; Fairbanks, MS; Spehar, B				Taylor, R. P.; Martin, T. P.; Montgomery, R. D.; Smith, J. H.; Micolich, A. P.; Boydston, C.; Scannell, B. C.; Fairbanks, M. S.; Spehar, B.			Seeing shapes in seemingly random spatial patterns: Fractal analysis of Rorschach inkblots	PLOS ONE			English	Article							RESPONSES; GEOMETRY	Rorschach inkblots have had a striking impact on the worlds of art and science because of the remarkable variety of associations with recognizable and namable objects they induce. Originally adopted as a projective psychological tool to probe mental health, psychologists and artists have more recently interpreted the variety of induced images simply as a signature of the observers' creativity. Here we analyze the relationship between the spatial scaling parameters of the inkblot patterns and the number of induced associations, and suggest that the perceived images are induced by the fractal characteristics of the blot edges. We discuss how this relationship explains the frequent observation of images in natural scenery.	[Taylor, R. P.; Montgomery, R. D.; Smith, J. H.; Boydston, C.; Scannell, B. C.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; [Martin, T. P.] US Naval Res Lab, Code 7165, Washington, DC USA; [Micolich, A. P.] UNSW Australia, Sch Phys, Sydney, NSW, Australia; [Fairbanks, M. S.] Calif State Univ, Dept Sci & Math, Maritime Acad, Vallejo, CA USA; [Spehar, B.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia	University of Oregon; United States Department of Defense; United States Navy; Naval Research Laboratory; University of New South Wales Sydney; University of New South Wales Sydney	Taylor, RP (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	rpt@uoregon.edu	spehar, branka/D-8519-2012	spehar, branka/0000-0002-3344-7162; Taylor, Richard/0000-0002-5248-4524	Australian Research Council, the Research Corporation for Science Advancement; W. M. Keck Foundation	Australian Research Council, the Research Corporation for Science Advancement(Australian Research Council); W. M. Keck Foundation(W.M. Keck Foundation)	This study was supported by the Australian Research Council, the Research Corporation for Science Advancement, and the W. M. Keck Foundation.	Aks DJ, 1996, J EMPIRICAL STUDIES, V4, P1; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Bies AJ, VIS SCI ANN M 2016; Bies AJ, 2015, J VISION, V15, P769; Bies AJ, 2016, NEUROSCIENCE, V10, P1; Bies AJ, 2016, SYMMETRY, V66, P1; Castrejon Pita JR, 2005, J MATH BIOL, V50, P584, DOI [10.1007/s00285-004-0302-6, DOI 10.1007/S00285-004-0302-6]; Cerf M, 2007, VISION RES, V47, P3052, DOI 10.1016/j.visres.2007.06.025; Conte E, 2008, CHAOS COMPLEXITY LET, V4, P1; CUTTING JE, 1987, PERCEPT PSYCHOPHYS, V42, P365, DOI 10.3758/BF03203093; Fairbanks MS, 2011, NONLINEAR DYNAMICAL; Frame M, 2002, FRACTALS GRAPHICS MA; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; GILDEN DL, 1993, PSYCHOL REV, V100, P460, DOI 10.1037/0033-295X.100.3.460; Gouyet J. F., 1996, PHYS FRACTAL STRUCTU; Gregory R, 2000, NATURE, V404, P19, DOI 10.1038/35003661; Hagerhall CM, 2015, NONLIN DYNAM PSYCHOL, V19, P1; Hagerhall CM, 2008, PERCEPTION, V37, P1488, DOI 10.1068/p5918; Hagerhall CM, 2004, J ENVIRON PSYCHOL, V24, P247, DOI 10.1016/j.jenvp.2003.12.004; Hertz MR, 1936, CHILD DEV, V7, P237; Hertz MR, FREQUENCY TABLES SCO, P5; Hunt G, 1949, TIME, P45; KNILL DC, 1990, J OPT SOC AM A, V7, P1113, DOI 10.1364/JOSAA.7.001113; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Montgomery R. T., 2014, THESIS; Mureika JR, 2013, SIGNAL PROCESS, V93, P573, DOI 10.1016/j.sigpro.2012.05.002; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591; Richards R, 2001, J HUMANIST PSYCHOL, V41, P59, DOI 10.1177/0022167801412006; ROGOWITZ BE, 1990, P SOC PHOTO-OPT INS, V1249, P387, DOI 10.1117/12.19691; Rorschach H., 1921, PSYCHODIAGNOSTIK MET; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; Spehar B, FRONTIERS HUMAN NEUR, V9, P1; Spehar B, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00350; Spehar B, 2013, PROC SPIE, V8651, DOI 10.1117/12.2012076; Stangos N, 1994, CONCEPTS MODERN ART; Street N, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00213; Taylor RP, 2007, PATTERN RECOGN LETT, V28, P695, DOI 10.1016/j.patrec.2006.08.012; Taylor R P, 2008, Nonlinear Dynamics Psychol Life Sci, V12, P117; Taylor RP, 1999, NATURE, V442, P399; Taylor RP., 2011, FRONT HUM NEUROSCI, V5, P1, DOI [10.3389/fnhum.2011.00060, DOI 10.3389/FNHUM.2011.00060, DOI 10.1002/NME.3048.URL]; Taylor RP, 2006, NATURE COMMUNICATION, P44; Turner MJ., 1998, FRACTAL GEOMETRY DIG; Wirt RD, 1953, J PROJ TECH, V17, P493, DOI 10.1080/08853126.1953.10380520; Wood JM., 2003, WHATS WRONG RORSCHAC	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171289	10.1371/journal.pone.0171289	http://dx.doi.org/10.1371/journal.pone.0171289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196082	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900015
J	Oehlke, K; Behsnilian, D; Mayer-Miebach, E; Weidler, PG; Greiner, R				Oehlke, Kathleen; Behsnilian, Diana; Mayer-Miebach, Esther; Weidler, Peter G.; Greiner, Ralf			Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; BETA-CAROTENE; PHYSICOCHEMICAL CHARACTERIZATION; ALPHA-TOCOPHEROL; VITAMIN-E; STABILITY; ACID; TRISTEARIN; LOCATION; IMPACT	Ferulic acid (FA) and tocopherol (Toc) loaded solid lipid nanoparticles (SLN) were prepared by a hot homogenisation method. The particle size distribution, zeta potential and melting behaviour of the SLN as well as the stability, encapsulation efficiency and radical scavenging activity of FA and Toc in the SLN were analysed. The different formulations containing up to 2.8 mg g(-1) of FA or Toc were stable during at least 15 weeks of storage at room temperature. Despite partial degradation and / or release of FA and Toc during storage, significant radical scavenging activity was maintained. DSC measurements and radical scavenging tests after different time periods revealed that the re-structuring of the lipid matrix was connected to the enhanced antioxidant activity of Toc but did not affect the activity of FA.	[Oehlke, Kathleen; Behsnilian, Diana; Mayer-Miebach, Esther; Greiner, Ralf] Max Rubner Inst, Inst Food Technol & Bioproc Engn, Karlsruhe, Germany; [Weidler, Peter G.] KIT, Inst Funct Interfaces, Div Oxid & Organ Interfaces, Hermann von Helmoltz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Oehlke, K (corresponding author), Max Rubner Inst, Inst Food Technol & Bioproc Engn, Karlsruhe, Germany.	kathleen.oehlke@mri.bund.de			Federal Ministry of Food and Agriculture (BMEL)	Federal Ministry of Food and Agriculture (BMEL)	The project was supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditya NP, 2014, LWT-FOOD SCI TECHNOL, V59, P115, DOI 10.1016/j.lwt.2014.04.058; Ahlin P, 2000, INT J PHARM, V196, P241, DOI 10.1016/S0378-5173(99)00431-7; Berton-Carabin CC, 2013, COLLOID SURFACE A, V431, P9, DOI 10.1016/j.colsurfa.2013.04.016; Bondi ML, 2009, CURR NANOSCI, V5, P26, DOI 10.2174/157341309787314656; Bose S, 2013, INT J PHARMACEUT, V441, P56, DOI 10.1016/j.ijpharm.2012.12.013; Bunjes H, 2000, LANGMUIR, V16, P5234, DOI 10.1021/la990856l; Bunjes H, 2007, ADV DRUG DELIVER REV, V59, P379, DOI 10.1016/j.addr.2007.04.013; Bunjes H, 2011, CURR OPIN COLLOID IN, V16, P405, DOI 10.1016/j.cocis.2011.06.007; Campos DA, 2014, COLLOID SURFACE B, V115, P109, DOI 10.1016/j.colsurfb.2013.10.035; Carbone C, 2014, EUR J PHARM SCI, V52, P12, DOI 10.1016/j.ejps.2013.10.003; Carvalho S.M., 2013, IND CROP PROD, V49, P278; Dijkstra A. J., 2007, LIPID HDB, P471, DOI DOI 10.1201/9781420009675.CH7; Dingler A, 1999, J MICROENCAPSUL, V16, P751; Elisabettini P, 1996, J AM OIL CHEM SOC, V73, P187, DOI 10.1007/BF02523893; Freitas C, 1999, EUR J PHARM BIOPHARM, V47, P125, DOI 10.1016/S0939-6411(98)00074-5; Gokce EH, 2012, INT J NANOMED, V7, P1841, DOI 10.2147/IJN.S29710; Heins A, 2007, LIPIDS, V42, P573, DOI 10.1007/s11745-007-3052-6; Heins A, 2007, LIPIDS, V42, P561, DOI 10.1007/s11745-007-3053-5; Helgason T, 2008, J AM OIL CHEM SOC, V85, P501, DOI 10.1007/s11746-008-1219-9; Helgason T, 2009, J COLLOID INTERF SCI, V334, P75, DOI 10.1016/j.jcis.2009.03.012; Helgason T, 2009, J AGR FOOD CHEM, V57, P8033, DOI 10.1021/jf901682m; Hentschel A, 2008, J FOOD SCI, V73, pN1, DOI 10.1111/j.1750-3841.2007.00641.x; Jenning V, 2000, J CONTROL RELEASE, V66, P115, DOI 10.1016/S0168-3659(99)00223-0; Jores K, 2005, PHARM RES-DORDR, V22, P1887, DOI 10.1007/s11095-005-7148-5; Jores K, 2003, PHARM RES-DORDR, V20, P1274, DOI 10.1023/A:1025065418309; Korkmaz E, 2013, ACTA PHARMACEUT, V63, P517, DOI 10.2478/acph-2013-0039; Lacatusu I, 2013, SOFT MATER, V11, P75, DOI 10.1080/1539445X.2011.582914; LAVIGNE F, 1993, J PHYS IV, V3, P137, DOI 10.1051/jp4:1993825; Niculae G, 2014, COMPTES RENDUS CHIMI; Nik AM, 2012, J AGR FOOD CHEM, V60, P4126, DOI 10.1021/jf204810m; Noack A, 2012, INT J PHARMACEUT, V423, P440, DOI 10.1016/j.ijpharm.2011.12.011; Oehlke K, 2011, FOOD CHEM, V124, P781, DOI 10.1016/j.foodchem.2010.06.095; Oehlke K, 2010, FOOD CHEM, V118, P48, DOI 10.1016/j.foodchem.2009.04.078; Oh JH, 2005, J AM OIL CHEM SOC, V82, P13, DOI 10.1007/s11746-005-1036-y; Oh JH, 2002, J FOOD SCI, V67, P2911, DOI 10.1111/j.1365-2621.2002.tb08837.x; Rousseau D, 2005, J AM OIL CHEM SOC, V82, P7, DOI 10.1007/s11746-005-1035-z; Sanchez-Paz V, 2008, J COLLOID INTERF SCI, V320, P1, DOI 10.1016/j.jcis.2007.12.018; Seetapan N, 2010, MICRON, V41, P51, DOI 10.1016/j.micron.2009.08.003; Sonnen AFP, 2005, J AM CHEM SOC, V127, P15575, DOI 10.1021/ja054367l; Trombino S, 2013, COLLOID SURFACE B, V109, P273, DOI 10.1016/j.colsurfb.2013.04.005; Trombino S, 2009, COLLOID SURFACE B, V72, P181, DOI 10.1016/j.colsurfb.2009.03.032; Unruh T, 2001, COLLOID POLYM SCI, V279, P398, DOI 10.1007/s003960000436; Weiss J, 2008, FOOD BIOPHYS, V3, P146, DOI 10.1007/s11483-008-9065-8; Westesen K, 1997, J CONTROL RELEASE, V48, P223, DOI 10.1016/S0168-3659(97)00046-1; Yucel U, 2013, J COLLOID INTERF SCI, V394, P20, DOI 10.1016/j.jcis.2012.12.042; Zimmermann E, 2001, EUR J PHARM BIOPHARM, V52, P203, DOI 10.1016/S0939-6411(01)00167-9	46	48	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171662	10.1371/journal.pone.0171662	http://dx.doi.org/10.1371/journal.pone.0171662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192494	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800036
J	Ogbo, FA; Agho, K; Ogeleka, P; Woolfenden, S; Page, A; Eastwood, J				Ogbo, Felix A.; Agho, Kingsley; Ogeleka, Pascal; Woolfenden, Sue; Page, Andrew; Eastwood, John		Global Child Hlth Res Interest Grp	Infant feeding practices and diarrhoea in sub-Saharan African countries with high diarrhoea mortality	PLOS ONE			English	Article							BREAST-MILK SUBSTITUTES; INTERNATIONAL CODE; NIGERIA EVIDENCE; CHILD-MORTALITY; DETERMINANTS; PREVALENCE; PATTERNS; DISEASE; AGE	Background The impacts of optimal infant feeding practices on diarrhoea have been documented in some developing countries, but not in countries with high diarrhoea mortality as reported by the World Health Organisation/United Nations Children's Fund. We aimed to investigate the association between infant feeding practices and diarrhoea in sub-Saharan African countries with high diarrhoea mortality. Method The study used the most recent Demographic and Health Survey datasets collected in nine sub-Saharan African countries with high diarrhoea mortality, namely: Burkina Faso (2010, N = 9,733); Demographic Republic of Congo (2013; N = 10,458); Ethiopia (2013, N = 7,251); Kenya (2014, N = 14,034); Mali (2013, N = 6,365); Niger (2013, N = 7,235); Nigeria (2013, N = 18,539); Tanzania (2010, N = 5,013); and Uganda (2010, N = 4,472). Multilevel logistic regression models that adjusted for cluster and sampling weights were used to investigate the association between infant feeding practices and diarrhoea in these nine African countries. Results Diarrhoea prevalence was lower among children whose mothers practiced early initiation of breastfeeding, exclusive and predominant breastfeeding. Early initiation of breastfeeding and exclusive breastfeeding were significantly associated with lower risk of diarrhoea (OR = 0.81; 95% confidence interval (CI): 0.77-0.85, P<0.001 and OR = 0.50; 95% CI: 0.43-0.57, respectively). In contrast, introduction of complementary foods (OR = 1.31; 95% CI: 1.14-1.50) and continued breastfeeding at one year (OR = 1.27; 95% CI: 1.05-1.55) were significantly associated with a higher risk of diarrhoea. Conclusion Early initiation of breastfeeding and exclusive breastfeeding are protective of diarrhoea in sub-Saharan African countries with high diarrhoea mortality. To reduce diarrhoea mortality and also achieve the health-related sustainable development goals in sub-Saharan African, an integrated, multi-agency strategic partnership within each country is needed to improve optimal infant feeding practices.	[Ogbo, Felix A.; Page, Andrew] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Sydney, NSW, Australia; [Ogbo, Felix A.; Woolfenden, Sue; Page, Andrew; Eastwood, John] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Agho, Kingsley] Univ Western Sydney, Sch Sci & Hlth, Campbelltown Campus, Sydney, NSW, Australia; [Ogeleka, Pascal] La Trobe Univ, Coll Sci, Sch Publ Hlth Hlth & Engn, Dept Publ Hlth, Bundoora, Vic, Australia; [Woolfenden, Sue] Sydney Childrens Hosp Network, Dept Commun Child Hlth Integrated Care, Randwick, NSW, Australia; [Eastwood, John] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Eastwood, John] Univ Sydney, Sch Publ Hlth, Charles Perkins Ctr, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Eastwood, John] Griffith Univ, Sch Publ Hlth, Gold Coast, Qld, Australia; [Eastwood, John] Croydon Community Hlth Ctr, Sydney Local Hlth Dist, Dept Commun Paediat, Croydon, NSW, Australia; [Global Child Hlth Res Interest Grp] Sydney Childrens Hosp Network, Randwick, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; Western Sydney University; La Trobe University; University of New South Wales Sydney; University of Sydney; Griffith University	Ogbo, FA (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Sydney, NSW, Australia.; Ogbo, FA (corresponding author), Ingham Inst Appl Med Res, Liverpool, NSW, Australia.	felgbo@yahoo.co.uk	Agho, Kingsley/AAE-9971-2020; Agho, Kingsley/AAW-5622-2021; Woolfenden, Susan/S-9234-2019; Zwi, Karen/S-4547-2016	Agho, Kingsley/0000-0003-4111-3207; Woolfenden, Susan/0000-0002-6954-5071; Oei, Ju Lee/0000-0002-7799-3771; Homaira, Nusrat/0000-0003-3341-7964; Zwi, Karen/0000-0002-5561-5200; Gunasekera, Hasantha/0000-0003-4900-1277; Jaffe, Adam/0000-0002-1963-5415				Abrahams SW, 2012, J HUM LACT, V28, P400, DOI 10.1177/0890334412447080; Abrahams SW, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-11; Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; Agunbiade OM, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-5; Ahs J.W., 2010, OPEN INFECT DIS J, V4, P113, DOI 10.2174/1874279301004010113; Anigo KM, 2009, AFRICAN J BIOTECHNOL, V8; [Anonymous], 2010, CONS REP 6 COUNTR RE; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Baker P, 2016, PUBLIC HEALTH NUTR, V19, P2540, DOI 10.1017/S1368980016001117; Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Centers for Disease Control and Prevention, 2016, DIARRH COMM ILLN GLO; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Ehiri JE, 2001, B WORLD HEALTH ORGAN, V79, P423; Federal Ministry of Health-Nigeria, 2015, WORLD BREASTF TRENDS; Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441; Future Market Insights, 2016, INF FORM MARK RAP IN; Gibson RS, 1998, EUR J CLIN NUTR, V52, P764, DOI 10.1038/sj.ejcn.1600645; Godana W, 2013, RURAL REMOTE HEALTH, V13; Hajeebhoy N, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-12; Horta B., 2013, EVIDENCE LONG TERM E, P1; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Institute for Health Metrics and Evaluation, 2016, FIN GLOB HLTH 2015 D; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Kaferstein FK, 2003, B WORLD HEALTH ORGAN, V81, P842; Kent G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0020-7; Kerr RB, 2008, SOC SCI MED, V66, P1095, DOI 10.1016/j.socscimed.2007.11.019; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Liu AH, 2014, BREASTFEED MED, V9, P467, DOI 10.1089/bfm.2014.0053; MICKLESON KNP, 1982, J PEDIATR GASTR NUTR, V1, P381, DOI 10.1097/00005176-198201030-00018; Mihrshahi S, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-28; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Ogbo FA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008467; Ogbo FA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1595-7; Ogbo FA, 2015, PUBLIC HEALTH NUTR, V18, P3287, DOI 10.1017/S136898001500052X; Oni GA, 1996, E AFR MED J, V73, P283; Onofiok N. O., 1998, Food and Nutrition Bulletin, V19, P27; Philipp BL, 2001, PEDIATRICS, V108, P677, DOI 10.1542/peds.108.3.677; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Save the Children, 2015, BREASTF POL MATT ID; Sheth Mini, 2006, Indian Journal of Pediatrics, V73, P61, DOI 10.1007/BF02758262; Tambe AB., 2015, CHALLENGES, V6, P229, DOI [DOI 10.3390/CHALLE6020229, 10.3390/challe6020229]; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; Unicef, 2010, DIARRH WHY CHILDR AR; UNICEF WHO, 2012, PNEUM DIARRH TRACKL; Unicef World Health Organization, 2015, PROGR SAN DRINK WAT; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Victor R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001529; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; WHO, 2008, IND ASS INF YOUNG CH, V1; WHO; UNICEF USAID AED UCDAVIS IFPRI, 2008, IND ASS INF YOUNG 2; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2014, POLICY BRIEF SERIES; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2011, AB DECL 10 YEARS; World Health Organization, 2013, COUNTR IMPL INT COD; World Health Organization, 2013, SHORT TERM EFF BREAS; World Health Organization, 1991, IND ACC BREASTF PRAC; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ziyane IS, 1999, J ADV NURS, V29, P721, DOI 10.1046/j.1365-2648.1999.00942.x	71	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171792	10.1371/journal.pone.0171792	http://dx.doi.org/10.1371/journal.pone.0171792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192518	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800041
J	Rogier, E; Plucinski, M; Lucchi, N; Mace, K; Chang, M; Lemoine, JF; Candrinho, B; Colborn, J; Dimbu, R; Fortes, F; Udhayakumar, V; Barnwell, J				Rogier, Eric; Plucinski, Mateusz; Lucchi, Naomi; Mace, Kimberly; Chang, Michelle; Lemoine, Jean Frantz; Candrinho, Baltazar; Colborn, James; Dimbu, Rafael; Fortes, Filomeno; Udhayakumar, Venkatachalam; Barnwell, John			Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests	PLOS ONE			English	Article							ANTIGEN-DETECTION; PREGNANT-WOMEN; PARASITE; PLASMA; HRP2; PERFORMANCE; PFHRP2; BLOOD; COMBINATION; MANAGEMENT	Detection of histidine-rich protein 2 (HRP2) from the malaria parasite Plasmodium falciparum provides evidence for active or recent infection, and is utilized for both diagnostic and surveillance purposes, but current laboratory immunoassays for HRP2 are hindered by low sensitivities and high costs. Here we present a new HRP2 immunoassay based on antigen capture through a bead-based system capable of detecting HRP2 at sub-picogram levels. The assay is highly specific and cost-effective, allowing fast processing and screening of large numbers of samples. We utilized the assay to assess results of HRP2-based rapid diagnostic tests (RDTs) in different P. falciparum transmission settings, generating estimates for true performance in the field. Through this method of external validation, HRP2 RDTs were found to perform well in the high-endemic areas of Mozambique and Angola with 86.4% and 73.9% of persons with HRP2 in their blood testing positive by RDTs, respectively, and false-positive rates of 4.3% and 0.5%. However, in the low-endemic setting of Haiti, only 14.5% of persons found to be HRP2 positive by the bead assay were RDT positive. Additionally, 62.5% of Haitians showing a positive RDT test had no detectable HRP2 by the bead assay, likely indicating that these were false positive tests. In addition to RDT validation, HRP2 biomass was assessed for the populations in these different settings, and may provide an additional metric by which to estimate P. falciparum transmission intensity and measure the impact of interventions.	[Rogier, Eric; Plucinski, Mateusz; Lucchi, Naomi; Mace, Kimberly; Chang, Michelle; Udhayakumar, Venkatachalam; Barnwell, John] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30329 USA; [Lemoine, Jean Frantz] Minist Sante Publ & Populat, Programme Natl Controle Malaria, Port Au Prince, Haiti; [Candrinho, Baltazar] Natl Malaria Control Program, Maputo, Mozambique; [Colborn, James] Clinton Hlth Access Initiat, Boston, MA USA; [Dimbu, Rafael; Fortes, Filomeno] Natl Malaria Control Program, Luanda, Angola	Centers for Disease Control & Prevention - USA	Rogier, E (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30329 USA.	erogier@cdc.gov		Fortes, Fabiane/0000-0001-6217-3474; Lucchi, Naomi/0000-0001-8789-8041; Plucinski, Mateusz/0000-0002-7322-4625	Global Fund; President's Malaria Initiative; World Health Organization	Global Fund; President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); World Health Organization(World Health Organization)	This work was supported by: The Global Fund, grant number not available, http://www.theglobalfund.org/en/; President's Malaria Initiative, grant number not available, https://www.pmi.gov/; and the World Health Organization, www.who.int, grant number not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1990, AM J TROP MED HYG, V43, P30, DOI 10.4269/ajtmh.1990.43.30; Atroosh WM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1008-x; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bashir IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056828; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Biswas S, 2005, ANN TROP MED PARASIT, V99, P553, DOI 10.1179/136485905X51463; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; Bushman M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3038; Butterworth AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-95; Candrinho B. MJ, 2016, EVALUATING COVERAGE; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Imwong M, 2016, J INFECT DIS, V213, P1322, DOI 10.1093/infdis/jiv596; Imwong M, 2015, J INFECT DIS, V211, P1128, DOI 10.1093/infdis/jiu590; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Kifude CM, 2008, CLIN VACCINE IMMUNOL, V15, P1012, DOI 10.1128/CVI.00385-07; KILEJIAN A, 1974, J BIOL CHEM, V249, P4650; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Laban NM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0544-3; Martin SK, 2009, AM J TROP MED HYG, V80, P516, DOI 10.4269/ajtmh.2009.80.516; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Noedl H, 2007, ANTIMICROB AGENTS CH, V51, P651, DOI 10.1128/AAC.01023-06; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; PARRA ME, 1991, J CLIN MICROBIOL, V29, P1629, DOI 10.1128/JCM.29.8.1629-1634.1991; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Plucinski MM, 2015, TROP MED INT HEALTH, V20, P1685, DOI 10.1111/tmi.12596; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sinha I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0900-3; Sullivan RT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1190-0; Tjitra E, 1999, J CLIN MICROBIOL, V37, P2412, DOI 10.1128/JCM.37.8.2412-2417.1999; Tjitra E, 2001, J CLIN MICROBIOL, V39, P1025, DOI 10.1128/JCM.39.3.1025-1031.2001; Williams JE, 2016, CLIN INFECT DIS, V62, P837, DOI 10.1093/cid/civ1198; World Health Oganization, 2015, WORLD MALARIA REPORT, DOI [10.1186/s12936-015-0544-3PMID:25888818, DOI 10.1186/S12936-015-0544-3]; World Health Organization, 2015, MAL RAP DIAGN TEST P, DOI [10.1186/s12936-015-0753-9, DOI 10.1186/S12936-015-0753-9]	43	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172139	10.1371/journal.pone.0172139	http://dx.doi.org/10.1371/journal.pone.0172139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192523	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800075
J	Sabran, MI; Rahim, SKA; Leow, CY; Soh, PJ; Chew, BW; Vandenbosch, GAE				Sabran, Mursyidul Idzam; Rahim, Sharul Kamal Abdul; Leow, Chee Yen; Soh, Ping Jack; Chew, Beng Wah; Vandenbosch, Guy A. E.			Compact circularly polarized truncated square ring slot antenna with suppressed higher resonances	PLOS ONE			English	Article							DEFECTED GROUND STRUCTURE; WIRELESS POWER TRANSMISSION; MICROSTRIP ANTENNA; HARMONIC SUPPRESSION; DATA COMMUNICATION; RECTENNA; DESIGN; FILTENNA	This paper presents a compact circularly polarized (CP) antenna with an integrated higher order harmonic rejection filter. The proposed design operates within the ISM band of 2.32 GHz-2.63 GHz and is suitable for example for wireless power transfer applications. Asymmetrical truncated edges on a square ring create a defected ground structure to excite the CP property, simultaneously realizing compactness. It offers a 50.5% reduced patch area compared to a conventional design. Novel stubs and slot shapes are integrated in the transmission line to reduce higher (up to the third) order harmonics. The proposed prototype yields a -10 dB reflection coefficient (S-11) impedance bandwidth of 12.53%, a 3 dB axial ratio bandwidth of 3.27%, and a gain of 5.64 dBi. Measurements also show good agreement with simulations.	[Sabran, Mursyidul Idzam; Rahim, Sharul Kamal Abdul; Leow, Chee Yen] Univ Teknol Malaysia, Wireless Commun Ctr, Skudai, Johor, Malaysia; [Soh, Ping Jack] Univ Malaysia Perlis, Sch Comp & Commun Engn, Adv Commun Engn ACE CoE, Arau, Perlis, Malaysia; [Chew, Beng Wah] Intel Microelect, Halaman Kampung Jawa, Penang, Malaysia; [Vandenbosch, Guy A. E.] Katholieke Univ Leuven, Dept Elect Engn, Leuven, Belgium	Universiti Teknologi Malaysia; Universiti Malaysia Perlis; Intel Corporation; KU Leuven	Rahim, SKA (corresponding author), Univ Teknol Malaysia, Wireless Commun Ctr, Skudai, Johor, Malaysia.	sharulkamal@fke.utm.my	Soh, Ping Jack/C-7255-2008; rahim, sharul kamal abdul/K-6346-2012; LEOW, CHEE YEN/J-9206-2018; Vandenbosch, Guy A/J-3209-2012; Sabran, Mursyidul Idzam/AAM-2727-2021	Soh, Ping Jack/0000-0002-6394-5330; rahim, sharul kamal abdul/0000-0003-4511-1989; LEOW, CHEE YEN/0000-0001-6418-0184; 	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia [4B151]; Universiti Teknologi Malaysia [05H39, 4F617]	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia; Universiti Teknologi Malaysia	This work was supported in part by the Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia, under Grant Number 4B151; and Universiti Teknologi Malaysia under Grant Numbers 05H39 and 4F617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for author BWC, and was involved in the decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section	Abedian M, 2012, IEEE ANTENN WIREL PR, V11, P1533, DOI 10.1109/LAWP.2012.2232639; Ali M, 2005, IEEE ANTENN WIREL PR, V4, P205, DOI 10.1109/LAWP.2005.851004; Ali M, 2006, IEEE ANTENNAS WIRELE, V5; Biswas S, 2013, IEEE T ANTENN PROPAG, V61, P3349, DOI 10.1109/TAP.2013.2250240; Chen JX, 2011, PROG ELECTROMAGN RES, V111, P25, DOI 10.2528/PIER10100808; Chen L, 2014, ELECTRON LETT, V50, P1496, DOI 10.1049/el.2014.2703; Chen XW, 2013, IEEE ANTENN WIREL PR, V12, P857, DOI 10.1109/LAWP.2013.2271972; Dahlan A, 2010, J ELECTROMAGNET WAVE, V24, P27; Huang FJ, 2012, IEEE ANTENN WIREL PR, V11, P592, DOI 10.1109/LAWP.2012.2201437; Liu HW, 2003, MICROW OPT TECHN LET, V39, P453, DOI 10.1002/mop.11246; Liu Q, 2013, IEEE ANTENN WIREL PR, V12, P1280, DOI 10.1109/LAWP.2013.2283218; Ma ZK, 2014, IEEE T ANTENN PROPAG, V62, P371, DOI 10.1109/TAP.2013.2287009; Monti G, 2011, IEEE ANTENN WIREL PR, V10, P1116, DOI 10.1109/LAWP.2011.2171029; Park JY, 2004, IEEE ANTENN WIREL PR, V3, P52, DOI 10.1109/LAWP.2004.827889; Pei-Ling C, 2011, IEEE T ANTENN PROPAG, V57, P2854; POZAR DM, 1992, P IEEE, V80, P79, DOI 10.1109/5.119568; Prajapati PR, 2015, IET MICROW ANTENNA P, V9, P1179, DOI 10.1049/iet-map.2014.0596; Reddy BRS, 2015, IEEE ANTENN WIREL PR, V14, P678, DOI 10.1109/LAWP.2014.2376984; Reddy VV, 2014, IEEE ANTENN WIREL PR, V13, P118, DOI 10.1109/LAWP.2013.2296951; Ren YJ, 2006, IEEE T MICROW THEORY, V54, P2970, DOI 10.1109/TMTT.2006.877422; Sabran MI, 2014, ASIA PACIF MICROWAVE, P1007; Sabran M. I., 2014, 2014 IEEE Symposium on Wireless Technology and Applications (ISWTA), P81, DOI 10.1109/ISWTA.2014.6981201; Sim CYD, 2014, IEEE T ANTENN PROPAG, V62, P4828, DOI 10.1109/TAP.2014.2330595; Suh YH, 2000, ELECTRON LETT, V36, P600, DOI 10.1049/el:20000527; Takhedmit H, 2012, ELECTRON LETT, V48, P253, DOI 10.1049/el.2011.3890; Tu WH, 2007, IEEE ANTENN WIREL PR, V6, P282, DOI 10.1109/LAWP.2007.898555; Visser HJ, 2013, P IEEE, V101, P1410, DOI 10.1109/JPROC.2013.2250891; Yang XX, 2013, IEEE T ANTENN PROPAG, V61, P2532, DOI 10.1109/TAP.2013.2244550; Yo TC, 2008, IEEE T ANTENN PROPAG, V56, P882, DOI 10.1109/TAP.2008.916956; Yu C, 2012, IEEE ANTENN WIREL PR, V11, P310, DOI 10.1109/LAWP.2012.2191259	30	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172162	10.1371/journal.pone.0172162	http://dx.doi.org/10.1371/journal.pone.0172162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192504	Green Published, gold			2022-12-27	WOS:000394423800079
J	Nguyen, TL; Leguelinel-Blache, G; Kinowski, JM; Roux-Marson, C; Rougier, M; Spence, J; Le Manach, Y; Landais, P				Tri-Long Nguyen; Leguelinel-Blache, Geraldine; Kinowski, Jean-Marie; Roux-Marson, Clarisse; Rougier, Marion; Spence, Jessica; Le Manach, Yannick; Landais, Paul			Improving medication safety: Development and impact of a multivariate model-based strategy to target high-risk patients	PLOS ONE			English	Article							LOGISTIC-REGRESSION ANALYSIS; COMORBIDITY CLASSIFICATION METHODS; ADVERSE DRUG EVENTS; SMALL DATA SETS; HOSPITAL ADMISSION; INDIVIDUAL PROGNOSIS; ADMINISTRATIVE DATA; PRESCRIBING ERRORS; PREDICTIVE MODELS; DIAGNOSIS TRIPOD	Background Preventive strategies to reduce clinically significant medication errors (MEs), such as medication review, are often limited by human resources. Identifying high-risk patients to allow for appropriate resource allocation is of the utmost importance. To this end, we developed a predictive model to identify high-risk patients and assessed its impact on clinical decision making. Methods From March 1st to April 31st 2014, we conducted a prospective cohort study on adult inpatients of a 1,644-bed University Hospital Centre. After a clinical evaluation of identified MEs, we fitted and internally validated a multivariate logistic model predicting their occurrence. Through 5,000 simulated randomized controlled trials, we compared two clinical decision pathways for intervention: one supported by our model and one based on the criterion of age. Results Among 1,408 patients, 365 (25.9%) experienced at least one clinically significant ME. Eleven variables were identified using multivariable logistic regression and used to build a predictive model which demonstrated fair performance (c-statistic: 0.72). Major predictors were age and number of prescribed drugs. When compared with a decision to treat based on the criterion of age, our model enhanced the interception of potential adverse drug events by 17.5%, with a number needed to treat of 6 patients. Conclusion We developed and tested a model predicting the occurrence of clinically significant MEs. Preliminary results suggest that its implementation into clinical practice could be used to focus interventions on high-risk patients. This must be confirmed on an independent set of patients and evaluated through a real clinical impact study.	[Tri-Long Nguyen; Leguelinel-Blache, Geraldine; Kinowski, Jean-Marie; Roux-Marson, Clarisse] Univ Nimes Hosp, Dept Pharm, Nimes, France; [Tri-Long Nguyen; Leguelinel-Blache, Geraldine; Kinowski, Jean-Marie; Landais, Paul] Univ Montpellier, Univ Inst Clin Res, Clin Res & Hlth Econ, Lab Biostat Epidemiol, Montpellier, France; [Tri-Long Nguyen; Spence, Jessica; Le Manach, Yannick] McMaster Univ, Michael DeGroote Sch Med, Dept Anesthesia, Fac Hlth Sci, Hamilton, ON, Canada; [Tri-Long Nguyen; Spence, Jessica; Le Manach, Yannick] Populat Hlth Res Inst, Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, David Braley Cardiac, Hamilton, ON, Canada; [Rougier, Marion] Nimes Univ Hosp, Dept Gen Med, Nimes, France; [Landais, Paul] Nimes Univ Hosp, Dept Biostat Epidemiol Clin Res & Hlth Econ, Nimes, France	Universite de Montpellier; CHU de Nimes; Universite de Montpellier; McMaster University; Population Health Research Institute; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes	Nguyen, TL (corresponding author), Univ Nimes Hosp, Dept Pharm, Nimes, France.	longbacon.nguyen@gmail.com	Kinowski, jean-marie/AAB-3155-2019; Leguelinel-Blache, Geraldine/F-2229-2015; Spence, Jessica/AAX-1520-2021; Le Manach, Yannick/AAE-5700-2019	Kinowski, jean-marie/0000-0002-2080-6816; Leguelinel-Blache, Geraldine/0000-0001-5191-0977; Spence, Jessica/0000-0003-1267-9455; Le Manach, Yannick/0000-0003-0474-8545; Nguyen, Tri-Long/0000-0002-6376-7212				Agrawal R, 1994, P 20 INT C VERY LARG, ppp487; Antoniou T, 2014, ANN EPIDEMIOL, V24, P532, DOI 10.1016/j.annepidem.2014.04.002; Austin P. C., 2014, STAT METHODS MED RES; Austin PC, 2012, ANN EPIDEMIOL, V22, P881, DOI 10.1016/j.annepidem.2012.09.011; Basey AJ, 2014, BMJ QUAL SAF, V23, P17, DOI 10.1136/bmjqs-2013-001978; Bladh L, 2011, BMJ QUAL SAF, V20, P738, DOI 10.1136/bmjqs.2009.039693; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Dean B, 2002, QUAL SAF HEALTH CARE, V11, P340, DOI 10.1136/qhc.11.4.340; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192; Fertleman M, 2005, QUAL SAF HEALTH CARE, V14, P207, DOI 10.1136/qshc.2004.011759; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Hadi MA, 2014, CLIN J PAIN, V30, P1006, DOI 10.1097/AJP.0000000000000063; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hatah E, 2014, BRIT J CLIN PHARMACO, V77, P102, DOI 10.1111/bcp.12140; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; Lee JK, 2013, J AM GERIATR SOC, V61, P1119, DOI 10.1111/jgs.12323; Leguelinel-Blache G, 2014, EUR J INTERN MED, V25, P808, DOI 10.1016/j.ejim.2014.09.012; Lehnbom EC, 2014, ANN PHARMACOTHER, V48, P1298, DOI 10.1177/1060028014543485; Martins ACM, 2014, J CLIN PHARM THER, V39, P609, DOI 10.1111/jcpt.12204; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; National Coordinating Council for Medication Error Reporting and Prevention, 2001, NCC MERP IND CAT MED; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Pharmaceutical Care Network Europe Foundation, 2010, PCNE CLASS V 6 2; Pippins JR, 2008, J GEN INTERN MED, V23, P1414, DOI 10.1007/s11606-008-0687-9; Quelennec B, 2013, EUR J INTERN MED, V24, P530, DOI 10.1016/j.ejim.2013.02.007; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Tangiisuran B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111254; Trivalle C, 2011, EUR GERIATR MED, V2, P284, DOI 10.1016/j.eurger.2011.07.002; Urbina O, 2014, PHARMACOEPIDEM DR S, V23, P923, DOI 10.1002/pds.3634; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347	41	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171995	10.1371/journal.pone.0171995	http://dx.doi.org/10.1371/journal.pone.0171995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192533	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800058
J	Yaesoubi, M; Miller, RL; Calhoun, VD				Yaesoubi, Maziar; Miller, Robyn L.; Calhoun, Vince D.			Time-varying spectral power of resting-state fMRI networks reveal cross-frequency dependence in dynamic connectivity	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NEURONAL OSCILLATIONS; BRAIN; PHASE; EEG; SYNCHRONY; COHERENCE; MEMORY	Brain oscillations and synchronicity among brain regions (brain connectivity) have been studied in resting-state (RS) and task-induced settings. RS-connectivity which captures brain functional integration during an unconstrained state is shown to vary with the frequency of oscillations. Indeed, high temporal resolution modalities have demonstrated both between and cross-frequency connectivity spanning across frequency bands such as theta and gamma. Despite high spatial resolution, functional magnetic resonance imaging (fMRI) suffers from low temporal resolution due to modulation with slow-varying hemodynamic response function (HRF) and also relatively low sampling rate. This limits the range of detectable frequency bands in fMRI and consequently there has been no evidence of cross frequency dependence in fMRI data. In the present work we uncover recurring patterns of spectral power in network timecourses which provides new insight on the actual nature of frequency variation in fMRI network activations. Moreover, we introduce a new measure of dependence between pairs of rs-fMRI networks which reveals significant cross-frequency dependence between functional brain networks specifically default-mode, cerebellar and visual networks. This is the first strong evidence of cross-frequency dependence between functional networks in fMRI and our subject group analysis based on age and gender supports usefulness of this observation for future clinical applications.	[Yaesoubi, Maziar; Miller, Robyn L.; Calhoun, Vince D.] Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Yaesoubi, Maziar; Calhoun, Vince D.] 1 Univ New Mexico, Deptartment ECE, MSC01 1100, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Yaesoubi, M (corresponding author), Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.; Yaesoubi, M (corresponding author), 1 Univ New Mexico, Deptartment ECE, MSC01 1100, Albuquerque, NM 87131 USA.	myaesoubi@mrn.org	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747	National Institutes of Health (NIH) [1R01B3006841, R01EB020407, P20GM103472]; National Science Foundation (NSF) [1539067]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020407] Funding Source: NIH RePORTER; Office of Integrative Activities [1539067] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Support was provided by the National Institutes of Health (NIH) 1R01B3006841 (to VC), R01EB020407, P20GM103472; and the National Science Foundation (NSF) 1539067.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Berendse HW, 2000, CLIN NEUROPHYSIOL, V111, P604, DOI 10.1016/S1388-2457(99)00309-0; BESTHORN C, 1994, ELECTROEN CLIN NEURO, V90, P242, DOI 10.1016/0013-4694(94)90095-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Yaesoubi M, 2015, NEUROIMAGE, V120, P133, DOI 10.1016/j.neuroimage.2015.07.002; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171647	10.1371/journal.pone.0171647	http://dx.doi.org/10.1371/journal.pone.0171647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192457	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800035
J	Zych, K; Snoek, BL; Elvin, M; Rodriguez, M; Van der Velde, KJ; Arends, D; Westra, HJ; Swertz, MA; Poulin, G; Kammenga, JE; Breitling, R; Jansen, RC; Li, Y				Zych, Konrad; Snoek, Basten L.; Elvin, Mark; Rodriguez, Miriam; Van der Velde, K. Joeri; Arends, Danny; Westra, Harm-Jan; Swertz, Morris A.; Poulin, Gino; Kammenga, Jan E.; Breitling, Rainer; Jansen, Ritsert C.; Li, Yang			reGenotyper: Detecting mislabeled samples in genetic data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NATURAL VARIATION DATA; C. ELEGANS; MIX-UPS; EXPRESSION; QTL; DISEASE; IDENTIFICATION; PERTURBATION; POPULATIONS	In high-throughput molecular profiling studies, genotype labels can be wrongly assigned at various experimental steps; the resulting mislabeled samples seriously reduce the power to detect the genetic basis of phenotypic variation. We have developed an approach to detect potential mislabeling, recover the "ideal" genotype and identify "best-matched " labels for mislabeled samples. On average, we identified 4% of samples as mislabeled in eight published datasets, highlighting the necessity of applying a "data cleaning" step before standard data analysis.	[Zych, Konrad; Arends, Danny; Jansen, Ritsert C.; Li, Yang] Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands; [Snoek, Basten L.; Rodriguez, Miriam; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands; [Elvin, Mark; Poulin, Gino] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Van der Velde, K. Joeri; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Harvard Med Sch, Boston, MA USA; [Westra, Harm-Jan] Partners Ctr Personalized Genet Med, Boston, MA USA; [Westra, Harm-Jan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Breitling, Rainer] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Li, Yang] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; Wageningen University & Research; University of Manchester; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; University of Groningen	Li, Y (corresponding author), Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands.; Li, Y (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	yang.li@rug.nl	Arends, Danny/C-5368-2012; Li, Yang/HGT-8446-2022; Snoek, Basten L/E-4713-2014	Arends, Danny/0000-0001-8738-0162; Li, Yang/0000-0003-4022-7341; Snoek, Basten L/0000-0001-5321-2996; Breitling, Rainer/0000-0001-7173-0922; Poulin, Gino/0000-0003-1016-348X	7th Framework Programme of the European Commission under the Research Project PANACEA [222936]; Netherlands Organisation for Scientific Research (NWO) VENI grant [863.13.011]; Dutch Carbohydrate Competence Center; European Regional Development Fund; Dutch Ministry of Economic Affairs; Municipality of Groningen; Province of Groningen [CCC WP23]	7th Framework Programme of the European Commission under the Research Project PANACEA; Netherlands Organisation for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); Dutch Carbohydrate Competence Center; European Regional Development Fund(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Municipality of Groningen; Province of Groningen	This work was supported by the 7th Framework Programme of the European Commission under the Research Project PANACEA [Contract No. 222936 to RCJ and JEK]; the Netherlands Organisation for Scientific Research (NWO) VENI grant [no 863.13.011 to YL]; and the Dutch Carbohydrate Competence Center, which is is co-financed by the European Regional Development Fund, the Dutch Ministry of Economic Affairs (as part of Pieken in de Delta, the governments regional economic agenda), the Municipality of Groningen and the Province of Groningen [CCC WP23 to KZ] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Arends D, 2012, BIOINFORMATICS, V28, P1042, DOI 10.1093/bioinformatics/bts049; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Baute J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0735-9; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Broman KW, 2015, G3-GENES GENOM GENET, V5, P2177, DOI 10.1534/g3.115.019778; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buyske S, 2009, HUM HERED, V67, P287, DOI 10.1159/000194981; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Ekstrom CT, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1772; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gutteling EW, 2006, HEREDITY; JANSEN RC, 1994, GENETICS, V138, P871; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jansen RC, 2007, HDB STAT GENETICS, P589; Li Y, 2008, TRENDS GENET, V24, P518, DOI 10.1016/j.tig.2008.08.001; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, TRENDS GENET, V26, P493, DOI 10.1016/j.tig.2010.09.002; Lynch AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041815; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Snoek LB, 2013, NUCLEIC ACIDS RES, V41, pD738, DOI 10.1093/nar/gks1124; van der Velde KJ, 2014, NUCLEIC ACIDS RES, V42, pD794, DOI 10.1093/nar/gkt1044; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171324	10.1371/journal.pone.0171324	http://dx.doi.org/10.1371/journal.pone.0171324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192439	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800019
J	Arranz, FJ; Peinado, JM				Arranz, F. J.; Peinado, J. M.			A mesoscopic stochastic model for the specific consumption rate in substrate-limited microbial growth	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KINETICS; TRANSPORTERS; CULTURES	The specific consumption rate of substrate, as well as the associated specific growth rate, is an essential parameter in the mathematical description of substrate-limited microbial growth. In this paper we develop a completely new kinetic model of substrate transport, based on recent knowledge on the structural biology of transport proteins, which correctly describes very accurate experimental results at near-zero substrate concentration values found in the literature, where the widespread Michaelis-Menten model fails. Additionally, our model converges asymptotically to Michaelis-Menten predictions as substrate concentration increases. Instead of the single active site enzymatic reaction of Michaelis-Menten type, the proposed model assumes a multi-site kinetics, simplified as an apparent all-or-none mechanism for the transport, which is controlled by means of the local substrate concentration in the close vicinity of the transport protein. Besides, the model also assumes that this local concentration is not equal to the mean substrate concentration experimentally determined in the culture medium. Instead, we propose that it fluctuates with a mostly exponential distribution of Weibull type.	[Arranz, F. J.] UPM, Grp Sist Complejos, Av Puerta Hierro 2-4, Madrid 28040, Spain; [Peinado, J. M.] UCM, Fac Biol, Dept Microbiol III, Madrid 28040, Spain; [Arranz, F. J.; Peinado, J. M.] UCM UPM, CEI Campus Moncloa, Madrid, Spain	Universidad Politecnica de Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid	Arranz, FJ (corresponding author), UPM, Grp Sist Complejos, Av Puerta Hierro 2-4, Madrid 28040, Spain.; Peinado, JM (corresponding author), UCM, Fac Biol, Dept Microbiol III, Madrid 28040, Spain.; Arranz, FJ; Peinado, JM (corresponding author), UCM UPM, CEI Campus Moncloa, Madrid, Spain.	fj.arranz@upm.es; jpeinado@ucm.es	Saiz, Francisco Javier Arranz/N-7377-2013	Saiz, Francisco Javier Arranz/0000-0003-1270-0701	Ministry of Economy and Competitiveness-Spain [MTM2015-63914, AGL2014-53928]	Ministry of Economy and Competitiveness-Spain	This research was supported by the Ministry of Economy and Competitiveness-Spain under Grants No. MTM2015-63914 and No. AGL2014-53928.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BIOCHEMISTRY-US, V50, P8264, DOI [10.1021/bi201284u], DOI 10.1021/BI201284U]; Boender LGM, 2009, APPL ENVIRON MICROB, V75, P5607, DOI 10.1128/AEM.00429-09; BUTTON DK, 1993, ANTON LEEUW INT J G, V63, P225, DOI 10.1007/BF00871220; Chaplin MF., 1990, EC ARGUMENT IMMOBILI, P80; Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012; Diallinas G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00207; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Michaelis L, 1913, BIOCHEM Z, V49, P333; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Naftalin RJ, 2010, J MEMBRANE BIOL, V234, P75, DOI 10.1007/s00232-010-9228-7; Ribes J, 2004, WATER RES, V38, P4502, DOI 10.1016/j.watres.2004.08.017; Roels JA, 1983, ENERGETICS KINETICS, P237; Snoep JL, 2009, MICROBIOL-SGM, V155, P1699, DOI 10.1099/mic.0.023119-0; VANUDEN N, 1969, ANNU REV MICROBIOL, V23, P473; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Westrhoff HV, 1987, THERMODYNAMICS CONTR, P343; Yu L, 2007, APPL MICROBIOL BIOT, V73, P1241, DOI 10.1007/s00253-006-0717-7	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171717	10.1371/journal.pone.0171717	http://dx.doi.org/10.1371/journal.pone.0171717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187189	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000394244300039
J	Evans, RK; Toews, MD; Sial, AA				Evans, Richard K.; Toews, Michael D.; Sial, Ashfaq A.			Diel periodicity of Drosophila suzukii (Diptera: Drosophilidae) under field conditions	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; CREPUSCULAR ACTIVITY; POPULATION-GROWTH; TEMPERATURE; MELANOGASTER; OVIPOSITION; HUMIDITY; LIGHT; RESISTANCE; MOONLIGHT	Drosophila suzukii Matsumura (Diptera: Drosophilidae), an economically important pest of blueberry and other thin-skinned fruits, persists and prolifically reproduces under seemingly lethal climatic conditions in the field. However, behavioral and physiological mechanisms employed by D. suzukii to tolerate such extreme climatic conditions in the field are unknown. The primary objective of this project was to investigate diel periodicity of D. suzukii and their reproductive success under field conditions as related by climatic factors such as temperature and relative humidity. Results show that D. suzukii reproductive success was significantly higher during the night (including dawn and dusk periods) than the day in terms of oviposition, pupation, adult eclosion, and the number of progeny per female. Female D. suzukii reproductive success was not significantly different between specific regions of a blueberry bush in relation to the amount of shade provided by the canopy. Our studies indicate that D. suzukii flight activity is crepuscular and is sensitive to fluctuations in temperature and relative humidity. Results also suggest that the majority of fly activity during peak hours is concentrated in areas around the border and within the center of blueberry orchards with little activity in the surrounding wooded areas. These findings suggest that D. suzukii prefers microclimate with mild temperatures and high humidity, and does not function well when exposed to direct sunlight with extreme heat. The authors propose that D. suzukii management strategies should be implemented during the early morning and immediately before darkness to maximize efficacy.	[Evans, Richard K.; Toews, Michael D.; Sial, Ashfaq A.] Univ Georgia, Coll Agr & Environm Sci, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Sial, AA (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Dept Entomol, Athens, GA 30602 USA.	ashsial@uga.edu		Toews, Michael D./0000-0003-1880-5926; Sial, Ashfaq/0000-0001-5471-1818	U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative [2015-5 1181-24252]; Organic Agriculture Research and Extension Initiative [2015-51300-24154]; Extension Implementation Program [2014-70006-22533]; Georgia Blueberry Growers Association; Georgia Agricultural Commodity Commission	U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative; Organic Agriculture Research and Extension Initiative; Extension Implementation Program; Georgia Blueberry Growers Association; Georgia Agricultural Commodity Commission	This research was partially supported by grants from the U.S. Department of Agriculture, National Institute of Food and Agriculture under Specialty Crop Research Initiative (Award # 2015-5 1181-24252), Organic Agriculture Research and Extension Initiative (Award # 2015-51300-24154), Extension Implementation Program (Award # 2014-70006-22533), Georgia Blueberry Growers Association, and Georgia Agricultural Commodity Commission for Blue berries to AAS.	Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M., 2011, UCANR BLOG; Bubliy OA, 2012, J EVOLUTION BIOL, V25, P1180, DOI 10.1111/j.1420-9101.2012.02506.x; Chen Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/504896; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Currie J, 2009, BMC BIOL, V7, P19, DOI [10.1038/nature10991, DOI 10.1038/NATURE10991]; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; De J, 2012, J BIOL RHYTHM, V27, P280, DOI 10.1177/0748730412448360; Diepenbrock LM, 2016, CROP PROT, V81, P76, DOI 10.1016/j.cropro.2015.12.012; Doge JD, 2015, BIOL INVASIONS, V17, P2461, DOI 10.1007/s10530-015-0889-0; eFly Group, 2012, SPOTTED WING DROSOPH, V1, P8; Emiljanowicz LM, 2014, J ECON ENTOMOL, V107, P1392, DOI 10.1603/EC13504; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Flerchinger GN, 2015, AGR FOREST METEOROL, V213, P251, DOI 10.1016/j.agrformet.2015.07.007; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamby KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068472; Hardin JA, 2015, ENTOMOL EXP APPL, V156, P59, DOI 10.1111/eea.12311; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hoffmann AA, 2003, J EVOLUTION BIOL, V16, P614, DOI 10.1046/j.1420-9101.2003.00561.x; Kempinger L, 2009, CHRONOBIOL INT, V26, P151, DOI 10.1080/07420520902747124; Ki Y, 2015, NEUROSCIENTIST, V21, P503, DOI 10.1177/1073858415577083; Kinjo H, 2013, J ECON ENTOMOL, V106, P1767, DOI 10.1603/EC12505; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Lin QC, 2014, FLA ENTOMOL, V97, P1434, DOI 10.1653/024.097.0418; Liu SS, 1999, B ENTOMOL RES, V89, P53, DOI 10.1017/S0007485399000073; Mainali BP, 2015, J STORED PROD RES, V63, P47, DOI 10.1016/j.jspr.2015.05.008; McQuate GT, 2013, J ASIA-PAC ENTOMOL, V16, P1, DOI 10.1016/j.aspen.2012.08.003; Muller GA, 2012, REV BRAS ENTOMOL, V56, P111, DOI 10.1590/S0085-56262012005000006; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; Petavy G, 2001, J THERM BIOL, V26, P29, DOI 10.1016/S0306-4565(00)00022-X; Rivas GBS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-278; Roets F, 2013, J INSECT CONSERV, V17, P279, DOI 10.1007/s10841-012-9507-y; Roubos CR, 2010, FLA ENTOMOL, V93, P283, DOI 10.1653/024.093.0220; Schlichting M, 2015, J BIOL RHYTHM, V30, P117, DOI 10.1177/0748730415575245; Singh K, 2015, PLOS ONE, V10; Soares Felipe Augusto, 2015, Revista de Patologia Tropical, V44, P77, DOI 10.5216/rpt.v44i1.34817; Suter RB, 2014, J ARACHNOL, V42, P178, DOI 10.1636/J13-66.1; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Turner JRG, 2013, BIOL J LINN SOC, V110, P305, DOI 10.1111/bij.12145; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Wei J, 2015, J ECON ENTOMOL, V108, P1915, DOI 10.1093/jee/tov135; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wiman NG, 2014, PLOS ONE, V9, P14; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zar J. H., 1999, BIOSTATISTICAL ANALY	47	39	40	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171718	10.1371/journal.pone.0171718	http://dx.doi.org/10.1371/journal.pone.0171718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187140	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300040
J	Fan, GW; Zhang, K; Yang, X; Ding, JS; Wang, ZJ; Li, JM				Fan, Gaowei; Zhang, Kuo; Yang, Xin; Ding, Jiansheng; Wang, Zujian; Li, Jinming			Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review	PLOS ONE			English	Review							METASTATIC COLORECTAL-CANCER; K-RAS MUTATIONS; ISLAND METHYLATOR PHENOTYPE; CELL LUNG-CANCER; LIQUID BIOPSIES; MUTANT-DNA; SERUM; SURVIVAL; PLASMA; METAANALYSIS	The application of circulating tumor DNA(ctDNA) represents a non-invasive method for tumor detection. Its prognostic significance in patients with colorectal cancer is controversial. We performed a systematic review of data from published studies to assess the prognostic values of ctDNA in patients with colorectal cancer. We searched Medline, Embase, Web of Science, the Cochrane Library, and Scopus databases to identify eligible studies reporting disease-free survival (DFS) and overall survival (OS) stratified by ctDNA prior to December 6, 2016. We evaluated the quality and design of these studies. A total of 22 studies were eligible for systematic review. Among them, 11 studies investigated the prognostic value of ctDNA on disease-free survival (DFS). Seven of 11 studies showed that ctDNA was an independent variable to estimate the probability of DFS by multivariate analyses. Thirteen studies assessed the relationship between ctDNA and overall survival (OS). Eight of 13 studies showed that ctDNA was an independent predictor of worse OS through the use of multivariate analyses. This analysis provides evidence that ctDNA may be a prognostic biomarker, negatively correlated with the survival of patients with colorectal cancer.	[Fan, Gaowei; Zhang, Kuo; Yang, Xin; Ding, Jiansheng; Li, Jinming] Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, Beijing, Peoples R China; [Fan, Gaowei] Capital Med Univ, Beijing Chaoyang Hosp, Dept Clin Lab, Beijing, Peoples R China; [Wang, Zujian] Beijing Childrens Hosp, Shunyi Women & Childrens Hosp, Dept Clin Lab, Beijing, Peoples R China	Beijing Hospital; Capital Medical University; Capital Medical University	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Natl Ctr Clin Labs, Beijing, Peoples R China.	jmli@nccl.org.cn	Yang, Xin/R-2335-2019; Yang, Xin/AAA-5027-2022	Yang, Xin/0000-0001-9452-3256				Bai Yan-qing, 2013, Zhonghua Zhong Liu Za Zhi, V35, P666; Bazan V, 2006, ANN ONCOL, V17, pVII84, DOI 10.1093/annonc/mdl958; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Duffy MJ, 2003, EUR J CANCER, V39, P718, DOI 10.1016/S0959-8049(02)00811-0; El Messaoudi S, 2016, CLIN CANCER RES, V22, P3067, DOI 10.1158/1078-0432.CCR-15-0297; El Messaoudi S, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3604; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm477; Herbst A, 2009, EUR J GASTROEN HEPAT, V21, P565, DOI 10.1097/MEG.0b013e328318ecf2; Higgins J, 2005, COCHRANE LIB, V4; Jo P, 2012, SURGERY, V151, P564, DOI 10.1016/j.surg.2011.08.013; Juo YY, 2014, ANN ONCOL, V25, P2314, DOI 10.1093/annonc/mdu149; Lecomte T, 2002, INT J CANCER, V100, P542, DOI 10.1002/ijc.10526; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee HS, 2013, TRANSL ONCOL, V6, P290, DOI 10.1593/tlo.13118; Lefebure B, 2010, ANN SURG, V251, P275, DOI 10.1097/SLA.0b013e3181c35c87; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lin JK, 2014, ANN SURG ONCOL, V21, pS680, DOI 10.1245/s10434-014-3804-5; Lin PC, 2015, ANN SURG ONCOL, V22, pS1419, DOI 10.1245/s10434-014-4277-2; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Lindforss U, 2005, ANTICANCER RES, V25, P657; Liu YQ, 2016, AM J CANCER RES, V6, P2098; Matthaios D, 2016, ONCOL LETT, V12, P748, DOI 10.3892/ol.2016.4649; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Philipp AB, 2012, INT J CANCER, V131, P2308, DOI 10.1002/ijc.27505; Qiu LX, 2010, EUR J CANCER, V46, P2781, DOI 10.1016/j.ejca.2010.05.022; Ryan BM, 2003, J CLIN PATHOL-MOL PA, V56, P172; Sefrioui D, 2015, DIGEST LIVER DIS, V47, P884, DOI 10.1016/j.dld.2015.05.023; Spindler KG, 2013, BRIT J CANCER, V109, P3067, DOI 10.1038/bjc.2013.633; Tham C, 2014, CANCER-AM CANCER SOC, V120, P3131, DOI 10.1002/cncr.28802; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Tie J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.11015; Tie J, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.518; Trevisiol C, 2006, INT J BIOL MARKER, V21, P223, DOI 10.1177/172460080602100405; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Wang JY, 2004, WORLD J SURG, V28, P721, DOI 10.1007/s00268-004-7366-8; Warton K, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00013; Wong ALA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0405-4; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	44	46	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171991	10.1371/journal.pone.0171991	http://dx.doi.org/10.1371/journal.pone.0171991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187169	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300067
J	Kok, PH; Akhir, MFM; Tangang, F; Husain, ML				Kok, Poh Heng; Akhir, Mohd Fadzil Mohd; Tangang, Fredolin; Husain, Mohd Lokman			Spatiotemporal trends in the southwest monsoon wind-driven upwelling in the southwestern part of the South China Sea	PLOS ONE			English	Article							INTERANNUAL VARIABILITY; SURFACE TEMPERATURE; NORTHWEST AFRICA; SYSTEM; COAST; CIRCULATION; WESTERN; STRESS	This study analyzes two wind-induced upwelling mechanisms, namely, Ekman transport and Ekman pumping that occur during the southwest monsoon. The results suggest that the coastline of the east coast of Peninsular Malaysia (ECPM) is affected by upwelling with spatiotemporal variations. Characterization of upwelling by using wind-induced upwelling indexes (UIw) indicate the existence of favorable upwelling conditions from May to September. Upwelling intensity increased in May and peaked in August before declining in September, decreasing intensity from the southern tip towards the northern tip along the coastline of the ECPM. The existence of upwelling along the ECPM has resulted in an important difference between the SSTs of the inshore and the oceanic regions. Nonetheless, the use of the SST gradient between the inshore and the oceanic SSTs to characterize upwelling (U/ssT) was found to be unsuitable because the SST along the ECPM was affected by water advection from the Java Sea and incessant changes in the SST. In order to indicate the major contributor of wind-induced upwelling along the ECPM in terms of the spatiotemporal scale, a comparison between Ekman transport and Ekman pumping was drawn by integrating Ekman pumping with respect to the distance where the positive wind stress curl existed. The estimation of Ekman transport and Ekman pumping indicated that Ekman pumping played a major role in contributing towards upwelling in any particular month during the southwest monsoon along the entire coastline of the ECPM as compared to Ekman transport, which contributed towards more than half of the total upwelling transport. By dividing the ECPM into three coastal sections, we observed that Ekman pumping was relatively predominant in the middle and northern coasts, whereas both Ekman transport and Ekman pumping were equally prevalent in the southern coast.	[Kok, Poh Heng; Akhir, Mohd Fadzil Mohd; Husain, Mohd Lokman] Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia; [Tangang, Fredolin] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi, Selangor, Malaysia; [Husain, Mohd Lokman] Univ Malaysia Terengganu, Sch Marine & Environm Sci, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu; Universiti Kebangsaan Malaysia; Universiti Malaysia Terengganu	Akhir, MFM (corresponding author), Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia.	mfadzil@umt.edu.my	Tangang, Fredolin/ABA-4058-2020; Kok, Poh Heng/D-8605-2015; Akhir, Mohd Fadzil/AAC-3711-2019	Tangang, Fredolin/0000-0002-4919-1800; Kok, Poh Heng/0000-0002-2570-6291; Akhir, Mohd Fadzil/0000-0003-2055-1988	Science Fund, Ministry of Science, Technology and Innovation (MOSTI); Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia [04-01-02-SF0747]; Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT)	Science Fund, Ministry of Science, Technology and Innovation (MOSTI); Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT)	This study was supported by the Science Fund, Ministry of Science, Technology and Innovation (MOSTI), 04-01-02-SF0747 and Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia, FRGS/1/2015/WAB09/UMT/03/2 for data collection and analysis; Higher Institution Center of Excellence (HICoE) of Institute of Oceanography and Environment (INOS), Universiti Malaysia Terengganu (UMT), TJ 66928 for supporting data collection and analysis and preparation of the manuscript.	Akhir M. F., 2014, INT J OCEANOGR, V2014, P1; Akhir M.F., 2015, OPEN J MAR SCI, V5, P273, DOI [10.4236/ojms.2015.53022, DOI 10.4236/OJMS.2015.53022]; Alvarez I, 2011, CONT SHELF RES, V31, P388, DOI 10.1016/j.csr.2010.07.009; [Anonymous], 2009, J GEOPHYS RES, V1, P1; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Bakun A., 1977, CALCOFI REPORTS, V19, P107; Bakun A., 1973, SSRF671 NOAA NMFS; Belkin IM, 2007, ICES ANN SCI C HELS, P1; Berrisford P, 2009, ERA REP SER, P1; Castelao RM, 2012, J PHYS OCEANOGR, V42, P2073, DOI 10.1175/JPO-D-11-0224.1; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chereskin TK, 2009, OCEAN CURRENTS, P525; Chu PC, 1998, J GEOPHYS RES-OCEANS, V103, P21637, DOI 10.1029/98JC02096; Cole J, 2000, INT J REMOTE SENS, V21, P1597, DOI 10.1080/014311600209922; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; Daryabor F, 2014, SAINS MALAYS, V43, P389; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dippner JW, 2007, OCEAN DYNAM, V57, P46, DOI 10.1007/s10236-006-0091-0; ECMWF, 2007, CY31R1 IFS ECMWF, P1; Ekman VW., 1905, ARKIV MAT ASTRON FIZ, V2, P1; FANG G, 2006, J GEOPHYS RES, V111, P1; Feldman GC, 2014, OCEAN COLOR WEB; Gan JP, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004660; Garrison T., 2007, OCEANOGRAPHY INVITAT; Gomez-Gesteira M, 2008, ANN NY ACAD SCI, V1146, P320, DOI 10.1196/annals.1446.004; Huang QZ, 1994, CEANOGRAPHY CHINA SE, V1, P39; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Jayaram Chiranjivi, 2010, Ocean Science Journal, V45, P27, DOI 10.1007/s12601-010-0003-6; Jing Z, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007142; Jing ZY, 2009, CONT SHELF RES, V29, P467, DOI 10.1016/j.csr.2008.11.008; Kok PH, 2015, CONT SHELF RES, V110, P1, DOI 10.1016/j.csr.2015.09.010; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Kuo NJ, 2000, REMOTE SENS ENVIRON, V74, P463, DOI 10.1016/S0034-4257(00)00138-3; Lehmann A, 2008, J MARINE SYST, V74, pS3, DOI 10.1016/j.jmarsys.2008.02.010; Mann KH, 2006, DYNAMICS MARINE ECOS; Morgan J.R., 1983, ATLAS MARINE POLICY, P4; *NOAA, 2006, 2 MIN GRIDD GLOB REL; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Perez-Santos I, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006292; Pickett MH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001902; Pohlmann T., 1987, 3 DIMENSIONAL MODELS, P245, DOI 10.1016/S0422-9894(08)70451-3; Pond S., 1983, INTRO DYNAMICAL OCEA; Roxy M, 2012, CLIM DYNAM, V39, P1209, DOI 10.1007/s00382-011-1118-x; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Segar D. A., 2007, INTRO OCEAN SCI; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; Taira K., 1996, MALAYS J OCEANOGR, V52, P251, DOI [10.1007/BF02235673, DOI 10.1007/BF02235673]; TALLEY L., 2011, DESCRIPTIVE PHYS OCE; Thurman H. V., 2004, INTRO OCEANOGRAPHY; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Wang D, 2012, J GEOPHYS RES, V117, P1; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Yoshida K., 1995, REC OCEANOGR WORKS J, V2, P8	59	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171979	10.1371/journal.pone.0171979	http://dx.doi.org/10.1371/journal.pone.0171979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187215	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300065
J	Shin, SS; Song, JH; Hwang, B; Noh, DH; Park, SL; Kim, WT; Park, SS; Kim, WJ; Moon, SK				Shin, Seung-Shick; Song, Jun-Hui; Hwang, Byungdoo; Noh, Dae-Hwa; Park, Sung Lyea; Kim, Won Tae; Park, Sung-Soo; Kim, Wun-Jae; Moon, Sung-Kwon			HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation	PLOS ONE			English	Article							UP-REGULATION; DIALLYL TRISULFIDE; EXPRESSION; GROWTH; ACTIVATION; APOPTOSIS; INACTIVATION; SUPPRESSES	Although recent studies have demonstrated the anti-tumor effects of garlic extract (GE), the exact molecular mechanism is still unclear. In this study, we investigated the molecular mechanism associated with the inhibitory action of GE against bladder cancer EJ cell responses. Treatment with GE significantly inhibited proliferation of EJ cells dose-dependently through G2/M-phase cell cycle arrest. This G2/M-phase cell cycle arrest by GE was due to the activation of ATM and CHK2, which appears to inhibit phosphorylation of Cdc25C (Ser216) and Cdc2 (Thr14/Tyr15), this in turn was accompanied by down-regulation of cyclin B1 and up-regulation of p21WAF1. Furthermore, GE treatment was also found to induce phosphorylation of MAPK (ERK1/2, p38MAPK, and JNK) and AKT. In addition, GE impeded the migration and invasion of EJ cells via inhibition of MMP-9 expression followed by decreased binding activities of AP-1, Sp-1, and NF-KB motifs. Based on microarray data sets, we selected Heat shock protein A6 (HSPA6) as the most up-regulated gene responsible for the inhibitory effects of GE. Interestingly, overexpression of HSPA6 gene resulted in an augmentation effect with GE inhibiting proliferation, migration, and invasion of EJ cells. The augmentation effect of HSPA6 was verified by enhancing the induction of G2/M-phasemediated ATM-CHK2-Cdc25C-p21WAF1-Cdc2 cascade, phosphorylation of MAPK and AKT signaling, and suppression of transcription factor-associated MMP-9 regulation in response to GE in EJ cells. Overall, our novel results indicate that HSPA6 reinforces the GE-mediated inhibitory effects of proliferation, migration, and invasion of EJ cells and may provide a new approach for therapeutic treatment of malignancies.	[Shin, Seung-Shick; Park, Sung-Soo] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju, South Korea; [Song, Jun-Hui; Hwang, Byungdoo; Noh, Dae-Hwa; Park, Sung Lyea; Moon, Sung-Kwon] Chung Ang Univ, Dept Food & Nutr, Anseong, South Korea; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Cheongju, Chungbuk, South Korea	Jeju National University; Chung Ang University; Chungbuk National University	Moon, SK (corresponding author), Chung Ang Univ, Dept Food & Nutr, Anseong, South Korea.	sumoon66@dreamwiz.com		Shin, Seung-Shick/0000-0002-8536-2056	National Research Foundation of Korea (NRF) - government of Korea (MSIP) [2014007036]	National Research Foundation of Korea (NRF) - government of Korea (MSIP)(National Research Foundation of Korea)	This study was supported by a National Research Foundation of Korea (NRF) grant by the government of Korea (MSIP) (no. 2014007036), http://www.nrf.re.kr/.	Bianco FJ, 1998, CLIN CANCER RES, V4, P3011; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Cho TM, 2014, FOOD CHEM TOXICOL, V64, P344, DOI 10.1016/j.fct.2013.12.009; Das A, 2007, CANCER-AM CANCER SOC, V110, P1083, DOI 10.1002/cncr.22888; DAVIES B, 1993, CANCER RES, V53, P5365; Dong MH, 2014, BIOMED REP, V2, P250, DOI 10.3892/br.2014.226; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Huang J, 2015, MOL NUTR FOOD RES, V59, P1063, DOI 10.1002/mnfr.201400668; IBERL B, 1990, PLANTA MED, V56, P320, DOI 10.1055/s-2006-961198; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khalouei S, 2014, CELL STRESS CHAPERON, V19, P321, DOI 10.1007/s12192-013-0459-2; Kim KH, 2013, INT J MOL MED, V32, P67, DOI 10.3892/ijmm.2013.1362; Lai KC, 2013, ENVIRON TOXICOL, V28, P479, DOI 10.1002/tox.20737; Lee SJ, 2013, J BIOL CHEM, V288, P5539, DOI 10.1074/jbc.M112.410233; Lee SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040267; Liu Y, 2015, J SENSORS, V2015, DOI 10.1155/2015/903981; Luke C, 2010, INTERN MED J, V40, P357, DOI 10.1111/j.1445-5994.2009.01980.x; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Qiu LH, 2006, ONCOL REP, V16, P907; Ramirez VP, 2015, CELL STRESS CHAPERON, V20, P95, DOI 10.1007/s12192-014-0529-0; Redondo-Gonzalez E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168682; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; SATO H, 1993, ONCOGENE, V8, P395; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Seiler R, 2011, J CLIN PATHOL, V64, P1078, DOI 10.1136/jclinpath-2011-200153; Suda S, 2014, BIOSCI BIOTECH BIOCH, V78, P1415, DOI 10.1080/09168451.2014.921563; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8	34	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171860	10.1371/journal.pone.0171860	http://dx.doi.org/10.1371/journal.pone.0171860			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187175	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300053
J	Ghosh, SKB; Hunter, WB; Park, AL; Gundersen-Rindal, DE				Ghosh, Saikat Kumar B.; Hunter, Wayne B.; Park, Alexis L.; Gundersen-Rindal, Dawn E.			Double strand RNA delivery system for plant-sap-feeding insects	PLOS ONE			English	Article							MARMORATED STINK BUG; GENETIC INTERFERENCE; RISK-ASSESSMENT; KNOCKDOWN; INGESTION; HEMIPTERA	Double-stranded RNA (dsRNA)-mediated gene silencing, also known as RNA interference (RNAi), has been a breakthrough technology for functional genomic studies and represents a potential tool for the management of insect pests. Since the inception of RNAi numerous studies documented successful introduction of exogenously synthesized dsRNA or siRNA into an organism triggering highly efficient gene silencing through the degradation of endogenous RNA homologous to the presented siRNA. Managing hemipteran insect pests, especially Halyomorpha halys (Stal) (Heteroptera: Pentatomidae), the brown marmorated stink bug (BMSB), is critical to food productivity. BMSB was recently introduced into North America where it is both an invasive agricultural pest of high value specialty, row, and staple crops, as well as an indoor nuisance pest. RNAi technology may serve as a viable tool to manage this voracious pest, but delivery of dsRNA to piercing-sucking insects has posed a tremendous challenge. Effective and practical use of RNAi as molecular biopesticides for biocontrol of insects like BMSB in the environment requires that dsRNAs be delivered in vivo through ingestion. Therefore, the key challenge for molecular biologists in developing insect-specific molecular biopesticides is to find effective and reliable methods for practical delivery of stable dsRNAs such as through oral ingestion. Here demonstrated is a reliable delivery system of effective insect-specific dsRNAs through oral feeding through a new delivery system to induce a significant decrease in expression of targeted genes such as JHAMT and Vg. This state-of-the-art delivery method overcomes environmental delivery challenges so that RNAi is induced through insect-specific dsRNAs orally delivered to hemipteran and other insect pests.	[Ghosh, Saikat Kumar B.; Park, Alexis L.; Gundersen-Rindal, Dawn E.] ARS, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Hunter, Wayne B.] ARS, USDA, Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), ARS, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.	dawn.gundersen-rindal@ars.usda.gov	hunter, wayne/AAB-9096-2020; Ghosh, Saikat/AAD-1176-2022	hunter, wayne/0000-0001-8603-3337; 				Allen ML, 2007, GENET MOL RES, V6, P206; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Anderson BE, 2012, DERMATITIS, V23, P170, DOI 10.1097/DER.0b013e318260d7be; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bachman PM, 2016, REGUL TOXICOL PHARM, V81, P77, DOI 10.1016/j.yrtph.2016.08.001; Bansal R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152730; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; De Andrade E., 2016, RNA INTERFERENCE; Doane CC, 1981, USDA TECHNICAL B; Dubelman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093155; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Hail D. A., 2010, P 10 ANN ZEBR CHIP R, P183; Hunter W.B., 2010, P S P 2010 PIERC DIS, P24; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Hunter WB, 2012, SOUTHWEST ENTOMOL, V37, P85, DOI 10.3958/059.037.0110; Ivashuta S, 2015, RNA, V21, P840, DOI 10.1261/rna.048116.114; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Kola VSR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00119; Kolliopoulou A, 2014, CURR OPIN INSECT SCI, V6, P28, DOI 10.1016/j.cois.2014.09.019; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mertz TL, 2012, J ALLERGY CLIN IMMUN, V130, P999, DOI 10.1016/j.jaci.2012.06.016; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Rodrigues T.B., 2016, MANAGEMENT INSECT PE; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Sparks ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111646; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; Xu JW, 2014, BIOL INVASIONS, V16, P153, DOI 10.1007/s10530-013-0510-3; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	56	44	45	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171861	10.1371/journal.pone.0171861	http://dx.doi.org/10.1371/journal.pone.0171861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182760	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800125
J	Li, DW; Fang, KY; Li, YJ; Chen, DL; Liu, XH; Dong, ZP; Zhou, FF; Guo, GY; Shi, F; Xu, CX; Li, YP				Li, Dawen; Fang, Keyan; Li, Yingjun; Chen, Deliang; Liu, Xiaohong; Dong, Zhipeng; Zhou, Feifei; Guo, Guoyang; Shi, Feng; Xu, Chenxi; Li, Yanping			Climate, intrinsic water-use efficiency and tree growth over the past 150 years in humid subtropical China	PLOS ONE			English	Article							SUMMER TEMPERATURE RECONSTRUCTION; CARBON-ISOTOPE DISCRIMINATION; ATMOSPHERIC CO2; ANNUAL PRECIPITATION; TIBETAN PLATEAU; RADIAL GROWTH; DELTA-C-13; RECORD; CELLULOSE; FORESTS	Influence of long-term changes in climate and CO2 concentration on intrinsic water-use efficiency (iWUE), defined as the ratio between net photosynthesis (A) and leaf conductance (g), and tree growth remain not fully revealed in humid subtropical China, which is distinct from other arid subtropical areas with dense coverage of broadleaf forests. This study presented the first tree-ring stable carbon isotope (delta C-13) and iWUE series of Pinus massoniana from 1865 to 2013 in Fujian province, humid subtropical China, and the first tree-ring width standard chronology during the period of 1836-2013 for the Niumulin Nature Reserve (NML). Tree-ring width growth was limited by precipitation in July-August (r = 0.40, p < 0.01). The tree-ring carbon isotope discrimination (Delta C-13) was mainly controlled by the sunshine hours (r = -0.66, p < 0.001) and relative humidity (r = 0.58, p < 0.001) in September-October, a season with rapid latewood formation in this area. The iWUE increased by 42.6% and the atmospheric CO2 concentration (c(a)) explained 92.6% of the iWUE variance over the last 150 years. The steady increase in iWUE suggests an active response with a proportional increase in intercellular CO2 concentration (c(i)) in response to increase in c(a). The contribution of iWUE to tree growth in the study region is not conspicuous, which points to influences of other factors such as climate.	[Li, Dawen; Fang, Keyan; Li, Yingjun; Dong, Zhipeng; Zhou, Feifei; Guo, Guoyang; Li, Yanping] Fujian Normal Univ, Coll Geog Sci, Inst Geog, Key Lab Humid Subtrop Ecogeog Proc,Minist Educ, Fuzhou, Peoples R China; [Fang, Keyan; Chen, Deliang] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden; [Liu, Xiaohong] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Lanzhou, Peoples R China; [Shi, Feng; Xu, Chenxi] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China	Fujian Normal University; University of Gothenburg; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Fang, KY (corresponding author), Fujian Normal Univ, Coll Geog Sci, Inst Geog, Key Lab Humid Subtrop Ecogeog Proc,Minist Educ, Fuzhou, Peoples R China.; Fang, KY (corresponding author), Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden.	kujanfang@gmail.com	Chen, Deliang/A-5107-2013; Xu, Chenxi/AAI-2686-2020; dong, zhipeng/AFN-4971-2022	Chen, Deliang/0000-0003-0288-5618; Xu, Chenxi/0000-0001-7747-0033; 	National Natural Science Foundation of China [41471172, U1405231]; Fellowship for Distinguished Young Scholars of Fujian Province [2015J06008]; Minjiang Special-term Professor fellowship; Biodiversity and Ecosystem Services in a Changing Climate of Sweden; Swedish Foundation for International Cooperation in Research and Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fellowship for Distinguished Young Scholars of Fujian Province; Minjiang Special-term Professor fellowship; Biodiversity and Ecosystem Services in a Changing Climate of Sweden; Swedish Foundation for International Cooperation in Research and Higher Education	This research is funded by the National Natural Science Foundation of China (41471172 and U1405231) (http://www.nsfc.gov.cn/), the Fellowship for Distinguished Young Scholars of Fujian Province (2015J06008) and the Minjiang Special-term Professor fellowship. Support from Biodiversity and Ecosystem Services in a Changing Climate of Sweden (http://www.becc.lu.se/) and the Swedish Foundation for International Cooperation in Research and Higher Education (http://www. stint.se/en/scholarships_and_grants/initiation_ grants) are also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Chen D, 2016, SCI CHINA EARTH SCI, V59, P328, DOI 10.1007/s11430-015-5188-1; Chen F, 2012, INT J CLIMATOL, V32, P1089, DOI 10.1002/joc.2327; Chen F, 2012, THEOR APPL CLIMATOL, V109, P141, DOI 10.1007/s00704-011-0563-0; Cook E. R., 1985, TIME SERIES ANAL APP; Cook ER, 2013, CLIM DYNAM, P1; COPLEN TB, 1995, NATURE, V375, P285, DOI 10.1038/375285a0; DARRALL NM, 1989, PLANT CELL ENVIRON, V12, P1, DOI 10.1111/j.1365-3040.1989.tb01913.x; Duan JP, 2013, J CLIMATE, V26, P4749, DOI 10.1175/JCLI-D-12-00332.1; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; EHLERINGER JR, 1995, TREE PHYSIOL, V15, P105, DOI 10.1093/treephys/15.2.105; Fang KY, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034010; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Feng XH, 1998, OECOLOGIA, V117, P19, DOI 10.1007/s004420050626; Feng XH, 1999, GEOCHIM COSMOCHIM AC, V63, P1891, DOI 10.1016/S0016-7037(99)00088-5; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Frank DC, 2015, NAT CLIM CHANGE, V5, P579, DOI 10.1038/nclimate2614; Fritts H. C., 1976, TREE RING CLIMATE; Gagen M, 2007, HOLOCENE, V17, P435, DOI 10.1177/0959683607077012; Gou XH, 2010, CHINESE SCI BULL, V55, P4179, DOI 10.1007/s11434-010-4215-z; Green JW, 1963, METHODS CARBOHYDRATE, P9; Hafner P, 2014, CLIM DYNAM, V43, P971, DOI 10.1007/s00382-013-1864-z; Haupt M, 2011, CLIMATIC CHANGE, V105, P243, DOI [10.1007/s10584-010-9862-1, 10.1007/S10584-010-9862-1]; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Laumer W, 2009, RAPID COMMUN MASS SP, V23, P1934, DOI 10.1002/rcm.4105; Leavitt SW, 2008, CHEM GEOL, V252, P52, DOI 10.1016/j.chemgeo.2008.01.014; Levesque M, 2014, NEW PHYTOL, V203, P94, DOI 10.1111/nph.12772; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li Y, 2016, CLIMATE RES, V67; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu XH, 2014, TREE PHYSIOL, V34, P966, DOI 10.1093/treephys/tpu067; Liu XH, 2012, CHEM GEOL, V291, P104, DOI 10.1016/j.chemgeo.2011.10.001; Liu Y, 2014, QUATERNARY SCI REV, V93, P67, DOI 10.1016/j.quascirev.2014.03.023; Loader NJ, 2007, TERR ECOL SER, V1, P27; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Luo Y, 1996, GLOBAL BIOGEOCHEMICA, V10, P1287; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Sleen PVD, 2015, BIOMATERIALS, V8, P5221; Stocks MA, 1968, INTRO TREE RING DATI; Tei S, 2014, POLAR SCI, V8, P183, DOI 10.1016/j.polar.2013.12.002; Wang WZ, 2012, FOREST ECOL MANAG, V275, P14, DOI 10.1016/j.foreco.2012.02.027; Waterhouse JS, 2004, QUATERNARY SCI REV, V23, P803, DOI 10.1016/j.quascirev.2003.06.011; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wright WE, 2014, CLIM DYNAM, V44, P1645; Wu G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00198; Xu C, 2013, J GEOPHYS RES ATMOSP; Xu GB, 2013, TREES-STRUCT FUNCT, V27, P465, DOI 10.1007/s00468-013-0855-3; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Young GHF, 2010, HOLOCENE, V20, P315, DOI 10.1177/0959683609351902; [俞亚勋 Yu Yaxun], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P149; Zhang QB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9062; Zhang Y., 2016, J SUBTROPICAL RESOUR, V11, P59	65	21	24	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172045	10.1371/journal.pone.0172045	http://dx.doi.org/10.1371/journal.pone.0172045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182751	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800146
J	Wang, H; Zhang, X; Liu, QH; Liu, XC; Ding, SX				Wang, Huan; Zhang, Xiang; Liu, Qiaohong; Liu, Xiaochun; Ding, Shaoxiong			Selection and evaluation of new reference genes for RT-qPCR analysis in Epinephelus akaara based on transcriptome data	PLOS ONE			English	Article							REAL-TIME PCR; ORANGE-SPOTTED GROUPER; POTENTIAL REFERENCE GENES; POLYMERASE-CHAIN-REACTION; SUITABLE REFERENCE GENES; CELL LUNG-CANCER; BETA-ACTIN; ABSOLUTE QUANTIFICATION; EXPRESSION PATTERN; MOLECULAR ANALYSIS	Groupers are an economically important fish species in world fishery markets. Because many studies using RT-qPCR have addressed gene expression in groupers, appropriate reference genes are required to obtain reliable and accurate results. In this study, the most suitable reference genes were identified from eleven candidate genes of one of the most valuable species, Epinephelus akaara, in a range of different experimental conditions. Using the software packages geNorm, NormFinder, BestKeeper and refFinder, three traditionally used reference genes, beta-actin (beta-ACT), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and beta-2-microglobulin (B2M), were identified as not suitable for E. akaara gene expression studies, whereas two newly identified reference genes, conserved oligomeric Golgi complex subunit 5 (Cog5) and brefeldin a-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1), could be universally applied under all the tested conditions. These data provide the foundation for more precise results in RT-qPCR studies of gene expression in E. akaara and other Epinephelus species.	[Wang, Huan; Zhang, Xiang; Liu, Qiaohong; Ding, Shaoxiong] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Wang, Huan; Zhang, Xiang; Liu, Qiaohong; Ding, Shaoxiong] Xiamen Univ, Coll Ocean & Earth Sci, State Prov Joint Engn Lab Marine Bioprod & Techno, Xiamen, Fujian, Peoples R China; [Liu, Xiaochun] Sun Yat Sen Univ, Inst Aquat Econ Anim, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Liu, Xiaochun] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China	Xiamen University; Xiamen University; Sun Yat Sen University; Sun Yat Sen University	Ding, SX (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.; Ding, SX (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Prov Joint Engn Lab Marine Bioprod & Techno, Xiamen, Fujian, Peoples R China.	sxding@xmu.edu.cn			National Basic Research Special Foundation of China [2013FY110700]; Guangdong province [U1401213]; National Natural Science Foundation of China [U1401213]; Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang [20160108]	National Basic Research Special Foundation of China; Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang	This work was supported by the National Basic Research Special Foundation of China (2013FY110700), the Joint Fund of Guangdong province and the National Natural Science Foundation of China (U1401213), and the Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang (No. 20160108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Bentzien F, 2013, THYROID, V23, P1569, DOI 10.1089/thy.2013.0137; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; EGIDIUS E, 1987, AQUACULTURE, V67, P15, DOI 10.1016/0044-8486(87)90004-4; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Gracia-Lopez V, 2004, AQUACULTURE, V237, P485, DOI 10.1016/j.aquaculture.2004.04.018; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Huang XN, 2016, GENE, V576, P79, DOI 10.1016/j.gene.2015.09.066; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huntsman Gene R., 1994, North American Journal of Fisheries Management, V14, P41, DOI 10.1577/1548-8675(1994)014<0041:SOTIOF>2.3.CO;2; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Kohno H, 1997, ICHTHYOL RES, V44, P267, DOI 10.1007/BF02678706; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Lim L. C., 1993, Journal of the World Aquaculture Society, V24, P262, DOI 10.1111/j.1749-7345.1993.tb00015.x; Liu M, 2016, J FISH BIOL, V88, P1598, DOI 10.1111/jfb.12936; Liu MC, 2014, GENES GENOM, V36, P573, DOI 10.1007/s13258-014-0193-x; Liu QY, 2012, COMP BIOCHEM PHYS B, V163, P86, DOI 10.1016/j.cbpb.2012.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YS, 2010, AQUACULTURE, V306, P322, DOI 10.1016/j.aquaculture.2010.06.019; Ma KY, 2016, MOL PHYLOGENET EVOL, V100, P21, DOI 10.1016/j.ympev.2016.02.012; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060758; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pierre S, 2008, AQUAT CONSERV, V18, P297, DOI 10.1002/aqc.840; Purohit GK, 2015, FISH PHYSL BIOCH; Rasheed V.M., 1989, Journal of Aquatic Animal Health, V1, P102, DOI 10.1577/1548-8667(1989)001&lt;0102:DOCBSG&gt;2.3.CO;2; Rodrigues P N, 1998, Dev Immunol, V5, P263, DOI 10.1155/1998/15984; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tang XC, 2008, GEN COMP ENDOCR, V159, P117, DOI 10.1016/j.ygcen.2008.08.015; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yin ZX, 2006, AQUACULTURE, V253, P204, DOI 10.1016/j.aquaculture.2005.10.002; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zhang J, 2013, VET IMMUNOL IMMUNOP, V152, P303, DOI 10.1016/j.vetimm.2012.12.018; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhuang HH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00475	64	22	26	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171646	10.1371/journal.pone.0171646	http://dx.doi.org/10.1371/journal.pone.0171646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182746	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800083
J	Kahende, J; Malarcher, A; England, L; Zhang, L; Mowery, P; Xu, X; Sevilimedu, V; Rolle, I				Kahende, Jennifer; Malarcher, Ann; England, Lucinda; Zhang, Lei; Mowery, Paul; Xu, Xin; Sevilimedu, Varadan; Rolle, Italia			Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; COVERAGE; SMOKERS; IMPACT; AIDS	Objective To assess state coverage and utilization of Medicaid smoking cessation medication benefits among fee-for-service enrollees who smoked cigarettes. Methods We used the linked National Health Interview Survey (survey years 1995, 1997 - 2005) and the Medicaid Analytic eXtract files (1999 - 2008) to assess utilization of smoking cessation medication benefits among 5,982 cigarette smokers aged 18 - 64 years enrolled in Medicaid fee-for-service whose state Medicaid insurance covered at least one cessation medication. We excluded visits during pregnancy, and those covered by managed care or under dual enrollment (Medicaid and Medicare). Multivariate logistic regression was used to determine correlates of cessation medication benefit utilization among Medicaid fee-for-service enrollees, including measures of drug coverage (comprehensive cessation medication coverage, number of medications in state benefit, varenicline coverage), individual-level demographics at NHIS interview, age at Medicaid enrollment, and state-level cigarette excise taxes, statewide smoke-free laws, and per-capita tobacco control funding. Results In 1999, the percent of smokers with >= 1 medication claims was 5.7% in the 30 states that covered at least one Food and Drug Administration (FDA)-approved cessation medication; this increased to 9.9% in 2008 in the 44 states that covered at least one FDA-approved medication (p < 0.01). Cessation medication utilization was greater among older individuals ( >= 25 years), females, non-Hispanic whites, and those with higher educational attainment. Comprehensive coverage, the number of smoking cessation medications covered and varenicline coverage were all positively associated with utilization; cigarette excise tax and percapita tobacco control funding were also positively associated with utilization. Conclusions Utilization of medication benefits among fee-for-service Medicaid enrollees increased from 1999 - 2008 and varied by individual and state-level characteristics. Given that the Affordable Care Act bars state Medicaid programs from excluding any FDA-approved cessation medications from coverage as of January 2014, monitoring Medicaid cessation medication claims may be beneficial for informing efforts to increase utilization and maximize smoking cessation.	[Kahende, Jennifer; Malarcher, Ann; England, Lucinda; Zhang, Lei; Xu, Xin; Rolle, Italia] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Mowery, Paul; Sevilimedu, Varadan] Biostatistics Inc, Sarasota, FL USA	Centers for Disease Control & Prevention - USA	Kahende, J (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	izk7@cdc.gov	Sevilimedu, Varadan/AHD-5676-2022	Xu, Xin/0000-0002-5219-499X	Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion [4157-026]; Biostatistics, Inc.	Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion; Biostatistics, Inc.	The Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion provided funding for this project (contract 4157-026). Through this funding, Biostatistics, Inc. served as a contractor to CDC for this project and did not provide any funding for the project. Biostatistics, Inc. provided support in the form of salaries for authors Paul Mowery and Varadan Sevilimedu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association, 2008, TOB POL TREND REP HE; Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Blackwell DL, 2012, VITAL HLTH STAT, V10, P1; Bondy SJ, 2012, CHRON DIS INJ CAN, V33, P19; Bush T, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/314740; Carpenter MJ, 2011, J NATL MED ASSOC, V103, P885, DOI 10.1016/S0027-9684(15)30444-2; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P1199; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1194; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P117; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P54; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P496; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P979; Centers for Medicare and Medicaid Services, 2014, MED MAN CAR ENR REP; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; Community Preventive Services Task Force, GUID COMM PREV SERV; Cook-Shimanek M, 2013, NICOTINE TOB RES, V15, P1926, DOI 10.1093/ntr/ntt085; Curry SJ, 2007, AM J PUBLIC HEALTH, V97, P1464, DOI 10.2105/AJPH.2006.103788; Fiore MC, 2008, TREATING TOBACCO USE; Frieden Thomas R, 2012, MMWR Suppl, V61, P1; Fu SS, 2005, AM J HEALTH PROMOT, V20, P108, DOI 10.4278/0890-1171-20.2.108; Fu SS, 2007, PREV MED, V44, P235, DOI 10.1016/j.ypmed.2006.11.002; Greene J, 2014, AM J PREV MED, V46, P331, DOI 10.1016/j.amepre.2013.11.019; Guide to Community Preventive Services, 2012, RED TOB US SEC SMOK; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Kotz D, 2009, ADDICTION, V104, P1403, DOI 10.1111/j.1360-0443.2009.02639.x; Ku L, 2016, HEALTH AFFAIR, V35, P62, DOI 10.1377/hlthaff.2015.0756; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; Levinson AH, 2004, AM J PREV MED, V26, P105, DOI 10.1016/j.amepre.2003.10.012; Li CH, 2012, AM J PREV MED, V42, P588, DOI 10.1016/j.amepre.2012.02.018; Liu F, 2010, PUBLIC HEALTH, V124, P553, DOI 10.1016/j.puhe.2010.05.015; McMenamin SB, 2006, AM J PREV MED, V31, P369, DOI 10.1016/j.amepre.2006.07.015; Metzger KB, 2005, AM J PUBLIC HEALTH, V95, P1050, DOI 10.2105/AJPH.2004.048025; O'Hara B, 2012, CURR POPUL REP, V2012, P70; Orzechowski W, 2007, TAX BURDEN TOBACCO H; Shiffman S, 2008, DRUG ALCOHOL DEPEN, V93, P121, DOI 10.1016/j.drugalcdep.2007.09.005; Simon AE, 2014, DOCUMENTATION ANAL G; Singleterry J, 2015, MMWR-MORBID MORTAL W, V64, P1194, DOI 10.15585/mmwr.mm6442a3; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; US Department of Health and Human Services, 2011, HLTH PEOPL 2020; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170381	10.1371/journal.pone.0170381	http://dx.doi.org/10.1371/journal.pone.0170381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207744	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500010
J	Kobayashi, T; Honjo, K; Eshak, ES; Iso, H; Sawada, N; Tsugane, S				Kobayashi, Tomoko; Honjo, Kaori; Eshak, Ehab Salah; Iso, Hiroyasu; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr-Based Prospe	Work-family conflict and self-rated health among Japanese workers: How household income modifies associations	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; PRESCHOOL-CHILDREN; FINLAND; WOMEN; MEN; PERSPECTIVE; DISORDERS; MORTALITY; EMPLOYEES; ROLES	To examine associations between work-family conflict and self-rated health among Japanese workers and to determine whether the associations differed by household income. Data was derived from the Japan Public Health Center-based Prospective Study for the Next Generation in Saku area in 2011-2012 (7,663 men and 7,070 women). Multivariate odds ratios (ORs) and 95% confidence intervals (CIs) for poor self-rated health by work -family conflict consisting of two dimensions (work-to-family and family-to-work conflicts) were calculated by gender and household income. Multivariate ORs of high work-to-family and family-to-work conflicts for poor self-rated health were 2.46 (95% CI; 2.04 - 2.97) for men and 3.54 (95% CI; 2.92 - 4.30) for women, with reference to the low work-to-family and family-to-work conflicts (p-value for gender interaction = 0.02). Subgroup analysis indicated that health effects of work - family conflict were likely to be more evident in the low income group only among women. Work - family conflict was associated with poor self-rated health among middle-aged Japanese men and women; its health impact was relatively stronger among women, and particularly economically disadvantaged women.	[Kobayashi, Tomoko; Honjo, Kaori; Eshak, Ehab Salah; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Osaka, Japan; [Eshak, Ehab Salah] Menia Univ, Dept Publ Hlth & Prevent Med, Al Minya, Egypt; [Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Tokyo, Japan	Osaka University; Egyptian Knowledge Bank (EKB); Minia University; National Cancer Center - Japan	Iso, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Osaka, Japan.	iso@pbhel.med.osaka-u.ac.jp	Tsugane, Shoichiro/A-2424-2015	Tsugane, Shoichiro/0000-0003-4105-2774; Eshak, Ehab/0000-0002-3564-1938	Grants-in-Aid for Scientific Research [17K09109] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Atkinson AB, 1995, INCOME DISTRIBUTION; Chandola T, 2004, INT J EPIDEMIOL, V33, P884, DOI 10.1093/ije/dyh155; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Emsile C, 2004, INT J BEHAV MED, V11, P127, DOI 10.1207/s15327558ijbm1103_1; Frone M R, 1996, J Occup Health Psychol, V1, P57, DOI 10.1037/1076-8998.1.1.57; Frone MR, 2000, J APPL PSYCHOL, V85, P888, DOI 10.1037//0021-9010.85.6.888; Fujita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151690; Fukuda Y, 2012, BIOSCI TRENDS, V6, P176, DOI 10.5582/bst.2012.v6.4.176; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Griep RH, 2016, INT J BEHAV MED, V23, P372, DOI 10.1007/s12529-015-9523-x; Grzywacz J G, 2000, J Occup Health Psychol, V5, P111, DOI 10.1037/1076-8998.5.1.111; Honjo K, 2011, EUR J EPIDEMIOL, V26, P13, DOI 10.1007/s10654-010-9515-8; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jesse SM, 2011, J ORGAN BEHAV, V32, P689; Kristin B., 2005, J VOCAT BEHAV, V67, P169; Lallukka T, 2014, INT J BEHAV MED, V21, P310, DOI 10.1007/s12529-013-9301-6; Lallukka T, 2013, SOC SCI MED, V79, P66, DOI 10.1016/j.socscimed.2012.05.011; Lallukka T, 2010, INT J BEHAV MED, V17, P134, DOI 10.1007/s12529-009-9050-8; Leineweber C, 2013, EUR J PUBLIC HEALTH, V23, P710, DOI 10.1093/eurpub/cks064; Mihelic K, 2014, INT J MANAGEMENT INF, V18, P15; Nelson CC, 2012, AM J PUBLIC HEALTH, V102, P1767, DOI 10.2105/AJPH.2011.300413; Roos E, 2006, DRUG ALCOHOL DEPEN, V83, P49, DOI 10.1016/j.drugalcdep.2005.10.009; Sekine M, 2010, SOC SCI MED, V71, P2091, DOI 10.1016/j.socscimed.2010.09.031; Shimazu A, 2013, J OCCUP HEALTH, V55, P234, DOI 10.1539/joh.12-0252-OA; Statistics Bureau Ministry of Internal Affairs and Communications, SURV TIM US LEIS ACT; Tsutsui J, 2014, JAPANESE J LABOUR ST, V648, P70; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Wang JL, 2007, AM J IND MED, V50, P143, DOI 10.1002/ajim.20428; Watai I, 2008, J OCCUP HEALTH, V50, P317, DOI 10.1539/joh.L7124; Winter T, 2006, INT J BEHAV MED, V13, P276, DOI 10.1207/s15327558ijbm1304_2	31	13	14	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169903	10.1371/journal.pone.0169903	http://dx.doi.org/10.1371/journal.pone.0169903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207757	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500006
J	Tomlekova, NB; White, PJ; Thompson, JA; Penchev, EA; Nielen, S				Tomlekova, Nasya B.; White, Philip J.; Thompson, Jacqueline A.; Penchev, Emil A.; Nielen, Stephan			Mutation increasing beta-carotene concentrations does not adversely affect concentrations of essential mineral elements in pepper fruit	PLOS ONE			English	Article							CAPSICUM-ANNUUM; GREEN-PEPPER; VARIETIES; ACCUMULATION; PROVITAMIN; CULTIVARS; COLORS; COPPER; CROPS; IRON	Vitamin and mineral deficiencies are prevalent in human populations throughout the world. Vitamin A deficiency affects hundreds of millions of pre-school age children in low income countries. Fruits of pepper (Capsicum annuum L.) can be a major dietary source of precursors to Vitamin A biosynthesis, such as beta-carotene. Recently, pepper breeding programs have introduced the orange-fruited (ot) trait of the mutant variety Oranzheva kapiya, which is associated with high fruit beta-carotene concentrations, to the mutant variety Albena. In this manuscript, concentrations of beta-carotene and mineral elements (magnesium, phosphorus, sulphur, potassium, zinc, calcium, manganese, iron and copper) were compared in fruit from P31, a red-fruited genotype derived from the variety Albena, and M38, a genotype developed by transferring the orange-fruited mutation (ot) into Albena. It was observed that fruit from M38 plants had greater beta-carotene concentration at both commercial and botanical maturity (4.9 and 52.7 mg /kg fresh weight, respectively) than fruit from P31 plants (2.3 and 30.1 mg /kg fresh weight, respectively). The mutation producing high beta-carotene concentrations in pepper fruits had no detrimental effect on the concentrations of mineral elements required for human nutrition.	[Tomlekova, Nasya B.] Maritsa Vegetable Crops Res Inst, Dept Breeding Variety Maintenance & Introduct, Plovdiv, Bulgaria; [White, Philip J.; Thompson, Jacqueline A.] James Hutton Inst, Dept Ecol Sci, Dundee, Scotland; [Penchev, Emil A.] Dobroudja Agr Inst, Dept Breeding, General Toshevo, Bulgaria; [Nielen, Stephan] IAEA, Vienna Int Ctr, Joint FAO IAEA Div, Vienna, Austria	Agricultural Academy - Bulgaria; James Hutton Institute; Agricultural Academy - Bulgaria; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Tomlekova, NB (corresponding author), Maritsa Vegetable Crops Res Inst, Dept Breeding Variety Maintenance & Introduct, Plovdiv, Bulgaria.	nasia.tomlekova@gmail.com	White, Philip John/C-5860-2008	White, Philip John/0000-0003-0827-288X; Tomlekova, Nasya/0000-0003-0965-170X	IAEA Coordinated Research Project [CRP15406, D23028]; Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	IAEA Coordinated Research Project(International Atomic Energy Agency); Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	This work was conducted in the IAEA Coordinated Research Project D23028 under the research contract CRP15406 (NBT, EAP, SN). This work was supported by the Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government (PJW, JAT).	Bates B., NATL DIET NUTR SURVE; Bernardo A, 2008, J FOOD QUALITY, V31, P701, DOI 10.1111/j.1745-4557.2008.00229.x; Biehler E, 2012, J FOOD COMPOS ANAL, V25, P56, DOI 10.1016/j.jfca.2011.07.005; Bohn T, 2008, CURR NUTR FOOD SCI, V4, P240, DOI 10.2174/157340108786263685; Chaiter Y, 2007, INT J VITAM NUTR RES, V77, P398, DOI 10.1024/0300-9831.77.6.398; Daskalov S., 1992, Mutation Breeding Newsletter, P9; Daskalov S., 1991, Capsicum Newsletter, P13; Daskalov S, 1995, P 9 EUC M GEN BREED, P24; Daskalov S, 1975, HORTICULTURE, V12, P22; Department of Health UK Dietary reference values for food energy and nutrients for the United Kingdom, 1991, UK DIET REF VAL FOOD; Esayas K, 2011, B CHEM SOC ETHIOPIA, V25, P451; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; Guzman I, 2010, PLANT SCI, V179, P49, DOI 10.1016/j.plantsci.2010.04.014; Ha SH, 2007, J EXP BOT, V58, P3135, DOI 10.1093/jxb/erm132; Holland B, 1991, VEGETABLES HERBS SPI; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Hulshof PJM, 1997, J AGR FOOD CHEM, V45, P1174, DOI 10.1021/jf9603137; Jadczak D, 2010, J ELEMENTOL, V15, P509, DOI 10.5601/jelem.2010.15.3.509-515; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; Vera-Guzman AM, 2011, CHIL J AGR RES, V71, P578, DOI 10.4067/S0718-58392011000400013; O'Neill ME, 2001, BRIT J NUTR, V85, P499, DOI 10.1079/BJN2000284; Park H, 2006, NUTR RES, V26, P546, DOI 10.1016/j.nutres.2006.09.001; Periago MJ, 2004, J AGR FOOD CHEM, V52, P5796, DOI 10.1021/jf049345h; Petrov V, 2013, CR ACAD BULG SCI, V66, P303; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; Rubio C, 2002, EUR FOOD RES TECHNOL, V214, P501, DOI 10.1007/s00217-002-0534-x; Simonne A. H., 1997, Journal of Food Composition and Analysis, V10, P299, DOI 10.1006/jfca.1997.0544; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Subramanian NK, 2011, ANN BOT-LONDON, V107, P681, DOI 10.1093/aob/mcr009; Timina OO, 2011, VAVILOV J GENETICS B, V15, P585; Todorova V, 2009, ACTA HORTIC, V830, P297, DOI 10.17660/ActaHortic.2009.830.42; Tomlekova N., 2009, Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008, P187; Tomlekova NB, 2009, ACTA HORTIC, V830, P205; Tomlekova N. B., 2010, Plant Mutation Reports, V2, P4; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; United States Department of Agriculture, 2007, AGR RES SERV USDA AR; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wall MM, 2001, HORTSCIENCE, V36, P746, DOI 10.21273/HORTSCI.36.4.746; West K. P. Jr., 2003, Food and Nutrition Bulletin, V24, pS78; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; White PJ, 2005, J HORTIC SCI BIOTECH, V80, P660, DOI 10.1080/14620316.2005.11511995; World Health Organization (WHO), 2009, GLOB PREV VIT DEF PO	43	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172180	10.1371/journal.pone.0172180	http://dx.doi.org/10.1371/journal.pone.0172180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207797	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500093
J	Hagemann, N; Kammann, CI; Schmidt, HP; Kappler, A; Behrens, S				Hagemann, Nikolas; Kammann, Claudia I.; Schmidt, Hans-Peter; Kappler, Andreas; Behrens, Sebastian			Nitrate capture and slow release in biochar amended compost and soil	PLOS ONE			English	Article							SUSTAINABLE AGRICULTURE; ABIOTIC IMMOBILIZATION; ORGANIC NITROGEN; TRANSFORMATION; MECHANISMS; ADSORPTION; AMENDMENTS; SORPTION; YIELD; MODEL	Slow release of nitrate by charred organic matter used as a soil amendment (i. e. biochar) was recently suggested as potential mechanism of nutrient delivery to plants which may explain some agronomic benefits of biochar. So far, isolated soil-aged and composted biochar particles were shown to release considerable amounts of nitrate only in extended (>1 h) extractions ("slow release"). In this study, we quantified nitrate and ammonium release by biochar-amended soil and compost during up to 167 h of repeated extractions in up to six consecutive steps to determine the effect of biochar on the overall mineral nitrogen retention. We used composts produced from mixed manures amended with three contrasting biochars prior to aerobic composting and a loamy soil that was amended with biochar three years prior to analysis and compared both to non-biochar amended controls. Composts were extracted with 2 M KCl at 22 degrees C and 65 degrees C, after sterilization, after treatment with H2O2, after removing biochar particles or without any modification. Soils were extracted with 2 M KCl at 22 degrees C. Ammonium was continuously released during the extractions, independent of biochar amendment and is probably the result of abiotic ammonification. For the pure compost, nitrate extraction was complete after 1 h, while from biochar-amended composts, up to 30% of total nitrate extracted was only released during subsequent extraction steps. The loamy soil released 70% of its total nitrate amount in subsequent extractions, the biochar-amended soil 58%. However, biochar amendment doubled the amount of total extractable nitrate. Thus, biochar nitrate capture can be a relevant contribution to the overall nitrate retention in agroecosystems. Our results also indicate that the total nitrate amount in biochar amended soils and composts may frequently be underestimated. Furthermore, biochars could prevent nitrate loss from agroecosystems and may be developed into slow-release fertilizers to reduce global N fertilizer demands.	[Hagemann, Nikolas; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, Tubingen, Germany; [Kammann, Claudia I.] Hsch Geisenheim Univ, Dept Soil Sci & Plant Nutr, Working Grp Climate Change Res Special Crops, Geisenheim, Germany; [Schmidt, Hans-Peter] Ithaka Inst Carbon Strategies, Ancienne Eglise 9, Arbaz, Switzerland; [Behrens, Sebastian] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA; [Behrens, Sebastian] Inst Biotechnol, 140 Gortner Labs,1479 Gortner Ave, St Paul, MN 55108 USA	Eberhard Karls University of Tubingen; University of Minnesota System; University of Minnesota Twin Cities	Hagemann, N (corresponding author), Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, Tubingen, Germany.; Behrens, S (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA.; Behrens, S (corresponding author), Inst Biotechnol, 140 Gortner Labs,1479 Gortner Ave, St Paul, MN 55108 USA.	nikolas@hagemann.at; sbehrens@umn.edu	Hagemann, Nikolas/AAI-1379-2019; Schmidt, Hans Peter/AAJ-1031-2020; Kammann, Claudia/GSD-6286-2022	Hagemann, Nikolas/0000-0001-8005-9392; Schmidt, Hans Peter/0000-0001-8275-7506; Kappler, Andreas/0000-0002-3558-9500	BMBF PhD scholarship - Rosa Luxemburg Foundation, Berlin, Germany; EU COST Action [TD1107]; DFG [KA-3442/1-1]	BMBF PhD scholarship - Rosa Luxemburg Foundation, Berlin, Germany(Federal Ministry of Education & Research (BMBF)); EU COST Action(European Cooperation in Science and Technology (COST)European Commission); DFG(German Research Foundation (DFG))	NH was financially supported by a BMBF PhD scholarship provided by the Rosa Luxemburg Foundation, Berlin, Germany. The composts used in this experiments were produced during a Short Term Scientific Mission (STSM) granted to NH by EU COST Action TD1107 Biochar as option for sustainable resource management. CK gratefully acknowledges DFG grant KA-3442/1-1 and the FACCE-JPI project "DesignerChar4Food" that enabled her to work on nitrate capture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen, 1847, BRIEF COMPEND AM AGR, DOI 10.5962/bhl.title.20151; Alling V, 2014, J PLANT NUTR SOIL SC, V177, P671, DOI 10.1002/jpln.201400109; Angst TE, 2013, J ENVIRON QUAL, V42, P672, DOI 10.2134/jeq2012.0341; Bhardwaj D, 2012, J HAZARD MATER, V227, P292, DOI 10.1016/j.jhazmat.2012.05.058; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Conte P, 2014, J AGR FOOD CHEM, V62, P4917, DOI 10.1021/jf5010034; Conte P, 2013, GCB BIOENERGY, V5, P116, DOI 10.1111/gcbb.12009; Cordovil CMDS, 2007, COMMUN SOIL SCI PLAN, V38, P989, DOI 10.1080/00103620701278088; Cornelissen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154617; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Curtin D, 2008, SOIL SAMPLING METHOD, P599; Dail DB, 2001, BIOGEOCHEMISTRY, V54, P131, DOI 10.1023/A:1010627431722; Davidson EA, 2003, GLOBAL CHANGE BIOL, V9, P228, DOI 10.1046/j.1365-2486.2003.00592.x; Davidson EA, 2008, BIOGEOCHEMISTRY, V90, P65, DOI 10.1007/s10533-008-9231-6; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; de Vries W, 2013, CURR OPIN ENV SUST, V5, P392, DOI 10.1016/j.cosust.2013.07.004; Dempster DN, 2012, SOIL RES, V50, P216, DOI 10.1071/SR11316; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eklind Y, 2000, BIORESOURCE TECHNOL, V74, P125, DOI 10.1016/S0960-8524(00)00005-5; European Biochar Foundation, 2012, GUID SUST PROD BIOCH; Fischer D, 2012, MANAGEMENT ORGANIC W, P1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2007, PHILOS T R SOC B, V362, P187, DOI 10.1098/rstb.2006.1978; Haber F, 1934, P ROYAL SOC LOND MAT; Hagemann N, 2016, BIOCHAR APPLICATION: ESSENTIAL SOIL MICROBIAL ECOLOGY, P163, DOI 10.1016/B978-0-12-803433-0.00007-2; Hagemann N, EXTENT KINETICS NITR; Haider G, J ENV QUALI IN PRESS, V45; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P10641, DOI 10.1021/es302971d; Hilber I, 2012, J AGR FOOD CHEM, V60, P3042, DOI 10.1021/jf205278v; Jeffery S., 2015, BIOCHAR ENV MANAGEME, V2nd, DOI [10.4324/9780203762264, DOI 10.1016/J.ECOLENG.2012.01.016]; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Kammann C., 2016, BIOCHAR EUROPEAN SOI, P136, DOI DOI 10.4324/9781315884462; Kammann CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11080; Klucakova M, 2010, ENVIRON CHEM LETT, V8, P145, DOI 10.1007/s10311-009-0201-6; Komarneni S, 2003, J POROUS MAT, V10, P243, DOI 10.1023/B:JOPO.0000011385.19108.49; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Laird D., 2015, BIOCHAR ENV MANAGEME, V2, P521; Lehmann J, 2015, BIOCHAR ENV MANAGEME, P235, DOI DOI 10.4324/9780203762264; Maynard DG, 1993, SOIL SAMPLING METHOD, P97; McLean W, 1931, J AGR SCI, V21, P251, DOI 10.1017/S0021859600008662; Pignatello J. J., 2015, BIOCHAR ENV MANAGEME, P195, DOI DOI 10.4324/9780203762264; Prost K, 2013, J ENVIRON QUAL, V42, P164, DOI 10.2134/jeq2012.0064; Schmidt H.-P., 2014, BIOCHAR J, V1, P14; Schmidt HP, 2015, AGRICULTURE-BASEL, V5, P723, DOI 10.3390/agriculture5030723; Sehn W, 2010, BWK-ENERGIE-FACHMAG, V62, P55; Spokas KA, 2014, ENVIRON SCI TECH LET, V1, P326, DOI 10.1021/ez500199t; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tani M, 2004, SOIL SCI PLANT NUTR, V50, P439, DOI 10.1080/00380768.2004.10408498; TRYON EH, 1948, ECOL MONOGR, V18, P81, DOI 10.2307/1948629; Wiedner K, 2015, BIOCHAR ENV MANAGEME, P15; Wiedner K, 2015, CATENA, V132, P114, DOI 10.1016/j.catena.2014.10.024; WONG MTF, 1990, J SOIL SCI, V41, P655, DOI 10.1111/j.1365-2389.1990.tb00234.x; Xi YF, 2010, APPL CLAY SCI, V48, P92, DOI 10.1016/j.clay.2009.11.047; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002	58	96	97	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171214	10.1371/journal.pone.0171214	http://dx.doi.org/10.1371/journal.pone.0171214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199354	Green Published, gold			2022-12-27	WOS:000394424400025
J	Tan, JR; Tan, KS; Yong, FL; Armugam, A; Wang, CW; Jeyaseelan, K; Wong, PTH				Tan, Jun Rong; Tan, Kay Sin; Yong, Fung Lin; Armugam, Arunmozhiarasi; Wang, Chee Woon; Jeyaseelan, Kandiah; Wong, Peter Tsun-Hon			MicroRNAs regulating cluster of differentiation 46 (CD46) in cardioembolic and non-cardioembolic stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BINDING LECTIN LEVELS; ENRICHMENT ANALYSIS; TARGET PREDICTION; GENE-EXPRESSION; CLIP-SEQ; RNA; DATABASE; INFLAMMATION; HOMEOSTASIS	Ischemic stroke is a major cause of mortality and morbidity globally. Among the ischemic stroke subtypes, cardioembolic stroke is with poor functional outcome (Modified Rankin score > 2). Early diagnosis of cardioembolic stroke will prove beneficial. This study examined the microRNAs targeting cluster of differentiation 46 (CD46), a potential biomarker for cardioembolic stroke. CD46 mRNA level was shown to be differentially expressed (p < 0.001) between cardioembolic stroke (median = 1.32) and non-cardioembolic stroke subtypes (large artery stroke median = 5.05; small vessel stroke median = 6.45). Bioinformatic search showed that miR-19a,-20a,-185 and-374b were found to target CD46 mRNA and further verified by luciferase reporter assay. The levels of miRNAs targeting CD46 were significantly reduced (p < 0.05) in non-cardioembolic stroke patients (large artery stroke median: miR-19a = 0.63, miR-20a = 0.42, miR-185 = 0.32, miR-374b = 0.27; small artery stroke median: miR-19a = 0.07, miR-20a = 0.06, miR-185 = 0.07, miR-374b = 0.05) as compared to cardioembolic stroke patients (median: miR-19a = 2.69, miR-20a = 1.36, miR-185 = 1.05, miR-374b = 1.23). ROC curve showed that the miRNAs could distinguish cardioembolic stroke from non-cardioembolic stroke with better AUC value as compared to CD46. Endogenous expression of CD46 in Human Umbilical Vein Endothelial Cells (HUVECs) were found to be regulated by miR-19a and miR-20a. Thus implicating that miR-19a and-20a may play a role in pathogenesis of cardioembolic stroke, possibly via the endothelial cells.	[Tan, Jun Rong; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Tan, Kay Sin; Yong, Fung Lin] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Wang, Chee Woon] MAHSA Univ, Dept Biochem, Fac Med, Kuala Lumpur, Malaysia; [Jeyaseelan, Kandiah] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Wong, Peter Tsun-Hon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, MD3, Singapore, Singapore	National University of Singapore; Universiti Malaya; Mahsa University; Monash University; National University of Singapore	Wong, PTH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, MD3, Singapore, Singapore.	phcwth@nus.edu.sg	TAN, KAY SIN/B-9911-2010; Wang, Chee/GQZ-3436-2022; WANG, CHEE WOON/GQZ-3715-2022; WOON, WANG CHEE/H-7458-2019	Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Research Foundation (NRF) [R-184-002-165-281]; National Medical Research Council (NMRC/EDG) [R-183-000-230-275]; National Medical Research Council (NMRC/IRG), Singapore [R-183-000-290-213]; University of Malaya (UM/HIR) [E0067, E0036]	National Research Foundation (NRF); National Medical Research Council (NMRC/EDG)(National Medical Research Council, Singapore); National Medical Research Council (NMRC/IRG), Singapore(National Medical Research Council, Singapore); University of Malaya (UM/HIR)	This work was supported by the research grants from National Research Foundation (NRF): R-184-002-165-281, National Medical Research Council (NMRC/EDG): R-183-000-230-275, and the National Medical Research Council (NMRC/IRG): R-183-000-290-213, Singapore; and the University of Malaya (UM/HIR): E0067 & E0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bohmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081427; Burke TA, 2006, INT J STROKE, V1, P208, DOI 10.1111/j.1747-4949.2006.00060.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; De Martino I, 2009, ONCOGENE, V28, P1432, DOI 10.1038/onc.2008.495; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elefant N, 2011, NUCLEIC ACIDS RES, V39, pD188, DOI 10.1093/nar/gkq1233; Enright AJ, 2004, GENOME BIOL, V5; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hallevi H, 2008, ARCH NEUROL-CHICAGO, V65, P1169, DOI 10.1001/archneur.65.9.noc70105; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Jiang WL, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0034-8; Jickling GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099283; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kaur P, 2016, BBA-MOL CELL RES, V1863, P533, DOI 10.1016/j.bbamcr.2015.12.012; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li SH, 2004, CIRCULATION, V109, P833, DOI 10.1161/01.CIR.0000117087.27524.0E; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu Chang-zheng, 2012, Chinese Medical Sciences Journal, V27, P65; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIFERT PS, 1989, ARTERIOSCLEROSIS, V9, P802, DOI 10.1161/01.ATV.9.6.802; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Song FY, 2015, MOL NEUROBIOL, V52, P1330, DOI 10.1007/s12035-014-8941-0; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Truelsen T., 2006, GLOBAL BURDEN CEREBR; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wang ZY, 2014, NEUROCHEM RES, V39, P248, DOI 10.1007/s11064-013-1214-x; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172131	10.1371/journal.pone.0172131	http://dx.doi.org/10.1371/journal.pone.0172131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199366	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400075
J	Wang, RJ; Cui, Y; Xu, Y; Irudayaraj, J				Wang, Renjie; Cui, Yi; Xu, Yi; Irudayaraj, Joseph			Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in vitro	PLOS ONE			English	Article							DNA-REPAIR GENES; PROMOTER HYPERMETHYLATION; CELL-PROLIFERATION; BETA-CARBOLINES; HUMAN CANCER; TRANSCRIPTION; METHYLATION; MECHANISMS; NEUROTOXIN; HYPOMETHYLATION	1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) has been widely studied as a neurotoxic substance, however, only few reports have explored its effect on carcinogenicity. Since the aberrant modification of DNA methylation occurs very early in almost all human cancers, the focus of this study is to assess the carcinogenicity of TaClo by characterizing alterations of the epigenetic state, specifically, DNA methylation, upon exposure to TaClo in a HEK 293 model cell line. Our results suggest that TaClo could induce global DNA hypomethylation and transcriptional repression of critical tumor suppressor genes by increasing their promoter methylation. Enhanced cell proliferation, migration and anchorage independent growth were observed in cells exposed to TaClo. Our study highlights the epigenetic toxicity of TaClo, which contributes to its carcinogenicity by altering the DNA methylation status.	[Wang, Renjie; Xu, Yi] Chongqing Univ, Coll Chem & Chem Engn, Chongqing, Peoples R China; [Wang, Renjie; Cui, Yi; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Wang, Renjie; Xu, Yi] Chongqing Univ, Int R&D Ctr Micronano Syst & New Mat Technolog, Chongqing, Peoples R China; [Wang, Renjie; Xu, Yi] Chongqing Univ, Key Disciplines Lab Novel Micronano Devices & Sys, Chongqing, Peoples R China; [Xu, Yi] Chongqing Univ, Sch Optoelect Engn, Microsyst Res Ctr, Chongqing, Peoples R China; [Cui, Yi] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA	Chongqing University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chongqing University; Chongqing University; Chongqing University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Irudayaraj, J (corresponding author), Purdue Univ, Bindley Biosci Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA.	josephi@purdue.edu	Cui, Yi/O-4109-2019	Irudayaraj, Joseph/0000-0002-0630-1520; Wang, Renjie/0000-0002-2969-0987	Executive Vice President for Research and Partnerships office for the Toxicology Pillar; W.M. Keck foundation; China scholarship council [201506050054]	Executive Vice President for Research and Partnerships office for the Toxicology Pillar; W.M. Keck foundation(W.M. Keck Foundation); China scholarship council(China Scholarship Council)	JI received funding from the Executive Vice President for Research and Partnerships office for the Toxicology Pillar (grant number:0000, URL: http://www.purdue.edu/research/), and the W.M. Keck foundation (grant number:0000, URLs: http://www.wmkeck.org/). RW was funded through the China scholarship council (grant number: 201506050054, URL: http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akundi RS, 2004, J NEUROCHEM, V91, P263, DOI 10.1111/j.1471-4159.2004.02710.x; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Benbrahim TL, 2007, ENV HLTH PERSPECT, V115, P1454; Bernd J, 1999, DRUG DEVELOP RES, V46, P51; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bringmann G, 2000, BIOORGAN MED CHEM, V8, P1467, DOI 10.1016/S0968-0896(00)00073-0; Bringmann G, 2004, TETRAHEDRON, V60, P8143, DOI 10.1016/j.tet.2004.06.093; Bringmann G, 2002, BIOORGAN MED CHEM, V10, P2207, DOI 10.1016/S0968-0896(02)00060-3; Bringmann G, 2001, NEUROSCI LETT, V304, P41, DOI 10.1016/S0304-3940(01)01731-1; BRINGMANN G, 1990, ARCH PHARM, V323, P567, DOI 10.1002/ardp.19903230903; Bringmann G, 2000, NEUROCHEM RES, V25, P837, DOI 10.1023/A:1007521625088; Bringmann G, 2006, Z NATURFORSCH C, V61, P601; Brocato J, 2013, CRIT REV TOXICOL, V43, P493, DOI 10.3109/10408444.2013.794769; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Cui Y, 2016, TOXICOL RES-UK, V5, P641, DOI [10.1039/c5tx00454c, 10.1039/C5TX00454C]; Cui Y, 2015, MOL PHARMACEUT, V12, P1279, DOI 10.1021/mp500815b; Cui Y, 2015, NUCLEIC ACIDS RES, V43, P3046, DOI 10.1093/nar/gkv098; Cui Y, 2013, EPIGENETICS-US, V8, P1089, DOI 10.4161/epi.25958; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Drosten M, 2014, P NATL ACAD SCI USA, V111, P15155, DOI 10.1073/pnas.1417549111; Esteller M, 2000, EUR J CANCER, V36, P2294, DOI 10.1016/S0959-8049(00)00303-8; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Foley P, 2000, J NEUROL, V247, P82; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gerlach M, 1998, NEUROSCI LETT, V257, P17, DOI 10.1016/S0304-3940(98)00791-5; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116179; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Komashko VM, 2014, EPIGENETICS, V5, P229; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lawrence LH, 2000, ENVIRON HEALTH PER S, V108, P177; Mazumder DNG, 2005, TOXICOL APPL PHARM, V206, P169, DOI 10.1016/j.taap.2004.08.025; Ordway JM, 2004, ONCOGENE, V23, P3737, DOI 10.1038/sj.onc.1207483; Pogribny IP, 2013, CANCER LETT, V334, P39, DOI 10.1016/j.canlet.2012.09.010; Przedborski S, 2001, CLIN NEUROSCI RES, V1, P407, DOI 10.1016/S1566-2772(01)00019-6; Riederer P, 2002, EUR J PHARMACOL, V442, P1, DOI 10.1016/S0014-2999(02)01308-0; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Statement S, 2013, SUMMARY STATEMENT, V14, P1; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Storch A, 2006, J NEURAL TRANSM, V113, P1895, DOI 10.1007/s00702-006-0495-5; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Torano EG, 2012, CLIN CHEM LAB MED, V50, P1733, DOI 10.1515/cclm-2011-0902; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; White RF, 1997, ENVIRON RES, V73, P113, DOI 10.1006/enrs.1997.3699; Wild CP, 2009, MUTAGENESIS, V24, P117, DOI 10.1093/mutage/gen061; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088	53	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172243	10.1371/journal.pone.0172243	http://dx.doi.org/10.1371/journal.pone.0172243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199384	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400085
J	Bor, D; Schwartzman, DJ; Barrett, AB; Seth, AK				Bor, Daniel; Schwartzman, David J.; Barrett, Adam B.; Seth, Anil K.			Theta-burst transcranial magnetic stimulation to the prefrontal or parietal cortex does not impair metacognitive visual awareness	PLOS ONE			English	Article							ACTIVITY FLUCTUATIONS; ACCURACY; DECISION; MEMORY; CONSCIOUSNESS; MECHANISMS; STRATEGIES; THRESHOLD; RIVALRY	Neuroimaging studies commonly associate dorsolateral prefrontal cortex (DLPFC) and posterior parietal cortex with conscious perception. However, such studies only investigate correlation, rather than causation. In addition, many studies conflate objective performance with subjective awareness. In an influential recent paper, Rounis and colleagues addressed these issues by showing that continuous theta burst transcranial magnetic stimulation (cTBS) applied to the DLPFC impaired metacognitive (subjective) awareness for a perceptual task, while objective performance was kept constant. We attempted to replicate this finding, with minor modifications, including an active cTBS control site. Using a between-subjects design for both DLPFC and posterior parietal cortices, we found no evidence of a cTBS-induced metacognitive impairment. In a second experiment, we devised a highly rigorous within-subjects cTBS design for DLPFC, but again failed to find any evidence of metacognitive impairment. One crucial difference between our results and the Rounis study is our strict exclusion of data deemed unsuitable for a signal detection theory analysis. Indeed, when we included this unstable data, a significant, though invalid, metacognitive impairment was found. These results cast doubt on previous findings relating metacognitive awareness to DLPFC, and inform the current debate concerning whether or not prefrontal regions are preferentially implicated in conscious perception.	[Bor, Daniel; Schwartzman, David J.; Barrett, Adam B.; Seth, Anil K.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Bor, Daniel; Barrett, Adam B.; Seth, Anil K.] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Sussex; University of Sussex	Bor, D (corresponding author), Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England.; Bor, D (corresponding author), Univ Sussex, Dept Informat, Brighton, E Sussex, England.	danielxbor@gmail.com		Schwartzman, David/0000-0002-3779-396X; Bor, Daniel/0000-0002-0741-8157	Dr Mortimer and Theresa Sackler Foundation; EPSRC [EP/L005131/1]; EPSRC [EP/G007543/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L005131/1] Funding Source: researchfish	Dr Mortimer and Theresa Sackler Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Dr Mortimer and Theresa Sackler Foundation. ABB is funded by EPSRC grant EP/L005131/1.; We thank the Alex Henderson and Arin Baboumian for all their work collecting the data, Ryan Scott and Zoltan Dienes for helpful theoretical discussions, and Justyna Hobot on many constructive comments on an earlier draft. This work was supported by The Dr Mortimer and Theresa Sackler Foundation. ABB is funded by EPSRC grant EP/L005131/1.	Barrett AB, 2013, PSYCHOL METHODS, V18, P535, DOI 10.1037/a0033268; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; Bor D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00063; Brascamp J, 2015, NAT NEUROSCI, V18, P1672, DOI 10.1038/nn.4130; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Del Cul A, 2009, BRAIN, V132, P2531, DOI 10.1093/brain/awp111; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fleming SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00443; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Herwig U, 2001, BIOL PSYCHIAT, V50, P58, DOI 10.1016/S0006-3223(01)01153-2; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kaller CP, 2013, HUM BRAIN MAPP, V34, P36, DOI 10.1002/hbm.21423; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macmillan NA, 2005, DETECTION THEORY USE; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; Rahnev D, 2016, P NATL ACAD SCI USA, V113, P6059, DOI 10.1073/pnas.1522551113; Rees G, 2007, PHILOS T R SOC B, V362, P877, DOI 10.1098/rstb.2007.2094; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schicktanz N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120640; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; Turatto M, 2004, NEUROREPORT, V15, P2549, DOI 10.1097/00001756-200411150-00024; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Westin GG, 2014, CLIN NEUROPHYSIOL, V125, P142, DOI 10.1016/j.clinph.2013.06.187	45	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171793	10.1371/journal.pone.0171793	http://dx.doi.org/10.1371/journal.pone.0171793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192502	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800042
J	Paillamanque, J; Sanchez-Tusie, A; Carmona, EM; Trevino, CL; Sandoval, C; Nualart, F; Osses, N; Reyes, JG				Paillamanque, Joaquin; Sanchez-Tusie, Ana; Carmona, Emerson M.; Trevino, Claudia L.; Sandoval, Carolina; Nualart, Francisco; Osses, Nelson; Reyes, Juan G.			Arachidonic acid triggers [Ca2+](i) increases in rat round spermatids by a likely GPR activation, ERK signalling and ER/acidic compartments Ca2+ release	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ALLOSTERIC MODULATOR SCH-202676; SPERMATOGENIC CELLS; SELECTIVE INHIBITOR; RYANODINE RECEPTOR; IN-VITRO; INTRACELLULAR CA2+; ARISTOLOCHIC ACID; SMALL MOLECULES; SERTOLI-CELLS	Arachidonic acid (AA), a compound secreted by Sertoli cells (SC) in a FSH-dependent manner, is able to induce the release of Ca2+ from internal stores in round spermatids and pachytene spermatocytes. In this study, the possible site(s) of action of AA in round spermatids, the signalling pathways associated and the intracellular Ca2+ stores targeted by AA-induced signalling were pharmacologically characterized by measuring intracellular Ca2+ using fluorescent Ca-2+ probes. Our results suggest that AA acts by interacting with a fatty acid G protein coupled receptor, initiating a G protein signalling cascade that may involve PLA2 and ERK activation, which in turn opens intracellular ryanodine-sensitive channels as well as NAADP-sensitive channels in acidic intracellular Ca2+ stores. The results presented here also suggest that AMPK and PKA modulate this AA-induced Ca2+ release from intracellular Ca2+ stores in round spermatids. We propose that unsaturated free fatty acid lipid signalling in the seminiferous tubule is a novel regulatory component of rat spermatogenesis.	[Paillamanque, Joaquin; Carmona, Emerson M.; Sandoval, Carolina; Osses, Nelson; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Sanchez-Tusie, Ana; Trevino, Claudia L.] Univ Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Nualart, Francisco] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Concepcion, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad Nacional Autonoma de Mexico; Universidad de Concepcion	Reyes, JG (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	juan.reyes@pucv.cl	Nualart, Francisco/AAB-9342-2021; Osses, Nelson/V-9065-2019	Osses, Nelson/0000-0003-0974-1051; Trevino, Claudia L/0000-0002-7281-0534; Carmona, Emerson/0000-0003-1332-0372; Sanchez Tusie, Ana Alicia/0000-0003-2671-2789	Fondecyt [1110267, 1140758]; PUCV [125.754/2011 125792/2014]; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) [128566]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) [IN202212-3]; Alexander von Humboldt Foundation	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PUCV; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM)(Universidad Nacional Autonoma de Mexico); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Fondecyt grant numbers 1110267 and 1140758; and PUCV grant number 125.754/2011 125792/2014 to JGR; and Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) (128566 to CT), Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) (IN202212-3 to CT) and The Alexander von Humboldt Foundation (to CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adasme T, 2015, BIOCHEM BIOPH RES CO, V458, P57, DOI 10.1016/j.bbrc.2015.01.065; AWAD JA, 1983, J BIOL CHEM, V258, P2960; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BECKMAN JK, 1979, LIPIDS, V14, P262, DOI 10.1007/BF02533912; Berrios J, 1998, BIOL CELL, V90, P391, DOI 10.1016/S0248-4900(98)80088-9; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; CHEN J, 1994, J BIOL CHEM, V269, P23018; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Christiansen E, 2011, J MED CHEM, V54, P6691, DOI 10.1021/jm2005699; Gao ZG, 2004, LIFE SCI, V74, P3173, DOI 10.1016/j.lfs.2003.11.014; GROGAN WM, 1981, LIPIDS, V16, P401, DOI 10.1007/BF02535006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Herrera E, 2000, BIOL CELL, V92, P429, DOI 10.1016/S0248-4900(00)01082-0; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Huleihel M, 2007, GROWTH FACTORS, V25, P236, DOI 10.1080/08977190701783400; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAMERS JMJ, 1983, CELL CALCIUM, V4, P281, DOI 10.1016/0143-4160(83)90005-2; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEVIN RM, 1980, NEUROPHARMACOLOGY, V19, P169, DOI 10.1016/0028-3908(80)90134-3; Lewandowicz AM, 2006, BRIT J PHARMACOL, V147, P422, DOI 10.1038/sj.bjp.0706624; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; MACDONALD ML, 1984, J NUTR, V114, P719, DOI 10.1093/jn/114.4.719; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Mauger JP, 2012, BIOL CELL, V104, P70, DOI 10.1111/boc.201100103; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Meroni SB, 2003, INT J ANDROL, V26, P310, DOI 10.1046/j.1365-2605.2003.00432.x; Mobraten K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-101; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; MUKAI H, 1992, J BIOL CHEM, V267, P16237; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Paillamanque J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158518; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; POWIS G, 1994, CANCER RES, V54, P2419; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Pozzan T, 2000, EUR J BIOCHEM, V267, P5269, DOI 10.1046/j.1432-1327.2000.01567.x; Qin J, 2009, PFLUG ARCH EUR J PHY, V458, P643, DOI 10.1007/s00424-009-0658-y; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; REGOLI D, 1984, PHARMACOLOGY, V28, P301, DOI 10.1159/000137979; Reyes JG, 1997, BIOL CELL, V89, P53, DOI 10.1016/S0248-4900(99)80081-1; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; Sanchez-Tusie AA, 2014, BIOCHEM BIOPH RES CO, V443, P531, DOI 10.1016/j.bbrc.2013.12.011; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Smith RJ, 1996, J PHARMACOL EXP THER, V278, P320; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Sun RQ, 2006, PAIN, V120, P86, DOI 10.1016/j.pain.2005.10.017; Sutko JL, 1997, PHARMACOL REV, V49, P53; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; TOHDA M, 1991, NEUROSCI LETT, V129, P47, DOI 10.1016/0304-3940(91)90717-8; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trevino CL, 1998, ZYGOTE, V6, P159, DOI 10.1017/S0967199498000094; Ulisse S, 2000, CELL DEATH DIFFER, V7, P916, DOI 10.1038/sj.cdd.4400716; VISHWANATH BS, 1988, INFLAMMATION, V12, P549, DOI 10.1007/BF00914317; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	76	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172128	10.1371/journal.pone.0172128	http://dx.doi.org/10.1371/journal.pone.0172128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192519	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800074
J	Regnell, SE; Hessner, MJ; Jia, S; Akesson, L; Stenlund, H; Moritz, T; La Torre, D; Lernmark, A				Regnell, Simon E.; Hessner, Martin J.; Jia, Shuang; Akesson, Lina; Stenlund, Hans; Moritz, Thomas; La Torre, Daria; Lernmark, Ake			Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats	PLOS ONE			English	Article							ORNITHINE DECARBOXYLASE; ISLET AUTOIMMUNITY; GENETIC DISSECTION; NOD MICE; BB RAT; TYPE-1; CHILDREN; PLASMA; IDENTIFICATION; LYMPHOPENIA	Type 1 diabetes is associated with abberations of fat metabolism before and after the clinical onset of disease. It has been hypothesized that the absence of the effect of insulin in the liver contributes to reduced hepatic fat synthesis. We measured hepatic gene expression and serum metabolites before and after the onset of hyperglycemia in a BioBreeding rat model of type 1 diabetes. Functional pathway annotation identified that lipid metabolism was differentially expressed in hyperglycemic rats and that these pathways significantly overlapped with genes regulated by insulin. 17 serum metabolites significantly changed in concentration. All but 2 of the identified metabolites had previously been reported in type 1 diabetes, and carbohydrates were overall the most upregulated class of metabolites. We conclude that lack of insulin in the liver contributes to the changes in fat metabolism observed in type 1 diabetes. Further studies are needed to understand the clinical consequences of a lack of insulin in the liver in patients with type 1 diabetes.	[Regnell, Simon E.; Akesson, Lina; La Torre, Daria; Lernmark, Ake] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Clin Res Ctr, Malmo, Sweden; [Regnell, Simon E.; Akesson, Lina; La Torre, Daria; Lernmark, Ake] Skane Univ Hosp, Malmo, Sweden; [Hessner, Martin J.; Jia, Shuang] Med Coll Wisconsin, Childrens Hosp Wisconsin, Childrens Res Inst, Max McGee Natl Res Ctr Juvenile Diabet, Milwaukee, WI 53226 USA; [Stenlund, Hans; Moritz, Thomas] Swedish Univ Agr Sci, Swedish Metabol Ctr, Umea, Sweden	Lund University; Lund University; Skane University Hospital; Children's Hospital of Wisconsin; Medical College of Wisconsin; Swedish University of Agricultural Sciences	Regnell, SE (corresponding author), Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Clin Res Ctr, Malmo, Sweden.; Regnell, SE (corresponding author), Skane Univ Hosp, Malmo, Sweden.	simon.regnell@med.lu.se	Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499; Regnell, Simon/0000-0002-6672-8972; Stenlund, Hans/0000-0001-9943-296X; Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council [K2011-54X-15312-07-6]; Juvenile Diabetes Research Foundation; Swedish Diabetes Foundation; SUS Funds; Skke County Council for Research and Development; National Institutes of Health [R01A1078713]; Children's Hospital of Wisconsin Foundation; Knut and Alice Wallenberg Foundation; UPSC Berzelii project; Biobanking and Molecular Resource Infrastructure of Sweden; Swedish Child Diabetes Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Diabetes Foundation; SUS Funds; Skke County Council for Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Wisconsin Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); UPSC Berzelii project; Biobanking and Molecular Resource Infrastructure of Sweden; Swedish Child Diabetes Foundation	AL has received support for this study from the Swedish Research Council (K2011-54X-15312-07-6), the Juvenile Diabetes Research Foundation, The Swedish Diabetes Foundation, SUS Funds, and the Skke County Council for Research and Development. MJH was supported by National Institutes of Health grant R01A1078713 and The Children's Hospital of Wisconsin Foundation. TM has received support from the Knut and Alice Wallenberg Foundation, the UPSC Berzelii project, and Biobanking and Molecular Resource Infrastructure of Sweden. SER and AL received a grant from the Swedish Child Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANUMA Y, 1988, DIABETOLOGIA, V31, P831; Akesson L, 2008, EXP CLIN ENDOCR DIAB, V116, P475, DOI 10.1055/s-2008-1062713; Akesson L, 2011, METABOLOMICS, V7, P593, DOI 10.1007/s11306-011-0278-3; [Anonymous], 2011, COMM UPD GUID CAR US; Atkinson MA, 2009, CURR OPIN ENDOCRINOL, V16, P279, DOI 10.1097/MED.0b013e32832e06ba; Balderas C, 2013, ELECTROPHORESIS, V34, P2882, DOI 10.1002/elps.201300062; Chen XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139019; Dutta T, 2012, DIABETES, V61, P1004, DOI 10.2337/db11-0874; Fahrmann J, 2015, AM J PHYSIOL-ENDOC M, V308, pE978, DOI 10.1152/ajpendo.00019.2015; Fuller JM, 2009, PHYSIOL GENOMICS, V38, P89, DOI 10.1152/physiolgenomics.00015.2009; Fuller JM, 2006, DIABETES, V55, P3351, DOI 10.2337/db06-0715; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grapov D, 2015, METABOLOMICS, V11, P425, DOI 10.1007/s11306-014-0706-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-171; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; Kaldunski M, 2010, DIABETES, V59, P2375, DOI 10.2337/db10-0372; La Torre D, 2013, DIABETES, V62, P3951, DOI 10.2337/db13-0215; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; LEVINE JH, 1980, DIABETES, V29, P532, DOI 10.2337/diabetes.29.7.532; Llaurado G, 2014, J CLIN ENDOCR METAB; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035445; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Overgaard AJ, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0889-1; Perseghin G, 2005, DIABETOLOGIA, V48, P2615, DOI 10.1007/s00125-005-0014-5; Regnell SE, 2013, DIABETIC MED, V30, P155, DOI 10.1111/dme.12099; Regnell SE, 2015, METABOLISM, V64, P872, DOI 10.1016/j.metabol.2015.04.002; Regnell Simon E, 2011, Rev Diabet Stud, V8, P454, DOI 10.1900/RDS.2011.8.454; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; YAMANOUCHI T, 1987, DIABETES, V36, P709, DOI 10.2337/diabetes.36.6.709; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041; Zuppi C, 2002, CLIN CHEM, V48, P660	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171372	10.1371/journal.pone.0171372	http://dx.doi.org/10.1371/journal.pone.0171372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192442	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800023
J	Tal, N; Morag, Y; Shatz, L; Levron, Y				Tal, Nikolay; Morag, Yahav; Shatz, Lisa; Levron, Yoash			Design optimization of transmitting antennas for weakly coupled magnetic induction communication systems	PLOS ONE			English	Article							SEARCH COIL MAGNETOMETER; NETWORKS	This work focuses on the design of transmitting coils in weakly coupled magnetic induction communication systems. We propose several optimization methods that reduce the active, reactive and apparent power consumption of the coil. These problems are formulated as minimization problems, in which the power consumed by the transmitting coil is minimized, under the constraint of providing a required magnetic field at the receiver location. We develop efficient numeric and analytic methods to solve the resulting problems, which are of high dimension, and in certain cases non-convex. For the objective of minimal reactive power an analytic solution for the optimal current distribution in flat disc transmitting coils is provided. This problem is extended to general three-dimensional coils, for which we develop an expression for the optimal current distribution. Considering the objective of minimal apparent power, a method is developed to reduce the computational complexity of the problem by transforming it to an equivalent problem of lower dimension, allowing a quick and accurate numeric solution. These results are verified experimentally by testing a number of coil geometries. The results obtained allow reduced power consumption and increased performances in magnetic induction communication systems. Specifically, for wideband systems, an optimal design of the transmitter coil reduces the peak instantaneous power provided by the transmitter circuitry, and thus reduces its size, complexity and cost.	[Tal, Nikolay; Morag, Yahav; Levron, Yoash] Technion Israel Inst Technol, Dept Elect Engn, Haifa, Israel; [Shatz, Lisa] Suffolk Univ, Dept Engn, Boston, MA 02114 USA	Technion Israel Institute of Technology; Suffolk University	Tal, N (corresponding author), Technion Israel Inst Technol, Dept Elect Engn, Haifa, Israel.	nikolayt@campus.technion.ac.il	Morag, Yahav/N-2579-2019	Morag, Yahav/0000-0002-1941-4284				Agbinya Johnson I., 2013, Progress In Electromagnetics Research B, V49, P129; Agbinya J. I., 2010, J BATTLEFIELD TECHNO, V13, P21; Agbinya JI, 2012, WIRELESS PERS COMMUN, V64, P831, DOI 10.1007/s11277-011-0222-x; Ahmed N., 2014, P UND COMM NETW C SE, P1; Akyildiz I.F., 2009, PHYS COMMUN-AMST, V2, P167, DOI [10.1016/j.phycom.2009.03.004, DOI 10.1016/J.PHYCOM.2009.03.004, DOI 10.1016/j.phycom.2009.03.004]; Al-Asadi MM, 1998, MICROW OPT TECHN LET, V19, P84, DOI 10.1002/(SICI)1098-2760(19981005)19:2<84::AID-MOP2>3.0.CO;2-B; Balanis C., 2005, ANTENNA THEORY ANAL, P236; Bansal R., 2004, IEEE Antennas and Propagation Magazine, V46, P114, DOI 10.1109/MAP.2004.1305555; Domingo MC, 2012, IEEE T ANTENN PROPAG, V60, P2929, DOI 10.1109/TAP.2012.2194670; Cavoit C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2214693; Coillot C, 2010, IEEE SENS J, V10, P255, DOI 10.1109/JSEN.2009.2030977; Drude S., 2007, MOB WIR COMM SUMM 20, P1, DOI DOI 10.1109/ISTMWC.2007.4299336; Evans-Pughe C, 2005, IEE REVIEW, V51, P38, DOI 10.1049/ir:20050505; Grosz A, 2012, IEEE SENS J, V12, P2719, DOI 10.1109/JSEN.2012.2202179; Grosz A, 2011, IEEE SENS J, V11, P1088, DOI 10.1109/JSEN.2010.2079929; Gulbahar B, 2012, IEEE T WIREL COMMUN, V11, P3326, DOI 10.1109/TWC.2012.070912.111943; Kisseleff S, 2014, IEEE T COMMUN, V62, P4426, DOI 10.1109/TCOMM.2014.2367030; Latre B, 2011, WIREL NETW, V17, P1, DOI 10.1007/s11276-010-0252-4; Li H. B., 2008, SPRINGER J ADV MOBIL, P223, DOI DOI 10.1007/978-3-540-79041-9_12; LUKOSCHUS DG, 1979, IEEE T GEOSCI REMOTE, V17, P56, DOI 10.1109/TGE.1979.294613; Masihpour M, 2013, J NETWORKS, V8; Shatz LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111643; Sun Z, 2013, IEEE T WIREL COMMUN, V12, P996, DOI 10.1109/TWC.2013.011713.111896; Sun Z, 2010, IEEE T ANTENN PROPAG, V58, P2426, DOI 10.1109/TAP.2010.2048858; Tal Nikolay, 2015, 2015 IEEE International Conference on Microwaves, Communications, Antennas and Electronic Systems (COMCAS), P1, DOI 10.1109/COMCAS.2015.7360398; Tal N, 2015, INT S POW EL EE2015; Tal N, 2016, IEEE SENS J, V16, P4671, DOI 10.1109/JSEN.2016.2550604; Volk T, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2300042; Yenchek MR, 2012, IEEE T IND APPL, V48, P1700, DOI 10.1109/TIA.2012.2209853	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171982	10.1371/journal.pone.0171982	http://dx.doi.org/10.1371/journal.pone.0171982			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192463	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800057
J	Aldhoon, B; Wichterle, D; Peichl, P; Cihak, R; Kautzner, J				Aldhoon, Bashar; Wichterle, Dan; Peichl, Petr; Cihak, Robert; Kautzner, Josef			Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; PROPHYLACTIC CATHETER ABLATION; PRIMARY PREVENTION; NONISCHEMIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CLINICAL PREDICTORS; SINGLE-CENTER; NONINDUCIBILITY; THERAPY; TERM	Aims To investigate predictors of long-term outcomes after catheter ablation (CA) for ventricular tachycardia (VT) and the impact of electrical storm (ES) prior to index ablation procedures. Methods We studied consecutive patients with structural heart disease and VT (n = 328; age: 63 +/- 12 years; 88% males; 72% ischaemic cardiomyopathy; LVEF: 32 +/- 12%) who had undergone CA. According to presenting arrhythmia at baseline, they were divided into ES (n = 93, 28%) and non-ES groups. Clinical predictors of all-cause mortality were investigated and a clinically useful risk score (SCORE) was constructed. Results During a median follow-up of 927 days (IQR: 564-1626), 67% vs. 60% of patients (p = 0.05) experienced VT recurrence in the ES vs. the non-ES group, respectively; and 41% vs. 32% patients died (p = 0.02), respectively. Five factors were independently associated with mortality: age >70 years (hazard ratio (HR): 1.6, 95% confidence interval (CI): 1.1-2.4, p = 0.01), NYHA class >= 3 (HR: 1.9, 95% CI: 1.2-2.9, p = 0.005), a serum creatinine level >1.3 mg/dL (HR: 1.6, 95% CI: 1.1-2.3, p = 0.02), LVEF <= 25% (HR: 2.4, 95% CI: 1.6-3.5, p = 0.00004), and amiodarone therapy (HR: 1.5, 95% CI: 1.0-2.2, p = 0.03). A risk SCORE ranging from 0-4 (1 point for either high-risk age, NYHA, creatinine, or LVEF) correlated with mortality. ES during index ablation independently predicted mortality only in patients with a SCORE <= 1. Conclusions Advanced LV dysfunction, older age, higher NYHA class, renal dysfunction, and amiodarone therapy, but not ES, were predictors of poor outcomes after CA for VT in the total population. However, ES did predict mortality in a low-risk sub-group of patients.	[Aldhoon, Bashar; Wichterle, Dan; Peichl, Petr; Cihak, Robert; Kautzner, Josef] Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM)	Aldhoon, B (corresponding author), Inst Clin & Expt Med IKEM, Dept Cardiol, Prague, Czech Republic.	bashar.aldhoon@ikem.cz	Wichterle, Dan/G-7611-2017; Peichl, Petr/AAZ-9509-2021; Peichl, Petr/L-7255-2018	Wichterle, Dan/0000-0002-0448-5143; Peichl, Petr/0000-0002-5625-0071; Peichl, Petr/0000-0002-5625-0071; Aldhoon, Bashar/0000-0002-1845-847X				Bansch D, 2000, J AM COLL CARDIOL, V36, P566, DOI 10.1016/S0735-1097(00)00726-9; Brigadeau F, 2006, EUR HEART J, V27, P700, DOI 10.1093/eurheartj/ehi726; Calkins H, 2000, J AM COLL CARDIOL, V35, P1905, DOI 10.1016/S0735-1097(00)00615-X; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Della Bella P, 2013, CIRCULATION, V127, P1359, DOI 10.1161/CIRCULATIONAHA.112.000872; Deneke T, 2011, AM J CARDIOL, V108, P233, DOI 10.1016/j.amjcard.2011.03.030; Dinov B, 2015, CIRC-ARRHYTHMIA ELEC, V8, P598, DOI 10.1161/CIRCEP.114.002295; Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063; Exner DV, 2001, CIRCULATION, V104, P1564, DOI 10.1161/hc3801.096395; Gatzoulis KA, 2005, EUROPACE, V7, P184, DOI 10.1016/j.eupc.2005.01.003; Ghanbari H, 2014, CIRC-ARRHYTHMIA ELEC, V7, P677, DOI 10.1161/CIRCEP.113.001404; Guerra F, 2014, EUROPACE, V16, P347, DOI 10.1093/europace/eut304; Hayashi T, 2013, EUROPACE, V15, P1507, DOI 10.1093/europace/eut050; Kozeluhova M, 2011, EUROPACE, V13, P109, DOI 10.1093/europace/euq364; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Peichl P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P684, DOI 10.1161/CIRCEP.114.001530; Piers SRD, 2013, CIRC-ARRHYTHMIA ELEC, V6, P513, DOI 10.1161/CIRCEP.113.000089; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Sesselberg HW, 2007, HEART RHYTHM, V4, P1395, DOI 10.1016/j.hrthm.2007.07.013; Tanner H, 2010, J CARDIOVASC ELECTR, V21, P47, DOI 10.1111/j.1540-8167.2009.01563.x	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171830	10.1371/journal.pone.0171830	http://dx.doi.org/10.1371/journal.pone.0171830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187168	gold, Green Submitted, Green Published			2022-12-27	WOS:000394244300047
J	Dishman, RK; Dowda, M; McIver, KL; Saunders, RP; Pate, RR				Dishman, Rod K.; Dowda, Marsha; McIver, Kerry L.; Saunders, Ruth P.; Pate, Russell R.			Naturally-occurring changes in social-cognitive factors modify change in physical activity during early adolescence	PLOS ONE			English	Article							MIDDLE-SCHOOL GIRLS; LONGITUDINAL ANALYSIS; ACTIVITY PLAN; MISSING DATA; 12TH GRADE; CHILDREN; BEHAVIOR; QUESTIONNAIRES; INTERVENTIONS; DETERMINANTS	Purpose To determine whether naturally-occurring changes in children's motives and beliefs are associated with the steep decline in physical activity observed from childhood to early adolescence. Methods Latent growth modeling was applied in longitudinal tests of social-cognitive influences, and their interactions, on physical activity in a large cohort of boys and girls evaluated annually between 5th and 7th grades. Results Measurement equivalence of motives and beliefs was confirmed between boys and girls. After adjustment for gender and maturity differences, physical activity declined less in children who reported the least decreases in self-efficacy for overcoming barriers to activity and perceived parental support. Physical activity also declined less in students who persistently felt they had more parental and friend support for activity compared to those who reported the largest decrease in support from friends. After further adjustment for race, the decline in physical activity was less in those who had the largest decrease in perceived barriers and maintained a favorable perception of their neighborhood environment. Changes in enjoyment and social motives were unrelated to change in physical activity. Conclusion Using an objective measure of physical activity, we confirm that naturally-occurring changes in children's beliefs about barriers to physical activity and their ability to overcome them, as well as perceptions of their neighborhood environment and social support, are concurrent with age-related declines in children's physical activity. The longitudinal findings confirm these putative social-cognitive mediators as plausible, interacting targets of interventions designed to mitigate the marked decline in physical activity that occurs during the transition between elementary and middle schools.	[Dishman, Rod K.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Dowda, Marsha; McIver, Kerry L.; Pate, Russell R.] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Saunders, Ruth P.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA	University System of Georgia; University of Georgia; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Dishman, RK (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.	rdishman@uga.edu	Dishman, Rodney/AAG-8047-2019		National Heart, Lung and Blood Institute [R01HL091002]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by a grant from the This study was funded by grant number R01HL091002 from the National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov/). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American Community Survey, 2010, 2006 2010 AM COMM SU, DOI [10.1093/jpepsy/jsp031PMID:19433571, DOI 10.1093/JPEPSY/JSP031]; [Anonymous], PHYS ACT GUID AM MID; Atkin AJ, 2016, PREV MED, V87, P167, DOI 10.1016/j.ypmed.2016.02.040; Bandura A., 1986, SOCIAL FDN THOUGHT A, P1; Cairney J, 2014, MED SCI SPORT EXER, V46, P730, DOI 10.1249/MSS.0000000000000168; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Corder K, 2015, BRIT J SPORT MED, V49, P730, DOI 10.1136/bjsports-2013-093190; Corder K, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-69; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Cumming SP, 2014, SCAND J MED SCI SPOR, V24, pe20, DOI 10.1111/sms.12103; Dishman RK, 2002, PREV MED, V34, P100, DOI 10.1006/pmed.2001.0959; Dishman RK, 2005, MED SCI SPORT EXER, V37, P478, DOI 10.1249/01.MSS.0000155391.62733.A7; Dishman RK, 2013, J PEDIATR PSYCHOL, V38, P563, DOI 10.1093/jpepsy/jst013; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P188, DOI 10.1093/jpepsy/jsp042; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P72, DOI 10.1093/jpepsy/jsp031; Dishman RK, 2009, J PEDIATR PSYCHOL, V34, P441, DOI 10.1093/jpepsy/jsn100; Dowda M, 2007, PREV MED, V44, P153, DOI 10.1016/j.ypmed.2006.10.001; Dowda M, 2009, ANN BEHAV MED, V37, P77, DOI 10.1007/s12160-009-9080-0; Dumith SC, 2012, PEDIATR EXERC SCI, V24, P58, DOI 10.1123/pes.24.1.58; Elder JP, 2007, HEALTH EDUC RES, V22, P155, DOI 10.1093/her/cyl059; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28; Hearst MO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kraus WE, 2015, CIRCULATION, V131, P1932, DOI 10.1161/CIR.0000000000000203; Kremers SPJ, 2007, AM J PREV MED, V32, P163, DOI 10.1016/j.amepre.2006.10.006; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Kwon S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-68; Labbrozzi D, 2013, J ADOLESCENCE, V36, P759, DOI 10.1016/j.adolescence.2013.06.002; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Lubans DR, 2008, PREV MED, V47, P463, DOI 10.1016/j.ypmed.2008.07.011; MacCallum RC, 2006, PSYCHOL METHODS, V11, P19, DOI 10.1037/1082-989X.11.1.19; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Rodrigues AMM, 2010, PEDIATR EXERC SCI, V22, P442, DOI 10.1123/pes.22.3.442; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Metcalf BS, 2015, MED SCI SPORT EXER, V47, P2084, DOI 10.1249/MSS.0000000000000644; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Motl RW, 2000, PREV MED, V31, P584, DOI 10.1006/pmed.2000.0735; Muthen L. K., 2006, MPLUS STAT ANAL LATE; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; O'Connor TM, 2009, AM J PREV MED, V37, P141, DOI 10.1016/j.amepre.2009.04.020; Pate RR, 2014, J PHYS ACT HEALTH, V11, P461, DOI 10.1123/jpah.2014-0072; Plotnikoff RC, 2013, PREV MED, V56, P245, DOI 10.1016/j.ypmed.2013.01.013; Prins RG, 2010, HEALTH EDUC RES, V25, P489, DOI 10.1093/her/cyq024; Ramires VV, 2015, J PHYS ACT HEALTH, V12, P1344, DOI 10.1123/jpah.2014-0222; Ryan R., 2007, INTRINSIC MOTIVATION, P1; Ryan RM, 1997, INT J SPORT PSYCHOL, V28, P335; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Sherar LB, 2010, PEDIATR EXERC SCI, V22, P332, DOI 10.1123/pes.22.3.332; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; United States. Department of Health and Human Services, 2008, PHYS ACT GUID AM; van Sluijs EMF, 2011, BRIT J SPORT MED, V45, P914, DOI 10.1136/bjsports-2011-090187; Yao CA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0163-y	61	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172040	10.1371/journal.pone.0172040	http://dx.doi.org/10.1371/journal.pone.0172040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187192	gold, Green Submitted, Green Published			2022-12-27	WOS:000394244300071
J	Salei, N; Hellberg, L; Kohl, J; Laskay, T				Salei, Natallia; Hellberg, Lars; Koehl, Joerg; Laskay, Tamas			Enhanced survival of Leishmania major in neutrophil granulocytes in the presence of apoptotic cells	PLOS ONE			English	Article							COMPLEMENT RECEPTORS; TNF-ALPHA; PHAGOCYTOSIS; CLEARANCE; PROMASTIGOTES; INFECTION; NECROSIS; PHOSPHORYLATION; SUSCEPTIBILITY; INVOLVEMENT	Neutrophil granulocytes are the first leukocytes that encounter and phagocytose Leishmania major (L. major) parasites in the infected skin. The parasites can nonetheless survive within neutrophils. However, the mechanisms enabling the survival of Leishmania within neutrophils are still elusive. Previous findings indicated that human neutrophils can engulf apoptotic cells. Since apoptotic neutrophils are abundant in infected tissues, we hypothesized that the uptake of apoptotic cells results in diminished anti-leishmanial activity and, consequently, contributes to enhanced survival of the parasites at the site of infection. In the present study, we demonstrated that L. major-infected primary human neutrophils acquire enhanced capacity to engulf apoptotic cells. This was associated with increased expression of the complement receptors 1 and 3 involved in phagocytosis of apoptotic cells. Next, we showed that ingestion of apoptotic cells affects neutrophil antimicrobial functions. We observed that phagocytosis of apoptotic cells by neutrophils downregulates the phosphorylation of p38 MAPK and PKC delta, the kinases involved in activation of NADPH oxidase and hence reactive oxygen species (ROS) production. In line, uptake of apoptotic cells inhibits TNF- and L. major-induced ROS production by neutrophils. Importantly, we found that the survival of Leishmania in neutrophils is strongly enhanced in neutrophils exposed to apoptotic cells. Together, our findings reveal that apoptotic cells promote L. majorsurvival within neutrophils by downregulating critical antimicrobial functions. This suggests that the induction of enhanced uptake of apoptotic cells represents a novel evasion mechanism of the parasites that facilitates their survival in neutrophil granulocytes.	[Salei, Natallia; Hellberg, Lars; Laskay, Tamas] Univ Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany; [Koehl, Joerg] Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany	University of Lubeck; University of Lubeck	Laskay, T (corresponding author), Univ Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany.	Tamas.Laskay@uksh.de	Laskay, Tamás/E-9190-2013; Koehl, Joerg/C-8531-2011	Laskay, Tamás/0000-0002-4212-8366; Koehl, Joerg/0000-0003-1121-3178	DFG (German Research Foundation) [IRTG1911]	DFG (German Research Foundation)(German Research Foundation (DFG))	This work was supported by DFG (German Research Foundation) IRTG1911 project B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; ALVAREZ V, 1991, KIDNEY INT, V40, P899, DOI 10.1038/ki.1991.291; BRIHEIM G, 1984, INFECT IMMUN, V45, P1; BUCHMULLER Y, 1981, J RETICULOENDOTH SOC, V29, P181; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DASILVA RP, 1989, J IMMUNOL, V143, P617; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; FALLMAN M, 1993, J IMMUNOL, V151, P330; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gullstrand B, 2012, J RHEUMATOL, V39, P1619, DOI 10.3899/jrheum.111511; Hart SP, 1997, J IMMUNOL, V159, P919; Hume DA, 2008, NAT IMMUNOL, V9, P12, DOI 10.1038/ni0108-12; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Laskay T, 1997, J IMMUNOL, V158, P1246; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; LIEW FY, 1990, IMMUNOLOGY, V69, P570; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mevorach D, 2000, ANN NY ACAD SCI, V926, P226; Mollinedo F, 2010, J BIOL CHEM, V285, P34528, DOI 10.1074/jbc.M110.125302; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Rabehi L, 2001, INFECT IMMUN, V69, P4590, DOI 10.1128/IAI.69.7.4590-4599.2001; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; ROBLEDO S, 1994, J IMMUNOL, V152, P1265; Rochael NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18302; Sarkar A, 2013, MED MICROBIOL IMMUN, V202, P25, DOI 10.1007/s00430-012-0246-1; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SOLBACH W, 1986, J IMMUNOL, V137, P702; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	52	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171850	10.1371/journal.pone.0171850	http://dx.doi.org/10.1371/journal.pone.0171850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187163	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300050
J	Tiotiu, A; Chenuel, B; Foucaud, L; Demoulin, B; Demoulin-Alexikova, S; Christov, C; Poussel, M				Tiotiu, Angelica; Chenuel, Bruno; Foucaud, Laurent; Demoulin, Bruno; Demoulin-Alexikova, Silvia; Christov, Christo; Poussel, Mathias			Lack of desensitization of the cough reflex in ovalbumin-sensitized rabbits during exercise	PLOS ONE			English	Article							INDUCED BRONCHOCONSTRICTION; MUSCULAR-CONTRACTION; INFLAMMATORY CELLS; GUINEA-PIGS; AIRWAY; ASTHMA; MODEL; RESPONSES; BRONCHODILATION; TRANSMISSION	Introduction Cough is a major symptom of asthma frequently experienced during exercise but little is known about interactions between cough and exercise. The goal of our study was to clarify the potential modulation of the cough reflex (CR) by exercise in a spontaneously breathing anaesthetized animal model of airway eosinophilic inflammation. Materials & methods Ten ovalbumin (OVA) sensitized adult rabbits and 8 controls were studied. The ventilatory response to direct tracheal stimulation, performed both at rest and during exercise was determined to quantify the incidence and the sensitivity of the CR. Broncho-alveolar lavages (BAL) and cell counts were performed to assess the level of the airway inflammation following OVA-induced sensitization. Exercise was mimicked by Electrically induced hindlimb Muscular Contractions (EMC). Results Among 494 tracheal stimulations, 261 were performed at rest and 233 at exercise. OVA challenges in sensitized rabbits caused a significant increase in the percentage of eosinophils (p = 0.008) in BAL. EMC increased minute ventilation by 36% and 35% in OVA and control rabbits respectively, compared to rest values. The sensitivity of the CR decreased during exercise compared to baseline in control rabbits (p = 0.0313) while it remained unchanged in OVA rabbits. Conclusion The desensitization of the CR during exercise in control rabbits was abolished in OVA rabbits. The precise role of airway inflammation in this lack of CR desensitization needs to be further investigated but it might contribute to the exercise-induced cough in asthmatics.	[Tiotiu, Angelica; Chenuel, Bruno; Foucaud, Laurent; Demoulin, Bruno; Demoulin-Alexikova, Silvia; Poussel, Mathias] Univ Lorraine, EA DevAH Dev Adaptat & Disadvantage 3450, Cardioresp Regulat & Motor Control, Vandoeuvre Les Nancy, France; [Tiotiu, Angelica] CHRU Nancy, Dept Pulmonol, Nancy, France; [Chenuel, Bruno; Poussel, Mathias] CHRU Nancy, Pulm Funct Testing & Exercise Physiol, Nancy, France; [Christov, Christo] Univ Lorraine, Dept Histol, Vandoeuvre Les Nancy, France	Universite de Lorraine; CHU de Nancy; CHU de Nancy; Universite de Lorraine	Tiotiu, A (corresponding author), Univ Lorraine, EA DevAH Dev Adaptat & Disadvantage 3450, Cardioresp Regulat & Motor Control, Vandoeuvre Les Nancy, France.; Tiotiu, A (corresponding author), CHRU Nancy, Dept Pulmonol, Nancy, France.	a.tiotiu@chru-nancy.fr	Poussel, Mathias/AAH-6433-2020; Demoulin-Alexikova, Silvia/AAQ-4732-2020; Tiotiu, Angelica/GVT-6259-2022; Chenuel, Bruno/G-4320-2015	Poussel, Mathias/0000-0002-4386-8606; Chenuel, Bruno/0000-0001-6619-6577				Ali S, 1996, J PHARMACOL EXP THER, V278, P639; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Belvisi MG, 2004, THORAX, V59, P438, DOI 10.1136/thx.2003.013490; BLOOM JW, 1988, IMMUNOPHARMACOLOGY, V15, P157, DOI 10.1016/0162-3109(88)90027-6; Bolser DC, 2006, RESP PHYSIOL NEUROBI, V152, P255, DOI 10.1016/j.resp.2006.01.008; Bonham AC, 2004, PULM PHARMACOL THER, V17, P453, DOI 10.1016/j.pupt.2004.09.008; Boulet LP, 2015, NEW ENGL J MED, V372, P641, DOI 10.1056/NEJMra1407552; Brozmanova M, 2006, PHYSIOL RES, V55, P577, DOI 10.33549/physiolres.930840; Chambers MA, 2000, INFECT IMMUN, V68, P7094, DOI 10.1128/IAI.68.12.7094-7099.2000; Chung KF, 2013, LANCET RESP MED, V1, P414, DOI 10.1016/S2213-2600(13)70043-2; Clay E, 2016, J PHARMACOL EXP THER, V357, P73, DOI 10.1124/jpet.115.230227; CROSS BA, 1982, J PHYSIOL-LONDON, V329, P37, DOI 10.1113/jphysiol.1982.sp014289; Del Giacco SR, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.27984; Duz M, 2010, RES VET SCI, V89, P266, DOI 10.1016/j.rvsc.2010.03.005; Fontana GA, 2002, J APPL PHYSIOL, V93, P1723, DOI 10.1152/japplphysiol.00326.2002; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Gu QH, 2008, AM J PHYSIOL-LUNG C, V294, pL544, DOI 10.1152/ajplung.00271.2007; Hallstrand TS, 2012, CURR OPIN ALLERGY CL, V12, P42, DOI 10.1097/ACI.0b013e32834ecc67; Hallstrand TS, 2009, CURR ALLERGY ASTHM R, V9, P18, DOI 10.1007/s11882-009-0003-8; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Haouzi P, 2005, J PHYSIOL-LONDON, V569, P975, DOI 10.1113/jphysiol.2005.089649; HERD CM, 1994, BRIT J PHARMACOL, V112, P292, DOI 10.1111/j.1476-5381.1994.tb13067.x; HERD CM, 1995, EUR J PHARMACOL, V282, P111, DOI 10.1016/0014-2999(95)00291-R; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; JACKSON DM, 1988, BRIT J PHARMACOL, V93, P609, DOI 10.1111/j.1476-5381.1988.tb10317.x; Kamaruzaman NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/691830; Keir S, 2008, PULM PHARMACOL THER, V21, P721, DOI 10.1016/j.pupt.2008.01.005; Kennedy MD, 2015, SCANDINAVIAN J MED S; Kingham PJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1229, DOI 10.1152/ajplung.00278.2001; Kodesh E, 2011, AM J PHYSIOL-REG I, V300, pR917, DOI 10.1152/ajpregu.00270.2010; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Lavorini F, 2010, J APPL PHYSIOL, V108, P1061, DOI 10.1152/japplphysiol.00423.2009; Liu Q, 2001, CLIN EXP ALLERGY, V31, P474, DOI 10.1046/j.1365-2222.2001.00989.x; Marchal F, 2008, RESP PHYSIOL NEUROBI, V160, P224, DOI 10.1016/j.resp.2007.10.002; Marchal F, 2012, RESP PHYSIOL NEUROBI, V180, P311, DOI 10.1016/j.resp.2011.12.006; MARSH WR, 1985, AM REV RESPIR DIS, V131, P875; McGovern AE, 2012, NEUROSCIENCE, V207, P148, DOI 10.1016/j.neuroscience.2012.01.029; Millqvist Eva, 2015, Temperature (Austin), V2, P172, DOI 10.1080/23328940.2015.1012979; Mutolo D, 2016, PULM PHARMACOL THER, V38, P1, DOI 10.1016/j.pupt.2016.04.001; Petak F, 2006, ANESTH ANALG, V103, P103, DOI 10.1213/01.ane.0000221439.87488.08; PINCKARD RN, 1977, J IMMUNOL, V119, P2185; Poussel M, 2014, PULM PHARMACOL THER, V27, P96, DOI 10.1016/j.pupt.2013.07.005; Poussel M, 2012, RESP PHYSIOL NEUROBI, V183, P20, DOI 10.1016/j.resp.2012.05.021; Schelegle ES, 2001, AM J PATHOL, V158, P333, DOI 10.1016/S0002-9440(10)63973-9; Schweitzer C, 2011, RESP PHYSIOL NEUROBI, V177, P169, DOI 10.1016/j.resp.2011.03.013; SHAMPAIN MP, 1982, AM REV RESPIR DIS, V126, P493; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; TURNER DL, 1991, J EXP BIOL, V160, P309; Varechova S, 2012, PULM PHARMACOL THER, V25, P242, DOI 10.1016/j.pupt.2012.03.006; Varechova S, 2011, BRATISL MED J, V112, P136; Varechova S, 2010, PULM PHARMACOL THER, V23, P397, DOI 10.1016/j.pupt.2010.05.008; Verratti V, 2009, J BIOL REG HOMEOS AG, V23, P203; Widdicombe J, 2001, RESP PHYSIOL, V125, P3, DOI 10.1016/S0034-5687(00)00201-2; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034; Widdicombe J, 2009, PULM PHARMACOL THER, V22, P143, DOI 10.1016/j.pupt.2008.12.009	56	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171862	10.1371/journal.pone.0171862	http://dx.doi.org/10.1371/journal.pone.0171862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182749	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800126
J	Borgstrom, E; Paterlini, M; Mold, JE; Frisen, J; Lundeberg, J				Borgstrom, Erik; Paterlini, Marta; Mold, Jeff E.; Frisen, Jonas; Lundeberg, Joakim			Comparison of whole genome amplification techniques for human single cell exome sequencing	PLOS ONE			English	Article							DISPLACEMENT AMPLIFICATION; DNA; FRAMEWORK; CANCER	Background Whole genome amplification (WGA) is currently a prerequisite for single cell whole genome or exome sequencing. Depending on the method used the rate of artifact formation, allelic dropout and sequence coverage over the genome may differ significantly. Results The largest difference between the evaluated protocols was observed when analyzing the target coverage and read depth distribution. These differences also had impact on the downstream variant calling. Conclusively, the products from the AMPLI1 and MALBAC kits were shown to be most similar to the bulk samples and are therefore recommended for WGA of single cells. Discussion In this study four commercial kits for WGA (AMPLI1, MALBAC, Repli-G and PicoPlex) were used to amplify human single cells. The WGA products were exome sequenced together with non-amplified bulk samples from the same source. The resulting data was evaluated in terms of genomic coverage, allelic dropout and SNP calling.	[Borgstrom, Erik; Lundeberg, Joakim] KTH Royal Inst Technol, Div Gene Technol, Scilifelab, Stockholm, Sweden; [Paterlini, Marta; Mold, Jeff E.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, CMB, Stockholm, Sweden	Royal Institute of Technology; SciLifeLab; Karolinska Institutet	Lundeberg, J (corresponding author), KTH Royal Inst Technol, Div Gene Technol, Scilifelab, Stockholm, Sweden.	joakim.lundeberg@scilifelab.se	t, lf/AAJ-4924-2020		Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Cancer Society; European Research Council; Karolinska Institutet; Tobias Foundation; Torsten Sbderbergs Foundation; StratRegen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society(Swedish Cancer Society); European Research Council(European Research Council (ERC)European Commission); Karolinska Institutet(Karolinska Institutet); Tobias Foundation; Torsten Sbderbergs Foundation; StratRegen	This work was supported by: Swedish Research Council, Knut and Alice Wallenberg Foundation, Swedish Cancer Society, European Research Council, Karolinska Institutet, Tobias Foundation, Torsten Sbderbergs Foundation, and StratRegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the funding agencies the Swedish Research Council, Knut and Alice Wallenberg Foundation, Swedish Cancer Society, European Research Council, Karolinska Institutet, Tobias Foundation, Torsten Soderbergs Foundation and StratRegen. We would also like to thank UPPMAX Next Generation Sequencing Cluster & Storage (UPPNEX) and the National Genomics Infrastructure at SciLifeLab Stockholm for providing access to its infrastructure.	Andrews S., 2010, FASTQC QUALITY CONTR; Bergen AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/humu.20213; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Carneiro MO, 2013, CURRENT PROTOCOLS BI, V11; Chen MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114520; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Hasmats J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084785; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Uda A, 2007, JPN J INFECT DIS, V60, P355; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	25	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171566	10.1371/journal.pone.0171566	http://dx.doi.org/10.1371/journal.pone.0171566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207771	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500038
J	Kosaka, PM; Pini, V; Calleja, M; Tamayo, J				Kosaka, Priscila M.; Pini, Valerio; Calleja, Montserrat; Tamayo, Javier			Ultrasensitive detection of HIV-1 p24 antigen by a hybrid nanomechanical-optoplasmonic platform with potential for detecting HIV-1 at first week after infection	PLOS ONE			English	Article							SENSITIVITY; BIOMARKERS; BIOSENSORS; DIAGNOSIS; PROTEIN	Early detection of HIV infection is the best way to prevent spread of the disease and to improve the efficiency of the antiretroviral therapy. Nucleic acid amplification tests (NAAT) have become the gold-standard for detecting low-concentrations of the virus in blood. However, these methods are technically demanding and cost-prohibitive in developing countries. Immunoassays are more affordable and can be more easily adapted for point-of-care diagnosis. However, the sensitivity so far of these methods has been too low. We here report the development of a sandwich immunoassay that combines nanomechanical and optoplasmonic transduction methods for detecting the HIV-1 capsid antigen p24 in human serum. The immunoreactions take place on the surface of a compliant microcantilever where gold nano particles are used as both mechanical and plasmonic labels. The microcantilever acts as both a mechanical resonator and an optical cavity for the transduction of the mechanical and plasmonic signals. The limit of detection of the immunoassay is 10(-17) g/mL that is equivalent to one virion in 10 mL of plasma. This is 5 orders of magnitude better than last generation of approved immunoassays and 2 orders of magnitude better than NAAT. This technology meets the demands to be produced en masse at low cost and the capability for miniaturization to be used at the point-of-care.	[Kosaka, Priscila M.; Pini, Valerio; Calleja, Montserrat; Tamayo, Javier] CSIC, IMM, CNM, PTM, Isaac Newton 8, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Kosaka, PM; Tamayo, J (corresponding author), CSIC, IMM, CNM, PTM, Isaac Newton 8, Madrid, Spain.	priscila@imm.cnm.csic.es; jtamayo@imm.cnm.csic.es	calleja, montserrat/B-7857-2014; Tamayo, Javier/M-2781-2014; Kosaka, Priscila M/A-4641-2012; Pini, Valerio/A-1682-2014	calleja, montserrat/0000-0003-2414-5725; Tamayo, Javier/0000-0002-5280-7215; Kosaka, Priscila M/0000-0003-4242-7064; Pini, Valerio/0000-0001-5615-1471	Spanish Ministry of Economy and Competitiveness [MAT2015-66904-R]; Spanish Association against Cancer (AECC) Scientific Foundation [PS15153089TAMA]; Fundacion General CSIC (Program ComFuturo)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Association against Cancer (AECC) Scientific Foundation; Fundacion General CSIC (Program ComFuturo)	This study has been supported by the Spanish Ministry of Economy and Competitiveness (grant MAT2015-66904-R) and Spanish Association against Cancer (AECC) Scientific Foundation (grant PS15153089TAMA). PMK acknowledges financial support by Fundacion General CSIC (Program ComFuturo).	Alvarez M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164537; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Cabrera C, 2015, CLIN CHEM, V61, P1372, DOI 10.1373/clinchem.2015.243287; Cohen MS, 2001, NEW ENGL J MED, V364, P1943; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; Fan PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125701; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Kosaka PM, 2014, NAT NANOTECHNOL, V9, P1047, DOI [10.1038/nnano.2014.250, 10.1038/NNANO.2014.250]; Kosaka PM, 2013, ANALYST, V138, P863, DOI 10.1039/c2an36192b; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Malvar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13452; Martinez NF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3525090; Nakatsuma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131319; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002; Schmidt MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2109; Tamayo J, 2013, CHEM SOC REV, V42, P1287, DOI 10.1039/c2cs35293a; Tamayo J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/31/315501; Uddin R, 2016, BIOSENS BIOELECTRON, V85, P351, DOI 10.1016/j.bios.2016.05.023	23	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171899	10.1371/journal.pone.0171899	http://dx.doi.org/10.1371/journal.pone.0171899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199410	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400058
J	Nordell, CJ; Hache, S; Bayne, EM; Solymos, P; Foster, KR; Godwin, CM; Krikun, R; Pyle, P; Hobson, KA				Nordell, Cameron J.; Hache, Samuel; Bayne, Erin M.; Solymos, Peter; Foster, Kenneth R.; Godwin, Christine M.; Krikun, Richard; Pyle, Peter; Hobson, Keith A.			Within-Site Variation in Feather Stable Hydrogen Isotope (delta H-2(f)) Values of Boreal Songbirds: Implications for Assignment to Molt Origin (vol 11, e0163957, 2016)	PLOS ONE			English	Correction													Sólymos, Péter/B-2775-2008	Sólymos, Péter/0000-0001-7337-1740	Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Conservation Association; Environment Canada; NSERC Postgraduate Scholarship; Queen Elizabeth II Graduate Scholarship (University of Alberta); Canadian Circumpolar Institute; Northern Scientific Program (University of Alberta); Dissertation Fellowship (University of Alberta); Syncrude Canada Ltd; Hammerstone Corporation; Canadian Natural Resources Limited; ConocoPhillips Canada; Husky Oil Operations Ltd; Imperial Oil Ltd; Suncor Energy; TOTAL EP Canada; Cenovus Energy; Devon Energy	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association; Environment Canada(CGIAR); NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship (University of Alberta); Canadian Circumpolar Institute; Northern Scientific Program (University of Alberta); Dissertation Fellowship (University of Alberta); Syncrude Canada Ltd; Hammerstone Corporation; Canadian Natural Resources Limited; ConocoPhillips Canada; Husky Oil Operations Ltd; Imperial Oil Ltd; Suncor Energy; TOTAL EP Canada; Cenovus Energy; Devon Energy	The following information is missing from the Funding section: This study was supported by research grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to E.M.B. and K.A.H., Conservation Funds from the Alberta Conservation Association to E.M.B., an operating grant from Environment Canada to K.A.H., a NSERC Postgraduate Scholarship, Queen Elizabeth II Graduate Scholarship (University of Alberta), grants from the Canadian Circumpolar Institute and the Northern Scientific Program (University of Alberta), and a Dissertation Fellowship (University of Alberta) to S.H. Funding in support of the Boreal MAPS in the Oil Sands Program was provided by Syncrude Canada Ltd., Hammerstone Corporation, Canadian Natural Resources Limited., Cenovus Energy, ConocoPhillips Canada, Devon Energy, Husky Oil Operations Ltd., Imperial Oil Ltd., Suncor Energy, and TOTAL E&P Canada.; The following information is missing from the Competing Interests section: The authors received funding in support of the Boreal MAPS in the Oil Sands Program from Syncrude Canada Ltd., Hammerstone Corporation, Canadian Natural Resources Limited, Cenovus Energy, ConocoPhillips Canada, Devon Energy, Husky Oil Operations Ltd., Imperial Oil Ltd., Suncor Energy, and TOTAL E&P Canada, all commercial companies, for this study.	Nordell CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163957	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172619	10.1371/journal.pone.0172619	http://dx.doi.org/10.1371/journal.pone.0172619			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199421	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400096
J	Kleinstern, G; Abu Seir, R; Perlman, R; Khatib, A; Abdeen, Z; Elyan, H; Nirel, R; Amir, G; Ramlawi, A; Sabatin, F; Boffetta, P; Dann, EJ; Kedmi, M; Ellis, M; Nagler, A; Ben Yehuda, D; Paltiel, O				Kleinstern, Geffen; Abu Seir, Rania; Perlman, Riki; Khatib, Areej; Abdeen, Ziad; Elyan, Husein; Nirel, Ronit; Amir, Gail; Ramlawi, Asad; Sabatin, Fouad; Boffetta, Paolo; Dann, Eldad J.; Kedmi, Meirav; Ellis, Martin; Nagler, Arnon; Ben Yehuda, Dina; Paltiel, Ora			Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians	PLOS ONE			English	Article							POOLED ANALYSIS; HEMATOLOGICAL MALIGNANCIES; ALCOHOL-CONSUMPTION; EPIDEMIOLOGY; COHORT; CLASSIFICATION; CONSORTIUM; INTERLYMPH; PATTERNS; EXPOSURE	Background Risk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Palestinian Arabs (PA) and Israeli Jews (IJ). Methods In a case-control study we investigated self-reported medical and lifestyle exposures, reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-NHL and subtypes. Results We recruited 823 cases and 808 healthy controls. Among 307 PA/516 IJ B-NHL cases (mean age at diagnosis = 51 [+/- 17] versus 60 [+/- 15] years, respectively) subtype distributions differed, with diffuse large B-cell lymphoma (DLBCL) being prominent among PA (71%) compared to IJ (41%); follicular lymphoma (FL), was observed in 14% versus 28%, and marginal zone lymphoma, in 2% versus 14%, respectively. Overall B-NHL in both populations was associated with recreational sun exposure OR = 1.43 [CI: 1.07-1.91], black hair-dye use OR = 1.70 [CI: 1.00-2.87], hospitalization for infection OR = 1.68 [CI: 1.34-2.11], and first-degree relative with hematopoietic cancer, OR = 1.69 [CI: 1.16-2.48]. An inverse association was noted with alcohol use, OR = 0.46 [CI: 0.34-0.62]. Subtype-specific exposures included smoking (FL, OR = 1.46 [CI: 1.01-2.11]) and > monthly indoor pesticide use (DLBCL, OR = 2.01 [CI: 1.35-3.00]). Associations observed for overall B-NHL in PA only included: gardening OR = 1.93 [CI: 1.39-2.70]; history of herpes, mononucleosis, rubella, blood transfusion (OR> 2.5, P< 0.01 for all); while for IJ risk factors included growing fruits and vegetables, OR = 1.87 [CI: 1.11-3.15]; and self-reported autoimmune diseases, OR = 1.99 [CI: 1.34-2.95]. Conclusions In these geographically proximate populations we found some unique risk factors for B-NHL. Heterogeneity in the observed associations by ethnicity could reflect differences in lifestyle, medical systems, and reporting patterns, while variations by histology infer specific etiologic factors for lymphoma subtypes.	[Kleinstern, Geffen; Paltiel, Ora] Hadassah Hebrew Univ Med Org, Sch Publ Hlth, Jerusalem, Israel; [Abu Seir, Rania; Perlman, Riki; Ben Yehuda, Dina; Paltiel, Ora] Hadassah Hebrew Univ Med Ctr, Dept Hematol, Jerusalem, Israel; [Abu Seir, Rania] Al Quds Univ, Dept Med Lab Sci, Fac Hlth Profess, Abu Deis, West Bank, Palestine; [Khatib, Areej; Sabatin, Fouad] Augusta Victoria Hosp, Canc Care Ctr, East Jerusalem, Palestine; [Abdeen, Ziad] Al Quds Univ, Dept Community Med, Sch Fac Med, Abu Deis, West Bank, Palestine; [Elyan, Husein] Beit Jalla Hosp, West Bank, PA, Palestine; [Nirel, Ronit] Hebrew Univ Jerusalem, Dept Stat, Jerusalem, Israel; [Amir, Gail] Hadassah Med Ctr, Dept Pathol, Jerusalem, Israel; [Ramlawi, Asad] Minist Hlth, Dept Primary Hlth Care, Ramallah, Palestine; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Dann, Eldad J.] Technion, Rambam Med Ctr, Haifa, Israel; [Dann, Eldad J.] Technion, Rappaport Fac Med, Haifa, Israel; [Kedmi, Meirav; Nagler, Arnon] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Kedmi, Meirav; Nagler, Arnon] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Ellis, Martin] Meir Med Ctr, Kefar Sava, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Paltiel, O (corresponding author), Hadassah Hebrew Univ Med Org, Sch Publ Hlth, Jerusalem, Israel.; Paltiel, O (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Hematol, Jerusalem, Israel.	Orap@hadassah.org.il	Boffetta, Paolo/AAI-7767-2021; Abdeen, Ziad/AAC-7889-2019; Abu Seir, Rania/AAB-2992-2019	Boffetta, Paolo/0000-0002-3811-2791; Abu Seir, Rania/0000-0002-4625-9742; Kleinstern, Geffen/0000-0001-6148-0421	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government; Israel Science Foundation; and the Hadassah University Hospital compensatory fund. We gratefully acknowledge Dr. Paul Brennan from IARC for support of the original 2003 Epilymph study and for reviewing the manuscript. The funding sources played no role in the design, execution or analysis of the study.	Akhtar SS, 2009, SAUDI MED J, V30, P677; Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Ali A, 2013, ASIAN PAC J CANCER P, V14, P841, DOI 10.7314/APJCP.2013.14.2.841; Almasri NM, 2004, SAUDI MED J, V25, P609; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Besson H, 2006, INT J CANCER, V119, P901, DOI 10.1002/ijc.21913; Cahoon EK, 2015, INT J CANCER, V136, pE432, DOI 10.1002/ijc.29237; Cerhan JR, 2015, BLOOD, V126, P2265, DOI 10.1182/blood-2015-04-537498; Chiu Brian C-H, 2015, Cancer Treat Res, V165, P1, DOI 10.1007/978-3-319-13150-4_1; Diver WR, 2012, CANCER CAUSE CONTROL, V23, P1231, DOI 10.1007/s10552-012-0001-3; Engels EA, 2007, CANCER EPIDEM BIOMAR, V16, P401, DOI 10.1158/1055-9965.EPI-06-1056; Fallah M, 2014, ANN ONCOL, V25, P2025, DOI 10.1093/annonc/mdu365; GLOBOCAN, 2012, GLOBOCAN 2012 EST CA; Goldman L, 2009, CANCER CAUSE CONTROL, V20, P981, DOI 10.1007/s10552-009-9316-0; Hagner PR, 2009, BLOOD, V113, P5526, DOI 10.1182/blood-2008-11-191783; Howlader N, SEER CANC STAT REV; Israel Ministry of Health, NAT CANC REG NONH LY; Israeli Central Bureau of Statistics, HLTH SURV 2009 PEOPL; Kleinstern G, 2016, HAEMATOLOGICA; Kricker A, 2008, INT J CANCER, V122, P144, DOI 10.1002/ijc.23003; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Morton LM, 2005, LANCET ONCOL, V6, P469, DOI 10.1016/S1470-2045(05)70214-X; Nelson RA, 1997, BRIT J CANCER, V76, P1532, DOI 10.1038/bjc.1997.590; Novack L, 2008, T ROY SOC TROP MED H, V102, P787, DOI 10.1016/j.trstmh.2008.04.005; Palestinian Ministry of Health, HLTH ANN REP 2014; Paltiel O, 2000, CANCER, V88, P2357, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2357::AID-CNCR21>3.3.CO;2-V; Paltiel O, 2006, CANCER EPIDEM BIOMAR, V15, P1964, DOI 10.1158/1055-9965.EPI-06-0313; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Roman E, 2011, HISTOPATHOLOGY, V58, P4, DOI 10.1111/j.1365-2559.2010.03696.x; Sader-Ghorra C, 2014, ASIAN PAC J CANCER P, V15, P5825, DOI 10.7314/APJCP.2014.15.14.5825; Thomson WM, 2010, J DENT RES, V89, P307, DOI 10.1177/0022034509356779; Tramacere I, 2012, ANN ONCOL, V23, P2791, DOI 10.1093/annonc/mds013; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Wang SS, 2015, AM J EPIDEMIOL, V181, P406, DOI 10.1093/aje/kwu290; Yassin K, 2002, J INFECTION, V44, P252, DOI 10.1053/jinf.2001.0998	35	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171709	10.1371/journal.pone.0171709	http://dx.doi.org/10.1371/journal.pone.0171709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196110	gold, Green Published			2022-12-27	WOS:000394423900030
J	Lee, HH; Bellat, V; Law, B				Lee, Hyun Hee; Bellat, Vanessa; Law, Benedict			Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; FACTOR-I; CXCR4; CHEMOKINE; CXCL12; GROWTH; AXIS; IDENTIFICATION; ACTIVATION	Ovarian cancer (OVC) patients who receive chemotherapy often acquire drug resistance within one year. This can lead to tumor reoccurrence and metastasis, the major causes of mortality. We report a transient increase of a small distinctive CXCR4(High)/CD24(Low) cancer stem cell population (CXCR4(High)) in A2780 and SKOV-3 OVC cell lines in response to cisplatin, doxorubicin, and paclitaxel, treatments. The withdrawal of the drug challenges reversed this cell-state transition. CXCR4(High) exhibits dormancy in drug resistance and mesenchymal-like invasion, migration, colonization, and tumor formation properties. The removal of this cell population from a doxorubicin-resistant A2780 lineage (A2780/ADR) recovered the sensitivity to drug treatments. A cytotoxic peptide (CXCR4-KLA) that can selectively target cell-surface CXCR4 receptor was further synthesized to investigate the therapeutic merits of targeting CXCR4(High). This peptide was more potent than the conventional CXCR4 antagonists(AMD3100 and CTCE-9908) in eradicating the cancer stem cells. When used together with cytotoxic agents such as doxorubicin and cisplatin, the combined drug-peptide regimens exhibited a synergistic cell-killing effect on A2780, A2780/ADR,and SKOV-3. Our data suggested that chemotherapy could establish drug-resistant and tumor-initiating properties of OVC via reversible CXCR4 cell state transition. Therapeutic strategies designed to eradicate rather than antagonize CXCR4(High) might offer a far-reaching potential as supportive chemotherapy.	[Lee, Hyun Hee; Bellat, Vanessa; Law, Benedict] Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA	Cornell University	Law, B (corresponding author), Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA.	sbl2004@med.cornell.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000457]; Radiology Department, WCM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Radiology Department, WCM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000457 and Radiology Department, WCM.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Cain JW, 2011, MOL CANCER RES, V9, P637, DOI 10.1158/1541-7786.MCR-09-0237; Casagrande F, 2011, CANCER-AM CANCER SOC, V117, P5519, DOI 10.1002/cncr.26215; Chen YF, 2016, ACTA BIOCH BIOPH SIN, V48, P282, DOI 10.1093/abbs/gmv132; Chiaramonte R, 2015, INT J BIOCHEM CELL B, V66, P134, DOI 10.1016/j.biocel.2015.07.015; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Elisseeva EL, 2000, J BIOL CHEM, V275, P26799; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Forster R, 1998, J IMMUNOL, V160, P1522; Gao Y, 2015, ONCOTARGET, V6, P9313, DOI 10.18632/oncotarget.3220; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Gravina GL, 2015, PROSTATE, V75, P1227, DOI 10.1002/pros.23007; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hsu EL, 2008, CANCER LETT, V265, P113, DOI 10.1016/j.canlet.2008.02.033; Huang AF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-115; Huang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115249; Jankowski K, 2003, CANCER RES, V63, P7926; Jung HK, 2016, J CONTROL RELEASE, V235, P259, DOI 10.1016/j.jconrel.2016.06.008; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kang KS, 2013, BIOCHEM BIOPH RES CO, V432, P333, DOI 10.1016/j.bbrc.2013.01.102; Kryczek I, 2005, CANCER RES, V65, P465; Kwong J, 2009, MOL CANCER THER, V8, P1893, DOI 10.1158/1535-7163.MCT-08-0966; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Li J, 2014, BMB REP, V47, P33, DOI 10.5483/BMBRep.2014.47.1.069; Li XQ, 2014, MOL CELL BIOCHEM, V392, P77, DOI 10.1007/s11010-014-2020-8; Li XQ, 2012, CANCER LETT, V322, P169, DOI 10.1016/j.canlet.2012.02.035; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Liu W, 2014, CELL BIOCHEM BIOPHYS, V70, P1893, DOI 10.1007/s12013-014-0148-5; Long HX, 2015, ONCOTARGET, V6, P5846, DOI 10.18632/oncotarget.3462; Ma WZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18789; Margolin DA, 2011, NEOPLASIA, V13, P874, DOI 10.1593/neo.11324; Meng EH, 2012, CLIN EXP METASTAS, V29, P939, DOI 10.1007/s10585-012-9482-4; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Porcile C, 2004, ANN NY ACAD SCI, V1030, P162, DOI 10.1196/annals.1329.021; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Salomonnson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051500; Scotton CJ, 2002, CANCER RES, V62, P5930; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Takenaga M, 2004, BIOCHEM BIOPH RES CO, V320, P226, DOI 10.1016/j.bbrc.2004.05.155; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Xue BY, 2013, MOL CELL BIOCHEM, V380, P177, DOI 10.1007/s11010-013-1671-1; Yu ZH, 2014, TUMOR BIOL, V35, P4637, DOI 10.1007/s13277-014-1607-8; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171044	10.1371/journal.pone.0171044	http://dx.doi.org/10.1371/journal.pone.0171044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196146	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423900010
J	Lim, HM; Sivasampu, S; Khoo, EM; Noh, KM				Lim, Huy Ming; Sivasampu, Sheamini; Khoo, Ee Ming; Noh, Kamaliah Mohamad			Chasm in primary care provision in a universal health system: Findings from a nationally representative survey of health facilities in Malaysia	PLOS ONE			English	Article							ENGLAND; COVERAGE	Background Malaysia has achieved universal health coverage since 1980s through the expansion of direct public provision, particularly in rural areas. However, no systematic examination of the rural-urban distribution of primary care services and resources has been conducted to date for policy impact evaluation. Methods We conducted a national cross-sectional survey of 316 public and 597 private primary care clinics, selected through proportionate stratified random sampling, from June 2011 through February 2012. Using a questionnaire developed based on the World Health Organization toolkits on monitoring health systems strengthening, we examined the availability of primary care services/resources and the associations between service/resource availability and clinic ownership, locality, and patient load. Data were weighted for all analyses to account for the complex survey design and produce unbiased national estimates. Results Private primary care clinics and doctors outnumbered their public counterparts by factors of 5.6 and 3.9, respectively, but the private clinics were significantly less well-equipped with basic facilities and provided a more limited range of services. Per capita densities of primary care clinics and workforce were higher in urban areas (2.2 clinics and 15.1 providers per 10,000 population in urban areas versus 1.1 clinics and 11.7 providers per 10,000 population in rural areas). Within the public sector, the distribution of health services and resources was unequal and strongly favored the urban clinics. Regression analysis revealed that rural clinics had lower availability of services and resources after adjusting for ownership and patient load, but the associations were not significant except for workforce availability (adjusted odds ratio [OR]: 0.82; 95% confidence interval [CI]: 0.71-0.96). Conclusions Targeted primary care expansion in rural areas could be an effective first step towards achieving universal health coverage, especially in countries with limited healthcare resources. Nonetheless, geographic expansion alone is inadequate to achieve effective coverage in a dichotomous primary care system, and the role of the private sector in primary care delivery should not be overlooked.	[Lim, Huy Ming; Sivasampu, Sheamini] Minist Hlth, Natl Inst Hlth, Healthcare Stat Unit, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Khoo, Ee Ming] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Noh, Kamaliah Mohamad] Minist Hlth, Family Hlth Dev Div, Putrajaya, Malaysia	Kementerian Kesihatan Malaysia; Universiti Malaya; Kementerian Kesihatan Malaysia	Lim, HM (corresponding author), Minist Hlth, Natl Inst Hlth, Healthcare Stat Unit, Natl Clin Res Ctr, Kuala Lumpur, Malaysia.	huyming@moh.gov.my	Lim, Huy Ming/GPW-6405-2022; KHOO, EE MING/B-8785-2010; Noh, Kamaliah Mohamad/AAD-2694-2020	KHOO, EE MING/0000-0003-3191-1264; Noh, Kamaliah Mohamad/0000-0001-5744-0515; Sivasampu, Sheamini/0000-0003-2314-6048; Lim, Huy Ming/0000-0002-4588-2233	Ministry of Health Malaysia via the Ministry of Health-National Institutes of Health Research Grant [NMRR-09-842-4718]	Ministry of Health Malaysia via the Ministry of Health-National Institutes of Health Research Grant	This study was funded by the Ministry of Health Malaysia via the Ministry of Health-National Institutes of Health Research Grant (grant number NMRR-09-842-4718). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariff Kamil Mohamed, 2002, Aust J Rural Health, V10, P99, DOI 10.1046/j.1440-1584.2002.00456.x; Asaria M, 2016, J EPIDEMIOL COMMUN H, V70, P637, DOI 10.1136/jech-2015-206742; Asaria M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008783; Australian Institute of Health and Welfare, 2014, AUSTR I HLTH WELF NA, V8; Chee Heng Leng, 2007, HLTH CARE MALAYSIA D; Chua HT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S7; D?az Y., 2013, IMPACT UNIVERSAL COV; Department of Statistics Malaysia, 2013, POP DISTR BAS DEM CH; Dixon Anna, 2007, J Health Serv Res Policy, V12, P104, DOI 10.1258/135581907780279549; Goddard M, 2010, J HEALTH SERV RES PO, V15, P28, DOI 10.1258/jhsrp.2009.009003; Hann M, 2004, BRIT J GEN PRACT, V54, P894; Institute for Public Health, 2008, 3 NAT HLTH MORB SURV; Institute for Public Health, 2011, NAT HLTH MOTB SURV 2; JAAFAR S, 2013, HLTH SYSTEM TRANSITI, V3, P1; Jahan NK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S8; Kahabuka C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-315; Lumley T, 2004, J STAT SOFTW, V9; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Maeda A, 2014, DIR DEV, P1, DOI 10.1596/978-1-4648-0297-3; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Paul Bimal Kanti, 2002, Transactions of the Kansas Academy of Science, V105, P79, DOI 10.1660/0022-8443(2002)105[0079:PCPBIR]2.0.CO;2; Rural Health West, 2014, RUR REM PRIM HLTH CA; Savedoff WD, 2011, ACHIEVING UNIVERSAL; Sivasampu S., 2011, NATL HEALTHCARE ESTA; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; The Centre for Workforce Intelligence, 2014, DEPTH REV GEN PRACT; United Nations, 2015, 2030 AG SUST DEV; WHO, 2010, MONITORING BUILDING; World Health Organization, 2015, TRACK UN HLTH COV 1	31	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172229	10.1371/journal.pone.0172229	http://dx.doi.org/10.1371/journal.pone.0172229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196113	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900061
J	Ouyang, W; Yan, QC; Zhang, Y; Fan, ZH				Ouyang, Wei; Yan, Qichao; Zhang, Yu; Fan, Zhiheng			Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; SPATIAL MEMORY; RECOGNITION MEMORY; THETA-FREQUENCY; WORKING-MEMORY; HIPPOCAMPAL; STIMULATION; MODEL; ANTAGONISTS	Moderate traumatic brain injury (TBI) in children often happen when there's a sudden blow to the frontal bone, end with long unconscious which can last for hours and progressive cognitive deficits. However, with regard to the influences of moderate TBI during children adulthood, injury-induced alterations of locomotive ability, long-term memory performance, and hippocampal electrophysiological firing changes have not yet been fully identified. In this study, lateral fluid percussion (LFP) method was used to fabricate moderate TBI in motor and somatosensory cortex of the 6-weeks-old mice. The motor function, learning and memory function, extracellular CA1 neural spikes were assessed during acute and subacute phase. Moreover, histopathology was performed on day post injury (DPI) 16 to evaluate the effect of TBI on tissue and cell morphological changes in cortical and hippocampal CA1 subregions. After moderate LFP injury, the 6-weeks-old mice showed severe motor deficits at the early stage in acute phase but gradually recovered later during adulthood. At the time points in acute and subacute phase after TBI, novel object recognition (NOR) ability and spatial memory functions were consistently impaired in TBI mice; hippocampal firing frequency and burst probability were hampered. Analysis of the altered burst firing shows a clear hippocampal theta rhythm drop. These electrophysiological impacts were associated with substantially lowered NOR preference as compared to the sham group during adulthood. These results suggest that moderate TBI introduced at motorsenory cortex in 6-weeks- old mice causes obvious motor and cognitive deficits during their adulthood. While the locomotive ability progressively recovers, the cognitive deficits persisted while the mice mature as adult mice. The cognitive deficits may be attributed to the general suppressing of whole neural network, which could be labeled by marked reduction of excitability in hippocampal CA1 subregion.	[Ouyang, Wei; Yan, Qichao; Fan, Zhiheng] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China; [Zhang, Yu] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China	Zhejiang Normal University; Shanxi Medical University	Ouyang, W (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China.	wouyang@zjnu.cn		Ouyang, Wei/0000-0003-2866-491X	Zhejiang Province Natural Science Foundation [LY15H090012]; General Administration of Sport of China [2014B101]	Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); General Administration of Sport of China	This work was supported by Zhejiang Province Natural Science Foundation (no. LY15H090012) and the General Administration of Sport of China (no. 2014B101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Constantinou M, 2015, BIOSYSTEMS, V136, P73, DOI 10.1016/j.biosystems.2015.08.004; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dewan MC, 2016, EPIDEMIOLOGY GLOBAL; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Guderian S, 2015, J NEUROSCI, V35, P14123, DOI 10.1523/JNEUROSCI.0801-15.2015; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Ho JW, 2015, J NEUROSCI, V35, P13323, DOI 10.1523/JNEUROSCI.2278-15.2015; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hoy K. E., 2015, CEREBRAL CORTEX; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kirkcaldie MTK, 2011, MOUSE NERVOUS SYSTEM; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parker A, 1997, EUR J NEUROSCI, V9, P2423, DOI 10.1111/j.1460-9568.1997.tb01659.x; PARKIN AJ, 1994, NEUROPSYCHOLOGIA, V32, P39, DOI 10.1016/0028-3932(94)90067-1; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Verleye M, 2003, NEUROSCI LETT, V353, P127, DOI 10.1016/j.neulet.2003.09.010; Warburton EC, 2015, BEHAV BRAIN RES, V285, P131, DOI 10.1016/j.bbr.2014.09.050; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	61	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171976	10.1371/journal.pone.0171976	http://dx.doi.org/10.1371/journal.pone.0171976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196142	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900040
J	Shibulal, B; Al-Bahry, SN; Al-Wahaibi, YM; Elshafie, AE; Al-Bemani, AS; Joshi, SJ				Shibulal, Biji; Al-Bahry, Saif N.; Al-Wahaibi, Yahya M.; Elshafie, Abdulkadir E.; Al-Bemani, Ali S.; Joshi, Sanket J.			The potential of indigenous Paenibacillus ehimensis BS1 for recovering heavy crude oil by biotransformation to light fractions	PLOS ONE			English	Article							HYDROCARBON-DEGRADING BACTERIA; CHAIN N-ALKANES; GENUS PAENIBACILLUS; CONTAMINATED SOIL; BACILLUS-SUBTILIS; BIODEGRADATION; WATER; DEGRADATION; REDUCTION; RESERVOIR	Microbial Enhanced Oil Recovery (MEOR) is a potential technology for residual heavy oil recovery. Many heavy oil fields in Oman and elsewhere have difficulty in crude oil recovery because it is expensive due to its high viscosity. Indigenous microbes are capable of improving the fluidity of heavy oil, by changing its high viscosity and producing lighter oil fractions. Many spore forming bacteria were isolated from soil samples collected from oil fields in Oman. Among the isolates, an autochthonous spore-forming bacterium was found to enhance heavy oil recovery, which was identified by 16S rDNA sequencing as Paenibacillus ehimensis BS1. The isolate showed maximum growth at high heavy oil concentrations within four days of incubation. Biotransformation of heavy crude oil to light aliphatic and aromatic compounds and its potential in FOR was analyzed under aerobic and anaerobic reservoir conditions. The isolates were grown aerobically in Bushnell-Haas medium with 1% (w/v) heavy crude oil. The crude oil analyzed by GC-MS showed a significant biotransformation from the ninth day of incubation under aerobic conditions. The total biotransformation of heavy crude oil was 67.1% with 45.9% in aliphatic and 85.3% in aromatic fractions. Core flooding experiments were carried out by injecting the isolates in brine supplemented with Bushnell-Haas medium into Berea sandstone cores and were incubated for twelve days under oil reservoir conditions (50 degrees C). The extra recovered oil was analyzed by GC-MS. The residual oil recovered from core flood experiments ranged between 10-13% compared to the control experiment. The GC-MS analyses of the extra recovered oil showed 38.99% biotransformation of heavy to light oil. The results also indicated the presence of 22.9% extra aliphatic compounds in the residual crude oil recovered compared to that of a control. The most abundant compound in the extra recovered crude oil was identified as 1-bromoeicosane. The investigations showed the potential of P. ehimensis BS1 in MEOR technology by the biotransformation of heavy to lighter crude oil under aerobic and reservoir conditions. Heavy oil recovery and biotransformation to lighter components are of great economic value and a few studies have been done.	[Shibulal, Biji; Al-Bahry, Saif N.; Elshafie, Abdulkadir E.; Joshi, Sanket J.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Wahaibi, Yahya M.; Al-Bemani, Ali S.] Sultan Qaboos Univ, Dept Petr & Chem Engn, Coll Engn, Muscat, Oman; [Joshi, Sanket J.] Sultan Qaboos Univ, Coll Sci, Cent Analyt & Appl Res Unit, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University	Al-Bahry, SN (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	snbahry@squ.edu.om	SHIBULAL, BIJI/ABD-6344-2021; Joshi, Sanket J./ABF-4999-2020	Joshi, Sanket J./0000-0001-7746-9905; Al-Bemani, Ali/0000-0003-3535-2586; Al-Wahaibi, Yahya/0000-0001-9580-6274; Shibulal, Biji/0000-0001-5339-2333				Al-Hattali R, 2013, J PETROL SCI ENG, V112, P178, DOI 10.1016/j.petrol.2013.11.003; Al-Sayegh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0330-5; Alinnor I.J., 2013, J ENV CHEM ECOTOXICO, V5, P292, DOI [10.5897/JECE2013.0298, DOI 10.5897/JECE2013.0298]; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Bagga J, 2015, ENG TECHNOLOGY, V4, P9993, DOI DOI 10.15680/IHRSET.2015.0410098; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Beckman J., 1926, IND ENG CHEM NEWS, V4, P3; Binazadeh M, 2009, ENZYME MICROB TECH, V45, P195, DOI 10.1016/j.enzmictec.2009.06.001; Brooijmans RJW, 2009, MICROB BIOTECHNOL, V2, P587, DOI 10.1111/j.1751-7915.2009.00151.x; Brown F. G., 1992, PERM BAS OIL GAS REC; Bruins MR, 2000, ECOTOX ENVIRON SAFE, V45, P198, DOI 10.1006/eesa.1999.1860; Calvo C, 2004, J BIOTECHNOL, V109, P255, DOI 10.1016/j.jbiotec.2004.01.009; COOPER DG, 1981, APPL ENVIRON MICROB, V42, P408, DOI 10.1128/AEM.42.3.408-412.1981; da Cunha CD, 2006, APPL MICROBIOL BIOT, V73, P949, DOI 10.1007/s00253-006-0531-2; Davey ME, 1998, GEOMICROBIOL J, V15, P335, DOI 10.1080/01490459809378087; Deng D, 1999, SPE AS PAC OIL GAS C; DIBBLE JT, 1979, APPL ENVIRON MICROB, V37, P729, DOI 10.1128/AEM.37.4.729-739.1979; Etoumi A, 2008, J IND MICROBIOL BIOT, V35, P1241, DOI 10.1007/s10295-008-0420-z; FELIX JA, 1971, J APPL BACTERIOL, V34, P411, DOI 10.1111/j.1365-2672.1971.tb02300.x; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fingas M., 2014, BASICS OIL SPILL CLE; Grishchenkov VG, 2000, PROCESS BIOCHEM, V35, P889, DOI 10.1016/S0032-9592(99)00145-4; Gudina EJ, 2012, INT BIODETER BIODEGR, V68, P56, DOI 10.1016/j.ibiod.2012.01.001; Haferburg G, 2007, J BASIC MICROB, V47, P453, DOI 10.1002/jobm.200700275; HAMBRICK GA, 1980, APPL ENVIRON MICROB, V40, P365, DOI 10.1128/AEM.40.2.365-369.1980; Hilyard EJ, 2008, APPL ENVIRON MICROB, V74, P1176, DOI 10.1128/AEM.01518-07; Hunt J.M., 1979, PETROLEUM GEOCHEMIST; IJAH U J J, 1992, Waste Management, V12, P55, DOI 10.1016/0956-053X(92)90009-8; Kalish PJ, 1964, EFFECT BACTERIA SAND; Kato T, 2001, APPL MICROBIOL BIOT, V55, P794, DOI 10.1007/s002530000556; Kleinheinz GT, 1997, J MICROBIOL METH, V29, P139, DOI 10.1016/S0167-7012(97)00033-X; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Koubek J, 2012, INT BIODETER BIODEGR, V69, P82, DOI 10.1016/j.ibiod.2011.12.007; Lee JS, 2004, INT J SYST EVOL MICR, V54, P929, DOI 10.1099/ijs.0.02765-0; LEON V, 2000, J CODICID, V2, P34; Li QX, 2002, BIOCHEM ENG J, V11, P197, DOI 10.1016/S1369-703X(02)00025-6; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Liu JF, 2005, J PETROL SCI ENG, V48, P265, DOI 10.1016/j.petrol.2005.06.008; Madigan M.T., 2003, BROCK BIOL MICROORGA, P137; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Marshall S.L., 2008, FUNDAMENTAL ASPECTS; Martinez AR, 1984, FUTURE HEAVY CRUDE T; Minai-Tehrani Dariush, 2007, Bioremediation Journal, V11, P71, DOI 10.1080/10889860701351589; Mittal A, 2009, INDIAN J EXP BIOL, V47, P760; Ojo OA, 2006, AFR J BIOTECHNOL, V5, P333; Ouoba LII, 2003, J APPL MICROBIOL, V95, P868, DOI 10.1046/j.1365-2672.2003.02063.x; Palanisamy N, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0142-2; Petersen N, 1987, CALIFORNIA PLIO MIOC; Rahman KSM, 2002, BIORESOURCE TECHNOL, V85, P257, DOI 10.1016/S0960-8524(02)00119-0; RAIDERS RA, 1989, J IND MICROBIOL, V4, P215, DOI 10.1007/BF01574079; Roadifer RE, 1987, SIZE DISTRIBUTION WO; Sabirova JS, 2006, J BACTERIOL, V188, P3763, DOI 10.1128/JB.00072-06; Scherzer J., 1996, HYDROCRACKING SCI TE, V1st ed.; Sepahi AA, 2008, IRAN J ENVIRON HEALT, V5, P149; She YH, 2011, APPL BIOCHEM BIOTECH, V163, P223, DOI 10.1007/s12010-010-9032-y; Shibulal B, 2014, SCI WORLD J, DOI 10.1155/2014/309159; Sobolev Dmitri, 2008, Int J Environ Res Public Health, V5, P450; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; US Environmental Protection Agency (USEPA), 2014, 8270D USEPA; Wang J, 2008, PETROL SCI, V5, P367, DOI 10.1007/s12182-008-0061-x; Wang L, 2006, EXTREMOPHILES, V10, P347, DOI 10.1007/s00792-006-0505-4; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Wu L, 2014, INT J CURR MICROBIOL, V3, P586; Wu WH, 1999, J PETROL SCI ENG, V22, P25, DOI 10.1016/S0920-4105(98)00053-9; Xu J, 2012, BIOREMEDIATION CRUDE; Yaghi BM, 2002, ENERG SOURCE, V24, P93, DOI 10.1080/00908310252774417; Yan SP, 2013, BIOTECHNOL BIOTEC EQ, V27, P3932, DOI 10.5504/BBEQ.2013.0050; Zhang Y, 1999, MICROBIAL EOR LAB ST; Zhuang WQ, 2003, LETT APPL MICROBIOL, V36, P251, DOI 10.1046/j.1472-765X.2003.01297.x	69	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171432	10.1371/journal.pone.0171432	http://dx.doi.org/10.1371/journal.pone.0171432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196087	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900020
J	Cavagnolli, G; Pimentel, AL; Freitas, PAC; Gross, JL; Camargo, JL				Cavagnolli, Gabriela; Pimentel, Ana Laura; Correa Freitas, Priscila Aparecida; Gross, Jorge Luiz; Camargo, Joiza Lins			Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis	PLOS ONE			English	Review							CROSS-SECTIONAL ANALYSIS; GLYCATED HEMOGLOBIN; RACIAL-DIFFERENCES; GLYCEMIC MARKERS; CLINICAL-IMPLICATIONS; GLYCOSYLATION GAP; SOUTH ASIANS; HBA(1C); DIAGNOSIS; A(1C)	Aims/Hypothesis Disparities in HbA1c levels have been observed among ethnic groups. Most studies were performed in patients with diabetes mellitus (DM), which may interfere with results due to the high variability of glucose levels. We conducted a systematic review and meta-analysis to investigate the effect of ethnicity on HbA1c levels in individuals without DM. Methods This is a systematic review with meta-analysis. We searched MEDLINE and EMBASE up to September 2016. Studies published after 1996, performed in adults without DM, reporting HbA1c results measured by certified/ standardized methods were included. A random effects model was used and the effect size was presented as weighted HbA1c mean difference (95% CI) between different ethnicities as compared to White ethnicity. Results Twelve studies met the inclusion criteria, totalling data from 49,238 individuals. There were significant differences between HbA1c levels in Blacks [0.26% (2.8 mmol/mol); 95% CI 0.18 to 0.33 (2.0 to 3.6), p < 0.001; I-2 = 90%, p < 0.001], Asians [0.24% (2.6 mmol/mol); 95% CI 0.16 to 0.33 (1.7 to 3.6), p < 0.001; I-2 = 80%, p = 0.0006] and Latinos [0.08% (0.9 mmol/mol); IC 95% 0.06 to 0.10 (0.7 to 1.1); p < 0.001; I-2 = 0%; p = 0.72] when compared to Whites. Conclusions/Interpretation This meta-analysis shows that, in individuals without DM, HbA1c values are higher in Blacks, Asians, and Latinos when compared to White persons. Although small, these differences might have impact on the use of a sole HbA1c point to diagnose DM in all ethnic populations.	[Cavagnolli, Gabriela; Pimentel, Ana Laura; Correa Freitas, Priscila Aparecida; Gross, Jorge Luiz; Camargo, Joiza Lins] Univ Fed Rio Grande do Sul, Grad Program Endocrinol, Porto Alegre, RS, Brazil; [Cavagnolli, Gabriela] Ctr Univ FSG, Caxias Do Sul, Brazil; [Correa Freitas, Priscila Aparecida] Santa Casa de Misericordia Porto Alegre, Lab Transplantat Immunol, Porto Alegre, RS, Brazil; [Gross, Jorge Luiz; Camargo, Joiza Lins] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Camargo, JL (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Endocrinol, Porto Alegre, RS, Brazil.; Camargo, JL (corresponding author), Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil.	jcamargo@hcpa.edu.br	Freitas, Priscila Aparecida Correa/AAU-4741-2021; Camargo, Joiza Lins/G-9301-2011	Camargo, Joiza Lins/0000-0001-8834-4075; Freitas, Priscila/0000-0001-9996-5600	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA) [100268]; Fundcao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [1987-2551/13-0 - PqG 2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Fundcao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA), grant number 100268 and by the Fundcao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), grant number 1987-2551/13-0 - PqG 2013. GC received a scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), ALP and PACF received scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Avemaria F, 2015, CLIN CHEM LAB MED, V53, P1315, DOI 10.1515/cclm-2015-0207; Aviles-Santa ML, 2016, DIABETES CARE, V39, P1010, DOI 10.2337/dc15-2579; Bower JK, 2013, DIABETES CARE, V36, P569, DOI 10.2337/dc12-0404; Burden ML., 1999, PRACT DIABETES INT, V16, P211; Carson AP, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000213; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Cavagnolli G, 2015, CLIN CHIM ACTA, V445, P107, DOI 10.1016/j.cca.2015.03.024; Chapp-Jumbo E, 2012, ENDOCR PRACT, V18, P356, DOI 10.4158/EP11245.OR; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Christenson RH, 2011, CLIN CHEM, V57, P816, DOI 10.1373/clinchem.2010.157131; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; de Miranda VA, 2013, PRIM CARE DIABETES, V7, P135, DOI 10.1016/j.pcd.2013.01.007; de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986; Drake TC, 2016, DIABETES OBES METAB, V18, P92, DOI 10.1111/dom.12569; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Hanas R, 2010, DIABETES RES CLIN PR, V90, P228, DOI 10.1016/j.diabres.2010.05.011; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2016, DIABETES CARE, V39, P1458, DOI 10.2337/dc15-2686; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Kehl KG, 2011, EUR J ENDOCRINOL, V165, P275, DOI 10.1530/EJE-11-0171; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Likhari T, 2009, DIABETIC MED, V26, P1068, DOI 10.1111/j.1464-5491.2009.02803.x; Likhari T, 2010, J CLIN PATHOL, V63, P278, DOI 10.1136/jcp.2009.065821; Little RR, 2001, CLIN CHEM, V47, P1985; Maruthur NM, 2011, DIABETES, V60, P2434, DOI 10.2337/db11-0319; Mohas M, 2010, EXP CLIN ENDOCR DIAB, V118, P209, DOI 10.1055/s-0029-1238319; Mostafa SA, 2010, DIABETIC MED, V27, P762, DOI 10.1111/j.1464-5491.2010.03015.x; Mostafa SA, 2012, DIABETES CARE, V35, P1746, DOI 10.2337/dc11-2079; Parrinello CM, 2016, DIABETES CARE, V39, P589, DOI 10.2337/dc15-1360; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Sacks DB, 2016, CLIN CHEM, V62, P1199, DOI 10.1373/clinchem.2016.255166; Sacks DB, 2002, CLIN CHEM, V48, P436; Selvin E, 2016, DIABETES CARE, V39, P1462, DOI 10.2337/dc16-0042; Selvin E, 2013, DIABETES CARE, V36, P2995, DOI 10.2337/dc12-2715; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shipman KE, 2015, ACTA DIABETOL, V52, P687, DOI 10.1007/s00592-014-0703-y; Silva JF, 2016, CLIN BIOCHEM, V49, P117, DOI 10.1016/j.clinbiochem.2015.09.004; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tillin T, 2013, DIABETIC MED, V30, P76; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van Schaftingen E, 2012, AMINO ACIDS, V42, P1143, DOI 10.1007/s00726-010-0780-3; Wells G.A., NEWCASTLE OTTAWA SCA; Wolffenbuttel BHR, 2013, DIABETES CARE, V36, P2931, DOI 10.2337/dc12-2711; World Health Organization, 2011, US GLYC HAEM HBA1C D; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	57	51	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171315	10.1371/journal.pone.0171315	http://dx.doi.org/10.1371/journal.pone.0171315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192447	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800018
J	Desselas, E; Pansieri, C; Leroux, S; Bonati, M; Jacqz-Aigrain, E				Desselas, Emilie; Pansieri, Claudia; Leroux, Stephanie; Bonati, Maurizio; Jacqz-Aigrain, Evelyne			Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry	PLOS ONE			English	Review							INHALED NITRIC-OXIDE; PREVENT BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; CLINICAL-TRIALS; PREMATURE-INFANTS; POSTNATAL CORTICOSTEROIDS; RESPIRATORY-FAILURE; MULTICENTER TRIAL; UNETHICAL USE; DOUBLE-BLIND	Background Despite specific initiatives and identified needs, most neonatal drugs are still used off-label, with variable dosage administrations and schedules. In high risk preterm and term neonates, drug evaluation is challenging and randomized controlled trials (RCT) are difficult to conduct and even more is the use of a placebo, required in the absence of a reference validated drug to be used as comparator. Methods We analyzed the complete ClinicalTrials.gov registry 1) to describe neonatal RCT involving a placebo, 2) to report on the medical context and ethical aspects of placebo use. Results Placebo versus drug RCT (n = 146), either prevention trials (n = 57, 39%) or therapeutic interventions (n = 89, 61%), represent more than a third of neonatal trials registered in the National Institute of Health clinical trial database (USA) since 1999. They mainly concerned preterm infants, evaluating complications of prematurity. Most trials were conducted in the USA, were single centered, and funded by non-profit organizations. For the three top drug trials evaluating steroids (n = 13, 9.6%), erythropoietin (EPO, n = 10, 6.8%) and nitric oxide (NO, n = 9, 6.2%), the objectives of the trial and follow-up were analyzed in more details. Conclusion Although a matter of debate, the use of placebo should be promoted in neonates to evaluate a potential new treatment, in the absence of reference drug. Analysis of the trials evaluating steroids showed that long-term follow-up of exposed patients, although required by international guidelines, is frequently missing and should be planned to collect additional information and optimize drug evaluation in these high-risk patients.	[Desselas, Emilie; Leroux, Stephanie; Jacqz-Aigrain, Evelyne] Hop Robert Debre, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Desselas, Emilie; Leroux, Stephanie; Jacqz-Aigrain, Evelyne] Hop Robert Debre, INSERM, CIC1426, Clin Invest Ctr, Paris, France; [Pansieri, Claudia; Bonati, Maurizio] IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy; [Jacqz-Aigrain, Evelyne] Univ Paris 7 Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; UDICE-French Research Universities; Universite Paris Cite	Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, Dept Pediat Pharmacol & Pharmacogenet, Paris, France.; Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, INSERM, CIC1426, Clin Invest Ctr, Paris, France.; Jacqz-Aigrain, E (corresponding author), Univ Paris 7 Diderot, Paris, France.	evelyne.jacqzaigrain@gmail.com	Bonati, Maurizio/K-8980-2016; Jacqz-Aigrain, Evelyne/AAW-7089-2021; Pansieri, Claudia/ABI-2205-2020	Bonati, Maurizio/0000-0003-3997-3726; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; Pansieri, Claudia/0000-0002-0976-7756				Ackerman Terrence F., 2002, American Journal of Bioethics, V2, P21, DOI 10.1162/152651602317533587; Allen Marilee C, 2010, Evid Rep Technol Assess (Full Rep), P1; Allmark P, 2001, J MED ETHICS, V27, P110, DOI 10.1136/jme.27.2.110; Ambalavanan N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004312; Askie LM, 2011, PEDIATRICS, V128, P729, DOI 10.1542/peds.2010-2725; Bachiocco V, 2010, PAIN, V150, P582, DOI 10.1016/j.pain.2010.05.023; Baer GR, 2006, CLIN THER, V28, P1399, DOI 10.1016/j.clinthera.2006.09.008; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; BARBIER P, 1994, THERAPIE, V49, P113; Barrington KJ, 2010, EVID BASED CHILD HLT, V5, P301; Bassler D, 2015, NEW ENGL J MED, V373, P1497, DOI 10.1056/NEJMoa1501917; Baud O, 2016, LANCET, V387, P1827, DOI 10.1016/S0140-6736(16)00202-6; Rivas AB, 2016, ARCH DIS CHILD, V101, P371, DOI 10.1136/archdischild-2015-309396; Bellieni CV, 2010, ACTA PAEDIATR, V99, P30, DOI 10.1111/j.1651-2227.2009.01570.x; Benedetti F, 2011, CLIN PHARMACOL THER, V90, P651, DOI 10.1038/clpt.2011.206; Benedetti F, 2014, EMBO REP, V15, P329, DOI 10.1002/embr.201338399; Benedetti F, 2012, WORLD PSYCHIATRY, V11, P70, DOI 10.1016/j.wpsyc.2012.05.003; Bevilacqua G, 2011, J MATERN-FETAL NEO M, V24, P171, DOI 10.3109/14767051003792779; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Boots I, 2007, EUR J PEDIATR, V166, P849, DOI 10.1007/s00431-006-0381-z; Braga LHP, 2010, J PEDIATR UROL, V6, P435, DOI 10.1016/j.jpurol.2010.02.208; Carlino E, 2012, CURR OPIN SUPPORT PA, V6, P220, DOI 10.1097/SPC.0b013e32835269c1; Chalumeau M, 2000, ARCH DIS CHILD, V83, P502, DOI 10.1136/adc.83.6.502; Choonara I, 2007, BRIT MED J, V335, P1221, DOI 10.1136/bmj.39400.376424.BE; Cohen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002632; Cole CH, 1999, NEW ENGL J MED, V340, P1005, DOI 10.1056/NEJM199904013401304; Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Cyna AM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000029; Davis JM, 2012, JAMA-J AM MED ASSOC, V308, P1435, DOI 10.1001/jama.2012.12883; de Wildt SN, 2014, ARCH DIS CHILD, V99, P1137, DOI 10.1136/archdischild-2013-305212; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garattini S, 2013, EUR J CLIN PHARMACOL, V69, P711, DOI 10.1007/s00228-012-1383-6; Giacoia GP, 2012, CLIN PERINATOL, V39, P11, DOI 10.1016/j.clp.2011.12.016; Guimaraes H, 2011, J MATERN-FETAL NEO M, V24, P855, DOI 10.3109/14767058.2010.531314; Hochwald O, 2014, INDIAN J PEDIATR, V81, P808, DOI 10.1007/s12098-013-1151-3; Jacqz-Aigrain E, 2012, CLIN INFECT DIS, V55, P1503, DOI 10.1093/cid/cis767; Jacqz-Aigrain E, 2011, EARLY HUM DEV, V87, pS27, DOI 10.1016/j.earlhumdev.2011.01.007; Jaillon P, 2007, B ACAD NAT MED PARIS, V191, P739, DOI 10.1016/S0001-4079(19)33007-9; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P573, DOI 10.1093/pch/17.10.573; Kaguelidou F, 2012, EUR J PEDIATR, V171, P439, DOI 10.1007/s00431-011-1565-8; Kairalla JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-145; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kinsella JP, 2014, J PEDIATR-US, V165, P1104, DOI 10.1016/j.jpeds.2014.06.018; Korppi M, 2013, ACTA PAEDIATR, V102, P1035, DOI 10.1111/apa.12372; Kumar P, 2014, PEDIATRICS, V133, P164, DOI 10.1542/peds.2013-3444; Li JS, 2007, JAMA-J AM MED ASSOC, V297, P480, DOI 10.1001/jama.297.5.480; Ligi I, 2011, EUR J CLIN PHARMACOL, V67, pS29, DOI 10.1007/s00228-010-0921-3; Meldrum ML, 2000, HEMATOL ONCOL CLIN N, V14, P745, DOI 10.1016/S0889-8588(05)70309-9; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Michels KB, 2003, BIOETHICS, V17, P188, DOI 10.1111/1467-8519.00332; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Neubert A, 2010, EUR J CLIN PHARMACOL, V66, P87, DOI 10.1007/s00228-009-0722-8; Pandolfini C, 2008, EUR J CLIN PHARMACOL, V64, P611, DOI 10.1007/s00228-007-0458-2; Pandolfini C, 2013, EUR J CLIN PHARMACOL, V69, P1031, DOI 10.1007/s00228-012-1415-2; Pandolfini C, 2009, ARCH DIS CHILD, V94, P717, DOI 10.1136/adc.2008.148155; Pansieri C, 2014, ARCH DIS CHILD-FETAL, V99, pE438, DOI 10.1136/archdischild-2013-305900; Papile LA, 1998, NEW ENGL J MED, V338, P1112, DOI 10.1056/NEJM199804163381604; Parikh NA, 2013, J PEDIATR-US, V162, P685, DOI 10.1016/j.jpeds.2012.09.054; Pasquali SK, 2012, PEDIATRICS, V130, pE1269, DOI 10.1542/peds.2011-3565; Peliowski A, 2012, PAED CHILD HEALT-CAN, V17, P95, DOI 10.1093/pch/17.2.95; Peltoniemi OM, 2016, ACTA PAEDIATR, V105, P159, DOI 10.1111/apa.13074; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Soll RF, 2012, NEONATOLOGY, V102, P251, DOI 10.1159/000338552; Stork E, 1997, NEW ENGL J MED, V336, P597; Turner MA, 2014, ADV DRUG DELIVER REV, V73, P2, DOI 10.1016/j.addr.2014.02.003; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Wang J, 2015, CLIN PHARMACOL THER, V98, P328, DOI 10.1002/cpt.149; Ward RM, 2015, PEDIATR DRUGS, V17, P37, DOI 10.1007/s40272-014-0099-8; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; Watterberg KL, 2010, PEDIATRICS, V126, P800, DOI 10.1542/peds.2010-1534; Winner P, 2000, PEDIATRICS, V106, P989, DOI 10.1542/peds.106.5.989; Yeh TF, 2016, AM J RESP CRIT CARE, V193, P86, DOI 10.1164/rccm.201505-0861OC	76	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171760	10.1371/journal.pone.0171760	http://dx.doi.org/10.1371/journal.pone.0171760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192509	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800040
J	Xiong, YQ; Li, JD; Ma, SJ; Ge, J; Zhou, LZ; Li, DL; Chen, Q				Xiong, YiQuan; Li, JianDong; Ma, ShuJuan; Ge, Jing; Zhou, Lizhi; Li, Dongliang; Chen, Qing			A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID FLUORESCENCE; ASSISTED TRANSURETHRAL RESECTION; WHITE-LIGHT CYSTOSCOPY; FLEXIBLE CYSTOSCOPY; PHOTODYNAMIC DIAGNOSIS; UROTHELIAL CARCINOMA; RECURRENCE; EXPERIENCE; IMPROVES; TUMORS	Objectives To assess the additional detection rate (ADR) of within-patient comparisons of Narrow band imaging (NBI) and white light cystoscopy (WLC) for non-muscle invasive bladder cancer (NMIBC) detection and compare the impact of NBI and WLC on bladder cancer recurrence risk. Methods We searched relevant studies from PubMed, Embase, Medline, Web of Science and the Cochrane Library database for all articles in English published beforeJuly26 th, 2016. Pooled ADR, diagnostic accuracy, relative risk (RR) and their 95% confidence intervals (CIs) were calculated. Results Twenty-five studies including 17 full texts and eight meeting abstracts were included for analysis. Compared to WLC, pooled ADR of NBI for NMIBC diagnosis was 9.9% (95% CI: 0.05 - 0.14) and 18.6% (95% CI: 0.15 - 0.25) in per-patient and per-lesion analysis, respectively. Pooled ADR of NBI for carcinoma in situ (CIS) diagnosis was 25.1% (95% CI: 0.09 - 0.42) and 31.1% (95% CI: 0.24 - 0.39) for per-patient and per-lesion analyses, respectively. The pooled sensitivity of NBI was significantly higher than WLC both at the per-patient (95.8% vs. 81.6%) and per-lesion levels (94.8% vs. 72.4%). In addition, NBI significantly reduced the recurrence rate of bladder cancer with a pooled RR value of 0.43 (95% CI: 0.23-0.79) and0.81 (95% CI: 0.69-0.95) at month three and twelve, respectively. Conclusions NBI is a valid technique that improves the diagnosis of NMIBC and CIS compared to standard WLC either at per-patient or per-lesion level. It can reduce the recurrence rate of bladder cancer accordingly.	[Xiong, YiQuan; Li, JianDong; Ge, Jing; Li, Dongliang; Chen, Qing] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Ma, ShuJuan] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Zhou, Lizhi] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Central South University; Southern Medical University - China	Chen, Q (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	qch.2009@163.com		Xiong, Yi-Quan/0000-0001-5978-416X				Altobelli E, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0527-5; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Bryan RT, 2007, BJU INT, V99, P21; Bryan RT, 2010, J ENDOUROL, V24, P1339, DOI 10.1089/end.2009.0598; Burger M, 2013, EUR UROL, V64, P846, DOI 10.1016/j.eururo.2013.03.059; Cauberg ECC, 2011, WORLD J UROL, V29, P503, DOI 10.1007/s00345-011-0659-2; Cauberg ECC, 2010, UROLOGY, V76, P658, DOI 10.1016/j.urology.2009.11.075; Chen GF, 2013, UROL ONCOL-SEMIN ORI, V31, P475, DOI 10.1016/j.urolonc.2011.02.009; Dalgaard L, 2015, EUROPEAN UROLOGY S, V14, pe840; Daniltchenko DI, 2005, J UROLOGY, V174, P2129, DOI 10.1097/01.ju.0000181814.73466.14; Drejer D. BS, 2016, EUR UROL SUPPL, V15, pe739; Fradet Y, 2007, J UROLOGY, V178, P68, DOI 10.1016/j.juro.2007.03.028; Geavlete B, 2012, THER ADV UROL, V4, P211, DOI 10.1177/1756287212454181; Geavlete B, 2012, UROLOGY, V79, P846, DOI 10.1016/j.urology.2011.08.081; Giulianelli R, 2015, EUROPEAN UROLOGY S, V14, pe1047; Herr H, 2010, BJU INT, V106, P53, DOI 10.1111/j.1464-410X.2009.09119.x; Herr HW, 2008, BJU INT, V102, P1111, DOI 10.1111/j.1464-410X.2008.07846.x; Jecu M, 2014, J Med Life, V7, P282; Jensen JB, 2012, EUR UROL SUPPL, V11, pE446; Kobatake K, 2015, ONCOL LETT, V10, P1097, DOI 10.3892/ol.2015.3280; Lam W, 2013, EUROPEAN UROLOGY S, V12, pe593; Lee JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1571-8; Lee JY, 2014, J UROLOGY, V191, pE240, DOI 10.1016/j.juro.2014.02.864; Li KW, 2013, INT J UROL, V20, P602, DOI 10.1111/j.1442-2042.2012.03211.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montanari Emanuele, 2012, Arch Ital Urol Androl, V84, P179; Morgan TM, 2011, CURR OPIN ONCOL, V23, P275, DOI 10.1097/CCO.0b013e3283446a11; Naito FA, 2015, J ENDOUROL, V29, pP1; Naselli A, 2012, EUR UROL, V61, P908, DOI 10.1016/j.eururo.2012.01.018; Naselli A, 2010, BJU INT, V105, P208, DOI 10.1111/j.1464-410X.2009.08701.x; Naya Y, 2015, INT J CLIN ONCOL, V20, P593, DOI 10.1007/s10147-014-0748-5; Saltirov I, 2011, EUROPEAN UROLOGY S, V10, P597; Shadpour Pejman, 2016, Nephrourol Mon, V8, pe33240, DOI 10.5812/numonthly.33240; Shen YJ, 2012, INT UROL NEPHROL, V44, P451, DOI 10.1007/s11255-011-0036-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sievert KD, 2009, WORLD J UROL, V27, P295, DOI 10.1007/s00345-009-0395-z; Song PH, 2016, CANCER RES TREAT, V48, P273, DOI 10.4143/crt.2014.190; Stenzl A, 2010, J UROLOGY, V184, P1907, DOI 10.1016/j.juro.2010.06.148; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tatsugami K, 2010, J ENDOUROL, V24, P1807, DOI 10.1089/end.2010.0055; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Ye Z, 2015, SCI REPORTS, V5; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zheng CJ, 2012, BJU INT, V110, pE680, DOI 10.1111/j.1464-410X.2012.11500.x; Zhu YP, 2012, UROL INT, V88, P84, DOI 10.1159/000333119; Zlatev DV, 2015, UROL CLIN N AM, V42, P147, DOI 10.1016/j.ucl.2015.01.001	46	32	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e010819	10.1371/journal.pone.0170819	http://dx.doi.org/10.1371/journal.pone.0170819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192481	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800012
J	Angelani, CR; Caramelo, JJ; Curto, LM; Delfino, JAM				Angelani, Carla R.; Caramelo, Julio J.; Curto, Lucrecia M.; Delfino, Jose A. M.			Structural coalescence underlies the aggregation propensity of a beta-barrel protein motif	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; CIRCULAR-DICHROISM; LIGAND-BINDING; PREDICTION; TRIFLUOROETHANOL; DELTA-98-DELTA; PEPTIDES; DISORDER	A clear understanding of the structural foundations underlying protein aggregation is an elusive goal of central biomedical importance. A step toward this aim is exemplified by the 13 barrel motif represented by the intestinal fatty acid binding protein (IFABP) and two abridged all-beta sheet forms (Delta 980 and Delta 078 Delta). At odds with the established notion that a perturbation of the native fold should necessarily favor a buildup of intermediate forms with an enhanced tendency to aggregate, the intrinsic stability (Delta G degrees(H2O)) of these proteins does not bear a straightforward correlation with their trifluoroethanol (TFE)-induced aggregation propensity. In view of this fact, we found it more insightful to delve into the connection between structure and stability under sub-aggregating conditions (10% TFE). In the absence of the co-solvent, the abridged variants display a common native-like region decorated with a disordered C-terminal stretch. Upon TFE addition, an increase in secondary structure content is observed, assimilating them to the parent protein. In this sense, TFE perturbs a common native like region while exerting a global compaction effect. Importantly, in all cases, fatty acid binding function is preserved. Interestingly, energetic as well as structural diversity in aqueous solution evolves into a common conformational ensemble more akin in stability. These facts reconcile apparent paradoxical findings related to stability and rates of aggregation. This scenario likely mimics the accrual of aggregation-prone species in the population, an early critical event for the development of fibrillation.	[Angelani, Carla R.; Curto, Lucrecia M.; Delfino, Jose A. M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina; [Angelani, Carla R.; Curto, Lucrecia M.; Delfino, Jose A. M.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires IIBBA, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Fdn Inst Leloir, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Curto, LM; Delfino, JAM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina.; Curto, LM; Delfino, JAM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina.	lcurto@qb.ffyb.uba.ar; delfino@qb.ffyb.uba.ar		Curto, Lucrecia/0000-0002-4335-5309	University of Buenos Aires (UBACyT) [Q-405]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0540]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2014-2757]	University of Buenos Aires (UBACyT)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This research has been supported by grants to JMD and LMC from the University of Buenos Aires (UBACyT Q-405), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET PIP 0540) and the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 2014-2757).	Angelani CR, 2014, BBA-PROTEINS PROTEOM, V1844, P1599, DOI 10.1016/j.bbapap.2014.06.002; Arighi CN, 2003, BIOCHEMISTRY-US, V42, P7539, DOI 10.1021/bi020680d; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Curto LM, 2015, PROSTAG LEUKOTR ESS, V93, P37, DOI 10.1016/j.plefa.2014.08.001; Curto LM, 2005, BIOCHEMISTRY-US, V44, P13847, DOI 10.1021/bi051080s; Curto LM, 2012, BIOPHYS J, V103, P1929, DOI 10.1016/j.bpj.2012.09.002; Dalessio PM, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20463; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Franchini GR, 2009, PROTEIN SCI, V18, P2592, DOI 10.1002/pro.273; Habchi J, 2015, SCI ADV; Hackl EV, 2014, BIOPOLYMERS, V101, P591, DOI 10.1002/bip.22422; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lakowicz J. R., PRINCIPLES FLUORESCE; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Curto LM, 2009, PROTEIN SCI, V18, P735, DOI 10.1002/pro.71; Mukhopadhyay K, 1998, BIOPHYS CHEM, V74, P175, DOI 10.1016/S0301-4622(98)00177-X; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Povey JF, 2007, J STRUCT BIOL, V157, P329, DOI 10.1016/j.jsb.2006.07.008; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yeh SR, 2001, BIOCHEMISTRY-US, V40, P4205, DOI 10.1021/bi0155044	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170607	10.1371/journal.pone.0170607	http://dx.doi.org/10.1371/journal.pone.0170607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187186	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300007
J	Mummert, A; Weiss, H				Mummert, Anna; Weiss, Howard			Controlling viral outbreaks: Quantitative strategies	PLOS ONE			English	Article							STAGED-PROGRESSION MODEL; MOUTH-DISEASE; GLOBAL DYNAMICS; FOOT; TRANSMISSION; EPIDEMIOLOGY; EMERGENCE; EBOLA	Preparing for and responding to outbreaks of serious livestock infectious diseases are critical measures to safeguard animal health, public health, and food supply. Almost all of the current control strategies are empirical, and mass culling or "stamping out" is frequently the principal strategy for controlling epidemics. However, there are ethical, ecological, and economic reasons to consider less drastic control strategies. Here we use modeling to quantitatively study the efficacy of different control measures for viral outbreaks, where the infectiousness, transmissibility and death rate of animals commonly depends on their viral load. We develop a broad theoretical framework for exploring and understanding this heterogeneity. The model includes both direct transmission from infectious animals and indirect transmission from an environmental reservoir. We then incorporate a large variety of control measures, including vaccination, antivirals, isolation, environmental disinfection, and several forms of culling, which may result in fewer culled animals. We provide explicit formulae for the basic reproduction number, R-0, for each intervention and for combinations. We evaluate the control methods for a realistic simulated outbreak of low pathogenic avian influenza on a mid-sized turkey farm. In this simulated outbreak, culling results in more total dead birds and dramatically more when culling all of the infected birds.	[Mummert, Anna] Marshall Univ, Dept Math, Huntington, WV 25755 USA; [Weiss, Howard] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	Marshall University; University System of Georgia; Georgia Institute of Technology	Mummert, A (corresponding author), Marshall Univ, Dept Math, Huntington, WV 25755 USA.	mummerta@marshall.edu						ANDERSON R M, 1991; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Dal Pozzo F, 2014, REV SCI TECHNIQUE IN, V33; de Rueda CB, 2015, VET RES, V46, DOI 10.1186/s13567-015-0156-5; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dion E, 2011, ECOL MODEL, V222, P2059, DOI 10.1016/j.ecolmodel.2011.03.026; Ducatez M, 2014, PREPRINT; Dwyer RM, 2004, VET CLIN N AM-EQUINE, V20, P531, DOI 10.1016/j.cveq.2004.07.001; FAO OIE, 2007, GLOB STRAT PROGR CON; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Grace D, 2012, MAPPING POVERTY ZOON; Guo HB, 2006, MATH BIOSCI ENG, V3, P513, DOI 10.3934/mbe.2006.3.513; Guo Hongbin, 2008, Journal of Biological Dynamics, V2, P154, DOI 10.1080/17513750802120877; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Heath S. E., 2012, Animal Frontiers, V2, P60; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jacob JP, 2014, AVIAN INFLUENZA POUL, pPS38; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Merck, MERCK VET MANUAL; Minh PQ, 2011, SPAT SPATIO-TEMPORAL, V2, P49, DOI 10.1016/j.sste.2010.11.001; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Saenz RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045059; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Shim E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005503; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Srikantiah Sridhar, 2008, Indian J Med Ethics, V5, P52; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; WEBSTER RG, 1986, J ANTIMICROB CHEMOTH, V18, P157, DOI 10.1093/jac/18.Supplement_B.157; Whiting TL, 2003, CAN VET J, V44, P805	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171199	10.1371/journal.pone.0171199	http://dx.doi.org/10.1371/journal.pone.0171199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187137	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300014
J	Xie, YY; Wang, Q; Wang, CL; Che, XJ; Shao, XH; Xu, Y; Ni, ZH; Mou, S				Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan			Association between the levels of urine kidney injury molecule-1 and the progression of acute kidney injury in the elderly	PLOS ONE			English	Article							DISEASE; RISK; BIOMARKERS	Background The factors influencing the prognosis of acute kidney injury (AKI) were analyzed in a group of elderly AKI patients to determine the markers of early prognosis. Methods A total of 258 patients were screened, and 201 patients were enrolled in the study. Eventually, 184 AKI patients were included in the study, including 79 elderly AKI patients (>60 years old). During one year of follow-up, renal function changes were observed, and the risk factors that influenced the prognosis of AKI were analyzed. Results When AKI occurred, the urine kidney injury molecule-1 (uKIM-1) level was significantly higher in the progressive deterioration of renal function group than in the renal function stable group. The ROC curve analysis revealed that the area under the curve for poor progressive deterioration of renal function as predicted by the uKIM-1 level was 0.681. At a cutoff point of 2.46 ng/mg, the sensitivity was 71.9% and the specificity was 70.0%. In elderly AKI patients, uKIM-1 levels exceeding 2.46 ng/mg were positively associated with poor kidney prognosis. Conclusions Elderly AKI patients are at risk of developing progressive deterioration of renal function. In elderly AKI patients, the high uKIM-1 level may predict the prognosis of kidney function and may be used as an early screening indicator of poor kidney prognosis.	[Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan] Shanghai Jiao Tong Univ, Dept Nephrol, Mol Cell Lab Kidney Dis, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China; [Xie, Yuanyuan; Wang, Qin; Wang, Chunlin; Che, Xiajing; Shao, Xinghua; Xu, Yao; Ni, Zhaohui; Mou, Shan] Shanghai Ctr Peritoneal Dialysis Res, Shanghai, Peoples R China	Shanghai Jiao Tong University	Ni, ZH; Mou, S (corresponding author), Shanghai Jiao Tong Univ, Dept Nephrol, Mol Cell Lab Kidney Dis, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.; Ni, ZH; Mou, S (corresponding author), Shanghai Ctr Peritoneal Dialysis Res, Shanghai, Peoples R China.	profnizh@126.com; shan_mou@shsmu.edu.cn	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China [2014DFT30090]; National Natural Science Foundation of China [81373865, 81370794, 81573748, 81570604]; Science and Technology Commission of Shanghai Municipality, China [14140903200]; Program of Shanghai Academic Research Leader [16XD1401900]; Shanghai Health Bureau [ZHYY-ZXYJHZX-1-02]	Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Program of Shanghai Academic Research Leader; Shanghai Health Bureau	The study was sponsored by the Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China (2014DFT30090) and the National Natural Science Foundation of China (81373865, 81370794, 81573748 and 81570604), as well as by grants (14140903200) from the Science and Technology Commission of Shanghai Municipality, China. The study was also sponsored by Program of Shanghai Academic Research Leader (16XD1401900). Program ZHYY-ZXYJHZX-1-02 from the Shanghai Health Bureau was also included in the funding report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Doi K, 2012, KIDNEY INT, V82, P1114, DOI 10.1038/ki.2012.266; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Muriithi AK, 2015, KIDNEY INT, V87, P458, DOI 10.1038/ki.2014.294; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Xie YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112865; Xue W, 2014, NEPHROLOGY, V19, P186, DOI 10.1111/nep.12173	20	1	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171076	10.1371/journal.pone.0171076	http://dx.doi.org/10.1371/journal.pone.0171076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187124	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300009
J	Hoogeveen, EK; Geleijnse, JM; Giltay, EJ; Soedamah-Muthu, SS; de Goede, J; Griep, LMO; Stijnen, T; Kromhout, D				Hoogeveen, Ellen K.; Geleijnse, Johanna M.; Giltay, Erik J.; Soedamah-Muthu, Sabita S.; de Goede, Janette; Griep, Linda M. Oude; Stijnen, Theo; Kromhout, Daan			Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: A 10-year follow-up study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALPHA OMEGA TRIAL; N-3 FATTY-ACIDS; CYSTATIN-C; MYOCARDIAL-INFARCTION; NONCARDIOVASCULAR MORTALITY; CARDIOVASCULAR OUTCOMES; SERUM CREATININE; RENAL-FUNCTION; UNITED-STATES	Chronic kidney disease (CKD) is highly prevalent among older post-myocardial infarction (MI) patients. It is not known whether CKD is an independent risk factor for mortality in older post-MI patients with optimal cardiovascular drug-treatment. Therefore, we studied the relation between kidney function and all-cause and specific mortality among older post-MI patients, without severe heart failure, who are treated with state-of-the-art pharmacotherapy. From 2002-2006, 4,561 Dutch post-MI patients were enrolled and followed until death or January 2012. We estimated Glomerular Filtration Rate (eGFR) with cystatin C (cysC) and creatinine (cr) using the CKD-EPI equations and analyzed the relation with any and major causes of death using Cox models and restricted cubic splines. Mean (SD) for age was 69 years (5.6), 79% were men, 17% smoked, 21% had diabetes, 90% used antihypertensive drugs, 98% used antithrombotic drugs and 85% used statins. Patients were divided into four categories of baseline eGFR(cysC): >= 90 (33%; reference), 60-89 (47%), 30-59 (18%), and < 30 (2%) ml/min/1.73m(2). Median follow-up was 6.4 years. During follow-up, 873 (19%) patients died: 370 (42%) from cardiovascular causes, 309 (35%) from cancer, and 194 (22%) from other causes. After adjustment for age, sex and classic cardiovascular risk factor, hazard ratios (95%-confidence intervals) for any death according to the four eGFRcysC categories were: 1 (reference), 1.4 (1.1-1.7), 2.9 (2.3-3.6) and 4.4 (3.0-6.4). The hazard ratios of all-cause and cause-specific mortality increased linearly below kidney functions of 80 ml/min/1.73 m(2). Weaker results were obtained for eGFR(cr). To conclude, we found in optimal cardiovascular drug-treated post-MI patients an inverse graded relation between kidney function and mortality for both cardiovascular as well as non-cardiovascular causes. Risk of mortality increased linearly below kidney function of about 80 ml/min/1.73 m(2)	[Hoogeveen, Ellen K.] Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands; [Hoogeveen, Ellen K.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands; [Hoogeveen, Ellen K.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Geleijnse, Johanna M.; Soedamah-Muthu, Sabita S.; de Goede, Janette; Griep, Linda M. Oude; Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Giltay, Erik J.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Jeroen Bosch Ziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoogeveen, EK (corresponding author), Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands.; Hoogeveen, EK (corresponding author), Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands.; Hoogeveen, EK (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	ellen.hoogeveen@planet.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Hoogeveen, Ellen K./I-2947-2019; Giltay, Erik J./AAL-9948-2021; Oude Griep, Linda/M-5112-2013	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Hoogeveen, Ellen K./0000-0002-5482-2013; Oude Griep, Linda/0000-0001-7697-7473	Royal Netherlands Academy of Arts and Sciences; Dutch Kidney Foundation [PV41]; Netherlands Heart Foundation [2000T401]; US National Institutes of Health [HL076200]; Dutch Kidney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076200] Funding Source: NIH RePORTER	Royal Netherlands Academy of Arts and Sciences; Dutch Kidney Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Kidney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The contribution of Prof. Daan Kromhout to this article was funded by the Royal Netherlands Academy of Arts and Sciences. Financial support was obtained from the Dutch Kidney Foundation (PV41) by Dr. Ellen K. Hoogeveen, the Netherlands Heart Foundation (2000T401), and US National Institutes of Health (HL076200) by Prof. Daan Kromhout. The grant from the Dutch Kidney Foundation covered baseline examinations of kidney function. The grant of the Netherlands Heart Foundation covered baseline examinations and mortality follow-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to Eveline Waterham MSc for data management. We are indebted to Dr. Eric Melse for graphic art work. The contribution of prof. Daan Kromhout to this article was funded by the Royal Netherlands Academy of Arts and Sciences. Financial support was obtained from the Dutch Kidney Foundation (PV41) by dr. Ellen K. Hoogeveen, the Netherlands Heart Foundation (2000T401), and US National Institutes of Health (HL076200) by prof. Daan Kromhout. The grant from the Dutch Kidney Foundation covered baseline examinations of kidney function. The grant of the Netherlands Heart Foundation covered baseline examinations and mortality follow-up. The funding organizations had no role in the design of the study, data collection, data analysis, interpretation, writing of the report or the decision to submit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Berger JS, 2013, AM J CARDIOL, V112, P737, DOI 10.1016/j.amjcard.2013.04.055; Bian ZX, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-64; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Duprez DA, 2013, HYPERTENSION, V61, P542, DOI 10.1161/HYPERTENSIONAHA.111.00272; Eijkelkamp WBA, 2007, AM J CARDIOL, V100, P7, DOI 10.1016/j.amjcard.2007.02.047; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; Giltay EJ, 2003, CLIN CHEM, V49, P652, DOI 10.1373/49.4.652; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harrell Jr F. E., 2001, SPRINGER SERIES IN S; Hoogeveen EK, 2014, EUR J PREV CARDIOL, V21, P1429, DOI 10.1177/2047487313494295; Hoogeveen EK, 2014, CLIN J AM SOC NEPHRO, V9, P1676, DOI 10.2215/CJN.10441013; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mafham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025920; Major RW, 2015, CLIN J AM SOC NEPHRO, V10, P732, DOI 10.2215/CJN.07460714; Marks A, 2013, FAM PRACT, V30, P282, DOI 10.1093/fampra/cms079; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Vogelzang JL, 2015, NEPHROL DIAL TRANSPL, V30, P1028, DOI 10.1093/ndt/gfv007; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171868	10.1371/journal.pone.0171868	http://dx.doi.org/10.1371/journal.pone.0171868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182761	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800127
J	Chi, L; Li, X; Liu, QH; Liu, Y				Chi, Liang; Li, Xian; Liu, Qinghua; Liu, Ying			Photoperiod regulate gonad development via kisspeptin/kissr in hypothalamus and saccus vasculosus of Atlantic salmon (Salmo solar)	PLOS ONE			English	Article							TYPE-2 DEIODINASE GENE; ENVIRONMENTAL-CONTROL; CIRCADIAN REGULATION; RECEPTOR GPR54; EXPRESSION; REPRODUCTION; NEURONS; INSIGHTS; SYSTEM; IDENTIFICATION	Atlantic salmon exhibit seasonal reproduction. However, the mechanisms governing this are still unclear. Generally speaking, kisspeptin has been recognized as a regulator of reproduction. Here, we report a relationship between kisspeptin, GnRH and photoperiod in Atlantic salmon. The results demonstrated that the expression of the Atlantic salmon kisspeptinreceptor (skissr) was not always consistent with the expression pattern of Atlantic salmon GnRH3 (sGnRH3) during all developmental processes. Kisspeptin may exert its influence primarily in the early and later stages of gonad development by promoting the secretion of sGnRH3. Meanwhile, the expression levels of kissrwere higher in fish with gonads at stage II and stage V under the long-day photoperiod regime than under the short-day regime. In addition, both skissrand sGnRH3 were also expressed in the saccus vasculosus (SV), an organ only found in fish. The SV might be a seasonal sensor regulating reproduction in addition to the hypothalamus (Hyp).	[Chi, Liang; Li, Xian; Liu, Qinghua; Liu, Ying] Chinese Acad Sci, Inst Oceanol, Ctr Biotechnol R&D, Qingdao, Peoples R China; [Chi, Liang] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Li, Xian; Liu, Ying] Natl & Local Joint Engn Lab Ecol Mari Culture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao Agricultural University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Ctr Biotechnol R&D, Qingdao, Peoples R China.; Liu, Y (corresponding author), Natl & Local Joint Engn Lab Ecol Mari Culture, Qingdao, Peoples R China.	Yinliuaquaculture@gmail.com			National Natural Science Fund of China [31402283, 31472312, 41306152]; fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China [0F2015N001]; Qingdao Innovation Talents Program [13-CX-16]; National Key Technologies RD Program [2014BAD08B09]; earmarked fund for Modern Agro-industry Technology Research System [CARS-48]; Shandong Oriental Ocean Sci-Tech Co., Ltd	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China; Qingdao Innovation Talents Program; National Key Technologies RD Program(National Key Technology R&D Program); earmarked fund for Modern Agro-industry Technology Research System; Shandong Oriental Ocean Sci-Tech Co., Ltd	This research was supported by the National Natural Science Fund of China (No 31402283, 31472312, 41306152),the fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China (No. 0F2015N001), the Qingdao Innovation Talents Program (13-CX-16), the National Key Technologies R&D Program (2014BAD08B09), and the earmarked fund for Modern Agro-industry Technology Research System (CARS-48).; The authors would like to give thanks to the Shandong Oriental Ocean Sci-Tech Co., Ltd for their supports during the experiment.	Beck BH, 2012, COMP BIOCHEM PHYS A, V162, P265, DOI 10.1016/j.cbpa.2012.03.019; BITTMAN EL, 1983, ENDOCRINOLOGY, V113, P2276, DOI 10.1210/endo-113-6-2276; Bromage N, 2001, AQUACULTURE, V197, P63, DOI 10.1016/S0044-8486(01)00583-X; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Elizur A, 2009, PEPTIDES, V30, P164, DOI 10.1016/j.peptides.2008.08.018; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Greives TJ, 2007, ENDOCRINOLOGY, V148, P1158, DOI 10.1210/en.2006-1249; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Iigo M, 2007, GEN COMP ENDOCR, V154, P91, DOI 10.1016/j.ygcen.2007.06.013; Iigo M, 2007, ZOOL SCI, V24, P67, DOI 10.2108/zsj.24.67; JANSEN WF, 1982, CELL TISSUE RES, V224, P169, DOI 10.1007/BF00217276; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Lincoln G A, 1980, Recent Prog Horm Res, V36, P1; Martinez-Chavez CC, 2008, GEN COMP ENDOCR, V156, P224, DOI 10.1016/j.ygcen.2008.01.019; Mechaly AS, 2009, BIOL REPROD, V80, P60, DOI 10.1095/biolreprod.108.072173; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Nakane Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00115; Nakane Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3108; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Pankhurst NW, 2003, FISH PHYSIOL BIOCHEM, V28, P385, DOI 10.1023/B:FISH.0000030602.51939.50; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Revel FG, 2007, REV ENDOCR METAB DIS, V8, P57, DOI 10.1007/s11154-007-9031-7; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Selvaraj S, 2010, GEN COMP ENDOCR, V169, P28, DOI 10.1016/j.ygcen.2010.07.011; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Simonneaux V, 2009, PEPTIDES, V30, P146, DOI 10.1016/j.peptides.2008.06.006; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Sueiro C, 2007, BRAIN BEHAV EVOLUT, V70, P187, DOI 10.1159/000104309; Taranger GL, 1998, AQUACULTURE, V162, P85, DOI 10.1016/S0044-8486(98)00168-9; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Wagner GC, 2008, ENDOCRINOLOGY, V149, P32, DOI 10.1210/en.2007-0658; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wood S, 2014, J ENDOCRINOL, V222, pR39, DOI 10.1530/JOE-14-0141; Yang B, 2010, GEN COMP ENDOCR, V165, P60, DOI 10.1016/j.ygcen.2009.06.001; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Zmora N, 2012, BIOLOGY OF REPRODUCT; Zmora N, 2014, ENDOCRINOLOGY, V155, P1874, DOI 10.1210/en.2013-1894	46	25	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169569	10.1371/journal.pone.0169569	http://dx.doi.org/10.1371/journal.pone.0169569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199332	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400008
J	Kusama, K; Bai, R; Nakamura, K; Okada, S; Yasuda, J; Imakawa, K				Kusama, Kazuya; Bai, Rulan; Nakamura, Keigo; Okada, Sayaka; Yasuda, Jiro; Imakawa, Kazuhiko			Endometrial factors similarly induced by IFNT2 and IFNTc1 through transcription factor FOXS1	PLOS ONE			English	Article							OVINE TROPHOBLAST PROTEIN-1; INTERFERON-TAU; BOVINE CONCEPTUSES; NERVOUS-SYSTEM; GENES; EXPRESSION; PROSTAGLANDIN; PREGNANCY; PERIOD	In ruminants, Interferon tau (IFNT) is the pregnancy recognition protein produced by the mononuclear trophectoderm of the conceptus, and is secreted into the uterine lumen during the peri-attachment period. In our previous study, the high-throughput RNA sequencing (RNA-seq) data obtained from bovine conceptuses during the peri-attachment period identified two /FNTmRNAs, IFNT2and IFNTc1. However, how each of these IFNT variants regulates endometrial gene expression has not been characterized. Using RNA-seq analysis, we evaluated how IFNT2 and IFNTc1 affected transcript expression in primary bovine endometrial epithelial cells (EECs). IFNT treatment induced 348 differentially expressed genes (DEGs); however, there are few DEGs in IFNT2 or IFNTc1 treated EECs, indicating that IFNT2-induced DEGs were similar to those induced by IFNTc1 treatment. In in silico analysis, we identified four IFNT2- and IFNTc1-induced pathways: 1) type II interferon signaling, 2) proteasome degradation, 3) type III interferon signaling, and 4) DNA damage response. We further demonstrated that IFNT2 and IFNTc1 up-regulated several transcription factors, among which forkhead box S1 (FOXS1) was identified as the most highly expressed gene. Furthermore, the knockdown of FOXS1 in IFNT2- or IFNTc1-treated EECs similarly down regulated 9 genes including IRF3 and IRF9, and up-regulated 9 genes including STAT1, STAT2, and IRF8. These represent the first demonstration that effects of each IFNT on EECs were studied, and suggest that endometrial response as well as signaling mechanisms were similar between two IFNT variants existed in utero.	[Kusama, Kazuya; Bai, Rulan; Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan; [Okada, Sayaka; Yasuda, Jiro] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Emerging Infect Dis, Nagasaki, Japan	University of Tokyo; Nagasaki University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Yasuda, Jiro/0000-0001-9928-5621	Ministry of Agriculture, Forestry and Fisheries [25030AB]; Japan Society for the Promotion of Science [15K18767]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Agriculture, Forestry and Fisheries (25030AB), http://www.maff.go.jp/e/index.html (to KI); and Japan Society for the Promotion of Science (15K18767), https://www.jsps.go.jp (to KK). These funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Ealy AD, 2001, ENDOCRINOLOGY, V142, P2906, DOI 10.1210/en.142.7.2906; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2014, REPRODUCTION, V147, P575, DOI 10.1530/REP-13-0010; GODKIN JD, 1984, ENDOCRINOLOGY, V114, P120, DOI 10.1210/endo-114-1-120; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Heglind M, 2005, MOL CELL BIOL, V25, P5616, DOI 10.1128/MCB.25.13.5616-5625.2005; Ideta A, 2010, MOL REPROD DEV, V77, P954, DOI 10.1002/mrd.21243; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Kim MS, 2013, ASIAN AUSTRAL J ANIM, V26, P795, DOI 10.5713/ajas.2012.12529; Kusama K, 2016, DOMEST ANIM ENDOCRIN, V57, P21, DOI 10.1016/j.domaniend.2016.05.002; Kusama K, 2016, MOL CELL ENDOCRINOL, V434, P81, DOI 10.1016/j.mce.2016.06.017; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; NEPHEW KP, 1993, BIOL REPROD, V48, P768, DOI 10.1095/biolreprod48.4.768; Noizet M, 2016, WOUND REPAIR REGEN, V24, P247, DOI 10.1111/wrr.12392; Pihlajoki M, 2013, ENDOCRINOLOGY, V154, P1754, DOI 10.1210/en.2012-1892; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Romero JJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132860; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080427; Sakurai T, 2013, MOL REPROD DEV, V80, P371, DOI 10.1002/mrd.22171; SALAMONSEN LA, 1988, J ENDOCRINOL, V117, pR1, DOI 10.1677/joe.0.117R001; Sato Y, 2008, MOL REPROD DEV, V75, P1361, DOI 10.1002/mrd.20888; Schillebeeckx M, 2015, MOL CELL ENDOCRINOL, V399, P122, DOI 10.1016/j.mce.2014.09.029; Spencer TE, 1996, ENDOCRINOLOGY, V137, P1144, DOI 10.1210/en.137.3.1144; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Tanikawa M, 2008, J ENDOCRINOL, V199, P425, DOI 10.1677/JOE-08-0237; Walker AM, 2009, THERIOGENOLOGY, V72, P44, DOI 10.1016/j.theriogenology.2009.01.017	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171858	10.1371/journal.pone.0171858	http://dx.doi.org/10.1371/journal.pone.0171858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199372	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400054
J	Singh, H; Nugent, Z; Yu, BN; Lix, LM; Targownik, L; Bernstein, C				Singh, Harminder; Nugent, Zoann; Yu, B. Nancy; Lix, Lisa M.; Targownik, Laura; Bernstein, Charles			Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; ULCERATIVE-COLITIS; EPIDEMIOLOGY; DIAGNOSIS; RISK; SURVEILLANCE; MANITOBA; OUTCOMES; BURDEN; IMPACT	Background Hospital discharge databases are used to study the epidemiology of Clostridium difficile infections (CDI) among hospitalized patients with inflammatory bowel disease (IBD). CDI in IBD is increasingly important and accurately estimating its occurrence is critical in understanding its comorbidity. There are limited data on the reliability of the International Classification of Diseases 10th revision (ICD-10) (now widely used in North America) CDI code in determining occurrence of CDI among hospitalized patients. We compared the performance of ICD-10 CDI coding to laboratory confirmed CDI diagnoses. Methods The University of Manitoba IBD Epidemiology Database was used to identify individuals with and without IBD discharged with CDI diagnoses between 07/01/2005 and 3/31/2014. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of ICD-10 CDI code was compared to laboratory CDI diagnoses recorded in a province wide CDI dataset. Multivariable logistic regression models were performed to test the predictors of diagnostic inaccuracy of ICD-10 CDI code. Results There were 273 episodes of laboratory confirmed CDI ( hospitalized and non-hospitalized) among 7396 individuals with IBD and 536 among 66,297 matched controls. The sensitivity, specificity, PPV and NPV of ICD-10 CDI code in discharge abstracts was 72.8%, 99.6%, 64.1% and 99.7% among those with IBD and 70.8%, 99.9%, 79.0% and 99.9% among those without IBD. Predictors of diagnostic inaccuracy included IBD, older age, increased co-morbidity and earlier years of hospitalization. Conclusions Identification of CDI using ICD-10 CDI code in hospital discharge abstracts may not identify up to 30% of CDI cases, with worse performance among those with IBD.	[Singh, Harminder; Nugent, Zoann; Targownik, Laura; Bernstein, Charles] Univ Manitoba, Internal Med, Winnipeg, MB, Canada; [Singh, Harminder; Nugent, Zoann; Targownik, Laura; Bernstein, Charles] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada; [Singh, Harminder; Yu, B. Nancy; Lix, Lisa M.] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada; [Nugent, Zoann] CancerCare Manitoba, Dept Epidemiol & Canc Registry, Winnipeg, MB, Canada; [Yu, B. Nancy] Manitoba Hlth Seniors & Act Living, Publ Hlth Branch, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation	Singh, H (corresponding author), Univ Manitoba, Internal Med, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada.	Harminder.singh@umanitoba.ca	Singh, Harminder/E-1848-2012; Targownik, Laura/ABD-2427-2021	Singh, Harminder/0000-0002-0024-5855; Targownik, Laura/0000-0002-4366-9076	American College of Gastroenterology	American College of Gastroenterology(General Electric)	This study was funded by an operating research grant from American College of Gastroenterology. The funding agency had no role in the conduct of the study or the reporting of the findings.	Berg AM, 2013, INFLAMM BOWEL DIS, V19, P194, DOI 10.1002/ibd.22964; Bernstein CN, 2008, CLIN GASTROENTEROL H, V6, P41, DOI 10.1016/j.cgh.2007.09.016; Bernstein CN, 2009, AM J GASTROENTEROL, V104, P2774, DOI 10.1038/ajg.2009.417; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Chan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015603; Chateau D, 2012, CAN J PUBLIC HEALTH, V103, pS23, DOI 10.1007/BF03403825; Collins CE, 2014, J AM COLL SURGEONS, V218, P1141, DOI 10.1016/j.jamcollsurg.2014.01.053; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Goto M, 2014, CLIN INFECT DIS, V58, P688, DOI 10.1093/cid/cit737; Green C, 2006, AM J EPIDEMIOL, V164, P615, DOI 10.1093/aje/kwj260; Jones G, 2012, EMERG INFECT DIS, V18, P979, DOI 10.3201/eid1806.111188; Longobardi T, 2007, AM J GASTROENTEROL, V102, P1683, DOI 10.1111/j.1572-0241.2007.01232.x; Murphy CR, 2012, INFECT CONT HOSP EP, V33, P20, DOI 10.1086/663209; Negron ME, 2016, AM J GASTROENTEROL, V111, P691, DOI 10.1038/ajg.2016.106; Pencina MJ, 2015, JAMA-J AM MED ASSOC, V314, P1063, DOI 10.1001/jama.2015.11082; REDELMEIER DA, 1991, J CLIN EPIDEMIOL, V44, P1141, DOI 10.1016/0895-4356(91)90146-Z; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Singh H, 2009, GASTROENTEROLOGY, V136, P451, DOI 10.1053/j.gastro.2008.10.021; To KB, 2014, SURG INFECT, V15, P490, DOI 10.1089/sur.2013.186; Walkty A, 2013, J CLIN MICROBIOL, V51, P1152, DOI 10.1128/JCM.03203-12; Welker JA, 2012, J HOSP MED, V7, P170, DOI 10.1002/jhm.990; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171266	10.1371/journal.pone.0171266	http://dx.doi.org/10.1371/journal.pone.0171266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199401	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400026
J	Tai, SY; Chien, CY; Wu, DC; Lin, KD; Ho, BL; Chang, YH; Chang, YP				Tai, Shu-Yu; Chien, Chen-Yu; Wu, Deng-Chyang; Lin, Kun-Der; Ho, Bo-Lin; Chang, Yu-Han; Chang, Yang-Pei			Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VITAMIN-B-12 STATUS; CLINICAL-USE; DEPRESSION; LANSOPRAZOLE; DIAGNOSIS; ARTICLE; KIDNEY; ACID	Introduction Concerns have been raised regarding the potential association between proton pump inhibitor (PPI) use and dementia. Objective This study aimed to examine this association in an Asian population. Methods Patients initiating PPI therapy between January 1, 2000 and December 31, 2003 without a prior history of dementia were identified from Taiwan's National Health Insurance Research Database. The outcome of interest was all-cause dementia. Cox regression models were applied to estimate the hazard ratio (HR) of dementia. The cumulative PPI dosage stratified by quartiles of defined daily doses and adjusted for baseline disease risk score served as the primary variables compared against no PPI use. Results We analyzed the data of 15726 participants aged 40 years or older and free of dementia at baseline. PPI users (n = 7863; average follow-up 8.44 years) had a significantly increased risk of dementia over non-PPI users (n = 7863; average follow-up 9.55 years) (adjusted HR [aHR] 1.22; 95% confidence interval: 1.05-1.42). A significant association was observed between cumulative PPI use and risk of dementia (P for trend =.013). Subgroup analysis showed excess frequency of dementia in PPI users diagnosed with depression (aHR 2.73 [1.91-3.89]), hyperlipidemia (aHR 1.81 [1.38-2.38]), ischemic heart disease (aHR 1.55 [1.12-2.14]), and hypertension (aHR 1.54 [1.21-1.95]). Conclusions An increased risk for dementia was identified among the Asian PPI users. Cumulative PPI use was significantly associated with dementia. Further investigation into the possible biological mechanisms underlying the relationship between dementia and PPI use is warranted.	[Tai, Shu-Yu] Kaohsiung Med Univ, Sch Med, Dept Family Med, Coll Med, Kaohsiung, Taiwan; [Tai, Shu-Yu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Tai, Shu-Yu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med, Kaohsiung, Taiwan; [Chien, Chen-Yu] Kaohsiung Med Univ, Sch Med, Dept Otorhinolaryngol, Coll Med, Kaohsiung, Taiwan; [Chien, Chen-Yu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Otorhinolaryngol, Kaohsiung, Taiwan; [Chien, Chen-Yu] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Otorhinolaryngol, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Lin, Kun-Der] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Kun-Der] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Ho, Bo-Lin; Chang, Yang-Pei] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan; [Ho, Bo-Lin; Chang, Yang-Pei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Yu-Han] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Management Off, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chang, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan.; Chang, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.	cyp905@gmail.com		Chang, Yang-Pei/0000-0002-1021-2643	Ministry of Science and Technology [MOST103-2314-B-037-004-MY3]; Research Center for Environmental Medicine, Kaohsiung Medical University [KMU-TP104A34]; Kaohsiung Medical University Hospital [KMUH105-5R64]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Research Center for Environmental Medicine, Kaohsiung Medical University; Kaohsiung Medical University Hospital	This study was supported by grants from the Ministry of Science and Technology (MOST103-2314-B-037-004-MY3), Research Center for Environmental Medicine, Kaohsiung Medical University (KMU-TP104A34), and Kaohsiung Medical University Hospital (KMUH105-5R64). The authors are thankful for the assistance provided by the Statistical Analysis Laboratory, Department of Medical Research, Kaohsiung Municipal Ta-Tung Hospital. None of these organizations had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058837; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Jager CPC, 2012, ALIMENT PHARM THER, V36, P941, DOI 10.1111/apt.12069; De Strooper B, 2000, J CELL SCI, V113, P1857; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fallahzadeh MK, 2010, J CLIN PHARM THER, V35, P125, DOI 10.1111/j.1365-2710.2009.01100.x; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Ghebremariam YT, 2013, CIRCULATION, V128, P845, DOI 10.1161/CIRCULATIONAHA.113.003602; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Haenisch B, 2015, EUR ARCH PSY CLIN N, V265, P419, DOI 10.1007/s00406-014-0554-0; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Hollingworth S, 2010, PHARMACOEPIDEM DR S, V19, P1019, DOI 10.1002/pds.1969; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Katz PO, 2006, ALIMENT PHARM THER, V23, P9, DOI 10.1111/j.1365-2036.2006.02944.x; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Khalili H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e372; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; LONDONG W, 1991, ALIMENT PHARM THERAP, V5, P245; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; MATTSSON JP, 1991, BIOCHIM BIOPHYS ACTA, V1065, P261, DOI 10.1016/0005-2736(91)90238-4; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; O'Leary F, 2012, BRIT J NUTR, V108, P1948, DOI 10.1017/S0007114512004175; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Rojo LE, 2010, J ALZHEIMERS DIS, V19, P573, DOI 10.3233/JAD-2010-1262; Sachs G, 2006, ALIMENT PHARM THERAP, V23, P2, DOI 10.1111/j.1365-2036.2006.02943.x; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P935, DOI 10.1007/s00228-008-0538-y; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Vogiatzoglou A, 2013, PSYCHOSOM MED, V75, P20, DOI 10.1097/PSY.0b013e3182761b6c; Wen YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003658; WHO, 2014, AG LIF COURS FACTS A; WHO Collaborating Centre for Drug Statistics Methodology, 2014, DEF DAIL DOS DEF GEN; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Yang YH, 2014, J ALZHEIMERS DIS, V42, P193, DOI 10.3233/JAD-140174; Yepuri G, 2016, CIRC RES, DOI [10.1097/MD.0000000000003658, DOI 10.1097/MD.0000000000003658]	41	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171006	10.1371/journal.pone.0171006	http://dx.doi.org/10.1371/journal.pone.0171006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199356	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400020
J	Zhang, T; Zhang, XQ; Han, KP; Zhang, GX; Wang, JY; Xie, KZ; Xue, Q; Fan, XM				Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian; Fan, Xiaomei			Analysis of long noncoding RNA and mRNA using RNA sequencing during the differentiation of intramuscular preadipocytes in chicken	PLOS ONE			English	Article							COEXPRESSION NETWORK ANALYSIS; SIGNALING PATHWAY; ADIPOSE-TISSUE; ADIPOGENIC DIFFERENTIATION; FAT DEPOSITION; CELL-DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INHIBITS ADIPOGENESIS	Long noncoding RNAs (lncRNAs) regulate metabolic tissue development and function, including adipogenesis. However, little is known about the function and profile of lncRNAs in intramuscular preadipocyte differentiation in chicken. Here, we identified lncRNAs in chicken intramuscular preadipocytes at different differentiation stages using RNA sequencing. A total of 1,311,382,604 clean reads and 25,435 lncRNAs were obtained from 12 samples. In total, 7,433 differentially expressed genes (4,698 lncRNAs and 2,735 mRNAs) were identified by pairwise comparison. These 7,433 differentially expressed genes were grouped into 11 clusters based on their expression patterns by K-means clustering. Using Weighted Gene Coexpression Network Analysis, we identified four stage-specific modules positively related to I0, I2, I4, and I6 stages and two stage-specific modules negatively related to I0 and I2 stages, respectively. Many well-known and novel pathways associated with intramuscular preadipocyte differentiation were identified. We also identified hub genes in each stage-specific module and visualized them in Cytoscape. Our analysis revealed many highly-connected genes, including XLOC_058593, BMP3, MYOD1, and LAMP3. This study provides a valuable resource for chicken lncRNA study and improves our understanding of the biology of preadipocyte differentiation in chicken.	[Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiaomei] Vazyme Biotech Co Ltd, Econ & Technol Dev Zone, Nanjing, Jiangsu, Peoples R China	Yangzhou University	Wang, JY (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.; Wang, JY (corresponding author), Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	jywang@yzu.edu.cn			National Broiler Industrial and Technology Sestem [nycytx-42-G1-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Broiler Industrial and Technology Sestem; Priority Academic Program Development of Jiangsu Higher Education Institutions	Support was provided by the National Broiler Industrial and Technology Sestem: nycytx-42-G1-05 and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonny SPF, 2016, ANIMAL, V10, P987, DOI 10.1017/S175173111500292X; Borensztein M, 2012, FASEB J, V26, P4584, DOI 10.1096/fj.12-208496; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen JT, 2015, MOL GENET GENOMICS, V290, P699, DOI 10.1007/s00438-014-0954-x; Chen QM, 2013, J APPL GENET, V54, P119, DOI 10.1007/s13353-012-0122-0; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151056; Chen X, 2016, INT J GRID DISTRIB, V9, P1, DOI 10.14257/ijgdc.2016.9.6.01; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Divoux A, 2014, OBESITY, V22, P1781, DOI 10.1002/oby.20793; Dong JQ, 2015, J ANIM SCI, V93, P3278, DOI 10.2527/jas.2015-8871; Dong XW, 2015, CHIN CONT DECIS CONF, P36, DOI 10.1109/CCDC.2015.7161663; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu YY, 2016, MOL CELL BIOCHEM, V418, P39, DOI 10.1007/s11010-016-2731-0; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gu HJ, 2014, CELL IMMUNOL, V290, P138, DOI 10.1016/j.cellimm.2014.05.004; Guiu-Jurado E., 2016, OBESITY SILVER SPRIN; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103; Jiang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077094; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Kim M, 2015, ARCH BIOCHEM BIOPHYS, V583, P79, DOI 10.1016/j.abb.2015.07.007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Li HL, 2011, MOL BIOL REP, V38, P4045, DOI 10.1007/s11033-010-0523-2; Li L, 2012, FEBS LETT, V586, P4100, DOI 10.1016/j.febslet.2012.10.030; Li MX, 2016, BBA-GENE REGUL MECH, V1859, P871, DOI 10.1016/j.bbagrm.2016.05.003; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; Li QY, 2015, PHARM BIOL, V53, P1567, DOI 10.3109/13880209.2014.993038; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1016/J.FUPR0C.2015.01.025; Luan A, 2015, PLAST RECONSTR SURG, V136, P752, DOI 10.1097/PRS.0000000000001582; Nie F, 2015, FOOD FUNCT, V6, DOI [10.1007/s13353-012-0122-0, DOI 10.1007/S13353-012-0122-0]; Nikolopoulou E, 2014, J LIPID RES, V55, P2479, DOI 10.1194/jlr.M049551; Pang WJ, 2014, J ANIM SCI, V92, P1968, DOI 10.2527/jas.2013-7098; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren HX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2365-3; Schwab CR, 2006, J ANIM SCI, V84, P1577, DOI 10.2527/2006.8461577x; Shu G, 2011, POULTRY SCI, V90, P2557, DOI 10.3382/ps.2010-01238; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Sun WX, 2016, DOMEST ANIM ENDOCRIN, V55, P25, DOI 10.1016/j.domaniend.2015.10.005; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tang HN, 2015, ENDOCR J, V62, P835, DOI 10.1507/endocrj.EJ15-0133; Tang Y, 2016, J MOL CELL BIOL, V8, P302, DOI 10.1093/jmcb/mjw019; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang GQ, 2015, J AGR FOOD CHEM, V63, P6212, DOI 10.1021/acs.jafc.5b01680; Wang H, 2013, ANIM GENET, V44, P458, DOI 10.1111/age.12025; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang SB, 2013, CELL PHYSIOL BIOCHEM, V31, P981, DOI 10.1159/000350116; Wang Y, 2015, ASIAN AUSTRAL J ANIM, V28, P1380, DOI 10.5713/ajas.14.0886; Wang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20238; Wu GF, 2014, ACTA BIOCH BIOPH SIN, V46, P1087, DOI 10.1093/abbs/gmu087; Xi G, 2013, ENDOCRINOLOGY, V154, P4146, DOI 10.1210/en.2013-1236; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan J, 2013, MOL BIOL REP, V40, P7017, DOI 10.1007/s11033-013-2821-y; Yau SW, 2014, INT J OBES LOND, V39, P770; Ye MH, 2010, ANIM BIOTECHNOL, V21, P14, DOI 10.1080/10495390903328116; Yonekura S, 2016, ANIM BIOTECHNOL, V27, P96, DOI 10.1080/10495398.2015.1102148; You LH, 2015, MOL GENET GENOMICS, V290, P1659, DOI 10.1007/s00438-015-1026-6; Yuan ZQ., 2013, SCREENING OF FAT DEP; Zappaterra M, 2016, MEAT SCI, V121, P27, DOI 10.1016/j.meatsci.2016.05.007; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang ZW, 2014, BIOSCI BIOTECH BIOCH, V78, P614, DOI 10.1080/09168451.2014.896735; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002	80	31	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172389	10.1371/journal.pone.0172389	http://dx.doi.org/10.1371/journal.pone.0172389			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199418	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400090
J	Catalani, S; Palma, F; Battistelli, S; Benedetti, S				Catalani, Simona; Palma, Francesco; Battistelli, Serafina; Benedetti, Serena			Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts	PLOS ONE			English	Article							BETA-CARYOPHYLLENE; ALPHA-PINENE; ANTICANCER; ANTIOXIDANT; CONSTITUENTS; PATHWAYS	Background Essential oils from the aerial parts (leaves, twigs and berries) of Pistacia lentiscus (PLEO) have been well characterized for their antibacterial and anti-inflammatory properties; however, poor information exists on their potential anticancer activity. Methods Increasing concentrations of PLEO (0.01 - 0.1% v/v, 80 - 800 mu g/ml) were administered to a wide variety of cultured cancer cells from breast, cervix, colon, liver, lung, prostate, and thyroid carcinomas. Fibroblasts were also included as healthy control cells. Cell viability was monitored by WST-8 assay up to 72 hours after PLEO administration. The intracellular formation of reactive oxygen species (ROS), the induction of apoptosis, and the enhancement of chemotherapeutic drug cytotoxicity by PLEO were further investigated in the most responsive cancer cell line. Results A dose-dependent reduction of tumor cell viability was observed upon PLEO exposure; while no cytotoxic effect was revealed in healthy fibroblasts. FTC-133 thyroid cancer cells were found to be the most sensitive cells to PLEO treatment; accordingly, an intracellular accumulation of ROS and an activation of both the extrinsic and intrinsic apoptotic pathways were evidenced in FTC-133 cells after PLEO administration. Furthermore, the cytotoxic effect of the antineoplastic drugs cisplatin, 5-fluorouracil and etoposide was enhanced in PLEO-exposed FTC-133 cells. Conclusion Taking into account its mode of action, PLEO might be considered as a promising source of natural antitumor agents which might have therapeutic potential in integrated oncology.	[Catalani, Simona; Battistelli, Serafina; Benedetti, Serena] Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy; [Palma, Francesco] Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy	University of Urbino; University of Urbino	Benedetti, S (corresponding author), Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy.	serena.benedetti@uniurb.it		PALMA, Francesco/0000-0001-9836-1821; Benedetti, Serena/0000-0002-9719-2381	onlus RUOTA (Rapallo, GE, Italy)	onlus RUOTA (Rapallo, GE, Italy)	SC had received a research grant from the onlus RUOTA (Rapallo, GE, Italy). RUOTA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorjan B, 2010, FLAVOUR FRAG J, V25, P407, DOI 10.1002/ffj.2024; Amorim JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153643; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Barra A, 2007, J AGR FOOD CHEM, V55, P7093, DOI 10.1021/jf071129w; Bayala B, 2014, AM J CANCER RES, V4, P591; Benedetti S, 2011, FOOD CHEM TOXICOL, V49, P2292, DOI 10.1016/j.fct.2011.06.029; Bhalla Y, 2013, J SCI FOOD AGR, V93, P3643, DOI 10.1002/jsfa.6267; Bozorgi M, 2013, SCI WORLD J, DOI 10.1155/2013/219815; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrows N, 2010, ENDOCR-RELAT CANCER, V17, P61, DOI 10.1677/ERC-08-0251; Burrows N, 2011, J THROID RES, V2011, DOI 10.4061/2011/762905; Catalani S, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-63; Chen WQ, 2015, J PHARMACOL SCI, V127, P332, DOI 10.1016/j.jphs.2015.01.008; Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808; Dimas KS, 2012, IN VIVO, V26, P777; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Jin KS, 2010, FOOD SCI BIOTECHNOL, V19, P1325, DOI 10.1007/s10068-010-0189-5; Lesgards JF, 2014, PHYTOTHER RES, V28, P1423, DOI 10.1002/ptr.5165; Li GQ, 2012, CANCER BIOTHER RADIO, V27, P56, DOI 10.1089/cbr.2011.1003; Maxia A, 2011, NAT PROD COMMUN, V6, P1543; Mharti FZ, 2011, NAT PROD COMMUN, V6, P1505; Paraschos S, 2012, CURR MED CHEM, V19, P2292; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Russo R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/397821; Saviuc CM, 2015, CURR PHARM BIOTECHNO, V16, P137, DOI 10.2174/138920101602150112151549; Sheweita SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165667; Sobral Marianna Vieira, 2014, ScientificWorldJournal, V2014, P953451, DOI 10.1155/2014/953451	28	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172138	10.1371/journal.pone.0172138	http://dx.doi.org/10.1371/journal.pone.0172138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196126	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900054
J	Luo, QY; Zhao, L; Hu, JX; Jin, HW; Liu, ZM; Zhang, LR				Luo, Qiyao; Zhao, Liang; Hu, Jianxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren			The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing	PLOS ONE			English	Article							PROTEIN INVERSE DOCKING; DRUG DISCOVERY; SMALL-MOLECULE; PHARMACOLOGY; PREDICTION; CHALLENGES; POLYPHARMACOLOGY; ACCURACY; SEARCH; GLIDE	Target fishing often relies on the use of reverse docking to identify potential target proteins of ligands from protein database. The limitation of reverse docking is the accuracy of current scoring funtions used to distinguish true target from non-target proteins. Many contemporary scoring functions are designed for the virtual screening of small molecules without special optimization for reverse docking, which would be easily influenced by the properties of protein pockets, resulting in scoring bias to the proteins with certain properties. This bias would cause lots of false positives in reverse docking, interferring the identification of true targets. In this paper, we have conducted a large-scale reverse docking (5000 molecules to 100 proteins) to study the scoring bias in reverse docking by DOCK, Glide, and AutoDock Vina. And we found that there were actually some frequency hits, namely interference proteins in all three docking procedures. After analyzing the differences of pocket properties between these interference proteins and the others, we speculated that the interference proteins have larger contact area (related to the size and shape of protein pockets) with ligands (for all three docking programs) or higher hydrophobicity (for Glide), which could be the causes of scoring bias. Then we applied the score normalization method to eliminate this scoring bias, which was effective to make docking score more balanced between different proteins in the reverse docking of benchmark dataset. Later, the Astex Diver Set was utilized to validate the effect of score normalization on actual cases of reverse docking, showing that the accuracy of target prediction significantly increased by 21.5% in the reverse docking by Glide after score normalization, though there was no obvious change in the reverse docking by DOCK and AutoDock Vina. Our results demonstrate the effectiveness of score normalization to eliminate the scoring bias and improve the accuracy of target prediction in reverse docking. Moreover, the properties of protein pockets causing scoring bias to certain proteins we found here can provide the theory basis to further optimize the scoring functions of docking programs for future research.	[Luo, Qiyao; Zhao, Liang; Hu, Jianxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China	Peking University	Liu, ZM; Zhang, LR (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China.	zmliu@bjmu.edu.cn; liangren@bjmu.edu.cn	liu, zhenming/D-8766-2012; Zhang, Liang/GWM-6088-2022; Hu, Jianxing/AAP-5351-2020	Hu, Jianxing/0000-0002-0635-3814	National Natural Science Foundation of China [21272017, 21572010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 21272017, 21572010). Author: Zhenming Liu [http://www.nsfc.gov.cn]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulHameed MDM, 2012, J CHEM INF MODEL, V52, P492, DOI 10.1021/ci2003544; [Anonymous], PIP PIL 7 5; [Anonymous], 2013, LIGPREP VERS 2 6; [Anonymous], AV CHEM DIR; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bottegoni G, 2012, DRUG DISCOV TODAY, V17, P23, DOI 10.1016/j.drudis.2011.08.002; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Burbaum J, 2002, CURR OPIN CHEM BIOL, V6, P427, DOI 10.1016/S1367-5931(02)00337-X; Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006; Chen X, 2003, NAT PROD REP, V20, P432, DOI 10.1039/b303745b; Chen YZ, 2001, J MOL GRAPH MODEL, V20, P199, DOI 10.1016/S1093-3263(01)00109-7; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Ekins S, 2007, BRIT J PHARMACOL, V152, P21, DOI 10.1038/sj.bjp.0707306; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Eric S, 2012, BIOORGAN MED CHEM, V20, P5220, DOI 10.1016/j.bmc.2012.06.051; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gowthaman R, 2013, J CHEM INF MODEL, V53, P2073, DOI 10.1021/ci4002316; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jenwitheesuk E, 2008, TRENDS PHARMACOL SCI, V29, P62, DOI 10.1016/j.tips.2007.11.007; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Khanna I, 2012, DRUG DISCOV TODAY, V17, P1088, DOI 10.1016/j.drudis.2012.05.007; Kinnings SL, 2011, J CHEM INF MODEL, V51, P624, DOI 10.1021/ci1003174; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Liu X, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-33; Liu ZC, 2013, DRUG DISCOV TODAY, V18, P110, DOI 10.1016/j.drudis.2012.08.005; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; McCulley TJ, 2000, J NEURO-OPHTHALMOL, V20, P227, DOI 10.1097/00041327-200020040-00001; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524; Schomburg KT, 2014, J CHEM INF MODEL, V54, P1676, DOI 10.1021/ci500130e; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang W, 2012, PROTEINS, V80, P169, DOI 10.1002/prot.23173	45	19	21	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171433	10.1371/journal.pone.0171433	http://dx.doi.org/10.1371/journal.pone.0171433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196116	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900021
J	Naderipour, A; Zin, AAM; Bin Habibuddin, MH; Miveh, MR; Guerrero, JM				Naderipour, Amirreza; Zin, Abdullah Asuhaimi Mohd; Bin Habibuddin, Mohd Hafiz; Miveh, Mohammad Reza; Guerrero, Josep M.			An improved synchronous reference frame current control strategy for a photovoltaic grid-connected inverter under unbalanced and nonlinear load conditions	PLOS ONE			English	Article							POWER QUALITY; COMPENSATION; FILTERS	In recent years, renewable energy sources have been considered the most encouraging resources for grid and off-grid power generation. This paper presents an improved current control strategy for a three-phase photovoltaic grid-connected inverter (GCI) under unbalanced and nonlinear load conditions. It is challenging to suppress the harmonic content in the output current below a pre-set value in the GCI. It is also difficult to compensate for unbalanced loads even when the grid is under disruption due to total harmonic distortion (THD) and unbalanced loads. The primary advantage and objective of this method is to effectively compensate for the harmonic current content of the grid current and microgrid without the use of any compensation devices, such as active and passive filters. This method leads to a very low THD in both the GCI currents and the current exchanged with the grid. The control approach is designed to control the active and reactive power and harmonic current compensation, and it also corrects the system unbalance. The proposed control method features the synchronous reference frame (SRF) method. Simulation results are presented to demonstrate the effective performance of the proposed method.	[Naderipour, Amirreza; Zin, Abdullah Asuhaimi Mohd; Bin Habibuddin, Mohd Hafiz; Miveh, Mohammad Reza] Univ Teknol Malaysia, Fac Elect Engn, Utm Skudai, Johor, Malaysia; [Guerrero, Josep M.] Aalborg Univ, Inst Energy Technol, Aalborg, Denmark	Universiti Teknologi Malaysia; Aalborg University	Zin, AAM (corresponding author), Univ Teknol Malaysia, Fac Elect Engn, Utm Skudai, Johor, Malaysia.	abdullah@fke.utm.my	Guerrero, Josep M./D-5519-2014; Guerrero, Josep M./Y-2929-2019; Naderipour, Amirreza/ABD-1421-2020	Guerrero, Josep M./0000-0001-5236-4592; Naderipour, Amirreza/0000-0002-1466-1702; Habibuddin, Mohd Hafiz/0000-0002-5591-3072	Universiti Teknologi Malaysia (UTM) [15H65]; Ministry of Higher Education (MOHE)	Universiti Teknologi Malaysia (UTM); Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	The authors sincerely would like to express their appreciation to the Universiti Teknologi Malaysia (UTM) for supporting this work through GUP Grant (Vote No: 15H65) and Ministry of Higher Education (MOHE) for providing funds to carry out the research reported in this paper.r The authors sincerely would like to express their appreciation to the Universiti Teknologi Malaysia (UTM) for supporting this work through GUP Grant (Vote No: 15H65) and Ministry of Higher Education (MOHE) for providing funds to carry out the research reported in this paper. Furthermore, I would also like to thank Aalborg University, Aalborg East, Denmark, for their cooperation.	Abbes M, 2012, ELECTR POW SYST RES, V88, P52, DOI 10.1016/j.epsr.2012.01.018; Akagi H, 1996, IEEE T IND APPL, V32, P1312, DOI 10.1109/28.556633; Arruda LN, 2001, IEEE IND APPLIC SOC, P2655, DOI 10.1109/IAS.2001.955993; Blaabjerg F, 2006, IEEE T IND ELECTRON, V53, P1398, DOI 10.1109/TIE.2006.881997; Chen Z, 2005, IEEE T POWER DELIVER, V20, P1719, DOI 10.1109/TPWRD.2004.834349; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Das JC, 2003, IEEE PULP P, P187, DOI 10.1109/PAPCON.2003.1216916; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Golovanov N, 2013, ENERGIES, V6, P634, DOI 10.3390/en6020634; Guerrero JM, 2009, IEEE T IND ELECTRON, V56, P726, DOI 10.1109/TIE.2008.2009274; Hamzeh M, 2014, IEEE T SMART GRID, V5, P167, DOI 10.1109/TSG.2013.2263842; Hamzeh M, 2012, IEEE T POWER SYST, V27, P2225, DOI 10.1109/TPWRS.2012.2193906; Hossain MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131279; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Humada AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152766; Jara AJ, 2015, 2015 IEEE 29TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS WAINA 2015, P668, DOI 10.1109/WAINA.2015.169; Jiang DD, 2016, IEEE INTERNET THINGS, V3, P1437, DOI 10.1109/JIOT.2016.2613111; Jou HL, 2008, IEEE T POWER ELECTR, V23, P2775, DOI 10.1109/TPEL.2008.2003015; Khunjar WO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044846; Naderipour A, 2016, ELECTRON WORLD, V122, P42; Ranjbar Mahmoud, 2011, 2011 2nd Power Electronics, Drive Systems & Technologies Conference (PEDSTC 2011), P111, DOI 10.1109/PEDSTC.2011.5742401; Salam Z., 2006, ELEKTR J ELECT ENG, V8, P17; Samrat NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130678; Savaghebi M, 2013, IEEE T IND ELECTRON, V60, P1390, DOI 10.1109/TIE.2012.2185914; Shi P, 2015, MIXED H INFINITY PAS; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Teodorescu R, 2004, IEEE T POWER ELECTR, V19, P1323, DOI 10.1109/TPEL.2004.833452; Timbus A, 2009, IEEE T POWER ELECTR, V24, P654, DOI 10.1109/TPEL.2009.2012527; Trinh Q-N, 2014, ENHANCED GRID CURREN; Twining E, 2003, IEEE T POWER ELECTR, V18, P888, DOI 10.1109/TPEL.2003.810838; Wei JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133725; Xu GB, 2016, SMART GRID: NETWORKING, DATA MANAGEMENT, AND BUSINESS MODELS, P73; Yang XY, 2015, SENSORS-BASEL, V15, P20799, DOI 10.3390/s150820799; Zhong QC, 2013, IEEE T IND ELECTRON, V60, P1344, DOI 10.1109/TIE.2012.2187415; Zin AAM, 2016, ELECT LETT IET	35	19	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0164856	10.1371/journal.pone.0164856	http://dx.doi.org/10.1371/journal.pone.0164856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192436	Green Published, gold			2022-12-27	WOS:000394423800001
J	Saintas, E; Abrahams, L; Ahmad, GT; Ajakaiye, AOM; AlHumaidi, ASHAM; Ashmore-Harris, C; Clark, I; Dura, UK; Fixmer, CN; Ike-Morris, C; Prado, MM; Mccullough, D; Mishra, S; Scholer, KMU; Timur, H; Williamson, MDC; Alatsatianos, M; Bahsoun, B; Blackburn, E; Hogwood, CE; Lithgow, PE; Rowe, M; Yiangou, L; Rothweiler, F; Cinatl, J; Zehner, R; Baines, AJ; Garrett, MD; Gourlay, CW; Griffin, DK; Gullick, WJ; Hargreaves, E; Howard, MJ; Lloyd, DR; Rossman, JS; Smales, CM; Tsaousis, AD; von der Haar, T; Wass, MN; Michaelis, M				Saintas, Emily; Abrahams, Liam; Ahmad, Gulshan T.; Ajakaiye, Anu-Oluwa M.; AlHumaidi, Abdulaziz S. H. A. M.; Ashmore-Harris, Candice; Clark, Iain; Dura, Usha K.; Fixmer, Carine N.; Ike-Morris, Chinedu; Prado, Mireia Mato; Mccullough, Danielle; Mishra, Shishir; Schoeler, Katia M. U.; Timur, Husne; Williamson, Maxwell D. C.; Alatsatianos, Markella; Bahsoun, Basma; Blackburn, Edith; Hogwood, Catherine E.; Lithgow, Pamela E.; Rowe, Michelle; Yiangou, Lyto; Rothweiler, Florian; Cinatl, Jindrich, Jr.; Zehner, Richard; Baines, Anthony J.; Garrett, Michelle D.; Gourlay, Campbell W.; Griffin, Darren K.; Gullick, William J.; Hargreaves, Emma; Howard, Mark J.; Lloyd, Daniel R.; Rossman, Jeremy S.; Smales, C. Mark; Tsaousis, Anastasios D.; von der Haar, Tobias; Wass, Mark N.; Michaelis, Martin			Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-AS(r) OXALI(4000), a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS	PLOS ONE			English	Article							PHASE-I; MOLECULAR-MECHANISMS; INFLUENZA-VIRUS; LUNG-CANCER; ANTICANCER; GEMCITABINE; CISPLATIN; THERAPY; COMBINATIONS; DOXORUBICIN	The formation of acquired drug resistance is a major reason for the failure of anti-cancer therapies after initial response. Here, we introduce a novel model of acquired oxaliplatin resistance, a sub-line of the non-MYCN-amplified neuroblastoma cell line SK-N-AS that was adapted to growth in the presence of 4000 ng/mL oxaliplatin (SK-N-AS(r) OXALI(4000)). SK-N-AS(r) OXALI(4000) cells displayed enhanced chromosomal aberrations compared to SK-N-AS, as indicated by 24-chromosome fluorescence in situ hybridisation. Moreover, SK-N-AS(r) OXALI(4000) cells were resistant not only to oxaliplatin but also to the two other commonly used anti-cancer platinum agents cisplatin and carboplatin. SK-N-AS(r) OXALI(4000) cells exhibited a stable resistance phenotype that was not affected by culturing the cells for 10 weeks in the absence of oxaliplatin. Interestingly, SK-N-AS(r) OXALI(4000) cells showed no cross resistance to gemcitabine and increased sensitivity to doxorubicin and UVC radiation, alternative treatments that like platinum drugs target DNA integrity. Notably, UVC-induced DNA damage is thought to be predominantly repaired by nucleotide excision repair and nucleotide excision repair has been described as the main oxaliplatin-induced DNA damage repair system. SK-N- AS(r) OXAL(4000) cells were also more sensitive to lysis by influenza A virus, a candidate for oncolytic therapy, than SK-N-AS cells. In conclusion, we introduce a novel oxaliplatin resistance model. The oxaliplatin resistance mechanisms in SK-N-AS(r) OXALI(4000) cells appear to be complex and not to directly depend on enhanced DNA repair capacity. Models of oxaliplatin resistance are of particular relevance since research on platinum drugs has so far predominantly focused on cisplatin and carboplatin.	[Saintas, Emily; Abrahams, Liam; Ahmad, Gulshan T.; Ajakaiye, Anu-Oluwa M.; AlHumaidi, Abdulaziz S. H. A. M.; Ashmore-Harris, Candice; Clark, Iain; Dura, Usha K.; Fixmer, Carine N.; Ike-Morris, Chinedu; Prado, Mireia Mato; Mccullough, Danielle; Mishra, Shishir; Schoeler, Katia M. U.; Timur, Husne; Williamson, Maxwell D. C.; Alatsatianos, Markella; Bahsoun, Basma; Blackburn, Edith; Hogwood, Catherine E.; Lithgow, Pamela E.; Rowe, Michelle; Yiangou, Lyto; Baines, Anthony J.; Garrett, Michelle D.; Gourlay, Campbell W.; Griffin, Darren K.; Gullick, William J.; Hargreaves, Emma; Howard, Mark J.; Lloyd, Daniel R.; Rossman, Jeremy S.; Smales, C. Mark; Tsaousis, Anastasios D.; von der Haar, Tobias; Wass, Mark N.; Michaelis, Martin] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Saintas, Emily; Hogwood, Catherine E.; Yiangou, Lyto; Hargreaves, Emma; Smales, C. Mark; Wass, Mark N.; Michaelis, Martin] Univ Kent, Ind Biotechnol Ctr, Canterbury, Kent, England; [Rothweiler, Florian; Cinatl, Jindrich, Jr.] Klinikum Goethe Univ, Inst Med Virol, Frankfurt, Germany; [Zehner, Richard] Klinikum Goethe Univ, Inst Rechtsmed, Frankfurt, Germany; [Howard, Mark J.] Univ Western Australia, Sch Chem & Biochem, Perth, WA, Australia	University of Kent; University of Kent; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Western Australia	Michaelis, M (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.; Michaelis, M (corresponding author), Univ Kent, Ind Biotechnol Ctr, Canterbury, Kent, England.	M.Michaelis@kent.ac.uk	Wass, Mark/H-3398-2019; z, r/ABA-2962-2021; Prado, Mireia Mato/W-4964-2019	Wass, Mark/0000-0001-5428-6479; Prado, Mireia Mato/0000-0002-0574-4098; Howard, Mark/0000-0002-0762-2887; Michaelis, Martin/0000-0002-5710-5888; Gourlay, Campbell/0000-0002-2373-6788; von der Haar, Tobias/0000-0002-6031-9254; Rossman, Jeremy/0000-0001-6124-4103; Lloyd, Daniel/0000-0002-4888-6790; Tsaousis, Anastasios/0000-0002-5424-1905; Schoeler, Katia/0000-0001-5136-5147; Abrahams, Liam/0000-0002-6466-5832; Smales, Christopher Mark/0000-0002-2762-4724	Kent Cancer Trust; Hilfe fuer krebskranke Kinder Frankfurt; Frankfurter Stiftung fuer krebskranke Kinder; BBSRC [BB/K017640/1] Funding Source: UKRI; MRC [MR/L00870X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G19438/2, BB/K017640/1] Funding Source: researchfish	Kent Cancer Trust; Hilfe fuer krebskranke Kinder Frankfurt; Frankfurter Stiftung fuer krebskranke Kinder; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Kent Cancer Trust, http://www.kentcancertrust.org.uk; Hilfe fuer krebskranke Kinder Frankfurt e.V., https://www.kinderkrebs-frankfurt.de; Frankfurter Stiftung fuer krebskranke Kinder, http://www.kinderkrebsstiftung-frankfurt.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Bergmann M, 2001, CANCER RES, V61, P8188; Bhattacharya B, 2016, BRIT J PHARMACOL, V173, P970, DOI 10.1111/bph.13422; Bianchi G, 2015, ONCOTARGET, V6, P11806, DOI 10.18632/oncotarget.3688; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Bucheit AD, 2014, BIOCHEM PHARMACOL, V87, P381, DOI 10.1016/j.bcp.2013.11.013; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; COHEN PS, 1995, CANCER RES, V55, P2380; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Faivre S, 2002, ANN ONCOL, V13, P1479, DOI 10.1093/annonc/mdf219; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Geoerger B, 2008, J CLIN ONCOL, V26, P4394, DOI 10.1200/JCO.2008.16.7585; Geoerger B, 2011, EUR J CANCER, V47, P230, DOI 10.1016/j.ejca.2010.09.015; GRIFFIN DK, 1994, J ASSIST REPROD GEN, V11, P132, DOI 10.1007/BF02332090; Guo ZS, 2008, BBA-REV CANCER, V1785, P217, DOI 10.1016/j.bbcan.2008.02.001; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartmann C, 2011, J PEDIAT HEMATOL ONC, V33, P344, DOI 10.1097/MPH.0b013e31820994ec; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Ioannou D, 2012, CHROMOSOME RES, V20, P447, DOI 10.1007/s10577-012-9294-z; Ioannou D, 2011, MOL CELL PROBE, V25, P199, DOI 10.1016/j.mcp.2011.08.002; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kasloff SB, 2014, J VIROL, V88, P9321, DOI 10.1128/JVI.00929-14; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kotchetkov R, 2005, INT J ONCOL, V27, P1029; Kushner BH, 2014, CANCER-AM CANCER SOC, V120, P2050, DOI 10.1002/cncr.28687; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Martinez-Balibrea E, 2015, MOL CANCER THER, V14, P1767, DOI 10.1158/1535-7163.MCT-14-0636; Mascarenhas L, 2013, PEDIATR BLOOD CANCER, V60, P1103, DOI 10.1002/pbc.24471; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Michaelis M, 2010, BIOCHEM PHARMACOL, V79, P130, DOI 10.1016/j.bcp.2009.08.013; Mir O, 2012, LUNG CANCER, V77, P104, DOI 10.1016/j.lungcan.2012.01.014; Morgenstern DA, 2013, J PEDIAT HEMATOL ONC, V35, P337, DOI 10.1097/MPH.0b013e318299d637; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Perego P, 2016, CANCER CHEMOTH PHARM, V77, P5, DOI 10.1007/s00280-015-2901-x; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Raez LE, 2010, CLIN LUNG CANCER, V11, P18, DOI 10.3816/CLC.2010.n.003; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Riccardi A, 1999, EUR J CANCER, V35, P86, DOI 10.1016/S0959-8049(98)00342-6; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Schneiderman J, 2008, J CLIN ONCOL, V26, P913, DOI 10.1200/JCO.2007.13.9493; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Seymour LW, 2016, BRIT J CANCER, V114, P357, DOI 10.1038/bjc.2015.481; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Taguchi K, 1997, JPN J CANCER RES, V88, P394, DOI 10.1111/j.1349-7006.1997.tb00395.x; Vallo S, 2015, TRANSL ONCOL, V8, P210, DOI 10.1016/j.tranon.2015.04.002; van Rikxoort M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036506; Wetterskog D, 2009, MOL CANCER RES, V7, P2031, DOI 10.1158/1541-7786.MCR-08-0501	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172140	10.1371/journal.pone.0172140	http://dx.doi.org/10.1371/journal.pone.0172140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192521	Green Published, gold, Green Accepted			2022-12-27	WOS:000394423800076
J	Daude, E; Mazumdar, S; Solanki, V				Daude, Eric; Mazumdar, Sumit; Solanki, Vandana			Widespread fear of dengue transmission but poor practices of dengue prevention: A study in the slums of Delhi, India	PLOS ONE			English	Article							FEVER; AWARENESS; KNOWLEDGE	Background This study has been conducted to throw light on the knowledge and practices related to dengue fever among the poor population living in Delhi's slums. Materials A household survey was conducted in 2013 among 3,350 households. The households were stratified by a number of variables related to socio-economic status and health events such as hospitalisation. The data collection was completed through face-to-face interviews conducted with the help of 25 field investigators. Results About 8% of the households had at least one diagnosed dengue case. In comparison to the population surveyed, teenagers (15-19 years) and adults (30-34 years) were more affected whereas children under four years of age were underrepresented. Housewives are more affected by dengue (24%) compared to their share of the population surveyed (17%). Despite the fact that 77% of the respondents are worried about mosquitoes, only 43% of them monitor environment to avoid the presence of breeding sites. Conclusion One cannot exclude the possibility that though young children under the age of four years are exposed to the virus, either their cases were asymptomatic or family members infected during this period had potentially more serious symptoms leading to hospitalisation. This result could thus be explained by budget-related health choices made by this population which do not favour small children. Educational programs should target housewives to improve their impact, as they are the ones mostly responsible for water storage and cleanliness of the house and its neighbourhood. Even with a dengue experience and potentially an acute perception of the risk and its factors, a proper management of environmental conditions is lacking. This along with the fact that word-of-mouth is the main source of information quoted should be a message for municipality health workers to give door-to-door information on how to prevent breeding sites and dengue infection.	[Daude, Eric; Solanki, Vandana] Natl Ctr Sci Res, Ctr Social Sci & Humanities, Delhi, India; [Mazumdar, Sumit] Inst Publ Hlth, Kalyani, W Bengal, India		Daude, E (corresponding author), Natl Ctr Sci Res, Ctr Social Sci & Humanities, Delhi, India.	eric.daude@cnrs.fr	Daude, Eric/P-4133-2014	Daude, Eric/0000-0001-8656-3346	Center for Social Sciences and Humanities; Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research	Center for Social Sciences and Humanities; Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research	The study, data collection and analysis was part of a larger project supported under the 'Extra-muralgrants of the Indian Council for Medical Research, Social and Behavioural Research'. The preparation of manuscript was supported by the Center for Social Sciences and Humanities.	Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Afreen N, 2014, PLOS CURRENTS OUTBRE; BALAYA S, 1969, INDIAN J MED RES, V57, P767; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005; Chinnakali P, 2012, N AM J MED SCI, V4, P278, DOI 10.4103/1947-2714.97210; Dar L, 1999, EMERG INFECT DIS, V5, P589, DOI 10.3201/eid0504.990427; Diesh P, 1972, J COMMUN DIS, V4, P8; Eric Daude, 2016, Economic and Political Weekly, V51, P77; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; KABRA SK, 1992, B WORLD HEALTH ORGAN, V70, P105; Kumari R, 2011, TROP MED INT HEALTH, V16, P949, DOI 10.1111/j.1365-3156.2011.02789.x; Mazumdar S, 2014, EQUITY IMPACTS TARGE; Pandey A, 2007, J CLIN VIROL, V40, P87, DOI 10.1016/j.jcv.2007.05.011; Rao C, 1985, INDIAN J MED RES, V82, P271; Scheper-Hughes Nancy, 1993, DEATH WEEPING VIOLEN; Singh N. P., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1174; Singh R. K., 2011, Dengue Bulletin, V35, P131; Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x; Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; Vikram Kumar, 2015, International Journal of Mosquito Research, V2, P83; Vikram K, 2016, ACTA TROP, V153, P21, DOI 10.1016/j.actatropica.2015.09.025; World Health Organization (WHO), 2012, GLOB STRAT DENG PREV	29	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171543	10.1371/journal.pone.0171543	http://dx.doi.org/10.1371/journal.pone.0171543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187147	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000394244300029
J	de Jong, M; Cranendonk, A; Twisk, JWR; van Weissenbruch, MM				de Jong, Miranda; Cranendonk, Anneke; Twisk, Jos W. R.; van Weissenbruch, Mirjam M.			IGF-I and relation to growth in infancy and early childhood in very-low-birth-weight infants and term born infants	PLOS ONE			English	Article							PREMATURE-INFANTS; PRETERM INFANTS; METABOLIC SYNDROME; INSULIN; LEPTIN; RETINOPATHY; COMPONENTS	Background In very-low-birth-weight infants IGF-I plays an important role in postnatal growth restriction and is probably also involved in growth restriction in childhood. We compared IGF-I and its relation to growth in early childhood in very-low-birth-weight infants and term appropriate for gestational age born infants. Methods We included 41 very-low-birth-weight and 64 term infants. Anthropometry was performed at all visits to the outpatient clinic. IGF-I and insulin were measured in blood samples taken at 6 months and 2 years corrected age (very-low-birth-weight children) and at 3 months, 1 and 2 years (term children). Results Over the first 2 years of life growth parameters are lower in very-low-birth-weight children compared to term children, but the difference in length decreases significantly. During the first 2 years of life IGF-I is higher in very-low-birth-weight children compared to term children. In both groups there is a significant relationship between IGF-I and (change in) length and weight over the first 2 years of life and between insulin and change in total body fat. Conclusions Considering the relation of IGF-I to growth and the decrease in difference in length, higher IGF-I levels in very-low-birth-weight infants in early childhood probably have an important role in catch-up growth in length.	[de Jong, Miranda] Albert Schweitzer Hosp, Dept Pediat, Dordrecht, Netherlands; [Cranendonk, Anneke; van Weissenbruch, Mirjam M.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands	Albert Schweitzer Ziekenhuis; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Weissenbruch, MM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Div Neonatol, Amsterdam, Netherlands.	m.vanweissenbruch@vumc.nl		van Weissenbruch, Mirjam M/0000-0002-8086-9552				Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Cutfield WS, 2004, GROWTH HORM IGF RES, V14, pS130, DOI 10.1016/j.ghir.2004.03.028; DAUNCEY MJ, 1977, ARCH DIS CHILD, V52, P223, DOI 10.1136/adc.52.3.223; de Jong M, 2015, PEDIATR RES, V78, P476, DOI 10.1038/pr.2015.128; de Jong M, 2015, PEDIATR RES, V78, P457, DOI 10.1038/pr.2015.118; de Jong M, 2014, HORM RES PAEDIAT, V81, P43, DOI 10.1159/000355597; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Hansen-Pupp I, 2011, J CLIN ENDOCR METAB, V96, P1129, DOI 10.1210/jc.2010-2440; Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000; Hikino S, 2001, PEDIATR RES, V50, P732, DOI 10.1203/00006450-200112000-00017; Kajantie E, 2002, J CLIN ENDOCR METAB, V87, P2171, DOI 10.1210/jc.87.5.2171; Kistner A, 2014, ACTA PAEDIATR, V103, P1198, DOI 10.1111/apa.12751; Kwinta P, 2011, J PEDIATR ENDOCR MET, V24, P651, DOI 10.1515/JPEM.2011.264; LINEHAM JD, 1986, EARLY HUM DEV, V13, P37, DOI 10.1016/0378-3782(86)90096-4; Lo HC, 2005, JPEN-PARENTER ENTER, V29, P87, DOI 10.1177/014860710502900287; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Ohkawa N, 2010, ACTA PAEDIATR, V99, P37, DOI 10.1111/j.1651-2227.2009.01516.x; Okuma C, 2013, HORM RES PAEDIAT, V79, P197, DOI 10.1159/000348517; Patel L, 2007, PEDIATR RES, V61, P99, DOI 10.1203/01.pdr.0000250036.34522.f1; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; RAJARAM S, 1995, PEDIATR RES, V37, P581, DOI 10.1203/00006450-199505000-00004; Tjoa ML, 2003, J REPROD IMMUNOL, V59, P29, DOI 10.1016/S0165-0378(02)00085-2; van de Lagemaat M, 2013, HORM RES PAEDIAT, V80, P92, DOI 10.1159/000351710	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171650	10.1371/journal.pone.0171650	http://dx.doi.org/10.1371/journal.pone.0171650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182752	Green Published, gold			2022-12-27	WOS:000394231800085
J	Meier, A; Higashigaito, K; Martini, K; Wurnig, M; Seifert, B; Keller, DI; Frauenfelder, T; Alkadhi, H				Meier, Andreas; Higashigaito, Kai; Martini, Katharina; Wurnig, Moritz; Seifert, Burkhardt; Keller, Dagmar I.; Frauenfelder, Thomas; Alkadhi, Hatem			Dual Energy CT Pulmonary Angiography with 6g Iodine-A Propensity Score-Matched Study (vol 11, e0167214, 2016)	PLOS ONE			English	Correction													Frauenfelder, Thomas/O-1734-2016; Martini, Katharina/AAW-7995-2020	Frauenfelder, Thomas/0000-0002-3295-6619; Seifert, Burkhardt/0000-0002-5829-2478; Wurnig, Moritz/0000-0001-7865-4010				Meier A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167214	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172251	10.1371/journal.pone.0172251	http://dx.doi.org/10.1371/journal.pone.0172251			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182767	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000394231800158
J	Walker, R; Deppen, S; Smith, G; Shi, CJ; Lehman, J; Clanton, J; Moore, B; Burns, R; Grogan, EL; Massion, PP				Walker, Ronald; Deppen, Stephen; Smith, Gary; Shi, Chanjuan; Lehman, Jonathan; Clanton, Jeff; Moore, Brandon; Burns, Rena; Grogan, Eric L.; Massion, Pierre P.			Ga-68-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; TC-99M-DEPREOTIDE SPECT; QUANTITATIVE ASSESSMENT; SOMATOSTATIN RECEPTORS; NEUROENDOCRINE TUMORS; TC-99M DEPREOTIDE; EXPRESSION; ACCURACY; F-18-FDG	Purpose F-18-FDG PET/CT is widely used to evaluate indeterminate pulmonary nodules (IPNs). False positive results occur, especially from active granulomatous nodules. A PET-based imaging agent with superior specificity to F-18-FDG for IPNs, is badly needed, especially in areas of endemic granulomatous nodules. Somatostatin receptors (SSTR) are expressed in many malignant cells including small cell and non-small cell lung cancers (NSCLCs). Ga-68-DOTATATE, a positron emitter labeled somatostatin analog, combined with PET/CT imaging, may improve the diagnosis of IPNs over F-18-FDG by reducing false positives. Our study purpose was to test this hypothesis in our region with high endemic granulomatous IPNs. Methods We prospectively performed Ga-68-DOTATATE PET/CT and F-18-FDG PET/CT scans in the same 30 patients with newly diagnosed, treatment-naive lung cancer (N = 14) or IPNs (N = 15) and one metastatic nodule. Ga-68-DOTATATE SUVmax levels at or above 1.5 were considered likely malignant. We analyzed the scan results, correlating with ultimate diagnosis via biopsy or 2-year chest CT follow-up. We also correlated Ga-68-DOTATATE uptake with immunohistochemical (IHC) staining for SSTR subtype 2A (SSTR2A) in pathological specimens. Results We analyzed 31 lesions in 30 individuals, with 14 (45%) being non-neuroendocrine lung cancers and 1 (3%) being metastatic disease. McNemar's result comparing the two radiopharmaceuticals (p = 0.65) indicates that their accuracy of diagnosis in this indication are equivalent. Ga-68-DOTATATE was more specific (94% compared to 81%) and less sensitive 73% compared to 93%) than F-18-FDG. Ga-68-DOTATATE uptake correlated with SSTR2A expression in tumor stroma determined by immunohistochemical (IHC) staining in 5 of 9 (55%) NSCLCs. Conclusion Ga-68-DOTATATE and F-18-FDG PET/CT had equivalent accuracy in the diagnosis of nonneuroendocrine lung cancer and Ga-68-DOTATATE was more specific than F-18-FDG for the diagnosis of IPNs. IHC staining for SSTR2A receptor expression correlated with tumor stroma but not tumor cells.	[Walker, Ronald; Smith, Gary; Moore, Brandon] Tennessee Valley VA Healthcare Syst, Med Imaging Serv, Nashville, TN USA; [Walker, Ronald; Smith, Gary; Clanton, Jeff] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Walker, Ronald; Burns, Rena; Massion, Pierre P.] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Deppen, Stephen; Grogan, Eric L.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Shi, Chanjuan] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Lehman, Jonathan] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Grogan, Eric L.] Tennessee Valley Healthcare Syst, Dept Surg, Nashville, TN USA; [Massion, Pierre P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Nashville, TN 37232 USA; [Massion, Pierre P.] Tennessee Valley Healthcare Syst, Pulm Crit Care Sect Med Serv, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Massion, PP (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	pierre.massion@vanderbilt.edu	Aguiar, Isabel/AAC-1095-2020	Lehman, Jonathan/0000-0001-6349-0332	NATIONAL CANCER INSTITUTE [U01CA152662] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ambrosini V, 2010, J NUCL MED, V51, P1950, DOI 10.2967/jnumed.110.079962; Armani C, 2007, J LEUKOCYTE BIOL, V81, P845, DOI 10.1189/jlb.0606417; Blum J, 2000, CHEST, V117, P1232, DOI 10.1378/chest.117.5.1232; Bodmer D, 2012, DEV NEUROSCI-BASEL, V34, P342, DOI 10.1159/000341291; Brogsitter C, 2014, CLIN NUCL MED, V39, P462, DOI 10.1097/RLU.0000000000000282; Callison J Clay Jr, 2011, J Lung Cancer, V10, P69; Croft DR, 2002, LUNG CANCER-J IASLC, V36, P297, DOI 10.1016/S0169-5002(02)00023-5; Daniel K, 2014, INT J CLIN EXP PATHO, V7, P4971; Deppen S, 2011, ANN THORAC SURG, V92, P428, DOI 10.1016/j.athoracsur.2011.02.052; Deppen SA, 2014, JAMA-J AM MED ASSOC, V312, P1227, DOI 10.1001/jama.2014.11488; Dimitrakopoulou-Strauss A, 2006, EUR J NUCL MED MOL I, V33, P823, DOI 10.1007/s00259-005-0063-5; Elliott DE, 1999, EUR J IMMUNOL, V29, P2454, DOI 10.1002/(SICI)1521-4141(199908)29:08<2454::AID-IMMU2454>3.0.CO;2-H; Ferran N, 2006, NUCL MED COMMUN, V27, P507, DOI 10.1097/00006231-200606000-00006; Fletcher JW, 2009, J NUCL MED; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Grogan EL, 2014, ANN THORAC SURG, V97, P1142, DOI 10.1016/j.athoracsur.2013.12.043; Grogan EL, 2011, J THORAC ONCOL, V6, P1720, DOI 10.1097/JTO.0b013e318226b48a; Halley A, 2005, EUR J NUCL MED MOL I, V32, P1026, DOI 10.1007/s00259-005-1812-1; Herlin G, 2009, ACTA RADIOL, V50, P902, DOI 10.1080/02841850903127477; Herrmann K, 2014, J NUCL MED; Howe MC, 2005, HISTOPATHOLOGY, V46, P195, DOI 10.1111/j.1365-2559.2005.02047.x; Islam S, 2013, CANCER J, V19, P208, DOI 10.1097/PPO.0b013e318295185f; Kaemmerer D, 2012, INT J CLIN EXP PATHO, V5, P187; Kahn D, 2004, CHEST, V125, P494, DOI 10.1378/chest.125.2.494; Kim SK, 2007, J NUCL MED, V48, P214; KWEKKEBOOM DJ, 1991, J NUCL MED, V32, P1845; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McKee BJ, 2014, J AM COLL RADIOL; Naalsund A, 2006, RESPIRATION, V73, P634, DOI 10.1159/000093232; Papotti M, 2002, VIRCHOWS ARCH, V440, P461, DOI 10.1007/s00428-002-0609-x; Papotti M, 2001, VIRCHOWS ARCH, V439, P787, DOI 10.1007/s004280100494; REUBI JC, 1994, INT J CANCER, V56, P681, DOI 10.1002/ijc.2910560513; Righi L, 2010, ANN ONCOL, V21, P548, DOI 10.1093/annonc/mdp334; Sandstrom M, 2013, J NUCL MED, V54, P1755, DOI 10.2967/jnumed.113.120600; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138144; Theodoropoulou M, 2013, FRONTIERS NEUROENDOC; Tsuta K, 2012, PATHOL RES PRACT, V208, P470, DOI 10.1016/j.prp.2012.05.014; Walker RC, 2013, J NUCL MED	40	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171301	10.1371/journal.pone.0171301	http://dx.doi.org/10.1371/journal.pone.0171301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182730	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800053
J	Hengl, T; de Jesus, JM; Heuvelink, GBM; Gonzalez, MR; Kilibarda, M; Blagotic, A; Shangguan, W; Wright, MN; Geng, XY; Bauer-Marschallinger, B; Guevara, MA; Vargas, R; MacMillan, RA; Batjes, NH; Leenaars, JGB; Ribeiro, E; Wheeler, I; Mantel, S; Kempen, B				Hengl, Tomislav; de Jesus, Jorge Mendes; Heuvelink, Gerard B. M.; Gonzalez, Maria Ruiperez; Kilibarda, Milan; Blagotic, Aleksandar; Shangguan, Wei; Wright, Marvin N.; Geng, Xiaoyuan; Bauer-Marschallinger, Bernhard; Guevara, Mario Antonio; Vargas, Rodrigo; MacMillan, Robert A.; Batjes, Niels H.; Leenaars, Johan G. B.; Ribeiro, Eloi; Wheeler, Ichsani; Mantel, Stephan; Kempen, Bas			SoilGrids250m: Global gridded soil information based on machine learning	PLOS ONE			English	Article							SPATIOTEMPORAL INTERPOLATION; ORGANIC-CARBON; DATABASE; PREDICTIONS; DATASETS; FORESTS; MODELS; WATER; MAPS; TOOL	This paper describes the technical development and accuracy assessment of the most recent and improved version of the SoilGrids system at 250m resolution (June 2016 update). SoilGrids provides global predictions for standard numeric soil properties (organic carbon, bulk density, Cation Exchange Capacity (CEC), pH, soil texture fractions and coarse fragments) at seven standard depths (0, 5, 15, 30, 60, 100 and 200 cm), in addition to predictions of depth to bedrock and distribution of soil classes based on the World Reference Base (WRB) and USDA classification systems (ca. 280 raster layers in total). Predictions were based on ca. 150,000 soil profiles used for training and a stack of 158 remote sensing-based soil covariates (primarily derived from MODIS land products, SRTM DEM derivatives, climatic images and global landform and lithology maps), which were used to fit an ensemble of machine learning methods D random forest and gradient boosting and/or multinomial logistic regression D as implemented in the R packages ranger, xgboost, nnet and caret. The results of 10 -fold cross-validation show that the ensemble models explain between 56% (coarse fragments) and 83% (pH) of variation with an overall average of 61%. Improvements in the relative accuracy considering the amount of variation explained, in comparison to the previous version of SoilGrids at 1 km spatial resolution, range from 60 to 230%. Improvements can be attributed to: (1) the use of machine learning instead of linear regression, (2) to considerable investments in preparing finer resolution covariate layers and (3) to insertion of additional soil profiles. Further development of SoilGrids could include refinement of methods to incorporate input uncertainties and derivation of posterior probability distributions (per pixel), and further automation of spatial modeling so that soil maps can be generated for potentially hundreds of soil variables. Another area of future research is the development of methods for multiscale merging of SoilGrids predictions with local and/or national gridded soil products (e.g. up to 50 m spatial resolution) so that increasingly more accurate, complete and consistent global soil information can be produced. SoilGrids are available under the Open Data Base License.	[Hengl, Tomislav; de Jesus, Jorge Mendes; Heuvelink, Gerard B. M.; Gonzalez, Maria Ruiperez; Batjes, Niels H.; Leenaars, Johan G. B.; Ribeiro, Eloi; Mantel, Stephan; Kempen, Bas] ISRIC World Soil Informat, Wageningen, Netherlands; [Kilibarda, Milan] Univ Belgrade, Fac Civil Engn, Belgrade, Serbia; [Blagotic, Aleksandar] GILab Ltd, Belgrade, Serbia; [Shangguan, Wei] Sun Yat Sen Univ, Sch Atmospher Sci, Guangzhou, Guangdong, Peoples R China; [Wright, Marvin N.] Inst Med Biometrie & Stat, Lubeck, Germany; [Geng, Xiaoyuan] Agr & Agri Food Canada, Ottawa, ON, Canada; [Bauer-Marschallinger, Bernhard] Vienna Univ Technol, Dept Geodesy & Geoinformat, Vienna, Austria; [Guevara, Mario Antonio; Vargas, Rodrigo] Univ Delaware, Newark, DE USA; [MacMillan, Robert A.] LandMapper Environm Solut Inc, Edmonton, AB, Canada; [Wheeler, Ichsani] Envirometrix Inc, Wageningen, Netherlands	University of Belgrade; Sun Yat Sen University; Agriculture & Agri Food Canada; Technische Universitat Wien; University of Delaware	Hengl, T (corresponding author), ISRIC World Soil Informat, Wageningen, Netherlands.	tom.hengl@isric.org	Hengl, Tomislav/AAE-9320-2019; Heuvelink, Gerard/AAD-5916-2022; Shangguan, Wei/C-5157-2008; Vargas, Rodrigo/C-4720-2008; Guevara, Mario/AAH-9539-2019; Marschallinger, Berhard/AAP-8088-2020; Snow, Val O/O-8693-2016; Batjes, Niels H./F-7195-2010	Hengl, Tomislav/0000-0002-9921-5129; Heuvelink, Gerard/0000-0003-0959-9358; Shangguan, Wei/0000-0001-7622-8210; Vargas, Rodrigo/0000-0001-6829-5333; Guevara, Mario/0000-0002-9788-9947; Marschallinger, Berhard/0000-0001-7356-7516; Snow, Val O/0000-0002-6911-8184; Batjes, Niels H./0000-0003-2367-3067; Leenaars, Johan G.B./0000-0003-1091-7114; Ribeiro, Eloi/0000-0002-2324-3000; Mendes de Jesus, Jorge Samuel/0000-0001-9890-067X; Wright, Marvin/0000-0002-8542-6291; Kilibarda, Milan/0000-0002-2930-3596	Dutch government; GILAB DOO	Dutch government; GILAB DOO	ISRIC is a non-profit organization primarily funded by the Dutch government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GILAB DOO provided support in the form of salaries for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions' section.	Aksoy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152098; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Baade Jussi, 2014, 2014 IEEE Geoscience and Remote Sensing Symposium. (IGARSS). Proceedings, P4327, DOI 10.1109/IGARSS.2014.6947447; Batjes NH, 2009, SOIL USE MANAGE, V25, P124, DOI 10.1111/j.1475-2743.2009.00202.x; Bauer-Marschallinger B, 2014, COMPUT GEOSCI-UK, V72, P84, DOI 10.1016/j.cageo.2014.07.005; BORDA M, 2011, FUND INF THEOR COD, P1; Brevik EC, 2016, GEODERMA, V264, P256, DOI 10.1016/j.geoderma.2015.05.017; Brus DJ, 2011, EUR J SOIL SCI, V62, P394, DOI 10.1111/j.1365-2389.2011.01364.x; Carroll ML, 2009, INT J DIGIT EARTH, V2, P291, DOI 10.1080/17538940902951401; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Chen T, 2016, XG BOOST A SCALABLE; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cooper M, 2005, SOIL SCI SOC AM J, V69, P649, DOI 10.2136/sssaj2004.0140; Danielson JJ, 2011, OPEN FILE REPORT 201; Domisch S, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.73; Eberhardt E., 2011, NCSS NATIONAL CONFER, P1; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; FAO, 2006, GUIDELINES FOR SOIL; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2012, HARMONIZED WORLD SOI; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Folberth C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11872; Gasch CK, 2015, SPAT STAT-NETH, V14, P70, DOI 10.1016/j.spasta.2015.04.001; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Griffiths RI, 2016, APPL SOIL ECOL, V97, P61, DOI 10.1016/j.apsoil.2015.06.018; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; Hall DK, 2007, HYDROL PROCESS, V21, P1534, DOI 10.1002/hyp.6715; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hollis JM, 2006, SPADE 2 THE SOIL PRO; Huffman GJ, 2009, GPCP VERSION 2 COMBI, V1; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; IUSS Working Group WRB, 2006, WORLD SOIL RESOURCES; Jenny H, 1994, DOVER BOOKS ON EARTH; Karssies L, 2011, CSIRO NATIONAL SOIL; Kempen B, 2011, THESIS; Kidd D, 2015, SOIL RES, V53, P932, DOI 10.1071/SR14268; Kilibarda M, 2014, J GEOPHYS RES-ATMOS, V119, P2294, DOI 10.1002/2013JD020803; Knaus J, 2009, R J, V1, P54; Krasilnikov P, 2009, A HANDBOOK OF SOIL T; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lang V, 2013, GEODERMA, V192, P269, DOI 10.1016/j.geoderma.2012.07.023; Leenaars JGB, 2014, AFRICA SOIL PROFILES; Lei SA, 1998, SOUTHWEST NAT, V43, P47; Liaw A, 2002, APPLIED PREDICTIVE M, V2, P18; Lopes ME, 2015, MEASURING THE ALGORI; MacDonald KB, 1992, CANSIS NSDB A GENERA; Malone BP, 2014, GEODERMA, V232, P34, DOI 10.1016/j.geoderma.2014.04.033; Mantel S, 2007, ISRIC REPORT 2007 01; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Minasny B, 2006, COMPUT GEOSCI-UK, V32, P1378, DOI 10.1016/j.cageo.2005.12.009; Mira M, 2015, REMOTE SENS ENVIRON, V170, P216, DOI 10.1016/j.rse.2015.09.021; Mitchell T., 2014, GEOSPATIAL POWER TOO; Montanarella L., 2013, JRC TECHNICAL REPORT; Montanarella L, 2012, CURR OPIN ENV SUST, V4, P559, DOI 10.1016/j.cosust.2012.06.007; Mulder VL, 2016, GEODERMA, V263, P16, DOI 10.1016/j.geoderma.2015.08.035; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pebesma E.J., 2005, R NEWS, V5; Pelletier JD, 2016, J ADV MODEL EARTH SY, V8, P41, DOI 10.1002/2015MS000526; Pogson M, 2012, ENVIRON MODELL SOFTW, V29, P37, DOI 10.1016/j.envsoft.2011.10.008; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Raup B, 2007, GLOBAL PLANET CHANGE, V56, P101, DOI 10.1016/j.gloplacha.2006.07.018; Ribeiro E, 2015, ISRIC REPORT 2015 03; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Sayre R, 2014, A NEW MAP OF GLOBAL; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Searle R, 2014, GLOBALSOILMAP: BASIS OF THE GLOBAL SPATIAL SOIL INFORMATION SYSTEM, P127; Shangguan W, 2016, JOURNAL OF ADVANCES; Shangguan W, 2013, J ADV MODEL EARTH SY, V5, P212, DOI 10.1002/jame.20026; Shani U, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005313; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shaw C, 2005, INFORMATION REPORT; Shepherd KD, 2015, AGR SYST, V132, P93, DOI 10.1016/j.agsy.2014.09.002; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sing T, 2016, ROCR VISUALIZING THE; Sollich P, 1996, ADV NEUR IN, V8, P190; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Stockmann U, 2015, GLOB FOOD SECUR-AGR, V6, P9, DOI 10.1016/j.gfs.2015.07.001; U S Department of Agriculture, 2014, KEYS TO SOIL TAXONOM; Van Engelen VWP, 2012, GLOBAL AND NATIONAL; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Wan Z., 2013, MODIS LAND SURFACE T; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Wright MN, 2015, RANGER A FAST IMPLEM	89	1538	1584	132	672	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169748	10.1371/journal.pone.0169748	http://dx.doi.org/10.1371/journal.pone.0169748			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207752	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500005
J	Leske, H; Hornemann, S; Herrmann, US; Zhu, CH; Pelczar, P; Li, B; Laferriere, F; Polymenidou, M; Pelczar, P; Reimann, RR; Schwarz, P; Rushing, EJ; Wuthrich, K; Aguzzi, A				Leske, Henning; Hornemann, Simone; Herrmann, Uli Simon; Zhu, Caihong; Dametto, Paolo; Li, Bei; Laferriere, Florent; Polymenidou, Magdalini; Pelczar, Pawel; Reimann, Regina Rose; Schwarz, Petra; Rushing, Elisabeth Jane; Wuthrich, Kurt; Aguzzi, Adriano			Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein	PLOS ONE			English	Article							FATAL FAMILIAL INSOMNIA; TRANSGENIC MICE; NMR STRUCTURE; BETA-2-ALPHA-2 LOOP; SPONGIFORM ENCEPHALOPATHY; SCRAPIE; DISEASE; PRP; SHEEP; TRANSMISSION	Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues of organisms suffering from transmissible spongiform encephalopathies. Detection of proteinase K-resistant prion protein (PrPSc) still represents the diagnostic gold standard for prion diseases in humans, sheep and cattle. However, it has become increasingly apparent that the accumulation of PrPSc does not always accompany prion infections: high titers of prion infectivity can be reached also in the absence of protease resistant PrPSc. Here, we describe a structural basis for the phenomenon of protease-sensitive prion infectivity. We studied the effect on proteinase K (PK) resistance of the amino acid substitution Y169F, which removes a single oxygen atom from the beta 2-alpha 2 loop of the cellular prion protein (PrPC). When infected with RML or the 263K strain of prions, transgenic mice lacking wildtype (wt) PrPC but expressing MoPrP169F generated prion infectivity at levels comparable to wt mice. The newly generated MoPrP169F prions were biologically indistinguishable from those recovered from prion-infected wt mice, and elicited similar pathologies in vivo. Surprisingly, MoPrP169F prions showed greatly reduced PK resistance and density gradient analyses showed a significant reduction in high-density aggregates. Passage of MoPrP169F prions into mice expressing wt MoPrP led to full recovery of protease resistance, indicating that no strain shift had taken place. We conclude that a subtle structural variation in the beta 2-alpha 2 loop of PrPC affects the sensitivity of PrPSc to protease but does not impact prion replication and infectivity. With these findings a specific structural feature of PrPC can be linked to a physicochemical property of the corresponding PrPSc.	[Leske, Henning; Hornemann, Simone; Herrmann, Uli Simon; Zhu, Caihong; Dametto, Paolo; Li, Bei; Reimann, Regina Rose; Schwarz, Petra; Rushing, Elisabeth Jane; Aguzzi, Adriano] Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, Zurich, Switzerland; [Laferriere, Florent; Polymenidou, Magdalini] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, Zurich, Switzerland; [Pelczar, Pawel] ETH, Inst Mol Biol & Biophys, Otto Stern Weg 5, Zurich, Switzerland; [Wuthrich, Kurt] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wuthrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Leske, Henning] Oslo Univ Hosp, Dept Neuro Pathol, Sognsvannsveien 20, Oslo, Norway; [Herrmann, Uli Simon] Univ Zurich, Dept Pediat, Kinderspital Zurich, Steinwiesstr 75, Zurich, Switzerland; [Dametto, Paolo] CSL Behring AG, Wankdorfstr 10, Bern, Switzerland; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Mattenstr 22, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; Scripps Research Institute; University of Oslo; University Children's Hospital Zurich; University of Zurich; CSL; University of Basel	Aguzzi, A (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, Zurich, Switzerland.; Wuthrich, K (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wuthrich, K (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wuthrich@mol.biol.ethz.ch; adriano.aguzzi@usz.ch	Polymenidou, Magdalini/D-2254-2014; Reimann, Regina Rose/A-1195-2016	Reimann, Regina Rose/0000-0002-6396-4195; Aguzzi, Adriano/0000-0002-0344-6708; Wuthrich, Kurt/0000-0001-8739-6965; Laferriere, Florent/0000-0002-0753-5505; Leske, Henning/0000-0002-3057-8730	European Research Council [ERC: 670958]; Swiss National Foundation [SNF: 160329, 147660]; Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch [2014/260, 2015/320]; Novartis Research Foundation; JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS"; SystemsX.ch [2015/320]; commission innovations of the University Hospital of Zurich	European Research Council(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch; Novartis Research Foundation; JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS"; SystemsX.ch; commission innovations of the University Hospital of Zurich	AA is a recipient of an Advanced Grant of the European Research Council (ERC: 670958 http://erc.europa.eu/advanced-grants) and the Swiss National Foundation (SNF: 160329 and 147660), the Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch (2014/260 and 2015/320), the Novartis Research Foundation, and the JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS". KW is the Cecil H. and Ida M. Green Professor of Structural Biology at The Scripps Research Institute. SH is the recipient of SystemsX.ch (2015/320) and the commission innovations of the University Hospital of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante E, 2015, NATURE, P1; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2013, P NATL ACAD SCI USA, V110, P8549, DOI 10.1073/pnas.1306178110; Christen B, 2012, J MOL BIOL, V423, P496, DOI 10.1016/j.jmb.2012.08.011; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Colucci M, 2006, J NEUROPATH EXP NEUR, V65, P642, DOI 10.1097/01.jnen.0000228198.81797.4d; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Gorfe AA, 2007, FASEB J, V21, P3279, DOI 10.1096/fj.07-8292com; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Miyazawa K, 2011, J CELL BIOCHEM, V112, P3630, DOI 10.1002/jcb.23286; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reimann RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005401; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Rossetti G, 2010, PROTEINS, V78, P3270, DOI 10.1002/prot.22834; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Saverioni D, 2013, J BIOL CHEM, V288, P27972, DOI 10.1074/jbc.M113.477547; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170503	10.1371/journal.pone.0170503	http://dx.doi.org/10.1371/journal.pone.0170503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207746	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500011
J	Luo, ZP; Dauter, Z				Luo, Zhipu; Dauter, Zbigniew			Embarras de richesses - It is not good to be too anomalous: Accurate structure of selenourea, a chiral crystal of planar molecules	PLOS ONE			English	Article							DIFFRACTION	Selenourea, SeC(NH2)(2), recently found an application as a derivatization reagent providing a significant anomalous diffraction signal used for phasing macromolecular crystal structures. The crystal structure of selenourea itself was solved about 50 years ago, from data recorded on films and evaluated by eye and refined to R= 0.15 with errors of bond lengths and angles about 0.1 angstrom and 6 degrees. In the current work this structure is re-evaluated on the basis of synchrotron data and refined to R1 = 0.021 with bond and angle errors about 0.007 angstrom and 0.5. The nine planar molecules of selenourea pack either in the P3(1) or in the P3(2) unit cell. All unique molecules are connected by a complex network of Se center dot center dot center dot H-N hydrogen bonds and Se center dot center dot center dot Se contacts. The packing of selenourea molecules is highly pseudosymmetric, approximating either of the P3(1(2))12, R3, and R32 space groups. Because the overwhelming majority of diffracted X-ray intensity originates form the anomalously scattering selenium atoms, the measurable anomalous Bijvoet differences are diminished and it was not possible to solve this crystal structure based on the anomalous signal alone.	[Luo, Zhipu; Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, Argonne Natl Lab, Argonne, IL 60439 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Argonne National Laboratory	Dauter, Z (corresponding author), NCI, Synchrotron Radiat Res Sect, Argonne Natl Lab, Argonne, IL 60439 USA.	dauter@anl.gov			Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibelayi D, 2016, ACTA CRYSTALLOGR B, V72, P317, DOI 10.1107/S2052520616003644; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; James RW, 1954, OPTICAL PRINCIPLES D, P32; Kondrashev YD, 1964, J STRUCT CHEM, V4, P413; Luo ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37123; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; McCrea WH, 1940, P ROY SOC EDINB, V60, P281, DOI [10.1017/S0370164600020265, DOI 10.1017/S0370164600020265]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARTHASARATHY S, 1967, ACTA CRYSTALLOGR, V22, P98, DOI 10.1107/S0365110X67000179; RODRIGUEZ MP, 1964, NATURE, V201, P180, DOI 10.1038/201180a0; RUTHERFORD JS, 1969, Z KRISTALLOGR KRIST, V128, P229, DOI 10.1524/zkri.1969.128.3-6.229; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; WILSON AJC, 1949, ACTA CRYSTALLOGR, V2, P318, DOI 10.1107/S0365110X49000813; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206	18	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171740	10.1371/journal.pone.0171740	http://dx.doi.org/10.1371/journal.pone.0171740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207770	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500049
J	Merali, Z; Huang, K; Mikulis, D; Silver, F; Kassner, A				Merali, Zamir; Huang, Kun; Mikulis, David; Silver, Frank; Kassner, Andrea			Evolution of blood-brain-barrier permeability after acute ischemic stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; ARTERY OCCLUSION; TRANSFER CONSTANTS; REPERFUSION; RATS; MRI; THERAPY; INJURY; DISRUPTION	The dynamics of BBB permeability after AIS in humans are not well understood. In the present study we measured the evolution of BBB permeability after AIS in humans using MRI. Patients presenting to our institution with a diagnosis of AIS underwent a single dynamic contrast-enhanced MRI (DCE-MRI) sequence to measure BBB permeability during their initial workup. Forty-two patients were included in the final analysis. The patient sample underwent DCE-MRI at a mean time of 23.8hrs after the onset of AIS symptoms (range: 1.3 - 90.7hrs). At all time-points the BBB permeability within the infarct region of the brain as defined on DWI/ADC was higher compared to the homologous region of the contralateral hemisphere (p<0.005). BBB permeability, expressed as a ratio of infarct permeability to contralateral permeability, was greatest at 6- 48hrs after the onset of AIS. Although the data was not acquired longitudinally, these findings suggest that the permeability of the BBB is continually elevated following AIS, which contradicts previous assertions that BBB permeability after AIS follows a biphasic course. Knowledge of BBB dynamics following AIS may provide insight into future treatments for AIS, especially BBB stabilizing agents.	[Merali, Zamir; Kassner, Andrea] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Merali, Zamir; Kassner, Andrea] Hosp Sick Children, Div Physiol & Expt Med, Toronto, ON, Canada; [Huang, Kun] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Mikulis, David] Toronto Western Hosp, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Silver, Frank] Toronto Western Hosp, Div Neurol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kassner, A (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.; Kassner, A (corresponding author), Hosp Sick Children, Div Physiol & Expt Med, Toronto, ON, Canada.	andrea.kassner@utoronto.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892	Heart and Stroke Foundation of Canada [NA 7035]; Canada Research Chairs Program [950-220786]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chairs Program(Canada Research Chairs)	This study was funded by The Heart and Stroke Foundation of Canada (NA 7035) and the Canada Research Chairs Program (950-220786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Heye AK, 2016, NEUROIMAGE, V125, P446, DOI 10.1016/j.neuroimage.2015.10.018; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Karonen JO, 2001, AM J NEURORADIOL, V22, P103; Kassner A, 2005, AM J NEURORADIOL, V26, P2213; Kassner A, 2009, AM J NEURORADIOL, V30, P1864, DOI 10.3174/ajnr.A1774; Kassner A, 2011, METHODS MOL BIOL, V686, P229, DOI 10.1007/978-1-60761-938-3_10; Kastrup A, 1999, J NEUROL SCI, V166, P91, DOI 10.1016/S0022-510X(99)00121-5; Kastrup A, 2008, STROKE, V39, P2385, DOI 10.1161/STROKEAHA.107.505420; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; Liu HS, 2013, STROKE, V44, P1872, DOI 10.1161/STROKEAHA.113.001558; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; Nagel S, 2004, BRAIN RES PROTOC, V12, P172, DOI 10.1016/j.brainresprot.2003.11.004; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Singh V, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/510481; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang XY, 2003, MOL NEUROBIOL, V28, P229, DOI 10.1385/MN:28:3:229; Wu XD, 2001, ACUPUNCTURE ELECTRO, V26, P1	34	94	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171558	10.1371/journal.pone.0171558	http://dx.doi.org/10.1371/journal.pone.0171558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207745	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500036
J	Qu, PF; Mi, BB; Wang, DL; Zhang, R; Yang, JM; Liu, DM; Dang, SN; Yan, H				Qu, Pengfei; Mi, Baibing; Wang, Duolao; Zhang, Ruo; Yang, Jiaomei; Liu, Danmeng; Dang, Shaonong; Yan, Hong			Association between the Infant and Child Feeding Index (ICFI) and nutritional status of 6-to 35-month-old children in rural western China	PLOS ONE			English	Article							QUANTILE REGRESSION; GROWTH	Background The objective of this study was to determine the relationship between the quality of feeding practices and children's nutritional status in rural western China. Methods A sample of 12,146 pairs of 6- to 35-month-old children and their mothers were recruited using stratified multistage cluster random sampling in rural western China. Quantile regression was used to analyze the relationship between the Infant and Child Feeding Index (ICFI) and children's nutritional status. Results In rural western China, 24.37% of all infants and young children suffer from malnutrition. Of this total, 19.57%, 8.74% and 4.63% of infants and children are classified as stunting, underweight and wasting, respectively. After adjusting for covariates, the quantile regression results suggested that qualified ICFI (ICFI > 13.8) was associated with all length and HAZ quantiles (P<0.05) and had a greater effect on the following: poor length and HAZ, the beta-estimates (length) from 0.76 cm (95% CI: 0.53 to 0.99 cm) to 0.34 cm (95% CI: 0.09 to 0.59 cm) and the beta-estimates (HAZ) from 0.17 (95% CI: 0.10 to 0.24) to 0.11 (95% CI: 0.04 to 0.19). Qualified ICFI was also associated with most weight quantiles (P<0.05 except the 80th and 90th quantiles) and poor and intermediate WAZ quantiles (P<0.05 including the 10th, 20th 30th and 40th quantiles). Additionally, qualified ICFI had a greater effect on poor weight and WAZ quantiles in which the beta-estimates (weight) were from 0.20 kg (95% CI: 0.14 to 0.26 kg) to 0.06 kg (95% CI: 0.00 to 0.12 kg) and the beta-estimates (WAZ) were from 0.14 (95% CI: 0.08 to 0.21) to 0.05 (95% CI: 0.01 to 0.10). Conclusions Feeding practices were associated with the physical development of infants and young children, and proper feeding practices had a greater effect on poor physical development in infants and young children. For mothers in rural western China, proper guidelines and messaging on complementary feeding practices are necessary.	[Qu, Pengfei; Mi, Baibing; Zhang, Ruo; Yang, Jiaomei; Liu, Danmeng; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi Provinc, Peoples R China; [Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Pembroke Pl, Liverpool, Merseyside, England; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Liverpool School of Tropical Medicine; University of Liverpool	Dang, SN; Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi Provinc, Peoples R China.; Yan, H (corresponding author), Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi Provinc, Peoples R China.	tjdshn@mail.xjtu.edu.cn; xjtu_yh.paper@aliyun.com	Shaonong, Dang/J-7421-2019; mi, baibing/ABO-1246-2022	Shaonong, Dang/0000-0002-6980-8169; mi, baibing/0000-0002-5208-7633; Wang, Duolao/0000-0003-2788-2464	National Natural Science Foundation of China [81230016]; Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF) [YH001]; Project of birth defect control and prevention in Shaanxi [Sxwsjswzfcght2016-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF); Project of birth defect control and prevention in Shaanxi	This work was supported by the National Natural Science Foundation of China 81230016. Financial support was provided by the Chinese Ministry of Health (MOH), the United Nations Childrens Fund (UNICEF) - YH001; Project of birth defect control and prevention in Shaanxi - Sxwsjswzfcght2016-013.	Austin PC, 2005, STAT MED, V24, P791, DOI 10.1002/sim.1851; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Dang S, 2005, EUR J CLIN NUTR, V59, P1022, DOI 10.1038/sj.ejcn.1602207; Garg A, 2009, J HEALTH POPUL NUTR, V27, P763; Jian-qiang L, 2005, J HYGIENE RES, V34, P617; Langendorf C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001714; Lohia N, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0290-7; Ma JQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-568; Qu PF, 2015, PUBLIC HEALTH NUTR, V18, P3386, DOI 10.1017/S1368980015000208; Ruel MT, 2002, J NUTR, V132, P1180, DOI 10.1093/jn/132.6.1180; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sawadogo PS, 2006, J NUTR, V136, P656, DOI 10.1093/jn/136.3.656; Watkins K, 2016, STATES WORLDS CHILDR, P1; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; World Health Organization, 2006, WORLD HLTH REP 2006; World Health Organization, 2009, INF YOUNG CHILD FEED, P1, DOI 10.1659/0276-4741(2004)024[0019:MDFR]2.0.CO;2; Yu K, 2012, J AM STAT ASSOC, V93, P228; Zheng Q., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1214/15-A0S1340	18	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171984	10.1371/journal.pone.0171984	http://dx.doi.org/10.1371/journal.pone.0171984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207774	gold, Green Accepted, Green Published			2022-12-27	WOS:000394424500066
J	Etxeberria, J; Goicoa, T; Lopez-Abente, G; Riebler, A; Ugarte, MD				Etxeberria, Jaione; Goicoa, Tomas; Lopez-Abente, Gonzalo; Riebler, Andrea; Dolores Ugarte, Maria			Spatial gender-age-period-cohort analysis of pancreatic cancer mortality in Spain (1990-2013)	PLOS ONE			English	Article							RATES; SUSCEPTIBILITY; TRENDS	Recently, the interest in studying pancreatic cancer mortality has increased due to its high lethality. In this work a detailed analysis of pancreatic cancer mortality in Spanish provinces was performed using recent data. A set of multivariate spatial gender-age-period-cohort models was considered to look for potential candidates to analyze pancreatic cancer mortality rates. The selected model combines features of APC (age-period-cohort) models with disease mapping approaches. To ensure model identifiability sum-to-zero constraints were applied. A fully Bayesian approach based on integrated nested Laplace approximations (INLA) was considered for model fitting and inference. Sensitivity analyses were also conducted. In general, estimated average rates by age, cohort, and period are higher in males than in females. The higher differences according to age between males and females correspond to the age groups [65, 70), [70, 75), and [75, 80). Regarding the cohort, the greatest difference between men and women is observed for those born between the forties and the sixties. From there on, the younger the birth cohort is, the smaller the difference becomes. Some cohort differences are also identified by regions and age-groups. The spatial pattern indicates a North-South gradient of pancreatic cancer mortality in Spain, the provinces in the North being the ones with the highest effects on mortality during the studied period. Finally, the space-time evolution shows that the space pattern has changed little over time.	[Etxeberria, Jaione; Goicoa, Tomas; Dolores Ugarte, Maria] Univ Publ Navarra, Dept Stat & Operat Res, Pamplona, Spain; [Etxeberria, Jaione; Goicoa, Tomas; Dolores Ugarte, Maria] Univ Publ Navarra, Inst Adv Mat, InaMat, Pamplona, Spain; [Etxeberria, Jaione] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Goicoa, Tomas] Res Network Hlth Serv Chron Dis REDISSEC, Madrid, Spain; [Lopez-Abente, Gonzalo] Inst Hlth Carlos III, Madrid, Spain; [Riebler, Andrea] Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway	Universidad Publica de Navarra; Universidad Publica de Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Norwegian University of Science & Technology (NTNU)	Ugarte, MD (corresponding author), Univ Publ Navarra, Dept Stat & Operat Res, Pamplona, Spain.; Ugarte, MD (corresponding author), Univ Publ Navarra, Inst Adv Mat, InaMat, Pamplona, Spain.	lola@unavarra.es	Etxeberria, Jaione/J-7199-2017; Ugarte, Maria Dolores/J-8834-2014; Goicoa, Tomás/J-8848-2014; Lopez-Abente, Gonzalo/E-5221-2010	Ugarte, Maria Dolores/0000-0002-3505-8400; Goicoa, Tomás/0000-0002-0588-0137; Lopez-Abente, Gonzalo/0000-0003-2423-8075; Etxeberria, Jaione/0000-0003-2415-4322	Spanish Ministry of Economy and Competitiveness [MTM 2014-51992-R]; Health Department of the Navarre Government (Project 113) [2186/2014]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Health Department of the Navarre Government (Project 113)	This work was supported by Spanish Ministry of Economy and Competitiveness (Project MTM 2014-51992-R) (Ugarte, Etxeberria, Goicoa) and Health Department of the Navarre Government (Project 113, Res.2186/2014) (Ugarte, Elm be rria, Goicoa).	BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Cabanes A, 2010, ANN ONCOL, V3, P14, DOI DOI 10.1093/ANN0NC/MDQ089; Eurostat, 2012, REV EUR STAND POP 20; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Heuer C, 1997, BIOMETRICS, V53, P161, DOI 10.2307/2533105; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Leon-Gomez B, 2016, EUR J PUBLIC HLTH; Lopez-Abente G, 2010, ANN ONCOL, V21, piii76, DOI 10.1093/annonc/mdq091; Lopez-Abente G, 2006, ATLAS MUNICIPAL MORT; Lopez-Abente G, 2015, SITUACION CANC INFOR; Lopez-Abente G, 1984, ATLAS CANC; Maisonneuve P, 2015, INT J EPIDEMIOL, V44, P186, DOI 10.1093/ije/dyu240; Papoila AL, 2014, BIOMETRICAL J, V56, P403, DOI 10.1002/bimj.201200264; Rosso T, 2016, EUROPEAN J CANC PREV; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Seoane-Mato D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-254; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	24	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169751	10.1371/journal.pone.0169751	http://dx.doi.org/10.1371/journal.pone.0169751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199327	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400009
J	Medina, JL; Brooks, EG; Chaparro, A; Dube, PH				Medina, Jorge L.; Brooks, Edward G.; Chaparro, Adriana; Dube, Peter H.			Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice	PLOS ONE			English	Article							MAST-CELLS PROTECT; IMMUNOGLOBULIN-E; VACUOLATING CYTOTOXIN; ASTHMA; INFECTION; PERTUSSIS; ALLERGY; RISK; INFLAMMATION; EPITHELIUM	Mycoplasma pneumoniae is strongly associated with new onset asthma and asthma exacerbations. Until recently, the molecular mechanisms utilized by M. pneumoniae to influence asthma symptoms were unknown. However, we recently reported that an ADP-ribosylating and vacuolating toxin called the Community Acquired Respiratory Distress Syndrome toxin, CARDS toxin, produced by M. pneumoniae was sufficient to promote allergic inflammation and asthma-like disease in mice. A mouse model of CARDS toxin exposure was used to evaluate total and CARDS-toxin specific serum IgE responses. Mast cell sensitization, challenge, and degranulation studies determined functionality of the CARDS toxin-specific IgE. In the current study, we report that a single mucosal exposure to CARDS toxin was sufficient to increase total serum IgE and CARDS toxin-specific IgE in mice. Mice given a second mucosal challenge of CARDS toxin responded with significant increases in total and CARDS toxin-specific IgE. CARDS toxin-specific IgE bound to an N-terminal peptide of CARDS toxin but not the C-terminal peptide. Likewise, full-length CARDS toxin and the N-terminal peptide induced mast cell degranulation. Altogether, these data demonstrate that exposure to CARDS toxin is sufficient to generate functional IgE in mice. M. pneumoniae and CARDS toxin are strongly associated with asthma exacerbations raising the possibility that the CARDS toxin-specific IgE-mast cell axis contributes to disease pathogenesis.	[Medina, Jorge L.; Brooks, Edward G.; Dube, Peter H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Brooks, Edward G.; Chaparro, Adriana] Univ Texas Hlth Sci Ctr San Antonio, Div Immunol & Infect Dis, Dept Pediat, San Antonio, TX 78229 USA; [Medina, Jorge L.] US Army Inst Surg Res, JBSA Ft Sam Houston, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; United States Department of Defense; United States Army	Dube, PH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Dube@uthscsa.edu			National Institutes of Health [AI070412]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health, AI070412, WWW.NIH.GOV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akinbami Lara J, 2012, NCHS Data Brief, P1; Anto JM, 2012, J ALLERGY CLIN IMMUN, V129, P943, DOI 10.1016/j.jaci.2012.01.047; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arroyave WD, 2013, J ALLER CL IMM-PRACT, V1, P501, DOI 10.1016/j.jaip.2013.06.013; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; Becker A, 2015, P NATL ACAD SCI USA, V112, P5165, DOI 10.1073/pnas.1420308112; Boulay ME, 2003, CURR OPIN ALLERGY CL, V3, P51, DOI 10.1097/01.all.0000053268.39029.19; Burks ML, 2013, ANN ALLERG ASTHMA IM, V111, P14, DOI 10.1016/j.anai.2013.05.008; Capili CR, 2012, J ALLERGY CLIN IMMUN, V129, P957, DOI 10.1016/j.jaci.2011.11.020; Darveaux JI, 2014, J ALLER CL IMM-PRACT, V2, P658, DOI 10.1016/j.jaip.2014.09.011; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, DISCOV MED, V17, P247; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Graham AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00238; Graham AC, 2013, J IMMUNOL, V190, P4676, DOI 10.4049/jimmunol.1202096; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; Holgate ST, 2006, J ALLERGY CLIN IMMUN, V118, P587, DOI 10.1016/j.jaci.2006.06.023; Holgate ST, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-17; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jain S, 2015, NEW ENGL J MED, V373, P2382; Jensen Bettina M, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0323s74; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kannan TR, 2010, MOL MICROBIOL, V76, P1127, DOI 10.1111/j.1365-2958.2010.07092.x; Kannan TR, 2014, MOL MICROBIOL, V93, P568, DOI 10.1111/mmi.12680; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kennedy JL, 2012, CLIN EXP ALLERGY, V42, P659, DOI 10.1111/j.1365-2222.2011.03944.x; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Medina JL, 2012, AM J RESP CELL MOL B; Medina JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102613; Michels NM, 2010, CLIN EXP ALLERGY, V40, P1406, DOI 10.1111/j.1365-2222.2010.03488.x; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; MU HH, 1993, INFECT IMMUN, V61, P2834, DOI 10.1128/IAI.61.7.2834-2840.1993; MUNOZ JJ, 1990, CELL IMMUNOL, V127, P327, DOI 10.1016/0008-8749(90)90136-F; Munoz S, 2003, J IMMUNOL, V170, P5590, DOI 10.4049/jimmunol.170.11.5590; NAGAYAMA Y, 1987, J ASTHMA, V24, P159, DOI 10.3109/02770908709070932; Peters J, 2011, CHEST; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Sauteur PMM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00329; SEKIYA K, 1983, MICROBIOL IMMUNOL, V27, P905, DOI 10.1111/j.1348-0421.1983.tb00656.x; Sohn MH, 2012, ALLERGY ASTHMA IMMUN, V4, P264, DOI 10.4168/aair.2012.4.5.264; Starkl P, 2015, J ALLERGY CLIN IMMUN, DOI [10.1186/1939-4551-7-17, DOI 10.1186/1939-4551-7-17]; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wood PR, 2013, ANN ALLERG ASTHMA IM, V110, P328, DOI 10.1016/j.anai.2013.01.022; Wu LC, 2011, J BIOL CHEM, V286, P32891, DOI 10.1074/jbc.R110.205104; Xu X, 2006, AM J RESP CRIT CARE, V173, P219, DOI 10.1164/rccm.200507-1034OC; Yeh JJ, 2015, J ALLERGY CLIN IMMUN	64	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172447	10.1371/journal.pone.0172447	http://dx.doi.org/10.1371/journal.pone.0172447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199385	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400092
J	Neulen, A; Pantel, T; Kosterhon, M; Kirschner, S; Brockmann, MA; Kantelhardt, SR; Giese, A; Thal, SC				Neulen, Axel; Pantel, Tobias; Kosterhon, Michael; Kirschner, Stefanie; Brockmann, Marc A.; Kantelhardt, Sven R.; Giese, Alf; Thal, Serge C.			A segmentation-based volumetric approach to localize and quantify cerebral vasospasm based on tomographic imaging data	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLA PROTEIN-DEFICIENCY; ARTERIOVENOUS-MALFORMATIONS; CT ANGIOGRAPHY; MICE; MANAGEMENT; DIAGNOSIS; ISCHEMIA; VESSELS; MODEL	Introduction Quantification of cerebral vasospasm after subarachnoid hemorrhage (SAH) is crucial in animal studies as well as clinical routine. We have developed a method for computer-based volumetric assessment of intracranial blood vessels from cross-sectional imaging data. Here we demonstrate the quantification of vasospasm from micro computed tomography (micro-CT) data in a rodent SAH model and the transferability of the volumetric approach to clinical data. Methods We obtained rodent data by performing an ex vivo micro-CT of murine brains after sham surgery or SAH by endovascular filament perforation on day 3 post hemorrhage. Clinical CT angiography (CTA) was performed for diagnostic reasons unrelated to this study. We digitally reconstructed and segmented intracranial vascular trees, followed by calculating volumes of defined vessel segments by standardized protocols using Amira r software. Results SAH animals demonstrated significantly smaller vessel diameters compared with sham (MCA: 134.4 +/- 26.9 mu m vs. 165.0 +/- 18.7 mu m, p< 0.05). We could highlight this difference by analyzing vessel volumes of a defined MCA-ICA segment (SAH: 0.044 +/- 0.017 mu l vs. sham: 0.07 +/- 0.006 mu l, p<0.001). Analysis of clinical CTA data allowed us to detect and volumetrically quantify vasospasm in a series of 5 SAH patients. Vessel diameters from digital reconstructions correlated well with those measured microscopically (rodent data, correlation coefficient 0.8, p<0.001), or angiographically (clinical data, 0.9, p<0.001). Conclusions Our methodological approach provides accurate anatomical reconstructions of intracranial vessels from cross-sectional imaging data. It allows volumetric assessment of entire vessel segments, hereby highlighting vasospasm-induced changes objectively in a murine SAH model. This method could also be a helpful tool for analysis of clinical CTA.	[Neulen, Axel; Pantel, Tobias; Kosterhon, Michael; Kantelhardt, Sven R.; Giese, Alf] Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany; [Kirschner, Stefanie; Brockmann, Marc A.] Univ Med Ctr Mainz, Dept Neuroradiol, Mainz, Germany; [Thal, Serge C.] Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Neulen, A (corresponding author), Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany.; Thal, SC (corresponding author), Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany.	axel.neulen@unimedizin-mainz.de; thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Neulen, Axel/0000-0003-3547-1630	Friedhelm Frees Stiftung; Stiftung Neurochirurgische Forschung	Friedhelm Frees Stiftung; Stiftung Neurochirurgische Forschung	The study was supported by the Friedhelm Frees Stiftung (http://www.unimedizin-mainz.de/friedhelmfreesstiftung/) and by the Stiftung Neurochirurgische Forschung (http://www.dgnc.de/mitgliederbereich/stipendien-stiftungen/stiftungen/neurochirurgische-forschung/stiftung.html) (grants to A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay T, 2009, J NEUROSCI METH, V183, P136, DOI 10.1016/j.jneumeth.2009.06.027; Beseoglu Kerim, 2015, Acta Neurochir Suppl, V120, P35, DOI 10.1007/978-3-319-04981-6_6; Chaudhary SR, 2008, CEREBROVASC DIS, V25, P144, DOI 10.1159/000112325; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Felix MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126246; Figueiredo G, 2012, CLIN NEURORADIOL, V22, P21, DOI 10.1007/s00062-011-0113-2; Froehler MT, 2010, J CLIN NEUROSCI, V17, P1169, DOI 10.1016/j.jocn.2010.04.014; Ghanavati S, 2014, NEUROIMAGE, V95, P117, DOI 10.1016/j.neuroimage.2014.03.044; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; Kamp MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114946; Kerl HU, 2011, J COMPUT ASSIST TOMO, V35, P517, DOI 10.1097/RCT.0b013e31821c662b; Laslo AM, 2006, AM J NEURORADIOL, V27, P624; Lin CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151772; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Momin EN, 2009, NEUROSURGERY, V65, P937, DOI 10.1227/01.NEU.0000356974.14230.B8; Murphy PA, 2014, P NATL ACAD SCI USA, V111, P18007, DOI 10.1073/pnas.1415316111; Otawara Y, 2002, NEUROSURGERY, V51, P939, DOI 10.1097/00006123-200210000-00015; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wilson CD, 2014, CAN J NEUROL SCI, V41, P314, DOI 10.1017/S031716710001725X; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Xie BH, 2012, TRANSL STROKE RES, V3, pS174, DOI 10.1007/s12975-012-0164-y; Yao YC, 2013, P NATL ACAD SCI USA, V110, P19071, DOI 10.1073/pnas.1310905110; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567	31	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172010	10.1371/journal.pone.0172010	http://dx.doi.org/10.1371/journal.pone.0172010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199398	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400066
J	Sama, CB; Feteh, VF; Tindong, M; Tanyi, JT; Bihle, NM; Angwafo, FF				Sama, Carlson-Babila; Feteh, Vitalis F.; Tindong, Maxime; Tanyi, John T.; Bihle, Nestor Mbinkar; Angwafo, Fru F., III			Prevalence of maternal HIV infection and knowledge on mother-to-child transmission of HIV and its prevention among antenatal care attendees in a rural area in northwest Cameroon	PLOS ONE			English	Article							INFANTS	Background In 2010, an estimated 141 new HIV infections occurred per day in Cameroon and reports suggest an upsurge of these rates by 2020 if current trends continue. Mother to child transmission (MTCT) of HIV is a major public health challenge, and maternal knowledge on HIV transmission during pregnancy and its prevention is important in curtailing paediatric HIV acquisition. Objectives We aimed at establishing the prevalence of maternal HIV infection as well as assessing knowledge on HIV, MTCT and prevention of MTCT (PMTCT) of HIV among pregnant women in a rural area of Cameroon. Methods This study was conducted in two phases: a 29 month retrospective analysis of 1866 deliveries within three rural health facilities in the Babessi sub division, Northwest Cameroon and a 1 month prospective phase wherein 150 consenting pregnant women attending antenatal care (ANC) at the study centres were consecutively recruited. Results Overall, the prevalence of maternal HIV infection was 5.0% (100/2016). All (100%) of the interviewed pregnant women were aware of HIV infection and most (76.7%) had adequate knowledge on its routes of transmission. Meanwhile, only 79.3% (119/150) of them were aware of MTCT with slightly above a third (37.0%) having adequate knowledge on the periods of transmission. The proportions of women correctly stating: during pregnancy, during labour/delivery and during breastfeeding as possible periods of MTCT of HIV were 63.0%, 60.5% and 89.1% respectively. A majority (76.3%) of these women had inadequate knowledge on PMTCT of HIV. Conclusion The overall prevalence of maternal HIV warrants strengthening of current intervention strategies including scaling up of PMTCT measures. Among others, intensification of HIV related ANC services to improve the pregnant women's awareness and knowledge on MTCT and its prevention are vital steps in curbing the growing burden of paediatric HIV.	[Sama, Carlson-Babila] Islamic Medicalized Hlth Ctr, Babessi, Northwest Regio, Cameroon; [Sama, Carlson-Babila; Tindong, Maxime; Bihle, Nestor Mbinkar] GCRG, Buea, Southwest Regio, Cameroon; [Feteh, Vitalis F.] Mboppi Baptist Hosp Douala, Douala, Cameroon; [Feteh, Vitalis F.; Tindong, Maxime] Hlth & Human Dev 2HD Res Grp, Douala, Cameroon; [Tindong, Maxime] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Tanyi, John T.] Konye Subdiv Hosp, Konye, Southwest Regio, Cameroon; [Bihle, Nestor Mbinkar] Babessi Subdiv Hosp, Babessi, Northwest Regio, Cameroon; [Angwafo, Fru F., III] Gynaecoobstet & Paediat Hosp, Yaounde, Cameroon; [Angwafo, Fru F., III] Univ Teaching Hosp, Dept Surg, Yaounde, Cameroon	Universite Libre de Bruxelles	Sama, CB (corresponding author), Islamic Medicalized Hlth Ctr, Babessi, Northwest Regio, Cameroon.; Sama, CB (corresponding author), GCRG, Buea, Southwest Regio, Cameroon.	sama.carlson@yahoo.com		Feteh, Vitalis Fambombi/0000-0001-7072-7422; Tanyi, John/0000-0001-5438-1599				[Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2010, PMTCT STRAT VIS 2010; [Anonymous], 2010, ARCADIS GEOTECNIA RE, P1; Asefa A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-66; Awungafac G, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.20.5137; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Birhane T, 2015, J PREGNANCY, V2015, DOI 10.1155/2015/960830; Byamugisha R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-52; Egbe TO, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/7397695; Ezechi O. C., 2004, Tropical Journal of Obstetrics and Gynaecology, V21, P164; Hussein M, 2011, ETHIOP J HEALTH SCI, V21, P1; Igwegbe A O, 2005, Niger J Clin Pract, V8, P97; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; Lamina MA, 2012, OPEN J OBSTET GYNECO, V2, P98, DOI DOI 10.4236/ojog.2012.22019; Malaju MT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-73; Manyahi J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1848-5; MINSANTE-CNLS Cameroun, 2012, RAPP NAT SUIV DECL P; National AIDS Control Committee (NACC), RAPP ANN 2014 ACT LU; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nguefack HLN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1336-2; UNAIDS, CAM DEM HLTH SURV DH; Wudineh F, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/3262746; Zoung-Kanyi Bissek Anne-Cirenecile, 2011, Open AIDS J, V5, P25, DOI 10.2174/1874613601105010025	23	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172102	10.1371/journal.pone.0172102	http://dx.doi.org/10.1371/journal.pone.0172102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199373	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400071
J	Flamand, C; Fritzell, C; Prince, C; Abboud, P; Ardillon, V; Carvalho, L; Demar, M; Boukhari, R; Papaix-Puech, M; Elenga, N; Rousset, D; Matheus, S; Nacher, M; Quenel, P; Djossou, F				Flamand, Claude; Fritzell, Camille; Prince, Christelle; Abboud, Philippe; Ardillon, Vanessa; Carvalho, Luisiane; Demar, Magalie; Boukhari, Rachida; Papaix-Puech, Martine; Elenga, Narcisse; Rousset, Dominique; Matheus, Severine; Nacher, Mathieu; Quenel, Philippe; Djossou, Felix			Epidemiological assessment of the severity of dengue epidemics in French Guiana	PLOS ONE			English	Article							DISEASE SEVERITY; SHOCK SYNDROME; ADULT DENGUE; RISK-FACTORS; CLASSIFICATION; INFECTION; COUNTRIES; FEVER; MULTICENTER; CHILDREN	Background Dengue fever is the most important arboviral infection that affects humans, particularly in tropical and subtropical regions. Here, we provide the first comprehensive overview of the severity of dengue epidemics in French Guiana. Methodology/Principal findings We monitored hospitalized cases between 2008 and 2013. Detailed clinical features and biological parameters were collected on a daily basis from all cases. Among the 1,356 cases, 216 (16%) were classified according to the WHO 2009 classification as dengue without warning signs (WS), 926 (68%) were classified as dengue with WS and 214 (16%) were classified as severe dengue. The severity rates were similar between the three major epidemics that occurred during the study period, whereas the hospitalization rate was highest in 2013. Fluid accumulation, aspartate aminotransferase (ASAT) counts>193 IU/L and platelet counts<75,000 cells/mm3 were associated with dengue severity. Conclusions/Significance Our findings provide a recent epidemiological description of the severity of dengue epidemics in French Guiana. These results highlight the potential impacts and consequences of implementing the WHO 2009 classification on hospital activity. Future studies should include virological and immunological investigations of well-documented serum samples.	[Flamand, Claude; Fritzell, Camille; Rousset, Dominique; Matheus, Severine; Quenel, Philippe] Inst Pasteur, Cayenne, French Guiana; [Prince, Christelle; Abboud, Philippe; Demar, Magalie; Elenga, Narcisse; Nacher, Mathieu; Djossou, Felix] Ctr Hosp Andree Rosemon, Cayenne, French Guiana; [Ardillon, Vanessa; Carvalho, Luisiane] St Publ France, Cayenne, French Guiana; [Boukhari, Rachida] Ctr Hosp Ouest Guyanais, St Laurent Du Maroni, French Guiana; [Papaix-Puech, Martine] Ctr Med Chirurg Kourou, Kourou, French Guiana; [Quenel, Philippe] EHESP, UMR 1085, IRSET, INSERM, Rennes, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm)	Flamand, C (corresponding author), Inst Pasteur, Cayenne, French Guiana.	cflamand@pasteur-cayenne.fr	Djossou, Felix/AAM-8640-2020; Rousset, Dominique/S-5400-2019; ELENGA, Narcisse NE/C-2272-2015; Demar, Magalie Pierre/AAM-6913-2020; nacher, mathieu/AAH-4796-2021; QUENEL, PHILIPPE/J-4351-2015	Rousset, Dominique/0000-0002-1473-3147; ELENGA, Narcisse NE/0000-0003-0624-4180; Demar, Magalie Pierre/0000-0003-3414-0821; nacher, mathieu/0000-0001-9397-3204; QUENEL, PHILIPPE/0000-0003-3361-3623; Flamand, Claude/0000-0002-8064-445X; Matheus, Severine/0000-0001-9171-1964	French Public Health Agency; Regional Health Agency of French Guiana	French Public Health Agency; Regional Health Agency of French Guiana	We are grateful to all of the collaborators involved in the surveillance system for hospitalized dengue cases. We especially thank Cayenne Hospital Center, the French Public Health Agency and the Regional Health Agency of French Guiana for their support.	Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681; Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Djossou F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150828; Djossou F, 2016, T ROY SOC TROP MED H, V110, P134, DOI 10.1093/trstmh/trv117; Flamand C, 2014, J AM MED INFORM ASSN, V21, P232, DOI 10.1136/amiajnl-2013-002348; Flamand C, 2011, STUD HEALTH TECHNOL, V169, P629, DOI 10.3233/978-1-60750-806-9-629; Hanf M, 2014, TROP MED INT HEALTH, V19, P153, DOI 10.1111/tmi.12240; Jayaratne S D, 2012, BMC Res Notes, V5, P645, DOI 10.1186/1756-0500-5-645; Khan MIH, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.014; L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003235; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498; Lima FR, 2013, CLINICS, V68, P1299, DOI 10.6061/clinics/2013(10)02; Maron GM, 2011, PEDIATR INFECT DIS J, V30, P449, DOI 10.1097/INF.0b013e318212ab8e; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Pan American Health Organization, SURV FEAT SURV IT; Pawitan Jeanne A, 2011, Acta Med Indones, V43, P129; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; Quenel P., 2011, Bulletin Epidemiologique Hebdomadaire, P358; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Thomas L, 2008, AM J TROP MED HYG, V78, P990; Vaughn DW, 2000, AM J EPIDEMIOL, V152, P800, DOI 10.1093/aje/152.9.800; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; World Health Organization, DENG GUID DIAGN TREA	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172267	10.1371/journal.pone.0172267	http://dx.doi.org/10.1371/journal.pone.0172267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196111	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900066
J	Kijak, E; Pyza, E				Kijak, Ewelina; Pyza, Elzbieta			TOR signaling pathway and autophagy are involved in the regulation of circadian rhythms in behavior and plasticity of L2 interneurons in the brain of Drosophila melanogaster	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE-AKT-MAMMALIAN TARGET; LONG-TERM POTENTIATION; 1ST OPTIC NEUROPIL; VISUAL-SYSTEM; EXPRESSION; ACTIVATION; INDUCTION; LAMINA; GROWTH; CLOCK	Drosophila melanogaster is a common model used to study circadian rhythms in behavior and circadian clocks. However, numerous circadian rhythms have also been detected in non-clock neurons, especially in the first optic neuropil (lamina) of the fly's visual system. Such rhythms have been observed in the number of synapses and in the structure of interneurons, which exhibit changes in size and shape in a circadian manner. Although the patterns of these changes are known, the mechanism remains unclear. In the present study, we investigated the role of the TOR signaling pathway and autophagy in regulating circadian rhythms based on the behavior and structural plasticity of the lamina L2 monopolar cell dendritic trees. In addition, we examined the cyclic expression of the TOR signaling pathway (Tor, Pi3K class 1, Akt1) and autophagy (Atg5 and Atg7) genes in the fly's brain. We observed that Tor, Atg5 and Atg7 exhibit rhythmic expressions in the brain of wild-type flies in day/night conditions (LD 12: 12) that are abolished in per 01 clock mutants. The silencing of Tor in per expressing cells shortens a period of the locomotor activity rhythm of flies. In addition, silencing of the Tor and Atg5 genes in L2 cells disrupts the circadian plasticity of the L2 cell dendritic trees measured in the distal lamina. In turn, silencing of the Atg7 gene in L2 cells changes the pattern of this rhythm. Our results indicate that the TOR signaling pathway and autophagy are involved in the regulation of circadian rhythms in the behavior and plasticity of neurons in the brain of adult flies.	[Kijak, Ewelina; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Krakow, Poland	Jagiellonian University	Pyza, E (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Krakow, Poland.	elzbieta.pyza@uj.edu.pl			Polish National Science Centre [DEC-2 011/03/N/NZ/01250]; The Polish Ministry of Science and High Education [3118/7.PR/2014/2]	Polish National Science Centre; The Polish Ministry of Science and High Education	This study was supported by the Polish National Science Centre based on award No DEC-2 011/03/N/NZ/01250 to EK and by The Polish Ministry of Science and High Education grant no 3118/7.PR/2014/2 to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban BK, 2013, MOL CELL BIOL, V33, P3907, DOI 10.1128/MCB.00627-13; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Damulewicz M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00353, 10.3389/fncel.2075.00353]; Damulewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073690; Damulewicz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021258; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Gorska-Andrzejak J, 2015, CURR OPIN INSECT SCI, V7, P76, DOI 10.1016/j.cois.2015.01.005; Gorska-Andrzejak J, 2013, DEV NEUROBIOL, V73, P14, DOI 10.1002/dneu.22032; Gorska-Andrzejak J, 2009, J INSECT PHYSIOL, V55, P459, DOI 10.1016/j.jinsphys.2009.02.003; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Ma D, 2012, TRENDS ENDOCRIN MET, V23, P319, DOI 10.1016/j.tem.2012.03.004; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Parisi F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-65; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 2008, ACTA NEUROBIOL EXP, V68, P322; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Tataroglu O, 2015, CURR OPIN INSECT SCI, V7, P51, DOI 10.1016/j.cois.2015.01.002; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Weber P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004290; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027	43	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171848	10.1371/journal.pone.0171848	http://dx.doi.org/10.1371/journal.pone.0171848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196106	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900036
J	Long, Y; Liu, L				Long, Ying; Liu, Liu			How green are the streets? An analysis for central areas of Chinese cities using Tencent Street View	PLOS ONE			English	Article							URBAN STREET; NEIGHBORHOODS	Extensive evidence has revealed that street greenery, as a quality-of-life component, is important for oxygen production, pollutant absorption, and urban heat island effect mitigation. Determining how green our streets are has always been difficult given the time and money consumed using conventional methods. This study proposes an automatic method using an emerging online street-view service to address this issue. This method was used to analyze street greenery in the central areas (28.3 km(2) each) of 245 major Chinese cities; this differs from previous studies, which have investigated small areas in a given city. Such a city-system-level study enabled us to detect potential universal laws governing street greenery as well as the impact factors. We collected over one million Tencent Street View pictures and calculated the green view index for each picture. We found the following rules: (1) longer streets in more economically developed and highly administrated cities tended to be greener; (2) cities in western China tend to have greener streets; and (3) the aggregated green view indices at the municipal level match with the approved National Garden Cities of China. These findings can prove useful for drafting more appropriate policies regarding planning and engineering practices for street greenery.	[Long, Ying] Tsinghua Univ, Sch Architecture, Beijing, Peoples R China; [Long, Ying] Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China; [Liu, Liu] China Acad Urban Planning & Design, Shanghai, Peoples R China	Tsinghua University; Tsinghua University	Long, Y (corresponding author), Tsinghua Univ, Sch Architecture, Beijing, Peoples R China.; Long, Y (corresponding author), Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China.	ylong@tsinghua.edu.cn	LONG, YING/AAG-4329-2021; Liu, Liu/GXA-0581-2022	Liu, Liu/0000-0003-0100-9763; Long, Ying/0000-0002-8657-6988	National Natural Science Foundation of China [51408039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The first author would like to acknowledge the funding of the National Natural Science Foundation of China (No. 51408039).	Aoki Y., 1987, J JPN I LANDSC ARCHI, V51, P1, DOI [DOI 10.5632/JILA1934.51.1, 10.5632/jila1934.51.1]; Badrinarayanan V., 2015, ARXIV; Batty M, 2012, CITIES, V29, pS9, DOI 10.1016/j.cities.2011.11.008; BLODGETT G, 1976, J AM HIST, V62, P869, DOI 10.2307/1903842; Carrasco-Hernandez R, 2015, ENERG BUILDINGS, V86, P340, DOI 10.1016/j.enbuild.2014.10.001; FABOS JG, 1995, LANDSCAPE URBAN PLAN, V33, P1, DOI 10.1016/0169-2046(95)02035-R; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Frome A, 2009, IEEE I CONF COMP VIS, P2373, DOI 10.1109/ICCV.2009.5459413; Gatta C, 2014, IEEE COMPUT SOC CONF, P504, DOI 10.1109/CVPRW.2014.80; Gupta S, 2013, PROC CVPR IEEE, P564, DOI 10.1109/CVPR.2013.79; Hara K., 2013, P SIGCHI C HUMAN FAC, P631, DOI [10.1145/2470654.2470744, DOI 10.1145/2470654.2470744]; Howard E., 2010, MORROW PEACEFUL PATH; Hwang J, 2014, AM SOCIOL REV, V79, P726, DOI 10.1177/0003122414535774; Kelly CM, 2013, ANN BEHAV MED, V45, pS108, DOI 10.1007/s12160-012-9419-9; Li X., 2016, ENVIRONMENTAL INEQUI; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P751, DOI 10.1016/j.ufug.2015.07.006; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P675, DOI 10.1016/j.ufug.2015.06.006; Liu L., 2014, C IMAGE CITY COGNITI; Liu M. Y., 2015, ARXIV PREPRINT ARXIV; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Liu XJ, 2015, CITIES, V47, P53, DOI 10.1016/j.cities.2015.03.006; Long Y., 2015, GEOSPATIAL ANAL SUPP, DOI [10.1007/978-3-319-19342-7_10, DOI 10.1007/978-3-319-19342-7_10]; Lynch K, 1960, IMAGE CITY, V11; NASAR JL, 1984, J CROSS CULT PSYCHOL, V15, P79, DOI 10.1177/0022002184015001005; Neumann L, 2012, PROC CVPR IEEE, P3538, DOI 10.1109/CVPR.2012.6248097; Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x; Ohno R., 1991, HLTH ENV, P237; Ohno R., 2000, THEORETICAL PERSPECT, P149; Pugh TAM, 2012, ENVIRON SCI TECHNOL, V46, P7692, DOI 10.1021/es300826w; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Saw LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133781; Shashua-Bar L, 2000, ENERG BUILDINGS, V31, P221, DOI 10.1016/S0378-7788(99)00018-3; Torii Akihiko, 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P2188, DOI 10.1109/ICCVW.2009.5457551; Yang J, 2009, LANDSCAPE URBAN PLAN, V91, P97, DOI 10.1016/j.landurbplan.2008.12.004; Zamir A. R., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P380, DOI 10.1109/ICMLA.2011.181	35	94	101	18	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171110	10.1371/journal.pone.0171110	http://dx.doi.org/10.1371/journal.pone.0171110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196071	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900012
J	Wu, CL; Kor, CT; Chiu, PF; Tsai, CC; Lian, IB; Yang, TH; Tarng, DC; Chang, CC				Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Tsai, Chun-Chieh; Lian, Ie-Bin; Yang, Tao-Hsiang; Tarng, Der-Cherng; Chang, Chia-Chu			Long-term renal outcomes in patients with traumatic brain injury: A nationwide population-based cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; HEAD-INJURY; DEATH; TAIWAN; SYSTEM	Background Traumatic brain injury (TBI) is an important cause of death and disability worldwide. The relationship between TBI and kidney diseases is largely unknown. Methods We aimed to determine whether TBI is associated with long-term adverse renal outcomes. We performed a nationwide, population-based, propensity score-matched cohort study of 32,152 TBI patients and 128,608 propensity score-matched controls. Data were collected by the National Health Insurance Research Database of Taiwan from 2000 to 2012. Our clinical outcomes were chronic kidney disease (CKD), end-stage renal disease (ESRD) and the composite endpoint of ESRD or all-cause mortality. Results The incidence rate of CKD was higher in the TBI than in the control cohort (8.99 vs. 7.4 per 1000 person-years). The TBI patients also showed higher risks of CKD (adjusted hazard ratio [aHR] 1.14, 95% confidence interval [CI] 1.08-1.20; P < 0.001) and composite endpoints (aHR 1.08, 95% CI 1.01-1.15; P = 0.022) than the control groups, but the ESRD was not significantly different between the groups. In subgroup analyses, the risks of incident CKD and composite endpoints were significantly raised in TBI patients aged < 65 years and/ or without comorbidities. However, the risks of both CKD and composite outcome were little affected by the severity of TBI. Conclusions TBI has a modest but significant effect on incident CKD and composite endpoint, but not on ESRD alone. TBI patients under 65 are at greater risk of CKD and composite outcome than their older counterparts.	[Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Wu, Chia-Lin; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; National Changhua University of Education; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, CC (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan.; Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan.	dctarng@vghtpe.gov.tw; 27509@cch.org.tw	Lian, Ie-Bin/AAE-3368-2021; Wu, Chia-Lin/V-8888-2017	Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049	Changhua Christian Hospital Research Foundation [104-CCH-IRP-010]	Changhua Christian Hospital Research Foundation	This study was funded by grants 104-CCH-IRP-010 from the Changhua Christian Hospital Research Foundation.	[Anonymous], 2015, 2015 USRDS ANN DAT R; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Levin A, 2001, NEPHROL DIAL TRANSPL, V16, P57, DOI 10.1093/ndt/16.suppl_7.57; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lin JW, 2008, ACT NEUR S, V101, P113; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Morariu AM, 2008, AM J TRANSPLANT, V8, P933, DOI 10.1111/j.1600-6143.2008.02166.x; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Sanchez-Fructuoso AI, 2004, TRANSPLANTATION, V78, P142, DOI 10.1097/01.TP.0000134769.65550.70; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SIPKINS JH, 1981, NEPHRON, V28, P36, DOI 10.1159/000182092; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158533; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	30	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171999	10.1371/journal.pone.0171999	http://dx.doi.org/10.1371/journal.pone.0171999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196132	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900041
J	Cortez, V; Verdu, JR; Ortiz, AJ; Halffter, G				Cortez, Vieyle; Verdu, Jose R.; Ortiz, Antonio J.; Halffter, Gonzalo			Identification and evaluation of semiochemicals for the biological control of the beetle Omorgus suberosus (F.) (Coleoptera: Trogidae), a facultative predator of eggs of the sea turtle Lepidochelys olivacea (Eschscholtz)	PLOS ONE			English	Article							MALE DUNG BEETLE; EAD-ACTIVE CONSTITUENTS; OLIVE RIDLEY TURTLE; ANAL-SAC SECRETION; ATTRACTING SECRETION; AGGREGATION PHEROMONE; INFECTED CHICKENS; HATCHING SUCCESS; SCARABAEINAE; VIRUS	The beetle Omorgus suberosus (F.) is a facultative predator of eggs of the olive ridley turtle Lepidochelys olivacea (Eschscholtz). Laboratory and field investigations were conducted in order to characterize volatile attractants of 0. suberosus and to explore the potential for application of these volatiles in a selective mass trapping method. Headspace sorptive extraction (HSSE) coupled to thermo-desorption gas chromatography mass spectrometry (TD-GC-MS) analysis of the volatile constituents from beetles or turtle nests revealed 24 potential compounds. However, electroantennographic (EAG) measurements revealed antennal sensitivity only to indole, linoleic acid, trimethylamine, dimethyl sulphide, dimethyl disulphide and ammonia. Behavioural tests showed that these compounds are highly attractive to O. suberosus. Field trapping experiments revealed that indole and ammonia were more attractive than the other volatile compounds and showed similar attractiveness to that produced by conventional baits (chicken feathers). The use of a combined bait of indole and NH3 would therefore be the most effective trap design. The data presented are the first to demonstrate effective massive capture of O. suberosus using an attractant-based trapping method. These findings have potential for the development of an efficient mass trapping method for control of this beetle as part of efforts towards conservation of L. olivacea at La Escobilla in Oaxaca, Mexico.	[Cortez, Vieyle; Verdu, Jose R.] Univ Alicante, IUI CIBIO, Alicante, Spain; [Ortiz, Antonio J.] Univ Jaen, EPS Linares, Dept Quim Inorgan & Quim Organ, Linares, Spain; [Halffter, Gonzalo] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico	Universitat d'Alacant; Universidad de Jaen; Instituto de Ecologia - Mexico	Verdu, JR (corresponding author), Univ Alicante, IUI CIBIO, Alicante, Spain.	jr.verdu@ua.es	Halffter, Gonzalo/R-3652-2018; Verdú, José/F-8269-2010; Gallardo, Vieyle Cortez/L-4692-2014	Verdú, José/0000-0002-0805-8341; Gallardo, Vieyle Cortez/0000-0003-0217-3899	Programa de Conservacion de Especies en Riesgo (PROCER); Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); National Commission for Protected Natural Areas (CONANP Mexico); INECOL A.G.	Programa de Conservacion de Especies en Riesgo (PROCER); Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); National Commission for Protected Natural Areas (CONANP Mexico); INECOL A.G.	The study was funded by the Programa de Conservacion de Especies en Riesgo (PROCER) and the Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP) to GH. We are also grateful to INECOL A.G. for financial support awarded to GH. This research was fully funded by the National Commission for Protected Natural Areas (CONANP Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A., LEPIDOCHELYS OLIVACE; Allgower K, 1979, INF ESTAC CI CH DARW, P152; [Anonymous], 1992, THREATENED BIRDS AM; Baena ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139538; BANKS GR, 1992, Z NATURFORSCH C, V47, P618; Bartelt RJ, 2009, J CHEM ECOL, V35, P422, DOI 10.1007/s10886-009-9611-y; Bernardo Joseph, 2007, P58; BirdLife International, 2012, BUT ALB IUCN RED LIS, V2012; BirdLife International, 2012, ACC STRAIT, V2012; BirdLife International, 2014, AUL PRAS IUCN RED LI, V2014; Burger BV, 2008, J CHROMATOGR A, V1186, P245, DOI 10.1016/j.chroma.2007.09.041; BURGER BV, 1983, Z NATURFORSCH C, V38, P848; Burger BV, 2002, J CHEM ECOL, V28, P2527, DOI 10.1023/A:1021440220329; Burger BV, 2002, J CHEM ECOL, V28, P501, DOI 10.1023/A:1014583826875; Clarke KR, 2008, PRIMER 6 USER MANUAL; Cortez V, 2015, CHEMOECOLOGY, V25, P201, DOI 10.1007/s00049-015-0189-2; Cortez Vieyle, 2013, Cuadernos de Biodiversidad, V41, P16; Davidson I, 2009, BRAZ J POULTRY SCI, V11, P139, DOI 10.1590/S1516-635X2009000300001; DAVIS CJ, 1967, P HAWAII ENTOMOL SOC, V19, P375; Donlan EM, 2004, CARIBB J SCI, V40, P415; Emden F. I. van., 1948, Proceedings of the Royal Entomological Society of London (B), V17, P145; FOWLER LE, 1979, ECOLOGY, V60, P946, DOI 10.2307/1936863; Gitau CW, 2013, FOREST ECOL MANAG, V297, P1, DOI 10.1016/j.foreco.2013.02.019; Gorley C.K., 2006, GETTING STARTED PRIM; Harfush M, 2008, P 25 ANN S SEA TURTL, P89; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; HONDA K, 1982, APPL ENTOMOL ZOOL, V17, P325, DOI 10.1303/aez.17.325; HOOP RK, 1992, AVIAN PATHOL, V21, P493, DOI 10.1080/03079459208418867; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Lopez-Castro MC, 2004, MAR BIOL, V145, P811, DOI 10.1007/s00227-004-1359-x; Lopez-Reyes E, 2000, P 20 ANN S SEA TURTL, P477; Marquez R, 1996, MARINE TURTLE NEWSLE, V75, P5; MASON RT, 1990, J CHEM ECOL, V16, P27, DOI 10.1007/BF01021265; Morgan ED, 2003, J CHEM ECOL, V29, P95, DOI 10.1023/A:1021928630441; Nuradji H, 2015, J VET DIAGN INVEST, V27, P704, DOI 10.1177/1040638715611443; Ocana M., 2012, Endangered Species Research, V16, P45, DOI 10.3354/esr00388; Ortius-Lechner D, 2000, J CHEM ECOL, V26, P1667, DOI 10.1023/A:1005543030518; PALESTRINI C, 1992, B ZOOL, V59, P69, DOI 10.1080/11250009209386650; Plotkin PT, 1997, J HERPETOL, V31, P17, DOI 10.2307/1565323; Podskalska H, 2009, ENTOMOL EXP APPL, V132, P59, DOI 10.1111/j.1570-7458.2009.00871.x; RAYMER J, 1985, J CHEM ECOL, V11, P593, DOI 10.1007/BF00988570; Rosano-Hernández María C., 2002, Acta Zool. Mex, P29; Sarles L, 2015, CROP PROT, V78, P114, DOI 10.1016/j.cropro.2015.09.001; Schat KA, 2008, DIS POULTRY, P449; Shanker K, 2004, BIOL CONSERV, V115, P149, DOI 10.1016/S0006-3207(03)00104-6; Singh N, 2012, J ECON ENTOMOL, V105, P2196, DOI 10.1603/EC11422; Soini HA, 2005, J CHEM ECOL, V31, P1125, DOI 10.1007/s10886-005-4252-2; Soini HA, 2012, J CHEM ECOL, V38, P145, DOI 10.1007/s10886-012-0075-0; SPENCER JL, 1983, AVIAN PATHOL, V12, P85, DOI 10.1080/03079458308436151; Stavert JR, 2014, ECOL ENTOMOL, V39, P556, DOI 10.1111/een.12133; Swayne D.E., 2008, DIS POULTRY, P153; Tribe G.D., 2011, P87; Valverde RA, 2012, CHELONIAN CONSERV BI, V11, P1; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; von Hoermann C, 2011, FORENSIC SCI INT, V212, P173, DOI 10.1016/j.forsciint.2011.06.009; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2; Zarate P, 2013, AQUAT BIOL, V19, P217, DOI 10.3354/ab00534; Zito P, 2014, CHEMOECOLOGY, V24, P261, DOI 10.1007/s00049-014-0169-y	58	6	6	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172015	10.1371/journal.pone.0172015	http://dx.doi.org/10.1371/journal.pone.0172015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192472	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800059
J	Li, YR; Geary, DC				Li, Yaoran; Geary, David C.			Children's visuospatial memory predicts mathematics achievement through early adolescence	PLOS ONE			English	Article							LEARNING-DISABILITY; PRECOCIOUS YOUTH; WORKING-MEMORY; SPATIAL SKILLS; PRIMARY-SCHOOL; INTELLIGENCE; ABILITY	A previous study showed that gains in visuospatial memory from first to fifth grade predicted end-of-fifth grade mathematics but not reading achievement, controlling other factors. In this follow up study, these relations were assessed from sixth to ninth grade, inclusive (n = 145). The results showed that growth in visuospatial memory across the elementary school years was related to growth in mathematics achievement after fifth grade, controlling intelligence, the central executive and phonological memory components of working memory, in-class attentive behavior, parental education, and fifth grade mathematics achievement. As found for fifth grade, this relation was not found for reading achievement after fifth grade. In total, the results suggest that visuospatial memory has a unique influence on ease of learning some types of mathematics and that this influence becomes more important across successive grades.	[Li, Yaoran] Univ San Diego, Inst Entrepreneurship Educ, San Diego, CA 92110 USA; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO 65211 USA	University of San Diego; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Geary, DC (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.; Geary, DC (corresponding author), Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO 65211 USA.	GearyD@Missouri.edu		Geary, David/0000-0003-3029-6343	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD38283, R37 HD045914]; National Science Foundation [DRL-1250359]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants R01 HD38283 and R37 HD045914 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and DRL-1250359 from the National Science Foundation.	Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bull R, 2014, CHILD DEV PERSPECT, V8, P36, DOI 10.1111/cdep.12059; Casey MB, 1997, DEV PSYCHOL, V33, P669, DOI 10.1037/0012-1649.33.4.669; Chu FW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00775; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Fuchs LS, 2006, J EDUC PSYCHOL, V98, P29, DOI 10.1037/0022-0663.98.1.29; Fuchs LS, 2016, CHILD DEV; Fuchs LS, 2016, CHILD DEV, V87, P558, DOI 10.1111/cdev.12474; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; GEARY DC, 1987, J EXP PSYCHOL GEN, V116, P154, DOI 10.1037/0096-3445.116.2.154; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, J ED PSYCHO IN PRESS; JOHNSON ES, 1984, J EDUC PSYCHOL, V76, P1359, DOI 10.1037/0022-0663.76.6.1359; Kell HJ, 2013, PSYCHOL SCI, V24, P1831, DOI 10.1177/0956797613478615; Kyttala M, 2008, EUR J PSYCHOL EDUC, V23, P77, DOI 10.1007/BF03173141; Lee K, 2016, J ED PSYCHOL; Li YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070160; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Mazzocco MMM, 2003, ANN DYSLEXIA, V53, P218, DOI 10.1007/s11881-003-0011-7; Mix KS, 2012, ADV CHILD DEV BEHAV, V42, P197; Pickering S., 2001, WORKING MEMORY TEST; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Swanson J. M., 2008, CATEGORICAL DIMENSIO; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Van de Weijer-Bergsma E, 2015, MEM COGNITION, V43, P367, DOI 10.3758/s13421-014-0480-4; Webb RM, 2007, J EDUC PSYCHOL, V99, P397, DOI 10.1037/0022-0663.99.2.397; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond	30	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e172046	10.1371/journal.pone.0172046	http://dx.doi.org/10.1371/journal.pone.0172046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192484	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800064
J	Pattamayutanon, P; Angeli, S; Thakeow, P; Abraham, J; Disayathanoowat, T; Chantawannakul, P				Pattamayutanon, Praetinee; Angeli, Sergio; Thakeow, Prodpran; Abraham, John; Disayathanoowat, Terd; Chantawannakul, Panuwan			Volatile organic compounds of Thai honeys produced from several floral sources by different honey bee species	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; GC-MS ANALYSIS; CHEMICAL-COMPOSITION; AROMA COMPOUNDS; ESSENTIAL OILS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; MASS-SPECTROMETRY; UNIFLORAL HONEYS; ALPHA-TERPINEOL	The volatile organic compounds (VOCs) of four monofloral and one multifloral of Thai honeys produced by Apis cerana, Apis dorsata and Apis mellifera were analyzed by headspace solid-phase microextraction (HS-SPME) followed by gas chromatography and mass spectrometry (GC-MS). The floral sources were longan, sunflower, coffee, wild flowers (wild) and lychee. Honey originating from longan had more VOCs than all other floral sources. Sunflower honey had the least numbers of VOCs. cis-Linalool oxide, trans-linalool oxide, ho-trienol, and furan-2,5-dicarbaldehyde were present in all the honeys studied, independent of their floral origin. Interestingly, 2-phenylacetaldehyde was detected in all honey sample except longan honey produced by A. cerana. Thirty-two VOCs were identified as possible floral markers. After validating differences in honey volatiles from different floral sources and honeybee species, the results suggest that differences in quality and quantity of honey volatiles are influenced by both floral source and honeybee species. The group of honey volatiles detected from A. cerana was completely different from those of A. mellifera and A. dorsata. VOCs could therefore be applied as chemical markers of honeys and may reflect preferences of shared floral sources amongst different honeybee species.	[Pattamayutanon, Praetinee; Disayathanoowat, Terd; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Angeli, Sergio; Abraham, John] Free Univ Bozen Bolzano, Fac Sci & Technol, Piazza Univ, Bolzano, Italy; [Thakeow, Prodpran] Chiang Mai Univ, Fac Agroind, Div Prod Dev Technol, Chiang Mai, Thailand; [Abraham, John] Univ Cape Coast, Sch Biol Sci, Dept Conservat Biol & Entomol, Cape Coast, Ghana	Chiang Mai University; Free University of Bozen-Bolzano; Chiang Mai University; University of Cape Coast	Chantawannakul, P (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.	panuwan@gmail.com	Angeli, Sergio/A-7720-2008; Abraham, John/L-5517-2018	Angeli, Sergio/0000-0002-8463-7476; Abraham, John/0000-0001-6049-6042; Disayathanoowat, Terd/0000-0002-6416-2266; Thakeow, Prodpran/0000-0001-5824-1171	Royal Golden Jubilee (RGJ) Ph.D. Programme	Royal Golden Jubilee (RGJ) Ph.D. Programme	This work was supported by The Royal Golden Jubilee (RGJ) Ph.D. Programme Tel: 02-278-8200 ext. 1 (http://rgj.trf.or.th/main/en/) to PP and PC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol D. P, 2013, J INDIAN I SCI, V68, P43; Al-Qassemi R., 2003, Nutrition & Food Science, V33, P254, DOI 10.1108/00346650310507073; Alissandrakis E, 2005, J SCI FOOD AGR, V85, P91, DOI 10.1002/jsfa.1934; Alissandrakis E, 2007, J AGR FOOD CHEM, V55, P8152, DOI 10.1021/jf071442y; Alissandrakis E, 2011, LWT-FOOD SCI TECHNOL, V44, P1042, DOI 10.1016/j.lwt.2010.10.002; Alviano WS, 2005, ORAL MICROBIOL IMMUN, V20, P101, DOI 10.1111/j.1399-302X.2004.00201.x; Aronne G., 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/428141; Baroni MV, 2006, J AGR FOOD CHEM, V54, P7235, DOI 10.1021/jf061080e; Bentivenga G, 2004, INT J FOOD SCI TECH, V39, P1079, DOI 10.1111/j.1365-2621.2004.00889.x; Bianchi F, 2005, FOOD CHEM, V89, P527, DOI 10.1016/j.foodchem.2004.03.009; Bonvehi JS, 2003, J SCI FOOD AGR, V83, P275, DOI 10.1002/jsfa.1308; Bougatsos C, 2004, Z NATURFORSCH C, V59, P368; Brickell C, 2008, ENCY GARDEN PLANTS, P1136; Cajka T, 2007, J SEP SCI, V30, P534, DOI 10.1002/jssc.200600413; Vazquez LC, 2006, EUR FOOD RES TECHNOL, V224, P27, DOI 10.1007/s00217-006-0284-2; Castro-Vazquez L, 2003, CHROMATOGRAPHIA, V57, P227, DOI 10.1007/BF02491721; Castro-Vazquez L, 2006, J AGR FOOD CHEM, V54, P4809, DOI 10.1021/jf0604384; Cha JD, 2007, J MICROBIOL BIOTECHN, V17, P2061; Soria AC, 2009, EUR FOOD RES TECHNOL, V228, P579, DOI 10.1007/s00217-008-0966-z; de la Fuente E, 2007, FOOD CHEM, V105, P84, DOI 10.1016/j.foodchem.2007.03.039; de la Fuente E, 2005, J SEP SCI, V28, P1093, DOI 10.1002/jssc.200500018; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; El-Moaty H. I. A., 2010, Journal of Natural Products (India), V3, P103; Elsheikh ATA, 2015, PHYSICOCHEMICAL PROP; Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0; Ferreira ACS, 2004, ANAL CHIM ACTA, V513, P169, DOI 10.1016/j.aca.2003.12.027; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Gopanraj G, 2005, Acta Pharm, V55, P315; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Jerkovic I, 2009, FOOD CHEM, V112, P239, DOI 10.1016/j.foodchem.2008.05.080; Jerkovic I, 2007, 55 INT C ANN M SOC M; Jerkovic I, 2013, CHEM BIODIVERS, V10, P1549, DOI 10.1002/cbdv.201300074; Jerkovic I, 2010, MOLECULES, V15, P4572, DOI 10.3390/molecules15074572; Jerkovic I, 2010, MOLECULES, V15, P2911, DOI 10.3390/molecules15042911; Jerkovic I, 2009, CHEM BIODIVERS, V6, P421, DOI 10.1002/cbdv.200800074; KOENIGER N, 1979, J APICULT RES, V18, P95, DOI 10.1080/00218839.1979.11099952; Kotan R, 2007, Z NATURFORSCH C, V62, P507; Lee SJ, 2005, FOOD CHEM, V91, P131, DOI 10.1016/j.foodchem.2004.05.056; Molan P, 1988, J APICULT RES; Montenegro G, 2009, PHYTON-INT J EXP BOT, V78, P61; Ningrum A, 2015, INT J FOOD PROP, V18, P1905, DOI 10.1080/10942912.2014.971186; Odeh I, 2007, FOOD CHEM, V101, P1393, DOI 10.1016/j.foodchem.2006.03.046; Park MJ, 2009, FITOTERAPIA, V80, P290, DOI 10.1016/j.fitote.2009.03.007; Park SN, 2012, ANAEROBE, V18, P369, DOI 10.1016/j.anaerobe.2012.04.001; Pattamayutanon P, 2015, J FOOD SCI, V80, pM2228, DOI 10.1111/1750-3841.12993; Pena RM, 2004, J SEP SCI, V27, P1540, DOI 10.1002/jssc.200301705; Piasenzotto L, 2003, J SCI FOOD AGR, V83, P1037, DOI 10.1002/jsfa.1502; Pripdeevech P, 2010, J SERB CHEM SOC, V75, P1503, DOI 10.2298/JSC100203125P; Radovic BS, 2001, FOOD CHEM, V72, P511, DOI 10.1016/S0308-8146(00)00263-6; Samarghandian S, 2013, J PHARM PHARM SCI, V16, P352, DOI 10.18433/J3ZS3Q; Shimoda M, 1996, J AGR FOOD CHEM, V44, P3913, DOI 10.1021/jf9601168; Sokovic M, 2010, MOLECULES, V15, P7532, DOI 10.3390/molecules15117532; Soria AC, 2003, J SEP SCI, V26, P793, DOI 10.1002/jssc.200301368; Stanimirova I, 2010, FOOD CHEM, V118, P171, DOI 10.1016/j.foodchem.2009.04.079; TAN ST, 1988, J AGR FOOD CHEM, V36, P453, DOI 10.1021/jf00081a012; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Viuda-Martos M, 2010, INT J FOOD SCI TECH, V45, P1111, DOI 10.1111/j.1365-2621.2010.02243.x; Wall MM, 2006, J FOOD COMPOS ANAL, V19, P655, DOI 10.1016/j.jfca.2005.12.001; Wang SL, 2012, INT J FOOD PROP, V15, P1381, DOI 10.1080/10942912.2010.526275; White J W Jr, 1978, Adv Food Res, V24, P287; WOLSKI T, 2006, J APIC SCI, V50, P115; Yue XD, 2012, J ASIAN NAT PROD RES, V14, P486, DOI 10.1080/10286020.2012.678331	62	15	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172099	10.1371/journal.pone.0172099	http://dx.doi.org/10.1371/journal.pone.0172099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192487	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800067
J	Pujadas-Mestres, L; Lopez-Vilchez, I; Arellano-Rodrigo, E; Reverter, JC; Lopez-Farre, A; Diaz-Ricart, M; Badimon, JJ; Escolar, G				Pujadas-Mestres, Lluis; Lopez-Vilchez, Irene; Arellano-Rodrigo, Eduardo; Carles Reverter, Joan; Lopez-Farre, Antonio; Diaz-Ricart, Maribel; Badimon, Juan Jose; Escolar, Gines			Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; FACTOR-XA INHIBITOR; CELL-BASED MODEL; VENOUS THROMBOEMBOLISM; SYSTEMS-APPROACH; FLOWING BLOOD; TISSUE FACTOR; HEMOSTASIS; RIVAROXABAN; PREVENTION	Introduction Mechanisms of action of direct oral anticoagulants (DOAC) suggest a potential therapeutic use in the prevention of thrombotic complications in arterial territories. However, effects of DOACs on platelet activation and aggregation have not been explored in detail. We have investigated the effects of apixaban on platelet and fibrin components of thrombus formation under static and flow conditions. Methods We assessed the effects of apixaban (10, 40 and 160 ng/mL) on: 1) platelet deposition and fibrin formation onto a thrombogenic surface, with blood circulating at arterial shear-rates; 2) viscoelastic properties of forming clots, and 3) thrombin generation in a cell-model of coagulation primed by platelets. Results In studies with flowing blood, only the highest concentration of apixaban, equivalent to the therapeutic C-max, was capable to significantly reduce thrombus formation, fibrin association and platelet-aggregate formation. Apixaban significantly prolonged thromboelastometry parameters, but did not affect clot firmness. Interestingly, results in a platelet-based model of thrombin generation under more static conditions, revealed a dose dependent persistent inhibitory action by apixaban, with concentrations 4 to 16 times below the therapeutic C-max significantly prolonging kinetic parameters and reducing the total amount of thrombin generated. Conclusions Our studies demonstrate the critical impact of rheological conditions on the antithrombotic effects of apixaban. Studies under flow conditions combined with modified thrombin generation assays could help discriminating concentrations of apixaban that prevent excessive platelet accumulation, from those that deeply impair fibrin formation and may unnecessarily compromise hemostasis.	[Pujadas-Mestres, Lluis; Lopez-Vilchez, Irene; Arellano-Rodrigo, Eduardo; Carles Reverter, Joan; Diaz-Ricart, Maribel; Escolar, Gines] Univ Barcelona, Inst Biomed Res August Pi & Sunyer IDIBAPS, Ctr Biomed Diag CDB, Hosp Clin Barcelona,Dept Hemotherapy & Hemostasis, Barcelona, Spain; [Lopez-Farre, Antonio] Univ Complutense, Sch Med, Dept Med, Madrid, Spain; [Badimon, Juan Jose] Mt Sinai Sch Med, Cardiovasc Inst, Atherothrombosis Res Unit, New York, NY USA; [Pujadas-Mestres, Lluis] Biogen Spain S L, Dept Med, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complutense University of Madrid; Icahn School of Medicine at Mount Sinai	Escolar, G (corresponding author), Univ Barcelona, Inst Biomed Res August Pi & Sunyer IDIBAPS, Ctr Biomed Diag CDB, Hosp Clin Barcelona,Dept Hemotherapy & Hemostasis, Barcelona, Spain.	gescolar@clinic.ub.es	Escolar, Gines/ABF-9003-2021; Albaladejo, Gines Escolar/AAC-9695-2020; Arellano-Rodrigo, Eduardo/H-4094-2015; Arellano-Rodrigo, Eduardo/R-7079-2019; Escolar, Gines/I-1530-2015	Albaladejo, Gines Escolar/0000-0002-6658-0381; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Escolar, Gines/0000-0002-6658-0381; LOPEZ FARRE, ANTONIO/0000-0003-0301-067X; Reverter, Joan Carles/0000-0002-1274-4782	Health Institute Carlos III (ISCIII): Health Research Funds [FIS-P113/00517]; Cardiovascular Research Net (RIC) [RD12/0042/0016, RD12/0042/0040]; European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes [PIE15/00027]; Spanish government	Health Institute Carlos III (ISCIII): Health Research Funds; Cardiovascular Research Net (RIC); European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes; Spanish government(Spanish GovernmentEuropean Commission)	This work was partially supported by the Health Institute Carlos III (ISCIII): Health Research Funds (FIS-P113/00517) and Cardiovascular Research Net (RIC) RD12/0042/0016 and RD12/0042/0040 together with the European Regional Development Funds (FEDER) and Integrated Excellence Project in Health Institutes PIE15/00027; from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Arellano-Rodrigo E, 2015, TRANSFUS MED REV, V29, P242, DOI 10.1016/j.tmrv.2015.08.001; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Becker EM, 2012, J THROMB HAEMOST, V10, P2470, DOI 10.1111/jth.12033; Bristol-Myers Squibb, 2016, ELIQUIS AP PROD MON, P32; Caballo C, 2013, BLOOD TRANSFUS-ITALY, V11, P391, DOI 10.2450/2012.0034-12; Carreras ET, 2015, ARTERIOSCL THROM VAS, V35, P520, DOI 10.1161/ATVBAHA.114.303401; Diaz-Ricart M, 1999, THROMB HAEMOSTASIS, V82, P1312; Escolar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078696; Frost C, 2013, BRIT J CLIN PHARMACO, V76, P776, DOI 10.1111/bcp.12106; Frost C, 2013, BRIT J CLIN PHARMACO, V75, P476, DOI 10.1111/j.1365-2125.2012.04369.x; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Gibson C.M., 2016, CIRCULATION; GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415; Goldsmith HL, 1999, BIORHEOLOGY, V36, P461; HOFFMAN M, 1992, THROMB HAEMOSTASIS, V68, P74; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 2015, ANESTHESIOLOGY, V122, P353, DOI 10.1097/ALN.0000000000000540; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Lopez-Vilchez I, 2009, CORONARY ARTERY DIS, V20, P392, DOI 10.1097/MCA.0b013e32832cff1f; Lowe GDO, 1999, BEST PRACT RES CL HA, V12, P435, DOI 10.1053/beha.1999.0035; Lowe Gordon D O, 2002, Semin Vasc Med, V2, P429, DOI 10.1055/s-2002-36771; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Muthard RW, 2015, ARTERIOSCL THROM VAS, V35, P645, DOI 10.1161/ATVBAHA.114.305054; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Roberts HR, 2006, SEMIN THROMB HEMOST, V32, P32, DOI 10.1055/s-2006-939552; Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Tomaiuolo M, 2014, BLOOD, V124, P1816, DOI 10.1182/blood-2014-01-550343; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; Turitto VT, 1998, THROMB RES, V92, pS25, DOI 10.1016/S0049-3848(98)00157-1; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2002, BMJ-BRIT MED J, V325, P887, DOI 10.1136/bmj.325.7369.887; Turpie AGG, 2011, THROMB HAEMOSTASIS, V105, P586, DOI 10.1160/TH10-10-0683	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171486	10.1371/journal.pone.0171486	http://dx.doi.org/10.1371/journal.pone.0171486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192448	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423800028
J	Quiner, CA; Moses, C; Monroe, BP; Nakazawa, Y; Doty, JB; Hughes, CM; McCollum, AM; Ibata, S; Malekani, J; Okitolonda, E; Carroll, DS; Reynolds, MG				Quiner, Claire A.; Moses, Cynthia; Monroe, Benjamin P.; Nakazawa, Yoshinori; Doty, Jeffrey B.; Hughes, Christine M.; McCollum, Andrea M.; Ibata, Saturnin; Malekani, Jean; Okitolonda, Emile; Carroll, Darin S.; Reynolds, Mary G.			Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo	PLOS ONE			English	Article							EBOLA-VIRUS DISEASE; SMALLPOX VACCINATION; TRANSMISSION; OUTBREAK	Monkeypox virus (MPXV), a close relative of Variola virus, is a zoonotic virus with an unknown reservoir. Interaction with infected wildlife, bites from peri-domestic animals, and bushmeat hunting are hypothesized routes of infection from wildlife to humans. Using a Risk Questionnaire, performed in monkeypox-affected areas of rural Democratic Republic of the Congo, we describe the lifestyles and demographics associated with presumptive risk factors for MPXV infection. We generated two indices to assess risk: Household Materials Index (HMI), a proxy for socioeconomic status of households and Risk Activity Index (RAI), which describes presumptive risk for animal-to-human transmission of MPXV. Based on participant self-reported activity patterns, we found that people in this population are more likely to visit the forest than a market to fulfill material needs, and that the reported occupation is limited in describing behavior of individuals may participate. Being bitten by rodents in the home was commonly reported, and this was significantly associated with a low HMI. The highest scoring RAI sub-groups were 'hunters' and males aged >= 18 years; however, several activities involving MPXV-implicated animals were distributed across all sub-groups. The current analysis may be useful in identifying at-risk groups and help to direct education, outreach and prevention efforts more efficiently.	[Quiner, Claire A.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA; [Quiner, Claire A.; Monroe, Benjamin P.; Nakazawa, Yoshinori; Doty, Jeffrey B.; Hughes, Christine M.; McCollum, Andrea M.; Reynolds, Mary G.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA; [Moses, Cynthia; Ibata, Saturnin; Carroll, Darin S.] Int Conservat Educ Fund, Washington, DC USA; [Malekani, Jean] Univ Kinshasa, Dept Biol, Kinshasa, DEM REP CONGO; [Okitolonda, Emile] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA; Universite de Kinshasa	Reynolds, MG (corresponding author), US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA.	cquiner@berkeley.edu; cynmoses@gmail.com; ihd2@cdc.gov; inp7@cdc.gov; uwb7@cdc.gov; bvp6@cdc.gov; zuz4@cdc.gov; sribata@gmail.com; jean.malekani@unikin.ac.cd; okitow@yahoo.fr; azv4@cdc.gov; nzr6@cdc.gov		Reynolds, Mary/0000-0001-7882-4614; Quiner, Claire/0000-0003-4419-1542	Centers for Disease Control and Prevention; Oakridge Institute for Science and Education, (ORISE)	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Oakridge Institute for Science and Education, (ORISE)	This work was financially supported by the Centers for Disease Control and Prevention, and Oakridge Institute for Science and Education, (ORISE).	Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; BREMAN JG, 1977, B WORLD HEALTH ORGAN, V55, P605; Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Household transmission of Neisseria meningitidis in the African meningitis belt, 2016, LANCET GLOB HLTH, V4, pe989, DOI 10.1016/S2214-109X(16)30244-3; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028295; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P465; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Onyango AC, 2009, AJAR-AFR J AIDS RES, V8, P359, DOI 10.2989/AJAR.2009.8.3.12.933; Radonic A, 2014, EMERG INFECT DIS, V20, P1009, DOI 10.3201/eid2006.13-1329; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Tshikuka JG, 1996, ANN TROP MED PARASIT, V90, P277, DOI 10.1080/00034983.1996.11813053	25	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0168664	10.1371/journal.pone.0168664	http://dx.doi.org/10.1371/journal.pone.0168664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192435	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423800002
J	Raza, QS; Vanderploeg, JL; Jacobs, JR				Raza, Qanber S.; Vanderploeg, Jessica L.; Jacobs, J. Roger			Matrix Metalloproteinases are required for membrane motility and lumenogenesis during Drosophila heart development	PLOS ONE			English	Article							CELL-MIGRATION; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; LUMEN FORMATION; CARDIAC MORPHOGENESIS; DORSAL CLOSURE; TUBE FORMATION; EXPRESSION; DISEASE; LAMININ	Matrix Metalloproteinases (Mmps) degrade glycoproteins and proteoglycans of the extracellular matrix (ECM) or cell surface and are crucial for morphogenesis. Mmps and their inhibitors are expressed during early stages of cardiac development in vertebrates and expression is altered in multiple congenital cardiomyopathies such as cardia bifida. Drosophila genome encodes two copies of Mmps, Mmp1 and Mmp2 whereas in humans up to 25 Mmps have been identified with overlapping functions. We investigated the role of Mmps during embryonic heart development in Drosophila, a process which is morphogenetically similar to early heart tube formation in vertebrates. We demonstrate that the two Mmps in Drosophila have distinct and overlapping roles in cell motility, cell adhesion and cardiac lumenogenesis. We determined that Mmp1 and Mmp2 promote Leading Edge membrane dynamics of cardioblasts during collective migration. Mmp2 is essential for cardiac lumen formation, and mutants generate a cardia bifida phenotype. Mmp1 is required for luminal expansion. Mmp1 and Mmp2 both localise to the basal domains of cardiac cells, however, occupy non-overlapping domains apically. Mmp1 and Mmp2 regulate the proteoglycan composition and size of the apical and basal ECM, yet only Mmp2 is required to restrict ECM assembly to the lumen. Mmp1 negatively regulates the size of the adhesive Cadherin cell surface domain, whereas in a complementary fashion, Mmp2 negatively regulates the size of the Integrin-ECM domain and thereby prescribes the domain to establish and restrict Slit morphogen signalling. Inhibition of Mmp activity through ectopic expression of Tissue Inhibitor of Metalloproteinase in the ectoderm blocks lumen formation. Therefore, Mmp expression and function identifies ECM differentiation and remodelling as a key element for cell polarisation and organogenesis.	[Raza, Qanber S.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Vanderploeg, Jessica L.] Taylor Univ, Dept Biol, Upland, IN USA; [Jacobs, J. Roger] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McMaster University	Raza, QS (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	syr10@pitt.edu		jacobs, j roger/0000-0002-5878-5416	Natural Sciences and Engineering Research Council Discovery [46651]	Natural Sciences and Engineering Research Council Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council Discovery 46651 - JRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brauer PR, 2002, MECH DEVELOP, V113, P175, DOI 10.1016/S0925-4773(02)00016-3; Cai DH, 2000, ANAT RECORD, V259, P168, DOI 10.1002/(SICI)1097-0185(20000601)259:2<168::AID-AR7>3.0.CO;2-U; Cantemir V, 2004, DEV DYNAM, V231, P709, DOI 10.1002/dvdy.20171; Chartier A, 2002, DEVELOPMENT, V129, P3241; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Deady LD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004989; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Glasheen BM, 2010, DEV BIOL, V344, P772, DOI 10.1016/j.ydbio.2010.05.504; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; Haack T, 2014, DEV BIOL, V396, P169, DOI 10.1016/j.ydbio.2014.08.033; Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188; Hollfelder D, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-26; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Jia QQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07535; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Knox J, 2011, DEV BIOL, V356, P279, DOI 10.1016/j.ydbio.2011.04.006; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Miller CM, 2011, J NEUROSCI, V31, P5335, DOI 10.1523/JNEUROSCI.4811-10.2011; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Raza Q, 2016, DEV BIOL, DOI [10.1186/1471-213X-14-26, DOI 10.1186/1471-213X-14-26]; Reed BH, 2009, JOVE; Roper JA, 2012, CURR OPIN STRUC BIOL, V22, P583, DOI 10.1016/j.sbi.2012.07.003; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Urbano JM, 2009, DEVELOPMENT, V136, P4165, DOI 10.1242/dev.044263; Vanderploeg J, 2015, DEV BIOL, DOI [10.1016/j.sbi.2012.07.003, DOI 10.1016/J.SBI.2012.07.003]; Vanderploeg J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-8; Vogler G, 2014, J CELL BIOL, V206, P909, DOI 10.1083/jcb.201405075; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Watanabe A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003086; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243	60	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171905	10.1371/journal.pone.0171905	http://dx.doi.org/10.1371/journal.pone.0171905			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192468	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800049
J	Yaya, S; Bishwajit, G; Ekholuenetale, M				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael			Factors associated with the utilization of institutional delivery services in Bangladesh	PLOS ONE			English	Article							REDUCING MATERNAL MORTALITY; CARE SERVICES; HEALTH; WOMEN	Introduction Bangladesh has made remarkable progress towards reducing its maternal mortality rate (MMR) over the last two decades and is one of the few countries on track to achieving the MMR-related Millennium Development Goals (MDG-5A). However, the provision of universal access to reproductive healthcare (MDG-5B) and the utilization of maternal healthcare services (MHS) such as institutional delivery, which are crucial to the reduction of maternal mortality, are far behind the internationally agreed-upon target. Effective policymaking to promote the utilization of MHS can be greatly facilitated by the identification of the factors that hinder service uptake. In this study, we therefore aim to measure the prevalence of institutional delivery services and explore the factors associated with their utilization in Bangladesh. Methods Data for this study were extracted from the 2011 Bangladesh Demographic and Health Survey (BDHS, 2011); participants were 7,313 women between the ages of 15 and 49 years, selected from both urban and rural households. Data were analyzed using Chi-square analysis, and conditional logistic regression. Results According to the findings, fewer than one in three women reported delivering at a health facility. The multivariable regression analysis showed that participants from rural areas were 46.9% less likely to have institutional deliveries compared to urban dwellers (OR = 0.531; p<0.001; 95% CI: 0.467-0.604), and participants aged between 30 and 49 years had a 23.6% higher prevalence of institutional delivery service utilization compared to those aged 15 to 29 years (OR = 1.236; p = 0.006; 95% CI: 1.062-1.437). Moreover, participants with higher educational attainment were about twice as likely to deliver at a standard health facility when compared to those without formal education (OR = 2.081; p<0.001; 95% CI: 1.650-2.624), and similarly, husbands with higher educational attainment exhibited an approximately 71% higher service utilization of institutional delivery facilities compared to those without formal education (OR = 1.709; p<0.001; 95% CI: 1.412-2.069). Wealth status was also a significant predictor of institutional delivery service use, with participants belonging to the highest economic stratum being more likely to receive skilled care compared to the lowest economic stratum (OR = 2.507; p<0.001; 95% CI: 2.118-2.968). In addition, results indicated that households of average economic class had a 27% higher level of institutional delivery service utilization compared to those of lower economic status (OR = 1.272; p = 0.011; 95% CI: 1.057-1.531). Furthermore, institutional health service use was 18% higher among participants who were aware of community clinical services compared to those who were hardly aware of these services (OR = 0.816; p = 0.012; 95% CI: 0.696-0.957). Lastly, the odds of utilizing delivery services was 1.553 times more likely for participants who use family planning compared to those who do not (p<0.001; 95% CI: 1.374-1.754), and 3.639 times more likely for those who receive antenatal care compared to those who do not (p<0.001; 95% CI: 3.074-4.308). These were found to be significant predictors of the choice of delivery services. Discussion Our results suggest that efforts towards reducing national maternal mortality in Bangladesh could be aided by investments into education, poverty reduction and the strengthening of reproductive healthcare services through community clinics, with particular focus on rural areas.	[Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada; [Bishwajit, Ghose] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria	University of Ottawa; Huazhong University of Science & Technology	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019; Ekholuenetale, Michael/AAL-3655-2021	Yaya, Sanni/0000-0002-4876-6043; Ekholuenetale, Michael/0000-0002-2372-3020				Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Bishwajit G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3915-y; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130077; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Dutamo Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1047-1; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; El Mhamdi S, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0198-x; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Igberase GO, 2009, ANN AFR MED, V8, P261, DOI 10.4103/1596-3519.59582; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1372, DOI 10.1177/1010539513486178; Karkee R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004372; Khan N, 2013, J HEALTH POPUL NUTR, V31, P262; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; NIPORT, 2013, NAT I POP RES TRAIN; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Prakash R, 2013, J BIOSOC SCI, V45, P433, DOI 10.1017/S0021932012000831; Prata N, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-78; Ruiz JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140796; Sen A, 2013, LANCET, V382, P1966, DOI 10.1016/S0140-6736(13)62162-5; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; United Nations, 2000, UN MILL DECL; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; Yaya S, 2016, BMJ GLOBAL HLTH; Zahodne LB, 2015, J INT NEUROPSYCH SOC, V21, P297, DOI 10.1017/S1355617715000193; Zanconato G, 2006, SEMIN FETAL NEONAT M, V11, P15, DOI 10.1016/j.siny.2005.10.002	34	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171573	10.1371/journal.pone.0171573	http://dx.doi.org/10.1371/journal.pone.0171573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192478	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800030
J	Yurie, H; Ikeguchi, R; Aoyama, T; Kaizawa, Y; Tajino, J; Ito, A; Ohta, S; Oda, H; Takeuchi, H; Akieda, S; Tsuji, M; Nakayama, K; Matsuda, S				Yurie, Hirofumi; Ikeguchi, Ryosuke; Aoyama, Tomoki; Kaizawa, Yukitoshi; Tajino, Junichi; Ito, Akira; Ohta, Souichi; Oda, Hiroki; Takeuchi, Hisataka; Akieda, Shizuka; Tsuji, Manami; Nakayama, Koichi; Matsuda, Shuichi			The efficacy of a scaffold-free Bio 3D conduit developed from human fibroblasts on peripheral nerve regeneration in a rat sciatic nerve model	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; ELECTRICAL-STIMULATION; EXTRACELLULAR-MATRIX; REPAIR; TRANSPLANTATION; GUIDE; EXPERIENCE; LOCOMOTION; EXPRESS	Background Although autologous nerve grafting is the gold standard treatment of peripheral nerve injuries, several alternative methods have been developed, including nerve conduits that use supportive cells. However, the seeding efficacy and viability of supportive cells injected in nerve grafts remain unclear. Here, we focused on a novel completely biological, tissue-engineered, scaffold-free conduit. Methods We developed six scaffold-free conduits from human normal dermal fibroblasts using a Bio 3D Printer. Twelve adult male rats with immune deficiency underwent mid-thigh-level transection of the right sciatic nerve. The resulting 5-mm nerve gap was bridged using 8-mm Bio 3D conduits (Bio 3D group, n = 6) and silicone tube (silicone group, n = 6). Several assessments were conducted to examine nerve regeneration eight weeks post-surgery. Results Kinematic analysis revealed that the toe angle to the metatarsal bone at the final segment of the swing phase was significantly higher in the Bio 3D group than the silicone group (-35.78 +/- 10.68 versus -62.48 +/- 6.15, respectively; p < 0.01). Electrophysiological studies revealed significantly higher compound muscle action potential in the Bio 3D group than the silicone group (53.60 +/- 26.36% versus 2.93 +/- 1.84%; p < 0.01). Histological and morphological studies revealed neural cell expression in all regions of the regenerated nerves and the presence of many well-myelinated axons in the Bio 3D group. The wet muscle weight of the tibialis anterior muscle was significantly higher in the Bio 3D group than the silicone group (0.544 +/- 0.063 versus 0.396 +/- 0.031, respectively; p < 0.01). Conclusions We confirmed that scaffold-free Bio 3D conduits composed entirely of fibroblast cells promote nerve regeneration in a rat sciatic nerve model.	[Yurie, Hirofumi; Ikeguchi, Ryosuke; Ito, Akira; Ohta, Souichi; Oda, Hiroki; Takeuchi, Hisataka; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Aoyama, Tomoki; Tajino, Junichi] Kyoto Univ, Dept Phys Therapy, Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Kaizawa, Yukitoshi] Iseikai Yawata Chuo Hosp, Dept Orthopaed Surg, Kyoto, Japan; [Akieda, Shizuka; Tsuji, Manami] Cyfuse Biomed KK, Tokyo, Japan; [Nakayama, Koichi] Saga Univ, Dept Regenerat Med & Biomed Engn, Fac Med, Saga, Japan	Kyoto University; Kyoto University; Saga University	Ikeguchi, R (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.	ikeguchir@me.com	Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777; Nakayama, Koichi/0000-0002-7324-8862	JSPS KAKENHI [15K10441]; Collaborative Research Agreement with Kyoto University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Collaborative Research Agreement with Kyoto University	This study was supported by JSPS KAKENHI Grant Number 15K10441. Cyfuse provided access to the Bio 3D printer that was used in this study, and contributed financially to this study via a Collaborative Research Agreement with Kyoto University. Cyfuse also provided support in the form of salaries for authors SA, KN, and MT and provided research grants to RI, TA, KN and SM. Cyfuse did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127; Bojados M, 2013, BEHAV BRAIN RES, V244, P48, DOI 10.1016/j.bbr.2013.01.017; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184; Chiriac S, 2012, J HAND SURG-EUR VOL, V37E, P342, DOI 10.1177/1753193411422685; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cuevas P, 2004, NEUROL RES, V26, P230, DOI 10.1179/016164104225013897; Cuevas P, 2002, NEUROL RES, V24, P634, DOI 10.1179/016164102101200564; de Luca AC, 2014, NEURAL REGEN RES, V9, P1943, DOI 10.4103/1673-5374.145366; Dikina AD, 2015, BIOMATERIALS, V52, P452, DOI 10.1016/j.biomaterials.2015.01.073; Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]; Francoise M, 2012, BIOFABRICATION, P4; Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009; Ishihara K, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0098-z; Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004; Jesuraj NJ, 2011, J NEUROSCI METH, V197, P209, DOI 10.1016/j.jneumeth.2011.02.015; Jia H, 2012, SYNAPSE, V66, P256, DOI 10.1002/syn.21508; Kaizawa Y, 2015, MICROSURGER IN PRESS; KAKINOKI R, 1995, NEUROSCI RES, V23, P35, DOI 10.1016/0168-0102(95)00923-H; Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993; Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316; Luk HW, 2003, J NEUROSCI RES, V73, P644, DOI 10.1002/jnr.10701; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P833, DOI 10.1097/00006534-198506000-00013; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Millesi H, 2000, HAND CLIN, V16, P73; Nakayama K, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-17; Nijhuis THJ, 2010, MICROSURG, V30, P639, DOI 10.1002/micr.20818; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Lopes FRP, 2010, MICRON, V41, P783, DOI 10.1016/j.micron.2010.05.010; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Siemionow M, 2011, ANN PLAS SURG, V67, P73, DOI 10.1097/SAP.0b013e318223c2db; Tajino J, 2015, J MOTOR BEHAV, V47, P397, DOI 10.1080/00222895.2014.1003779; Tajino J, 2015, BEHAV BRAIN RES, V287, P276, DOI 10.1016/j.bbr.2015.03.030; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037; Walsh SK, 2012, STEM CELL RES, V8, P226, DOI 10.1016/j.scr.2011.11.004; Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098; Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056; Wang Y, 2015, NEURAL REGEN RES, V10, P965, DOI 10.4103/1673-5374.158362; Widgerow AD, 2014, MICROSURG, V34, P324, DOI 10.1002/micr.22219; Yamakawa T, 2007, CELL TRANSPLANT, V16, P811, DOI 10.3727/000000007783465226	47	70	76	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171448	10.1371/journal.pone.0171448	http://dx.doi.org/10.1371/journal.pone.0171448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192527	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800026
J	Dominguez, A; Soldevila, N; Toledo, D; Torner, N; Force, L; Perez, MJ; Martin, V; Rodriguez-Rojas, L; Astray, J; Egurrola, M; Sanz, F; Castilla, J				Dominguez, Angela; Soldevila, Nuria; Toledo, Diana; Torner, Nuria; Force, Luis; Jose Perez, Maria; Martin, Vicente; Rodriguez-Rojas, Lourdes; Astray, Jenaro; Egurrola, Mikel; Sanz, Francisco; Castilla, Jesus		Working Grp Project PI12 02079	Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain	PLOS ONE			English	Article							AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; CONJUGATE VACCINE; ADVISORY-COMMITTEE; GENERAL-POPULATION; DISEASE; OLDER; INFLUENZA; PEOPLE; ADULTS; IMPACT	Pneumococcal pneumonia is a serious cause of morbidity and mortality in the elderly, but investigation of the etiological agent of community-acquired pneumonia (CAP) is not possible in most hospitalized patients. The aim of this study was to estimate the effect of pneumococcal polysaccharide vaccination (PPSV23) in preventing CAP hospitalization and reducing the risk of intensive care unit admission (ICU) and fatal outcomes in hospitalized people aged >= 65 years. We made a multicenter case-control study in 20 Spanish hospitals during 2013-2014 and 2014-2015. We selected patients aged >= 65 years hospitalized with a diagnosis of pneumonia and controls matched by sex, age and date of hospitalization. Multivariate analysis was performed using conditional logistic regression to estimate vaccine effectiveness and unconditional logistic regression to evaluate the reduction in the risk of severe and fatal outcomes. 1895 cases and 1895 controls were included; 13.7% of cases and 14.4% of controls had received PPSV23 in the last five years. The effectiveness of PPSV23 in preventing CAP hospitalization was 15.2% (95% CI-3.1-30.3). The benefit of PPSV23 in avoiding ICU admission or death was 28.1% (95% CI-14.3-56.9) in all patients, 30.9% (95% CI-32.2-67.4) in immunocompetent patients and 26.9% (95% CI-38.6-64.8) in immunocompromised patients. In conclusion, PPSV23 showed a modest trend to avoidance of hospitalizations due to CAP and to the prevention of death or ICU admission in elderly patients hospitalized with a diagnosis of CAP.	[Dominguez, Angela; Soldevila, Nuria; Toledo, Diana; Torner, Nuria] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Dominguez, Angela; Soldevila, Nuria; Toledo, Diana; Torner, Nuria; Castilla, Jesus] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Torner, Nuria] Agencia Salut Publ Catalunya, Barcelona, Spain; [Force, Luis] Hosp Mataro, Mataro, Spain; [Jose Perez, Maria] Hosp Univ Virgen de Valme, Seville, Spain; [Martin, Vicente] Univ Leon, Leon, Spain; [Rodriguez-Rojas, Lourdes] Hosp Ramon & Cajal, Madrid, Spain; [Astray, Jenaro] Consejeria Sanidad, Madrid, Spain; [Egurrola, Mikel] Hosp Galdakao, Usansolo, Spain; [Sanz, Francisco] Univ Valencia, Consorci Hosp Gen, Valencia, Spain; [Castilla, Jesus] IdiSNA, Inst Salud Publ Navarra, Pamplona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Valme; Universidad de Leon; Hospital Universitario Ramon y Cajal; Galdakao Hospital; University of Valencia; Public Health Institute of Navarra	Dominguez, A (corresponding author), Univ Barcelona, Dept Salut Publ, Barcelona, Spain.; Dominguez, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	angela.dominguez@ub.edu	Martin, Vicente/GRE-8306-2022; Antón, Andrés/B-3308-2011; Martin, Vicente/ABF-2276-2021; Blanco, Leire/O-5114-2017; Campins-Marti, Magda/N-9934-2017; Casado, Itziar/B-1341-2017; Martin, Vicente/A-1597-2008; Casado, Itziar/AAE-2973-2021; Castilla, Jesus/B-9048-2008; , Nuria/AAG-8951-2019	Martin, Vicente/0000-0003-0552-2804; Antón, Andrés/0000-0002-1476-0815; Campins-Marti, Magda/0000-0002-8841-6195; Casado, Itziar/0000-0001-6879-4984; Martin, Vicente/0000-0003-0552-2804; Casado, Itziar/0000-0001-6879-4984; Castilla, Jesus/0000-0002-6396-7265; , Nuria/0000-0003-0143-5295; Dominguez, Angela/0000-0003-0219-1907; Chamorro Camazon, Judith/0000-0002-8251-0885; Cayla, Joan A./0000-0003-3891-111X; Sanz, Francisco/0000-0003-4076-0816; Godoy, Pere/0000-0002-2896-7286	National Plan of I+D+I; ISCIII-Subdreccion General de Evaluacion y Fomento de la Investigacion [PI12/02079]; Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/SGR 1403]	National Plan of I+D+I; ISCIII-Subdreccion General de Evaluacion y Fomento de la Investigacion; Catalan Agency for the Management of Grants for University Research (AGAUR)	This study was funded by the National Plan of I+D+I 2008-2011 and ISCIII-Subdreccion General de Evaluacion y Fomento de la Investigacion (Project PI12/02079) and cofounded by FEDER and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/SGR 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 2004, VACCINE, V23, P132, DOI 10.1016/j.vaccine.2004.06.016; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2015, SIST VIG GRIP ESP IN; [Anonymous], 2014, SIST VIG GRIP ESP IN; [Anonymous], 2015, STAND ORD ADM PNEUM; Baldo V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166637; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Centers for Disease Control and Prevention, 2016, REC AD IMM SCHED; del Amo E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151125; Dominguez A, 2005, CLIN INFECT DIS, V40, P1250, DOI 10.1086/429236; Dominguez A, 2010, EUR RESPIR J, V36, P608, DOI 10.1183/09031936.00171309; Dominguez A, 2016, HUM VACC IMMUNOTHER, V12, P1891, DOI 10.1080/21645515.2016.1149661; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; FARR BM, 1995, ARCH INTERN MED, V155, P2336, DOI 10.1001/archinte.155.21.2336; Saldias PF, 2015, REV MED CHILE, V143, P553, DOI 10.4067/S0034-98872015000500001; Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054; Gutierrez Rodriguez M A, 2014, Euro Surveill, V19, P20922, DOI 10.2807/1560-7917.ES2014.19.40.20922; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hedlund J, 2003, VACCINE, V21, P3906, DOI 10.1016/S0264-410X(03)00296-2; High K, 2007, CLIN GERIATR MED, V23, P669, DOI 10.1016/j.cger.2007.03.007; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson LA, 2013, VACCINES; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Janoff EN., 2015, MANDELL DOUGLAS BENN, V2; Johnstone J, 2007, ARCH INTERN MED, V167, P1938, DOI 10.1001/archinte.167.18.1938; Joint Committee on Vaccination and Immunisation, 2015, INT JCVI STAT AD PNE; Julian-Jimenez A, 2016, ARCH BRONCONEUMOL, V52, P450, DOI 10.1016/j.arbres.2015.12.006; Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P944, DOI 10.15585/mmwr.mm6434a4; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Lopez A, 2015, EPIDEMIOLOGY PREVENT; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Ministerio de Sanidad Servicios Sociales e Igualdad, 2015, UT VAC FRENT NEUM GR; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Ochoa-Gondar O, 2014, CLIN INFECT DIS, V58, P909, DOI 10.1093/cid/ciu002; Ochoa-Gondar O, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-222; Pebody R G, 2005, Euro Surveill, V10, P174, DOI 10.2807/esm.10.09.00564-en; Pilishvili T, 2015, VACCINE, V33, pD60, DOI 10.1016/j.vaccine.2015.05.102; Prato R, 2016, CURR MED RES OPIN, V32, P543, DOI 10.1185/03007995.2015.1131150; Regev-Yochay G, 2015, VACCINE, V33, P1135, DOI 10.1016/j.vaccine.2015.01.030; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Salleras L, 2001, MED CLIN BARC S1, V116, P18; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Singleton RJ, 2007, VACCINE, V25, P2288, DOI 10.1016/j.vaccine.2006.11.065; Sullivan SG, 2013, VACCINE, V31, P4280, DOI 10.1016/j.vaccine.2013.06.103; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Verhaegen J, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.31.20869; Vila-Corcoles A, 2006, CLIN INFECT DIS, V43, P860, DOI 10.1086/507340; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Washio M, 2016, GERIATR GERONTOL INT, V16, P223, DOI 10.1111/ggi.12456; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030	56	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171943	10.1371/journal.pone.0171943	http://dx.doi.org/10.1371/journal.pone.0171943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187206	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300063
J	Li, JY; Liu, B; Zhou, YY; Chen, ZP; Jiang, LL; Yuan, W; Liang, L				Li, Jiyu; Liu, Bin; Zhou, Yingying; Chen, Zhipeng; Jiang, Lelun; Yuan, Wei; Liang, Liang			Fabrication of a Ti porous microneedle array by metal injection molding for transdermal drug delivery	PLOS ONE			English	Article							VIVO FLUORESCENCE MICROSCOPY; PRESSURE WAVE DEVICE; VACCINE DELIVERY; AMINOLEVULINIC ACID; POLYMER MICRONEEDLES; ALZHEIMERS-DISEASE; SKIN; ELECTROPORATION; ENHANCE; MODEL	Microneedle arrays (MA) have been extensively investigated in recent decades for transdermal drug delivery due to their pain-free delivery, minimal skin trauma, and reduced risk of infection. However, porous MA received relatively less attention due to their complex fabrication process and ease of fracturing. Here, we present a titanium porous microneedle array (TPMA) fabricated by modified metal injection molding (MIM) technology. The sintering process is simple and suitable for mass production. TPMA was sintered at a sintering temperature of 1250 degrees C for 2 h. The porosity of TPMA was approximately 30.1% and its average pore diameter was about 1.3 mu m. The elements distributed on the surface of TPMA were only Ti and O, which may guarantee the biocompatibility of TPMA. TPMA could easily penetrate the skin of a human forearm without fracture. TPMA could diffuse dry Rhodamine B stored in micropores into rabbit skin. The cumulative permeated flux of calcein across TPMA with punctured skin was 27 times greater than that across intact skin. Thus, TPMA can continually and efficiently deliver a liquid drug through open micropores in skin.	[Li, Jiyu; Liu, Bin; Zhou, Yingying; Chen, Zhipeng; Jiang, Lelun] Sun Yat Sen Univ, Sch Engn, Guangdong Prov Key Lab Sensor Technol & Biomed In, Guangzhou, Guangdong, Peoples R China; [Yuan, Wei; Liang, Liang] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology	Jiang, LL (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangdong Prov Key Lab Sensor Technol & Biomed In, Guangzhou, Guangdong, Peoples R China.; Liang, L (corresponding author), South China Univ Technol, Sch Mech & Automot Engn, Guangzhou, Guangdong, Peoples R China.	jianglel@mail.sysu.edu.cn; meliang@scut.edu.cn	YUAN, WEI/C-4438-2012	YUAN, WEI/0000-0003-4235-2533; Jiang, Lelun/0000-0002-5530-3266	National Nature Science Foundation of China [51575543]; Natural Science Foundation of Guangdong Province, China [2014A030313211]; Guangdong-Hongkong Technology Cooperation Funding Scheme [2016A050503027]; Science and Technology Planning Project of Guangdong Province, China [20156010125004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangdong-Hongkong Technology Cooperation Funding Scheme; Science and Technology Planning Project of Guangdong Province, China	This research is financially supported by the National Nature Science Foundation of China (Project No. 51575543); Natural Science Foundation of Guangdong Province, China (Project No. 2014A030313211); Guangdong-Hongkong Technology Cooperation Funding Scheme (2016A050503027); and Science and Technology Planning Project of Guangdong Province, China (No. 20156010125004).	Akimoto M, 2014, J AM ACAD DERMATOL, V70, pAB32; Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Balazs B, 2016, BIOMED OPT EXPRESS, V7, P67, DOI 10.1364/BOE.7.000067; Boks MA, 2015, INT J PHARMACEUT, V491, P375, DOI 10.1016/j.ijpharm.2015.06.025; Bystrova S, 2011, MICROELECTRON ENG, V88, P1681, DOI 10.1016/j.mee.2010.12.067; Caffarel-Salvador E, 2016, CURR PHARM DESIGN, V22, P1105, DOI 10.2174/1381612822666151216145645; Chen BT, 2008, MICROSYST TECHNOL, V14, P1015, DOI 10.1007/s00542-007-0530-y; Chen KY, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091533; Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0; Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001; Dardano P, 2015, MATERIALS, V8, P8661, DOI 10.3390/ma8125484; Garland MJ, 2012, J CONTROL RELEASE, V159, P52, DOI 10.1016/j.jconrel.2012.01.003; Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401; Indermun S, 2014, J CONTROL RELEASE, V185, P130, DOI 10.1016/j.jconrel.2014.04.052; Jang HJ, 2014, J BIOMED OPT, V19; Ji J, 2006, J MICROMECH MICROENG, V16, P958, DOI 10.1088/0960-1317/16/5/012; Ji J, 2006, J PHYS CONF SER, V34, P1132, DOI 10.1088/1742-6596/34/1/187; Ji J, 2006, J PHYS CONF SER, V34, P1127, DOI 10.1088/1742-6596/34/1/186; Jiang LL, 2014, T NONFERR METAL SOC, V24, P292, DOI 10.1016/S1003-6326(14)63060-0; Kathuria H, 2015, JOVE-J VIS EXP, DOI 10.3791/52914; Kearney MC, 2016, EUR J PHARM BIOPHARM, V103, P43, DOI 10.1016/j.ejpb.2016.03.026; Kim JY, 2016, EUR J PHARM BIOPHARM, V105, P148, DOI 10.1016/j.ejpb.2016.06.006; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Labala S, 2016, COLLOID SURFACE B, V146, P188, DOI 10.1016/j.colsurfb.2016.05.076; Larraneta E, 2016, MAT SCI ENG R, V104, P1, DOI 10.1016/j.mser.2016.03.001; Larraneta E, 2014, INT J PHARMACEUT, V472, P65, DOI 10.1016/j.ijpharm.2014.05.042; Lee K, 2012, BIOMATERIALS, V33, P7309, DOI 10.1016/j.biomaterials.2012.06.065; Liu LM, 2016, RSC ADV, V6, P48630, DOI 10.1039/c6ra07882f; Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Mohammed YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101956; Murthy SN, 2010, J CONTROL RELEASE, V148, P197, DOI 10.1016/j.jconrel.2010.08.015; Nguyen HX, 2015, DRUG DELIV TRANSL RE, V5, P407, DOI 10.1007/s13346-015-0241-3; Parhi R, 2016, J ADV RES, V7, P539, DOI 10.1016/j.jare.2015.09.001; Parhi R, 2015, CURR DRUG DELIV, V12, P122, DOI 10.2174/1567201811666140515145329; Park JM, 2016, LASER MED SCI, V31, P113, DOI 10.1007/s10103-015-1835-1; Park JH, 2007, BIOMED MICRODEVICES, V9, P223, DOI 10.1007/s10544-006-9024-4; Park YH, 2016, BIOTECHNOL BIOPROC E, V21, P110, DOI 10.1007/s12257-015-0634-7; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Rao PR, 2003, EUR J PHARM BIOPHARM, V56, P81, DOI 10.1016/S0939-6411(03)00038-9; Raphael AP, 2016, J CONTROL RELEASE, V225, P40, DOI 10.1016/j.jconrel.2016.01.027; Ren L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060908; Roxhed N, 2007, J MICROELECTROMECH S, V16, P1429, DOI 10.1109/JMEMS.2007.907461; Sammeta SM, 2011, DRUG DEV IND PHARM, V37, P1076, DOI 10.3109/03639045.2011.559659; Schoellhammer CM, 2015, J CONTROL RELEASE, V202, P93, DOI 10.1016/j.jconrel.2015.02.002; Schoellhammer CM, 2014, EXPERT OPIN DRUG DEL, V11, P393, DOI 10.1517/17425247.2014.875528; Scott LJ, 2016, CLIN DRUG INVEST, V36, P321, DOI 10.1007/s40261-016-0387-x; Shin SC, 2005, EUR J PHARM BIOPHARM, V61, P14, DOI 10.1016/j.ejpb.2005.03.010; Shirkhanzadeh M, 2005, J MATER SCI-MATER M, V16, P37, DOI 10.1007/s10856-005-6444-2; Sidambe AT, 2014, MATERIALS, V7, P8168, DOI 10.3390/ma7128168; Tokumoto S, 2016, BIOL PHARM BULL, V39, P1206, DOI 10.1248/bpb.b15-00696; Uddin MJ, 2015, INT J PHARMACEUT, V494, P593, DOI 10.1016/j.ijpharm.2015.01.038; van der Maaden K, 2015, DRUG DELIV TRANSL RE, V5, P397, DOI 10.1007/s13346-015-0238-y; van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042; Vecchione R, 2014, ADV FUNCT MATER, V24, P3515, DOI 10.1002/adfm.201303679; Verhoeven M, 2012, MICROELECTRON ENG, V98, P659, DOI 10.1016/j.mee.2012.07.022; Vinayakumar KB, 2016, J MICROMECH MICROENG, V26, DOI 10.1088/0960-1317/26/6/065013; Waibel J, 2015, J AM ACAD DERMATOL, V72, pAB268; Waibel J, 2015, LASER SURG MED, V47, P31; Waibel JS, 2016, J DRUGS DERMATOL, V15, P14; Wang QL, 2016, MAT SCI ENG C-MATER, V65, P135, DOI 10.1016/j.msec.2016.03.097; Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007; Yan XX, 2013, MICRO NANO LETT, V8, P906, DOI 10.1049/mnl.2013.0630; Yan XX, 2013, MICROELECTRON ENG, V111, P33, DOI 10.1016/j.mee.2013.04.039; Yan XX, 2011, KEY ENG MATER, V483, P443, DOI 10.4028/www.scientific.net/KEM.483.443; Zhang L, 2015, VACUUM, V122, P187, DOI 10.1016/j.vacuum.2015.09.024; Zhou W, 2013, SENSOR ACTUAT A-PHYS, V201, P127, DOI 10.1016/j.sna.2013.06.025; Zorec B, 2013, INT J PHARMACEUT, V457, P214, DOI 10.1016/j.ijpharm.2013.09.020	69	69	70	10	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172043	10.1371/journal.pone.0172043	http://dx.doi.org/10.1371/journal.pone.0172043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187179	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300073
J	Piao, J; Li, YJ; Whang, WJ; Choi, M; Kang, MJ; Lee, JH; Yoon, G; Joo, CK				Piao, JunJie; Li, Ying-Jun; Whang, Woong-Joo; Choi, Mihyun; Kang, Min Ji; Lee, Jee Hye; Yoon, Geunyoung; Joo, Choun-Ki			Comparative evaluation of visual outcomes and corneal asphericity after laser-assisted in situ keratomileusis with the six-dimension Amaris excimer laser system	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; REFRACTIVE SURGERY; LASIK; MYOPIA; EYE; CYCLOTORSION; CENTRATION; HYPEROPIA; ABLATION; CORRECT	Purpose To compare the visual and refractive outcomes after laser-assisted in situ keratomileusis (LASIK) surgery for correction of myopia or myopic astigmatism using a six-dimensional Amaris excimer laser. Methods In this retrospective cohort study, we enrolled 47 eyes of 28 patients (age: 19-36 years) with myopia or myopic astigmatism. We used the Custom Ablation Manager protocol and performed ablations with the SCHWIND AMARIS system. LASIK flaps were cut with an iFS Advanced Femtosecond Laser. Mean static (SCC) and dynamic cyclotorsion (DCC) were evaluated. Visual and refractive outcomes were evaluated during 6 months' follow-up. Corneal asphericity (Q-value) was analyzed at 4 months postoperatively. Results The spherical equivalent (SE) reduction was statistically significant reduce 1 day after refractive surgery (P < 0.001), with no additional significant changes during follow-up (P = 0.854). SCC registration rates were 81% in the Aberration-Free mode (AF) and 90% in the Corneal Wavefront mode (CW). SCC measurements were within +/- 5 degrees in 57% (AF) and 68% (CW) of eyes. Mean DCC was within +/- 1 degree in 96% (AF) or 95% (CW) of cases. At 6 months, the uncorrected distance visual acuity was 20/25 or better in all eyes. At last follow-up, both steep and flat keratometry values had significantly flattened in both groups (P < 0.001). Corneal asphericity also increased significantly during the postoperative period for an 8-mm corneal diameter (P < 0.001). Conclusions LASIK for myopia or myopic compound astigmatism correction using the six-dimensional AMARIS 750S excimer laser is safe, effective, and predictable. Postoperative corneal asphericity can be analyzed by linear regression to predict the changes in postoperative corneal asphericity with this approach.	[Piao, JunJie] Catholic Univ Korea, Catholic Inst Visual Sci, Coll Med, Seoul, South Korea; [Li, Ying-Jun] Yanbian Univ, Coll Med, Dept Ophthalmol, Affiliated Hosp, Yanji, Jilin, Peoples R China; [Whang, Woong-Joo; Choi, Mihyun; Kang, Min Ji; Lee, Jee Hye; Joo, Choun-Ki] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Inst Visual Sci, Dept Ophthalmol,Coll Med, Seoul, South Korea; [Yoon, Geunyoung] Univ Rochester, Ctr Visual Sci, Flaum Eye Inst, Inst Opt, Rochester, NY 14627 USA	Catholic University of Korea; Yanbian University; Catholic University of Korea; Seoul St. Mary's Hospital; University of Rochester	Joo, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Catholic Inst Visual Sci, Dept Ophthalmol,Coll Med, Seoul, South Korea.	ckjoo@catholic.ac.kr		PIAO, Junjie/0000-0003-3393-5518	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A03010528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (2016R1A6A1A03010528).	Alio JL, 2003, J REFRACT SURG, V19, P516; Alio JL, 2011, AM J OPHTHALMOL, V152, P954, DOI 10.1016/j.ajo.2011.05.009; Arba-Mosquera S, 2016, J REFRACT SURG, V32, P78, DOI 10.3928/1081597X-20151119-04; Bottos KM, 2011, J CATARACT REFR SURG, V37, P1109, DOI 10.1016/j.jcrs.2010.12.058; de Ortueta D, 2007, J REFRACT SURG, V23, P11; de Ortueta D, 2012, J REFRACT SURG, V28, P53, DOI 10.3928/1081597X-20110906-01; Denoyer A, 2012, OPHTHALMOLOGY, V119, P1811, DOI 10.1016/j.ophtha.2012.03.004; Frings A, 2016, GRAEF ARCH CLIN EXP, V254, P1399, DOI 10.1007/s00417-016-3308-z; Goyal JL, 2014, J REFRACT SURG, V30, P777, DOI 10.3928/1081597X-20141021-10; Guirao A, 2001, J OPT SOC AM A, V18, P1003, DOI 10.1364/JOSAA.18.001003; Khoramnia R, 2012, ACTA OPHTHALMOL, V90, P508, DOI 10.1111/j.1755-3768.2010.02052.x; Kim H, 2008, J CATARACT REFR SURG, V34, P557, DOI 10.1016/j.jcrs.2007.11.030; Levinson BA, 2008, J CATARACT REFR SURG, V34, P32, DOI 10.1016/j.jcrs.2007.08.028; LIANG JZ, 1994, J OPT SOC AM A, V11, P1949, DOI 10.1364/JOSAA.11.001949; Lim Sung A, 2016, Korean J Ophthalmol, V30, P92, DOI 10.3341/kjo.2016.30.2.92; Miyata K, 2004, J CATARACT REFR SURG, V30, P1067, DOI 10.1016/j.jcrs.2003.09.046; Moreno-Barriuso E, 2001, INVEST OPHTH VIS SCI, V42, P1396; Mrochen M, 2003, J REFRACT SURG, V19, P104; Mrochen M, 2001, J CATARACT REFR SURG, V27, P201, DOI 10.1016/S0886-3350(00)00827-0; Munnerlyn CR, 2001, J CATARACT REFR SURG, V14, P46; Salmon TO, 1999, THESIS, V70; Savini G, 2015, J CATARACT REFR SURG, V41, P785, DOI 10.1016/j.jcrs.2014.07.035; SMITH EM, 1995, J CATARACT REFR SURG, V21, P402, DOI 10.1016/S0886-3350(13)80528-7; Vega-Estrada A, 2012, J REFRACT SURG, V28, P689, DOI 10.3928/1081597X-20120921-03	24	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171851	10.1371/journal.pone.0171851	http://dx.doi.org/10.1371/journal.pone.0171851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187180	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300051
J	Roberts, HL; Schneider, BL; Brown, DR				Roberts, Hazel L.; Schneider, Bernard L.; Brown, David R.			alpha-Synuclein increases beta-amyloid secretion by promoting beta-/gamma-secretase processing of APP	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; RAT MODEL; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MEMBRANE-BINDING; OXIDATIVE STRESS; A-BETA; LEWY BODIES; PHOSPHORYLATION; PROTEIN	alpha-Synuclein misfolding and aggregation is often accompanied by beta-amyloid deposition in some neurodegenerative diseases. We hypothesised that alpha-synuclein promotes beta-amyloid production from APP. beta-Amyloid levels and APP amyloidogenic processing were investigated in neuronal cell lines stably overexpressing wildtype and mutant alpha-synuclein. gamma-Secretase activity and beta-secretase expression were also measured. We show that alpha-synuclein expression induces beta-amyloid secretion and amyloidogenic processing of APP in neuronal cell lines. Certain mutations of a-synuclein potentiate APP amyloidogenic processing. gamma-Secretase activity was not enhanced by wildtype alpha-synuclein expression, however beta-secretase protein levels were induced. Furthermore, a correlation between alpha-synuclein and beta-secretase protein was seen in rat brain striata. Iron chelation abolishes the effect of alpha-synuclein on neuronal cell beta-amyloid secretion, whereas overexpression of the ferrireductase enzyme Steap3 is robustly pro-amyloidogenic. We propose that alpha-synuclein promotes beta-amyloid formation by modulating beta-cleavage of APP, and that this is potentially mediated by the levels of reduced iron and oxidative stress.	[Roberts, Hazel L.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Schneider, Bernard L.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	University of Bath; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	D.R.Brown@bath.ac.uk	Schneider, Bernard/H-6168-2011	Schneider, Bernard/0000-0001-5485-8748; Hall-Roberts, Hazel/0000-0003-0330-9604	UK Charity, BRACE	UK Charity, BRACE	This work was funded by the UK Charity, BRACE, in the form of a PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Atsmon-Raz Y, 2016, ACS CHEM NEUROSCI, V7, P46, DOI 10.1021/acschemneuro.5b00204; Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-55; Bender A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062277; Brown DR, 2013, BIOCHEM SOC T, V41, P1513, DOI 10.1042/BST20130130; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cox CJ, 2015, NEUROBIOL AGING, V36, P178, DOI 10.1016/j.neurobiolaging.2014.07.032; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Febbraro F, 2013, NEUROBIOL DIS, V56, P47, DOI 10.1016/j.nbd.2013.03.014; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; George S, 2015, J PARKINSON DIS, V5, P413, DOI 10.3233/JPD-150630; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Guo C, 2013, NEUROBIOL AGING, V34, P562, DOI 10.1016/j.neurobiolaging.2012.05.009; Guo LY, 2014, EXP EYE RES, V129, P31, DOI 10.1016/j.exer.2014.10.012; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Kallhoff V, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-6; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Kim CH, 2013, KOREAN J PHYSIOL PHA, V17, P189, DOI 10.4196/kjpp.2013.17.3.189; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lashley T, 2008, ACTA NEUROPATHOL, V115, P417, DOI 10.1007/s00401-007-0336-0; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Majd S, 2013, NEUROTOX RES, V23, P69, DOI 10.1007/s12640-012-9330-y; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McHugh PC, 2012, NEUROCHEM INT, V61, P672, DOI 10.1016/j.neuint.2012.07.002; Mei ZR, 2015, NEUROCHEM RES, V40, P829, DOI 10.1007/s11064-015-1533-1; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oaks AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070872; Oda A, 2010, J NEUROSCI RES, V88, P1137, DOI 10.1002/jnr.22271; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Parkkinen L, 2003, J NEUROPATH EXP NEUR, V62, P363, DOI 10.1093/jnen/62.4.363; Petrou M, 2015, MOVEMENT DISORD, V30, P928, DOI 10.1002/mds.26191; Pino E, 2014, HUM MOL GENET, V23, P1435, DOI 10.1093/hmg/ddt530; Pletnikova O, 2005, NEUROBIOL AGING, V26, P1183, DOI 10.1016/j.neurobiolaging.2004.10.006; Ringman JM, 2016, J NEUROPATH EXP NEUR, V75, P284, DOI 10.1093/jnen/nlv028; Robotta M, 2012, BIOCHEMISTRY-US, V51, P3960, DOI 10.1021/bi300357a; Sambamurti K, 2004, FASEB J, V26, P1; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schneider JA, 2009, J ALZHEIMERS DIS, V18, P691, DOI 10.3233/JAD-2009-1227; Skogseth RE, 2015, J PARKINSON DIS, V5, P783, DOI 10.3233/JPD-150682; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stav Ane Lovli, 2015, Parkinsonism Relat Disord, V21, P758, DOI 10.1016/j.parkreldis.2015.04.027; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Terrelonge M, 2016, J MOL NEUROSCI, V58, P88, DOI 10.1007/s12031-015-0647-x; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vranova HP, 2014, J NEUROL SCI, V343, P120, DOI 10.1016/j.jns.2014.05.052; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhou XL, 2016, AM J TRANSL RES, V8, P246	93	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171925	10.1371/journal.pone.0171925	http://dx.doi.org/10.1371/journal.pone.0171925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187176	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300060
J	Faria, SC; Provete, DB; Thurman, CL; McNamara, JC				Faria, Samuel Coelho; Provete, Diogo Borges; Thurman, Carl Leo; McNamara, John Campbell			Phylogenetic patterns and the adaptive evolution of osmoregulation in fiddler crabs (Brachyura, Uca)	PLOS ONE			English	Article							GULF-OF-MEXICO; OSMOTIC REGULATION; NORTH-AMERICA; FRESH-WATER; GENUS UCA; REGRESSION; PHYSIOLOGY; GILLS; ADAPTATIONS; ENVIRONMENT	Salinity is the primary driver of osmoregulatory evolution in decapods, and may have influenced their diversification into different osmotic niches. In semi-terrestrial crabs, hyperosmoregulatory ability favors sojourns into burrows and dilute media, and provides a safeguard against hemolymph dilution; hypo-osmoregulatory ability underlies emersion capability and a life more removed from water sources. However, most comparative studies have neglected the roles of the phylogenetic and environmental components of inter-specific physiological variation, hindering evaluation of phylogenetic patterns and the adaptive nature of osmoregulatory evolution. Semi-terrestrial fiddler crabs (Uca) inhabit fresh to hyper-saline waters, with species from the Americas occupying higher intertidal habitats than Indo-west Pacific species mainly found in the low intertidal zone. Here, we characterize numerous osmoregulatory traits in all ten fiddler crabs found along the Atlantic coast of Brazil, and we employ phylogenetic comparative methods using 24 species to test for: (i) similarities of osmoregulatory ability among closely related species; (ii) salinity as a driver of osmoregulatory evolution; (iii) correlation between salt uptake and secretion; and (iv) adaptive peaks in osmoregulatory ability in the high intertidal American lineages. Our findings reveal that osmoregulation in Uca exhibits strong phylogenetic patterns in salt uptake traits. Salinity does not correlate with hyper/hypo-regulatory abilities, but drives hemolymph osmolality at ambient salinities. Osmoregulatory traits have evolved towards three adaptive peaks, revealing a significant contribution of hyper/hypo-regulatory ability in the American clades. Thus, during the evolutionary history of fiddler crabs, salinity has driven some of the osmoregulatory transformations that underpin habitat diversification, although others are apparently constrained phylogenetically.	[Faria, Samuel Coelho; McNamara, John Campbell] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil; [Provete, Diogo Borges] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil; [Provete, Diogo Borges] Gothenburg Global Biodivers Ctr, Gothenburg, Sweden; [Thurman, Carl Leo] Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA; [McNamara, John Campbell] Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil; [Faria, Samuel Coelho] Univ Fed Rio Grande FURG, Inst Ciencias Biol, Rio Grande, RS, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; University of Gothenburg; University of Northern Iowa; Universidade de Sao Paulo; Universidade Federal do Rio Grande	McNamara, JC (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil.; McNamara, JC (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil.	mcnamara@ffclrp.usp.br	Faria, Samuel C/E-6819-2013; McNamara, John Campbell/B-9823-2012; Provete, Diogo B./B-3704-2008	Faria, Samuel C/0000-0003-3143-2191; McNamara, John Campbell/0000-0002-6530-8706; Provete, Diogo B./0000-0002-0097-0651	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56305-6, 2011/08852-0, 2007/04870-9, 2009/50799-0, 2016/13949-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [450320/2010-3, 300662/2009-2, 203734/2014-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [33002029031P8]; Biology Department, the College of Natural Sciences; Graduate College of the University of Northern Iowa; University of Iowa Global Regional Environmental Research Center (GRERC SA) [1000716062, 1802010001]; Fulbright Foundation;  [2009/06]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Biology Department, the College of Natural Sciences; Graduate College of the University of Northern Iowa; University of Iowa Global Regional Environmental Research Center (GRERC SA); Fulbright Foundation; 	This research was supported in Brazil by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP fellowships #2008/56305-6 and #2011/08852-0 to SCF, and grants #2007/04870-9 to JCM and #2009/50799-0 to JCM and CLT), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #450320/2010-3 and #300662/2009-2 to JCM) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, 33002029031P8). CLT received funding from the Biology Department, the College of Natural Sciences, and the Graduate College of the University of Northern Iowa, the University of Iowa Global Regional Environmental Research Center (GRERC SA #1000716062, G/P # 1802010001) and the Fulbright Foundation. DBP received post-doctoral fellowships from CNPq (#203734/2014-9) and FAPESP (2016/13949-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are most grateful to the Centro de Biologia Marinha, Universidade de Sao Paulo, for providing laboratory space and facilities (Project #2009/06) and we thank T. Alves, C. Antunes, F. Assis, L. Bezerra, M. Capparelli, R. Faleiros, A. Filhos, J. Hall, M. Hopkins, S. Milograna, F. Penha, L. Perez, E. Ribeiro, H. Silva, C. M. Thurman and J. Vieira for helping with field work. We also thank Dr Hsi-Te Shih for providing the phylogenetic tree, the IBAMA office in Amapa, AP, for supplying the boat, motor and trailer to collect at the mouth of the Amapa River, and M. Sommerlot (Hawkeye Corrugated Box, Cedar Falls, IA) who kindly donated our transportation container. SCF is indebted to Lucas B. Martins and Rafael C. Duarte for fundamental support with the R platform and discussions of phylogenetic comparative methods. Crabs were collected under MMA/ICMBio permits #18559-1, #23976-1, #29594-1 and #29594-3 to JCM. This investigation constitutes part of an M Sc dissertation submitted by SCF to the Graduate Program in Comparative Biology, Departamento de Biologia, FFCLRP, Universidade de Sao Paulo.	Augusto A, 2007, J EXP ZOOL PART A, V307A, P688, DOI 10.1002/jez.a.422; Burggren WW, 1988, BIOL LAND CRABS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Charmantier Guy, 2009, P165; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; DIAZ H, 1977, BIOL BULL, V153, P485, DOI 10.2307/1540602; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Faria SC, 2017, ECOL EVOL, P1; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finney D.J., 1971, PROBIT ANAL; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Goolsby EW, 2016, METHODS ECOL EVOL; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRAY IE, 1957, BIOL BULL, V112, P34, DOI 10.2307/1538877; Greenaway P., 1988, CRUSTACEANS BIODIVER, P823; GROSS WJ, 1964, BIOL BULL, V127, P447, DOI 10.2307/1539247; GROSS WJ, 1955, AM NAT, V89, P205, DOI 10.1086/281884; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; Hurman CL, 2005, B MAR SCI, V77, P83; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Jones LL, 1941, J CELL COMPAR PHYSL, V18, P79, DOI 10.1002/jcp.1030180109; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Levinton J, 1996, J EXP MAR BIOL ECOL, V203, P117, DOI 10.1016/0022-0981(96)02573-7; Lin HC, 2002, ZOOL SCI, V19, P643, DOI 10.2108/zsj.19.643; Little C, 1990, TERRESTRIAL INVASION; Mantel L.H., 1983, P53; Martins E. P., 1996, PHYLOGENIES COMP MET; McNamara JC, 2015, BIOL J LINN SOC, V114, P673, DOI 10.1111/bij.12443; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearse AS., 1929, PAP TORTUGAS LAB, V391, P205; Pequeux A, 1985, J CRUSTACEAN BIOL, V15, P1; Pinheiro J, R PACKAGE VERSION; R Core Team, 2013, R LANG ENV STAT COMP; RABALAIS NN, 1985, BIOL BULL, V168, P135, DOI 10.2307/1541179; Rangel TF, 2015, EVOLUTION, V69, P1301, DOI 10.1111/evo.12644; Revell LJ, 2013, METHODS ECOL EVOL, V4, P754, DOI 10.1111/2041-210X.12066; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rezende EL, 2012, COMPREHENSIVE PHYSL, V2, P645; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; Shih HT, 2015, ZOOTAXA, V4034, P471, DOI 10.11646/zootaxa.4034.3.3; SPAARGAREN DH, 1977, NETH J SEA RES, V11, P200, DOI 10.1016/0077-7579(77)90006-0; Sturmbauer C, 1996, P NATL ACAD SCI USA, V93, P10855, DOI 10.1073/pnas.93.20.10855; Takeda S, 1996, J CRUSTACEAN BIOL, V16, P472, DOI 10.2307/1548737; Thurman C, 2003, J EXP MAR BIOL ECOL, V291, P233, DOI 10.1016/S0022-0981(03)00138-2; Thurman C, 2003, MAR BIOL, V142, P77, DOI 10.1007/s00227-002-0920-8; Thurman C, 2010, MAR FRESHW BEHAV PHY, V43, P339, DOI 10.1080/10236244.2010.526407; Thurman Carl L., 2013, Marine Biodiversity Records, V6, pe1, DOI 10.1017/S1755267212000942; Thurman CL, 2002, MAR ECOL-P S Z N I, V23, P269, DOI 10.1046/j.1439-0485.2002.02785.x; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Venice System, 1959, ARCHO OCEANOGR LIM S, V11, P243	58	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171870	10.1371/journal.pone.0171870	http://dx.doi.org/10.1371/journal.pone.0171870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182764	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800128
J	Guo, Q; Du, XJ; Zhao, JC; Ma, YK; Huang, B; Yuan, D; Yang, Y; Zeng, GJ; Xiong, F				Guo, Qiang; Du, Xiaojiong; Zhao, Jichun; Ma, Yukui; Huang, Bin; Yuan, Ding; Yang, Yi; Zeng, Guojun; Xiong, Fei			Prevalence and risk factors of type II endoleaks after endovascular aneurysm repair: A meta-analysis	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; SELECTIVE INTERVENTION; NATURAL-HISTORY; SAC ENLARGEMENT; OPEN CONVERSION; OUTCOMES; EMBOLIZATION; PREDICT; SAFE; ANGIOGRAPHY	Objectives This systematic review and meta-analysis aims to determine the current evidence on risk factors for type II endoleaks after endovascular aneurysm repair (EVAR). Materials and methods A systematic literature search was carried out for studies that evaluated the association of demographic, co-morbidity, and other patient-determined factors with the onset of type II endoleaks. Pooled prevalence of type II endoleaks after EVAR was updated. Results Among the 504 studies screened, 45 studies with a total of 36,588 participants were included in this review. The pooled prevalence of type II endoleaks after EVAR was 22% [95% confidence interval (CI), 19%-25%]. The main factors consistently associated with type II endoleaks included age [pooled odds ratio (OR), 0.37; 95% CI, 0.31-0.43; P<0.001], smoking (pooled OR, 0.71; 95% CI, 0.55-0.92; P<0.001), patent inferior mesenteric artery (pooled OR, 1.98; 95% CI, 1.06-3.71; P = 0.012), maximum aneurysm diameter (pooled OR, 0.23; 95% CI, 0.17-0.30; P<0.001), and number of patent lumbar arteries (pooled OR, 3.07; 95% CI, 2.81-3.33; P<0.001). Sex, diabetes, hypertension, anticoagulants, antiplatelet, hyperlipidemia, chronic renal insufficiency, types of graft material, and chronic obstructive pulmonary diseases (COPD) did not show any association with the onset of type II endoleaks. Conclusions Clinicians can use the identified risk factors to detect and manage patients at risk of developing type II endoleaks after EVAR. However, further studies are needed to analyze a number of potential risk factors.	[Guo, Qiang; Du, Xiaojiong; Zhao, Jichun; Ma, Yukui; Huang, Bin; Yuan, Ding; Yang, Yi; Zeng, Guojun; Xiong, Fei] Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu, Sichuan Provinc, Peoples R China	Sichuan University	Zhao, JC (corresponding author), Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu, Sichuan Provinc, Peoples R China.	zjcwch@163.com						Abularrage CJ, 2010, J VASC SURG, V52, P19, DOI 10.1016/j.jvs.2010.02.023; Arko FR, 2003, J VASC SURG, V37, P8, DOI 10.1067/mva.2003.55; Batti SE, 2013, J VASC SURG, V57, P1291, DOI DOI 10.1016/J.JVS.2012.10.118; Brountzos E, 2012, DIAGN INTERV RADIOL, V18, P307, DOI 10.4261/1305-3825.DIR.4646-11.1; Buth J, 2002, J AM COLL SURGEONS, V194, pS98, DOI 10.1016/S1072-7515(01)01128-0; Carpenter JP, 2004, J VASC SURG, V39, P34, DOI 10.1016/j.jvs.2003.10.036; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Chang RW, 2013, J VASC SURG, V58, P324, DOI 10.1016/j.jvs.2013.01.051; Chuter TAM, 2001, J VASC SURG, V34, P98, DOI 10.1067/mva.2001.111487; Cieri E, 2014, J VASC SURG, V59, P930, DOI 10.1016/j.jvs.2013.10.092; Phan DDN, 2015, WIEN KLIN WOCHENSCHR, V127, P851, DOI 10.1007/s00508-015-0871-y; Dudeck O, 2015, CARDIOVASC INTER RAD, V38, P45, DOI 10.1007/s00270-014-0901-6; Faries PL, 2003, J VASC SURG, V37, P1155, DOI 10.1016/S0741-5214(03)00084-3; Farner MC, 2003, J VASC INTERV RADIOL, V14, P205, DOI 10.1097/01.RVI.0000058322.82956.ad; Fujimura N, 2015, CIRC J, V80, P118, DOI 10.1253/circj.CJ-15-0850; Gallitto E, 2015, J CARDIOVASC SURG TO; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Haulon S, 2001, J VASC SURG, V34, P600, DOI 10.1067/mva.2001.117888; Hiraoka A, 2015, ANN VASC SURG, V29, P1440, DOI 10.1016/j.avsg.2015.05.022; Ikoma A, 2016, CARDIOVASC INTER RAD, V39, P522, DOI 10.1007/s00270-015-1191-3; Ilyas S, 2010, CLIN RADIOL, V362, P1863; Jones JE, 2007, J VASC SURG, V46, P1, DOI 10.1016/j.jvs.2007.02.073; Jouhannet C, 2014, ANN VASC SURG, V28, P192, DOI 10.1016/j.avsg.2012.10.038; Kasirajan K, 2003, J VASC SURG, V38, P61, DOI 10.1016/S0741-5214(02)75467-0; Koole D, 2012, J VASC SURG, V55, P1581, DOI 10.1016/j.jvs.2011.12.018; Kray J, 2015, J VASC SURG, V61, P869, DOI 10.1016/j.jvs.2014.11.003; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Liewald F, 2001, EUR J VASC ENDOVASC, V21, P339, DOI 10.1053/ejvs.2001.1333; Lo RC, 2016, J VASC SURG, V63, P895, DOI 10.1016/j.jvs.2015.10.088; Lowenthal D, 2015, ROFO-FORTSCHR RONTG, V187, P49, DOI 10.1055/s-0034-1385123; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maeda T, 2015, SURG TODAY, V45, P1373, DOI 10.1007/s00595-014-1070-6; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Muller-Wille R, 2015, RADIOLOGY, V274, P906, DOI 10.1148/radiol.14140284; Mursalin R, 2016, AM J ROENTGENOL, V206, P1335, DOI 10.2214/AJR.15.15254; Nolz R, 2015, EUR J VASC ENDOVASC, V50, P181, DOI 10.1016/j.ejvs.2015.03.031; Nolz R, 2012, J ENDOVASC THER, V19, P193, DOI 10.1583/11-3803.1; Parent FN, 2002, J VASC SURG, V35, P474, DOI 10.1067/mva.2002.121848; Piazza M, 2016, J VASC SURG, V63, P32, DOI 10.1016/j.jvs.2015.08.049; Pini R, 2015, ANN VASC SURG, V29, P1167, DOI 10.1016/j.avsg.2015.03.036; Pippin K, 2016, CLIN IMAG, V40, P875, DOI 10.1016/j.clinimag.2016.04.004; Rousie M, 2015, ACTA CHIR BELG, V115, P404; Sheehan MK, 2006, J VASC SURG, V43, P657, DOI 10.1016/j.jvs.2005.12.044; Sidloff DA, 2014, EUR J VASC ENDOVASC, V48, P391, DOI 10.1016/j.ejvs.2014.06.035; Sidloff DA, 2013, BRIT J SURG, V100, P1262, DOI 10.1002/bjs.9181; Silverberg D, 2006, J VASC SURG, V44, P453, DOI 10.1016/j.jvs.2006.04.058; Solis MM, 2002, J VASC SURG, V36, P485, DOI 10.1067/mva.2002.126542; Steinmetz E, 2004, J VASC SURG, V39, P306, DOI 10.1016/j.jvs.2003.10.026; Tolia AJ, 2005, RADIOLOGY, V235, P683, DOI 10.1148/radiol.2352040649; Tuerff SN, 2002, ANN VASC SURG, V16, P50, DOI 10.1007/s10016-001-0126-4; van Marrewijk CJ, 2004, EUR J VASC ENDOVASC, V27, P128, DOI 10.1016/j.ejvs.2003.10.016; Walker J, 2015, J VASC SURG, V62, P551, DOI 10.1016/j.jvs.2015.04.389; Ward TJ, 2014, CARDIOVASC INTER RAD, V37, P324, DOI 10.1007/s00270-013-0646-7; Ward TJ, 2013, J VASC INTERV RADIOL, V24, P49, DOI 10.1016/j.jvir.2012.09.022; Wells G.A., NEWCASTLE OTTAWA SCA	58	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170600	10.1371/journal.pone.0170600	http://dx.doi.org/10.1371/journal.pone.0170600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182753	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800014
J	Abadi, SH; Tolstoy, M; Wilcock, WSD				Abadi, Shima H.; Tolstoy, Maya; Wilcock, William S. D.			Estimating the location of baleen whale calls using dual streamers to support mitigation procedures in seismic reflection surveys	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; NORTHEAST PACIFIC; DIVE PROFILES; FIN WHALES; ARRAY; TRACKING; SEA; OCEAN; BLUE	In order to mitigate against possible impacts of seismic surveys on baleen whales it is important to know as much as possible about the presence of whales within the vicinity of seismic operations. This study expands on previous work that analyzes single seismic streamer data to locate nearby calling baleen whales with a grid search method that utilizes the propagation angles and relative arrival times of received signals along the streamer. Three dimensional seismic reflection surveys use multiple towed hydrophone arrays for imaging the structure beneath the seafloor, providing an opportunity to significantly improve the uncertainty associated with streamer-generated call locations. All seismic surveys utilizing airguns conduct visual marine mammal monitoring surveys concurrent with the experiment, with powering-down of seismic source if a marine mammal is observed within the exposure zone. This study utilizes data from power-down periods of a seismic experiment conducted with two 8-km long seismic hydrophone arrays by the R/V Marcus G. Langseth near Alaska in summer 2011. Simulated and experiment data demonstrate that a single streamer can be utilized to resolve left-right ambiguity because the streamer is rarely perfectly straight in a field setting, but dual streamers provides significantly improved locations. Both methods represent a dramatic improvement over the existing Passive Acoustic Monitoring (PAM) system for detecting low frequency baleen whale calls, with similar to 60 calls detected utilizing the seismic streamers, zero of which were detected using the current R/V Langseth PAM system. Furthermore, this method has the potential to be utilized not only for improving mitigation processes, but also for studying baleen whale behavior within the vicinity of seismic operations.	[Abadi, Shima H.] Univ Washington, Sch STEM, Bothell, WA 98011 USA; [Tolstoy, Maya] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Wilcock, William S. D.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Bothell; Columbia University; University of Washington; University of Washington Seattle	Abadi, SH (corresponding author), Univ Washington, Sch STEM, Bothell, WA 98011 USA.	abadi@uw.edu		Wilcock, William/0000-0001-7224-7246	National Science Foundation [OCE12-14328]	National Science Foundation(National Science Foundation (NSF))	OCE12-14328, National Science Foundation (https://www.nsf.gov), MT.	Abadi SH, 2015, J ACOUST SOC AM, V138, P3951, DOI 10.1121/1.4937768; Abadi SH, 2014, J ACOUST SOC AM, V136, P130, DOI 10.1121/1.4881924; Baker K., 2013, NATL STANDARDS PROTE; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Blackwell SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125720; Crone T. J., 2014, GEOCHEM GEOPHYS GEOS; Diebold JB, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003216; Gambell R, 1985, HDB MARINE MAMMALS, P3171; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104733; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Guerra M, 2011, J ACOUST SOC AM, V130, P3046, DOI 10.1121/1.3628326; Lee S, 2006, J ACOUST SOC AM, V119, P336, DOI 10.1121/1.2139074; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; McCauley R. D., 1998, APPEA J, P692; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; PORTER M, 1984, J ACOUST SOC AM, V76, P244, DOI 10.1121/1.391101; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Shillington DJ, 2015, NAT GEOSCI, V8, P961, DOI [10.1038/ngeo2586, 10.1038/NGEO2586]; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Thode A, 2005, J ACOUST SOC AM, V118, P3575, DOI 10.1121/1.2049068; Thode A, 2004, J ACOUST SOC AM, V116, P245, DOI 10.1121/1.1758972; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; Tolstoy M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020234; Tolstoy M., 2009, GEOCHEM GEOPHY GEOSY, P10; Tran DD, 2014, J ACOUST SOC AM, V135, P3352, DOI 10.1121/1.4874601; WATKINS WA, 1981, SCI REP WHALES RES, V33, P83; Wilcock WSD, 2012, J ACOUST SOC AM, V132, P2408, DOI 10.1121/1.4747017	28	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171115	10.1371/journal.pone.0171115	http://dx.doi.org/10.1371/journal.pone.0171115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199400	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400024
J	Aziz, S; Wik, E; Knutsvik, G; Klingen, TA; Chen, Y; Davidsen, B; Aas, H; Aas, T; Akslen, LA				Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Davidsen, Benedicte; Aas, Hans; Aas, Turid; Akslen, Lars A.			Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer	PLOS ONE			English	Article							EXTRACAPSULAR EXTENSION; POSTOPERATIVE IRRADIATION; TUMOR BURDEN; RECURRENCE; METASTASIS; DISSECTION; EXPRESSION; SPREAD; SIZE	Presence of lymph node (LN) metastasis is a strong prognostic factor in breast cancer, whereas the importance of extra-nodal extension and other nodal tumor features have not yet been fully recognized. Here, we examined microscopic features of lymph node metastases and their prognostic value in a population-based cohort of node positive breast cancer (n = 218), as part of the prospective Norwegian Breast Cancer Screening Program NBCSP (1996-2009). Sections were reviewed for the largest metastatic tumor diameter (TD-MET), nodal afferent and efferent vascular invasion (AVI and EVI), extra-nodal extension (ENE), number of ENE foci, as well as circumferential (CD-ENE) and perpendicular (PD-ENE) diameter of extra-nodal growth. Number of positive lymph nodes, EVI, and PD-ENE were significantly increased with larger primary tumor (PT) diameter. Univariate survival analysis showed that several features of nodal metastases were associated with disease-free (DFS) or breast cancer specific survival (BCSS). Multivariate analysis demonstrated an independent prognostic value of PD-ENE (with 3 mm as cut-off value) in predicting DFS and BCSS, along with number of positive nodes and histologic grade of the primary tumor (for DFS: P= 0.01, P= 0.02, P= 0.01, respectively; for BCSS: P = 0.02, P = 0.008, P= 0.02, respectively). To conclude, the extent of ENE by its perpendicular diameter was independently prognostic and should be considered in line with nodal tumor burden in treatment decisions of node positive breast cancer.	[Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Klingen, Tor Audun] Vestfold Hosp Trust, Dept Pathol, Tonsberg, Norway; [Chen, Ying] Akershus Univ Hosp, Dept Pathol, Lorenskog, Norway; [Davidsen, Benedicte; Aas, Turid] Haukeland Hosp, Dept Surg, Bergen, Norway; [Aas, Hans] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	lars.akslen@uib.no	Akslen, Lars A/C-1202-2017; Wik, E./AAA-9105-2020; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543	Research Council of Norway through its Centre of Excellence [223250]; Norwegian Cancer Society, Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen; Vestfold Hospital Research Fund	Research Council of Norway through its Centre of Excellence(Research Council of Norway); Norwegian Cancer Society, Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen; Vestfold Hospital Research Fund	This work was partly supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223250 (received by LA). The study was also supported by the Norwegian Cancer Society, Helse Vest RHF, and the Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen and Vestfold Hospital Research Fund.	Aziz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150979; Bucci JA, 2001, BREAST, V10, P213, DOI 10.1054/brst.2000.0233; Chen Y, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0230-8; Choi AH, 2014, AM SURGEON, V80, P932; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colleoni M, 2005, J CLIN ONCOL, V23, P1379, DOI 10.1200/JCO.2005.07.094; Cserni G, 2008, J CLIN PATHOL, V61, P115, DOI 10.1136/jcp.2007.047357; Cserni G, 1990, EUR J CANCER, V44, P2185; Dobi E, 2013, INT J CLIN ONCOL, V18, P607, DOI 10.1007/s10147-012-0439-z; Drinka E, 2015, METASTATIC TUMOR VOL; Fan YG, 2005, ANN SURG ONCOL, V12, P705, DOI 10.1245/ASO.2005.08.020; Gooch J, 2014, ANN SURG ONCOL, V21, P2897, DOI 10.1245/s10434-014-3752-0; Hartveit FM, 2000, ACTA ONCOL, V39, P309, DOI 10.1080/028418600750013069; Katz A, 2000, J CLIN ONCOL, V18, P2817, DOI 10.1200/JCO.2000.18.15.2817; Klingen TA, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-80; Knutsvik G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112121; Neri A, 2005, ANN SURG ONCOL, V12, P246, DOI 10.1245/ASO.2005.02.029; Nottegar A, 2016, EUROPEAN J SURG ONCO; ROSEN PP, 1981, ANN SURG, V194, P585, DOI 10.1097/00000658-198111000-00006; Stitzenberg KB, 2003, ANN SURG, V237, P607, DOI 10.1097/00000658-200305000-00002; Stranzl H, 2006, STRAHLENTHER ONKOL, V182, P583, DOI 10.1007/s00066-006-1562-4	21	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171853	10.1371/journal.pone.0171853	http://dx.doi.org/10.1371/journal.pone.0171853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199370	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400052
J	Christensen, TD; Vad, H; Pedersen, S; Hornbech, K; Zois, NE; Licht, PB; Nybo, M; Hvas, AM				Christensen, Thomas Decker; Vad, Henrik; Pedersen, Soren; Hornbech, Kare; Zois, Nora Elisabeth; Licht, Peter B.; Nybo, Mads; Hvas, Anne-Mette			Coagulation profile in patients undergoing video-assisted thoracoscopic lobectomy: A randomized, controlled trial	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; SEVERE SEPSIS; CANCER; RISK; THROMBOPROPHYLAXIS; PROPHYLAXIS; HEMOSTASIS; TOOL	Background Knowledge about the impact of Low-Molecular-Weight Heparin (LMWH) on the coagulation system in patients undergoing minimal invasive lung cancer surgery is sparse. The aim of this study was to assess the effect of LMWH on the coagulation system in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS) lobectomy for primary lung cancer. Methods Sixty-three patients diagnosed with primary lung cancer undergoing VATS lobectomy were randomized to either subcutaneous injection with dalteparin (Fragmin r) 5000 IE once daily or no intervention. Coagulation was assessed pre-, peri-, and the first two days postoperatively by standard coagulation blood test, thromboelastometry (ROTEM (R)) and thrombin generation. Results Patients undergoing potential curative surgery for lung cancer were not hypercoagulable preoperatively. There was no statistically significant difference in the majority of the assessed coagulation parameters after LMWH, except that the no intervention group had a higher peak thrombin and a shorter INTEM clotting time on the first postoperative day and a lower fibrinogen level on the second postoperative day. A lower level of fibrin d-dimer in the LMWH group was found on the 1. and 2. postoperative day, although not statistical significant. No differences were found between the two groups in the amount of bleeding or number of thromboembolic events. Conclusions Use of LMWH administered once daily as thromboprophylaxis did not alter the coagulation profile per se. As the present study primarily evaluated biochemical endpoints, further studies using clinical endpoints are needed in regards of an optimized thromboprophylaxis approach.	[Christensen, Thomas Decker; Vad, Henrik] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Aarhus, Denmark; [Christensen, Thomas Decker; Vad, Henrik; Pedersen, Soren; Hvas, Anne-Mette] Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark; [Pedersen, Soren] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, Aarhus, Denmark; [Hornbech, Kare] Copenhagen Univ Hosp, Dept Cardiothorac Surg, Rigshosp, Copenhagen, Denmark; [Zois, Nora Elisabeth] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark; [Licht, Peter B.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark; [Nybo, Mads] Odense Univ Hosp, Dept Clin Biochem, Odense, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University	Christensen, TD (corresponding author), Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Aarhus, Denmark.; Christensen, TD (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark.	tdc@clin.au.dk	Nybo, Mads/J-6040-2019	Nybo, Mads/0000-0002-3029-2855; Licht, Peter/0000-0003-1270-8068	Arvid Nilssons fond; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Fru Agnes Niebuhr Andersons Cancerforskningsfonds pris	Arvid Nilssons fond; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Fru Agnes Niebuhr Andersons Cancerforskningsfonds pris	The study was financially supported by Arvid Nilssons fond, Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond and Fru Agnes Niebuhr Andersons Cancerforskningsfonds pris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-4; Andersen MG, 2014, ACTA ANAESTH SCAND, V58, P525, DOI 10.1111/aas.12290; Attaran S, 2010, EUR J CARDIO-THORAC, V37, P1384, DOI 10.1016/j.ejcts.2009.12.027; AY C, 2015, HAMOSTASEOLOGIE, V35, P319, DOI DOI 10.5482/HAMO-14-11-0066; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Farge D, 2013, J THROMB HAEMOST, V11, P56, DOI 10.1111/jth.12070; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P795, DOI 10.1111/j.1538-7836.2009.03331.x; Kyriazi V, 2013, ARCH PATHOL LAB MED, V137, P1286, DOI 10.5858/arpa.2012-0490-RA; Laursen LO, 2016, EUR J CARDIO-THORAC, V49, P870, DOI 10.1093/ejcts/ezv205; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Madarame H, 2010, CLIN PHYSIOL FUNCT I, V30, P210, DOI 10.1111/j.1475-097X.2010.00927.x; Papa M. L., 2007, Experimental Oncology, V29, P111; Papageorgiou C, 2013, THROMB RES, V132, P584, DOI 10.1016/j.thromres.2013.07.005; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Wei MY, 2015, HEMATOL REP, V7, P80, DOI 10.4081/hr.2015.5844	16	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171809	10.1371/journal.pone.0171809	http://dx.doi.org/10.1371/journal.pone.0171809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199364	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400050
J	Hassan-Smith, ZK; Jenkinson, C; Smith, DJ; Hernandez, I; Morgan, SA; Crabtree, NJ; Gittoes, NJ; Keevil, BG; Stewart, PM; Hewison, M				Hassan-Smith, Zaki K.; Jenkinson, Carl; Smith, David J.; Hernandez, Ivan; Morgan, Stuart A.; Crabtree, Nicola J.; Gittoes, Neil J.; Keevil, Brian G.; Stewart, Paul M.; Hewison, Martin			25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression	PLOS ONE			English	Article							VITAMIN-D STATUS; D DEFICIENCY; STRENGTH; METAANALYSIS; MYOPATHY; FORM; MASS; AGE	Age-associated decline in muscle function represents a significant public health burden. Vitamin D-deficiency is also prevalent in aging subjects, and has been linked to loss of muscle mass and strength (sarcopenia), but the precise role of specific vitamin D metabolites in determining muscle phenotype and function is still unclear. To address this we quantified serum concentrations of multiple vitamin D metabolites, and assessed the impact of these metabolites on body composition/muscle function parameters, and muscle biopsy gene expression in a retrospective study of a cohort of healthy volunteers. Active serum 1,25-dihydroxyvitamin D3 (1 alpha, 25(OH)(2)D3), but not inactive 25-hydroxyvitamin D3 (25OHD3), correlated positively with measures of lower limb strength including power (rho = 0.42, p = 0.02), velocity (Vmax, rho = 0.40, p = 0.02) and jump height (rho = 0.36, p = 0.04). Lean mass correlated positively with 1a, 25(OH)(2)D3 (rho = 0.47, p = 0.02), in women. Serum 25OHD3 and inactive 24,25-dihydroxyvitamin D3 (24,25(OH)(2)D3) had an inverse relationship with body fat (rho = -0.30, p = 0.02 and rho = -0.33, p = 0.01, respectively). Serum 25OHD3 and 24,25(OH)(2)D3 were also correlated with urinary steroid metabolites, suggesting a link with glucocorticoid metabolism. PCR array analysis of 92 muscle genes identified vitamin D receptor (VDR) mRNA in all muscle biopsies, with this expression being negatively correlated with serum 25OHD3, and Vmax, and positively correlated with fat mass. Of the other 91 muscle genes analysed by PCR array, 24 were positively correlated with 25OHD3, but only 4 were correlated with active 1 alpha, 25(OH)(2)D3. These data show that although 25OHD3 has potent actions on muscle gene expression, the circulating concentrations of this metabolite are more closely linked to body fat mass, suggesting that 25OHD3 can influence muscle function via indirect effects on adipose tissue. By contrast, serum 1 alpha, 25(OH)(2)D3 has limited effects on muscle gene expression, but is associated with increased muscle strength and lean mass in women. These pleiotropic effects of the vitamin D ` metabolome' on muscle function indicate that future supplementation studies should not be restricted to conventional analysis of the major circulating form of vitamin D, 25OHD3.	[Hassan-Smith, Zaki K.; Jenkinson, Carl; Smith, David J.; Hernandez, Ivan; Morgan, Stuart A.; Hewison, Martin] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Hassan-Smith, Zaki K.; Gittoes, Neil J.; Hewison, Martin] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Hassan-Smith, Zaki K.; Gittoes, Neil J.] Queen Elizabeth Hosp Birmingham, Dept Endocrinol, Birmingham, W Midlands, England; [Smith, David J.] Univ Birmingham, Sch Math, Birmingham, W Midlands, England; [Crabtree, Nicola J.] Queen Elizabeth Hosp Birmingham, Dept Nucl Med, Birmingham, W Midlands, England; [Keevil, Brian G.] Univ Manchester, Dept Clin Biochem, Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Stewart, Paul M.] Univ Leeds, Fac Med & Hlth, Worsley Bldg, Leeds, W Yorkshire, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Leeds	Hewison, M (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England.; Hewison, M (corresponding author), Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England.	m.hewison@bham.ac.uk	keevil, brian/AAP-6147-2020; Smith, David J/G-5775-2011; Jenkinson, Carl/M-7907-2017	Smith, David J/0000-0002-3427-0936; Jenkinson, Carl/0000-0002-1838-5282; , Zaki/0000-0002-8387-3039; Hewison, Martin/0000-0001-5806-9690	NIH [P50, AR063020-01]; European Research Council (Advanced Grant "Precort"); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063910] Funding Source: NIH RePORTER; MRC [G0100729] Funding Source: UKRI; Medical Research Council [G0100729] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (Advanced Grant "Precort"); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by an NIH P50 grant to M.H. (AR063020-01 NIH/NIAMS) and the European Research Council (Advanced Grant "Precort" to P.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern T, 2014, J CLIN ENDOCR METAB, V99, pE1327, DOI 10.1210/jc.2014-1704; Andreozzi P, 2016, NUTR ELSEVIER; [Anonymous], 2021, LANG ENV STAT COMP; Beaudart C, 2014, J CLIN ENDOCR METAB, V99, P4336, DOI 10.1210/jc.2014-1742; Bhat M, 2015, J STEROID BIOCHEM, V152, P171, DOI 10.1016/j.jsbmb.2015.05.012; Bischoff HA, 1999, ARCH PHYS MED REHAB, V80, P54, DOI 10.1016/S0003-9993(99)90307-6; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; Buehring B, 2010, J CLIN DENSITOM, V13, P283, DOI 10.1016/j.jocd.2010.04.002; Chesney R, 2016, LANCET ELSEVIER, V312, P1123; Douglas M, 2014, NEUROMUSCULAR DISORD, P1341; Fox J., 2019, R COMPANION APPL REG, V.; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Hassan-Smith ZK, 2015, J CLIN ENDOCR METAB, V100, P2673, DOI 10.1210/jc.2015-1516; Henry HL, 2016, BEST PRACT RES CLIN, V25, P531; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; IRANI PF, 1976, J NEUROL NEUROSUR PS, V39, P686, DOI 10.1136/jnnp.39.7.686; Jenkinson C, 2016, J CHROMATOGR B, V1014, P56, DOI 10.1016/j.jchromb.2016.01.049; Lee L, 2013, NADA NONDETECTS DATA, P5; Lisse TS, 2011, FASEB J, V25, P937, DOI 10.1096/fj.10-172577; Lumley T., 2009, LEAPS REGRESSION SUB; Marantes I, 2011, J BONE MINER RES, V26, P2860, DOI 10.1002/jbmr.510; Muir SW, 2011, J AM GERIATR SOC, V59, P2291, DOI 10.1111/j.1532-5415.2011.03733.x; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Nanduri R, 2015, J BIOL CHEM, V290, P12222, DOI 10.1074/jbc.M114.621839; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ryan Z. C., 2015, J BIOL CHEM M, V115; Salles J, 2013, MOL NUTR FOOD RES, V57, P2137, DOI 10.1002/mnfr.201300074; Sanchez CP, 2007, KIDNEY INT, V72, P582, DOI 10.1038/sj.ki.5002375; Siglinsky E, 2015, J MUSCULOSKEL NEURON, V15, P301; SORENSEN OH, 1979, CLIN SCI, V56, P157, DOI 10.1042/cs0560157; Tesic D, 2015, ENDOCRINOLOGY, V156, P3673, DOI 10.1210/en.2015-1377; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; Ward KA, 2009, J CLIN ENDOCR METAB, V94, P559, DOI 10.1210/jc.2008-1284; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	39	52	53	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170665	10.1371/journal.pone.0170665	http://dx.doi.org/10.1371/journal.pone.0170665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199350	Green Published, gold			2022-12-27	WOS:000394424400019
J	Kim, B; Kim, SZ; Lee, J; Jung, AH; Jung, SH; Hahn, HJ; Kang, HR; Suh, DI				Kim, Bomi; Kim, Sunwha Zara; Lee, Jin; Jung, Ae Hee; Jung, Sun-Hoi; Hahn, Hyeon-Joo; Kang, Hye Ryun; Suh, Dong In			Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions	PLOS ONE			English	Article							OFF-LABEL; CARE; PHARMACOVIGILANCE; SAFETY; COHORT; WARDS; ADR	Children with complex chronic conditions (CCC) are presumed to be vulnerable to adverse drug reactions (ADRs). The clinical profiles of ADRs in CCC are not well known. Herein, we aim to describe the ADR profiles in CCC with regard to typical presentations and vulnerable groups. We accessed the ADR yearly reports at a tertiary children's hospital whose practice is mainly dedicated to CCC and descriptively analyzed their clinical profiles according to the presence of a complex chronic condition, ADR severity, and age groups. A total of 1841 cases were analyzed, among which 1258 (68.3%) were mild, 493 (26.8%) moderate, and 90 (4.9%) cases were severe. A total of 1581 (85.9%) cases of complex chronic condition were reported. The proportion of CCC in each severity group increased as the ADR becomes more severe. In CCC, ADRs were most frequently reported by nurses in the adolescent group and in cases where the symptoms involved the gastrointestinal system. The class of antineoplastic and immunomodulating drugs was the most commonly suspected of causing an ADR, followed by one of the antibiotics. When we focus on the trend across the age groups, the ratio of severe-to-total ADRs decreased with older age. Among severe cases, the ratio of off-label prescription-related cases was the highest in the infant/toddler group and decreased as the groups aged. In conclusion, ADRs of CCCs admitted to a tertiary children's hospital have a unique profile. These groups are vulnerable to ADRs and thus they should be monitored closely, especially when they are infants or toddlers, so that severe ADRs can be identified and treated immediately.	[Kim, Bomi; Lee, Jin; Jung, Ae Hee; Jung, Sun-Hoi; Hahn, Hyeon-Joo] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea; [Kim, Sunwha Zara] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China; [Lee, Jin; Kang, Hye Ryun; Suh, Dong In] Seoul Natl Univ Hosp, Reg Drug Safety Monitoring Ctr, Seoul, South Korea; [Kang, Hye Ryun] Seoul Natl Univ Hosp, Dept Internal Med, Div Allergy, Seoul, South Korea; [Suh, Dong In] Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Fudan University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Suh, DI (corresponding author), Seoul Natl Univ Hosp, Reg Drug Safety Monitoring Ctr, Seoul, South Korea.; Suh, DI (corresponding author), Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea.	dongins0@snu.ac.kr		Suh, Dong In/0000-0002-7817-8728				Aagaard L, 2010, DRUG SAFETY, V33, P327, DOI 10.2165/11319100-000000000-00000; Lobo MGAD, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-5; Baek HJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3151-z; Bellis JR, 2014, BRIT J CLIN PHARMACO, V77, P545, DOI 10.1111/bcp.12222; Bergqvist M, 2008, EUR J CLIN PHARMACOL, V64, P451, DOI 10.1007/s00228-007-0449-3; chungjihyeon, 2013, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V30, P108; Dang A, 2012, J CLIN DIAGN RES, V6, P1504, DOI 10.7860/JCDR/2012/4340.2544; Digra KK, 2015, CLIN MED INSIGHTS-PE, V9, P73, DOI 10.4137/CMPed.S29493; European Commission, 2014, CHMP43704 REV 1, P1; Feudtner C., 2000, PEDIATRICS 2, V106, P205; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Gholami K, 2015, J RES PHARM PRACT, V4, P212, DOI 10.4103/2279-042X.167045; Gor AP, 2008, INDIAN J PHARMACOL, V40, P37, DOI 10.4103/0253-7613.40488; Haile DB, 2013, ETHIOP J HEALTH SCI, V23, P39; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; ICH, 2022, E11A PED EXTR ICH AP; Ilhan MN, 2009, PHARMACOEPIDEM DR S, V18, P1150, DOI 10.1002/pds.1829; Kairuz TE, 2007, CURR DRUG SAF, V2, P89; Kim HM, 2012, KOREAN SOC PHARMACOE, V5, P40; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089829; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Patidar Dindayal, 2013, Interdiscip Toxicol, V6, P41, DOI 10.2478/intox-2013-0008; Rehan HS, 2012, CURR DRUG SAF, V7, P384, DOI 10.2174/1574886311207050011; Rosli R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155385; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Smith PB, 2008, PEDIATRICS, V122, pE628, DOI 10.1542/peds.2008-0585; Srivastava R, 2005, PEDIATR CLIN N AM, V52, P1165, DOI 10.1016/j.pcl.2005.03.007; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Thiesen S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-237; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; U.S. Food and Drug Administration, 2020, FDA ONL LAB REP; Ufer M, 2004, PHARMACOEPIDEM DR S, V13, P147, DOI 10.1002/pds.858; Valente S, 2007, J NURS CARE QUAL, V22, P322, DOI 10.1097/01.NCQ.0000290413.04522.0b; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Wallerstedt SM, 2011, DRUG SAFETY, V34, P669, DOI 10.2165/11591730-000000000-00000; WHO-UMC, US WHO UMC SYST STAN; World Health Organization the UMC, WHO ART WHO ADV REAC; 김정미, 2015, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V32, P318	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172425	10.1371/journal.pone.0172425	http://dx.doi.org/10.1371/journal.pone.0172425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199420	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400091
J	Wang, XF; Hui, Y; Zhao, L; Hao, YL; Guo, HY; Ren, FZ				Wang, Xifan; Hui, Yan; Zhao, Liang; Hao, Yanling; Guo, Huiyuan; Ren, Fazheng			Oral administration of Lactobacillus paracasei L9 attenuates PM2.5-induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma	PLOS ONE			English	Article							IL-17 FAMILY CYTOKINES; REGULATORY T-CELLS; MOUSE MODEL; TH17 CELLS; POLLUTION; MICE; INFLAMMATION; PROBIOTICS; PARTICLES; METAL	This study investigated allergy immunotherapy potential of Lactobacillus paracasei L9 to prevent or mitigate the particulate matter 2.5 (PM2.5) enhanced pre-existing asthma in mice. Firstly, we used a mouse model of asthma (a 21-day ovalbumin (OVA) sensitization and challenge model) followed by PM2.5 exposure twice on the same day of the last challenge. PM2.5 was collected from the urban area of Beijing and underwent analysis for metals and polycyclic aromatic hydrocarbon contents. The results showed that PM2.5 exposure enhanced airway hyper-responsiveness (AHR) and lead to a mixed Th2/IL-17 response in asthmatic mice. Secondly, the PM2.5 exposed asthmatic mice were orally administered with L9 (4x10(7), 4x10(9) CFU/mouse, day) from the day of first sensitization to the endpoint, for 20 days, to investigate the potential mitigative effect of L9 on asthma. The results showed that L9 ameliorated PM2.5 exposure enhanced AHR with an approximate 50% decrease in total airway resistance response to methacholine (48 mg/ml). L9 also prevented the exacerbated eosinophil and neutrophil infiltration in bronchoalveolar lavage fluid (BALF), and decreased the serum level of total IgE and OVA-specific IgG1 by 0.44-fold and 0.3-fold, respectively. Additionally, cytokine production showed that L9 significantly decreased T-helper cell type 2 (Th2)- related cytokines (IL-4, -5, -13) and elevated levels of Th1 related IFN-gamma in BALF. L9 also reduced the level of IL-17A and increased the level of TGF-beta. Taken together, these results indicate that L9 may exert the anti-allergic benefit, possibly through rebalancing Th1/Th2 immune response and modulating IL-17 pro-inflammatory immune response. Thus, L9 is a promising candidate for preventing PM exposure enhanced pre-existing asthma.	[Wang, Xifan; Hui, Yan; Zhao, Liang; Hao, Yanling; Guo, Huiyuan; Ren, Fazheng] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Wang, Xifan; Hui, Yan; Guo, Huiyuan; Ren, Fazheng] China Agr Univ, Key Lab Funct Dairy, Minist Educ & Beijing Govt, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Zhao, Liang; Ren, Fazheng] China Agr Univ, Beijing Higher Inst Engn Res Ctr Anim Prod, Coll Food Sci & Nutr Engn, Beijing, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Ren, FZ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; Ren, FZ (corresponding author), China Agr Univ, Key Lab Funct Dairy, Minist Educ & Beijing Govt, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Ren, FZ (corresponding author), China Agr Univ, Beijing Higher Inst Engn Res Ctr Anim Prod, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.	renfazheng@cau.edu.cn	Hui, Yan/J-8811-2017; Hui, Yan/X-4011-2019	Hui, Yan/0000-0002-2388-131X; Hui, Yan/0000-0002-2388-131X; Zhao, Liang/0000-0001-9244-3121	National Natural Science Foundation of China [31401668]; Beijing Municipal Commission of Education Co-constructed program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Co-constructed program	This study was supported by National Natural Science Foundation of China (31401668), and the Beijing Municipal Commission of Education Co-constructed program.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Aldinucci C, 2002, EUR J CLIN NUTR, V56, P1155, DOI 10.1038/sj.ejcn.1601465; Belkaid Y, 2003, EXPERT OPIN BIOL TH, V3, P875, DOI 10.1517/14712598.3.6.875; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Chen RJ, 2013, AM J RESP CRIT CARE, V188, P1170, DOI 10.1164/rccm.201304-0678LE; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300; Gavett SH, 1997, ENVIRON RES, V72, P162, DOI 10.1006/enrs.1997.3732; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Heinrich J, 1999, ENVIRON HEALTH PERSP, V107, P53, DOI 10.2307/3434289; Hong HJ, 2010, J CLIN IMMUNOL, V30, P449, DOI 10.1007/s10875-010-9375-8; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Jan RL, 2012, BRIT J NUTR, V108, P130, DOI 10.1017/S0007114511005265; Jang SO, 2012, ALLERGY ASTHMA IMMUN, V4, P150, DOI 10.4168/aair.2012.4.3.150; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kim H, 2005, FEMS IMMUNOL MED MIC, V45, P259, DOI 10.1016/j.femsim.2005.05.005; Kim HJ, 2014, CLIN IMMUNOL, V153, P178, DOI 10.1016/j.clim.2014.04.008; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Laake KO, 2005, SCAND J GASTROENTERO, V40, P43, DOI 10.1080/00365520410009339; Laan M, 1999, J IMMUNOL, V162, P2347; Lambert AL, 1999, AM J RESP CRIT CARE, V159, pA26; Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010; Lim LH, 2009, INT ARCH ALLERGY IMM, V148, P297, DOI 10.1159/000170383; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085323; Luo X, 2015, J MICROBIOL BIOTECHN, V25, P1687, DOI [10.4014/imb.1503.03022, DOI 10.4014/JMB.1503.03022]; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Nikasinovic L, 2006, J ALLERGY CLIN IMMUN, V117, P1382, DOI 10.1016/j.jaci.2006.03.023; Ogino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092710; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Penton PC, 2013, J ALLERGY CLIN IMMUN, V131, P512, DOI 10.1016/j.jaci.2012.07.039; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Triggianese P, 2016, CLIN EXP RHEUMATOL, V34, P1085; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wagner JG, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-45; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yao XJ, 2014, CLIN EXP ALLERGY, V44, P765, DOI 10.1111/cea.12298; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	60	42	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171721	10.1371/journal.pone.0171721	http://dx.doi.org/10.1371/journal.pone.0171721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199353	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400046
J	Jhee, JH; Kim, H; Park, S; Yun, HR; Jung, SY; Kee, YK; Yoon, CY; Park, JT; Han, SH; Kang, SW; Yoo, TH				Jhee, Jong Hyun; Kim, Hyoungnae; Park, Seohyun; Yun, Hae-Ryong; Jung, Su-Young; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Han, Seung Hyeok; Kang, Shin-Wook; Yoo, Tae-Hyun			Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS-D; MORTALITY; SYMPTOMS; RISK; PREVALENCE; DIALYSIS; HEALTH	Background Depression is reported to be the most common psychological problem in patients with chronic kidney disease (CKD). Several studies have reported that lower levels of serum vitamin D are significantly associated with depression. Both vitamin D deficiency and depression are prevalent in patients with CKD, yet the relationship between these two factors remains poorly understood. This study aimed to investigate the association between vitamin D levels and depression among CKD patients. Methods Totally, 21,257 individuals who participated in the Korean National Health and Nutrition Examination Survey (KNHANES V, VI) from 2010-2014 were screened for the study; 533 CKD patients were included. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D3 [25(OH) D3] <= 10 ng/mL. Patients were divided into vitamin D deficient or sufficient groups. Depression was screened for using the Korean version of the WHO Composite International Diagnostic Interview-Short Form. The association between vitamin D deficiency and depression was evaluated by multivariate logistic regression analysis. Results The mean participant age was 70.1 +/- 9.4 years; 262 patients (49.2%) were male. The median 25(OH) D-3 level was 19.1 +/- 6.9 ng/mL. The prevalence of depression was higher in CKD patients than in the general population (14.3 vs. 11.1%, P = 0.03). Additionally, the prevalence of depression was significantly higher in CKD patients with (vs. without) vitamin D deficiency (32.5% vs. 50.0%, P < 0.001). Multivariate logistic regression analysis showed that vitamin D deficiency was a significant independent predictor of depression after adjusting for confounding factors Conclusion Depression was highly prevalent in CKD patients, in whom vitamin D deficiency was a significant independent predictor of depression. Therefore, management of vitamin D deficiency might help prevent depression in CKD patients.	[Jhee, Jong Hyun; Kim, Hyoungnae; Park, Seohyun; Yun, Hae-Ryong; Jung, Su-Young; Kee, Youn Kyung; Yoon, Chang-Yun; Park, Jung Tak; Han, Seung Hyeok; Kang, Shin-Wook; Yoo, Tae-Hyun] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Brain Korea PLUS 21, Severance Biomed Sci Inst, Dept Internal Med,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoo, TH (corresponding author), Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea.	yoosy0316@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kang, Shin-Wook/0000-0002-5677-4756; Park, Jung Tak/0000-0002-2325-8982; Yun, Hae-Ryong/0000-0002-7038-0251; Yoo, Tae-Hyun/0000-0002-9183-4507				Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Boulware LE, 2006, CLIN J AM SOC NEPHRO, V1, P496, DOI 10.2215/CJN.00030505; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; Chan R, 2011, J PSYCHOSOM RES, V71, P300, DOI 10.1016/j.jpsychores.2011.05.002; Chung HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099185; Cukor D, 2009, KIDNEY INT, V75, P1223, DOI 10.1038/ki.2009.51; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Drechsler C, 2011, NEPHROL DIAL TRANSPL, V26, P1024, DOI 10.1093/ndt/gfq606; Drechsler C, 2010, EUR HEART J, V31, P2253, DOI 10.1093/eurheartj/ehq246; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Formiga F, 2011, MED CLIN-BARCELONA, V137, P137, DOI 10.1016/j.medcli.2010.01.014; Gahche Jamie, 2011, NCHS Data Brief, P1; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Grant WB, 2010, MOL NUTR FOOD RES, V54, P1172, DOI 10.1002/mnfr.200900420; Hedayati SS, 2010, JAMA-J AM MED ASSOC, V303, P1946, DOI 10.1001/jama.2010.619; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P424, DOI 10.1053/j.ajkd.2009.03.017; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Helgadottir B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115894; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; JACOB AI, 1984, J NUTR, V114, P1313, DOI 10.1093/jn/114.7.1313; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; KOENIG KG, 1992, KIDNEY INT, V41, P161, DOI 10.1038/ki.1992.22; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Lopes AA, 2002, KIDNEY INT, V62, P199, DOI 10.1046/j.1523-1755.2002.00411.x; Maddock J, 2013, CLIN NUTR, V32, P758, DOI 10.1016/j.clnu.2013.01.006; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Palmer SC, 2013, AM J KIDNEY DIS, V62, P493, DOI 10.1053/j.ajkd.2013.02.369; Park SJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0645-7; Pilz S, 2008, CANCER EPIDEM BIOMAR, V17, P1228, DOI 10.1158/1055-9965.EPI-08-0002; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; REICHEL H, 1991, NEPHROL DIAL TRANSPL, V6, P162, DOI 10.1093/ndt/6.3.162; RICKERS H, 1985, NEPHRON, V39, P267, DOI 10.1159/000183383; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; SATO KA, 1982, J LAB CLIN MED, V99, P325; Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063; Tsai YC, 2012, AM J KIDNEY DIS, V60, P54, DOI 10.1053/j.ajkd.2012.02.325; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; von Kanel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138550; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	56	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171009	10.1371/journal.pone.0171009	http://dx.doi.org/10.1371/journal.pone.0171009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192445	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800015
J	Lee, SJ; ter Kuile, FO; Price, RN; Luxemburger, C; Nosten, F				Lee, Sue J.; ter Kuile, Feiko O.; Price, Ric N.; Luxemburger, Christine; Nosten, Francois			Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients	PLOS ONE			English	Article							RESISTANT FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; ARTESUNATE-MEFLOQUINE; RANDOMIZED-TRIAL; DIHYDROARTEMISININ-PIPERAQUINE; CLINICAL-TRIAL; DOUBLE-BLIND; COMBINATION; PHARMACOKINETICS	Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine (MSP) and since the mid-1990s in combination with artesunate. There is a renewed interested in MQ as part of a triple therapy for the treatment of multi-drug resistance P. falciparum malaria. The widespread use of MQ beyond south-East Asia has been constrained by reports of poor tolerability. Here we present the side effect profile of MQ for the treatment of uncomplicated malaria on the Thai-Myanmar/Cambodia borders. In total 19,850 patients received seven different regimens containing either 15 or 24-25 mg/kg of MQ, the latter given either as a single dose, or split over two or three days. The analysis focused on (predominantly) gastrointestinal and neuropsychiatric events as compared to the new fixed dose combination of MQ plus artesunate given as equal doses of 8 mg/kg MQ per day over three days. Gastrointestinal side effects were dose-dependent and associated with the severity of malaria symptoms. Serious neuropsychiatric side effects associated with MQ use were rare: for a single 25 mg/ kg dose it was 11.9 per 10,000 treatments (95% confidence interval, CI, 4-285) vs. 7.8 (3- 15) for the 15 mg/kg dose. The risk with 25 mg/kg was much higher when it was given as repeat dosing in patients who had failed treatment with 15 mg/kg MQ in the preceding month; (RR 6.57 (95% CI 1.33 to 32.4), p = 0.0077). MQ was best tolerated as 15 mg/kg or as 24 mg/kg when given over three days in combination with artesunate. We conclude that the tolerance of a single dose of MQ in the treatment of uncomplicated malaria is moderate, but can be improved by administering it as a split dose over three days.	[Lee, Sue J.] Mahidol Univ, Mahidol Oxford Res Unit, Bangkok, Thailand; [Lee, Sue J.; Price, Ric N.; Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Price, Ric N.] Charles Darwin Univ, Darwin, NT, Australia; [Luxemburger, Christine; Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Liverpool School of Tropical Medicine; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Nosten, F (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.; Nosten, F (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.	francois@tropmedres.ac	Kuile, Feiko ter/ABD-6681-2020; Nosten, Francois/AAC-5509-2019	Kuile, Feiko ter/0000-0003-3663-5617; Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874	Wellcome Trust; Medecins Sans Frontieres (France); Drug for Neglected Diseases Initiative (DNDI); Wellcome Trust of Great Britain	Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres (France); Drug for Neglected Diseases Initiative (DNDI); Wellcome Trust of Great Britain(Wellcome Trust)	The studies at SMRU were funded by the Wellcome Trust and the work at MSF was funded by Medecins Sans Frontieres (France). The analysis and writing of the manuscript were supported by Drug for Neglected Diseases Initiative (DNDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit supported by the Wellcome Trust of Great Britain. We thank the medical staff of the Medecins Sans Frontieres clinics for their assistance in the field work, the staff of the Shoklo Malaria Research Unit, the MSF staff in Mae Sot and Bangkok, Khun Patchari Prakongpan, and Grainne Dolan, Michel Thieren and Charles Woodrow who helped in conducting part of the field work. We thank Dr. Rob Hooft van Huijsduijnen for writing/editorial assistance with the manuscript.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Ashley E, 2006, TROP MED INT HEALTH, V11, P1898, DOI 10.1111/j.1365-3156.2006.01749_1.x; Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; BJORKMAN A, 1989, LANCET, V2, P865; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; CHANTHAVANICH P, 1985, AM J TROP MED HYG, V34, P1028, DOI 10.4269/ajtmh.1985.34.1028; CLYDE DF, 1976, ANTIMICROB AGENTS CH, V9, P384, DOI 10.1128/AAC.9.3.384; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; EKUE JMK, 1983, B WORLD HEALTH ORGAN, V61, P713; Fusetti M, 1999, Clin Ter, V150, P379; Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Grabias B, 2016, EXPERT OPIN DRUG SAF, V15, P903, DOI 10.1080/14740338.2016.1175428; Gribble FM, 2000, BRIT J PHARMACOL, V131, P756, DOI 10.1038/sj.bjp.0703638; HARINASUTA T, 1983, B WORLD HEALTH ORGAN, V61, P299; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; JIANG JB, 1982, LANCET, V2, P285; KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P83; LOOAREESUWAN S, 1994, ANN TROP MED PARASIT, V88, P131, DOI 10.1080/00034983.1994.11812850; LOOAREESUWAN S, 1992, LANCET, V339, P821, DOI 10.1016/0140-6736(92)90276-9; LOOAREESUWAN S, 1992, AM J TROP MED HYG, V47, P794, DOI 10.4269/ajtmh.1992.47.794; Looareesuwan Sornchai, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P230; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P213, DOI 10.1016/0035-9203(94)90303-4; LUXEMBURGER C, 1991, LANCET, V338, P1268, DOI 10.1016/0140-6736(91)92131-K; MANSOR SM, 1989, BRIT J CLIN PHARMACO, V27, P381, DOI 10.1111/j.1365-2125.1989.tb05381.x; McArdle JJ, 2005, NEUROPHARMACOLOGY, V49, P1132, DOI 10.1016/j.neuropharm.2005.06.011; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P578, DOI 10.1016/j.neuro.2011.01.001; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Nevin RL, 2016, NEUROL THER, V5, P69, DOI 10.1007/s40120-016-0045-5; Nevin RL, 2014, INT J PARASITOL-DRUG, V4, P118, DOI 10.1016/j.ijpddr.2014.03.002; NGIAM TL, 1987, CHEM PHARM BULL, V35, P409; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; PHILLIPSHOWARD PA, 1995, DRUG SAFETY, V12, P370, DOI 10.2165/00002018-199512060-00003; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; PRICE RN, 1995, T ROY SOC TROP MED H, V89, P523, DOI 10.1016/0035-9203(95)90094-2; ROGERS JH, 1980, J LARYNGOL OTOL, V94, P1401, DOI 10.1017/S002221510009023X; ROPPER AH, 1985, CAN J NEUROL SCI, V12, P282, DOI 10.1017/S0317167100047193; ROUVEIX B, 1989, ANN INTERN MED, V110, P577, DOI 10.7326/0003-4819-110-7-577; Schlagenhauf P, 1996, TROP MED INT HEALTH, V1, P485, DOI 10.1046/j.1365-3156.1996.d01-85.x; SCHWARTZ DE, 1987, CHEMOTHERAPY, V33, P1; Sirima SB, 2016, LANCET INFECT DIS; SMITHUIS FM, 1993, ANTIMICROB AGENTS CH, V37, P1977, DOI 10.1128/AAC.37.9.1977; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; Tansley R, 2010, AM J TROP MED HYG, V83, P1195, DOI 10.4269/ajtmh.2010.10-0228; TERKUILE FO, 1992, J INFECT DIS, V166, P1393, DOI 10.1093/infdis/166.6.1393; terKuile FO, 1995, B WORLD HEALTH ORGAN, V73, P631; TERKUILE FO, 1993, LANCET, V341, P1044, DOI 10.1016/0140-6736(93)92409-M; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; TRENHOLME GM, 1975, SCIENCE, V190, P792, DOI 10.1126/science.1105787; Tsou TS, 2006, J STAT PLAN INFER, V136, P3173, DOI 10.1016/j.jspi.2004.12.008; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 2002, CLIN INFECT DIS, V35, P1498, DOI 10.1086/344901; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Weiss S. M., 2003, Neurology, V61, pS101; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; *WHO, 1991, WHOMAL911063; World Health Organization, 2015, GUID TREATM MAL, Vthird	62	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0168780	10.1371/journal.pone.0168780	http://dx.doi.org/10.1371/journal.pone.0168780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192434	gold, Green Published, Green Accepted			2022-12-27	WOS:000394423800003
J	Necchi, F; Saul, A; Rondini, S				Necchi, Francesca; Saul, Allan; Rondini, Simona			Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout	PLOS ONE			English	Article							INFLUENZAE TYPE-B; NEISSERIA-MENINGITIDIS; HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; ANTIBODY; ASSAY; SALMONELLA; COMPLEMENT; SEROGROUP; STANDARDIZATION	Serum Bactericidal Activity (SBA) assay is the method of choice to evaluate the complement- mediated functional activity of both infection-and vaccine-induced antibodies. To perform a typical SBA assay, serial dilutions of sera are incubated with target bacterial strains and complement. The conventional SBA assay is based on plating on agar the SBA reaction mix and counting the surviving bacterial colony forming units (CFU) at each serum dilution. Even with automated colony counting, it is labor-intensive, time-consuming and not amenable for large-scale studies. Here, we have developed a luminescence-based SBA (L-SBA) method able to detect surviving bacteria by measuring their ATP. At the end of the SBA reaction, a single commercially available reagent is added to each well of the SBA plate, and the resulting luminescence signal is measured in a microplate reader. The signal obtained is proportional to the ATP present, which is directly proportional to the number of viable bacteria. Bactericidal activity is subsequently calculated. We demonstrated the applicability of L-SBA with multiple bacterial serovars, from 5 species: Citrobacter freundii, Salmonella enterica serovars Typhimurium and Enteritidis, Shigella flexneri serovars 2a and 3a, Shigella sonnei and Neisseria meningitidis. Serum bactericidal titers obtained by the luminescence readout method strongly correlate with the data obtained by the conventional agar plate-based assay, and the new assay is highly reproducible. L-SBA considerably shortens assay time, facilitates data acquisition and analysis and reduces the operator dependency, avoiding the plating and counting of CFUs. Our results demonstrate that LSBA is a useful high-throughput bactericidal assay.	[Necchi, Francesca; Saul, Allan; Rondini, Simona] GSK Vaccines Inst Global Hlth GVGH Srl, Siena, Italy	GlaxoSmithKline	Necchi, F (corresponding author), GSK Vaccines Inst Global Hlth GVGH Srl, Siena, Italy.	francesca.x.necchi@gsk.com	Saul, Allan J/I-6968-2013; Saul, Allan/ABH-2091-2020; Rondini, Simona/GLN-4357-2022	Saul, Allan J/0000-0003-0665-4091; Saul, Allan/0000-0003-0665-4091; Necchi, Francesca/0000-0003-1239-8696	Novartis Vaccines Institute	Novartis Vaccines Institute	This study was sponsored by Novartis Vaccines Institute for Global Health, now acquired by the GSK group of companies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Boyd MA, 2014, CLIN VACCINE IMMUNOL, V21, P712, DOI 10.1128/CVI.00115-14; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; ELKINS C, 1992, MOL MICROBIOL, V6, P2617, DOI 10.1111/j.1365-2958.1992.tb01439.x; Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478; Gill CJ, 2010, HUM VACCINES, V6, P881, DOI 10.4161/hv.6.11.12849; Goh YS, 2013, J IMMUNOL METHODS, V387, P121, DOI 10.1016/j.jim.2012.10.005; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GREEN BA, 1987, INFECT IMMUN, V55, P2878, DOI 10.1128/IAI.55.12.2878-2883.1987; Jacobs JFM, 2015, AUTOIMMUN REV, V14, P160, DOI 10.1016/j.autrev.2014.10.018; Jang MS, 2016, MICROB PATHOGENESIS, V97, P19, DOI 10.1016/j.micpath.2016.05.013; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Mak PA, 2011, CLIN VACCINE IMMUNOL, V18, P1252, DOI 10.1128/CVI.05028-11; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; MOUNTZOUROS KT, 1992, INFECT IMMUN, V60, P5316, DOI 10.1128/IAI.60.12.5316-5318.1992; Mountzouros KT, 2000, J CLIN MICROBIOL, V38, P2878, DOI 10.1128/JCM.38.8.2878-2884.2000; Onsare RS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003573; Rodriguez T, 2003, BIOLOGICALS, V31, P209, DOI 10.1016/S1045-1056(03)00060-5; Romero-Steiner S, 2004, CLIN DIAGN LAB IMMUN, V11, P89, DOI 10.1128/CDLI.11.1.89-93.2004; Rondini S, 2013, MICROB PATHOGENESIS, V63, P19, DOI 10.1016/j.micpath.2013.05.014; Rondini S, 2012, J INFECT DEV COUNTR, V6, P763, DOI 10.3855/jidc.2495; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Son MS., 2011, CURR PROTOC MICROBIO, VChapter 6, pUnit6A.3; Yang JS, 2007, J MICROBIOL METH, V71, P141, DOI 10.1016/j.mimet.2007.08.009	27	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172163	10.1371/journal.pone.0172163	http://dx.doi.org/10.1371/journal.pone.0172163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192483	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800080
J	Yamashita, T; Miyamoto, Y; Bando, Y; Ono, T; Kobayashi, S; Doi, A; Araki, T; Kato, Y; Shirakawa, T; Suzuki, Y; Yamauchi, J; Yoshida, S; Sato, N				Yamashita, Tomoko; Miyamoto, Yuki; Bando, Yoshio; Ono, Takashi; Kobayashi, Sakurako; Doi, Ayano; Araki, Toshihiro; Kato, Yosuke; Shirakawa, Takayuki; Suzuki, Yutaka; Yamauchi, Junji; Yoshida, Shigetaka; Sato, Naoya			Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder free cultured pluripotent stem cells	PLOS ONE			English	Article							EFFICIENT GENERATION; MULTIPLE-SCLEROSIS; PRIMATE MODELS; NERVOUS-SYSTEM; MYELINATION; MOUSE; INVOLVEMENT	Oligodendrocytes myelinate axons and form myelin sheaths in the central nervous system. The development of therapies for demyelinating diseases, including multiple sclerosis and leukodystrophies, is a challenge because the pathogenic mechanisms of disease remain poorly understood. Primate pluripotent stem cell-derived oligodendrocytes are expected to help elucidate the molecular pathogenesis of these diseases. Oligodendrocytes have been successfully differentiated from human pluripotent stem cells. However, it is challenging to prepare large amounts of oligodendrocytes over a short amount of time because of manipulation difficulties under conventional primate pluripotent stem cell culture methods. We developed a proprietary dissociated monolayer and feeder-free culture system to handle pluripotent stem cell cultures. Because the dissociated monolayer and feeder-free culture system improves the quality and growth of primate pluripotent stem cells, these cells could potentially be differentiated into any desired functional cells and consistently cultured in large-scale conditions. In the current study, oligodendrocyte progenitor cells and mature oligodendrocytes were generated within three months from monkey embryonic stem cells. The embryonic stem cell-derived oligodendrocytes exhibited in vitro myelinogenic potency with rat dorsal root ganglion neurons. Additionally, the transplanted oligodendrocyte progenitor cells differentiated into myelin basic protein-positive mature oligodendrocytes in the mouse corpus callosum. This preparative method was used for human induced pluripotent stem cells, which were also successfully differentiated into oligodendrocyte progenitor cells and mature oligodendrocytes that were capable of myelinating rat dorsal root ganglion neurons. Moreover, it was possible to freeze, thaw, and successfully re-culture the differentiating cells. These results showed that embryonic stem cells and human induced pluripotent stem cells maintained in a dissociated monolayer and feeder-free culture system have the potential to generate oligodendrocyte progenitor cells and mature oligodendrocytes in vitro and in vivo. This culture method could be applied to prepare large amounts of oligodendrocyte progenitor cells and mature oligodendrocytes in a relatively short amount of time.	[Yamashita, Tomoko; Ono, Takashi; Kobayashi, Sakurako; Doi, Ayano; Araki, Toshihiro; Kato, Yosuke; Shirakawa, Takayuki; Suzuki, Yutaka; Sato, Naoya] Mitsubishi Tanabe Pharma Corp, Div Res, Discovery Res Labs, Yokohama, Kanagawa, Japan; [Miyamoto, Yuki; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo, Japan; [Bando, Yoshio; Yoshida, Shigetaka] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido, Japan; [Sato, Naoya] MP Healthcare Venture Management, Boston, MA USA	Mitsubishi Tanabe Pharma Corporation; National Center for Child Health & Development - Japan; Asahikawa Medical College	Yamashita, T (corresponding author), Mitsubishi Tanabe Pharma Corp, Div Res, Discovery Res Labs, Yokohama, Kanagawa, Japan.	yamashita.tomoko@md.mt-pharma.co.jp	Ono, Takashi/ABC-4644-2020	Ono, Takashi/0000-0002-8043-660X; Yamashita, Tomoko/0000-0001-5167-1128	Mitsubishi Tanabe Pharma Corporation	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This study was funded by Mitsubishi Tanabe Pharma Corporation. The funder also provided support in the form of salaries for TY, TO, SK, AD, TA, YK, TS, YS and NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bando Y, 2015, NEUROCHEM INT, V81, P16, DOI 10.1016/j.neuint.2015.01.002; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Chan Anthony W S, 2004, Reprod Biol Endocrinol, V2, P39, DOI 10.1186/1477-7827-2-39; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chew LJ, 2015, NEUROPHARMA IN PRESS; Cui QL, 2012, STEM CELLS DEV, V21, P1831, DOI 10.1089/scd.2011.0494; Davidson KC, 2015, DEVELOPMENT, V142, P3090, DOI 10.1242/dev.116061; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gorris R, 2015, GLIA, V63, P2152, DOI 10.1002/glia.22882; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Miyamoto Y, 2015, MOL BIOL CELL, V26, P3489, DOI 10.1091/mbc.E14-05-1020; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Neely MD, 2012, ACS CHEM NEUROSCI, V3, P482, DOI 10.1021/cn300029t; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Ono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088346; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Simena AA, 2009, PROG BRAIN RES, V179, P117, DOI 10.1016/S0079-6123(09)17913-X; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Fonseca SAS, 2015, WORLD J STEM CELLS, V7, P649, DOI 10.4252/wjsc.v7.i3.649; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Verdier JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00064; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Watson KK, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-21	30	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171947	10.1371/journal.pone.0171947	http://dx.doi.org/10.1371/journal.pone.0171947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192470	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800054
J	Zhang, K; Zheng, H; Chen, FL; Li, RD; Yang, M; Ouyang, ZY; Lan, J; Xiang, XW				Zhang, Kai; Zheng, Hua; Chen, Falin; Li, Ruida; Yang, Miao; Ouyang, Zhiyun; Lan, Jun; Xiang, Xuewu			Impact of nitrogen fertilization on soil-Atmosphere greenhouse gas exchanges in eucalypt plantations with different soil characteristics in southern China	PLOS ONE			English	Article							METHANE OXIDATION; UNDERSTORY REMOVAL; FOREST; EMISSIONS; CARBON; RESPIRATION; N2O; FLUXES; OXIDE; ECOSYSTEMS	Nitrogen (N) fertilization is necessary to sustain productivity in eucalypt plantations, but it can increase the risk of greenhouse gas emissions. However, the response of soil greenhouse gas emissions to N fertilization might be influenced by soil characteristics, which is of great significance for accurately assessing greenhouse gas budgets and scientific fertilization in plantations. We conducted a two-year N fertilization experiment (control [CK], low N [LN], middle N [MN] and high N [HN] fertilization) in two eucalypt plantations with different soil characteristics (higher and lower soil organic carbon sites [HSOC and LSOC]) in Guangxi, China, and assessed soil-atmosphere greenhouse gas exchanges. The annual mean fluxes of soil CO2, CH4, and N2O were separately 153-266 mg m(-2) h(-1), -55 -40 mu g m(-2) h(-1), and 11-95 mu g m(-2) h(-1), with CO2 and N2O emis sions showing significant seasonal variations. N fertilization significantly increased soil CO2 and N2O emissions and decreased CH4 uptake at both sites. There were significant interactions of N fertilization and SOC level on soil CO2 and N2O emissions. At the LSOC site, the annual mean flux of soil CO2 emission was only significantly higher than the CK treatment in the HN treatment, but, at the HSOC site, the annual mean flux of soil CO2 emission was significantly higher for both the LN (or MN) and HN treatments in comparison to the CK treatment. Under the CK and LN treatments, the annual mean flux of N2O emission was not significantly different between HSOC and LSOC sites, but under the HN treatment, it was significantly higher in the HSOC site than in the LSOC site. Correlation analysis showed that changes in soil CO2 and N2O emissions were significantly related to soil dissolved organic carbon, ammonia, nitrate and pH. Our results suggested significant interactions of N fertilization and soil characteristics existed in soil - atmosphere greenhouse gas exchanges, which should be considered in assessing greenhouse gas budgets and scientific fertilization strategies in eucalypt plantations.	[Zhang, Kai; Zheng, Hua; Li, Ruida; Yang, Miao; Ouyang, Zhiyun] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Kai] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Chen, Falin] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Lan, Jun; Xiang, Xuewu] Guangxi Dongmen Forest Farm, Inst Forestry Sci, Fusui, Guangxi, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Xinjiang Agricultural University; Hunan Agricultural University	Zheng, H (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	zhenghua@rcees.ac.cn		Zheng, Hua/0000-0002-2301-1744	Chinese Academy of Science [KZCX2-EW-QN406]; National Natural Science Foundation of China [31170425, 40871130]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Science (grant number KZCX2-EW-QN406) and the National Natural Science Foundation of China (grant numbers 31170425, 40871130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2010, NUTR CYCL AGROECOSYS, V86, P53, DOI 10.1007/s10705-009-9273-8; ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485, DOI 10.1128/AEM.59.2.485-490.1993; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Bradford MA, 2001, SOIL BIOL BIOCHEM, V33, P1695, DOI 10.1016/S0038-0717(01)00091-8; Carle J, 2002, FOREST PROD J, V52, P12; Chen FL, 2013, FOREST ECOL MANAG, V291, P65, DOI 10.1016/j.foreco.2012.11.016; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Du Rui, 2004, Huanjing Kexue, V25, P12; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fest BJ, 2009, AGR FOREST METEOROL, V149, P393, DOI 10.1016/j.agrformet.2008.09.007; Franzluebbers A. J., 2012, AGROCIENCIA, V16, P162; [龚伟 GONG Wei], 2008, [生态学报, Acta Ecologica Sinica], V28, P2536; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Hall SJ, 1999, NATURE, V400, P152, DOI 10.1038/22094; Jassal RS, 2011, GEODERMA, V162, P182, DOI 10.1016/j.geoderma.2011.02.002; KING GM, 1994, APPL ENVIRON MICROB, V60, P3508, DOI 10.1128/AEM.60.10.3508-3513.1994; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Li Hai-Fang, 2009, Chinese Journal of Plant Ecology, V33, P1015, DOI 10.3773/j.issn.1005-264x.2009.06.001; Li HF, 2010, SOIL SCI PLANT NUTR, V56, P541, DOI 10.1111/j.1747-0765.2010.00498.x; Li Rui-da, 2014, Huanjing Kexue, V35, P3903; [李睿达 Li Ruida], 2015, [生态学报, Acta Ecologica Sinica], V35, P5931; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; MATSON PA, 1992, BIOGEOCHEMISTRY, V18, P101, DOI 10.1007/BF00002705; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Reth S, 2005, PLANT SOIL, V268, P21, DOI 10.1007/s11104-005-0175-5; Russow R, 2008, SOIL BIOL BIOCHEM, V40, P380, DOI 10.1016/j.soilbio.2007.08.020; [李长生 Li Changsheng], 2003, [第四纪研究, Quaternary Sciences], V23, P493; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; [苏丹 Su Dan], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P423; Suwanwaree P, 2005, SOIL SCI SOC AM J, V69, P1722, DOI 10.2136/sssaj2004.0223; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Turnbull JW, 1999, NEW FOREST, V17, P37, DOI 10.1023/A:1006524911242; Uchida Y, 2012, AGR ECOSYST ENVIRON, V156, P116, DOI 10.1016/j.agee.2012.05.012; Wang YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093571; [项文化 XIANG WenHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P2365; Xu MJ, 2014, FOREST SCI, V60, P973, DOI 10.5849/forsci.13-075; Yu GuiRui, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1; Yu X.B., 2000, STUDIES LONG TERM PR, P1; Zhang Kai, 2015, Shengtaixue Zazhi, V34, P1779; Zhang W, 2008, PLANT SOIL, V306, P221, DOI 10.1007/s11104-008-9575-7; Zhang W, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009195; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010	44	14	14	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172142	10.1371/journal.pone.0172142	http://dx.doi.org/10.1371/journal.pone.0172142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192496	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800078
J	Bressa, C; Bailen-Andrino, M; Perez-Santiago, J; Gonzalez-Soltero, R; Perez, M; Montalvo-Lominchar, MG; Mate-Munoz, JL; Dominguez, R; Moreno, D; Larrosa, M				Bressa, Carlo; Bailen-Andrino, Maria; Perez-Santiago, Jennifer; Gonzalez-Soltero, Rocio; Perez, Margarita; Gregoria Montalvo-Lominchar, Maria; Luis Mate-Munoz, Jose; Dominguez, Raul; Moreno, Diego; Larrosa, Mar			Differences in gut microbiota profile between women with active lifestyle and sedentary women	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DIET; OBESITY; DIVERSITY; BUTYRATE; HEALTH; ASSOCIATIONS; METABOLISM; MODULATION; DISEASE	Physical exercise is a tool to prevent and treat some of the chronic diseases affecting the world's population. A mechanism through which exercise could exert beneficial effects in the body is by provoking alterations to the gut microbiota, an environmental factor that in recent years has been associated with numerous chronic diseases. Here we show that physical exercise performed by women to at least the degree recommended by the World Health Organization can modify the composition of gut microbiota. Using high-throughput sequencing of the 16s rRNA gene, eleven genera were found to be significantly different between active and sedentary women. Quantitative PCR analysis revealed higher abundance of health-promoting bacterial species in active women, including Faecalibacterium prausnitzii, Roseburia hominis and Akkermansia muciniphila. Moreover, body fat percentage, muscular mass and physical activity significantly correlated with several bacterial populations. In summary, we provide the first demonstration of interdependence between some bacterial genera and sedentary behavior parameters, and show that not only does the dose and type of exercise influence the composition of gut microbiota, but also the breaking of sedentary behavior.	[Bressa, Carlo; Bailen-Andrino, Maria; Gonzalez-Soltero, Rocio] European Univ, Dept Basic Sci, Madrid, Spain; [Perez-Santiago, Jennifer; Perez, Margarita; Gregoria Montalvo-Lominchar, Maria; Moreno, Diego; Larrosa, Mar] European Univ, Res Grp Nutr Phys Act & Hlth, Sch Doctorate Studies & Res, Madrid, Spain; [Luis Mate-Munoz, Jose; Dominguez, Raul] Alfonso X El Sabio Univ, Dept Phys Act & Sports Sci, Villanueva De La Canada, Spain	Universidad Alfonso X el Sabio (UAX)	Larrosa, M (corresponding author), European Univ, Res Grp Nutr Phys Act & Hlth, Sch Doctorate Studies & Res, Madrid, Spain.	mar.larrosa@universidadeuropea.es	Bressa, Carlo/P-1131-2019; Domínguez, Raúl/AAX-1068-2021; Gonzalez-Soltero, Rocio/Z-2702-2019; Bailen, Maria/ABF-9684-2020; Bressa, Carlo/AAC-9622-2022; Bailen, Maria/AAD-7198-2022; González-Soltero, Rocío/O-7686-2019; Perez, Margarita/K-8172-2014; LARROSA, MAR/H-6012-2012	Bressa, Carlo/0000-0001-5530-4958; Gonzalez-Soltero, Rocio/0000-0001-9799-0570; Bressa, Carlo/0000-0001-5530-4958; Bailen, Maria/0000-0001-5201-906X; González-Soltero, Rocío/0000-0001-9799-0570; Perez, Margarita/0000-0001-7240-2082; LARROSA, MAR/0000-0002-8863-4686; Mate-Munoz, Jose Luis/0000-0003-3282-1455; Dominguez, Raul/0000-0002-6891-391X	Ministerio de Economia y Competitividad; Ramon y Cajal Grant [2012_11910]; Universidad Europea de Madrid [2015UEM06, 2015UEM24]; Catedra ASISA Grant [2015UEM46]	Ministerio de Economia y Competitividad(Spanish Government); Ramon y Cajal Grant(Spanish Government); Universidad Europea de Madrid; Catedra ASISA Grant	Ministerio de Economia y Competitividad. Ramon y Cajal Grant 2012_11910. www.mineco.gob.es. Universidad Europea de Madrid 2015UEM06, 2015UEM24 and Catedra ASISA Grant 2015UEM46. www.universidadeuropea.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baumann S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0195-3; Bernalier-Donadille A, 2010, GASTROEN CLIN BIOL, V34, pS16, DOI 10.1016/S0399-8320(10)70016-6; Brahe LK, 2016, ADV NUTR, V7, P90, DOI 10.3945/an.115.010587; Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke SF, 2014, GUT; Delgado S, 2006, DIGEST DIS SCI, V51, P737, DOI 10.1007/s10620-006-3200-5; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Denou E, 2016, AM J PHYSIOL-ENDOC M, V310, pE982, DOI 10.1152/ajpendo.00537.2015; Derrien M, 2016, MICROBIAL PATHOGENES; Endoh Kaori, 2016, Asian Pac J Cancer Prev, V17, P2007; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Huang CJ, 2013, SCI WORLD J, DOI 10.1155/2013/752071; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Kampmann C, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.004; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Knip M, 2016, NAT REV ENDOCRINOL; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martinez Alvarez JR, 2010, NUTR CLIN DIETETICA, V30, P4; Mika A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125889; Morotomi M, 2009, INT J SYST EVOL MICR, V59, P1895, DOI 10.1099/ijs.0.008169-0; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Ott SJ, 2006, GUT, V55, P1207; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qu WB, 2012, NUCLEIC ACIDS RES, V40, pW205, DOI 10.1093/nar/gks552; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shaw KA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0331-y; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Viitasalo A, 2016, PREV MED, V87, P81, DOI 10.1016/j.ypmed.2016.02.027; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Welly RJ, 2016, MED SCI SPORTS EXERC; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187	73	212	237	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171352	10.1371/journal.pone.0171352	http://dx.doi.org/10.1371/journal.pone.0171352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187199	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300020
J	Chang, XY; Xu, B; Bai, YG; Luo, HY; Ma, R; Shi, PJ; Yao, B				Chang, Xiaoyu; Xu, Bo; Bai, Yingguo; Luo, Huiying; Ma, Rui; Shi, Pengjun; Yao, Bin			Role of N-linked glycosylation in the enzymatic properties of a thermophilic GH 10 xylanase from Aspergillus fumigatus expressed in Pichia pastoris	PLOS ONE			English	Article							MICROBIAL XYLANASES; THERMOSTABLE XYLANASE; FUNGUS; ACID; SECRETION; MECHANISM; NIDULANS; CLONING	N-Glycosylation is a posttranslational modification commonly occurred in fungi and plays roles in a variety of enzyme functions. In this study, a xylanase (Af-XYNA) of glycoside hydrolase (GH) family 10 from Aspergillus fumigatus harboring three potential N-glycosylation sites (N87, N124 and N335) was heterologously produced in Pichia pastoris. The N-glycosylated Af-XYNA (WT) exhibited favorable temperature and pH optima (75 degrees C and pH 5.0) and good thermostability (maintaining stable at 60 degrees C). To reveal the role of N-glycosylation on Af-XYNA, the enzyme was deglycosylated by endo-beta-N-acetylglucosaminidase H (DE) or modified by site-directed mutagenesis at N124 (N124T). The deglycosylated DE and mutant N124T showed narrower pH adaptation range, lower specific activity, and worse pH and thermal stability. Further thermodynamic analysis revealed that the enzyme with higher N-glycosylation degree was more thermostable. This study demonstrated that the effects of glycosylation at different degrees and sites were diverse, in which the glycan linked to N124 played a key role in pH and thermal stability of Af-XYNA.	[Chang, Xiaoyu; Xu, Bo] Jiangxi Agr Univ, Coll Biol Sci & Engn, Nanchang, Jiangxi, Peoples R China; [Chang, Xiaoyu; Bai, Yingguo; Luo, Huiying; Ma, Rui; Shi, Pengjun; Yao, Bin] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Xu, B (corresponding author), Jiangxi Agr Univ, Coll Biol Sci & Engn, Nanchang, Jiangxi, Peoples R China.; Shi, PJ (corresponding author), Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China.	xubo583@sina.com; shipengjun@caas.cn			National Natural Science Foundation of China [31372345, 31360372]; National Science Fund for Distinguished Young Scholars [31225026]; China Modern Agriculture Research System [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	Financial support includes the National Natural Science Foundation of China (grant numbers 31372345 (PS) and 31360372 (BX); [http://www.nsfc.gov.cn/]), the National Science Fund for Distinguished Young Scholars (grant number 31225026 (BY); [http://www.nsfc.gov.cn/]), and the China Modern Agriculture Research System (grant number CARS-42 (BY); [http://www.zgrj.org/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2015, J PROTEOMICS, V119, P154, DOI 10.1016/j.jprot.2015.02.007; Alvarez C, 2016, MICROB BIOTECHNOL, V9, P149, DOI 10.1111/1751-7915.12346; Anbarasan S, 2010, APPL ENVIRON MICROB, V76, P356, DOI 10.1128/AEM.00357-09; Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Azhar S, 2015, CARBOHYD POLYM, V117, P19, DOI 10.1016/j.carbpol.2014.09.050; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Chadha BS, 2004, J BIOTECHNOL, V109, P227, DOI 10.1016/j.jbiotec.2003.12.010; Chantasingh D, 2006, PROTEIN EXPRES PURIF, V46, P143, DOI 10.1016/j.pep.2005.09.013; Chavez R, 2006, J BIOTECHNOL, V123, P413, DOI 10.1016/j.jbiotec.2005.12.036; Chen LL, 2009, BIORESOURCE TECHNOL, V100, P5230, DOI 10.1016/j.biortech.2009.05.038; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Davoodi J, 2007, BIOPHYS CHEM, V125, P453, DOI 10.1016/j.bpc.2006.10.006; Decelle B, 2004, CURR GENET, V46, P166, DOI 10.1007/s00294-004-0520-x; Dotsenko AS, 2016, BIOTECHNOL BIOENG, V113, P283, DOI 10.1002/bit.25812; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Ergun BG, 2016, BIOPROC BIOSYST ENG, V39, P1, DOI 10.1007/s00449-015-1476-6; Fan GS, 2012, BIOTECHNOL LETT, V34, P2043, DOI 10.1007/s10529-012-0995-3; Fonseca-Maldonado R, 2013, J BIOL CHEM, V288, P25522, DOI 10.1074/jbc.M113.485953; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Juturu V, 2012, BIOTECHNOL ADV, V30, P1219, DOI 10.1016/j.biotechadv.2011.11.006; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo HY, 2009, EXTREMOPHILES, V13, P849, DOI 10.1007/s00792-009-0272-0; Malsuradze IG, 2011, GENETIKA, V47, P174; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2016, APPL MICROBIOL BIOT, V100, P5205, DOI 10.1007/s00253-016-7555-z; Oliveira DS, 2010, J FOOD SCI, V75, pC588, DOI 10.1111/j.1750-3841.2010.01740.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Ribeiro LFC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-115; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Taneja K, 2002, BIORESOURCE TECHNOL, V85, P39, DOI 10.1016/S0960-8524(02)00064-0; Tomas-Gamisans M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148031; Ustinov BB, 2008, ENZYME MICROB TECH, V43, P56, DOI 10.1016/j.enzmictec.2008.01.017; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wei W, 2013, BIOTECHNOL BIOENG, V110, P3075, DOI 10.1002/bit.24990; Wei YD, 2005, BIOCHEM BIOPH RES CO, V329, P331, DOI 10.1016/j.bbrc.2005.01.013; Yang M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0225-5; Zhang F, 2011, APPL MICROBIOL BIOT, V89, P1851, DOI 10.1007/s00253-010-3016-2; Zou SP, 2012, J BIOTECHNOL, V157, P399, DOI 10.1016/j.jbiotec.2011.12.017	41	25	30	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171111	10.1371/journal.pone.0171111	http://dx.doi.org/10.1371/journal.pone.0171111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187141	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300012
J	Liu, QQ; Stewart, J; Wang, H; Rashid, A; Zhao, J; Katz, MH; Lee, JE; Fleming, JB; Maitra, A; Wolff, RA; Varadhachary, GR; Krishnan, S; Wang, HM				Liu, Qingqing; Stewart, John; Wang, Hua; Rashid, Asif; Zhao, Jun; Katz, Matthew H.; Lee, Jeffrey E.; Fleming, Jason B.; Maitra, Anirban; Wolff, Robert A.; Varadhachary, Gauri R.; Krishnan, Sunil; Wang, Huamin			Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							SINGLE-INSTITUTION EXPERIENCE; ARGININE DEPRIVATION; CANCER; DEIMINASE; RESECTION; SURVIVAL; GEMCITABINE; CARCINOMA; DEFICIENT; HEAD	Argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme for arginine biosynthesis, is expressed in many types of human malignancies. Recent studies showed that ASS1 may have tumor suppressor function and that ASS1 deficiency is associated with clinical aggressiveness in nasopharyngeal carcinoma, myxofibrosarcomas and bladder cancer. The goal of this study was to evaluate the prognostic impact of ASS1 expression in patients with pancreatic ductal adenocarcinoma (PDAC). Our study included two independent cohorts: untreated cohort, which was comprised of 135 patients with PDAC who underwent pancreatoduodenectomy (PD) without pre-operative neoadjuvant therapy, and treated cohort, which was comprised of 122 patients with PDAC who have completed neoadjuvant therapy and PD. The expression level of ASS1 was evaluated by immunohistochemistry and the results were correlated with clinicopathologic parameters and survival using SPSS statistics. Our study showed that 12% of PDAC in untreated cohort and 15% of PDAC in treated cohort has low expression of ASS1 (ASS1-low). ASS1-low was associated with higher recurrence (p = 0.045), shorter disease-free survival (DFS, 4.8 +/- 1.6 months vs 15.3 +/- 2.2 months, p = 0.001) and shorter overall survival (OS, 14.6 +/- 6.4 months vs 26.5 +/- 3.5 months, p = 0.005) in untreated cohort and shorter OS in treated cohort compared to ASS1-high tumors. In multivariate analysis, ASS1-low (HR: 0.45, 95% CI: 0.26-0.79, p = 0.005) was an independent prognostic factor for DFS in untreated cohort and an independent prognostic factor for OS (HR: 0.56, 95% CI: 0.32-0.97, p = 0.04) in treated cohort. Our results provide supporting evidence for future clinical trial using arginine deprivation agents either alone or in combination with conventional chemotherapy in treating pancreatic cancer.	[Liu, Qingqing; Stewart, John; Rashid, Asif; Zhao, Jun; Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Hua; Wolff, Robert A.; Varadhachary, Gauri R.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Katz, Matthew H.; Lee, Jeffrey E.; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Krishnan, Sunil] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	hmwang@mdanderson.org	liu, qingqing/HHD-0360-2022		National Institutes of Health [1R01 CA196941-01A1]; Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center	Support was provided by the National Institutes of Health grant (1R01 CA196941-01A1) [https://www.nih.gov/grants-funding] and the Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at The University of Texas M. D. Anderson Cancer Center [https://www.mdanderson.org/publications/conquest/fall-2011/khalifa-bin-zayed-al-nahyan-foundation.html].	Allen MD, 2014, CANCER RES, V74, P896, DOI 10.1158/0008-5472.CAN-13-1702; Benassai G, 2000, J SURG ONCOL, V73, P212; Bowles TL, 2008, INT J CANCER, V123, P1950, DOI 10.1002/ijc.23723; Daylami R, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0102-9; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Glazer ES, 2010, SURGERY, V148, P310, DOI 10.1016/j.surg.2010.03.022; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Kedra B, 2001, HEPATO-GASTROENTEROL, V48, P1762; Lan J, 2014, TUMOR BIOL, V35, P161, DOI 10.1007/s13277-013-1020-8; Liu JB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-686; Meyer W, 2000, SURG TODAY, V30, P582, DOI 10.1007/s005950070096; Ozaki H, 1999, SURG TODAY, V29, P16; Paniccia A, 2015, CHINESE J CANCER RES, V27, P376, DOI 10.3978/j.issn.1000-9604.2015.05.01; Perera RM, 2015, CANCER DISCOV, V5, P1247, DOI 10.1158/2159-8290.CD-15-0671; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; Takai S, 2003, PANCREAS, V26, P243, DOI 10.1097/00006676-200304000-00007; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P439, DOI 10.1016/S0753-3322(02)00284-6; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Yang H, 2010, ONCOL LETT, V1, P31, DOI 10.3892/ol_00000005; YEO CJ, 1995, ANN SURG, V221, P721, DOI 10.1097/00000658-199506000-00011; Yoon CY, 2007, INT J CANCER, V120, P897, DOI 10.1002/ijc.22322	27	45	46	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171985	10.1371/journal.pone.0171985	http://dx.doi.org/10.1371/journal.pone.0171985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187218	gold, Green Submitted, Green Published			2022-12-27	WOS:000394244300066
J	Sales, G; Deagle, BE; Calura, E; Martini, P; Biscontin, A; De Pitta, C; Kawaguchi, S; Romualdi, C; Meyer, B; Costa, R; Jarman, S				Sales, Gabriele; Deagle, Bruce E.; Calura, Enrica; Martini, Paolo; Biscontin, Alberto; De Pitta, Cristiano; Kawaguchi, So; Romualdi, Chiara; Meyer, Bettina; Costa, Rodolfo; Jarman, Simon			KriIIDB: A de novo transcriptome database for the Antarctic krill (Euphausia superba)	PLOS ONE			English	Article							RNA-SEQ DATA; EXPRESSION; DANA	Antarctic krill (Euphausia superba) is a key species in the Southern Ocean with an estimated biomass between 100 and 500 million tonnes. Changes in krill population viability would have catastrophic effect on the Antarctic ecosystem. One looming threat due to elevated levels of anthropogenic atmospheric carbon dioxide (CO2) is ocean acidification (lowering of sea water pH by CO2 dissolving into the oceans). The genetics of Antarctic krill has long been of scientific interest for both for the analysis of population structure and analysis of functional genetics. However, the genetic resources available for the species are relatively modest. We have developed the most advanced genetic database on Euphausia superba, KriIIDB, which includes comprehensive data sets of former and present transcriptome projects. In particular, we have built a de novo transcriptome assembly using more than 360 million Illumina sequence reads generated from larval krill including individuals subjected to different CO2 levels. The database gives access to: 1) the full list of assembled genes and transcripts; 2) their level of similarity to transcripts and proteins from other species; 3) the predicted protein domains contained within each transcript; 4) their predicted GO terms; 5) the level of expression of each transcript in the different larval stages and CO2 treatments. All references to external entities (sequences, domains, GO terms) are equipped with a link to the appropriate source database. Moreover, the software implements a full-text search engine that makes it possible to submit free-form queries. KriIIDB represents the first largescale attempt at classifying and annotating the full krill transcriptome. For this reason, we believe it will constitute a cornerstone of future approaches devoted to physiological and molecular study of this key species in the Southern Ocean food web.	[Sales, Gabriele; Calura, Enrica; Martini, Paolo; Biscontin, Alberto; De Pitta, Cristiano; Romualdi, Chiara; Costa, Rodolfo] Univ Padua, Dept Biol, Padua, Italy; [Deagle, Bruce E.; Kawaguchi, So; Jarman, Simon] Australian Antarctic Div, Kingston, Tas, Australia; [Meyer, Bettina] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Meyer, Bettina] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Oldenburg, Germany	University of Padua; Australian Antarctic Division; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Carl von Ossietzky Universitat Oldenburg	Costa, R (corresponding author), Univ Padua, Dept Biol, Padua, Italy.; Jarman, S (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.; Meyer, B (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.; Meyer, B (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Oldenburg, Germany.	bettina.meyer@awi.de; rodolfo.costa@unipd.it; simon.jarman@gmail.com	De Pitta, Cristiano/AAY-7302-2020; Meyer, Bettina/ABB-5311-2020; Calura, Enrica/AAA-1847-2021; Martini, Paolo/AAG-7398-2020; Deagle, Bruce E/R-2999-2019; Romualdi, Chiara/K-1132-2016; Sales, Gabriele/K-5065-2016	De Pitta, Cristiano/0000-0001-8013-8162; Meyer, Bettina/0000-0001-6804-9896; Calura, Enrica/0000-0001-8463-2432; Martini, Paolo/0000-0002-0146-1031; Deagle, Bruce E/0000-0001-7651-3687; Biscontin, Alberto/0000-0003-1492-7715; Kawaguchi, So/0000-0002-2042-5095; Romualdi, Chiara/0000-0003-4792-9047; Sales, Gabriele/0000-0003-2078-5661	Helmholtz Virtual Institute PolarTime [VH-VI-500]; Italian Programma Nazionale di Ricerche in Antartide - PNRA [2013/C1.05]; Australian Antarctic Science Program (AAS Project) [4015]; Alfred Wegener Institute through the research programme PACES II	Helmholtz Virtual Institute PolarTime; Italian Programma Nazionale di Ricerche in Antartide - PNRA; Australian Antarctic Science Program (AAS Project); Alfred Wegener Institute through the research programme PACES II	This work was supported by the following: * the Helmholtz Virtual Institute PolarTime (VH-VI-500: Biological timing in a changing marine environment - clocks and rhythms in polar pelagic organisms, www.polartime.org), to BM; * the Italian Programma Nazionale di Ricerche in Antartide - PNRA (grant 2013/C1.05, http://www.pnra.it/) to RC; * the Australian Antarctic Science Program (AAS Project 4015, http://www.antarctica.gov.au/science/information-for-scientists/research-guidelines/AASP-guidelines) to SJ; * the Alfred Wegener Institute through the research programme PACES II (topic 1, workpackage 5, https://www.awi.de/en.html) to BM.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biscontin A, 2016, MAR GENOM, V29, P61, DOI 10.1016/j.margen.2016.04.010; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; De Pitta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068652; De Pitta C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-45; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; FEVOLDEN SE, 1989, POLAR BIOL, V9, P533, DOI 10.1007/BF00261038; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; IKEDA T, 1984, J EXP MAR BIOL ECOL, V75, P107, DOI 10.1016/0022-0981(84)90175-8; Jarman S, 2016, GENETICS ANTARCTIC K; Jeffery NW, 2012, POLAR BIOL, V35, P959, DOI 10.1007/s00300-011-1137-4; Jia ZN, 2014, POLAR BIOL, V37, P165, DOI 10.1007/s00300-013-1420-7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Martins MJF, 2015, MAR GENOM, V23, P45, DOI 10.1016/j.margen.2015.04.008; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Meyer B, 2015, MOL ECOL RESOUR, V15, P1460, DOI 10.1111/1755-0998.12408; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Peng Y, 2013, BIOINFORMATICS, V29, P326, DOI 10.1093/bioinformatics/btt219; Raven J., 2005, OCEAN ACIDIFICATION; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	32	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171908	10.1371/journal.pone.0171908	http://dx.doi.org/10.1371/journal.pone.0171908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187156	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300059
J	Scarano, D; Rao, R; Corrado, G				Scarano, Daria; Rao, Rosa; Corrado, Giandomenico			In Silico identification and annotation of noncoding RNAs by RNA-seq and De Novo assembly of the transcriptome of Tomato Fruits	PLOS ONE			English	Article							GENOME; EXPRESSION; LANDSCAPE; UNCOVERS	The complexity of the tomato (Solanum lycopersicum) transcriptome has not yet been fully elucidated. To gain insights into the diversity and features of coding and non-coding RNA molecules of tomato fruits, we generated strand-specific libraries from berries of two tomato cultivars grown in two open-field conditions with different soil type. Following high-throughput Illumina RNA-sequencing (RNA-seq), more than 90% of the reads (over one billion, derived from twelve dataset) were aligned to the tomato reference genome. We report a comprehensive analysis of the transcriptome, improved with 39,095 transcripts, which reveals previously unannotated novel transcripts, natural antisense transcripts, long noncoding RNAs and alternative splicing variants. In addition, we investigated the sequence variants between the cultivars under investigation to highlight their genetic difference. Our strand-specific analysis allowed us to expand the current tomato transcriptome annotation and it is the first to reveal the complexity of the poly-adenylated RNA world in tomato. Moreover, our work demonstrates the usefulness of strand specific RNA-seq approach for the transcriptome-based genome annotation and provides a resource valuable for further functional studies.	[Scarano, Daria; Rao, Rosa; Corrado, Giandomenico] Univ Napoli Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy	University of Naples Federico II	Corrado, G (corresponding author), Univ Napoli Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy.	giandomenico.corrado@unina.it		Corrado, Giandomenico/0000-0002-8681-6988				Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Argyris JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1196-3; Bai Y, 2014, MOL GENET GENOMICS, V289, P427, DOI 10.1007/s00438-014-0819-3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen J, 2008, GENOME RES, V18, P751, DOI 10.1101/gr.068304.107; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coppola V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-515; Corrado G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-835; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JE, 2014, MOL CELLS, V37, P36, DOI 10.14348/molcells.2014.2241; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kumar R, 2014, J BIOSCIENCES, V39, P917, DOI 10.1007/s12038-014-9480-6; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Olson A., 2013, PLANT GENOME, V10, P3835, DOI DOI 10.3835/PLANTGENOME2013.08.0025; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scott J.W., 2013, GENETICS GENOMICS BR, P60, DOI [10.1201/b14578-3, DOI 10.1201/B14578-3]; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wu PY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S8; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	55	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171504	10.1371/journal.pone.0171504	http://dx.doi.org/10.1371/journal.pone.0171504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187155	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300025
J	Pichyangkul, S; Spring, MD; Yongvanitchit, K; Kum-Arb, U; Limsalakpetch, A; Im-Erbsin, R; Ubalee, R; Vanachayangkul, P; Remarque, EJ; Angov, E; Smith, PL; Saunders, DL				Pichyangkul, Sathit; Spring, Michele D.; Yongvanitchit, Kosol; Kum-Arb, Utaiwan; Limsalakpetch, Amporn; Im-Erbsin, Rawiwan; Ubalee, Ratawan; Vanachayangkul, Pattaraporn; Remarque, Edmond J.; Angov, Evelina; Smith, Philip L.; Saunders, David L.			Chemoprophylaxis with sporozoite immunization in P-knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI; BONE-MARROW; MALARIA; STAGE; LYMPHOCYTES; CHALLENGE; INFECTION; RESPONSES; IMMUNITY; HEPATOCYTES	Whole malaria sporozoite vaccine regimens are promising new strategies, and some candidates have demonstrated high rates of durable clinical protection associated with memory T cell responses. Little is known about the anatomical distribution of memory T cells following whole sporozoite vaccines, and immunization of nonhuman primates can be used as a relevant model for humans. We conducted a chemoprophylaxis with sporozoite (CPS) immunization in P. knowlesi rhesus monkeys and challenged via mosquito bites. Half of CPS immunized animals developed complete protection, with a marked delay in parasitemia demonstrated in the other half. Antibody responses to whole sporozoites, CSP, and AMA1, but not CelTOS were detected. Peripheral blood T cell responses to whole sporozoites, but not CSP and AMA1 peptides were observed. Unlike peripheral blood, there was a high frequency of sporozoite-specific memory T cells observed in the liver and bone marrow. Interestingly, sporozoite-specific CD4(+) and CD8(+) memory T cells in the liver highly expressed chemokine receptors CCR5 and CXCR6, both of which are known for liver sinusoid homing. The majority of liver sporozoite-specific memory T cells expressed CD69, a phenotypic marker of tissue-resident memory (T-RM) cells, which are well positioned to rapidly control liver-stage infection. Vaccine strategies that aim to elicit large number of liver TRM cells may efficiently increase the efficacy and durability of response against pre-erythrocytic parasites.	[Pichyangkul, Sathit; Spring, Michele D.; Yongvanitchit, Kosol; Kum-Arb, Utaiwan; Limsalakpetch, Amporn; Im-Erbsin, Rawiwan; Ubalee, Ratawan; Vanachayangkul, Pattaraporn; Smith, Philip L.; Saunders, David L.] AFRIMS, Bangkok, Thailand; [Remarque, Edmond J.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Angov, Evelina] Walter Reed Army Inst Res, Silver Spring, MD USA	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Pichyangkul, S (corresponding author), AFRIMS, Bangkok, Thailand.	sathitp@afrims.org	Remarque, Ed/AAE-8643-2020		Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America	Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America	This work was supported by the Military Infectious Diseases Research Program (MIDRP), Fort Detrick, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Alp OS, 2015, EUR J IMMUNOL, V45, P975, DOI 10.1002/eji.201445295; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Antinori S, 2013, ACTA TROP, V125, P191, DOI 10.1016/j.actatropica.2012.10.008; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Corradin G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00527; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Frevert U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00482; Frost EL, 2015, J IMMUNOL, V195, P3520, DOI 10.4049/jimmunol.1501521; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Heesch K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097701; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hudspeth K, 2016, J AUTOIMMUN, V66, P40, DOI 10.1016/j.jaut.2015.08.011; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Liehl P, 2015, INFECT IMMUN, V83, P1172, DOI 10.1128/IAI.02796-14; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Milo I, 2013, BLOOD, V122, P193, DOI 10.1182/blood-2012-01-401265; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murphy JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-215; Nahrendorf W, 2015, ELIFE, V4, DOI 10.7554/eLife.05165; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; ORJIH AU, 1982, T ROY SOC TROP MED H, V76, P57, DOI 10.1016/0035-9203(82)90019-0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pichyangkul S, 2015, J IMMUNOL, V195, P4378, DOI 10.4049/jimmunol.1501702; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Tuncer C, 2013, LIVER INT, V33, P852, DOI 10.1111/liv.12182; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; WEISS WR, 1992, J IMMUNOL, V149, P2103; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053	54	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171826	10.1371/journal.pone.0171826	http://dx.doi.org/10.1371/journal.pone.0171826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182750	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800122
J	Rewell, SSJ; Churilov, L; Sidon, TK; Aleksoska, E; Cox, SF; Macleod, MR; Howells, DW				Rewell, Sarah S. J.; Churilov, Leonid; Sidon, T. Kate; Aleksoska, Elena; Cox, Susan F.; Macleod, Malcolm R.; Howells, David W.			Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ADHESIVE REMOVAL TEST; MODIFIED RANKIN SCALE; EXPERIMENTAL STROKE; FOCAL ISCHEMIA; FUNCTIONAL RECOVERY; SOCIAL-INTERACTION; NEURONAL DAMAGE; EDEMA FORMATION; BRAIN-DAMAGE	Key disparities between the timing and methods of assessment in animal stroke studies and clinical trial may be part of the reason for the failure to translate promising findings. This study investigates the development of ischemic damage after thread occlusion MCAo in the rat, using histological and behavioural outcomes. Using the adhesive removal test we investigate the longevity of behavioural deficit after ischemic stroke in rats, and examine the practicality of using such measures as the primary outcome for future studies. Ischemic stroke was induced in 132 Spontaneously Hypertensive Rats which were assessed for behavioural and histological deficits at 1, 3, 7, 14, 21, 28 days, 12 and 24 weeks (n> 11 per timepoint). The basic behavioural score confirmed induction of stroke, with deficits specific to stroke animals. Within 7 days, these deficits resolved in 50% of animals. The adhesive removal test revealed contralateral neglect for up to 6 months following stroke. Sample size calculations to facilitate the use of this test as the primary experimental outcome resulted in cohort sizes much larger than are the norm for experimental studies. Histological damage progressed from a necrotic infarct to a hypercellular area that cleared to leave a fluid filled cavity. Whilst absolute volume of damage changed over time, when corrected for changes in hemispheric volume, an equivalent area of damage was lost at all timepoints. Using behavioural measures at chronic timepoints presents significant challenges to the basic science community in terms of the large number of animals required and the practicalities associated with this. Multicentre preclinical randomised controlled trials as advocated by the MultiPART consortium may be the only practical way to deal with this issue.	[Rewell, Sarah S. J.; Churilov, Leonid; Sidon, T. Kate; Aleksoska, Elena; Cox, Susan F.; Howells, David W.] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Macleod, Malcolm R.] Univ Edinburgh, Dept Clin Neurosci, Edinburgh EH8 9YL, Midlothian, Scotland; [Howells, David W.] Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia	Florey Institute of Neuroscience & Mental Health; University of Edinburgh; University of Tasmania	Howells, DW (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia.; Howells, DW (corresponding author), Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia.	david.howells@utas.edu.au	Macleod, Malcolm Robert/B-2052-2010	Macleod, Malcolm Robert/0000-0001-9187-9839; Rewell, Sarah/0000-0002-4754-6524; Howells, David/0000-0002-2512-7724	National Health & Medical Research Council [GNT1013612]; NHMRC-EU collaborative grant; Victorian State Government; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC-EU collaborative grant; Victorian State Government; National Centre for the Replacement	This work was supported by the National Health & Medical Research Council (https://www.nhmrc.gov.au/)) [GNT1013612] (DWH) and an NHMRC-EU collaborative grant (DWH, MRM). The Florey gratefully acknowledges the operational infrastructure support of the Victorian State Government. The Victorian Cancer Biobank is supported by the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaverdashvili M, 2015, J NEUROSCI METH, V247, P58, DOI 10.1016/j.jneumeth.2015.03.029; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Aspey BS, 1998, NEUROPATH APPL NEURO, V24, P487; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bouet V, 2012, A MASTER KEY TO ASSE; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; CHEN H, 1993, J NEUROL SCI, V118, P109, DOI 10.1016/0022-510X(93)90099-K; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; CLARK RK, 1994, BRAIN RES BULL, V35, P387, DOI 10.1016/0361-9230(94)90119-8; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Craft TKS, 2005, STROKE, V36, P2006, DOI 10.1161/01.STR.0000177538.17687.54; DERESKI MO, 1993, ACTA NEUROPATHOL, V85, P327; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Dirnagl U, 2013, STROKE, V44, P1754, DOI 10.1161/STROKEAHA.113.000734; Dirnagl U, 2012, J CEREBR BLOOD F MET, V32, P933, DOI 10.1038/jcbfm.2012.51; Dittmar M, 2003, STROKE, V34, P2252, DOI 10.1161/01.STR.0000083625.54851.9A; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00338; Dogan A, 1998, NEUROL RES, V20, P265; FARBER JL, 1981, AM J PATHOL, V102, P271; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; GARCIA JH, 1994, AM J PATHOL, V144, P188; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Graham SM, 2004, COMPARATIVE MED, V54, P486; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Harada H, 2005, BRAIN RES PROTOC, V14, P165, DOI 10.1016/j.brainresprot.2004.12.007; Henninger N, 2006, STROKE, V37, P1283, DOI 10.1161/01.STR.0000217223.72193.98; Ishibashi S, 2003, STROKE, V34, P1501, DOI 10.1161/01.STR.0000074034.32371.13; Justicia C, 2008, STROKE, V39, P1541, DOI 10.1161/STROKEAHA.107.503565; Karelina K, 2011, STROKE, V42, P3606, DOI 10.1161/STROKEAHA.111.628008; Karelina K, 2009, EXP NEUROL, V220, P276, DOI 10.1016/j.expneurol.2009.08.022; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleikers PWM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13428; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Lindner MD, 2003, J NEUROSCI, V23, P10913; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lourbopoulos A, 2016, J CEREB BLOOD FLOW M; Macleod M, 2010, NEUROMETHODS, V47, P7, DOI 10.1007/978-1-60761-750-1_2; Mammen E F, 2000, Clin Lab Sci, V13, P239; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Mergenthaler P, 2012, DIS MODEL MECH, V5, P718, DOI 10.1242/dmm.010033; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Modo M, 2003, NEUROREPORT, V14, P39, DOI 10.1097/00001756-200301200-00007; Modo Michel, 2009, J Exp Stroke Transl Med, V2, P52; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P267, DOI 10.1007/BF00686621; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; O'Collins VE, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P531, DOI 10.1016/B978-0-12-415894-8.00023-3; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Philip M, 2009, STROKE, V40, P577, DOI 10.1161/STROKEAHA.108.524330; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schellinger PD, 2012, INT J STROKE, V7, P227, DOI 10.1111/j.1747-4949.2012.00773.x; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; Soleman S, 2010, EXP NEUROL, V222, P13, DOI 10.1016/j.expneurol.2009.11.007; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Stuller KA, 2012, EXP NEUROL, V233, P33, DOI 10.1016/j.expneurol.2011.01.016; Sun LY, 2009, NEUROPATHOLOGY, V29, P45, DOI 10.1111/j.1440-1789.2008.00939.x; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; Trueman RC, 2016, J CEREB BLOOD FLOW M; Turner RJ, 2011, TRANSL STROKE RES, V2, P138, DOI 10.1007/s12975-011-0067-3; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Venna VR, 2011, STROKE, V42, P3329, DOI 10.1161/STROKEAHA.111.632570; Venna VR, 2012, ACTA NEUROPATHOL, V124, P425, DOI 10.1007/s00401-012-0990-8; Virley D, 2000, J CEREB BLOOD FLOW M, V20, P536; Wang MM, 2013, TRANSL STROKE RES, V4, P3, DOI 10.1007/s12975-012-0219-0; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129	94	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171688	10.1371/journal.pone.0171688	http://dx.doi.org/10.1371/journal.pone.0171688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182727	Green Published, gold			2022-12-27	WOS:000394231800090
J	Afonso, E; Goydadin, AC; Giraudoux, P; Farny, G				Afonso, Eve; Goydadin, Anne-Claude; Giraudoux, Patrick; Farny, Gilles			Investigating Hybridization between the Two Sibling Bat Species Myotis myotis and M-blythii from Guano in a Natural Mixed Maternity Colony	PLOS ONE			English	Article							MOUSE-EARED BATS; SEX IDENTIFICATION; HYBRID INDIVIDUALS; POPULATION-SIZE; DOMESTIC CATS; VESPERTILIONIDAE; CHIROPTERA; HABITS; AMPLIFICATION; STRATEGY	Because they can form seasonal mixed-species groups during mating and maternal care, bats are exciting models for studying interspecific hybridization. Myotis myotis and M. blythii are genetically close and morphologically almost identical, but they differ in some aspects of their ecology and life-history traits. When they occur in sympatry, they often form large mixed maternity colonies, in which their relative abundance can vary across time due to a shift in the timing of parturition. For the first time, we used non-invasive genetic methods to assess the hybridization rate and colony composition in a maternity colony of M. myotis and M. blythii located in the French Alps. Bat guano was collected on five sampling dates spread across the roost occupancy period and was analysed for individual genotype. We investigated whether the presence of hybrids followed the pattern of one of the parental species or if it was intermediate. We identified 140 M. myotis, 12 M. blythii and 13 hybrids among 250 samples. Parental species appeared as genetically well-differentiated clusters, with an asymmetrical introgression towards M. blythii. By studying colony parameters (effective size, sex ratio and proportion of the three bat types) across the sampling dates, we found that the abundances of hybrid and M. blythii individuals were positively correlated. Our study provides a promising non-invasive method to study hybridization in bats and raises questions about the taxonomic status of the two Myotis species. We discuss the contribution of this study to the knowledge of hybrid ecology, and we make recommendations for possible future research to better understand the ecology and behaviour of hybrid individuals.	[Afonso, Eve; Goydadin, Anne-Claude; Giraudoux, Patrick] Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France; [Giraudoux, Patrick] Inst Univ France, Paris, France; [Farny, Gilles] Parc Natl Ecrins, Gap, France	Universite de Franche-Comte; Institut Universitaire de France	Afonso, E (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France.	eve.afonso@univ-fcomte.fr	Afonso, Eve/L-1286-2013; Giraudoux, Patrick/B-9274-2011	Afonso, Eve/0000-0001-5836-9909; Giraudoux, Patrick/0000-0003-2376-0136	Conseil Regional de Rhone Alpes	Conseil Regional de Rhone Alpes(Region Auvergne-Rhone-Alpes)	The authors was supported by the Conseil Regional de Rhone Alpes (http://www.rhonealpes.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Adams JR, 2007, MOL ECOL, V16, P1823, DOI 10.1111/j.1365-294X.2007.03270.x; Afonso E, 2016, GLOB ECOL CONSERV, V8, P123, DOI 10.1016/j.gecco.2016.09.002; Aguiar LM, 2008, PRIMATES, V49, P149, DOI 10.1007/s10329-007-0065-y; Anderson EC, 2002, GENETICS, V160, P1217; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 2001, OIKOS, V95, P105, DOI 10.1034/j.1600-0706.2001.950112.x; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; ARLETTAZ R, 1991, MYOTIS, V29, P7; Arlettaz R, 1994, THESIS; Arnold ML, 2004, EVOL GENET, P399; Artyushin IV, 2009, ZOOTAXA, P40; Bachanek J, 2010, ACTA CHIROPTEROL, V12, P439, DOI 10.3161/150811010X538007; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P279, DOI 10.3161/150811012X661611; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Bogdanowicz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053334; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Bradley RD, 2003, SOUTHWEST NAT, V48, P654, DOI 10.1894/0038-4909(2003)048&lt;0654:IOHBWD&gt;2.0.CO;2; Bryja J, 2003, FOLIA ZOOL, V52, P269; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burland TM, 2001, BIOL REV, V76, P389, DOI 10.1017/S1464793101005747; Castella V, 2000, MOL ECOL, V9, P1000, DOI 10.1046/j.1365-294x.2000.00939-6.x; Dietz C, 2009, ENCY CHAUVES SOURIS; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Germain E, 2009, MAMM BIOL, V74, P412, DOI 10.1016/j.mambio.2009.05.008; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hoffmann FG, 2003, MOL ECOL, V12, P2981, DOI 10.1046/j.1365-294X.2003.01959.x; Jan C, 2012, MOL ECOL RESOUR, V12, P532, DOI 10.1111/j.1755-0998.2012.03114.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RUEDI M, 1990, MAMMALIA, V54, P415, DOI 10.1515/mamm.1990.54.3.415; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Sanchez A, 1996, MAMM GENOME, V7, P536, DOI 10.1007/s003359900158; Schwartz MK, 2004, CONSERV GENET, V5, P349, DOI 10.1023/B:COGE.0000031141.47148.8b; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Sztencel-Jablonka A, 2012, CAN J ZOOL, V90, P1251, DOI 10.1139/Z2012-092; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vallo P, 2013, ZOOL SCR, V42, P1, DOI 10.1111/j.1463-6409.2012.00563.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; Zahn A, 1997, J ZOOL, V243, P659, DOI 10.1111/j.1469-7998.1997.tb01968.x	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170534	10.1371/journal.pone.0170534	http://dx.doi.org/10.1371/journal.pone.0170534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199337	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400016
J	Chen, Y; Min, LF; Ren, CL; Xu, XX; Yang, JQ; Sun, XC; Wang, T; Wang, F; Sun, CJ; Zhang, XZ				Chen, Yong; Min, Lingfeng; Ren, Chuanli; Xu, Xingxiang; Yang, Jianqi; Sun, Xinchen; Wang, Tao; Wang, Fang; Sun, Changjiang; Zhang, Xizhi			miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; BREAST-CANCER; STEM-CELLS; HEPATOCELLULAR-CARCINOMA; SURGICAL RESECTION; EARLY MORTALITY; POOR-PROGNOSIS; GASTRIC-CANCER; FRESH-FROZEN	Lung cancer is the leading cause of cancer death in the world, and aberrant expression of miRNA is a common feature during the cancer initiation and development. Our previous study showed that levels of miRNA-148a assessed by quantitative real-time polymerase chain reaction (qRT-PCR) were a good prognosis factor for non-small cell lung cancer (NSCLC) patients. In this study, we used high-throughput formalin-fixed and paraffinembedded (FFPE) lung cancer tissue arrays and in situ hybridization (ISH) to determine the clinical significances of miRNA-148a and aimed to find novel target of miRNA-148a in lung cancer. Our results showed that there were 86 of 159 patients with low miRNA-148a expression and miRNA-148a was significantly down-regulated in primary cancer tissues when compared with their adjacent normal lung tissues. Low expression of miRNA-148a was strongly associated with high tumor grade, lymph node (LN) metastasis and a higher risk of tumor-related death in NSCLC. Lentivirus mediated overexpression of miRNA-148a inhibited migration and invasion of A549 and H1299 lung cancer cells. Furthermore, we validated Wnt1 as a direct target of miRNA-148a. Our data showed that the Wnt1 expression was negatively correlated with the expression of miRNA-148a in both primary cancer tissues and their corresponding adjacent normal lung tissues. In addition, overexpression of miRNA148a inhibited Wnt1 protein expression in cancer cells. And knocking down of Wnt-1 by siRNA had the similar effect of miRNA-148a overexpression on cell migration and invasion in lung cancer cells. In conclusion, our results suggest that miRNA-148a inhibited cell migration and invasion through targeting Wnt1 and this might provide a new insight into the molecular mechanisms of lung cancer metastasis.	[Chen, Yong; Yang, Jianqi; Wang, Tao; Sun, Changjiang; Zhang, Xizhi] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Med Oncol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Min, Lingfeng; Xu, Xingxiang; Wang, Fang] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Resp Med, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Ren, Chuanli] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Clin Med Testing Lab, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Sun, Xinchen] Nanjing Med Univ, Dept Radiotherapy, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Nanjing Medical University	Sun, CJ; Zhang, XZ (corresponding author), Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Med Oncol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.	835052071@qq.com; zhangxizhi@medmail.com.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81302015, 81302016]; National Natural Science Foundation of Jiangsu Province [BK20130455]; Natural Science Foundation of Yangzhou City [YZ2014044]; Jiangsu Government Scholarship for Overseas Study	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Yangzhou City; Jiangsu Government Scholarship for Overseas Study	This work is supported by the National Natural Science Foundation of China (No. 81302015, 81302016), the National Natural Science Foundation of Jiangsu Province (BK20130455), the Natural Science Foundation of Yangzhou City (YZ2014044) and Jiangsu Government Scholarship for Overseas Study.	Aoi T, 2016, GEN THORAC CARDIOVAS, V64, P517, DOI 10.1007/s11748-016-0682-8; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Y, 2013, ONCOL REP, V30, P1832, DOI 10.3892/or.2013.2611; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Dong N, 2016, SEMIN CELL DEV BIOL; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Ganti S, 2012, BRIT J SURG, V99, P1602, DOI 10.1002/bjs.8948; Grivaux M, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0205-5; Heo MJ, 2014, ONCOTARGET, V5, P2792, DOI 10.18632/oncotarget.1920; Huang MX, 2016, J CANCER RES THER, V12, P671, DOI 10.4103/0973-1482.150420; Hug KA, 2015, ANTICANCER RES, V35, P3175; Jang K, 2014, TRANSL RES, V163, P242, DOI 10.1016/j.trsl.2013.11.005; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Jiang Q, 2016, ONCOL REP, V35, P1425, DOI 10.3892/or.2015.4502; Jin JJ, 2016, TRANSL LUNG CANCER R, V5, P436, DOI 10.21037/tlcr.2016.08.08; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li J, 2015, CELL PHYSIOL BIOCHEM, V37, P1847, DOI 10.1159/000438546; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li JP, 2013, MOL CELL BIOCHEM, V380, P277, DOI 10.1007/s11010-013-1682-y; Li L, 2015, MED SCI MONITOR, V21, P1155, DOI 10.12659/MSM.892940; Li Y, 2016, J CANCER, V7, P1233, DOI 10.7150/jca.14616; Liu L, 2015, INT J CLIN EXP MED, V8; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Powell HA, 2013, THORAX, V68, P826, DOI 10.1136/thoraxjnl-2012-203123; REMMELE W, 1987, PATHOLOGE, V8, P138; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; Sheffield KM, 2012, ANN SURG ONCOL, V19, P1670, DOI 10.1245/s10434-011-2152-y; Shi CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09930; Si WT, 2016, AM J MED SCI, V352, P191, DOI 10.1016/j.amjms.2016.05.002; Sun YJ, 2015, COMPUT AIDED GEOM D, V35-36, P2, DOI 10.1016/j.cagd.2015.03.011; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046684; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wang SH, 2013, TUMOR BIOL, V34, P3705, DOI 10.1007/s13277-013-0954-1; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu X, 2016, ONCOTARGET, V7, P20381, DOI 10.18632/oncotarget.7953; Yan H, 2014, MOL CARCINOGEN, V53, P960, DOI 10.1002/mc.22064; Yang JS, 2015, TUMOR BIOL, V36, P3035, DOI 10.1007/s13277-014-2938-1; Yu B, 2016, PLOS ONE, V11; Zhang JP, 2014, ONCOGENE, V33, P4069, DOI 10.1038/onc.2013.369; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zhao SG, 2013, NEURO-ONCOLOGY, V15, P707, DOI 10.1093/neuonc/not001; Zhu M, 2014, PATHOL RES PRACT, V210, P909, DOI 10.1016/j.prp.2014.07.008	49	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171751	10.1371/journal.pone.0171751	http://dx.doi.org/10.1371/journal.pone.0171751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199399	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400047
J	Lee, TJ; Fu, CH; Wang, CH; Huang, CC; Huang, CC; Chang, PH; Chen, YW; Wu, CC; Wu, CL; Kuo, HP				Lee, Ta-Jen; Fu, Chia-Hsiang; Wang, Chun-Hua; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung; Kuo, Han-Pin			Impact of chronic rhinosinusitis on severe asthma patients	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; ENDOSCOPIC SINUS SURGERY; NATURAL HELPER-CELLS; ALLERGIC RHINITIS; INFLAMMATION; EXPRESSION; CYTOKINES; INTERLEUKIN-13; ASSOCIATION; EPITHELIUM	Coexistence of chronic rhinosinusitis (CRS) with asthma appears to impair asthma control. Type-2 innate lymphoid cells (ILC2s) respond to the cytokines of thymic stromal lymphopoietin (TSLP), interleukin (IL)-25 and IL-33, thus contributing to airway diseases such as CRS and asthma. We investigate whether the augmented Th-2-cytokines in CRS might be related to sinonasal tract ILC2s corresponding to enhanced IL-25, IL-33 and TSLP release in severe asthmatics, and be involved in asthma control. Twenty-eight asthmatics (12 non-severe and 16 severe) with CRS receiving nasal surgery were enrolled. The predicted FEV1 inversely associated with CRS severity of CT or endoscopy scores. Higher expression of Th-2-driven cytokines (IL-4, IL-5, IL-9, and IL-13), TSLP, IL-25 and IL-33 in nasal tissues was observed in severe asthma. Severe asthmatics had higher ILC2 cell counts in their nasal tissues. ILC2 counts were positively correlated with Th-2-cytokines. Nasal surgery significantly improved asthma control and lung function decline in severe asthma and CRS. The higher expression of IL-33/ILC2 axis-directed type 2 immune responses in nasal tissue of CRS brought the greater decline of lung function in severe asthma. ILC2-induced the upregulated activity of Th-2-related cytokines in asthmatics with CRS may contribute to a recalcitrant status of asthma control.	[Lee, Ta-Jen; Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung] Chang Gung Mem Hosp, Dept Otolaryngol, Div Rhinol, Taoyuan, Taiwan; [Lee, Ta-Jen; Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Kuo, Han-Pin] Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Kuo, HP (corresponding author), Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan.	q8828@ms11.hinet.net	Chen, Yi/HIR-2608-2022; Huang, Chien-Chia/ABF-3606-2020; Wang, Chun-Hua/C-1488-2016; Huang, Chien-Chia/GLR-6528-2022	Huang, Chien-Chia/0000-0003-4188-3498; Lee, Ta-Jen/0000-0003-0508-1359	Chang Gung Memorial Hospital [CMRPG3D0831]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The research grant of this work was supported by Chang Gung Memorial Hospital (CMRPG3D0831).	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Chen FH, 2014, LARYNGOSCOPE, V124, P24, DOI 10.1002/lary.24196; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Dejima K, 2005, INT ARCH ALLERGY IMM, V138, P97, DOI 10.1159/000088430; Dixon AE, 2006, CHEST, V130, P429, DOI 10.1378/chest.130.2.429; Doherty TA, 2015, J INVEST ALLERG CLIN, V25, P1; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Firszt R, 2014, EUR RESPIR J, V43, P464, DOI 10.1183/09031936.00068712; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Garetier M, 2013, RHINOLOGY, V51, P162, DOI [10.4193/Rhin12.131, 10.4193/Rhino12.131]; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mortuaire G, 2015, ANN ALLERG ASTHMA IM, V114, P299, DOI 10.1016/j.anai.2015.01.012; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Riccio AN, 2002, CLIN EXP ALLERGY, V32, P422, DOI 10.1046/j.1365-2222.2002.01315.x; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Suzaki H, 2013, CURR OPIN ALLERGY CL, V13, P45, DOI 10.1097/ACI.0b013e32835b34f6; Tay TR, 2016, RESPIROLOGY, V21, P1384, DOI 10.1111/resp.12838; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458; Truyen E, 2006, THORAX, V61, P202, DOI 10.1136/thx.2005.052399; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wabnitz DAM, 2005, AM J RHINOL, V19, P91, DOI 10.1177/194589240501900116; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831	40	28	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171047	10.1371/journal.pone.0171047	http://dx.doi.org/10.1371/journal.pone.0171047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199345	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400021
J	Rudd, KE; Tutaryebwa, LK; West, TE				Rudd, Kristina E.; Tutaryebwa, Leonard K.; West, T. Eoin			Presentation, management, and outcomes of sepsis in adults and children admitted to a rural Ugandan hospital: A prospective observational cohort study	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SURVIVING SEPSIS; CLINICAL CARE; SEPTIC SHOCK; MORTALITY; GUIDELINES; INFECTIONS; BACTERIAL; AVAILABILITY; DEFINITIONS	Objectives Limited data are available on sepsis in low-resource settings, particularly outside of urban referral centers. We conducted a prospective observational single-center cohort study in May 2013 to assess the presentation, management and outcomes of adult and pediatric patients admitted with sepsis to a community hospital in rural Uganda. Methods We consecutively screened all patients admitted to medical wards who met sepsis criteria. We evaluated eligible patients within 24 hours of presentation and 24-48 hours after admission, and followed them until hospital discharge. In addition to chart review, mental status evaluation, peripheral capillary oxygen saturation, and point-of-care venous whole blood lactate and glucose testing were performed. Results Of 56 eligible patients, we analyzed data on 51 (20 adults and 31 children). Median age was 8 years (IQR 2-23 years). Sepsis accounted for a quarter of all adult and pediatric medical ward admissions during the study period. HIV prevalence among adults was 30%. On enrollment, over half of patients had elevated point-of-care whole blood lactate, few were hypoglycemic or had altered mental status, and one third were hypoxic. Over 80% of patients received at least one antibiotic, all severely hypoxic patients received supplemental oxygen, and half of patients with elevated lactate received fluid resuscitation. The most common causes of sepsis were malaria and pneumonia. In-hospital mortality was 3.9%. Conclusions This study highlights the importance of sepsis among adult and pediatric patients admitted to a rural Ugandan hospital and underscores the need for continued research on sepsis in low resource settings.	[Rudd, Kristina E.; West, T. Eoin] Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA; [Rudd, Kristina E.; West, T. Eoin] Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA; [Tutaryebwa, Leonard K.] Bwindi Community Hosp, Dept Paediat & Child Hlth, Kanungu, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudd, KE (corresponding author), Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA.; Rudd, KE (corresponding author), Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA.	krudd@uw.edu	Rudd, Kristina/AFM-0440-2022; Rudd, Kristina/AAH-2770-2022	Rudd, Kristina/0000-0002-6695-8401; Rudd, Kristina/0000-0002-6695-8401; West, T Eoin/0000-0001-5503-7204	INTERSECT-Ellison Fellowship; National Heart, Lung, and Blood Institute (NIH-NHLBI) [T32 HL007287]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER	INTERSECT-Ellison Fellowship; National Heart, Lung, and Blood Institute (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Rudd was supported by a grant from the INTERSECT-Ellison Fellowship (http://depts.washington.edu/intrsect/fellowship/) and by the National Heart, Lung, and Blood Institute (NIH-NHLBI T32 HL007287; http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Tutaryebwa received no specific funding for this work. Dr. West received no specific funding for this work.	Abou Dagher G, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0068-1; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Asiimwe SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089879; Auma MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-146; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Baelani Inipavudu, 2012, Middle East Journal of Anesthesiology, V21, P559; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Banajeh SM, 1998, J TROP PEDIATRICS, V44, P343, DOI 10.1093/tropej/44.6.343; Bass CM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0995-5; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Bell M, 2001, Int J Infect Dis, V5, P63, DOI 10.1016/S1201-9712(01)90027-X; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bwindi Community Hospital, 2014, BWINDI COMM HOSP ANN; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Chimese Sophie Mwinsa, 2012, Med J Zambia, V39, P19; Chisti MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139966; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Doka NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048356; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2011, CRIT CARE, V15, DOI 10.1186/cc9981; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahavanakul W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029858; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Moore CC, 2009, AM J TROP MED HYG, V80, P723, DOI 10.4269/ajtmh.2009.80.723; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Norrgren H, 1997, SCAND J INFECT DIS, V29, P453, DOI 10.3109/00365549709011853; Ortiz JR, 2013, INFLUENZA OTHER RESP, V7, P87, DOI 10.1111/irv.12086; Papali A, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.04.003; Pollach G, 2013, PEDIATR CRIT CARE ME, V14, P561, DOI 10.1097/PCC.0b013e318291774b; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Ssekitoleko R, 2011, AM J TROP MED HYG, V85, P697, DOI 10.4269/ajtmh.2011.10-0692; Ssekitoleko R, 2011, CRIT CARE MED, V39, P2271, DOI 10.1097/CCM.0b013e3182227bd2; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Waitt PI, 2015, J INFECTION, V70, P11, DOI 10.1016/j.jinf.2014.07.004	46	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171422	10.1371/journal.pone.0171422	http://dx.doi.org/10.1371/journal.pone.0171422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199348	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400029
J	Bailey, RC; Nyaboke, I; Otieno, FO				Bailey, Robert C.; Nyaboke, Irene; Otieno, Fredrick O.			What device would be best for early infant male circumcision in east and southern Africa? Provider experiences and opinions with three different devices in Kenya	PLOS ONE			English	Article							HIV PREVENTION; ACCUCIRC DEVICE; MOGEN CLAMP; RANDOMIZED-TRIAL; AMPUTATION; ZIMBABWE; BOTSWANA; MEN	Voluntary medical male circumcision (VMMC) reduces risk of HIV acquisition in heterosexual men by approximately 60%. As some countries approach targets for proportions of adolescents and adults circumcised, some are considering early infant male circumcision (EIMC) as a means to achieve sustainability of VMMC for long term reduction of HIV incidence. Evaluations of specialized devices for EIMC are important to provide programs with information required to make informed decisions about how to design safe, effective EIMC programs. We provide assessments by 11 providers with experience in Kenya employing all three of the devices most likely to be considered by various EIMC programs in east and Southern Africa. There was no one device that was seen to be clearly superior to the others. Each had its own advantages and disadvantages. Provider preferences were situation-specific. Most preferred the Mogen Clamp if they themselves were performing the procedure. However, most were concerned that not everyone will have the skills necessary for optimal safety. If someone else were circumcising their son, most would opt for the AccuCirc because of the risk of severing the glans when using the Mogen. A minority preferred the PrePex, but only if the baby received local anesthesia, not EMLA cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%), as presently prescribed by the manufacturer. In the context of a national EIMC program, all participants agreed that AccuCirc would be the device they would recommend due to protection of the glans from laceration and to the provision of a pre-assembled sterile kit that overcomes the need for additional supplies or autoclaving. All agreed that scaling up EIMC, integrating it with existing maternal child health services, will face significant challenges, not least of which is persuading already over-burdened providers to take on additional workload. These results will be useful to programmers considering introduction of EIMC services in sub-Saharan African settings.	[Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Nyaboke, Irene; Otieno, Fredrick O.] Nyanza Reprod Hlth Soc, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bailey, RC (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA.	rcbailey@uic.edu		Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Division of AIDS, National Institute of Allergy and Infectious Disease [R01A1108371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108371, U01AI099953] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grant R01A1108371 to RCB from the Division of AIDS, National Institute of Allergy and Infectious Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adera F, 2016, AIDS 2016 21 INT AID; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2016, FACTORS ASS UPTAKE E; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Fitzgerald L, 2016, GLOB HEALTH-SCI PRAC, V4, pS76, DOI 10.9745/GHSP-D-15-00186; Government of Kenya, 2009, KEN NAT STRAT VOL ME; Government of Kenya Ministry of Health National AIDS and STD Control Programme, 2014, CLIN MAN EARL INF MA; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kankaka EN, 2016, BJU INT; Kikaya V, 2016, GLOB HEALTH-SCI PRAC, V4, pS87, DOI 10.9745/GHSP-D-15-00231; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Mavhu W, 2016, GLOB HEALTH-SCI PRAC, V4, pS42, DOI 10.9745/GHSP-D-15-00199; Mehta SD, 2013, J INFECT DIS, V30, P30; Nyaboke I, 2016, AIDS 2016 21 INT AID; Otieno FO, 2016, HIV PREVENTION FEASI; Patel HI, 2001, J PEDIATR SURG, V36, P235, DOI 10.1053/jpsu.2001.20062; Plank RM, 2014, JAIDS-J ACQ IMM DEF, V66, P1, DOI 10.1097/QAI.0000000000000136; Plank RM, 2013, JAIDS-J ACQ IMM DEF, V62, pE131, DOI 10.1097/QAI.0b013e318285d449; Sherman J, 1996, J UROLOGY, V156, P842, DOI 10.1016/S0022-5347(01)65836-1; Strimling BS, 1996, PEDIATRICS, V97, P906; World Health Organization, 2009, MAN MAL CIRC LOC AN; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047395; Young MR, 2012, PEDIATRICS, V130, pE175, DOI 10.1542/peds.2011-2290	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171445	10.1371/journal.pone.0171445	http://dx.doi.org/10.1371/journal.pone.0171445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196085	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900022
J	Hora, M; Soumar, L; Pontzer, H; Sladek, V				Hora, Martin; Soumar, Libor; Pontzer, Herman; Sladek, Vladimir			Body size and lower limb posture during walking in humans	PLOS ONE			English	Article							3-DIMENSIONAL GAIT ANALYSIS; GENERATING MUSCULAR FORCE; JOINT COORDINATE SYSTEM; HIGH-HEELED SHOES; ENERGY-COST; METABOLIC COST; KINETIC-PARAMETERS; GENDER-DIFFERENCES; INVERSE DYNAMICS; HUMAN LOCOMOTION	We test whether locomotor posture is associated with body mass and lower limb length in humans and explore how body size and posture affect net joint moments during walking. We acquired gait data for 24 females and 25 males using a three-dimensional motion capture system and pressure-measuring insoles. We employed the general linear model and commonality analysis to assess the independent effect of body mass and lower limb length on flexion angles at the hip, knee, and ankle while controlling for sex and velocity. In addition, we used inverse dynamics to model the effect of size and posture on net joint moments. At early stance, body mass has a negative effect on knee flexion (p < 0.01), whereas lower limb length has a negative effect on hip flexion (p < 0.05). Body mass uniquely explains 15.8% of the variance in knee flexion, whereas lower limb length uniquely explains 5.4% of the variance in hip flexion. Both of the detected relationships between body size and posture are consistent with the moment moderating postural adjustments predicted by our model. At late stance, no significant relationship between body size and posture was detected. Humans of greater body size reduce the flexion of the hip and knee at early stance, which results in the moderation of net moments at these joints.	[Hora, Martin; Sladek, Vladimir] Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic; [Soumar, Libor] CASRI Sports Res Inst Czech Armed Forces, Prague, Czech Republic; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY USA	Charles University Prague; City University of New York (CUNY) System; Hunter College (CUNY)	Hora, M (corresponding author), Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic.	mrtnh@seznam.cz	Hora, Martin/L-7253-2017	Hora, Martin/0000-0002-9742-6985; Pontzer, Herman/0000-0003-2397-6543	Czech Science Foundation [14-22823S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was funded by the Czech Science Foundation, grant number 14-22823S to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. M., 1992, BIOL SCI, V338, P189, DOI [10.1098/rstb.1992.0138, DOI 10.1098/RSTB.1992.0138]; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Begon M, 2007, GAIT POSTURE, V25, P353, DOI 10.1016/j.gaitpost.2006.04.010; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Blaszczyk JW, 2011, ACTA NEUROBIOL EXP, V71, P528; Boyer KA, 2008, J BIOMECH, V41, P3360, DOI 10.1016/j.jbiomech.2008.09.030; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; BRESLER B, 1950, T AM SOC MECH ENG, V72, P27; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chang YH, 1999, J APPL PHYSIOL, V86, P1657, DOI 10.1152/jappl.1999.86.5.1657; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Chung MJ, 2010, GAIT POSTURE, V31, P131, DOI 10.1016/j.gaitpost.2009.09.013; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; de David AC, 2015, J SPORT SCI, V33, P391, DOI 10.1080/02640414.2014.946074; Derrick TR, 2016, J BIOMECH, V49, P429, DOI 10.1016/j.jbiomech.2016.01.003; DeVita P, 2003, J BIOMECH, V36, P1355, DOI 10.1016/S0021-9290(03)00119-2; Duffell LD, 2014, P I MECH ENG H, V228, P206, DOI 10.1177/0954411913518747; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; Edwards WB, 2016, J BIOMECH, V49, P1206, DOI 10.1016/j.jbiomech.2016.03.007; Edwards WB, 2008, CLIN BIOMECH, V23, P1269, DOI 10.1016/j.clinbiomech.2008.06.011; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Foster AD, 2013, J HUM EVOL, V65, P294, DOI 10.1016/j.jhevol.2013.06.012; Gregory WK., 1912, ANN NY ACAD SCI, V22, P267, DOI DOI 10.1111/J.1749-6632.1912.TB55164.X; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Gruben KG, 2012, HUM MOVEMENT SCI, V31, P649, DOI 10.1016/j.humov.2011.07.006; Gruss LT, 2007, AM J PHYS ANTHROPOL, V134, P106, DOI 10.1002/ajpa.20642; Gushue DL, 2005, J PEDIATR ORTHOPED, V25, P763, DOI 10.1097/01.bpo.0000176163.17098.f4; Hanlon M, 2006, GAIT POSTURE, V24, P280, DOI 10.1016/j.gaitpost.2005.10.007; Harding GT, 2012, OSTEOARTHR CARTILAGE, V20, P1234, DOI 10.1016/j.joca.2012.08.004; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HENNIG EM, 1995, J APPL BIOMECH, V11, P299, DOI 10.1123/jab.11.3.299; Holliday TW, 1999, J HUM EVOL, V36, P549, DOI 10.1006/jhev.1998.0289; Hora M, 2014, J HUM EVOL, V67, P19, DOI 10.1016/j.jhevol.2013.09.011; Hora M, 2012, FOLIA ZOOL, V61, P330, DOI 10.25225/fozo.v61.i3.a15.2012; Hortobagyi T, 2011, J APPL PHYSIOL, V111, P1391, DOI 10.1152/japplphysiol.00291.2011; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hurd WJ, 2004, CLIN BIOMECH, V19, P465, DOI 10.1016/j.clinbiomech.2004.01.013; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; KETTELKAMP DB, 1970, J BONE JOINT SURG AM, VA 52, P775, DOI 10.2106/00004623-197052040-00008; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Maus HM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1073; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; MOOD AM, 1969, OPER RES, V17, P770, DOI 10.1287/opre.17.5.770; NEWTON RG, 1967, ROY STAT SOC C-APP, V16, P51; OBERG T, 1994, J REHABIL RES DEV, V31, P199; PANDOLF KB, 1976, ERGONOMICS, V19, P683, DOI 10.1080/00140137608931583; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; PANDY MG, 1991, J BIOMECH, V24, P1, DOI 10.1016/0021-9290(91)90321-D; Patel BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071020; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; PETERS M, 1988, PSYCHOL BULL, V103, P179, DOI 10.1037/0033-2909.103.2.179; Polk JD, 2002, J EXP BIOL, V205, P3399; Pontzer H, 2005, J EXP BIOL, V208, P1513, DOI 10.1242/jeb.01549; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Pontzer H, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0935; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Redl C, 2007, HUM MOVEMENT SCI, V26, P306, DOI 10.1016/j.humov.2007.01.008; Ren L, 2008, J EXP BIOL, V211, P2735, DOI 10.1242/jeb.018820; Roberts TJ, 1998, J EXP BIOL, V201, P2753; Roislien J, 2009, GAIT POSTURE, V30, P441, DOI 10.1016/j.gaitpost.2009.07.002; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357; Sellers WI, 2010, INT J PRIMATOL, V31, P321, DOI 10.1007/s10764-010-9396-4; Sladek V, 2010, AM J PHYS ANTHROPOL, V141, P325, DOI 10.1002/ajpa.21153; SPYROPOULOS P, 1991, ARCH PHYS MED REHAB, V72, P1065; Stansfield BW, 2001, J PEDIATR ORTHOPED, V21, P403, DOI 10.1097/00004694-200105000-00027; Stefanyshyn DJ, 2000, J APPL BIOMECH, V16, P309, DOI 10.1123/jab.16.3.309; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; Stoquart G, 2008, NEUROPHYSIOL CLIN, V38, P105, DOI 10.1016/j.neucli.2008.02.002; TAYLOR CR, 1980, J EXP BIOL, V86, P9; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; van der Linden ML, 2002, J PEDIATR ORTHOPED, V22, P800, DOI 10.1097/00004694-200211000-00021; van Hedel HJA, 2006, GAIT POSTURE, V24, P35, DOI 10.1016/j.gaitpost.2005.06.015; Warrener AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118903; Whittlesey S, 2013, 2 DIMENSIONAL INVERS; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WITTE H, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P407; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yoshioka S, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-27; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; ZAMPARO P, 1992, EUR J APPL PHYSIOL O, V65, P183, DOI 10.1007/BF00705078; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	101	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172112	10.1371/journal.pone.0172112	http://dx.doi.org/10.1371/journal.pone.0172112			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192522	Green Published, gold			2022-12-27	WOS:000394423800071
J	Olusanya, BO; Mabogunje, CA; Imosemi, DO; Emokpae, AA				Olusanya, Bolajoko O.; Mabogunje, Cecilia A.; Imosemi, Donald O.; Emokpae, Abieyuwa A.			Transcutaneous bilirubin nomograms in African neonates	PLOS ONE			English	Article							CLINICAL RISK-FACTORS; LATE-PRETERM; NEWBORN POPULATION; SERUM BILIRUBIN; HEALTHY TERM; HYPERBILIRUBINEMIA; MANAGEMENT; BILICHECK; JAUNDICE; INFANTS	Background The use of transcutaneous bilirubin (TcB) as a screening tool, based on relevant population-specific nomogram, or proxy for total serum bilirubin (TSB) levels in assessing the risk of subsequent hyperbilirubinemia is supported by several clinical guidelines on the management of neonatal hyperbilirubinemia. However, while TcB has been found to significantly over-estimate TSB in neonates of African-American ancestry, with variations across TcB devices, no nomogram has been specifically reported for this racial group. This study therefore set out to develop TcB nomograms for healthy late pre-term and term black African neonates derived from two widely used bilirubinometers. Methods A retrospective analysis of 12,377 TcB measurements obtained from 6,373 neonates in the first postnatal week, over a period of 48 months using Bilichek and JM-103 bilirubinometers. TcB percentiles were computed from hour-specific TcB values and nomograms developed for each of the screening devices. Predictive ability of the 75th and 95th percentiles to detect significant hyperbilirubinemia was evaluated between 24-96 hours of age. The 95th percentile curve was compared with those from other populations. Results The velocity of TcB rise at 75th and 95th percentiles was generally higher with JM-103 than Bilichek. Both percentiles also peaked at higher TcB levels with JM-103. The 95th percentile for both instruments showed a downward trend as from approximately 114 hours. Both instruments had high negative predictive values across the selected time-epochs and lower discriminatory ability than reported in non-black populations. Conclusions The predictive utility of TcB as a potential screening tool varies across devices in black African neonates with or without risk of significant hyperbilirubinemia, and lower than levels reported in non-black populations. Equipment-specific nomograms should be considered for TcB monitoring in this racial population where TSB is not routinely available.	[Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Mabogunje, Cecilia A.; Emokpae, Abieyuwa A.] Massey St Childrens Hosp, Lagos, Nigeria; [Imosemi, Donald O.] Lagos Isl Matern Hosp, Lagos, Nigeria		Olusanya, BO (corresponding author), Ctr Hlth Start Initiat, Lagos, Nigeria.	boolusanya@aol.com	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				Akahira-Azuma M, 2015, EUR J PEDIATR, V174, P1299, DOI 10.1007/s00431-015-2536-2; American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Bental YA, 2009, ACTA PAEDIATR, V98, P1902, DOI 10.1111/j.1651-2227.2009.01385.x; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Bhutani VK, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e17; Bonellie SR, 1996, STAT MED, V15, P2657; Dalal SS, 2009, PEDIATRICS, V124, pE851, DOI 10.1542/peds.2008-3623; de Araujo Peres C, 2011, PEDIATRICS, V128, pe565; De Luca D, 2008, ACTA PAEDIATR, V97, P146, DOI 10.1111/j.1651-2227.2007.00622.x; De Luca D, 2009, ARCH PEDIAT ADOL MED, V163, P1054, DOI 10.1001/archpediatrics.2009.187; Engle WD, 2014, SEMIN PERINATOL, V38, P438, DOI 10.1053/j.semperi.2014.08.007; Engle WD, 2009, AM J PERINAT, V26, P425, DOI 10.1055/s-0029-1214238; Fouzas S, 2010, PEDIATRICS, V125, pE52, DOI 10.1542/peds.2009-0403; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Keren R, 2009, ARCH DIS CHILD-FETAL, V94, pF317, DOI 10.1136/adc.2008.150714; Maisels MJ, 2009, J PERINATOL, V29, P612, DOI 10.1038/jp.2009.43; Maisels MJ, 2006, PEDIATRICS, V117, P1169, DOI 10.1542/peds.2005-0744; Maisels MJ, 2004, PEDIATRICS, V113, P1628, DOI 10.1542/peds.113.6.1628; Mishra S, 2009, ACTA PAEDIATR, V98, P1916, DOI 10.1111/j.1651-2227.2009.01505.x; National Institute for Health and Clinical Excellence, 2010, NEON JAUND; Newman TB, 2005, ARCH PEDIAT ADOL MED, V159, P113, DOI 10.1001/archpedi.159.2.113; Olusanya BO, 2016, NIGER J CLIN PRACT, V19, P1, DOI 10.4103/1119-3077.173703; Olusanya BO, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0907; Olusanya BO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0358-z; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Rodriguez-Capote K, 2009, CLIN BIOCHEM, V42, P176, DOI 10.1016/j.clinbiochem.2008.09.108; Romagnoli C, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-46; Romagnoli C, 2012, CLIN BIOCHEM, V45, P659, DOI 10.1016/j.clinbiochem.2012.03.014; Slusher TM, 2015, NEW ENGL J MED, V373, P1115, DOI 10.1056/NEJMoa1501074; Wainer S, 2009, ACTA PAEDIATR, V98, P1909, DOI 10.1111/j.1651-2227.2009.01497.x; Watchko JF, 2010, SEMIN FETAL NEONAT M, V15, P176, DOI 10.1016/j.siny.2009.11.001; Yu ZB, 2014, WORLD J PEDIATR, V10, P211, DOI 10.1007/s12519-014-0495-8; Yu ZB, 2011, EUR J PEDIATR, V170, P185, DOI 10.1007/s00431-010-1281-9	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172058	10.1371/journal.pone.0172058	http://dx.doi.org/10.1371/journal.pone.0172058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192492	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800065
J	Vaitaitis, GM; Yussman, MG; Waid, DM; Wagner, DH				Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.			Th40 cells (CD4(+)CD40(+) Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; EXPRESSION; MODEL; MICE; RECEPTOR; DISEASE; ACTIVATION; POPULATION; PROTEINS; PREVENTS	CD40-CD154 interaction is critically involved in autoimmune diseases, and CD4 T cells play a dominant role in the Experimental Autoimmune Encephalomyelitis (EAE) model of Multiple Sclerosis (MS). CD4 T cells expressing CD40 (Th40) are pathogenic in type I diabetes but have not been evaluated in EAE. We demonstrate here that Th40 cells drive a rapid, more severe EAE disease course than conventional CD4 T cells. Adoptively transferred Th40 cells are present in lesions in the CNS and are associated with wide spread demyelination. Primary Th40 cells from EAE-induced donors adoptively transfer EAE without further in-vitro expansion and without requiring the administration of the EAE induction regimen to the recipient animals. This has not been accomplished with primary, non-TCR-transgenic donor cells previously. If co-injection of Th40 donor cells with Freund's adjuvant (CFA) in the recipient animals is done, the disease course is more severe. The CFA component of the EAE induction regimen causes generalized inflammation, promoting expansion of Th40 cells and infiltration of the CNS, while MOG-antigen shapes the antigen-specific TCR repertoire. Those events are both necessary to precipitate disease. In MS, viral infections or trauma may induce generalized inflammation in susceptible individuals with subsequent disease onset. It will be important to further understand the events leading up to disease onset and to elucidate the contributions of the Th40 T cell subset. Also, evaluating Th40 levels as predictors of disease onset would be highly useful because if either the generalized inflammation event or the TCR-honing can be interrupted, disease onset may be prevented.	[Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.] Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.] Univ Colorado Denver, Webb Waring Ctr, Anschutz Med Campus, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wagner, DH (corresponding author), Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Wagner, DH (corresponding author), Univ Colorado Denver, Webb Waring Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.	david.wagner@ucdenver.edu		Vaitaitis, Gisela/0000-0001-6413-8322	National Institute of Diabetes and Digestive and Kidney Diseases [5R01 DK075013]; National Institute of Allergy and Infectious Diseases [R41 AI113977]; National Multiple Sclerosis Society [RG 5070-A-1]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was funded by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov; grant number 5R01 DK075013), the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov; grant number R41 AI113977) and the National Multiple Sclerosis Society (http://www.nationalmssociety.org/; grant number RG 5070-A-1) awarded to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; Baker RL, 2008, J AUTOIMMUN, V31, P385, DOI 10.1016/j.jaut.2008.09.001; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Carter J, 2012, EUR J IMMUNOL, V42, P424, DOI 10.1002/eji.201141880; Casiraghi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13995; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Deng GY, 2014, J NEUROIMMUNOL, V274, P132, DOI 10.1016/j.jneuroim.2014.07.009; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Ghalamfarsa G, 2016, J IMMUNOTOXICOL, V13, P274, DOI 10.3109/1547691X.2015.1089343; Girvin AM, 2002, J AUTOIMMUN, V18, P83, DOI 10.1006/jaut.2001.0573; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hong GU, 2013, J NEUROIMMUNOL, V260, P60, DOI 10.1016/j.jneuroim.2013.04.002; Howard LM, 1999, J CLIN INVEST, V103, P281, DOI 10.1172/JCI5388; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ichikawa M, 2000, J NEUROIMMUNOL, V102, P56, DOI 10.1016/S0165-5728(99)00153-8; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Rabchevsky AG, 1999, BRAIN RES, V832, P84, DOI 10.1016/S0006-8993(99)01479-1; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4; Vaitaitis Gisela, 2010, Current Immunology Reviews, V6, P130; Vaitaitis GM, 2013, CELL MOL IMMUNOL, V10, P483, DOI 10.1038/cmi.2013.24; Vaitaitis GM, 2010, MOL IMMUNOL, V47, P2303, DOI 10.1016/j.molimm.2010.05.288; Vaitaitis GM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002076; Vaitaitis GM, 2003, J IMMUNOL, V170, P3455, DOI 10.4049/jimmunol.170.7.3455; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Waid DM, 2007, CLIN IMMUNOL, V124, P138, DOI 10.1016/j.clim.2007.05.003; Waid DM, 2014, J NEUROIMMUNOL, V270, P75, DOI 10.1016/j.jneuroim.2014.03.009; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; Williams JL, 2011, J NEUROIMMUNOL, V234, P84, DOI 10.1016/j.jneuroim.2011.02.008	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172037	10.1371/journal.pone.0172037	http://dx.doi.org/10.1371/journal.pone.0172037			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192476	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800063
J	Boonma, S; Romsang, A; Duang-nkern, J; Atichartpongkul, S; Trinachartvanit, W; Vattanaviboon, P; Mongkolsuk, S				Boonma, Siriwan; Romsang, Adisak; Duang-nkern, Jintana; Atichartpongkul, Sopapan; Trinachartvanit, Wachareeporn; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			The FinR-regulated essential gene fprA, encoding ferredoxin NADP(+) reductase: Roles in superoxide-mediated stress protection and virulence of Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; TRANSCRIPTIONAL REGULATOR; OXIDATIVE STRESS; ESCHERICHIA-COLI; RHODOCOCCUS-EQUI; PUTIDA KT2440; EXPRESSION; BIOSYNTHESIS; HOST; RESISTANCE	Pseudomonas aeruginosa has two genes encoding ferredoxin NADP(+) reductases, denoted fprA and fprB. We show here that P. aeruginosa fprA is an essential gene. However, the Delta fprA mutant could only be successfully constructed in PAO1 strains containing an extra copy of fprA on a mini-Tn7 vector integrated into the chromosome or carrying it on a temperature-sensitive plasmid. The strain containing an extra copy of the ferredoxin gene (fdx1) could suppress the essentiality of FprA. Other ferredoxin genes could not suppress the requirement for FprA, suggesting that Fdx1 mediates the essentiality of FprA. The expression of fprA was highly induced in response to treatments with a superoxide generator, paraquat, or sodium hypochlorite (NaOCl). The induction of fprA by these treatments depended on FinR, a LysR-family transcription regulator. In vivo and in vitro analysis suggested that oxidized FinR acted as a transcriptional activator of fprA expression by binding to its regulatory box, located 20 bases upstream of the fprA -35 promoter motif. This location of the FinR box also placed it between the -35 and -10 motifs of the finR promoter, where the reduced regulator functions as a repressor. Under uninduced conditions, binding of FinR repressed its own transcription but had no effect on fprA expression. Exposure to paraquat or NaOCl converted FinR to a transcriptional activator, leading to the expression of both fprA and finR. The Delta finR mutant showed an increased paraquat sensitivity phenotype and attenuated virulence in the Drosophila melanogaster host model. These phenotypes could be complemented by high expression of fprA, indicating that the observed phenotypes of the Delta finR mutant arose from the inability to up-regulate fprA expression. In addition, increased expression of fprB was unable to rescue essentiality of fprA or the superoxide-sensitive phenotype of the.finR mutant, suggesting distinct mechanisms of the FprA and FprB enzymes.	[Boonma, Siriwan; Romsang, Adisak; Mongkolsuk, Skorn] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Duang-nkern, Jintana; Atichartpongkul, Sopapan; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Trinachartvanit, Wachareeporn] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Minist Educ, CHE, Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand	Mahidol University; Chulabhorn Research Institute; Mahidol University; Chulabhorn Graduate Institute; Mahidol University	Mongkolsuk, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Minist Educ, CHE, Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok, Thailand.	skorn.mon@mahidol.ac.th	Romsang, Adisak/K-2630-2019; Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/H-7142-2014	Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Chulabhorn Research Institute; Faculty of Science; Mahidol University; Office of the Higher Education Commission; Thailand Research Fund [MRG5980047]; Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand	Chulabhorn Research Institute; Faculty of Science; Mahidol University; Office of the Higher Education Commission; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand	This work was supported by grants from the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php), the Faculty of Science (http://science.mahidotac.th/), and the Mahidol University (https://www.manidolac.th). AR was supported by the grant from the joint funding of Office of the Higher Education Commission and Thailand Research Fund (MRG5980047) with SM as his mentor. SB was supported by the Royal Thai Government Scholarship under the Development and Promotion of Science and Technology Talents Project (DPST), Thailand (www.dpstenter.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Braz VS, 2010, J BACTERIOL, V192, P5480, DOI 10.1128/JB.00496-10; Byrne GA, 2007, J BACTERIOL, V189, P5082, DOI 10.1128/JB.00431-07; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Deghmane AE, 2000, EMBO J, V19, P1068, DOI 10.1093/emboj/19.5.1068; Dietrich LEP, 2011, MOL MICROBIOL, V79, P1119, DOI 10.1111/j.1365-2958.2011.07552.x; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Elsen S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-271; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Fuangthong M, 2015, MICROBIOL RES, V170, P139, DOI 10.1016/j.micres.2014.08.004; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; ISAS JM, 1995, J BIOL CHEM, V270, P21258, DOI 10.1074/jbc.270.36.21258; Kang IH, 2007, J MICROBIOL BIOTECHN, V17, P176; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim SH, 2009, J MICROBIOL BIOTECHN, V19, P1520, DOI 10.4014/jmb.0906.06028; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Lee SA, 2015, P NATL ACAD SCI USA, V112, P5189, DOI 10.1073/pnas.1422186112; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; Lewis TA, 2013, J BACTERIOL, V195, P3876, DOI 10.1128/JB.00528-13; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Lu Z, 2007, J BACTERIOL, V189, P5642, DOI 10.1128/JB.00467-07; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2016, STRESS ENV CONTROL G, V2, P1090; Romsang A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134374; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Runyen-Janecky L, 2008, INFECT IMMUN, V76, P1083, DOI 10.1128/IAI.01211-07; Russell DA, 2004, J BACTERIOL, V186, P5576, DOI 10.1128/JB.186.17.5576-5584.2004; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Silo-Suh LA, 2009, J MICROBIOL METH, V78, P319, DOI 10.1016/j.mimet.2009.07.002; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Srijaruskul K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123699; STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627; Stover C. K., 2000, NATURE, V406, P1, DOI DOI 10.1038/35023203; Suwantarat N, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0115-6; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Velayudhan J, 2014, INFECT IMMUN, V82, P1390, DOI 10.1128/IAI.01022-13; Vollack KU, 1998, MICROBIOL-SGM, V144, P441, DOI 10.1099/00221287-144-2-441; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Yeom J, 2012, BMB REP, V45, P476, DOI 10.5483/BMBRep.2012.45.8.071; Yeom J, 2009, J BIOCHEM, V145, P481, DOI 10.1093/jb/mvn185; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105	63	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172071	10.1371/journal.pone.0172071	http://dx.doi.org/10.1371/journal.pone.0172071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187184	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300079
J	Murray, JM; Maher, S; Mota, T; Suzuki, K; Kelleher, AD; Center, RJ; Purcell, D				Murray, John M.; Maher, Stephen; Mota, Talia; Suzuki, Kazuo; Kelleher, Anthony D.; Center, Rob J.; Purcell, Damian			Differentiating founder and chronic HIV envelope sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTEGRIN ALPHA(4)BETA(7); HETEROSEXUAL TRANSMISSION; GLYCOPROTEIN GP120; DEPENDENT EPITOPE; HUMAN-ANTIBODY; INFECTION; NEUTRALIZATION; DOMAINS; GP41	Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV envelope glycoprotein Env, but an effective vaccine has proven elusive. Vaccine development would be facilitated if common features of early founder virus required for transmission could be identified. Here we employ a combination of bioinformatic and operations research methods to determine the most prevalent features that distinguish 78 subtype B and 55 subtype C founder Env sequences from an equal number of chronic sequences. There were a number of equivalent optimal networks (based on the fewest covarying amino acid (AA) pairs or a measure of maximal covariance) that separated founders from chronics: 13 pairs for subtype B and 75 for subtype C. Every subtype B optimal solution contained the founder pairs 178-346 Asn-Val, 232-236 Thr-Ser, 240-340 Lys-Lys, 279-315 Asp-Lys, 291-792 Ala-Ile, 322-347 Asp-Thr, 535-620 Leu-Asp, 742-837 Arg-Phe, and 750-836 Asp-Ile; the most common optimal pairs for subtype C were 644-781 Lys-Ala (74 of 75 networks), 133-287 Ala-Gln (73/75) and 307-337 Ile-Gln (73/75). No pair was present in all optimal subtype C solutions highlighting the difficulty in targeting transmission with a single vaccine strain. Relative to the size of its domain (0.35% of Env), the alpha(4)beta(7) binding site occurred most frequently among optimal pairs, especially for subtype C: 4.2% of optimal pairs (1.2% for subtype B). Early sequences from 5 subtype B pre-seroconverters each exhibited at least one clone containing an optimal feature 553-624 (Ser-Asn), 724-747 (Arg-Arg), or 46-293 (Arg-Glu).	[Murray, John M.; Maher, Stephen] UNSW Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Maher, Stephen] Zuse Inst Berlin, Berlin, Germany; [Mota, Talia; Center, Rob J.; Purcell, Damian] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Suzuki, Kazuo; Kelleher, Anthony D.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Center, Rob J.] Ctr Biomed Res, Burnet Inst, Melbourne, Vic, Australia	University of New South Wales Sydney; Zuse Institute Berlin; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Burnet Institute	Murray, JM (corresponding author), UNSW Sydney, Sch Math & Stat, Sydney, NSW, Australia.	J.Murray@unsw.edu.au	Murray, John/B-5481-2009; Purcell, Damian F/G-5068-2011	Murray, John/0000-0001-9314-2283; Kelleher, Anthony/0000-0002-0009-3337; Mota, Talia/0000-0002-8925-0158; Suzuki, Kazuo/0000-0002-2531-794X	UNSW Goldstar grant [RG134772]	UNSW Goldstar grant	JM was funded by a UNSW Goldstar grant (RG134772, https://research.unsw.edu.au/ unsw-internal-funding-opportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; [Anonymous], SCIENCE; [Anonymous], SCIENCE; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Asmal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023673; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cocchi F, 1996, NAT MED, P2; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-123; Day TA, 2013, CURR HIV RES, V11, P441, DOI 10.2174/1570162X113116660051; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gorny MK, 1993, J IMMUNOL, P150; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Korazim O, 2006, J MOL BIOL, V364, P1103, DOI 10.1016/j.jmb.2006.08.091; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Kuhlmann AS, 2014, J BIOL CHEM, V289, P7630, DOI 10.1074/jbc.M113.529339; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liao H-X, 2013, NATURE; Maher SJ, 2016, EUR J OPER RES, V248, P668, DOI 10.1016/j.ejor.2015.07.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Mota TM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-54; Murray JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067254; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Perez LG, 2014, J VIROL, V88, P10767, DOI 10.1128/JVI.03296-13; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Wang WK, 1996, J VIROL, V70, P607, DOI 10.1128/JVI.70.1.607-611.1996; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171572	10.1371/journal.pone.0171572	http://dx.doi.org/10.1371/journal.pone.0171572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187204	Green Published, gold			2022-12-27	WOS:000394244300031
J	Oles, V; Panchenko, A; Smertenko, A				Oles, Vladyslav; Panchenko, Alexander; Smertenko, Andrei			Modeling hormonal control of cambium proliferation	PLOS ONE			English	Article							GENE REGULATORY NETWORK; CYTOKININ BIOSYNTHESIS; ARABIDOPSIS HYPOCOTYL; TRANSCRIPTION FACTOR; VASCULAR PATTERN; RECEPTOR KINASE; HOMEOBOX GENE; POLAR AUXIN; CELL FATE; GROWTH	Rise of atmospheric CO2 is one of the main causes of global warming. Catastrophic climate change can be avoided by reducing emissions and increasing sequestration of CO2. Trees are known to sequester CO2 during photosynthesis, and then store it as wood biomass. Thus, breeding of trees with higher wood yield would mitigate global warming as well as augment production of renewable construction materials, energy, and industrial feedstock. Wood is made of cellulose-rich xylem cells produced through proliferation of a specialized stem cell niche called cambium. Importance of cambium in xylem cells production makes it an ideal target for the tree breeding programs; however our knowledge about control of cambium proliferation remains limited. The morphology and regulation of cambium are different from those of stem cell niches that control axial growth. For this reason, translating the knowledge about axial growth to radial growth has limited use. Furthermore, genetic approaches cannot be easily applied because overlaying tissues conceal cambium from direct observation and complicate identification of mutants. To overcome the paucity of experimental tools in cambium biology, we constructed a Boolean network CARENET (CAmbium REgulation gene NETwork) for modelling cambium activity, which includes the key transcription factors WOX4 and HD-ZIP III as well as their potential regulators. Our simulations predict that: (1) auxin, cytokinin, gibberellin, and brassinosteroids act cooperatively in promoting transcription of WOX4 and HD-ZIP III; (2) auxin and cytokinin pathways negatively regulate each other; (3) hormonal pathways act redundantly in sustaining cambium activity; (4) individual cambium cells can have diverse molecular identities. CARENET can be extended to include components of other signalling pathways and be integrated with models of xylem and phloem differentiation. Such extended models would facilitate breeding trees with higher wood yield.	[Oles, Vladyslav; Panchenko, Alexander] Washington State Univ, Dept Math, Pullman, WA 99164 USA; [Smertenko, Andrei] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Panchenko, A (corresponding author), Washington State Univ, Dept Math, Pullman, WA 99164 USA.; Smertenko, A (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	panchenko@math.wsu.edu; andrei.smertenko@wsu.edu		Smertenko, Andrei/0000-0002-5078-4881	NIFA hatch project [WNP00826]	NIFA hatch project	This project was supported by NIFA hatch project WNP00826 (to AS).	Agusti J, 2013, MECH DEVELOP, V130, P34, DOI 10.1016/j.mod.2012.05.011; Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Agusti J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001312; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Benitez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063108; Bhalerao RP, 2014, PHYSIOL PLANTARUM, V151, P43, DOI 10.1111/ppl.12134; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Ckurshumova W, 2014, NEW PHYTOL, V204, P556, DOI 10.1111/nph.13014; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Ding ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1941; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Etchells JP, 2015, CURR BIOL, V25, P1050, DOI 10.1016/j.cub.2015.02.023; Etchells JP, 2013, DEVELOPMENT, V140, P2224, DOI 10.1242/dev.091314; Etchells JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002997; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Furuta KM, 2014, ANNU REV PLANT BIOL, V65, P607, DOI 10.1146/annurev-arplant-050213-040306; Gerttula S, 2015, PLANT CELL, V27, P2800, DOI 10.1105/tpc.15.00531; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Jouannet V, 2015, CURR OPIN PLANT BIOL, V23, P54, DOI 10.1016/j.pbi.2014.10.010; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; Lavenus J, 2015, PLANT CELL, V27, P1368, DOI 10.1105/tpc.114.132993; Liebsch D, 2014, DEVELOPMENT, V141, P4311, DOI 10.1242/dev.111369; Little CHA, 2002, INT J PLANT SCI, V163, P519, DOI 10.1086/339642; Liu LJ, 2015, NEW PHYTOL, V205, P682, DOI 10.1111/nph.13151; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Milhinhos A, 2013, PLANT CELL REP, V32, P867, DOI 10.1007/s00299-013-1420-7; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Oh MH, 2011, PLANT PHYSIOL, V157, P120, DOI 10.1104/pp.111.182741; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Pernisova M, 2009, P NATL ACAD SCI USA, V106, P3609, DOI 10.1073/pnas.0811539106; Ragni L, 2014, PHYSIOL PLANTARUM, V151, P164, DOI 10.1111/ppl.12118; Ragni L, 2011, PLANT CELL, V23, P1322, DOI 10.1105/tpc.111.084020; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Sanio K., 1872, JB WISS BOT, V8, P401; Sankar M, 2011, BIOINFORMATICS, V27, P1404, DOI 10.1093/bioinformatics/btr158; Sawchuk MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003294; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Shmulevich I., 2014, GENOMIC SIGNAL PROCE; Shmulevich I., 2010, PROB BOOL NETW; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Veliz-Cuba A, 2015, ELECTRON NOTES THEOR, V316, P83, DOI 10.1016/j.entcs.2015.06.012; Voss U, 2014, TRENDS PLANT SCI, V19, P311, DOI 10.1016/j.tplants.2014.02.004; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang JH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-94; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	76	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171927	10.1371/journal.pone.0171927	http://dx.doi.org/10.1371/journal.pone.0171927			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187161	Green Submitted, gold, Green Published			2022-12-27	WOS:000394244300061
J	Dutra, LM; Glantz, SA; Lisha, NE; Song, AV				Dutra, Lauren M.; Glantz, Stanton A.; Lisha, Nadra E.; Song, Anna V.			Beyond experimentation: Five trajectories of cigarette smoking in a longitudinal sample of youth	PLOS ONE			English	Article							GROWTH MIXTURE-MODELS; DEVELOPMENTAL TRAJECTORIES; YOUNG ADULTHOOD; HIGH-SCHOOL; EMERGING ADULTHOOD; EARLY ADOLESCENCE; COLLEGE-STUDENTS; PREDICT INSOMNIA; NATURAL-HISTORY; TOBACCO-CONTROL	The first goal of this study was to identify the most appropriate measure of cigarette smoking for identifying unique smoking trajectories among adolescents; the second goal was to describe the resulting trajectories and their characteristics. Using 15 annual waves of smoking data in the National Longitudinal Survey of Youth 1997 (NLSY97), we conducted an exploratory latent class growth analysis to determine the best of four outcome variables for yearly smoking (cigarettes per day on days smoked, days smoked per month, mean cigarettes per day, and total cigarettes per month) among individuals aged 12 to 30 (n = 8,791). Days smoked per month was the best outcome variable for identifying unique longitudinal trajectories of smoking and characteristics of these trajectories that could be used to target different types of smokers for prevention and cessation. Objective statistics were used to identify four trajectories in addition to never smokers (34.1%): experimenters (13.6%), quitters (8.1%), early established smokers (39.0%), and late escalators (5.2%). We identified a quitter and late escalator class not identified in the only other comparable latent class growth analysis. Logistic regressions were used to identify the characteristics of individuals in each trajectory. Compared with never smokers, all trajectories except late escalators were less likely to be black; experimenters were more likely to be out of school and unemployed and drink alcohol in adolescence; quitters were more likely to have a mother with a high school degree/GED or higher (versus none) and to use substances in adolescence and less likely to have ever married as a young adult; early established smokers were more likely to have a mother with a high school diploma or GED, be out of school and unemployed, not live with both parents, have used substances, be depressed, and have peers who smoked in adolescence and to have children as young adults and less likely to be Hispanic and to have ever married as young adults; and late escalators were more likely to be Hispanic, drink alcohol, and break rules in adolescence and less likely to have ever married as young adults. Because of the number of waves of data analyzed, this analysis provided a clearer temporal depiction of smoking behavior and more easily distinguishable smoking trajectories than previous analyses. Tobacco control interventions need to move beyond youth-focused approaches to reach all smokers.	[Dutra, Lauren M.; Glantz, Stanton A.; Lisha, Nadra E.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Dutra, Lauren M.] RTI Int, Ctr Hlth Policy Sci & Tobacco Res, Berkeley, CA USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Song, Anna V.] Univ Calif Merced, Psychol Sci Hlth Sci Res Inst, Merced, CA USA	University of California System; University of California San Francisco; Research Triangle Institute; University of California System; University of California San Francisco; University of California System; University of California Merced	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.; Glantz, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu		Dutra, Lauren/0000-0001-8505-7994; Glantz, Stanton/0000-0003-4620-6672	National Institutes of Health and Food and Drug Administration Center for Tobacco Products [R01 CA-060121, R25CA-113710, P50CA180890, 1U01CA154240]; NATIONAL CANCER INSTITUTE [R25CA113710, P50CA180890, T32CA113710, R01CA061021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043950] Funding Source: NIH RePORTER	National Institutes of Health and Food and Drug Administration Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by R01 CA-060121 (Drs. Glantz and Song), R25CA-113710 and P50CA180890 (Dr. Dutra), 1U01CA154240 (Dr. Lisha) from the National Institutes of Health and Food and Drug Administration Center for Tobacco Products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US FDA. This research was conducted with Bureau of Labor Statistics data. The views expressed here do not necessarily reflect the views of the Bureau of Labor Statistics.	Abroms L, 2005, ADDICTION, V100, P852, DOI 10.1111/j.1360-0443.2005.01090.x; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Akhtar-Khaleel WZ, 2016, AIDS BEHAV; Amstadter AB, 2009, J TRAUMA STRESS, V22, P113, DOI 10.1002/jts.20398; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bauer DJ, 2003, PSYCHOL METHODS, V8, P338, DOI 10.1037/1082-989X.8.3.338; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P188, DOI 10.1093/jpepsy/jst085; Bernat DH, 2008, J ADOLESCENT HEALTH, V43, P334, DOI 10.1016/j.jadohealth.2008.02.014; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Brook DW, 2012, SLEEP MED, V13, P1130, DOI 10.1016/j.sleep.2012.05.008; Brook JS, 2006, NICOTINE TOB RES, V8, P639, DOI 10.1080/14622200600789627; Brook JS, 2014, NICOTINE TOB RES, V16, P1559, DOI 10.1093/ntr/ntu107; Brown AE, 2011, ADDICT BEHAV, V36, P1199, DOI 10.1016/j.addbeh.2011.07.024; Caldeira KM, 2012, NICOTINE TOB RES, V14, P777, DOI 10.1093/ntr/nts131; Centers for Disease Control and Prevention, 2015, CAMP OV; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1434; Chassin L, 2000, HEALTH PSYCHOL, V19, P223, DOI 10.1037//0278-6133.19.3.223; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; Cheng KW, 2015, TOB CONTROL, V24, P168, DOI 10.1136/tobaccocontrol-2013-051121; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Colder CR, 2008, ADDICTION, V103, P1534, DOI 10.1111/j.1360-0443.2008.02280.x; Costello DM, 2008, HEALTH PSYCHOL, V27, P811, DOI 10.1037/0278-6133.27.6.811; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Etzel RA, 2015, PEDIATRICS, V136, P998, DOI 10.1542/peds.2015-3109; Frosch ZAK, 2009, ADDICT BEHAV, V34, P701, DOI 10.1016/j.addbeh.2009.04.007; Fuemmeler B, 2013, DRUG ALCOHOL DEPEN, V132, P301, DOI 10.1016/j.drugalcdep.2013.02.021; Glantz SA, 2012, PRIMER BIOSTATISTICS; Glenn N, 2009, IS APPARENT U SHAPE, V66, P1733; Glenn N, 2009, SOC SCI MED, V69, P481, DOI 10.1016/j.socscimed.2009.05.038; Hampson SE, 2013, NICOTINE TOB RES, V15, P1400, DOI 10.1093/ntr/nts338; Husten CG, 2009, NICOTINE TOB RES, V11, P111, DOI 10.1093/ntr/ntp010; Hyland A, 2009, NICOTINE TOB RES, V11, P614, DOI 10.1093/ntr/ntp022; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Karp I, 2005, ANN EPIDEMIOL, V15, P445, DOI 10.1016/j.annepidem.2004.10.002; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Lee JY, 2016, SUBST USE MISUSE, V51, P616, DOI 10.3109/10826084.2015.1126747; Lessov-Schlaggar CN, 2012, ADDICTION, V107, P1696, DOI 10.1111/j.1360-0443.2012.03871.x; Ling PM, 2014, AM J PUBLIC HEALTH, V104, P751, DOI 10.2105/AJPH.2013.301666; Ling PM, 2002, JAMA-J AM MED ASSOC, V287, P2983, DOI 10.1001/jama.287.22.2983; Long J.S., 2006, REGRESSION MODELS CA; Mays D, 2014, PEDIATRICS, V133, P983, DOI 10.1542/peds.2013-3003; Morgan GB, 2014, STRUCTURAL EQUATION, V22, P76; Munafo M, 2008, NICOTINE TOB RES, V10, P1609, DOI 10.1080/14622200802412895; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen B, 2003, PSYCHOL METHODS, V8, P369, DOI 10.1037/1082-989X.8.3.369; Muthen B, 2016, COMMUNICATION; Muthen L.K., 2010, MPLUS USERS GUIDE; Muthen LK, GOODNESS FIT STAT MI; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Orlando M, 2004, J CONSULT CLIN PSYCH, V72, P400, DOI 10.1037/0022-006X.72.3.400; Orpinas P, 2016, NICOTINE TOB RES, V18, P156, DOI 10.1093/ntr/ntv040; Pollard MS, 2010, ADDICT BEHAV, V35, P678, DOI 10.1016/j.addbeh.2010.02.013; Riggs NR, 2007, NICOTINE TOB RES, V9, P1147, DOI 10.1080/14622200701648359; Schane RE, 2009, ARCH INTERN MED, V169, P1742, DOI 10.1001/archinternmed.2009.315; Scott-Sheldon LAJ, 2010, NICOTINE TOB RES, V12, P1019, DOI 10.1093/ntr/ntq142; Shmueli D, 2010, AM J PREV MED, V38, P351, DOI 10.1016/j.amepre.2009.12.025; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Song AV, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.2285; Stanton WR, 2004, NICOTINE TOB RES, V6, P843, DOI 10.1080/14622200410001734076; Tucker JS, 2006, WOMEN HEALTH ISS, V16, P30, DOI 10.1016/j.whi.2005.08.004; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Tukey JW, 1977, EXPLORATORY DATA ANA; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Vijayaraghavan M, 2013, AM J PUBLIC HEALTH, V103, P2276, DOI 10.2105/AJPH.2013.301300; White HR, 2002, DRUG ALCOHOL DEPEN, V65, P167, DOI 10.1016/S0376-8716(01)00159-4	66	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171808	10.1371/journal.pone.0171808	http://dx.doi.org/10.1371/journal.pone.0171808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182748	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800116
J	Wu, LF; Lin, J; Jin, ZC; Cai, XB; Gao, WY				Wu, Lingfeng; Lin, Jun; Jin, Zhicheng; Cai, Xiaobin; Gao, Weiyang			Comparison of clinical and radiological outcomes between opening-wedge and closing-wedge high tibial osteotomy: A comprehensive meta-analysis	PLOS ONE			English	Article							CLOSED-WEDGE; PATELLAR HEIGHT; KNEE; OSTEOARTHRITIS; ALIGNMENT; SLOPE; RADIOSTEREOMETRY; HEMICALLOTASIS; LENGTH; TRIAL	High tibial osteotomy (HTO) has been widely used for clinical treatment of osteoarthritis of the medial compartment of the knee, and both opening-wedge and closing-wedge HTO are the most commonly used methods. However, it remains unclear which technique has better clinical and radiological outcomes in practice. To systematically evaluate this issue, we conducted a comprehensive meta-analysis by pooling all available data for the opening-wedge HTO and closing-wedge HTO techniques from the electronic databases including PubMed, Embase, Wed of Science and Cochrane Library. A total of 22 studies encompassing 2582 cases were finally enrolled in the meta-analysis. There was no significant difference regarding surgery time, duration of hospitalization, knee pain VAS, Lysholm score and HSS knee score (clinical outcomes) between the opening-wedge and closing-wedge HTO groups (P > 0.05). However, the opening-wedge HTO group showed wider range of motion than the closing-wedge HTO group (P = 0.003). Moreover, as for Hip-Knee-Ankle angle and mean angle of correction, no significant difference was observed between the opening-wedge and closing-wedge HTO groups (P > 0.05), while the opening-wedge HTO group showed greater posterior tibial slope angle (P < 0.001) and lesser patellar height than the closing-wedge HTO group (P < 0.001). On light of the above analysis, we believe that individualized surgical approach should be introduced based on the clinical characteristics of each patient.	[Wu, Lingfeng; Cai, Xiaobin] Wenzhou Med Univ, Affiliated Hosp 5, Dept Orthoped, Lishui, Peoples R China; [Wu, Lingfeng; Cai, Xiaobin] Wenzhou Med Univ, Cent Hosp Lishui City, Lishui, Peoples R China; [Lin, Jun] Qingyuan Country Peoples Hosp, Dept Orthoped, Lishui, Peoples R China; [Jin, Zhicheng] Wenzhou Med Univ, Clin Med Coll 2, Dept Surg, Wenzhou, Peoples R China; [Gao, Weiyang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped, Wenzhou, Peoples R China; [Gao, Weiyang] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Gao, WY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped, Wenzhou, Peoples R China.; Gao, WY (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	wmu_gwy@163.com			Science and Technology Bureau of Lishui [2014JYZB24]	Science and Technology Bureau of Lishui	This study was supported by the Science and Technology Bureau of Lishui (No. 2014JYZB24). The funder has no role in study design, data collection, manuscript preparation and submission.	Agneskirchner JD, 2007, ARTHROSCOPY, V23, P852, DOI 10.1016/j.arthro.2007.05.018; Amzallag J, 2013, KNEE SURG SPORT TR A, V21, P255, DOI 10.1007/s00167-012-2304-z; Asada S, 2012, KNEE SURG SPORT TR A, V20, P571, DOI 10.1007/s00167-011-1610-1; Bae DK, 2013, KNEE SURG SPORT TR A, V21, P120, DOI 10.1007/s00167-012-1898-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brouwer RW, 2006, J BONE JOINT SURG BR, V88B, P1454, DOI 10.1302/0301-620X.88B11.17743; Brouwer RW, 2005, J BONE JOINT SURG BR, V87B, P1227, DOI 10.1302/0301-620X.87B9.15972; Brouwer RW, 2014, COCHRANE DB SYST REV, V12; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; Deie M, 2014, KNEE, V21, P1046, DOI 10.1016/j.knee.2014.04.007; Ducat A, 2012, ORTHOP TRAUMATOL-SUR, V98, P68, DOI 10.1016/j.otsr.2011.08.013; Duivenvoorden T, 2014, J BONE JOINT SURG AM, V96A, P1425, DOI 10.2106/JBJS.M.00786; Duivenvoorden T, 2015, KNEE SURG SPORTS TRA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Azab H, 2008, J BONE JOINT SURG BR, V90B, P1193, DOI 10.1302/0301-620X.90B9.20688; El-Azab H, 2010, AM J SPORT MED, V38, P323, DOI 10.1177/0363546509348050; Esenkaya I, 2012, STRATEG TRAUMA LIMB, V7, P13, DOI 10.1007/s11751-012-0131-x; Fibel KH, 2015, WORLD J CLIN CASES, V3, P89, DOI 10.12998/wjcc.v3.i2.89; Gaasbeek RDA, 2010, INT ORTHOP, V34, P201, DOI 10.1007/s00264-009-0861-7; Giffin JR, 2004, AM J SPORT MED, V32, P376, DOI 10.1177/0363546503258880; Hankemeier S, 2010, KNEE SURG SPORT TR A, V18, P1328, DOI 10.1007/s00167-009-1020-9; Hoell S, 2005, ARCH ORTHOP TRAUM SU, V125, P638, DOI 10.1007/s00402-005-0004-6; Lee Dong Chul, 2012, Knee Surg Relat Res, V24, P61, DOI 10.5792/ksrr.2012.24.2.61; Luites JWH, 2009, J BONE JOINT SURG BR, V91B, P1459, DOI 10.1302/0301-620X.91B11.22614; Magnussen RA, 2011, AM J SPORT MED, V39, P1900, DOI 10.1177/0363546511410025; Magyar G, 1999, ACTA ORTHOP SCAND, V70, P473, DOI 10.3109/17453679909000983; Magyar G, 1999, J BONE JOINT SURG BR, V81B, P444, DOI 10.1302/0301-620X.81B3.8925; Nakamura E, 2001, J BONE JOINT SURG BR, V83B, P1111, DOI 10.1302/0301-620X.83B8.11993; Nerhus TK, 2015, KNEE SURG SPORTS TRA; Portner O, 2014, CLIN ORTHOP RELAT R, V472, P3432, DOI 10.1007/s11999-014-3821-5; Schaefer TK, 2008, J INT MED RES, V36, P1085, DOI 10.1177/147323000803600528; Song EK, 2010, J BONE JOINT SURG BR, V92B, P1245, DOI 10.1302/0301-620X.92B9.23660; Song IH, 2012, ARTHROSCOPY, V28, P1087, DOI 10.1016/j.arthro.2012.02.002; Tabrizi A, 2013, MALAYS ORTHOP J, V7, P7, DOI 10.5704/MOJ.1303.009; Takeuchi R, 2009, ARTHROSCOPY, V25, P46, DOI 10.1016/j.arthro.2008.08.015; van den Bekerom Michel P J, 2008, J Knee Surg, V21, P68; van Egmond N, 2016, KNEE SURG SPORT TR A, V24, P34, DOI 10.1007/s00167-014-3303-z; van Raaij TM, 2008, ACTA ORTHOP, V79, P508, DOI 10.1080/17453670710015508	38	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171700	10.1371/journal.pone.0171700	http://dx.doi.org/10.1371/journal.pone.0171700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182736	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800093
J	Byun, TM; Tiede, M				Byun, Tara McAllister; Tiede, Mark			Perception-production relations in later development of American English rhotics	PLOS ONE			English	Article							R-VERTICAL-BAR; AUDITORY-FEEDBACK CONTROL; SPEECH SOUND DISORDERS; SENSORIMOTOR ADAPTATION; CHILDREN; VOWEL; DISCRIMINATION; ARTICULATION; DYSLEXIA; PERTURBATION	It is known that some adult listeners have more sharply defined perceptual categories than others, and listeners with more precise auditory targets are also more precise in their production of contrasts. There is additionally evidence that children who have not yet mastered production of a contrast show diminished performance on perceptual measures of the same contrast. To date, however, few studies have investigated developmental perception-production relations using the fine-grained measures typical of adult studies. Existing evidence suggests that perception and production can be closely connected in development, but this relationship may break down as perception and articulation mature at different rates. This study evaluated perception and production of the English /r-w/ contrast in 40 typically-developing children aged 9-14. Perceptual sensitivity was measured with a logistic function fitted over responses in a forced-choice identification task using two synthetic 10-step continua from rake to wake. Participants also produced rhotic and non-rhotic words. Across participants, there was a significant correlation between perceptual acuity and rhoticity in production, although this effect was only observed for one of two continua tested. These results provide preliminary evidence compatible with the hypothesis that children with a more refined auditory target for a sound also produce that sound more accurately.	[Byun, Tara McAllister] NYU, Dept Commun Sci & Disorders, New York, NY 10003 USA; [Tiede, Mark] Haskins Labs Inc, New Haven, CT USA	New York University; Yale University; Haskins Laboratories	Byun, TM (corresponding author), NYU, Dept Commun Sci & Disorders, New York, NY 10003 USA.	tara.byun@nyu.edu			NIH NIDCD grant [R03DC012883, R01DC013668]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013668, R03DC012883] Funding Source: NIH RePORTER	NIH NIDCD grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by NIH NIDCD grant R03DC012883 to TMB and R01DC013668 to TMB and MT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Bock M, 2007, AM J SPEECH-LANG PAT, V16, P128, DOI 10.1044/1058-0360(2007/017); Becker M, 2013, EXPERIGEN D ONLINE E; Blomert L, 2004, J SPEECH LANG HEAR R, V47, P1030, DOI 10.1044/1092-4388(2004/077); Boersma P., 2015, PRAAT; Boyce S, 1997, J ACOUST SOC AM, V101, P3741, DOI 10.1121/1.418333; Boyce SE, 2015, SEMIN SPEECH LANG, V36, P257, DOI 10.1055/s-0035-1562909; Burris C, 2014, J SPEECH LANG HEAR R, V57, P26, DOI 10.1044/1092-4388(2013/12-0103); Byun T McAllister, 2016, INT J LANG IN PRESS; Byun TM, 2015, J COMMUN DISORD, V53, P70, DOI 10.1016/j.jcomdis.2014.11.003; Byun TM, 2012, CLIN LINGUIST PHONET, V26, P397, DOI 10.3109/02699206.2011.641060; Cai SQ, 2010, J ACOUST SOC AM, V128, P2033, DOI 10.1121/1.3479539; Callan DE, 2000, J SPEECH LANG HEAR R, V43, P721, DOI 10.1044/jslhr.4303.721; DELATTRE P, 1968, LINGUISTICS, P29; Ghosh SS, 2010, J ACOUST SOC AM, V128, P3079, DOI 10.1121/1.3493430; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 1999, J ACOUST SOC AM, V105, P2854, DOI 10.1121/1.426900; Hagiwara R., 1995, THESIS; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; HOFFMAN PR, 1985, J SPEECH HEAR DISORD, V50, P46, DOI 10.1044/jshd.5001.46; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Idemaru K, 2013, J ACOUST SOC AM, V133, P4232, DOI 10.1121/1.4802905; Klein HB, 2013, AM J SPEECH-LANG PAT, V22, P540, DOI 10.1044/1058-0360(2013/12-0137); KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Lane H, 2005, J ACOUST SOC AM, V118, P1636, DOI 10.1121/1.2001527; Lane H, 2007, J SPEECH LANG HEAR R, V50, P913, DOI 10.1044/1092-4388(2007/065); Lennes M., 2003, COLLECT FORMANT DATA; Lewis BA, 1994, P MIN ANN CONV AM SP; Lin S, 2015, J SPEECH LANG HEAR R, V58, P13, DOI 10.1044/2014_JSLHR-S-14-0041; LOCKE JL, 1980, J SPEECH HEAR DISORD, V45, P431, DOI 10.1044/jshd.4504.431; Manis FR, 1997, J EXP CHILD PSYCHOL, V66, P211, DOI 10.1006/jecp.1997.2383; Matthies ML, 2008, J ACOUST SOC AM, V124, P3191, DOI 10.1121/1.2987427; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; McBrideChang C, 1996, CHILD DEV, V67, P1836, DOI 10.1111/j.1467-8624.1996.tb01831.x; McGowan RS, 2004, J ACOUST SOC AM, V115, P871, DOI 10.1121/1.1642624; Menard L, 2008, J ACOUST SOC AM, V124, P1192, DOI 10.1121/1.2945704; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); Mielke J, 2016, LANGUAGE, V92, P101, DOI 10.1353/lan.2016.0019; Munson B., 2012, PERSPECT LANG LEARN, V19, P19, DOI 10.1044/lle19.1.19; Newman RS, 2003, J ACOUST SOC AM, V113, P2850, DOI 10.1121/1.1567280; Perkell JS, 2004, J SPEECH LANG HEAR R, V47, P1259, DOI 10.1044/1092-4388(2004/095); Perkell JS, 2004, J ACOUST SOC AM, V116, P2338, DOI 10.1121/1.1787524; Preston JL, 2015, SEMIN SPEECH LANG, V36, P224, DOI 10.1055/s-0035-1562906; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; RUSCELLO DM, 1995, J COMMUN DISORD, V28, P279, DOI 10.1016/0021-9924(95)00058-X; RVACHEW S, 1989, J SPEECH HEAR DISORD, V54, P193, DOI 10.1044/jshd.5402.193; Scobbie JM, 2015, P 18 ICPHS GLASG; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Shiller DM, 2014, J EXP PSYCHOL HUMAN, V40, P1308, DOI 10.1037/a0036660; Shiller DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012975; Shuster LI, 1998, J SPEECH LANG HEAR R, V41, P941, DOI 10.1044/jslhr.4104.941; SMIT AB, 1990, J SPEECH HEAR DISORD, V55, P779, DOI 10.1044/jshd.5504.779; Terband H, 2014, J COMMUN DISORD, V51, P64, DOI 10.1016/j.jcomdis.2014.06.009; Terband H, 2009, J SPEECH LANG HEAR R, V52, P1595, DOI 10.1044/1092-4388(2009/07-0283); Tiede M.K., 2004, J ACOUST SOC AM, V115, P2633, DOI [10.1121/1.4784878, DOI 10.1121/1.4784878]; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Whitehill TL, 2003, J SPEECH LANG HEAR R, V46, P451, DOI 10.1044/1092-4388(2003/037)	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172022	10.1371/journal.pone.0172022	http://dx.doi.org/10.1371/journal.pone.0172022			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207800	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500074
J	Cao, P; Dou, GF; Cheng, YG; Che, JJ				Cao, Ping; Dou, Guifang; Cheng, Yuanguo; Che, Jinjing			The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 FUSION INHIBITOR; MEMBRANE MICRODOMAINS; PHOSPHOLIPASES A(2); PROTEIN; GP41; IDENTIFICATION; REPLICATION; STABILITY; PEPTIDES	Most mechanistic studies on human immunodeficiency virus (HIV) peptide fusion inhibitors have focused on the interactions between fusion inhibitors and viral envelope proteins. However, the interactions of fusion inhibitors with viral membranes are also essential for the efficacy of these drugs. Here, we utilized surface plasmon resonance (SPR) technology to study the interactions between the HIV fusion inhibitor peptides sifuvirtide and enfuvirtide and biomembrane models. Sifuvirtide presented selectivity toward biomembrane models composed of saturated dipalmitoylphosphatidylcholine (DPPC) (32-fold higher compared with unsaturated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine [POPC]) and sphingomyelin (SM) (31-fold higher compared with POPC), which are rigid compositions enriched in the HIV viral membrane. In contrast, enfuvirtide showed no significant selectively toward these rigid membrane models. Furthermore, the bindings of sifuvirtide and enfuvirtide to SM bilayers were markedly higher than those to monolayers (14-fold and 23-fold, respectively), indicating that the inner leaflet influences the binding of these drugs to SM bilayers. No obvious differences were noted in the bindings of either peptide to the other mono-and bilayer models tested, illustrating that both peptides interact with these membranes through surface-binding. The bindings of the inhibitor peptides to biomembranes were found to be driven predominantly by hydrophobic interactions rather than electrostatic interactions, as determined by comparing their affinities to those of positively charged 1-palmitoyl-2-oleoylsn- glycero-3-ethylphosphocholine (EPC) to zwitterionic membrane models. The improved efficiency of sifuvirtide relative to enfuvirtide might be related to its ability to adsorb on rigid lipidic areas, such as the viral envelope and lipid rafts, which results in an increased sifuvirtide concentration at the fusion site.	[Cao, Ping; Dou, Guifang] Beijing Inst Transfus Med, State Key Lab Drug Metab, Lab Hematol Pharmacol, Beijing, Peoples R China; [Cao, Ping; Cheng, Yuanguo] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Che, Jinjing] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Cheng, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.; Che, JJ (corresponding author), Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.	chengyuanguo@vip.sina.com; chejinjing80@126.com			National Natural Science Foundation of People's Republic of China [81001458]	National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of People's Republic of China, Grant No.81001458. Jinjing Che, the sponsors, had the role of Conceptualization, Methodology, Project Administration, Validation, Visualization and Writing Review & Editing.; We would like to thank Dr. Qingfang Meng for providing help during the development of the experimental methods and Baihui Hu for providing technical assistance. This work was supported by the National Natural Science Foundation of People's Republic of China (grant No.81001458).	Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Del Vecchio K, 2016, METHODS MOL BIOL, V1376, P141, DOI 10.1007/978-1-4939-3170-5_12; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; Dwyer JJ, 2008, PROTEIN SCI, V17, P633, DOI 10.1110/ps.073307608; Franquelim HG, 2008, J AM CHEM SOC, V130, P6215, DOI 10.1021/ja711247n; Franquelim HG, 2010, BBA-BIOMEMBRANES, V1798, P1234, DOI 10.1016/j.bbamem.2010.02.010; Hall D, 2001, ANAL BIOCHEM, V288, P109, DOI 10.1006/abio.2000.4851; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hollmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060302; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Kilby JM, 2003, NEW ENGL J MED, V348, P2228, DOI 10.1056/NEJMra022812; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; Meng QF, 2014, J PHARM SCI-US, V103, P4038, DOI 10.1002/jps.24174; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2008, BIOORGAN MED CHEM, V16, P9184, DOI 10.1016/j.bmc.2008.09.018; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Veiga S, 2004, BIOCHEM J, V377, P107, DOI 10.1042/BJ20031350; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Zhang XB, 2011, PEPTIDE DRUG DISCOVERY AND DEVELOPMENT: TRANSLATIONAL RESEARCH IN ACADEMIA AND INDUSTRY, P231, DOI 10.1109/NCIS.2011.52	32	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171567	10.1371/journal.pone.0171567	http://dx.doi.org/10.1371/journal.pone.0171567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207776	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500039
J	Matsumoto, Y; Mori, S; Ueda, K; Kurimoto, T; Kanamori, A; Yamada, Y; Nakashima, I; Nakamura, M				Matsumoto, Yoshiko; Mori, Sotaro; Ueda, Kaori; Kurimoto, Takuji; Kanamori, Akiyasu; Yamada, Yuko; Nakashima, Ichiro; Nakamura, Makoto			Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis	PLOS ONE			English	Article							NERVE-FIBER LAYER; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS-OPTICA; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; SPECTRUM DISORDER; AQUAPORIN 4; THICKNESS; NMO; ABNORMALITIES	Purpose An autoantibody against aquaporin-4 (AQP4 Ab) is highly specific for neuromyelitis optica spectrum disorder and plays a pathogenic role in this disease. The purpose of this study was to investigate the impact of AQP4 Ab on inner retinal structure, function, and the structure -function relationships in eyes with optic neuritis. Methods Thirty five eyes from 25 cases who had received visual function tests and RTVue optical coherence tomography (OCT) measurement at least six months after the latest episode of optic neuritis were enrolled. Patients with multiple sclerosis were excluded. AQP4 Ab was measured using a cell -based assay. Visual acuity, mean deviation (MD) of the Humphrey visual field SITA standard 30-2 tests, retinal nerve fiber layer (RNFL), ganglion cell complex (GCC) thicknesses, and other clinical variables were compared between the AQP4 Ab-positive and-negative groups. Parameters associated with visual functions were evaluated by generalized estimating equation (GEE) models. Results The AQP4 Ab-positive group (20 eyes from 12 cases) had a higher proportion of bilateral involvement and longer duration of follow-up than the AQP4 Ab-negative group (15 eyes from 13 cases). Linear mixed effect models revealed worse MD and visual acuity in AQP4 Ab-positive eyes than those in AQP4 Ab-negative eyes after adjusting for within -patient inter-eye dependence, whereas there were no differences in RNFL and GCC thickness between the two groups. In seropositive eyes, GEE regression analyses revealed that depending on age and the number of recurrences of ON episodes, OCT parameters correlated strongly with MD and more weakly with visual acuity. Conclusions Reductions in RNFL and GCC thickness were proportional to the visual field defect in eyes with AQP4 Ab but not in eyes without AQP4 Ab. The presence of AQP4 Ab probably plays a critical role in retinal ganglion cell loss in optic neuritis.	[Matsumoto, Yoshiko; Mori, Sotaro; Ueda, Kaori; Kurimoto, Takuji; Kanamori, Akiyasu; Yamada, Yuko; Nakamura, Makoto] Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo, Japan; [Nakashima, Ichiro] Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi, Japan	Kobe University; Tohoku University	Matsumoto, Y (corresponding author), Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo, Japan.	manakamu@med.kobe-u.ac.jp	Mori, Sotaro/AAD-2574-2022; Nakashima, Ichiro/AAC-3073-2019	Mori, Sotaro/0000-0003-1991-3232; Nakashima, Ichiro/0000-0002-2612-8948; Nakamura, Makoto/0000-0002-6464-4302	Japan Society of the Promotion Science [26462661]	Japan Society of the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid 26462661 (MN, AK, YY) from Japan Society of the Promotion Science (URL https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi T, 2016, J NEUROIMMUNOL, V293, P28, DOI 10.1016/j.jneuroim.2016.02.004; Akaishi T, 2016, J NEUROL NEUROSUR PS, V87, P446, DOI 10.1136/jnnp-2014-310206; Akashi A, 2015, INVEST OPHTH VIS SCI, V56, P6573, DOI 10.1167/iovs.15-17635; Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216; Bichuetti DB, 2013, J NEURO-OPHTHALMOL, V33, P220, DOI 10.1097/WNO.0b013e31829f39f1; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Harwerth RS, 2008, GRAEF ARCH CLIN EXP, V246, P305, DOI 10.1007/s00417-007-0691-5; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Kanamori A, 2003, OPHTHALMOLOGICA, V217, P273, DOI 10.1159/000070634; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Lange AP, 2013, J NEURO-OPHTHALMOL, V33, P213, DOI 10.1097/WNO.0b013e31829c510e; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Martinez-Hernandez E, 2015, JAMA NEUROL, V72, P187, DOI 10.1001/jamaneurol.2014.3602; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Matsumoto Y, 2014, EXP EYE RES, V119, P61, DOI 10.1016/j.exer.2013.12.010; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Merle H, 2007, OPHTHALMOLOGY, V114, P810, DOI 10.1016/j.ophtha.2006.06.060; Merle H, 2012, ARCH OPHTHALMOL-CHIC, V130, P858, DOI 10.1001/archophthalmol.2012.1126; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Naismith RT, 2009, NEUROLOGY, V73, P46, DOI 10.1212/WNL.0b013e3181aaea32; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Nakamura M, 2012, GRAEF ARCH CLIN EXP, V250, P1499, DOI 10.1007/s00417-012-2095-4; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Outteryck O, 2015, MULT SCLER J, V21, P1781, DOI 10.1177/1352458515578888; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Ueda K, 2016, J GLAUCOMA, V25, P383, DOI 10.1097/IJG.0000000000000216; von Glehn F, 2014, MULT SCLER J, V20, P1189, DOI 10.1177/1352458513519838; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	42	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171880	10.1371/journal.pone.0171880	http://dx.doi.org/10.1371/journal.pone.0171880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199381	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400057
J	McKenzie, LM; Allshouse, WB; Byers, TE; Bedrick, EJ; Serdar, B; Adgate, JL				McKenzie, Lisa M.; Allshouse, William B.; Byers, Tim E.; Bedrick, Edward J.; Serdar, Berrin; Adgate, John L.			Childhood hematologic cancer and residential proximity to oil and gas development	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PARENTAL OCCUPATIONAL-EXPOSURE; VOLATILE ORGANIC-COMPOUNDS; AMBIENT AIR-POLLUTION; BRITISH-COLUMBIA; BENZENE EXPOSURE; BIRTH OUTCOMES; RISK; HYDROCARBONS; PREGNANCY	Background Oil and gas development emits known hematological carcinogens, such as benzene, and increasingly occurs in residential areas. We explored whether residential proximity to oil and gas development was associated with risk for hematologic cancers using a registry-based case-control study design. Methods Participants were 0-24 years old, living in rural Colorado, and diagnosed with cancer between 2001-2013. For each child in our study, we calculated inverse distance weighted (IDW) oil and gas well counts within a 16.1-kilometer radius of residence at cancer diagnosis for each year in a 10 year latency period to estimate density of oil and gas development. Logistic regression, adjusted for age, race, gender, income, and elevation was used to estimate associations across IDW well count tertiles for 87 acute lymphocytic leukemia (ALL) cases and 50 non-Hodgkin lymphoma (NHL) cases, compared to 528 controls with non-hematologic cancers. Findings Overall, ALL cases 0-24 years old were more likely to live in the highest IDW well count tertiles compared to controls, but findings differed substantially by age. For ages 5-24, ALL cases were 4.3 times as likely to live in the highest tertile, compared to controls (95% CI: 1.1 to 16), with a monotonic increase in risk across tertiles (trend p-value = 0.035). Further adjustment for year of diagnosis increased the association. No association was found between ALL for children aged 0-4 years or NHL and IDW well counts. While our study benefited from the ability to select cases and controls from the same population, use of cancer- controls, the limited number of ALL and NHL cases, and aggregation of ages into five year ranges, may have biased our associations toward the null. In addition, absence of information on O&G well activities, meteorology, and topography likely reduced temporal and spatial specificity in IDW well counts. Conclusion Because oil and gas development has potential to expose a large population to known hematologic carcinogens, further study is clearly needed to substantiate both our positive and negative findings. Future studies should incorporate information on oil and gas development activities and production levels, as well as levels of specific pollutants of interest (e.g. benzene) near homes, schools, and day care centers; provide age-specific residential histories; compare cases to controls without cancer; and address other potential confounders, and environmental stressors.	[McKenzie, Lisa M.; Allshouse, William B.; Serdar, Berrin; Adgate, John L.] Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA; [Byers, Tim E.] Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bedrick, Edward J.] Univ Arizona, Epidemiol & Biostat Dept, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arizona	McKenzie, LM (corresponding author), Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA.	Lisa.McKenzie@ucdenver.edu	McKenzie, Lisa/AAX-2390-2021; McKenzie, Lisa M/D-4501-2014	Adgate, John/0000-0003-1271-3465	University of Colorado Cancer Center; Div Of Chem, Bioeng, Env, & Transp Sys [1240584] Funding Source: National Science Foundation	University of Colorado Cancer Center; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the University of Colorado Cancer Center: http://www. ucdenver.edu/academics/colleges/medicalschool/centters/cancercenter/Pages/CancerCeriter.aspx.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Antonopoulos CN, 2011, INT J CANCER, V129, P2694, DOI 10.1002/ijc.25929; ATSDR, 2007, TOX PROF BENZ; Bates MN, 2007, AM J IND MED, V50, P339, DOI 10.1002/ajim.20446; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Carlton EJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003444; CDPHE, 2012, AIR EM CAS STUD REL; Centers for Disease Control and Prevention Wonder, US CANC STAT PUBL IN; Colorado Department of Public Health and Environment (CDPHE), 2015, COL CENTR CANC REG A; Colorado Oil and Gas Conservation Commission (COGCC), STAFF REP SEPT 14 20; Colorado Oil and Gas Information System (COGIS), 2015, WELL PROD DAT; Coste A, 2015, CANCER CAUSE CONTROL, V26, P1339, DOI 10.1007/s10552-015-0629-x; Deziel NC, 2014, ENVIRON RES, V133, P388, DOI 10.1016/j.envres.2014.04.033; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Fang R, 2011, INT J ENV RES PUB HE, V8, P3821, DOI 10.3390/ijerph8103821; Fryzek J, 2013, J OCCUP ENVIRON MED, V55, P796, DOI 10.1097/JOM.0b013e318289ee02; Ghosh JKC, 2013, AM J EPIDEMIOL, V178, P1233, DOI 10.1093/aje/kwt129; Ghosh JKC, 2012, AM J EPIDEMIOL, V175, P1262, DOI 10.1093/aje/kwr469; Gilman JB, 2013, ENVIRON SCI TECHNOL, V47, P1297, DOI 10.1021/es304119a; Gittleman HR, 2015, CANCER-AM CANCER SOC, V121, P102, DOI 10.1002/cncr.29015; Gold R., 2013, WALL STR J; Goldstein BD, 2013, J OCCUP ENVIRON MED, V55, P1376, DOI 10.1097/JOM.0000000000000014; Greaves M, 2015, CANCER CELL, V27, P433, DOI 10.1016/j.ccell.2015.03.016; Gross SA, 2013, J AIR WASTE MANAGE, V63, P424, DOI 10.1080/10962247.2012.759166; Heck JE, 2014, INT J HYG ENVIR HEAL, V217, P662, DOI 10.1016/j.ijheh.2013.12.003; Helmig D, 2014, ENVIRON SCI TECHNOL, V48, P4707, DOI 10.1021/es405046r; Helmig D., 2015, FINAL REPORT BOULDER; Houot J, 2015, AM J EPIDEMIOL, V182, P685, DOI 10.1093/aje/kwv111; Howard J., 2013, MINIMUM LATENCY TYP; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; MacArthur AC, 2009, AM J IND MED, V52, P221, DOI 10.1002/ajim.20663; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; McNally RJQ, 2006, LEUKEMIA LYMPHOMA, V47, P583, DOI 10.1080/10428190500420973; Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951; Mokry BJ, 2010, SUMMARY INVESTIGATIO; Natelson EA, 2007, AM J HEMATOL, V82, P826, DOI 10.1002/ajh.20934; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Ritz B, 2008, BASIC CLIN PHARMACOL, V102, P182, DOI 10.1111/j.1742-7843.2007.00161.x; Ritz B, 2007, AM J EPIDEMIOL, V166, P1045, DOI 10.1093/aje/kwm181; Shu XO, 1999, CANCER EPIDEM BIOMAR, V8, P783; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Stacy SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126425; Steffen C, 2004, OCCUP ENVIRON MED, V61, P773, DOI 10.1136/oem.2003.010868; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tamai H, 2010, J CLIN EXP HEMATOP, V50, P91, DOI 10.3960/jslrt.50.91; Thompson Chelsea R., 2014, Elementa-Science of the Anthropocene, V2, P000035, DOI 10.12952/journal.elementa.000035; Triebig G, 2010, CHEM-BIOL INTERACT, V184, P26, DOI 10.1016/j.cbi.2009.12.014; United State Environmental Protection Agency (EPA), 2015, RISK BAS SCR TABL; Urayama KY, 2009, ANN EPIDEMIOL, V19, P834, DOI 10.1016/j.annepidem.2009.03.001; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Whitworth KW, 2008, ENVIRON HEALTH PERSP, V116, P1576, DOI 10.1289/ehp.11593; Wiemels JL, 1999, BLOOD, V94, P1057, DOI 10.1182/blood.V94.3.1057.415k10_1057_1062; Wiemels J, 2015, EUR J EPIDEMIOL, V30, P1225, DOI 10.1007/s10654-015-0115-5; Yan KK, 2015, PEDIATR BLOOD CANCER, V62, P1162, DOI 10.1002/pbc.25443; Yousif L, 2013, GMS GERMAN MED SCI, V11	60	79	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170423	10.1371/journal.pone.0170423	http://dx.doi.org/10.1371/journal.pone.0170423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199334	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400014
J	Poole, CB; Li, ZR; Alhassan, A; Guelig, D; Diesburg, S; Tanner, NA; Zhang, YH; Evans, TC; LaBarre, P; Wanji, S; Burton, RA; Carlow, CKS				Poole, Catherine B.; Li, Zhiru; Alhassan, Andy; Guelig, Dylan; Diesburg, Steven; Tanner, Nathan A.; Zhang, Yinhua; Evans, Thomas C., Jr.; LaBarre, Paul; Wanji, Samuel; Burton, Robert A.; Carlow, Clotilde K. S.			Colorimetric tests for diagnosis of filarial infection and vector surveillance using non-instrumented nucleic acid loop-mediated isothermal amplification (NINA-LAMP)	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; WUCHERERIA-BANCROFTI DNA; ONCHOCERCA-VOLVULUS; VISUAL DETECTION; BLOOD; ELIMINATION; BRUGIA; ASSAY; COMMUNITIES; PROGRAMS	Accurate detection of filarial parasites in humans is essential for the implementation and evaluation of mass drug administration programs to control onchocerciasis and lymphatic filariasis. Determining the infection levels in vector populations is also important for assessing transmission, deciding when drug treatments may be terminated and for monitoring recrudescence. Immunological methods to detect infection in humans are available, however, cross-reactivity issues have been reported. Nucleic acid-based molecular assays offer high levels of specificity and sensitivity, and can be used to detect infection in both humans and vectors. In this study we developed loop-mediated isothermal amplification (LAMP) tests to detect three different filarial DNAs in human and insect samples using pH sensitive dyes for enhanced visual detection of amplification. Furthermore, reactions were performed in a portable, non-instrumented nucleic acid amplification (NINA) device that provides a stable heat source for LAMP. The efficacy of several strand displacing DNA polymerases were evaluated in combination with neutral red or phenol red dyes. Colorimetric NINA-LAMP assays targeting Brugia Hha I repeat, Onchocerca volvulus GST1a and Wuchereria bancrofti LDR each exhibit species-specificity and are also highly sensitive, detecting DNA equivalent to 1/10-1/5000th of one microfilaria. Reaction times varied depending on whether a single copy gene (70 minutes, O. volvulus) or repetitive DNA (40 min, B. malayiand W. bancrofti) was employed as a biomarker. The NINA heater can be used to detect multiple infections simultaneously. The accuracy, simplicity and versatility of the technology suggests that colorimetric NINA-LAMP assays are ideally suited for monitoring the success of filariasis control programs.	[Poole, Catherine B.; Li, Zhiru; Alhassan, Andy; Tanner, Nathan A.; Zhang, Yinhua; Evans, Thomas C., Jr.; Carlow, Clotilde K. S.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Guelig, Dylan; Diesburg, Steven; LaBarre, Paul; Burton, Robert A.] PATH, Seattle, WA USA; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	carlow@neb.com			New England Biolabs	New England Biolabs	CKSC, CBP, ZL, AA, NAT, YZ and TCE received funding from New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan A, 2015, EXPANDING MDX TOOLBO; Alhassan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108927; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P345; [Anonymous], 2011, WHOHTMNTDPCT20114; Bakajika DK, 2014, AM J TROP MED HYG, V91, P1142, DOI 10.4269/ajtmh.14-0358; Luz SLB, 2014, MEM I OSWALDO CRUZ, V109, P506, DOI 10.1590/0074-0276140079; Buser JR, 2015, LAB CHIP, V15, P4423, DOI 10.1039/c5lc01053e; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fischer P, 2005, ANN TROP MED PARASIT, V99, P53, DOI 10.1179/136485905X13339; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Gounoue-Kamkumo R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1317-x; Joseph H, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/492023; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kouassi BL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1077-x; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; LOBOS E, 1991, SCIENCE, V251, P1603, DOI 10.1126/science.2011741; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; MEREDITH SEO, 1991, EXP PARASITOL, V73, P335, DOI 10.1016/0014-4894(91)90105-6; MEREDITH SEO, 1989, MOL BIOCHEM PARASIT, V36, P1, DOI 10.1016/0166-6851(89)90194-1; Merriweather A, 1996, EXP PARASITOL, V83, P164, DOI 10.1006/expr.1996.0062; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Noordin Rahmah, 2004, Filaria J, V3, P10, DOI 10.1186/1475-2883-3-10; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Oguttu D, 2014, AM J TROP MED HYG, V90, P339, DOI 10.4269/ajtmh.13-0546; Okorie PN, 2016, T ROY SOC TROP MED H, V110, P90, DOI 10.1093/trstmh/trv104; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Poole CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139286; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; POOLE CB, 1990, MOL BIOCHEM PARASIT, V40, P129, DOI 10.1016/0166-6851(90)90086-2; Poon LLM, 2006, CLIN CHEM, V52, P303; Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Sergev SS, 1981, Patent No. [US 4264362 A, 4264362]; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Steel C, 2013, CLIN VACCINE IMMUNOL, V20, P1155, DOI 10.1128/CVI.00252-13; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Ton TGN, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0068-7; Wahl G, 1998, PARASITOLOGY, V116, P327, DOI 10.1017/S0031182097002333; Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1556-8; Wanji S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004184; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0817-2; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	54	57	58	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169011	10.1371/journal.pone.0169011	http://dx.doi.org/10.1371/journal.pone.0169011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199317	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400003
J	Sempa, JB; Ujeneza, EL; Nieuwoudt, M				Sempa, Joseph B.; Ujeneza, Eva L.; Nieuwoudt, Martin			Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan Africa	PLOS ONE			English	Review							FOLLOW-UP; HIV-1-INFECTED PATIENTS; IMMUNE RECONSTITUTION; VIROLOGICAL OUTCOMES; COUNT INCREASE; TUBERCULOSIS; INITIATION; MORTALITY; RECOVERY; CRITERIA	Introduction In Sub-Saharan African (SSA) resource limited settings, Cluster of Differentiation 4 (CD4) counts continue to be used for clinical decision making in antiretroviral therapy (ART). Here, HIV-infected people often remain with CD4 counts <350 cells/pL even after 5 years of viral load suppression. Ongoing immunological monitoring is necessary. Due to varying statistical modeling methods comparing immune response to ART across different cohorts is difficult. We systematically review such models and detail the similarities, differences and problems. Methods 'Preferred Reporting Items for Systematic Review and Meta-Analyses' guidelines were used. Only studies of immune-response after ART initiation from SSA in adults were included. Data was extracted from each study and tabulated. Outcomes were categorized into 3 groups: 'slope', 'survival', and 'asymptote' models. Wordclouds were drawn wherein the frequency of variables occurring in the reviewed models is indicated by their size and color. Results 69 covariates were identified in the final models of 35 studies. Effect sizes of covariates were not directly quantitatively comparable in view of the combination of differing variables and scale transformation methods across models. Wordclouds enabled the identification of qualitative and semi-quantitative covariate sets for each outcome category. Comparison across categories identified sex, baseline age, baseline log viral load, baseline CD4, ART initiation regimen and ART duration as a minimal consensus set. Conclusion Most models were different with respect to covariates included, variable transformations and scales, model assumptions, modelling strategies and reporting methods, even for the same outcomes. To enable comparison across cohorts, statistical models would benefit from the application of more uniform modelling techniques. Historic efforts have produced results that are anecdotal to individual cohorts only. This study was able to define 'prior' knowledge in the Bayesian sense. Such information has value for prospective modelling efforts.	[Sempa, Joseph B.; Ujeneza, Eva L.; Nieuwoudt, Martin] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University	Sempa, JB (corresponding author), Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, Stellenbosch, South Africa.	jbsempa@yahoo.co.uk		Nieuwoudt, Martin/0000-0002-6354-799X; Ujeneza, Eva Liliane/0000-0002-5760-4847; Bukulu Sempa, Joseph/0000-0003-1062-0417	South African Department of Science and Technology/National Research Foundation	South African Department of Science and Technology/National Research Foundation	Authors are funded by South African Department of Science and Technology/National Research Foundation. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2012, BASIC IMMUNOLOGY FUN, DOI DOI 10.1007/978-1-62703-589-7_1; Alemu H, 2012, AIDS CARE, V24, P866, DOI 10.1080/09540121.2011.648160; Alemu Melsew Y, 2013, J AIDS CLIN RES, V4; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; [Anonymous], 2015, GLOB HLTH SECT RESP; Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Assefa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-468; BECHER H, 1992, STAT MED, V11, P1747, DOI 10.1002/sim.4780111308; Boulle A, 2007, ANTIVIR THER, V12, P753; Boulle C, 2013, JAIDS-J ACQ IMM DEF, V62, P569, DOI 10.1097/QAI.0b013e318285f7b6; Burnham Judy F, 2006, Biomed Digit Libr, V3, P1; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047; Diabate S, 2009, HIV MED, V10, P640, DOI 10.1111/j.1468-1293.2009.00736.x; Efraim L, 2013, JAIDS-J ACQ IMM DEF, V62, pE153, DOI 10.1097/QAI.0b013e318282a1a4; Fellows I., 2014, WORDCLOUD WORD CLOUD; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Fung ICH, 2012, JAIDS-J ACQ IMM DEF, V60, P5, DOI 10.1097/QAI.0b013e3182487a20; Giacometti Andrea, 2010, Infez Med, V18, P20; Gordon CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125248; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hardwick RJ, 2012, J INFECT DIS, V206, P1012, DOI 10.1093/infdis/jis448; Harrell FE, 2001, REGRESSION MODELING; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Kigozi Brian K, 2009, AIDS Res Ther, V6, P17, DOI 10.1186/1742-6405-6-17; Kiragga AN, 2012, AIDS, V26, P768, DOI 10.1097/QAD.0b013e32835143e3; Lesaffre E., 2012, BAYESIAN BIOSTATISTI, DOI [10.1002/9781119942412, DOI 10.1002/9781119942412]; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Maskew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064392; Maskew M, 2013, JAIDS-J ACQ IMM DEF, V63, P442, DOI 10.1097/QAI.0b013e3182969cc1; Mayanja BN, 2012, TROP MED INT HEALTH, V17, P343, DOI 10.1111/j.1365-3156.2011.02921.x; McKinnon LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011434; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mudiope PK, 2013, TROP MED INT HEALTH, V18, P344, DOI 10.1111/tmi.12054; Nakanjako D, 2016, FREQUENCY IMPACT SUB; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), 2010, Clin Infect Dis, V51, P611, DOI 10.1086/655761; [Organization WH World Health Organization Joint United Nations Programme on HIV/AIDS], 2003, TREAT 3 MILL 2005 MA; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Pandeya N, 2005, AM J EPIDEMIOL, V161, P748, DOI 10.1093/aje/kwi098; Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb; Pinzone MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/515962; Poole C, 2001, EPIDEMIOLOGY, V12, P291, DOI 10.1097/00001648-200105000-00005; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Reynolds SJ, 2014, AIDS PATIENT CARE ST, V28, P575, DOI 10.1089/apc.2014.0086; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P51; Rood Y, 2008, CLIN EXP IMMUNOL, V86, P349; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Schomaker M, 2013, JAIDS-J ACQ IMM DEF, V63, P142, DOI 10.1097/QAI.0b013e318288b39d; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Stone SF, 2005, HIV MED, V6, P278, DOI 10.1111/j.1468-1293.2005.00307.x; Sudfeld CR, 2013, AM J CLIN NUTR, V97, P1278, DOI 10.3945/ajcn.112.053728; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040036; Takuva S, 2012, INT J TUBERC LUNG D, V16, P1358, DOI 10.5588/ijtld.11.0769; Teshome W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115125; Therneau T.M., 2000, MODELING SURVIVAL DA; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Vinikoor MJ, 2014, AIDS RES HUM RETROV, V30, P949, DOI [10.1089/aid.2014.0046, 10.1089/AID.2014.0046]; Wandeler G, 2013, AIDS, V27, P2225, DOI 10.1097/QAD.0b013e328362d887; World Health Organization, 2013, CONSOLIDATED GUIDELI	71	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171658	10.1371/journal.pone.0171658	http://dx.doi.org/10.1371/journal.pone.0171658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199360	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400040
J	Zheng, S; Xu, H; Zhou, H; Ren, XX; Han, TT; Chen, YW; Qiu, HY; Wu, PH; Zheng, J; Wang, LH; Liu, W; Hu, YM				Zheng, Shuang; Xu, Hua; Zhou, Huan; Ren, Xingxing; Han, Tingting; Chen, Yawen; Qiu, Huiying; Wu, Peihong; Zheng, Jun; Wang, Lihua; Liu, Wei; Hu, Yaomin			Associations of lipid profiles with insulin resistance and beta cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR RISK; FASTING GLUCOSE; NITRIC-OXIDE; SECRETION; CHOLESTEROL; SENSITIVITY; INDIVIDUALS; DYSFUNCTION; PREVALENCE	Aims To investigate the associations of dyslipidemia with insulin resistance and beta cell function in individuals with normal glucose tolerance (NGT) and different categories of impaired glucose regulation (IGR). Methods 544 subjects (365 with dyslipidemia and/or IGR and 179 with normal lipid and glucose tolerance) were enrolled in the study. All subjects underwent oral glucose tolerance test (OGTT). HOMA-IR was used to evaluate insulin sensitivity. Disposition index (DI) was used to evaluate beta cell function. Multiple linear regression analysis was performed to assess correlations among lipid profiles, insulin resistance and beta cell function. Results Among subjects with NGT, those with dyslipidemia had higher level of HOMA-IR but lower level of DI. While among subjects with different categories of IGR, those with dyslipidemia and CGI had significantly decreased DI. No obvious differences of insulin resistance or beta cell function were found in IFG or IGT subjects with or without dyslipidemia. TG and HDL-C were correlated with HOMA-IR (beta = 0.79, p < 0.001; beta = -0.38, p = 0.027, respectively, compared with subjects in the low level groups). Moreover, TG and TC were negatively correlated with DI (beta = -2.17, p = 0.013; beta = -2.01, p = 0.034 respectively, compared with subjects in the low level groups) after adjusting for confounding parameters. Conclusions Dyslipidemia induces insulin resistance and impaired beta cell response to insulin resistance in individuals with NGT. Furthermore, dyslipidemia diminishes beta cell function in subjects with CGI. TG and HDL-C were correlated with insulin resistance, and TG, TC were negatively correlated with beta cell response to insulin resistance in non-diabetic individuals.	[Zheng, Shuang; Xu, Hua; Zhou, Huan; Ren, Xingxing; Han, Tingting; Chen, Yawen; Qiu, Huiying; Wu, Peihong; Zheng, Jun; Wang, Lihua; Liu, Wei; Hu, Yaomin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Liu, W; Hu, YM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China.	sue_liuwei@163.com; amin1031@hotmail.com	HAN, TINGTING/GQZ-8692-2022		National Natural Science Foundation of China [81270946, 81170758, 30670988]; Renji Hospital, school of medicine, Shanghai Jiaotong University [RJZZ14-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Renji Hospital, school of medicine, Shanghai Jiaotong University	This study was supported by the National Natural Science Foundation of China (No. 81270946, 81170758, 30670988) and the Foundation from Renji Hospital, school of medicine, Shanghai Jiaotong University (RJZZ14-003).	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aoyama-Sasabe S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1298601; Baralla A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128029; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Brunisholz KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157729; Chen G, 2010, METABOLISM, V59, P1823, DOI 10.1016/j.metabol.2010.06.009; Chen GY, 2015, MED SCI MONITOR, V21, P2476, DOI 10.12659/MSM.894246; Colman PG, 1999, NEW ZEAL MED J, V112, P139; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Downing LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140267; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hong J, 2008, DIABETIC MED, V25, P73, DOI 10.1111/j.1464-5491.2007.02329.x; Kong XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143607; Li XY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0629-3; Man ZW, 1997, DIABETES, V46, P1718, DOI 10.2337/diabetes.46.11.1718; Novoa FJ, 2005, DIABETES CARE, V28, P2388, DOI 10.2337/diacare.28.10.2388; Ohashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143880; Okwechime IO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145781; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pedersen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138654; Ren LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144182; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Rhee SY, 2010, DIABETES RES CLIN PR, V89, P250, DOI 10.1016/j.diabres.2010.05.002; De Ita JR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0684-9; SOSENKO JM, 1993, DIABETIC MED, V10, P814, DOI 10.1111/j.1464-5491.1993.tb00172.x; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Xu F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0407-2; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang L, 2008, DIABETES RES CLIN PR, V82, P364, DOI 10.1016/j.diabres.2008.08.022; Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8; Zheng S, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0018-1; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580	40	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172221	10.1371/journal.pone.0172221	http://dx.doi.org/10.1371/journal.pone.0172221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199386	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400082
J	Michel, P; Brami, J; Chaneliere, M; Kret, M; Mosnier, A; Dupie, I; Haeringer-Cholet, A; Keriel-Gascou, M; Maradan, C; Villebrun, F; Makeham, M; Quenon, JL				Michel, Philippe; Brami, Jean; Chaneliere, Marc; Kret, Marion; Mosnier, Anne; Dupie, Isabelle; Haeringer-Cholet, Anouk; Keriel-Gascou, Maud; Maradan, Claire; Villebrun, Frederic; Makeham, Meredith; Quenon, Jean-Luc			Patient safety incidents are common in primary care: A national prospective active incident reporting survey	PLOS ONE			English	Article							GENERAL-PRACTICE; ADVERSE EVENTS; MEDICAL ERRORS; SYSTEM; CLASSIFICATION; MANAGEMENT; TAXONOMY	Background The study objectives were to describe the incidence and the nature of patient safety incidents (PSIs) in primary care general practice settings, and to explore the association between these incidents and practice or organizational characteristics. Methods GPs, randomly selected from a national influenza surveillance network (n = 800) across France, prospectively reported any incidents observed each day over a one-week period between May and July 2013. An incident was an event or circumstance that could have resulted, or did result, in harm to a patient, which the GP would not wish to recur. Primary outcome was the incidence of PSIs which was determined by counting reports per total number of patient encounters. Reports were categorized using existing taxonomies. The association with practice and organizational characteristics was calculated using a negative binomial regression model. Results 127 GPs (participation rate 79%) reported 317 incidents of which 270 were deemed to be a posteriori judged preventable, among 12,348 encounters. 77% had no consequences for the patient. The incidence of reported PSIs was 26 per 1000 patient encounters per week (95% CI [23 parts per thousand -28 parts per thousand]). Incidents were three times more frequently related to the organization of healthcare than to knowledge and skills of health professionals, and especially to the workflow in the GPs' offices and to the communication between providers and with patients. Among GP characteristics, three were related with an increased incidence in the final multivariable model: length of consultation higher than 15 minutes, method of receiving radiological results (by fax compared to paper or email), and being in a multidisciplinary clinic compared with sole practitioners. Conclusions Patient safety incidents (PSIs) occurred in mean once every two days in the sampled GPs and 2% of them were associated with a definite possibility for harm. Studying the association between organizational features of general practices and PSIs remains a major challenge and one of the most important issues for safety in primary care.	[Michel, Philippe; Kret, Marion; Quenon, Jean-Luc] Com Coordinat Valuat & Qual Aquitaine, Bordeaux, France; [Michel, Philippe; Kret, Marion; Quenon, Jean-Luc] Hospices Civils Lyon, Lyon, France; [Michel, Philippe] Univ Claude Bernard Lyon 1, Univ Lyon, HESPER, Lyon, France; [Brami, Jean] Haute Autorite Sante, St Denis, France; [Chaneliere, Marc; Keriel-Gascou, Maud] Univ Lyon 1, Dept Med Gen, Lyon, France; [Mosnier, Anne] Open Rome & Reseau Grog, Paris, France; [Dupie, Isabelle] Med Generaliste, Paris, France; [Haeringer-Cholet, Anouk] ReQua, Reseau Qual Franche Comte, Besancon, France; [Maradan, Claire; Villebrun, Frederic] Augustines Clin, Malestroit, France; [Villebrun, Frederic] Ctr Municipaux Sante, St Denis, France; [Makeham, Meredith] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Macquarie University	Michel, P (corresponding author), Com Coordinat Valuat & Qual Aquitaine, Bordeaux, France.; Michel, P (corresponding author), Hospices Civils Lyon, Lyon, France.; Michel, P (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, HESPER, Lyon, France.	philippe.michel@chu-lyon.fr	michel, philippe/J-9443-2017; Makeham, Meredith AB/ABC-7512-2020	michel, philippe/0000-0001-8455-8332; CHANELIERE, Marc/0000-0001-7114-5483; Makeham, Meredith/0000-0001-7510-0901	French Ministry of Health	French Ministry of Health	The funds were provided by the Direction Generale de l'Offre de Soins, from the French Ministry of Health. The funder had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Amalberti R, 2012, BMJ QUAL SAF, V21, P729, DOI 10.1136/bmjqs-2011-048710; Amalberti R, 2009, RESPONSABILITE, V8, P5; Baines R, 2015, BMJ QUAL SAF, V24, P561, DOI 10.1136/bmjqs-2014-003702; Chaneliere Marc, 2013, Presse Med, V42, pe363, DOI 10.1016/j.lpm.2013.05.004; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Dovey SM, 2011, BMJ QUAL SAF, V20, P1001, DOI 10.1136/bmjqs-2011-000465; Dwamena F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003267.pub2; Elder NC, 2004, ANN FAM MED, V2, P125, DOI 10.1370/afm.16; Esmail A., 2013, MEASURING MONITORING; Expert Group on Learning from Adverse Events in the NHS, 2000, ORG MEM; Fernald DH, 2004, ANN FAM MED, V2, P327, DOI 10.1370/afm.221; Gaal S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-37; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Gandhi TK, 2010, NEW ENGL J MED, V363, P1001, DOI 10.1056/NEJMp1003294; Gay B, 2013, PRESSE MED, V42, P258, DOI [10.1016/j.lpm.2012.10.016, 10.1016/j.lpm.2013.04.013]; Giles S, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0052-0; Hanskamp-Sebregts M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011078; Harmsen M, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-50; Hoffmann B, 2008, QUAL SAF HEALTH CARE, V17, P307, DOI 10.1136/qshc.2006.018440; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Keriel-Gascou M, 2014, REV EPIDEMIOL SANTE, V62, P41, DOI 10.1016/j.respe.2013.10.007; Kostopoulou O, 2007, QUAL SAF HEALTH CARE, V16, P95, DOI 10.1136/qshc.2006.020909; Letrilliart L, 2014, EXERCER, V114, P148, DOI DOI 10.1037/0278-6133.25.1.3; Makeham M, 2007, METHODS MEASURES USE; Makeham MAB, 2008, QUAL SAF HEALTH CARE, V17, P53, DOI 10.1136/qshc.2007.022491; Makeham MAB, 2002, MED J AUSTRALIA, V177, P68, DOI 10.5694/j.1326-5377.2002.tb04668.x; Makeham MAB, 2006, MED J AUSTRALIA, V185, P95, DOI 10.5694/j.1326-5377.2006.tb00482.x; Michel P., 2014, Bulletin Epidemiologique Hebdomadaire, P410; O'Beirne M, 2011, BMJ QUAL SAF, V20, P1005, DOI 10.1136/bmjqs-2011-000105; O'Connor E, 2010, INT J QUAL HEALTH C, V22, P371, DOI 10.1093/intqhc/mzq042; Panesar SS, 2016, BMJ QUAL SAF, V25, P544, DOI 10.1136/bmjqs-2015-004178; Phillips RL., 2006, J PATIENT SAF, V2, P140; Rees P, 2015, PEDIATRICS, V135, P1027, DOI 10.1542/peds.2014-3259; Rosser W, 2005, CAN FAM PHYSICIAN, V51, P386; Rubin G, 2003, QUAL SAF HEALTH CARE, V12, P443, DOI 10.1136/qhc.12.6.443; Sarkar U., 2015, BMJ QUAL SAF, P1; Shaw R, 2005, QUAL SAF HEALTH CARE, V14, P279, DOI 10.1136/qshc.2004.010553; Tsang C, 2013, BRIT J GEN PRACT, V63, pE534, DOI 10.3399/bjgp13X670660; van Dulmen SA, 2011, MED CARE, V49, P1089, DOI 10.1097/MLR.0b013e3182367105; Wachter RM, 2006, ANN INTERN MED, V145, P547, DOI 10.7326/0003-4819-145-7-200610030-00014; Wilf-Miron R, 2003, QUAL SAF HEALTH CARE, V12, P35, DOI 10.1136/qhc.12.1.35; Wilson RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e832; World Health Organization, 2009, CONCEPTUAL FRAMEWORK; Zwart DLM, 2011, BMJ QUAL SAF, V20, P857, DOI 10.1136/bmjqs.2010.045484; Zwart DLM, 2011, BRIT J GEN PRACT, V61, P183, DOI 10.3399/bjgp11X561168; Zwart DLM, 2011, BMJ QUAL SAF, V20, P121, DOI 10.1136/bmjqs.2009.033472	47	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0165455	10.1371/journal.pone.0165455	http://dx.doi.org/10.1371/journal.pone.0165455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196076	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900001
J	Perrotta, AR; Kumaraswamy, R; Bastidas-Oyanedel, JR; Alm, EJ; Rodriguez, J				Perrotta, Allison R.; Kumaraswamy, Rajkumari; Bastidas-Oyanedel, Juan R.; Alm, Eric J.; Rodriguez, Jorge			Inoculum composition determines microbial community and function in an anaerobic sequential batch reactor	PLOS ONE			English	Article							DARK FERMENTATION; WASTE-WATER; DIVERSITY; DIGESTION; DYNAMICS; PATTERNS; BIOTECHNOLOGY; INSTABILITY; BIOREACTOR; STABILITY	The sustainable recovery of resources from wastewater streams can provide many social and environmental benefits. A common strategy to recover valuable resources from wastewater is to harness the products of fermentation by complex microbial communities. In these fermentation bioreactors high microbial community diversity within the inoculum source is commonly assumed as sufficient for the selection of a functional microbial community. However, variability of the product profile obtained from these bioreactors is a persistent challenge in this field. In an attempt to address this variability, the impact of inoculum on the microbial community structure and function within the bioreactor was evaluated using controlled laboratory experiments. In the course of this work, sequential batch reactors were inoculated with three complex microbial inocula and the chemical and microbial compositions were monitored by HPLC and 16S rRNA amplicon analysis, respectively. Microbial community dynamics and chemical profiles were found to be distinct to initial inoculate and highly reproducible. Additionally we found that the generation of a complex volatile fatty acid profile was not specific to the diversity of the initial microbial inoculum. Our results suggest that the composition of the original inoculum predictably contributes to bioreactor community structure and function.	[Perrotta, Allison R.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kumaraswamy, Rajkumari; Bastidas-Oyanedel, Juan R.; Rodriguez, Jorge] Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates; [Alm, Eric J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst MIT, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Khalifa University of Science & Technology; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rodriguez, J (corresponding author), Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates.	jrodriguez@masdar.ac.ae	Bastidas-Oyanedel, Juan-Rodrigo/I-3372-2016; R., Jorge Rodríguez/A-9879-2008; R., Jorge Rodríguez/N-5916-2019	Bastidas-Oyanedel, Juan-Rodrigo/0000-0002-2418-441X; R., Jorge Rodríguez/0000-0002-5936-9676; R., Jorge Rodríguez/0000-0002-5936-9676	Masdar Institute/MIT joint research program [11WAMA1]; National Institute of Environmental Health Sciences of the NIH [P30-ES002109]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Masdar Institute/MIT joint research program; National Institute of Environmental Health Sciences of the NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Masdar Institute/MIT joint research program (grant 11WAMA1) to ARP, JRBO, and RK, and the National Institute of Environmental Health Sciences of the NIH (P30-ES002109) for sequencing efforts through the MIT BioMicro Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; Baas-Becking LGM, 1934, GEOBIOLOGIE INLEIDIN, DOI [10.1038/ismej.2011.107, DOI 10.1038/ISMEJ.2011.107]; Bastidas-Oyanedel JR, 2015, REV ENVIRON SCI BIO, V14, P473, DOI 10.1007/s11157-015-9369-3; Bastidas-Oyanedel JR, 2010, TALANTA, V83, P482, DOI 10.1016/j.talanta.2010.09.034; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; De Vrieze J, 2015, APPL MICROBIOL BIOT, V99, P189, DOI 10.1007/s00253-014-6046-3; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Hanski I., 2009, PRINCETON GUIDE ECOL, P177; Hawkes FR, 2002, INT J HYDROGEN ENERG, V27, P1339, DOI 10.1016/S0360-3199(02)00090-3; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Kleerebezem R, 2015, REV ENVIRON SCI BIO, V14, P787, DOI 10.1007/s11157-015-9374-6; Koskinen PEP, 2007, BIOTECHNOL BIOENG, V97, P742, DOI 10.1002/bit.21299; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mendez-Acosta HO, 2013, BIOTECHNOL BIOENG, V110, P2131, DOI 10.1002/bit.24838; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quemeneur M, 2011, INT J HYDROGEN ENERG, V36, P11654, DOI 10.1016/j.ijhydene.2011.06.010; Rodriguez J, 2008, TRENDS BIOTECHNOL, V26, P366, DOI 10.1016/j.tibtech.2008.04.003; Stegen JC, 2013, ISME J, V7, P2069, DOI 10.1038/ismej.2013.93; Temudo MF, 2007, BIOTECHNOL BIOENG, V98, P69, DOI 10.1002/bit.21412; Vanwonterghem I, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Walker M, 2009, BIORESOURCE TECHNOL, V100, P6339, DOI 10.1016/j.biortech.2009.07.018; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zhou J, 2013, MBIO, V4, P1	42	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171369	10.1371/journal.pone.0171369	http://dx.doi.org/10.1371/journal.pone.0171369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196102	gold, Green Published			2022-12-27	WOS:000394423900018
J	Raffan, H; Guevar, J; Poyade, M; Rea, PM				Raffan, Hazel; Guevar, Julien; Poyade, Matthieu; Rea, Paul M.			Canine neuroanatomy: Development of a 3D reconstruction and interactive application for undergraduate veterinary education	PLOS ONE			English	Article							ANATOMY; HEAD	Current methods used to communicate and present the complex arrangement of vasculature related to the brain and spinal cord is limited in undergraduate veterinary neuroanatomy training. Traditionally it is taught with 2-dimensional (2D) diagrams, photographs and medical imaging scans which show a fixed viewpoint. 2D representations of 3-dimensional (3D) objects however lead to loss of spatial information, which can present problems when translating this to the patient. Computer-assisted learning packages with interactive 3D anatomical models have become established in medical training, yet equivalent resources are scarce in veterinary education. For this reason, we set out to develop a workflow methodology creating an interactive model depicting the vasculature of the canine brain that could be used in undergraduate education. Using MR images of a dog and several commonly available software programs, we set out to show how combining image editing, segmentation and surface generation, 3D modeling and texturing can result in the creation of a fully interactive application for veterinary training. In addition to clearly identifying a workflow methodology for the creation of this dataset, we have also demonstrated how an interactive tutorial and self-assessment tool can be incorporated into this. In conclusion, we present a workflow which has been successful in developing a 3D reconstruction of the canine brain and associated vasculature through segmentation, surface generation and post-processing of readily available medical imaging data. The reconstructed model was implemented into an interactive application for veterinary education that has been designed to target the problems associated with learning neuroanatomy, primarily the inability to visualise complex spatial arrangements from 2D resources. The lack of similar resources in this field suggests this workflow is original within a veterinary context. There is great potential to explore this method, and introduce a new dimension into veterinary education and training.	[Raffan, Hazel; Rea, Paul M.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Lab Human Anat, Thomson Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Raffan, Hazel; Poyade, Matthieu] Glasgow Sch Art, Digital Design Studio, Glasgow, Lanark, Scotland; [Guevar, Julien] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; Glasgow School of Art; University of Glasgow	Rea, PM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Lab Human Anat, Thomson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	Paul.Rea@glasgow.ac.uk		REA, PAUL/0000-0002-8486-373X				Anderson P, 2013, CURR MED IMAGING REV, V9, P298; Assheur J, 1997, MRI CT ATLAS DOG; Bogert K, 2015, J VET MED EDUC, P1; Boon JM, 2002, CLIN ANAT, V15, P45, DOI 10.1002/ca.1091; Borden N.M., 2007, 3D ANGIOGRAPHIC ATLA; Bottcher P, 1999, VET RADIOL ULTRASOUN, V40, P611, DOI 10.1111/j.1740-8261.1999.tb00887.x; Buchanan G., 2014, INT J MED IMAGING, V2, P44; Bulla A, 2014, SURG RADIOL ANAT, V36, P79, DOI 10.1007/s00276-013-1143-z; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; Evans H.E., 2013, MILLERS ANATOMY DOG; Holmes MA, 1996, VET REC, V138, P199, DOI 10.1136/vr.138.9.199; Jacqmot OD, 2011, ANAT REC, V294, P1834, DOI 10.1002/ar.21479; Jastrow Holger, 2004, Anatomical Record Part B:The New Anatomist, V280, P20, DOI 10.1002/ar.b.20027; Jocks I, 2015, INTED PROC, P6377; Linton A, 2005, J VET MED EDUC, V32, P249, DOI 10.3138/jvme.32.2.249; Ma M, 2012, LNCS, P43; Manson A, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0088-6; Martinelli MJ, 1997, VET RADIOL ULTRASOUN, V38, P193, DOI 10.1111/j.1740-8261.1997.tb00840.x; Nowinski WL, 2005, RADIOGRAPHICS, V25, P263, DOI 10.1148/rg.251045051; Park JS, 2006, CLIN ANAT, V19, P216, DOI 10.1002/ca.20275; Ramos RL, 2008, J UNDERGRADUATE NEUR, V6, P53; Rea P, ADV ANATOMICAL MED V, P244; Robertson D, 2 INT WWW C 1994; Robertson D, 1994, 2 INT WWW C 1994; Spitze VM, 1998, ATLAS VISIBLE HUMAN; Sugand K, 2010, ANAT SCI EDUC, V3, P83, DOI 10.1002/ase.139; TOGA AW, 1995, BRAIN RES BULL, V38, P77, DOI 10.1016/0361-9230(95)00074-O; Turney BW, 2007, ANN ROY COLL SURG, V89, P104, DOI 10.1308/003588407X168244; Welsh E., 2014, INT J RECENT INNOVAT, V2, P2265; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x	30	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0168911	10.1371/journal.pone.0168911	http://dx.doi.org/10.1371/journal.pone.0168911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192461	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000394423800004
J	Sun, LM; Liao, K; Hang, CC; Wang, DY				Sun, Lingmei; Liao, Kai; Hang, Chengcheng; Wang, Dayong			Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction	PLOS ONE			English	Article							SUPEROXIDE DISMUTASES; LIPID-PEROXIDATION; ANTIFUNGAL AGENTS; FLUORESCENT-PROBE; OXIDATIVE STRESS; DRUG-RESISTANCE; RESPONSES; MECHANISM; MAGNOLOL; CELLS	Objective To investigate the effects of honokiol on induction of reactive oxygen species (ROS), antioxidant defense systems, mitochondrial dysfunction, and apoptosis in Candida albicans. Methods To measure ROS accumulation, 2',7'-dichlorofluorescein diacetate fluorescence was used. Lipid peroxidation was assessed using both fluorescence staining and a thiobarbituric acid reactive substances (TBARS) assay. Protein oxidation was determined using dinitrophenylhydrazine derivatization. Antioxidant enzymatic activities were measured using commercially available detection kits. Superoxide dismutase (SOD) genes expression was measured using real time RT-PCR. To assess its antifungal abilities and effectiveness on ROS accumulation, honokiol and the SOD inhibitor N,N'-diethyldithiocarbamate (DDC) were used simultaneously. Mitochondrial dysfunction was assessed by measuring the mitochondrial membrane potential (mt Delta psi). Honokiol-induced apoptosis was assessed using an Annexin V-FITC apoptosis detection kit. Results ROS, lipid peroxidation, and protein oxidation occurred in a dose-dependent manner in C. albicans after honokiol treatment. Honokiol caused an increase in antioxidant enzymatic activity. In addition, honokiol treatment induced SOD genes expression in C. albicans cells. Moreover, addition of DDC resulted in increased endogenous ROS levels and potentiated the antifungal activity of honokiol. Mitochondrial dysfunction was confirmed by measured changes to mt Delta psi. The level of apoptosis increased in a dose-dependent manner after honokiol treatment. Conclusions Collectively, these results indicate that honokiol acts as a pro-oxidant in C. albicans. Furthermore, the SOD inhibitor DDC can be used to potentiate the activity of honokiol against C. albicans.	[Sun, Lingmei; Hang, Chengcheng] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn			National Natural Science Foundation of China [81302814]; Jiangsu Province Natural Science Foundation [BK20130640, BK20140624]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (NO 81302814) and Jiangsu Province Natural Science Foundation (NO BK20130640; BK20140624).	Arora S, 2012, CURR MOL MED, V12, P1244, DOI 10.2174/156652412803833508; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bang KH, 2000, ARCH PHARM RES, V23, P46, DOI 10.1007/BF02976465; Bink A, 2011, ANTIMICROB AGENTS CH, V55, P4033, DOI 10.1128/AAC.00280-11; Chang WQ, 2011, BBA-GEN SUBJECTS, V1810, P569, DOI 10.1016/j.bbagen.2011.02.001; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; De Brucker K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/704654; Delattin N, 2014, FUTURE MED CHEM, V6, P77, DOI [10.4155/FMC.13.189, 10.4155/fmc.13.189]; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; GEORGOPAPADAKOU NH, 1987, ANTIMICROB AGENTS CH, V31, P46, DOI 10.1128/AAC.31.1.46; Haque F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23575; Jangra A, 2016, EUR J PHARMACOL, V770, P25, DOI 10.1016/j.ejphar.2015.11.047; Jiang QQ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-242; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Khan A, 2015, MICROB PATHOGENESIS, V80, P50, DOI 10.1016/j.micpath.2015.02.004; Li Y, 2015, PLOS ONE, V10; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pan J, 2016, MOL NUTR FOOD RES, V60, P1383, DOI 10.1002/mnfr.201501007; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; Rawal MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27132; Richardson JP, 2015, VIRULENCE, V6, P327, DOI 10.1080/21505594.2015.1004977; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sharma M, 2010, BIOSCIENCE REP, V30, P391, DOI 10.1042/BSR20090151; Sun J, 2015, DRUG DES DEV THER, V9, P6327, DOI 10.2147/DDDT.S92777; Sun LM, 2015, J APPL MICROBIOL, V118, P826, DOI 10.1111/jam.12737; Sun LM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0117695, 10.1371/journal.pone.0143820]; Teodoro GR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01420; Wang XD, 2015, INT J CLIN EXP PATHO, V8, P7929; Yu CH, 2013, BASIC CLIN PHARMACOL, V113, P377, DOI 10.1111/bcpt.12110	41	48	51	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172228	10.1371/journal.pone.0172228	http://dx.doi.org/10.1371/journal.pone.0172228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192489	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800085
J	Alajajian, SE; Williams, JR; Reagan, AJ; Alajajian, SC; Frank, MR; Mitchell, L; Lahne, J; Danforth, CM; Dodds, PS				Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Alajajian, Stephen C.; Frank, Morgan R.; Mitchell, Lewis; Lahne, Jacob; Danforth, Christopher M.; Dodds, Peter Sheridan			The Lexicocalorimeter: Gauging public health through caloric input and output on social media	PLOS ONE			English	Article								We propose and develop a Lexicocalorimeter: an online, interactive instrument for measuring the "caloric content" of social media and other large-scale texts. We do so by constructing extensive yet improvable tables of food and activity related phrases, and respectively assigning them with sourced estimates of caloric intake and expenditure. We show that for Twitter, our naive measures of "caloric input", "caloric output", and the ratio of these measures are all strong correlates with health and well-being measures for the contiguous United States. Our caloric balance measure in many cases outperforms both its constituent quantities; is tunable to specific health and well-being measures such as diabetes rates; has the capability of providing a real-time signal reflecting a population's health; and has the potential to be used alongside traditional survey data in the development of public policy and collective self-awareness. Because our Lexicocalorimeter is a linear superposition of principled phrase scores, we also show we can move beyond correlations to explore what people talk about in collective detail, and assist in the understanding and explanation of how population -scale conditions vary, a capacity unavailable to black -box type methods.	[Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA; [Alajajian, Sharon E.; Williams, Jake Ryland; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA; [Williams, Jake Ryland] Univ Calif Berkeley, Sch Informat, 102 South Hall 4600, Berkeley, CA 94720 USA; [Alajajian, Stephen C.] Women Infants & Children, East Boston, MA 02128 USA; [Frank, Morgan R.] MIT, Media Lab, Cambridge, MA 02139 USA; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, North Terrace Campus, Adelaide, SA 5005, Australia; [Lahne, Jacob] Drexel Univ, Culinary Arts & Food Sci, 3141 Chestnut St, Philadelphia, PA 19104 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of Adelaide; Drexel University	Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Vermont Ctr Complex Syst, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA.; Alajajian, SE; Dodds, PS (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05401 USA.	salajajian@asc.upenn.edu; peter.dodds@uvm.edu	Mitchell, Lewis/W-1312-2018; Mitchell, Lewis/U-8250-2019; Frank, Morgan R/L-3124-2016; Dodds, Peter/C-9119-2014	Mitchell, Lewis/0000-0001-8191-1997; Mitchell, Lewis/0000-0001-8191-1997; /0000-0001-9487-9359; Dodds, Peter/0000-0003-1973-8614; Lahne, Jacob/0000-0002-2344-1816	NSF CA-REER [0846668]; NSF BIGDATA [1447634]; Women, Infants and Children, East Boston	NSF CA-REER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF BIGDATA; Women, Infants and Children, East Boston	PSD was supported by NSF CA-REER Grant No. 0846668. CM D and PSD were supported by NSF BIGDATA Grant No.1447634. The funder Women, Infants and Children, East Boston provided support in the form of salary for author SCA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abbar S, 2015, YOU TWEET WHAT YOU E; Ainsworth B, 2013, COMPENDIUM PHYS ACTI; [Anonymous], 2013, USDA NAT NUTR DAT ST; [Anonymous], 2013, HLTH RELATED QUALITY; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061373; Culotta A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P1335, DOI 10.1145/2556288.2557139; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037/0022-3514.69.5.851; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Eichstaedt J. C., 2015, PSYCHOL SCI; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; National Center for Chronic Disease Prevention and Health Promo- tion. Division of Nutrition Physical Activity and Centers for Disease Control and Prevention, 2013, STAT IND REP FRUITS; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Pesta BJ, 2012, INTELLIGENCE, V40, P107, DOI 10.1016/j.intell.2012.01.011; Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191; Rentfrow PJ, 2013, J PERS SOC PSYCHOL, V105, P996, DOI 10.1037/a0034434; Siebens J., 2013, EXTENDED MEASURES WE; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; West R., 2013, WWW, P1399; Williams JR, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042808; Williams JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12209	28	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0168893	10.1371/journal.pone.0168893	http://dx.doi.org/10.1371/journal.pone.0168893			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187216	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300002
J	Atkinson, RJ; Fulham, WR; Michie, PT; Ward, PB; Todd, J; Stain, H; Langdon, R; Thienel, R; Paulik, G; Cooper, G; Consortium, M; Schall, U				Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Ward, Philip B.; Todd, Juanita; Stain, Helen; Langdon, Robyn; Thienel, Renate; Paulik, Georgie; Cooper, Gavin; Consortium, MinT; Schall, Ulrich			Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study	PLOS ONE			English	Article							ULTRA-HIGH-RISK; MISMATCH NEGATIVITY MMN; INFORMATION-PROCESSING DEFICITS; 1ST-EPISODE PSYCHOSIS; INVOLUNTARY ATTENTION; FORECASTING PSYCHOSIS; AUDITORY DYSFUNCTION; IDENTIFICATION TEST; REVISED VERSION; PRODROMAL PHASE	The onset of schizophrenia is typically preceded by a prodromal period lasting several years during which sub-threshold symptoms may be identified retrospectively. Clinical interviews are currently used to identify individuals who have an ultra-high risk (UHR) of developing a psychotic illness with a view to provision of interventions that prevent, delay or reduce severity of future mental health issues. The utility of bio-markers as an adjunct in the identification of UHR individuals is not yet established. Several event-related potential measures, especially mismatch-negativity (MMN), have been identified as potential biomarkers for schizophrenia. In this 12-month longitudinal study, demographic, clinical and neuropsychological data were acquired from 102 anti-psychotic naive UHR and 61 healthy controls, of whom 80 UHR and 58 controls provided valid EEG data during a passive auditory task at baseline. Despite widespread differences between UHR and controls on demographic, clinical and neuropsychological measures, MMN and P3a did not differ between these groups. Of 67 UHR at the 12-month follow-up, 7 (10%) had transitioned to a psychotic illness. The statistical power to detect differences between those who did or did not transition was limited by the lower than expected transition rate. ERPs did not predict transition, with trends in the opposite direction to that predicted. In exploratory analysis, the strongest predictors of transition were measures of verbal memory and subjective emotional disturbance.	[Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Todd, Juanita; Thienel, Renate; Cooper, Gavin; Schall, Ulrich] Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia; [Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Thienel, Renate; Schall, Ulrich] Hunter Med Res Inst, Newcastle, NSW, Australia; [Atkinson, Rebbekah J.; Fulham, W. Ross; Michie, Patricia T.; Todd, Juanita; Langdon, Robyn; Thienel, Renate; Paulik, Georgie; Cooper, Gavin; Schall, Ulrich] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Michie, Patricia T.; Todd, Juanita] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia; [Ward, Philip B.] Univ New South Wales, Sch Med & Populat Hlth Univ, Sydney, NSW, Australia; [Ward, Philip B.] Schizophrenia Res Unit, South Western Sydney Local Hlth, Sydney, NSW, Australia; [Stain, Helen] Bloomfield Hosp, Ctr Rural & Remote Mental Hlth, Orange, NSW, Australia; [Stain, Helen] Leeds Trin Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England; [Langdon, Robyn] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Langdon, Robyn] Macquarie Univ, Dept Cognit Sci, Sydney, NSW, Australia; [Thienel, Renate] Hunter Inst Mental Hlth, Newcastle, NSW, Australia; [Paulik, Georgie] Univ Western Australia, Sch Psychol, Nedlands, WA, Australia; [Paulik, Georgie] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Schall, Ulrich] Hunter New England Hlth, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of New South Wales Sydney; Macquarie University; Macquarie University; University of Western Australia; Murdoch University	Fulham, WR (corresponding author), Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia.; Fulham, WR (corresponding author), Hunter Med Res Inst, Newcastle, NSW, Australia.; Fulham, WR (corresponding author), Schizophrenia Res Inst, Darlinghurst, NSW, Australia.	ross.fulham@newcastle.edu.au	Weickert, Thomas/AFS-7669-2022; SCHALL, ULRICH ANDREAS/G-7452-2013; Ward, Philip/E-3959-2010; Thienel, Renate/H-8813-2012; , Juanita/B-6191-2013; Cooper, Gavin/G-7458-2013; Fulham, Ross/G-7266-2013	Weickert, Thomas/0000-0002-6408-718X; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Ward, Philip/0000-0002-5779-7722; Curtis, Jackie/0000-0001-6884-0098; Thienel, Renate/0000-0003-0381-7828; , Juanita/0000-0002-0443-600X; Mathersul, Danielle/0000-0003-2372-8654; Langdon, Robyn/0000-0002-1044-7194; Cooper, Gavin/0000-0002-7186-5293; Fulham, Ross/0000-0001-8828-1588; Tooney, Paul/0000-0003-3745-4367; Seal, Marc/0000-0002-8396-140X; Paulik-White, Georgie/0000-0001-8973-8922	National Health & Medical Research Council of Australia [569259]; University of Newcastle Post-doctoral Fellowship; Schizophrenia Research Institute utilizining frastructure from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia); Australia Research Council Future Fellowship [FT110100631]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Newcastle Post-doctoral Fellowship; Schizophrenia Research Institute utilizining frastructure from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia); Australia Research Council Future Fellowship(Australian Research Council)	The MinT study was supported by the National Health & Medical Research Council of Australia (Project 569259). RT was supported by a University of Newcastle Post-doctoral Fellowship. US and GC were supported by the Schizophrenia Research Institute utilizining frastructure funding from the New South Wales Ministry of Health and New South Wales Ministry of Trade and Investment (Australia). RL was supported by an Australia Research Council Future Fellowship (FT110100631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Babor T. F, 2001, GUIDELINES USE PRIMA; Baldeweg T, 2015, INT J PSYCHOPHYSIOL, V95, P145, DOI 10.1016/j.ijpsycho.2014.03.008; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bodatsch M, 2015, BIOL PSYCHIAT, V77, P951, DOI 10.1016/j.biopsych.2014.09.025; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Brewer WJ, 2006, SCHIZOPHRENIA BULL, V32, P538, DOI 10.1093/schbul/sbj077; Brewer WJ, 2003, AM J PSYCHIAT, V160, P1790, DOI 10.1176/appi.ajp.160.10.1790; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Bruggemann JM, 2013, INT J PSYCHOPHYSIOL, V89, P374, DOI 10.1016/j.ijpsycho.2013.05.008; Buysse D J, 1989, Psychiatry Res, V28, P193; Carlozzi NE, 2011, CLIN NEUROPSYCHOL, V25, P757, DOI 10.1080/13854046.2011.577811; Carlsson ML, 2004, CURR MED CHEM, V11, P267, DOI 10.2174/0929867043456034; Carrion RE, 2015, SCHIZOPHR RES, V164, P1, DOI 10.1016/j.schres.2015.01.030; Clark S, 2015, J NEURAL TRANSM, V122, P155, DOI 10.1007/s00702-014-1325-9; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cornblatt BA, 2007, SCHIZOPHRENIA BULL, V33, P688, DOI 10.1093/schbul/sbm029; Cullen AE, 2013, SCHIZOPHRENIA BULL, V39, P1318, DOI 10.1093/schbul/sbs128; Daneault JG, 2013, FRONT PSYCHIAT, V4; Darke S., 1991, 11 NAT DRUG ALC RES; Delis D. C., 1994, CALIFORNIA VERBAL LE; Delis DC, 2001, DELIS KAPLAN EXECUTI; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P351, DOI 10.1093/schbul/sbq088; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Dittmann-Balcar A, 1999, NEUROREPORT, V10, P3749, DOI 10.1097/00001756-199912160-00005; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Erickson MA, 2016, BIOL PSYCHIAT, V79, P980, DOI 10.1016/j.biopsych.2015.08.025; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; First M.B., 2014, STRUCTURED CLIN INTE; Fulham WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100221; Fusar-Poli P, 2013, SCHIZOPHRENIA BULL, V39, P923, DOI 10.1093/schbul/sbs060; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gross G., 2010, ACTA CLIN CROAT, V49, P47; Harmony T, 2000, COGNITIVE BRAIN RES, V9, P53, DOI 10.1016/S0926-6410(99)00044-0; Hay RA, 2015, BIOL PSYCHOL, V105, P130, DOI 10.1016/j.biopsycho.2015.01.004; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Higuchi Y, 2014, FRONT BEHAV NEUROSCI, P8; Hill SK, 2004, SCHIZOPHR RES, V68, P127, DOI 10.1016/S0920-9964(03)00125-7; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Hsieh MH, 2012, SCHIZOPHR RES, V140, P243, DOI 10.1016/j.schres.2012.06.021; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 2015, NAT REV NEUROSCI, V16, P535, DOI 10.1038/nrn4002; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jobe TH, 2005, CAN J PSYCHIAT, V50, P892, DOI 10.1177/070674370505001403; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaur M, 2013, PROG NEURO-PSYCHOPH, V46, P161, DOI 10.1016/j.pnpbp.2013.07.002; Kenemans JL, 2011, NEUROPSYCHOPHARMACOL, V36, P26, DOI 10.1038/npp.2010.157; Kettle JWL, 2008, SCHIZOPHR RES, V99, P96, DOI 10.1016/j.schres.2007.11.011; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kirkbride JB, 2006, ARCH GEN PSYCHIAT, V63, P250, DOI 10.1001/archpsyc.63.3.250; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; KOEHLER K, 1984, COMPR PSYCHIAT, V25, P174, DOI 10.1016/0010-440X(84)90006-3; Kumarasinghe N, 2014, NEUROL PSYCHIAT BR, V20, P29; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; Langdon R., 2003, INDIVIDUAL DIFFERENC, P241; Langdon R., 2005, OTHER MINDS HUMANS B, P333; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2015, ANN NY ACAD SCI, V1344, P105, DOI 10.1111/nyas.12730; Light GA, 2015, SCHIZOPHR RES, V163, P63, DOI 10.1016/j.schres.2014.09.042; Lin A, 2015, SCHIZOPHR RES, V161, P156, DOI 10.1016/j.schres.2014.10.051; Marco-Pallares J, 2010, NEUROIMAGE, V53, P962, DOI 10.1016/j.neuroimage.2010.02.012; McGorry PD, 2003, SCHIZOPHRENIA BULL, V29, P771, DOI 10.1093/oxfordjournals.schbul.a007046; Michie PT, 2000, CLIN NEUROPHYSIOL, V111, P1054, DOI 10.1016/S1388-2457(00)00275-3; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Mondragon-Maya A, 2013, J PSYCHIATR RES, V47, P755, DOI 10.1016/j.jpsychires.2012.12.017; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 2016, BIOL PSYCHOL; Naatanen R, 2015, INT J PSYCHOPHYSIOL, V95, P338, DOI 10.1016/j.ijpsycho.2014.12.012; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Naatanen R, 2014, BRAIN TOPOGR, V27, P451, DOI 10.1007/s10548-014-0374-6; Nagai T, 2013, FRONT PSYCHIAT, V4; Nagai T, 2013, SCHIZOPHR RES, V150, P547, DOI 10.1016/j.schres.2013.08.005; Nelson B, 2008, SCHIZOPHRENIA BULL, V34, P381, DOI 10.1093/schbul/sbm094; Oades RD, 1997, PSYCHOPHYSIOLOGY, V34, P677, DOI 10.1111/j.1469-8986.1997.tb02143.x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Perez VB, 2014, BIOL PSYCHIAT, V75, P459, DOI 10.1016/j.biopsych.2013.07.038; Phillips LJ, 2005, BRIT J PSYCHIAT, V187, pS33, DOI 10.1192/bjp.187.48.s33; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Raballo A, 2011, SCHIZOPHR RES, V127, P107, DOI 10.1016/j.schres.2010.12.021; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Schall U, 2016, BIOL PSYCHOL, V116, P41, DOI 10.1016/j.biopsycho.2015.09.001; Schmidt SJ, 2015, EUR PSYCHIAT, V30, P388, DOI 10.1016/j.eurpsy.2015.01.013; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shaikh M, 2012, SCHIZOPHR RES, V134, P42, DOI 10.1016/j.schres.2011.09.022; Shin KS, 2012, SCHIZOPHRENIA BULL, V38, P1258, DOI 10.1093/schbul/sbr138; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Solis-Vivanco R, 2014, SCHIZOPHR RES, V158, P58, DOI 10.1016/j.schres.2014.07.009; Solowij N, 2007, J PSYCHIATR NEUROSCI, V32, P30; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Todd J, 2013, FRONT PSYCHIATRY, V4, P1; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Todd J, 2012, INT J PSYCHOPHYSIOL, V83, P222, DOI 10.1016/j.ijpsycho.2011.10.003; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Valkonen-Korhonen M, 2003, COGNITIVE BRAIN RES, V17, P747, DOI 10.1016/S0926-6410(03)00199-X; van der Gaag M, 2013, SCHIZOPHR RES, V149, P56, DOI 10.1016/j.schres.2013.07.004; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wiltink S, 2015, EARLY INTERV PSYCHIA, V9, P200, DOI 10.1111/eip.12105; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x	129	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171657	10.1371/journal.pone.0171657	http://dx.doi.org/10.1371/journal.pone.0171657			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187217	Green Published, gold			2022-12-27	WOS:000394244300034
J	Kirichenko, N; Triberti, P; Ohshima, I; Haran, J; Byun, BK; Li, HH; Augustin, S; Roques, A; Lopez-Vaamonde, C				Kirichenko, Natalia; Triberti, Paolo; Ohshima, Issei; Haran, Julien; Byun, Bong-Kyu; Li, Houhun; Augustin, Sylvie; Roques, Alain; Lopez-Vaamonde, Carlos			From east to west across the Palearctic: Phylogeography of the invasive lime leaf miner Phyllonorycter issikii (Lepidoptera: Gracillariidae) and discovery of a putative new cryptic species in East Asia	PLOS ONE			English	Article							DNA BARCODES; MITOCHONDRIAL; POPULATION; TAXONOMY; SUCCESS; REVEAL; MOTH	Knowing the phylogeographic structure of invasive species is important for understanding the underlying processes of invasion. The micromoth Phyllonorycter issikii, whose larvae damage leaves of lime trees Tilia spp., was only known from East Asia. In the last three decades, it has been recorded in most of Europe, Western Russia and Siberia. We used the mitochondrial cytochrome c oxidase subunit I (COI) gene region to compare the genetic variability of P. issikii populations between these different regions. Additionally, we sequenced two nuclear genes (28S rRNA and Histone 3) and run morphometric analysis of male genitalia to probe for the existence of cryptic species. The analysis of COI data of 377 insect specimens collected in 16 countries across the Palearctic revealed the presence of two different lineages: P. issikiiand a putative new cryptic Phyllonorycterspecies distributed in the Russian Far East and Japan. In P. issikii, we identified 31 haplotypes among which 23 were detected in the invaded area (Europe) and 10 were found in its putative native range in East Asia (Russian Far East, Japan, South Korea and China), with only two common haplotypes. The high number of haplotypes found in the invaded area suggest a possible scenario of multiple introductions. One haplotype H1 was dominant (119 individuals, 67.2%), not only throughout its expanding range in Europe and Siberia but, intriguingly, also in 96% of individuals originating from Japan. We detected eight unique haplotypes of P. issikii in East Asia. Five of them were exclusively found in the Russian Far East representing 95% of individuals from that area. The putative new cryptic Phyllonorycterspecies showed differences from P. issikii for the three studied genes. However, both species are morphologically undistinguishable. They occur in sympatry on the same host plants in Japan (Sendai) and the Russian Far East (Primorsky krai) without evidence of admixture.	[Kirichenko, Natalia] Krasnoyarsk Sci Ctr SB RAS, Fed Res Ctr, Sukachev Inst Forest SB RAS, Krasnoyarsk, Russia; [Kirichenko, Natalia] Siberian Fed Univ, Krasnoyarsk, Russia; [Kirichenko, Natalia; Haran, Julien; Augustin, Sylvie; Roques, Alain; Lopez-Vaamonde, Carlos] INRA, Zool Forestiere UR0633, Orleans, France; [Triberti, Paolo] Museo Civ Storia Nat, Verona, Italy; [Ohshima, Issei] Kyoto Prefectural Univ, Dept Life & Environm Sci, Kyoto, Japan; [Haran, Julien] IRD, CIRAD, INRA, UMR CBGP,SupAgro, Montpellier, France; [Byun, Bong-Kyu] Hannam Univ, Dept Biol Sci & Biotechnol, Daejeon, South Korea; [Li, Houhun] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Lopez-Vaamonde, Carlos] Univ Francois Rabelais Tours, Inst Rech Biol Insecte, CNRS UMR 7261, UFR Sci & Tech, Tours, France	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; INRAE; Kyoto Prefectural University; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Hannam University; Nankai University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Kirichenko, N (corresponding author), Krasnoyarsk Sci Ctr SB RAS, Fed Res Ctr, Sukachev Inst Forest SB RAS, Krasnoyarsk, Russia.; Kirichenko, N (corresponding author), Siberian Fed Univ, Krasnoyarsk, Russia.; Kirichenko, N (corresponding author), INRA, Zool Forestiere UR0633, Orleans, France.		Vaamonde, Carlos Lopez/A-5548-2009; Byun, Bong-Kyu/G-1520-2010	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Byun, Bong-Kyu/0000-0003-0393-6464; Kirichenko, Natalia/0000-0002-7362-6464	LE STUDIUM Loire Valley Institute for Advanced Studies, France [INRA-URZF-007]; Russian Foundation for Basic Research, Russia [15-29-02645]	LE STUDIUM Loire Valley Institute for Advanced Studies, France; Russian Foundation for Basic Research, Russia(Russian Foundation for Basic Research (RFBR))	NK was supported by a fellowship of LE STUDIUM Loire Valley Institute for Advanced Studies, France, http://www.lestudium-ias.com/ (grant No INRA-URZF-007) and the Russian Foundation for Basic Research, Russia, http.//www.rfbr.ru/rffi/eng (grant No 15-29-02645). The role of LE STUDIUM Loire Valley Institute for Advanced Studies: study design, data collection and analysis, decision to publish. The role of the Russian Foundation for Basic Research: data collection and analysis, preparation of the manuscript.	[Anonymous], 2015, DATABASE; [Anonymous], 2015, DATABASE; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Baranova AL, 2015, RED BOOK TOMSK OBLAS; Beguinot J, 2016, PHYLLONORYCTER ISSIK; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeWaard Jeremy R., 2008, V410, P275; Ellis WN, 2016, LEAFMINERS PLANT GAL; Ermolaev IV, 2014, CONTEMP PROBL ECOL+, V7, P324, DOI 10.1134/S1995425514030032; Ermolaev I.V., 2011, ENTOMOL REV, V91, P592, DOI [10.1134/S0013873811050046, DOI 10.1134/S0013873811050046]; Ermolaev V. P., 1977, Trudy zool Inst Leningr, V70, P98; ESRI, 2008, ARCGIS DESKT REL 9 3; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gerasimov AM, 1952, FAUNA USSR; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Glavendekic M, 2014, INVASIVE INSECTS CHA, P15; Gurzenkov NN, 1967, THESIS; Gusev VI, 1984, KEY DAMAGE FOREST OR; Gutzwiller F, 2015, ECOL EVOL, V5, P4049, DOI 10.1002/ece3.1580; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hayashi Y, 1969, YU YO JUMOKU ZUSETSU; Hellrigl Klaus, 2012, Forest Observer, V6, P99; Hering EM, 1957, BESTIMMUNGSTABELLEN; Hespenheide Henry A., 2011, Zootaxa, V2805, P36; Kazantseva M.N, 2015, RED BOOK TYUMEN OBLA; Kenis M., 2013, Aliens: The Invasive Species Bulletin, P38; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Khlonov YP, 1965, LIME TREES LIME GROV; Kirichenko NI, 2014, CONTEMP PROBL ECOL+, V7, P114, DOI 10.1134/S1995425514010077; Kirichenko N, 2016, ZOOKEYS, P99, DOI 10.3897/zookeys.579.7166; Kirichenko N, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.473.8543; Kirichenko NI, 2009, T SAINT PETERSBURG F, V187, P140; Kirichenko NI, 2013, PESTS DIS WOODY PLAN, P47; Kozlov M.V., 1991, PLANT PROT QUAR, V4, P46; Krapivkina ED, 1996, GREEN BOOK SIBERIA, P58; Krylov PN, 1894, P IMP TOMSK U TOMSK, P1; Kullberg J., 2002, SAHLBERGIA, V6, P45; Kumata T., 1983, Korean Journal of Plant Protection, V22, P213; Kumata T, 1963, INSECTA MATSUMURANA, V25, P53; Kumata T, 2013, STANDARD MOTHS JAPAN; Kuznetzov VI, 1999, INSECTS MITES PESTS, P9; Lastuvka Z, 2013, SHILAP-REV LEPIDOPT, V41, P251; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez VM, 2014, BIOL INVASIONS, V16, P2393, DOI 10.1007/s10530-014-0672-7; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lopez-Vaamonde Carlos, 2010, BioRisk, V4, P603; Matosevic D., 2007, RAD SUMAR I JASTREBA, V42, P127; McLachlan G.J., 2004, DISCRIMINANT ANAL ST; Meng PS, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv003; Noreika Remigijus, 1998, Acta Zoologica Lituanica, V8, P34; Pigott D, 2012, BIOL MONOGRAPH GENUS; Polozhiy AV, 1985, TERTIARY RELIC BROAD, P1; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Rennwald E., 2008, ENTOMOL NACHR BER, V51, P233; Revyakina NV, 1998, RED BOOK ALTAI TERRI; Rewicz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118121; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Roques Alain, 2010, BioRisk, V4, P11; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Schreurs A, 2007, DATABASE; Sefrova H., 2002, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V50, P99; Shigesada N., 1997, BIOL INVASIONS THEOR; Stepanov NV, 1993, BOT J, V78, P142; Svejgaard JJ, 2003, EUFORGEN TECHNICAL G; Szocs L, 2015, EUR J ENTOMOL, V112, P591, DOI 10.14411/eje.2015.101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timofeeva YA, 2014, T SAINT PETERSBURG S, V207, P133; Tomov R., 2009, P 6 C PLANT PROTECTI, P83; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Urusov VM, 1993, STRUCTURE DIVERSITY; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; van Nieukerken EJ, 2012, ZOOKEYS, P29, DOI 10.3897/zookeys.170.2617; Wullaert S, 2012, PHEGEA, V40, P63; Zhuravlev BB, 2009, MAP AREAS MAIN TYPES	79	21	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171104	10.1371/journal.pone.0171104	http://dx.doi.org/10.1371/journal.pone.0171104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187126	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300011
J	Wang, HL; Zhang, H; Wu, SL; Liao, GC; Fang, AP; Zhu, MF; Zhu, HL				Wang, Hai-lin; Zhang, Hui; Wu, Shang-ling; Liao, Gong-cheng; Fang, Ai-ping; Zhu, Ming-fan; Zhu, Hui-lian			Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease	PLOS ONE			English	Article							METABOLIC SYNDROME; HEMATOLOGICAL PARAMETERS; INSULIN-RESISTANCE; ASSOCIATION; CHINESE; INFLAMMATION; PREVALENCE; COMPONENTS; FERRITIN; RISK	Background & aims Red blood cell (RBC) indices have been demonstrated to be associated with fatty liver disease (FLD) and metabolic syndrome. However, controversy exists regarding the relationship of RBC indices with FLD to date and few has focused on RBC count. This study aimed to explore the association between RBC count and risk of FLD in Southern Chinese adults. Methods A hospital-based cross-sectional study was performed in two hospital health examination centers, including information on ultrasonography-diagnosed FLD, anthropometric indices and biochemical measurements. Covariance analysis was used to evaluate group differences. After quintile classification of RBC counts, logistic regression analysis was conducted to evaluate the odds ratios (ORs) of FLD. Results This study consisted of 8618 subjects (4137 men and 4481 women) aged between 20 and 89 years. FLD cases had higher RBC counts than non-FLD cases in both genders (P<0.001). The prevalence rates of FLD increased with the RBC quintiles in both genders (all P trend<0.001), and were higher in men than women. Binary logistic regression analysis showed positive association between RBC count and FLD, and the OR (95% confidence interval (CI)) were 2.56 (2.06-3.18) in men and 3.69 (2.74-4.98) in women, respectively, when comparing Q5 with Q1. Stratified analyses showed similar trends among subjects with and without FLD risk factors. Gender independent results were similar to gender dependent results. Conclusions Elevated RBC count is independently associated with high risk of FLD, suggesting that the RBC count may be a potential risk predictor for FLD.	[Wang, Hai-lin; Wu, Shang-ling; Liao, Gong-cheng; Fang, Ai-ping; Zhu, Hui-lian] Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou, Guangdong, Peoples R China; [Zhang, Hui] Shenzhen Luohu Peoples Hosp, Hlth Examinat Ctr, Shenzhen, Guangdong, Peoples R China; [Zhu, Ming-fan] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Examinat Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhu, HL (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Nutr, Guangzhou, Guangdong, Peoples R China.	zhuhl@mail.sysu.edu.cn	Zhu, Huilian/V-1040-2019; Fang, Aiping/V-1792-2019	Fang, Aiping/0000-0001-9139-3898; Wu, Shang-ling/0000-0002-2816-3755	National Natural Science Foundation of China [81273050]; Key Program of National Natural Science Foundation of Guangdong, China [2015A030311035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation of Guangdong, China	This work was funded by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/publish/portal1/, (NO. 81273050), recipient: HLZ; and Key Program of National Natural Science Foundation of Guangdong, China, http://www.gdstc.gov.cn/, (NO. 2015A030311035), recipient: HLZ.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Association AD, 2005, DIABETES CARE S1, V28, pS42; Barbieri M, 2001, DIABETOLOGIA, V44, P1232, DOI 10.1007/s001250100634; Buttari B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/616834; Crawford JH, 2004, ANTIOXID REDOX SIGN, V6, P992, DOI 10.1089/ars.2004.6.992; Das SK, 2011, SINGAP MED J, V52, P175; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Giovannetti A, 2012, CELL PHYSIOL BIOCHEM, V30, P418, DOI 10.1159/000339035; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Haukeland JW, 2006, J HEPATOL, P44; Issa D, 2014, EUR J GASTROEN HEPAT, V26, P363, DOI 10.1097/MEG.0000000000000031; Jiang YZ, 2014, J GASTROEN HEPATOL, V29, P1508, DOI 10.1111/jgh.12580; Kawamoto R, 2013, ENDOCRINE, V43, P334, DOI 10.1007/s12020-012-9662-7; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lohsoonthorn V, 2007, DIABETES METAB SYND, V1, P143, DOI 10.1016/j.dsx.2007.05.002; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Manousou P, 2011, LIVER INT, V31, P730, DOI 10.1111/j.1478-3231.2011.02488.x; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Sanchez-Chaparro Miguel Angel, 2010, Diabetes Care, V33, pe40, DOI 10.2337/dc09-1707; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Straface Elisabetta, 2011, Int J Cell Biol, V2011, P204157, DOI 10.1155/2011/204157; Tabara Y, 2013, CLIN HEMORHEOL MICRO, V55, P297, DOI 10.3233/CH-2012-1634; Wang YY, 2004, J DIABETES COMPLICAT, V18, P322, DOI 10.1016/S1056-8727(04)00003-0; Wu S, 2013, BMC PUBLIC HEALTH, P13; Wu S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-989; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172027	10.1371/journal.pone.0172027	http://dx.doi.org/10.1371/journal.pone.0172027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187211	Green Submitted, gold, Green Published			2022-12-27	WOS:000394244300069
J	Kamei, J; Hayashi, S; Sakai, A; Nakanishi, Y; Kai, M; Ikegami, M; Ikeda, H				Kamei, Junzo; Hayashi, Shunsuke; Sakai, Akane; Nakanishi, Yuki; Kai, Misa; Ikegami, Megumi; Ikeda, Hiroko			Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NF kappa B) phosphorylation in spinal cord of mice	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; METASTATIC BREAST-CANCER; ACETYL-L-CARNITINE; LEUKEMIA GROUP-B; MECHANICAL ALLODYNIA; CYTOKINE EXPRESSION; INFLAMMATORY PAIN; INDUCED APOPTOSIS; DOSE PACLITAXEL; RATS	Peripheral neuropathy is the major side effect caused by paclitaxel, a microtubule-binding antineoplastic drug. Paclitaxel-induced peripheral neuropathy causes a long-term negative impact on the patient's quality of life. However, the mechanism underlying paclitaxel-induced peripheral neuropathy is still unknown, and there is no established treatment. Ghrelin is known to attenuate thermal hyperalgesia and mechanical allodynia in chronic constriction injury of the sciatic nerve, and inhibit the activation of nuclear factor kappa B (NF kappa B) in the spinal dorsal horn. Rikkunshito (RKT), a kampo medicine, increases the secretion of ghrelin in rodents and humans. Thus, RKT may attenuate paclitaxel-induced peripheral neuropathy by inhibiting phosphorylated NF kappa B (pNF kappa B) in the spinal cord. We found that paclitaxel dose-dependently induced mechanical hyperalgesia in mice. Paclitaxel increased the protein levels of spinal pNF kappa B, but not those of spinal NF kappa B. NF kappa B inhibitor attenuated paclitaxel-induced mechanical hyperalgesia suggesting that the activation of NF kappa B mediates paclitaxel-induced hyperalgesia. RKT dose-dependently attenuated paclitaxel-induced mechanical hyperalgesia. Ghrelin receptor antagonist reversed the RKT-induced attenuation of paclitaxel-induced mechanical hyperalgesia. RKT inhibited the paclitaxel-induced increase in the protein levels of spinal pNF kappa B. Taken together, the present study indicates that RKT exerts an antihyperalgesic effect in paclitaxel-induced neuropathic pain by suppressing the activation of spinal NF kappa B.	[Kamei, Junzo; Hayashi, Shunsuke; Sakai, Akane; Nakanishi, Yuki; Kai, Misa; Ikegami, Megumi; Ikeda, Hiroko] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, Tokyo, Japan	Hoshi University	Kamei, J (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Shinagawa Ku, Tokyo, Japan.	kamei@hoshi.ac.jp						Akerley W, 2003, CANCER, V97, P2480, DOI 10.1002/cncr.11375; Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Bames P.J., 1997, NEW ENGL J MED, V336, P1066; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Cata JP, 2008, BRAIN RES, V1229, P100, DOI 10.1016/j.brainres.2008.07.001; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Esin E, 2014, ONCOTARGETS THER, V7, P599, DOI 10.2147/OTT.S60995; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Forsyth PA, 1997, J NEURO-ONCOL, V35, P47, DOI 10.1023/A:1005805907311; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Garcia JM, 2008, ENDOCRINOLOGY, V149, P455, DOI 10.1210/en.2007-0828; Gogas H, 1996, GYNECOL ONCOL, V61, P22, DOI 10.1006/gyno.1996.0090; Guneli E, 2010, NEUROSCI LETT, V479, P226, DOI 10.1016/j.neulet.2010.05.066; Guo CJ, 2004, GLIA, V48, P259, DOI 10.1002/glia.20079; Hatton T., 2010, INT J PEPT; Hiyama T, 2008, WORLD J GASTROENTERO, V14, P3123, DOI 10.3748/wjg.14.3123; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Ito S, 2012, J PHARMACOL EXP THER, V342, P53, DOI 10.1124/jpet.111.187401; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Kawahara H, 2007, PEDIATR SURG INT, V23, P1001, DOI 10.1007/s00383-007-1986-7; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Ma VY, 1998, BRAIN RES, V797, P243, DOI 10.1016/S0006-8993(98)00380-1; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; Matsumura T, 2010, J GASTROENTEROL, V45, P300, DOI 10.1007/s00535-009-0166-z; Nabholtz JM, 1996, J CLIN ONCOL, V14, P1858, DOI 10.1200/JCO.1996.14.6.1858; Pan YD, 2010, REGION ANESTH PAIN M, V35, P231, DOI 10.1097/AAP.0b013e3181df245b; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Sakaue G, 2001, NEUROREPORT, V12, P2079, DOI 10.1097/00001756-200107200-00008; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Sibilia V, 2006, NEUROPHARMACOLOGY, V51, P497, DOI 10.1016/j.neuropharm.2006.04.009; Sibilia V, 2012, AMINO ACIDS, V43, P1751, DOI 10.1007/s00726-012-1260-8; Sun T, 2012, EUR J PHARMACOL, V682, P79, DOI 10.1016/j.ejphar.2012.02.017; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Tanabe Y, 2013, INT J CLIN ONCOL, V18, P132, DOI 10.1007/s10147-011-0352-x; TATSUTA M, 1993, ALIMENT PHARM THERAP, V7, P459; Tegeder I, 2004, J NEUROSCI, V24, P1637, DOI 10.1523/JNEUROSCI.3118-03.2004; Tominaga K, 2013, J GASTROENTEROL, V48, P452, DOI 10.1007/s00535-013-0788-z; Tominaga K, 2012, J GASTROENTEROL, V47, P284, DOI 10.1007/s00535-011-0488-5; Vergnano AM, 2008, ENDOCRINOLOGY, V149, P2306, DOI 10.1210/en.2007-1164; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; WIERNIK PH, 1987, CANCER RES, V47, P2486; Winer EP, 2004, J CLIN ONCOL, V22, P2061, DOI 10.1200/JCO.2004.08.048; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yanai M, 2013, J GASTROENTEROL, V48, P611, DOI 10.1007/s00535-012-0687-8; Zhou CH, 2014, REGION ANESTH PAIN M, V39, P137, DOI 10.1097/AAP.0000000000000050	57	6	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171819	10.1371/journal.pone.0171819	http://dx.doi.org/10.1371/journal.pone.0171819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182729	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800120
J	Luo, F; Wang, YS; Su, YH; Zhang, ZH; Sun, HH; Li, J				Luo, Fei; Wang, Ya-Shen; Su, Yan-Hui; Zhang, Zhi-Hua; Sun, Hong-Hong; Li, Jian			Prognostic implications of preoperative anemia in urothelial carcinoma: A meta-analysis	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; CANCER-RELATED ANEMIA; RADICAL CYSTECTOMY; PRETREATMENT HEMOGLOBIN; PERFORMANCE STATUS; LOCAL-CONTROL; BLADDER; SURVIVAL; IMPACT; NEPHROURETERECTOMY	The prognostic significance of preoperative anemia (PA) has been identified in various malignancies. However, its predictive role in urothelial carcinoma (UC) remains controversial. The aim of this study was to investigate the prognostic value of PA in UC patients. We performed a meta-analysis of the association between PA and survival outcome in UC patients. Electronic databases were searched up to June 30, 2016. Study characteristics and prognostic data were extracted from each included study. Cancer-specific survival (CSS), recurrencefree survival (RFS), and overall survival (OS) were pooled using hazard ratio (HR) with corresponding 95% confidence intervals (CI). Herein, 12 studies comprising 3815 patients were included in the meta-analysis. There were 1593 (41.76%) patients in the PA group and 2222 (58.24%) in the control group. The overall pooled HRs of PA for CSS, RFS, and OS were significant at 2.21, (95% CI: 1.83-2.65, P-heterogeneity = 0.49, I-2 = 0%), 1.87 (95% CI: 1.59-2.20, P-heterogeneity = 0.22, I-2 = 28%), and 2.04(95% CI: 1.76-2.37, P-heterogeneity = 0.36, I-2 = 9%) respectively. Stratified analyses indicated that PA was a predictor of poor prognosis based on ethnicity, sample size, tumor T stage, G grade, lymphovascular invasion (LVI), concomitant carcinoma in situ (CIS), and follow-up values. Our findings show that PA has negative prognostic effects on the survival outcome (CSS, RFS, and OS) in UC patients and can serve as a useful and cost-effective marker to aid prognosis prediction.	[Luo, Fei; Wang, Ya-Shen; Su, Yan-Hui; Zhang, Zhi-Hua; Sun, Hong-Hong; Li, Jian] Tianjin Union Med Ctr, Dept Urol, Tianjin, Peoples R China		Li, J (corresponding author), Tianjin Union Med Ctr, Dept Urol, Tianjin, Peoples R China.	lijian_2016tj@163.com	zhang, zh/GWV-4677-2022					Akdogan B, 2006, J UROLOGY, V176, P48, DOI 10.1016/S0022-5347(06)00511-8; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Birgegard G, 2005, ONCOLOGY-BASEL, V68, P3, DOI 10.1159/000083128; Bruins HM, 2013, J UROLOGY, V189, pE584, DOI 10.1016/j.juro.2013.02.2780; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Celik O, 2015, ASIAN PAC J CANCER P, V17, P1755; Chen Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/504896; Dunst J, 1999, STRAHLENTHER ONKOL, V175, P93, DOI 10.1007/BF02742340; Dunst J, 2002, STRAHLENTHER ONKOL, V178, P436, DOI 10.1007/s00066-002-0925-8; Eisenberg MS, 2013, J UROLOGY, V190, P2005, DOI 10.1016/j.juro.2013.06.022; Fechner G, 2005, ANTICANCER RES, V25, P3413; FEIN DA, 1995, J CLIN ONCOL, V13, P2077, DOI 10.1200/JCO.1995.13.8.2077; Gierth M, 2015, J CANCER RES CLIN, V141, P1819, DOI 10.1007/s00432-015-1957-7; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hara T, 2016, INT J CLIN ONCOL, V21, P139, DOI 10.1007/s10147-015-0857-9; Hinata N, 2015, INT J UROL, V22, P742, DOI 10.1111/iju.12804; Hutterer GC, 2015, ANTICANCER RES, V35, P3463; Jo JK, 2016, INT UROL NEPHROL, V48, P489, DOI 10.1007/s11255-016-1219-x; Joynson CP, 2006, CLIN ONCOL-UK, V18, P728, DOI 10.1016/j.clon.2006.09.001; Ke HL, 2008, INT J UROL, V15, P200, DOI 10.1111/j.1442-2042.2007.01978.x; Maccio A, 2015, HAEMATOLOGICA, V100, P124, DOI 10.3324/haematol.2014.112813; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Mercadante S, 2000, CANCER TREAT REV, V26, P303, DOI 10.1053/ctrv.2000.0181; Milojevic B, 2015, CLIN GENITOURIN CANC, V13, P485, DOI 10.1016/j.clgc.2015.03.007; Morceau F, 2010, MEDIAT INFLAMM, P2009; Morizane S, 2013, INT UROL NEPHROL, V45, P99, DOI 10.1007/s11255-012-0347-1; Rink M, 2014, J UROLOGY, V191, P316, DOI 10.1016/j.juro.2013.09.010; Rink M, 2012, CURR UROL REP, V13, P122, DOI 10.1007/s11934-012-0237-1; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Sabbatini P., 2000, ONCOLOGIST, V5, P19, DOI 10.1634/theoncologist.5-suppl_2-19; Schrijvers D, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S3-12; Schubert T, 2016, WORLD J UROL, P1; Shariat SF, 2010, UROL ONCOL-SEMIN ORI, V28, P389, DOI 10.1016/j.urolonc.2010.02.011; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tanaka N, 2014, EUR UROL, V65, P227, DOI 10.1016/j.eururo.2012.11.050; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vaupel P, 2001, SEMINARS ONCOLOGY; Warde P, 1998, INT J RADIAT ONCOL, V41, P347, DOI 10.1016/S0360-3016(98)00062-5; Xia GB, 2006, J UROLOGY, V175, P1245, DOI 10.1016/S0022-5347(05)00736-6; Xylinas E, 2013, BJU INT, V112, P453, DOI 10.1111/j.1464-410X.2012.11649.x; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yeh H-C, 2016, UROLOGIC ONCOLOGY SE; Yurut-Caloglu V, 2009, ASIAN PAC J CANCER P, V10, P1151; 2003, LANCET LONDON ENGLAN, V361, P1927	48	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171701	10.1371/journal.pone.0171701	http://dx.doi.org/10.1371/journal.pone.0171701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182725	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800094
J	Gerland, TA; Sun, B; Smialowski, P; Lukacs, A; Thomae, AW; Imhof, A				Gerland, Thomas Andreas; Sun, Bo; Smialowski, Pawel; Lukacs, Andrea; Thomae, Andreas Walter; Imhof, Axel			The Drosophila speciation factor HMR localizes to genomic insulator sites	PLOS ONE			English	Article							CHROMATIN INSULATOR; BINDING-SITES; DOSAGE COMPENSATION; CHIP DATA; MELANOGASTER; PROTEIN; GENE; HETEROCHROMATIN; SUPPRESSOR; CENTROMERE	Hybrid incompatibility between Drosophila melanogaster and D. simulans is caused by a lethal interaction of the proteins encoded by the Hmr and Lhr genes. In D. melanogaster the loss of HMR results in mitotic defects, an increase in transcription of transposable elements and a deregulation of heterochromatic genes. To better understand the molecular mechanisms that mediate HMR's function, we measured genome-wide localization of HMR in D. melanogaster tissue culture cells by chromatin immunoprecipitation. Interestingly, we find HMR localizing to genomic insulator sites that can be classified into two groups. One group belongs to gypsy insulators and another one borders HP1a bound regions at active genes. The transcription of the latter group genes is strongly affected in larvae and ovaries of Hmr mutant flies. Our data suggest a novel link between HMR and insulator proteins, a finding that implicates a potential role for genome organization in the formation of species.	[Gerland, Thomas Andreas; Sun, Bo; Smialowski, Pawel; Lukacs, Andrea; Thomae, Andreas Walter; Imhof, Axel] Ludwig Maximilians Univ Munchen, Biomed Ctr, Histone Modificat Grp, Dept Mol Biol, Planegg Martinsried, Germany; [Gerland, Thomas Andreas; Imhof, Axel] Ludwig Maximilians Univ Munchen, CIPSM, Munich, Germany; [Smialowski, Pawel] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Computat Biol, Planegg Martinsried, Germany; [Thomae, Andreas Walter] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioimaging, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Imhof, A (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Histone Modificat Grp, Dept Mol Biol, Planegg Martinsried, Germany.; Imhof, A (corresponding author), Ludwig Maximilians Univ Munchen, CIPSM, Munich, Germany.	imhof@lmu.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Thomae, Andreas/0000-0003-3156-9075	Deutsche Forschungsgemeinschaft (DFG) [IM/9-1]; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Chinese Scholarship Council(China Scholarship Council)	The work was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG) to Andrea Lukacs (QBM) and Axel Imhof (IM/9-1). B. S. was funded by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD JP, 1992, P NATL ACAD SCI USA, V89, P4663, DOI 10.1073/pnas.89.10.4663; Andrews S, 2010, FATSQC QUALITY CONTR; Aruna S, 2009, GENETICS, V181, P1437, DOI 10.1534/genetics.108.100057; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Barth TK, 2014, PROTEOMICS, V14, P2167, DOI 10.1002/pmic.201400052; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Bohla D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107765; Bolkan BJ, 2007, GENETICS, V177, P2233, DOI 10.1534/genetics.107.079939; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Brideau NJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-57; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dai HZ, 2008, P NATL ACAD SCI USA, V105, P7478, DOI 10.1073/pnas.0800693105; Emberly E, 2008, PLOS BIOL, V6, P2896, DOI 10.1371/journal.pbio.0060327; FRASCH M, 1986, J CELL SCI, V82, P155; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2003, DEVELOPMENT, V130, P3249, DOI 10.1242/dev.00543; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Hannon GJ, FASTX TOOLKITS FASTA; Heger P, 2013, EVOLUTION, V67, P2945, DOI 10.1111/evo.12155; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; KAMINKER JS, 2002, GENOME BIOL, V0003; Kelleher ES, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001428; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerat E, 2011, GENE, V473, P100, DOI 10.1016/j.gene.2010.11.009; Maheshwari S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002597; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ni XC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001420; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Olszak AM, 2011, NAT CELL BIOL, V13, P799, DOI 10.1038/ncb2272; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Padeken J, 2013, MOL CELL, P1; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parnell TJ, 2003, P NATL ACAD SCI USA, V100, P13436, DOI 10.1073/pnas.2333111100; Phadnis N, 2015, SCIENCE, V350, P1552, DOI 10.1126/science.aac7504; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rodriguez MA, 2007, P NATL ACAD SCI USA, V104, P15412, DOI 10.1073/pnas.0707445104; Ross BD, 2013, SCIENCE, V340, P1211, DOI 10.1126/science.1234393; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Satyaki PRV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004240; Sawamura Kyoichi, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/301894; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thomae AW, 2013, DEV CELL, V27, P412, DOI 10.1016/j.devcel.2013.10.001; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vieira C, 2004, GENETICA, V120, P115, DOI 10.1023/B:GENE.0000017635.34955.b5; Wei KHC, 2014, MOL BIOL EVOL, V31, P1767, DOI 10.1093/molbev/msu127; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang JP, 2012, GENOME RES, V22, P2199, DOI 10.1101/gr.142125.112; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	73	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171798	10.1371/journal.pone.0171798	http://dx.doi.org/10.1371/journal.pone.0171798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207793	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500054
J	Abulizi, X; Pryor, L; Michel, G; Melchior, M; van der Waerden, J				Abulizi, Xian; Pryor, Laura; Michel, Gregory; Melchior, Maria; van der Waerden, Judith		EDEN Mother-Child Cohort Study Grp	Temperament in infancy and behavioral and emotional problems at age 5.5: The EDEN mother-child cohort	PLOS ONE			English	Article							JOURNAL-OF-PSYCHIATRY; INHIBITED TEMPERAMENT; NEGATIVE EMOTIONALITY; MATERNAL DEPRESSION; GENDER-DIFFERENCES; PREDICTORS; RISK; SYMPTOMS; ANXIETY; PSYCHOPATHOLOGY	Objective Early temperamental characteristics may influence children's developmental pathways and predict future psychopathology. However, the environmental context may also shape or interact with infant temperament and indirectly contribute to increased vulnerability to adverse developmental outcomes. The aim of the present study is to explore the long-term contribution of temperamental traits at twelve months of age to the presence of emotional and behavioral problems later in childhood, and whether this association varies with the child's sex, parental separation, family socioeconomic status and maternal depression. Method 1184 mother-child pairs from the EDEN mother-child birth cohort study based in France (2003- 2011), were followed from 24-28 weeks of pregnancy to the child's fifth birthday. Infant temperament at 12 months was assessed with the Emotionality Activity and Sociability (EAS) questionnaire and behavior at 5.5 years was assessed with the Strengths and Difficulties Questionnaire (SDQ). Results Emotional temperament in infancy predicts children's overall behavioral scores (beta = 1.16, p<0.001), emotional difficulties (beta = 0.30, p<0.001), conduct problems (beta = 0.51, p<0.001) and symptoms of hyperactivity/ inattention (beta = 0.31, p = 0.01) at 5.5 years. Infants' active temperament predicts later conduct problems (beta = 0.30, p = 0.02), while shyness predicts later emotional problems (beta = 0.22, p = 0.04). The association between the child's temperament in infancy and later behavior did not vary with children's own or family characteristics. Conclusion An emotional temperament in infancy is associated with higher levels of emotional and behavioral difficulties at the age of 5.5 years. Children who show high emotionality early on may require early prevention and intervention efforts to divert possible adverse developmental pathways.	[Abulizi, Xian; Pryor, Laura; Melchior, Maria; van der Waerden, Judith] IPLESP, Social Epidemiol Res Grp, INSERM UMR S 1136, Paris, France; [Abulizi, Xian; Pryor, Laura; Melchior, Maria; van der Waerden, Judith] Sorbonne Univ Pierre & Marie Curie, Paris, France; [Michel, Gregory] Univ Bordeaux, Fac Psychol, INSERM, Res Ctr Epidemiol & Biostat,U897, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	van der Waerden, J (corresponding author), IPLESP, Social Epidemiol Res Grp, INSERM UMR S 1136, Paris, France.; van der Waerden, J (corresponding author), Sorbonne Univ Pierre & Marie Curie, Paris, France.	judith.van-der-waerden@inserm.fr	Charles, Marie Aline/F-8567-2017; Bernard, Jonathan/T-7064-2017; Michel, Gregory/T-4702-2019; de Lauzon-Guillain, Blandine/P-4659-2016; Melchior, Maria/E-3992-2017; Heude, Barbara/G-3095-2016	Charles, Marie Aline/0000-0003-4025-4390; Bernard, Jonathan/0000-0002-6418-983X; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; van der Waerden, Judith/0000-0002-5324-1372; Heude, Barbara/0000-0002-1565-1629	Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR Program; INSERM Human Nutrition National Research Program; French Ministry of Health, French Agency for Environment Security (AFSSET); French National Institute for Population Health Surveillance (InVS); Paris-Sud University; French National Institute for Health Education (INPES); Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French speaking association for the study of diabetes and metabolism (ALFEDIAM); National Agency for Research (ANR nonthematic program); National Institute for Research in Public Health; French National Research Agency (ANR); Fondation pour la Recherche en Psychiatrie et Sante Mentale (FRPSM-JW); Congres Francais de Psychiatrie; French Association of Diabetic Patients (AFD)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministry of Research: IFR Program(Ministry of Research, France); INSERM Human Nutrition National Research Program; French Ministry of Health, French Agency for Environment Security (AFSSET); French National Institute for Population Health Surveillance (InVS); Paris-Sud University; French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Nestle(Nestle SA); Mutuelle Generale de l'Education Nationale (MGEN); French speaking association for the study of diabetes and metabolism (ALFEDIAM); National Agency for Research (ANR nonthematic program)(French National Research Agency (ANR)); National Institute for Research in Public Health; French National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche en Psychiatrie et Sante Mentale (FRPSM-JW); Congres Francais de Psychiatrie; French Association of Diabetic Patients (AFD)	The EDEN study was funded by Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR Program; INSERM Human Nutrition National Research Program and Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)); French Ministry of Health, French Agency for Environment Security (AFSSET); French National Institute for Population Health Surveillance (InVS); Paris-Sud University; French National Institute for Health Education (INPES); Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French speaking association for the study of diabetes and metabolism (ALFEDIAM); National Agency for Research (ANR nonthematic program) and National Institute for Research in Public Health (IRESP: TGIR Cohorte Sante 2008 programme), This study was funded by the French National Research Agency (ANR, Program on Social Determinants of Health-MM); the Fondation pour la Recherche en Psychiatrie et Sante Mentale (FRPSM-JW) and the National Institute for Research in Public Health (IRESP: General Project Call 2014-JW). XA received a research grant from the Congres Francais de Psychiatrie 2014. The funders had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Bauer DJ, 2005, MULTIVAR BEHAV RES, V40, P373, DOI 10.1207/s15327906mbr4003_5; Beekman C, 2015, CHILD DEV, V86, P1794, DOI 10.1111/cdev.12417; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Blair KA, 2004, J SCHOOL PSYCHOL, V42, P419, DOI 10.1016/j.jsp.2004.10.002; Blandon AY, 2010, DEV PSYCHOPATHOL, V22, P119, DOI 10.1017/S0954579409990307; Bornstein MH, 2015, CHILD DEV, V86, P844, DOI 10.1111/cdev.12367; Bould H, 2014, DEPRESS ANXIETY, V31, P729, DOI 10.1002/da.22294; Bould H, 2013, PERS INDIV DIFFER, V54, P628, DOI 10.1016/j.paid.2012.11.010; Bruder-Costello B, 2007, PSYCHIAT RES, V153, P145, DOI 10.1016/j.psychres.2007.02.013; Buss A., 1984, TEMPERAMENT EARLY DE; Bussing R, 2003, J AM ACAD CHILD PSY, V42, P184, DOI 10.1097/00004583-200302000-00012; Cameron JR, 2013, J COMMUNITY PSYCHOL, V41, P236, DOI 10.1002/jcop.21526; Chen N, 2014, J ABNORM CHILD PSYCH, V42, P1251, DOI 10.1007/s10802-014-9872-y; Chen X., 2012, HDB TEMPERAMENT, P462; Clauss JA, 2015, PROG NEUROBIOL, V127, P23, DOI 10.1016/j.pneurobio.2015.03.001; Clauss JA, 2012, J AM ACAD CHILD PSY, V51, P1066, DOI 10.1016/j.jaac.2012.08.002; Crick NR, 2003, DEV PSYCHOPATHOL, V15, P719, DOI 10.1017/S095457940300035X; De Pauw SSW, 2010, CHILD PSYCHIAT HUM D, V41, P313, DOI 10.1007/s10578-009-0171-8; Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001134.pub3; Derauf C, 2011, J DEV BEHAV PEDIATR, V32, P125, DOI 10.1097/DBP.0b013e31820839d7; Dirks MA, 2012, J CHILD PSYCHOL PSYC, V53, P558, DOI 10.1111/j.1469-7610.2012.02537.x; Dix T, 2014, DEV PSYCHOPATHOL, V26, P111, DOI 10.1017/S0954579413000898; Edhborg M, 2000, J REPROD INFANT PSYC, V18, P225, DOI 10.1080/713683036; Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33; Farrell M, 2003, INT REV PSYCHIATR, V15, P50, DOI 10.1080/0954026021000045949; Flouri E, 2008, CHILD PSYCHIAT HUM D, V39, P369, DOI 10.1007/s10578-007-0094-1; Frankel LA, 2015, INFANT BEHAV DEV, V40, P73, DOI 10.1016/j.infbeh.2015.03.004; Gagne JR, 2013, PERS INDIV DIFFER, V55, P95, DOI 10.1016/j.paid.2013.02.006; Gaillard A, 2014, PSYCHIAT RES, V215, P341, DOI 10.1016/j.psychres.2013.10.003; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gartstein MA, 2008, INFANT CHILD DEV, V17, P223, DOI 10.1002/icd.549; Gasman I, 2002, EUR CHILD ADOLES PSY, V11, P101, DOI 10.1007/s00787-002-0248-4; Gjone H, 1997, J AM ACAD CHILD PSY, V36, P1448, DOI 10.1097/00004583-199710000-00028; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Hanington L, 2010, INFANT BEHAV DEV, V33, P88, DOI 10.1016/j.infbeh.2009.11.004; Hayes A. F., 2013, INTRODUCTION TO MEDI; Heude B, 2016, INT J EPIDEMIOL, V45, P353, DOI 10.1093/ije/dyv151; Jansen PW, 2009, SOC PSYCH PSYCH EPID, V44, P87, DOI 10.1007/s00127-008-0416-z; Janson H, 2008, DEV PSYCHOL, V44, P1314, DOI 10.1037/a0012713; Jessee A, 2012, SOC DEV, V21, P610, DOI 10.1111/j.1467-9507.2011.00639.x; Karevold E, 2009, DEV PSYCHOL, V45, P1051, DOI 10.1037/a0016123; Lemery-Chalfant K, 2013, DEV PSYCHOPATHOL, V25, P51, DOI 10.1017/S0954579412000892; Lewis Andrew J, 2011, Depress Res Treat, V2011, P296026, DOI 10.1155/2011/296026; Lewis KJS, 2012, J AFFECT DISORDERS, V141, P233, DOI 10.1016/j.jad.2012.03.008; Mantymaa M, 2012, CHILD PSYCHIAT HUM D, V43, P153, DOI 10.1007/s10578-011-0255-0; Mathiesen KS, 2006, EUR J DEV PSYCHOL, V3, P357, DOI 10.1080/17405620600557797; Melchior M, 2012, J AFFECT DISORDERS, V137, P165, DOI 10.1016/j.jad.2011.09.018; Muller JM, 2013, PSYCHIAT RES, V210, P294, DOI 10.1016/j.psychres.2013.03.025; Nigg JT, 2006, J CHILD PSYCHOL PSYC, V47, P395, DOI 10.1111/j.1469-7610.2006.01612.x; Nolvi S, 2016, J AFFECT DISORDERS, V199, P163, DOI 10.1016/j.jad.2016.04.020; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; OBERKLAID F, 1993, PEDIATRICS, V91, P113; Paulussen-Hoogeboom MC, 2007, DEV PSYCHOL, V43, P438, DOI 10.1037/0012-1649.43.2.438; Pitzer M, 2009, EUR ARCH PSY CLIN N, V259, P445, DOI 10.1007/s00406-009-0009-1; Pollock G. H., 1989, EARLY CHILDHOOD, V2, P163; Prior M, 2000, J AM ACAD CHILD PSY, V39, P461, DOI 10.1097/00004583-200004000-00015; Prior M, 2001, AUST NZ J PSYCHIAT, V35, P297, DOI 10.1046/j.1440-1614.2001.00903.x; Rettew DC, 2005, HARVARD REV PSYCHIAT, V13, P14, DOI 10.1080/10673220590923146; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; Saudino KJ, 2005, J DEV BEHAV PEDIATR, V26, P214, DOI 10.1097/00004703-200506000-00010; Sayal K, 2014, CHILD CARE HLTH DEV, V40, P292, DOI 10.1111/cch.12054; Schermerhorn AC, 2013, CHILD DEV, V84, P1579, DOI 10.1111/cdev.12076; Sentse M, 2011, J FAM PSYCHOL, V25, P97, DOI 10.1037/a0022446; Shigeto A, 2014, J SOC PERS RELAT, V31, P200, DOI 10.1177/0265407513490586; Shiner RL, 2012, CHILD DEV PERSPECT, V6, P436, DOI 10.1111/j.1750-8606.2012.00254.x; Slagt M, 2016, PSYCHOL BULL, V142, P1068, DOI 10.1037/bul0000061; Spielberger CD, 1983, MANUAL FOR THE STATE; van den Akker AL, 2010, J ABNORM CHILD PSYCH, V38, P485, DOI 10.1007/s10802-009-9379-0; van den Heuvel MI, 2015, EARLY HUM DEV, V91, P103, DOI 10.1016/j.earlhumdev.2014.12.003; Volbrecht MM, 2010, DEV PSYCHOL, V46, P1192, DOI 10.1037/a0020616; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Zalewski M, 2015, J CLIN CHILD ADOLESC, P1	76	47	48	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171971	10.1371/journal.pone.0171971	http://dx.doi.org/10.1371/journal.pone.0171971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199415	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400062
J	Quinnies, KM; Harris, EP; Snyder, RW; Sumner, SS; Rissman, EF				Quinnies, Kayla M.; Harris, Erin P.; Snyder, Rodney W.; Sumner, Susan S.; Rissman, Emilie F.			Direct and transgenerational effects of low doses of perinatal di-(2-ethylhexyl) phthalate (DEHP) on social behaviors in mice	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; 1ST TRIMESTER PHTHALATE; BISPHENOL-A; DNA METHYLATION; IN-UTERO; ENVIRONMENTAL CHEMICALS; ENDOCRINE DISRUPTORS; LACTATIONAL EXPOSURE; ANOGENITAL DISTANCE; PUBERTAL EXPOSURE	Di-(2-ethylhexyl) phthalate (DEHP) is an endocrine disrupting chemical commonly used as a plasticizer in medical equipment, food packaging, flooring, and children's toys. DEHP exposure during early development has been associated with adverse neurobehavioral outcomes in children. In animal models, early exposure to DEHP results in abnormal development of the reproductive system as well as altered behavior and neurodevelopment. Based on these data, we hypothesized that developmental exposure to DEHP would decrease social interactions and increase anxiety-like behaviors in mice in a dose-dependent manner, and that the effects would persist over generations. C57BL/6J mice consumed one of three DEHP doses (0, 5, 40, and 400 mu g/kg body weight) throughout pregnancy and during the first ten days of lactation. The two higher doses yielded detectable levels of DEHP metabolites in serum. Pairs of mice from control, low, and high DEHP doses were bred to create three dose lineages in the third generation (F3). Average anogenital index (AGI: anogenital distance/body weight) was decreased in F1 males exposed to the low dose of DEHP and in F1 females exposed to the highest dose. In F1 mice, juvenile pairs from the two highest DEHP dose groups displayed fewer socially investigative behaviors and more exploratory behaviors as compared with control mice. The effect of DEHP on these behaviors was reversed in F3 mice as compared with F1 mice. F1 mice exposed to low and medium DEHP doses spent more time in the closed arms of the elevated plus maze than controls, indicating increased anxiety-like behavior. The generation-dependent effects on behavior and AGI suggest complex mechanisms by which DEHP directly impacts reproductive and neurobehavioral development and influences germline-inherited traits.	[Quinnies, Kayla M.; Harris, Erin P.; Rissman, Emilie F.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Quinnies, Kayla M.; Harris, Erin P.; Rissman, Emilie F.] Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA; [Snyder, Rodney W.; Sumner, Susan S.] RTI Int, Discovery Sci Technol, Res Triangle Pk, NC USA; [Sumner, Susan S.; Rissman, Emilie F.] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA	University of Virginia; University of Virginia; Research Triangle Institute; University of North Carolina; North Carolina State University	Rissman, EF (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.; Rissman, EF (corresponding author), Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA.; Rissman, EF (corresponding author), North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA.	e_rissman@ncsu.edu	Harris, Erin/T-7690-2019	Snyder, Rodney/0000-0001-5546-3158; Sumner, Susan/0000-0003-3381-6084; Harris, Erin/0000-0002-7710-732X	NIEHS [R01ES022759]; NIH Common Fund [U24DK097193];  [T32GM008328]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022759, P30ES025128] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS R01ES022759 (EFR), NIH Common Fund Grant U24DK097193 (SSS). EPH was supported in part by T32GM008328.	Adibi JJ, 2015, J CLIN ENDOCR METAB, V100, pE1216, DOI 10.1210/jc.2015-2370; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Araki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109039; Barrett ES, 2016, PAEDIATR PERINAT EP, V30, P105, DOI 10.1111/ppe.12264; Barrett ES, 2015, ENDOCRINOLOGY, V156, P3435, DOI 10.1210/en.2015-1335; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Bornehag CG, 2015, ENVIRON HEALTH PERSP, V123, P101, DOI 10.1289/ehp.1408163; Brummelte S, 2012, NEUROPHARMACOLOGY, V62, P406, DOI 10.1016/j.neuropharm.2011.08.017; Carbone S, 2013, HORM BEHAV, V63, P692, DOI 10.1016/j.yhbeh.2013.01.006; Chang YJ, 2013, CLIN CHIM ACTA, V420, P155, DOI 10.1016/j.cca.2012.10.009; Chen JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126403; Chourbaji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019218; Cottrell EC, 2014, ACTA PHYSIOL, V210, P288, DOI 10.1111/apha.12187; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dobrzynska Malgorzata M, 2016, Rocz Panstw Zakl Hig, V67, P97; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Ejaredar M, 2015, ENVIRON RES, V142, P51, DOI 10.1016/j.envres.2015.06.014; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Hong D, 2009, BIOCHEM BIOPH RES CO, V389, P305, DOI 10.1016/j.bbrc.2009.08.134; Hopf NB, 2014, TOXICOL LETT, V224, P47, DOI 10.1016/j.toxlet.2013.10.004; Huen K, 2016, ENVIRON RES, V148, P55, DOI 10.1016/j.envres.2016.03.025; Jeddi MZ, 2016, ENVIRON RES, V151, P493, DOI 10.1016/j.envres.2016.08.021; Kardas F, 2016, J CHILD NEUROL, V31, P629, DOI 10.1177/0883073815609150; Katsikantami I, 2016, ENVIRON INT, V97, P212, DOI 10.1016/j.envint.2016.09.013; Kim S, 2015, SCI TOTAL ENVIRON, V508, P13, DOI 10.1016/j.scitotenv.2014.11.019; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; LaRocca J, 2014, ENVIRON RES, V133, P396, DOI 10.1016/j.envres.2014.04.032; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017; Li L, 2014, MOL BIOL REP, V41, P1227, DOI 10.1007/s11033-013-2967-7; Lien YJ, 2015, ENVIRON HEALTH PERSP, V123, P95, DOI 10.1289/ehp.1307154; Liu PY, 2010, AM J PHYSIOL-ENDOC M, V299, pE446, DOI 10.1152/ajpendo.00085.2010; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; Martinez-Arguelles DB, 2016, ANDROLOGY, DOI 10.1016/j.reprotox.2012.09.006; McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002; Miodovnik A, 2014, NEUROTOXICOLOGY, V41, P112, DOI 10.1016/j.neuro.2014.01.007; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Park S, 2015, PSYCHOL MED, V45, P1601, DOI 10.1017/S0033291714002694; Park S, 2015, J CHILD NEUROL, V30, P48, DOI 10.1177/0883073814532544; Prados J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132136; Quinnies KM, 2015, ENDOCRINOLOGY, V156, P3077, DOI 10.1210/EN.2015-1326; Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006; SINGH AR, 1975, J PHARM SCI-US, V64, P1347, DOI 10.1002/jps.2600640819; Singh S, 2012, INT J MOL SCI, V13, P10143, DOI 10.3390/ijms130810143; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Stein TP, 2013, J AUTISM DEV DISORD, V43, P2677, DOI 10.1007/s10803-013-1822-y; Stokes WS, 2004, ILAR J, V45, P387, DOI 10.1093/ilar.45.4.387; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Wang DC, 2014, HORM BEHAV, V66, P674, DOI 10.1016/j.yhbeh.2014.09.010; Wang R, 2016, HORM BEHAV, V80, P117, DOI 10.1016/j.yhbeh.2016.01.012; Wang R, 2016, CHEMOSPHERE, V144, P1771, DOI 10.1016/j.chemosphere.2015.10.062; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Wu SD, 2010, BASIC CLIN PHARMACOL, V106, P118, DOI 10.1111/j.1742-7843.2009.00483.x; Wu Y, 2014, J ENVIRON SCI-CHINA, V26, P1145, DOI 10.1016/S1001-0742(13)60504-5; Xu XH, 2015, CHEMOSPHERE, V124, P22, DOI 10.1016/j.chemosphere.2014.10.056; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Zhao BH, 2010, CHEM-BIOL INTERACT, V183, P79, DOI 10.1016/j.cbi.2009.09.014; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33449; Zhao Y, 2015, ENVIRON MOL MUTAGEN, V56, P286, DOI 10.1002/em.21916; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	73	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171977	10.1371/journal.pone.0171977	http://dx.doi.org/10.1371/journal.pone.0171977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199414	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400064
J	Hosoya, R; Uesawa, Y; Ishii-Nozawa, R; Kagaya, H				Hosoya, Ryuichiro; Uesawa, Yoshihiro; Ishii-Nozawa, Reiko; Kagaya, Hajime			Analysis of factors associated with hiccups based on the Japanese Adverse Drug Event Report database	PLOS ONE			English	Article							RECEPTOR; CATS; DEXAMETHASONE; STIMULATION; GENERATION; BIAS	Hiccups are occasionally experienced by most individuals. Although hiccups are not life threatening, they may lead to a decline in quality of life. Previous studies showed that hiccups may occur as an adverse effect of certain medicines during chemotherapy. Furthermore, a male dominance in hiccups has been reported. However, due to the limited number of studies conducted on this phenomenon, debate still surrounds the few factors influencing hiccups. The present study aimed to investigate the influence of medicines and patient characteristics on hiccups using a large-sized adverse drug event report database and, specifically, the Japanese Adverse Drug Event Report (JADER) database. Cases of adverse effects associated with medications were extracted from JADER, and Fisher's exact test was performed to assess the presence or absence of hiccups for each medication. In a multivariate analysis, we conducted a multiple logistic regression analysis using medication and patient characteristic variables exhibiting significance. We also examined the role of dexamethasone in inducing hiccups during chemotherapy. Medicines associated with hiccups included dexamethasone, levofolinate, fluorouracil, oxaliplatin, carboplatin, and irinotecan. Patient characteristics associated with hiccups included a male gender and greater height. The combination of anti-cancer agent and dexamethasone use was noted in more than 95% of patients in the dexamethasone-use group. Hiccups also occurred in patients in the anticancer agent-use group who did not use dexamethasone. Most of the medications that induce hiccups are used in chemotherapy. The results of the present study suggest that it is possible to predict a high risk of hiccups using patient characteristics. We confirmed that dexamethasone was the drug that has the strongest influence on the induction of hiccups. However, the influence of anti-cancer agents on the induction of hiccups cannot be denied. We consider the results of the present study to be helpful for the prevention and treatment of hiccups.	[Hosoya, Ryuichiro; Uesawa, Yoshihiro; Ishii-Nozawa, Reiko; Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Tokyo, Japan; [Hosoya, Ryuichiro] Japanese Red Cross Musashino Hosp, Dept Pharm, Musashino, Tokyo, Japan	Meiji Pharmaceutical University; Musashino RedCross Hospital	Uesawa, Y (corresponding author), Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Tokyo, Japan.	uesawa@my-pharm.ac.jp	, uesawa/AAA-1691-2020; Hosoya, Ryuichiro/AAU-8994-2020	Uesawa, Yoshihiro/0000-0002-5773-991X	KAKENHI from the Japan Society for the Promotion of Science [15K08111]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from the Japan Society for the Promotion of Science (Grant Number 15K08111). https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15K08111/.	[Anonymous], 2014, PMDRS, V45, P98; ARITA H, 1994, NEUROSCI LETT, V175, P67, DOI 10.1016/0304-3940(94)91079-0; Avillach P, 2014, PHARMACOEPIDEM DR S, V23, P186, DOI 10.1002/pds.3454; Chen JJ, 2007, PHARMACOGENOMICS J, V7, P212, DOI 10.1038/sj.tpj.6500412; de Boissieu P, 2014, PHARMACOEPIDEM DR S, V23, P989, DOI 10.1002/pds.3622; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; GRUNBERG SM, 1993, NEW ENGL J MED, V329, P1790; Hayashi M., 2009, J PHARM HEALTH CARE, V35, P89, DOI [10.5649/jjphcs.35.89, DOI 10.5649/JJPHCS.35.89]; Hirooka T, 2012, DATABASE SAS USER GR, P263; JONES MV, 1995, J PHARMACOL EXP THER, V274, P962; Kitraki E, 2004, NEUROSCIENCE, V125, P47, DOI 10.1016/j.neuroscience.2003.12.024; KOLODZIK PW, 1991, ANN EMERG MED, V20, P565, DOI 10.1016/S0196-0644(05)81620-8; Kondo T, 2003, NEUROSCI RES, V47, P317, DOI 10.1016/S0168-0102(03)00225-6; Kondo T., 2005, J CLIN ANESTH, V29, P225; Lee GW, 2016, J PAIN SYMPTOM MANAG, V51, P278, DOI 10.1016/j.jpainsymman.2015.09.013; Lee GW, 2013, ONCOLOGIST, V18, P1229, DOI 10.1634/theoncologist.2013-0224; Liaw CC, 2005, J PAIN SYMPTOM MANAG, V30, P359, DOI 10.1016/j.jpainsymman.2005.08.008; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; Maeda R., 2014, JPN J PHARMACOEPIDEM, V19, P51, DOI [DOI 10.3820/JJPE.19.51, 10.3820/jjpe.19.51]; Nausheen F, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3034-3; OSHIMA T, 1994, J APPL PHYSIOL, V76, P1888, DOI 10.1152/jappl.1994.76.5.1888; Pariente A, 2012, DRUG SAFETY, V35, P855, DOI 10.2165/11631780-000000000-00000; Pharmaceuticals and Medical Devices Agency, 2014, GUID PHARM STUD SAF; Ray P, 2009, GEN HOSP PSYCHIAT, V31, P382, DOI 10.1016/j.genhosppsych.2008.09.014; Steger M, 2015, ALIMENT PHARM THER, V42, P1037, DOI 10.1111/apt.13374; Tamaoka A., 2005, BRAIN MED, V17, P133	26	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172057	10.1371/journal.pone.0172057	http://dx.doi.org/10.1371/journal.pone.0172057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196104	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900048
J	Klupp, E; Weidlich, D; Schlaeger, S; Baum, T; Cervantes, B; Deschauer, M; Kooijman, H; Rummeny, EJ; Zimmer, C; Kirschke, JS; Karampinos, DC				Klupp, Elisabeth; Weidlich, Dominik; Schlaeger, Sarah; Baum, Thomas; Cervantes, Barbara; Deschauer, Marcus; Kooijman, Hendrik; Rummeny, Ernst J.; Zimmer, Claus; Kirschke, Jan S.; Karampinos, Dimitrios C.			B1-insensitive T2 mapping of healthy thigh muscles using a T2-prepared 3D TSE sequence	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; STIMULATED ECHO COMPENSATION; SKELETAL-MUSCLE; TRANSVERSE RELAXOMETRY; RELAXATION-TIMES; T-2 PREPARATION; FAT-FRACTION; MRI; QUANTIFICATION; INVOLVEMENT	Purpose To propose a T2-prepared 3D turbo spin echo (T2prep 3D TSE) sequence for B1-insensitive skeletal muscle T2 mapping and compare its performance with 2D and 3D multi-echo spin echo (MESE) for T2 mapping in thigh muscles of healthy subjects. Methods The performance of 2D MESE, 3D MESE and the proposed T2prep 3D TSE in the presence of transmit B1 and B0 inhomogeneities was first simulated. The thigh muscles of ten young and healthy subjects were then scanned on a 3 T system and T2 mapping was performed using the three sequences. Transmit B1-maps and proton density fat fraction (PDFF) maps were also acquired. The subjects were scanned three times to assess reproducibility. T2 values were compared among sequences and their sensitivity to B1 inhomogeneities was compared to simulation results. Correlations were also determined between T2 values, PDFF and B1. Results The left rectus femoris muscle showed the largest B1 deviations from the nominal value (from 54.2% to 92.9%). Significant negative correlations between T2 values and B1 values were found in the left rectus femoris muscle for 3D MESE (r = -0.72, p<0.001) and 2D MESE (r = -0.71, p<0.001), but not for T2prep 3D TSE (r = -0.32, p = 0.09). Reproducibility of T2 expressed by root mean square coefficients of variation (RMSCVs) were equal to 3.5% in T2prep 3D TSE, 2.6% in 3D MESE and 2.4% in 2D MESE. Significant differences between T2 values of 3D sequences (T2prep 3D TSE and 3D MESE) and 2D MESE were found in all muscles with the highest values for 2D MESE (p<0.05). No significant correlations were found between PDFF and T2 values. Conclusion A strong influence of an inhomogeneous B1 field on the T2 values of 3D MESE and 2D MESE was shown, whereas the proposed T2prep 3D TSE gives B1-insensitive and reproducible thigh muscle T2 mapping.	[Klupp, Elisabeth; Schlaeger, Sarah; Zimmer, Claus; Kirschke, Jan S.] Tech Univ Munich, Inst Diagnost & Intervent Neuroradiol, Munich, Germany; [Weidlich, Dominik; Baum, Thomas; Cervantes, Barbara; Rummeny, Ernst J.; Karampinos, Dimitrios C.] Tech Univ Munich, Inst Diagnost & Intervent Radiol, Munich, Germany; [Deschauer, Marcus] Tech Univ Munich, Neurol Klin & Poliklin, Munich, Germany; [Kooijman, Hendrik] Philips Healthcare, Hamburg, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philips; Philips Healthcare	Klupp, E (corresponding author), Tech Univ Munich, Inst Diagnost & Intervent Neuroradiol, Munich, Germany.	Elisabeth.Klupp@tum.de	Baum, Thomas/M-6522-2014; Karampinos, Dimitrios C/A-5994-2011; Kirschke, Jan/E-2550-2012	Baum, Thomas/0000-0002-4574-5212; Karampinos, Dimitrios C/0000-0003-4922-3662; Kirschke, Jan/0000-0002-7557-0003	Philips Healthcare; European Research Council (ERC) under the European Unions Horizon research and innovation programme [637164, 677661]; German Research Foundation (DFG); Technical University of Munich (TUM)	Philips Healthcare; European Research Council (ERC) under the European Unions Horizon research and innovation programme(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This project has received funding from Philips Healthcare and the European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme (GA No 637164 - iBack to J.S.K. and GA No 677661 - ProFatMRI to D.C.K.) and was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Azzabou N, 2015, EXP GERONTOL, V70, P54, DOI 10.1016/j.exger.2015.06.015; Azzabou N, 2015, J MAGN RESON IMAGING, V41, P645, DOI 10.1002/jmri.24613; Bydder M, 2011, MAGN RESON IMAGING, V29, P216, DOI 10.1016/j.mri.2010.08.011; Carlier PG, 2015, J INHERIT METAB DIS, V38, P565, DOI 10.1007/s10545-015-9825-9; Chen W, 2011, P 19 ANN M ISMRM MON; Coolen BF, 2014, MAGN RESON MED, V72, P409, DOI 10.1002/mrm.24952; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Hogrel Jean-Yves, 2015, Age (Dordr), V37, P9798, DOI 10.1007/s11357-015-9798-5; HUANG YM, 1994, JMRI-J MAGN RESON IM, V4, P59, DOI 10.1002/jmri.1880040113; Karampinos DC, 2011, MAGN RESON MED, V66, P1312, DOI 10.1002/mrm.22925; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Lebel RM, 2010, MAGN RESON MED, V64, P1005, DOI 10.1002/mrm.22487; Li XJ, 2008, MAGN RESON MED, V59, P298, DOI 10.1002/mrm.21414; Maillard SM, 2004, RHEUMATOLOGY, V43, P603, DOI 10.1093/rheumatology/keh130; Marty B, 2016, NMR BIOMED, V29, P431, DOI 10.1002/nbm.3459; Mercuri E, 2002, NEUROPEDIATRICS, V33, P10, DOI 10.1055/s-2002-23593; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mugler JP, 2014, J MAGN RESON IMAGING, V39, P745, DOI 10.1002/jmri.24542; Nezafat R, 2006, MAGN RESON MED, V55, P858, DOI 10.1002/mrm.20835; Nguyen TD, 2015, MAGNETIC RESONANCE M; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Phoenix J, 1996, MUSCLE NERVE, V19, P302, DOI 10.1002/(SICI)1097-4598(199603)19:3<302::AID-MUS4>3.0.CO;2-H; Poliachik SL, 2012, PHYS MED REH CLIN N, V23, P107, DOI 10.1016/j.pmr.2011.11.016; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Rooney WD PJ, 2011, P 19 ANN M ISMRM MON; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Wokke BH, 2015, T2 RELAXATION TIMES; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yu W, 1995, OSTEOPOROSIS INT, V5, P433, DOI 10.1007/BF01626604	33	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171337	10.1371/journal.pone.0171337	http://dx.doi.org/10.1371/journal.pone.0171337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196133	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900016
J	Amjad, MS; Qaeem, MF; Ahmad, I; Khan, SU; Chaudhari, SK; Malik, NZ; Shaheen, H; Khan, AM				Amjad, Muhammad Shoaib; Qaeem, Mirza Faisal; Ahmad, Israr; Khan, Sami Ullah; Chaudhari, Sunbal Khalil; Malik, Nafeesa Zahid; Shaheen, Humaira; Khan, Arshad Mehmood			Descriptive study of plant resources in the context of the ethnomedicinal relevance of indigenous flora: A case study from Toli Peer National Park, Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							MEDICINAL-PLANTS; ETHNOBOTANICAL SURVEY; TRADITIONAL MEDICINE; HEALERS CONSENSUS; KNOWLEDGE; DISTRICT; PEOPLE; VALLEY; HILLS; COMMUNITIES	Background This paper presents the first quantitative ethnobotanical study of the flora in Toli Peer National Park of Azad Jammu and Kashmir, Pakistan. Being a remote area, there is a strong dependence by local people on ethnobotanical practices. Thus, we attempted to record the folk uses of the native plants of the area with a view to acknowledging and documenting the ethnobotanical knowledge. The aims of the study were to compile an inventory of the medicinal plants in the study area and to record the methods by which herbal drugs were prepared and administered. Materials and methods Information on the therapeutic properties of medicinal plants was collected from 64 local inhabitants and herbalists using open ended and semi-structured questionnaires over the period Aug 2013-Jul 2014. The data were recorded into a synoptic table comprising an ethnobotanical inventory of plants, the parts used, therapeutic indications and modes of application or administration. Different ethnobotanical indices i.e. relative frequencies of citation (RFC), relative importance (RI), use value (UV) and informant consensus factor (Fic), were calculated for each of the recorded medicinal plants. In addition, a correlation analysis was performed using SPSS ver. 16 to check the level of association between use value and relative frequency of citation. Results A total of 121 species of medicinal plants belonging to 57 families and 98 genera were recorded. The study area was dominated by herbaceous species (48%) with leaves (41%) as the most exploited plant part. The Lamiaceae and Rosaceae (9% each) were the dominant families in the study area. Among different methods of preparation, the most frequently used method was decoction (26 species) of different plant parts followed by use as juice and powder (24 species each), paste (22 species), chewing (16 species), extract (11 species), infusion (10 species) and poultice (8 species). The maximum Informant consensus factor (Fic) value was for gastro-intestinal, parasitic and hepatobiliary complaints (0.90). Berberis lycium Ajuga bracteosa, Prunella vulgaris, Adiantum capillus-veneris, Desmodium polycarpum, Pinus roxburgii, Albizia lebbeck, Cedrella serrata, Rosa brunonii, Punica granatum, Jasminum mesnyi and Zanthoxylum armatum were the most valuable plants with the highest UV, RFC and relative importance values. The Pearson correlation coefficient between UV and RFC (0.881) reflects a significant positive correlation between the use value and relative frequency of citation. The coefficient of determination indicated that 77% of the variability in UV could be explained in terms of RFC. Conclusion Systematic documentation of the medicinal plants in the Toli Peer National Park shows that the area is rich in plants with ethnomedicinal value and that the inhabitants of the area have significant knowledge about the use of such plants with herbal drugs commonly used to cure infirmities. The results of this study indicate that carrying out subsequent pharmacological and phytochemical investigations in this part of Pakistan could lead to new drug discoveries.	[Amjad, Muhammad Shoaib; Ahmad, Israr; Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Amjad, Muhammad Shoaib; Qaeem, Mirza Faisal; Chaudhari, Sunbal Khalil; Khan, Arshad Mehmood] Univ Arid Agr, PMAS, Dept Bot, Rawalpindi, Pakistan; [Malik, Nafeesa Zahid] Mirpur Univ Sci & Technol, Dept Bot, Mirpur, Pakistan; [Shaheen, Humaira] Comsat Gen Corp, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan	Arid Agriculture University; COMSATS University Islamabad (CUI)	Amjad, MS (corresponding author), Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan.; Amjad, MS (corresponding author), Univ Arid Agr, PMAS, Dept Bot, Rawalpindi, Pakistan.	malikshoaib1165@yahoo.com	Khan, Arshad Mahmood/V-7426-2019; Amjad, Muhammad Shoaib/GQQ-1505-2022	Khan, Arshad Mahmood/0000-0003-0683-1553; Chaudhari, Sunbal Khalil/0000-0002-9590-3514	IDEA WILD USA; IDEA WILD of the U.S. Department of Agriculture; Women University of Azad Jammu Kashmir; PMAS-University of Arid Agriculture Rawalpindi, Pakistan	IDEA WILD USA; IDEA WILD of the U.S. Department of Agriculture; Women University of Azad Jammu Kashmir; PMAS-University of Arid Agriculture Rawalpindi, Pakistan	This work was supported by the The IDEA WILD USA (http://www.ideawild.org/). The IDEA WILD of the U.S. Department of Agriculture (http://www.sare.org/) provided research instrument and funding to carry out field survey. None of the current authors were Pls on the initial grants and the authors do not have a record of the grant numbers. Funding to support student research collaborators was received from Women University of Azad Jammu & Kashmir and PMAS-University of Arid Agriculture Rawalpindi, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-84; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Adzu B, 2003, ACTA TROP, V87, P245, DOI 10.1016/S0001-706X(03)00114-1; Ahmad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-36; Ahmed E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-13; Alam N, 2011, PAK J BOT, V43, P773; Albuquerque U. P., 2006, Ethnobotany Research and Applications, V4, P51; Ali H, 2009, PAK J BOT, V41, P2009; Ali S. I., 1993, FLORA PAKISTAN NOS 1; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P292; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P234, DOI 10.1016/S2221-1691(15)30011-3; Amjad Muhammad Shoaib, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P952; Ankli A, 1999, ECON BOT, V53, P144, DOI 10.1007/BF02866493; Arshad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-13; Bahar G., 2013, J ETHNOPHARMACOL, V146, P113, DOI DOI 10.1016/J.JEP.2012.12.012; Balick MJ, 1996, ANN MO BOT GARD, V83, P58, DOI 10.2307/2399968; Bano A, 2014, J ETHNOPHARMACOL, V155, P1046, DOI 10.1016/j.jep.2014.05.045; Bano A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-43; BASUALDO I, 1995, ECON BOT, V49, P387, DOI 10.1007/BF02863089; Baydoun S, 2015, J ETHNOPHARMACOL, V173, P139, DOI 10.1016/j.jep.2015.06.052; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bibi T, 2014, J ETHNOPHARMACOL, V157, P79, DOI 10.1016/j.jep.2014.08.042; Bruni A, 1997, J ETHNOPHARMACOL, V57, P97, DOI 10.1016/S0378-8741(97)00055-X; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Chen GT, 2008, BIOMED CHROMATOGR, V22, P779, DOI 10.1002/bmc.1001; Edwards S, 2005, J ETHNOPHARMACOL, V100, P30, DOI 10.1016/j.jep.2005.05.026; El Amri J., 2015, J RES BIOL, V4, P1568; FAIZ AUH, 2014, BIOLOGIA-LAHORE, V60, P43; Farooq S., 2012, PAKISTAN J WEED SCI, V18, P277; Ghorbani A, 2005, J ETHNOPHARMACOL, V102, P58, DOI 10.1016/j.jep.2005.05.035; Ghorbani A, 2011, J ETHNOPHARMACOL, V134, P651, DOI 10.1016/j.jep.2011.01.011; Gonza T. M. R., 2008, J ETHNOPHARMACOL, V116, P341, DOI DOI 10.1016/J.JEP.2007.11.045; Hamayun M., 2005, ETHNOBOTANICAL PROFI; Han J, 2007, J PHARMACEUT BIOMED, V44, P430, DOI 10.1016/j.jpba.2007.02.023; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Husain SZ, 2008, PAK J BOT, V40, P1897; Ijaz F, 2016, J ETHNOPHARMACOL, V179, P208, DOI 10.1016/j.jep.2015.12.050; Islam MK, 2014, J ETHNOPHARMACOL, V151, P921, DOI 10.1016/j.jep.2013.11.056; JAIN S K, 1977, P157; Jamila F, 2014, J ETHNOPHARMACOL, V154, P76, DOI 10.1016/j.jep.2014.03.016; Jeruto P, 2008, J ETHNOPHARMACOL, V116, P370, DOI 10.1016/j.jep.2007.11.041; Kargioglu M, 2008, HUM ECOL, V36, P763, DOI 10.1007/s10745-008-9198-x; Kayani S, 2015, J ETHNOPHARMACOL, V164, P186, DOI 10.1016/j.jep.2015.02.004; Kayani S, 2014, J ETHNOPHARMACOL, V156, P47, DOI 10.1016/j.jep.2014.08.005; Khan M. A., 2012, Pakistan Journal of Weed Science Research, V18, P495; Khan M. A., 2010, Ethnobotany Research and Applications, V8, P107; Khan M. B., 2008, THESIS; Khan MPZ, 2015, J ETHNOPHARMACOL, V173, P191, DOI 10.1016/j.jep.2015.07.029; Khan SM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-4; Khatoon S., 2004, INT J BIOTECHNOLOGY, V1, P584; Kichu M, 2015, J ETHNOPHARMACOL, V166, P5, DOI 10.1016/j.jep.2015.02.053; Ladio A, 2007, J ARID ENVIRON, V69, P695, DOI 10.1016/j.jaridenv.2006.11.008; Leonti M, 2003, J ETHNOPHARMACOL, V88, P119, DOI 10.1016/S0378-8741(03)00188-0; Leonti M, 2011, J ETHNOPHARMACOL, V134, P542, DOI 10.1016/j.jep.2011.01.017; Lin J, 2002, J ETHNOPHARMACOL, V79, P53, DOI 10.1016/S0378-8741(01)00353-1; Madikizela B, 2012, J ETHNOPHARMACOL, V141, P61, DOI 10.1016/j.jep.2012.01.053; Mahmood A, 2011, J MED PLANTS RES, V5, P4493; Mahmood A, 2011, PAK J BOT, V43, P105; Mahmood AS, 2011, J APPL PHARM, V3, P212, DOI DOI 10.21065/19204159.3.212; Malla B, 2015, J ETHNOPHARMACOL, V165, P103, DOI 10.1016/j.jep.2014.12.057; Miraldi E, 2001, J ETHNOPHARMACOL, V75, P77, DOI 10.1016/S0378-8741(00)00381-0; Moerman Daniel, 1998, NATIVE AM ETHNOBOTAN; MOORE PD, 1994, NATURE, V372, P410, DOI 10.1038/372410a0; Mosaddegh M, 2012, J ETHNOPHARMACOL, V141, P80, DOI 10.1016/j.jep.2012.02.004; Muhammad Ishtiaq, 2012, African Journal of Biotechnology, V11, P3087; Mukheriee PK, 2006, J ETHNOPHARMACOL, V103, P25, DOI 10.1016/j.jep.2005.09.024; Mukherjee PK, 2012, J ETHNOPHARMACOL, V143, P424, DOI 10.1016/j.jep.2012.07.036; Murad W, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-77; Nasab FK, 2014, J ETHNOPHARMACOL, V154, P190, DOI 10.1016/j.jep.2014.04.003; Nasir E., 1970, FLORA PAKISTAN ISLAM; Nondo R. S. O., 2015, Journal of Medicinal Plants Research, V9, P179; Qureshi R, 2001, PAKISTAN J BOT, V33, P109; Qureshi R., 2002, HAMDARD MED, V45, P86; Qureshi R, 2008, FITOTERAPIA, V79, P468, DOI 10.1016/j.fitote.2008.03.010; ROBINSON T, 1974, SCIENCE, V184, P430, DOI 10.1126/science.184.4135.430; Sadeghi Z, 2014, J ETHNOPHARMACOL, V153, P111, DOI 10.1016/j.jep.2014.01.007; Safa O, 2012, AVICENNA J PHYTOMEDI, V3, P64; Savikin K, 2013, J ETHNOPHARMACOL, V146, P803, DOI 10.1016/j.jep.2013.02.006; Schlage C, 2000, PLANT BIOLOGY, V2, P83, DOI 10.1055/s-2000-296; Schoene RB, 1999, LUNG DIS HIGH ALTITU, P47; Shaheen H, 2012, PAK J BOT, V44, P739; Shinwari ZK, 2010, J MED PLANTS RES, V4, P161; Siew YY, 2014, J ETHNOPHARMACOL, V155, P1450, DOI 10.1016/j.jep.2014.07.024; Singh H, 2014, J ETHNOPHARMACOL, V154, P98, DOI 10.1016/j.jep.2014.03.026; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Tangjitman K, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0011-9; Thirumalai T., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS910; Trotter I. I. R. T., 1986, PLANTS INDIGENOUS ME; Ullah R, 2010, J MED PLANTS RES, V4, P1815; Vijayakumar S, 2015, J ETHNOPHARMACOL, V161, P238, DOI 10.1016/j.jep.2014.12.006; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024; Zhang JL, 2005, J PHARMACEUT BIOMED, V36, P1029, DOI 10.1016/j.jpba.2004.09.009	93	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171896	10.1371/journal.pone.0171896	http://dx.doi.org/10.1371/journal.pone.0171896			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192466	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800048
J	Behbehani, R; Abu Al-Hassan, A; Al-Salahat, A; Sriraman, D; Oakley, JD; Alroughani, R				Behbehani, Raed; Abu Al-Hassan, Abdullah; Al-Salahat, Ali; Sriraman, Devarajan; Oakley, J. D.; Alroughani, Raed			Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis	PLOS ONE			English	Article							FIBER LAYER THICKNESS; PATHOLOGY; NEURITIS; MS	Introduction Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable tool in assessing axonal loss and neuro-degeneration in multiple sclerosis ( MS) by in-vivo imaging, delineation and quantification of retinal layers. There is evidence of deep retinal involvement in MS beyond the inner retinal layers. The ultra-structural retinal changes in MS in different MS phenotypes can reflect differences in the pathophysiologic mechanisms. There is limited data on the pattern of deeper retinal layer involvement in progressive MS (PMS) versus relapsing remitting MS (RRMS). We have compared the OCT segmentation analysis in patients with relapsing-remitting MS and progressive MS. Methods Cross-sectional study of 113 MS patients (226 eyes) (29 PMS, 84 RRMS) and 38 healthy controls (72 eyes). Spectral domain OCT (SDOCT) using the macular cube acquisition protocol (Cirrus HDOCT 5000; Carl Zeiss Meditec) and segmentation of the retinal layers for quantifying the thicknesses of the retinal layers. Segmentation of the retinal layers was carried out utilizing Orion software (Voxeleron, USA) for quantifying the thicknesses of individual retinal layers. Results The retinal nerve finer layer (RNFL) (p = 0.023), the ganglion-cell/inner plexiform layer (GCIPL) (p = 0.006) and the outer plexiform layer (OPL) (p = 0.033) were significantly thinner in PMS compared to RRMS. There was significant negative correlation between the outer nuclear layer (ONL) and EDSS (r = -0.554, p = 0.02) in PMS patients. In RRMS patients with prior optic neuritis, the GCIPL correlated negatively (r = -0.317; p = 0.046), while the photoreceptor layer (PR) correlated positively with EDSS (r = 0.478; p = 0.003). Conclusions Patients with PMS exhibit more atrophy of both the inner and outer retinal layers than RRMS. The ONL in PMS and the GCIPL and PR in RRMS can serve as potential surrogate of disease burden and progression (EDSS). The specific retinal layer predilection and its correlation with disability may reflect different pathophysiologic mechanisms and various stages of progression in MS.	[Behbehani, Raed; Abu Al-Hassan, Abdullah; Al-Salahat, Ali] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait; [Behbehani, Raed; Alroughani, Raed] Dasman Inst, Neurol Clin, Dasman, Kuwait; [Sriraman, Devarajan] Dasman Inst, Natl Dasman Diabet Biobank, Dasman, Kuwait; [Oakley, J. D.] Voxeleron LLC, Pleasanton, CA USA; [Alroughani, Raed] Amiri Hosp, Div Neurol, Sharq, Kuwait		Behbehani, R (corresponding author), Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait.; Behbehani, R (corresponding author), Dasman Inst, Neurol Clin, Dasman, Kuwait.	raed.behbehani@dasmaninstitute.org	Behbehani, Raed/CAF-0180-2022	BEHBEHANI, RAED/0000-0002-6633-3567; AL-SALAHAT, ALI/0000-0003-4047-0835				Al-Louzi OA, 2016, MULT SCLER J, V22, P362, DOI 10.1177/1352458515590646; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Balk LJ, 2014, MULT SCLER J, V20, P1198, DOI 10.1177/1352458513518626; Balk L. J., 2016, J NEUROL; Behbehani R, 2015, J NEUROL SCI, V359, P305, DOI 10.1016/j.jns.2015.11.017; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gelfand JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036847; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Isobe N, 2013, GENES IMMUN, V14, P434, DOI 10.1038/gene.2013.37; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; PAPAKOSTOPOULOS D, 1989, ELECTROEN CLIN NEURO, V74, P1, DOI 10.1016/0168-5597(89)90045-2; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2013, NEUROLOGY, V80, P47, DOI 10.1212/WNL.0b013e31827b1a1c; Rovaris M, 2001, BRAIN, V124, P2540, DOI 10.1093/brain/124.12.2540; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tremlett H, 2010, NEUROLOGY, V74, P2004, DOI 10.1212/WNL.0b013e3181e3973f; Weinshenker BG, 1996, NEUROLOGY, V46, P1613, DOI 10.1212/WNL.46.6.1613	24	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172120	10.1371/journal.pone.0172120	http://dx.doi.org/10.1371/journal.pone.0172120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192539	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800072
J	Nino, ME; Serrano, SE; Nino, DC; McCosham, DM; Cardenas, ME; Villareal, VP; Lopez, M; Pazin, A; Jaimes, FA; Cunha, F; Schulz, R; Torres-Duenas, D				Eugenia Nino, Maria; Eduardo Serrano, Sergio; Camila Nino, Daniela; Margarita McCosham, Diana; Eugenia Cardenas, Maria; Poleth Villareal, Vivian; Lopez, Marcos; Pazin-Filho, Antonio; Alberto Jaimes, Fabian; Cunha, Fernando; Schulz, Richard; Torres-Duenas, Diego			TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASES; TISSUE INHIBITOR; CARDIAC DYSFUNCTION; PROGNOSTIC VALUE; SEVERE SEPSIS; BIOMARKERS; MATRIX-METALLOPROTEINASE-9; BLOOD; FAILURE; SHOCK	Introduction Matrix metalloproteinases and tissue inhibitors of metalloproteinases could be promising biomarkers for establishing prognosis during the development of sepsis. It is necessary to clarify the relationship between matrix metalloproteinases and their tissue inhibitors. We conducted a cohort study with 563 septic patients, in order to elucidate the biological role and significance of these inflammatory biomarkers and their relationship to the severity and mortality of patients with sepsis. Materials and methods A multicentric prospective cohort was performed. The sample was composed of patients who had sepsis as defined by the International Conference 2001. Serum procalcitonin, creatinine, urea nitrogen, C-Reactive protein, TIMP1, TIMP2, MMP2 and MMP9 were quantified; each patient was followed until death or up to 30 days. A descriptive analysis was performed by calculating the mean and the 95% confidence interval for continuous variables and proportions for categorical variables. A multivariate logistic regression model was constructed by the method of intentional selection of covariates with mortality at 30 days as dependent variable and all the other variables as predictors. Results Of the 563 patients, 68 patients (12.1%) died within the first 30 days of hospitalization in the ICU. The mean values for TIMP1, TIMP2 and MMP2 were lower in survivors, MMP9 was higher in survivors. Multivariate logistic regression showed that age, SOFA and Charlson scores, along with TIMP1 concentration, were statistically associated with mortality at 30 days of septic patients; serum MMP9 was not statistically associated with mortality of patients, but was a confounder of the TIMP1 variable. Conclusion It could be argued that plasma levels of TIMP1 should be considered as a promising prognostic biomarker in the setting of sepsis. Additionally, this study, like other studies with large numbers of septic patients does not support the predictive value of TIMP1 / MMP9.	[Eugenia Nino, Maria; Eduardo Serrano, Sergio] Univ Autonoma Bucaramanga, Fac Hlth Sci, Program Med, Dept Publ Hlth, Bucaramanga, Santander, Colombia; [Camila Nino, Daniela; Margarita McCosham, Diana; Poleth Villareal, Vivian; Torres-Duenas, Diego] Univ Autonoma Bucaramanga, Fac Hlth Sci, Program Med, Dept Pharmacol, Bucaramanga, Santander, Colombia; [Eugenia Cardenas, Maria] Univ Autonoma Bucaramanga, Fac Hlth Sci, Program Med, Microbiol & Inmunol Dept, Bucaramanga, Santander, Colombia; [Lopez, Marcos] Fdn Cardiovasc Colombia, Enterprise Technol Ctr, Dept Biotechnol, Bucaramanga, Santander, Colombia; [Pazin-Filho, Antonio] Univ Sao Paulo, Fac Med, Emergency unit, Dept Clin Med, Ribeirao Preto, SP, Brazil; [Alberto Jaimes, Fabian] Univ Antioquia, Sch Med, Dept Internal Med, Medellin, Antioquia, Colombia; [Cunha, Fernando] Univ Sao Paulo, Fac Med, Dept Pharmacol, Ribeirao Preto, SP, Brazil; [Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Schulz, Richard] Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB, Canada	Universidade de Sao Paulo; Universidad de Antioquia; Universidade de Sao Paulo; University of Alberta; University of Alberta	Torres-Duenas, D (corresponding author), Univ Autonoma Bucaramanga, Fac Hlth Sci, Program Med, Dept Pharmacol, Bucaramanga, Santander, Colombia.	dtorres@unab.edu.co	Cunha, Fernando Q/M-3090-2014; Jaimes, Fabian/AAE-4109-2020; Lopez, Marcos/AAQ-9872-2021; Pazin Filho, Antonio/E-9495-2010; Jaimes, Fabian/R-4258-2016	Jaimes, Fabian/0000-0002-7315-5367; Pazin Filho, Antonio/0000-0001-5242-329X; Jaimes, Fabian/0000-0002-7315-5367; Cunha, Fernando Queiroz/0000-0003-4755-1670	Departamento administrativo de ciencia, tecnologia e innovacion-COLCIENCIAS [515-2008 (124145921713), 504-2009 (124149326164)]	Departamento administrativo de ciencia, tecnologia e innovacion-COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by Departamento administrativo de ciencia, tecnologia e innovacion-COLCIENCIAS: Contract number 515-2008 (124145921713), 504-2009 (124149326164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Biron BM, 2015, BIOMARK INSIGHTS, V10, P7, DOI 10.4137/BMI.S29519; Bouza C., 2015, BMC INFECT DIS, V14, P717, DOI [10.1186/s12879-014-0717-7, DOI 10.1186/S12879-014-0717-7]; Cena JJ, 2010, AM J PHYSIOL-HEART C, V298, pH45, DOI 10.1152/ajpheart.00273.2009; Cheng B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846935; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hoffmann U, 2006, SCAND J INFECT DIS, V38, P867, DOI 10.1080/00365540600702058; Hoffmann U, 2009, CRIT CARE, V13, DOI 10.1186/cc8156; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Jung K, 2001, CLIN CHIM ACTA, V314, P241, DOI 10.1016/S0009-8981(01)00679-9; Lalu MM, 2006, BRIT J PHARMACOL, V149, P31, DOI 10.1038/sj.bjp.0706823; Lalu MM, 2003, MOL CELL BIOCHEM, V251, P61, DOI 10.1023/A:1025417529167; Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lijnen HR, 2003, PATHOPHYSIOL HAEMO T, V33, P275, DOI 10.1159/000083814; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094318; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Maitra SR, 2003, SHOCK, V20, P280, DOI 10.1097/00024382-200309000-00014; Maitra SR, 2003, ACAD EMERG MED, V10, P1; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura T, 1998, AM J MED SCI, V316, P355, DOI 10.1097/00000441-199812000-00001; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Renckens R, 2006, J IMMUNOL, V176, P3735, DOI 10.4049/jimmunol.176.6.3735; Sakata Y, 2004, CIRCULATION, V109, P2143, DOI 10.1161/01.CIR.0000125741.88712.77; Sivula M, 2015, ACTA ANAESTH SCAND, V59, P176, DOI 10.1111/aas.12423; Steinberg J, 2005, SHOCK, V24, P348, DOI 10.1097/01.shk.0000180619.06317.2c; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang MM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0634-6; Wohlschlaeger J, 2005, PATHOL RES PRACT, V201, P809, DOI 10.1016/j.prp.2005.08.009	33	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171191	10.1371/journal.pone.0171191	http://dx.doi.org/10.1371/journal.pone.0171191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192449	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800017
J	Neelofar, K; Arif, Z; Ahmad, J; Alam, K				Neelofar, Km; Arif, Zarina; Ahmad, Jamal; Alam, Khursheed			Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study	PLOS ONE			English	Article							DIABETES-MELLITUS; PROTEIN GLYCATION; MODIFIED DNA; PEROXYNITRITE; ANTIBODIES; IMMUNOGENICITY	Hyperglycaemia induced non enzymatic glycation is accelerated in diabetic patients and aggressively involved in diabetes progression. Human serum albumin (HSA) is the most abundant protein in blood circulation. In hyperglycaemia, it undergoes fast glycation and results in the impairment of structure. Our previous study has demonstrated structural alterations in Amadori-albumin modified with different glucose concentrations from physiological to pathophysiological range. Here, we focused on immunological characterization of Amadori- albumin. Immunogenicity of Amadori-albumin was analysed by direct binding and competitive ELISA. Amadori-albumin was found to be highly immunogenic (expect albumin modified with 5mM) and induced high titre antibodies depending upon the extent of modification. Very high titre antibodies were obtained with albumin modified with 75mM glucose as compared to native albumin. Anti-Amadori-albumin-IgG from rabbit sera exhibited increased recognition of Amadori-albumin than native albumin in competitive immunoassay. Alteration induced in albumin after glucosylation has made it highly immunogenic. Induced antibodies were quite specific for respective immunogens but showed cross-reaction with other Amadori/native proteins. It suggests that glucosylation has generated highly immunogenic epitopes on albumin. Formation of high molecular weight immune complex with retarded mobility further supports specificity of anti-Amadori-albumin-IgG towards Amadori-albumin. It may be concluded that due to early glycation, an array of modification occurred in HSA structure. Such gross structural changes might favour polymerization of most of the native epitopes into potent immunogenic neo-epitopes, but some original epitopes were still active and has contributed in the immunogenicity. It could be concluded that induction of anti-Amadori-albumin antibodies may be due to protection of glucose modified albumin from protiolytic breakdown. We assumed that this type of protein modifications might occur in diabetic patients in hyperglycaemic conditions that may be recognised as foreign molecules and can induce autoantibodies. Increased level of anti-Amadori-albumin autoantibodies may be used as a biomarker in disease diagnosis and its progression.	[Neelofar, Km; Ahmad, Jamal] Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India; [Arif, Zarina; Alam, Khursheed] Aligarh Muslim Univ, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Neelofar, K (corresponding author), Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India.	neloferbiotech@gmail.com	Arif, Zarina/AAI-4441-2020	Arif, Zarina/0000-0002-8895-353X; Alam, Khursheed/0000-0001-9729-9966	Indian Council of Medical Research, New Delhi	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was supported by senior research fellowship (SRF) from the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2013, INT J BIOL MACROMOL, V59, P349, DOI 10.1016/j.ijbiomac.2013.04.068; Alam K, 2007, CELL IMMUNOL, V247, P12, DOI 10.1016/j.cellimm.2007.06.007; Ali Rashid, 2002, Methods Mol Biol, V186, P171; Ansari NA, 2013, AGING DIS, V4, P50; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Arif B, 2012, ARCH BIOCHEM BIOPHYS, V522, P17, DOI 10.1016/j.abb.2012.04.005; Bustin M, 1972, J BIOL CHEM, V57, P16; Chesne S, 2006, BIOCHIMIE, V88, P1467, DOI 10.1016/j.biochi.2006.05.011; COHEN MP, 1994, KIDNEY INT, V45, P475, DOI 10.1038/ki.1994.62; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; DAY JF, 1979, J BIOL CHEM, V254, P595; Dixit K, 2004, LUPUS, V13, P95, DOI 10.1191/0961203304lu492oa; DOYEN N, 1985, MOL IMMUNOL, V22, P1, DOI 10.1016/0161-5890(85)90028-8; Elaheh R, 2015, J BIOMOL STRU DYN, V33, P513; Fatemeh PZ, 2014, J BIOMOL STRU DYN, V32, P613; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Habib S, 2005, INT J BIOL MACROMOL, V35, P221, DOI 10.1016/j.ijbiomac.2005.02.005; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; Joseph L, 1983, MED SCI, V80, P2757; Khan MA, 2009, SCAND J IMMUNOL, V69, P99, DOI 10.1111/j.1365-3083.2008.02200.x; Khan MWA, 2010, INT ARCH ALLERGY IMM, V153, P207, DOI 10.1159/000312639; Maryam MM, 2014, LUMINESCENCE, V29, P314, DOI [10.1002/bio.2546, DOI 10.1002/BIO.2546]; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Neelofar, 2015, RSC ADV, V5, P63605, DOI 10.1039/c5ra07232h; Neelofar K, 2016, MOL BIOSYST, V12, P2481, DOI 10.1039/c6mb00324a; Rondeau P, 2008, FREE RADIC BIOL MED, V132, P171; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Smith EB, 1982, ATHEROSCLERO, V37, P579; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172074	10.1371/journal.pone.0172074	http://dx.doi.org/10.1371/journal.pone.0172074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192530	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800066
J	Nwosu, BU; Maranda, L; Candela, N				Nwosu, Benjamin Udoka; Maranda, Louise; Candela, Ninfa			Vitamin D status in pediatric irritable bowel syndrome	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D DEFICIENCY; DEPRESSIVE SYMPTOMS; 25-HYDROXYVITAMIN D; ASSOCIATION; CHILDREN; DISEASE; HEALTH; SERUM; ADOLESCENTS	Importance Irritable bowel syndrome (IBS) is associated with significant morbidity in children and adolescents, and the therapeutic efficacy of available treatment options is limited. The role of vitamin D supplementation in pediatric IBS is unclear as the vitamin D status of pediatric patients with IBS is unknown. Equally, the relationship of vitamin D status with psychosomatic symptoms in children and adolescents is unclear. Aim To characterize the vitamin D status of pediatric patients with IBS using a case-control study design. Hypothesis Serum 25-hydroxyvitamin D [25(OH)D] concentration will be similar between patients with IBS and controls. Subjects and methods A retrospective case-controlled study of 116 controls (age 14.6 +/- 4.3 y), female (n = 67; 58%) and 55 subjects with IBS (age 16.5 +/- 3.1y), female (n = 44; 80%). Overweight was defined as BMI of >= 85th but <= 95th percentile, and obesity as BMI >95th percentile. Vitamin D deficiency was defined as 25(OH)D of <50 nmol/L, while seasons of vitamin D draw were categorized as summer, winter, spring, and fall. Major psychosomatic manifestations included in the analysis were depression, anxiety, and migraine. Results More than 50% of IBS subjects had vitamin D deficiency at a cut-off point of <50 nmol/L (53% vs. 27%, p = 0.001); and >90% of IBS subjects had vitamin D deficiency at a cut-off point of <75 nmol/L (93% vs. 75%, p = 0.006). IBS subjects had significantly lower mean 25(OH)D: 53.2 +/- 15.8 nmol/L vs. 65.2 +/- 28.0 nmol/L, p = 0.003; and albumin: 6.2 +/- 0.6 vs. 6.5 +/- 0.6 pmol/L, p = 0.0.01. IBS subjects with migraine had significantly lower mean 25 (OH)D concentration compared to controls (p = 0.01). BMI z -score was similar between the controls and IBS subjects (0.5 +/- 1.4 vs. 1.2 +/- 2.9, p = 0.11). Conclusions Pediatric patients with IBS had significantly lower 25(OH)D concentration compared to controls despite having similar mean BMI values as controls. Only 7% of the children and adolescents with IBS were vitamin D sufficient, and >50% of the subjects with IBS had vitamin D deficiency. This is a much higher prevalence of vitamin D deficiency compared to IBD and other malabsorption syndromes. Monitoring for vitamin D deficiency should be part of the routine care for patients with IBS. Randomized control trials are warranted to determine the role of adjunctive vitamin D therapy in pediatric IBS.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Candela, Ninfa] Univ Massachusetts, Sch Med, Dept Pediat, Div Gastroenterol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Nwosu, Benjamin/0000-0003-2212-0276				Abbasnezhad A, 2016, NEUROGASTROENT MOTIL, V28, P1533, DOI 10.1111/nmo.12851; Abbasnezhad A, 2016, NEUROGASTROENTEROL M; Acosta A, 2015, EXPERT OPIN DRUG MET, V11, P1187, DOI 10.1517/17425255.2015.1048223; Ataie-Jafari A, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0191-9; Bohn L, 2013, NEUROGASTROENT MOTIL, V25, P23, DOI 10.1111/nmo.12001; Bours PHA, 2011, OSTEOPOROSIS INT, V22, P2857, DOI 10.1007/s00198-010-1484-y; Buettner C, 2015, CEPHALALGIA, V35, P757, DOI 10.1177/0333102414559733; Cheng H, 2016, J PSYCHOSOM RES, V88, P54, DOI 10.1016/j.jpsychores.2016.07.012; Chirila I, 2012, J GASTROINTEST LIVER, V21, P357; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; El-Matary W, 2011, DIGEST DIS SCI, V56, P825, DOI 10.1007/s10620-010-1380-5; Fletcher PC, 2006, CLIN NURSE SPEC, V20, P241, DOI 10.1097/00002800-200609000-00011; Gibson PR, 2011, J GASTROEN HEPATOL, V26, P128, DOI 10.1111/j.1440-1746.2011.06650.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Goodhand JR, 2012, ALIMENT PHARM THER, V35, P929, DOI 10.1111/j.1365-2036.2012.05043.x; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Guo YB, 2015, GUT LIVER, V9, P649, DOI 10.5009/gnl13437; Hayes P, 2014, J HUM NUTR DIET, V27, P36, DOI 10.1111/jhn.12114; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; Hogberg G, 2012, ACTA PAEDIATR, V101, P779, DOI 10.1111/j.1651-2227.2012.02655.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714; Khayyat Yasir, 2015, Oman Med J, V30, P115, DOI 10.5001/omj.2015.25; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Levin AD, 2011, DIGEST DIS SCI, V56, P830, DOI 10.1007/s10620-010-1544-3; Margulies SL, 2015, J DIGEST DIS, V16, P617, DOI 10.1111/1751-2980.12283; Middleton JP, 2013, J PEDIATR GASTR NUTR, V57, P587, DOI 10.1097/MPG.0b013e31829e0b89; Pappa HM, 2006, INFLAMM BOWEL DIS, V12, P1162, DOI 10.1097/01.mib.0000236929.74040.b0; Pappa HM, 2006, PEDIATRICS, V118, P1950, DOI 10.1542/peds.2006-0841; Pappa HM, 2011, J PEDIATR GASTR NUTR, V53, P361, DOI 10.1097/MPG.0b013e3182250b3e; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; Saps M, 2016, NEUROGASTROENT MOTIL, V28, P1619, DOI 10.1111/nmo.12896; Setty-Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078653; Sikoglu EM, 2015, J CHILD ADOL PSYCHOP, V25, P415, DOI 10.1089/cap.2014.0110; Skaaby T, 2013, ENDOCRINE; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Smith BA, 2014, PSYCHOSOMATICS, V55, P76, DOI 10.1016/j.psym.2013.01.012; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sprake EF, 2012, BMJ CASE REPORTS, V2012; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tazzyman S, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000052; Tolppanen AM, 2012, J CHILD PSYCHOL PSYC, V53, P757, DOI 10.1111/j.1469-7610.2011.02518.x; Veit LE, 2015, NUTRITION, V31, P994, DOI 10.1016/j.nut.2015.03.010; Veit LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101583; Veit LE, 2015, NUTRITION IN PRESS; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Zender R, 2009, NURS CLIN N AM, V44, P355, DOI 10.1016/j.cnur.2009.06.002	53	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172183	10.1371/journal.pone.0172183	http://dx.doi.org/10.1371/journal.pone.0172183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192499	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800082
J	Suarez-Garcia, S; del Bas, JM; Caimari, A; Escorihuela, RM; Arola, L; Suarez, M				Suarez-Garcia, Susana; del Bas, Josep M.; Caimari, Antoni; Escorihuela, Rosa M.; Arola, Lluis; Suarez, Manuel			Impact of a cafeteria diet and daily physical training on the rat serum metabolome	PLOS ONE			English	Article							INSULIN-RESISTANCE; ALPHA-TOCOPHEROL; AEROBIC EXERCISE; ACTIVATED RECEPTOR; GAMMA-TOCOPHEROL; ADIPOSE-TISSUE; OBESE CHILDREN; POTENTIAL ROLE; OLDER-ADULTS; FEMALE RATS	Regular physical activity and healthy dietary patterns are commonly recommended for the prevention and treatment of metabolic syndrome (MetS), which is diagnosed at an alarmingly increasing rate, especially among adolescents. Nevertheless, little is known regarding the relevance of physical exercise on the modulation of the metabolome in healthy people and those with MetS. We have previously shown that treadmill exercise ameliorated different symptoms of MetS. The aim of this study was to investigate the impact of a MetS-inducing diet and different intensities of aerobic training on the overall serum metabolome of adolescent rats. For 8 weeks, young rats were fed either standard chow (ST) or cafeteria diet (CAF) and were subjected to a daily program of training on a treadmill at different speeds. Non-targeted metabolomics was used to identify changes in circulating metabolites, and a combination of multivariate analysis techniques was implemented to achieve a holistic understanding of the metabolome. Among all the identified circulating metabolites influenced by CAF, lysophosphatidylcholines were the most represented family. Serum sphingolipids, bile acids, acylcarnitines, unsaturated fatty acids and vitamin E and A derivatives also changed significantly in CAF-fed rats. These findings suggest that an enduring systemic inflammatory state is induced by CAF. The impact of physical training on the metabolome was less striking than the impact of diet and mainly altered circulating bile acids and glycerophospholipids. Furthermore, the serum levels of monocyte chemoattractant protein-1 were increased in CAF-fed rats, and C-reactive protein was decreased in trained groups. The leptin/adiponectin ratio, a useful marker of MetS, was increased in CAF groups, but decreased in proportion to training intensity. Multivariate analysis revealed that ST-fed animals were more susceptible to exercise-induced changes in metabolites than animals with MetS, in which moderate-intensity seems more effective than high-intensity training. Our results indicate that CAF has a strong negative impact on the metabolome of animals that is difficult to reverse by daily exercise.	[Suarez-Garcia, Susana; Arola, Lluis; Suarez, Manuel] Univ Rovira & Virgili, Nutrigenom Res Grp, Dept Bioquim & Biotecnol, Tarragona, Spain; [del Bas, Josep M.; Caimari, Antoni; Arola, Lluis] EURECAT Technol Ctr Catalonia, Technol Unit Nutr & Hlth, Reus, Spain; [Escorihuela, Rosa M.] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Inst Neurociencies, Barcelona, Spain	Universitat Rovira i Virgili; Autonomous University of Barcelona	Arola, L (corresponding author), Univ Rovira & Virgili, Nutrigenom Res Grp, Dept Bioquim & Biotecnol, Tarragona, Spain.; Arola, L (corresponding author), EURECAT Technol Ctr Catalonia, Technol Unit Nutr & Hlth, Reus, Spain.	lluis.arola@urv.cat	Arola, Lluís/C-6074-2011; Escorihuela, Rosa M/L-4524-2014; del Bas, Josep M/K-2327-2014; Suárez-García, Susana/AAI-5703-2021; del Bas, Josep Maria/K-9310-2019; Recio, Manuel Suarez/F-5039-2016	Arola, Lluís/0000-0003-2767-1974; Escorihuela, Rosa M/0000-0001-9368-5173; del Bas, Josep M/0000-0002-0700-2004; Suárez-García, Susana/0000-0001-9482-5078; del Bas, Josep Maria/0000-0002-0700-2004; Recio, Manuel Suarez/0000-0003-0122-8253; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [AGL2013-40707-R, PSI 2011-29807-C02/PSIC]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	Support was provided by the Spanish Ministry of Economy and Competitiveness PSI 2011-29807-C02/PSIC to Rosa Maria Escorihuela, and by the Spanish Ministry of Economy and Competitiveness AGL2013-40707-R to Lluis Arola.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bispo K., 2014, J FOOD NUTR DISORD, V3, P4; Bollard ME, 2001, ANAL BIOCHEM, V295, P194, DOI 10.1006/abio.2001.5211; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brozinick JT, 2013, INT J OBESITY, V37, P1064, DOI 10.1038/ijo.2012.191; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Campbell PT, 2009, MED SCI SPORT EXER, V41, P1533, DOI 10.1249/MSS.0b013e31819c7feb; CATHCART MK, 1985, J LEUKOCYTE BIOL, V38, P341, DOI 10.1002/jlb.38.2.341; Cigarroa I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153687; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Bas JM, 2016, IMPAIRMENT LYSOPHOSP, P1; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848; Donges CE, 2010, MED SCI SPORT EXER, V42, P304, DOI 10.1249/MSS.0b013e3181b117ca; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garvey SM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12319; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Gilardini L, 2006, ATHEROSCLEROSIS, V189, P401, DOI 10.1016/j.atherosclerosis.2005.12.021; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; HALEVY O, 1987, BIOCHIM BIOPHYS ACTA, V918, P304, DOI 10.1016/0005-2760(87)90235-9; Hardwick JP, 2013, ADV PHARMACOL, V66, P157, DOI 10.1016/B978-0-12-404717-4.00005-6; Heemskerk MM, 2015, NUTRIENTS, V7, P7676, DOI 10.3390/nu7095362; Heimerl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111348; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOPE WC, 1975, PROSTAGLANDINS, V10, P557, DOI 10.1016/S0090-6980(75)80002-5; Hrabovsky V, 2009, WIEN KLIN WOCHENSCHR, V121, P270, DOI 10.1007/s00508-009-1150-6; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Jedrychowski MP, 2015, CELL METAB, P1; Jialal I, 2001, J NUTR, V131, p389S, DOI 10.1093/jn/131.2.389S; Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kohut ML, 2006, BRAIN BEHAV IMMUN, V20, P201, DOI 10.1016/j.bbi.2005.12.002; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lalanza JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16166; Lalanza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085049; Lavoie JM, 2016, WORLD J HEPATOL, V8, P961, DOI 10.4254/wjh.v8.i23.961; LIPID MAPS, 2010, LIP NAT LIP GAT 2010; Liu J, 2015, EUR REV MED PHARMACO, V19, P2168; MARTIN JE, 1990, CIRCULATION, V81, P1560, DOI 10.1161/01.CIR.81.5.1560; Martinez-Micaelo N, 2015, J FUNCT FOODS, V15, P61, DOI 10.1016/j.jff.2015.02.017; Memon RA, 2001, J BIOL CHEM, V276, P30118, DOI 10.1074/jbc.M102516200; Memon RA, 1998, ARTERIOSCL THROM VAS, V18, P1257, DOI 10.1161/01.ATV.18.8.1257; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Penno G, 2006, PHARMACOL RES, V53, P457, DOI 10.1016/j.phrs.2006.03.010; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Pruzanski W, 2015, INFLAMM RES, V64, P497, DOI 10.1007/s00011-015-0830-0; Ravipati S, 2015, METABOLOMICS, V11, P1600, DOI 10.1007/s11306-015-0811-x; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sakurai T, 2009, BIOCHEM BIOPH RES CO, V379, P605, DOI 10.1016/j.bbrc.2008.12.127; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Suizdak G, 2010, ABAGYAN LAB; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Troseid M, 2004, EUR HEART J, V25, P349, DOI 10.1016/j.ehj.2003.12.006; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Wang Y, 2016, BIOMED CHROMATOGR, V30, P48, DOI 10.1002/bmc.3491; Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081; Wishart D, 2009, HMDB HUMAN METABOLOM; Yao K, 2016, TRENDS PHARMACOL SCI, V37, P714, DOI 10.1016/j.tips.2016.05.004; Yoon JH, 2011, CLIN CHIM ACTA, V412, P2199, DOI 10.1016/j.cca.2011.08.003; Zeeni N, 2015, INFLAMM RES, V64, P501, DOI 10.1007/s00011-015-0831-z; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126952; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	80	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171970	10.1371/journal.pone.0171970	http://dx.doi.org/10.1371/journal.pone.0171970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192465	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800055
J	de Carvalho, DL; Sousa-Neves, T; Cerqueira, PV; Gonsioroski, G; Silva, SM; Silva, DP; Santos, MPD				de Carvalho, Dorinny Lisboa; Sousa-Neves, Tiago; Cerqueira, Pablo Vieira; Gonsioroski, Gustavo; Silva, Sofia Marques; Silva, Daniel Paiva; Dantas Santos, Marcos Persio			Delimiting priority areas for the conservation of endemic and threatened Neotropical birds using a niche-based gap analysis	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIODIVERSITY HOTSPOTS; PREDICTIVE MODELS; PROTECTED AREAS; CERRADO REGION; SAMPLE-SIZE; DISTRIBUTIONS; ACCURACY; PATTERNS; ENVIRONMENT	Knowledge of spatiotemporal distribution of biodiversity is still very incomplete in the tropics. This is one of the major problems preventing the assessment and effectiveness of conservation actions. Mega-diverse tropical regions are being exposed to fast and profound environmental changes, and the amount of resources available to describe the distribution of species is generally limited. Thus, the tropics is losing species at unprecedented rates, without a proper assessment of its biodiversity. Species distribution models (SDMs) can be used to fill such biogeographic gaps within a species' range and, when allied with systematic conservation planning (e.g. analyses of representativeness, gap analysis), help transcend such data shortage and support practical conservation actions. Within the Neotropics, eastern Amazon and northern Cerrado present a high variety of environments and are some of the most interesting ecotonal areas within South America, but are also among the most threatened biogeographic provinces in the world. Here, we test the effectiveness of the current system of Protected Areas (PAs), in protecting 24 threatened and endemic bird species using SDMs. We found that taxa with wider distributions are potentially as protected as taxa with smaller ranges, and larger PAs were more efficient than smaller PAs, while protecting these bird species. Nonetheless, Cerrado PAs are mostly misallocated. We suggest six priority areas for conservation of Neotropical birds. Finally, we highlight the importance of indigenous lands in the conservation of Neotropical biodiversity, and recommend the development of community management plans to conserve the biological resources of the region.	[de Carvalho, Dorinny Lisboa; Sousa-Neves, Tiago; Cerqueira, Pablo Vieira; Silva, Sofia Marques; Dantas Santos, Marcos Persio] Fed Univ Para, Museu Paraense Emilio Goeldi, Programa Posgrad Zool, Av Perimetral 1901, Belem, Para, Brazil; [Sousa-Neves, Tiago; Silva, Sofia Marques] Res Ctr Biodivers & Genet Resources, InBIO Associate Lab, Campus Agr Vairao, Vairao, Portugal; [Gonsioroski, Gustavo] Eudocimus Consultoria Ambiental, R 31,28b, Sao Luis, Maranhao, Brazil; [Silva, Daniel Paiva] Inst Fed Goiano, Dept Biol, Rodovia Geraldo Silva Nascimento, Urutai, Go, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidade do Porto; Instituto Federal Goiano	de Carvalho, DL (corresponding author), Fed Univ Para, Museu Paraense Emilio Goeldi, Programa Posgrad Zool, Av Perimetral 1901, Belem, Para, Brazil.	dorinny.lisboa@gmail.com	Cerqueira, Pablo Vieira/D-9268-2013; Gonsioroski, Gustavo/AAR-4331-2021; Silva, Daniel Paiva/F-8052-2010; Silva, Sofia Marques/Z-4854-2019; Pérsio, Marcos/B-8653-2016	Silva, Daniel Paiva/0000-0002-2457-6245; Pérsio, Marcos/0000-0001-8819-867X; Gonsioroski, Gustavo/0000-0002-5323-3794; Silva, Sofia/0000-0002-0502-3071	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship; Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Eudocimus Consultoria Ambiental	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Eudocimus Consultoria Ambiental	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) doctoral fellowships: DLC and PVC. Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) doctoral fellowship: TSN. Programa de Pos-Graduacao em Zoologia Museu Paraense Emilio Goeldi / Universidade Federal do Para (PPGZOO MPEG/UFPA) Programa Nacional de Pos-Doutorado (PNPD) / Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship: SMS. Eudocimus Consultoria Ambiental provided support in the form of salaries for GG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thus, I assure that GG's commercial affiliation did not play a role in our study. The specific roles of all the authors are shown in the author contributions section.	AbSaber A. N., 1977, ESPACOS OCUPADOS PEL; Ahmed SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1742; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo Miguel B., 1999, Diversity and Distributions, V5, P151, DOI 10.1046/j.1472-4642.1999.00052.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bawa KS, 2004, BIOTROPICA, V36, P437, DOI 10.1111/j.1744-7429.2004.tb00341.x; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Borges SH, 2007, POLITICA AMBIENTAL, V4, P1; Brasileiro de Ornitologia, 2014, LIST AV BRAS; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Camm JD, 1994, BIOL CONSERV; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Couto RG, 2004, ATLAS CONSERVACAO NA; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; DaSilva JMC, 1997, BIODIVERS CONSERV, V6, P435, DOI 10.1023/A:1018368809116; De Luca AC, 2009, AREAS IMPORTANTES CO; de Siqueira MF, 2009, J NAT CONSERV, V17, P25, DOI 10.1016/j.jnc.2008.11.001; del Hoyo J., 2003, HDB BIRDS WORLD, V8; Diniz JAF, 2004, AMPHIBIA-REPTILIA, V25, P63, DOI 10.1163/156853804322992841; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; DORNAS T, 2012, REV BRAS ORNITOL, V20, P119; Dutra RCD, 2006, POLITICA AMBIENT, V1, P3; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fagundes CK, 2016, DIVERS DISTRIB, V22, P123, DOI 10.1111/ddi.12396; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; FIEMA, 2009, PLAN ESTR DES IND MA; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Girardello M, 2009, ANIM CONSERV, V12, P20, DOI 10.1111/j.1469-1795.2008.00216.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hong SK, 2006, ECOL RES, V21, P783, DOI 10.1007/s11284-006-0032-x; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Instituto Brasileiro de Geografia e Estatstica, 2013, MAP TEM BRAS; Instituto Brasileiro do Meio Ambiente Ministerio do Meio Ambiente, 2014, LIST ESP FAUN BRAS A; Instituto Nacional de Pesquisa Espacial, 2014, TAX EST DESM AM LEG; Instituto Socioambiental Instituto do Homem e Meio Ambiente da Amazonia Instituto de Pesquisa Ambiental da Amazonia Instituto Sociedade Populacao e Natureza Grupo de Trabalho Amazonico Conservation International, 1999, SEM CONS MAC 99; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Jimenez ALM, 2005, AM J PRIMATOL, V66, P131; Kamino LHY, 2012, BIOL LETTERS, V8, P324, DOI 10.1098/rsbl.2011.0942; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Ko CY, 2009, ZOOL STUD, V48, P418; Laurance WF, 2005, TRENDS ECOL EVOL, V20, P645, DOI 10.1016/j.tree.2005.10.009; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lees AC, 2015, CURR BIOL, V25, pR177, DOI 10.1016/j.cub.2014.12.017; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Leite LO, 2006, ANALISE ENDEMISMO VA, P187; Lima-Ribeiro MD, 2012, REV BRAS PALEONTOLOG, V15, P371, DOI 10.4072/rbp.2012.3.12; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Machado R.B, 2004, ESTIMATIVAS PERDA AR; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martinez I, 2006, BIOL CONSERV, V133, P500, DOI 10.1016/j.biocon.2006.08.003; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Mello CF, 2000, IBAMA DIAGNOSTICO AV; Miller MP, 2013, CONSERV GENET, V14, P333, DOI 10.1007/s10592-012-0420-4; Ministerio do Meio Ambiente, 2008, MON DES BIOM BRAS; Ministerio do Meio Ambiente, 2003, AR PRIOR CONS UT SUS; Moura NG, 2014, CONSERV BIOL, V28, P1271, DOI 10.1111/cobi.12300; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nantel P, 1998, BIOL CONSERV, V84, P223, DOI 10.1016/S0006-3207(97)00133-X; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Nitta R, 2009, BUDGET STAFF ANAL MA; Nobrega CC, 2011, DIVERS DISTRIB, V17, P491, DOI 10.1111/j.1472-4642.2011.00749.x; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; OREN D. C., 2011, AMAZONIA MARANHENSE, P221; Oren DC., 1991, AVES ESTADO MARANHAO; Payne R. B., 1997, HDB BIRDS WORLD, V4, P508; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pinheiro Renato Torres, 2009, Biota Neotropica, V9, P187; Portes CEB, 2013, BRAZILIAN J ORNITHOL, V19, P19; Prado D.E., 2003, ECOLOGIA CONSERVACA; Pressey RL, 2009, SPATIAL CONSERVATION, P211; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P351; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; Rego MA, 2011, BIOTA NEOTROP, V11, P283, DOI 10.1590/S1676-06032011000100027; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rylands AB., 1991, STATUS CONSERVATION; Rylands AB, 1998, CONSERVACAO BIODIVER; Santos MPD, 2005, IMPORTANCIA RELATIVA; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Secretaria do Meio Ambiente e Recursos Hidricos (SEMA), 2011, PLANO ACAO PREVENCAO; Silva DP, 2015, J INSECT CONSERV, V19, P901, DOI 10.1007/s10841-015-9807-0; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Silva Jose Maria Cardoso Da, 1995, Steenstrupia, V21, P69; Silveira LF., 2008, LIVRO VERMELHO FAUNA; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarroso P, 2014, MOL ECOL, V23, P1108, DOI 10.1111/mec.12671; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Peterson AT, 2006, J MAMMAL, V87, P427, DOI 10.1644/05-MAMM-A-133R3.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; Verissimo A, 2002, CONSERV ECOL, V6; Vieira ICG, 2008, BRAZ J BIOL, V68, P949, DOI 10.1590/S1519-69842008000500004; White C.M., 1994, NEW WORLD VULTURES G; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; WILSON JA, 1994, MAR POLICY, V18, P291, DOI 10.1016/0308-597X(94)90044-2; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhao L, 2016, BOTANY, V94, DOI 10.1139/cjb-2015-0232	131	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171838	10.1371/journal.pone.0171838	http://dx.doi.org/10.1371/journal.pone.0171838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187182	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300049
J	Bonamichi, BDF; Parente, EB; Campos, ACN; Cury, AN; Salles, JEN				Francisco Bonamichi, Beatriz Dal Santo; Parente, Erika Bezerra; Campos, Ana Carolina Noronha; Cury, Adriano Namo; Nunes Salles, Joao Eduardo			Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; GLUCOSE CONTROL; CONSENSUS STATEMENT; EXPERT CONSENSUS; COMPLICATIONS; ANGIOGRAPHY; STANDARDS; SOCIETY	Introduction Metabolic syndrome (MS) is characterized by dyslipidemia, central obesity, hypertension and hyperglycemia. However, type 2 diabetes mellitus (T2DM) may or may not be present in metabolic syndrome. MS and T2DM are considered important cardiovascular risk factors, but the role of hyperglycemia in coronary disease is still contested in the literature. Therefore, we decided to evaluate the effect of hyperglycemia on the severity of coronary disease in MS patients, with or without T2DM, submitted to coronary angiography (CA) and intravascular ultrasonography (IVUS). Materials and methods This is a cross sectional, observational study with 100 MS patients (50% with T2DM), 60% male. All of the patients had been referred for CA procedures. The obstruction was considered severe when stenosis was greater than 70% and moderate if it was between 50-69%. Patients detected with a moderate obstruction by CA were indicated to IVUS. A minimal luminal area of less than 4mm2 detected by IVUS was also considered severe. IDF criteria were used to define Metabolic Syndrome and T2DM diagnosis was defined according to the American Diabetes Association criteria. Student's t-test and Pearson Chi-square were used for statistical analysis, considering p < 0.05 statistically significant. Results and discussion The majority of T2DM patients presented severe arterial lesions (74% vs 22%, p<0.001). Using CA procedure, 12% of T2DM had moderate obstructions, compared to 38% of the non-diabetic group (p< 0.05). 8% of patients with moderate lesions by CA were diagnosed with a luminal area less than 4mm(2) using IVUS. This luminal area was significantly smaller in the T2DM group than in the control group (3.8mm(2) +/- 2.42. vs 4.6mm(2) +/- 2.58, p = 0.03). Conclusion Patients with MS and T2DM submitted to angiography and IVUS, had more severe coronary lesions compared to MS patients without diabetes. This finding suggests that beyond insulin resistance that is present in MS, hyperglycemia may also play a role in the development of atherosclerotic disease. IVUS was useful for diagnosing 8% of severe cases initially considered to be moderate obstructions when using just CA in this scenario.	[Francisco Bonamichi, Beatriz Dal Santo; Parente, Erika Bezerra; Cury, Adriano Namo; Nunes Salles, Joao Eduardo] Santa Casa Sao Paulo Hosp, Dept Internal Med, Endocrinol Unit, Sao Paulo, Brazil; [Campos, Ana Carolina Noronha] Santa Casa Sao Paulo Hosp, Dept Internal Med, Sao Paulo, Brazil		Parente, EB (corresponding author), Santa Casa Sao Paulo Hosp, Dept Internal Med, Endocrinol Unit, Sao Paulo, Brazil.	ebparente@gmail.com	Salles, Joao Eduardo Nunes/AAG-6050-2019; Parente, Erika/ABE-7029-2020; Cury, Adriano N/E-8752-2012	Salles, Joao Eduardo Nunes/0000-0003-3865-5320; Parente, Erika/0000-0002-8101-912X; Cury, Adriano N/0000-0002-9777-8366				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; [Anonymous], 2016, CIRCULATION; Athyros VG, 2007, INT J CARDIOL, V117, P204, DOI 10.1016/j.ijcard.2006.04.078; Bonello L, 2009, ARCH CARDIOVASC DIS, V102, P143, DOI 10.1016/j.acvd.2008.11.002; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Grimaldi A, 1999, DIABETES METAB, V25, P12; Haffner SM, 2003, AM J CARDIOL, V92, p18J, DOI 10.1016/S0002-9149(03)00612-X; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Ikmal SIQS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/698567; Jung CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128627; KIMURA BJ, 1995, AM HEART J, V130, P386, DOI 10.1016/0002-8703(95)90457-3; Lotfi A, 2014, CATHETER CARDIO INTE, V83, P509, DOI 10.1002/ccd.25222; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Menegazzo L, 2015, ATHEROSCLEROSIS, V241, P533, DOI 10.1016/j.atherosclerosis.2015.06.013; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Orford JL, 2004, J AM COLL CARDIOL, V43, P1335, DOI 10.1016/j.jacc.2003.12.035; Pansuria Meghana, 2012, Front Biosci (Schol Ed), V4, P916; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pinsker JE, 2015, DIABETES CARE, V38, pE174, DOI 10.2337/dc15-0839; Yang DJ, 2013, J INVASIVE CARDIOL, V25, P137	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171733	10.1371/journal.pone.0171733	http://dx.doi.org/10.1371/journal.pone.0171733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187174	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300041
J	Rath, H; Stumpp, SN; Stiesch, M				Rath, Henryke; Stumpp, Sascha Nico; Stiesch, Meike			Development of a flow chamber system for the reproducible in vitro analysis of biofilm formation on implant materials	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; VIRIDANS STREPTOCOCCI; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-RESISTANCE; ORAL STREPTOCOCCI; DENTAL IMPLANT; GROWTH; ADHESION; IDENTIFICATION; CELLS	Since the introduction of modern dental implants in the 1980s, the number of inserted implants has steadily increased. Implant systems have become more sophisticated and have enormously enhanced patients' quality of life. Although there has been tremendous development in implant materials and clinical methods, bacterial infections are still one of the major causes of implant failure. These infections involve the formation of sessile microbial communities, called biofilms. Biofilms possess unique physical and biochemical properties and are hard to treat conventionally. There is a great demand for innovative methods to functionalize surfaces antibacterially, which could be used as the basis of new implant technologies. Present, there are few test systems to evaluate bacterial growth on these surfaces under physiological flow conditions. We developed a flow chamber model optimized for the assessment of dental implant materials. As a result it could be shown that biofilms of the five important oral bacteria Streptococcus gordonii, Streptococcus oralis, Streptococcus salivarius, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans, can be reproducibly formed on the surface of titanium, a frequent implant material. This system can be run automatically in combination with an appropriate microscopic device and is a promising approach for testing the antibacterial effect of innovative dental materials.	[Rath, Henryke; Stumpp, Sascha Nico; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany	Hannover Medical School	Rath, H (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany.	henryke.rath@ibnm.uni-hannover.de			Multifunktionale aktive und reaktive Interfaces und Oberflachen; Ministry of Science and Culture of Lower Saxony	Multifunktionale aktive und reaktive Interfaces und Oberflachen; Ministry of Science and Culture of Lower Saxony	Henryke Rath was funded by Multifunktionale aktive und reaktive Interfaces und Oberflachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Henryke Rath was financially supported provided by the Ministry of Science and Culture of Lower Saxony, within the framework of the Doctoral Program MARIO (Multifunctional Active and Reactive Interfaces and Surfaces). Additionally, we thank Dr. Andeas Winkel, Dr. Sebastian Grade and Manly Felicia Dalton for statistical and technical support. The authors declare no conflicts of interest related to this study.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Alam S, 2000, APPL ENVIRON MICROB, V66, P3330, DOI 10.1128/AEM.66.8.3330-3336.2000; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; BEIGHTON D, 1994, J MED MICROBIOL, V40, P202, DOI 10.1099/00222615-40-3-202; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Byers HL, 2000, J MED MICROBIOL, V49, P235, DOI 10.1099/0022-1317-49-3-235; Chalmers NI, 2008, MULTISPECIES ORAL BI; Chin MYH, 2006, EUR J ORTHODONT, V28, P1, DOI 10.1093/ejo/cji094; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Davey ME, 2006, PERIODONTOL 2000, V42, P27, DOI 10.1111/j.1600-0757.2006.00183.x; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DEBEER D, 1994, BIOTECHNOL BIOENG, V44, P636, DOI 10.1002/bit.260440510; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; Domingues JFD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070046; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P803, DOI 10.1093/jac/30.6.803; DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P791, DOI 10.1093/jac/30.6.791; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gashti MP, 2016, LAB CHIP, V16, P1412, DOI 10.1039/c5lc01540e; Gilmore KS, 2003, INFECT IMMUN, V71, P4759, DOI 10.1128/IAI.71.8.4759-4766.2003; Gowrishankar S, 2015, RSC ADV, V5, P95788, DOI 10.1039/c5ra11641d; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hardie JM, 1994, REV MED MICROBIOL, P151; Hauser-Gerspach I, 2007, DENT MATER J, V26, P361, DOI 10.4012/dmj.26.361; Henderson B, 2003, ANNU REV MICROBIOL, V57, P29, DOI 10.1146/annurev.micro.57.030502.090908; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; HOYLE BD, 1992, CAN J MICROBIOL, V38, P1214, DOI 10.1139/m92-201; Islam N, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-21; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Kroukamp O, 2010, APPL ENVIRON MICROB, V76, P6025, DOI 10.1128/AEM.00070-10; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Meier R, 2008, J MATER SCI-MATER M, V19, P3249, DOI 10.1007/s10856-008-3457-7; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Paquette David W, 2006, Dent Clin North Am, V50, P361, DOI 10.1016/j.cden.2006.05.002; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Park A, 2011, BIOCHIP J, V5, P236, DOI 10.1007/s13206-011-5307-9; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Raj M, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/10067.5133; RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255, DOI 10.1128/AEM.59.10.3255-3265.1993; Roberts AP, 1999, FEMS MICROBIOL LETT, V177, P63; ROTHE B, 1991, MOL GEN GENET, V226, P190, DOI 10.1007/BF00273603; Schonfeld ES, 1992, CONT ORAL MICROBIOLO, P267; Shemesh J, 2015, LAB CHIP, V15, P4114, DOI 10.1039/c5lc00633c; Sliepen I, 2008, ORAL MICROBIOL IMMUN, V23, P520, DOI 10.1111/j.1399-302X.2008.00456.x; Sterer N, 2006, J DENT RES, V85, P910, DOI 10.1177/154405910608501007; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Waters EM, 2014, METHODS MOL BIOL, V1106, P157, DOI 10.1007/978-1-62703-736-5_14; Weiger R, 1999, ARCH ORAL BIOL, V44, P621, DOI 10.1016/S0003-9969(99)00061-8; West PWJ, 1998, J MED MICROBIOL, V47, P923, DOI 10.1099/00222615-47-10-923; WOLFAARDT GM, 1994, APPL ENVIRON MICROB, V60, P434, DOI 10.1128/AEM.60.2.434-446.1994; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; Zhang W, 2011, BIOTECHNOL BIOENG, V108, P2571, DOI 10.1002/bit.23234; Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001	66	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172095	10.1371/journal.pone.0172095	http://dx.doi.org/10.1371/journal.pone.0172095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187188	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300080
J	Chua, CL; Sam, IC; Chiam, CW; Chan, YF				Chua, Chong-Long; Sam, I-Ching; Chiam, Chun-Wei; Chan, Yoke-Fun			The neutralizing role of IgM during early Chikungunya virus infection	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; DIAGNOSIS; E2; DISEASE; RESPONSES; EPITOPE; ASSAY; SERODIAGNOSIS; PROTECTION; CLEARANCE	The antibody isotype IgM appears earlier than IgG, within days of onset of symptoms, and is important during the early stages of the adaptive immune response. Little is known about the functional role of IgM during infection with chikungunya virus (CHIKV), a recently reemerging arbovirus that has caused large global outbreaks. In this study, we studied antibody responses in 102 serum samples collected during CHIKV outbreaks in Malaysia. We described the neutralizing role of IgM at different times post-infection and examined the independent contributions of IgM and IgG towards the neutralizing capacity of human immune sera during the early phase of infection, including the differences in targets of neutralizing epitopes. Neutralizing IgM starts to appear as early as day 4 of symptoms, and their appearance from day 6 is associated with a reduction in viremia. IgM acts in a complementary manner with the early IgG, but plays the main neutralizing role up to a point between days 4 and 10 which varies between individuals. After this point, total neutralizing capacity is attributable almost entirely to the robust neutralizing IgG response. IgM preferentially binds and targets epitopes on the CHIKV surface E1-E2 glycoproteins, rather than individual E1 or E2. These findings provide insight into the early antibody responses to CHIKV, and have implications for design of diagnostic serological assays.	[Chua, Chong-Long; Sam, I-Ching; Chiam, Chun-Wei; Chan, Yoke-Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya	Sam, IC; Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jicsam@ummc.edu.my; chanyf@ummc.edu.my	Chua, Chong Long/J-3028-2016; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010	Chua, Chong Long/0000-0002-8854-4955; Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510	University of Malaya High Impact Research grant [E000013-20001]; Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia [FP035-2015A]; MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia	University of Malaya High Impact Research grant; Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia; MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia	This study was funded by grants from University of Malaya High Impact Research grant E000013-20001 and Fundamental Research Grant Scheme FP035-2015A of the Ministry of Higher Education, Malaysia. CLC was supported by the MyBrain15 (MyPhD) scheme of the Ministry of Higher Education, Malaysia. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Amor S, 1996, J GEN VIROL, V77, P281, DOI 10.1099/0022-1317-77-2-281; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Burdino E, 2016, EMERG INFECT DIS, V22, P1837, DOI 10.3201/eid2210.151784; Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Chua CL, 2016, METHODS MOL BIOL, V1426, P51, DOI 10.1007/978-1-4939-3618-2_5; Chua CL, 2014, J VIROL METHODS, V195, P126, DOI 10.1016/j.jviromet.2013.10.015; Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960; Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dorfmeier CL, 2013, J VIROL, V87, P9217, DOI 10.1128/JVI.00995-13; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119; Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050; Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674; Gauri L A, 2012, J Assoc Physicians India, V60, P68; Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085; Hawman DW, 2016, CELL REP, V16, P1326, DOI 10.1016/j.celrep.2016.06.076; Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013; Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Kashyap Rajpal S, 2010, Cerebrospinal Fluid Res, V7, P12, DOI 10.1186/1743-8454-7-12; Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483; Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55; Kumar P, 2014, J VIROL METHODS, V206, P67, DOI 10.1016/j.jviromet.2014.05.014; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Lam S, 2015, MABS-AUSTIN, V7, P1178, DOI 10.1080/19420862.2015.1083664; Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200; Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Oliver M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000374; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354; Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269; Prince HE, 2016, CLIN VACCINE IMMUNOL, V23, P825, DOI 10.1128/CVI.00330-16; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Rianthavorn P, 2010, SE ASIAN J TROP MED, V41, P92; Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032; Sam I-C, 2006, Med J Malaysia, V61, P264; Sam IC, 2015, EMERG INFECT DIS, V21, P1683, DOI 10.3201/eid2109.150439; Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680; Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476; Sam IC, 2011, EXPERT REV ANTI-INFE, V9, P1089, DOI [10.1586/eri.11.132, 10.1586/ERI.11.132]; Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423; Simarmata D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26097; Skountzou I, 2014, CLIN VACCINE IMMUNOL, V21, P1481, DOI 10.1128/CVI.00374-14; Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177; Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753; Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764; Zim MAM, 2013, J CLIN VIROL, V56, P141, DOI 10.1016/j.jcv.2012.10.019	74	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171989	10.1371/journal.pone.0171989	http://dx.doi.org/10.1371/journal.pone.0171989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182795	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800141
J	Ma, X; Yan, L; Zhu, Q; Shao, FM				Ma, Xu; Yan, Lei; Zhu, Qing; Shao, Fengmin			Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-kappa B signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; RENAL INJURY; LUNG-CANCER; IN-VITRO; INDUCED TOXICITY; APOPTOSIS; CELLS; INFLAMMATION; EXPRESSION	Puerarin was a major isoflavonoid derived from the Chinese medical herb radix puerariae (Gegen). In present study effect of puerarin on cisplatin nephrotoxicity was evaluated. Rat model of nephrotoxicity was established by a single intraperitoneal injection of cisplatin (7mg/kg). Puerarin was administrated through caudal vein injection once per day at the dose of 10mg/kg, 30mg/kg and 50mg/kg. Biochemical assays showed that after cisplatin treatment the serum urea and creatinine increased significantly compared with control (P<0.05). Cisplatin treatment significantly increased xanthine oxidase (XO) activity and malondialdehyde (MDA) formation, and significantly decreased the levels and /or activities of enzymatic and non-enzymatic antioxidants (GSH, GPx, GST, GR, SOD, CAT), in the kidney tissues. Renal levels of TNF-alpha and IL-6, two important inflammatory cytokines, were also upregulated by cisplatin. Histopathological examination indicated that cisplatin treatment resulted in severe necrosis and degeneration, hyaline casts in the tubules, intertubular hemorrhage, congestion and swelling in glomerulus and leukocytes infiltration in the kidney tissues. Western blot results demonstrated that cisplatin increased TLR4 and NF-kappa B protein expression in the kidney tissues. However, all these changes induced by cisplatin were significantly attenuated by puerarin treatment in dose-dependent manner, which indicated the renal protective effect of puerarin. Cell culture experiments illustrated that puerarin alone treatment concentration-dependently inhibited COLO205 and HeLa tumor cell growth and dose-dependently promoted the antitumor activity of cisplatin in COLO205 and HeLa tumor cells. The promotion effects might be attributed to suppression of cisplatin-increased NF-kappa B p65 expression by puerarin. Taken together, findings in this study suggested that puerarin exhibited renal protection against cisplatin nephrotoxicity via inhibiting TLR4/NF-kappa B signaling, with no inhibition but promotion effect on the antitumor activity of cisplatin. Puerarin might be a promising adjuvant agent for cisplatin chemotherapy.	[Ma, Xu; Yan, Lei; Zhu, Qing; Shao, Fengmin] Zhengzhou Univ, Peoples Hosp, Dept Nephrol, Zhengzhou, Peoples R China	Zhengzhou University	Shao, FM (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Nephrol, Zhengzhou, Peoples R China.	shaofengmin98@sina.com		Shao, Fengmin/0000-0003-2905-4312				Bai JX, 2001, BIOL SIGNAL RECEPT, V10, P189; Cetin R, 2006, J APPL TOXICOL, V26, P42, DOI 10.1002/jat.1103; Chen T, 2016, PHARM BIOL, V54, P1793, DOI 10.3109/13880209.2015.1127980; Chen YZ, 2014, ANTI-CANCER DRUG, V25, P983, DOI 10.1097/CAD.0000000000000127; Eichholtz-Wirth H, 2000, APOPTOSIS, V5, P255, DOI 10.1023/A:1009656513307; Erstad DJ, 2013, SURG ONCOL CLIN N AM, V22, P705, DOI 10.1016/j.soc.2013.06.011; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Hagar H, 2015, EXP TOXICOL PATHOL, V67, P133, DOI 10.1016/j.etp.2014.11.001; Hermenean A, 2013, CHEM-BIOL INTERACT, V205, P138, DOI 10.1016/j.cbi.2013.06.016; Hu WZ, 2011, PHARMACOL REP, V63, P781, DOI 10.1016/S1734-1140(11)70590-4; Jariyawat S, 2009, J NAT MED-TOKYO, V63, P430, DOI 10.1007/s11418-009-0345-5; Jiang L, 2012, INTERN MED J, V42, P1297, DOI 10.1111/j.1445-5994.2012.02821.x; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kandemir FM, 2015, RENAL FAILURE, V37, P518, DOI 10.3109/0886022X.2015.1006100; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuper C, 2012, AM J PHYSIOL-RENAL, V302, pF38, DOI 10.1152/ajprenal.00590.2010; Li GM, 2002, LAB INVEST, V82, P585, DOI 10.1038/labinvest.3780453; Lin L, 2015, CELL BIOCHEM BIOPHYS, V71, P535, DOI 10.1007/s12013-014-0231-y; Liu CM, 2012, TOXICOL APPL PHARM, V258, P330, DOI 10.1016/j.taap.2011.11.015; Liu G, 2014, HUM EXP TOXICOL, V33, P1071, DOI 10.1177/0960327114521048; Liu H, 2003, KIDNEY INT, V63, P1687, DOI 10.1046/j.1523-1755.2003.00908.x; Liu XJ, 2013, NEURAL REGEN RES, V8, P3203, DOI 10.3969/j.issn.1673-5374.2013.34.004; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Oh GS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4048390; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Park BH, 2016, ONCOTARGET, V7, P63870, DOI 10.18632/oncotarget.11563; Petrelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083022; Ramesh G, 2004, KIDNEY INT, V65, P490, DOI 10.1111/j.1523-1755.2004.00413.x; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ramesh G, 2007, AM J PHYSIOL-RENAL, V292, pF812, DOI 10.1152/ajprenal.00277.2006; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2014, TOXICOL APPL PHARM, V277, P8, DOI 10.1016/j.taap.2014.02.022; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sanatani MS, 2013, CASE REP ONCOL MED, V2013, DOI 10.1155/2013/594787; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Song X, 2016, J AM COLL NUTR, P1; Sultana S, 2012, J PHARM PHARMACOL, V64, P872, DOI 10.1111/j.2042-7158.2012.01470.x; Tarang S, 2007, INT IMMUNOL, V19, P635, DOI 10.1093/intimm/dxm029; Topcu-Tarladacalisir Y, 2016, REN FAIL, P1; Ugur S, 2015, RENAL FAILURE, V37, P332, DOI 10.3109/0886022X.2014.986005; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; Wang CY, 2014, AM J CHINESE MED, V42, P543, DOI 10.1142/S0192415X14500359; Wang L, 2013, HUM EXP TOXICOL, V32, P172, DOI 10.1177/0960327112462729; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wang YC, 2013, INT J PHARMACEUT, V441, P728, DOI 10.1016/j.ijpharm.2012.10.021; Wangpaichitr M, 2012, MOL CANCER THER, V11, P604, DOI 10.1158/1535-7163.MCT-11-0599; Yuan Y, 2016, EXP THER MED, V11, P415, DOI 10.3892/etm.2015.2910; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982; Zhang GY, 2012, INT J GYNECOL CANCER, V22, P1220, DOI 10.1097/IGC.0b013e3182643b7c; Zhang WG, 2014, MOL MED REP, V10, P2752, DOI 10.3892/mmr.2014.2512; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083	54	47	47	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171612	10.1371/journal.pone.0171612	http://dx.doi.org/10.1371/journal.pone.0171612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182789	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800078
J	Zeiss, CJ; Allore, HG; Beck, AP				Zeiss, Caroline J.; Allore, Heather G.; Beck, Amanda P.			Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; CLINICAL-TRIALS; MODELS; NEUROPROTECTION; MOUSE; REPRODUCIBILITY; DISCONNECT; EFFICACY; LESSONS	Translation of disease-modifying therapies in neurodegenerative disease has been disappointing. Parkinson's disease (PD) was used to compare patterns of preclinical study design for symptomatic and potentially disease-modifying interventions. We examined the relationship of model, intervention type and timing, outcomes and outcome measures in 543 animal and human studies (1973-2015) across a contemporary cohort of animal and human interventional studies (n = 445), animal studies for approved interventions (n = 28), animal and human studies for those that failed to translate (n = 70). Detailed study design data were collected for 216 studies in non-human primate (NHP) and rodent toxin-induced models. Species-specific patterns of study design prevailed regardless of whether interventions were symptomatic or potentially disease-modifying. In humans and NHPs, interventions were typically given to both sexes well after the PD phenotype was established, and clinical outcome measures were collected at single (symptomatic) or multiple (disease-modifying) time-points. In rodents, interventions often preceded induction of the model, acute toxic protocols were common, usually given to young males, clinical outcome measures were used less commonly, and outcomes were less commonly assessed at multiple time points. These patterns were more prevalent in mice than rats. In contrast, study design factors such as randomization and blinding did not differ appreciably across symptomatic and disease-modifying intervention categories. The translational gap for potentially disease-modifying interventions in PD in part results from study designs, particularly in mice, that fail to model the progressive nature and relatively late intervention characteristic of PD, or that anchor mechanistic and neuropathologic data to longitudinal clinical outcomes. Even if measures to improve reproducibility are broadly adopted, perpetuation of these norms will continue to impede effective translation.	[Zeiss, Caroline J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Allore, Heather G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Allore, Heather G.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Beck, Amanda P.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yale University; Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine	Zeiss, CJ (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA.	caroline.zeiss@yale.edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110; Allore, Heather/0000-0001-7685-8175	US Department of Energy (DoE); NLM; NIH/NIA [P50 AG047270]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047270] Funding Source: NIH RePORTER	US Department of Energy (DoE)(United States Department of Energy (DOE)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by an appointment (CJZ) to the NLM Research Participation Program, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the US Department of Energy (DoE) and the NLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author (CJZ) had full access to all the data in the study and had final responsibility for the decision to submit for publication. This research is in part supported by NIH/NIA (Yale Alzheimers Disease Research Center, Data Management and Statistics Core P50 AG047270 (HGA)). There are no financial conflicts of interest to disclose.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; Anderson DW, 2006, EUR J NEUROSCI, V24, P3174, DOI 10.1111/j.1460-9568.2006.05192.x; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bailoo JD, 2014, ILAR J, V55, P383, DOI 10.1093/ilar/ilu037; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Bury A, 2013, NEUROSCI BIOBEHAV R, V37, P846, DOI 10.1016/j.neubiorev.2013.03.007; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cenci MA, 2007, TRENDS NEUROSCI, V30, P236, DOI 10.1016/j.tins.2007.03.005; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Fay MP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004073; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Festing Michael F W, 2002, ILAR J, V43, P191; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Goetz CG, 2008, MOVEMENT DISORD, V23, P2398, DOI 10.1002/mds.22341; Goldberg NRS, 2011, NEUROSCIENCE, V180, P256, DOI 10.1016/j.neuroscience.2011.02.027; Goldberg NRS, 2011, J NEUROSCI RES, V89, P1698, DOI 10.1002/jnr.22699; Gronvalli GK, 2007, NAT BIOTECHNOL, V25, P1084, DOI 10.1038/nbt1007-1084; Guzzi G, 2016, J NEUROSURG SCI, V60, P181; Hauser RA, 2015, JAMA NEUROL, V72, P1491, DOI 10.1001/jamaneurol.2015.2268; Ikeda K, 2002, J NEUROCHEM, V80, P262, DOI 10.1046/j.0022-3042.2001.00694.x; Ioannidis JPA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004631; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Janusonis S, 2009, J NEUROSCI METH, V179, P173, DOI 10.1016/j.jneumeth.2009.01.017; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kelly MJ, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.6; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kimmelman J, 2009, MOVEMENT DISORD, V24, P1893, DOI 10.1002/mds.22712; Kong QM, 2012, CNS NEUROSCI THER, V18, P791, DOI 10.1111/j.1755-5949.2012.00358.x; Kordower JH, 2016, METHODS MOL BIOL, V1382, P485, DOI 10.1007/978-1-4939-3271-9_32; LIMOUSIN P, 1995, MOVEMENT DISORD, V10, P672, DOI 10.1002/mds.870100523; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Lindholm D, 2016, CELL MOL LIFE SCI, V73, P1365, DOI 10.1007/s00018-015-2101-1; Lohe M, 2010, J NEUROL SCI, V289, P104, DOI 10.1016/j.jns.2009.08.025; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Giraldez-Perez RM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0176-9; Meissner W, 2003, MOL NEUROBIOL, V28, P209, DOI 10.1385/MN:28:3:209; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Moja L, 2014, EUR J CLIN INVEST; Munoz-Manchado AB, 2015, J NEUROCHEM; Novack GD, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.6.1; Olanow CW, 2015, MOVEMENT DISORD, V30, P1715, DOI 10.1002/mds.26426; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Potts LF, 2014, EXP NEUROL, V256, P133, DOI 10.1016/j.expneurol.2013.09.014; Pusztai L, 2013, NAT REV CLIN ONCOL, V10, P720, DOI 10.1038/nrclinonc.2013.171; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Snoy PJ, 2010, VET PATHOL, V47, P774, DOI 10.1177/0300985810372506; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Van Kampen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139694; Vesterinen HV, 2011, J CEREBR BLOOD F MET, V31, P1064, DOI 10.1038/jcbfm.2010.217; Zeiss CJ, 2015, DRUG DISCOV TODAY, V20, P475, DOI 10.1016/j.drudis.2014.10.015	68	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171790	10.1371/journal.pone.0171790	http://dx.doi.org/10.1371/journal.pone.0171790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182759	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800113
J	Bartolino, V; Tian, HD; Bergstrom, U; Jounela, P; Aro, E; Dieterich, C; Meier, HEM; Cardinale, M; Bland, B; Casini, M				Bartolino, Valerio; Tian, Huidong; Bergstrom, Ulf; Jounela, Pekka; Aro, Eero; Dieterich, Christian; Meier, H. E. Markus; Cardinale, Massimiliano; Bland, Barbara; Casini, Michele			Spatio-temporal dynamics of a fish predator: Density-dependent and hydrographic effects on Baltic Sea cod population	PLOS ONE			English	Article							GADUS-MORHUA; SPATIAL-DISTRIBUTION; HABITAT SELECTION; TROPHIC CASCADES; CLIMATE IMPACT; RECRUITMENT; ATLANTIC; SURVIVAL; MODEL; SCALE	Understanding the mechanisms of spatial population dynamics is crucial for the successful management of exploited species and ecosystems. However, the underlying mechanisms of spatial distribution are generally complex due to the concurrent forcing of both density-dependent species interactions and density-independent environmental factors. Despite the high economic value and central ecological importance of cod in the Baltic Sea, the drivers of its spatio-temporal population dynamics have not been analytically investigated so far. In this paper, we used an extensive trawl survey dataset in combination with environmental data to investigate the spatial dynamics of the distribution of the Eastern Baltic cod during the past three decades using Generalized Additive Models. The results showed that adult cod distribution was mainly affected by cod population size, and to a minor degree by small-scale hydrological factors and the extent of suitable reproductive areas. As population size decreases, the cod population concentrates to the southern part of the Baltic Sea, where the preferred more marine environment conditions are encountered. Using the fitted models, we predicted the Baltic cod distribution back to the 1970s and a temporal index of cod spatial occupation was developed. Our study will contribute to the management and conservation of this important resource and of the ecosystem where it occurs, by showing the forces shaping its spatial distribution and therefore the potential response of the population to future exploitation and environmental changes.	[Bartolino, Valerio; Tian, Huidong; Cardinale, Massimiliano; Bland, Barbara; Casini, Michele] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden; [Bergstrom, Ulf] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Oregrund, Sweden; [Jounela, Pekka] Nat Resources Inst Finland Luke, Turku, Finland; [Aro, Eero] Puolipaivankatu 4 A 6, Helsinki, Finland; [Dieterich, Christian; Meier, H. E. Markus] Swedish Meteorol & Hydrol Inst, Res Dept, Norrkoping, Sweden; [Meier, H. E. Markus] Leibniz Inst Baltic Sea Res Warnemunde, Dept Phys Oceanog & Instrumentat, Rostock, Germany	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Natural Resources Institute Finland (Luke); Swedish Meteorological & Hydrological Institute; Leibniz Institut fur Ostseeforschung Warnemunde	Casini, M (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden.	michele.casini@slu.se	Dieterich, Christian/AAJ-8913-2020	Dieterich, Christian/0000-0001-7086-4881; Bartolino, Valerio/0000-0002-4506-4329; Meier, H. E. Markus/0000-0001-5855-4645; Bergstrom, Ulf/0000-0002-5478-0634; Casini, Michele/0000-0003-4910-5236	BONUS INSPIRE project - joint Baltic Sea research and development programme BONUS [185]; EU; Swedish Research Council Formas; PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; European Community [217246]; BONUS; Baltic Sea research and development program; Swedish Environmental Protection Agency [08/381]; Swedish Research Council	BONUS INSPIRE project - joint Baltic Sea research and development programme BONUS; EU(European Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; European Community(European Commission); BONUS; Baltic Sea research and development program; Swedish Environmental Protection Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financed by the BONUS INSPIRE project supported by the joint Baltic Sea research and development programme BONUS (Art 185), funded jointly by the EU and the Swedish Research Council Formas. This study was also funded by the PLAN FISH project funded by the Swedish Environmental Protection Agency and the Swedish Agency for Marine and Water Management (formerly the Swedish Board of Fisheries). The high-resolution, three-dimensional model simulation was performed within the project ECOSUPPORT (Advanced modeling tool for scenarios of the Baltic Sea ECOsystem to SUPPORT decision making) funded by the European Community's Seventh Framework Program (FP/2007-2013) under grant agreement no. 217246 made with BONUS, the joint Baltic Sea research and development program, and by the Swedish Environmental Protection Agency (08/381). Additional support came from the Swedish Research Council Formas within the project Impact of accelerated future global mean sea level rise on the phosphorus cycle in the Baltic Sea.; This work was financed by the BONUS INSPIRE project supported by the joint Baltic Sea research and development programme BONUS (Art 185), funded jointly by the EU and the Swedish Research Council Formas. This study was also funded by the PLAN FISH project funded by the Swedish Environmental Protection Agency and the Swedish Agency for Marine and Water Management (formerly the Swedish Board of Fisheries). The high-resolution, three-dimensional model simulation was performed within the project ECOSUPPORT (Advanced modeling tool for scenarios of the Baltic Sea ECOsystem to SUPPORT decision making) funded by the European Community's Seventh Framework Program (FP/2007-2013) under grant agreement no. 217246 made with BONUS, the joint Baltic Sea research and development program, and by the Swedish Environmental Protection Agency (08/381). Additional support came from the Swedish Research Council Formas within the project "Impact of accelerated future global mean sea level rise on the phosphorus cycle in the Baltic Sea".	Anderson JT, 2000, ICES J MAR SCI, V57, P349, DOI 10.1006/jmsc.1999.0530; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bacheler NM, 2009, MAR ECOL PROG SER, V391, P1, DOI 10.3354/meps08259; Balbontin J, 2008, OIKOS, V117, P1111, DOI 10.1111/j.0030-1299.2008.16232.x; Barange M, 2009, PROG OCEANOGR, V83, P251, DOI 10.1016/j.pocean.2009.07.027; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bartolino V, 2012, MAR ECOL PROG SER, V444, P251, DOI 10.3354/meps09434; Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; Bergstrom U, 2015, ESTUAR COAST SHELF S, V163, P134, DOI 10.1016/j.ecss.2015.06.017; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cardinale M, 2000, CAN J FISH AQUAT SCI, V57, P2402, DOI 10.1139/cjfas-57-12-2402; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Dingsor GE, 2007, ECOLOGY, V88, P625, DOI 10.1890/05-1782; Eero M, 2015, ICES J MAR SCI, V72, P2180, DOI 10.1093/icesjms/fsv109; Eero M, 2011, ECOL APPL, V21, P214, DOI 10.1890/09-1879.1; Eilola K, 2009, J MARINE SYST, V75, P163, DOI 10.1016/j.jmarsys.2008.08.009; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Folmer EO, 2010, J ANIM ECOL, V79, P747, DOI 10.1111/j.1365-2656.2010.01680.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fromentin JM, 2001, ECOLOGY, V82, P567, DOI 10.1890/0012-9658(2001)082[0567:EODDAS]2.0.CO;2; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hansson M., 2013, 49 SWED MET HYDR I; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Haugen TO, 2007, ECOL MONOGR, V77, P483, DOI 10.1890/06-0163.1; Hines AH, 2009, MAR ECOL PROG SER, V385, P127, DOI 10.3354/meps08055; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Humphries AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028339; ICES, 2013, BALT FISH ASS WORK G; ICES, 2014, BALT INT FISH SURV W; ICES, 2013, STUD GROUP SPAT AN B, P2013; ICES. Report of the Baltic Fisheries Assessment Working Group (WGBFAS), 2015, BALT FISH ASS WORK G; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kendall MS, 2008, T AM FISH SOC, V137, P1134, DOI 10.1577/T07-210.1; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Lewin WC, 2010, ECOL INDIC, V10, P572, DOI 10.1016/j.ecolind.2009.09.006; Lindegren M, 2011, ECOLOGY, V92, P1407, DOI 10.1890/10-2229.1; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; MacKenzie BR, 2000, MAR ECOL PROG SER, V193, P143, DOI 10.3354/meps193143; Margonski P, 2010, PROG OCEANOGR, V87, P277, DOI 10.1016/j.pocean.2010.08.003; Marshall CT, 1999, CAN J FISH AQUAT SCI, V56, P347, DOI 10.1139/cjfas-56-3-347; Meier HEM, 2012, CLIM DYNAM, V39, P2421, DOI 10.1007/s00382-012-1339-7; Meier HEM, 2007, ESTUAR COAST SHELF S, V74, P610, DOI 10.1016/j.ecss.2007.05.019; Meier HEM, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000521; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; MORRIS DW, 1994, EVOL ECOL, V8, P387, DOI 10.1007/BF01238190; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Schaber M, 2012, FISH OCEANOGR, V21, P33, DOI 10.1111/j.1365-2419.2011.00607.x; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Slotte A, 1999, SARSIA, V84, P111, DOI 10.1080/00364827.1999.10420439; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Stelzenmuller V, 2008, ICES J MAR SCI, V65, P1081, DOI 10.1093/icesjms/fsn073; Stige LC, 2006, MAR ECOL PROG SER, V325, P227, DOI 10.3354/meps325227; Swain DP, 1999, FISH OCEANOGR, V8, P1, DOI 10.1046/j.1365-2419.1999.00090.x; Tamdrari H, 2010, ICES J MAR SCI, V67, P1676, DOI 10.1093/icesjms/fsq108; Tomkiewicz J, 1998, FISH OCEANOGR, V7, P48, DOI 10.1046/j.1365-2419.1998.00051.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	71	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172004	10.1371/journal.pone.0172004	http://dx.doi.org/10.1371/journal.pone.0172004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207804	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500071
J	Alessandretti, L; Sapiezynski, P; Lehmann, S; Baronchelli, A				Alessandretti, Laura; Sapiezynski, Piotr; Lehmann, Sune; Baronchelli, Andrea			Multi-scale spatio-temporal analysis of human mobility	PLOS ONE			English	Article							BEHAVIOR; PATTERNS; MODEL	The recent availability of digital traces generated by phone calls and online logins has significantly increased the scientific understanding of human mobility. Until now, however, limited data resolution and coverage have hindered a coherent description of human displacements across different spatial and temporal scales. Here, we characterise mobility behaviour across several orders of magnitude by analysing similar to 850 individuals' digital traces sampled every similar to 16 seconds for 25 months with similar to 10 meters spatial resolution. We show that the distributions of distances and waiting times between consecutive locations are best described by log-normal and gamma distributions, respectively, and that natural time-scales emerge from the regularity of human mobility. We point out that log-normal distributions also characterise the patterns of discovery of new places, implying that they are not a simple consequence of the routine of modern life.	[Alessandretti, Laura; Baronchelli, Andrea] City Univ London, London EC1V 0HB, England; [Sapiezynski, Piotr; Lehmann, Sune] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen O, Denmark	City University London; Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Baronchelli, A (corresponding author), City Univ London, London EC1V 0HB, England.	Andrea.Baronchelli.1@city.ac.uk	Baronchelli, Andrea/F-9550-2016	Baronchelli, Andrea/0000-0002-0255-0829; Lehmann, Sune/0000-0001-6099-2345; Alessandretti, Laura/0000-0001-6003-1165	Villum Foundation; University of Copenhagen; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); University of Copenhagen; Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation, http://villumfoundation.dk/C12576AB0041F11B/0/4F7615B6F43A8EA5C1257AEF003D9930?OpenDocument, Young Investigator programme 2012, High Resolution Networks (SL) and University of Copenhagen, http://dsin.ku.dk/news/ucph_funds/, through the UCPH2016 Social Fabric grant (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cheng Zhiyuan, 2011, ICWSM, P81; Deville P, 2016, PROCEEDINGS OF THE N; Gallotti R, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0055-z; Gong L, 2016, CARTOGR GEOGR INF SC, V43, P103, DOI 10.1080/15230406.2015.1014424; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Hasan S, 2013, J STAT PHYS, V151, P304, DOI 10.1007/s10955-012-0645-0; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kivela M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052813; Krings G, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds4; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liu H, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60232-1; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Liu Y, 2012, J GEOGR SYST, V14, P463, DOI 10.1007/s10109-012-0166-z; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Mouri H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042124; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Paul T, 2016, LECT NOTES COMPUT SC, V9927, P145, DOI 10.1007/978-3-319-45738-3_10; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Poletto C, 2013, J THEOR BIOL, V338, P41, DOI 10.1016/j.jtbi.2013.08.032; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Raposo EP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434003; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Santos MC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061114; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; Van Mieghem P, 2011, EUR PHYS J B, V83, P251, DOI 10.1140/epjb/e2011-20124-0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang WJ, 2015, PHYSICA A, V420, P134, DOI 10.1016/j.physa.2014.10.085; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Yan X-Y., 2013, SCI REP-UK, P3; Yao CZ, 2016, TRANSPORT RES A-POL, V87, P51, DOI 10.1016/j.tra.2016.03.005; Zhao K, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P1136, DOI 10.1109/ICDMW.2015.176	57	42	42	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171686	10.1371/journal.pone.0171686	http://dx.doi.org/10.1371/journal.pone.0171686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199347	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000394424400043
J	Davies, B; Turner, KME; Leung, S; Yu, BN; Frolund, M; Benfield, T; Blanchard, J; Westh, H; Ward, H				Davies, Bethan; Turner, Katy M. E.; Leung, Stella; Yu, B. Nancy; Frolund, Maria; Benfield, Thomas; Blanchard, James; Westh, Henrik; Ward, Helen		Danish Chlamydia Study	Comparison of the population excess fraction of Chlamydia trachomatis infection on pelvic inflammatory disease at 12-months in the presence and absence of chlamydia testing and treatment: Systematic review and retrospective cohort analysis	PLOS ONE			English	Review							RISK	Background The impact of Chlamydia trachomatis (chlamydia) control on the incidence of pelvic inflammatory disease (PID) is theoretically limited by the proportion of PID caused by chlamydia. We estimate the population excess fraction (PEF) of treated chlamydia infection on PID at 12-months in settings with widespread chlamydia control (testing and treatment) and compare this to the estimated PEF of untreated chlamydia. Methods We used two large retrospective population-based cohorts of women of reproductive age from settings with widespread chlamydia control to calculate the PEF of treated chlamydia on PID at 12-months. We undertook a systematic review to identify further studies that reported the risk of PID in women who were tested for chlamydia (infected and uninfected). We used the same method to calculate the PEF in eligible studies then compared all estimates of PEF. Results The systematic review identified a single study, a randomised controlled trial of chlamydia screening (POPI-RCT). In the presence of testing and treatment <10% of PID at 12-months was attributable to treated (baseline) chlamydia infections (Manitoba: 8.86%(95%Cl 7.15-10.75); Denmark: 3.84%(3.26-4.45); screened-arm POPI-RCT: 0.99%(0.00-29.06)). In the absence of active chlamydia treatment 26.44%(11.57-46.32) of PID at 12-months was attributable to untreated (baseline) chlamydia infections (deferred-arm POPI-RCT). The PEFs suggest that eradicating baseline chlamydia infections could prevent 484 cases of PID at 12-months per 100,000 women in the untreated setting and 13-184 cases of PID per 100,000 tested women in the presence of testing and treatment. Conclusion Testing and treating chlamydia reduced the PEF of chlamydia on PID by 65% compared to the untreated setting. But in the presence of testing and treatment over 90% of PID could not be attributed to a baseline chlamydia infection. More information is needed about the aetiology of PID to develop effective strategies for improving the reproductive health of women.	[Davies, Bethan; Ward, Helen] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Turner, Katy M. E.] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Leung, Stella; Yu, B. Nancy; Blanchard, James] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Yu, B. Nancy] Manitoba Hlth Hlth Living & Seniors, Publ Hlth Branch, Epidemiol & Surveillance, Winnipeg, MB, Canada; [Frolund, Maria] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Benfield, Thomas] Hvidovre Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Benfield, Thomas; Westh, Henrik] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Westh, Henrik] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark	Imperial College London; University of Bristol; University of Manitoba; Statens Serum Institut; University of Copenhagen; University of Copenhagen; University of Copenhagen	Davies, B (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	bethan.davies06@imperial.ac.uk	Andersen, Berit/J-3402-2017; Turner, Katy/R-3853-2019; Ward, Helen/A-1836-2009	Andersen, Berit/0000-0003-4074-6504; Turner, Katy/0000-0002-8152-6017; Ward, Helen/0000-0001-8238-5036; Westh, Henrik/0000-0001-5681-647X; Davies, Bethan/0000-0002-6585-7641; Dessau, Ram/0000-0002-1497-6309; Benfield, Thomas/0000-0003-0698-9385; Blanchard, James/0000-0002-4701-590X	Medical Research Council Population Health Scientist Fellowship [G0902120]; National Institute of Health Research Post-Doctoral Fellowship [2009-02-055]; National Institute for Health Research (NIHR); Wellcome Trust [090285/Z/09/Z]; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London, UK; Frederiksberg Kommune, Frederiksberg, Denmark; Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project Health Information Privacy Committee (HIPC) [2010/2011-48]; Medical Research Council [G0902120] Funding Source: researchfish; MRC [G0902120] Funding Source: UKRI	Medical Research Council Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Post-Doctoral Fellowship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London, UK; Frederiksberg Kommune, Frederiksberg, Denmark; Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project Health Information Privacy Committee (HIPC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BD was funded by an Medical Research Council Population Health Scientist Fellowship (G0902120); KT was funded by a National Institute of Health Research Post-Doctoral Fellowship 2009-02-055 (Jan 2009 - Dec 2014). This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. (Note only KT received direct funding during the preparation of this paper). The Wellcome Trust (090285/Z/09/Z) funded H. Ward and the development and analysis of the MWSRH cohort; BD and HW received funding from the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London, UK; Unrestricted partial funding for the Danish Chlamydia Study was received from Frederiksberg Kommune, Frederiksberg, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Manitoba Health Healthy Living and Seniors (MHHLS) for allowing us to access their administrative data, Public Health Surveillance data, and Cadham Provincial Laboratory (CPL) data. We acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project Health Information Privacy Committee (HIPC) 2010/2011-48. The results and conclusions are those of the authors, and no official endorsement by the Manitoba Centre for Health Policy, MHHLS, or other data providers is intended or should be inferred.	Davies B, 2016, LANCET INFECT DIS, V16, P1057, DOI 10.1016/S1473-3099(16)30092-5; Davies B, 2014, J INFECT DIS, V210, pS549, DOI 10.1093/infdis/jiu483; European Centre for Disease Prevention and Control, 2014, CHLAM CONTR EUR LIT; Gottlieb SL, 2013, SEX TRANSM DIS, V40, P97, DOI 10.1097/OLQ.0b013e31827bd637; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; Low N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010866.pub2; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Manitoba Centre for Health Policy, 2012, MAN HLTH INS REG OV; Oakeshott P, 2010, BMJ, V340; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Price MJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20220; Public Health England, 2015, SEX TRANSM INF STIS; Public Health England, 2015, 22 PUBL HLTH ENGL; Reekie J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094361; van Bergen J, 2006, DRUG TODAY, V42, P25	16	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171551	10.1371/journal.pone.0171551	http://dx.doi.org/10.1371/journal.pone.0171551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199392	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400034
J	Quyen, LTN; Nguyen, LH; Tran, BX; Huong, TTP; Le, HT; Nguyen, HD; Tran, TD; Do, CD; Nguyen, CM; Vu, TMT; Latkin, C; Zhang, MWB; Ho, RCM				Quyen Le Thi Nguyen; Long Hoang Nguyen; Bach Xuan Tran; Huong Thi Thu Phan; Huong Thi Le; Hinh Duc Nguyen; Tho Dinh Tran; Cuong Duy Do; Cuong Manh Nguyen; Vu Thi Minh Thuc; Latkin, Carl; Zhang, Melvyn W. B.; Ho, Roger C. M.			Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ATTITUDES; HIV; COHORT; RISK	Background Viral load testing is considered the gold standard for monitoring HIV treatment; however, given its high cost, some patients cannot afford viral load testing if this testing is not subsidized. Since foreign aid for HIV/AIDS in Vietnam is rapidly decreasing, we sought to assess willingness to pay (WTP) for viral load and CD4 cell count tests among HIV-positive patients, and identified factors that might inform future co-payment schemes. Methods A multi-site cross-sectional survey was conducted with 1133 HIV-positive patients on antiretroviral therapy (ART) in Hanoi and Nam Dinh. Patients' health insurance coverage, quality of life, and history of illicit drug use were assessed. A contingent valuation approach was employed to measure patients' WTP for CD4 cell count and viral load testing. Results HIV-positive patients receiving ART at provincial sites reported more difficulty obtaining health insurance (HI) and had the overall the poorest quality of life. Most patients (90.9%) were willing to pay for CD4 cell count testing; here, the mean WTP was valued at US$8.2 (95% CI = 7.6-8.8 US$) per test. Most patients (87.3%) were also willing to pay for viral load testing; here, mean WTP was valued at US$18.6 (95% CI = 16.3-20.9 US$) per test. High income, high education level, and hospitalization were positively associated with WTP, while co-morbidity with psychiatric symptoms and trouble paying for health insurance were both negatively related to WTP. Conclusions These findings raise concerns that HIV-positive patients in Vietnam might have low WTP for CD4 cell count and viral load testing. This means that without foreign financial subsidies, many of these patients would likely go without these important tests. Treating psychiatric co-morbidities, promoting healthcare services utilization, and removing barriers to accessing health insurance may increase WTP for monitoring of HIV/AIDS treatment among HIV+-positive Vietnamese patients.	[Quyen Le Thi Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Bach Xuan Tran; Huong Thi Le; Hinh Duc Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Vu Thi Minh Thuc] Natl Otolaryngol Hosp, Dept Immunol & Allergy, Hanoi, Vietnam; [Huong Thi Thu Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tho Dinh Tran] Viet Duc Hosp, Dept Hepatobiliary Surg, Hanoi, Vietnam; [Cuong Duy Do] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Cuong Manh Nguyen] Minist Hlth, Dept Int Affairs, Hanoi, Vietnam; [Latkin, Carl] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Melvyn W. B.] Natl Univ Singapore, Biomed Global Inst Healthcare Res Technol BIGHEAR, Singapore, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore	Duy Tan University; Vietnam National University Hanoi; Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore; National University of Singapore	Quyen, LTN (corresponding author), Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.	quyen.ighi@gmail.com	Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; 				Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Bach TX, 2011, BUDGET IMPACT SCALIN; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Bank TW, 2014, GDP PER CAP CURR US; Cawley J, 2008, ECON HUM BIOL, V6, P281, DOI 10.1016/j.ehb.2008.05.003; CCRD, 2013, SUST FIN HIV AIDS SE; Control VAoHA, 2015, ANN REV HIV AIDS CON; Corso PS, 2013, INT J ENV RES PUB HE, V10, P1342, DOI 10.3390/ijerph10041342; Cross MJ, 2000, RHEUMATOLOGY, V39, P1242, DOI 10.1093/rheumatology/39.11.1242; Development FEAS, 2000, APPL CONT VAL METH D; EuroQol Research, 2015, EQ 5D 5L USER GUIDE; FAUCI AS, 1984, ANN INTERN MED, V100, P92, DOI 10.7326/0003-4819-100-1-92; [FHI360 PEPFAR USAID Committee HCMCPA], 2014, OPP EXP HIV TREATM P; [Finance Mo Health Mo], 2015, 372015TTLTBYTBTC HLT; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Frontieres MB, 2012, UNDETECTABLE VIRAL L; Frontieres MS, 2013, HIV STAT UND 4 ESS I; Gale HB, 2013, CLIN INFECT DIS, V5, P1340, DOI [10.1093/CID/CI004, DOI 10.1093/CID/CI004]; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; Health  V. M. o, 2014, OPT VIET NAMS HIV RE; Health VMo, 2015, 152015TTBYT HLTH VMO; Herriges JA, 1996, J ENVIRON ECON MANAG, V30, P112, DOI 10.1006/jeem.1996.0008; HIV/AIDS JUNPo, 2016, NEED ROUT VIR LOAD T; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jorgensen BS, 1999, ENVIRON RESOUR ECON, V14, P131, DOI 10.1023/A:1008372522243; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Lang HC, 2010, VALUE HEALTH, V13, P743, DOI 10.1111/j.1524-4733.2010.00743.x; Nguyen LH, 2016, AIDS BEHAV, V20, P848, DOI 10.1007/s10461-015-1188-6; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Organization WH, 2010, ANT THER HIV INF AD; Organization WH, 2015, GUID START ANT THER; Organization WH, 2014, GLOB UPD HLTH SECT R; Organization WH, 2013, CONS GUID US ANT DRU, P272; Organization WH, 2014, MARCH 2014 S 2013 CO; PHILLIPS AN, 1991, LANCET, V337, P389; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Rosenberger RS, 2012, J FOREST ECON, V18, P271, DOI 10.1016/j.jfe.2012.06.003; SAAH AJ, 1994, J ACQ IMMUN DEF SYND, V7, P287; Ternent L, 2010, EXPLORING BIASES DOU; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Tran BX, 2016, PLOS ONE, V11; Tran BX, 2016, INT J DRUG POLICY	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172050	10.1371/journal.pone.0172050	http://dx.doi.org/10.1371/journal.pone.0172050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199405	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424400069
J	Judah, G; Huberts, JD; Drassal, A; Aunger, R				Judah, Gaby; Huberts, Jessie de Witt; Drassal, Allan; Aunger, Robert			The development and validation of a Real Time Location System to reliably monitor everyday activities in natural contexts	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY RECOGNITION; DIETARY RESTRAINT; HYGIENE BEHAVIORS; HABIT FORMATION; SMART HOMES; QUESTIONNAIRES; TECHNOLOGY; VALIDITY; ADULTS	Introduction The accurate measurement of behaviour is vitally important to many disciplines and practitioners of various kinds. While different methods have been used (such as observation, diaries, questionnaire), none are able to accurately monitor behaviour over the long term in the natural context of people's own lives. The aim of this work was therefore to develop and test a reliable system for unobtrusively monitoring various behaviours of multiple individuals within the same household over a period of several months. Methods A commercial Real Time Location System was adapted to meet these requirements and subsequently validated in three households by monitoring various bathroom behaviours. Results The results indicate that the system is robust, can monitor behaviours over the long-term in different households and can reliably distinguish between individuals. Precision rates were high and consistent. Recall rates were less consistent across households and behaviours, although recall rates improved considerably with practice at set-up of the system. The achieved precision and recall rates were comparable to the rates observed in more controlled environments using more valid methods of ground truthing. Conclusion These initial findings indicate that the system is a valuable, flexible and robust system for monitoring behaviour in its natural environment that would allow new research questions to be addressed.	[Judah, Gaby; Huberts, Jessie de Witt; Aunger, Robert] London Sch Hyg & Trop Med, Environm Hlth Grp, London, England; [Drassal, Allan] Washington State Univ, Ctr Adv Studies Adapt Syst, Pullman, WA 99164 USA; [Judah, Gaby] Imperial Coll, Ctr Hlth Policy, London, England; [Huberts, Jessie de Witt] Univ Potsdam, Dept Sport & Hlth Sci, Potsdam, Germany	University of London; London School of Hygiene & Tropical Medicine; Washington State University; Imperial College London; University of Potsdam	Huberts, JD (corresponding author), London Sch Hyg & Trop Med, Environm Hlth Grp, London, England.; Huberts, JD (corresponding author), Univ Potsdam, Dept Sport & Hlth Sci, Potsdam, Germany.	witthub@uni-potsdam.de			commercial source, Unilever (PLC)	commercial source, Unilever (PLC)	This study was funded by a commercial source, Unilever (PLC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta FJ, 2013, SCHIZOPHR RES, V146, P196, DOI 10.1016/j.schres.2013.02.016; Altini M., 2012, WIRELESS HLTH, P12; Aunger R, 2007, INT DENT J, V57, P364; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Brandberg Y, 1997, MELANOMA RES, V7, P347, DOI 10.1097/00008390-199708000-00011; Buettner M, 2009, UBICOMP'09: PROCEEDINGS OF THE 11TH ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P51; Cardinaux F, 2011, J AMB INTEL SMART EN, V3, P253, DOI 10.3233/AIS-2011-0110; Chen JF, 2005, LECT NOTES COMPUT SC, V3468, P47, DOI 10.1385/1-59259-820-x:047; Clasen T, 2012, ENVIRON SCI TECHNOL, V46, P3295, DOI 10.1021/es2036702; Cone J. D., 1999, HDB RES METHODS CLIN, P183; Cook D. J., 2013, CASAS SMART HOME BOX; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Ding D, 2011, MATURITAS, V69, P131, DOI 10.1016/j.maturitas.2011.03.016; Dombrowski SU, 2012, HEALTH PSYCHOL REV, V6, P7, DOI 10.1080/17437199.2010.513298; Haas JP, 2007, J HOSP INFECT, V66, P6, DOI 10.1016/j.jhin.2006.11.013; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Helaoui R, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P345, DOI 10.1145/2493432.2493501; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Huynh T, 2007, LECT NOTES COMPUT SC, V4718, P50, DOI 10.1007/978-3-540-75160-1_4; Judah G. D., 2015, THESIS; Judah G, 2013, BRIT J HEALTH PSYCH, V18, P338, DOI 10.1111/j.2044-8287.2012.02086.x; Khan AR, 2010, FIXED POINT THEORY A, DOI 10.1155/2010/385986; KLESGES RC, 1992, J ABNORM PSYCHOL, V101, P668, DOI 10.1037/0021-843X.101.4.668; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Llor C, 2013, INT J INFECT DIS, V17, pE168, DOI 10.1016/j.ijid.2012.09.012; Logan B, 2007, LECT NOTES COMPUT SC, V4717, P483; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; NALBONE DP, 2005, INDIVIDUAL DIFFERENC, V3, P171; Ni Q, 2015, SENSORS-BASEL, V15, P11312, DOI 10.3390/s150511312; Philipose M., 2005, BRIDGE NATL ACAD ENG, V35; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rashidi P, 2011, IEEE T KNOWL DATA EN, V23, P527, DOI 10.1109/TKDE.2010.148; Rose E, 2009, ARCH PEDIAT ADOL MED, V163, P61, DOI 10.1001/archpediatrics.2008.509; Rumo M, 2011, PHYSIOL MEAS, V32, P1983, DOI 10.1088/0967-3334/32/12/008; Scott BE, 2008, HEALTH EDUC RES, V23, P392, DOI 10.1093/her/cym056; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Stice E, 2004, PSYCHOL ASSESSMENT, V16, P51, DOI 10.1037/1040-3590.16.1.51; Tobias R, 2009, PSYCHOL REV, V116, P408, DOI 10.1037/a0015512; van Kasteren TLM, 2010, J AMB INTEL SMART EN, V2, P311, DOI 10.3233/AIS-2010-0070; Wang L, 2010, IEEE INT CONF EMBED, P43, DOI 10.1109/RTCSA.2010.19; Ward JA, 2006, IEEE T PATTERN ANAL, V28, P1553, DOI 10.1109/TPAMI.2006.197; Wilson DH, 2005, LECT NOTES COMPUT SC, V3468, P62; Yang J., 2009, ACM INT WORKSH INT M, P1, DOI DOI 10.1145/1631040.1631042; Yu-Jin Hong, 2008, 2008 Second International Conference on Future Generation Communication and Networking (FGCN), P302, DOI 10.1109/FGCN.2008.165	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171610	10.1371/journal.pone.0171610	http://dx.doi.org/10.1371/journal.pone.0171610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196100	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000394423900024
J	De Groot, AS; Tounkara, K; Rochas, M; Beseme, S; Yekta, S; Diallo, FS; Tracy, JK; Teguete, I; Koita, OA				De Groot, Anne S.; Tounkara, Karamoko; Rochas, Mali; Beseme, Sarah; Yekta, Shahla; Diallo, Fanta Siby; Tracy, J. Kathleen; Teguete, Ibrahima; Koita, Ousmane A.			Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; RISK-FACTORS; PREVALENCE; DELIVERY; BARRIERS; AFRICA; WOMEN	Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.	[De Groot, Anne S.; Rochas, Mali; Beseme, Sarah; Yekta, Shahla] GAIA Vaccine Fdn, Providence, RI 02903 USA; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA; [Tounkara, Karamoko] Fdn GAIA, Bamako, Mali; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Publ Hlth, Baltimore, MD 21201 USA; [Teguete, Ibrahima] Hop Gabriel Toure, Bamako, Mali; [Koita, Ousmane A.] USTTB, Sci & Technol Fac FST, Lab Appl Mol Biol LBMA, Bamako, Mali	University of Rhode Island; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Science & Technology of Bamako	De Groot, AS (corresponding author), GAIA Vaccine Fdn, Providence, RI 02903 USA.; De Groot, AS (corresponding author), Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA.	dr.annie.degroot@gmail.com	De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); GAIA Vaccine Foundation; EpiVax, Inc.	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); GAIA Vaccine Foundation; EpiVax, Inc.	This study was supported in part by a research grant from the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MS&D). The opinions expressed in this paper are those of the authors and do not necessarily represent those of MS&D. MS&D had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Donors to GAIA Vaccine Foundation provided additional financial support for field site identification and logistics. EpiVax, Inc. provided funding in the form of salaries for author Anne S De Groot, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bruni L, 2014, 20140131 ICO INF CTR; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Curry DW, 2014, J HEALTH POPUL NUTR, V32, P356; De Groot A, 2008, VACCINE, V26, P3783, DOI 10.1016/j.vaccine.2008.04.088; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Herrmann C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1660-8; Katz IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072094; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Markovic M, 2005, SOC SCI MED, V61, P2528, DOI 10.1016/j.socscimed.2005.05.001; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munthali AC, 2015, PATIENT PREFER ADHER, V9, P501, DOI 10.2147/PPA.S69286; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Tagbo BN, 2014, VACCINE, V32, P6157, DOI 10.1016/j.vaccine.2014.08.053; Tracy JK, 2014, VACCINE, V32, P3316, DOI 10.1016/j.vaccine.2014.03.067; Tracy JK, 2011, TROP MED INT HEALTH, V16, P1432, DOI 10.1111/j.1365-3156.2011.02843.x; Tracy L, 2011, CLIN INFECT DIS, V52, P641, DOI 10.1093/cid/ciq190; Upadhyay UD, 2012, INT PERSPECT SEX R H, V38, P78, DOI 10.1363/3807812; Wong CA, 2011, VACCINE, V29, P878, DOI 10.1016/j.vaccine.2010.10.018; World Health Organization, 2013, COMPR CERV CANC PREV; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	25	20	20	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171631	10.1371/journal.pone.0171631	http://dx.doi.org/10.1371/journal.pone.0171631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192460	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800033
J	Fasterius, E; Raso, C; Kennedy, S; Rauch, N; Lundin, P; Kolch, W; Uhlen, M; Szigyarto, CA				Fasterius, Erik; Raso, Cinzia; Kennedy, Susan; Rauch, Nora; Lundin, Par; Kolch, Walter; Uhlen, Mathias; Szigyarto, Cristina Al-Khalili			A novel RNA sequencing data analysis method for cell line authentication	PLOS ONE			English	Article							COLON; CARCINOMA; CULTURE; IDENTIFICATION; CONTAMINATION; EXPRESSION; PROGRAM; GENOME; HCT-15; GROWTH	We have developed a novel analysis method that can interrogate the authenticity of biological samples used for generation of transcriptome profiles in public data repositories. The method uses RNA sequencing information to reveal mutations in expressed transcripts and subsequently confirms the identity of analysed cells by comparison with publicly available cell-specific mutational profiles. Cell lines constitute key model systems widely used within cancer research, but their identity needs to be confirmed in order to minimise the influence of cell contaminations and genetic drift on the analysis. Using both public and novel data, we demonstrate the use of RNA-sequencing data analysis for cell line authentication by examining the validity of COLO205, DLD1, HCT15, HCT116, HKE3, HT29 and RKO colorectal cancer cell lines. We successfully authenticate the studied cell lines and validate previous reports indicating that DLD1 and HCT15 are synonymous. We also show that the analysed HKE3 cells harbour an unexpected KRAS-G13D mutation and confirm that this cell line is a genuine KRAS dosage mutant, rather than a true isogenic derivative of HCT116 expressing only the wild type KRAS. This authentication method could be used to revisit the numerous cell line based RNA sequencing experiments available in public data repositories, analyse new experiments where whole genome sequencing is not available, as well as facilitate comparisons of data from different experiments, platforms and laboratories.	[Fasterius, Erik; Uhlen, Mathias; Szigyarto, Cristina Al-Khalili] Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Raso, Cinzia; Kennedy, Susan; Rauch, Nora; Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Lundin, Par] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Kolch, Walter] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Uhlen, Mathias] Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; University College Dublin; Stockholm University; University College Dublin; University College Dublin	Szigyarto, CA (corresponding author), Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	caks@kth.se	Uhlen, Mathias/AAV-8746-2021; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Al-Khalili Szigyarto, Cristina/0000-0001-6990-1905; Kennedy, Susan/0000-0002-5898-8993; Rauch, Nora/0000-0001-6009-5177; Fasterius, Erik/0000-0003-0492-9960	European Community [278568]; Science for Life Laboratory, the National Genomics Infrastructure, NGI; Uppmax	European Community(European Commission); Science for Life Laboratory, the National Genomics Infrastructure, NGI; Uppmax	This work was supported by the European Community 7'th Framework Program under grant agreement no. 278568 "PRIMES" (https://ec.europa.eu/research/fp7/index_en.cfrn).; We would like to thank Ola Soderberg (Uppsala University, Sweden) for providing the RKO cell line, and Senji Shirasawa (Fukuoka University, Tokyo) for the HCT116 and HKE3 cell lines used in this study. Additional thanks also go to Bjorn Hallstrom for valuable guidance at the beginning of the project, as well as to Olof Emanuelsson for fruitful discussions on data analysis (Science for Life Laboratory, Stockholm, Sweden). We also acknowledge support from Science for Life Laboratory, the National Genomics Infrastructure, NGI, and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure, as well as assistance from the UCD Conway Mass Spectrometry Core Facility. This work was supported by the European Community 7'th Framework Program under grant agreement no. 278568 "PRIMES".	Almeida JL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002476; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; BOYD D, 1988, CANCER RES, V48, P3112; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Capes-Davis A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002477; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; Cingolani P, 2011, FRONT GENET, V3, P35; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; FORGUELAFITTE ME, 1989, CANCER RES, V49, P6566; Freedman LP, 2015, NAT METHODS, V12, P493, DOI 10.1038/nmeth.3403; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; Liang-Chu MMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116218; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olarerin-George AO, 2015, NUCLEIC ACIDS RES, V43, P2535, DOI 10.1093/nar/gkv136; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SEMPLE TU, 1978, CANCER RES, V38, P1345; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Strong MJ, 2014, J VIROL, V88, P10696, DOI 10.1128/JVI.01457-14; TIBBETTS LM, 1977, CANCER, V40, P2651, DOI 10.1002/1097-0142(197711)40:5+<2651::AID-CNCR2820400939>3.0.CO;2-V; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Vermeulen SJ, 1998, CANCER GENET CYTOGEN, V107, P76, DOI 10.1016/S0165-4608(98)00081-8; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xu GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089445; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	40	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171435	10.1371/journal.pone.0171435	http://dx.doi.org/10.1371/journal.pone.0171435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192450	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800024
J	Bazin, M; Purohit, NK; Shah, GM				Bazin, Marc; Purohit, Nupur K.; Shah, Girish M.			Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method	PLOS ONE			English	Article							HAIRLESS MICE; TUMORS; CARCINOGENESIS; RADIATION; MECHANISM	The vernier caliper has been used as a gold standard to measure the length, width and height of skin tumors to calculate their total area and volume. It is a simple method for collecting data on a few tumors at a time, but becomes tedious, time-consuming and stressful for the animals and the operator when used for measuring multiple tumors in a large number of animals in protocols such as UVB-induced non-melanoma skin cancer (NMSC) in SKH-1 mice. Here, we show that photographic images of these mice taken within a few minutes under optimized conditions can be subjected to computerized analyses to determine tumor volume and area as accurately and precisely as the caliper method. Unlike the caliper method, the photographic method also records the incidence and multiplicity of tumors, thus permitting comprehensive measurement of tumor burden in the animal. The simplicity and ease of this method will permit more frequent monitoring of tumor burden in long protocols, resulting in the creation of additional data about dynamic changes in progression of cancer or the efficacy of therapeutic intervention. The photographic method can broadly substitute the caliper method for quantifying other skin pathologies.	[Bazin, Marc; Purohit, Nupur K.; Shah, Girish M.] Univ Laval, Lab Skin Canc Res, CHU Q CHUL, Quebec Univ Hosp,Res Ctr, Quebec City, PQ, Canada	Laval University	Shah, GM (corresponding author), Univ Laval, Lab Skin Canc Res, CHU Q CHUL, Quebec Univ Hosp,Res Ctr, Quebec City, PQ, Canada.	girish.shah@crchul.ulaval.ca		Shah, Girish/0000-0002-9291-1164	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05868, RGPAS-492875-2016]; Quebec Government; Shastri Indo-Canadian Institute; Neuroscience Axis of CR-CHU-Q	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Government; Shastri Indo-Canadian Institute; Neuroscience Axis of CR-CHU-Q	This work was supported by the grants to GMS from Natural Sciences and Engineering Research Council of Canada (Discovery Grants # RGPIN-2016-05868 and Discovery Accelerator Grant # RGPAS-492875-2016). NKP received a foreign student fee-waiver scholarship from Quebec Government and Shastri Indo-Canadian Institute. NKP was also a recipient of the graduate scholarships from the Neuroscience Axis of CR-CHU-Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; Chang Angela Christine, 2011, Eplasty, V11, pe18; Chilampalli C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-456; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Gilman Thomas, 2004, Int J Low Extrem Wounds, V3, P125; GRIFFIN JW, 1993, PHYS THER, V73, P117, DOI 10.1093/ptj/73.2.117; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Lou YR, 2011, CARCINOGENESIS, V32, P1078, DOI 10.1093/carcin/bgr074; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Sapi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142190; Singh A, 2015, J INVEST DERMATOL, V135, P1098, DOI 10.1038/jid.2014.460; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; Tsai KD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/593952; Vaid M, 2014, TOXICOL APPL PHARM, V274, P147, DOI 10.1016/j.taap.2013.10.030; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wysocki AB, 1996, INT J DERMATOL, V35, P82, DOI 10.1111/j.1365-4362.1996.tb03266.x	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171875	10.1371/journal.pone.0171875	http://dx.doi.org/10.1371/journal.pone.0171875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187193	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300056
J	Lam, VYY; Doropoulos, C; Mumby, PJ				Lam, Vivian Y. Y.; Doropoulos, Christopher; Mumby, Peter J.			The influence of resilience-based management on coral reef monitoring: A systematic review	PLOS ONE			English	Review							BAYESIAN BELIEF NETWORK; ECOSYSTEM-BASED MANAGEMENT; MULTIPLE STRESSORS; GLOBAL DISPARITY; LINKING THEORY; REGIME SHIFTS; INSIGHTS; CONSERVATION; RECOVERY	With rapid changes taking place on coral reefs, managers and scientists are faced with prioritising interventions that might avoid undesirable losses in ecosystem health. The property of resilience captures how reefs react and respond to stressors and environmental changes. Therefore, in principle, management goals are more likely to be realised if resilience theory is used to inform decision making and help set realistic expectations for reef outcomes. Indeed, a new approach to reef management has been termed 'resilience-based management' (RBM). Yet, resilience concepts have often been criticised for being vague, difficult to operationalise, and beset by multiple definitions. Here, we evaluate how the advent of RBM has changed one aspect of reef management: assessment and monitoring. We compare the metrics used in conventional monitoring programs with those developed through resilience assessments and find that the latter have a stronger focus on ecological processes and exposure to environmental drivers. In contrast, monitoring tends to focus on metrics of reef state and has greater taxonomic resolution, which provides comprehensive information on the nature of changes but does not predict the future responses of reefs in part because it is difficult to extrapolate statistical trends of complex ecological systems. In addition, metrics measured by resilience studies are more diverse, owing in part to the reliance of state metrics as proxies of processes given the difficulty in quantifying key ecological processes directly. We conclude by describing practical ways of improving resilience assessments, and avenues for future research.	[Lam, Vivian Y. Y.; Doropoulos, Christopher; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Doropoulos, Christopher] CSIRO Oceans & Atmosphere, Dutton Pk, Canberra, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lam, VYY (corresponding author), Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia.	vivian.lam@uq.edu.au	Mumby, Peter/F-9914-2010; Doropoulos, Christopher/B-7249-2016	Mumby, Peter/0000-0002-6297-9053; Doropoulos, Christopher/0000-0001-8038-2771; Lam, Vivian/0000-0003-0436-3629	Australian Research Council Linkage Grant; International Postgraduate Research Scholarship, Australian Government	Australian Research Council Linkage Grant(Australian Research Council); International Postgraduate Research Scholarship, Australian Government(Australian Government)	This work was supported by the Australian Research Council Linkage Grant, www.arc.gov.au PJM and International Postgraduate Research Scholarship, Australian Government, https://education.gov.au/intemational-postgraduate-research-scholarships: VYYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by an ARC Linkage grant and ARC Centre of Excellence for Coral Reef Science grant to PJM and an IPRS to VYYL.	Allen CR, 2011, WILDLIFE BIOL, V17, P337, DOI 10.2981/10-084; Anderies JM, 2006, ECOL SOC, V11; Angeler DG, 2016, J APPL ECOL, V53, P617, DOI 10.1111/1365-2664.12649; [Anonymous], 2005, EC HUM WELL BEING SY; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Ban SS, 2014, GLOBAL ENVIRON CHANG, V27, P64, DOI 10.1016/j.gloenvcha.2014.04.018; Bestelmeyer BT, 2012, RANGELAND ECOL MANAG, V65, P654, DOI 10.2111/REM-D-12-00072.1; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P359, DOI 10.2111/07-051.1; Bruckner AW, 2012, REV BIOL TROP, V60, P39; Carpenter SR, 2005, ECOSYSTEMS, V8, P941, DOI 10.1007/s10021-005-0170-y; Chapin F. S., 2009, PRINCIPLES ECOSYSTEM, DOI DOI 10.1007/978-0-387-73033-2; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cooper JK, 2015, ECOLOGY, V96, P1802, DOI 10.1890/14-0112.1; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; English S., 1997, SURVEY MANUAL TROPIC, V2; Floros C, CORAL REEFS, V2016, P1; Flower J, 2017, ECOL INDIC, V72, P848, DOI 10.1016/j.ecolind.2016.09.003; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Franco C, 2016, ENVIRON MODELL SOFTW, V80, P132, DOI 10.1016/j.envsoft.2016.02.029; Gilljam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9412; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Green A.L., 2009, MONITORING FUNCTIONA; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harborne AR, 2017, ANNU REV MAR SCI, V9, P445, DOI 10.1146/annurev-marine-010816-060551; Herrick Jeffrey E., 2006, Journal for Nature Conservation (Jena), V14, P161, DOI 10.1016/j.jnc.2006.05.001; Hill J., 2004, METHODS ECOLOGICAL M, DOI DOI 10.1017/CBO9781107415324.004; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Karr KA, 2015, J APPL ECOL, V52, P402, DOI 10.1111/1365-2664.12388; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kupschus S, 2016, J APPL ECOL, V53, P1236, DOI 10.1111/1365-2664.12648; Ladd MC, 2013, BIODIVERS CONSERV, V22, P1591, DOI 10.1007/s10531-013-0493-5; Lang J., 2003, ATOLL RES B, V496, P496; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; Mcleod E, 2013, FRONT ECOL ENVIRON, V11, P20, DOI 10.1890/110240; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2014, CONSERV LETT, V7, P176, DOI 10.1111/conl.12047; Mumby PJ, 2014, CURR OPIN ENV SUST, V7, P22, DOI 10.1016/j.cosust.2013.11.021; Mumby PJ, 2015, HIGH RESILIENCE MASK; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; NOAA Coral Program, 2014, NAT COR REEF MON PLA; Noss R. F., 1994, SAVING NATURES LEGAC; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Obura D, 2009, RESILIENCE ASSESSMEN; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; Quinlan AE, 2016, J APPL ECOL, V53, P677, DOI 10.1111/1365-2664.12550; Renken H, 2009, ECOL MODEL, V220, P1305, DOI 10.1016/j.ecolmodel.2009.02.022; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Siddig AAH, 2016, ECOL INDIC, V60, P223, DOI 10.1016/j.ecolind.2015.06.036; Standish RJ, 2014, BIOL CONSERV, V177, P43, DOI 10.1016/j.biocon.2014.06.008; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Walker B., 2006, RESILIENCE THINKING; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson CR, 1998, STATUS CORAL REEFS W; Williams SM, 2015, J BIOGEOGR, V42, P1327, DOI 10.1111/jbi.12509; Zychaluk K, 2012, ECOL LETT, V15, P151, DOI 10.1111/j.1461-0248.2011.01720.x	75	21	21	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172064	10.1371/journal.pone.0172064	http://dx.doi.org/10.1371/journal.pone.0172064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187165	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300076
J	Hahn, H; Kropp, P; Kirschstein, T; Rucker, G; Muller-Hilke, B				Hahn, Henry; Kropp, Peter; Kirschstein, Timo; Ruecker, Gernot; Mueller-Hilke, Brigitte			Test anxiety in medical school is unrelated to academic performance but correlates with an effort/reward imbalance	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; EMOTIONAL INTELLIGENCE; DEPRESSION; STRESS; STUDENTS; WORK; SUPPORT; QUESTIONNAIRE; HEALTH; RISK	Purpose During their early years at medical school, students repeatedly criticize their workload, time constraints and test associated stress. At the same time, depressiveness and anxiety among first and second year medical students are on the rise. We therefore hypothesized that test anxiety may be related to depressiveness and considered cognitive and academic performances as confounders for the former and psychosocial distress for the latter. Methods A whole class of 200 second year students was invited to participate in the study. Anxiety as a trait, depressiveness, crystallized intelligence, verbal fluency and psychosocial distress were assessed using validated tests and questionnaires. Acute state anxiety and sympathetic stress parameters were measured in real life situations immediately before an oral and a written exam and paired tests were used to compare the individual anxieties at the various time points. Previous academic performances were self-reported, the results of the impending exams were monitored. Finally, correlations were performed to test for interrelatedness between academic performances and the various personal, cognitive and psychosocial factors. Results Acute test anxiety did not correlate with depressiveness nor did it correlate with previous nor impending academic performances nor any of the expected confounders on academic performance. However both, depressiveness and test anxiety strongly correlated with the perceived imbalance between efforts spent and rewards received. Moreover, anxiety as a trait not only correlated with acute state anxiety before an exam but was also significantly correlated to the feeling of over-commitment. Conclusion Depressiveness during the early years of medical school seems unrelated to test anxiety and academic performance. Instead, it strongly correlated with the psychosocial distress emanating from attending medical school and points at a perceived imbalance between efforts spent and rewards received.	[Hahn, Henry] Univ Med Ctr Rostock, Inst Immunol, Rostock, Germany; [Kropp, Peter] Univ Med Ctr Rostock, Inst Med Psychol & Med Sociol, Rostock, Germany; [Kirschstein, Timo] Univ Med Ctr Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany; [Ruecker, Gernot] Univ Med Ctr Rostock, Clin Anesthesiol & Intens Care Med, Rostock, Germany; [Mueller-Hilke, Brigitte] Univ Med Ctr Rostock, Inst Immunol, Rostock, Germany; [Mueller-Hilke, Brigitte] Univ Med Ctr Rostock, Study Res Grp, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock	Muller-Hilke, B (corresponding author), Univ Med Ctr Rostock, Inst Immunol, Rostock, Germany.; Muller-Hilke, B (corresponding author), Univ Med Ctr Rostock, Study Res Grp, Rostock, Germany.	brigitte.mueller-hilke@med.uni-rostock.de	Kropp, Peter/B-8132-2012					Aktekin M, 2001, MED EDUC, V35, P12, DOI 10.1046/j.1365-2923.2001.00726.x; Albishri JA, 2012, SAUDI MED J, V33, P1222; Ali M, 2015, MED EDUC ONLINE, V20, DOI 10.3402/meo.v20.27706; ARNDT CB, 1986, MED EDUC, V20, P274, DOI 10.1111/j.1365-2923.1986.tb01366.x; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Chew BH, 2015, PSYCHOL HEALTH MED, V20, P198, DOI 10.1080/13548506.2014.913797; Dahlin M, 2005, MED EDUC, V39, P594, DOI 10.1111/j.1365-2929.2005.02176.x; DEPABLO J, 1990, ACAD MED, V65, P706, DOI 10.1097/00001888-199011000-00016; Dunleavy DM, 2013, ACAD MED, V88, P666, DOI 10.1097/ACM.0b013e3182864299; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Eysenck MW, 1989, AVOIDANCE ANXIETY PE; Furnham A, 2009, BRIT J EDUC PSYCHOL, V79, P769, DOI 10.1348/978185409X412147; Hebbel FH, 2014, GRATIFIKATIONSKRISEN; Hintsa T, 2015, J EPIDEMIOL COMMUN H, V69, P543, DOI 10.1136/jech-2014-205148; Kadmon G, 2014, GMS Z MED AUSBILD, V31; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Lange K.W., 2000, RWT REGENSBURGER WOR; Larsson MR, 2007, BEHAV BRAIN FUNCT, V3; Laux L., 1981, STATE TRAIT ANGSTINV; Lehrl S., 1989, MEHRFACHWAHL WORTSCH; Libbrecht N, 2014, EMOTION, V14, P64, DOI 10.1037/a0034392; Mark G, 2012, BRIT J HEALTH PSYCH, V17, P505, DOI 10.1111/j.2044-8287.2011.02051.x; Hokerberg YHM, 2010, INT ARCH OCC ENV HEA, V83, P407, DOI 10.1007/s00420-009-0488-4; Msaouel P, 2012, J OCCUP HEALTH, V54, P119, DOI 10.1539/joh.11-0197-OA; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 2013, NERVENARZT, V84, P33, DOI 10.1007/s00115-012-3667-6; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J, 2009, INT ARCH OCC ENV HEA, V82, P1005, DOI 10.1007/s00420-008-0384-3; Sieverding M, 2013, PSYCHOL RUNDSCH, V64, P94, DOI 10.1026/0033-3042/a000152; Sparfeldt JR, 2013, LEARN INDIVID DIFFER, V24, P198, DOI 10.1016/j.lindif.2012.12.010; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Wada K, 2008, INT ARCH OCC ENV HEA, V81, P331, DOI 10.1007/s00420-007-0217-9; Yates J., 2012, BMC MED ED, V12; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yu SF, 2013, BIOMED ENVIRON SCI, V26, P962, DOI 10.3967/bes2013.031	38	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171220	10.1371/journal.pone.0171220	http://dx.doi.org/10.1371/journal.pone.0171220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182781	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800047
J	Masuda, R; Nonaka, M; Nishimura, A; Gotoh, K; Oka, S; Iijima, T				Masuda, Rikuo; Nonaka, Mutsumi; Nishimura, Akiko; Gotoh, Kinuko; Oka, Shuichirou; Iijima, Takehiko			Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study	PLOS ONE			English	Article							TARGET-CONTROLLED INFUSION; EFFECT-SITE CONCENTRATION; INTRAVENOUS SEDATION; DEEP SEDATION; POPULATION; FLUMAZENIL; ANESTHESIA; SURGERY; SYSTEM	Background The incidences of morbidity and mortality caused by pharmacosedation for dental treatment have not yet reached zero. Adverse events are related to inappropriate respiratory management, mostly originating from an overdose of sedatives. Since sedation is utilized for the satisfaction of both the dentist and the patient, the optimal dose should be minimized to prevent adverse events. We attempted to define the optimal doses of midazolam and propofol required to achieve high levels of patient and dentist satisfaction. Methods One thousand dental patients, including those undergoing third molar extractions, were enrolled in this study. A dose of 1 mg of midazolam was administered at 1-minute intervals until adequate sedation was achieved. Propofol was then infused continuously to maintain the sedation level. Both the patients and the dentists were subsequently interviewed and asked to complete a questionnaire. A multivariate logistic regression analysis was used to examine the factors that contributed to patient and dentist satisfaction. Results The peak midazolam dose resulting in the highest percentage of patient satisfaction was 3 mg. Both a lower dose and a higher dose reduced patient satisfaction. Patient satisfaction increased with an increasing dosage of propofol up until 4 mg/kg/hr, reaching a peak of 78.6%. The peak midazolam dose resulting in the highest percentage of dentist satisfaction (78.8%) was 2 mg. Incremental propofol doses reduced dentist satisfaction, in contrast to their effect on patient satisfaction. The strongest independent predictors of patient satisfaction and dentist satisfaction were no intraoperative memory (OR, 5.073; 95% CI, 3.532-7.287; P < 0.001) and unintentional movements by the patient (OR, 0.035; 95% CI, 0.012-0.104; P < 0.001), respectively. No serious adverse events were reported. Conclusion We found that 3 mg of midazolam and 3 mg/kg/hr of propofol may be the optimal doses for maximizing both patient and dentist satisfaction. Although this level of sedation is relatively light, memory loss and an absence of unintentional patient movements can be expected without adverse events.	[Masuda, Rikuo; Nonaka, Mutsumi; Nishimura, Akiko; Gotoh, Kinuko; Oka, Shuichirou; Iijima, Takehiko] Showa Univ, Sch Dent, Dept Perioperat Med, Div Anesthesiol, Tokyo, Japan; [Oka, Shuichirou] Showa Univ Hosp, Dept Anesthesiol, Tokyo, Japan	Showa University; Showa University	Masuda, R (corresponding author), Showa Univ, Sch Dent, Dept Perioperat Med, Div Anesthesiol, Tokyo, Japan.	rikuo14@dent.showa-u.ac.jp	èæ, æå/HCH-0584-2022					Bennett J, 1998, J ORAL MAXIL SURG, V56, P1049, DOI 10.1016/S0278-2391(98)90253-1; Braidy HF, 2011, J ORAL MAXIL SURG, V69, P2112, DOI 10.1016/j.joms.2011.04.017; Chapman RM, 2006, ANAESTHESIA, V61, P345, DOI 10.1111/j.1365-2044.2006.04544.x; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Collado V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071240; FISET P, 1995, CLIN PHARMACOL THER, V58, P567, DOI 10.1016/0009-9236(95)90177-9; Greenblatt DJ, 2004, J CLIN PHARMACOL, V44, P605, DOI 10.1177/0091270004265368; Hsu WH, 2013, J DIGEST DIS, V14, P147, DOI 10.1111/1751-2980.12020; Kucukyavuz Z, 2004, BRIT J ORAL MAX SURG, V42, P215, DOI 10.1016/j.bjoms.2004.01.005; Lee JS, 2014, ACTA ANAESTH SCAND, V58, P597, DOI 10.1111/aas.12307; Lepere A J, 2002, Anesth Prog, V49, P77; Mancuso CE, 2004, PHARMACOTHERAPY, V24, P1177, DOI 10.1592/phco.24.13.1177.38089; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Rodgers SF, 2011, J ORAL MAXIL SURG, V69, P2525, DOI 10.1016/j.joms.2011.02.030; Sago T, 2015, J ORAL MAXIL SURG, V73, P1058, DOI 10.1016/j.joms.2014.12.020; Schwamburger Nathan T, 2012, Gen Dent, V60, pe341; VUKSANAJ D, 1992, J CLIN ANESTH, V4, P402, DOI 10.1016/0952-8180(92)90166-X; Weinbroum AA, 2001, EUR J ANAESTH, V18, P789, DOI 10.1046/j.1365-2346.2001.00922.x; ZACHARIAS M, 1994, BRIT J ORAL MAX SURG, V32, P168, DOI 10.1016/0266-4356(94)90103-1; Zomorodi K, 1998, ANESTHESIOLOGY, V89, P1418, DOI 10.1097/00000542-199812000-00020	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171627	10.1371/journal.pone.0171627	http://dx.doi.org/10.1371/journal.pone.0171627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182732	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800081
J	Bao, YH; Fan, GR; Zou, DD; Wang, T; Xue, D				Bao, Yuhua; Fan, Guanrong; Zou, Dongdong; Wang, Tong; Xue, Di			Patient experience with outpatient encounters at public hospitals in Shanghai: Examining different aspects of physician services and implications of overcrowding	PLOS ONE			English	Article							CARE; PERFORMANCE; OUTCOMES; QUALITY; TIME	Background Over 90% of outpatient care in China was delivered at public hospitals, making outpatient experience in this setting an important aspect of quality of care. Objective To assess outpatient experience with different aspects of physician services at China's public hospitals and its association with overcrowding of the hospital outpatient departments. Research design Retrospective analysis of a large survey of outpatient experience in Shanghai, China. We tested the hypotheses that patient experience was poorer with physician-patient communication, education, and shared decision-making and where and when there was greater overcrowding of the hospital outpatient departments. Ordered logistic models were estimated separately for general and specialty hospitals. Subjects 7,147 outpatients at 40 public hospitals in Shanghai, China, in 2014. Measures Patient experience with physician services were self-reported based on 12 questions as part of a validated instrument. Indicators of overcrowding included time of visit (morning vs. afternoon, Monday vs. rest of the week) and hospital outpatient volume in the first half of 2014. Results Overall, patients reported very favorable experience with physician services. Two out of the 12 questions pertaining to both communication and shared decision-making consistently received lower ratings. Hospitals whose outpatient volumes were in the top two quartiles received lower patient ratings, but the relationship achieved statistical significance among specialty hospitals only. Conclusions Inadequate physician-patient communication and shared decision-making and hospital overcrowding compromise outpatient experience with physician services at Chinese public hospitals. Effective diversion of patients with chronic and less complex conditions to community health centers will be critical to alleviate the extreme workloads at hospitals with high patient volumes and, in turn, improve patient experience.	[Bao, Yuhua] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Bao, Yuhua] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Fan, Guanrong; Zou, Dongdong] Shanghai Med Ethos Assoc, Shanghai, Peoples R China; [Wang, Tong] Shanghai Hlth & Family Planning Commiss, Shanghai, Peoples R China; [Xue, Di] Fudan Univ, Sch Publ Hlth, Dept Hosp Management, Shanghai, Peoples R China; [Xue, Di] Fudan Univ, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China	Cornell University; Cornell University; Fudan University; Fudan University	Xue, D (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hosp Management, Shanghai, Peoples R China.; Xue, D (corresponding author), Fudan Univ, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China.	xuedi@shmu.edu.cn			Weill Cornell Medical College; Shanghai Health and Family Planning Commission	Weill Cornell Medical College; Shanghai Health and Family Planning Commission	The Shanghai Health and Family Planning Commission (www.wsjsw.gov.cn) funded the patient experience survey in 2014, which provided data for this study. The sponsor of the study facilitated the study team's access to the public hospitals included in the survey and provided input in interpretation of data. YB was supported by Weill Cornell Medical College (weill.cornell.edu) sabbatical fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2015, CLIN GROUP SURV CG C; [Anonymous], 2015, CHINESE HLTH RESOURC, V18, P115; CAREY RG, 1993, MED CARE, V31, P834, DOI 10.1097/00005650-199309000-00008; Centers for Medicare and Medicaid Services, 2014, CONS ASS HEALTHC PRO; Chen T, 2015, CHINA HOSP CEO, P38; Coulter A, 2011, ENGAGING PATIENTS HE; de Silva A, MEASURING RESPONSIVE; Department of Health, 2008, US COMM QUAL INN CQU; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Guangyu H, 2016, CHIN J HOSP ADM, V32, P423; Hays RD, 2003, AM J MED QUAL, V18, P190, DOI 10.1177/106286060301800503; He JA, 2016, HEALTH ECON POLICY L, V28, P1; Henderson JW, 2002, EDUC PSYCHOL MEAS, V62, P995, DOI 10.1177/0013164402238086; Hsiao WC, 2008, HEALTH AFFAIR, V27, P949, DOI 10.1377/hlthaff.27.4.949; IOM Quality of Health Care Committee, 2001, CROSSING QUALITY CHA; Isaac T, 2010, HEALTH SERV RES, V45, P1024, DOI 10.1111/j.1475-6773.2010.01122.x; Janssen PPM, 1999, J ADV NURS, V29, P1360, DOI 10.1046/j.1365-2648.1999.01022.x; Kahn KL, 2007, HEALTH SERV RES, V42, P63, DOI 10.1111/j.1475-6773.2006.00604.x; Li H., 2014, OXID MED CELL LONGEV, V2014, P1, DOI DOI 10.1016/J.BI0MATERIALS.2014.01.039; Liebman BL, 2013, COLUMBIA LAW REV, V113, P181; Liu YH, 2013, BREAST CANCER RES TR, V137, P829, DOI 10.1007/s10549-012-2387-8; National Health and Family Planning Commision of the People's Republic of China, 2014, 2014 CHIN HLTH FAM P; Nichols A, 2007, RES PAPERS EC; Price RA, 2014, MED CARE RES REV, V71, P522, DOI 10.1177/1077558714541480; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Safran DG, 1998, J FAM PRACTICE, V47, P213; Saman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061097; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Tai-Seale M, 2012, HEALTH ECON, V21, P457, DOI 10.1002/hec.1726; Wang XQ, 2012, LANCET, V380, P647, DOI 10.1016/S0140-6736(12)61367-1; Wei W, 2017, CHINA MED ARCH, V14, P18; Wu Q., 2014, J TRADITIONAL CHINES, V22, P653; Xue D, 2013, HEALTH CARE MANAGE R, V38, P258, DOI 10.1097/HMR.0b013e3182678f9a; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; 张丹, 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P671	36	28	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171684	10.1371/journal.pone.0171684	http://dx.doi.org/10.1371/journal.pone.0171684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207783	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500047
J	Templer, PH; Reinmann, AB; Sanders-DeMott, R; Sorensen, PO; Juice, SM; Bowles, F; Sofen, LE; Harrison, JL; Halm, I; Rustad, L; Martin, ME; Grant, N				Templer, Pamela H.; Reinmann, Andrew B.; Sanders-DeMott, Rebecca; Sorensen, Patrick O.; Juice, Stephanie M.; Bowles, Francis; Sofen, Laura E.; Harrison, Jamie L.; Halm, Ian; Rustad, Lindsey; Martin, Mary E.; Grant, Nicholas			Climate Change Across Seasons Experiment (CCASE): A new method for simulating future climate in seasonally snow-covered ecosystems	PLOS ONE			English	Article							LONG-TERM; NITROGEN DYNAMICS; SOIL RESPIRATION; NEW-HAMPSHIRE; CARBON-CYCLE; FOREST; TUNDRA; MANIPULATION; METAANALYSIS; RESPONSES	Climate models project an increase in mean annual air temperatures and a reduction in the depth and duration of winter snowpack for many mid and high latitude and high elevation seasonally snow-covered ecosystems over the next century. The combined effects of these changes in climate will lead to warmer soils in the growing season and increased frequency of soil freeze-thaw cycles (FTCs) in winter due to the loss of a continuous, insulating snowpack. Previous experiments have warmed soils or removed snow via shoveling or with shelters to mimic projected declines in the winter snowpack. To our knowledge, no experiment has examined the interactive effects of declining snowpack and increased frequency of soil FTCs, combined with soil warming in the snow-free season on terrestrial ecosystems. In addition, none have mimicked directly the projected increase in soil FTC frequency in tall statured forests that is expected as a result of a loss of insulating snow in winter. We established the Climate Change Across Seasons Experiment (CCASE) at Hubbard Brook Experimental Forest in the White Mountains of New Hampshire in 2012 to assess the combined effects of these changes in climate on a variety of pedoclimate conditions, biogeochemical processes, and ecology of northern hardwood forests. This paper demonstrates the feasibility of creating soil FTC events in a tall statured ecosystem in winter to simulate the projected increase in soil FTC frequency over the next century and combines this projected change in winter climate with ecosystem warming throughout the snow-free season. Together, this experiment provides a new and more comprehensive approach for climate change experiments that can be adopted in other seasonally snow-covered ecosystems to simulate expected changes resulting from global air temperature rise.	[Templer, Pamela H.; Reinmann, Andrew B.; Sanders-DeMott, Rebecca; Sorensen, Patrick O.; Juice, Stephanie M.; Sofen, Laura E.; Harrison, Jamie L.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Bowles, Francis] Res Designs, Lyme, NH USA; [Halm, Ian; Rustad, Lindsey; Grant, Nicholas] US Forest Serv, Hubbard Brook Expt Forest, Woodstock, NH USA; [Martin, Mary E.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	Boston University; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire	Templer, PH (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	ptempler@bu.edu	Juice, Stephanie M/D-4316-2019; Sorensen, Patrick O./K-1401-2017; Brook, Hubbard/AAD-1112-2022	Juice, Stephanie M/0000-0002-0891-2202; Sorensen, Patrick O./0000-0002-0558-2789; Sanders-DeMott, Rebecca/0000-0002-0709-8042; Martin, Mary/0000-0003-1791-5584; Harrison, Jamie/0000-0001-7937-0503	National Science Foundation [1114804, NSF DEB 1149929]; Direct For Biological Sciences [1633026] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by an award from the National Science Foundation with the number 1114804 and by a National Science Foundation CAREER grant to PH Templer (NSF DEB 1149929). These awards were used as salary for authors PT, RSD, SMJ, FB, LEF, JLH, and the NSF did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Bailey A. S., 2003, HYDROMETEOROLOGICAL; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Bokhorst S, 2008, GLOBAL CHANGE BIOL, V14, P2603, DOI 10.1111/j.1365-2486.2008.01689.x; Borchers H. W., 2015, PRACMA PRACTICAL NUM; BOUTIN R, 1995, CAN J FOREST RES, V25, P588, DOI 10.1139/x95-066; Brown PJ, 2011, AGR FOREST METEOROL, V151, P947, DOI 10.1016/j.agrformet.2011.02.014; Burakowski EA, 2008, J GEOPHYS RES-ATMOS, P113; Campbell JL, 2014, GLOBAL CHANGE BIOL, V20, P2663, DOI 10.1111/gcb.12532; Campbell JL, 2010, HYDROL PROCESS, V24, P2465, DOI 10.1002/hyp.7666; Duran J, 2014, GLOBAL CHANGE BIOL, V20, P3568, DOI 10.1111/gcb.12624; Edenhofer O., 2014, CONTRIBUTION WORKING; Flanagan LB, 2013, AGR FOREST METEOROL, V173, P40, DOI 10.1016/j.agrformet.2013.01.002; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P191, DOI 10.1023/A:1013024603959; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Hamburg SP, 2013, CLIMATIC CHANGE, V116, P457, DOI 10.1007/s10584-012-0517-2; Hardy JP, 2001, BIOGEOCHEMISTRY, V56, P151, DOI 10.1023/A:1013036803050; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Hothorn T., 2008, MULTCOMP SIMULTANEOU; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Johnstone JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082903; Kreyling J, 2011, PLANT ECOL DIVERS, V4, P13, DOI 10.1080/17550874.2011.558125; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; LeCain D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116834; Li WB, 2016, SOIL BIOL BIOCHEM, V100, P51, DOI 10.1016/j.soilbio.2016.05.018; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Melillo JM, 2011, PROCEEDINGS OF THE N; Pelini SL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00097.1; Pinheiro J, 2016, R CORE TEAM LINEAR N; RICARD J, 1976, FIELD ASSEMBLED FROS; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schimel JP, 1996, SOIL BIOL BIOCHEM, V28, P1061, DOI 10.1016/0038-0717(96)00083-1; Shibata H, 2015, AMBIO, V44, P178, DOI 10.1007/s13280-014-0545-4; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Templer PH, 2012, BIOL FERT SOILS, V48, P413, DOI 10.1007/s00374-011-0636-3; Templer PH, 2011, NEW PHYTOL, V192, P797, DOI 10.1111/j.1469-8137.2011.03959.x; Viglietti D, 2014, HYDROL PROCESS, V28, P5309, DOI 10.1002/hyp.10008; Winter TC, 2008, HYDROL PROCESS, V22, P21, DOI 10.1002/hyp.6593; Xu WF, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044027; Zhang T, 2003, PERMAFROST, VOLS 1 AND 2, P1289	44	26	26	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171928	10.1371/journal.pone.0171928	http://dx.doi.org/10.1371/journal.pone.0171928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207766	Green Published, gold			2022-12-27	WOS:000394424500061
J	Barker, AL; Morello, RT; Ayton, DR; Hill, KD; Brand, CA; Livingston, PM; Botti, M				Barker, Anna L.; Morello, Renata T.; Ayton, Darshini R.; Hill, Keith D.; Brand, Caroline A.; Livingston, Patricia M.; Botti, Mari			Acceptability of the 6-PACK falls prevention program: A pre-implementation study in hospitals participating in a cluster randomized controlled trial	PLOS ONE			English	Article							PRACTICE GUIDELINE; INJURIES; PROTOCOL; LESSONS	There is limited evidence to support the effectiveness of falls prevention interventions in the acute hospital setting. The 6-PACK falls prevention program includes a fall-risk tool; 'falls alert' signs; supervision of patients in the bathroom; ensuring patients' walking aids are within reach; toileting regimes; low-low beds; and bed/chair alarms. This study explored the acceptability of the 6-PACK program from the perspective of nurses and senior staff prior to its implementation in a randomised controlled trial. A mixed-methods approach was applied involving 24 acute wards from six Australian hospitals. Participants were nurses working on participating wards and senior hospital staff including: Nurse Unit Managers; senior physicians; Directors of Nursing; and senior personnel involved in quality and safety or falls prevention. Information on program acceptability (suitability, practicality and benefits) was obtained by surveys, focus groups and interviews. Survey data were analysed descriptively, and focus group and interview data thematically. The survey response rate was 60%. Twelve focus groups (n = 96 nurses) and 24 interviews with senior staff were conducted. Falls were identified as a priority patient safety issue and nurses as key players in falls prevention. The 6-PACK program was perceived to offer practical benefits compared to current practice. Nurses agreed fall-risk tools, low-low beds and alert signs were useful for preventing falls (>70%). Views were mixed regarding positioning patients' walking aid within reach. Practical issues raised included access to equipment; and risk of staff injury with low-low bed use. Bathroom supervision was seen to be beneficial, however not always practical. Views on the program appropriateness and benefits were consistent across nurses and senior staff. Staff perceived the 6-PACK program as suitable, practical and beneficial, and were open to adopting the program. Some practical concerns were raised highlighting issues to be addressed by the implementation plan.	[Barker, Anna L.; Morello, Renata T.; Ayton, Darshini R.; Brand, Caroline A.] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Hill, Keith D.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Bentley, WA, Australia; [Livingston, Patricia M.] Deakin Univ, Epworth Deakin Ctr Clin Nursing Res, Richmond, Vic, Australia; [Botti, Mari] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic, Australia	Monash University; Curtin University; Deakin University; Deakin University	Barker, AL (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	anna.barker@monash.edu	Hill, Keith D/L-6398-2017; Morello, Renata/AAC-6300-2019	Hill, Keith D/0000-0002-2191-0308; Barker, Anna/0000-0001-6607-975X	National Health and Medical Research Council (NHMRC), Australia [APP1007627]; NHMRC [APP1067236, APP1055604]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC), Australia (APP1007627). AB's salary was funded by a Fellowship from the NHMRC (APP1067236). RM's salary was supported by a scholarship from the NHMRC (APP1055604).	Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P467, DOI 10.1136/qshc.2007.025676; Barker AL, 2016, INJURY PREVENTION J; Barker A, 2011, INJURY PREV, V17, P1, DOI 10.1136/injuryprev-2011-040074; Barker A, 2011, J ADV NURS, V67, P450, DOI 10.1111/j.1365-2648.2010.05503.x; Barker AL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6781; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Dubois CA, 2013, INT J QUAL HEALTH C, V25, P110, DOI 10.1093/intqhc/mzt019; Fereday J, 2006, INT J QUAL METH, V5, P7; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Ireland S, 2013, WORLDV EVID-BASED NU, V10, P95, DOI 10.1111/j.1741-6787.2012.00258.x; Jorgensen TS, 2015, INT J CLIN PRACTICE; Koh SSL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-105; Kumar A, 2012, BLOOD CELL MOL DIS, V48, P238, DOI 10.1016/j.bcmd.2012.02.006; Manojlovich M, 2011, NURS RES, V60, P214, DOI 10.1097/NNR.0b013e31822228dc; Morello R, 2012, INJURY PREV, V18, DOI 10.1136/injuryprev-2011-040302; OCATHAIN A, 2010, BMJ-BRIT MED J, V341, pC4587, DOI DOI 10.1136/BMJ.C4587; Ploeg J, 2007, WORLDV EVID-BASED NU, V4, P210, DOI 10.1111/j.1741-6787.2007.00106.x; Robert G., 2005, DIFFUSION INNOVATION; Shee AW, 2014, J NURS CARE QUAL, V29, P253, DOI 10.1097/NCQ.0000000000000054; Vassallo M, 2004, AGE AGEING, V33, P400, DOI 10.1093/ageing/afh138; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Waters TM, 2015, JAMA INTERN MED, V175, P347, DOI 10.1001/jamainternmed.2014.5486; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	25	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172005	10.1371/journal.pone.0172005	http://dx.doi.org/10.1371/journal.pone.0172005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199376	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400065
J	Brozio, S; Manson, C; Gourevitch, E; Burns, TJ; Greener, MS; Downie, JR; Hoskisson, PA				Brozio, Sarah; Manson, Chloe; Gourevitch, Eleanor; Burns, Thomas J.; Greener, Mark S.; Downie, J. Roger; Hoskisson, Paul A.			Development and Application of an eDNA Method to Detect the Critically Endangered Trinidad Golden Tree Frog (Phytotriades auratus) in Bromeliad Phytotelmata	PLOS ONE			English	Article							ENVIRONMENTAL DNA; CONSERVATION	The use of environmental DNA (eDNA) to monitor rare and elusive species has great potential for conservation biology. Traditional surveying methods can be time-consuming, labourintensive, subject to error or can be invasive and potentially damaging to habitat. The Trinidad golden treefrog (Phytotriades auratus) is one such species that would benefit from such an approach. This species inhabits the giant bromeliad (Glomeropitcairnia erectiflora) on two peaks on the Caribbean island of Trinidad. Traditional survey methods for this species have required the destruction of the giant bromeliad, which is the only known habitat of this frog. Here we described the development of an eDNA PCR-based assay that uses water drawn from the water-filled phytotelmata of the giant bromeliad along with the use of a synthetic DNA positive control that can be easily amplified in the bacterium Escherichia coli. The assay can detect to a DNA concentration of 1.4ng. Sampling of 142 bromeliads using this method revealed 9% were positive for P. auratus DNA. These data suggest that eDNA methods also have great potential for revealing the presence of elusive species in arboreal habitats.	[Brozio, Sarah; Manson, Chloe; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Gourevitch, Eleanor; Burns, Thomas J.; Greener, Mark S.; Downie, J. Roger] Univ Glasgow, Sch Life Sci, Graham Kerr Bldg, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Hoskisson, PA (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	Paul.hoskisson@strath.ac.uk	Gourevitch, Eleanor/ADY-9795-2022	Hoskisson, Paul/0000-0003-4332-1640; Greener, Mark/0000-0002-0600-0912; Burns, Thomas J/0000-0003-0408-8014; Gourevitch, Eleanor/0000-0003-1929-0135	Amphibian Survival Alliance's Seed Grant	Amphibian Survival Alliance's Seed Grant	This work was supported by Amphibian Survival Alliance's Seed Grant (http://www.amphibians.org/seedgrants/).	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bornschein MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142791; Brown RP, 2006, MOL ECOL, V15, P3631, DOI 10.1111/j.1365-294X.2006.03048.x; Clark FM, B BRIT HERPETOLOGICA, V54, P3; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall EM, 2016, MOL ECOL RESOUR, V16, P423, DOI 10.1111/1755-0998.12461; Jowers MJ, 2008, STUD NEOTROP FAUNA E, V43, P181, DOI 10.1080/01650520801965490; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2016, METHODS MOL BIOL, V1452, P131, DOI 10.1007/978-1-4939-3774-5_8; Murphy J., 1997, REPTILES AMPHIBIANS; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Palumbi S. R., 1996, NUCL ACIDS; Rivas GA, 2015, HERPETOLOGICAL REV, V46, P1; Rowley JJL, 2014, ZOOTAXA, V3785, P25, DOI 10.11646/zootaxa.3785.1.2; Ryan MJ, 2011, J HERPETOL, V45, P438; Sambrook J., 2001, MOL CLONING LAB MANU; Stockley V, 2015, INNOVATION NEW TECHN, V9, P39; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Torresdal JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168787	20	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170619	10.1371/journal.pone.0170619	http://dx.doi.org/10.1371/journal.pone.0170619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199338	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000394424400017
J	Mascherbauer, J; Kammerlander, AA; Zotter-Tufaro, C; Aschauer, S; Duca, F; Dalos, D; Winkler, S; Schneider, M; Bergler-Klein, J; Bonderman, D				Mascherbauer, Julia; Kammerlander, Andreas A.; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Dalos, Daniel; Winkler, Susanne; Schneider, Matthias; Bergler-Klein, Jutta; Bonderman, Diana			Presence of 'isolated' tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; ASSOCIATION TASK-FORCE; ECHOCARDIOGRAPHIC-ASSESSMENT; AORTIC REGURGITATION; EUROPEAN ASSOCIATION; PRESSURE-GRADIENT; AMERICAN-COLLEGE; DIAGNOSIS; RECOMMENDATIONS; GUIDELINES	Background Diastolic dysfunction of the left ventricle is common but frequently under-diagnosed. Particularly in advanced stages affected patients may present with significant functional tricuspid regurgitation (TR) as the most prominent sign on echocardiography. The underlying left ventricular pathology may eventually be missed and symptoms of heart failure are attributed to TR, with respective therapeutic consequences. The aim of the present study was to determine prevalence and mechanisms underlying TR evolution in heart failure with preserved ejection fraction (HFpEF). Methods and results Consecutive HFpEF patients were enrolled in this prospective, observational study. Confirmatory diagnostic tests including echocardiography and invasive hemodynamic assessments were performed. Of the 175 patients registered between 2010 and 2014, 51% had significant (moderate or severe) TR without structural abnormalities of the tricuspid valve. Significant hemodynamic differences between patients with and without relevant TR were encountered. These included elevated pulmonary vascular resistance (p = 0.038), reduced pulmonary arterial compliance (PAC, p = 0.005), and elevated left ventricular filling pressures (p = 0.039) in the TR group. Multivariable binary logistic regression analysis revealed diastolic pulmonary artery pressure (p = 0.029) and PAC (p = 0.048) as independent determinants of TR. Patients were followed for 18.1 +/- 14.1 months, during which 32% had a cardiac event. While TR was associated with outcome in the univariable analysis, it failed to predict event free survival in the multivariable model. Conclusions The presence of 'isolated' functional TR should prompt the suspicion of HFpEF. Our data show that significant TR is a marker of advanced HFpEF but neither an isolated entity nor independently associated with event-free survival.	[Mascherbauer, Julia; Kammerlander, Andreas A.; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Dalos, Daniel; Winkler, Susanne; Schneider, Matthias; Bergler-Klein, Jutta; Bonderman, Diana] Med Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Vienna, Austria	Medical University of Vienna	Mascherbauer, J (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Vienna, Austria.	julia.mascherbauer@meduniwien.ac.at	Bergler-Klein, Jutta/AAE-9604-2022; Schneider, Matthias/AAB-4670-2020; Bergler-Klein, Jutta/AFE-6999-2022; Kammerlander, Andreas/F-7391-2018	Schneider, Matthias/0000-0002-6320-3708; Kammerlander, Andreas/0000-0002-7632-9879; Mascherbauer, Julia/0000-0001-7478-1450; Aschauer, Stefan/0000-0003-2220-9182; Dalos, Daniel/0000-0002-9597-5745	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian Science Fund (FWF) [KLI 245, KLI 246]	Austrian Society of Cardiology; Osterreichischer Herzfonds; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study received support from the Austrian Society of Cardiology (to JM; http://www.atcardio.at/en), the Osterreichischer Herzfonds (to JM; http://www.herzfonds.at) and the Austrian Science Fund (FWF; https://www.fwf.ac.at) grant KLI 245 (to JM) and KLI 246 (to DB). There are no relationships with industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschauer S, 2016, EUR J HEART FAIL, V18, P71, DOI 10.1002/ejhf.418; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Goliasch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134479; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Hung J, 1998, AM J CARDIOL, V82, P1301, DOI 10.1016/S0002-9149(98)00624-9; Kammerlander AA, 2014, J AM COLL CARDIOL, V64, P2633, DOI 10.1016/j.jacc.2014.09.062; Karakus G, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0184-3; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Mascherbauer J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136024; Mascherbauer J, 2013, CIRC-CARDIOVASC IMAG, V6, P1056, DOI 10.1161/CIRCIMAGING.113.000633; Mascherbauer J, 2010, EUR HEART J, V31, P2841, DOI 10.1093/eurheartj/ehq303; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Neuhold S, 2013, EUR HEART J, V34, P844, DOI 10.1093/eurheartj/ehs465; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pierard LA, 2010, ESC TXB CARDIOVASCUL, P150; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; RIVERA JM, 1994, AM HEART J, V127, P1354, DOI 10.1016/0002-8703(94)90056-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sagie A, 1997, J AM SOC ECHOCARDIOG, V10, P141, DOI 10.1016/S0894-7317(97)70086-5; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Taramasso M, 2012, J AM COLL CARDIOL, V59, P703, DOI 10.1016/j.jacc.2011.09.069; Tschoepe C, 2009, HERZ, V34, P89, DOI 10.1007/s00059-009-3197-6; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Varadarajan P, 2012, INTERACT CARDIOV TH, V14, P580, DOI 10.1093/icvts/ivr047; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zotter-Tufaro C, 2015, J AM COLL CARDIOL, V66, P1308, DOI 10.1016/j.jacc.2015.07.011	31	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171542	10.1371/journal.pone.0171542	http://dx.doi.org/10.1371/journal.pone.0171542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199339	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400033
J	Radell, ML; Beck, KD; Gilbertson, MW; Myers, CE				Radell, Milen L.; Beck, Kevin D.; Gilbertson, Mark W.; Myers, Catherine E.			Post-traumatic stress disorder symptom burden and gender each affect generalization in a reward- and punishment-learning task	PLOS ONE			English	Article							PTSD CHECKLIST; PSYCHOMETRIC PROPERTIES; HEALTH-PROBLEMS; PRIMARY-CARE; VETERANS; PREVALENCE; VIETNAM; DEPRESSION; BARRIERS; DUTY	traumatic stress disorder (PTSD) can develop following exposure to a traumatic event. Re-experiencing, which includes intrusive memories or flashbacks of the trauma, is a core symptom cluster of PTSD. From an associative learning perspective, this cluster may be attributed to cues associated with the trauma, which have come to elicit symptoms in a variety of situations encountered in daily life due to a tendency to overgeneralize. Consistent with this, prior studies have indicated that both individuals with clinically diagnosed with PTSD, and those with self-reported symptoms who may not meet full diagnostic criteria, show changes in generalization. Building on prior research, the current study examined whether PTSD symptom burden, but also gender, veteran status, and combat experience-all associated with PTSD vulnerability-modulate learning and generalization in a computer-based task. Participants were presented with stimulus compounds consisting of a foreground and background that could be predictive of reward, punishment or no outcome. Learning was followed by a generalization test where these components were recombined to form novel configurations. An interaction between PTSD symptom burden and gender was found where females with more severe PTSD symptoms showed no evidence of sensitivity to the background. This result is consistent with increased generalization, and may indicate a decrease in the ability to process cue configurations leading to re-experiencing in a variety of situations. Further work is indicated to help elucidate the cognitive processes driving gender differences that may confer vulnerability to PTSD.	[Radell, Milen L.] Niagara Univ, Dept Psychol, Lewiston, NY 14109 USA; [Radell, Milen L.; Beck, Kevin D.; Myers, Catherine E.] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ 07018 USA; [Beck, Kevin D.; Myers, Catherine E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Gilbertson, Mark W.] Dept Vet Affairs, Manchester, NH USA	New Jersey Department of Health & Senior Services; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Radell, ML (corresponding author), Niagara Univ, Dept Psychol, Lewiston, NY 14109 USA.; Radell, ML (corresponding author), New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ 07018 USA.	milenre@gmail.com	Myers, Catherine E./AAU-5804-2020	Myers, Catherine E./0000-0002-2776-4823	U. S. Department of Veterans Affairs Clinical Science Research and Development Service [I01 CX000771]; Veterans Affairs [I01CX000771] Funding Source: NIH RePORTER	U. S. Department of Veterans Affairs Clinical Science Research and Development Service; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Award I01 CX000771 to CEM from the U. S. Department of Veterans Affairs Clinical Science Research and Development Service (http://www.research.va.gov/services/csrd/default.cfm). The funder played no role in the study design, collection, analysis, or interpretation of the data, in the writing of the report, or decision to submit the article for publication. Opinions stated herein do not necessarily represent the official views of the Department of Veterans Affairs or the U. S. Government.	Alim TN, 2006, J CLIN PSYCHOL, V62, P801, DOI 10.1002/jclp.20280; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2004, DIAGN STAT MAN MENT, P136; Anastasides N, 2015, STRESS, V18, P484, DOI 10.3109/10253890.2015.1053450; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Davis RG, 2008, J TRAUMA STRESS, V21, P218, DOI 10.1002/jts.20313; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Fetzner MG, 2013, COGNITIVE THER RES, V37, P725, DOI 10.1007/s10608-013-9531-6; Ginsberg JP, 2008, J ANXIETY DISORD, V22, P809, DOI 10.1016/j.janxdis.2007.08.009; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Ishihara S, 2012, ISHIHARAS TESTS COLO; JONES JC, 1990, CLIN PSYCHOL REV, V10, P299, DOI 10.1016/0272-7358(90)90064-H; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kostek JA, 2014, J TRAUMA STRESS, V27, P717, DOI 10.1002/jts.21974; Levy-Gigi E, 2015, NEUROPSYCHOLOGY, V29, P151, DOI 10.1037/neu0000131; Levy-Gigi E, 2012, NEUROPSYCHOLOGY, V26, P758, DOI 10.1037/a0029361; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Magruder KM, 2016, J TRAUMA STRESS, V29, P5, DOI 10.1002/jts.22075; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072508; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tryon WW, 1998, J ANXIETY DISORD, V12, P373, DOI 10.1016/S0887-6185(98)00021-8; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172144	10.1371/journal.pone.0172144	http://dx.doi.org/10.1371/journal.pone.0172144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196108	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900055
J	Arora, N; Alsaied, O; Dauer, P; Majumder, K; Modi, S; Giri, B; Dudeja, V; Banerjee, S; Von Hoff, D; Saluja, A				Arora, Nivedita; Alsaied, Osama; Dauer, Patricia; Majumder, Kaustav; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Von Hoff, Daniel; Saluja, Ashok			Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; GROWTH-FACTOR EXPRESSION; HUMAN PANCREATIC-CANCER; NF-KAPPA-B; POOR SURVIVAL; CELL-DEATH; TRIPTOLIDE; ADENOCARCINOMA; PROLIFERATION; METASTASIS	Background Gastric cancer is the third leading cause of cancer related mortality worldwide with poor survival rates. Even though a number of chemotherapeutic compounds have been used against this disease, stomach cancer has not been particularly sensitive to these drugs. In this study we have evaluated the effect of triptolide, a naturally derived diterpene triepoxide and its water soluble pro-drug Minnelide on several gastric adenocarcinoma cell lines both as monotherapy and in combination with CPT-11. Methods Gastric cancer cell lines MKN28 and MKN45 were treated with varying doses of triptolide in vitro. Cell viability was measured using MTT based assay kit. Apoptotic cell death was assayed by measuring caspase activity. Effect of the triptolide pro-drug, Minnelide, was evaluated by implanting the gastric cancer cells subcutaneously in athymic nude mice. Results Gastric cancer cell lines MKN28 and MKN45 cells exhibited decreased cell viability and increased apoptosis when treated with varying doses of triptolide in vitro. When implanted in athymic nude mice, treatment with Minnelide reduced tumor burden in both MKN28 derived tumors as well as MKN45 derived tumors. Additionally, we also evaluated Minnelide as a single agent and in combination with CPT-11 in the NCI-N87 human gastric tumor xenograft model. Conclusion Our results indicated that the combination of Minnelide with CPT-11 resulted in significantly smaller tumors compared to control. These studies are extremely encouraging as Minnelide is currently undergoing phase 1 clinical trials for gastrointestinal cancers.	[Arora, Nivedita; Alsaied, Osama; Dauer, Patricia; Majumder, Kaustav; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Saluja, Ashok] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Dauer, Patricia; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Saluja, Ashok] Univ Miami, Div Surg Oncol, Dept Surg, Miami, FL 33146 USA; [Von Hoff, Daniel] TGen Virginia G Piper Canc Ctr, Suite 600, Phoenix, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Miami; Translational Genomics Research Institute	Saluja, A (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA.; Saluja, A (corresponding author), Univ Miami, Div Surg Oncol, Dept Surg, Miami, FL 33146 USA.	asaluja@miami.edu			NIH [R01-CA170946, CA124723, R01-CA184274]; Katherine and Robert Goodale foundation support; Minneamrita Therapeutics LLC	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine and Robert Goodale foundation support; Minneamrita Therapeutics LLC	This study was funded by NIH grants R01-CA170946 and CA124723 (to AS); NIH grant R01-CA184274 (to SB); Katherine and Robert Goodale foundation support (to AS) and Minneamrita Therapeutics LLC (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Banerjee S, 2013, J BIOL CHEM, V288, P33927, DOI 10.1074/jbc.M113.500983; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bleiberg H, 1999, EUR J CANCER, V35, P371, DOI 10.1016/S0959-8049(98)00423-7; Carcas Lauren Peirce, 2014, J Carcinog, V13, P14, DOI 10.4103/1477-3163.146506; Chang HJ, 2007, ANTICANCER RES, V27, P3411; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2012, THER ADV GASTROENTER, V5, P49, DOI 10.1177/1756283X11410771; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Guimbaud R, 2014, J CLIN ONCOL, V32, P3520, DOI 10.1200/JCO.2013.54.1011; Guo MM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0542-7; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Lee HW, 2013, VIRCHOWS ARCH, V463, P489, DOI 10.1007/s00428-013-1461-x; Lim JW, 2002, J BIOL CHEM, V277, P46093, DOI 10.1074/jbc.M206603200; Mahipal A, 2015, J NATL COMPR CANC NE, V13, P1281, DOI 10.6004/jnccn.2015.0154; Mahipal A, 2015, INVEST NEW DRUG, V33, P1093, DOI 10.1007/s10637-015-0277-8; Meng CC, 2014, CHINESE J CANCER RES, V26, P622, DOI 10.3978/j.issn.1000-9604.2014.09.01; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Oliveira AR, 2015, LAB INVEST, V95, P648, DOI 10.1038/labinvest.2015.46; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Piazuelo MB, 2013, COLOMB MEDICA, V44, P192; Qiu TZ, 2014, FEBS LETT, V588, P1168, DOI 10.1016/j.febslet.2014.02.054; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Sherman MY, 2014, ONCOGENE; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vizcaino C, 2015, PHARM THER; Wang JH, 2002, J CANCER RES CLIN, V128, P547, DOI 10.1007/s00432-002-0379-5; Wang LW, 2008, INT J ONCOL, V33, P161; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang J, 2005, WORLD J GASTROENTERO, V11, P2213, DOI 10.3748/wjg.v11.i15.2213; Zhao SJ, 2003, CANCER RES, V63, P2624; Zhao ZG, 2005, WORLD J GASTROENTERO, V11, P73, DOI 10.3748/wjg.v11.i1.73	40	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171827	10.1371/journal.pone.0171827	http://dx.doi.org/10.1371/journal.pone.0171827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192510	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800043
J	Eve, AMJ; Place, ES; Smith, JC				Eve, Alexander M. J.; Place, Elsie S.; Smith, James C.			Comparison of Zebrafish tmem88a mutant and morpholino knockdown phenotypes	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; CANONICAL WNT PATHWAY; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; IDENTIFICATION; SPECIFICATION; ANGIOGENESIS; REPOPULATION; ACTIVATION	Tmem88a is a transmembrane protein that is thought to be a negative regulator of the Wnt signalling pathway. Several groups have used antisense morpholino oligonucleotides in an effort to characterise the role of tmem88a in zebrafish cardiovascular development, but they have not obtained consistent results. Here, we generate an 8 bp deletion in the coding region of the tmem88a locus using TALENs, and we have gone on to establish a viable homozygous tmem88a Delta 8 mutant line. Although tmem88a Delta 8 mutants have reduced expression of some key haematopoietic genes, differentiation of erythrocytes and neutrophils is unaffected, contradicting our previous study using antisense morpholino oligonucleotides. We find that expression of the tmem88a paralogue tmem88b is not significantly changed in tmem88a8,8 mutants and injection of the tmem88a splice-blocking morpholino oligonucleotide into tmem88a Delta 8 mutants recapitulates the reduction of erythrocytes observed in morphants using o-Dianisidine. This suggests that there is a partial, but inessential, requirement for tmem88a during haematopoiesis and that morpholino injection exacerbates this phenotype in tmem88a morpholino knockdown embryos.	[Eve, Alexander M. J.; Place, Elsie S.; Smith, James C.] Francis Crick Inst, Mill Hill Lab, London, England	Francis Crick Institute	Smith, JC (corresponding author), Francis Crick Inst, Mill Hill Lab, London, England.	Jim.Smith@crick.ac.uk		Eve, Alexander/0000-0003-3577-4324; Smith, Jim/0000-0003-2413-9392	Cancer Research UK [FC001-157]; UK Medical Research Council [FC001-157]; Wellcome Trust [FC001-157]; Fondation Leducq; Francis Crick Institute; MRC [MC_U117597140] Funding Source: UKRI; Medical Research Council [MC_U117597140] Funding Source: researchfish; The Francis Crick Institute [10158] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Leducq(Leducq Foundation); Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute (www.crick.ac.uk), which receives its core funding from Cancer Research UK (FC001-157), the UK Medical Research Council (FC001-157), and the Wellcome Trust (FC001-157). We are also grateful to the Fondation Leducq (www.fondationleducq.org) for a Transatlantic Network of Excellence Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Cannon JE, 2013, MECH DEVELOP, V130, P122, DOI 10.1016/j.mod.2012.10.002; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen J, 2013, ZEBRAFISH, V10, P389, DOI 10.1089/zeb.2013.0875; Cheng CN, 2014, JOVE-J VIS EXP, DOI 10.3791/51604; Dabrowski M, 2015, RNA BIOL, V12, P950, DOI 10.1080/15476286.2015.1068497; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Famili F, 2016, STEM CELL REP, V6, P652, DOI 10.1016/j.stemcr.2016.04.009; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Felsenstein J, 1989, CLADISTICS, V5, P3; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Musso G, 2014, DEVELOPMENT, V141, P224, DOI 10.1242/dev.099796; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Novikov N, 2013, DEVELOPMENT, V140, P3787, DOI 10.1242/dev.093567; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Palpant NJ, 2013, DEVELOPMENT, V140, P3799, DOI 10.1242/dev.094789; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NEUROPSYCHOLOGIA, P1, DOI DOI 10.1016/J.NEUROPSYCHOLOGIA.2015.01.019; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shmukler BE, 2015, HAEMATOLOGICA, V100, pE483, DOI 10.3324/haematol.2015.132449; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Swift MR, 2014, DEV BIOL, V390, P116, DOI 10.1016/j.ydbio.2014.03.018; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tikole S, 2006, J BIOMOL STRUCT DYN, V24, P33, DOI 10.1080/07391102.2006.10507096; van Impel A, 2014, DEVELOPMENT, V141, P1228, DOI 10.1242/dev.105031; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172227	10.1371/journal.pone.0172227	http://dx.doi.org/10.1371/journal.pone.0172227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192479	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800084
J	Szantho, F; Mikloski, A; Kubinyi, E				Szantho, Flora; Mikloski, Adam; Kubinyi, Eniko			Is your dog empathic? Developing a Dog Emotional Reactivity Survey	PLOS ONE			English	Article							CANIS-FAMILIARIS; GENDER-DIFFERENCES; PERSONALITY; HUMANS; CONTAGION; ANTHROPOMORPHISM; QUESTIONNAIRE; ATTRIBUTION; PERFORMANCE; CHIMPANZEES	Dogs' seemingly empathic behaviour attracts general and scientific attention alike. Behaviour tests are usually not sufficiently realistic to evoke empathic-like behaviour; therefore we decided to ask owners about their experiences with their dogs in emotionally loaded situations. Owners from Hungary (N = 591) and from Germany (N = 2283) were asked to rate their level of agreement on a 1-5 Likert scale with statements about the reactivity of their dogs to their emotions and to other dogs' behaviour. We created two scales with satisfactory internal reliability: reactivity to the owner's emotion and reactivity to other dogs' behaviour. Based on an owner-dog personality matching theory, we hypothesised that the owner's empathy, as measured by the subscale on the cooperativeness character factor of the human personality, will correlate with their dog's emotional reactivity in emotionally loaded situations. In addition we also examined how anthropomorphism, contagious yawning, attitude toward the dog are related to emotional reactivity in dogs as perceived by the owner. In addition we examined how owners rate dog pictures. We found that the scale scores were largely independent from demographic and environmental variables like breed, sex, age, age at acquiring, keeping practices, training experiences and owner's age. However, anthropomorphic and emotional attitude of the owners probably biased the responses. In the German sample more empathic owners reported to have more emotionally reactive dog, as expected by the personality matching theory. More empathic owners reported to have fewer problems with their dogs and they rated a puppy picture as more cute in both countries. 62% of owners from Hungary and 36% of owner from Germany agreed with the statement "My dog is more important for me than any human being". In Germany, more empathic owners agreed less with this statement and indicated that their dogs have a tendency for contagious yawning. Owners whose attitudes toward their dogs were anthropomorphic (agreed more with the statement that ''My dog thinks like a child"), perceived their dogs as more reactive to their emotions. This findings highlights the importance of testing the attitudes of the respondents when they assess the personality and the emotions of animals. The criterion validity of the Dog Emotional Reactivity Survey should be confirmed by objective behavioural tests.	[Szantho, Flora; Mikloski, Adam; Kubinyi, Eniko] Eotvos Lorand Univ, Dept Ethol, Pazmany Ps 1-C, Budapest, Hungary; [Mikloski, Adam] MTA ELTE Comparat Ethol Res Grp, Pazmany Ps 1-C, Budapest, Hungary	Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Szantho, F (corresponding author), Eotvos Lorand Univ, Dept Ethol, Pazmany Ps 1-C, Budapest, Hungary.	floraceae@gmail.com	Kubinyi, Eniko/B-5824-2013	Kubinyi, Eniko/0000-0002-4468-9845	NKFIH [K84036, K112138]; Bolyai Foundation of the Hungarian Academy of Sciences; MTA-ELTE Comparative Ethological Research Group [01 031]; ERC Starting Grant [680040]; European Research Council (ERC) under the European Union's Horizon research and innovation programme [680040]	NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); MTA-ELTE Comparative Ethological Research Group; ERC Starting Grant(European Research Council (ERC)); European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC))	This work is supported by NKFIH (K84036, K112138) (http:/nkfih.gov.hu/english), Bolyai Foundation of the Hungarian Academy of Sciences (http:/mta.hu/english), MTA-ELTE Comparative Ethological Research Group (01 031) (http://mta-etologia.elte.hu/?p=0&s=0&lang=eng), and ERC Starting Grant to KE (680040) (https://erc.europa.eu/funding-and-grarts/funding-schemes/starting-grants).; This work was supported by the NKFIH (K84036, K112138), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the MTA-ELTE Comparative Ethological Research Group (01 031). The research has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No [680040]). We are grateful for the owners for their participation and especially to Jesko Wilke journalist, Dr. Barbara Schoning, veterinary, who helped collect the German data, and Dr. Lisa J. Wallis for language editing and for useful comments.	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; BAENNINGER R, 1987, J COMP PSYCHOL, V101, P349, DOI 10.1037/0735-7036.101.4.349; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; BYRNE D, 1971, HUM RELAT, V24, P201, DOI 10.1177/001872677102400302; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Champagne F, 2009, CROSS CULTURAL COMP; COPPINGER R, 1987, ETHOLOGY, V75, P89; Custance D, 2012, EMPATHIC LIKE RESPON, P851; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; EDDY TJ, 1993, J SOC ISSUES, V49, P87, DOI 10.1111/j.1540-4560.1993.tb00910.x; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; Harrison M. A., 2010, J SOC EVOL CULT PSYC, V4, P34, DOI DOI 10.1037/H0099303; Hills AM, 1995, ANTHROZOOS, V8, P132, DOI 10.2752/089279395787156347; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kwan VSY, 2008, SOC COGNITION, V26, P129, DOI 10.1521/soco.2008.26.2.129; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lehmann V, 2013, BEHAV PROCESS, V94, P99, DOI 10.1016/j.beproc.2013.01.001; Lorenz K, 1943, Z TIERPSYCHOL, V5, P245; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Miklosi A., 2015, DOG BEHAV EVOLUTION; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Paul ES, 2000, ANTHROZOOS, V13, P194, DOI 10.2752/089279300786999699; Perez-Albeniz A, 2004, CHILD ABUSE NEGLECT, V28, P289, DOI 10.1016/j.chiabu.2003.11.017; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rieffe C, 2010, PERS INDIV DIFFER, V49, P362, DOI 10.1016/j.paid.2010.03.046; Robert Cloninger C., 1993, ARCH GEN PSYCHIAT, V50; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Rozsa S, 2008, J AFFECT DISORDERS, V106, P45, DOI 10.1016/j.jad.2007.03.016; Rueckert L, 2008, BRAIN COGNITION, V67, P162, DOI 10.1016/j.bandc.2008.01.002; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Silva K, 2011, BIOL LETTERS, V7, P489, DOI 10.1098/rsbl.2011.0083; Sumegi Z, 2014, APPL ANIM BEHAV SCI, V160, P106, DOI 10.1016/j.applanim.2014.09.001; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; TEMPLER DI, 1981, PSYCHOL REC, V31, P343, DOI 10.1007/BF03394747; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; Yong MH, 2014, BEHAV PROCESS, V108, P155, DOI 10.1016/j.beproc.2014.10.006	50	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170397	10.1371/journal.pone.0170397	http://dx.doi.org/10.1371/journal.pone.0170397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192495	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800009
J	Gormley, M; Aspray, TJ; Kelly, DA; Rodriguez-Gil, C				Gormley, Michael; Aspray, Thomas J.; Kelly, David A.; Rodriguez-Gil, Cristina			Pathogen cross-transmission via building sanitary plumbing systems in a full scale pilot test-rig	PLOS ONE			English	Article							HONG-KONG; CONTAMINATION; BIOFILM; TOILET; IMPACT; SARS	The WHO Consensus Document on the epidemiology of the SARS epidemic in 2003, included a report on a concentrated outbreak in one Hong Kong housing block which was considered a 'super-spreading event'. The WHO report conjectured that the sanitary plumbing system was one transmission route for the virus. Empty U-traps allowed the aerosolised virus to enter households from the sewerage system. No biological evidence was presented. This research reports evidence that pathogens can be aerosolised and transported on airstreams within sanitary plumbing systems and enter buildings via empty U-traps. A sanitary plumbing system was built, representing two floors of a building, with simulated toilet flushes on the lower floor and a sterile chamber with extractor fan on the floor above. Cultures of a model organism, Pseudomonas putida at 10(6) - 10(9) cfu ml(-1) in 0.85% NaCl were flushed into the system in volumes of 6 to 20 litres to represent single or multiple toilet flushes. Air and surface samples were cultured on agar plates and assessed qualitatively and semi-quantitatively. Flushing from a toilet into a sanitary plumbing system generated enough turbulence to aerosolise pathogens. Typical sanitary plumbing system airflows (between 20-30 ls(-1)) were sufficient to carry aerosolised pathogens between different floors of a building. Empty U-traps allowed aerosolised pathogens to enter the chamber, encouraging cross-transmission. All parts of the system were found to be contaminated post-flush. Empty U-traps have been observed in many buildings and a risk assessment indicates the potential for high risk cross-transmission under defect conditions in buildings with high pathogen loading such as hospitals. Under defective conditions (which are not uncommon) aerosolised pathogens can be carried on the airflows within sanitary plumbing systems. Our findings show that greater consideration should be given to this mode of pathogen transmission.	[Gormley, Michael; Aspray, Thomas J.; Kelly, David A.; Rodriguez-Gil, Cristina] Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Riccarton Campus, Edinburgh, Midlothian, Scotland	Heriot Watt University	Gormley, M (corresponding author), Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Riccarton Campus, Edinburgh, Midlothian, Scotland.	m.gormley@hw.ac.uk		Kelly, David/0000-0003-4230-8823; Gormley, Michael/0000-0003-3418-4621; Aspray, Thomas/0000-0001-7087-1846	Dyteqta Ltd. [D13R10169]	Dyteqta Ltd.	A small Funding grant ((sic)15k) was obtained from Dyteqta Ltd., Funding No. D13R10169. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had final responsibility for the decision to submit for publication.	[Anonymous], 1882015 ANSI ASHRAE; [Anonymous], 2013, WHOCDSCSRGAR2003; Aspray TJ, 2005, FEMS MICROBIOL ECOL, V54, P317, DOI 10.1016/j.femsec.2005.04.007; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; British Standards Institute, 2003, 1469812003 BS EN ISO; British Standards Institution, 2000, 120562 BS EN; CHANG CW, 1994, APPL ENVIRON MICROB, V60, P3732, DOI 10.1128/AEM.60.10.3732-3738.1994; CIBSE, 2013, TM13 MIN RISK LEG DI; Gebra CP, 1975, APPL ENVIRON MICROB, V30, P229; Gormley M, 2007, BUILD SERV ENG RES T, V28, P55, DOI 10.1177/0143624406071980; Gormley M, 2014, BUILD SERV ENG RES T, V35, P244, DOI 10.1177/0143624413485080; Gormley M, 2012, BUILD SERV ENG RES T, V33, P203, DOI 10.1177/0143624411410619; Gormley M, IND AIR 2014 13 INT, P132; Hathway EA, 2011, BUILD ENVIRON, V46, P2500, DOI 10.1016/j.buildenv.2011.06.001; Hung HCK, 2006, BUILD SERV ENG RES T, V27, P91, DOI 10.1191/0143624406bt145oa; Moore G, 2013, BIOFILMS INFECT PREV; Moore G, 2015, BIOFOULING, V31, P677, DOI 10.1080/08927014.2015.1089986; OECD, 2005, LESS DANG SCH SAF SE; Pitts B, 1998, BIOFOULING, V13, P19, DOI 10.1080/08927019809378368; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232, DOI 10.1128/AEM.61.4.1232-1239.1995; Swaffield, 2015, TRANSIENT FREE SURFA; Swaffield J., 2010, TRANSIENT AIRFLOWS B; Swaffield J. A., 2005, Building Services Engineering Research & Technology, V26, P195, DOI 10.1191/0143624405bt120oa; Swaffield JA, 2005, PRESSURE TRANSIENT I, V26, P99; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Walker J, 2015, J HOSP INFECT, V89, P324, DOI 10.1016/j.jhin.2014.11.019; Wise AFE, 1995, WATER SANITARY WASTE	29	42	42	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171556	10.1371/journal.pone.0171556	http://dx.doi.org/10.1371/journal.pone.0171556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187135	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300030
J	Jang, MH; Kim, HJ; Chung, YR; Lee, Y; Park, SY				Jang, Min Hye; Kim, Hyun Jung; Chung, Yul Ri; Lee, Yangkyu; Park, So Yeon			A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PROGESTERONE-RECEPTOR; PROGNOSTIC-SIGNIFICANCE; PRIMARY THERAPY; KI67; RECOMMENDATIONS; HIGHLIGHTS; SUBTYPES; TUMOR; INDEX	In spite of the usefulness of the Ki-67 labeling index (LI) as a prognostic and predictive marker in breast cancer, its clinical application remains limited due to variability in its measurement and the absence of a standard method of interpretation. This study was designed to compare the two methods of assessing Ki-67 LI: the average method vs. the hot spot method and thus to determine which method is more appropriate in predicting prognosis of luminal/HER2-negative breast cancers. Ki-67 Lls were calculated by direct counting of three representative areas of 493 luminal/HER2-negative breast cancers using the two methods. We calculated the differences in the Ki-67 Lls (Delta Ki-67) between the two methods and the ratio of the Ki-67 Lls (H/A ratio) of the two methods. In addition, we compared the performance of the Ki-67 Lls obtained by the two methods as prognostic markers. AKi-67 ranged from 0.01% to 33.3% and the H/A ratio ranged from 1.0 to 2.6. Based on the receiver operating characteristic curve method, the predictive powers of the KI-67 LI measured by the two methods were similar (Area under curve: hot spot method, 0.711; average method, 0.700). In multivariate analysis, high Ki-67 LI based on either method was an independent poor prognostic factor, along with high T stage and node metastasis. However, in repeated counts, the hot spot method did not consistently classify tumors into high vs. low Ki-67 LI groups. In conclusion, both the average and hot spot method of evaluating Ki-67 LI have good predictive performances for tumor recurrence in luminal/HER2-negative breast cancers. However, we recommend using the average method for the present because of its greater reproducibility.	[Jang, Min Hye; Kim, Hyun Jung; Lee, Yangkyu; Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Jang, Min Hye] Yeungnam Univ, Med Ctr, Dept Pathol, Daegu, South Korea; [Chung, Yul Ri; Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Yeungnam University; Seoul National University (SNU)	Park, SY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea.; Park, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.	sypmd@snu.ac.kr		Park, So Yeon/0000-0002-0299-7268	National Research Foundation of Korea (NRF)'s Basic Science Research Program - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A2A01007907]	National Research Foundation of Korea (NRF)'s Basic Science Research Program - Ministry of Science, ICT and Future Planning	This study was funded by a grant from the National Research Foundation of Korea (NRF)'s Basic Science Research Program funded by the Ministry of Science, ICT and Future Planning (Grant No. NRF-2015R1A2A2A01007907) to Park SY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima N, 2016, ONCOLOGY-BASEL, V90, P43, DOI 10.1159/000441525; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chung YR, 2016, J PATHOL TRANSL MED, V50, P129, DOI 10.4132/jptm.2015.12.24; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Feeley LP, 2014, MODERN PATHOL, V27, P554, DOI 10.1038/modpathol.2013.153; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Honma N, 2015, BREAST CANCER-TOKYO, V22, P71, DOI 10.1007/s12282-013-0455-5; Iwamoto T, 2012, J CLIN ONCOL, V30, P729, DOI 10.1200/JCO.2011.36.2574; Leung SCY, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.14; LOPEZ F, 1991, CYTOMETRY, V12, P42, DOI 10.1002/cyto.990120107; Mu K, 2015, ANN DIAGN PATHOL, V19, P243, DOI 10.1016/j.anndiagpath.2015.05.002; Nishimura R, 2014, MOL CLIN ONCOL, V2, P1062, DOI 10.3892/mco.2014.400; Polley MYC, 2015, MODERN PATHOL, V28, P778, DOI 10.1038/modpathol.2015.38; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Prabhu JS, 2014, J CANCER, V5, P156, DOI 10.7150/jca.7668; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sato K, 2016, BREAST CANCER-TOKYO, V23, P310, DOI 10.1007/s12282-014-0575-6; Shui RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125131; Varga Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123435; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yamamoto Shinya, 2015, Clin Breast Cancer, V15, pe35, DOI 10.1016/j.clbc.2014.09.005; Zong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095629	28	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172031	10.1371/journal.pone.0172031	http://dx.doi.org/10.1371/journal.pone.0172031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187177	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300070
J	Marczyk, J				Marczyk, Jesse			Human punishment is not primarily motivated by inequality	PLOS ONE			English	Article							FAIRNESS; INTENTIONS	Previous theorizing about punishment has suggested that humans desire to punish inequality per se. However, the research supporting such an interpretation contains important methodological confounds. The main objective of the current experiment was to remove those confounds in order to test whether generating inequality per se is punished. Participants were recruited from an online market to take part in a wealth-alteration game with an ostensible second player. The participants were given an option to deduct from the other player's payment as punishment for their behavior during the game. The results suggest that human punishment does not appear to be motivated by inequality per se, as inequality that was generated without inflicting costs on others was not reliably punished. Instead, punishment seems to respond primarily to the infliction of costs, with inequality only becoming relevant as a secondary input for punishment decisions. The theoretical significance of this finding is discussed in the context of its possible adaptive value.	[Marczyk, Jesse] New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA	New Mexico State University	Marczyk, J (corresponding author), New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA.	jmarczyk@nmsu.edu						Aaroe L, 2014, J POLIT, V76, P684, DOI 10.1017/S002238161400019X; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Berinsky A., 2010, POLITICAL ANAL; Blake PR, 2015, NATURE, V528, P258, DOI 10.1038/nature15703; Bone JE, 2015, EVOL HUM BEHAV, V36, P323, DOI 10.1016/j.evolhumbehav.2015.02.002; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; DeScioli P, 2009, COGNITION, V112, P281, DOI 10.1016/j.cognition.2009.05.008; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Houser D, 2010, ECON LETT, V109, P20, DOI 10.1016/j.econlet.2010.07.008; Kurzban R, 2012, EVOL HUM BEHAV, V33, P323, DOI 10.1016/j.evolhumbehav.2011.11.002; Marczyk J., 2015, EVOLUTIONARY PSYCHOL, V1, P77; Marczyk J, 2014, EVOL HUM BEHAV, V35, P272, DOI 10.1016/j.evolhumbehav.2014.02.007; Raihani NJ, 2012, BIOL LETTERS, V8, P802, DOI 10.1098/rsbl.2012.0470; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Shaw Alex, 2013, Behav Brain Sci, V36, P100, DOI 10.1017/S0140525X12000878; Shaw A, 2012, J EXP PSYCHOL GEN, V141, P382, DOI 10.1037/a0025907; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055	22	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171298	10.1371/journal.pone.0171298	http://dx.doi.org/10.1371/journal.pone.0171298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187166	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300016
J	Palidis, DJ; Wyder-Hodge, PA; Fooken, J; Spering, M				Palidis, Dimitrios J.; Wyder-Hodge, Pearson A.; Fooken, Jolande; Spering, Miriam			Distinct eye movement patterns enhance dynamic visual acuity	PLOS ONE			English	Article							BASEBALL PLAYERS; MOVING TARGETS; TRACKING; PERFORMANCE; RESOLUTION; MOTION; BALL; PERCEPTION; SACCADES; VISION	Dynamic visual acuity (DVA) is the ability to resolve fine spatial detail in dynamic objects during head fixation, or in static objects during head or body rotation. This ability is important for many activities such as ball sports, and a close relation has been shown between DVA and sports expertise. DVA tasks involve eye movements, yet, it is unclear which aspects of eye movements contribute to successful performance. Here we examined the relation between DVA and the kinematics of smooth pursuit and saccadic eye movements in a cohort of 23 varsity baseball players. In a computerized dynamic-object DVA test, observers reported the location of the gap in a small Landolt-C ring moving at various speeds while eye movements were recorded. Smooth pursuit kinematics-eye latency, acceleration, velocity gain, position error-and the direction and amplitude of saccadic eye movements were linked to perceptual performance. Results reveal that distinct eye movement patterns-minimizing eye position error, tracking smoothly, and inhibiting reverse saccades-were related to dynamic visual acuity. The close link between eye movement quality and DVA performance has important implications for the development of perceptual training programs to improve DVA.	[Palidis, Dimitrios J.; Wyder-Hodge, Pearson A.; Fooken, Jolande; Spering, Miriam] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada; [Palidis, Dimitrios J.; Fooken, Jolande; Spering, Miriam] Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC, Canada; [Spering, Miriam] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Spering, M (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC, Canada.; Spering, M (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada.	mspering@mail.ubc.ca			Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC) [RGPIN 418493]; Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund	Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC); Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund	This study was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council Canada (NSERC RGPIN 418493) and Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1984, AM SCI, V72, P249; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN B, 1972, VISION RES, V12, P293, DOI 10.1016/0042-6989(72)90119-8; BROWN B, 1972, VISION RES, V12, P305, DOI 10.1016/0042-6989(72)90120-4; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Demer JL, 2001, ANN NY ACAD SCI, V942, P428; Deveau J, 2014, CURR BIOL, V24, pR146, DOI 10.1016/j.cub.2014.01.004; Diaz G, 2013, J VISION, V13, DOI 10.1167/13.12.5; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Fooken J, 2016, J VISION, V16, DOI 10.1167/16.14.1; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hughes PK, 1993, CLIN EXP OPTOM, V76, P51, DOI DOI 10.1111/J.1444-0938.1993.TB05090.X; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; ISHIGAKI H, 1993, PERCEPT MOTOR SKILL, V77, P835, DOI 10.2466/pms.1993.77.3.835; Jacob R, 2005, OPTOMETRY VISION SCI, V82, P1060, DOI 10.1097/01.opx.0000192346.84549.6a; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Laby DM, 1996, AM J OPHTHALMOL, V122, P476, DOI 10.1016/S0002-9394(14)72106-3; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; Millslagle DG, 2000, PERCEPT MOTOR SKILL, V90, P498, DOI 10.2466/PMS.90.2.498-504; MORRIS GSD, 1977, RES QUART, V48, P480; Moulder MJ, 2013, VISION RES, V81, P6, DOI 10.1016/j.visres.2013.01.004; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Quevedo-Junyent L, 2011, RES Q EXERCISE SPORT, V82, P644, DOI 10.1080/02701367.2011.10599801; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Rouse M W, 1988, J Am Optom Assoc, V59, P946; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tong JL, 2007, VISION RES, V47, P1011, DOI 10.1016/j.visres.2006.12.002; Uchida Y, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0031530; Uchida Y, 2013, MED SCI SPORT EXER, V45, P319, DOI 10.1249/MSS.0b013e31826fec97; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93	39	23	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172061	10.1371/journal.pone.0172061	http://dx.doi.org/10.1371/journal.pone.0172061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187157	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300075
J	Shea, AA; Bernhards, RC; Cote, CK; Chase, CJ; Koehler, JW; Klimko, CP; Ladner, JT; Rozak, DA; Wolcott, MJ; Fetterer, DP; Kern, SJ; Koroleva, GI; Lovett, SP; Palacios, GF; Toothman, RG; Bozue, JA; Worsham, PL; Welkos, SL				Shea, A. A.; Bernhards, R. C.; Cote, C. K.; Chase, C. J.; Koehler, J. W.; Klimko, C. P.; Ladner, J. T.; Rozak, D. A.; Wolcott, M. J.; Fetterer, D. P.; Kern, S. J.; Koroleva, G. I.; Lovett, S. P.; Palacios, G. F.; Toothman, R. G.; Bozue, J. A.; Worsham, P. L.; Welkos, S. L.			Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences	PLOS ONE			English	Article							COLONY MORPHOLOGY VARIATION; ANTIGENIC VARIATION; PSEUDOMONAS-PSEUDOMALLEI; CAPSULAR POLYSACCHARIDE; OXIDATIVE STRESS; ANTIMICROBIAL PEPTIDES; CYSTIC-FIBROSIS; MICROARRAY DATA; D-SERINE; MELIOIDOSIS	Burkholderia pseudomallei (Bp), the agent of melioidosis, causes disease ranging from acute and rapidly fatal to protracted and chronic. Bp is highly infectious by aerosol, can cause severe disease with nonspecific symptoms, and is naturally resistant to multiple antibiotics. However, no vaccine exists. Unlike many Bp strains, which exhibit random variability in traits such as colony morphology, Bp strain MSHR5848 exhibited two distinct and relatively stable colony morphologies on sheep blood agar plates: a smooth, glossy, pale yellow colony and a flat, rough, white colony. Passage of the two variants, designated "Smooth" and "Rough", under standard laboratory conditions produced cultures composed of > 99.9% of the single corresponding type; however, both could switch to the other type at different frequencies when incubated in certain nutritionally stringent or stressful growth conditions. These MSHR5848 derivatives were extensively characterized to identify variant-associated differences. Microscopic and colony morphology differences on six differential media were observed and only the Rough variant metabolized sugars in selective agar. Antimicrobial susceptibilities and lipopolysaccharide (LPS) features were characterized and phenotype microarray profiles revealed distinct metabolic and susceptibility disparities between the variants. Results using the phenotype microarray system narrowed the 1,920 substrates to a subset which differentiated the two variants. Smooth grew more rapidly in vitro than Rough, yet the latter exhibited a nearly 10-fold lower lethal dose for mice than Smooth. Finally, the Smooth variant was phagocytosed and replicated to a greater extent and was more cytotoxic than Rough in macrophages. In contrast, multiple locus sequence type (MLST) analysis, ribotyping, and whole genome sequence analysis demonstrated the variants' genetic conservation; only a single consistent genetic difference between the two was identified for further study. These distinct differences shown by two variants of a Bp strain will be leveraged to better understand the mechanism of Bp phenotypic variability and to possibly identify in vitro markers of infection.	[Shea, A. A.; Chase, C. J.; Koehler, J. W.; Rozak, D. A.; Wolcott, M. J.] USAMRIID, Diagnost Syst Div, Frederick, MD USA; [Bernhards, R. C.; Cote, C. K.; Klimko, C. P.; Toothman, R. G.; Bozue, J. A.; Worsham, P. L.; Welkos, S. L.] USAMRIID, Bacteriol Div, Frederick, MD 21702 USA; [Ladner, J. T.; Koroleva, G. I.; Lovett, S. P.; Palacios, G. F.] USAMRIID, Ctr Genome Sci, Frederick, MD USA; [Fetterer, D. P.; Kern, S. J.] USAMRIID, Biostat Serv Div, Frederick, MD USA; [Bernhards, R. C.] Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA; [Kern, S. J.] NIH, Bldg 10, Bethesda, MD 20892 USA	United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); National Institutes of Health (NIH) - USA	Welkos, SL (corresponding author), USAMRIID, Bacteriol Div, Frederick, MD 21702 USA.	susan.l.welkos.civ@mail.mil	Bozue, Joel/AAE-4363-2022; Palacios, Gustavo/I-7773-2015; Bozue, Joel/AAE-4357-2022; Ladner, Jason/G-3486-2011	Bozue, Joel/0000-0001-6959-8176; Palacios, Gustavo/0000-0001-5062-1938; Bozue, Joel/0000-0001-6959-8176; Ladner, Jason/0000-0001-7751-4366; Koehler, Jeffrey/0000-0003-3225-6599	Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA) [CB3846PPE-1, CB10246]	Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA)	This research was funded by the Joint Science & Technology Office for Chemical & Biological Defense (JSTO-CBD), Defense Threat Reduction Agency (DTRA) - (1) Project CCAR# CB3846PPE-1 Burkholderia (PatriciaWorsham). (2) Project CB10246: High Speed Sequencing for Rapid Response and Countermeasure Development (GustavoPalacios) http://www.dtra. mil/Research/Chemical-Biological-TechnologyD epartment/.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Alice AF, 2006, J BACTERIOL, V188, P1551, DOI 10.1128/JB.188.4.1551-1566.2006; Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; Austin CR, 2015, MBIO, V6, DOI 10.1128/mBio.02462-14; Biggins JB, 2012, J AM CHEM SOC, V134, P13192, DOI 10.1021/ja3052156; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Caballero JD, 2015, MBIO, V6, DOI 10.1128/mBio.00981-15; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00085; Conerly O, 2009, TOXICOLOGICAL REV TH; Conway T, 2015, METABOLISM BACTERIAL; Cuccui J, 2012, INFECT IMMUN, V80, P1209, DOI 10.1128/IAI.05805-11; Cullen L, 2015, PATHOGENS, V4, P66, DOI 10.3390/pathogens4010066; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Daligault HE, 2014, GENOME ANNOUNCE, V2; DANCE DAB, 1991, J ANTIMICROB CHEMOTH, V28, P321, DOI 10.1093/jac/28.2.321; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Fazeli M, 2011, HUM EXP TOXICOL, V30, P152, DOI 10.1177/0960327110369821; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Fox MA, 2012, PEPTIDES, V33, P197, DOI 10.1016/j.peptides.2012.01.013; Fuentes DE, 2007, J BACTERIOL, V189, P8953, DOI 10.1128/JB.01252-07; Galardini M, 2014, GENOMICS, V103, P1, DOI 10.1016/j.ygeno.2013.11.005; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gierok P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004483; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; GRULA EA, 1963, BIOCHIM BIOPHYS ACTA, V74, P776, DOI 10.1016/0006-3002(63)91430-6; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Hayden HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036507; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1; Korte-Berwanger M, 2013, INFECT IMMUN, V81, P4525, DOI 10.1128/IAI.00599-13; Kvitko BH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001715; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Madhongsa K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002267; MATTHEWS DM, 1980, CURR TOP MEMBR TRANS, V14, P331; Meadows JA, 2015, MICROBIOL-SGM, V161, P1161, DOI 10.1099/mic.0.000080; Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140; Mott TM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003863; Mulye M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002988; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Nicholls L, 1930, BRIT J EXP PATHOL, V11, P393; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Ouellette SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016783; Palmer GC, 2015, METABOLISM BACTERIAL, P185; Pletzer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111311; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; ROGUL M, 1972, J BACTERIOL, V112, P372, DOI 10.1128/JB.112.1.372-380.1972; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Ronning CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-202; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Senior NJ, J CYSTIC FIBROSIS; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Sperandio V, 2015, CELL HOST MICROBE, V18, P7, DOI 10.1016/j.chom.2015.06.010; Stanton AT, 1924, J HYG-CAMBRIDGE, V23, P268, DOI 10.1017/S0022172400034197; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tatusova T., 2013, NCBI HDB; Telford JR, 1997, J BIOL INORG CHEM, V2, P750, DOI 10.1007/s007750050191; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Utaisincharoen P, 2001, MICROBIOL IMMUNOL, V45, P307, DOI 10.1111/j.1348-0421.2001.tb02623.x; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vehkala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118392; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wikraiphat C, 2015, INFECT IMMUN, V83, P2127, DOI 10.1128/IAI.02785-14; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6; Wong J, 2015, CELL HOST MICROBE, V18, P38, DOI 10.1016/j.chom.2015.06.002; Woodman ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052276; YANG HM, 1993, INFECT IMMUN, V61, P656, DOI 10.1128/IAI.61.2.656-662.1993; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	98	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171363	10.1371/journal.pone.0171363	http://dx.doi.org/10.1371/journal.pone.0171363			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187198	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300022
J	Zhang, FD; Liu, L; Sun, MY; Sun, JJ; Lu, HZ				Zhang, Fengdi; Liu, Li; Sun, Meiyan; Sun, Jianjun; Lu, Hongzhou			An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; NAIVE HIV-1-INFECTED PATIENTS; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; EFAVIRENZ; TENOFOVIR; METAANALYSIS; LAMIVUDINE; SAFETY	Background Understanding the mechanisms of drug resistance can facilitate better management of antiretroviral therapy, helping to prevent transmission and decrease the morbidity and mortality of people living with HIV/AIDS. However, there is little data about transmitted drug resistance and acquired drug resistance for HIV/AIDS patients in Shanghai. Methods A retrospective cohort study of HIV-infected patients who visited the Department of Infectious Disease from June 2008 to June 2015 was conducted in Shanghai, China. Logistic regression analysis was performed to analyze risk factors for drug resistance among HIV infected people with virological failure. The related collected factors included patient age, gender, marital status, infection route, baseline CD4 count, antiretroviral therapy regimens, time between HIV diagnosis and initiating antiretroviral therapy. Factors with p<0.1 in the univariate logistic regression test were analyzed by multivariate logistic regression test. Results There were 575 subjects selected for this study and 369 participated in this research. For the antiretroviral therapy drugs, the rates of transmitted drug resistance and acquired drug resistance were significantly different. The non -nucleoside reverse transcriptase inhibitor (NNRTI) had the highest drug resistance rate (transmitted drug resistance, 10.9%; acquired drug resistance, 53.3%) and protease inhibitors (Pis) had the lowest drug resistance rate (transmitted drug resistance, 1.7%; acquired drug resistance, 2.7%). Logistic regression analysis found no factors that were related to drug resistance except marital status (married status for tenofovir: odds ratio = 6.345, 95% confidence interval = 1.553-25.921, P = 0.010) and the time span between HIV diagnosis and initiating antiretroviral therapy (<6M for stavudine: odds ratio = 0.271, 95% confidence interval = 0.086-0.850, P = 0.025; <6M for didanosine: odds ratio = 0.284, 95% confidence interval = 0.096-0.842, P = 0.023; <6M for tenofovir: odds ratio = 0.079, 95% confidence interval = 0.018-0.350,P<0.001). Conclusion NNRTI had a higher DR rate compared with nucleoside reverse transcriptase inhibitor (NRTI) and Pls, consequently, LPV/r was a reasonable choice for patients with NNRTI drugs resistance in China. Only married status and a time span <= 6 month between the HIV confirmed date and the time initiating antiretroviral therapy were risk factors for TDF drug resistance. Both baseline HIV-RNA load and resistance test is crucial for TDR diagnosis, and frequent monitoring of HIV-RNA load is crucial for ADR identification and intervention. Treatment adherence still plays a positive role on the outcome of ART.	[Zhang, Fengdi; Liu, Li; Sun, Meiyan; Sun, Jianjun; Lu, Hongzhou] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Hongzhou] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Hongzhou] Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Lu, HZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai, Peoples R China.; Lu, HZ (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China.; Lu, HZ (corresponding author), Fudan Univ, Dept Internal Med, Shanghai Med Coll, Shanghai, Peoples R China.	luhongzhou@fudan.edu.cn			Natural Science Foundation of China [81571977]; National High Technology Research and Development Program (863 Program) [2014AA021403]; fourth round of three-year public health active plan [15GWZK0103]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); fourth round of three-year public health active plan	HZL received the grant of Natural Science Foundation of China (grant 81571977), The National High Technology Research and Development Program (863 Program) (grant 2014AA021403), and the fourth round of three-year public health active plan (grant 15GWZK0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain N, 2011, AIDS, V25, P1481, DOI 10.1097/QAD.0b013e328348dab0; Mata-Marin JA, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0072-9; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Bartolo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113626; Bastos MM, 2016, EUR J MED CHEM, V108, P455, DOI 10.1016/j.ejmech.2015.11.025; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Boyer PL, 2015, ANTIMICROB AGENTS CH, V59, P7184, DOI 10.1128/AAC.05069-14; Bulteel N, 2014, J INFECTION, V68, P77, DOI 10.1016/j.jinf.2013.09.005; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Chung MH, 2016, AIDS; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Etiebet MAA, 2013, AIDS, V27, P553, DOI 10.1097/QAD.0b013e32835b0f59; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Health NIo, GUIDELINES USE ANTIR; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Larru B, 2014, PEDIATR HEALTH MED T, V5, P29, DOI 10.2147/PHMT.S47794; Liu L, 2007, J MED VIROL, V79, P1593, DOI 10.1002/jmv.20998; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Muri L, 2017, AIDS, V31, P61, DOI 10.1097/QAD.0000000000001273; Mutenda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166649; Ndahimana JD, 2016, TROPICAL MED INT HLT; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Rodriguez-French A, 2004, JAIDS-J ACQ IMM DEF, V35, P22, DOI 10.1097/00126334-200401010-00003; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; TenoRes Study G, 2016, LANCET INFECT DIS; Xing YF, 2013, SCI WORLD J, DOI [10.1155/2013/381219, 10.1155/2013/630654]; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077	30	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0165110	10.1371/journal.pone.0165110	http://dx.doi.org/10.1371/journal.pone.0165110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187212	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300001
J	Hocevar, T; Demsar, J				Hocevar, Tomaz; Demsar, Janez			Combinatorial algorithm for counting small induced graphs and orbits	PLOS ONE			English	Article							SUBGRAPHS; NETWORKS	Graphlet analysis is an approach to network analysis that is particularly popular in bioinformatics. We show how to set up a system of linear equations that relate the orbit counts and can be used in an algorithm that is significantly faster than the existing approaches based on direct enumeration of graphlets. The approach presented in this paper presents a generalization of the currently fastest method for counting 5-node graphlets in bioinformatics. The algorithm requires existence of a vertex with certain properties; we show that such vertex exists for graphlets of arbitrary size, except for complete graphs and a cycle with four nodes, which are treated separately. Empirical analysis of running time agrees with the theoretical results.	[Hocevar, Tomaz; Demsar, Janez] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	University of Ljubljana	Hocevar, T (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia.	tomaz.hocevar@fri.uni-lj.si	Demšar, Janez/AAS-2762-2020; Hočevar, Tomaž/GWM-8593-2022	Hocevar, Tomaz/0000-0002-7998-2638	Slovenian research agency [J2-5480, P2-0209]	Slovenian research agency(Slovenian Research Agency - Slovenia)	This work has been funded by the Slovenian research agency (https://www.arrs.gov.si/en/) grants J2-5480 and P2-0209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Alon N, 1997, ALGORITHMICA, V17, P209, DOI 10.1007/BF02523189; Alon N, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn163; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Eppstein D, 2010, LECT NOTES COMPUT SC, V6506, P403, DOI 10.1007/978-3-642-17517-6_36; Floderus P, 2012, 18 ANN INT COMP COMB, P37; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; ITAI A, 1978, SIAM J COMPUT, V7, P413, DOI 10.1137/0207033; Kloks T, 2000, INFORM PROCESS LETT, V74, P115, DOI 10.1016/S0020-0190(00)00047-8; Kowaluk M, 2013, SIAM J DISCRETE MATH, V27, P892, DOI 10.1137/110859798; Kuramochi M, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P313, DOI 10.1109/ICDM.2001.989534; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Marcus D, 2012, COMPUT NETW, V56, P810, DOI 10.1016/j.comnet.2011.08.019; Melckenbeeck I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147078; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Nesetril Jaroslav, 1985, COMMENT MATH UNIV CA, V26, P415; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Vassilevska V, 2009, ACM S THEORY COMPUT, P455	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171428	10.1371/journal.pone.0171428	http://dx.doi.org/10.1371/journal.pone.0171428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182743	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800059
J	Aoki, N; Mochizuki, K; Matsui, Y				Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa			DNA methylation of the Fth1175 '-upstream region regulates differential Fth117 expression in lung cancer cells and germline stem cells	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASES G9A; PROLIFERATION; CHROMATIN; PLZF; SPERMATOGENESIS; UBIQUITINATION; DEMETHYLATION; SPERMATOGONIA; CHROMOSOME; LYSINE-9	The Ferritin heavy polypeptide-like 17 (Fth117) gene is a member of the cancer/testis antigen gene family, and is preferentially expressed in cancer cells and in testis. Although DNA methylation has been linked to the regulation of human FTHL17gene expression, detailed epigenetic regulation of its expression has not been investigated. To address this, we assessed the epigenetic regulation of murine Fth117gene expression in cancer cells and germ cells. Fthll7was more highly expressed in testis, a murine lung cancer cell line, KLN205, and in germline stem cells (GSCs) than in normal lung tissues. Furthermore, the Fth117expression level in GSCs was significantly higher than in KLN205 cells. We performed bisulfite-sequencing and luciferase (luc) reporter assays to examine the role of DNA methylation of the Fth/l7promoter in the regulation of Fth117expression. In KLN205 cells, testis, and GSCs, the Fth//75'-upstream region was hypo -methylated compared with normal lung tissues. Luc reporter assays indicated that hypo-methylation of the -0.6 kb to 0 kb region upstream from the transcription start site (TSS) was involved in the up -regulation of Fth/17 expression in KLN205 cells and GSCs. Because the -0.6 kb to -0.3 kb or the -0.3 kb to 0 kb region were relatively more hypo -methylated in KLN205 cells and in GSCs, respectively, compared with other regions between -0.6 kb to 0 kb, those regions may contribute to Fth117 up -regulation in each cell type. Following treatment with 5-Azacytidine, the -0.3 kb to 0 kb region became hypo -methylated, and Fth/17 expression was up -regulated in KLN205 cells to a level comparable to that in GSCs. Together, the results suggest that hypo-methylation of different but adjacent regions immediately upstream of the Fth117gene contribute to differential expression levels in lung cancer cells and GSCs, and hypo-methylation of the TSS-proximal region may be critical for high level expression.	[Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan; [Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Mochizuki, Kentaro; Matsui, Yasuhisa] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, AMED CREST, Tokyo, Japan; [Matsui, Yasuhisa] Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, AMED CREST, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Division for Interdisciplinary Advanced Research and Education in Tohoku University; Ministry of Education, Culture, Sports, Science and Technology of Japan [25114003]; AMED-CREST from the Japan Agency for Medical Research and Development [16gm0510017h0004]; Grants-in-Aid for Scientific Research [25114003] Funding Source: KAKEN	Division for Interdisciplinary Advanced Research and Education in Tohoku University; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Division for Interdisciplinary Advanced Research and Education in Tohoku University (http://mv.iiare.tohoku.ac. jp/ed ucation/indextitrni), by Grants-in-Aid for Scientific Research on Innovative Areas (grant #25114003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/index.html) and by AMED-CREST (16gm0510017h0004) from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Choi WI, 2014, J BIOL CHEM, V289, P18625, DOI 10.1074/jbc.M113.538751; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Honda T, 2004, BRIT J CANCER, V90, P838, DOI 10.1038/sj.bjc.6601600; Hsu SH, 2005, CANCER RES, V65, P4041, DOI 10.1158/0008-5472.CAN-04-3658; Ikeda R, 2013, DNA RES, V20, P549, DOI 10.1093/dnares/dst030; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kobayashi S, 2010, NUCLEIC ACIDS RES, V38, P3672, DOI 10.1093/nar/gkq113; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Lovelace DL, 2016, DEVELOPMENT, V143, P1893, DOI 10.1242/dev.132761; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ruzzenenti P, 2015, BBA-GEN SUBJECTS, V1850, P1267, DOI 10.1016/j.bbagen.2015.02.016; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sin HS, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0159-8; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; WEBER J, 1994, CANCER RES, V54, P1766	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172219	10.1371/journal.pone.0172219	http://dx.doi.org/10.1371/journal.pone.0172219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207785	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500101
J	Li, XC; Huang, CM; Zhong, CF; Liang, RW; Luo, SJ				Li, Xiao-Chuan; Huang, Chun-Ming; Zhong, Cheng-Fan; Liang, Rong-Wei; Luo, Shao-Jian			Minimally invasive procedure reduces adjacent segment degeneration and disease: New benefit-based global meta-analysis	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; COST-EFFECTIVENESS ANALYSIS; SURGERY; OUTCOMES; PATHOLOGY; RISK; SPONDYLOLISTHESIS; STENOSIS; MINIMUM; QUALITY	Objective Adjacent segment pathology (ASP) is a common complication presenting in patients with axial pain and dysfunction, requiring treatment or follow-up surgery. However, whether minimally invasive surgery (MIS), including MIS transforaminal / posterior lumbar interbody fusion (MIS-TLIF/PLIF) decreases the incidence rate of ASP remains unknown. The aim of this meta-analysis was to compare the incidence rate of ASP in patients undergoing MIS versus open procedures. Methods This systematic review was undertaken by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. We searched electronic databases, including PubMed, EMBASE, SinoMed, and the Cochrane Library, without language restrictions, to identify clinical trials comparing MIS to open procedures. The results retrieved were last updated on June 15, 2016. Results Overall, 9 trials comprising 770 patients were included in the study; the quality of the studies included 4 moderate and 5 low-quality studies. The pooled data analysis demonstrated low heterogeneity between the trials and a significantly lower ASP incidence rate in patients who underwent MIS procedure, compared with those who underwent open procedure (p = 0.0001). Single-level lumbar interbody fusion was performed in 6 trials of 408 patients and we found a lower ASP incidence rate in MIS group, compared with those who underwent open surgery (p = 0.002). Moreover, the pooled data analysis showed a significant reduction in the incidence rate of adjacent segment disease (ASDis) (p = 0.0003) and adjacent segment degeneration (ASDeg) (p = 0.0002) for both procedures, favoring MIS procedure. Subgroup analyses showed no difference in follow-up durations between the procedures (p = 0.93). Conclusion Therefore, we conclude that MIS-TLIF/PLIF can reduce the incidence rate of ASDis and ASDeg, compared with open surgery. Although the subgroup analysis did not indicate a difference in follow-up duration between the two procedures, larger-scale, well-designed clinical trials with extensive follow-up are needed to confirm and update the findings of this analysis.	[Li, Xiao-Chuan; Huang, Chun-Ming; Zhong, Cheng-Fan; Liang, Rong-Wei; Luo, Shao-Jian] Gaozhou Peoples Hosp, Dept Orthoped Surg, Maoming, Guangdong, Peoples R China		Luo, SJ (corresponding author), Gaozhou Peoples Hosp, Dept Orthoped Surg, Maoming, Guangdong, Peoples R China.	lixcgzph@163.com						Adogwa O, 2015, WORLD NEUROSURG, V83, P860, DOI 10.1016/j.wneu.2014.12.034; Adogwa O, 2013, J NEUROSURG-SPINE, V18, P147, DOI 10.3171/2012.11.SPINE12226; Ahn J, 2015, J SPINAL DISORD TECH, V28, P222, DOI 10.1097/BSD.0000000000000289; Alentado VJ, 2016, SPINE, V41, P1167, DOI 10.1097/BRS.0000000000001493; Archavlis E, 2013, EUR SPINE J, V22, P1731, DOI 10.1007/s00586-013-2732-6; Chung JY, 2016, ASIAN SPINE J, V10, P582, DOI 10.4184/asj.2016.10.3.582; Goldstein CL, 2014, CLIN ORTHOP RELAT R, V472, P1727, DOI 10.1007/s11999-014-3465-5; Gu GF, 2014, INT ORTHOP, V38, P817, DOI 10.1007/s00264-013-2169-x; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Ishii K, 2014, SPINE J, V14, pS65; LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029; Lee JC, 2015, ASIAN SPINE J, V9, P807, DOI 10.4184/asj.2015.9.5.807; Lee JK, 2016, SPINE, V41, pE785, DOI 10.1097/BRS.0000000000001387; Li XC, 2016, PAIN PHYSICIAN, V19, P103; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lund T, 2011, ORTHOP CLIN N AM, V42, P529, DOI 10.1016/j.ocl.2011.07.006; Meerpohl JJ, 2012, Z EVIDENZ FORTBILD Q, V106, P449, DOI 10.1016/j.zefq.2012.06.013; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Pan AX, 2016, EUR SPINE J, V25, P1522, DOI 10.1007/s00586-016-4415-6; Parker SL, 2014, WORLD NEUROSURG, V82, P230, DOI 10.1016/j.wneu.2013.01.041; Parker SL, 2014, SPINE J, V14, pS64; Radcliff KE, 2014, ORTHOP SURG, V6, P118, DOI 10.1111/os.12103; Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020; Ren Chunpeng, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS245, DOI 10.1007/s00590-014-1445-9; Rodriguez-Vela J, 2013, EUR SPINE J, V22, P2857, DOI 10.1007/s00586-013-2853-y; Rothenfluh DA, 2015, EUR SPINE J, V24, P1251, DOI 10.1007/s00586-014-3454-0; Saavedra-Pozo FM, 2014, OCHSNER J, V14, P78; Scemama C, 2016, J NEUROSURG-SPINE, V25, P46, DOI 10.3171/2015.11.SPINE15700; Seng CS, 2013, SPINE, V38, P2049, DOI 10.1097/BRS.0b013e3182a8212d; Shriver MF, 2015, SPINE J, V15, P2016, DOI 10.1016/j.spinee.2015.05.010; St-Pierre GH, 2016, SPINE, V41, P265, DOI 10.1097/BRS.0000000000001158; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tobert DG, 2016, CLIN SPINE SURG; Tsutsumimoto T, 2013, EUR SPINE J; Virk SS, 2014, ORTHOPEDICS, V37, P547, DOI 10.3928/01477447-20140728-08; Wang JC, 2012, SPINE, V37, pS133, DOI 10.1097/BRS.0b013e31826cadf2; Watanabe K, 2011, J NEUROSURG-SPINE, V14, P51, DOI 10.3171/2010.9.SPINE09933; Wong AP, 2014, NEUROSURG CLIN N AM, V25, P279, DOI 10.1016/j.nec.2013.12.007; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Yee TJ, 2014, J CLIN NEUROSCI, V21, P1796, DOI 10.1016/j.jocn.2014.03.010; YU Weiyang, 2015, ZHEJIANG JOURNAL OF, V2015; Zhou ZJ, 2013, TURK NEUROSURG, V23, P579, DOI 10.5137/1019-5149.JTN.6573-12.1	43	14	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171546	10.1371/journal.pone.0171546	http://dx.doi.org/10.1371/journal.pone.0171546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207762	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500035
J	Ouyang, XH; Panetta, NJ; Talbott, MD; Payumo, AY; Halluin, C; Longaker, MT; Chen, JK				Ouyang, Xiaohu; Panetta, Nicholas J.; Talbott, Maya D.; Payumo, Alexander Y.; Halluin, Caroline; Longaker, Michael T.; Chen, James K.			Hyaluronic acid synthesis is required for zebrafish tail fin regeneration	PLOS ONE			English	Article							MOLECULAR-MASS HYALURONAN; TISSUE REGENERATION; CAUDAL FIN; VERTEBRATE REGENERATION; HEART REGENERATION; LIMB REGENERATION; WOUND EPIDERMIS; PROLIFERATION; MIGRATION; BLASTEMA	Using genome-wide transcriptional profiling and whole-mount expression analyses of zebrafish larvae, we have identified hyaluronan synthase 3 (has3) as an upregulated gene during caudal fin regeneration. has3 expression is induced in the wound epithelium within hours after tail amputation, and its onset and maintenance requires fibroblast growth factor, phosphoinositide 3-kinase, and transforming growth factor-beta signaling. Inhibition of hyaluronic acid (HA) synthesis by the small molecule 4-methylumbelliferone (4-MU) impairs tail regeneration in zebrafish larvae by preventing injury-induced cell proliferation. In addition, 4-MU reduces the expression of genes associated with wound epithelium and blastema function. Treatment with glycogen synthase kinase 3 inhibitors rescues 4-MU induced defects in cell proliferation and tail regeneration, while restoring a subset of wound epithelium and blastema markers. Our findings demonstrate a role for HA biosynthesis in zebrafish tail regeneration and delineate its epistatic relationships with other regenerative processes.	[Ouyang, Xiaohu; Talbott, Maya D.; Payumo, Alexander Y.; Halluin, Caroline; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Panetta, Nicholas J.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Chen, James K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Panetta, Nicholas J.] Univ Pittsburgh, Med Ctr, Dept Plast Surg, Pittsburgh, PA USA	Stanford University; Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011; Ouyang, Xiaohu/V-4452-2017	Chen, James/0000-0002-9220-8436; Ouyang, Xiaohu/0000-0003-1600-0251; Talbott, Maya/0000-0003-1197-2705	Stanford Interdisciplinary Graduate Fellowship; Hagey Fellowship in Pediatric Regenerative Medicine; Stanford Bio-X Undergraduate Summer Research Program Award; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Gunn/Olivier Fund; California Institute for Regenerative Medicine [TR1-01249]; National Institutes of Health, NHLBI [U01 HL099776]; National Institutes of Health, NICHD, NIH Pioneer Award [DP1 HD075622]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; Hagey Fellowship in Pediatric Regenerative Medicine; Stanford Bio-X Undergraduate Summer Research Program Award; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Gunn/Olivier Fund; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NICHD, NIH Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: Stanford Interdisciplinary Graduate Fellowship, https//vpge.stanford.edu/fellmaships-funding/sisf, XO; Hagey Fellowship in Pediatric Regenerative Medicine, NJP; Stanford Bio-X Undergraduate Summer Research Program Award, http://biox.stanford.edu/research/undergraduate-research, MDT; Hagey Laboratory for Pediatric Regenerative Medicine, MTL; Oak Foundation, http://oakfrid.org, MTL; Gunn/Olivier Fund, MTL; California Institute for Regenerative Medicine, TR1-01249, https://www.cirm.ca.gov, MTL; National Institutes of Health, NHLBI. U01 HL099776, https://www.nhib. nh.gov, MTL; National Institutes of Health, NICHD, NIH Pioneer Award, DP1 HD075622, naps:// commonfund.nh.govipioneer/index, JKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Campbell LJ, 2008, CELL MOL LIFE SCI, V65, P73, DOI 10.1007/s00018-007-7433-z; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Govindan J, 2015, GENE EXPR PATTERNS; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koprunner M, 2000, MECH DEVELOP, V90, P275, DOI 10.1016/S0925-4773(99)00238-5; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Letamendia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036690; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Missinato MA, 2015, CARDIOVASC RES, V107, P487, DOI 10.1093/cvr/cvv190; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Nakatani Y, 2008, DEV GROWTH DIFFER, V50, P71, DOI 10.1111/j.1440-169x.2007.00977.x; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	60	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171898	10.1371/journal.pone.0171898	http://dx.doi.org/10.1371/journal.pone.0171898			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207787	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500058
J	Balan, A; Szaingurten-Solodkin, I; Swissa, SS; Feinshtein, V; Huleihel, M; Holcberg, G; Dukler, D; Beharier, O				Balan, Adelina; Szaingurten-Solodkin, Irit; Swissa, Shani S.; Feinshtein, Valeria; Huleihel, Mahmoud; Holcberg, Gershon; Dukler, Doron; Beharier, Ofer			The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models	PLOS ONE			English	Article							ENDOTHELIAL NITRIC-OXIDE; ANGIOTENSIN-II; ACUTE-HYPOXIA; MOUSE MODEL; FETAL; PREECLAMPSIA; PERFUSION; HYPERTENSION; HYPOXEMIA; IMBALANCE	Introduction Research in animal models and preliminary clinical studies in humans support the use of pravastatin for the prevention of preeclampsia. However, its use during pregnancy is still controversial due to limited data about its effect on the human placenta and fetus. Methods In the present study, human placental cotyledons were perfused in the absence or presence of pravastatin in the maternal reservoir (PraM). In addition, placental explants were treated with pravastatin for 5, 24 and 72 h under normoxia and hypoxia. We monitored the secretion of placental growth factor (PIGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), endothelial nitric oxide synthase (eNOS) expression and activation and the fetal vasoconstriction response to angiotensin-II. Results The concentrations of PIGF, sFlt-1 and sEng were not significantly altered by pravastatin in PraM cotyledons and in placental explants compared to control. Under hypoxic conditions, pravastatin decreased sFlt-1 concentrations. eNOS expression was significantly increased in PraM cotyledons but not in pravastatin-treated placental explants cultured under normoxia or hypoxia. eNOS phosphorylation was not significantly affected by pravastatin. The feto-placental vascular tone and the fetal vasoconstriction response to angiotensin-II, did not change following exposure of the maternal circulation to pravastatin. Conclusion We found that pravastatin does not alter the essential physiological functions of the placenta investigated in the study. The relevance of the study lays in the fact that it expands the current knowledge obtained thus far regarding the effect of the drug on the normal human placenta. This data is reassuring and important for clinicians that consider the treatment of high-risk patients with pravastatin, a treatment that exposes some normal pregnancies to the drug.	[Balan, Adelina; Swissa, Shani S.; Huleihel, Mahmoud] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Fac Hlth Sci, Beer Sheva, Israel; [Szaingurten-Solodkin, Irit] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Feinshtein, Valeria] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Holcberg, Gershon; Dukler, Doron; Beharier, Ofer] Soroka Univ, Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel; [Holcberg, Gershon; Dukler, Doron; Beharier, Ofer] Ben Gurion Univ Negev, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Beharier, O (corresponding author), Soroka Univ, Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel.; Beharier, O (corresponding author), Ben Gurion Univ Negev, Beer Sheva, Israel.	oferbeharier@gmail.com	Beharier, Ofer/AAC-8016-2021	Huleihel, Mahmoud/0000-0003-4246-9299	Faculty of Health Sciences, Ben-Gurion University of the Negev; Soroka University Medical Center	Faculty of Health Sciences, Ben-Gurion University of the Negev; Soroka University Medical Center	This study was sponsored by the "Medical Research during residency program fund granted by the Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Ala-Kokko TI, 2000, INT J OBSTET ANESTH, V9, P26, DOI 10.1054/ijoa.1999.0312; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Burke SD, 2016, J CLIN INVEST, V126, P2561, DOI 10.1172/JCI83918; Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; COHN HE, 1974, AM J OBSTET GYNECOL, V120, P817, DOI 10.1016/0002-9378(74)90587-0; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Gillis EE, 2016, HYPERTENSION, V67, P647, DOI 10.1161/HYPERTENSIONAHA.115.06071; Girardi G, 2014, J REPROD IMMUNOL, V101, P161, DOI 10.1016/j.jri.2013.07.005; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gostamme MM, 2015, AM J OBSTET GYNECOL, V214; JONES CT, 1975, J PHYSIOL-LONDON, V248, P15, DOI 10.1113/jphysiol.1975.sp010960; Kaesemeyer WH, 1999, J AM COLL CARDIOL, V33, P234, DOI 10.1016/S0735-1097(98)00514-2; Kane AD, 2012, J PHYSIOL-LONDON, V590, P323, DOI 10.1113/jphysiol.2011.217968; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Lefkou E, 2016, J CLIN INVEST, V126, P2933, DOI 10.1172/JCI86957; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Low JA, 2004, BEST PRACT RES CL OB, V18, P375, DOI 10.1016/j.bpobgyn.2004.02.002; Ma FX, 2005, CARDIOVASC DRUG REV, V23, P281; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mathiesen L, 2010, REPROD TOXICOL, V30, P138, DOI 10.1016/j.reprotox.2010.01.006; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Morrison S, 2003, J PHYSIOL-LONDON, V547, P283, DOI 10.1113/jphysiol.2002.032615; MYATT L, 1992, AM J OBSTET GYNECOL, V166, P224, DOI 10.1016/0002-9378(92)91863-6; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Odiari EA, 2012, HUM REPROD, V27, P2933, DOI 10.1093/humrep/des288; Pauli JM, 2015, OBSTET GYN CLIN N AM, V42, P299, DOI 10.1016/j.ogc.2015.01.007; Ramma W, 2014, J REPROD IMMUNOL, V101, P153, DOI 10.1016/j.jri.2013.12.120; Saad AF, 2014, REPROD SCI, V21, P138, DOI 10.1177/1933719113492207; Schneider H, 1985, Contrib Gynecol Obstet, V13, P98; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; Vahakangas K, 2006, MUTAT RES-GEN TOX EN, V608, P129, DOI 10.1016/j.mrgentox.2006.02.014; von Dadelszen P, 2011, BJOG-INT J OBSTET GY, V118, P624, DOI 10.1111/j.1471-0528.2010.02879.x; Yan C, 2003, ARTERIOSCL THROM VAS, V23, P26, DOI 10.1161/01.ATV.0000046231.17365.9D; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	45	24	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172174	10.1371/journal.pone.0172174	http://dx.doi.org/10.1371/journal.pone.0172174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199380	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400080
J	Choi, BY; Bair, E; Lee, JW				Choi, Byeong Yeob; Bair, Eric; Lee, Jae Won			Nearest shrunken centroids via alternative genewise shrinkages	PLOS ONE			English	Article							LINEAR DISCRIMINANT-ANALYSIS; VARIABLE SELECTION; ORACLE PROPERTIES; CLASS PREDICTION; EXPRESSION; CLASSIFICATION; CANCER; MICROARRAYS; DISCOVERY; DIAGNOSIS	Nearest shrunken centroids (NSC) is a popular classification method for microarray data. NSC calculates centroids for each class and "shrinks" the centroids toward 0 using soft thresholding. Future observations are then assigned to the class with the minimum distance between the observation and the (shrunken) centroid. Under certain conditions the soft shrinkage used by NSC is equivalent to a LASSO penalty. However, this penalty can produce biased estimates when the true coefficients are large. In addition, NSC ignores the fact that multiple measures of the same gene are likely to be related to one another. We consider several alternative genewise shrinkage methods to address the aforementioned shortcomings of NSC. Three alternative penalties were considered: the smoothly clipped absolute deviation (SCAD), the adaptive LASSO (ADA), and the minimax concave penalty (MCP). We also showed that NSC can be performed in a genewise manner. Classification methods were derived for each alternative shrinkage method or alternative genewise penalty, and the performance of each new classification method was compared with that of conventional NSC on several simulated and real microarray data sets. Moreover, we applied the geometric mean approach for the alternative penalty functions. In general the alternative (genewise) penalties required fewer genes than NSC. The geometric mean of the class-specific prediction accuracies was improved, as well as the overall predictive accuracy in some cases. These results indicate that these alternative penalties should be considered when using NSC.	[Choi, Byeong Yeob] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Choi, Byeong Yeob; Bair, Eric] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bair, Eric] Univ N Carolina, Dept Endodont, Chapel Hill, NC USA; [Lee, Jae Won] Korea Univ, Dept Stat, Seoul, South Korea	University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Lee, JW (corresponding author), Korea Univ, Dept Stat, Seoul, South Korea.	jael@korea.ac.kr		Choi, Byeong Yeob/0000-0002-4205-1442	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016943438]; NIH/NIDCR [R03DE02359]; NIH/NCATS [UL1RR02574]; NIH/NIEHS [P03ES01012]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2016943438). Eric Bair was partially supported by NIH/NIDCR grant R03DE02359, NIH/NCATS grant UL1RR02574, and NIH/NIEHS grant P03ES01012.	Antoniadis A, 2001, J AM STAT ASSOC, V96, P939, DOI 10.1198/016214501753208942; BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gravier E, 2010, GENE CHROMOSOME CANC, V49, P1125, DOI 10.1002/gcc.20820; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Lusa, 2013, BMC BIOINFORMATICS, V14, P1; Mai Q, 2012, BIOMETRIKA, V99, P29, DOI 10.1093/biomet/asr066; Pang H, 2009, BIOMETRICS, V65, P1021, DOI 10.1111/j.1541-0420.2009.01200.x; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shao J, 2011, ANN STAT, V39, P1241, DOI 10.1214/10-AOS870; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2003, STAT SCI, V18, P104, DOI 10.1214/ss/1056397488; Wang SJ, 2007, BIOINFORMATICS, V23, P972, DOI 10.1093/bioinformatics/btm046; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171068	10.1371/journal.pone.0171068	http://dx.doi.org/10.1371/journal.pone.0171068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199352	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400022
J	Hu, YX; Bai, Y; Hua, ZY; Yang, J; Yang, HH; Chen, WJ; Xu, JW; Zhao, ZQ				Hu, Yunxia; Bai, Yu; Hua, Zhiyun; Yang, Jie; Yang, Huahui; Chen, Wenjun; Xu, Junwei; Zhao, Zhiqiang			Effect of Chinese patent medicine Si-Mo-Tang oral liquid for functional dyspepsia: A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Article							PATHOGENESIS; EXTRACT	Background Si-Mo-Tang oral liquid (SMT) has been widely used to treat functional dyspepsia (FD), but the effectiveness is still controversial. A systematic review and meta-analysis of randomized controlled trials (RCTs) were performed to assess the efficacy and adverse effects of SMT for FD. Methods Investigators searched for articles with publication dates to June 21, 2016, from 9 English and Chinese electronic databases. Comparisons were SMT alone or SMT in combination with western medicine as experimental intervention, and western medicine or placebo as the control. We used the Cochrane collaboration tool for assessing risk of bias to evaluate methodologies. Data were synthesized with RevMan 5.3 software. (PROSPERO Registration #CRD42016042003) Results Twenty-seven RCTs were included in the review, involving 2,713 participants: 1,383 subjects were in the experimental group and 1,330 in the control group. SMT showed a significant improvement in clinical efficacy (RR 1.14; 95% CI 1.09, 1.20; P<0.00001), but the heterogeneity was also significant (P = 0.0002,I-2 = 56%). Because of the different interventions in the 2 groups, we performed subgroup and sensitivity analyses to investigate potential sources of heterogeneity. The heterogeneity was smaller after subgroup analysis and the exclusion of a study by Zhu from 2009. The corresponding pooled RR has no obvious change (RR 1.17; 95% CI 1.13, 1.21; P<0.00001). Subgroup analysis by age and drugs administered in control interventions between SMT and western medicine also showed improvement in the efficacy rate. But a data synthesis that excluded high risk of bias in the blinding of participants and personnel showed no significant difference (RR 1.14; 95% CI 0.97, 1.35; P = 0.12). Three studies measured gastric emptying. Two of these studies reported no significant difference between the experimental and control groups, while 1 study showed that SMT reduced the time of gastric emptying. The relapse rate and adverse effects had no difference between 2 groups. Conclusions This meta-analysis suggests that SMT is an effective and safe therapy option for patients with FD. However, because of the high clinical heterogeneity, poor quality, high risk of bias and small sample size of some included studies, further standardized large-scale and strictly designed studies are needed.	[Hu, Yunxia; Bai, Yu; Xu, Junwei; Zhao, Zhiqiang] Nanjing Univ Chinese Med, Coll Clin Med 1, Nanjing, Jiangsu, Peoples R China; [Hua, Zhiyun] Zhenjiang Hosp Tradit Chinese Med, Dept Respirat, Zhenjiang, Jiangsu, Peoples R China; [Yang, Jie] Liyang Hosp Tradit Chinese Med, Dept Intens Care Unit, Changzhou, Jiangsu, Peoples R China; [Yang, Huahui] Chinese Univ Hong Kong, Jockey Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chen, Wenjun] Zhejiang Hosp Tradit Chinese Med, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China	Nanjing University of Chinese Medicine; Chinese University of Hong Kong; Zhejiang Chinese Medical University	Zhao, ZQ (corresponding author), Nanjing Univ Chinese Med, Coll Clin Med 1, Nanjing, Jiangsu, Peoples R China.	zzq11142004@126.com			National Natural Science Foundation of China [81373608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number: 81373608). The website is http/:/www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[蔡光先 Cai Guangxian], 2010, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V25, P856; Guo HM, 2014, PHARM BIOL, V52, P1141, DOI 10.3109/13880209.2013.879601; Guo JS, 2012, LISHIZHEN MED MAT ME, P56; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2016, COCHRANE HDB SYSTEMA; Hu P, 2015, CHINESE J MODERN DRU, V9, P143; Huang JD, 2015, J CLIN MED, P4341; Ji XH, 2010, CHINESE MODERN DOCTO, V48, P157; Jiang HS, 2010, CHINESE J MODERN DRU, V04, P187; Jiang YH, 2014, PHARM BIOL, V52, P581, DOI 10.3109/13880209.2013.854396; Jie Luo, 2013, THEORY PRACTICE SYST; Kazemi MH, 2015, UNITED EUR GASTROENT, V3, P11, DOI 10.1177/2050640614563373; Lacy BE, 2013, ALIMENT PHARM THER, V38, P170, DOI 10.1111/apt.12355; Lahner E, 2013, UNITED EUR GASTROENT, V1, P385, DOI 10.1177/2050640613499567; Li H, 2013, CHINESE J TRADITIONA, V20, P222; Li SX, 2011, CLIN J CHINESE MED, V03, P59; Li Y., 2012, ARCH ANIM NUTR, V1, P1, DOI DOI 10.1099/VIR.0.039289-0; Ling W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001111; Longstreth GF, 2016, FUNCTIONAL DYSPEPSIA; Meng F., 2014, HUNAN J TRADITIONAL, V30, P65; Ohno T, 2010, INT J PEPTIDES, V2010; Sander GB, 2011, VALUE HEALTH, V14, pS126, DOI 10.1016/j.jval.2011.05.021; Shen ZD, 2012, FRONTIERMED, P316; Sheng YZ, 1995, China, Patent No. [94110842.2, 941108422]; Talley NJ, 2016, KOREAN J INTERN MED, V31, P444, DOI 10.3904/kjim.2016.091; Talley NJ, 2015, NEW ENGL J MED, V373, P1853, DOI 10.1056/NEJMra1501505; Tang W, 2010, GUIDING J TRADITIONA, V16, P33; Tian LX, 2014, MED PEOPLE, V27, P222; Tu Y, 2009, JIANGXI J TRADITIONA, V40, P50; Wang JH, 2003, CLIN J PRACTICAL INT, V3, P33; Wang QZ, 2000, CHIN J INTEGR TRADIT, V8, P29; Wang YC, 2005, FEMS IMMUNOL MED MIC, V43, P295, DOI 10.1016/j.femsim.2004.09.008; Wei SH, 1999, ACTA MED SIN, V12, P758; Wen H, 2011, MED J IND ENTERPRISE, V24, P60; Wu L, 2014, J N PHARM, P92; Xiao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122397; Xiao ZH, 2012, J GUIYANG COLL TRADI, V34, P14; Xie YB, 2016, STRAIT PHARM J, P211; Ye S, 2005, HERALD MED, V24, P679; Yi YN, 2012, PHARM BIOL, V50, P832, DOI 10.3109/13880209.2011.637505; Yu DH, 2011, CHINESE COMMUNITY PH, V13, P148; Zhang K, 2015, CHINESE MED INNOVATI, P126; Zhang MM, 2016, NEW TRADITIONAL CHIN, P83; Zhang Y, 2011, CHINA HEALTHCARE INN, V06, P22; Zhang Y, 2011, CHINA HEALTHCARE INN, V06, P44; Zheng Y, 2005, HEBEI J TRADITIONAL, V27, P815; Zhou S, 2014, J EMERGENCY TRADITIO, V23, P1791; Zhu YL, 2009, WORLD CHINESE J DIGE, V17, P3028; 李玲, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P2853	49	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171878	10.1371/journal.pone.0171878	http://dx.doi.org/10.1371/journal.pone.0171878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199409	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400056
J	Vasconcellos, RCC; Oraguzie, OB; Soler, A; Arkwazee, H; Myers, JR; Ferreira, JJ; Song, QJ; McClean, P; Miklas, PN				Vasconcellos, Renato C. C.; Oraguzie, O. Blessing; Soler, Alvaro; Arkwazee, Haidar; Myers, James R.; Ferreira, Juan J.; Song, Qijian; McClean, Phil; Miklas, Phillip N.			Meta-QTL for resistance to white mold in common bean	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BUNSI-DERIVED RESISTANCE; PHYSIOLOGICAL RESISTANCE; SCLEROTINIA-SCLEROTIORUM; GERMPLASM LINE; DISEASE RESISTANCE; GENE-EXPRESSION; REGISTRATION; DEFENSE; ARABIDOPSIS	White mold, caused by the fungus Sclerotinia sclerotiorum (Lib.) de Bary, is a major disease that limits common bean production and quality worldwide. The host-pathogen interaction is complex, with partial resistance in the host inherited as a quantitative trait with low to moderate heritability. Our objective was to identify meta-QTL conditioning partial resistance to white mold from individual QTL identified across multiple populations and environments. The physical positions for 37 individual QTL were identified across 14 recombinant inbred bi-parental populations (six new, three re-genotyped, and five from the literature). A metaQTL analysis of the 37 QTL was conducted using the genetic linkage map of Stampede x Red Hawk population as the reference. The 37 QTL condensed into 17 named loci (12 previously named and five new) of which nine were defined as meta-QTL WM1.1, WM2.2, WM3.1, WM5.4, WM6.2, WM7.1, WM7.4, WM7.5, and WM8.3. The nine meta-QTL had confidence intervals ranging from 0.65 to 9.41 Mb. Candidate genes shown to express under S. sclerotiorum infection in other studies, including cell wall receptor kinase, CO/1, ethylene responsive transcription factor, peroxidase, and MYB transcription factor, were found within the confidence interval for five of the meta-QTL. The nine meta-QTL are recommended as potential targets for MAS for partial resistance to white mold in common bean.	[Vasconcellos, Renato C. C.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Oraguzie, O. Blessing] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Soler, Alvaro; Miklas, Phillip N.] USDA ARS, Grain Legume Genet & Physiol Res Unit, Prosser, WA 99350 USA; [Arkwazee, Haidar; Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Ferreira, Juan J.] Serv Reg Invest & Desarrollo Agroalimentario SERI, Area Cultivos Hort & Forestales, Villaviciosa, Asturias, Spain; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [McClean, Phil] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA	Universidade Federal de Lavras; Washington State University; United States Department of Agriculture (USDA); Oregon State University; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; United States Department of Agriculture (USDA); North Dakota State University Fargo	Miklas, PN (corresponding author), USDA ARS, Grain Legume Genet & Physiol Res Unit, Prosser, WA 99350 USA.	phil.miklas@ars.usda.gov	Ferreira, Juan Jose/J-9470-2016	Ferreira, Juan Jose/0000-0002-8782-8868; Coelho de Castro Vasconcellos, Renato/0000-0002-2610-601X; Bouca-Machado, Raquel/0000-0003-3756-2763; Soler-Garzon, Alvaro/0000-0002-7671-3109	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education) [BEX 10615/14-8]; USDA-ARS National Sclerotinia Initiative; USDA; National Institute of Food and Agricultural (NIFA); Agriculture and Food Research Initiative (AFRI) [2009-0192]	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USDA-ARS National Sclerotinia Initiative(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA(United States Department of Agriculture (USDA)); National Institute of Food and Agricultural (NIFA); Agriculture and Food Research Initiative (AFRI)	RV received support from CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education (BEX 10615/14-8) [www.iie.org/programs/capes]. PNM JM PM appreciate funding from the USDA-ARS National Sclerotinia Initiative [https://www.ars.usda.gov/plains-area/docs/white-mold-research/research/]. PM QS appreciate funding from the USDA, National Institute of Food and Agricultural (NIFA), Agriculture and Food Research Initiative (AFRI), Project #2009-0192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; [Anonymous], 2016, SCI REP; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Calla B, 2014, MOL PLANT PATHOL, V15, P576, DOI 10.1111/mpp.12113; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ender M, 2005, CROP SCI, V45, P2482, DOI 10.2135/cropsci2005.0064; Goffinet B, 2000, GENETICS, V155, P463; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Haggard JE, 2007, THESIS; Hamon C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-45; Higgins R, 2016, ANN REP BEAN IMPROV, V59, P133; Hoyos-Villegas V, 2015, CROP SCI, V55, P2116, DOI 10.2135/cropsci2015.02.0106; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P244, DOI 10.1034/j.1399-3054.2002.1150210.x; Kean D., 2002, ANN REP BEAN IMPROV, V45, P64; KELLY JD, 1994, CROP SCI, V34, P1406, DOI 10.2135/cropsci1994.0011183X003400050052x; Khowaja FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-276; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kolkman JM, 2003, CROP SCI, V43, P539, DOI 10.2135/cropsci2003.0539; Kwak M, 2008, J HERED, V99, P283, DOI 10.1093/jhered/esn005; Lara LADC, 2014, ISRN MOL BIOL, V2014; Leite ME, 2014, EUR J PLANT PATHOL, V138, P391, DOI 10.1007/s10658-013-0341-1; Levinson DF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S6; Malencic D, 2010, PLANT PHYSIOL BIOCH, V48, P903, DOI 10.1016/j.plaphy.2010.08.003; Maxwell JJ, 2007, CROP SCI, V47, P2285, DOI 10.2135/cropsci2007.01.0022; Miklas PN, 2006, CROP SCI, V46, P2339, DOI 10.2135/cropsci2006.04.0248; Miklas PN, 2007, CROP SCI, V47, P935, DOI 10.2135/cropsci2006.08.0525; Miklas PN, 2007, CROP SCI, V47, P174, DOI 10.2135/cropsci2006.06.0410; Miklas PN, 2014, J PLANT REGIST, V8, P183, DOI 10.3198/jpr2013.06.0034crg; Miklas PN, 2013, EUR J PLANT PATHOL, V135, P525, DOI 10.1007/s10658-012-0153-8; Miklas PN, 2004, CROP SCI, V44, P1584, DOI 10.2135/cropsci2004.1584; Miklas PN, 2003, J AM SOC HORTIC SCI, V128, P564, DOI 10.21273/JASHS.128.4.0564; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; Miklas PN, 1998, CROP SCI, V38, P1728, DOI 10.2135/cropsci1998.0011183X003800060073x; Mkwaila W, 2011, PLANT BREEDING, V130, P665, DOI 10.1111/j.1439-0523.2011.01876.x; Moghaddam SM, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.02.0012; Park SO, 2001, CROP SCI, V41, P1253, DOI 10.2135/cropsci2001.4141253x; Perez-Vega E, 2016, ANN REP BEAN IMPROV, V59, P189; Perez-Vega E, 2012, MOL BREEDING, V29, P31, DOI 10.1007/s11032-010-9522-1; Perez-Vega E, 2010, THEOR APPL GENET, V120, P1367, DOI 10.1007/s00122-010-1261-5; Petzoldt R., 1996, ANN REP BEAN IMPROV, V39, P142; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; SCHWARTZ HF, 1978, PHYTOPATHOLOGY, V68, P465, DOI 10.1094/Phyto-68-465; Schwartz HF, 2013, CROP SCI, V53, P1832, DOI 10.2135/cropsci2013.02.0081; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Singh S.P., 1982, ANN REP BEAN IMPROV, V25, P92; Singh SP, 2016, J PLANT REGIST, V10, P291, DOI 10.3198/jpr2015.04.0023crg; Singh SP, 2014, CAN J PLANT SCI, V94, P947, DOI [10.4141/CJPS2013-321, 10.4141/cjps2013-321]; Singh SP, 2009, CROP SCI, V49, P1629, DOI 10.2135/cropsci2008.08.0508; Singh SR, 2007, J PLANT REGIST, V1, P62, DOI 10.3198/jpr2006.10.0643crg; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Soule M, 2011, CROP SCI, V51, P123, DOI 10.2135/cropsci2010.06.0356; Teran H, 2010, PLANT BREEDING, V129, P327, DOI 10.1111/j.1439-0523.2009.01679.x; Teran H, 2009, EUPHYTICA, V167, P271, DOI 10.1007/s10681-009-9885-8; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; TOUBART P, 1992, PLANT J, V2, P367; Trapp JJ, 2015, CROP SCI, V55, P1596, DOI 10.2135/cropsci2014.11.0792; TU JC, 1982, CAN J PLANT SCI, V62, P65, DOI 10.4141/cjps82-010; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Viteri DM, 2015, EUPHYTICA, V204, P457, DOI 10.1007/s10681-015-1366-7; Viteri DM, 2015, CROP SCI, V55, P44, DOI 10.2135/cropsci2014.02.0145; Viteri DM, 2014, CROP SCI, V54, P1598, DOI 10.2135/cropsci2014.01.0008; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; [No title captured]	81	33	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171685	10.1371/journal.pone.0171685	http://dx.doi.org/10.1371/journal.pone.0171685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199342	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400042
J	Ghimire, S; Baral, BK; Callahan, K				Ghimire, Saruna; Baral, Binaya Kumar; Callahan, Karen			Nutritional assessment of community-dwelling older adults in rural Nepal	PLOS ONE			English	Article							BODY-MASS INDEX; ASSESSMENT MNA; SCREENING TOOL; HEALTH; PREVALENCE; RISK; MALNUTRITION; DETERMINANTS; POPULATION; VALIDATION	Background Demographic transition in Nepal, like in many developing countries, has resulted in a burgeoning elderly population whose health status is not currently monitored. One pillar of health is adequate nutrition. Yet, little is known about the nutritional health status of the elderly in Nepal. The financial, material, and personnel limitations in Nepal's health delivery services necessitate health screening instruments that require minimal clinical staff and resources. To our knowledge, no such nutritional assessment tool has been validated in Nepal. Therefore, our aims are two-fold: To assess the nutritional status of the elderly population in one typical Nepali village, Okharpauwa, in Nuwakot District, Nepal; and concurrently, to validate the Mini Nutritional Assessment (MNA) tool. Methods A cross-sectional field study was conducted with a sample of 242 elderly people in Okharpauwa, Nepal to obtain prevalence of malnutrition. Differences in demographic and lifestyle factors between these who were malnourished, those at risk of malnourishment, and those who had adequate nutritional status were analyzed. The MNA tool was evaluated using receiver operating characteristic (ROC) curve analysis; sensitivity, specificity, and diagnostic accuracy were calculated. Results 111 males and 131 females, with a mean age of 69.8 +/- 7.4 years, participated in this study. The mean BMI of the participants was 21.4 3.9 kg/m(2); the mean MNA score was 19.3 +/- 4.2. BMI was significantly correlated with the total MNA score (r = 0.58; p<0.001). The diagnostic accuracy, sensitivity and specificity of MNA were 81%, 86% and 67% respectively. Of the 242 elderly sampled, 24% were malnourished and 65% were at risk of malnutrition. Malnutrition was more prevalent among females (29%) than males (18%), and most prevalent among the marginalized Dalit ethnic group (40%). Elderly persons who were married and literate had better nutritional health than their counterparts. Conclusions The MNA appears to be a valid and sensitive tool for rapid nutritional screening of the elderly in Nepal. The prevalence of malnutrition was high among Nepalese elderly in the Okharpauwa VDC, which requires urgent health monitoring and management attention.	[Ghimire, Saruna; Callahan, Karen] Univ Nevada, Dept Environm & Occupat Hlth, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Baral, Binaya Kumar] Nepal Med Coll & Teaching Hosp, Dept Biochem, Kathmandu, Nepal	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Ghimire, S (corresponding author), Univ Nevada, Dept Environm & Occupat Hlth, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.	saruna.ghimire@unlv.edu	Ghimire, Saruna/Y-7905-2019	Ghimire, Saruna/0000-0002-2662-2006				Agarwalla R, 2015, J FAM COMMUNITY MED, V22, P39, DOI 10.4103/2230-8229.149588; [Anonymous], 2009, WORLD POP EXC 9 BILL; [Anonymous], 2012, NEP DEM HLTH SURV ND; [Anonymous], 2013, NEP THEM REP FOOD SE; [Anonymous], 2002, NEP DEM HLTH SURV ND; [Anonymous], 2001, NAT POP HOUS CENS 20; [Anonymous], 2010, STAT REP ELD PEOPL 6; [Anonymous], 2012, DEF AD OV OB ATL; [Anonymous], 2023, MULTISECTOR NUTR PLA; [Anonymous], 1998, NEP MICR STAT SURV N; [Anonymous], 2013, COUNTR POV AN DET NE; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Bennett L., 2008, CASTE ETHNIC REGIONA; Bhadra C, 2007, NEPAL COUNTRY GENDER; Bhandari S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0114-3; Bhattachan K.B., 2009, CASTE BASED DISCRIMI; Bonnefoy M, 2002, GERONTOLOGY, V48, P162, DOI 10.1159/000052836; Burden ST, 2001, J HUM NUTR DIET, V14, P269, DOI 10.1046/j.1365-277x.2001.00294.x; Chapman IM, 2006, MED CLIN N AM, V90, P887, DOI 10.1016/j.mcna.2006.05.010; Charlton KE, 2005, PUBLIC HEALTH NUTR, V8, P468, DOI 10.1079/PHN2005783; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; Correia MITD, 2003, NUTRITION, V19, P823, DOI 10.1016/S0899-9007(03)00168-0; Dahal D, 2002, SITUATIONAL ANAL DAL, V1; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; Dean A, 2011, EPI INFO TICS PROGRA; Delacorte R R, 2004, J Nutr Health Aging, V8, P531; Donini L M, 2002, J Nutr Health Aging, V6, P141; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; Gaiki V, 2014, J ACAD IND RES JAIR, V2, P638; Ghani A, 2013, INT J MED APPL HLTH, V2013; GITTELSOHN J, 1991, SOC SCI MED, V33, P1141, DOI 10.1016/0277-9536(91)90230-A; Gittelsohn J, 1997, SOC SCI MED, V44, P1739, DOI 10.1016/S0277-9536(96)00375-9; Guigoz Y, 1996, NUTR REV, V54, pS59; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Guigoz Y, 1997, MINI NUTR ASSESSMENT; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Hays NP, 2006, PHYSIOL BEHAV, V88, P257, DOI 10.1016/j.physbeh.2006.05.029; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Kabir ZN, 2006, PUBLIC HEALTH NUTR, V9, P968, DOI 10.1017/PHN2006990; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kansal D, 2016, INT J MED SCI PUBLIC, V5; Kavosi E, 2014, INT J HEALTH POLICY, V3, P71, DOI 10.15171/ijhpm.2014.63; Lauritsen J, 2000, EPIDATA DATA ENTRY D; Lyons G, 2012, MALNUTRITION ELDERLY; Majumder Mondrita, 2014, Journal of Nutrition in Gerontology and Geriatrics, V33, P126, DOI 10.1080/21551197.2014.908596; Mathew A., 2015, ASIAN PAC J HLTH SCI, V2, P43; Murphy MC, 2000, EUR J CLIN NUTR, V54, P555, DOI 10.1038/sj.ejcn.1601055; National Nutrition Policy and Strategy, 2004, NAT NUTR POL STRAT; National Population and Housing Census, 2011, NAT POP HOUS CENS 20; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; Nowack S., 2015, GENDER DISCRIMINATIO; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Ockenga J, 2005, CLIN NUTR, V24, P913, DOI 10.1016/j.clnu.2005.05.019; Machado RSP, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0129-6; Pichard C, 2004, AM J CLIN NUTR, V79, P613; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Read JA, 2005, NUTR CANCER, V53, P51, DOI 10.1207/s15327914nc5301_6; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366, DOI 10.1093/gerona/56.6.M366; Schoonjans F, 2014, MEDCALC STAT BIOMEDI; Shakya K., 2014, POPULATION MONOGRAPH, V2, P221; Shetty P, 2003, KEYNOTE PAPER MEASUR; Shetty P S, 1994, FAO Food Nutr Pap, V56, P1; Stash S, 2001, COMP EDUC REV, V45, P354, DOI 10.1086/447676; Sullivan D H, 2002, J Nutr Health Aging, V6, P275; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vedantam A, 2010, PUBLIC HEALTH NUTR, V13, P1328, DOI 10.1017/S1368980009991674; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Vellas B, 2000, J AM GERIATR SOC, V48, P1300, DOI 10.1111/j.1532-5415.2000.tb02605.x; Visvanathan R, 2004, AGE AGEING, V33, P260, DOI 10.1093/ageing/afh078; Wells JL, 2006, CLIN INTERV AGING, V1, P67, DOI 10.2147/ciia.2006.1.1.67; World Health Organization, 2016, MAN SUBST AB RES TOO; Youden W. J., 1969, Precision Measurement & Calibration , N.B.S. papers on on statistical concepts and procedures, P133; Zhu H, 2010, J POPUL AGEING, V3, P161, DOI 10.1007/s12062-011-9034-8	79	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172052	10.1371/journal.pone.0172052	http://dx.doi.org/10.1371/journal.pone.0172052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196115	Green Published, gold			2022-12-27	WOS:000394423900047
J	Kim, IY; Kim, JH; Lee, DW; Lee, SB; Rhee, H; Seong, EY; Kwak, IS; Song, SH				Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon			Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; SEPTIC SHOCK; RIFLE CRITERIA; FAILURE; BALANCE; MULTICENTER; MORTALITY; RECOVERY; MANAGEMENT; DIALYSIS	Background Fluid overload is known to be associated with increased mortality in patients with acute kidney injury (AKI) who are critically ill. In this study, we intended to uncover whether the adverse effect of fluid overload on survival could be applied to all of the patients with AKI who received continuous renal replacement therapy (CRRT). Methods We analyzed 341 patients with AKI who received CRRT in our intensive care units. The presence of fluid overload was defined as a minimum 10% increase in body weight from the baseline. Demographics, comorbid diseases, clinical data, severity of illness [the sequential organ failure assessment (SOFA) score, number of vasopressors, diagnosis of sepsis, use of ventilator] upon ICU admission, fluid overload status, and time elapsed from AKI diagnosis until CRRT initiation were reviewed from the medical charts. Results Patients with total fluid overload from 3 days before CRRT initiation to ICU discharge had a significantly lower survival rate after ICU admission, as compared to patients with no fluid overload (P < 0.001). Among patients with sepsis (P < 0.001) or with high SOFA scores (P < 0.001), there was a significant difference in survival of the patients with and without fluid overload. In patients without sepsis or with low SOFA score, there was no significant difference in survival of patients irrespective of fluid overload. Conclusion Our study demonstrates that the adverse effect of fluid overload on survival is more evident in patients with sepsis or with more severe illness, and that it might not apply to patients without sepsis or with less severe illness.	[Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan, South Korea; [Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea; [Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Song, SH (corresponding author), Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan, South Korea.; Song, SH (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea.	shsong0209@gmail.com	Kim, Il Young/ABG-2153-2021; Kim, Il Young/ABG-2156-2021	Kim, Il Young/0000-0002-1731-6357; song, sangheon/0000-0002-8218-6974				Alsous F, 2000, CHEST, V117, P1749, DOI 10.1378/chest.117.6.1749; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Cantarovich F, 2004, AM J KIDNEY DIS, V44, P402, DOI 10.1053/j.ajkd.2004.05.021; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Gillespie RS, 2004, PEDIATR NEPHROL, V19, P1394, DOI 10.1007/s00467-004-1655-1; Goldstein SL, 2001, PEDIATRICS, V107, P1309, DOI 10.1542/peds.107.6.1309; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Jacobs R, 2011, BLOOD PURIFICAT, V32, P262, DOI 10.1159/000330244; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kielstein JT, 2004, AM J KIDNEY DIS, V43, P342, DOI 10.1053/j.ajkd.2003.10.021; Langenberg C, 2007, INTENS CARE MED, V33, P1614, DOI 10.1007/s00134-007-0734-8; Licari E, 2007, CONTRIB NEPHROL, V156, P167; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Mehta RL, 2009, NAT CLIN PRACT NEPHR, V5, P10, DOI 10.1038/ncpneph0988; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Piccinni P, 2006, INTENS CARE MED, V32, P80, DOI 10.1007/s00134-005-2815-x; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P733, DOI 10.2215/CJN.00060110; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	31	39	44	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172137	10.1371/journal.pone.0172137	http://dx.doi.org/10.1371/journal.pone.0172137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196107	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900053
J	Huang, NS; Quan, CL; Mo, M; Chen, JJ; Yang, BL; Huang, XY; Wu, J				Huang, Nai-si; Quan, Chen-lian; Mo, Miao; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong			A prospective study of breast anthropomorphic measurements, volume and ptosis in 605 Asian patients with breast cancer or benign breast disease	PLOS ONE			English	Article							UNITED-STATES; FORMULA; WOMEN; RECONSTRUCTION	Objectives The current study aims to summarize breast anthropomorphic measurement features in Chinese patients with breast diseases and to investigate their potential correlations with demographic factors. Materials and methods Fifteen breast anthropomorphic parameters of 605 Chinese female patients were collected prospectively. Breast ptosis status was scaled by two methods and breast volume was calculated according to a modified formula of BREAST-V. Results Among 1210 breasts, the average breast volume was 340.0 +/- 109.1 ml (91.8 +/- 919.2 ml). The distance from the nipple to the inframammary fold was 7.5 +/- 1.6 cm in the standing position. The width of the breast base was 14.3 +/- 1.4 cm (8.5 +/- 23.5 cm). The incidence of breast ptosis was 22.8% (274/1204), of which 37 (23.5%) and 79 (31.7%) women had severe ptosis assessed by different criteria. Increased height (OR[ odds ratio] = 1.500, P<0.001), postmenopausal status (OR = 1.463, P = 0.02), increased BMI, breastfeeding for 7 - 12 months (OR = 1.882, P = 0.008) and more than one year (OR = 2.367, P = 0.001) were risk factors for an increased breast volume. Post-menopausal status (OR = 2.390, P< 0.001 and OR = 2.621, P< 0.001 for different scales), BMI >= 24.7 kg/m(2) (OR = 3.149, P< 0.001 and OR = 2.495, P = 0.002), breastfeeding for 7 - 12 months (OR = 4.136, P = 0.004 and OR = 4.010, P = 0.002), and breastfeeding for more than one year (OR = 6.934, P< 0.001 and OR = 6.707, P< 0.001) were independent risk factors for breast ptosis. Conclusions The current study provides anthropomorphic measurements data of Chinese women with breast diseases, which are useful for cosmetic and reconstructive breast surgery decisions. Post-menopausal status, increased BMI, and breastfeeding for more than six months were independent risk factors for both increased breast volume and breast ptosis.	[Huang, Nai-si; Quan, Chen-lian; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai, Peoples R China; [Huang, Nai-si; Quan, Chen-lian; Mo, Miao; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Mo, Miao] Fudan Univ, Dept Clin Stat, Shanghai Canc Ctr, Shanghai, Peoples R China; [Wu, Jiong] Collaborat Innovat Ctr Canc Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai, Peoples R China.; Wu, J (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Wu, J (corresponding author), Collaborat Innovat Ctr Canc Med, Shanghai, Peoples R China.	wujiong1122@vip.sina.com						Avsar DK, 2010, AESTHET SURG J, V30, P44, DOI 10.1177/1090820X09358078; Brown RW, 2000, PLAST RECONSTR SURG, V106, P1342, DOI 10.1097/00006534-200011000-00018; DEWEY KG, 1995, J PEDIATR-US, V126, P696, DOI 10.1016/S0022-3476(95)70395-0; Jagsi R, 2014, J CLIN ONCOL, V32, P919, DOI 10.1200/JCO.2013.52.2284; Kayar R, 2011, BREAST CANCER-BASIC, V5, P43, DOI 10.4137/BCBCR.S6128; Kim SJ, 2014, BREASTFEED MED, V9, P73, DOI 10.1089/bfm.2013.0068; LaTrenta GS, 1994, BREAST REDUCTION AES, P971; Liu YJ, 2011, ANN PLAS SURG, V67, P7, DOI 10.1097/SAP.0b013e3181f77ab5; Longo B, 2013, PLAST RECONSTR SURG, V132, p1E, DOI 10.1097/PRS.0b013e318290f6bd; Qiao Q, 1997, AESTHET PLAST SURG, V21, P362, DOI 10.1007/s002669900139; Regnault P, 1976, Clin Plast Surg, V3, P193; Rinker B, 2010, ANN PLAS SURG, V64, P579, DOI 10.1097/SAP.0b013e3181c39377; Ryan AS, 2006, WOMEN HEALTH ISS, V16, P243, DOI 10.1016/j.whi.2006.08.001; Sanuki J, 2009, AESTHET PLAST SURG, V33, P295, DOI 10.1007/s00266-008-9194-y; Sigurdson LJ, 2006, PLAST RECONSTR SURG, V118, P313, DOI 10.1097/01.prs.0000227627.75771.5c; STROMBECK JO, 1986, ANN PLAS SURG, V17, P498; Tepper OM, 2008, BREAST J, V14, P543, DOI 10.1111/j.1524-4741.2008.00645.x; Westreich M, 1997, PLAST RECONSTR SURG, V100, P468, DOI 10.1097/00006534-199708000-00032; Xi WJ, 2014, AESTHET PLAST SURG, V38, P1116, DOI 10.1007/s00266-014-0412-5; Zhang BN, 2013, BREAST, V22, P676, DOI 10.1016/j.breast.2013.01.004	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172122	10.1371/journal.pone.0172122	http://dx.doi.org/10.1371/journal.pone.0172122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192525	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800073
J	Lindner, M; Bell, T; Iqbal, S; Mullins, PG; Christakou, A				Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Mullins, Paul Gerald; Christakou, Anastasia			In vivo functional neurochemistry of human cortical cholinergic function during visuospatial attention	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VISUAL-SPATIAL ATTENTION; SIGNAL INTENSITY; TRANSPORTER CHT; BRAIN-REGIONS; PARIETAL; ACETYLCHOLINE; QUANTITATION; CORTEX; MRS	Cortical acetylcholine is involved in key cognitive processes such as visuospatial attention. Dysfunction in the cholinergic system has been described in a number of neuropsychiatric disorders. Levels of brain acetylcholine can be pharmacologically manipulated, but it is not possible to directly measure it in vivo in humans. However, key parts of its biochemical cascade in neural tissue, such as choline, can be measured using magnetic resonance spectroscopy (MRS). There is evidence that levels of choline may be an indirect but proportional measure of acetylcholine availability in brain tissue. In this study, we measured relative choline levels in the parietal cortex using functional (event-related) MRS (fMRS) during performance of a visuospatial attention task, with a modelling approach verified using simulated data. We describe a task-driven interaction effect on choline concentration, specifically driven by contralateral attention shifts. Our results suggest that choline MRS has the potential to serve as a proxy of brain acetylcholine function in humans.	[Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Christakou, Anastasia] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Lindner, Michael; Bell, Tiffany; Iqbal, Somya; Christakou, Anastasia] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Mullins, Paul Gerald] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	University of Reading; University of Reading; Bangor University	Christakou, A (corresponding author), Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England.; Christakou, A (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	anastasia.christakou@reading.ac.uk	Bell, Tiffany/AAB-4896-2019; Christakou, Anastasia/B-7838-2008	Bell, Tiffany/0000-0002-9591-706X; Mullins, Paul/0000-0002-1339-6361; Christakou, Anastasia/0000-0002-4267-3436	Human Frontier Science Program [RGP0048/2012]; Engineering and Physical Sciences Research Council [1374682] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was supported by a Human Frontier Science Program (Navw.hfsp.org) grant to AC (RGP0048/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsvalka D, 2015, NEUROIMAGE; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Beane M, 2002, 13 ABSTR VIEWER ITER; Berry AS, 2015, NEUROIMAGE, V108, P386, DOI 10.1016/j.neuroimage.2014.12.036; Bidulescu A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-14; Black Stefanie A. G., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P114; Boulanger Y, 2000, BRAIN RES REV, V33, P380, DOI 10.1016/S0165-0173(00)00037-0; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ennis EA, 2015, ACS CHEM NEUROSCI, V6, P417, DOI 10.1021/cn5001809; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gates J, 2004, J PHARMACOL EXP THER, V310, P536, DOI 10.1124/jpet.104.066795; Graveron-Demilly D, 2014, MAGN RESON MATER PHY, V27, P113, DOI 10.1007/s10334-013-0393-4; Gussew A, 2010, NEUROIMAGE, V49, P1895, DOI 10.1016/j.neuroimage.2009.09.007; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Henry ME, 2011, J MAGN RESON, V208, P210, DOI 10.1016/j.jmr.2010.11.003; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Holt DJ, 2005, BIOL PSYCHIAT, V58, P408, DOI 10.1016/j.biopsych.2005.04.007; Huang Z, 2015, HUM BRAIN MAPP; Katz-Brull R, 2005, BRAIN RES, V1048, P202, DOI 10.1016/j.brainres.2005.04.080; KLATSKIN G, 1954, J EXP MED, V100, P605, DOI 10.1084/jem.100.6.605; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; Kus L, 2003, J COMP NEUROL, V463, P341, DOI 10.1002/cne.10759; Lally N, 2014, NEUROIMAGE, V85, P823, DOI 10.1016/j.neuroimage.2013.07.049; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lin Y, 2012, J CEREBR BLOOD F MET, V32, P1484, DOI 10.1038/jcbfm.2012.33; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P749, DOI 10.1081/DDC-120005622; Mangia S, 2006, MAGN RESON IMAGING, V24, P343, DOI 10.1016/j.mri.2005.12.023; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Minati L, 2010, J MED PHYS, V35, P154, DOI 10.4103/0971-6203.62128; Mullins PG, 2005, NEUROIMAGE, V26, P642, DOI 10.1016/j.neuroimage.2005.02.001; Mullins PG, 2012, CURRENT PRACTICE USE; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Nishitani N, 2003, NEUROIMAGE, V20, P561, DOI 10.1016/S1053-8119(03)00280-5; Okuda T, 2011, J NEUROSCI, V31, P14989, DOI 10.1523/JNEUROSCI.2983-11.2011; Osipova D, 2005, NEUROIMAGE, V27, P835, DOI 10.1016/j.neuroimage.2005.05.011; Osipova D, 2003, CLIN NEUROPHYSIOL, V114, P1902, DOI 10.1016/S1388-2457(03)00165-2; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pinthong M, 2008, MOL PHARMACOL, V73, P801, DOI 10.1124/mol.107.040881; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; Poullet JB, 2007, NMR BIOMED, V20, P493, DOI 10.1002/nbm.1112; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; SALTARELLI MD, 1990, J NEUROSCI, V10, P62; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; Taylor R, 2015, NEUROREPORT, V26, P107, DOI 10.1097/WNR.0000000000000309; VONALLWORDEN HN, 1993, EUR J APPL PHYSIOL O, V67, P87, DOI 10.1007/BF00377711; Wang XC, 2008, NEUROCHEM RES, V33, P814, DOI 10.1007/s11064-007-9509-4; Wauschkuhn B, 1998, J NEUROPHYSIOL, V80, P2900, DOI 10.1152/jn.1998.80.6.2900; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9	57	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171338	10.1371/journal.pone.0171338	http://dx.doi.org/10.1371/journal.pone.0171338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192451	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000394423800022
J	Michetti, D; Brandsdal, BO; Bon, D; Isaksen, GV; Tiberti, M; Papaleo, E				Michetti, Davide; Brandsdal, Bjorn Olav; Bon, Davide; Isaksen, Geir Villy; Tiberti, Matteo; Papaleo, Elena			A comparative study of cold- and warm-adapted Endonucleases A using sequence analyses and molecular dynamics simulations	PLOS ONE			English	Article							PSYCHROPHILIC ENZYMES; VIBRIO-SALMONICIDA; PROTEIN-STRUCTURE; CATALYTIC-ACTIVITY; ADAPTATION; NETWORK; FLEXIBILITY; CHOLERAE; HOT; OPTIMIZATION	The psychrophilic and mesophilic endonucleases A (EndA) from Aliivibrio salmonicida (VsEndA) and Vibrio cholera (VcEndA) have been studied experimentally in terms of the biophysical properties related to thermal adaptation. The analyses of their static X-ray structures was no sufficient to rationalize the determinants of their adaptive traits at the molecular level. Thus, we used Molecular Dynamics (MD) simulations to compare the two proteins and unveil their structural and dynamical differences. Our simulations did not show a substantial increase in flexibility in the cold-adapted variant on the nanosecond time scale. The only exception is a more rigid C-terminal region in VcEndA, which is ascribable to a cluster of electrostatic interactions and hydrogen bonds, as also supported by MD simulations of the VsEndA mutant variant where the cluster of interactions was introduced. Moreover, we identified three additional amino acidic substitutions through multiple sequence alignment and the analyses of MD-based protein structure networks. In particular, T120V occurs in the proximity of the catalytic residue H80 and alters the interaction with the residue Y43, which belongs to the second coordination sphere of the Mg2+ ion. This makes T120V an amenable candidate for future experimental mutagenesis.	[Michetti, Davide; Brandsdal, Bjorn Olav; Bon, Davide; Isaksen, Geir Villy] Arctic Univ Norway, Fac Sci & Technol, Ctr Theoret & Computat Chem, Dept Chem, Tromso, Norway; [Tiberti, Matteo] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Papaleo, Elena] Danish Canc Soc Res Ctr, Computat Biol Lab, Strandboulevarden 49, Copenhagen, Denmark; [Papaleo, Elena] Univ Milano Bicocca, Dept Biotechnol & Biosci, Pzza Sci 2, Milan, Italy	UiT The Arctic University of Tromso; University of London; Queen Mary University London; Danish Cancer Society; University of Milano-Bicocca	Papaleo, E (corresponding author), Danish Canc Soc Res Ctr, Computat Biol Lab, Strandboulevarden 49, Copenhagen, Denmark.; Papaleo, E (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Pzza Sci 2, Milan, Italy.	elenap@cancer.dk	Brandsdal, Bjørn O/J-7099-2015; Tiberti, Matteo/AGU-8969-2022; Isaksen, Geir Villy/AAE-7598-2020; Papaleo, Elena/M-6629-2014	Brandsdal, Bjørn O/0000-0002-4681-8081; Isaksen, Geir Villy/0000-0001-7828-7652; Papaleo, Elena/0000-0002-7376-5894	Research Council of Norway through Centre of Excellence Grant [179568N30]; Research Council of Norway through a Centre of Excellence Grant [179568/V30]; ISCRA-CINECA [HP10C2TOOC]	Research Council of Norway through Centre of Excellence Grant; Research Council of Norway through a Centre of Excellence Grant(Research Council of Norway); ISCRA-CINECA	This work was supported by a Research Council of Norway through Centre of Excellence Grant 179568N30. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the Research Council of Norway through a Centre of Excellence Grant (Grant 179568/V30) and the ISCRA-CINECA Grant HP10C2TOOC (NetDyn).	Agrafiotis DK, 2002, P NATL ACAD SCI USA, V99, P15869, DOI 10.1073/pnas.242424399; Altermark B, 2008, ACTA CRYSTALLOGR D, V64, P368, DOI 10.1107/S0907444908000097; Altermark B, 2006, ACTA CRYSTALLOGR D, V62, P1387, DOI 10.1107/S0907444906034196; Altermark B, 2007, FEBS J, V274, P252, DOI 10.1111/j.1742-4658.2006.05580.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bhattacharyya M, 2016, CURR PROTEIN PEPT SC, V17, P4, DOI 10.2174/1389203716666150923105727; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Brandsdal BO, 1999, J BIOMOL STRUCT DYN, V17, P493, DOI 10.1080/07391102.1999.10508380; Brenner DJ, 2004, BERGEYS MANUAL SYSTE; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Bueren-Calabuig JA, 2011, CHEMBIOCHEM, V12, P2615, DOI 10.1002/cbic.201100485; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Cavicchioli R, 2002, CURR OPIN BIOTECH, V13, P253, DOI 10.1016/S0958-1669(02)00317-8; Chiuri R, 2009, BIOPHYS J, V96, P1586, DOI 10.1016/j.bpj.2008.11.017; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Fields PA, 2001, COMP BIOCH PHYSL A, P129; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gerday Charles, 2013, Biology (Basel), V2, P719, DOI 10.3390/biology2020719; Gerike U, 1997, EUR J BIOCHEM, V248, P49, DOI 10.1111/j.1432-1033.1997.00049.x; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Greene LH, 2012, BRIEF FUNCT GENOMICS, V11, P469, DOI 10.1093/bfgp/els039; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; Isaksen GV, 2016, P NATL ACAD SCI USA, V113, P7822, DOI 10.1073/pnas.1605237113; Isaksen GV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003813; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Li C, 2003, MICROBIOLOGY, V22, P1; Lindorff-Larsen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004203; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; LOW PS, 1973, P NATL ACAD SCI USA, V70, P430, DOI 10.1073/pnas.70.2.430; Martin-Garcia F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121114; Martinez R, 2011, PROTEIN ENG DES SEL, V24, P533, DOI 10.1093/protein/gzr014; Niiranen L, 2008, FEBS J, V275, P1593, DOI 10.1111/j.1742-4658.2008.06317.x; Oskarsson KR, 2016, BBA-PROTEINS PROTEOM, V1864, P1436, DOI 10.1016/j.bbapap.2016.07.003; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Papaleo E, 2006, BBA-PROTEINS PROTEOM, V1764, P1397, DOI 10.1016/j.bbapap.2006.06.005; Papaleo E, 2016, GD CHALL BIO BIOTECH, V1, P675, DOI 10.1007/978-3-319-13521-2_24; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Papaleo E, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00028; Papaleo E, 2011, CURR PROTEIN PEPT SC, V12, P657, DOI 10.2174/1389203711109070657; Robert X, 2014, NUCLEIC ACIDS RES, P42; Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Siddiqui KS, 2015, BIOTECHNOL ADV, V33, P1912, DOI 10.1016/j.biotechadv.2015.11.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siglioccolo A, 2010, BIOPHYS CHEM, V153, P104, DOI 10.1016/j.bpc.2010.10.009; Smalas A O, 2000, Biotechnol Annu Rev, V6, P1, DOI 10.1016/S1387-2656(00)06018-X; Struvay C, 2012, INT J MOL SCI, V13, P11643, DOI 10.3390/ijms130911643; Tiberti M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004415; Tiberti M, 2014, J CHEM INF MODEL, V54, P1537, DOI 10.1021/ci400639r; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590	63	21	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0169586	10.1371/journal.pone.0169586	http://dx.doi.org/10.1371/journal.pone.0169586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192428	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800005
J	Scholz, S; Schneider, SL; Rose, M				Scholz, Sebastian; Schneider, Signe Luisa; Rose, Michael			Differential effects of ongoing EEG beta and theta power on memory formation	PLOS ONE			English	Article							BRAIN OSCILLATIONS; PRESTIMULUS THETA; ALPHA-BAND; PREDICT; SYNCHRONIZATION; DISCRIMINATION; PERSPECTIVE; INHIBITION	Recently, elevated ongoing pre-stimulus beta power (13-17 Hz) at encoding has been associated with subsequent memory formation for visual stimulus material. It is unclear whether this activity is merely specific to visual processing or whether it reflects a state facilitating general memory formation, independent of stimulus modality. To answer that question, the present study investigated the relationship between neural pre-stimulus oscillations and verbal memory formation in different sensory modalities. For that purpose, a within-subject design was employed to explore differences between successful and failed memory formation in the visual and auditory modality. Furthermore, associative memory was addressed by presenting the stimuli in combination with background images. Results revealed that similar EEG activity in the low beta frequency range (13-17 Hz) is associated with subsequent memory success, independent of stimulus modality. Elevated power prior to stimulus onset differentiated successful from failed memory formation. In contrast, differential effects between modalities were found in the theta band (3-7 Hz), with an increased oscillatory activity before the onset of later remembered visually presented words. In addition, pre stimulus theta power dissociated between successful and failed encoding of associated context, independent of the stimulus modality of the item itself. We therefore suggest that increased ongoing low beta activity reflects a memory promoting state, which is likely to be moderated by modality-independent attentional or inhibitory processes, whereas high ongoing theta power is suggested as an indicator of the enhanced binding of incoming interlinked information.	[Scholz, Sebastian; Schneider, Signe Luisa; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Scholz, Sebastian] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Carl von Ossietzky Universitat Oldenburg	Rose, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	rose@uke.uni-hamburg.de		Scholz, Sebastian/0000-0003-1074-3281	DFG [2653/6-1]	DFG(German Research Foundation (DFG))	This work was funded by the DFG, www.dfg.de, Grant 2653/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Addante RJ, 2015, NEUROIMAGE, V105, P21, DOI 10.1016/j.neuroimage.2014.10.046; Bengson JJ, 2014, J COGNITIVE NEUROSCI, V26, P2578, DOI 10.1162/jocn_a_00650; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Burke JF, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01055; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Fellner MC, 2013, NEUROIMAGE, V79, P361, DOI 10.1016/j.neuroimage.2013.04.121; Gruber MJ, 2013, NEUROIMAGE, V64, P68, DOI 10.1016/j.neuroimage.2012.07.064; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hanslmayr S, 2014, CURR BIOL, V24, P904, DOI 10.1016/j.cub.2014.03.007; Hanslmayr S, 2014, NEUROIMAGE, V85, P648, DOI 10.1016/j.neuroimage.2013.05.121; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Herrmann C. S., 2013, FRONTIERS HUMAN NEUR, V7; Huster RJ, 2014, INT J PSYCHOPHYSIOL, V91, P36, DOI 10.1016/j.ijpsycho.2013.08.011; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Kleberg FI, 2014, NEUROSCI RES, V83, P69, DOI 10.1016/j.neures.2014.02.010; Kleiner M, 2007, PERCEPTION, V36, P14; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Long NM, 2014, NEUROIMAGE, V84, P488, DOI 10.1016/j.neuroimage.2013.08.052; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merkow MB, 2014, HIPPOCAMPUS, V24, P1562, DOI 10.1002/hipo.22335; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Noh E, 2014, NEUROIMAGE, V84, P712, DOI 10.1016/j.neuroimage.2013.09.028; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Park H, 2010, HIPPOCAMPUS, V20, P24, DOI 10.1002/hipo.20663; Park H, 2014, HUM BRAIN MAPP, V35, P3972, DOI 10.1002/hbm.22452; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roberts DM, 2014, J COGNITIVE NEUROSCI, V26, P1615, DOI 10.1162/jocn_a_00569; Salari N, 2016, NEUROIMAGE, V125, P1013, DOI 10.1016/j.neuroimage.2015.10.037; Salari N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038090; Schneider SL, 2016, NEUROIMAGE, V125, P978, DOI 10.1016/j.neuroimage.2015.11.024; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Waldhauser GT, 2012, J NEUROSCI, V32, P1953, DOI 10.1523/JNEUROSCI.4201-11.2012; Weiss S, 2005, INT J PSYCHOPHYSIOL, V57, P129, DOI 10.1016/j.ijpsycho.2005.03.013; Weiss S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00201	48	30	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171913	10.1371/journal.pone.0171913	http://dx.doi.org/10.1371/journal.pone.0171913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192459	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800051
J	Dong, W; Farooqui, A; Leon, AJ; Kelvin, DJ				Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.			Inhibition of influenza A virus infection by ginsenosides	PLOS ONE			English	Article							RECEPTOR-BINDING; PHASE-II; HEMAGGLUTININ; MICE	Influenza viruses cause mild to severe respiratory infections in humans. Due to efficient means of transmission, the viruses infect human population on a large scale. Apart from vaccines, antiviral drugs are used to control infection; neuraminidase inhibitors are thought to be the first choice of treatment, particularly for severe cases. Rapidly evolving and emerging influenza viruses with increased frequency of viral resistance to these drugs stress the need to explore novel antiviral compounds. In this study, we investigated antiviral activity of ginseng extract and ginsenosides, the ginseng-derived triterpene and saponin compounds, against 2009 pandemic H1 N1 virus in vitro and in vivo. Our data showed that treatment of mice with ginsenosides protected the animals from lethal 2009 pandemic H1N1 infection and lowered viral titers in animal lungs. Mechanistic studies revealed that ginsenosides interact with viral hemagglutinin protein and prevent the attachment of virus with a 2-3' sialic acid receptors present on host cell surfaces. The interference in the viral attachment process subsequently minimizes viral entry into the cells and decreases the severity of the viral infection. We also describe that sugar moieties present in ginsenosides are indispensible for their attachment with viral HA protein. On the basis of our observations, we can say that ginsenosides are promising candidates for the development of antiviral drugs for influenza viruses.	[Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Univ Hlth Network, Int Inst Infect & Immun, Div Immunol, Shantou, Peoples R China; [Dong, Wei; Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Coll Med, Shantou, Peoples R China; [Farooqui, Amber; Leon, Alberto J.; Kelvin, David J.] Univ Hlth Network, Div Expt Therapeut, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Farooqui, Amber; Kelvin, David J.] Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China; [Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Kelvin, David J.] Univ Toronto, Deptartment Immunol, Fac Med, Toronto, ON, Canada	Shantou University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Kelvin, DJ (corresponding author), Univ Hlth Network, Int Inst Infect & Immun, Div Immunol, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Shantou Univ, Coll Med, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Univ Hlth Network, Div Expt Therapeut, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Kelvin, DJ (corresponding author), Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China.; Kelvin, DJ (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada.; Kelvin, DJ (corresponding author), Univ Toronto, Deptartment Immunol, Fac Med, Toronto, ON, Canada.	dkelvin@jidc.org	Ohba, Yusuke/E-7944-2011	Farooqui, Amber/0000-0002-6031-9561	Li Ka Shing Foundation	Li Ka Shing Foundation	This work was financially supported by the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Farooqui A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-104; Farooqui A, 2011, J INFECT DEV COUNTR, V5, P700, DOI 10.3855/jidc.2251; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Hoffmann J, 2014, ANTIVIR RES, V104, P23, DOI 10.1016/j.antiviral.2014.01.015; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Leung KW, 2009, BRIT J PHARMACOL, V156, P626, DOI 10.1111/j.1476-5381.2008.00066.x; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Moss RB, 2012, J INFECT DIS, V206, P1844, DOI 10.1093/infdis/jis622; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rowe T, 2010, J GEN VIROL, V91, P2898, DOI 10.1099/vir.0.024323-0; Seida JK, 2011, ECAM, V2011, DOI 10.1542/peds.2007-2186; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Vohra S, 2008, PEDIATRICS, V122, pE402, DOI 10.1542/peds.2007-2186; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; World Health Organization, 2012, DENG SEV DENG; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031	24	23	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171936	10.1371/journal.pone.0171936	http://dx.doi.org/10.1371/journal.pone.0171936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187149	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300062
J	Pereira, S; Katzmarzyk, PT; Gomes, TN; Souza, M; Chaves, RN; dos Santos, FK; Santos, D; Hedeker, D; Maia, J				Pereira, Sara; Katzmarzyk, Peter Todd; Gomes, Thayse Natacha; Souza, Michele; Chaves, Raquel Nichele; dos Santos, Fernanda Karina; Santos, Daniel; Hedeker, Donald; Maia, Jose			A multilevel analysis of health-related physical fitness. The Portuguese sibling study on growth, fitness, lifestyle and health	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; HEART-DISEASE RISK; FAMILIAL RESEMBLANCE; CARDIORESPIRATORY FITNESS; PRO12ALA POLYMORPHISM; SOCIOECONOMIC-STATUS; SEXUAL-DIMORPHISM; AEROBIC FITNESS; SEDENTARY TIME; SCREEN TIME	This study investigates biological, behavioural and sociodemographic correlates of intrapair similarities, and estimates sibling resemblance in health-related physical fitness (PF). The sample comprises 1101 biological siblings (525 females) aged 9-20 years. PF components and markers were: morphological [waist circumference (WC) and %body fat (%BF)], muscular [handgrip strength (GS) and standing long jump (SLJ)], motor [50-yard dash (50YD) and shuttle run (SR)], and cardiorespiratory (1-mile run). Biological maturation was assessed; physical activity (PA), TV viewing and socioeconomic status (SES) information was obtained. On average, older and more mature subjects are better performers in all PF components; PA was negatively associated with SR, while SES was negatively associated with SLJ and SR. A pattern was observed in the intraclass correlations (rho) wherein same sex siblings demonstrate greater resemblance for most PF components (sister-sister: 0.35 <= p <= 0.55; brother-brother: (0.25 <=rho <= 0.60) than brother-sister pairs (BS) (0<rho<0.15), except for %BF (rho BB>rho SS>rho BS), and the 1-mile run (pSS>pBS>pBB). In conclusion, behavioural and sociodemographic correlates play different roles in siblings PF expression. Further, a significant familial PF resemblance was observed with different trends in different sibling types, probably due to variations in shared genetic factors and sociodemographic conditions.	[Pereira, Sara; Gomes, Thayse Natacha; Souza, Michele; Chaves, Raquel Nichele; dos Santos, Fernanda Karina; Santos, Daniel; Maia, Jose] Univ Porto, CIFI2D, Fac Sport, Porto, Portugal; [Katzmarzyk, Peter Todd] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Souza, Michele] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil; [Chaves, Raquel Nichele] Fed Univ Technol Parana UTFPR, Campus Curitiba, Curitiba, Parana, Brazil; [dos Santos, Fernanda Karina] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Hedeker, Donald] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	Universidade do Porto; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universidade Federal de Santa Catarina (UFSC); Universidade Tecnologica Federal do Parana; Universidade Federal de Vicosa; University of Chicago	Maia, J (corresponding author), Univ Porto, CIFI2D, Fac Sport, Porto, Portugal.	jmaia@fade.up.pt	Hedeker, Donald/R-7055-2019; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020; Pereira, Sara/V-1516-2019; Katzmarzyk, Peter T/N-1974-2017; de Souza Ribas, Michele/AAG-5110-2021	Pereira, Sara/0000-0002-4661-3879; Katzmarzyk, Peter T/0000-0002-9280-6022; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238				Antunes AM, 2015, AM J HUM BIOL, V27, P681, DOI 10.1002/ajhb.22715; Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; Arango CM, 2014, J SCI MED SPORT, V17, P491, DOI 10.1016/j.jsams.2013.09.010; Asmussen E, 1973, PHYSICAL ACTIVITY HU, P60; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148038; Bohr AD, 2013, J SCHOOL HEALTH, V83, P542, DOI 10.1111/josh.12063; Boreham C, 2001, MED SCI SPORT EXER, V33, P270; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Chan JPL, 2015, AGE, V37, DOI 10.1007/s11357-015-9745-5; de Chaves RN, 2014, ANN HUM BIOL, V41, P157, DOI 10.3109/03014460.2013.838303; Dencker M, 2006, EUR J APPL PHYSIOL, V96, P587, DOI 10.1007/s00421-005-0117-1; Ekelund U, 2001, EUR J APPL PHYSIOL, V85, P195, DOI 10.1007/s004210100460; Erikssen G, 2001, SPORTS MED, V31, P571, DOI 10.2165/00007256-200131080-00001; Falconer D. S., 1996, Introduction to quantitative genetics.; Ferreira J, 2002, PHYS FITNESS PHYS AC; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Fornage M, 2005, METABOLISM, V54, P910, DOI 10.1016/j.metabol.2005.02.005; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Greca João Paulo de Aguiar, 2016, Rev. paul. pediatr., V34, P316, DOI [10.1016/j.rppede.2016.01.001, 10.1016/j.rpped.2015.11.001]; Guedes DP, 2012, J PHYS ACT HEALTH, V9, P473, DOI 10.1123/jpah.9.4.473; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hedeker D, 2012, STAT MED, V31, P3328, DOI 10.1002/sim.5338; Herman KM, 2014, PEDIATR EXERC SCI, V26, P76, DOI 10.1123/pes.2012-0128; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Hubal M, 2011, EXERCISE GENOMIC; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Jones MA, 2000, ANN HUM BIOL, V27, P57, DOI 10.1080/030144600282389; Katzmarzyk PT, 2000, AM J HUM BIOL, V12, P395, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<395::AID-AJHB10>3.0.CO;2-J; Kenny D.A., 2006, DYADIC DATA ANAL MET; Kim HT, 2014, INT CONF UBIQ FUTUR, P3, DOI 10.1109/ICUFN.2014.6876736; Kim KS, 2004, METABOLISM, V53, P1538, DOI 10.1016/j.metabol.2004.06.019; Kovar R, 1976, J Sports Med Phys Fitness, V16, P205; Lloyd RS, 2014, BRIT J SPORT MED, V48, P498, DOI 10.1136/bjsports-2013-092952; Loos RJF, 2015, MED SCI SPORT EXER, V47, P1105, DOI 10.1249/MSS.0000000000000645; LORTIE G, 1982, HUM BIOL, V54, P801; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Maes HHM, 1996, MED SCI SPORT EXER, V28, P1479, DOI 10.1097/00005768-199612000-00007; Maia J, 2014, J SCI MED SPORT, V17, P381, DOI 10.1016/j.jsams.2013.09.004; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MALINA RM, 1981, HUM BIOL, V53, P163; Matton L, 2007, J SPORT SCI, V25, P1011, DOI 10.1080/02640410600951563; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moliner-Urdiales D, 2011, BRIT J SPORT MED, V45, P101, DOI 10.1136/bjsm.2009.062430; Mutunga M, 2006, INT J PEDIATR OBES, V1, P114, DOI 10.1080/17477160600569560; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pawlak K., 1984, GENETICS PSYCHOMOTOR; Pereira S, 2015, NUTRIENTS, V7, P4345, DOI 10.3390/nu7064345; PERUSSE L, 1987, PREV MED, V16, P607, DOI 10.1016/0091-7435(87)90044-2; Philippaerts RM, 1999, INT J SPORTS MED, V20, P284, DOI 10.1055/s-2007-971132; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rice T, 1997, OBES RES, V5, P557; Rigby N, 2015, J CELL PHYSIOL, V230, P2304, DOI 10.1002/jcp.24979; Robitaille J, 2003, CLIN GENET, V63, P109, DOI 10.1034/j.1399-0004.2003.00026.x; Ross D., 1986, INANTHROPOMETRY 3 CO; Safrit MJ, 1990, PEDIATRIC EXERCISE S, V2, P9, DOI DOI 10.1123/PES.2.1.9; Santiago C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016323; Santos DMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110025; Saranga S, REV BRASILEIRA EDUCA; Schutte NM, 2016, BEHAV GENET, V46, P217, DOI 10.1007/s10519-015-9754-2; Seabra Andre F, 2007, J Phys Act Health, V4, P370; Shang Lei, 2015, Prev Med Rep, V2, P265, DOI 10.1016/j.pmedr.2015.04.003; Starc G., 2013, ANNALES KINESIOLOGIA, V4, P95; Stephens, 1994, PHYS ACTIVITY FITNES, P77, DOI DOI 10.1249/00005768-199401000-00024; Taylor RW, 2010, OBESITY, V18, P1410, DOI 10.1038/oby.2009.399; Thomis M, 2011, GENETIC MOL ASPECTS, P159; Tomkinson GR., 2007, MED SPORT SCI BASEL, V50, P46; Vallance JK, 2015, AM J HEALTH BEHAV, V39, P62, DOI 10.5993/AJHB.39.1.7; Vasconcelos M. A., 2001, PORTUGUESE J SPORTS, V1, P44; Vasques C, 2007, REV PORTUGUESA CIENC, V9; Welk GJ, 2015, RES Q EXERCISE SPORT, V86, pS45, DOI 10.1080/02701367.2015.1043231; Wolfarth B, 2011, GENETIC MOL ASPECTS; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	78	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172013	10.1371/journal.pone.0172013	http://dx.doi.org/10.1371/journal.pone.0172013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187195	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300068
J	Bruffaerts, N; Vluggen, C; Roupie, V; Duytschaever, L; Van den Poel, C; Denoel, J; Wattiez, R; Letesson, JJ; Fretin, D; Rigouts, L; Chapeira, O; Mathys, V; Saegerman, C; Huygen, K				Bruffaerts, Nicolas; Vluggen, Christelle; Roupie, Virginie; Duytschaever, Lucille; Van den Poel, Christophe; Denoel, Joseph; Wattiez, Ruddy; Letesson, Jean-Jacques; Fretin, David; Rigouts, Leen; Chapeira, Ophelie; Mathys, Vanessa; Saegerman, Claude; Huygen, Kris			Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp hominissuis in an experimental mouse infection	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; NONTUBERCULOUS MYCOBACTERIA; PROTECTIVE EFFICACY; PARATUBERCULOSIS; TUBERCULOSIS; DISEASE; COMPLEX; MICE; PIGS; ORGANISMS	Mycobacterium avium subsp. hominissuis (Mah) represents a health concern for humans and to a lesser extent for pigs, but its zoonotic potential remains elusive. Using multispacer sequence typing (MST) we previously identified 49 different genotypes of Mah among Belgian clinical and porcine isolates, with 5 MSTs shared by both hosts. Using experimental intranasal infection of BALB/ c mice, we compared the virulence and immunogenicity of porcine and clinical human isolates with shared genotype or with a genotype only found in humans or pigs. Bacterial replication was monitored for 20 weeks in lungs, spleen and liver and mycobacteria specific spleen cell IFN-gamma , IL-10 and IL-17 production as well as serum antibody responses were analyzed. Isolates varied in virulence, with human and porcine isolates sharing MST22 genotype showing a thousand fold higher bacterial replication in lungs and more dissemination to spleen and liver than the human and porcine MST91 isolates. Virulent MST22 type was also associated with progressive suppression of IFN-gamma and IL-17 responses, and increased IL-10 production. Whole genome sequencing of the two virulent isolates with MST22 genotype and two avirulent isolates of genotype MST91 and comparison with two well-studied M. avium subsp. hominissuis reference strains i.e. Mah 104 and Mah TH135, identified in the two MST22 isolates nine specific virulence factors of the mammalian cell entry family, that were identical with Mah 104 strain. Despite the obvious limitations of the mouse model, a striking link of virulence and identity at the genome level of porcine and human isolates with the same multisequence type, for which no correlation of place of residence (humans) or farm of origin (pigs) was observed, seems to point to the existence in the environment of certain genotypes of Mah which may be more infectious both for humans and pigs than other genotypes.	[Bruffaerts, Nicolas; Van den Poel, Christophe; Huygen, Kris] Sci Inst Publ Hlth, Serv Immunol, Operat Direct Communicable & Infect Dis, Brussels, Belgium; [Vluggen, Christelle; Mathys, Vanessa] Sci Inst Publ Hlth, Serv Bacterial Dis, Operat Direct Communicable & Infect Dis, Brussels, Belgium; [Roupie, Virginie; Duytschaever, Lucille; Fretin, David] Vet & Agrochem Res Ctr, Unit Bacterial Zoonoses Livestock, Operat Direct Bacterial Dis, Brussels, Belgium; [Duytschaever, Lucille; Denoel, Joseph; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci, Fundamental & Appl Res Anim & Hlth, Liege, Belgium; [Wattiez, Ruddy] Univ Mons, Serv Prote & Microbiol, Mons, Belgium; [Letesson, Jean-Jacques] Univ Namur, Unite Rech Biol Microorganismes, Namur, Belgium; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Unit Mycobacteriol, Antwerp, Belgium; [Chapeira, Ophelie] Genoscreen, Serv Bioinformat, Lille, France; [Bruffaerts, Nicolas] Sci Inst Publ Hlth, Serv Mycol & Aerobiol, Operat Direct Communicable & Infect Dis, Brussels, Belgium	University of Liege; University of Mons; University of Namur; University of Antwerp; Institute of Tropical Medicine (ITM)	Bruffaerts, N; Huygen, K (corresponding author), Sci Inst Publ Hlth, Serv Immunol, Operat Direct Communicable & Infect Dis, Brussels, Belgium.	nicolas.bruffaerts@wiv-isp.be; kris.huygen@wiv-isp.be	Bruffaerts, Nicolas/AAQ-2647-2020; Jean-Jacques, LETESSON/AHB-6921-2022	Bruffaerts, Nicolas/0000-0001-6310-9140; Huygen, Kris/0000-0001-7808-0512; wattiez, ruddy/0000-0003-2071-4310; Saegerman, Claude/0000-0001-9087-7436; LETESSON, Jean-Jacques/0000-0002-5838-0224	Federal Public Service of Public Health, Safety of the Food Chain and Environment [RT-07/6, RT12/5]; Walloon Region; Belgian Ministry of Social Affairs through Health Insurance System; Genoscreen	Federal Public Service of Public Health, Safety of the Food Chain and Environment; Walloon Region; Belgian Ministry of Social Affairs through Health Insurance System; Genoscreen	This work was partially financed by the Federal Public Service of Public Health, Safety of the Food Chain and Environment (Convention RT-07/6 PARATUB, 2008-2012 and RT12/5 LYMPHINDIC 1, 2012-2015). This work was also funded through a grant from the Walloon Region (J-JL and RW). The National Reference Centre for Tuberculosis & Mycobacteria is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genoscreen provided support in the form of salaries for author OC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agdestein A, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-46; Agdestein A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-11; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bruffaerts N, 2016, GENOME ANNOUNC, V4; Cayrou C, 2010, MICROBIOL-SGM, V156, P687, DOI 10.1099/mic.0.033522-0; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Despierres L, 2012, EUR J CLIN MICROBIOL, V31, P1373, DOI 10.1007/s10096-011-1452-2; Falkinham JO, 2015, CLIN CHEST MED, V36, P35, DOI 10.1016/j.ccm.2014.10.003; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; GANGADHARAM PRJ, 1995, ANTIMICROB AGENTS CH, V39, P1647, DOI 10.1128/AAC.39.8.1647; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; HUYGEN K, 1993, INFECT IMMUN, V61, P2687, DOI 10.1128/IAI.61.6.2687-2693.1993; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Ichikawa K, 2015, INFECT GENET EVOL, V36, P250, DOI 10.1016/j.meegid.2015.09.029; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882, DOI 10.1128/JCM.31.11.2882-2889.1993; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Leroy B, 2009, VET MICROBIOL, V135, P313, DOI 10.1016/j.vetmic.2008.09.065; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Lim A, 2010, CLIN IMMUNOL, V137, P296, DOI 10.1016/j.clim.2010.07.011; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Moriyama Makoto, 2016, Kekkaku, V91, P9; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Roque S, 2007, J IMMUNOL, V178, P8028, DOI 10.4049/jimmunol.178.12.8028; Roupie V, 2008, VACCINE, V26, P4783, DOI 10.1016/j.vaccine.2008.07.009; Roupie V, 2008, INFECT IMMUN, V76, P2099, DOI 10.1128/IAI.01137-07; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Slany M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4387461; Tanghe A, 1999, J IMMUNOL, V162, P1113; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Uchiya K, 2017, SCI REP-UK, V7, DOI 10.1038/srep39750; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; Vluggen Christelle, 2016, Euro Surveill, V21, P30111, DOI 10.2807/1560-7917.ES.2016.21.3.30111; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Weiss CH, 2012, EXPERT REV RESP MED, V6, P597, DOI [10.1586/ERS.12.58, 10.1586/ers.12.58]; Wilkinson RJ, 1997, J CLIN MICROBIOL, V35, P553, DOI 10.1128/JCM.35.3.553-557.1997; Winthrop K, 2016, AM J RESP CELL MOL, V54, P170, DOI 10.1165/rcmb.2015-0256RC	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171895	10.1371/journal.pone.0171895	http://dx.doi.org/10.1371/journal.pone.0171895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182785	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800130
J	Bubici, G; Carluccio, AV; Stavolone, L; Cillo, F				Bubici, Giovanni; Carluccio, Anna Vittoria; Stavolone, Livia; Cillo, Fabrizio			Prosystemin overexpression induces transcriptional modifications of defense-related and receptor-like kinase genes and reduces the susceptibility to Cucumber mosaic virus and its satellite RNAs in transgenic tomato plants	PLOS ONE			English	Article							SALICYLIC-ACID; CELL-DEATH; SIGNALING PATHWAY; BOTRYTIS-CINEREA; SYSTEMIN; RESISTANCE; EXPRESSION; DISEASE; ARABIDOPSIS; RESPONSES	Systemin is a plant signal peptide hormone involved in the responses to wounding and insect damage in the Solanaceae family. It works in the same signaling pathway of jasmonic acid (JA) and enhances the expression of proteinase inhibitors. With the aim of studying a role for systemin in plant antiviral responses, a tomato ( Solanum lycopersicum) transgenic line overexpressing the prosystemin cDNA, i.e. the systemin precursor, was inoculated with Cucumber mosaic virus (CMV) strain Fny supporting either a necrogenic or a non-necrogenic satellite RNA (satRNA) variant. Transgenic plants showed reduced susceptibility to both CMV/satRNA combinations. While symptoms of the non-necrogenic inoculum were completely suppressed, a delayed onset of lethal disease occurred in about half of plants challenged with the necrogenic inoculum. RT-qPCR analysis showed a correlation between the systemin-mediated reduced susceptibility and the JA biosynthetic and signaling pathways (e.g. transcriptional alteration of lipoxygenase D and proteinase inhibitor II). Moreover, transgenically overexpressed systemin modulated the expression of a selected set of receptor-like protein kinase (RLK) genes, including some playing a known role in plant innate immunity. A significant correlation was found between the expression profiles of some RLKs and the systemin-mediated reduced susceptibility to CMV/satRNA. These results show that systemin can increase plant defenses against CMV/satRNA through transcriptional reprogramming of diverse signaling pathways.	[Bubici, Giovanni; Carluccio, Anna Vittoria; Stavolone, Livia; Cillo, Fabrizio] CNR, Ist Protez Sostenibile Piante, Bari, Italy; [Stavolone, Livia] Int Inst Trop Agr, Ibadan, Oyo State, Nigeria	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); CGIAR; International Institute of Tropical Agriculture (IITA)	Cillo, F (corresponding author), CNR, Ist Protez Sostenibile Piante, Bari, Italy.	fabrizio.cillo@cnr.it	Cillo, Fabrizio/G-1178-2010; Carluccio, Anna Vittoria/AAI-3463-2021; Stavolone, Livia/AAY-2967-2020; Bubici, Giovanni/O-4793-2015	Cillo, Fabrizio/0000-0001-9898-7533; Stavolone, Livia/0000-0002-0691-1302; Bubici, Giovanni/0000-0001-9143-2711	Ministry of Economy and Finance [I. 191/2009, PON02_00395_3082360]	Ministry of Economy and Finance	This work was supported with a grant from the Ministry of Economy and Finance to the CNR, "Integrate knowledge for Sustainability and Innovation of Made in Italy Agro-Food" (CISIA, I. 191/2009), and a grant to the Public-Private Laboratory GenoPom Integrating post-genomic platforms to enhance the tomato production chain (GenoPOMpro, Cod. PON02_00395_3082360).	Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Cillo F, 2007, J GEN VIROL, V88, P3166, DOI 10.1099/vir.0.83110-0; COLLMER CW, 1992, ANNU REV PHYTOPATHOL, V30, P419, DOI 10.1146/annurev.py.30.090192.002223; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Coppola M, 2015, PLANT MOL BIOL REP, V33, P1270, DOI 10.1007/s11105-014-0834-x; Corrado G, 2007, J CHEM ECOL, V33, P669, DOI 10.1007/s10886-007-9254-9; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Garcia-Arenal F, 1999, CURR TOP MICROBIOL, V239, P37; Garcia-Marcos A, 2009, MOL PLANT MICROBE IN, V22, P1431, DOI 10.1094/MPMI-22-11-1431; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Korner CJ, 2013, MOL PLANT MICROBE IN, V26, P1271, DOI 10.1094/MPMI-06-13-0179-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2011, PLANT PATHOLOGY J, V27, P53, DOI 10.5423/PPJ.2011.27.1.053; Malinowski R, 2009, PLANT MOL BIOL, V70, P603, DOI 10.1007/s11103-009-9494-x; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Maule AJ, 2000, MOL PLANT PATHOL, V1, P9, DOI 10.1046/j.1364-3703.2000.00002.x; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; MCGURL B, 1994, P NATL ACAD SCI USA, V91, P9799, DOI 10.1073/pnas.91.21.9799; Nicaise V, 2016, MOL PLANT PATHOL; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; OROZCOCARDENAS M, 1993, P NATL ACAD SCI USA, V90, P8273, DOI 10.1073/pnas.90.17.8273; Orsini F, 2010, PHYSIOL PLANTARUM, V138, P10, DOI 10.1111/j.1399-3054.2009.01292.x; OWEN J, 1988, VIROLOGY, V166, P495, DOI 10.1016/0042-6822(88)90520-X; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265, DOI 10.1128/MMBR.56.2.265-279.1992; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; SLEAT DE, 1994, MOL PLANT MICROBE IN, V7, P189, DOI 10.1094/MPMI-7-0189; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yi SY, 2010, NEW PHYTOL, V185, P701, DOI 10.1111/j.1469-8137.2009.03095.x; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	51	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171902	10.1371/journal.pone.0171902	http://dx.doi.org/10.1371/journal.pone.0171902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182745	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800131
J	Bielesz, B; Patsch, JM; Fischer, L; Bojic, M; Winnicki, W; Weber, M; Cejka, D				Bielesz, Bernhard; Patsch, Janina M.; Fischer, Lukas; Bojic, Marija; Winnicki, Wolfgang; Weber, Michael; Cejka, Daniel			Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DISTAL RADIUS; HR-PQCT; MICROARCHITECTURE; STRENGTH; RISK; TURNOVER; WOMEN	Hemodialysis (HD) patients face increased fracture risk, which is further associated with elevated risk of hospitalization and mortality. High-resolution peripheral computed tomography (HR-pQCT) has advanced our understanding of bone disease in chronic kidney disease by characterizing distinct changes in both the cortical and trabecular compartments. Increased cortical porosity (Ct.Po) has been shown to be associated with fracture in patients with osteopenia or in postmenopausal diabetic women. We tested whether the degree of Ct.Po identifies hemodialysis patients with prevalent fragility fractures in comparison to bone mineral density (BMD) assessed by dual X-ray absorptiometry (DXA). We performed a post hoc analysis of a cross-sectional study in 76 prevalent hemodialysis patients. Markers of mineral metabolism, coronary calcification score, DXA-, and HR-pQCT-data were analyzed, and Ct.Po determined at radius and tibia. Ct.Po was significantly higher in patients with fracture but association was lost after adjusting for age and gender (tibia p = 0.228, radius p = 0.5). Instead, femoral (F) BMD neck area (p = 0.03), F T-score neck area (p = 0.03), radius (R) BMD (p = 0.03), R T-score (p = 0.03), and cortical HR-pQCT indices such as cortical area (Ct.Ar) (tibia: p = 0.01; radius: p = 0.02) and cortical thickness (Ct.Th) (tibia: p = 0.03; radius: p = 0.02) correctly classified patients with fragility fractures. Area under receiver operating characteristic curves (AUC) for Ct.Po (tibia AUC: 0.711; p = 0.01; radius AUC: 0.666; p = 0.04), Ct.Ar (tibia AUC: 0.832; p<0.001; radius AUC: 0.796; p<0.001), and F neck BMD (AUC: 0.758; p= 0.002) did not differ significantly among each other. In conclusion, measuring Ct.Po is not superior to BMD determined by DXA for identification of HD patients with fragility fracture.	[Bielesz, Bernhard; Bojic, Marija; Winnicki, Wolfgang] Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria; [Patsch, Janina M.; Weber, Michael] Dept Biomed Imaging & Image Guided Therapy, Div Gen Radiol & Pediat Radiol, Vienna, Austria; [Fischer, Lukas] Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res CIR Lab, Vienna, Austria; [Fischer, Lukas] Software Competence Ctr Hagenberg, Hagenberg, Austria; [Cejka, Daniel] Ordensklinikum Linz, Dept Med 3, Nephrol, Transplantat,Rheumatol,Geriatr, Linz, Austria	Medical University of Vienna; Softwarepark Hagenberg	Bielesz, B (corresponding author), Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria.	bernhard.bielesz@meduniwien.ac.at	Winnicki, Wolfgang/ABB-1864-2021; Bielesz, Bernhard/AAQ-2683-2021; Patsch, Janina M/AAF-6040-2019; Fischer, Lukas/E-5573-2019; Weber, Michael/L-9836-2016	Winnicki, Wolfgang/0000-0002-0511-6120; Bielesz, Bernhard/0000-0002-4491-0562; Patsch, Janina M/0000-0002-5936-5608; Fischer, Lukas/0000-0001-5303-6638; Bojic, Marija/0000-0001-9732-4439; Cejka, Daniel/0000-0001-7162-1443; Weber, Michael/0000-0002-8507-2219				Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Bala Y, 2014, J BONE MINER RES, V29, P1356, DOI 10.1002/jbmr.2167; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Burghardt AJ, 2011, CLIN ORTHOP RELAT R, V469, P2179, DOI 10.1007/s11999-010-1766-x; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Cejka D, 2014, BONE, V64, P33, DOI 10.1016/j.bone.2014.03.048; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Davis KA, 2007, CALCIFIED TISSUE INT, V81, P364, DOI 10.1007/s00223-007-9076-3; Fischer L, 2015, RADIOLOGY, V274, P473, DOI 10.1148/radiol.14140201; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; GROTZ WH, 1994, TRANSPLANTATION, V58, P912, DOI 10.1097/00007890-199410270-00009; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105; Jamal SA, 2002, AM J KIDNEY DIS, V39, P843, DOI 10.1053/ajkd.2002.32006; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Malluche HH, 2012, J AM SOC NEPHROL, V23, P525, DOI 10.1681/ASN.2010121253; Naylor KL, 2014, KIDNEY INT, V86, P810, DOI 10.1038/ki.2013.547; Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916; Nickolas TL, 2011, J AM SOC NEPHROL, V22, P1560, DOI 10.1681/ASN.2010121275; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Nishiyama KK, 2015, J BONE MINER RES, V30, P456, DOI 10.1002/jbmr.2358; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Prischl FC, 2015, NEPHROL DIAL TRANSPL, V30, P1920, DOI 10.1093/ndt/gfv113; Shanbhogue V.V., 2016, J BONE MINER RES; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Trombetti A, 2013, OSTEOPOROSIS INT, V24, P1721, DOI 10.1007/s00198-012-2133-4; Vilayphiou N, 2016, BONE, V83, P233, DOI 10.1016/j.bone.2015.10.012; West SL, 2015, J BONE MINER RES, V30, P913, DOI 10.1002/jbmr.2406; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171873	10.1371/journal.pone.0171873	http://dx.doi.org/10.1371/journal.pone.0171873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199411	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400055
J	Chen, ZJ; An, Y; Zhao, BF; Yang, WD; Yu, Q; Cai, L; Ni, HY; Yin, JZ				Chen, Zhijuan; An, Yang; Zhao, Bofeng; Yang, Weidong; Yu, Qing; Cai, Li; Ni, Hongyan; Yin, Jianzhong			The value of resting-state functional magnetic resonance imaging for detecting epileptogenic zones in patients with focal epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; LINE BRAIN ACTIVITY; REGIONAL HOMOGENEITY; FMRI; FLUCTUATION; FREQUENCY; AMPLITUDE; EEG/FMRI; SIGNAL; MRI	Objective To determine the value of resting-state functional magnetic resonance imaging (RS-fMRI) based on the local analysis methods regional homogeneity (ReHo), amplitude of low-frequency fluctuations (ALFF), and fractional ALFF (fALFF), for detecting epileptogenic zones (EZs). Methods A total of 42 consecutive patients with focal epilepsy were enrolled. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of visually assessed RS-fMRI, MRI, magnetic resonance spectroscopy (MRS), video electroencephalography (VEEG), and positron-emission tomography computed tomography (PET-CT) in EZ localization were evaluated to assess their diagnostic abilities. ReHo, ALFF, and fALFF were also compared for their diagnostic values. Results RS-fMRI showed comparable sensitivity to PET (83.3%) and specificity to VEEG (66.7%), respectively, for EZ localization in patients with focal epilepsy. There were no significant differences between RS-fMRI and the other localization techniques in terms of sensitivity, specificity, PPV, and NPV. The sensitivities of ReHo, ALFF, and fALFF were 69.4%, 52.8%, and 38.9%, respectively, and for specificities of 66.7%, 83.3%, and 66.7%, respectively. There were no significant differences among ReHo, ALFF, and fALFF, except that ReHo was more sensitive than fALFF. Conclusions RS-fMRI may be an efficient tool for detecting EZs in focal epilepsy patients.	[Chen, Zhijuan] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [An, Yang; Yang, Weidong] Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China; [Zhao, Bofeng; Ni, Hongyan; Yin, Jianzhong] Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China; [Yu, Qing] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Cai, Li] Tianjin Med Univ, Gen Hosp, Clin PET CT Ctr, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, JZ (corresponding author), Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China.	yin3000@126.com		Yin, Jianzhong/0000-0002-6821-1686	Tianjin Science and Technology Support Project [15ZCZDSY00520]; Tianjin Bureau of Public Health [13KG107]	Tianjin Science and Technology Support Project; Tianjin Bureau of Public Health	This work was supported by the Tianjin Science and Technology Support Project (15ZCZDSY00520) and Tianjin Bureau of Public Health (13KG107).	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Di Bonaventura C, 2006, EPILEPSIA, V47, P52, DOI 10.1111/j.1528-1167.2006.00878.x; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Duncan J, 2009, CURR OPIN NEUROL, V22, P179, DOI 10.1097/WCO.0b013e328328f260; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; la Fougere C, 2009, EPILEPSY BEHAV, V15, P50, DOI 10.1016/j.yebeh.2009.02.025; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Marcar VL, 2006, AM J NEURORADIOL, V27, P799; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Matsuda K, 2001, EPILEPSIA, V42, P29, DOI 10.1046/j.1528-1157.42.s6.6.x; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Olson LD, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S012906571230001X; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Restom K, 2008, NEUROIMAGE, V40, P1495, DOI 10.1016/j.neuroimage.2008.01.038; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stafstrom CE, 2006, J CEREBR BLOOD F MET, V26, P983, DOI 10.1038/sj.jcbfm.9600265; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Urbach H, 2005, EUR RADIOL, V15, P494, DOI 10.1007/s00330-004-2629-1; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	30	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172094	10.1371/journal.pone.0172094	http://dx.doi.org/10.1371/journal.pone.0172094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199371	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400070
J	Elansary, HO; Ashfaq, M; Ali, HM; Yessoufou, K				Elansary, Hosam O.; Ashfaq, Muhammad; Ali, Hayssam M.; Yessoufou, Kowiyou			The first initiative of DNA barcoding of ornamental plants from Egypt and potential applications in horticulture industry	PLOS ONE			English	Article							TRNH-PSBA SPACER; SPECIES IDENTIFICATION; DIVERSITY; REVEALS; GENERA; RBCL	DNA barcoding relies on short and standardized gene regions to identify species. The agricultural and horticultural applications of barcoding such as for marketplace regulation and copyright protection remain poorly explored. This study examines the effectiveness of the standard plant barcode markers (matK and rbcL) for the identification of plant species in private and public nurseries in northern Egypt. These two markers were sequenced from 225 specimens of 161 species and 62 plant families of horticultural importance. The sequence recovery was similar for rbcL (96.4%) and matK (84%), but the number of specimens assigned correctly to the respective genera and species was lower for rbcL (75% and 29%) than matK (85% and 40%). The combination of rbcL and matKbrought the number of correct generic and species assignments to 83.4% and 40%, respectively. Individually, the efficiency of both markers varied among different plant families; for example, all palm specimens (Arecaceae) were correctly assigned to species while only one individual of Asteraceae was correctly assigned to species. Further, barcodes reliably assigned ornamental horticultural and medicinal plants correctly to genus while they showed a lower or no success in assigning these plants to species and cultivars. For future, we recommend the combination of a complementary barcode (e.g. ITS or trnH-psbA) with rbcL + matKto increase the performance of taxa identification. By aiding species identification of horticultural crops and ornamental palms, the analysis of the barcode regions will have large impact on horticultural industry.	[Elansary, Hosam O.] Univ Alexandria, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt; [Ashfaq, Muhammad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON, Canada; [Ali, Hayssam M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [Ali, Hayssam M.] Agr Res Ctr, Inst Hort Res, Timber Trees Res Dept, Sabahia Hort Res Stn, Alexandria, Egypt; [Yessoufou, Kowiyou] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa	Egyptian Knowledge Bank (EKB); Alexandria University; University of Guelph; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; University of Johannesburg	Elansary, HO (corresponding author), Univ Alexandria, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt.	hosammail2003@yahoo.com	Ali, Hayssam M./A-6054-2013; Elansary, Hosam O./E-3684-2019; Ashfaq, Muhammad/J-4723-2019	Ali, Hayssam M./0000-0001-6801-4263; Elansary, Hosam O./0000-0002-4476-2408; Ashfaq, Muhammad/0000-0003-1351-4126	King Saud University, Deanship of Scientific Research, College of Science Research Center; Government of Canada through Genome Canada; Ontario Genomics Institution; Faculty of Agriculture, Alexandria University	King Saud University, Deanship of Scientific Research, College of Science Research Center(King Saud University); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institution; Faculty of Agriculture, Alexandria University(Alexandria University)	This project was supported by the King Saud University, Deanship of Scientific Research, College of Science Research Center. Sequence analysis was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institution in support of the International Barcode of Life Project. The Faculty of Agriculture, Alexandria University funded the collection of material and delivery costs.	Ali MA, 2014, SAUDI J BIOL SCI, V21, P204, DOI 10.1016/j.sjbs.2014.03.003; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Besnard G, 2000, THEOR APPL GENET, V100, P1018, DOI 10.1007/s001220051383; Bezeng BS, 2013, BOT J LINN SOC, V172, P142, DOI 10.1111/boj.12030; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen XC, 2013, GENE, V530, P39, DOI 10.1016/j.gene.2013.07.097; Christina VLP, 2014, MOL ECOL RESOUR, V14, P60, DOI 10.1111/1755-0998.12167; CIOPORA Green Paper, 2002, CIOPORA GREEN PAPER; CIOPORA Strategy Paper, 2007, CIOPORA STRATEGY PAP; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Daru BH, 2016, J BIOGEOGR, V43, P155, DOI 10.1111/jbi.12619; Daru BH, 2016, TESTING THE RELIABIL; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elansary H. O., 2013, DNA BARCODES, V1, P46, DOI DOI 10.2478/DNA-2013-0004; Elansary HO, 2015, ECON BOT, V69, P114, DOI 10.1007/s12231-015-9308-9; Elansary HO, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-11; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gere J, 2013, ZOOKEYS, P127, DOI 10.3897/zookeys.365.5728; Griffiths AJF, 2006, AN INTRODUCTION TO G; Guo YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146880; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoveka LN, 2016, S AFR J BOT, V102, P208, DOI 10.1016/j.sajb.2015.06.014; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KEIL M, 1994, THEOR APPL GENET, V89, P442, DOI 10.1007/BF00225379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Liu YM, 2012, PHARMACOGN MAG, V8, P29, DOI 10.4103/0973-1296.93311; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Maurin O, 2014, NEW PHYTOL, V204, P201, DOI 10.1111/nph.12936; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monro AK, 2006, AM J BOT, V93, P426, DOI 10.3732/ajb.93.3.426; Nei M., 1987, MOLECULAR EVOLUTIONA; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ochieng JW, 2007, GENET MOL BIOL, V30, P1125, DOI 10.1590/S1415-47572007000600016; Pardee WD, 2007, INTELLECTUAL PROPERT; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rikken M., 2011, FIFTH VIDEO CONFEREN; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Stoeckle MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100755; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theodoridis S, 2012, MOL ECOL RESOUR, V12, P620, DOI 10.1111/j.1755-0998.2012.03129.x; Williamson J, 2016, GENOME; Yessoufou K, 2013, J ECOL, V101, P614, DOI 10.1111/1365-2745.12059	68	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172170	10.1371/journal.pone.0172170	http://dx.doi.org/10.1371/journal.pone.0172170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199378	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400078
J	Fiore, G; Anderson, E; Garborg, CS; Murray, M; Johnson, M; Moore, MJ; Howle, L; Shorter, KA				Fiore, Giovani; Anderson, Erik; Garborg, C. Spencer; Murray, Mark; Johnson, Mark; Moore, Michael J.; Howle, Laurens; Shorter, K. Alex			From the track to the ocean: Using flow control to improve marine bio-logging tags for cetaceans	PLOS ONE			English	Article							DOLPHIN TELEMETRY; DESIGN; DRAG; ATTACHMENT; BUOYANCY; BEHAVIOR; ENERGETICS; PENGUINS; ANIMALS; DEVICES	Bio-logging tags are an important tool for the study of cetaceans, but superficial tags inevitably increase hydrodynamic loading. Substantial forces can be generated by tags on fast-swimming animals, potentially affecting behavior and energetics or promoting early tag removal. Streamlined forms have been used to reduce loading, but these designs can accelerate flow over the top of the tag. This non-axisymmetric flow results in large lift forces (normal to the animal) that become the dominant force component at high speeds. In order to reduce lift and minimize total hydrodynamic loading this work presents a new tag design (Model A) that incorporates a hydrodynamic body, a channel to reduce fluid speed differences above and below the housing and wing to redirect flow to counter lift. Additionally, three derivatives of the Model A design were used to examine the contribution of individual flow control features to overall performance. Hydrodynamic loadings of four models were compared using computational fluid dynamics (CFD). The Model A design eliminated all lift force and generated up to similar to 30 N of downward force in simulated 6 m/s aligned flow. The simulations were validated using particle image velocimetry (PIV) to experimentally characterize the flow around the tag design. The results of these experiments confirm the trends predicted by the simulations and demonstrate the potential benefit of flow control elements for the reduction of tag induced forces on the animal.	[Fiore, Giovani] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA; [Anderson, Erik; Garborg, C. Spencer] Grove City Coll, Dept Mech Engn, Grove City, PA USA; [Murray, Mark] US Naval Acad, Dept Mech Engn, Annapolis, MD 21402 USA; [Johnson, Mark] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Johnson, Mark] Univ Aarhus, Dept Biosci, Aarhus, Denmark; [Moore, Michael J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Howle, Laurens] Duke Univ, Pratt Sch Engn, Durham, NC USA; [Howle, Laurens] BelleQuant Engn PLLC, Mebane, NC USA; [Shorter, K. Alex] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Defense; United States Navy; United States Naval Academy; University of St Andrews; Aarhus University; Woods Hole Oceanographic Institution; Duke University; University of Michigan System; University of Michigan	Shorter, KA (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	kshorter@umich.edu	Howle, Laurens/AAJ-2238-2021	Anderson, Erik/0000-0001-8508-0131; Johnson, Mark/0000-0001-8424-3197	National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research] [N00014-11-1-0113]; Grove City College Swezey Student Fellowship; Marie Curie-Sklodowska grant from the European Union; Natural Environment Research Council [smru10001] Funding Source: researchfish	National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research]; Grove City College Swezey Student Fellowship; Marie Curie-Sklodowska grant from the European Union; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research N00014-11-1-0113]. C. Spencer Garborg was supported by a Grove City College Swezey Student Fellowship to Erik Anderson. Mark Johnson was funded by a Marie Curie-Sklodowska grant from the European Union.	Abbott IH., 1959, THEORY WING SECTIONS; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Balmer BC, 2014, MAR MAMMAL SCI, V30, P656, DOI 10.1111/mms.12072; BANNASCH R, 1994, J EXP BIOL, V194, P83; Barnard R.H., 2001, ROAD VEHICLE AERODYN, V2nd; Cornick LA, 2006, J EXP MAR BIOL ECOL, V333, P306, DOI 10.1016/j.jembe.2006.01.010; Crossin GT, 2014, MAR ECOL PROG SER, V496, P1, DOI 10.3354/meps10691; CULIK BM, 1994, MAR BIOL, V118, P353, DOI 10.1007/BF00350291; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; FISH FE, 1994, AUST J ZOOL, V42, P79, DOI 10.1071/ZO9940079; Fish FE, 2014, J EXP BIOL, V217, P252, DOI 10.1242/jeb.087924; Hucho W.H., 2013, AERODYNAMICS ROAD VE; Jepsen N., 2005, P255; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Katz J., 1995, RACE CARE AERODYNAMI; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; McCormick B.W., 1995, AERODYNAMICS AERONAU; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Munson B. R., 1990, N Y, V3, P4; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Pavlov VV, 2007, DEEP-SEA RES PT II, V54, P404, DOI 10.1016/j.dsr2.2006.11.010; Pavlov VV, 2012, MAR MAMMAL SCI, V28, pE16, DOI 10.1111/j.1748-7692.2011.00476.x; Shorter KA, 2014, MAR MAMMAL SCI, V30, P726, DOI 10.1111/mms.12083; van der Hoop JM, 2014, J EXP BIOL, V217, P4229, DOI 10.1242/jeb.108225; Webb PM, 1998, J EXP BIOL, V201, P2349; Weber PW, 2009, J EXP BIOL, V212, P2149, DOI 10.1242/jeb.029868; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	30	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170962	10.1371/journal.pone.0170962	http://dx.doi.org/10.1371/journal.pone.0170962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196148	Green Published, gold			2022-12-27	WOS:000394423900009
J	Ko, PS; Liu, YC; Yeh, CM; Gau, JP; Yu, YB; Hsiao, LT; Tzeng, CH; Chen, PM; Chiou, TJ; Liu, CJ; Liu, JH				Ko, Po-Shen; Liu, Yao-Chung; Yeh, Chiu-Mei; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chia-Jen; Liu, Jin-Hwang			The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification	PLOS ONE			English	Article							MYELODYSPLASIA-RELATED CHANGES; STEM-CELL TRANSPLANTATION; ACUTE ERYTHROLEUKEMIA; SCORING SYSTEM; BLASTS; 50-PERCENT; AML	We reviewed 97 consecutive cases of myeloid neoplasm with erythroid predominance (MN-EP) between 2000 and 2015. Following 2016 WHO classification, MN-EP patients were classified into four groups. Eight pure erythroid leukemia (PEL) (including t-MN and AML-MRC morphologically fulfilled criteria for PEL) patients had dismal outcomes (median OS: 1 month) and showed more bone marrow fibrosis, worse performance status (PS) and higher serum lactate dehydrogenase (LDH) at diagnosis than the other groups. In the univariate analysis, risks of death in MN-EP patients included the morphologic features of PEL, very poor cytogenetic risk by IPSS-R, bone marrow fibrosis, leukocytosis, anemia, hypoalbuminemia, high LDH, and poor PS. In the multivariate analysis, independent predictors of death were morphologic features of PEL (adjusted hazards ratio [HR] 3.48, 95% confidence interval [CI] 1.24-9.74, p = 0.018), very poor cytogenetic risk by IPSS-R (adjusted HR 2.73, 95% CI 1.22-6.10, p = 0.015), hypoalbuminemia (< 3.7 g/dI) (adjusted HR 2.33, 95% CI 1.10-4.91, p = 0.026) and high serum LDH (>= 250 U/L) (adjusted HR 2.36, 95% CI 1.28-4.36, p = 0.006). Poor or unfavorable risk in different cytogenetic risk systems independently predicted death and UKMRC-R was the best model.	[Ko, Po-Shen; Liu, Yao-Chung; Yeh, Chiu-Mei; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Liu, Chia-Jen; Liu, Jin-Hwang] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Ko, Po-Shen; Liu, Yao-Chung; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Liu, Jin-Hwang] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Liu, Jin-Hwang] Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, CJ; Liu, JH (corresponding author), Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Liu, JH (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.; Liu, JH (corresponding author), Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan.	chiajenliu@gmail.com; jhliu@vghtpe.gov.tw		Ko, Po-Shen/0000-0001-9299-0352	Taipei Veterans General Hospital [V105B-016, V105E10-002-MY2-1]; Ministry of Science and Technology [MOST 104-2314-B-075-085-MY2]; Taiwan Clinical Oncology Research Foundation; Szu-Yuan Research Foundation of Internal Medicine; Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan Clinical Oncology Research Foundation; Szu-Yuan Research Foundation of Internal Medicine; Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University	This study was supported by grants from Taipei Veterans General Hospital (V105B-016 and V105E10-002-MY2-1), the Ministry of Science and Technology (MOST 104-2314-B-075-085-MY2), the Taiwan Clinical Oncology Research Foundation, Szu-Yuan Research Foundation of Internal Medicine, and Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bacher U, 2011, HAEMATOL-HEMATOL J, V96, P1284, DOI 10.3324/haematol.2011.043687; BENNETT JM, 1981, CANCER RES, V41, P4833; Bennett JM, 2016, LEUKEMIA RES, V47, P63, DOI 10.1016/j.leukres.2016.05.006; Calvo X, 2016, MODERN PATHOL, V29, P1541, DOI 10.1038/modpathol.2016.146; Chen PM, 2008, BONE MARROW TRANSPL, V42, pS133, DOI 10.1038/bmt.2008.141; DAMESHEK W, 1958, BLOOD, V13, P192, DOI 10.1182/blood.V13.2.192.192; Devillier R, 2015, AM J HEMATOL, V90, pE22, DOI 10.1002/ajh.23850; Devillier R, 2012, AM J HEMATOL, V87, P659, DOI 10.1002/ajh.23211; Di Guglielmo G, 1917, FOLIA MED, V3, P386; Fouillard L, 2002, BLOOD, V100, P3135, DOI 10.1182/blood.V100.9.3135; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Khan AM, 2011, BLOOD S, V118; Komrokji RS, 2012, AM J HEMATOL, V87, P1006, DOI 10.1002/ajh.23303; KORNBERG A, 1980, BLOOD, V56, P351; Lessard M, 2005, CANCER GENET CYTOGEN, V163, P113, DOI 10.1016/j.cancergencyto.2005.05.006; Liu CJ, 2012, LEUKEMIA LYMPHOMA, V53, P289, DOI 10.3109/10428194.2011.607526; Liu W, 2011, MODERN PATHOL, V24, P375, DOI 10.1038/modpathol.2010.194; MIHOVA D, 2012, N A J MED SCI, V5, P110, DOI DOI 10.7156/V5I2P110; OLOPADE OI, 1992, BLOOD, V80, P2873; Park S, 2002, LEUKEMIA RES, V26, P423, DOI 10.1016/S0145-2126(01)00146-1; Peng J, 2016, LEUKEMIA LYMPHOMA, V57, P812, DOI 10.3109/10428194.2015.1079318; Porwit A, 2011, HAEMATOL-HEMATOL J, V96, P1241, DOI 10.3324/haematol.2011.050526; Santos FPS, 2009, LEUKEMIA, V23, P2275, DOI 10.1038/leu.2009.181; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Walter RB, 2013, BLOOD, V121, P2424, DOI 10.1182/blood-2012-10-462440; Wang SA, 2008, MODERN PATHOL, V21, P1394, DOI 10.1038/modpathol.2008.142; Wang SA, 2016, MODERN PATHOL, V29, P1221, DOI 10.1038/modpathol.2016.118; Wang SA, 2012, HUM PATHOL, V43, P153, DOI 10.1016/j.humpath.2011.08.008; Wimazal F, 2001, LEUKEMIA RES, V25, P287, DOI 10.1016/S0145-2126(00)00140-5; Wong E, 2015, PATHOLOGY, V47, P289, DOI 10.1097/PAT.0000000000000244; Wong E, 2015, J CLIN PATHOL, V68, P301, DOI 10.1136/jclinpath-2014-202740; Zuo Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041485	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172029	10.1371/journal.pone.0172029	http://dx.doi.org/10.1371/journal.pone.0172029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196090	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423900045
J	Ratnasiri, S; Bandara, J				Ratnasiri, Shyama; Bandara, Jayatilleke			Changing patterns of meat consumption and greenhouse gas emissions in Australia: Will kangaroo meat make a difference?	PLOS ONE			English	Article							IDEAL DEMAND SYSTEM; CLIMATE-CHANGE; FOOD-CONSUMPTION; METHANE PRODUCTION; DIETARY CHOICES; LIVESTOCK; MITIGATION; MODEL; RANGELANDS; IMPACTS	The Australian per capita consumption of ruminant meat such as beef and lamb has declined over the last two decades. Over the same period, however, per capita consumption of non-ruminant meat such as chicken and pork has continued to increase. Furthermore, it is now observed that the human consumption of kangaroo meat is on the rise. This study investigates the implications of these changes in meat consumption patterns on Green House Gases (GHGs) emission mitigation in Australia using a Vector Auto Regression (VAR) forecasting approach. Our results suggest that the increase will continue in non-ruminant meat consumption and this will not only offset the decline in ruminant meat consumption, but will also raise the overall per capita meat consumption by approximately 1% annually. The per capita GHGs emissions will likely decrease by approximately 2.3% per annum, due to the inclusion of non-ruminant meat in Australian diets. The GHGs emissions can further be reduced if the average Australian consumer partially replaces ruminant meat with kangaroo meat.	[Ratnasiri, Shyama; Bandara, Jayatilleke] Griffith Univ, Dept Accounting Finance & Econ, Brisbane, Qld, Australia	Griffith University	Ratnasiri, S (corresponding author), Griffith Univ, Dept Accounting Finance & Econ, Brisbane, Qld, Australia.	s.ratnasiri@griffith.edu.au	Ratnasiri, Shyama/AAP-9863-2021	Ratnasiri, Shyama/0000-0002-9295-4076	Griffith University New Researcher Grant Scheme [40642]; New Researcher Grant Scheme of Griffith University, Australia	Griffith University New Researcher Grant Scheme; New Researcher Grant Scheme of Griffith University, Australia	This study was supported by the Griffith University New Researcher Grant Scheme, project number 40642. The funders had no role in study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.; We would like to thank financial support provided for this research under New Researcher Grant Scheme of Griffith University, Australia.; We also acknowledge the anonymous reviewers for their constructive comments.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Audsley E., 2010, LOW CAN WE GO ASSESS; Australian Bureau of Agriculture and Resource Economics ABARE, 2009, VAL RED MEAT IND AUS; Bajzelj B, 2014, NAT CLIM CHANGE, V4, P924, DOI [10.1038/nclimate2353, 10.1038/NCLIMATE2353]; Barai B. K., 1992, Trends in Food Science & Technology, V3, P69, DOI 10.1016/0924-2244(92)90133-H; Barten AP, 1966, THEORIE EMPIRE VOLLE; Beardsworth A., 1999, British Food Journal, V101, P289, DOI 10.1108/00070709910272169; Ben-Ami D., 2010, ADVOCATING KANGAROO; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Carlsson-Kanyama A, 1998, AMBIO, V27, P528; Carlsson-Kanyama A, 1998, FOOD POLICY, V23, P277, DOI 10.1016/S0306-9192(98)00037-2; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; CASHIN P, 1991, AUST J AGR ECON, V35, P263, DOI 10.1111/j.1467-8489.1991.tb00509.x; Chapman M, 2003, RANGELAND J, V25, P20, DOI 10.1071/RJ03003; CHEN PY, 1991, CAN J AGR ECON, V39, P223, DOI 10.1111/j.1744-7976.1991.tb03569.x; Climate Change Committee, 2008, BUILD LOW CARB EC UK; Cooney R., 2012, SCI UNDER SIEGE, P150, DOI [10.7882/FS.2012.051, DOI 10.7882/FS.2012.051]; Craw C, 2008, MEDIA INT AUST, P82; DEATON A, 1980, AM ECON REV, V70, P312; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Deparment of Agriculture and Water Resources, LIV EM AUSTR GOV; Department of Climate Change and Energy Efficiency, 2008, NAT GREENH GAS INV; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Duchin F, 2005, J IND ECOL, V9, P99, DOI 10.1162/1088198054084707; Edjabou LD, 2013, FOOD POLICY, V39, P84, DOI 10.1016/j.foodpol.2012.12.004; Edwards-Jones G, 2009, J AGR SCI-CAMBRIDGE, V147, P707, DOI 10.1017/S0021859609990165; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; Fiala N, 2008, ECOL ECON, V67, P412, DOI 10.1016/j.ecolecon.2007.12.021; Flachowsky G. H., 2007, ANIMAL FEED SCI TECH, V135, P188; Foster M., 2014, EMERGING ANIMAL PLAN; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Goodland R, 1997, ECOL ECON, V23, P189, DOI 10.1016/S0921-8009(97)00579-X; Griffith G, 2001, PREVIOUS DEMAND ELAS, P3; GRIGG G, 1989, CONSERV BIOL, V3, P194, DOI 10.1111/j.1523-1739.1989.tb00072.x; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; Hyde CE, 1998, APPL ECON, V30, P1169, DOI 10.1080/000368498325066; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; Kim B, 2009, ECOL ECON, V69, P186, DOI 10.1016/j.ecolecon.2009.08.017; Madsen J, 2012, J ANIM SCI, V90, P1364, DOI 10.2527/jas.2011-4011; Maguire A, 2008, 12 INT S RUM MICR EC; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Nc S, 1983, FEASIBILITY FARMING; OECD, 2016, MEAT CONS IND; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Piggott NE, 1996, AM J AGR ECON, V78, P268, DOI 10.2307/1243701; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Ripple WJ, 2014, NAT CLIM CHANGE, V4, P2, DOI 10.1038/nclimate2081; Rutherford AS, 1999, AGR ECON, V21, P21, DOI 10.1016/S0169-5150(99)00008-0; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Stone R, 1954, ECON J, V64, P511, DOI 10.2307/2227743; THEIL H, 1965, ECONOMETRICA, V33, P67, DOI 10.2307/1911889; Verbeke W, 2001, AGR ECON-BLACKWELL, V25, P359, DOI 10.1111/j.1574-0862.2001.tb00215.x; Wang Z. J., 2003, Agribusiness (New York), V19, P505, DOI 10.1002/agr.10074; Williams P, 2007, NUTR DIET, V64, pS113, DOI 10.1111/j.1747-0080.2007.00197.x; Wilson GR, 2008, CONSERV LETT, V1, P119, DOI 10.1111/j.1755-263X.2008.00023.x; Wirsenius S, 2011, CLIMATIC CHANGE, V108, P159, DOI 10.1007/s10584-010-9971-x	68	10	10	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170130	10.1371/journal.pone.0170130	http://dx.doi.org/10.1371/journal.pone.0170130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196141	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900004
J	Omar, S; Clarke, R; Abdullah, H; Brady, C; Corry, J; Winter, H; Touzelet, O; Power, UF; Lundy, F; McGarvey, LPA; Cosby, SL				Omar, Shadia; Clarke, Rebecca; Abdullah, Haniah; Brady, Clare; Corry, John; Winter, Hanagh; Touzelet, Olivier; Power, Ultan F.; Lundy, Fionnuala; McGarvey, Lorcan P. A.; Cosby, S. Louise			Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells	PLOS ONE			English	Article							SENSING ION CHANNELS; POTENTIAL VANILLOID-1; EXPRESSION; ACTIVATION; NEURONS; PROTEIN; MECHANISMS; RELEASE; ASTHMA; IL-8	Receptors implicated in cough hypersensitivity are transient receptor potential vanilloid 1 (TRPV1), transient receptor potential cation channel, Subfamily A, Member 1 (TRPA1) and acid sensing ion channel receptor 3 (ASIC3). Respiratory viruses, such as respiratory syncytial virus (RSV) and measles virus (MV) may interact directly and/or indirectly with these receptors on sensory nerves and epithelial cells in the airways. We used in vitro models of sensory neurones (SHSY5Y or differentiated IMR-32 cells) and human bronchial epithelium (BEAS-2B cells) as well as primary human bronchial epithelial cells (PBEC) to study the effect of MV and RSV infection on receptor expression. Receptor mRNA and protein levels were examined by qPCR and flow cytometry, respectively, following infection or treatment with UV inactivated virus, virus-induced soluble factors or pelleted virus. Concentrations of a range of cytokines in resultant BEAS-2B and PBEC supernatants were determined by ELISA. Up-regulation of TRPV1, TRPA1 and ASICS3 expression occurred by 12 hours postinfection in each cell type. This was independent of replicating virus, within the same cell, as virus-induced soluble factors alone were sufficient to increase channel expression. IL-8 and IL-6 increased in infected cell supernatants. Antibodies against these factors inhibited TRP receptor up-regulation. Capsazepine treatment inhibited virus induced up-regulation of TRPV1 indicating that these receptors are targets for treating virus-induced cough.	[Omar, Shadia; Clarke, Rebecca; Abdullah, Haniah; Brady, Clare; Corry, John; Winter, Hanagh; Touzelet, Olivier; Power, Ultan F.; Lundy, Fionnuala; McGarvey, Lorcan P. A.; Cosby, S. Louise] Queens Univ Belfast, Ctr Med Expt, Ctr Med Biol, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Cosby, SL (corresponding author), Queens Univ Belfast, Ctr Med Expt, Ctr Med Biol, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland.	l.cosby@qub.ac.uk	Linden, Gerard/AFN-7508-2022; Cosby, Louise/W-9239-2019; Lundy, Fionnuala/AAE-7128-2020	Linden, Gerard/0000-0003-1523-3934; Cosby, Louise/0000-0002-2617-8603; Power, Ultan/0000-0003-3246-3774; Lundy, Fionnuala/0000-0003-3150-1150	Department of Education and Learning, Northern Ireland	Department of Education and Learning, Northern Ireland	This work was supported by a Ph.D. studentship from Department of Education and Learning, Northern Ireland.; Shadia Omar was the recipient of a Ph.D. studentship from the Department of Education and Learning, Northern Ireland.	Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cosby SL, 2002, J NEUROVIROL, V8, P85, DOI 10.1080/13550280290167975; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Dicpinigaitis Peter V, 2009, Cough, V5, P11, DOI 10.1186/1745-9974-5-11; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; Espinoza JA, 2013, P NATL ACAD SCI USA, V110, P9112, DOI 10.1073/pnas.1217508110; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Footitt J, 2009, PULM PHARMACOL THER, V22, P108, DOI 10.1016/j.pupt.2008.12.022; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Guo-Parke H, 2013, AM J RESP CRIT CARE, V188, P842, DOI 10.1164/rccm.201304-0750OC; Hatano N, 2012, J BIOL CHEM, V287, P31962, DOI 10.1074/jbc.M112.361139; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kollarik M, 2007, PULM PHARMACOL THER, V20, P402, DOI 10.1016/j.pupt.2006.11.010; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; Louhivuori LM, 2009, J CELL PHYSIOL, V221, P67, DOI 10.1002/jcp.21828; McGarvey LP, 2013, J ALLERGY CLIN IMMUN, P01442; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nagaeva EI, 2015, ACTA NATURAE, V7, P95, DOI 10.32607/20758251-2015-7-2-95-101; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Preti D, 2012, EXPERT OPIN THER PAT, V22, P663, DOI 10.1517/13543776.2012.696099; Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Ristoiu V, 2011, PAIN, V152, P936, DOI 10.1016/j.pain.2011.02.024; Son GY, 2015, ARCH ORAL BIOL, V60, P526, DOI 10.1016/j.archoralbio.2014.12.014; Sui F, 2010, AM J CHINESE MED, V38, P789, DOI 10.1142/S0192415X1000824X; Sui F, 2010, J ETHNOPHARMACOL, V129, P361, DOI 10.1016/j.jep.2010.03.039; Takemura M, 2008, PULM PHARMACOL THER, V21, P833, DOI 10.1016/j.pupt.2008.09.005; Villenave R, 2013, TRENDS MICROBIOL, V21, P238, DOI 10.1016/j.tim.2013.02.004; Wang Z, 2011, MOL VIS, V17, P3137; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Westerly BD, 2010, IMMUNOL ALLERGY CLIN, V30, P523, DOI 10.1016/j.iac.2010.08.006; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Yingjun G, 2013, CHANNELS, P7231; Yousaf Nadia, 2011, Cough, V7, P4, DOI 10.1186/1745-9974-7-4; Zhang F, 2007, J CELL PHYSIOL, V213, P730, DOI 10.1002/jcp.21141	43	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171681	10.1371/journal.pone.0171681	http://dx.doi.org/10.1371/journal.pone.0171681			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187208	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300037
J	Schechner, V; Carmeli, Y; Leshno, M				Schechner, Vered; Carmeli, Yehuda; Leshno, Moshe			A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation	PLOS ONE			English	Article							ASYMPTOMATIC CARRIAGE; INFECTION; CARRIERS; EPIDEMIOLOGY; ACQUISITION; STRAIN	Background Clostridium difficile infection (CDI) is a common and potentially fatal healthcare-associated infection. Improving diagnostic tests and infection control measures may prevent transmission. We aimed to determine, in resource-limited settings, whether it is more effective and cost-effective to allocate resources to isolation or to diagnostics. Methods We constructed a mathematical model of CDI transmission based on hospital data (9 medical wards, 350 beds) between March 2010 and February 2013. The model consisted of three compartments: susceptible patients, asymptomatic carriers and CDI patients. We used our model results to perform a cost-effectiveness analysis, comparing four strategies that were different combinations of 2 test methods (the two-step test and uniform PCR) and 2 infection control measures (contact isolation in multiple-bed rooms or single-bed rooms/ cohorting). For each strategy, we calculated the annual cost (of CDI diagnosis and isolation) for a decrease of 1 in the average daily number of CDI patients; the strategy of the two-step test and contact isolation in multiple-bed rooms was the reference strategy. Results Our model showed that the average number of CDI patients increased exponentially as the transmission rate increased. Improving diagnosis by adopting uniform PCR assay reduced the average number of CDI cases per day per 350 beds from 9.4 to 8.5, while improving isolation by using single-bed rooms reduced the number to about 1; the latter was cost saving. Conclusions CDI can be decreased by better isolation and more sensitive laboratory methods. From the hospital perspective, improving isolation is more cost-effective than improving diagnostics.	[Schechner, Vered; Carmeli, Yehuda] Tel Aviv Sourasky Med Ctr, Div Epidemiol, Tel Aviv, Israel; [Leshno, Moshe] Tel Aviv Univ, Fac Management, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Schechner, V (corresponding author), Tel Aviv Sourasky Med Ctr, Div Epidemiol, Tel Aviv, Israel.	vereds@tlvmc.gov.il						Adler A, 2014, CLIN MICROBIOL INFEC, V20, P904; Adler A, 2015, DIAGN MICR INFEC DIS, V83, P21, DOI 10.1016/j.diagmicrobio.2015.05.015; BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bracco D, 2007, INTENS CARE MED, V33, P836, DOI 10.1007/s00134-007-0559-5; Brecher SM, 2013, CLIN INFECT DIS, V57, P1175, DOI 10.1093/cid/cit424; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Gingras G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163880; Grein JD, 2014, CLIN MICROBIOL INFEC, V20, P65, DOI 10.1111/1469-0691.12198; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; JOHNSON S, 1990, AM J MED, V88, P137, DOI 10.1016/0002-9343(90)90462-M; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Longtin Y, 2016, JAMA INTERN MED, V176, P796, DOI [10.1001/jamainternmed.2016.0177, 10.1001/jama]; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Mermel LA, 2013, JT COMM J QUAL PATIE, V39, P298, DOI 10.1016/S1553-7250(13)39042-4; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Teltsch DY, 2011, ARCH INTERN MED, V171, P32, DOI 10.1001/archinternmed.2010.469; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171327	10.1371/journal.pone.0171327	http://dx.doi.org/10.1371/journal.pone.0171327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187144	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300018
J	Smith, AN; Kabelik, D				Smith, Alexandra N.; Kabelik, David			The effects of dopamine receptor 1 and 2 agonists and antagonists on sexual and aggressive behaviors in male green anoles	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; MALE-RAT; JAPANESE-QUAIL; CONSUMMATORY ASPECTS; COURTSHIP BEHAVIOR; ACCUMBAL DOPAMINE; NEURAL ACTIVITY; SOCIAL SIGNAL; BROWN ANOLE; CAROLINENSIS	The propensity to exhibit social behaviors during interactions with same-sex and opposite-sex conspecifics is modulated by various neurotransmitters, including dopamine. Dopamine is a conserved neurotransmitter among vertebrates and dopaminergic receptors are also highly conserved among taxa. Activation of D-1 and D-2 dopamine receptor subtypes has been shown to modulate social behaviors, especially in mammalian and avian studies. However, the specific behavioral functions of these receptors vary across taxa. In reptiles there have been few studies examining the relationship between dopaminergic receptors and social behaviors. We therefore examined the effects of D-1 and D-2 agonists and antagonists on sexual and aggressive behaviors in the male green anole lizard (Anolis carolinensis). Treatment with high doses of both D-1 and D-2 agonists was found to impair both sexual and aggressive behaviors. However, the D-1 agonist treatment was also found to impair motor function, suggesting that those effects were likely nonspecific. Lower doses of both agonists and antagonists failed to affect social behaviors. These findings provide some evidence for D-2 receptor regulation of social behaviors, but in contrast with previous research, these effects are all inhibitory and no effects were found for manipulations of D-1 receptors. A potential reason for the lack of more widespread effects on social behaviors using moderate or low drug doses is that systemic injection of drugs resulted in effects throughout the whole brain, thus affecting counteracting circuits which negated one another, making measurable changes in behavioral output difficult to detect. Future studies should administer drugs directly into brain regions known to regulate sexual and aggressive behaviors.	[Smith, Alexandra N.; Kabelik, David] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Smith, Alexandra N.; Kabelik, David] Rhodes Coll, Program Neurosci, Memphis, TN 38112 USA		Kabelik, D (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.; Kabelik, D (corresponding author), Rhodes Coll, Program Neurosci, Memphis, TN 38112 USA.	kabelikd@rhodes.edu	Kabelik, David/O-9932-2019	Kabelik, David/0000-0002-1196-8071	Rhodes College	Rhodes College	Funding for this study was provided by Rhodes College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AD, 2014, NEUROBIOL LEARN MEM, V108, P65, DOI 10.1016/j.nlm.2013.11.007; AHLENIUS S, 1990, EXPERIENTIA, V46, P1026, DOI 10.1007/BF01940663; ANDERSEN PH, 1990, EUR J PHARM-MOLEC PH, V188, P335, DOI 10.1016/0922-4106(90)90194-3; Balthazart J, 1997, PHYSIOL BEHAV, V62, P571, DOI 10.1016/S0031-9384(97)00163-7; Beck J, 2002, PHYSIOL BEHAV, V76, P91, DOI 10.1016/S0031-9384(02)00678-9; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BITRAN D, 1989, PHARMACOL BIOCHEM BE, V34, P453, DOI 10.1016/0091-3057(89)90540-6; Castagna C, 1997, PHARMACOL BIOCHEM BE, V58, P403, DOI 10.1016/S0091-3057(97)00243-8; Clemens S, 2012, J NEUROPHYSIOL, V107, P2250, DOI 10.1152/jn.00366.2011; D'Aquila PS, 2003, EUR J PHARMACOL, V460, P71, DOI 10.1016/S0014-2999(02)02881-9; Dennis RL, 2011, POULTRY SCI, V90, P2440, DOI 10.3382/ps.2011-01513; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; FOREMAN MM, 1987, J NEURAL TRANSM, V68, P153, DOI 10.1007/BF02098495; Forster GL, 2005, ANIM BEHAV, V69, P733, DOI 10.1016/j.anbehav.2004.06.026; Giuliano F, 2001, EUR UROL, V40, P601, DOI 10.1159/000049844; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Hoglund E, 2005, BEHAV BRAIN RES, V156, P53, DOI 10.1016/j.bbr.2004.05.009; HULL EM, 1986, BRAIN RES, V370, P73, DOI 10.1016/0006-8993(86)91106-6; HULL EM, 1995, J NEUROSCI, V15, P7465; Kabelik D, 2014, BRAIN RES, V1553, P41, DOI 10.1016/j.brainres.2014.01.026; Kabelik D, 2013, HORM BEHAV, V63, P437, DOI 10.1016/j.yhbeh.2012.11.016; Kabelik D, 2010, NEUROPHARMACOLOGY, V58, P117, DOI 10.1016/j.neuropharm.2009.06.009; Kleitz-Nelson HK, 2010, EUR J NEUROSCI, V32, P118, DOI 10.1111/j.1460-9568.2010.07257.x; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P300, DOI 10.1037/a0018767; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P773, DOI 10.1037/a0021490; Korzan WJ, 2006, BEHAV NEUROSCI, V120, P93, DOI 10.1037/0735-7044.120.1.93; Korzan WJ, 2000, HORM BEHAV, V38, P193, DOI 10.1006/hbeh.2000.1619; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; LICHT P, 1973, COPEIA, P465; McHenry JA, 2012, BEHAV NEUROSCI, V126, P523, DOI 10.1037/a0028707; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; NODA K, 1985, Society for Neuroscience Abstracts, V11, P549; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; PUGLISIALLEGRA S, 1990, AGGRESSIVE BEHAV, V16, P271, DOI 10.1002/1098-2337(1990)16:3/4<271::AID-AB2480160312>3.0.CO;2-H; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Smeets W.J.A.J., 1994, P103; Smeets W. J. A. J., 1994, PHYLOGENY DEV CATECH; SWEIDAN S, 1991, BRAIN RES, V549, P127, DOI 10.1016/0006-8993(91)90608-X; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Watt MJ, 2007, PHYSIOL BEHAV, V90, P567, DOI 10.1016/j.physbeh.2006.11.006; Woolley SC, 2004, PHYSIOL BEHAV, V83, P347, DOI 10.1016/j.physbeh.2004.08.021; Woolley SC, 2001, HORM BEHAV, V40, P483, DOI 10.1006/hbeh.2001.1713	44	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172041	10.1371/journal.pone.0172041	http://dx.doi.org/10.1371/journal.pone.0172041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187160	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300072
J	Zhang, Y; Wang, TL; Wei, J; He, JG; Wang, T; Liu, Y; Xu, H; Dong, JS				Zhang, Yi; Wang, Tingliang; Wei, Jiao; He, Jinguang; Wang, Tao; Liu, Ying; Xu, Hua; Dong, Jiasheng			What's the remedy for the distal necrosis of DIEP flap, better venous drain or more arterial supply?	PLOS ONE			English	Article							EPIGASTRIC PERFORATOR FLAP; UNILATERAL BREAST RECONSTRUCTION; VASCULAR AUGMENTATION; MODEL; EXPERIENCE; TRAM; ANASTOMOSIS; ANGIOSOMES; SELECTION; EFFICACY	Background We developed a novel pedicled DIEP flap model in rat to explore the possible remedy for the distal necrosis of the flap. Methods A deep inferior epigastric perforator (DIEP) flap, based on the second right cranial perforator (P2) as the main pedicle, was elevated in 48 Sprague-Dawley rats. The rats were randomized into 4 groups: group I, the left P2 remaining intact as supercharging; group II, the left P2 artery alone kept as supercharging; group III, the left P2 vein alone kept as supercharging; group IV, no supercharging. Transcutaneous oxygen pressure (TcPO2) and transcutaneous carbon dioxide pressure (TcPCO2) were measured immediately after flap elevation, protein level of Hif- 1a was measured 48 hours later, and flap survival was assessed 7 days postoperatively. Results Blockade of artery led to significantly lower TcPO2, higher TcPCO2, and higher expression level of Hif- 1a in the distal side of the flap in group III and group IV, than those of group I and group II. At 7 days post surgery, significantly lower flap survival rates were observed in group III (81.9 +/- 5.7%) and group IV (78.4 +/- 6.5%), compared to observed in group I (97.2 +/- 3.0%) and group II (94.2 +/- 6.2%). Conclusions It might be arterial insufficiency, not venous congestion, which mainly caused the distal necrosis of the DIEP flap in rat. Arterial instead of venous supercharging might be a more effective procedure that improves circulation to zone IV of the flap.	[Zhang, Yi; Wang, Tingliang; Wei, Jiao; He, Jinguang; Wang, Tao; Liu, Ying; Xu, Hua; Dong, Jiasheng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China.	doctorxuhua@hotmail.com; dongjiasheng_9y@163.com		Wang, Tingliang/0000-0001-7440-7119				Agarwal JP, 2007, ANN PLAS SURG, V58, P359, DOI 10.1097/01.sap.0000239818.28900.81; Barabas AG, 2008, J PLAST RECONSTR AES, V61, P1249, DOI 10.1016/j.bjps.2008.01.018; Beahm EK, 2007, PLAST RECONSTR SURG, V120, P41, DOI 10.1097/01.prs.0000263729.26936.31; Blondeel PN, 2000, PLAST RECONSTR SURG, V106, P1295, DOI 10.1097/00006534-200011000-00009; Blondeel PN, 1999, BRIT J PLAST SURG, V52, P104, DOI 10.1054/bjps.1998.3033; Chang H, 2004, PLAST RECONSTR SURG, V113, P277, DOI 10.1097/01.PRS.0000095953.57320.2F; DellaCroce FJ, 2011, PLAST RECONSTR SURG, V127, P1093, DOI 10.1097/PRS.0b013e318205f223; Gimbel ML, 2009, PLAST RECONSTR SURG, V124, P796, DOI 10.1097/PRS.0b013e3181b03768; Groth AK, 2007, ACTA CIR BRAS, V22, P474, DOI 10.1590/S0102-86502007000600011; Gumus N, 2012, MICROSURG, V32, P303, DOI 10.1002/micr.21952; Hallock GG, 2005, PLAST RECONSTR SURG, V116, P551, DOI 10.1097/01.prs.0000172889.62564.e1; Hamdi M, 1999, PLAST RECONSTR SURG, V103, P86, DOI 10.1097/00006534-199901000-00015; Hamdi M, 2007, J PLAST RECONSTR AES, V60, P904, DOI 10.1016/j.bjps.2007.02.016; Holm C, 2007, J PLAST RECONSTR AES, V60, P946, DOI 10.1016/j.bjps.2005.12.066; Holm C, 2008, PLAST RECONSTR SURG, V122, P1612, DOI 10.1097/PRS.0b013e31818a9a3f; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; KOSHIMA I, 1989, BRIT J PLAST SURG, V42, P645, DOI 10.1016/0007-1226(89)90075-1; Kroll SS, 2000, PLAST RECONSTR SURG, V106, P576, DOI 10.1097/00006534-200009030-00008; Laporta R, 2015, AESTHET PLAST SURG, V39, P339, DOI 10.1007/s00266-015-0475-y; Li SK, 2002, J RECONSTR MICROSURG, V18, P161, DOI 10.1055/s-2002-28498; Mohan AT, 2016, PLAST RECONSTR SURG, V138, p790E, DOI 10.1097/PRS.0000000000002716; Nahabedian MY, 2002, PLAST RECONSTR SURG, V110, P466, DOI 10.1097/00006534-200208000-00015; NAKAYAMA Y, 1982, PLAST RECONSTR SURG, V69, P61, DOI 10.1097/00006534-198269010-00009; Oksar HS, 2001, PLAST RECONSTR SURG, V108, P125, DOI 10.1097/00006534-200107000-00018; Roberts AP, 1996, PLAST RECONSTR SURG, V97, P610, DOI 10.1097/00006534-199603000-00019; Rozen WM, 2009, PLAST RECONSTR SURG, V124, P848, DOI 10.1097/PRS.0b013e3181b037a2; Rubino C, 2009, J PLAST RECONSTR AES, V62, P1666, DOI 10.1016/j.bjps.2008.05.045; Talbot SG, 2010, J RECONSTR MICROSURG, V26, P513, DOI 10.1055/s-0030-1261697; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; TAYLOR GI, 1992, PLAST RECONSTR SURG, V89, P181, DOI 10.1097/00006534-199202000-00001; Walters JA, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000527; Wang T, 2015, AESTHET PLAST SURG, V39, P63, DOI 10.1007/s00266-014-0413-4; Xu H, 2009, PLAST RECONSTR SURG, V124, P1797, DOI 10.1097/PRS.0b013e3181bf81cf; Yamamoto Y, 2009, J PLAST RECONSTR AES, V62, P244, DOI 10.1016/j.bjps.2007.11.078; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597	35	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171651	10.1371/journal.pone.0171651	http://dx.doi.org/10.1371/journal.pone.0171651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187214	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300033
J	Zhao, H; Yin, ZY; Xiang, HY; Liao, ZK; Wang, ZG				Zhao, Hui; Yin, Zhiyong; Xiang, Hongyi; Liao, Zhikang; Wang, Zhengguo			Preliminary study on alterations of altitude road traffic in China from 2006 to 2013	PLOS ONE			English	Article							FATALITIES	Introduction Road traffic can play an important role in strengthening regional economic activities, especially at high altitude, and it is necessary to know important traffic-related information. Although previous studies reported on road traffic in China, there has been little research on high-altitude road traffic to date. Method The annual official census of road traffic safety from 2006 to 2013 was used to obtain data on the general population, registered drivers, registered vehicles, newly built roads, road traffic accidents (RTAs), mortality rate per 100 000 populations and per 10 000 vehicles in high-altitude provinces, including Tibet, Qinghai, Xinjiang, Gansu, Yunnan, Sichuan, and Chongqing. These provincial data were reviewed retrospectively, with the national data as the reference. Statistical analysis (i.e., t test) was used to compare the estimated average annual change rate of population, number of registered drivers, registered vehicles, and newly built roads in high-altitude provinces with the national rates. Results Compared with the national data, there are significantly higher annual rates of population growth in Tibet and Xinjiang, registered drivers in Gansu, registered vehicles in Gansu, Sichuan, and Chongqing, and newly built roads in Tibet and Qinghai. Among the investigated provinces, Tibet, Qinghai, and Yunnan had a higher proportion of the roads with the high class. RTAs and RTA-induced casualties in the high-altitude provinces indicated a decreasing trend. The mortality rate per 10 000 vehicles and per 100 000 populations showed a decreasing trend, while the RTA-related mortality rate in Tibet, Qinghai, Xinjiang and Gansu remained high. Conclusions Major changes for road traffic in high-altitude provinces have occurred over the past decade; however, the RTA-related mortality rate in high-altitude provinces has remained high. This study furthers understanding about road traffic safety in China; further studies on road traffic safety at high altitude should be performed.	[Zhao, Hui; Yin, Zhiyong; Xiang, Hongyi; Liao, Zhikang; Wang, Zhengguo] Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Dept 4, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China	Army Medical University	Zhao, H (corresponding author), Third Mil Med Univ, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Dept 4, Inst Surg Res,Daping Hosp, Chongqing, Peoples R China.	box.zhaohui@163.com		Zhao, Hui/0000-0001-5074-0128	National Natural Science Foundation of China [31470913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (No. 31470913).	Brude U, 2015, ACCIDENT ANAL PREV, V74, P60, DOI 10.1016/j.aap.2014.10.004; Gururaj G, 2016, INT J INJ CONTROL SA, V23, P64, DOI 10.1080/17457300.2014.945465; Huang HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153251; Li YY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-46; Mishra Badrinarayan, 2010, Indian J Community Med, V35, P115, DOI 10.4103/0970-0218.62568; Ning PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164560; Organisation for Economic Co-operation and Development -OECD, 2015, ROAD SAF ANN REP 201; Organization WH, 2009, GLOB STAT REP ROAD S, V15, P286; Qiu J, 2015, TRAFFIC INJ PREV, V16, P565, DOI 10.1080/15389588.2014.973946; Qu JF, 2012, J TRAUMATIC SURG, V14, P317; Saha S, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0189-x; Traffic Administration Bureau of Police Ministry (TABPM), 2014, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2008, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2012, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2011, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2009, ROAD TRAFF ACC CENS; Traffic Administration Bureau of Police Ministry (TABPM), 2013, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2010, ROAD TRAFF ACC ANN C; Traffic Administration Bureau of Police Ministry (TABPM), 2007, ROAD TRAFF ACC ANN C; Wang Q. Q., 2004, CHIN AGR SCI B, V20, P20; Wang TB, 2015, LANCET, V385, P1622, DOI 10.1016/S0140-6736(15)60794-2; Wang ZG, 2002, TRAFFIC INJ PREV, V3, P251; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2013, GLOB STAT REP ROAD S; Xu QH, 2005, CHINESE J NEUROSURGI, V4, P137; [张礼均 Zhang Lijun], 2006, [中华神经外科杂志, Chinese Journal of Neurosurgery], V22, P670; Zhang XJ, 2010, J SAFETY RES, V41, P521, DOI 10.1016/j.jsr.2010.09.003; Zhao H, 2016, CHIN J TRAUMA, V32, P360; Zhao SC, 2009, IATSS RES, V33, P125, DOI 10.1016/S0386-1112(14)60251-X; Zhou Ji-hong, 2003, Chin J Traumatol, V6, P355; Zhu HT, 2013, ACTA NEUROCHIR, V155, P655, DOI 10.1007/s00701-013-1618-z; [朱海涛 Zhu Haitao], 2011, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V33, P869; Zhu Xinglin, 2013, HIGHWAYS AUTOMOTIVE, P78	33	6	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171090	10.1371/journal.pone.0171090	http://dx.doi.org/10.1371/journal.pone.0171090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187203	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300010
J	Al-Mansob, RA; Ismail, A; Yusoff, NIM; Rahmat, RAOK; Borhan, MN; Albrka, SI; Azhari, CH; Karim, MR				Al-Mansob, Ramez A.; Ismail, Amiruddin; Yusoff, Nur Izzi Md.; Rahmat, Riza Atiq O. K.; Borhan, Muhamad Nazri; Albrka, Shaban Ismael; Azhari, Che Husna; Karim, Mohamed Rehan			Engineering characterisation of epoxidized natural rubber-modified hot-mix asphalt	PLOS ONE			English	Article							RHEOLOGICAL CHARACTERISTICS; RESISTANCE; COPOLYMER	Road distress results in high maintenance costs. However, increased understandings of asphalt behaviour and properties coupled with technological developments have allowed paving technologists to examine the benefits of introducing additives and modifiers. As a result, polymers have become extremely popular as modifiers to improve the performance of the asphalt mix. This study investigates the performance characteristics of epoxidized natural rubber (ENR)-modified hot-mix asphalt. Tests were conducted using ENR-asphalt mixes prepared using the wet process. Mechanical testing on the ENR-asphalt mixes showed that the resilient modulus of the mixes was greatly affected by testing temperature and frequency. On the other hand, although rutting performance decreased at high temperatures because of the increased elasticity of the ENR-asphalt mixes, fatigue performance improved at intermediate temperatures as compared to the base mix. However, durability tests indicated that the ENR-asphalt mixes were slightly susceptible to the presence of moisture. In conclusion, the performance of asphalt pavement can be enhanced by incorporating ENR as a modifier to counter major road distress.	[Al-Mansob, Ramez A.; Ismail, Amiruddin; Yusoff, Nur Izzi Md.; Rahmat, Riza Atiq O. K.; Borhan, Muhamad Nazri; Albrka, Shaban Ismael] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Civil & Struct Engn, Sustainable Urban Transport Res Ctr SUTRA, Bangi, Selangor, Malaysia; [Azhari, Che Husna] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Bangi, Selangor, Malaysia; [Karim, Mohamed Rehan] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Ismail, A (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Civil & Struct Engn, Sustainable Urban Transport Res Ctr SUTRA, Bangi, Selangor, Malaysia.	aismail@ukm.edu.my	KARIM, MOHAMED REHAN/B-9040-2010; ISMAIL, AMIRUDDIN BIN/C-3140-2017; Zangena, Shaban Ali/L-1619-2017; Borhan, Muhamad Nazri/E-1035-2017; Yusoff, Nur Izzi Md/I-2043-2019; Al-Mansob, Ramez A./G-3023-2015	ISMAIL, AMIRUDDIN BIN/0000-0001-6547-8169; Zangena, Shaban Ali/0000-0003-1938-9127; Borhan, Muhamad Nazri/0000-0003-4517-5659; Yusoff, Nur Izzi Md/0000-0003-4449-4981; Al-Mansob, Ramez A./0000-0003-1702-4191	Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded [DIP-2015-019]; National University of Malaysia (UKM), Malaysia through the project Dana Impak Perdana [DIP-2015-019]	Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded; National University of Malaysia (UKM), Malaysia through the project Dana Impak Perdana	The funder is Universiti Kebangsaan Malaysia (UKM) through the project name Dana Impak Perdana coded, DIP-2015-019.; The authors would like to thank The National University of Malaysia (UKM), Malaysia for providing research funding through the project Dana Impak Perdana DIP-2015-019 and the Sustainable Urban Transport Research Centre (SUTRA) for providing research facilities. We also thank the faculty at the University of Malaya (UM) for their experimental collaboration.	AASHTO, 2018, T283 AASHTO; Airey GD, 2003, FUEL, V82, P1709, DOI 10.1016/S0016-2361(03)00146-7; Al-Hadidy AI, 2009, CONSTR BUILD MATER, V23, P2941, DOI 10.1016/j.conbuildmat.2009.02.023; Al-Mansob RA, 2016, CONSTR BUILD MATER, V102, P190, DOI 10.1016/j.conbuildmat.2015.10.133; Al-Mansob RA, 2014, APPL MECH MATER, V505-506, P174, DOI 10.4028/www.scientific.net/AMM.505-506.174; Al-Mansob RA, 2014, CONSTR BUILD MATER, V63, P242, DOI 10.1016/j.conbuildmat.2014.04.026; [Anonymous], 1995, ASTMD4123; [Anonymous], 1980, P 1 ASPH RUBB US PRO; [Anonymous], 2007, AASHTOT321; [Anonymous], 1980, VISCOELASTIC PROPERT; Asphalt Institute, 2007, ASPH HDB, V7th; BALaWC Vonk, 1984, THERM RUBB BIT BLEND; Becker Y, 2001, VIS TECNOL, V9, P39; Bennert T, 2010, J ASSOC ASPHALT PAV, V79, P773; Brown E., 2009, HOT MIX ASPHALT MAT; Brown E, 1989, D4123 ASTM; Christensen D.W., 1992, J ASS ASPH PAVING TE, V61, P67; Cominsky R.J., 1994, SUPERPAVE MIX DESIGN; Eaton RA, 1991, DTIC DOCUMENT; Fernando M, 1984, AUSTR ROAD RES, V12; Hunter R.N., 2015, SHELL BITUMEN HDB; Institution B.S, 1998, METHODS TEST DETERMI; IR G., 1991, J NAT RUBBER, V6, P184; Ismail A, 2012, AUSTR J BASIC APPL S, V6; Ismail H, 2001, EUR POLYM J, V37, P39, DOI 10.1016/S0014-3057(00)00099-9; Khodaii A, 2009, CONSTR BUILD MATER, V23, P2586, DOI 10.1016/j.conbuildmat.2009.02.015; Kim M-G, 1999, COATINGS IMPROVE LOW; Kulash DJ, 1994, P ICE TRANSP; Li J, 2008, CONSTR BUILD MATER, V22, P1067, DOI 10.1016/j.conbuildmat.2007.03.007; Lu X, 1997, CONSTR BUILD MATER, V11, P23, DOI 10.1016/S0950-0618(96)00033-5; Lundy JR, 1993, GROUND RUBBER TIRES; Michael A., 1992, FHWASA92022; Mo LT, 2012, MATER DESIGN, V37, P137, DOI 10.1016/j.matdes.2012.01.003; Moreno F, 2013, MATER DESIGN, V47, P274, DOI 10.1016/j.matdes.2012.12.022; Raad L, 1998, TRANSPORT RES REC, P73, DOI 10.3141/1639-08; Sargand S, 2001, 2 INT S MAINT REH PA; Shih CT, 1996, AM CHEM SOC FUEL CHE, V41, P1227; Tayfur S, 2007, CONSTR BUILD MATER, V21, P328, DOI 10.1016/j.conbuildmat.2005.08.014; Tian P, 1998, J TEST EVAL, V26, P329; Witczak M.W., 1995, LAB CHARACTERIZATION; Witczak M. W., 2005, SIMPLE PERFORMANCE T; Yidirim Y, 2007, CONSTR BUILD MATER, V21, P66, DOI 10.1016/j.conbuildmat.2005.07.007; Yoksan R, 2008, KASETSART JNAT SCI, V42, P325; Yousefi AA, 2002, IRAN POLYM J, V11, P303	44	11	12	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171648	10.1371/journal.pone.0171648	http://dx.doi.org/10.1371/journal.pone.0171648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182724	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800084
J	Castillo, GM; Nishimoto-Ashfield, A; Jones, CC; Kabirov, KK; Zakharov, A; Lyubimov, AV				Castillo, Gerardo M.; Nishimoto-Ashfield, Akiko; Jones, Cynthia C.; Kabirov, Kasim K.; Zakharov, Alexander; Lyubimov, Alexander V.			Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACUTE GASTROINTESTINAL SYNDROME; ADENOVIRUS-MEDIATED TRANSFER; MYOCARDIAL INFARCT SIZE; THROMBOPOIETIN LEVELS; ORAL MUCOSITIS; CELL-SURVIVAL; RECEPTOR SPECIFICITY; ENDOTHELIAL-CELLS; RADIATION	We evaluated the mitigating effects of fibroblast growth factor 4 and 7 (FGF4 and FGF7, respectively) in comparison with long acting protected graft copolymer (PGC)-formulated FGF4 and 7 (PF4 and PF7, respectively) administered to C57BL/6J mice a day after exposure to LD50/30 (15.7 Gy) partial body irradiation (PBI) which targeted the gastrointestinal (GI) system. The PGC that we developed increased the bioavailability of FGF4 and FGF7 by 5- and 250-fold compared to without PGC, respectively, and also sustained a 24 hr presence in the blood after a single subcutaneous administration. The dose levels tested for mitigating effects on radiation injury were 3 mg/kg for the PF4 and PF7 and 1.5 mg each for their combination (PF4/7). Amifostine administered prior to PBI was used as a positive control. The PF4, PF7, or PF4/7 mitigated the radiation lethality in mice. The mitigating effect of PF4 and PF7 was similar to the positive control and PF7 was better than other mitigators tested. The plasma citrulline levels and hematology parameters were early markers of recovery and survival. GI permeability function appeared to be a late or full recovery indicator. The villus length and crypt number correlated with plasma citrulline level, indicating that it can act as a surrogate marker for these histology evaluations. The IL-18 concentrations in jejunum as early as day 4 and TPO levels in colon on day 10 following PBI showed statistically significant changes in irradiated versus non-irradiated mice which makes them potential biomarkers of radiation exposure. Other colon and jejunum cytokine levels are potentially useful but require larger numbers of samples than in the present study before their full utility can be realized.	[Castillo, Gerardo M.; Nishimoto-Ashfield, Akiko; Jones, Cynthia C.] PharmaIN Corp, Bothell, WA 98011 USA; [Kabirov, Kasim K.; Zakharov, Alexander; Lyubimov, Alexander V.] Univ Illinois, Dept Pharmacol, Toxicol Res Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Castillo, GM (corresponding author), PharmaIN Corp, Bothell, WA 98011 USA.; Lyubimov, AV (corresponding author), Univ Illinois, Dept Pharmacol, Toxicol Res Lab, Chicago, IL 60607 USA.	gcastillo@pharmain.com; alyubimov1@gmail.com			National Institutes of Health through SBIR grant [R43AI107953]	National Institutes of Health through SBIR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the National Institutes of Health through SBIR grant R43AI107953 to G.M.C. who is an employee of PharmalN Corp. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of authors' salaries and/or research materials.	Akisu M, 2001, EUR J PEDIATR SURG, V11, P167, DOI 10.1055/s-2001-15485; Alvarez E, 2003, CLIN CANCER RES, V9, P3454; Baker JE, 2008, CARDIOVASC RES, V77, P44, DOI 10.1093/cvr/cvm026; Basilico C, 2005, CYTOKINE GROWTH F R, V16, P105, DOI 10.1016/j.cytogfr.2005.02.001; Beer HD, 2000, J BIOL CHEM, V275, P16091, DOI 10.1074/jbc.275.21.16091; Bogdanov AA, 2012, THERANOSTICS, V2, P553, DOI 10.7150/thno.4070; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Booth C, 2012, HEALTH PHYS, V103, P400, DOI 10.1097/HP.0b013e31826530e2; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Castillo GM, 2012, PHARM RES-DORDR, V29, P306, DOI 10.1007/s11095-011-0542-2; Cerutti A, 1997, BRIT J HAEMATOL, V99, P281, DOI 10.1046/j.1365-2141.1997.3823196.x; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Cuccurullo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151088; de Groot MJM, 1999, CARDIOVASC RES, V44, P315, DOI 10.1016/S0008-6363(99)00199-6; Dorr W, 2002, CELL PROLIFERAT, V35, P86, DOI 10.1046/j.1365-2184.35.s1.9.x; Dorr W, 2001, INT J RADIAT BIOL, V77, P341, DOI 10.1080/09553000010018873; Dorr W, 2005, RADIOTHER ONCOL, V75, P99, DOI 10.1016/j.radonc.2004.12.006; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Farrell CL, 2002, CELL PROLIFERAT, V35, P78, DOI 10.1046/j.1365-2184.35.s1.8.x; Farrell CL, 1998, CANCER RES, V58, P933; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Gomez-De-Segura IA, 1998, ACTA ONCOL, V37, P179, DOI 10.1080/028418698429748; HENDRY JH, 1983, RADIAT RES, V96, P100, DOI 10.2307/3576169; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013; Jilma-Stohlawetz P, 2001, J LAB CLIN MED, V137, P64, DOI 10.1067/mlc.2001.111468; Jones JW, 2015, HEALTH PHYS, V109, P452, DOI 10.1097/HP.0000000000000346; Jones JW, 2015, HEALTH PHYS, V109, P440, DOI 10.1097/HP.0000000000000347; Kabirov KK, 2015, 61 ANN M RAD RES SOC; Katoh M, 2006, INT J ONCOL, V29, P163; KONISHI H, 1995, J CLIN INVEST, V96, P1125, DOI 10.1172/JCI118099; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8; Lutgens L, 2007, WORLD J GASTROENTERO, V13, P3033, DOI 10.3748/wjg.v13.i22.3033; MacDonald KPA, 2002, CURR PHARM DESIGN, V8, P395, DOI 10.2174/1381612023396104; Maj JG, 2003, CANCER RES, V63, P4338; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Matthews MAB, 2013, J PEDIATR SURG, V48, P1316, DOI 10.1016/j.jpedsurg.2013.03.030; Niewold TA, 2004, RES VET SCI, V77, P89, DOI 10.1016/j.rvsc.2004.02.006; Nomura S, 1997, EXP HEMATOL, V25, P565; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Potten CS, 2002, CELL PROLIFERAT, V35, P32, DOI 10.1046/j.1365-2184.35.s1.4.x; Radtke Michelle L, 2005, J Oncol Pharm Pract, V11, P121, DOI 10.1191/1078155205jp159oa; Reichstetter S, 2012, PHARM RES IN PRESS; Reichstetter S, 2012, PHARM RES-DORDR, V29, P1033, DOI 10.1007/s11095-011-0646-8; Sasaki H, 2004, ONCOGENE, V23, P3681, DOI 10.1038/sj.onc.1207348; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Sung C, 2002, AAPS PHARMSCI, V4; Takahama Y, 1999, ONCOGENE, V18, P5943, DOI 10.1038/sj.onc.1203171; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; Thiagarajah JR, 2000, GUT, V47, P675, DOI 10.1136/gut.47.5.675; Vigneulle RM, 2002, DIGEST DIS SCI, V47, P1480, DOI 10.1023/A:1015846514471; Wuechner C, 1996, INT J DEV BIOL, V40, P1185; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zakynthinos SG, 2004, CRIT CARE MED, V32, P1004, DOI 10.1097/01.CCM.0000121433.61546.A0; Zhang JA, 2010, J INTERF CYTOK RES, V30, P465, DOI 10.1089/jir.2009.0062; Zhang LR, 2010, INT J RADIAT ONCOL, V77, P261, DOI 10.1016/j.ijrobp.2009.11.026; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	69	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171703	10.1371/journal.pone.0171703	http://dx.doi.org/10.1371/journal.pone.0171703			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207794	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500048
J	Huang, XW; Zhang, HH; Yu, PQ				Huang, Xuewei; Zhang, Huihua; Yu, Peiqiang			Structural changes on a molecular basis of canola meal by conditioning temperature and time during pelleting process in relation to physiochemical (energy and protein) properties relevant to ruminants	PLOS ONE			English	Article							DRIED DISTILLERS GRAINS; RUMEN DEGRADATION KINETICS; COMMON PRAIRIE FEEDS; CLUSTER-ANALYSIS CLA; HORDEUM-VULGARE L.; DAIRY-CATTLE; METABOLIC CHARACTERISTICS; HULLESS BARLEY; FTIR MICROSPECTROSCOPY; INTESTINAL AVAILABILITY	The objectives of this study were: (1) To investigate the effects of conditioning temperature (70, 80, 90 degrees regression study with model variables selection showed that the energy and protein profiles in pelleted co-products could be predicted with the protein molecular structure profiles. This approach provides us a relatively new way to estimate protein value in dairy cows based on internal protein molecular structure profile.C), time (30, 60 sec), and interaction (temperature x time) during the pelleting process on internal protein molecular structure changes of the co-products; (2) To identify differences in protein molecular structures among pellets that were processed under different conditions, and between unprocessed mash and pellets; 3) To quantify protein molecular structure changes in relation to predicted energy and protein utilization in dairy cows. The final goal of this program was to show how processing conditions changed internal feed structure on a molecular basis and how molecular structure changes induced by feed processing affected feed milk value in dairy cows. The hypothesis in this study was that processing-induced protein inherent structure changes affected energy and protein availability in dairy cattle and the sensitivity and response of protein internal structure to the different pelleting process conditions could be detected by advanced molecular spectroscopy. The protein molecular structures, amides I and II, amide I to II ratios, a-helix structure, beta-sheet structure, and alpha to beta structure ratios, were determined using the advanced vibrational molecular spectroscopy (ATR-FT/IR). The energy values were determined using NRC2001 summary approach in terms of total digestible nutrients, metabolizable and net energy for lactation. The protein and carbohydrate subfactions that are related to rumen degradation characteristics and rumen undegraded protein supply were determined using updated CNCPS system. The experiment design was a RCBD and the treatment design was a 3x2 factorial design. The results showed that pelleting induced changes in protein molecular structure. The sensitivity and response of protein inherent structure to the pelleting depended on the conditioning temperature and time. The protein molecular structure changes were correlated (P < 0.05) with energy values and protein subfractions of the pelleted co-product. The results indicated that the protein internal molecular structure had significant roles in determining energy and protein nutritive values in dairy cows. Multiregression study with model variables selection showed that the energy and protein profiles in pelleted co-products could be predicted with the protein molecular structure profiles. This approach provides us a relatively new way to estimate protein value in dairy cows based on internal protein molecular structure profile.	[Huang, Xuewei; Yu, Peiqiang] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada; [Zhang, Huihua; Yu, Peiqiang] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China	University of Saskatchewan; Foshan University	Yu, PQ (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada.; Yu, PQ (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.	peiqiang.yu@usask.ca	weixian, zhang/H-4046-2013	weixian, zhang/0000-0002-0250-4013	Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government); Ministry of Agriculture Strategic Research Chair Program; Saskatchewan Agricultural Development Fund (ADF)	Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government); Ministry of Agriculture Strategic Research Chair Program; Saskatchewan Agricultural Development Fund (ADF)	This research has been supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government), the Ministry of Agriculture Strategic Research Chair Program, and the Saskatchewan Agricultural Development Fund (ADF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekara S, 2013, J DAIRY SCI, V96, P6631, DOI 10.3168/jds.2013-6841; Abeysekara S, 2012, SPECTROCHIM ACTA A, V90, P63, DOI 10.1016/j.saa.2011.12.045; Becker PM, 2013, MOL NUTR FOOD RES, V57, P1695, DOI 10.1002/mnfr.201200592; Damiran D, 2011, J DAIRY SCI, V94, P5151, DOI 10.3168/jds.2011-4564; Doiron K, 2009, J DAIRY SCI, V92, P3319, DOI 10.3168/jds.2008-1946; Gamage IH, 2013, J DAIRY SCI, V96, P5908, DOI 10.3168/jds.2012-6105; Gamage IH, 2012, J DAIRY SCI, V95, P6695, DOI 10.3168/jds.2012-5685; Heendeniya RG, 2012, J DAIRY SCI, V95, P4488, DOI 10.3168/jds.2011-5029; Huang XW, 2015, J DAIRY SCI, V98, P8836, DOI 10.3168/jds.2014-9295; Huang XW, 2015, J DAIRY SCI, V98, P4869, DOI 10.3168/jds.2014-9290; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Liu B, 2012, J AGR FOOD CHEM, V60, P10064, DOI 10.1021/jf302382b; Liu N, 2011, J CEREAL SCI, V53, P379, DOI 10.1016/j.jcs.2011.02.011; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Newkirk R, 2009, CANOLA CHEM PRODUCTI, P229; Nuez-Ortin WG, 2010, J DAIRY SCI, V93, P3775, DOI 10.3168/jds.2010-3143; Peng QH, 2014, ANIM FEED SCI TECH, V194, P58, DOI 10.1016/j.anifeedsci.2014.05.004; Peng QH, 2014, SPECTROCHIM ACTA A, V121, P14, DOI 10.1016/j.saa.2013.10.029; Peng QH, 2014, J DAIRY SCI, V97, P446, DOI 10.3168/jds.2013-7298; ROE MB, 1990, PROCEEDINGS 1990 : CORNELL NUTRITION CONFERENCE FOR FEED MANUFACTURERS, P81; Samadi, 2013, SPECTROCHIM ACTA A, V105, P304, DOI 10.1016/j.saa.2012.11.096; Samadi, 2011, J DAIRY SCI, V94, P6092, DOI 10.3168/jds.2011-4619; SMITH B. C., 2011, FUNDAMENTALS FOURIER; Theodoridou K, 2013, J AGR FOOD CHEM, V61, P5449, DOI 10.1021/jf400301y; Theodoridou K, 2013, J AGR FOOD CHEM, V61, P2820, DOI 10.1021/jf305171z; Thomas M, 1996, ANIM FEED SCI TECH, V61, P89, DOI 10.1016/0377-8401(96)00949-2; Van Amburgh ME, UPDATING CNCPS FEED; Van Amburgh ME, P CORN NUTR C FEED M; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wetzel DL, 1998, CELL MOL BIOL, V44, P145; Xin HS, 2013, J AGR FOOD CHEM, V61, P10118, DOI 10.1021/jf4020763; Xin HS, 2013, SPECTROCHIM ACTA A, V112, P318, DOI 10.1016/j.saa.2013.04.073; Xin HS, 2013, J AGR FOOD CHEM, V61, P3926, DOI 10.1021/jf400028n; Yang L, 2014, J CEREAL SCI, V60, P48, DOI 10.1016/j.jcs.2013.12.013; Yang L, 2013, J AGR FOOD CHEM, V61, P11250, DOI 10.1021/jf403196z; Yu P, 2004, BRIT J NUTR, V92, P869, DOI 10.1079/BJN20041298; Yu P, 2012, J DAIRY SCI, V95, P2091, DOI 10.3168/jds.2011-4885; Yu PQ, 2008, J AGR FOOD CHEM, V56, P3417, DOI 10.1021/jf800015x; Yu PQ, 2006, SPECTROSC-INT J, V20, P229, DOI 10.1155/2006/263634; Yu PQ, 2010, BRIT J NUTR, V104, P1429, DOI 10.1017/S0007114510002539; Yu PQ, 2008, CAN J ANAL SCI SPECT, V53, P220; Yu PQ, 2005, BRIT J NUTR, V94, P655, DOI 10.1079/BJN20051532; Yu PQ, 2005, J AGR FOOD CHEM, V53, P7115, DOI 10.1021/jf050959b; Yu PQ, 2005, J AGR FOOD CHEM, V53, P2872, DOI 10.1021/jf0479564; Yu PQ, 2004, J AGR FOOD CHEM, V52, P7353, DOI 10.1021/jf0490955; Zhang X, 2012, J DAIRY SCI, V95, P3363, DOI 10.3168/jds.2011-5308; Zhang XW, 2012, J DAIRY SCI, V95, P6624, DOI 10.3168/jds.2012-5450; Zhang XW, 2012, SPECTROCHIM ACTA A, V95, P53, DOI 10.1016/j.saa.2012.04.022	49	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170173	10.1371/journal.pone.0170173	http://dx.doi.org/10.1371/journal.pone.0170173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207756	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500007
J	Wetzel, L; Jorg, DJ; Pollakis, A; Rave, W; Fettweis, G; Julicher, F				Wetzel, Lucas; Joerg, David J.; Pollakis, Alexandros; Rave, Wolfgang; Fettweis, Gerhard; Juelicher, Frank			Self-organized synchronization of digital phase-locked loops with delayed coupling in theory and experiment	PLOS ONE			English	Article							MASSIVE MIMO; KURAMOTO MODEL; TIME-DELAY; SEGMENTATION; OSCILLATORS; POPULATIONS	Self-organized synchronization occurs in a variety of natural and technical systems but has so far only attracted limited attention as an engineering principle. In distributed electronic systems, such as antenna arrays and multi-core processors, a common time reference is key to coordinate signal transmission and processing. Here we show how the self-organized synchronization of mutually coupled digital phase-locked loops (DPLLs) can provide robust clocking in large-scale systems. We develop a nonlinear phase description of individual and coupled DPLLs that takes into account filter impulse responses and delayed signal transmission. Our phase model permits analytical expressions for the collective frequencies of synchronized states, the analysis of stability properties and the time scale of synchronization. In particular, we find that signal filtering introduces stability transitions that are not found in systems without filtering. To test our theoretical predictions, we designed and carried out experiments using networks of off-the-shelf DPLL integrated circuitry. We show that the phase model can quantitatively predict the existence, frequency, and stability of synchronized states. Our results demonstrate that mutually delay-coupled DPLLs can provide robust and self-organized synchronous clocking in electronic systems.	[Wetzel, Lucas; Joerg, David J.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany; [Wetzel, Lucas; Joerg, David J.; Pollakis, Alexandros; Rave, Wolfgang; Fettweis, Gerhard; Juelicher, Frank] Cfaed, Ctr Adv Elect Dresden, D-01062 Dresden, Germany; [Pollakis, Alexandros; Rave, Wolfgang; Fettweis, Gerhard] Tech Univ Dresden, Vodafone Chair Mobile Commun Syst, D-01062 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Vodafone Group	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.; Fettweis, G; Julicher, F (corresponding author), Cfaed, Ctr Adv Elect Dresden, D-01062 Dresden, Germany.; Fettweis, G (corresponding author), Tech Univ Dresden, Vodafone Chair Mobile Commun Syst, D-01062 Dresden, Germany.	Gerhard.Fettweis@vodafone-chair.com; julicher@pks.mpg.de	Julicher, Frank/B-1828-2009; Jorg, David/I-3905-2012	Julicher, Frank/0000-0003-4731-9185; Jorg, David/0000-0001-5960-0260	DFG, Cluster of Excellence, Center for Advancing Electronics Dresden (cfaed) [1056]; Max-Planck Gesellschaft; company Vodafone	DFG, Cluster of Excellence, Center for Advancing Electronics Dresden (cfaed)(German Research Foundation (DFG)); Max-Planck Gesellschaft(Max Planck Society); company Vodafone	This work was supported by DFG, Cluster of Excellence 1056, Center for Advancing Electronics Dresden (cfaed) recipients: G.F.; W.R.; A.P (http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=194636624& and Max-Planck Gesellschaft (https://www.mpg.de/de) recipients: F.J.; D.J.; L.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The "Vodafone Chair Mobile Communications Systems" is a chair at Technische Universitat Dresden. While the company Vodafone financially supports the chair, Vodafone did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of contributions to salaries for the author GF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Response to Reviewers specific roles of these authors are articulated in the 'author contributions' section.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Acebron JA, 1998, PHYS REV LETT, V81, P2229, DOI 10.1103/PhysRevLett.81.2229; Amann A, 2007, PHYSICA A, V373, P191, DOI 10.1016/j.physa.2005.12.073; [Anonymous], 2004, PHYS TODAY; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; Digilent Inc, CHIPKIT MAX32 REF MA; Ding WD, 2008, ETRI J, V30, P59, DOI 10.4218/etrij.08.0106.0306; Earl MG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036204; Gardner FM, 2005, PHASELOCK TECHNIQUES, 3RD EDITION, P1, DOI 10.1002/0471732699; Ho R, 2001, P IEEE, V89, P490, DOI 10.1109/5.920580; Jeong SO, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.154104; Ji P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.218701; Jorg DJ, 2015, IEEE ICC, P1716, DOI 10.1109/ICC.2015.7248572; Jorg DJ, 2015, CHAOS, V25, DOI 10.1063/1.4919831; Larsson EG, 2014, IEEE COMMUN MAG, V52, P186, DOI 10.1109/MCOM.2014.6736761; Lee JW, 2008, CONF PROC INT SYMP C, P89, DOI 10.1109/ISCA.2008.31; Lee WS, 2011, CHAOS, V21, DOI 10.1063/1.3596697; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Liao BK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11861; LINDSEY WC, 1985, P IEEE, V73, P1445, DOI 10.1109/PROC.1985.13317; Mancini R, 2003, OP AMPS EVERYONE DES; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mensink E, 2010, IEEE J SOLID-ST CIRC, V45, P447, DOI 10.1109/JSSC.2009.2036761; MEYR H, 1986, IEEE T COMMUN, V34, P436, DOI 10.1109/TCOM.1986.1096569; Michelson AA, 1887, AM J SCI, V34, P333, DOI [DOI 10.2475/AJS.S3-34.203.333, 10.2475/ajs.s3-34.203.333]; MILLS DL, 1991, IEEE T COMMUN, V39, P1482, DOI 10.1109/26.103043; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Muller H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.020401; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Olmi S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042905; Orsatti FM, 2008, IET CIRCUITS DEVICES, V2; Pico Technology, PICOSCOPE 2205 MIX S; Pitarokoilis A, 2015, IEEE T WIREL COMMUN, V14, P711, DOI 10.1109/TWC.2014.2359018; Pollakis A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113009; Rahn DG, 2005, IEEE J SOLID-ST CIRC, V40, P1629, DOI 10.1109/JSSC.2005.852419; Rodrigues FA, 2016, PHYS REP, V610, P1, DOI 10.1016/j.physrep.2015.10.008; Schenk T. C. W., 2008, RF IMPERFECTIONS HIG; SCHUSTER HG, 1989, PROG THEOR PHYS, V81, P939, DOI 10.1143/PTP.81.939; Shepard C, 2012, MOBICOM 12: PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P53; Shih XW, 2012, IEEE T COMPUT AID D, V31, P1393, DOI 10.1109/TCAD.2012.2191554; Strogatz S. H., 2008, NONLINEAR DYNAMICS C; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Swadlow HA, 2012, SCHOLARPEDIA, V7, P1451, DOI DOI 10.4249/SCHOLARPEDIA.1451; Swindlehurst AL, 2014, IEEE COMMUN MAG, V52, P56, DOI 10.1109/MCOM.2014.6894453; Tanaka HA, 1997, PHYS REV LETT, V78, P2104, DOI 10.1103/PhysRevLett.78.2104; Texas Instruments, CD4046B CMOS MICR PH; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648	48	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171590	10.1371/journal.pone.0171590	http://dx.doi.org/10.1371/journal.pone.0171590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207779	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500041
J	Birnie, K; Hay, AD; Wootton, M; Howe, R; MacGowan, A; Whiting, P; Lawton, M; Delaney, B; Downing, H; Dudley, J; Hollingworth, W; Lisles, C; Little, P; O'Brien, K; Pickles, T; Rumsby, K; Thomas-Jones, E; Van der Voort, J; Waldron, CA; Harman, K; Hood, K; Butler, CC; Sterne, JAC				Birnie, Kate; Hay, Alastair D.; Wootton, Mandy; Howe, Robin; MacGowan, Alasdair; Whiting, Penny; Lawton, Michael; Delaney, Brendan; Downing, Harriet; Dudley, Jan; Hollingworth, William; Lisles, Catherine; Little, Paul; O'Brien, Kathryn; Pickles, Timothy; Rumsby, Kate; Thomas-Jones, Emma; Van der Voort, Judith; Waldron, Cherry-Ann; Harman, Kim; Hood, Kerenza; Butler, Christopher C.; Sterne, Jonathan A. C.			Comparison of microbiological diagnosis of urinary tract infection in young children by routine health service laboratories and a research laboratory: Diagnostic cohort study	PLOS ONE			English	Article							BACTERIURIA	Objectives To compare the validity of diagnosis of urinary tract infection (UTI) through urine culture between samples processed in routine health service laboratories and those processed in a research laboratory. Population and methods We conducted a prospective diagnostic cohort study in 4808 acutely ill children aged < 5 years attending UK primary health care. UTI, defined as pure/predominant growth >= 10(5) CFU/mL of a uropathogen (the reference standard), was diagnosed at routine health service laboratories and a central research laboratory by culture of urine samples. We calculated areas under the receiver-operator curve (AUC) for UTI predicted by pre-specified symptoms, signs and dipstick test results (the "index test"), separately according to whether samples were obtained by clean catch or nappy (diaper) pads. Results 251 (5.2%) and 88 (1.8%) children were classified as UTI positive by health service and research laboratories respectively. Agreement between laboratories was moderate (kappa = 0.36; 95% confidence interval [CI] 0.29, 0.43), and better for clean catch (0.54; 0.45, 0.63) than nappy pad samples (0.20; 0.12, 0.28). In clean catch samples, the AUC was lower for health service laboratories (AUC = 0.75; 95% CI 0.69, 0.80) than the research laboratory (0.86; 0.79, 0.92). Values of AUC were lower in nappy pad samples (0.65 [0.61, 0.70] and 0.79 [0.70, 0.88] for health service and research laboratory positivity, respectively) than clean catch samples. Conclusions The agreement of microbiological diagnosis of UTI comparing routine health service laboratories with a research laboratory was moderate for clean catch samples and poor for nappy pad samples and reliability is lower for nappy pad than for clean catch samples. Positive results from the research laboratory appear more likely to reflect real UTIs than those from routine health service laboratories, many of which (particularly from nappy pad samples) could be due to contamination. Health service laboratories should consider adopting procedures used in the research laboratory for paediatric urine samples. Primary care clinicians should try to obtain clean catch samples, even in very young children.	[Birnie, Kate; Lawton, Michael; Hollingworth, William; Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hay, Alastair D.; Downing, Harriet] Univ Bristol, NIHR Sch Primary Care Res, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Wootton, Mandy; Howe, Robin] Univ Wales Hosp, Specialist Antimicrobial Chemotherapy Unit, Publ Hlth Wales Microbiol Cardiff, Cardiff, S Glam, Wales; [MacGowan, Alasdair] North Bristol NHS Trust, Bristol, Avon, England; [Whiting, Penny] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; [Delaney, Brendan] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Delaney, Brendan] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Dudley, Jan] Univ Hosp Bristol, Bristol Royal Hosp Children, NHS Fdn Trust, Bristol, Avon, England; [Lisles, Catherine; Pickles, Timothy; Thomas-Jones, Emma; Waldron, Cherry-Ann; Hood, Kerenza] Cardiff Univ, Inst Translat Innovat Methodol & Engagement, Sch Med, SEWTU, Cardiff, S Glam, Wales; [Little, Paul; Rumsby, Kate; Harman, Kim] Univ Southampton, Primary Care & Populat Sci Div, Southampton, Hants, England; [O'Brien, Kathryn; Butler, Christopher C.] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff, S Glam, Wales; [Van der Voort, Judith] Univ Wales Hosp, Dept Paediat & Child Hlth, Cardiff, S Glam, Wales; [Butler, Christopher C.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Bristol; University of Bristol; Cardiff University; North Bristol NHS Trust; Kleijnen Systematic Reviews; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Bristol Eye Hospital; Bristol Royal Hospital For Children; University of Bristol; Cardiff University; University of Southampton; Cardiff University; Cardiff University; University of Oxford	Sterne, JAC (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	jonathan.sterne@bristol.ac.uk	Sterne, Jonathan/Z-3106-2019; Hay, Alastair/L-1818-2019; MacGowan, Alasdair/AAM-1582-2020; Hood, Kerenza/C-2528-2008	Sterne, Jonathan/0000-0001-8496-6053; MacGowan, Alasdair/0000-0002-6720-5268; Harman, Kim/0000-0002-5173-7753; Wootton, Mandy/0000-0002-2227-3355; Hood, Kerenza/0000-0002-5268-8631; Thomas-Jones, Emma/0000-0001-7716-2786; Little, Paul/0000-0003-3664-1873; Hughes, Kathryn/0000-0002-8099-066X; Waldron, Cherry-Ann/0000-0001-8465-2492; Hay, Alastair/0000-0003-3012-375X; Pickles, Timothy/0000-0001-7743-0234; Whiting, Penny/0000-0003-1138-5682; Butler, Christopher/0000-0002-0102-3453; Hollingworth, William/0000-0002-0840-6254; Lawton, Michael/0000-0002-3419-0354	National Institute for Health Research (NIHR) as a Health Technology Assessment Programme [08/66/01]; NIHR Senior Investigator Award [NF-SI-0611-10168]; NIHR Research Professorship [NIHR-RP-02-12-012]; Medical Research Council UK [RD1826]; Medical Research Council [MR/K021699/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-012, NF-SI-0611-10168, NF-SI-0515-10056, NF-SI-0616-10111, 08/66/01, CDF-2009-02-10] Funding Source: researchfish; MRC [MR/K021699/1] Funding Source: UKRI	National Institute for Health Research (NIHR) as a Health Technology Assessment Programme(National Institute for Health Research (NIHR)); NIHR Senior Investigator Award; NIHR Research Professorship; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institute for Health Research (NIHR) as a Health Technology Assessment Programme (project number 08/66/01). The DUTY study was published in full as an NIHR Health Technology Assessment (HTA) monograph. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. Jonathan Sterne was supported by NIHR Senior Investigator Award NF-SI-0611-10168. AH is funded by NIHR Research Professorship (NIHR-RP-02-12-012). KB was supported by a Medical Research Council UK fellowship (RD1826). PW was employed by Kleijnen Systematic Reviews Ltd. The funders provided support in the form of salaries for authors [KB, AH, MW, RH, AM, PW, ML, BD, HD, JD, WH, CL, PL, KOB, TP, KR, ETJ, JV, CAW, KiH, KH, CB, JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Butler CC, 2015, BRIT J GEN PRACT, V65, pE217, DOI 10.3399/bjgp15X684361; CATTELL WR, 1963, BRIT MED J, P97, DOI 10.1136/bmj.1.5323.97; CHEETHAM P, 1986, J CLIN PATHOL, V39, P335, DOI 10.1136/jcp.39.3.335; Coulthard MG, 2010, PEDIATRICS, V125, P335, DOI 10.1542/peds.2008-1455; Downing H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-158; EAU, 2022, EAU ANN C AMST; Hay AD, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20510; Hay AD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6316; HEDGES AJ, 1978, J APPL BACTERIOL, V45, P57, DOI 10.1111/j.1365-2672.1978.tb04198.x; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; LEIGH DA, 1964, J CLIN PATHOL, V17, P498, DOI 10.1136/jcp.17.5.498; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; National Institute for Health and Care Excellence, 2007, UR TRACT INF CHILDR; OBrien K, 2013, BR J GEN PRAC, V63, P91; Public Health England, 2014, INV UR UK STAND MICR, V41; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; SACKS SH, 1987, LANCET, V2, P991; TURNER GM, 1995, BRIT MED J, V311, P924; Vernon SJ, 1997, BMJ-BRIT MED J, V315, P905	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171113	10.1371/journal.pone.0171113	http://dx.doi.org/10.1371/journal.pone.0171113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199403	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400023
J	Feng, ZY; Min, XD; Margolis, DJA; Duan, CH; Chen, YP; Sah, VK; Chaudhary, N; Li, BS; Ke, Z; Zhang, PP; Wang, L				Feng, Zhaoyan; Min, Xiangde; Margolis, Daniel J. A.; Duan, Caohui; Chen, Yuping; Sah, Vivek Kumar; Chaudhary, Nabin; Li, Basen; Ke, Zan; Zhang, Peipei; Wang, Liang			Evaluation of different mathematical models and different b-value ranges of diffusion weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm(2)	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; MULTIPARAMETRIC MRI; DIAGNOSIS; AGGRESSIVENESS; REPEATABILITY; SPECTROSCOPY; TISSUES	Objectives To evaluate the diagnostic performance of different mathematical models and different b value ranges of diffusion-weighted imaging (DWI) in peripheral zone prostate cancer (PZ PCa) detection. Methods Fifty-six patients with histologically proven PZ PCa who underwent DWI-magnetic resonance imaging (MRI) using 21 b-values (0-4500 s/mm(2)) were included. The mean signal intensities of the regions of interest (ROls) placed in benign PZs and cancerous tissues on DWI images were fitted using mono-exponential, bi-exponential, stretched-exponential, and kurtosis models. The b -values were divided into four ranges: 0-1000, 0-2000, 0-3200, and 0-4500 s/mm2, grouped as A, B, C, and D, respectively. ADC, <D>, D*, f, DDC, a, D-app, and K-app were estimated for each group. The adjusted coefficient of determination (R-2) was calculated to measure goodness-of-fit. Receiver operating characteristic curve analysis was performed to evaluate the diagnostic performance of the parameters. Results All parameters except D* showed significant differences between cancerous tissues and benign PZs in each group. The area under the curve values (AUCs) of ADC were comparable in groups C and D (p = 0.980) and were significantly higher than those in groups A and B (p<0.05 for all). The AUCs of ADC and Kapp in groups B and C were similar (p = 0.07 and p = 0.954), and were significantly higher than the other parameters (p<0.001 for all). The AUCs of ADC in group D was slightly higher than Kapp (p = 0.002), and both were significantly higher than the other parameters (p<0.001 for all). Conclusions ADC derived from conventional mono-exponential high b-value (3200 s/mm(2)) models is an optimal parameter for PZ PCa detection.	[Feng, Zhaoyan; Min, Xiangde; Sah, Vivek Kumar; Chaudhary, Nabin; Li, Basen; Ke, Zan; Zhang, Peipei; Wang, Liang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Margolis, Daniel J. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Ronald Reagan UCLA Med Ctr, Los Angeles, CA 90095 USA; [Duan, Caohui] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Natl Ctr Magnet Resonance,Wuhan Wuhan Inst Phys &, Wuhan, Hubei, Peoples R China; [Chen, Yuping] Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China	Huazhong University of Science & Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ronald Reagan UCLA Medical Center; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	wang6@tjh.tjmu.edu.cn		Min, Xiangde/0000-0002-1589-6861				Bai Y, 2016, RADIOLOGY, V278, P496, DOI 10.1148/radiol.2015142173; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bourne R, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6020021; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fusco R, 2016, MAGN RESON IMAGING, V34, P839, DOI 10.1016/j.mri.2016.04.001; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Han CK, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150220; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Jambor I, 2015, MAGN RESON MED, V73, P1988, DOI 10.1002/mrm.25323; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kitajima Kazuhiro, 2008, Magn Reson Med Sci, V7, P93, DOI 10.2463/mrms.7.93; Kobus T, 2012, RADIOLOGY, V265, P457, DOI 10.1148/radiol.12111744; Li B, 2013, J MAGN RESON IMAGING, V37, P194, DOI 10.1002/jmri.23809; Liu XH, 2015, J MAGN RESON IMAGING, V42, P1078, DOI 10.1002/jmri.24872; Mazzoni LN, 2014, J MAGN RESON IMAGING, V39, P512, DOI 10.1002/jmri.24184; Merisaari H, 2016, MAGN RESON MED; Merisaari H, 2015, MAGN RESON IMAGING, V33, P1212, DOI 10.1016/j.mri.2015.07.004; Merisaari H, 2015, MAGN RESON MED, V73, P1954, DOI 10.1002/mrm.25310; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Peng YH, 2013, RADIOLOGY, V267, P787, DOI 10.1148/radiol.13121454; Quentin M, 2012, MAGN RESON IMAGING, V30, P1468, DOI 10.1016/j.mri.2012.04.025; Riva-Amarante E, 2011, NEUROLOGIA, V26, P331, DOI 10.1016/j.nrl.2010.12.003; Roethke MC, 2015, INVEST RADIOL, V50, P483, DOI 10.1097/RLI.0000000000000155; Rosenkrantz AB, 2015, J MAGN RESON IMAGING; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Tamada T, 2011, AM J ROENTGENOL, V197, P664, DOI 10.2214/AJR.10.5923; Taouli B, 2016, J MAGNETIC RESONANCE; Thormer G, 2012, EUR RADIOL, V22, P1820, DOI 10.1007/s00330-012-2432-3; Toivonen J, 2014, MAGNETIC RESONANCE M; Valerio M, 2016, EUR J RADIOL, V85, P790, DOI 10.1016/j.ejrad.2016.01.006; Vargas HA, 2012, RADIOLOGY, V262, P26, DOI 10.1148/radiol.11101996; Weinreb J, 2015, PI RADS PROSTATE IMA; Winfield JM, 2016, EUROPEAN RADIOLOGY; Zhang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151176	35	19	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172127	10.1371/journal.pone.0172127	http://dx.doi.org/10.1371/journal.pone.0172127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199367	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400073
J	Fruzangohar, M; Ebrahimie, E; Adelson, DL				Fruzangohar, Mario; Ebrahimie, Esmaeil; Adelson, David L.			A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-1; MOTILITY; VIRULENCE; DEFICITS; SYSTEM; INJURY; TOOL	Gene Ontology (GO) classification of statistically significantly differentially expressed genes is commonly used to interpret transcriptomics data as a part of functional genomic analysis. In this approach, all significantly expressed genes contribute equally to the final GO classification regardless of their actual expression levels. Gene expression levels can significantly affect protein production and hence should be reflected in GO term enrichment. Genes with low expression levels can also participate in GO term enrichment through cumulative effects. In this report, we have introduced a new GO enrichment method that is suitable for multiple samples and time series experiments that uses a statistical outlier test to detect GO categories with special patterns of variation that can potentially identify candidate biological mechanisms. To demonstrate the value of our approach, we have performed two case studies. Whole transcriptome expression profiles of Salmonella enteritidis and Alzheimer's disease (AD) were analysed in order to determine GO term enrichment across the entire transcriptome instead of a subset of differentially expressed genes used in traditional GO analysis. Our result highlights the key role of inflammation related functional groups in AD pathology as granulocyte colony-stimulating factor receptor binding, neuromedin U binding, and interleukin were remarkably upregulated in AD brain when all using all of the gene expression data in the transcriptome. Mitochondrial components and the molybdopterin synthase complex were identified as potential key cellular components involved in AD pathology.	[Fruzangohar, Mario; Adelson, David L.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Fruzangohar, Mario] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Med, Fac Hlth Sci, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ South Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA, Australia; [Adelson, David L.] Univ Adelaide, Zhendong Australia, China Ctr Mol Chinese Med, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; University of South Australia; Flinders University South Australia; University of Adelaide	Fruzangohar, M; Adelson, DL (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Fruzangohar, M (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.; Adelson, DL (corresponding author), Univ Adelaide, Zhendong Australia, China Ctr Mol Chinese Med, Adelaide, SA, Australia.	mario.fruzangohar@adelaide.edu.au; david.adelson@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021; Adelson, David L/E-5506-2011	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Adelson, David L/0000-0003-2404-5636	PhD divisional scholarship of The University of Adelaide; NHMRC in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences [APP1061006]; Nectar; Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)	PhD divisional scholarship of The University of Adelaide; NHMRC in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences(National Health and Medical Research Council (NHMRC) of Australia); Nectar; Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	MF was supported by PhD divisional scholarship of The University of Adelaide. EE was partially supported by NHMRC APP1061006 in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences. We acknowledge funding from Nectar to host the web and database server of this study. Nectar is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS, V2008; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Franzen R, 2004, NEUROSCI LETT, V361, P76, DOI 10.1016/j.neulet.2003.12.018; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Garlind A, 1999, BRAIN RES, V826, P112, DOI 10.1016/S0006-8993(99)01092-6; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Laske C, 2015, ALZHEIMERS DEMENT, V11, P465, DOI 10.1016/j.jalz.2014.06.003; Ling H, 2010, BIOCHEM BIOPH RES CO, V401, P521, DOI 10.1016/j.bbrc.2010.09.080; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Shah DH, 2013, APPL ENV MICROBIOLOG; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Szklarczyk D, 2010, NUCLEIC ACIDS RES; Talamo BR, 1989, PATHOLOGICAL CHANGES; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Team RC, 2005, R LANG ENV STAT COMP; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006	37	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170486	10.1371/journal.pone.0170486	http://dx.doi.org/10.1371/journal.pone.0170486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199395	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000394424400015
J	Lavoie, KH; Winter, AS; Read, KJH; Hughes, EM; Spilde, MN; Northup, DE				Lavoie, Kathleen H.; Winter, Ara S.; Read, Kaitlyn J. H.; Hughes, Evan M.; Spilde, Michael N.; Northup, Diana E.			Comparison of bacterial communities from lava cave microbial mats to overlying surface soils from Lava Beds National Monument, USA	PLOS ONE			English	Article							SP-NOV.; GEN. NOV.; DIVERSITY; ACTINOBACTERIA; GEOMICROBIOLOGY; MICROORGANISMS; SUBDIVISION; MINERALS; TAXONOMY; MEMBERS	Subsurface habitats harbor novel diversity that has received little attention until recently. Accessible subsurface habitats include lava caves around the world that often support extensive microbial mats on ceilings and walls in a range of colors. Little is known about lava cave microbial diversity and how these subsurface mats differ from microbial communities in overlying surface soils. To investigate these differences, we analyzed bacterial 16S rDNA from 454 pyrosequencing from three colors of microbial mats (tan, white, and yellow) from seven lava caves in Lava Beds National Monument, CA, USA, and compared them with surface soil overlying each cave. The same phyla were represented in both surface soils and cave microbial mats, but the overlap in shared OTUs (operational taxonomic unit) was only 11.2%. Number of entrances per cave and temperature contributed to observed differences in diversity. In terms of species richness, diversity by mat color differed, but not significantly. Actinobacteria dominated in all cave samples, with 39% from caves and 21% from surface soils. Proteobacteria made up 30% of phyla from caves and 36% from surface soil. Other major phyla in caves were Nitrospirae (7%) followed by minor phyla (7%), compared to surface soils with Bacteroidetes (8%) and minor phyla (8%). Many of the most abundant sequences could not be identified to genus, indicating a high degree of novelty. Surface soil samples had more OTUs and greater diversity indices than cave samples. Although surface soil microbes immigrate into underlying caves, the environment selects for microbes able to live in the cave habitats, resulting in very different cave microbial communities. This study is the first comprehensive comparison of bacterial communities in lava caves with the overlying soil community.	[Lavoie, Kathleen H.] SUNY Coll Plattsburgh, Biol, Plattsburgh, NY 12901 USA; [Winter, Ara S.; Read, Kaitlyn J. H.; Hughes, Evan M.; Northup, Diana E.] Univ New Mexico, Biol, Albuquerque, NM 87131 USA; [Spilde, Michael N.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA	State University of New York (SUNY) System; SUNY Plattsburgh; University of New Mexico; University of New Mexico	Lavoie, KH (corresponding author), SUNY Coll Plattsburgh, Biol, Plattsburgh, NY 12901 USA.	lavoiekh@plattsburgh.edu			Lava Beds National Monument (LABE) through the Colorado Plateau Cooperative Ecosystem Studies Unit [J8410100028-UNM-56]	Lava Beds National Monument (LABE) through the Colorado Plateau Cooperative Ecosystem Studies Unit	Funding was provided by Lava Beds National Monument (LABE) through the Colorado Plateau Cooperative Ecosystem Studies Unit (http//eau edu/CEENS/Forestry/cpcesu/), Award number J8410100028-UNM-56. Funder's role: LABE personnel Shane Fryer and Shawn Thomas helped in the selection of study sites, supplied metadata for all sites, and assisted with field work.	Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Barton H.A., 2007, MICROBE, V2, P132; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Barton HA, 2007, J CAVE KARST STUD, V69, P163; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Boston PJ, 2001, ASTROBIOLOGY, V1, P25, DOI 10.1089/153110701750137413; BOSTON PJ, 1992, ICARUS, V95, P300, DOI 10.1016/0019-1035(92)90045-9; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caporaso JG, 2007, NATURE METH, V7, P335; CHAO A, 1984, SCAND J STAT, V11, P265; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Culver DC, 2009, THE BIOLOGY OF CAVES; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Donnelly-Nola JM, US GEOLOG SURV SCI I; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards KJ, 2012, ANNU REV EARTH PL SC, V40, P551, DOI 10.1146/annurev-earth-042711-105500; Engel AS, FRONTIERS OF KARST R; Fahrbach M, 2008, INT J SYST EVOL MICR, V58, P2215, DOI 10.1099/ijs.0.65342-0; Farris MH, 2007, LETT APPL MICROBIOL, V45, P376, DOI 10.1111/j.1472-765X.2007.02198.x; Forti P, 2005, J CAVE KARST STUD, V67, P3; Gabriel CR., 2013, CAVE MICROBIOMES NOV, P85, DOI DOI 10.1007/978-1-4614-5206-5_; Gabry A, 2016, RSTANARM BAYESIAN AP; Garcia M.G., 2009, P 15 INT C SPEL, P364; GERBER NN, 1979, CRC CR REV MICROBIOL, V7, P191, DOI 10.3109/10408417909082014; GIOVANNONI SJ, 1990, APPL ENVIRON MICROB, V56, P2572, DOI 10.1128/AEM.56.8.2572-2575.1990; Griffin DW, 2014, GEOMICROBIOL J, V31, P175, DOI 10.1080/01490451.2013.815294; Groth I, 2002, INT J SYST EVOL MICR, V52, P77, DOI 10.1099/00207713-52-1-77; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P221, DOI 10.1080/01490451.2012.752424; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P205, DOI 10.1080/01490451.2013.777491; Holmes AJ, 2000, FEMS MICROBIOL ECOL, V33, P111, DOI 10.1016/S0168-6496(00)00051-9; Howarth F.G., 1981, US-IBP Synthesis Series, V15, P318; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones AA, 2014, GEOMICROBIOL J, V31, P246, DOI 10.1080/01490451.2013.809174; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kanaparthi D, 2013, ISME J, V7, P1582, DOI 10.1038/ismej.2013.38; Laiz L, 1999, J MICROBIOL METH, V36, P129, DOI 10.1016/S0167-7012(99)00018-4; Lee SD, 2006, INT J SYST EVOL MICR, V56, P549, DOI 10.1099/ijs.0.63881-0; Letunic I, 2016, NUCL ACIDS RES; Leveille RJ, 2010, PLANET SPACE SCI, V58, P592, DOI 10.1016/j.pss.2009.06.004; Levy DB, 2007, J CAVE KARST STUD, V69, P342; Lim JH, 2009, INT J SYST EVOL MICR, V59, P2394, DOI 10.1099/ijs.0.009480-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maskey RP, 2003, Z NATURFORSCH B, V58, P692; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mercier C., 2013, SUMATRA SUMACLUST FA; Moya M, 2009, P 15 INT C SPEL, V2, P709; Northup D, 2015, LIFE IN EXTREME ENVI, V3, P161; Northup DE, 2011, ASTROBIOLOGY, V11, P601, DOI 10.1089/ast.2010.0562; Northup D.E., 2008, AMCS B, V19, P119; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Northup DE, 2016, PROC 16TH INT SYMP V; Northup DE, 2012, LIFE EARTH OTHER PLA, P459; Northup Diana E., 1997, New Mexico Bureau of Mines & Mineral Resources Bulletin, V156, P69; Northup DE, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001107; Ortiz M, 2014, ISME J, V8, P478, DOI 10.1038/ismej.2013.159; Ortiz M, 2013, MICROB ECOL, V65, P371, DOI 10.1007/s00248-012-0143-6; Palmer A.N., 2007, CAVE GEOLOGY; Pelaez F, 2006, BIO CHEM PARMACOL; Pfaff JD, 1997, METHOD 300 1; Porca E, 2012, FEMS MICROBIOL ECOL, V81, P255, DOI 10.1111/j.1574-6941.2012.01383.x; POULSON TL, 1969, SCIENCE, V165, P971; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin S, 2008, INT J SYST EVOL MICR, V58, P2086, DOI 10.1099/ijs.0.65721-0; R Development Core Team, 2012, R A LANGUAGE AND ENV; Riquelme C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv141; Riquelme C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01342; Simon KS, 2003, ECOLOGY, V84, P2395, DOI 10.1890/02-334; Skerman VBD, 1989, BERGEYS MANUAL SYSTE, V3, P2074; Snider JR, 2010, THESIS; Spilde MN, 2016, PROC 16TH INT SYMP V; Tetu SG, 2013, ISME J, V7, P1227, DOI 10.1038/ismej.2013.14; White WB, 2010, J CAVE KARST STUD, V72, P75, DOI 10.4311/jcks2009es0080; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang L, 2005, NATURAL PRODUCTS DRU, P30	77	51	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169339	10.1371/journal.pone.0169339	http://dx.doi.org/10.1371/journal.pone.0169339			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199330	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400007
J	Lorenz, K; Wasielica-Poslednik, J; Bell, K; Renieri, G; Keicher, A; Ruckes, C; Pfeiffer, N; Thieme, H				Lorenz, Katrin; Wasielica-Poslednik, Joanna; Bell, Katharina; Renieri, Giulia; Keicher, Alexander; Ruckes, Christian; Pfeiffer, Norbert; Thieme, Hagen			Efficacy and safety of preoperative lop reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma	PLOS ONE			English	Article							TOPICAL ANTIGLAUCOMA MEDICATION; SURGERY; DRUGS; CONJUNCTIVA; SUCCESS	Introduction To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Delta = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (10P) reduction 3 and 6 months after trabeculectomy in glaucoma patients. Materials and methods Sixty-two eyes undergoing trabeculectomy with mitomycin C were included in this mono centric prospective randomized controlled study. 10P change between baseline and 3 months post-op was defined as the primary efficacy variable. Secondary efficacy variables included the number of 5-fluorouracil (5-FU) injections, needlings, suture lyses, preoperative 10P change, hypertension rate and change of conjunctival redness 3 and 6 months post-op. Safety was assessed based on the documentation of adverse events. Results Preoperative treatment with topical dorzolamide/timolol was non-inferior to oral acetazolamide and topical dexamethasone in terms of 10P reduction 3 months after trabeculectomy (adjusted means -8.12 mmHg versus-8.30 mmHg; Difference: 0.18; 95% CI-1.91 to 2.26, p = 0.8662). Similar results were found 6 months after trabeculectomy (-9.13 mmHg versus -9.06 mmHg; p = 0.9401). Comparable results were also shown for both groups concerning the classification of the filtering bleb, corneal staining, and numbers of treatments with 5-FU, needlings and suture lyses. More patients reported AEs in the acetazolamide/dexamethasone group than in the dorzolamide/timolol group. Discussion Preoperative, preservative-free, fixed-dose dorzolamide/timolol seems to be equally effective as preoperative acetazolamide and dexamethasone and has a favourable safety profile.	[Lorenz, Katrin; Wasielica-Poslednik, Joanna; Bell, Katharina; Renieri, Giulia; Keicher, Alexander; Pfeiffer, Norbert; Thieme, Hagen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Renieri, Giulia; Thieme, Hagen] Otto von Guericke Univ, Univ Eye Clin, Magdeburg, Germany; [Keicher, Alexander] Augenarzte Basteictr, Ulm, Germany; [Ruckes, Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Interdisciplinary Ctr Clin Trials Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz; Otto von Guericke University; Johannes Gutenberg University of Mainz	Lorenz, K (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	katrin.lorenz@unimedizin-mainz.de	Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020		MSD SHARP & DOHME GmbH, Germany; Santen Pharmaceutical Co., Ltd., Japan; Augenarzte im Basteicenter	MSD SHARP & DOHME GmbH, Germany; Santen Pharmaceutical Co., Ltd., Japan; Augenarzte im Basteicenter	The authors received a research grant by MSD SHARP & DOHME GmbH, Germany and Santen Pharmaceutical Co., Ltd., Japan. This funder reviewed the study protocol, but played no role in data collection, analysis, or decision to publish the data. Augenarzte im Basteicenter also provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaei M, 2015, DRUG RES, V65, P164, DOI 10.1055/s-0034-1376964; Baudouin C, 1999, OPHTHALMOLOGY, V106, P556, DOI 10.1016/S0161-6420(99)90116-1; Breusegem C, 2010, OPHTHALMOLOGY, V117, P1324, DOI 10.1016/j.ophtha.2009.11.038; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Broadway DC, 1996, ARCH OPHTHALMOL-CHIC, V114, P262, DOI 10.1001/archopht.1996.01100130258004; FAIRBAIRN WD, 1971, ARCH OPHTHALMOL-CHIC, V86, P138, DOI 10.1001/archopht.1971.01000010140004; Flach Allan Joseph, 2004, Trans Am Ophthalmol Soc, V102, P219; Her Y, 2011, J DERMATOL, V38, P272, DOI 10.1111/j.1346-8138.2010.00921.x; Kelly TE, 2010, HIGH ALT MED BIOL, V11, P319, DOI 10.1089/ham.2010.1051; Klink T, 2013, OPHTHALMOLOGE, V110, P299, DOI 10.1007/s00347-012-2710-0; LAVIN MJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P1543, DOI 10.1001/archopht.1990.01070130045027; Leibowitz HM, 1996, ARCH OPHTHALMOL-CHIC, V114, P933, DOI 10.1001/archopht.1996.01100140141005; LONGSTAFF S, 1990, OPHTHALMIC SURG LAS, V21, P786; Ozturker ZK, 2014, J OCUL PHARMACOL TH, V30, P554, DOI 10.1089/jop.2014.0008; Pfeiffer N, 2006, INFLUENCE LOCAL GLAU; SHERWOOD MB, 1989, OPHTHALMOLOGY, V96, P327, DOI 10.1016/S0161-6420(89)32888-0; SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9; ZEIMER RC, 1991, OPHTHALMOLOGY, V98, P64; Zimmermann S, 2014, HEART LUNG, V43, P124, DOI 10.1016/j.hrtlng.2013.11.008; ZINK HA, 1975, AM J OPHTHALMOL, V80, P478, DOI 10.1016/0002-9394(75)90537-1	21	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171636	10.1371/journal.pone.0171636	http://dx.doi.org/10.1371/journal.pone.0171636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199397	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400037
J	Urrecha, M; Romero, I; DeFelipe, J; Merchan-Perez, A				Urrecha, Miguel; Romero, Ignacio; DeFelipe, Javier; Merchan-Perez, Angel			Influence of cerebral blood vessel movements on the position of perivascular synapses	PLOS ONE			English	Article							NEURONAL-ACTIVITY; BRAIN; CORTEX; FLOW; MICROVESSELS; MICROSCOPY; NEOCORTEX	Synaptic activity is regulated and limited by blood flow, which is controlled by blood vessel dilation and contraction. Traditionally, the study of neurovascular coupling has mainly focused on energy consumption and oxygen delivery. However, the mechanical changes that blood vessel movements induce in the surrounding tissue have not been considered. We have modeled the mechanical changes that movements of blood vessels cause in neighboring synapses. Our simulations indicate that synaptic densities increase or decrease during vascular dilation and contraction, respectively, near the blood vessel walls. This phenomenon may alter the concentration of neurotransmitters and vasoactive substances in the immediate vicinity of the vessel wall and thus may have an influence on local blood flow.	[Urrecha, Miguel; Romero, Ignacio] Univ Politecn Madrid, Dept Mech Engn, Madrid, Spain; [Romero, Ignacio] IMDEA Mat Inst, Madrid, Spain; [DeFelipe, Javier; Merchan-Perez, Angel] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain; [Merchan-Perez, Angel] Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain	Universidad Politecnica de Madrid; IMDEA Materials Institute; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid	Merchan-Perez, A (corresponding author), Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain.; Merchan-Perez, A (corresponding author), Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain.	amerchan@fi.upm.es	Romero, Ignacio/H-2129-2015; Merchan-Perez, Angel/D-7417-2014; Merchan-Perez, Angel/AAY-8947-2020; DEFELIPE, JAVIER/D-1195-2014	Romero, Ignacio/0000-0003-0364-6969; Merchan-Perez, Angel/0000-0002-7228-5821; Merchan-Perez, Angel/0000-0002-7228-5821; DEFELIPE, JAVIER/0000-0001-5484-0660	Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) [CB06/05/0066]; Spanish Ministerio de Economia y Competitividad [BFU2012-34963]; Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union Seventh Framework Programme (FP7) [604102]; European Union Horizon research and innovation programme [720270]	Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain); Spanish Ministerio de Economia y Competitividad(Spanish Government); Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union Seventh Framework Programme (FP7); European Union Horizon research and innovation programme	This work was supported by grants from the following entities: Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, CB06/05/0066, Spain, https://www.ciberned.es/); the Spanish Ministerio de Economia y Competitividad (grant BFU2012-34963, http://www.mineco.gob.es/) and the Cajal Blue Brain Project, (http://cajalbbp.cesvima.upm.es/), Spanish partner of the Blue Brain Project initiative from EPFL); the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 604102 (Human Brain Project) and the European Union Horizon 2020 research and innovation programme under grant agreement No. 720270 (Human Brain Project, https://www.humanbrainproject.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2015, CEREB CORTEX, V25, P3673, DOI 10.1093/cercor/bhu221; Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Dalkara T, 2015, BRAIN RES; Estrada C, 1998, CEREB CORTEX, V8, P193, DOI 10.1093/cercor/8.3.193; Fergus A, 1997, BRAIN RES, V754, P35, DOI 10.1016/S0006-8993(97)00040-1; Filosa JA, 2015, NEUROSCIENCE; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Gagnon L, 2015, J NEUROSCI, V35, P3663, DOI 10.1523/JNEUROSCI.3555-14.2015; Gao YR, 2015, NEUROIMAGE, V115, P162, DOI 10.1016/j.neuroimage.2015.04.054; Hotta H, 2016, PROG BRAIN RES, V225, P3, DOI 10.1016/bs.pbr.2016.03.001; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Hughes T.J.R, 1987, FINITE ELEMENT METHO, P311; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Merchan-Perez A, 2014, CEREB CORTEX, V24, P1579, DOI 10.1093/cercor/bht018; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Slaughter W.S., 2002, LINEARIZED THEORY EL, P331; Srinivasan VJ, 2014, NEUROIMAGE, V102, P393, DOI 10.1016/j.neuroimage.2014.08.004; Wu JP, 2016, CEREB CORTEX, V26, P23, DOI 10.1093/cercor/bhu166; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172368	10.1371/journal.pone.0172368	http://dx.doi.org/10.1371/journal.pone.0172368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199396	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400089
J	Gao, XL; Hicks, KC; Neumann, P; Patel, TB				Gao, Xianlong; Hicks, Kristin C.; Neumann, Paul; Patel, Tarun B.			Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein	PLOS ONE			English	Article							DE-NOVO METHYLATION; CANDIDATE TUMOR-SUPPRESSOR; DNA-METHYLTRANSFERASE; PROGNOSTIC-SIGNIFICANCE; CELL-PROLIFERATION; DOWN-REGULATION; KINASE PATHWAY; UP-REGULATION; GROWTH; INHIBITOR	Receptor Tyrosine Kinase (RTK) signaling plays a major role in tumorigenesis and normal development. Sprouty2 (Spry2) attenuates RTK signaling and inhibits processes such as angiogenesis, cell proliferation, migration and survival, which are all upregulated in tumors. Indeed in cancers of the liver, lung, prostate and breast, Spry2 protein levels are markedly decreased correlating with poor patient prognosis and shorter survival. Thus, it is important to understand how expression of Spry2 is regulated. While prior studies have focused on the post-translation regulation of Spry2, very few studies have focused on the transcriptional regulation of SPRY2 gene. Here, we demonstrate that in the human hepatoma cell line, Hep3B, the transcription of SPRY2 is inhibited by the transcription regulating hypoxia inducible factors (HIFs). HIFs are composed of an oxygen regulated alpha subunit (HIF1 alpha or HIF2 alpha) and a beta subunit (HIF1 beta). Intriguingly, silencing of HIF1 alpha and HIF2 alpha elevates SPRY2 mRNA and protein levels suggesting HIFs reduce the transcription of the SPRY2 promoter. In silico analysis identified ten hypoxia response elements (HREs) in the proximal promoter and first intron of SPRY2. Using chromatin immunoprecipitation (ChIP), we show that HIF1 alpha/2 alpha bind near the putative HREs in the proximal promoter and intron of SPRY2. Our studies demonstrated that not only is the SPRY2 promoter methylated, but silencing HIF1 alpha/2 alpha reduced the methylation. ChIP assays also showed DNA methyltransferase1 (DNMT1) binding to the proximal promoter and first intron of SPRY2 and silencing HIF1 alpha/2 alpha decreased this association. Additionally, silencing of DNMT1 mimicked the HIF1 alpha/2 alpha silencing-mediated increase in SPRY2 mRNA and protein. While simultaneous silencing of HIF1 alpha/2 alpha and DNMT1 increased SPRY2 mRNA a little more, the increase was not additive suggesting a common mechanism by which DNMT1 and HIF1 alpha/2 alpha regulate SPRY2 transcription. Together these data suggest that the transcription of SPRY2 is inhibited by HIFs, in part, via DNMT1-mediated methylation.	[Gao, Xianlong] Loyola Univ, Dept Surg, Chicago, IL 60611 USA; [Hicks, Kristin C.; Neumann, Paul; Patel, Tarun B.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Loyola University Chicago; Albany College of Pharmacy & Health Sciences	Patel, TB (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA.	Tarun.patel@acphs.edu		Hicks, Kristin/0000-0001-9192-875X				Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MOL CELL NEUROSCI, V15, P22, DOI 10.1006/mcne.1999.0801; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; De Bonis ML, 2006, HUM MOL GENET, V15, P1123, DOI 10.1093/hmg/ddl027; Denko N, 2003, J BIOL CHEM, V278, P5744, DOI 10.1074/jbc.M212534200; Ding W, 2003, GENE, V322, P175, DOI 10.1016/j.gene.2003.09.004; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haigl B, 2010, BIOL CHEM, V391, P813, DOI 10.1515/BC.2010.082; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hicks KC, 2016, J BIOL CHEM, V291, P16787, DOI 10.1074/jbc.M116.714139; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10366, DOI 10.1073/pnas.93.19.10366; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Mastrogiannaki M, 2011, HAEMATOLOGICA; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mirabello L, 2012, INT J MOL EPIDEMIOL, V3, P213; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ordonez-Moran P, 2014, ONCOGENE, V33, P1975, DOI 10.1038/onc.2013.140; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 1997, NUCLEIC ACIDS RES, V25, P4666, DOI 10.1093/nar/25.22.4666; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Reich A, 1999, DEVELOPMENT, V126, P4139; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Ryu K, 2011, BIOCHEM BIOPH RES CO, V407, P831, DOI 10.1016/j.bbrc.2011.03.119; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sirivatanauksorn Y, 2012, J SURG ONCOL, V105, P273, DOI 10.1002/jso.22095; Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Tanimoto Kousuke, 2010, Hugo J, V4, P35, DOI 10.1007/s11568-011-9150-9; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wietecha MS, 2011, AM J PHYSIOL-HEART C, V300, pH459, DOI 10.1152/ajpheart.00244.2010; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; WU JC, 1987, J BIOL CHEM, V262, P4778; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	91	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171616	10.1371/journal.pone.0171616	http://dx.doi.org/10.1371/journal.pone.0171616			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196140	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423900025
J	Park, JI; Jung, HH				Park, Ji In; Jung, Hae Hyuk			Estimation of years lived with disability due to noncommunicable diseases and injuries using a population-representative survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; GLOBAL BURDEN; HEALTH; WEIGHTS	The Global Burden of Disease 2010 and the WHO Global Health Estimates of years lived with disability (YLDs) uses disability-weights obtained from lay health-state descriptions, which cannot fully reflect different disease manifestations, according to severity, treatment, and environment. The aim of this study was to provide population-representative YLDs of noncommunicable diseases and injuries using a prevalence-based approach, with the disability weight measured in subjects with specific diseases or injuries. We included a total of 44969 adults, who completed the EQ-5D questionnaire as participation in the Korea National Health and Nutrition Examination Survey 2007-2014. We estimated the prevalence of each of 40 conditions identified from the noncommunicable diseases and injuries in the WHO list. Modified condition-specific disability-weight was determined from the adjusted mean difference of the EQ-5D index between the condition and reference groups. Condition -specific YLDs were calculated as the condition's prevalence multiplied by the condition's disability-weight. All-cause YLDs, estimated as "number of population x (1-mean score of EQ-5D)" were 2165 thousands in 39044 thousand adults aged >= 20. The combined YLDs for all 40 conditions accounted for 67.6% of all-cause YLDs, and were 1604, 2126, 8749, and 12847 per 100000 young (age 20-59) males, young females, old (age >= 60) males, and old females, respectively. Back pain/osteoarthritis YLDs were exceptionally large (442/40, 864/146, 2037/836, and 4644/3039 per 100000 young males, young females, old males, and old females, respectively). Back pain, osteoarthritis, depression, diabetes, periodontitis, and stroke accounted for 22.3%, 9.1%, 4.6%, 3.3%, 3.2%, and 2.9% of all cause YLDs, respectively. In conclusion, this estimation of YLDs using prevalence rates and disability-weights measured in a population-representative survey may form the basis for population-level strategies to prevent age-related worsening of disability.	[Park, Ji In; Jung, Hae Hyuk] Kangwon Natl Univ, Sch Med, Dept Med, Kangwon Natl Univ Hosp, Chunchon, Gangwon Do, South Korea	Kangwon National University; Kangwon National University Hospital	Jung, HH (corresponding author), Kangwon Natl Univ, Sch Med, Dept Med, Kangwon Natl Univ Hosp, Chunchon, Gangwon Do, South Korea.	haehyuk@kangwon.ac.kr		Jung, Hae Hyuk/0000-0002-3202-6307; Park, Ji In/0000-0003-4662-3759				[Anonymous], 2013, WHOHISHSIGHE20134; [Anonymous], 2015, FACT SHEET N300; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Baltussen RMPM, 2002, HEALTH ECON, V11, P155, DOI 10.1002/hec.658; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Brennan DS, 2007, J DENT RES, V86, P713, DOI 10.1177/154405910708600805; Celio MA, 2016, ALCOHOL CLIN EXP RES, V40, P638, DOI 10.1111/acer.12988; Clark Leslie L, 2015, MSMR, V22, P8; Contrera KJ, 2016, LARYNGOSCOPE, V126, P2110, DOI 10.1002/lary.25848; Darba J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1684-7; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Fransen M, 2014, BEST PRACT RES CL RH, V28, P435, DOI 10.1016/j.berh.2014.07.002; Global Initiative for Chronic Obstructive Lung Disease, 2016, GLOB STRAT DIAGN MAN; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Holtslag HR, 2008, B WORLD HEALTH ORGAN, V86, P111, DOI 10.2471/BLT.06.033803; Iron Deficiency Anaemia Assessment, 2001, IR DEF AN ASS PREV C; Jia TW, 2007, B WORLD HEALTH ORGAN, V85, P458, DOI 10.2471/BLT.06.033035; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Kruijshaar ME, 2005, B WORLD HEALTH ORGAN, V83, P443; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lam SK, 2000, BEST PRACT RES CL GA, V14, P41, DOI 10.1053/bega.1999.0058; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schwarzinger Michael, 2003, Popul Health Metr, V1, P9, DOI 10.1186/1478-7954-1-9; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Szende A., 2004, MEASURING SELF REPOR; Tomlin S., 2015, HLTH WELLBEING ADULT; Voigt K, 2014, B WORLD HEALTH ORGAN, V92, P226, DOI 10.2471/BLT.13.126227; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weintraub William S, 2008, N Engl J Med, V359, P677, DOI 10.1056/NEJMoa072771; Yoon Kyung Chul, 2015, Korean J Ophthalmol, V29, P359, DOI 10.3341/kjo.2015.29.6.359; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518	39	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172001	10.1371/journal.pone.0172001	http://dx.doi.org/10.1371/journal.pone.0172001			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196151	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900042
J	Rieznik, A; Moscovich, L; Frieiro, A; Figini, J; Catalano, R; Garrido, JM; Heduan, FA; Sigman, M; Gonzalez, PA				Rieznik, Andres; Moscovich, Lorena; Frieiro, Alan; Figini, Julieta; Catalano, Rodrigo; Manuel Garrido, Juan; Alvarez Heduan, Facundo; Sigman, Mariano; Gonzalez, Pablo A.			A massive experiment on choice blindness in political decisions: Confidence, confabulation, and unconscious detection of self-deception	PLOS ONE			English	Article							AWARENESS	We implemented a Choice Blindness Paradigm containing political statements in Argentina to reveal the existence of categorical ranges of introspective reports, identified by confidence and agreement levels, separating easy from very hard to manipulate decisions. CBP was implemented in both live and web-based forms. Importantly, and contrary to what was observed in Sweden, we did not observe changes in voting intentions. Also, confidence levels in the manipulated replies where significantly lower than in non-manipulated cases even in undetected manipulations. We name this phenomenon unconscious detection of self-deception. Results also show that females are more difficult to manipulate than men.	[Rieznik, Andres; Sigman, Mariano] Univ Torcuato Di Tella, Lab Neurociencia, Buenos Aires, DF, Argentina; [Rieznik, Andres; Sigman, Mariano] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rieznik, Andres; Catalano, Rodrigo; Manuel Garrido, Juan; Alvarez Heduan, Facundo; Gonzalez, Pablo A.] El Gato & La Caja, Buenos Aires, DF, Argentina; [Moscovich, Lorena; Figini, Julieta] Univ San Andres, Buenos Aires, DF, Argentina; [Frieiro, Alan] Univ Vigo, Vigo, Spain	Universidad Torcuato Di Tella; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de San Andres Argentina; Universidade de Vigo	Rieznik, A (corresponding author), Univ Torcuato Di Tella, Lab Neurociencia, Buenos Aires, DF, Argentina.; Rieznik, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Rieznik, A (corresponding author), El Gato & La Caja, Buenos Aires, DF, Argentina.	arieznik@gmail.com			CONICET, Argentina	CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by CONICET, Argentina.	Arceneaux K, 2012, AM J POLIT SCI, V56, P271, DOI 10.1111/j.1540-5907.2011.00573.x; Bachner J, 2014, POLICY STUD J, V42, pS51, DOI 10.1111/psj.12052; Barttfeld P, 2013, P NATL ACAD SCI USA, V110, P11577, DOI 10.1073/pnas.1301353110; Calvo E, 2014, ELECT STUD, V36, P94, DOI 10.1016/j.electstud.2014.07.003; Center PR., 2016, PART POL AN 2016; Center PR., 2016, WID ID GAP MOR LESS; Charles L, 2013, NEUROIMAGE, V73, P80, DOI 10.1016/j.neuroimage.2013.01.054; Chong D, 2013, J POLIT, V75, P1, DOI 10.1017/S0022381612000837; Combs DJY, 2009, J EXP SOC PSYCHOL, V45, P635, DOI 10.1016/j.jesp.2009.02.009; Dehaene S., 2020, WE LEARN NEW SCI ED; Dennett Daniel, 1993, CONSCIOUSNESS EXPLAI; Dennett DC, 2015, ELBOW ROOM: THE VARIETIES OF FREE WILL WORTH WANTING, P1; DePaulo B M, 1997, Pers Soc Psychol Rev, V1, P346, DOI 10.1207/s15327957pspr0104_5; Druckman JN, 2004, AM POLIT SCI REV, V98, P671, DOI 10.1017/S0003055404041413; Evans S, 2007, SPATIAL VISION, V20, P61, DOI 10.1163/156856807779369742; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Figini J., 2015, ILLUSIONES INTROSPEC; Fleming Stephen M, 2014, Front Hum Neurosci, V8, P443, DOI 10.3389/fnhum.2014.00443; Gazzaniga M. S., 1998, THE MINDS PAST; Hall L, 2008, USING CHOICE BLINDNE, P267; Hall L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060554; Hall L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045457; Hall L, 2010, COGNITION, V117, P54, DOI 10.1016/j.cognition.2010.06.010; Harris S., 2012, FREE WILL; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Johansson P, 2006, CONSCIOUS COGN, V15, P673, DOI 10.1016/j.concog.2006.09.004; Kanai R, 2010, CONSCIOUS COGN, V19, P1045, DOI 10.1016/j.concog.2010.06.003; Kuhn G, 2008, TRENDS COGN SCI, V12, P349, DOI 10.1016/j.tics.2008.05.008; Levitsky Steven, 2013, RESURGENCE LATIN AM; Lipset S. M., 1967, PARTY SYSTEMS VOTER, P91; Macknik Stephen, 2010, SLEIGHTS MIND WHAT N; Malamud Andres, 2005, JOINT SESS WORKSH EU; Merola V, 2016, PUBLIC OPIN QUART, V80, P554, DOI 10.1093/poq/nfv051; Meyniel F, 2015, NEURON, V88, P78, DOI 10.1016/j.neuron.2015.09.039; Moore J, 2006, CONSCIOUSNESS COGNIT, V15; Nahum M, 2010, J NEUROSCI, V30, P1128, DOI 10.1523/JNEUROSCI.1781-09.2010; Nisbett R.E., 2015, MINDWARE TOOLS SMART; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ostiguy P., 2009, CITESEER; Prior M, 2013, ANNU REV POLIT SCI, V16, P101, DOI 10.1146/annurev-polisci-100711-135242; Sagana A, 2014, FRONT PSYCHOL, P5; Sagana A, 2013, BEHAV SCI LAW, V31, P624, DOI 10.1002/bsl.2082; Saiegh SM., 2015, POLIT ANAL; Sauerland M, 2013, LEGAL CRIMINOL PSYCH, V18, P371, DOI 10.1111/j.2044-8333.2012.02049.x; Shalom DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058254; Somerville J, 2016, J BEHAV EXPT EC; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Zollo Fabiana, 2015, ARXIV151004267	48	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171108	10.1371/journal.pone.0171108	http://dx.doi.org/10.1371/journal.pone.0171108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196093	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900011
J	ten Broeke, GA; van Voorn, GAK; Ligtenberg, A; Molenaar, J				ten Broeke, Guus A.; van Voorn, George A. K.; Ligtenberg, Arend; Molenaar, Jaap			Resilience through adaptation	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; COMPLEX ADAPTIVE SYSTEMS; AGENT-BASED MODEL; SENSITIVITY-ANALYSIS; PERSPECTIVE; EMERGENCE	Adaptation of agents through learning or evolution is an important component of the resilience of Complex Adaptive Systems (CAS). Without adaptation, the flexibility of such systems to cope with outside pressures would be much lower. To study the capabilities of CAS to adapt, social simulations with agent-based models (ABMs) provide a helpful tool. However, the value of ABMs for studying adaptation depends on the availability of methodologies for sensitivity analysis that can quantify resilience and adaptation in ABMs. In this paper we propose a sensitivity analysis methodology that is based on comparing time-dependent probability density functions of output of ABMs with and without agent adaptation. The differences between the probability density functions are quantified by the socalled earth-mover's distance. We use this sensitivity analysis methodology to quantify the probability of occurrence of critical transitions and other long-term effects of agent adaptation. To test the potential of this new approach, it is used to analyse the resilience of an ABM of adaptive agents competing for a common-pool resource. Adaptation is shown to contribute positively to the resilience of this ABM. If adaptation proceeds sufficiently fast, it may delay or avert the collapse of this system.	[ten Broeke, Guus A.; van Voorn, George A. K.; Molenaar, Jaap] Wageningen Univ & Res, Biometris, Wageningen, Netherlands; [Ligtenberg, Arend] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	ten Broeke, GA (corresponding author), Wageningen Univ & Res, Biometris, Wageningen, Netherlands.	guus.tenbroeke@wur.nl	ligtenberg, arend/L-4267-2019	ligtenberg, arend/0000-0002-2093-7947; ten Broeke, Guus/0000-0002-9956-7415	IO/OP theme Complex Adaptive Systems at Wageningen University Research	IO/OP theme Complex Adaptive Systems at Wageningen University Research	There search by GTB is funded by the IO/OP theme Complex Adaptive Systems at Wageningen University & Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SOLUTIONS; [Anonymous], 2011, RANDOM DATA ANAL MEA; Arthur WB, 2006, HANDB ECON, V13, P1551; Aubert-Kato N, 2015, ECAL 2015: THE THIRTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE, P357, DOI 10.7551/978-0-262-33027-5-ch065; Auder B, 2009, SAFETY, RELIABILITY AND RISK ANALYSIS: THEORY, METHODS AND APPLICATIONS, VOLS 1-4, P2107; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Borgonovo E, 2007, RELIAB ENG SYST SAFE, V92, P771, DOI 10.1016/j.ress.2006.04.015; Broeke Ten GA, 2016, J ARTIF SOC SOC SIMU, V19; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Colon C, 2015, ECOL MODEL, V317, P93, DOI 10.1016/j.ecolmodel.2015.09.004; Crooks A, 2008, COMPUT ENVIRON URBAN, V32, P417, DOI 10.1016/j.compenvurbsys.2008.09.004; Filatova T, 2013, ENVIRON MODELL SOFTW, V45, P1, DOI 10.1016/j.envsoft.2013.03.017; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Froncek P, 2015, JASSS-J ARTIF SOC S, V18, DOI 10.18564/jasss.2949; GELLMANN M, 1994, SFI S SCI C, V19, P17; Grazzini J, 2015, J ECON DYN CONTROL, V51, P148, DOI 10.1016/j.jedc.2014.10.006; Grazzini J, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.1929; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Holland J. H., 2006, Journal of Systems Science and Complexity, V19, P1, DOI 10.1007/s11424-006-0001-z; Holland JH, 1992, COMPLEX ADAPTIVE SYS, P17; Janssen MA, 1999, CONSERV ECOL, V3, P15; LEE JS, 2015, JASSS J ARTIF SOC S, V18; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Levin S, 2013, ENVIRON DEV ECON, V18, P111, DOI 10.1017/S1355770X12000460; Ling H, 2007, IEEE T PATTERN ANAL, V29, P840, DOI 10.1109/TPAMI.2007.1058; Liu HB, 2006, J MECH DESIGN, V128, P326, DOI 10.1115/1.2159025; Macal CM, 2016, J SIMUL, V10, P144, DOI 10.1057/jos.2016.7; Nelson BL, 2016, J SIMUL, V10, P2, DOI 10.1057/jos.2015.22; Nelson DR, 2011, WIRES CLIM CHANGE, V2, P113, DOI 10.1002/wcc.91; Rammel C, 2007, ECOL ECON, V63, P9, DOI 10.1016/j.ecolecon.2006.12.014; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Schluter M, 2007, ECOL SOC, V12; Schouten M, 2013, LAND USE POLICY, V30, P934, DOI 10.1016/j.landusepol.2012.06.008; ten Broeke GA, 2016, MATH MODEL NAT PHENO, V11, P47, DOI 10.1051/mmnp/201611405; The Resilience Alliance, 2010, ASSESSING RESILIENCE; Troitzsch K. G., 2014, ARTIFICIAL EC SELFOR, V669, P17; van Lith J, 2001, STUD HIST PHILOS M P, V32B, P581, DOI 10.1016/S1355-2198(01)00027-2; Venkatasubramanian Suresh, 2013, SIGACT News, V44, P56; Walker B, 2004, ECOL SOC, V9	41	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171833	10.1371/journal.pone.0171833	http://dx.doi.org/10.1371/journal.pone.0171833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196372	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900034
J	Burrell, LM; Gayed, D; Griggs, K; Patel, SK; Velkoska, E				Burrell, Louise M.; Gayed, Daniel; Griggs, Karen; Patel, Sheila K.; Velkoska, Elena			Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition	PLOS ONE			English	Article							COUPLED RECEPTOR MAS; CONVERTING-ENZYME; MYOCARDIAL-INFARCTION; EXPRESSION; FIBROSIS; HYPERTENSION; MOUSE; HEART; CARBOXYPEPTIDASE; TRANSFORMATION	We previously reported that exogenous angiotensin (Ang) 1-7 has adverse cardiac effects in experimental kidney failure due to its action to increase cardiac angiotensin converting enzyme (ACE) activity. This study investigated if the addition of an ACE inhibitor (ACEi) to Ang 1-7 infusion would unmask any beneficial effects of Ang 1-7 on the heart in experimental kidney failure. Male Sprague-Dawley rats underwent subtotal nephrectomy (STNx) and were treated with vehicle, the ACEi ramipril (oral 1mg/kg/day), Ang 1-7 (subcutaneous 24 lag/kg/h) or dual therapy (all groups, n = 12). A control group (n = 10) of sham-operated rats were also studied. STNx led to hypertension, renal impairment, cardiac hypertrophy and fibrosis, and increased both left ventricular ACE2 activity and ACE binding. STNx was not associated with changes in plasma levels of ACE, ACE2 or angiotensin peptides. Ramipril reduced blood pressure, improved cardiac hypertrophy and fibrosis and inhibited cardiac ACE. Ang 1-7 infusion increased blood pressure, cardiac interstitial fibrosis and cardiac ACE binding compared to untreated STNx rats. Although in STNx rats, the addition of ACEi to Ang 1-7 prevented any deleterious cardiac effects of Ang 1-7, a limitation of the study is that the large increase in plasma Ang 1-7 with ramipril may have masked any effect of infused Ang 1-7.	[Burrell, Louise M.; Gayed, Daniel; Griggs, Karen; Patel, Sheila K.; Velkoska, Elena] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Velkoska, E (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia.	velkoska@unimelb.edu.au			National Health and Medical Research Council of Australia [APP1048285]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding granted to EV from the National Health and Medical Research Council of Australia (APP1048285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzayadneh EM, 2014, CELL SIGNAL, V26, P3027, DOI 10.1016/j.cellsig.2014.09.010; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2006, AM J PHYSIOL-HEART C, V290, pH684, DOI 10.1152/ajpheart.00632.2005; Bi JL, 2013, J RENIN-ANGIO-ALDO S, V14, P290, DOI 10.1177/1470320312465217; Burgelova M, 2009, J HYPERTENS, V27, P1988, DOI 10.1097/HJH.0b013e32832f0d06; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Burrell LM, 2012, EXP PHYSIOL, V97, P477, DOI 10.1113/expphysiol.2011.063156; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Ferrario CM, 2002, KIDNEY INT, V62, P1349, DOI 10.1111/j.1523-1755.2002.kid559.x; Fraga-Silva RA, 2014, THROMB HAEMOSTASIS, V111, P736, DOI 10.1160/TH13-06-0448; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Herath CB, 2007, J HEPATOL, V47, P387, DOI 10.1016/j.jhep.2007.03.008; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kim CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142664; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Liu EZ, 2010, REGUL PEPTIDES, V162, P73, DOI 10.1016/j.regpep.2009.12.020; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Papinska A.M., 2015, BR J PHARM; Papinska AM, 2016, PHARM RES; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Shi YX, 2015, CLIN SCI, V128, P649, DOI 10.1042/CS20140329; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Velez JCQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110083; Velez JCQ, 2009, NAT CLIN PRACT NEPHR, V5, P89, DOI 10.1038/ncpneph1015; Velkoska E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161760; Velkoska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118758; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Xu C, 2013, EURASIP J ADV SIG PR, V2013, P1, DOI DOI 10.1016/J.MFGLET.2013.09.003; Yamada K, 1998, HYPERTENSION, V32, P496, DOI 10.1161/01.HYP.32.3.496; Zimmerman DL, 2015, AM J PATHOL, V185, P729, DOI 10.1016/j.ajpath.2014.11.013	42	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171975	10.1371/journal.pone.0171975	http://dx.doi.org/10.1371/journal.pone.0171975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192475	Green Published, gold			2022-12-27	WOS:000394423800056
J	Serra-Varela, MJ; Alia, R; Portoles, J; Gonzalo, J; Solino, M; Grivet, D; Raposo, R				Jesus Serra-Varela, Maria; Alia, Ricardo; Portoles, Javier; Gonzalo, Julian; Solino, Mario; Grivet, Delphine; Raposo, Rosa			Incorporating exposure to pitch canker disease to support management decisions of Pinus pinaster Ait. in the face of climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FUSARIUM-CIRCINATUM; POTENTIAL DISTRIBUTION; BIOTIC INTERACTIONS; FOREST MANAGEMENT; RANGE SHIFTS; PART I; DISTRIBUTIONS; NICHE; CONSERVATION	Climate change is gravely affecting forest ecosystems, resulting in large distribution shifts as well as in increasing infection diseases and biological invasions. Accordingly, forest management requires an evaluation of exposure to climate change that should integrate both its abiotic and biotic components. Here we address the implications of climate change in an emerging disease by analysing both the host species (Pinus pinaster, Maritime pine) and the pathogen's (Fusarium circinatum, pitch canker) environmental suitability i.e. estimating the host's risk of habitat loss and the disease's future environmental range. We constrained our study area to the Spanish Iberian Peninsula, where accurate climate and pitch canker occurrence databases were available. While P. pinaster is widely distributed across the study area, the disease has only been detected in its north-central and north-western edges. We fitted species distribution models for the current distribution of the conifer and the disease. Then, these models were projected into nine Global Climate Models and two different climatic scenarios which totalled to 18 different future climate predictions representative of 2050. Based on the level of agreement among them, we created future suitability maps for the pine and for the disease independently, which were then used to assess exposure of current populations of P. pinaster to abiotic and biotic effects of climate change. Almost the entire distribution of P. pinaster in the Spanish Iberian Peninsula will be subjected to abiotic exposure likely to be driven by the predicted increase in drought events in the future. Furthermore, we detected a reduction in exposure to pitch canker that will be concentrated along the north-western edge of the study area. Setting up breeding programs is recommended in highly exposed and productive populations, while silvicultural methods and monitoring should be applied in those less productive, but still exposed, populations.	[Jesus Serra-Varela, Maria] Univ Valladolid, Dept Plant Prod & Forest Resources, Palencia, Spain; [Jesus Serra-Varela, Maria; Alia, Ricardo; Gonzalo, Julian; Solino, Mario; Grivet, Delphine; Raposo, Rosa] Univ Valladolid, Sustainable Forest Management Res Inst, INIA, Palencia, Spain; [Jesus Serra-Varela, Maria; Alia, Ricardo; Solino, Mario; Grivet, Delphine; Raposo, Rosa] Forest Res Ctr, INIA, Madrid, Spain; [Portoles, Javier] Fdn Invest Clima, Madrid, Spain	Universidad de Valladolid; Universidad de Valladolid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Serra-Varela, MJ (corresponding author), Univ Valladolid, Dept Plant Prod & Forest Resources, Palencia, Spain.; Serra-Varela, MJ (corresponding author), Univ Valladolid, Sustainable Forest Management Res Inst, INIA, Palencia, Spain.; Serra-Varela, MJ (corresponding author), Forest Res Ctr, INIA, Madrid, Spain.	maje.serra@gmail.com	Grivet, Delphine/G-9708-2012; Soliño, Mario/A-5648-2012; Alia, Ricardo/B-5160-2011; Pórtoles, Javier/L-4612-2014; Raposo, Rosa/A-3185-2012	Grivet, Delphine/0000-0001-8168-4456; Alia, Ricardo/0000-0002-9426-0967; Pórtoles, Javier/0000-0002-5207-8825; Raposo, Rosa/0000-0002-4893-6874	Spanish Ministry of Agriculture, Food and Environment; Spanish National Research Plan AdapCon [CGL2011-30182-C02-01]; TipTree (BiodivERsA-ERANET); INIA Spanish Ministry of Economy and Competitiveness [RTA2013-00048-C03-01]; FPU from the Spanish Ministry of Education, Culture and Sport; Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation	Spanish Ministry of Agriculture, Food and Environment(Spanish Government); Spanish National Research Plan AdapCon; TipTree (BiodivERsA-ERANET); INIA Spanish Ministry of Economy and Competitiveness; FPU from the Spanish Ministry of Education, Culture and Sport; Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation(Spanish Government)	We thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halapensis Mill. to climate change project, funded by the Spanish Ministry of Agriculture, Food and Environment, for enabling the collaboration between the different groups involved, as well as the Spanish National Research Plan AdapCon (CGL2011-30182-C02-01), and the TipTree (BiodivERsA-ERANET) which have supported the development of this paper. This study is framed within the project "Integrated Production in Spanish Pine Forests: From the Diversity of Species to Genetic Improvement Programs", funded by the the INIA Spanish Ministry of Economy and Competitiveness (RTA2013-00048-C03-01). MJSV was supported by a FPU from the Spanish Ministry of Education, Culture and Sport. D.G. was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation.; We are grateful to Jesus Martinez Fernandez for his collaboration during the analysis stage and to Felipe Bravo-Oviedo for insightful discussion. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for the 5th Coupled Model Intercomparison Project CMIP, and we thank the climate modelling groups (listed in able 2 of this article) for producing and making available their model output. Thanks are extended to the Spanish Meteorological Agency (AEMET) for providing the climatic observational data, and to Gerardo Sanchez Pena at Spanish Ministry of Agriculture, Food and Environment for providing records of Fusarium circinatum. We also thank Grant&Co. Language Services, for kindly revising the language through the text. We thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halapensis Mill. to climate change" project, funded by the Spanish Ministry of Agriculture, Food and Environment, for enabling the collaboration between the different groups involved, as well as the Spanish National Research Plan AdapCon (CGL2011-30182-C02-01), and the TipTree (BiodivERsA-ERANET) which have supported the development of this paper. This study is framed within the project "Integrated Production in Spanish Pine Forests: From the Diversity of Species to Genetic Improvement Programs", funded by the INIA Spanish Ministry of Economy and Competitiveness (RTA2013-00048-C03-01). MJSV was supported by a FPU from the Spanish Ministry of Education, Culture and Sport. D.G. was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation.	Alia R, 2009, REGIONES PROCEDENCIA; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Arnaldo PS, 2005, FOREST ECOL MANAG, V210, P1, DOI 10.1016/j.foreco.2005.02.041; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Baker R., 2010, EFSA J, V8, P1, DOI DOI 10.2903/J.EFSA.2010.AVAILABLE; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Barbero Marcel, 1998, P153; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Belsley D. A., 1991, CONDITIONING DIAGNOS; Berbegal M, 2013, PHYTOPATHOLOGY, V103, P851, DOI 10.1094/PHYTO-11-12-0281-R; Bolte A, 2009, SCAND J FOREST RES, V24, P473, DOI 10.1080/02827580903418224; Bravo-Oviedo A, 2004, FOREST ECOL MANAG, V201, P187, DOI 10.1016/j.foreco.2004.06.031; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; da Silva RS, 2016, PEST MANAG SCI; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Edenhofer O., 2014, CONTRIBUTION WORKING; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Elvira-Recuenco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114971; Fernandes PM, 2007, FOREST ECOL MANAG, V241, P1, DOI 10.1016/j.foreco.2007.01.010; Food and Agriculture Organization of the United Nations (FAO), 2006, BETT FOR LESS POV PR; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Garcia J, 2001, MINISTERIO MEDIO AMB; Gaspar M. J., 2013, PLOS ONE, V8, P1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hair J.F., 1995, MULTIVARIATE DATA AN, V4th; Hamann A, 2013, DIVERS DISTRIB, V19, P268, DOI 10.1111/j.1472-4642.2012.00945.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hartkamp AD, 1999, NRG GEOGRAPHIC IN 99; Hastie T., 1986, STAT SCI, V1, P297; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Higgins SI, 2012, J BIOGEOGR, V39, P2132, DOI 10.1111/j.1365-2699.2012.02752.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 1991, BMRC RES REP, V27, P104; Iturritxa E, 2015, PLANT PATHOL, V64, P880, DOI 10.1111/ppa.12328; Iturritxa E, 2012, AUSTRALAS PLANT PATH, V41, P601, DOI 10.1007/s13313-012-0160-4; Iturritxa E, 2011, FUNGAL BIOL-UK, V115, P288, DOI 10.1016/j.funbio.2010.12.014; Jarvis CH, 2001, J APPL METEOROL, V40, P1060, DOI 10.1175/1520-0450(2001)040<1060:ACASFI>2.0.CO;2; Johnston M. H., 2009, VULNERABILITY CANADA; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Madrigal-Gonzalez J, 2014, AGR FOREST METEOROL, V192, P18, DOI 10.1016/j.agrformet.2014.02.011; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Martinez-Alvarez P, 2014, PLANT PATHOL, V63, P1086, DOI 10.1111/ppa.12187; Monjo R, 2014, THEOR APPL CLIMATOL, V117, P317, DOI 10.1007/s00704-013-1008-8; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moykkynen T, 2014, ANN FOREST SCI, V72, P169; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Pautasso M, 2015, MICROB ECOL, V69, P826, DOI 10.1007/s00248-014-0545-8; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pearson, 2010, LESSONS CONSERVATION, V3, P54, DOI [DOI 10.1016/S0140-6736(10)61462-6, 10.1016/S0140-6736(10)61462-6]; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perez-Sierra A, 2007, MYCOL RES, V111, P832, DOI 10.1016/j.mycres.2007.05.009; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Prieto-Recio C, 2015, FOREST ECOL MANAG, V356, P74, DOI 10.1016/j.foreco.2015.07.033; R Core Team, 2021, R LANGUAGE ENV STAT; Ribalaygua J, 2013, THEOR APPL CLIMATOL, V111; Rosso PH, 2003, PHYTOPATHOLOGY, V93, P790, DOI 10.1094/PHYTO.2003.93.7.790; Sakamoto JM, 2006, PLANT PATHOL, V55, P130, DOI 10.1111/j.1365-3059.2005.01310.x; Sakamoto JM, 2007, CAN ENTOMOL, V139, P864, DOI 10.4039/N07-022; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schueler S, 2014, GLOBAL CHANGE BIOL, V20, P1498, DOI 10.1111/gcb.12476; Serra-Varela MJ, 2015, GLOBAL ECOL BIOGEOGR, V24, P1302, DOI 10.1111/geb.12369; Serra-Varela MJ, DIVERS DIST IN PRESS; Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332; Shabani F, 2014, AGR ECOSYST ENVIRON, V197, P96, DOI 10.1016/j.agee.2014.08.005; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Taylor K.E., 2009, SUMMARY CMIP5 EXPT D; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Vivas M, 2012, FORESTRY, V85, P185, DOI 10.1093/forestry/cpr055; Walther G, 2012, NATURE, V416, P389; Watt MS, 2011, CAN J FOREST RES, V41, P412, DOI 10.1139/X10-204; Wingfield MJ, 2008, AUSTRALAS PLANT PATH, V37, P319, DOI 10.1071/AP08036; Zas R, 2005, ANN FOREST SCI, V62, P681, DOI 10.1051/forest:2005064; Zorita E, 1999, J CLIMATE, V12, P2474, DOI 10.1175/1520-0442(1999)012<2474:TAMAAS>2.0.CO;2	85	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171549	10.1371/journal.pone.0171549	http://dx.doi.org/10.1371/journal.pone.0171549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192454	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800029
J	Yu, X; Zhang, XQ				Yu, Xiang; Zhang, Xueqing			Multiswarm comprehensive learning particle swarm optimization for solving multiobjective optimization problems	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHMS; MULTIPLE OBJECTIVES; MOEA/D; DECOMPOSITION	Comprehensive learning particle swarm optimization (CLPSO) is a powerful state-of-the-art single-objective metaheuristic. Extending from CLPSO, this paper proposes multiswarm CLPSO (MSCLPSO) for multiobjective optimization. MSCLPSO involves multiple swarms, with each swarm associated with a separate original objective. Each particle's personal best position is determined just according to the corresponding single objective. Elitists are stored externally. MSCLPSO differs from existing multiobjective particle swarm optimizers in three aspects. First, each swarm focuses on optimizing the associated objective using CLPSO, without learning from the elitists or any other swarm. Second, mutation is applied to the elitists and the mutation strategy appropriately exploits the personal best positions and elitists. Third, a modified differential evolution (DE) strategy is applied to some extreme and least crowded elitists. The DE strategy updates an elitist based on the differences of the elitists. The personal best positions carry useful information about the Pareto set, and the mutation and DE strategies help MSCLPSO discover the true Pareto front. Experiments conducted on various benchmark problems demonstrate that MSCLPSO can find nondominated solutions distributed reasonably over the true Pareto front in a single run.	[Yu, Xiang] Nanchang Inst Technol, Prov Key Lab Water Informat Cooperat Sensing & In, Nanchang, Jiangxi, Peoples R China; [Zhang, Xueqing] Hong Kong Univ Sci & Technol, Dept Civil & Environm Engn, Hong Kong, Hong Kong, Peoples R China	Nanchang Institute Technology; Hong Kong University of Science & Technology	Yu, X (corresponding author), Nanchang Inst Technol, Prov Key Lab Water Informat Cooperat Sensing & In, Nanchang, Jiangxi, Peoples R China.	xiang.yu@nit.edu.cn	Zhang, Xueqing/ABC-3938-2020	Zhang, Xueqing/0000-0002-9397-1011	Jiangxi Province Department of Education Science and Technology Research Project [GJJ151099]; Public Benefit Special Research Fund of the Ministry of Water Resources of China [201201017]	Jiangxi Province Department of Education Science and Technology Research Project; Public Benefit Special Research Fund of the Ministry of Water Resources of China	This work was supported by the Jiangxi Province Department of Education Science and Technology Research Project (GJJ151099) and the Public Benefit Special Research Fund of the Ministry of Water Resources of China (201201017).	Ali H, 2013, APPL SOFT COMPUT, V13, P3903, DOI 10.1016/j.asoc.2013.04.015; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Bringmann K, INT S ALG COMP 2008, P436; Coello CAC, 2004, IEEE T EVOLUT COMPUT, V8, P256, DOI [10.1109/TEVC.2004.826067, 10.1109/tevc.2004.826067]; COHON JL, 1975, WATER RESOUR RES, V11, P208, DOI 10.1029/WR011i002p00208; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Eberhart R., 1995, INT S MICR HUM SCI; Fleischer M, 2003, INT C EV MULT OPT; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Gulcu S, 2015, ENG APPL ARTIF INTEL, V45, P33, DOI 10.1016/j.engappai.2015.06.013; Harrison KR, 2013, INT C EV MULT OPT; Horn J, 1994, IEEE C EV COMP; Huang VL, 2006, INT J INTELL SYST, V21, P209, DOI 10.1002/int.20128; Huband S, 2006, IEEE T EVOLUT COMPUT, V10, P477, DOI 10.1109/TEVC.2005.861417; Igel C, 2007, EVOL COMPUT, V15, P1, DOI 10.1162/evco.2007.15.1.1; Ke LJ, 2013, IEEE T CYBERNETICS, V43, P1845, DOI 10.1109/TSMCB.2012.2231860; Kennedy J., 1995, P ICNN 95 INT C NEUR; Knowles J, 1999, C EV COMP; Knowles JD, 2000, EVOL COMPUT, V8, P149, DOI 10.1162/106365600568167; Kukkonen S, INT C PAR PROBL SOLV, P553; Laumanns M, 2002, EVOL COMPUT, V10, P263, DOI 10.1162/106365602760234108; Li H, 2009, IEEE T EVOLUT COMPUT, V13, P284, DOI 10.1109/TEVC.2008.925798; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liu Y-M, 2013, INT C INT COMP, P200; Ma XL, 2014, NEUROCOMPUTING, V145, P336, DOI 10.1016/j.neucom.2014.05.025; Ma XY, 2014, AUSTIN J PATHOLOGY L, V1, P1, DOI DOI 10.1093/JXB/ERU447; Martinez SZ, 2011, INT C GEN EV COMP; Mashwani WK, SGAI INT C INN TECH, P217; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Parsopoulos KE, IASTED INT C ART INT; Peng W, 2008, INT C GRAN COMP; Pires EJS, 2005, INT C EV MULT OPT; Qi YT, 2014, EVOL COMPUT, V22, P231, DOI 10.1162/EVCO_a_00109; Schaffer JD, 1985, INT C GEN ALG; Tan YY, 2013, COMPUT OPER RES, V40, P1648, DOI 10.1016/j.cor.2012.01.001; Tan YY, 2012, INFORM SCIENCES, V213, P14, DOI 10.1016/j.ins.2012.06.007; Yang DD, 2010, COMPUT INTELL-US, V26, P359, DOI 10.1111/j.1467-8640.2010.00363.x; Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163; Yu X, 2016, ENERGIES, V9, DOI 10.3390/en9060438; Zhan ZH, 2013, IEEE T CYBERNETICS, V43, P445, DOI 10.1109/TSMCB.2012.2209115; Zhan ZH, 2011, IEEE T EVOLUT COMPUT, V15, P832, DOI 10.1109/TEVC.2010.2052054; Zhang Q., 2009, IEEE C EV COMP; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhou B, 2013, IEEE T POWER SYST, V28, P3534, DOI 10.1109/TPWRS.2013.2259641; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969; Zitzler E, 2001, EVOLUTIONARY METHODS; Zitzler E., 2007, INT C EV MULT OPT; Zitzler E, 2000, EVOL COMPUT, V8, P173, DOI 10.1162/106365600568202	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172033	10.1371/journal.pone.0172033	http://dx.doi.org/10.1371/journal.pone.0172033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192508	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800062
J	Hasegawa, K; Kudoh, S; Ito, T				Hasegawa, Koki; Kudoh, Shinji; Ito, Takaaki			Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CARCINOIDS; FIXATION; ANTIBODY	The confirmation of target expression in tissues is a prerequisite for molecular-targeted therapy. However, difficulties are sometimes associated with the production of appropriate antibodies against receptors. We herein developed a ligand derivative dye for the staining of receptors. The somatostatin receptor (sstr) was selected as the target and FITC-octreotate as the detective agent. We performed a blot analysis to detect sstr in the transfer membrane. The sstr2 recombinant protein or cell lysate from a small cell lung carcinoma cell line (H69) was boiled and loaded onto SDS-PAGE, and the proteins were transferred to a membrane. Even after denaturing processes, FITC-octreotate still bound sstr on the membrane. Furthermore, FITC-octreotate depicted the expression of sstr in formalin-fixed and paraffin-embedded (FFPE) sections, a method that we named ligand derivative staining (LDS). The accuracies of immunostaining and LDS were compared at the points of the detection of sstr using FFPE sections of 30 neuroendocrine tumor specimens. The sensitivity of LDS was 81.8%, while those of immunostaining using anti-sstr2 and sstr5 antibodies were 72.7% and 63.6%, respectively. Thus, LDS appears to be superior to immunostaining. A ligand derivative may be used as a substitute for antibodies, and has the potential to support economical, simple, and accurate detection methods.	[Hasegawa, Koki; Kudoh, Shinji; Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Hasegawa, Koki] Kyoto Pharmaceut Univ, Ctr Instrumental Anal, Kyoto, Japan	Kumamoto University; Kyoto Pharmaceutical University	Hasegawa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan.; Hasegawa, K (corresponding author), Kyoto Pharmaceut Univ, Ctr Instrumental Anal, Kyoto, Japan.	hkoki@mb.kyoto-phu.ac.jp	Hasegawa, Koki/U-2470-2019	Hasegawa, Koki/0000-0002-1479-2534	Japan society for the promotion of science [14474783, 13219990]; Grants-in-Aid for Scientific Research [17K08749] Funding Source: KAKEN	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Koki Hasegawa was funded by the Japan society for the promotion of science, 14474783, https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26460453/; and 13219990, https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-23791465/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Caplin ME, 2015, ANN ONCOL, V26, P1604, DOI 10.1093/annonc/mdv041; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; Fisher WE, 1998, BRIEF EXPRESSION SOM, V90, P5; Fowler CB, 2011, J HISTOCHEM CYTOCHEM, V59, P366, DOI 10.1369/0022155411400866; Handa RK, 2002, PEPTIDES, V23, P1847, DOI 10.1016/S0196-9781(02)00142-0; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Korner M, 2012, AM J SURG PATHOL, V36, P242, DOI 10.1097/PAS.0b013e31823d07f3; Kwekkeboom DJ, 2010, ENDOCRINE RELATED CA, V17; Marx V, 2013, NAT METHODS, V10, P703, DOI 10.1038/nmeth.2570; MASON JT, 1991, J HISTOCHEM CYTOCHEM, V39, P225, DOI 10.1177/39.2.1987266; Mundschenk J, 2016, SOMATOSTATIN RECEPTO, V88, P5150; Reubi JC, 1999, J CLIN ENDOCR METAB, V84, P2942, DOI 10.1210/jc.84.8.2942; REUBI JC, 1990, CANCER RES, V50, P5969; Reubi JC, 2001, EUR J NUCL MED, V28, P836, DOI 10.1007/s002590100541; Rost F W, 1971, Histochem J, V3, P207, DOI 10.1007/BF01002565; Ruggeri R M, 2009, Eur J Histochem, V53, pe1, DOI 10.4081/ejh.2009.e1; Salahpour A, 2000, FUNCTIONAL SIGNIFICA, V11; SALIH H, 1979, ENDOCRINOLOGY, V105, P21, DOI 10.1210/endo-105-1-21; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Taniyama Y, 2005, ENDOCR J, V52, P605, DOI 10.1507/endocrj.52.605; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Watson JC, 2001, BRIT J CANCER, V85, P266, DOI 10.1054/bjoc.2001.1881	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172030	10.1371/journal.pone.0172030	http://dx.doi.org/10.1371/journal.pone.0172030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182792	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800144
J	Hileman, ET; King, RB; Adamski, JM; Anton, TG; Bailey, RL; Baker, SJ; Bieser, ND; Bell, TA; Bissell, KM; Bradke, DR; Campa, H; Casper, GS; Cedar, K; Cross, MD; DeGregorio, BA; Dreslik, MJ; Faust, LJ; Harvey, DS; Hay, RW; Jellen, BC; Johnson, BD; Johnson, G; Kiel, BD; Kingsbury, BA; Kowalski, MJ; Lee, YM; Lentini, AM; Marshall, JC; Mauger, D; Moore, JA; Paloski, RA; Phillips, CA; Pratt, PD; Preney, T; Prior, KA; Promaine, A; Redmer, M; Reinert, HK; Rouse, JD; Shoemaker, KT; Sutton, S; VanDeWalle, TJ; Weatherhead, PJ; Wynn, D; Yagi, A				Hileman, Eric T.; King, Richard B.; Adamski, John M.; Anton, Thomas G.; Bailey, Robyn L.; Baker, Sarah J.; Bieser, Nickolas D.; Bell, Thomas A., Jr.; Bissell, Kristin M.; Bradke, Danielle R.; Campa, Henry, III; Casper, Gary S.; Cedar, Karen; Cross, Matthew D.; DeGregorio, Brett A.; Dreslik, Michael J.; Faust, Lisa J.; Harvey, Daniel S.; Hay, Robert W.; Jellen, Benjamin C.; Johnson, Brent D.; Johnson, Glenn; Kiel, Brooke D.; Kingsbury, Bruce A.; Kowalski, Matthew J.; Lee, Yu Man; Lentini, Andrew M.; Marshall, John C.; Mauger, David; Moore, Jennifer A.; Paloski, Rori A.; Phillips, Christopher A.; Pratt, Paul D.; Preney, Thomas; Prior, Kent A.; Promaine, Andrew; Redmer, Michael; Reinert, Howard K.; Rouse, Jeremy D.; Shoemaker, Kevin T.; Sutton, Scott; VanDeWalle, Terry J.; Weatherhead, Patrick J.; Wynn, Doug; Yagi, Anne			Climatic and geographic predictors of life history variation in Eastern Massasauga (Sistrurus catenatus): A range-wide synthesis	PLOS ONE			English	Article							BODY-SIZE VARIATION; HABITAT SELECTION; REPRODUCTIVE STRATEGIES; NORTHERN POPULATION; THERMAL ECOLOGY; SPATIAL ECOLOGY; BERGMANNS RULE; RATTLESNAKE; SNAKES; GROWTH	Elucidating how life history traits vary geographically is important to understanding variation in population dynamics. Because many aspects of ectotherm life history are climate-dependent, geographic variation in climate is expected to have a large impact on population dynamics through effects on annual survival, body size, growth rate, age at first reproduction, size-fecundity relationship, and reproductive frequency. The Eastern Massasauga (Sistrurus catenatus) is a small, imperiled North American rattlesnake with a distribution centered on the Great Lakes region, where lake effects strongly influence local conditions. To address Eastern Massasauga life history data gaps, we compiled data from 47 study sites representing 38 counties across the range. We used multimodel inference and general linear models with geographic coordinates and annual climate normals as explanatory variables to clarify patterns of variation in life history traits. We found strong evidence for geographic variation in six of nine life history variables. Adult female snout-vent length and neonate mass increased with increasing mean annual precipitation. Litter size decreased with increasing mean temperature, and the size-fecundity relationship and growth prior to first hibernation both increased with increasing latitude. The proportion of gravid females also increased with increasing latitude, but this relationship may be the result of geographically varying detection bias. Our results provide insights into ectotherm life history variation and fill critical data gaps, which will inform Eastern Massasauga conservation efforts by improving biological realism for models of population viability and climate change.	[Hileman, Eric T.; King, Richard B.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Adamski, John M.] Seneca Pk Zoo, Rochester, NY USA; [Anton, Thomas G.] Field Museum, Dept Zool, Chicago, IL USA; [Bailey, Robyn L.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Baker, Sarah J.; Dreslik, Michael J.; Phillips, Christopher A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL USA; [Bieser, Nickolas D.; Kingsbury, Bruce A.; Marshall, John C.] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA; [Bell, Thomas A., Jr.] New York State Dept Environm Conservat, Albany, NY USA; [Bissell, Kristin M.] Michigan Dept Nat Resources, Wildlife Div, Grass Lake, MI USA; [Bradke, Danielle R.; Kiel, Brooke D.; Moore, Jennifer A.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Campa, Henry, III] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Casper, Gary S.] Univ Wisconsin, Field Stn, Saukville, WI USA; [Cedar, Karen] Ojibway Nat Ctr, Windsor, ON, Canada; [Cross, Matthew D.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [DeGregorio, Brett A.; Harvey, Daniel S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Faust, Lisa J.] Lincoln Pk Zoo, Alexander Ctr Appl Populat Biol, Chicago, IL USA; [Hay, Robert W.] Turtles Tomorrow, Madison, WI USA; [Jellen, Benjamin C.] Urban Chestnut Brewing Co, St Louis, MO USA; [Johnson, Brent D.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Johnson, Glenn] SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA; [Kowalski, Matthew J.] Chesapeake Bay Fdn, Richmond, VA USA; [Lee, Yu Man] Michigan State Univ Extens, Michigan Nat Features Inventory, Lansing, MI USA; [Lentini, Andrew M.] Toronto Zoo, Scarborough, ON, Canada; [Mauger, David] Forest Preserve Dist Lake Cty, Libertyville, IL USA; [Paloski, Rori A.] Wisconsin Dept Nat Resources, Bur Nat Heritage Conservat, Madison, WI USA; [Pratt, Paul D.; Preney, Thomas] Ojibway Nat Ctr, Windsor, ON, Canada; [Prior, Kent A.] Pk Canada, Gatineau, PQ, Canada; [Promaine, Andrew; Sutton, Scott] Pk Canada, Midland, ON, Canada; [Redmer, Michael] US Fish & Wildlife Serv, Chicago, IL USA; [Reinert, Howard K.] Coll New Jersey, Dept Biol, Ewing, NJ USA; [Rouse, Jeremy D.] Ontario Minist Nat Resources, Parry Sound, ON, Canada; [Shoemaker, Kevin T.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [VanDeWalle, Terry J.] Stantec Consulting Serv Inc, Independence, IA USA; [Weatherhead, Patrick J.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Wynn, Doug] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Yagi, Anne] Minist Nat Resources, Vineland Stn, ON, Canada	Northern Illinois University; Field Museum of Natural History (Chicago); Cornell University; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Indiana University Purdue University Fort Wayne; Grand Valley State University; Michigan State University; University of Wisconsin System; University System of Ohio; Bowling Green State University; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; Michigan State University; United States Department of the Interior; US Fish & Wildlife Service; College of New Jersey; Ministry of Natural Resources & Forestry; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University; Natural Resources Canada	Hileman, ET (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	hileman.et@gmail.com	Dreslik, Michael J/G-5325-2012	Kingsbury, Bruce/0000-0003-3375-0193; Hileman, Eric/0000-0002-7044-370X; Bradke, Danielle/0000-0002-3037-1377	U.S. Fish and Wildlife Service; Edward Lowe Foundation; Northern Illinois University; Columbus Zoo; EMR SSP; Fort Wayne Children's Zoo; Potawatomi Zoo	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Edward Lowe Foundation; Northern Illinois University; Columbus Zoo; EMR SSP; Fort Wayne Children's Zoo; Potawatomi Zoo	This work was supported by U.S. Fish and Wildlife Service, Edward Lowe Foundation, Northern Illinois University, Columbus Zoo, EMR SSP, Fort Wayne Children's Zoo, and Potawatomi Zoo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adams DC, 2008, EVOLUTION, V62, P413, DOI 10.1111/j.1558-5646.2007.00297.x; Adler K. K., 1960, Herpetologica, V16, P38; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aldridge R.D., 2008, BIOL RATTLESNAKES, P403; ALDRIDGE RD, 1979, HERPETOLOGICA, V35, P256; Allender MC, 2006, J WILDLIFE DIS, V42, P107, DOI 10.7589/0090-3558-42.1.107; Anderson D. R., 2008, MODEL BASED INFERENC; Angilletta MJ, 2006, AM NAT, V168, pE123, DOI 10.1086/507880; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2016, AICCMODAVG MODEL SEL; Anton TG, 1999, 2 INT S WORKSH CONS, P94; Anton Thomas G., 2000, Herpetological Review, V31, P248; Anton Thomas G., 1993, P71; Arguez A, 2012, B AM METEOROL SOC, V93, P1687, DOI 10.1175/BAMS-D-11-00197.1; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Ashton KG, 2001, EVOLUTION, V55, P2523; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; BAILEY RA, 2010, THESIS; Bailey RL, 2011, HERPETOLOGICA, V67, P167, DOI 10.1655/HERPETOLOGICA-D-10-00005.1; Baron JP, 2013, FUNCT ECOL, V27, P173, DOI 10.1111/1365-2435.12023; BEAUPRE SJ, 1995, HERPETOLOGICA, V51, P45; Beissinger S. R., 2002, POPULATION VIABILITY; Bielema BJ., 1973, THESIS; Bieser N.D., 2008, THESIS PURDUE U; Bissell K. M., 2006, THESIS; BLACKBURN D G, 1985, Amphibia-Reptilia, V6, P259, DOI 10.1163/156853885X00290; BLEM C R, 1981, Brimleyana, P117; BLEM CR, 1982, COPEIA, P961, DOI 10.2307/1444108; Bonnet X, 1996, CAN J ZOOL, V74, P233, DOI 10.1139/z96-029; Brennan JM, 2004, E MASSASUGA RATTLESN; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Brown GP, 2007, OECOLOGIA, V154, P361, DOI 10.1007/s00442-007-0842-8; Brown RP, 1999, ECOGRAPHY, V22, P277, DOI 10.1111/j.1600-0587.1999.tb00503.x; BROWN WS, 1991, HERPETOLOGICA, V47, P101; BURKETT RAY D., 1966, UNIV KANS PUBLICATIONS MUS NATUR HIST, V17, P435; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calder WA., 1984, SIZE FUNCTION LIFE H; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Conant R., 1951, THE REPTILES OF OHIO; CONANT ROGER, 1938, AMER MIDL NAT, V20, P1, DOI 10.2307/2485190; COSEWIC, COSEWIC ASS STAT REP; Cross M., 2009, THESIS; Cross MD, 2015, AM MIDL NAT, V173, P346, DOI 10.1674/amid-173-02-346-362.1; De Block M, 2003, J EVOLUTION BIOL, V16, P986, DOI 10.1046/j.1420-9101.2003.00581.x; DeGregorio B.A., 2008, THESIS; DeGregorio BA, 2011, HERPETOL CONSERV BIO, V6, P372; Degregorio BA, 2011, HERPETOLOGICA, V67, P71, DOI 10.1655/09-049R1.1; DILLER LV, 1984, HERPETOLOGICA, V40, P182; Dreslik M. J., 2005, THESIS; Dreslik MJ, 2011, 14 ILL NAT HIS SURV; Du WG, 2010, BIOL J LINN SOC, V101, P59, DOI 10.1111/j.1095-8312.2010.01492.x; Durbian FE, 2008, J WILDLIFE MANAGE, V72, P754, DOI 10.2193/2007-710; EICHENLAUB VL, 1979, WEATHER CLIMATE GREA; Faust L., 2011, RANGE WIDE EXTINCTIO; Fischer K, 2002, EVOL ECOL, V16, P333, DOI 10.1023/A:1020271600025; FITCH H S, 1985, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Food and Drug Administration, 2016, FED REG; Foster MA, 2009, HERPETOL CONSERV BIO, V4, P48; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GREGORY PT, 1993, COPEIA, P946; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Gvozdik V, 2008, BIOL J LINN SOC, V95, P539; Harvey DS, 2011, CAN J ZOOL, V89, P60, DOI 10.1139/Z10-094; Harvey DS, 2010, ECOSCIENCE, V17, P411, DOI 10.2980/17-4-3363; Harvey DS, 2006, BIOL CONSERV, V130, P206, DOI 10.1016/j.biocon.2005.12.015; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Harvey DS., 2006, THESIS; Haufler JB, 2002, WILDL SOC TECH REV, V02, P33; Hay OP., 1887, AM NAT, V21, P211; Hecht SE, 2007, THESIS; Hileman ET, 2015, HERPETOL CONSERV BIO, V10, P654; Holycross AT, 2002, J HERPETOL, V36, P454, DOI 10.2307/1566190; Jaeger CP, 2016, ECOL EVOL, V6, P3991, DOI 10.1002/ece3.2159; Jaffe AL, 2016, BIOL J LINN SOC, V117, P760, DOI 10.1111/bij.12711; Jellen BC, 2005, THESIS; Johnson BD, 2016, J HERPETOL, V50, P534, DOI 10.1670/121; Johnson G, 1995, THESIS; Jones PC, 2016, J HERPETOLO IN PRESS; Jones PC, 2012, J WILDLIFE MANAGE, V76, P1576, DOI 10.1002/jwmg.418; KEENLYNE K D, 1973, Journal of Herpetology, V7, P381, DOI 10.2307/1562875; KEENLYNE K D, 1973, Journal of Herpetology, V7, P382, DOI 10.2307/1562876; Keenlyne KD, 1968, THESIS; Keenlyne KD, 1978, MIDLAND NATURALIST, V100, P368; King R, 2004, HERPETOLOGICA, V60, P429, DOI 10.1655/03-01; King RB, 2006, CAN J ZOOL, V84, P108, DOI 10.1139/Z05-182; King RB, 2000, J HERPETOL, V34, P148, DOI 10.2307/1565253; King Richard B., 2008, South American Journal of Herpetology, V3, P155, DOI 10.2994/1808-9798(2008)3[155:RCOACP]2.0.CO;2; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Kutner M., 2004, APPL LINEAR STAT MOD; Lourdais O, 2004, OIKOS, V104, P551, DOI 10.1111/j.0030-1299.2004.12961.x; Madsen T, 2006, AUSTRAL ECOL, V31, P30, DOI 10.1111/j.1442-9993.2006.01540.x; MADSEN T, 1993, EVOLUTION, V47, P321, DOI 10.1111/j.1558-5646.1993.tb01222.x; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Marshall JC, 2006, HERPETOLOGICA, V62, P141, DOI 10.1655/04-12.1; Martin William Henry, 2002, P285; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Middleton J, 2004, GEORGIAN BAY ISLANDS; Miller P, 2006, 3 INT E MASS S POP V; Moore J. M., 2004, THESIS; Moore JA, 2006, COPEIA, P742, DOI 10.1643/0045-8511(2006)6[742:SEAMHS]2.0.CO;2; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Parent C, 2000, OECOLOGIA, V125, P170, DOI 10.1007/s004420000442; PARENT C. E., 1997, THESIS; Parker S, 1999, 2 INT S WORKSH CONS, P63; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pomara LY, 2014, GLOBAL CHANGE BIOL, V20, P2087, DOI 10.1111/gcb.12510; R Core Team, 2016, R LANG ENV STAT COMP; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; REINERT HK, 1981, AM MIDL NAT, V105, P393, DOI 10.2307/2424761; Reinert HK, 1978, THESIS; Roff Derek A., 1992; Roitberg ES, 2013, EVOL BIOL, V40, P420, DOI 10.1007/s11692-013-9247-2; Rouse JD, 2006, THESIS; Ryberg WA, 2015, J FISH WILDL MANAG, V6, P350, DOI 10.3996/122014-JFWM-093; Sage JR, 2005, THESIS; Scharf I, 2015, GLOBAL ECOL BIOGEOGR, V24, P396, DOI 10.1111/geb.12244; SEIGEL R A, 1987, P210; SEIGEL RA, 1985, J ANIM ECOL, V54, P497, DOI 10.2307/4494; Shepard DB, 2004, AM MIDL NAT, V152, P360, DOI 10.1674/0003-0031(2004)152[0360:PPADON]2.0.CO;2; SHINE R, 1981, COPEIA, P14, DOI 10.2307/1444037; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 2003, P ROY SOC B-BIOL SCI, V270, P995, DOI 10.1098/rspb.2002.2307; Shine R., 1985, Biology of Reptilia, V15, P605; Shoemaker KT, 2010, J WILDLIFE MANAGE, V74, P504, DOI 10.2193/2008-519; Smith C.A., 2009, THESIS; STAMPS JA, 1992, OECOLOGIA, V92, P503, DOI 10.1007/BF00317842; Stearns S.C., 1992, pi; Swanson P. L., 1933, Copeia Ann Arbor, V1933, P37, DOI 10.2307/1436191; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tobiasz EC, 1941, COPEIA, V1941, P269; Tuttle KN, 2014, COPEIA, P130, DOI 10.1643/CH-13-119; Tuttle KN, 2012, CAN J ZOOL, V90, P758, DOI 10.1139/Z2012-044; Volynchik Stanislav, 2014, International Journal of Zoology, P795387; Watkins-Colwell Gregory J., 1995, Herpetological Review, V26, P40; Weatherhead PJ, 2009, J HERPETOL, V43, P693, DOI 10.1670/08-244.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wittenberg RD, 2014, HERPETOLOGICA, V70, P171, DOI 10.1655/HERPETOLOGICA-D-12-00074R2; WORTHINGTON RD, 1982, J HERPETOL, V16, P332, DOI 10.2307/1563733; WRIGHT BERTRAND ALBERT, 1941, AMER MIDLAND NAT, V25, P659, DOI 10.2307/2420721; Zuffi MAL, 2009, BIOL J LINN SOC, V96, P383, DOI 10.1111/j.1095-8312.2008.01124.x	150	11	11	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172011	10.1371/journal.pone.0172011	http://dx.doi.org/10.1371/journal.pone.0172011			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196149	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900043
J	Kabaghe, AN; Chipeta, MG; McCann, RS; Phiri, KS; van Vugt, M; Takken, W; Diggle, P; Terlouw, AD				Kabaghe, Alinune N.; Chipeta, Michael G.; McCann, Robert S.; Phiri, Kamija S.; van Vugt, Michele; Takken, Willem; Diggle, Peter; Terlouw, Anja D.			Adaptive geostatistical sampling enables efficient identification of malaria hotspots in repeated cross-sectional surveys in rural Malawi	PLOS ONE			English	Article							PREVALENCE SURVEYS; MORTALITY; QUALITY; AFRICA; MODELS	Introduction In the context of malaria elimination, interventions will need to target high burden areas to further reduce transmission. Current tools to monitor and report disease burden lack the capacity to continuously detect fine-scale spatial and temporal variations of disease distribution exhibited by malaria. These tools use random sampling techniques that are inefficient for capturing underlying heterogeneity while health facility data in resource-limited settings are inaccurate. Continuous community surveys of malaria burden provide real-time results of local spatio-temporal variation. Adaptive geostatistical design (AGD) improves prediction of outcome of interest compared to current random sampling techniques. We present findings of continuous malaria prevalence surveys using an adaptive sampling design. Methods We conducted repeated cross sectional surveys guided by an adaptive sampling design to monitor the prevalence of malaria parasitaemia and anaemia in children below five years old in the communities living around Majete Wildlife Reserve in Chikwawa district, Southern Malawi. AGD sampling uses previously collected data to sample new locations of high prediction variance or, where prediction exceeds a set threshold. We fitted a geostatistical model to predict malaria prevalence in the area. Findings We conducted five rounds of sampling, and tested 876 children aged 6-59 months from 1377 households over a 12-month period. Malaria prevalence prediction maps showed spatial heterogeneity and presence of hotspots where predicted malaria prevalence was above 30%; predictors of malaria included age, socio-economic status and ownership of insecticide-treated mosquito nets. Conclusions Continuous malaria prevalence surveys using adaptive sampling increased malaria prevalence prediction accuracy. Results from the surveys were readily available after data collection. The tool can assist local managers to target malaria control interventions in areas with the greatest health impact and is ready for assessment in other diseases.	[Kabaghe, Alinune N.; van Vugt, Michele] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Infect Dis,Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Kabaghe, Alinune N.; Chipeta, Michael G.; McCann, Robert S.; Phiri, Kamija S.] Univ Malawi, Dept Publ Hlth, Coll Med, Blantyre, Malawi; [Chipeta, Michael G.; Diggle, Peter] Univ Lancaster, Lancaster Med Sch, Lancaster, England; [Chipeta, Michael G.; Terlouw, Anja D.] Malawi Liverpool Wellcome Trust, Malaria Theme, Blantyre, Malawi; [Takken, Willem] Wageningen Univ & Res, Entomol Lab, Wageningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Malawi; Lancaster University; University of Malawi; Wageningen University & Research	Kabaghe, AN (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Infect Dis,Ctr Trop Med & Travel Med, Amsterdam, Netherlands.; Kabaghe, AN (corresponding author), Univ Malawi, Dept Publ Hlth, Coll Med, Blantyre, Malawi.	akabaghe@medcol.mw		Chipeta, Michael Give/0000-0001-5882-9936; McCann, Robert/0000-0002-2195-6461; Terlouw, Anja/0000-0001-5327-8995; Kabaghe, Alinune/0000-0001-8517-1586; Phiri, Kamija/0000-0003-1753-2727	Dioraphte Foundation; Economic and Social Research Council [1367450] Funding Source: researchfish	Dioraphte Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Majete Malaria Project is funded by Dioraphte Foundation (www.dioraphte.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054305; Alemu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079966; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2014, MAL MAL IND SURV MIS; Baidjoe AY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1362-y; Beron K. J., 2004, ADV SPATIAL ECONOMET; Berrett C, 2012, COMPUT STAT DATA AN, V56, P478, DOI 10.1016/j.csda.2011.08.020; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; BURTON DC, 2011, J HLTH POPUL NUTR, V29, P9136; Chilundo B, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-3; Chipeta M, 2016, INHIBITORY GEOSTATIS; Chipeta MG, 2016, SPAT STAT-NETH, V15, P70, DOI 10.1016/j.spasta.2015.12.004; CRAN, 2016, R STAT ENV; Giorgi E, 2015, J R STAT SOC A STAT, V178, P445, DOI 10.1111/rssa.12069; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Grimes JET, 2015, LANCET INFECT DIS, V15, P869, DOI 10.1016/S1473-3099(15)00067-5; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kondo MC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-338; Matern B., 1986, SPATIAL VARIATION; Mzilahowa T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-380; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003; Reid H, 2010, AM J TROP MED HYG, V83, P861, DOI 10.4269/ajtmh.2010.10-0154; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Roll Back Malaria Partnership, MAL IND SURV TOOLK 2; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe AK, 2009, AM J TROP MED HYG, V80, P971, DOI 10.4269/ajtmh.2009.80.971; RUE H., 2005, GAUSSIAN MARKOV RAND; Schur N., 2011, PLOS NEGL TROP DIS, V5, DOI 10.13715(6); Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Stanton MC, 2014, J R STAT SOC A STAT, V177, P661, DOI 10.1111/rssa.12033; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; WHO, 2015, GLOB TECHN STAT MAL; WHO, 2015, WORLD MAL REP 2015	37	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172266	10.1371/journal.pone.0172266	http://dx.doi.org/10.1371/journal.pone.0172266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196105	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000394423900065
J	Yang, Y; Gu, CG; Xiao, Q; Yang, HJ				Yang, Yue; Gu, Changgui; Xiao, Qin; Yang, Huijie			Evolution of scaling behaviors embedded in sentence series from A Story of the Stone	PLOS ONE			English	Article							DIFFUSION ENTROPY ANALYSIS; LONG-RANGE CORRELATIONS; TIME-SERIES; COMPLEX NETWORK; MULTIFRACTAL FORMALISM; CROSS-CORRELATIONS; MOVING AVERAGE; SIGNALS; LANGUAGE; DISTRIBUTIONS	The novel entitled A Story of the Stone provides us precise details of life and social structure of the 18th century China. Its writing lasted a long duration of about 10 years, in which the author's habit may change significantly. It had been published anonymously up to the beginning of the 20th century, which left a mystery of the author's attribution. In the present work we focus our attention on scaling behavior embedded in the sentence series from this novel, hope to find how the ideas are organized from single sentences to the whole text. Especially we are interested in the evolution of scale invariance to monitor the changes of the author's language habit and to find some clues on the author's attribution. The sentence series are separated into a total of 69 non-overlapping segments with a length of 500 sentences each. The correlation dependent balanced estimation of diffusion entropy (cBEDE) is employed to evaluate the scaling behaviors embedded in the short segments. It is found that the total, the part attributed currently to Xueqin Cao (X-part), and the other part attributed to E Gao (E-part), display scale invariance in a large scale up to 10(3) sentences, while their scaling exponents are almost identical. All the segments behave scale invariant in considerable wide scales, most of which reach one third of the length. In the curve of scaling exponent versus segment number, the X-part has rich patterns with averagely larger values, while the E-part has a U-shape with a significant low bottom. This finding is a new clue to support the attribution of the E-part to E Gao.	[Yang, Yue; Gu, Changgui; Yang, Huijie] Univ Shanghai Sci & Technol, Sch Business, Shanghai 200093, Peoples R China; [Xiao, Qin] Shanghai Inst Technol, Coll Sci, Shanghai 201418, Peoples R China	University of Shanghai for Science & Technology; Shanghai Institute of Technology	Gu, CG; Yang, HJ (corresponding author), Univ Shanghai Sci & Technol, Sch Business, Shanghai 200093, Peoples R China.	changguigu@usst.edu.cn; hjyang@ustc.edu.cn			National Natural Science Foundation of China [10975099, 11505114]; Shanghai Municipal Education Commission [13YZ072, D-USST02, QD2015016]; Shanghai Natural Science Foundation [16ZR1447200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work is supported by the National Natural Science Foundation of China under the Grant No. 10975099 to Professor Huijie Yang; The National Natural Science Foundation of China 11505114 to Prof. Changgui Gu; the Shanghai Municipal Education Commission 13YZ072 to Professor Huijie Yang; the Shanghai Municipal Education Commission D-USST02 to Professor Huijie Yang; the Shanghai Municipal Education Commission QD2015016 to Prof. Changgui Gu; and the Shanghai Natural Science Foundation 16ZR1447200 to QinXiao.	Acquisti C, 2004, CHAOS SOLITON FRACT, V20, P127, DOI 10.1016/S0960-0779(03)00435-1; Alessio E, 2002, EUR PHYS J B, V27, P197, DOI 10.1140/epjb/e20020150; Altmann EG, 2012, P NATL ACAD SCI USA, V109, P11582, DOI 10.1073/pnas.1117723109; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Ausloos M, 2012, CHAOS SOLITON FRACT, V45, P1349, DOI 10.1016/j.chaos.2012.06.016; Ausloos M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031108; Bonachela JA, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/20/202001; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Cai SM, 2007, PHYSICA A, V375, P687, DOI 10.1016/j.physa.2006.10.027; Cai SM, 2006, PHYSICA A, V367, P337, DOI 10.1016/j.physa.2005.12.004; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Chen G, 2015, PHYSICA A, V424, P73, DOI 10.1016/j.physa.2015.01.001; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Drozdz S, 2016, INFORM SCIENCES, V331, P32, DOI 10.1016/j.ins.2015.10.023; Forster P, 2003, P NATL ACAD SCI USA, V100, P9079, DOI 10.1073/pnas.1331158100; Gao YC, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113500058; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Grigolini P, 2001, FRACTALS, V9, P439, DOI 10.1142/S0218348X01000865; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Jackendoff R, 1999, TRENDS COGN SCI, V3, P272, DOI 10.1016/S1364-6613(99)01333-9; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kulig A, 2017, INFORM SCIENCES, V375, P98, DOI 10.1016/j.ins.2016.09.051; Kulig A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032810; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; MALLAT S, 1992, IEEE T INFORM THEORY, V38, P617, DOI 10.1109/18.119727; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Montemurro MA, 2002, FRACTALS, V10, P451, DOI 10.1142/S0218348X02001257; Mutua S, 2016, CHAOS, V26, DOI 10.1063/1.4951681; MUZY JF, 1993, PHYS REV E, V47, P875, DOI 10.1103/PhysRevE.47.875; MUZY JF, 1991, PHYS REV LETT, V67, P3515, DOI 10.1103/PhysRevLett.67.3515; Pan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116128; Pan X, 2014, PHYS LETT A, V378, P2591, DOI 10.1016/j.physleta.2014.07.012; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Perello J, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/11/P11011; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Qi JC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066114; Qiu L, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.062201; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Scafetta N, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026303; Scafetta N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.138501; Scafetta N, 2005, COMPLEXITY, V10, P51, DOI 10.1002/cplx.20076; Scafetta N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.248701; Scafetta N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036130; Scafetta N, 2001, FRACTALS, V9, P193, DOI 10.1142/S0218348X0100052X; Scafetta N, 2010, DIFFUSION ENTROPY AN; Scafetta N, 2007, COMPLEXITY, V12, P12, DOI 10.1002/cplx.20183; Scafetta N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.219801; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Stephen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143015; Tsai CY, 2008, PHYSICA A, V387, P5561, DOI 10.1016/j.physa.2008.05.023; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Xiao Q, 2015, PHYSICA A, V421, P161, DOI 10.1016/j.physa.2014.11.032; Xiao Q, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/7/078904; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Xu WJ, 2015, ADV COMPLEX SYST, V18, DOI 10.1142/S0219525915500034; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Yang HJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066104; Yang HJ, 2005, PHYSICA A, V347, P704, DOI 10.1016/j.physa.2004.08.017; Yang TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162423; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang W, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061134; Zhao FC, 2007, J THEOR BIOL, V247, P645, DOI 10.1016/j.jtbi.2007.03.035; Zhao ZD, 2016, PHYSICA A, V461, P117, DOI 10.1016/j.physa.2016.05.033; Zhao ZD, 2015, CHAOS, V25, DOI 10.1063/1.4922302; Zhou RC, 2009, NOBLE HUMBLE CAO XUE; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	82	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171776	10.1371/journal.pone.0171776	http://dx.doi.org/10.1371/journal.pone.0171776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196096	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900033
J	Carment, L; Maier, MA; Sangla, S; Guiraud, V; Mesure, S; Vidailhet, M; Lindberg, PG; Bleton, JP				Carment, Loic; Maier, Marc A.; Sangla, Sophie; Guiraud, Vincent; Mesure, Serge; Vidailhet, Marie; Lindberg, Pavel G.; Bleton, Jean-Pierre			Does dystonic muscle activity affect sense of effort in cervical dystonia?	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; WRITERS CRAMP; VIBRATION; MOVEMENT; FORCE; TORTICOLLIS; THERAPY	Background Focal dystonia has been associated with deficient processing of sense of effort cues. However, corresponding studies are lacking in cervical dystonia (CD). We hypothesized that dystonic muscle activity would perturb neck force control based on sense of effort cues. Methods Neck extension force control was investigated in 18 CD patients with different clinical features (7 with and 11 without retrocollis) and in 19 control subjects. Subjects performed force matching and force-maintaining tasks at 5% and 20% of maximum voluntary contraction (MVC). Three task conditions were tested: i) with visual force feedback, ii) withoutvisual feedback (requiring use of sense of effort), iii) without visual feedback, but with neck extensor muscle vibration (modifying muscle afferent cues). Trapezius muscle activity was recorded using electromyography (EMG). Results CD patients did not differ in task performance from healthy subjects when using visual feedback (ANOVA, p>0.7). In contrast, when relying on sense of effort cues (without visual feedback, 5% MVC), force control was impaired in patients without retrocollis (p = 0.006), but not in patients with retrocollis (p>0.2). Compared to controls, muscle vibration without visual feedback significantly affected performance in patients with retrocollis (p<0.001), but not in patients without retrocollis. Extensor EMG during rest, included as covariate in ANOVA, explained these group differences. Conclusion This study shows that muscle afferent feedback biases sense of effort cues when controlling neck forces in patients with CD. The bias acts on peripheral or central sense of effort cues depending on whether the task involves dystonic muscles. This may explain why patients with retrocollis more accurately matched isometric neck extension forces. This highlights the need to consider clinical features (pattern of dystonic muscles) when evaluating sensorimotor integration in CD.	[Carment, Loic; Maier, Marc A.; Lindberg, Pavel G.] Univ Paris 05, FR3636, Sorbonne Paris Cite, CNRS, Paris, France; [Maier, Marc A.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Sangla, Sophie; Bleton, Jean-Pierre] Fondat OPH Rothschild, Serv Neurol, Paris, France; [Guiraud, Vincent] Univ Paris 05, Sorbonne Paris Cite, INSERM U894, Paris, France; [Guiraud, Vincent] Hop St Anne, Serv Neurol, Paris, France; [Guiraud, Vincent] Hop St Anne, Unite Neurovasc, Paris, France; [Mesure, Serge] Aix Marseille Univ, CNRS, UMR 7287, Inst Sci Mouvement, Marseille, France; [Vidailhet, Marie] UPMC Univ Paris 06, UMR S 1127, Sorbonne Univ, Paris, France; [Vidailhet, Marie] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Lindberg, Pavel G.] Inserm U894, Ctr Psychiat & Neurosci, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Carment, L (corresponding author), Univ Paris 05, FR3636, Sorbonne Paris Cite, CNRS, Paris, France.	loic.carment@inserm.fr	Lindberg, Pavel/P-9792-2019; MESURE, Serge/CAF-8351-2022; Maier, Marc/HGU-9498-2022; Lindberg, Pavel G/E-5926-2017	Lindberg, Pavel/0000-0001-6976-6387; Lindberg, Pavel G/0000-0001-6976-6387; Lindberg, Pavel/0000-0002-7507-7817; BLETON, Jean-Pierre/0000-0002-2313-2263	Rothschild Foundation Hospital; Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie	Rothschild Foundation Hospital; Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie	This work was supported by the Rothschild Foundation Hospital and the Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Avanzino L, 2015, NEUROPSYCHOLOGIA, V79, P288, DOI 10.1016/j.neuropsychologia.2015.07.008; Avanzino L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01000; Beck S, 2009, J APPL PHYSIOL, V107, P1513, DOI 10.1152/japplphysiol.91580.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleton JP, 2014, MOVEMENT DISORD, V29, P130, DOI 10.1002/mds.25690; Boccagni C, 2008, NEUROL SCI, V29, P375, DOI 10.1007/s10072-008-1033-z; Boyce MJ, 2012, PARKINSONISM RELAT D, V18, P635, DOI 10.1016/j.parkreldis.2012.02.007; Buccolieri A, 2004, MOVEMENT DISORD, V19, P681, DOI 10.1002/mds.10711; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; KAJI R, 1995, ANN NEUROL, V38, P155, DOI 10.1002/ana.410380206; Lekhel H, 1997, BRAIN, V120, P583, DOI 10.1093/brain/120.4.583; Obermann M, 2010, MOVEMENT DISORD, V25, P2627, DOI 10.1002/mds.23321; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Ronsse R, 2009, J NEUROSCI, V29, P8419, DOI 10.1523/JNEUROSCI.5734-08.2009; Rosenkranz K, 2009, J NEUROSCI, V29, P14627, DOI 10.1523/JNEUROSCI.2094-09.2009; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Sadnicka A, 2014, CEREBELLUM, V13, P558, DOI 10.1007/s12311-014-0569-0; Shaikh AG, 2016, BRAIN, V139, P2590, DOI 10.1093/brain/aww141; van den Dool J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-85; Vo A, 2015, CEREB CORTEX, V25, P3086, DOI 10.1093/cercor/bhu104; Zittel S, 2015, J NEUROL, P1	25	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172019	10.1371/journal.pone.0172019	http://dx.doi.org/10.1371/journal.pone.0172019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192488	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423800060
J	Tsai, HH; Yen, RF; Lin, CL; Kao, CH				Tsai, Hsin-Hsi; Yen, Ruoh-Fang; Lin, Cheng-Li; Kao, Chia-Hung			Increased risk of dementia in patients hospitalized with acute kidney injury: A nationwide population-based cohort study	PLOS ONE			English	Article							DISEASE; PREVALENCE; EPIDEMIOLOGY; MORTALITY; OUTCOMES	Purpose To determine whether acute kidney injury (AKI) is a risk factor for dementia. Methods This nationwide population-based cohort study was based on data from the Taiwan National Health Insurance Research Database for 2000-2011. The incidence and relative risk of dementia were assessed in 207788 patients hospitalized for AKI. The comparison control was selected using the propensity score based on age, sex, index year and comorbidities. Results During the 12-year follow-up, patients with AKI had a significantly higher incidence for developing dementia than did the controls (8.84 vs 5.75 per 1000 person -y). A 1.88-fold increased risk of dementia (95% confidence interval, 1.76-2.01) was observed after adjustment for age, sex, and several comorbidities (diabetes, hypertension, hyperlipidemia, head injury, depression, stroke, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, atrial fibrillation, cancer, liver disease, chronic infection/inflammation, autoimmune disease, malnutrition). Conclusions We found that patients with AKI exhibited a significantly increased risk of developing dementia. This study provides evidence on the association between AKI and long-term adverse outcomes. Additional clinical studies investigating the related pathways are warranted.	[Tsai, Hsin-Hsi] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Yen, Ruoh-Fang] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Yen, Ruoh-Fang] Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Tsai, Cynthia/AAT-2420-2021	YEN, RUOH-FANG/0000-0003-1648-6482	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Chawla LS, 2011, CONTRIB NEPHROL, V174, P182, DOI 10.1159/000329396; Cheng KC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-129; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Doyle JF, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1353-y; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Gaudry S, 2014, J CRIT CARE, V29, P1022, DOI 10.1016/j.jcrc.2014.07.014; Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jacqmin-Gadda H, 2013, EUR J EPIDEMIOL, V28, P493, DOI 10.1007/s10654-013-9818-7; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/306189; Ologunde R, 2014, INT UROL NEPHROL, V46, P2337, DOI 10.1007/s11255-014-0766-2; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Raz L, 2015, J CEREB BLOOD FLOW M; Sasaki Y, 2011, J AM GERIATR SOC, V59, P1175, DOI 10.1111/j.1532-5415.2011.03477.x; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Talabani B, 2014, NEPHROLOGY, V19, P282, DOI 10.1111/nep.12221; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Wu Y-T, 2015, LANCET NEUROL	33	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171671	10.1371/journal.pone.0171671	http://dx.doi.org/10.1371/journal.pone.0171671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192452	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800037
J	Chen, TLW; Wong, DWC; Wang, Y; Ren, SC; Yan, F; Zhang, M				Chen, Tony Lin-Wei; Wong, Duo Wai-Chi; Wang, Yan; Ren, Sicong; Yan, Fei; Zhang, Ming			Biomechanics of fencing sport: A scoping review	PLOS ONE			English	Review							GENDER-DIFFERENCES; INTENSIVE PRACTICE; BALANCE ABILITY; SERUM HORMONES; TARGET CHANGE; PERFORMANCE; ELITE; STRENGTH; LUNGE; POWER	Objectives The aim of our scoping review was to identify and summarize current evidence on the biomechanics of fencing to inform athlete development and injury prevention. Design Scoping review. Method Peer-reviewed research was identified from electronic databases using a structured keyword search. Details regarding experimental design, study group characteristics and measured outcomes were extracted from retrieved studies, summarized and information regrouped under themes for analysis. The methodological quality of the evidence was evaluated. Results Thirty-seven peer-reviewed studies were retrieved, the majority being observational studies conducted with experienced and elite athletes. The methodological quality of the evidence was "fair" due to the limited scope of research. Male fencers were the prevalent group studied, with the lunge and use of a foil weapon being the principal movement evaluated. Motion capture and pedabarography were the most frequently used data collection techniques. Conclusions Elite fencers exhibited sequential coordination of upper and lower limb movements with coherent patterns of muscle activation, compared to novice fencers. These elite features of neuromuscular coordination resulted in higher magnitudes of forward linear velocity of the body center of mass and weapon. Training should focus on explosive power. Sex- and equipment-specific effects could not be evaluated based on available research.	[Chen, Tony Lin-Wei; Wong, Duo Wai-Chi; Wang, Yan; Ren, Sicong; Yan, Fei; Zhang, Ming] Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wong, Duo Wai-Chi; Wang, Yan; Zhang, Ming] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Yan, Fei] Sichuan Univ, Dept Appl Mech, Chengdu, Sichuan, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Sichuan University	Zhang, M (corresponding author), Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	ming.zhang@polyu.edu.hk	Chen, Tony Lin-Wei/AAX-6276-2020; Wang, Yan/AAU-3194-2021; Zhang, Ming/F-8331-2011; Wong, Duo Wai-Chi/B-4127-2015	Chen, Tony Lin-Wei/0000-0003-0737-0859; Wang, Yan/0000-0002-5404-4098; Zhang, Ming/0000-0002-6027-4594; Wong, Duo Wai-Chi/0000-0002-8805-1157	Innovation and Technology Commission of Hong Kong [ITP/018/5TP]	Innovation and Technology Commission of Hong Kong	This work was supported by the Innovation and Technology Commission of Hong Kong; Grant number: ITP/018/5TP; Funding recipient: MZ; URLs:http://www.itc.gov.hk/en/ welcome.htm. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Akpinar S, 2015, J MOTOR BEHAV, V47, P302, DOI 10.1080/00222895.2014.981500; Angelo D, 2005, SCH FENCING GEN EXPL; [Anonymous], 2011, SERB J SPORTS SCI; Aquili A, 2013, J STRENGTH COND RES, V27, P624, DOI 10.1519/JSC.0b013e318257803f; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Asci A, 2007, J STRENGTH COND RES, V21, P10; Barth B, 2006, COMPLETE GUIDE FENCI; Bobbert M F, 2001, Exerc Sport Sci Rev, V29, P95, DOI 10.1097/00003677-200107000-00002; Bottoms L, 2013, ACTA BIOENG BIOMECH, V15, P109, DOI 10.5277/abb130414; Chang CL, 2009, PERCEPT MOTOR SKILL, V108, P524, DOI 10.2466/PMS.108.2.524-530; Chen TL, 2016, CLIN BIOMECH, V33, P49, DOI 10.1016/j.clinbiomech.2016.02.013; Cronin J, 2003, J SPORT SCI, V21, P49, DOI 10.1080/0264041031000070958; Dahab KS, 2009, SPORTS HEALTH, V1, P223, DOI 10.1177/1941738109334215; Do MC, 1999, EXP BRAIN RES, V129, P462, DOI 10.1007/s002210050914; Evangelista N, 1999, ART SCI FENCING; Frere J, 2011, INT J SPORTS MED, V32, P28, DOI 10.1055/s-0030-1267199; Geil MD, 2002, J APPL BIOMECH, V18, P155, DOI 10.1123/jab.18.2.155; Gholipour M, 2008, WORLD J SPORT SCI, V1, P32; Goncalves CEB, 2012, INT J SPORT PHYSIOL, V7, P390, DOI 10.1123/ijspp.7.4.390; Gray J, 2016, J SCI MED SPORT, V19, P222, DOI 10.1016/j.jsams.2015.04.009; Greenhalgh A, 2013, J APPL BIOMECH, V29, P463, DOI 10.1123/jab.29.4.463; Gresham-Fiegel CN, 2013, J STRENGTH COND RES, V27, P57, DOI 10.1519/JSC.0b013e31824e0e9d; Guilhem G, 2014, MED SCI SPORT EXER, V46, P341, DOI 10.1249/MSS.0b013e3182a6401b; Gutierrez-Cruz C, 2015, J SPORTS SCI, P1; Gutierrez-Davila M, 2013, EUR J SPORT SCI, V13, P364, DOI 10.1080/17461391.2011.635704; Gutierrez-Davila M, 2013, J SPORT SCI, V31, P1100, DOI 10.1080/02640414.2013.770908; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; Harmer PA, 2008, CLIN J SPORT MED, V18, P137, DOI 10.1097/JSM.0b013e318161548d; Harmer PA, 2008, CURR SPORT MED REP, V7, P303, DOI 10.1249/JSR.0b013e318187083b; Hassan SEA, 1998, ISBS C P ARCH, V1, P170; Hassanlouei H, 2014, J ELECTROMYOGR KINES, V24, P682, DOI 10.1016/j.jelekin.2014.06.004; Hutton A, 2006, COLD STEEL ART FENCI; Hyun J, 2014, J PHYS THER SCI, V26, P291, DOI 10.1589/jpts.26.291; Irurtia A, 2008, FENC SCI TECHNOL BAR, P185; Jayanthi N, 2013, CURR SPORT MED REP, V12, P329, DOI 10.1249/JSR.0b013e3182a4bad0; Katis A, 2015, SPORT BIOMECH, V14, P287, DOI 10.1080/14763141.2015.1056221; KawaLek K, 2014, TRENDS SPORT SCI, V21; Kim T, 2015, J PHYS THER SCI, V27, P1589, DOI 10.1589/jpts.27.1589; Lin F. L., 2010, 2010 IEEE 17th International Conference on Industrial Engineering and Engineering Management (IE&EM2010), P1624, DOI 10.1109/ICIEEM.2010.5646097; Margonato V, 1994, J SPORT SCI, V12, P567, DOI 10.1080/02640419408732207; Morris N, 2011, PORT J SPORT SCI, V11, P343; Mulloy F, 2015, USE KINEMATIC CHAIN; Murgu Andreia-Ileana, 2006, Phys Med Rehabil Clin N Am, V17, P725, DOI 10.1016/j.pmr.2006.05.008; Newton R.U., 1994, STRENGTH COND J, V16, P20, DOI [10.1519/1073-6840(1994)0162.3.CO;2, DOI 10.1519/1073-6840(1994)0162.3.CO;2]; Niu WX, 2010, AVIAT SPACE ENVIR MD, V81, P761, DOI 10.3357/ASEM.2725.2010; Poulis I, 2009, PERCEPT MOTOR SKILL, V108, P949, DOI 10.2466/PMS.108.3.949-961; Reeser JC, 2010, PM&R, V2, P27, DOI 10.1016/j.pmrj.2009.11.010; Roi GS, 2008, SPORTS MED, V38, P465, DOI 10.2165/00007256-200838060-00003; Sekizawa K, 2001, GAIT POSTURE, V13, P221, DOI 10.1016/S0966-6362(01)00099-6; Sinclair J, 2015, RES SPORTS MED, V23, P51, DOI 10.1080/15438627.2014.975813; Sinclair J, 2012, INT J SPORTSCI ENG, V6, P118; Sinclair J, 2013, INT J PERF ANAL SPOR, V13, P440, DOI 10.1080/24748668.2013.11868660; Sinclair J, 2010, SPORT BIOMECH, V9, P65, DOI 10.1080/14763141.2010.491161; Sterkowicz-Przybycien K, 2009, COLLEGIUM ANTROPOL, V33, P765; Stewart SI, 2005, J SPORT SCI, V23, P105; Timpka T, 2006, SPORTS MED, V36, P733, DOI 10.2165/00007256-200636090-00002; Trautmann C, 2011, J SPORT SCI, V29, P1585, DOI 10.1080/02640414.2011.605458; Tsolakis C, 2010, PERCEPT MOTOR SKILL, V110, P1015, DOI 10.2466/05.25.26.PMS.110.C.1015-1028; Tsolakis CK, 2006, J STRENGTH COND RES, V20, P908; Tsolaks C, 2006, J HUM MOVEMENT STUD, V50, P201; Turner A, 2016, J STRENGTH COND RES, V1; Turner A, 2014, J STRENGTH COND RES, V28, P3001, DOI 10.1519/JSC.0000000000000478; Turner A, 2013, STRENGTH COND J, V35, P1, DOI 10.1519/SSC.0b013e31826e7283; Weist R, 2004, AM J SPORT MED, V32, P1893, DOI 10.1177/0363546504265191; Wild A, 2001, SPORTVERLETZ SPORTSC, V15, P59, DOI 10.1055/s-2001-17277; Williams L R, 2000, J Sci Med Sport, V3, P460, DOI 10.1016/S1440-2440(00)80011-0; Williams LRT, 2000, PERCEPT MOTOR SKILL, V91, P131, DOI 10.2466/PMS.91.5.131-142; Wong DWC, 2014, MED ENG PHYS, V36, P1388, DOI 10.1016/j.medengphy.2014.03.004; Wylde MJ, 2013, INT J PERFORM ANAL S, V13; Yiou E, 2000, INT J SPORTS MED, V21, P122; Yiou E, 2001, EXP BRAIN RES, V137, P197, DOI 10.1007/s002210000624; Zhang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16282	73	30	30	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171578	10.1371/journal.pone.0171578	http://dx.doi.org/10.1371/journal.pone.0171578			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187164	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300032
J	Moreno, LF; Feng, PY; Weiss, VA; Vicente, VA; Stielow, JB; de Hoog, S				Moreno, Leandro Ferreira; Feng, Peiying; Weiss, Vinicius Almir; Vicente, Vania Aparecida; Stielow, J. Benjamin; de Hoog, Sybren			Phylogenomic analyses reveal the diversity of laccase-coding genes in Fonsecaea genomes	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FUNGAL LACCASE; MELANOCARPUS-ALBOMYCES; WANGIELLA-DERMATITIDIS; FUSARIUM-OXYSPORUM; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; PHEOHYPHOMYCOSIS; MELANIN; FAMILY	The genus Fonsecaea comprises black yeast-like fungi of clinical relevance, including etiologic agents of chromoblastomycosis and cerebral phaeohyphomycosis. Presence of melanin and assimilation of monoaromatic hydrocarbons and alkylbenzenes have been proposed as virulence factors. Multicopper oxidase (MCO) is a family of enzymes including lac cases, ferroxidases and ascorbate oxidases which are able to catalyze the oxidation of various aromatic organic compounds with the reduction of molecular oxygen to water. Additionally, laccases are required for the production of fungal melanins, a cell-wall black pigment recognized as a key polymer for pathogenicity and extremotolerance in black yeast like fungi. Although the activity of laccase enzymes has previously been reported in many wood-rotting fungi, the diversity of laccase genes in Fonsecaea has not yet been assessed. In this study, we identified and characterized laccase-coding genes and determined their genomic location in five clinical and environmental Fonsecaea species. The identification of laccases sensu stricto will provide insights into carbon acquisition strategies as well as melanin production in Fonsecaea.	[Moreno, Leandro Ferreira; Feng, Peiying; Stielow, J. Benjamin; de Hoog, Sybren] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Moreno, Leandro Ferreira; de Hoog, Sybren] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Moreno, Leandro Ferreira; Weiss, Vinicius Almir; Vicente, Vania Aparecida; de Hoog, Sybren] Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil; [Feng, Peiying; de Hoog, Sybren] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou, Guangdong, Peoples R China	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Amsterdam; Universidade Federal do Parana; Sun Yat Sen University	de Hoog, S (corresponding author), CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.; de Hoog, S (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.; de Hoog, S (corresponding author), Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil.; de Hoog, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou, Guangdong, Peoples R China.	s.hoog@cbs.knaw.nl	vicente, vania/AAF-3464-2020	vicente, vania/0000-0002-2953-4861	Science without Borders fellowship [1331-13-2]; CAPES-Brazil; National Science Foundation of China [81401650]; Young Teacher Foundation of Sun Yat-sen University [13ykpy32]	Science without Borders fellowship; CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teacher Foundation of Sun Yat-sen University	LFM was funded by the Science without Borders fellowship (Process-number: 1331-13-2), CAPES-Brazil [capes.gov.br]. PF was partly funded by the National Science Foundation of China No. 81401650 and the Young Teacher Foundation of Sun Yat-sen University No. 13ykpy32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bleve G, 2014, APPL BIOCHEM BIOTECH, V172, P2916, DOI 10.1007/s12010-014-0734-4; Bleve G, 2013, PROTEIN ENG DES SEL, V26, P1, DOI 10.1093/protein/gzs056; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Canero DC, 2008, PHYTOPATHOLOGY, V98, P509, DOI 10.1094/PHYTO-98-5-0509; Chen ZH, 2014, G3-GENES GENOM GENET, V4, P561, DOI 10.1534/g3.113.009241; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; de Azevedo CMPS, 2015, J CLIN MICROBIOL, V53, P2674, DOI 10.1128/JCM.00637-15; de Hoog GS, 2004, MED MYCOL, V42, P405, DOI 10.1080/13693780410001661464; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Gianfreda L., 1999, BIOREMEDIAT J, V3, P1, DOI DOI 10.1080/10889869991219163; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Koo S, 2010, MED MYCOL, V48, P769, DOI 10.3109/13693780903471081; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Kwiatos N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00933; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lettera V, 2010, FUNGAL BIOL-UK, V114, P724, DOI 10.1016/j.funbio.2010.06.004; Li XQ, 2016, STUD MYCOL, P1, DOI 10.1016/j.simyco.2016.02.001; Li XQ, 2016, STUDIES MYCOLOGY; Mate DM, 2015, BIOTECHNOL ADV, V33, P25, DOI 10.1016/j.biotechadv.2014.12.007; Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; POLACHECK I, 1982, J BACTERIOL, V150, P1212, DOI 10.1128/JB.150.3.1212-1220.1982; Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x; Ramos JAT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-78; Riley R, 2016, P NATL ACAD SCI USA, V113, P9882, DOI 10.1073/pnas.1603941113; Schnitzler N, 1999, INFECT IMMUN, V67, P94, DOI 10.1128/IAI.67.1.94-101.1999; Sirim Demet, 2011, Database (Oxford), V2011, pbar006, DOI 10.1093/database/bar006; Surash S, 2005, MED MYCOL, V43, P465, DOI 10.1080/13693780500220373; Takei H, 2007, CLIN NEUROPATHOL, V26, P21; Teixeira MdM, 2016, STUDIES MYC IN PRESS; Tetsch L, 2005, FEMS MICROBIOL LETT, V245, P161, DOI 10.1016/j.femsle.2005.03.007; Vicente VA, 2014, FUNGAL DIVERS, V65, P47, DOI 10.1007/s13225-013-0246-5; Vicente VA, 2012, VET MICROBIOL, V158, P109, DOI 10.1016/j.vetmic.2012.01.031; Cazares-Garcia SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055295; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Wahleithner JA, 1996, CURR GENET, V29, P395, DOI 10.1007/BF02208621; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Yanagihara S, 2015, J DERMATOL, V42, P833, DOI 10.1111/1346-8138.12898; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	48	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171291	10.1371/journal.pone.0171291	http://dx.doi.org/10.1371/journal.pone.0171291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187150	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300015
J	Wood, G; Miles, CAL; Coyles, G; Alizadehkhaiyat, O; Vine, SJ; Vickers, JN; Wilson, MR				Wood, Greg; Miles, Charlotte A. L.; Coyles, Ginny; Alizadehkhaiyat, Omid; Vine, Samuel J.; Vickers, Joan N.; Wilson, Mark R.			A randomized controlled trial of a group-based gaze training intervention for children with Developmental Coordination Disorder	PLOS ONE			English	Article							PERFORMANCE	The aim of this study was to integrate a gaze training intervention (i.e., quiet eye training; QET) that has been shown to improve the throwing and catching skill of children with Developmental Coordination Disorder (DCD), within an approach (i.e., group therapy) that might alleviate the negative psychosocial impact of these motor skill deficits. Twenty-one children with DCD were split into either QET (8 male 3 female, mean age of 8.6 years (SD = 1.04) or technical training (TT) groups (7 male 3 female, mean age of 8.6 years (SD = 1.84). The TT group were given movement-related instructions via video, relating to the throw and catch phases, while the QET group were also taught to fixate a target location on the wall prior to the throw (QE1) and to track the ball prior to the catch (QE2). Each group partook in a 4 week, group therapy intervention and measurements of QE duration and catching performance were taken before and after training, and at a 6-week delayed retention test. Parental feedback on psychosocial and motor skill outcomes was provided at delayed retention. Children improved their gaze control and catching coordination following QET, compared to TT. Mediation analysis showed that a longer QE aiming duration (QE1) predicted an earlier onset of tracking the ball prior to catching (QE2) which predicted catching success. Parents reported enhanced perceptions of their child's catching ability and general coordination in the QET group compared to the TT group. All parents reported improvements in their child's confidence, social skills and predilection for physical activity following the trial. The findings offer initial support for an intervention that practitioners could apply to address deficits in the motor and psychosocial skills of children with DCD.	[Wood, Greg] Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe, England; [Wood, Greg; Miles, Charlotte A. L.; Coyles, Ginny; Alizadehkhaiyat, Omid] Liverpool Hope Univ, Dept Hlth Sci, Liverpool, Merseyside, England; [Vine, Samuel J.; Wilson, Mark R.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Vickers, Joan N.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	Manchester Metropolitan University; Liverpool Hope University; University of Exeter; University of Calgary	Wood, G (corresponding author), Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe, England.; Wood, G (corresponding author), Liverpool Hope Univ, Dept Hlth Sci, Liverpool, Merseyside, England.	greg.wood@mmu.ac.uk	Vickers, Joan/AAW-2815-2020; Vine, Samuel J/AAD-5226-2019	Vine, Samuel J/0000-0001-9329-1262; Wood, Greg/0000-0003-0851-7090	Liverpool Hope University (HEIF5 Programme); Waterloo Foundation [1119/1603]	Liverpool Hope University (HEIF5 Programme); Waterloo Foundation	This research was funded by grants from Liverpool Hope University (HEIF5 Programme 2011-2015) and The Waterloo Foundation (1119/1603). The funders were not involved in the study design, data collection, data analysis, manuscript preparation, nor publication decisions. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.	Alloway TP, 2011, CHILD NEUROPSYCHOL, V17, P483, DOI 10.1080/09297049.2011.553590; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2005, BRIT J OCCUP THER, DOI [10.1177/030802260506800903, DOI 10.1177/030802260506800903]; Bart O, 2010, RES DEV DISABIL, V31, P46, DOI 10.1016/j.ridd.2009.07.021; Biotteau M., 2016, CURR DEV DISORD REP, V3, P152, DOI DOI 10.1007/S40474-016-0084-8; Bunker D, 1994, PRIMARY PHYS ED IMPL; Candler C, 2002, AM J OCCUP THER, V56, P429, DOI 10.5014/ajot.56.4.429; Chen Hsiu-Fen, 2003, Physical & Occupational Therapy in Pediatrics, V23, P61, DOI 10.1300/J006v23n04_05; Cole F L, 1988, Clin Nurse Spec, V2, P53, DOI 10.1097/00002800-198800210-00025; Cummins A, 2005, DEV MED CHILD NEUROL, V47, P437, DOI 10.1017/S001216220500085X; Debrabant J, 2013, RES DEV DISABIL, V34, P1478, DOI 10.1016/j.ridd.2013.02.008; DuPaul GJ, 1998, J PSYCHOPATHOL BEHAV, V20, P83, DOI 10.1023/A:1023087410712; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Henderson S., 2007, MOVEMENT ASSESSMENT, DOI 10.1037/t55281-000; Miles CAL, 2015, RES DEV DISABIL, V40, P31, DOI 10.1016/j.ridd.2015.01.005; Miles CA, 2015, EUROPEAN J SPORT SCI, V19, P1; Miles CAL, 2014, PSYCHOL SPORT EXERC, V15, P511, DOI 10.1016/j.psychsport.2014.04.009; Morgan R, 2012, BRIT J OCCUP THER, V75, P10, DOI 10.4276/030802212X13261082051337; Pless M, 2000, ADAPT PHYS ACT Q, V17, P381, DOI 10.1123/apaq.17.4.381; Poulsen AA, 2007, AM J OCCUP THER, V61, P451, DOI 10.5014/ajot.61.4.451; Robert MP, 2014, DEV MED CHILD NEUROL, V56, P595, DOI 10.1111/dmcn.12384; Sugden D., 2006, LEEDS CONSENSUS STAT; Sumner E, 2016, OCULOMOTOR ATYPICALI; Vickers JN, 1996, J EXP PSYCHOL HUMAN, V22, P342, DOI 10.1037/0096-1523.22.2.342; Vine SJ, 2013, INT J SPORT PSYCHOL, V44, P367, DOI 10.7352/IJSP2013.44.367; Wilson MR, 2013, MED SCI SPORT EXER, V45, P1144, DOI 10.1249/MSS.0b013e31828288f1; Wilson MR, 2011, SURG ENDOSC, V25, P2268, DOI 10.1007/s00464-010-1546-4; Wilson MR, 2016, CURRENT ISSUES SPORT, V1, P117, DOI DOI 10.15203/CISS_2016.117; Wilson PH, 2013, DEV MED CHILD NEUROL, V55, P217, DOI 10.1111/j.1469-8749.2012.04436.x	29	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171782	10.1371/journal.pone.0171782	http://dx.doi.org/10.1371/journal.pone.0171782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187138	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000394244300043
J	Zavorsky, GS; Tomko, KA; Smoliga, JM				Zavorsky, Gerald S.; Tomko, Kelly A.; Smoliga, James M.			Declines in marathon performance: Sex differences in elite and recreational athletes	PLOS ONE			English	Article							AGE; PARTICIPATION; SEDENTARY; RUNNERS; TRENDS; TIME; HALF	The first aim of this study was to determine the age group at which marathon performance declines in top male and female runners and to compare that to the runners of average ability. Another aim of this of this study was to examine the age-related yearly decline in marathon performance between age group winners and the average marathon finisher. Data from the New York (NYC), Boston, and Chicago marathons from 2001-2016 were analyzed. Age, sex, and location were used in multiple linear regression models to determine the rate of decline in marathon times. Winners of each age group were assessed in 5-year increments from 16 through 74 years old (n = 47 per age group). The fastest times were between 25 - 34 years old, with overall champion males at 28.3 years old, and overall champion females at 30.8 years old (p = 0.004). At 35 years of age up to 74 years of age, female age group winners had a faster yearly decline in marathon finishing times compared to male age group winners, irrespective of marathon location [women = (min: sec) 2: 33 per year, n = 336; men = 2: 06 per year, n = 373, p < 0.01]. The median times between each age group only slowed beginning at 50 years old, thereafter the decline was similar between both men and women (women = 2: 36, n = 140; men = 2: 57, n = 150, p = 0.11). The median times were fastest at Boston and similar between Chicago and NYC. In conclusion, the rate of decline at 35 years old up to 74 years old is roughly linear (adjusted r(2) = 0.88, p < 0.001) with female age group winners demonstrating 27 s per year greater decline per year compared to male age group winners.	[Zavorsky, Gerald S.] Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA; [Tomko, Kelly A.] Univ Bridgeport, Bridgeport, CT USA; [Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC USA	University System of Georgia; Georgia State University; University of Bridgeport	Zavorsky, GS (corresponding author), Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA.	zavorsky@gsu.edu	Zavorsky, Gerald S./I-7753-2013; Zavorsky, Gerald S./AAI-1422-2021	Zavorsky, Gerald S./0000-0002-4473-1601; Zavorsky, Gerald S./0000-0002-4473-1601; Smoliga, James/0000-0002-1895-5687				Addison Odessa, 2015, Br J Med Med Res, V8, P1074; Ahmadyar B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1254-6; Anthony D, 2014, CHINESE J PHYSIOL, V57, P209, DOI 10.4077/CJP.2014.BAC219; Berthelot G, 2012, AGE, V34, P1001, DOI 10.1007/s11357-011-9274-9; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Brendle DC, 2003, AM J CARDIOL, V91, P1154, DOI 10.1016/S0002-9149(03)00174-7; Bruinvels G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149881; Connick MJ, 2015, J SPORT SCI MED, V14, P669; Deaner RO, 2015, MED SCI SPORT EXER, V47, P607, DOI 10.1249/MSS.0000000000000432; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Fields A., 2014, DISCOVERING STAT USI; Florence SL, 1997, EUR J APPL PHYSIOL O, V75, P274, DOI 10.1007/s004210050160; Hagan R D, 1987, Br J Sports Med, V21, P3; Hagmar M, 2006, CLIN J SPORT MED, V16, P247, DOI 10.1097/00042752-200605000-00011; Hunter SK, 2013, MED SCI SPORT EXER, V45, P148, DOI 10.1249/MSS.0b013e31826900f6; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; Jokl P, 2004, BRIT J SPORT MED, V38, P408, DOI 10.1136/bjsm.2002.003566; Katzel LI, 2001, J AM GERIATR SOC, V49, P1657, DOI 10.1046/j.1532-5415.2001.t01-1-49276.x; Knechtle B, 2017, J SPORT SCI, V35, P1012, DOI 10.1080/02640414.2016.1209302; Knechtle B, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-31; Lara B, 2014, AGE, V36, P1003, DOI 10.1007/s11357-013-9614-z; Lavin KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044513; Lehto N, 2016, J SPORT HEALTH SCI, V5, P349, DOI 10.1016/j.jshs.2015.01.008; Lepers R, 2012, AGE, V34, P773, DOI 10.1007/s11357-011-9271-z; Leyk D, 2007, INT J SPORTS MED, V28, P513, DOI 10.1055/s-2006-924658; Leyk D, 2010, DTSCH ARZTEBL INT, V107, P809, DOI 10.3238/arztebl.2010.0809; Loftin M, 2007, J STRENGTH COND RES, V21, P1188; Maharam LG, 1999, SPORTS MED, V28, P273, DOI 10.2165/00007256-199928040-00005; March DS, 2011, J STRENGTH COND RES, V25, P386, DOI 10.1519/JSC.0b013e3181bffd0f; MAUGHAN RJ, 1983, EUR J APPL PHYSIOL O, V52, P80, DOI 10.1007/BF00429030; Medic N, 2013, J SPORT SCI MED, V12, P724; Nikolaidis PT, 2016, J STRENGTH COND RES; Santos-Lozano A, 2015, INT J SPORT PHYSIOL, V10, P840, DOI 10.1123/ijspp.2014-0366; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Tomten SE, 1996, SCAND J MED SCI SPOR, V6, P164; Trappe S, 2007, SPORTS MED, V37, P302, DOI 10.2165/00007256-200737040-00008	37	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172121	10.1371/journal.pone.0172121	http://dx.doi.org/10.1371/journal.pone.0172121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187185	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300081
J	Lacoste, S; Bhatia, S; Chen, YJ; Bhatia, R; O'Connor, TR				Lacoste, Sandrine; Bhatia, Smita; Chen, Yanjun; Bhatia, Ravi; O'Connor, Timothy R.			Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; CRYOPRESERVED ISOLATED LYMPHOCYTES; THERAPY-RELATED LEUKEMIA; NON-HODGKINS-LYMPHOMA; DNA-REPAIR; MYELODYSPLASTIC SYNDROME; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; MALIGNANT NEOPLASMS	Patients who undergo autologous hematopoietic stem cell transplantation (aHCT) for treatment of a relapsed or refractory lymphoma are at risk of developing therapy related-myelodysplasia/acute myeloid leukemia (t-MDS/AML). Part of the risk likely resides in inherent interindividual differences in their DNA repair capacity (DRC), which is thought to influence the effect chemotherapeutic treatments have on the patient's stem cells prior to aHCT. Measuring DRC involves identifying small differences in repair proficiency among individuals. Initially, we investigated the cell model in healthy individuals (primary lymphocytes and/or lymphoblastoid cell lines) that would be appropriate to measure genetically determined DRC using host-cell reactivation assays. We present evidence that interindividual differences in DRC double-strand break repair (by non-homologous end-joining [NHEJ] or single strand annealing [SSA]) are better preserved in non-induced primary lymphocytes. In contrast, lymphocytes induced to proliferate are required to assay base excision (BER) or nucleotide excision repair (NER). We established that both NHEJ and SSA DRCs in lymphocytes of healthy individuals were inversely correlated with the age of the donor, indicating that DSB repair in lymphocytes is likely not a constant feature but rather something that decreases with age (similar to 0.37% NHEJ DRC/year). To investigate the predictive value of preaHCT DRC on outcome in patients, we then applied the optimized assays to the analysis of primary lymphocytes from lymphoma patients and found that individuals who later developed t-MDS/AML (cases) were indistinguishable in their DRC from controls who never developed t-MDS/AML. However, when DRC was investigated shortly after aHCT in the same individuals (21.6 months later on average), aHCT patients (both cases and controls) showed a significant decrease in DSB repair measurements. The average decrease of 6.9% in NHEJ DRC observed among aHCT patients was much higher than the 0.65% predicted for such a short time frame, based on ageing results for healthy individuals.	[Lacoste, Sandrine; O'Connor, Timothy R.] Beckman Res Inst, Dept Canc Biol, Duarte, CA 91016 USA; [Bhatia, Smita; Chen, Yanjun] Univ Alabama Birmingham, Sch Med, Inst Canc Outcomes & Survivorship, Birmingham, AL USA; [Bhatia, Ravi] Univ Alabama Birmingham, Sch Med, Div Hematol & Oncol, Birmingham, AL USA	City of Hope; Beckman Research Institute of City of Hope; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lacoste, S (corresponding author), Beckman Res Inst, Dept Canc Biol, Duarte, CA 91016 USA.	sandrinelacoste@hotmail.com		O'Connor, Timothy/0000-0001-5848-3592	NIH SPORE grant [5 P50 CM 07399]; NIH City of Hope Comprehensive Cancer Center [NCI 5P30 CA033572]; NIH National Cancer Institute [1 R01 CA176611]; NATIONAL CANCER INSTITUTE [R01CA176611] Funding Source: NIH RePORTER	NIH SPORE grant; NIH City of Hope Comprehensive Cancer Center; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the NIH SPORE grant (5 P50 CM 07399, Project 2 to R. Bhatia/T.R. O'Connor, http//www.nih.gov/), the NIH City of Hope Comprehensive Cancer Center (NCI 5P30 CA033572), and the NIH National Cancer Institute (1 R01 CA176611, to T.R. O'Connor, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Akhtari M, 2013, CANCER BIOL THER, V14, P1077, DOI 10.4161/cbt.26342; ATHAS WF, 1991, CANCER RES, V51, P5786; Baeyens A, 2004, MUTAGENESIS, V19, P285, DOI 10.1093/mutage/geh029; Beck JC, 2001, CANCER EPIDEM BIOMAR, V10, P551; Bhatia S, 1996, BLOOD, V87, P3633, DOI 10.1182/blood.V87.9.3633.bloodjournal8793633; Bhatia S, 2015, CANCER-AM CANCER SOC, V121, P648, DOI 10.1002/cncr.29096; Bhatia S, 2013, SEMIN ONCOL, V40, P666, DOI 10.1053/j.seminoncol.2013.09.013; Brown JR, 2005, J CLIN ONCOL, V23, P2208, DOI 10.1200/JCO.2005.05.158; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; del Canizo MC, 2000, HAEMATOLOGICA, V85, P403; Deniz M, 2013, MUTAT RES-FUND MOL M, V743, P132, DOI 10.1016/j.mrfmmm.2013.03.009; Friedberg JW, 1999, J CLIN ONCOL, V17, P3128, DOI 10.1200/JCO.1999.17.10.3128; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gilliland DG, 2002, BIOL BLOOD MARROW TR, V8, P9, DOI 10.1053/bbmt.2002.v8.pm11846355; Goncalves A. C., 2016, MOL CARCINOG; Goukassian D, 2000, FASEB J, V14, P1325, DOI 10.1096/fj.14.10.1325; Grabarz A, 2012, AM J CANCER RES, V2, P249; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Guillem V, 2008, LEUKEMIA LYMPHOMA, V49, P204, DOI 10.1080/10428190701769657; Guillem VM, 2011, LEUKEMIA LYMPHOMA, V52, P1249, DOI 10.3109/10428194.2011.564694; Hanssen-Bauer A, 2012, INT J MOL SCI, V13, P17210, DOI 10.3390/ijms131217210; Harrison CN, 1999, BRIT J CANCER, V81, P476, DOI 10.1038/sj.bjc.6690718; Hatzimichael E, 2010, STEM CELLS CLONING, V3, P105, DOI 10.2147/SCCAA.S6815; Howe R, 2003, BONE MARROW TRANSPL, V32, P317, DOI 10.1038/sj.bmt.1704124; Howlett NG, 2006, DNA REPAIR, V5, P251, DOI 10.1016/j.dnarep.2005.10.004; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keimling M, 2012, FASEB J, V26, P2094, DOI 10.1096/fj.11-200790; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Krishnan A, 2000, BLOOD, V95, P1588, DOI 10.1182/blood.V95.5.1588.005k38_1588_1593; Lacoste S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093185; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Li TL, 2016, GENOM PROTEOM BIOINF, V14, P147, DOI 10.1016/j.gpb.2016.04.002; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Mayer C, 2002, DNA REPAIR, V1, P237, DOI 10.1016/S1568-7864(01)00019-2; Mazzei F, 2011, MUTAT RES-GEN TOX EN, V718, P62, DOI 10.1016/j.mrgentox.2010.10.004; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Metayer C, 2003, BLOOD, V101, P2015, DOI 10.1182/blood-2002-04-1261; MILLER JS, 1994, BLOOD, V83, P3780; Nagel ZD, 2014, DNA REPAIR, V19, P199, DOI 10.1016/j.dnarep.2014.03.009; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Nissar S, 2014, ONCOL RES TREAT, V37, P418, DOI 10.1159/000364898; Pedersen-Bjergaard J, 2000, BLOOD, V95, P3273, DOI 10.1182/blood.V95.11.3273.011k15_3273_3279; PedersenBjergaard J, 1997, LEUKEMIA, V11, P1654, DOI 10.1038/sj.leu.2400809; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Sevilla J, 2002, ANN HEMATOL, V81, P11, DOI 10.1007/s00277-001-0400-0; Takahashi Y, 2005, J INVEST DERMATOL, V124, P435, DOI 10.1111/j.0022-202X.2004.23591.x; Thoms KM, 2007, SCAND J CLIN LAB INV, V67, P580, DOI 10.1080/00365510701230481; Thoms KM, 2007, EXP DERMATOL, V16, P532, DOI 10.1111/j.1600-0625.2007.00559.x; Tsoncheva VL, 2008, Z NATURFORSCH C, V63, P303; Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Yakovlev VA, 2013, CANCER RES, V73, P706, DOI 10.1158/0008-5472.CAN-12-3270; Zijno A, 2010, MUTAT RES-FUND MOL M, V684, P98, DOI 10.1016/j.mrfmmm.2009.12.008	63	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171473	10.1371/journal.pone.0171473	http://dx.doi.org/10.1371/journal.pone.0171473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207808	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500030
J	Lede, V; Meusel, A; Garten, A; Popkova, Y; Penke, M; Franke, C; Ricken, A; Schulz, A; Kiess, W; Huster, D; Schoneberg, T; Schiller, J				Lede, Vera; Meusel, Andrej; Garten, Antje; Popkova, Yulia; Penke, Melanie; Franke, Christin; Ricken, Albert; Schulz, Angela; Kiess, Wieland; Huster, Daniel; Schoeneberg, Torsten; Schiller, Juergen			Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODELS; DEFICIENT MICE; HUMAN OBESITY; DIET; NAFLD; MUTATIONS; RATS; PATHOGENESIS	Obesity is often associated with dyslipidemia and hepatosteatosis. A number of animal models of non-alcoholic fatty liver disease (NAFLD) are established but they significantly differ in the molecular and biochemical changes depending on the genetic modification and diet used. Mice deficient for melanocortin type 4 receptor (Mc4r(mut)) develop hyperphagia, obesity, and subsequently NAFLD already under regular chow and resemble more closely the energy supply-driven obesity found in humans. This animal model was used to assess the molecular and biochemical consequences of hyperphagia-induced obesity on hepatic lipid metabolism. We analyzed transcriptome changes in Mc4r(mut) mice by RNA sequencing and used high resolution H-1 magic angle spinning NMR spectroscopy and MALDI-TOF mass spectrometry to assess changes in the lipid composition. On the transcriptomic level we found significant changes in components of the triacylglycerol metabolism, unsaturated fatty acids biosynthesis, peroxisome proliferator-activated receptor signaling pathways, and lipid transport and storage compared to the wild-type. These findings were supported by increases in triacylglycerol, monounsaturated fatty acid, and arachidonic acid levels. The transcriptome signatures significantly differ from those of other NAFLD mouse models supporting the concept of hepatic subphenotypes depending on the genetic background and diet. Comparative analyses of our data with previous studies allowed for the identification of common changes and genotype-specific components and pathways involved in obesity-associated NAFLD.	[Lede, Vera; Schulz, Angela; Schoeneberg, Torsten] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Mol Biochem, Leipzig, Germany; [Meusel, Andrej; Popkova, Yulia; Huster, Daniel; Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany; [Garten, Antje; Penke, Melanie; Kiess, Wieland] Univ Leipzig, Hosp Children & Adolescents, Dept Women & Child Hlth, Ctr Pediat Res Leipzig, Leipzig, Germany; [Franke, Christin] Heart & Vasc Ctr, Bad Bevensen, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Rudolf Schonheimer Inst Biochem, Mol Biochem, Leipzig, Germany.; Schiller, J (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de; juergen.schiller@medizin.uni-leipzig.de	Lede, Vera/C-7258-2014	Lede, Vera/0000-0001-6045-2605	Deutsche Forschungsgemeinschaft [SFB 1052/B6]; Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft [C01665]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft	This work was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) with the grant SFB 1052/B6 and the Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft (C01665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Dunser MW, 2008, CURR OPIN ANESTHESIO, V21, P122, DOI 10.1097/ACO.0b013e3282f4571a; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Goh VJ, 2013, SEMIN LIVER DIS, V33, P312, DOI 10.1055/s-0033-1358521; Grosse J, 2006, PHYSIOL GENOMICS, V26, P209, DOI 10.1152/physiolgenomics.00289.2005; Guri AJ, 2006, CLIN NUTR, V25, P871, DOI 10.1016/j.clnu.2006.08.006; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Lede V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167888; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; MAYER J, 1951, SCIENCE, V113, P746, DOI 10.1126/science.113.2948.746; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Obici S, 2015, MOL METAB, V4, P692, DOI 10.1016/j.molmet.2015.07.003; Pan XL, 2015, ENDOCRINE, V48, P834, DOI 10.1007/s12020-014-0384-x; Penke M, 2015, MOL CELL ENDOCRINOL, V412, P65, DOI 10.1016/j.mce.2015.05.028; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schiller J, 2002, EUR J LIPID SCI TECH, V104, P496, DOI 10.1002/1438-9312(200208)104:8<496::AID-EJLT496>3.0.CO;2-6; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tao YX, 2009, PROG MOL BIOL TRANSL, V88, P173, DOI 10.1016/S1877-1173(09)88006-X; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375; Than NN, 2015, ATHEROSCLEROSIS, V239, P192, DOI 10.1016/j.atherosclerosis.2015.01.001; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Yaligar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091436; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang W, 2012, BIOMED RES-TOKYO, V33, P83, DOI 10.2220/biomedres.33.83	53	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172000	10.1371/journal.pone.0172000	http://dx.doi.org/10.1371/journal.pone.0172000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207798	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500070
J	Confalonieri, M; Buratti, E; Grassi, G; Bussani, R; Chilosi, M; Farra, R; Abrami, M; Stuani, C; Salton, F; Ficial, M; Confalonieri, P; Zandona, L; Romano, M				Confalonieri, Marco; Buratti, Emanuele; Grassi, Gabriele; Bussani, Rossana; Chilosi, Marco; Farra, Rossella; Abrami, Michela; Stuani, Cristiana; Salton, Francesco; Ficial, Miriam; Confalonieri, Paola; Zandona, Lorenzo; Romano, Maurizio			Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; DOWN-REGULATION; STEM-CELLS; LUNG; PROLIFERATION; REGENERATION; DIFFERENTIATION; MECHANISMS; KNOCKOUT; CIRCUIT	The lung alveoli slowly self-renew pneumocytes, but their facultative regeneration capacity is rapidly efficient after an injury, so fibrosis infrequently occurs. We recently observed Keratin 14 (KRT14) expression during diffuse alveolar damage (DAD), but not in controls. We wonder if KRT14 may be a marker of pneumocyte transition from quiescence to regeneration. Quantitative PCR and Western blot analyses highlighted the presence of KRT14 (mRNA and protein) only in human lung samples with DAD or interstitial lung disease (ILD). In the exponentially growing cell lines A549 and H441, the mRNA and protein levels of KRT14 peaked at day one after cell seeding and decreased at day two, opposite to what observed for the proliferation marker E2F1. The inverse relation of KRT14 versus E2F1 expression holds true also for other proliferative markers, such as cyclin El and cyclin D1. Of interest, we also found that E2F1 silencing caused cell cycle arrest and increased KRT14 expression, whilst E2F1 stimulation induced cell cycle progression and decreased KRT14. KRT14 also increased in proliferative pneumocytes (HPAEpiC) just before transdifferentiation. Overall, our results suggest that KRT14 is a viable biomarker of pneumocyte activation, and repair/regeneration. The involvement of KRT14 in regenerative process may suggest a novel pharmaceutical target to accelerate lung repair.	[Confalonieri, Marco; Salton, Francesco; Confalonieri, Paola] Univ Hosp Cattinara, Dept Pulmonol, Trieste, Italy; [Buratti, Emanuele; Stuani, Cristiana; Romano, Maurizio] Int Ctr Genet Engn & Biotechnol, Mol Pathol, Trieste, Italy; [Grassi, Gabriele; Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy; [Bussani, Rossana; Zandona, Lorenzo] Univ Trieste, Inst Pathol Anat, Trieste, Italy; [Chilosi, Marco; Ficial, Miriam] Univ Verona, Dept Diagnost & Publ Hlth, Pathol Unit, Verona, Italy; [Farra, Rossella; Abrami, Michela] Univ Trieste, Dept Engn & Architecture, Trieste, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste; University of Verona; University of Trieste	Confalonieri, M (corresponding author), Univ Hosp Cattinara, Dept Pulmonol, Trieste, Italy.	marco.confalonieri@asuits.sanita.fvg.it	Buratti, Emanuele/K-4691-2016; CHILOSI, MARCO/ABB-8028-2021; Romano, Maurizio/G-9431-2012; Salton, Francesco/AAC-1992-2019; Confalonieri, Marco/AAA-3665-2019	Buratti, Emanuele/0000-0002-1356-9074; Romano, Maurizio/0000-0002-4820-2897; Salton, Francesco/0000-0002-0864-9766; Confalonieri, Marco/0000-0002-4791-768X; Bussani, Rossana/0000-0001-8241-9726; GRASSI, GABRIELE/0000-0001-9704-6651	"Beneficentia Stiftung" of Vaduz Liechtenstein; Italian Minister of Instruction, University and Research (MIUR) [20109PLMH2]; F.R.A., University of Trieste	"Beneficentia Stiftung" of Vaduz Liechtenstein; Italian Minister of Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); F.R.A., University of Trieste	This work was in part supported by the "Beneficentia Stiftung" of Vaduz Liechtenstein, by the Italian Minister of Instruction, University and Research (MIUR), PRIN 2010-11, number 20109PLMH2 and by F.R.A., University of Trieste 2015.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CRAPO JD, 1983, AM REV RESPIR DIS, V128, pS42; Dapas B, 2009, MOL MED, V15, P297, DOI 10.2119/molmed.2009.00030; Farra R, 2015, BIOCHIMIE, V112, P85, DOI 10.1016/j.biochi.2015.02.015; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Farra R, 2010, BIOCHIMIE, V92, P455, DOI 10.1016/j.biochi.2010.01.007; Ficial M, 2014, SHORTNESS BREATH, V3, P102; Ficial M, 2014, AM J RESP CRIT CARE, V189, P1142, DOI 10.1164/rccm.201312-2134LE; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Haines RL, 2012, J CELL SCI, V125, P3923, DOI 10.1242/jcs.099655; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Honda T, 2003, RESP MED, V97, P80, DOI 10.1053/rmed.2002.1408; Kaarteenaho R, 2011, PULM MED, V2011, DOI 10.1155/2011/531302; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Liu YR, 2015, AM J RESP CELL MOL, V53, P113, DOI 10.1165/rcmb.2013-0497OC; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Porter RM, 1996, J CELL BIOL, V132, P925, DOI 10.1083/jcb.132.5.925; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; Rucka Z, 2013, INT J MOL MED, V32, P211, DOI 10.3892/ijmm.2013.1363; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Schilders KAA, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0358-z; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Smirnova NF, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0404-x; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172130	10.1371/journal.pone.0172130	http://dx.doi.org/10.1371/journal.pone.0172130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199407	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400074
J	Favaro, L; Gamba, M; Gili, C; Pessani, D				Favaro, Livio; Gamba, Marco; Gili, Claudia; Pessani, Daniela			Acoustic correlates of body size and individual identity in banded penguins	PLOS ONE			English	Article							SOURCE-FILTER THEORY; DEER DAMA-DAMA; VOCAL INDIVIDUALITY; SOUND PRODUCTION; INFORMATION; RECOGNITION; BEHAVIOR; CALLS; ENEMY; DEAR	Animal vocalisations play a role in individual recognition and mate choice. In nesting penguins, acoustic variation in vocalisations originates from distinctiveness in the morphology of the vocal apparatus. Using the source-filter theory approach, we investigated vocal individuality cues and correlates of body size and mass in the ecstatic display songs the Humboldt and Magellanic penguins. We demonstrate that both fundamental frequency (f(0)) and formants (F-1-F-4) are essential vocal features to discriminate among individuals. However, we show that only duration and f0 are honest indicators of the body size and mass, respectively. We did not find any effect of body dimension on formants, formant dispersion nor estimated vocal tract length of the emitters. Overall, our findings provide the first evidence that the resonant frequencies of the vocal tract do not correlate with body size in penguins. Our results add important information to a growing body of literature on the role of the different vocal parameters in conveying biologically meaningful information in bird vocalisations.	[Favaro, Livio; Gamba, Marco; Pessani, Daniela] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Gili, Claudia] Costa Edutainment SpA, Acquario Genova, Genoa, Italy	University of Turin	Favaro, L (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	livio.favaro@unito.it	Favaro, Livio/B-8337-2013; Gamba, Marco/I-1184-2012	Favaro, Livio/0000-0002-8698-472X; Gamba, Marco/0000-0001-9545-2242				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Aubin T, 2004, AN ACAD BRAS CIENC, V76, P279, DOI 10.1590/S0001-37652004000200015; Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckers GJL, 2003, P NATL ACAD SCI USA, V100, P7372, DOI 10.1073/pnas.1232227100; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; BOERSMA P D, 1976, Living Bird, V15, P43; Boersma Paul, 2002, GLOT INT, V5, P341; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; Buchanan K., 2015, ANIM BEHAV, V99, pI, DOI DOI 10.1016/S0003-3472(14)00451-5; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Clark JA, 2006, ANIM BEHAV, V72, P1141, DOI 10.1016/j.anbehav.2006.04.002; Davis L.S., 1990, P377; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Elemans CPH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9978; Elemans CPH, 2009, J EXP BIOL, V212, P1212, DOI 10.1242/jeb.026872; Fairburn Daphne J., 2007, P1; Fant G., 1960, ACOUSTIC THEORY SPEE; Favaro L, 2016, BEHAV PROCESS, V128, P83, DOI 10.1016/j.beproc.2016.04.010; Favaro L, 2016, ANIM COGN, V19, P847, DOI 10.1007/s10071-016-0961-x; Favaro L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17255; Favaro L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103460; Favaro L, 2014, ACTA ACUST UNITED AC, V100, P782, DOI 10.3813/AAA.918758; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Fitch WT., 2006, ENCY LANGUAGE LINGUI, V2, P115, DOI DOI 10.1016/B0-08-044854-2/00821-X; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox J., 2018, R COMPANION APPL REG, VThird; Gamba M, 2012, INT J PRIMATOL, V33, P1453, DOI 10.1007/s10764-012-9635-y; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Garcia M, 2016, J EXP BIOL, V219, P1913, DOI 10.1242/jeb.138255; Hardouin LA, 2014, J AVIAN BIOL, V45, P157, DOI 10.1111/j.1600-048X.2013.00144.x; Holt MM, 2015, J EXP BIOL, V218, P1647, DOI 10.1242/jeb.122424; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; JOUVENTIN P, 1982, VISUAL VOCAL SIGNALS; M?ller-Schwarze, 1984, BEHAV PENGUINS ADAPT; Marks EJ, 2010, BEHAVIOUR, V147, P165, DOI 10.1163/000579509X12512863752751; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; Miyazaki M, 2003, IBIS, V145, P98, DOI 10.1046/j.1474-919X.2003.00126.x; Oberweger K, 2001, J EXP BIOL, V204, P3379; Ohms VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011923; Orben RA, 2015, J ANIM ECOL, V84, P1589, DOI 10.1111/1365-2656.12410; Pratt AE, 2006, BEHAVIOUR, V143, P597, DOI 10.1163/156853906776759501; R Core Team, 2021, R LANGUAGE ENV STAT; Reber SA, 2015, J EXP BIOL, V218, P2442, DOI 10.1242/jeb.119552; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Renison D, 2006, J ETHOL, V24, P189, DOI 10.1007/s10164-005-0180-4; Riede T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2306; Rosell F, 2002, ANIM BEHAV, V63, P1073, DOI 10.1006/anbe.2002.3010; Salton M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140390; Saraux C, 2011, BEHAV ECOL, V22, P837, DOI 10.1093/beheco/arr049; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Sheehan MJ, 2016, BEHAV ECOL, V27, P2, DOI 10.1093/beheco/arv109; STOKES DL, 1991, AUK, V108, P923; Stonehouse B., 1975, THE BIOLOGY OF PENGU; SUTHERS RA, 1994, J COMP PHYSIOL A, V175, P457; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Thumser N. N., 1998, Marine Ornithology, V26, P41; Thumser NN, 1996, WILSON BULL, V108, P72; Tibbetts EA, 2008, TRENDS ECOL EVOL, V23, P356, DOI 10.1016/j.tree.2008.03.007; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tripovich JS, 2008, BEHAV PROCESS, V79, P74, DOI 10.1016/j.beproc.2008.04.007; Tripovich JS, 2008, MAR MAMMAL SCI, V24, P941, DOI 10.1111/j.1748-7692.2008.00222.x; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WAZA, 2005, 60 ANN C WORLD ASS Z; Zahavi A, 1997, HANDICAP PRINCIPLE M; ZEEK PM, 1951, ANAT REC, V111, P327, DOI 10.1002/ar.1091110305	74	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170001	10.1371/journal.pone.0170001	http://dx.doi.org/10.1371/journal.pone.0170001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199318	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400011
J	Mukhopadhyay, S; Thatoi, PK; Pandey, AD; Das, BK; Ravindran, B; Bhattacharjee, S; Mohapatra, SK				Mukhopadhyay, Samanwoy; Thatoi, Pravat K.; Pandey, Abhay D.; Das, Bidyut K.; Ravindran, Balachandran; Bhattacharjee, Samsiddhi; Mohapatra, Saroj K.			Transcriptomic meta-analysis reveals upregulation of gene expression functional in osteoclast differentiation in human septic shock	PLOS ONE			English	Article							SEPSIS; ASSOCIATION	Septic shock is a major medical problem with high morbidity and mortality and incompletely understood biology. Integration of multiple data sets into a single analysis framework empowers discovery of new knowledge about the condition that may have been missed by individual analysis of each of these datasets. Electronic search was performed on medical literature and gene expression databases for selection of transcriptomic studies done in circulating leukocytes from human subjects suffering from septic shock. Gene-level meta-analysis was conducted on the six selected studies to identify the genes consistently differentially expressed in septic shock. This was followed by pathway-level analysis using three different algorithms (ORA, GSEA, SPIA). The identified up-regulated pathway, Osteoclast differentiation pathway (hsa04380) was validated in two independent cohorts. Of the pathway, 25 key genes were selected that serve as an expression signature of Septic Shock.	[Mukhopadhyay, Samanwoy; Pandey, Abhay D.; Bhattacharjee, Samsiddhi; Mohapatra, Saroj K.] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Thatoi, Pravat K.; Das, Bidyut K.] Sriram Chandra Bhanja Med Coll & Hosp, Dept Med, Cuttack, Orissa, India; [Ravindran, Balachandran] Inst Life Sci, NALCO Sq, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Srirama Chandra Bhanja Medical College & Hospital; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Mohapatra, SK (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.	skm1@nibmg.ac.in		MUKHOPADHYAYA, SAMANWOY/0000-0002-8660-5670; Bhattacharjee, Samsiddhi/0000-0002-8549-1130	NIBMG, Kalyani; Department of Biotechnology, Government of India [BT/PR5548/MED/29/571/ 2012]; University Grants Commission of India [F.2-45/2011(SA-I)]	NIBMG, Kalyani; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission of India(University Grants Commission, India)	This work was supported by an intramural grant from NIBMG, Kalyani and an extramural grant (No. BT/PR5548/MED/29/571/ 2012, duration of 3 years, sanctioned on 27-052013) from the Department of Biotechnology, Government of India. S.M. acknowledges research fellowship (No. F.2-45/2011(SA-I)) provided by the University Grants Commission of India.; This work was supported by an intramural grant from NIBMG, Kalyani and an extramural grant (No. BT/PR5548/MED/29/571/2012, duration of 3 years, sanctioned on 27-05-2013) from the Department of Biotechnology, Government of India. S.M. acknowledges research fellowship (No. F.2-45/2011(SA-I)) provided by the University Grants Commission of India. We are grateful to the patients of SCB Medical College Hospital for contributing blood samples for the study. We thank the Director, NIBMG, India for facilitating this work. We thank our colleagues at the NIBMG core facility and the ILS laboratory for timely processing of the samples, often at short notice. S.K.M. acknowledges very helpful advice received from Prof. Gagandeep Kang during data analysis. Presentation of Work: Part of this work was presented on 5-6 Feb, 2016 at Sepsis 2016, Agra, India.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Fisher R. A., 1946, Statistical methods for research workers.; Gentleman R, 2014, CATEGORY CATEGORY AN; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hesterberg TC, 2015, AM STAT, V69, P371, DOI 10.1080/00031305.2015.1089789; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parker HS, 2014, PEERJ, V2, DOI 10.7717/peerj.561; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Smith LM, 2002, CRIT CARE MED, V30, P837, DOI 10.1097/00003246-200204000-00020; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wagner EF, 2003, ANN RHEUM DIS, V62, P83, DOI 10.1136/ard.62.suppl_2.ii83; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34	25	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171689	10.1371/journal.pone.0171689	http://dx.doi.org/10.1371/journal.pone.0171689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199355	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400044
J	Schwarz, D; Raddatz, M; Wings, O				Schwarz, Daniela; Raddatz, Maik; Wings, Oliver			Knoetschkesuchus langenbergensis gen. nov sp nov., a new atoposaurid crocodyliform from the Upper Jurassic Langenberg Quarry (Lower Saxony, northwestern Germany), and its relationships to Theriosuchus	PLOS ONE			English	Article							MESOEUCROCODYLIA; CROCODYLOMORPHA; ORIGIN; GONIOPHOLIS; MORPHOLOGY; ALLIGATOR; GUIMAROTA; ANATOMY	We report a new, small-sized atoposaurid crocodyliform from the Upper Jurassic of Langenberg, Northeastern Germany. Atoposaurids are small-sized Mesozoic crocodyliforms of mainly European distribution, which are considered to be phylogenetically close to the origin of Eusuchia. Knoetschkesuchus langenbergensis gen. nov. sp. nov. is represented by two well-preserved skulls and additional cranial and postcranial remains representing different ontogenetic stages. 3D reconstructions of a juvenile skull based on micro-computed tomography allow the most detailed description of cranial remains of any atoposaurid hitherto presented. Our new analysis contradicts previous preliminary assignment of the Langenberg atoposaurids to Theriosuchus. Knoetschkesuchus gen. nov. is characterized in particular by the presence of two dental morphotypes in the maxilla and dentary, slit-like secondary choanae within a narrow groove on the surface of the pterygoid, absence of lacrimonasal contact, presence of an antorbital foramen and an external mandibular fenestra, and proportional characters of the interorbital and intertemporal region. A similar combination of characters allows attribution of Theriosuchus guimarotae to Knoetschkesuchus, forming the new combination Knoetschkesuchus guimarotae. Our analysis provides an osteological basis for the separation of Theriosuchus and Knoetschkesuchus and helps further delineate generic differences in other closely related crocodylomorphs. Our phylogenetic analysis corroborates inclusion of Knoetschkesuchus into Atoposauridae and supports a position of Atoposauridae within Eusuchia.	[Schwarz, Daniela; Raddatz, Maik] Museum Nat Kunde Berlin, Leibniz Inst Evolutionary & Biodivers Res, Berlin, Germany; [Wings, Oliver] Landesmuseum Hannover, Dept Nat Sci, Hannover, Germany; [Wings, Oliver] Museum Nat, Stiftung Schloss Friedenstein Gotha, Schloss Friedenstein, Gotha, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung	Schwarz, D (corresponding author), Museum Nat Kunde Berlin, Leibniz Inst Evolutionary & Biodivers Res, Berlin, Germany.	Daniela.Schwarz@mfn-berlin.de	Wings, Oliver/ABC-9644-2021	Schwarz, Daniela/0000-0003-4017-8914	Volkswagen Foundation [85 882]	Volkswagen Foundation(Volkswagen)	The Volkswagen Foundation generously funded the Europasaurus-Project (grant no. 85 882) and OW in the grant initiative "Research in Museums."	Adams TL, 2013, J VERTEBR PALEONTOL, V33, P85, DOI 10.1080/02724634.2012.713277; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Brinkmann W, 1989, DOCUMENTA NATURAE, V56, P1; Brinkmann W., 1992, BERLINER GEOWISSENSC, V5, P1; BUFFETAUT E, 1981, Geobios (Villeurbanne), V14, P815, DOI 10.1016/S0016-6995(81)80155-6; Buffetaut E., 1983, Bulletin of the British Museum (Natural History) Geology, V37, P93; Buffetaut E., 1982, ME MOIRES SOCIE TE G, V142, P1, DOI DOI 10.1016/S0016-6995(83)80048-5; Buscalioni A.D., 1990, Treballs del Museu de Geologia de Barcelona, V1, P77; Buscalioni A.D., 1990, Journal of Vertebrate Paleontology, V10, P244; BUSCALIONI A D, 1987, Estudios Geologicos (Madrid), P23; Buscalioni AD, 1996, J VERTEBR PALEONTOL, V16, P358, DOI 10.1080/02724634.1996.10011322; Buscalioni AD, 1988, HIST BIOL, V1988, P233; Buscalioni AD, 1988, INT S VERT BEH DER F, P65; Carballido JL, 2013, J SYSTEMATIC PALAEON, P1, DOI DOI 10.1080/14772019.2013.764935; Clark JM., 1986, THESIS; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Fiorillo A.R, 1999, UTAH GEOLOGICAL SURV, V1, P259; Fischer R., 1991, ARBEITSKREIS PAL ONT, V19, P21; Flynn JJ, NEW MEXICO MUSEUM NA, P476; GERKE O, 2014, J VERTEBR PALEONTOL, V2014, P137; Gervais P., 1871, CR HEBD ACAD SCI, V73, P603; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Hay OP, 1930, 2 BIBLIO CATALOG FOS, V2; Huxley T.H., 1875, Q J GEOLOGICAL SOC, V41, P423, DOI DOI 10.1144/GSL.JGS.1875.031.01-04.29; Iordansky N.N., 1973, P201; Jansen M, 2014, PALAEONTOLOGY, V57, P743, DOI 10.1111/pala.12085; Joffe J., 1967, Palaeontology, V10, P629; Kalin J, 1955, TRAITE PALEONTOL, V5, P695; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; Krebs B., 1968, Mems Serves geol Port NS, V14, P21; Krebs B., 1967, Palaeontologische Zeitschrift, V41, P46; Krebs Bernard, 2000, P69; Lallensack J.N., 2015, PALAEONTOL ELECTRON, V18, P1, DOI DOI 10.26879/529; Lauprasert K, 2010, PALAEONTOL Z, V85, P37; Lotze F, 1968, NEUES JB GEOLOGIE PA, V1968, P730; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Martin JE, 2014, J PALEONTOL, V88, P444, DOI 10.1666/13-106; Martin JE, 2010, NATURWISSENSCHAFTEN, V97, P845, DOI 10.1007/s00114-010-0702-y; Martin T, 2000, A JURASSIC ECOSYSTEM; Martin T, ACTA PALAEO IN PRESS; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; MOOK CHARLES C., 1934, JOUR GEOL, V42, P295; Mudroch A, 2001, FISCHZAHNE OBERJURA; Mudroch Alexander, 1996, Geologica et Palaeontologica, V30, P239; Nopcsa F., 1928, GEOL HUNG SER PALAEO, V1, P75; NORELL M A, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V60, P115; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Osi A, 2012, TRIBUTE C DARWIN BER, P533; Osi A, 2014, HIST BIOL, V26, P279, DOI 10.1080/08912963.2013.777533; Owen R., 1879, PALAEONTOGRAPHICAL S, V33, P1; OWEN R, 1878, PALAEONTOGRAPHICAL S, V32, P1; Pape H, 1970, MITTEILUNGEN GEOLOGI, V9, P41; Pienkowski G., 2008, GEOLOGY CENTRAL EURO, P823, DOI [10.1144/CEV2P.2, DOI 10.1144/CEV2P.2]; Pol D, 2009, B AM MUS NAT HIST, P1; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; RICHTER A, 2013, J VERTEBR PALEONTOL, V2013, P198; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Salisbury Steven W., 2011, Palaeontological Association Field Guides to Fossils, V14, P305; Salisbury SW, 2002, SPEC PAP PALAEONTOL, P121; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Salisbury SW, 1999, SPEC PAP PALAEONTOL, P121; Salisbury SW, 2006, P ROYAL SOC B, P1; Salisbury SW., 2001, THESIS; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Schwarz D, 2005, GEOBIOS-LYON, V38, P779, DOI 10.1016/j.geobios.2004.04.005; Schwarz D, 2004, CAN J EARTH SCI, V41, P1259, DOI 10.1139/E04-059; Schwarz D, 2002, PALAEONTOLOGY, V45, P185, DOI 10.1111/1475-4983.00233; Schwarz-Wings D, 2009, CRETACEOUS RES, V30, P1345, DOI 10.1016/j.cretres.2009.07.011; Schweigert G., 1999, OSNABRUCKER NATURWIS, V25, P25; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; STEEL R, 1973, HDB PALAOHERPETOLOGI, V16, P1; Tennant JP, 2014, PEERJ, V2, DOI 10.7717/peerj.599; Thies D, 1995, J VERTEBR PALEONTOL, V15, P463, DOI 10.1080/02724634.1995.10011242; THIES D, 2001, GEOLOGISCHE BEITRAGE, V2, P65; Thies Detlev, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P393; Turner AH, 2015, PEER J; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Wellnhofer P., 1971, Palaeontographica A, V138, P133; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004; WILSON RCL, 1989, AAPG BULL, V46, P341, DOI DOI 10.1306/M46497C22; Wings O., 2015, 12 S MES TERR EC SHE, P99; Wings O, 2012, IFUNDAMENTAL, V20, P281; Wings Oliver, 2010, Palaeobiodiversity Palaeoenvironments, V90, P283, DOI 10.1007/s12549-010-0033-1; Woodward A. S., 1885, Geological Magazine, V(3), P496; Wu XC, 1996, CAN J EARTH SCI, V33, P599, DOI 10.1139/e96-044; Wu XC, 1996, PALAEONTOLOGY, V39, P351; Young MT, 2015, ZOOLOGICAL J LINNEAN; Ziegler P, 1988, MEMOIR AM ASS PETROL, V43, P63; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C; Zittel R., 1890, HDB PALAEONTOLOGIE, V3	97	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0160617	10.1371/journal.pone.0160617	http://dx.doi.org/10.1371/journal.pone.0160617			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199316	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400001
J	Storch, LS; Glaser, SM; Ye, H; Rosenberg, AA				Storch, Laura S.; Glaser, Sarah M.; Ye, Hao; Rosenberg, Andrew A.			Stock assessment and end-to-end ecosystem models alter dynamics of fisheries data	PLOS ONE			English	Article							TIME-SERIES; MANAGEMENT; FLUCTUATIONS; VARIABILITY; POPULATIONS; TRENDS; OCEAN; ERROR	Although all models are simplified approximations of reality, they remain useful tools for understanding, predicting, and managing populations and ecosystems. However, a model's utility is contingent on its suitability for a given task. Here, we examine two model types: single-species fishery stock assessment and multispecies marine ecosystem models. Both are efforts to predict trajectories of populations and ecosystems to inform fisheries management and conceptual understanding. However, many of these ecosystems exhibit nonlinear dynamics, which may not be represented in the models. As a result, model outputs may underestimate variability and overestimate stability. Using nonlinear forecasting methods, we compare predictability and nonlinearity of model outputs against model inputs using data and models for the California Current System. Compared with model inputs, time series of model-processed outputs show more predictability but a higher prevalence of linearity, suggesting that the models misrepresent the actual predictability of the modeled systems. Thus, caution is warranted: using such models for management or scenario exploration may produce unforeseen consequences, especially in the context of unknown future impacts.	[Storch, Laura S.] Univ New Hampshire, Dept Math & Stat, Durham, NH 03824 USA; [Glaser, Sarah M.] Univ Denver, Korbel Sch Int Studies, Denver, CO USA; [Glaser, Sarah M.] One Earth Future Fdn, Secure Fisheries, Broomfield, CO USA; [Ye, Hao] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA	University System Of New Hampshire; University of New Hampshire; University of Denver; University of California System; University of California San Diego; Scripps Institution of Oceanography	Storch, LS (corresponding author), Univ New Hampshire, Dept Math & Stat, Durham, NH 03824 USA.	laura.storch@wildcats.unh.edu	Ye, Hao/HGD-5399-2022	Storch, Laura/0000-0002-5000-4929; Ye, Hao/0000-0002-8630-1458	United States National Science Foundation; National Oceanic and Atmospheric Administration's Comparative Analysis of Marine Ecosystem Organization (CAMEO) program [NA09NMF4720177, NA08OAR4320894]; United States Department of Defense Strategic Environmental Research and Development Program [15 RC-2509]; Lenfest Ocean Program [00028335]; McQuown Fund	United States National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration's Comparative Analysis of Marine Ecosystem Organization (CAMEO) program; United States Department of Defense Strategic Environmental Research and Development Program; Lenfest Ocean Program; McQuown Fund	Funding for the research study was provided through the United States National Science Foundation (http://www.nsf.gov) and National Oceanic and Atmospheric Administrations (http://www.noaa.gov) Comparative Analysis of Marine Ecosystem Organization (CAMEO) program, grants NA09NMF4720177 and NA08OAR4320894. Funding for the publication of the paper was provided through the United States Department of Defense Strategic Environmental Research and Development Program, grant 15 RC-2509, the Lenfest Ocean Program, award number 00028335, and the McQuown Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuddington K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00178.1; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Gewin V, 2015, NATURE, V524, P396, DOI 10.1038/nature.2015.18218; Glaser SM, 2014, FISH FISH, V15, P616, DOI 10.1111/faf.12037; Glaser SM, 2011, CAN J FISH AQUAT SCI, V68, P400, DOI 10.1139/F10-160; Haldane A., 2012, DOG FRISBEE; Horne PJ, 2010, NMFSNWFSC104140 NOAA, P104; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, AM NAT, V171, P71, DOI 10.1086/524202; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hsieh CH, 2006, ECOLOGY, V87, P1932, DOI 10.1890/0012-9658(2006)87[1932:BRTEFT]2.0.CO;2; Kaplan IC, 2016, ICES J MAR SCI, V73, P1715, DOI 10.1093/icesjms/fsw047; Kaplan IC, 2013, FISH FISH, V14, P515, DOI 10.1111/j.1467-2979.2012.00484.x; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Metcalf SJ, 2008, MAR ECOL PROG SER, V360, P25, DOI 10.3354/meps07394; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Mullon C, 2005, FISH FISH, V6, P111, DOI 10.1111/j.1467-2979.2005.00181.x; Olsen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146467; Perretti CT, 2013, P NATL ACAD SCI USA, V110, P5253, DOI 10.1073/pnas.1216076110; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Planque B, 2016, ICES J MAR SCI, V73, P204, DOI 10.1093/icesjms/fsv155; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2016, P NATL ACAD SCI USA, V113, P4895, DOI 10.1073/pnas.1604008113; [No title captured]	36	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171644	10.1371/journal.pone.0171644	http://dx.doi.org/10.1371/journal.pone.0171644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199344	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400039
J	Hamza, E; Kittl, S; Kuhnert, P				Hamza, Eman; Kittl, Sonja; Kuhnert, Peter			Temporal induction of pro-inflammatory and regulatory cytokines in human peripheral blood mononuclear cells by Campylobacter jejuni and Campylobacter coli	PLOS ONE			English	Article							IN-VITRO; RECEPTOR; INFECTIONS; EXPRESSION; SECRETION; ACTIVATION; SIGLEC-10; RESPONSES; UPDATE; ACID	Campylobacter jejuni along with C. coli are major cause of human gastroenteritis worldwide. So far, the human immune response against Campylobacter is not entirely clear. We hypothesize that it is coordinated by an interaction between pro-inflammatory and regulatory cytokines which is influenced by bacterial and host-individual differences. Accordingly, we used peripheral blood mononuclear cells (PBMC) from healthy donors to study the primary systemic immune response to C. jejuni and C. coli PBMC were stimulated by different strains of C. jejuniand C. co/ifor three time points (5, 10, 24 hours). The production of the pro-inflammatory (IL-6, IL-8, IFN-gamma) and the regulatory (IL-10) cytokines were measured by ELISA. All strains induced higher levels of IL-8 and IL-6 than IFN-gamma and IL-10. In contrast to IL-8 and IL 6, IL-10 showed a steeper increase over time. While IFN-gamma did not show any further increase between 10 and 24 hours. Interestingly, there was a significant correlation between IL-8 and IL-10 which peaked at 24 hours. Despite the variability of the used bacterial strains, their effect on cytokine production was less pronounced than the inter-person differences. The strongest significant effect of the strain was on the level of IL-10. IL-10 and IL-6 were significantly influenced by strain-person interaction. In conclusion, the systemic immune response to C. coli and C. jejuni is characterized by an early pro-inflammatory reaction with later initiation of regulatory immune response which is influenced mainly by the host, explaining the individual variations in disease severity. Additional work is needed to determine the cellular sources of the produced cytokines as well as the campylobacter molecules that might contribute to this stimulation.	[Hamza, Eman; Kittl, Sonja; Kuhnert, Peter] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland; [Hamza, Eman] Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt	University of Bern; Egyptian Knowledge Bank (EKB); Cairo University	Hamza, E (corresponding author), Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland.; Hamza, E (corresponding author), Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt.	e.hamza@gmx.ch	; Kuhnert, Peter/O-1651-2014	Hamza, Eman/0000-0001-9798-842X; Kuhnert, Peter/0000-0002-1575-5225				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; [Anonymous], 2015, CELL MOL IMMUNOL; Baqar S, 2001, CLIN INFECT DIS, V33, P901, DOI 10.1086/322594; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; Fimlaid KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112513; Friis LM, 2009, INFECT IMMUN, V77, P1553, DOI 10.1128/IAI.00707-08; Haller D, 2000, INFECT IMMUN, V68, P752, DOI 10.1128/IAI.68.2.752-759.2000; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Hu L, 2005, INFECT IMMUN, V73, P4437, DOI 10.1128/IAI.73.7.4437-4440.2005; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Islam D, 2014, APMIS, V122, P1102, DOI 10.1111/apm.12266; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; KIEHLBAUCH JA, 1985, INFECT IMMUN, V48, P446, DOI 10.1128/IAI.48.2.446-451.1985; Kirkpatrick BD, 2013, CLIN INFECT DIS; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Klancnlk A, 2016, VIRULENCE; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; MARTIN PMV, 1989, INFECT IMMUN, V57, P2542, DOI 10.1128/IAI.57.8.2542-2546.1989; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Murphy H, 2011, MICROBES INFECT, V13, P42, DOI 10.1016/j.micinf.2010.09.007; Naundorf S, 2009, EUR J IMMUNOL, V39, P1066, DOI 10.1002/eji.200838773; Stephenson HN, 2014, J INFECT DIS, V210, P1487, DOI 10.1093/infdis/jiu287; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; World Health Organization, 2013, GLOB VIEW CAMP REP E; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171350	10.1371/journal.pone.0171350	http://dx.doi.org/10.1371/journal.pone.0171350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196097	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900017
J	Akuoko, CP; Armah, E; Sarpong, T; Quansah, DY; Amankwaa, I; Boateng, D				Akuoko, Cynthia Pomaa; Armah, Ernestina; Sarpong, Theresa; Quansah, Dan Yedu; Amankwaa, Isaac; Boateng, Daniel			Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa	PLOS ONE			English	Article							LIMITED-RESOURCE COUNTRIES; DELAYED PRESENTATION; SCREENING PRACTICES; HEALTH; KNOWLEDGE; ATTITUDES; AWARENESS; SERVICES; DISTRICT; SYSTEMS	Background Breast cancer (BC) has been described as the leading cause of cancer deaths among women especially in the developing world including sub Saharan Africa (SSA). Delayed presentation and late diagnosis at health facilities are parts of the contributing factors of high BC mortality in Africa. This review aimed to appraise the contributing factors to delayed breast cancer presentation and diagnosis among SSA women. Methods Five databases encompassing medical and social sciences were systematically searched using predefined search terms linked with breast cancer presentation and diagnosis and sub Saharan Africa. Reference lists of relevant papers were also hand searched. Quality of quantitative and qualitative articles were assessed using the National Institute of Health (NIH) Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies and the Critical Appraisal Skills Programme (CASP) quality appraisal checklist. Thematic analysis was used to synthesize the qualitative studies to integrate findings. Results Fourteen (14) quantitative studies, two (2) qualitative studies and one (1) mixed method study merited inclusion for analysis. This review identified low knowledge of breast cancer among SSA women. This review also found lack of awareness of early detection treatment, poor perception of BC, socio-cultural factors such as belief, traditions and fear as factors impacting African women's health seeking behavior in relation to breast cancer. Conclusion Improving African women's knowledge and understanding will improve behaviors related to breast cancer and facilitate early presentation and detection and enhance proper management and treatment of breast cancer.	[Akuoko, Cynthia Pomaa; Armah, Ernestina; Sarpong, Theresa] Christian Serv Univ Coll, Kumasi, Ghana; [Quansah, Dan Yedu] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Amankwaa, Isaac] Garden City Univ Coll, Kumasi, Ghana; [Boateng, Daniel] Univ Utrecht, Univ Med Ctr, Julius Global Hlth, NL-3508 TC Utrecht, Netherlands; [Boateng, Daniel] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana	Seoul National University (SNU); Utrecht University; Utrecht University Medical Center; Kwame Nkrumah University Science & Technology	Boateng, D (corresponding author), Univ Utrecht, Univ Med Ctr, Julius Global Hlth, NL-3508 TC Utrecht, Netherlands.; Boateng, D (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana.	kingdannie@gmail.com	Armah, Ernestina/ABF-7001-2020; Boateng, Daniel/H-2918-2019; Amankwaa, Isaac/AAL-1702-2020; Akuoko, Cynthia/W-1519-2019; Quansah, Dan Yedu/B-8499-2018	Boateng, Daniel/0000-0001-7568-7298; Amankwaa, Isaac/0000-0002-7879-4731; Akuoko, Cynthia/0000-0002-3661-8625; Quansah, Dan Yedu/0000-0002-3091-9400				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Akhigbe AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-203; Amosu A. M., 2011, Archives of Applied Science Research, V3, P253; Anderson Benjamin O, 2003, Breast J, V9 Suppl 2, pS51, DOI 10.1046/j.1524-4741.9.s2.4.x; Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Archampong EQ, 1977, GHANA MED J, V16, P63; Azubuike SO, 2013, ANN MED HEALTH SCI R, V3, P155, DOI 10.4103/2141-9248.113653; Bairati I, 2007, CANCER DETECT PREV, V31, P323, DOI 10.1016/j.cdp.2007.08.001; Balogun MO, 2005, ANN IBADAN POSTGRADU, V3, P52; Bish A, 2005, J PSYCHOSOM RES, V58, P321, DOI 10.1016/j.jpsychores.2004.10.007; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Burgess CC, 1998, BRIT J CANCER, V77, P1343, DOI 10.1038/bjc.1998.224; Cancer Research UK, 2014, WORLDW CANC MORT STA; Carlson Robert W, 2003, Breast J, V9 Suppl 2, pS67, DOI 10.1046/j.1524-4741.9.s2.6.x; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; Clegg-Lamptey J, 2009, Ghana Med J, V43, P127; COATES RJ, 1992, JNCI-J NATL CANCER I, V84, P938, DOI 10.1093/jnci/84.12.938; Critical Appraisal Skills Programme, 2013, QUAL RES CHECKL; Cutler David M, 2010, J Health Econ, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2006, ED HLTH EVALUATING T; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Frisby CM, 2002, J BLACK STUD, V32, P489, DOI 10.1177/002193470203200501; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gates M F, 2001, Oncol Nurs Forum, V28, P529; Gullatte MM, 2010, J RELIG HEALTH, V49, P62, DOI 10.1007/s10943-008-9232-8; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Harmer Victoria, 2008, Br J Nurs, V17, P1028; Hoque E., 2009, Southern African Journal of Epidemiology & Infection, V24, P21; Ibrahim NA, 2012, BREAST, V21, P416, DOI 10.1016/j.breast.2012.02.006; International Agency for Research on Cancer, 2008, CANC INC MORT WORLDW; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kazaura RM, 2007, E AFR J PUBLIC HLTH, V4, P19; Kenkel DS, 2000, HDB HLTH EC; Kishore J, 2007, ASIAN PAC J CANCER P, V8, P155; Lannin DR, 2002, AM J SURG, V184, P418, DOI 10.1016/S0002-9610(02)01009-7; LONG E, 1993, CANCER NURS, V16, P1; Maree J, 2013, BREAST J, V19, P453, DOI 10.1111/tbj.12143; Maree JE, 2010, EUR J ONCOL NURS, V14, P190, DOI 10.1016/j.ejon.2009.10.009; Mbuka-Ongona D., 2013, African Journal of Primary Health Care and Family Medicine, V5; Morse EP, 2014, BREAST CANCER-BASIC, V8, P73, DOI 10.4137/BCBCR.S13745; Muthoni A, 2010, HEALTH CARE WOMEN IN, V31, P801, DOI 10.1080/07399331003628453; NIH National Heart Lung and Blood Institute, 2014, QUALITY ASSESSMENT T; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Nuamah GB, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0408-7; Okobia Michael N, 2006, World J Surg Oncol, V4, P11, DOI 10.1186/1477-7819-4-11; Oluwatosin OA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-271; Opoku SY, 2012, PAN AFR MED J, V11; Pace LE, 2015, ONCOLOGIST, V20, P780, DOI 10.1634/theoncologist.2014-0493; Pedersen VH, 2011, INT J TECHNOL ASSESS, V27, P238, DOI 10.1017/S0266462311000213; Pillay AL, 2002, ETHNIC HEALTH, V7, P103, DOI 10.1080/1355785022000038588; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Rauscher GH, 2002, CANCER EPIDEM BIOMAR, V19, P640; Smith RA, 2006, BREAST J, V12, pS16, DOI 10.1111/j.1075-122X.2006.00200.x; Suh Mary Atanga Bi, 2012, BMC Res Notes, V5, P627, DOI 10.1186/1756-0500-5-627; Sule E. A., 2011, Continental Journal of Medical Research, V5, P27; The United Nations Population Division Department of Economic and Social Affairs, 2012, WORLD POP PROSP 2012; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thomas VN, 2005, INT J PALLIAT NURS, V11, P562, DOI 10.12968/ijpn.2005.11.11.20096; UN, 2014, ESAPWP235 UN, P44; Witter S, 2004, INT J HEALTH PLAN M, V19, P195, DOI 10.1002/hpm.753; World Health Organization, 2008, CANC FACT SHEET 2008; Yan YY, 2009, GLOBAL J HLTH SCI, V1, P97, DOI DOI 10.5539/GJHS.V1N2P97]	63	78	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171024	10.1371/journal.pone.0171024	http://dx.doi.org/10.1371/journal.pone.0171024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192444	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800016
J	Casazza, G; Lumini, E; Ercole, E; Dovana, F; Guerrina, M; Arnulfo, A; Minuto, L; Fusconi, A; Mucciarelli, M				Casazza, Gabriele; Lumini, Erica; Ercole, Enrico; Dovana, Francesco; Guerrina, Maria; Arnulfo, Annamaria; Minuto, Luigi; Fusconi, Anna; Mucciarelli, Marco			The abundance and diversity of arbuscular mycorrhizal fungi are linked to the soil chemistry of screes and to slope in the Alpic paleo-endemic Berardia subacaulis	PLOS ONE			English	Article							MOLECULAR DIVERSITY; GLOBAL DIVERSITY; AMF COMMUNITIES; PLANT-ROOTS; COLONIZATION; ELEVATION; GRADIENT; BIODIVERSITY; RHIZOSPHERE; GRASSLANDS	Berardia subacaulis Vill. is a monospecific genus that is endemic to the South-western Alps, where it grows on alpine screes, which are extreme habitats characterized by soil disturbance and limiting growth conditions. Root colonization by arbuscular mycorrhizal fungi (AMF) is presumably of great importance in these environments, because of its positive effect on plant nutrition and stress tolerance, as well as on structuring the soil. However, there is currently a lack of information on this topic. In this paper, we tested which soil characteristics and biotic factors could contribute to determining the abundance and community composition of AMF in the roots of B. subacaulis, which had previously been found to be mycorrhizal. For such a reason, the influence of soil properties and environmental factors on AMF abundance and community composition in the roots of B. subacaulis, sampled on three different scree slopes, were analysed through microscopic and molecular analysis. The results have shown that the AMF community of Berardia roots was dominated by Glomeraceae, and included a core of AMF taxa, common to all three scree slopes. The vegetation coverage and dark septate endophytes were not related to the AMF colonization percentage and plant community did not influence the root AMF composition. The abundance of AMF in the roots was related to some chemical (available extractable calcium and potassium) and physical (cation exchange capacity, electrical conductivity and field capacity) properties of the soil, thus suggesting an effect of AMF on improving the soil quality. The non-metric multidimensional scaling (NMDS) ordination of the AMF community composition showed that the diversity of AMF in the various sites was influenced not only by the soil quality, but also by the slope. Therefore, the slopeinduced physical disturbance of alpine screes may contribute to the selection of disturbancetolerant AMF taxa, which in turn may lead to different plant-fungus assemblages.	[Casazza, Gabriele; Guerrina, Maria; Minuto, Luigi] Univ Genoa, DISTAV, Corso Europa 26, Genoa, Italy; [Lumini, Erica] CNR, Ist Protez Sostenibile Piante, Viale PA Mattioli 25, Turin, Italy; [Ercole, Enrico; Dovana, Francesco; Arnulfo, Annamaria; Fusconi, Anna; Mucciarelli, Marco] Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Viale PA Mattioli 25, Turin, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); University of Turin	Mucciarelli, M (corresponding author), Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Viale PA Mattioli 25, Turin, Italy.	marco.mucciarelli@unito.it	Dovana, Francesco/AAR-9737-2021; LUMINI, Erica/AAR-7802-2021; Mucciarelli, Marco/D-6054-2011; LUMINI, Erica/F-8901-2013	LUMINI, Erica/0000-0001-5864-8561; LUMINI, Erica/0000-0001-5864-8561; dovana, francesco/0000-0002-8556-7692; Mucciarelli, Marco/0000-0001-8256-7980				Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Becklin KM, 2012, MICROB ECOL, V63, P682, DOI 10.1007/s00248-011-9968-7; Berruti A, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01559; Binet MN, 2011, MYCORRHIZA, V21, P523, DOI 10.1007/s00572-010-0354-y; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Coutinho ES, 2015, MYCORRHIZA, V25, P627, DOI 10.1007/s00572-015-0636-5; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Davison J, 2016, SOIL BIOL BIOCHEM, V97, P63, DOI 10.1016/j.soilbio.2016.03.003; De Caceres M., 2015, PACKAGE INDICSPECIES; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Estrada B, 2013, J ARID ENVIRON, V97, P170, DOI 10.1016/j.jaridenv.2013.05.019; Fisher MA, 2004, FOREST ECOL MANAG, V200, P293, DOI 10.1016/j.foreco.2004.07.003; Gai JP, 2012, PEDOBIOLOGIA, V55, P145, DOI 10.1016/j.pedobi.2011.12.004; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Guerrina M, 2016, J PLANT RES, V129, P477, DOI 10.1007/s10265-016-0796-1; Guerrina M, 2016, REG ENVIRON CHANGE, V16, P1035, DOI 10.1007/s10113-015-0816-z; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jurasinski G., 2015, SIMBA COLLECTION FUN; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawahara A, 2013, OECOLOGIA, V173, P533, DOI 10.1007/s00442-013-2622-y; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 2002, MYCORRHIZA, V12, P181, DOI 10.1007/s00572-002-0169-6; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leigh EG, 1999, TROPICAL FOREST ECOL; Lekberg Y, 2016, FUNGAL ECOL, V24, P135, DOI 10.1016/j.funeco.2016.05.012; Li XL, 2014, MYCORRHIZA, V24, P95, DOI 10.1007/s00572-013-0518-7; Liu W, 2014, FEMS MICROBIOL ECOL, V90, P436, DOI 10.1111/1574-6941.12405; Lukesova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124752; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Mandyam K, 2005, STUD MYCOL, P173; Mandyam KG, 2014, FRONT MICROBIOL, V5, P1; Martin SL, 2012, SOIL BIOL BIOCHEM, V49, P167, DOI 10.1016/j.soilbio.2012.02.036; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Murphy B., 2008, IOP C SERIES EARTH E; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2006, MYCOLOGIA, V98, P286, DOI 10.3852/mycologia.98.2.286; Oehl F, 2014, ALPINE BOT, V124, P193, DOI 10.1007/s00035-014-0138-7; Oehl F, 2012, NOVA HEDWIGIA, V95, P105, DOI 10.1127/0029-5035/2012/0038; Oehl F, 2011, PEDOBIOLOGIA, V54, P321, DOI 10.1016/j.pedobi.2011.07.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Ohsowski BM, 2014, NEW PHYTOL, V204, P171, DOI 10.1111/nph.12894; Oksanen J., 2015, PACKAGE VEGAN; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Ozenda P, 2009, CR BIOL, V332, P1092, DOI 10.1016/j.crvi.2009.09.018; Pellissier L, 2014, MOL ECOL, V23, P4274, DOI 10.1111/mec.12854; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1981, NEW PHYTOL, V88, P341, DOI 10.1111/j.1469-8137.1981.tb01729.x; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2008, ARCT ANTARCT ALP RES, V40, P576, DOI 10.1657/1523-0430(07-068)[SCHMIDT]2.0.CO;2; Schnoor TK, 2011, MYCORRHIZA, V21, P211, DOI 10.1007/s00572-010-0325-3; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Senes-Guerrero C, 2016, FUNGAL DIVERS, V77, P317, DOI 10.1007/s13225-015-0328-7; Shi ZY, 2014, CAN J MICROBIOL, V60, P811, DOI 10.1139/cjm-2014-0416; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonjak S, 2009, PLANT SOIL, V314, P25, DOI 10.1007/s11104-008-9702-5; Stevens KJ, 2011, MYCORRHIZA, V21, P279, DOI 10.1007/s00572-010-0334-2; Sudduth KA, 2001, COMPUT ELECTRON AGR, V31, P239, DOI 10.1016/S0168-1699(00)00185-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Van Geel M, 2014, J MICROBIOL METH, V106, P93, DOI 10.1016/j.mimet.2014.08.006; Vandegrift R, 2015, PEERJ, V3, DOI 10.7717/peerj.1379; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Xiang D, 2014, NEW PHYTOL, V204, P968, DOI 10.1111/nph.12961; Yilmaz P., 2013, NUCL ACIDS RES; Zhang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130051; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zobel M, 2014, J VEG SCI, V25, P1133, DOI 10.1111/jvs.12191	83	29	30	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171866	10.1371/journal.pone.0171866	http://dx.doi.org/10.1371/journal.pone.0171866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192471	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800047
J	Jespersen, D; Belanger, FC; Huang, BR				Jespersen, David; Belanger, Faith C.; Huang, Bingru			Candidate genes and molecular markers associated with heat tolerance in colonial Bentgrass	PLOS ONE			English	Article							THERMAL AGROSTIS-SCABRA; INDUCED LEAF SENESCENCE; CREEPING BENTGRASS; DOLLAR SPOT; DROUGHT TOLERANCE; SHOCK PROTEINS; LINKAGE MAP; STRESS; IDENTIFICATION; EXPRESSION	Elevated temperature is a major abiotic stress limiting the growth of cool-season grasses during the summer months. The objectives of this study were to determine the genetic variation in the expression patterns of selected genes involved in several major metabolic pathways regulating heat tolerance for two genotypes contrasting in heat tolerance to confirm their status as potential candidate genes, and to identify PCR-based markers associated with candidate genes related to heat tolerance in a colonial (Agrostis capillaris L.) x creeping bentgrass (Agrostis stolonifera L.) hybrid backcross population. Plants were subjected to heat stress in controlled-environmental growth chambers for phenotypic evaluation and determination of genetic variation in candidate gene expression. Molecular markers were developed for genes involved in protein degradation (cysteine protease), antioxidant defense (catalase and glutathione-S-transferase), energy metabolism (glyceraldehyde-3-phosphate dehydrogenase), cell expansion (expansin), and stress protection (heat shock proteins HSP26, HSP70, and HSP101). Kruskal-Wallis analysis, a commonly used non parametric test used to compare population individuals with or without the gene marker, found the physiological traits of chlorophyll content, electrolyte leakage, normalized difference vegetative index, and turf quality were associated with all candidate gene markers with the exception of HSP101. Differential gene expression was frequently found for the tested candidate genes. The development of candidate gene markers for important heat tolerance genes may allow for the development of new cultivars with increased abiotic stress tolerance using marker-assisted selection.	[Jespersen, David; Belanger, Faith C.; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Jespersen, David] Univ Georgia, Dept Crop & Soil Sci, Griffin, GA USA	Rutgers State University New Brunswick; University System of Georgia; University of Georgia	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	Huang@aesop.rutgers.edu			United States Golf Association; New Jersey Agricultural Experimental Station	United States Golf Association; New Jersey Agricultural Experimental Station	This work was supported by the United States Golf Association and the New Jersey Agricultural Experimental Station for funding support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Beard J. B., 1972, TURFGRASS SCI CULTUR; Belanger FC, 2004, CROP SCI, V44, P581, DOI 10.2135/cropsci2004.5810; Belanger FC, 2003, CROP SCI, V43, P2172, DOI 10.2135/cropsci2003.2172; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CARROW RN, 1996, GOLF COURSE MANAG, V64, P51; Chakraborty N, 2014, HORTIC ENVIRON BIOTE, V55, P329, DOI 10.1007/s13580-014-0015-8; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DaCosta M, 2007, J AM SOC HORTIC SCI, V132, P60, DOI 10.21273/JASHS.132.1.60; Fenstermaker-Shaulis L. K., 1997, Journal of Turfgrass Management, V2, P65, DOI 10.1300/J099v02n01_06; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; He YL, 2005, J AM SOC HORTIC SCI, V130, P521, DOI 10.21273/JASHS.130.4.521; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Honig JA, 2014, MOL BREEDING, V34, P185, DOI 10.1007/s11032-014-0029-z; Jespersen D, 2013, INT TURFS SOC RES J, V12, P459; Jespersen D, 2015, CROP SCI, V55, P837, DOI 10.2135/cropsci2014.04.0335; Jespersen D, 2015, PROTEOMICS, V15, P798, DOI 10.1002/pmic.201400393; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee DG, 2007, PROTEOMICS, V7, P3369, DOI 10.1002/pmic.200700266; Marcum KB, 1998, CROP SCI, V38, P1214, DOI 10.2135/cropsci1998.0011183X003800050017x; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; Merewitz EB, 2012, CROP SCI, V52, P1891, DOI 10.2135/cropsci2012.01.0037; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Pelleschi S, 1999, PLANT MOL BIOL, V39, P373, DOI 10.1023/A:1006116310463; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Quint M, 2002, THEOR APPL GENET, V105, P355, DOI 10.1007/s00122-002-0953-x; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rotter D, 2012, PLANT BREEDING, V131, P193, DOI 10.1111/j.1439-0523.2011.01891.x; Rotter D, 2009, CROP SCI, V49, P1609, DOI 10.2135/cropsci2008.12.0714; SAS Institute, 1992, SAS STAT 9 2 US GUID; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; THOMAS H, 1980, ANNU REV PLANT PHYS, V31, P83, DOI 10.1146/annurev.pp.31.060180.000503; Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758; Tian J, 2009, J PLANT PHYSIOL, V166, P588, DOI 10.1016/j.jplph.2008.09.003; Tondelli A, 2006, THEOR APPL GENET, V112, P445, DOI 10.1007/s00122-005-0144-7; TURGEON AJ, 1999, TURFGRASS MANAGEMENT; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Veerasamy M, 2007, J AM SOC HORTIC SCI, V132, P467, DOI 10.21273/JASHS.132.4.467; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xu CP, 2010, PHYSIOL PLANTARUM, V139, P192, DOI 10.1111/j.1399-3054.2010.01357.x; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Xu QZ, 2004, CROP SCI, V44, P553, DOI 10.2135/cropsci2004.0553; Xu Y, 2010, J EXP BOT, V61, P3273, DOI 10.1093/jxb/erq149; YANG YJ, 1993, PLANT PHYSIOL, V101, P209, DOI 10.1104/pp.101.1.209; Yu XQ, 2013, J EXP BOT, V64, P1537, DOI 10.1093/jxb/ert018; Zhou P, 2011, CROP SCI, V51, P333, DOI 10.2135/cropsci2010.07.0391	56	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171183	10.1371/journal.pone.0171183	http://dx.doi.org/10.1371/journal.pone.0171183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187136	gold, Green Published			2022-12-27	WOS:000394244300013
J	O'Connor, JM; Limpus, CJ; Hofmeister, KM; Allen, BL; Burnett, SE				O'Connor, Julie M.; Limpus, Colin J.; Hofmeister, Kate M.; Allen, Benjamin L.; Burnett, Scott E.			Anti-predator meshing may provide greater protection for sea turtle nests than predator removal	PLOS ONE			English	Article							FOX VULPES-VULPES; CARETTA-CARETTA; RED FOX; CHRYSEMYS-PICTA; EXCLOSURES; POPULATION; DEPREDATION; BEHAVIOR; MARKING	The problem of how to protect sea turtle nests from terrestrial predators is of worldwide concern. On Queensland's southern Sunshine Coast, depredation of turtle nests by the introduced European red fox (Vulpes vulpes) has been recorded as the primary terrestrial cause of egg and hatchling mortality. We investigated the impact of foxes on the nests of the loggerhead turtle (Caretta caretta) and occasional green turtle (Chelonia mydas) over ten nesting seasons. Meshing of nests with fox exclusion devices (FEDs) was undertaken in all years accompanied by lethal fox control in the first five-year period, but not in the second five-year period. Lethal fox control was undertaken in the study area from 2005 to February 2010, but foxes still breached 27% (range19-52%) of turtle nests. In the second five-year period, despite the absence of lethal fox control, the average percentage of nests breached was less than 3% (range 0-4%). Comparison of clutch depredation rates in the two five-year periods demonstrated that continuous nest meshing may be more effective than lethal fox control in mitigating the impact of foxes on turtle nests. In the absence of unlimited resources available for the eradication of exotic predators, the use of FEDs and the support and resourcing of a dedicated volunteer base can be considered an effective turtle conservation tool on some beaches.	[O'Connor, Julie M.; Burnett, Scott E.] Univ Sunshine Coast, Sippy Downs Dr, Sippy Downs, Qld, Australia; [O'Connor, Julie M.; Hofmeister, Kate M.] Sunshine Coast Reg Council, Caloundra, Qld, Australia; [Limpus, Colin J.] Dept Environm & Heritage Protect, Threatened Species Unit, Brisbane, Qld, Australia; [Allen, Benjamin L.] Univ Southern Queensland, Inst Agr & Environm, Toowoomba, Qld, Australia	University of the Sunshine Coast; University of Southern Queensland	O'Connor, JM (corresponding author), Univ Sunshine Coast, Sippy Downs Dr, Sippy Downs, Qld, Australia.; O'Connor, JM (corresponding author), Sunshine Coast Reg Council, Caloundra, Qld, Australia.	Julie.OConnor@sunshinecoast.qld.gov.au	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163	Sunshine Coast Regional Council (SCRC)	Sunshine Coast Regional Council (SCRC)	Sunshine Coast Regional Council (SCRC) provide ongoing funding to support the Turtle Care volunteer base. SCRC had no role in study design, decision to publish, or preparation of the manuscript.	Alcock J., 1989, ANIMAL BEHAV EVOLUTI; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; Bowen KD, 2005, J HERPETOL, V39, P649, DOI 10.1670/34-05N.1; Chatto R., 2004, REDUCTIONS FERAL DOG; Danchin E., 2008, BEHAV ECOLOGY; Department of the Environment Water Heritage and the Arts (DEWHA), 2008, THREAT AB PLAN PRED; ECKRICH CE, 1995, HERPETOLOGICA, V51, P349; Engeman RM, 2006, WILDLIFE RES, V33, P187, DOI 10.1071/WR05049; Engeman Richard M., 2000, Integrated Pest Management Reviews, V5, P197, DOI 10.1023/A:1011380314051; Engeman RM, 2003, BIOL CONSERV, V113, P171, DOI 10.1016/S0006-3207(02)00295-1; FOWLER LE, 1979, ECOLOGY, V60, P946, DOI 10.2307/1936863; Friend J. Anthony, 2003, P452; Friend T, 1996, ASSESSMENT EFFECT FO; HENRY JD, 1977, BEHAVIOUR, V61, P82, DOI 10.1163/156853977X00496; Isaksson D, 2007, BIOL CONSERV, V136, P136, DOI 10.1016/j.biocon.2006.11.015; Johnson M, 2002, WATERBIRDS, V25, P184, DOI 10.1675/1524-4695(2002)025[0184:ANEAET]2.0.CO;2; Kinnear JE, 1998, WILDLIFE RES, V25, P81, DOI 10.1071/WR96072; Kurz DJ, 2012, ORYX, V46, P223, DOI 10.1017/S0030605311000147; LIMPUS CJ, 2006, CONSERVATION TECHNIC; Limpus CJ, 2008, BIOL REV MARINE TURT; MACDONALD DW, 1994, J MAMMAL, V75, P985, DOI 10.2307/1382480; Major RE, 2014, WILDLIFE RES, V41, P598, DOI 10.1071/WR14136; Morris Keith, 2003, P435; Murphy RK, 2003, WATERBIRDS, V26, P150, DOI 10.1675/1524-4695(2003)026[0150:POAPPA]2.0.CO;2; Niehaus AC, 2004, WATERBIRDS, V27, P79, DOI 10.1675/1524-4695(2004)027[0079:ROPTWS]2.0.CO;2; NOL E, 1982, J FIELD ORNITHOL, V53, P263; Ratnaswamy MJ, 1997, J WILDLIFE MANAGE, V61, P368, DOI 10.2307/3802593; Reddiex B., 2004, REV EXISTING RED FOX; Rollinson N, 2007, J HERPETOL, V41, P174, DOI 10.1670/0022-1511(2007)41[174:MNITFO]2.0.CO;2; Saunders G., 2007, IMPROVING FOX MANAGE; Saunders G., 1995, MANAGING VERTEBRATE; SHERRY D, 1984, ANIM BEHAV, V32, P451, DOI 10.1016/S0003-3472(84)80281-X; Thornton A, 2010, LEARN BEHAV, V38, P297, DOI 10.3758/LB.38.3.297; Whiting SD, 2007, WILDLIFE RES, V34, P200, DOI 10.1071/WR06131; Yerli S, 1997, BIOL CONSERV, V82, P109, DOI 10.1016/S0006-3207(97)00003-7	35	9	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171831	10.1371/journal.pone.0171831	http://dx.doi.org/10.1371/journal.pone.0171831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187181	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300048
J	Turner, AH; Pritchard, AC; Matzke, NJ				Turner, Alan H.; Pritchard, Adam C.; Matzke, Nicholas J.			Empirical and Bayesian approaches to fossil only divergence times: A study across three reptile clades	PLOS ONE			English	Article							MOLECULAR TIMESCALES; EARLY EVOLUTION; TERMINAL TAXA; BODY-SIZE; PHYLOGENY; RADIATION; DIVERSIFICATION; CROCODYLIFORMES; CALIBRATIONS; PATTERNS	Estimating divergence times on phylogenies is critical in paleontological and neontological studies. Chronostratigraphically-constrained fossils are the only direct evidence of absolute timing of species divergence. Strict temporal calibration of fossil -only phylogenies provides minimum divergence estimates, and various methods have been proposed to estimate divergences beyond these minimum values. We explore the utility of simultaneous estimation of tree topology and divergence times using BEAST tip-dating on datasets consisting only of fossils by using relaxed morphological clocks and birth -death tree priors that include serial sampling (BDSS) at a constant rate through time. We compare BEAST results to those from the traditional maximum parsimony (MP) and undated Bayesian inference (BI) methods. Three overlapping datasets were used that span 250 million years of archosauromorph evolution leading to crocodylians. The first dataset focuses on early Sauria (31 taxa, 240 chars.), the second on early Archosauria (76 taxa, 400 chars.) and the third on Crocodyliformes (101 taxa, 340 chars.). For each dataset three time -calibrated trees (timetrees) were calculated: a minimum -age timetree with node ages based on earliest occurrences in the fossil record; a 'smoothed' timetree using a range of time added to the root that is then averaged over zero -length internodes; and a tip -dated timetree. Comparisons within data sets show that the smoothed and tip -dated timetrees provide similar estimates. Only near the root node do BEAST estimates fall outside the smoothed timetree range. The BEAST model is not able to overcome limited sampling to correctly estimate divergences considerably older than sampled fossil occurrence dates. Conversely, the smoothed timetrees consistently provide node -ages far older than the strict dates or BEAST estimates for morphologically conservative sister-taxa when they sit on long ghost lineages. In this latter case, the relaxed -clock model appears to be correctly moderating the node -age estimate based on the limited morphological divergence. Topologies are generally similar across analyses, but BEAST trees for crocodyliforms differ when clades are deeply nested but contain very old taxa. It appears that the constant -rate sampling assumption of the BDSS tree prior influences topology inference by disfavoring long, unsampled branches.	[Turner, Alan H.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Pritchard, Adam C.] Yale Univ, Dept Geol, New Haven, CT USA; [Matzke, Nicholas J.] Australian Natl Univ, Div Ecol Evolut & Genet, Res Sch Biol, Canberra, ACT, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; Australian National University	Turner, AH (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	alan.turner@stonybrook.edu	Matzke, Nicholas/L-4109-2015	Matzke, Nicholas/0000-0002-8698-7656	National Science Foundation Doctoral Dissertation Improvement Grant Award [DEB 1501851]; NI MBioS fellowship under National Science Foundation Award [EFJ0832858]; Australian Research Council DECRA fellowship [DE150101773]; National Science Foundation [0919124, EAR 1349654, DEB 1257485]; Direct For Biological Sciences [1300426, 1501851] Funding Source: National Science Foundation	National Science Foundation Doctoral Dissertation Improvement Grant Award; NI MBioS fellowship under National Science Foundation Award; Australian Research Council DECRA fellowship(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AHT was supported under National Science Foundation Awards EAR 1349654 and DEB 1257485. ACP was supported under an National Science Foundation Doctoral Dissertation Improvement Grant Award (DEB 1501851) to AHT and ACP. NJM was supported by a NI MBioS fellowship under National Science Foundation Award #EFJ0832858, Australian Research Council DECRA fellowship DE150101773, and his work on BEASTmasteR began while supported by National Science Foundation 0919124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TL, 2014, J PALEONTOL, V88, P1031, DOI 10.1666/12-089; [Anonymous], 2014, TRACER V1 6; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bapst DW, 2014, PALEOBIOLOGY, V40, P331, DOI 10.1666/13033; Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; CODDINGTON J, 1994, CLADISTICS, V10, P415; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gavryushkina A, SYSTEMATIC IN PRESS; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff Pablo A., 2005, P148; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Heath TA, 2014, P NATL ACAD SCI USA, V111, pE2957, DOI 10.1073/pnas.1319091111; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Irmis RB, 2014, JOURNAL OF VERTEBRAT, V2014, P153; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lee MS, 2009, J EVOLUTIONARY BIOL, V22; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; MARSHALL CR, 1990, PALEOBIOLOGY, V16, P1, DOI 10.1017/S0094837300009672; Matzke N. J., 2015, BEASTMASTER CODE ARC; Matzke N.J., 2015, BEASTMASTER R TOOLS; Montefeltro FC, 2013, NATURWISSENSCHAFTEN, V100, P835, DOI 10.1007/s00114-013-1083-9; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Nesbitt SJ, 2015, B AM MUS NAT HIST, P1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norell MA, 1992, TAXIC ORIGIN TEMPORA, P89; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; OREILLY JE, 2016, BIOL LETT, V12; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pol D, 2013, BIOL REV, V88, P862, DOI 10.1111/brv.12030; Pritchard AC, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.911186; Puttick MN, 2016, EVOLUTION, V70, P873, DOI 10.1111/evo.12907; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; R Core Team, 2021, R LANGUAGE ENV STAT; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; RAUP DM, 1980, PALEOBIOLOGY, V6, P9, DOI 10.1017/S0094837300012458; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Simpson G. G., 1944, P1; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2015, PROCEEDINGS OF THE N, V112; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Spencer MR, 2013, CLADISTICS, V29, P663, DOI 10.1111/cla.12018; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Stadler T, 2010, J THEOR BIOL, V267, P396, DOI 10.1016/j.jtbi.2010.09.010; Turner AH, 2016, J VERTEBRATE PALE ON, V36; Turner AH, 2013, ANATOMY PHYLOGENY AN, P379; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; Turner AH, 2015, PEERJ, V3, DOI 10.7717/peerj.759; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; VRBA ES, 1985, S AFR J SCI, V81, P229; Warnock RCM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1013; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Zhang C, 2016, SYST BIOL, V65, P228, DOI 10.1093/sysbio/syv080	77	29	29	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0169885	10.1371/journal.pone.0169885	http://dx.doi.org/10.1371/journal.pone.0169885			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187191	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300004
J	Nucci, LA; Santos, SS; Brunialti, MKC; Sharma, NK; Machado, FR; Assuncao, M; de Azevedo, LCP; Salomao, R				Nucci, Laura A.; Santos, Sidneia S.; Brunialti, Milena K. C.; Sharma, Narendra Kumar; Machado, Flavia R.; Assuncao, Murillo; de Azevedo, Luciano C. P.; Salomao, Reinaldo			Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients	PLOS ONE			English	Article							CECAL LIGATION; MONONUCLEAR-CELLS; SEVERE SEPSIS; DYSFUNCTION; MONOCYTES; DEFINITIONS; RECOGNITION; ASSOCIATION; NEUTROPHILS; SEVERITY	Background and objectives Sepsis is a complex disease that is characterized by activation and inhibition of different cell signaling pathways according to the disease stage. Here, we evaluated genes involved in the TLR signaling pathway, oxidative phosphorylation and oxidative metabolism, aiming to assess their interactions and resulting cell functions and pathways that are disturbed in septic patients. Materials and methods Blood samples were obtained from 16 patients with sepsis secondary to community acquired pneumonia at admission (D0), and after 7 days (D7, N = 10) of therapy. Samples were also collected from 8 healthy volunteers who were matched according to age and gender. Gene expression of 84 genes was performed by real-time polymerase chain reactions. Their expression was considered up-or down-regulated when the fold change was greater than 1.5 compared to the healthy volunteers. A p-value of <= 0.05 was considered significant. Results Twenty-two genes were differently expressed in D0 samples; most of them were down-regulated. When gene expression was analyzed according to the outcomes, higher number of altered genes and a higher intensity in the disturbance was observed in non-survivor than in survivor patients. The canonical pathways altered in D0 samples included interferon and iNOS signaling; the role of JAK1, JAK2 and TYK2 in interferon signaling; mitochondrial dysfunction; and superoxide radical degradation pathways. When analyzed according to outcomes, different pathways were disturbed in surviving and non-surviving patients. Mitochondrial dysfunction, oxidative phosphorylation and superoxide radical degradation pathway were among the most altered in non-surviving patients. Conclusion Our data show changes in the expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and oxidative phosphorylation. Importantly, distinct patterns are clearly observed in surviving and non-surviving patients. Interferon signaling, marked by changes in JAK-STAT modulation, had prominent changes in both survivors and non-survivors, whereas the redox imbalance (iNOS signaling, oxidative phosphorylation and superoxide radical degradation) affecting mitochondrial functions was prominent in non-surviving patients.	[Nucci, Laura A.; Santos, Sidneia S.; Brunialti, Milena K. C.; Sharma, Narendra Kumar; Machado, Flavia R.; Salomao, Reinaldo] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil; [Assuncao, Murillo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [de Azevedo, Luciano C. P.] Hosp Sirio Libanes, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Hospital Sirio Libanes	Salomao, R (corresponding author), Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil.	rsalomao@unifesp.br	Santos, Sidneia Sousa/O-5203-2017; Assuncao, Murillo S C/K-1040-2012; Brunialti, Milena K C/C-4905-2012; Salomao, Reinaldo/C-6419-2013; Sharma, Narendra/D-2451-2017	Santos, Sidneia Sousa/0000-0002-6807-9881; Assuncao, Murillo S C/0000-0002-0741-4869; Brunialti, Milena K C/0000-0003-2874-520X; Salomao, Reinaldo/0000-0003-1149-4598; Sharma, Narendra/0000-0002-8681-3840	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20401-4]; Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq) [305685/2011-2]	Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RS was by Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP-www.fapesp.br) - Grant number 2011/20401-4 and Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (CNPq-www.cnp.br) - Grant number 305685/2011-2.	Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Cai B, 2015, INFLAMMATION, V38, P1599, DOI 10.1007/s10753-015-0135-z; Brunialti MKC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037393; Comim CM, 2008, MITOCHONDRION, V8, P313, DOI 10.1016/j.mito.2008.07.002; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36; Herzig D, 2012, SHOCK, V38, P395, DOI 10.1097/SHK.0b013e318265a2ab; Huang LJ, 2007, BBA-BIOENERGETICS, V1767, P888, DOI 10.1016/j.bbabio.2007.03.009; Hui L, 2009, J TRAUMA, V66, P859, DOI 10.1097/TA.0b013e318164d05f; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Jeger V, 2013, EUR J CLIN INVEST, V43, P532, DOI 10.1111/eci.12069; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Machado FR, 2013, CLINICS, V68, P586, DOI 10.6061/clinics/2013(05)02; Mendes ME, 2011, IMMUNOBIOLOGY, V216, P285, DOI 10.1016/j.imbio.2010.07.008; Ojeda MO, 2011, INFLAMM RES, V60, P289, DOI 10.1007/s00011-010-0267-4; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pena G, 2010, J MOL MED, V88, P851, DOI 10.1007/s00109-010-0628-z; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pontes Azevedo Luciano Cesar, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P214; Salomao R, 2009, CRIT CARE MED, V37, P132, DOI 10.1097/CCM.0b013e318192fbaf; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Santos Sidneia S, 2016, Intensive Care Med Exp, V4, P5, DOI 10.1186/s40635-016-0078-1; Santos SS, 2012, SHOCK, V38, P18, DOI 10.1097/SHK.0b013e318257114e; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Severino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091886; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Szabo C, 2010, SHOCK, V34, P4, DOI 10.1097/SHK.0b013e3181e7e9ba; Weiss SL, 2015, PEDIATR CRIT CARE ME, V16, pE4, DOI 10.1097/PCC.0000000000000277; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172024	10.1371/journal.pone.0172024	http://dx.doi.org/10.1371/journal.pone.0172024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182798	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800142
J	Roche, R; Bain, R; Cumming, O				Roche, Rachel; Bain, Robert; Cumming, Oliver			A long way to go - Estimates of combined water, sanitation and hygiene coverage for 25 sub-Saharan African countries	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; MIDDLE-INCOME SETTINGS; DRINKING-WATER; DIARRHEA; DISEASE; INTERVENTIONS; RISK; INDICATORS; COMMUNITY; BURDEN	Background Water, sanitation and hygiene (WASH) are essential for a healthy and dignified life. International targets to reduce inadequate WASH coverage were set under the Millennium Development Goals (MDGs, 1990-2015) and now the Sustainable Development Goals (SDGs, 2016-2030). The MDGs called for halving the proportion of the population without access to adequate water and sanitation, whereas the SDGs call for universal access, require the progressive reduction of inequalities, and include hygiene in addition to water and sanitation. Estimating access to complete WASH coverage provides a baseline for monitoring during the SDG period. Sub-Saharan Africa (SSA) has among the lowest rates of WASH coverage globally. Methods The most recent available Demographic Household Survey (DHS) or Multiple Indicator Cluster Survey (MICS) data for 25 countries in SSA were analysed to estimate national and regional coverage for combined water and sanitation (a combined MDG indicator for 'improved' access) and combined water with collection time within 30 minutes plus sanitation and hygiene (a combined SDG indicator for 'basic' access). Coverage rates were estimated separately for urban and rural populations and for wealth quintiles. Frequency ratios and percentage point differences for urban and rural coverage were calculated to give both relative and absolute measures of urban-rural inequality. Wealth inequalities were assessed by visual examination of coverage across wealth quintiles in urban and rural populations and by calculating concentration indices as standard measures of relative wealth related inequality that give an indication of how unevenly a health indicator is distributed across the wealth distribution. Results Combined MDG coverage in SSA was 20%, and combined basic SDG coverage was 4%; an estimated 921 million people lacked basic SDG coverage. Relative measures of inequality were higher for combined basic SDG coverage than combined MDG coverage, but absolute inequality was lower. Rural combined basic SDG coverage was close to zero in many countries. Conclusions Our estimates help to quantify the scale of progress required to achieve universal WASH access in low-income countries, as envisaged under the water and sanitation SDG. Monitoring and reporting changes in the proportion of the national population with access to water, sanitation and hygiene may be useful in focusing WASH policy and investments towards the areas of greatest need.	[Roche, Rachel; Cumming, Oliver] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England; [Bain, Robert] UNICEF, Div Data Res & Policy, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; UNICEF	Roche, R (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England.	rachel.roche@gmail.com		Cumming, Oliver/0000-0002-5074-8709				Abdelkrim A., 2007, DASP DISTRIBUTIVE AN; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Benova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106738; Biran A, 2008, TROP MED INT HEALTH, V13, P278, DOI 10.1111/j.1365-3156.2007.02001.x; Bradley DJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0420; Burt Z, 2016, GENDER EQUITY SANITA; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Cumming O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114699; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Dar OA, 2011, TROP MED INT HEALTH, V16, P540, DOI 10.1111/j.1365-3156.2011.02736.x; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, WATER SCI TECHNOL, V52, P133, DOI 10.2166/wst.2005.0244; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Graham JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155981; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Hutton G, 2013, J WATER HEALTH, V11, P1, DOI 10.2166/wh.2012.105; JMP, 2015, JMP GREEN PAP GLOB M; JMP, 2012, PROGR DRINK WAT SAN; JMP, 2015, PROGR SAN DRINK WAT; KAWATA K, 1978, AM J CLIN NUTR, V31, P2114, DOI 10.1093/ajcn/31.11.2114; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Loughnan L. C., 2015, Waterlines, V34, P296, DOI 10.3362/1756-3488.2015.028; Measure DHS/ICF International, 2008, DHS MOD QUEST PHAS 6; Onda Kyle, 2013, World Health Popul, V14, P32; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Rutstein S.O., 2004, DHS COMP REPORTS; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; StataCorp, 2015, STAT STAT SOFTW REL; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; UNICEF, 2008, MICS 4 HOUS QUEST; United Nations, 2010, RES HUM RIGHT WAT SA; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; United Nations Economic and Social Council, 2016, STAT COMM 47 SESS RE; United Nations Population Division, 2014, WORLD URB PROSP 2014; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; WAGNER E G, 1958, Monogr Ser World Health Organ, V39, P1; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Walker CLF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-70; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331	53	42	42	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171783	10.1371/journal.pone.0171783	http://dx.doi.org/10.1371/journal.pone.0171783			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182796	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000394231800110
J	Sorger, H; Hofstad, EF; Amundsen, T; Lango, T; Bakeng, JBL; Leira, HO				Sorger, Hanne; Hofstad, Erlend Fagertun; Amundsen, Tore; Lango, Thomas; Bakeng, Janne Beate Lervik; Leira, Hakon Olav			A multimodal image guiding system for Navigated Ultrasound Bronchoscopy (EBUS): A human feasibility study	PLOS ONE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; PERIPHERAL LUNG LESIONS; LYMPH-NODE MOVEMENT; ENDOBRONCHIAL ULTRASOUND; DIAGNOSTIC BRONCHOSCOPY; BIOPSY; CANCER; TRACKING	Background Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is the endoscopic method of choice for confirming lung cancer metastasis to mediastinal lymph nodes. Precision is crucial for correct staging and clinical decision-making. Navigation and multimodal imaging can potentially improve EBUS-TBNA efficiency. Aims To demonstrate the feasibility of a multimodal image guiding system using electromagnetic navigation for ultrasound bronchoschopy in humans. Methods Four patients referred for lung cancer diagnosis and staging with EBUS-TBNA were enrolled in the study. Target lymph nodes were predefined from the preoperative computed tomography (CT) images. A prototype convex probe ultrasound bronchoscope with an attached sensor for position tracking was used for EBUS-TBNA. Electromagnetic tracking of the ultrasound bronchoscope and ultrasound images allowed fusion of preoperative CT and intraoperative ultrasound in the navigation software. Navigated EBUS-TBNA was used to guide target lymph node localization and sampling. Navigation system accuracy was calculated, measured by the deviation between lymph node position in ultrasound and CT in three planes. Procedure time, diagnostic yield and adverse events were recorded. Results Preoperative CT and real-time ultrasound images were successfully fused and displayed in the navigation software during the procedures. Overall navigation accuracy (11 measurements) was 10.0 +/- 3.8 mm, maximum 17.6 mm, minimum 4.5 mm. An adequate sample was obtained in 6/6 (100%) of targeted lymph nodes. No adverse events were registered. Conclusions Electromagnetic navigated EBUS-TBNA was feasible, safe and easy in this human pilot study. The clinical usefulness was clearly demonstrated. Fusion of real-time ultrasound, pre-operative CT and electromagnetic navigational bronchoscopy provided a controlled guiding to level of target, intraoperative overview and procedure documentation.	[Sorger, Hanne; Amundsen, Tore; Leira, Hakon Olav] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Imaging, Fac Med, Trondheim, Norway; [Sorger, Hanne; Amundsen, Tore; Leira, Hakon Olav] Univ Trondheim Hosp, St Olavs Hosp, Dept Thorac Med, Trondheim, Norway; [Sorger, Hanne] North Trondelag Hlth Trust, Levanger Hosp, Dept Med, Levanger, Norway; [Hofstad, Erlend Fagertun; Lango, Thomas; Bakeng, Janne Beate Lervik] SINTEF Technol & Soc, Dept Med Technol, Trondheim, Norway; [Hofstad, Erlend Fagertun; Lango, Thomas; Bakeng, Janne Beate Lervik] St Olavs Hosp, Norwegian Natl Advisory Unit Ultrasound & Image G, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); SINTEF; Norwegian University of Science & Technology (NTNU)	Sorger, H (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Circulat & Imaging, Fac Med, Trondheim, Norway.; Sorger, H (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Thorac Med, Trondheim, Norway.; Sorger, H (corresponding author), North Trondelag Hlth Trust, Levanger Hosp, Dept Med, Levanger, Norway.	hanne.sorger@ntnu.no			Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olays Hospital, Trondheim, Norway); SINTEF; The Norwegian Research Council (NorMIT); Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU) [46056934]; EEA Financial Mechanism - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NaviCAD) [EEA-JRP-RO-NO-2013-1-0123, 3SEE/30.06.2014]	Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olays Hospital, Trondheim, Norway); SINTEF(SINTEF); The Norwegian Research Council (NorMIT); Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); EEA Financial Mechanism - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NaviCAD)	This work was supported by: The Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (St. Olays Hospital, Trondheim, Norway); SINTEF and The Norwegian Research Council (NorMIT). The work was funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (https://www.ntnu.no/dmf/rad/samorg) through project no. 46056934; and the EEA Financial Mechanism 2009-2014 under the project EEA-JRP-RO-NO-2013-1-0123 - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NaviCAD, http://navicad.ro), contract no. 3SEE/30.06.2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K, 2009, THORAX, V64, P757, DOI 10.1136/thx.2008.109868; Amundsen T A H, 2015, NASJONALT HANDLINGSP; Askeland C, 2015, INT J COMPUT ASSIST; Bakeng JBL, 2016, USING CUSTUSX TOOLKI; Becker HD, 2005, J BRONCHOL INTERN PU, V12, P9, DOI 10.1097/01.laboratory.0000147032.67754.22; Bo LE, 2015, PHYS MED BIOL, V60, P3499, DOI 10.1088/0031-9155/60/9/3499; Chandra S, 2012, RESP CARE, V57, P384, DOI 10.4187/respcare.01274; De Leyn P, 2014, EUROPEAN J CARDIO TH; Diken OE, 2015, CLIN RESPIR J, V9, P214, DOI 10.1111/crj.12126; Dong XF, 2013, ANN THORAC SURG, V96, P1502, DOI 10.1016/j.athoracsur.2013.05.016; Donnelly ED, 2007, INT J RADIAT ONCOL, V69, P580, DOI 10.1016/j.ijrobp.2007.05.083; Eberhardt R, 2007, CHEST, V131, P1800, DOI 10.1378/chest.06-3016; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Eberhardt Ralf, 2009, Expert Rev Respir Med, V3, P469, DOI 10.1586/ers.09.36; Gildea TR, 2006, AM J RESP CRIT CARE, V174, P982, DOI 10.1164/rccm.200603-344OC; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Higgins WE CR, 2016, AM THOR SOC ATS C MA, pA4383; Higgins WE Z X, 2014, AM J RESP CRITICAL C; Higgins WE ZX, 2016, AM THOR SOC ATS C MA; Higgins WE ZX, 2015, AM THOR SOC 2015 INT; Hofstad EF, 2014, MED PHYS, V41, DOI 10.1118/1.4866884; Lamprecht B, 2012, RESP MED, V106, P710, DOI 10.1016/j.rmed.2012.02.002; Leira HO, 2013, J BRONCHOL INTERN PU, V20, P206, DOI 10.1097/LBR.0b013e31829cb2b5; Leira HO, 2011, J BRONCHOL INTERN PU, V18, P329, DOI 10.1097/LBR.0b013e318235d471; Luo XB, 2013, LECT NOTES COMPUT SC, V8149, P388, DOI 10.1007/978-3-642-40811-3_49; Makris D, 2007, EUR RESPIR J, V29, P1187, DOI 10.1183/09031936.00165306; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Mori KKT, 2011, INT J CARS S1, V6, pS164; Pearlstein DP, 2012, ANN THORAC SURG, V93, P944, DOI 10.1016/j.athoracsur.2011.11.006; Reynisson PJ, 2014, J BRONCHOL INTERN PU, V21, P242, DOI 10.1097/LBR.0000000000000064; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Schwarz Y, 2006, CHEST, V129, P988, DOI 10.1378/chest.129.4.988; Seijo LM, 2010, CHEST, V138, P1316, DOI 10.1378/chest.09-2708; Sher DJ, 2007, INT J RADIAT ONCOL, V69, P1402, DOI 10.1016/j.ijrobp.2007.05.022; Smistad E, 2014, INT J COMPUT ASS RAD, V9, P561, DOI 10.1007/s11548-013-0956-x; Sorger H, 2015, INT J COMPUT ASSIST; Sorger H AT, 2015, CARS 29 ANN C 24 26; Sorger H AT, 2015, 3 EUR C BRONCH INT P; Sorger H HE, 2016, EUR RESP SOC ERS INT; Sorger H, 2016, INT J COMPUT ASS RAD, V11, P1431, DOI 10.1007/s11548-015-1326-7; Sorhaug S HH, 2015, EUROPEAN RESP J; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Zang XN, 2014, PROC SPIE, V9040, DOI 10.1117/12.2036115	43	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171841	10.1371/journal.pone.0171841	http://dx.doi.org/10.1371/journal.pone.0171841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182758	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800124
J	Veldhoen, ES; Smulders, CA; Kappen, TH; Calis, JC; van Woensel, J; Raymakers-Janssen, PAM; Bont, LJ; Hennus, MP				Veldhoen, Esther S.; Smulders, Charlotte A.; Kappen, Teus H.; Calis, Job C.; van Woensel, Job; Raymakers-Janssen, Paulien A. M.; Bont, Louis J.; Hennus, Marije P.			Post-extubation stridor in Respiratory Syncytial Virus bronchiolitis: Is there a role for prophylactic dexamethasone?	PLOS ONE			English	Article							PEDIATRIC INTENSIVE-CARE; EXTUBATION FAILURE; RISK-FACTORS; AIRWAY-OBSTRUCTION; DOUBLE-BLIND; PREVENTION; INFANTS; PRETREATMENT; INFECTION; CHILDREN	Aim The purpose of this study was to determine the incidence of reintubation due to upper airway obstruction in a homogeneous group of ventilated infants with Respiratory Syncytial Virus bronchiolitis. Our secondary objective was to determine whether prophylactic administration of dexamethasone prior to extubation was associated with decreased risk of reintubation. Methods This retrospective observational study in two Pediatric Intensive Care Units in 2 university hospitals in The Netherlands included two hundred patients younger than 13 months admitted with respiratory insufficiency caused by Respiratory Syncytial Virus bronchiolitis, requiring invasive mechanical ventilation. A logistic regression analysis with propensity score method was used to adjust for possible confounding. Results Reintubation due to post-extubation stridor occurred in 17 (8.5%) of 200 patients. After propensity score matching, administration of dexamethasone prior to extubation was associated with a significantly (p = 0.0011) decreased risk of reintubation due to post-extubation stridor compared to patients not receiving prophylactic dexamethasone (absolute risk reduction 13%, 95% CI 5.3 - 21%). Conclusion Reintubation due to post-extubation stridor is an important complication of ventilation for Respiratory Syncytial Virus bronchiolitis. Dexamethasone administered prior to extubation probably reduces the risk of post-extubation stridor necessitating reintubation in these infants. The results of this study support initiation of a placebo-controlled trial to confirm the beneficial effect of prophylactic dexamethasone.	[Veldhoen, Esther S.; Smulders, Charlotte A.; Raymakers-Janssen, Paulien A. M.; Hennus, Marije P.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Intens Care, Utrecht, Netherlands; [Kappen, Teus H.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Calis, Job C.; van Woensel, Job] Acad Med Ctr, Dept Pediat Intens Care, Emma Childrens Hosp, Amsterdam, Netherlands; [Bont, Louis J.] Univ Med Ctr Utrecht, Dept Pediat Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Vanderbilt University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Veldhoen, ES (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Intens Care, Utrecht, Netherlands.	e.s.veldhoen@umcutrecht.nl	Kappen, Teus H/J-8733-2015	Kappen, Teus H/0000-0003-1895-0998; Raymakers-Janssen, Paulien/0000-0001-5227-2057; Hennus, Marije/0000-0003-1508-0456				Ali M., 2016, THESIS; Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Baranwal AK, 2014, INTENS CARE MED, V40, P1285, DOI 10.1007/s00134-014-3358-9; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Edmunds S, 2001, CHEST, V119, P897, DOI 10.1378/chest.119.3.897; Elward AM, 2002, PEDIATRICS, V109, P758, DOI 10.1542/peds.109.5.758; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harel Y, 1997, INT J PEDIATR OTORHI, V39, P147, DOI 10.1016/S0165-5876(97)01488-2; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Johnston C, 2010, RESP CARE, V55, P328; Kawai K, 2015, CRIT CARE MED, V43; Khan N, 1996, CRIT CARE MED, V24, P1568, DOI 10.1097/00003246-199609000-00023; Khemani RG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001000.pub3; Khemani RG, 2013, J CRIT CARE, V28, P490, DOI 10.1016/j.jcrc.2012.11.009; Kurachek SC, 2003, CRIT CARE MED, V31, P2657, DOI 10.1097/01.CCM.0000094228.90557.85; Manczur T I, 2000, Pediatr Crit Care Med, V1, P124, DOI 10.1097/00130478-200010000-00006; Markovitz BP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001000.pub2; McCaffrey J, 2009, INTENS CARE MED, V35, P977, DOI 10.1007/s00134-009-1473-9; Newth CJL, 2009, PEDIATR CRIT CARE ME, V10, P1, DOI 10.1097/PCC.0b013e318193724d; Principi T, 2011, PEDIATR PULM, V46, P452, DOI 10.1002/ppul.21389; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; TELLEZ DW, 1991, J PEDIATR-US, V118, P289, DOI 10.1016/S0022-3476(05)80505-0; TIBBALLS J, 1992, LANCET, V340, P745, DOI 10.1016/0140-6736(92)92293-O; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Willson DF, 2003, J PEDIATR-US, V143, pS142, DOI 10.1067/S0022-3476(03)00514-6; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172096	10.1371/journal.pone.0172096	http://dx.doi.org/10.1371/journal.pone.0172096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207796	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500082
J	Wang, XY; Zhang, LS; Zhang, YN; Bai, ZQ; Liu, H; Zhang, DP				Wang, Xiaoyu; Zhang, Linsheng; Zhang, Yane; Bai, Zhenqing; Liu, Hao; Zhang, Dapeng			Triticum aestivum WRAB18 functions in plastids and confers abiotic stress tolerance when overexpressed in Escherichia coli and Nicotiania benthamiana	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; 3 LEA PROTEIN; AMINO-ACID MOTIF; GENE FAMILY; MODEL PEPTIDES; WATER-DEFICIT; ARABIDOPSIS; EXPRESSION; HVA1; PLANT	WRAB18, an ABA-inducible protein belongs to the third family of late embryogenesis abundant (LEA) proteins which can be induced by different biotic or abiotic stresses. In the present study, WRAB18 was cloned from the Zhengyin 1 cultivar of Triticum aestivum and overexpressed in Escherichia coli to explore its effects on the growth of E. coli under different abiotic stresses. Results suggested the enhanced exhibition of tolerance of E. coli to these stresses. Meanwhile, the WRAB18-transgenic tobacco plants were obtained to analyze the stress-related enzymatic activities of ascorbate peroxidase (APX), peroxidase (POD) and superoxide dismutase (SOD), and to quantify the content of malonaldehyde (MDA) under osmotic stress, high salinity, and low and high temperature stress. The activities of APX, POD and SOD in the transgenic tobacco lines were higher while the content of MDA was lower than those of WT lines. Moreover, plastid localization of WRAB18 in Nicotiana benthamiana plasma cells were found fusing with GFP. In addition, purified WRAB18 protein protected LDH (Lactate dehydrogenase) enzyme activity in vitro from various stress conditions. In brief, WRAB18 protein shows protective action behaving as a "molecular shield" in both prokaryotic and eukaryotic cells under various abiotic stresses, not only during ABA stress.	[Wang, Xiaoyu; Zhang, Linsheng; Zhang, Yane; Bai, Zhenqing; Liu, Hao; Zhang, Dapeng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Peoples R China	Northwest A&F University - China	Zhang, LS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Peoples R China.	linszhang@nwsuaf.edu.cn			State Key Laboratory of Crop Stress Biology for Arid Areas [CSBA2015007]; Specialized Research Fund for the Doctoral Program of Higher Education [20120204110033]	State Key Laboratory of Crop Stress Biology for Arid Areas; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by funding from the State Key Laboratory of Crop Stress Biology for Arid Areas (CSBA2015007) and the Specialized Research Fund for the Doctoral Program of Higher Education (20120204110033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; BAXTER RM, 1956, CAN J MICROBIOL, V2, P599, DOI 10.1139/m56-072; Boswell LC, 2014, TISSUE CELL, V46, P514, DOI 10.1016/j.tice.2014.09.004; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chen YS, 2015, PLANT BIOTECHNOL J, V13, P105, DOI 10.1111/pbi.12241; Chen Yu, 2003, Yichuan, V25, P367; Da Silva JM, 2004, J PLANT PHYSIOL, V161, P551, DOI 10.1078/0176-1617-01109; Dalal M, 2013, ACTA PHYSIOL PLANT, V35, P979, DOI 10.1007/s11738-012-1123-7; Dong CN, 2002, PLANT PHYSIOL, V129, P1368, DOI 10.1104/pp.001925; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Furuki T, 2014, BBA-BIOMEMBRANES, V1838, P2757, DOI 10.1016/j.bbamem.2014.07.009; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Gao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19467; Gawel Stefan, 2004, Wiad Lek, V57, P453; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goyal K, 2005, FEBS LETT, V579, P4093, DOI 10.1016/j.febslet.2005.06.036; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; HARWOOD JL, 1982, PLANTA, V156, P152, DOI 10.1007/BF00395429; Hernandez-Sanchez IE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00520; HONG BM, 1988, PLANT MOL BIOL, V11, P495, DOI 10.1007/BF00039030; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu TZ, 2012, APPL BIOCHEM BIOTECH, V166, P222, DOI 10.1007/s12010-011-9418-5; Kanamori Y, 2006, GENES GENET SYST, V81, P420; Kobayashi F, 2004, PHYSIOL PLANTARUM, V120, P585, DOI 10.1111/j.0031-9317.2004.0293.x; Kobayashi F, 2008, TRANSGENIC RES, V17, P755, DOI 10.1007/s11248-007-9158-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Gang, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P535; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long RC, 2014, MOL BREEDING, V34, P1465, DOI 10.1007/s11032-014-0130-3; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NEWTON RJ, 1986, PLANT PHYSIOL, V81, P626, DOI 10.1104/pp.81.2.626; Paul A, 2014, MOL BIOL REP, V41, P7191, DOI 10.1007/s11033-014-3602-y; Rajesh S, 2006, BIOINFORMATION, V1, P133, DOI 10.6026/97320630001133; Rogalski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00586; ROTH WG, 1985, BIOCHEM BIOPH RES CO, V126, P434, DOI 10.1016/0006-291X(85)90624-2; Sasaki K, 2014, PLANT CELL PHYSIOL, V55, P136, DOI 10.1093/pcp/pct164; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Shinde S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22535; Shukla PS, 2015, PLANTA, V242, P1291, DOI 10.1007/s00425-015-2366-5; Simontacchi M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00977; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Solhlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI [10.1104/pp.008599, DOI 10.1104/PP.008599]; SUTTON F, 1992, PLANT PHYSIOL, V99, P338, DOI 10.1104/pp.99.1.338; Thalhammer A, 2010, BBA-BIOMEMBRANES, V1798, P1812, DOI 10.1016/j.bbamem.2010.05.015; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tsuda K, 2000, GENES GENET SYST, V75, P179, DOI 10.1266/ggs.75.179; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Udawat P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00518; Ukaji N, 2001, PLANT PHYSIOL, V126, P1588, DOI 10.1104/pp.126.4.1588; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Xue R, 2012, BIOPOLYMERS, V98, P59, DOI 10.1002/bip.21693; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	64	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171340	10.1371/journal.pone.0171340	http://dx.doi.org/10.1371/journal.pone.0171340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207772	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500024
J	Gomes-Rochette, NF; Souza, LS; Tommasi, BO; Pedrosa, DF; Eis, SR; Fin, IDF; Vieira, FLH; Graceli, JB; Rangel, LBA; Silva, IV				Gomes-Rochette, Neuza Felix; Souza, Leticia Soncini; Tommasi, Bruno Otoni; Pedrosa, Diego Franca; Eis, Sergio Ragi; Francischetto Fin, Irani Do Carmo; Herkenhoff Vieira, Fernando Luiz; Graceli, Jones Bernardes; Azevedo Rangel, Leticia Batista; Silva, Ian Victor			Association of Pvull and Xbal polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of postmenopausal women: Effects of aging, body mass index and breast cancer incidence	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RISK; REPLACEMENT; PVUII; C454-397T-GREATER-THAN-C; HEALTHY; BINDING	Estrogen is a steroidal hormone involved in several physiological functions in the female body including regulation of serum lipid metabolism and breast cancer (BC). Estrogen actions on serum lipids mostly occur through its binding to intracellular Estrogen Receptor alpha (ERalpha) isoform, expressed in most of tissues. This gene (ESR1) exhibit many polymorphic sites (SNPs) located either on translated and non-translated regions that regulate ERalpha protein expression and function. This paper aimed to investigate the association of two intronic SNPs of ESR1 gene, namely c454-397T>C (Pvull) and c454-351A>G (Xbal) to alterations in serum levels of total cholesterol (T-chol), total lipid (TL), low density lipoprotein cholesterol (LDL), high density lipoprotein (HDL), and triglycerides (TG) in a cohort of postmenopausal women. In addition, we aimed to associate presence of these SNPs to development of BC along 5 years period. To do so, a group of healthy 499, highly miscigenated, post-menopausal Brazilian women, were carried using PCR-FRLP technique and further confirmed by automatic sequence analysis as well followed through 5 years for BC incidence. Measurements of serum lipid profile by standard commercial methods were carried individually whereas Dual Energy X-ray Absorciometry (DXA) measured Body Mass Indexes (BMI), Fat Mass (FM), Lean Body Mass (LBM), and Body Water Content (BWC). No effects of Pvul I SNP on ESR1 gene were observed on patient's serum T-chol, TL, LDL, HDL, and TG. However, c454-397T>C Pvull SNP is associated to lower body fat and higher levels of lean mass and body water and lower incidence of BC. On the other hand, statistically significant effect of Xbal c454-351A>G SNP on serum TG and TL levels. Patients homozygous for X allele were followed up from 2010-2015. They showed higher incidence of breast cancer (BC) when compared to either heterozygous and any P allele combination. Moreover, the increasing of TG and TL serum concentrations associated to SNP Xbal c454351A>G on ESR1 gene is enhanced in both obese (higher BMI) and elder women. Taken together, these results suggested that Xbal c454-351A>G SNP is associated to changes in lipid profile, particularly in serum TG and TL, in this cohort of post -menopausal woman. Also, this paper shows another link between obesity and BC corroborating the current thesis that both diseases are interlinked.	[Gomes-Rochette, Neuza Felix; Souza, Leticia Soncini; Pedrosa, Diego Franca; Herkenhoff Vieira, Fernando Luiz; Graceli, Jones Bernardes; Azevedo Rangel, Leticia Batista; Silva, Ian Victor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Morphol, Aging Cell Biol Lab, Vitoria, ES, Brazil; [Gomes-Rochette, Neuza Felix; Souza, Leticia Soncini; Pedrosa, Diego Franca; Graceli, Jones Bernardes; Azevedo Rangel, Leticia Batista; Silva, Ian Victor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Biotecnol, RENORBIO, Vitoria, ES, Brazil; [Tommasi, Bruno Otoni] Inst Tommasi Pesquisa & Desenvolvimento, Vila Velha, Brazil; [Eis, Sergio Ragi; Francischetto Fin, Irani Do Carmo] CEDOES, Ctr Diagnost & Pesquisa Osteoporose Espirito Sant, Vitoria, ES, Brazil; [Graceli, Jones Bernardes] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Ciencias Fisiol, Lab Endocrinol & Cellular Toxicol, Vitoria, ES, Brazil; [Azevedo Rangel, Leticia Batista] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Pharmaceut Sci, Lab Cellular & Mol Biol Human Canc, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Silva, IV (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Morphol, Aging Cell Biol Lab, Vitoria, ES, Brazil.; Silva, IV (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Biotecnol, RENORBIO, Vitoria, ES, Brazil.	iasilva@pq.cnpq.br	Bernardes Graceli, Jones/ABC-7439-2021; Rangel, Leticia B/E-6241-2018	Rangel, Leticia B/0000-0002-6150-4064	FACITEC [017/2006, 036/2006]; FAPES [172.1/2005]; DECIT-SUS [31614990/2005]; CNPq [480807/2006]	FACITEC; FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); DECIT-SUS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank FACITEC [no. 017/2006 and no. 036/2006], FAPES [no. 172.1/2005], DECIT-SUS [no. 31614990/2005] and CNPq [no. 480807/2006] for financial support. The authors would also gratefully acknowledge the Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo - CEDOES (Vitoria/ES, Brazil) and Instituto Tommasi de Pesquisa e Desenvolvimento (Vila Velha, Brazil). www.cnpq.br, www.fapes.es.gov.br, www.facitec.ivx.es.gov.brNo.	Almeida S, 2006, MATURITAS, V54, P119, DOI 10.1016/j.maturitas.2005.09.009; Araujo KL, 2011, BRAZ ARCH BIOL TECHN, V54, P1151, DOI 10.1590/S1516-89132011000600010; Bagger Y Z, 2000, Climacteric, V3, P84, DOI 10.3109/13697130009167609; Cifkova R, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0609-5; Della Torre S, 2016, CELL REP, V15, P360, DOI 10.1016/j.celrep.2016.03.019; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Jones DR, 2002, J LIPID RES, V43, P383; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lambrinoudaki I, 2006, EUR J ENDOCRINOL, V154, P907, DOI 10.1530/eje.1.02167; Lee YH, 2015, GENET MOL RES, V14, P9361, DOI 10.4238/2015.August.10.17; Lin J, 2010, CANCER CAUSE CONTROL, V21, P897, DOI 10.1007/s10552-010-9518-5; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; MA PTS, 1986, P NATL ACAD SCI USA, V83, P792, DOI 10.1073/pnas.83.3.792; Madeira KP, 2014, MOL BIOL REP, V41, P5459, DOI 10.1007/s11033-014-3419-8; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Mitchell ES, 2008, MENOPAUSE, V15, P105, DOI 10.1097/gme.0b013e31804d2406; Molvarec A, 2007, CLIN CHIM ACTA, V382, P100, DOI 10.1016/j.cca.2007.04.003; Organization WH, 2000, AS PAC PERSP RED OB, P56; Peter I, 2005, J HYPERTENS, V23, P2193, DOI 10.1097/01.hjh.0000188728.66183.92; Pines A, 2016, CLIMACTERIC, V19, P249, DOI 10.1080/13697137.2016.1175237; Sai AJ, 2011, MENOPAUSE, V18, P1101, DOI 10.1097/gme.0b013e318217d41d; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Silva IV, 2010, MATURITAS, V67, P363, DOI 10.1016/j.maturitas.2010.08.006; Straczek C, 2005, J THROMB HAEMOST, V3, P1535, DOI 10.1111/j.1538-7836.2005.01450.x; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Wei J, 2011, BBA-MOL CELL BIOL L, V1811, P1146, DOI 10.1016/j.bbalip.2011.07.003; Xie L, 2016, NEUROSCI LETT, V618, P77, DOI 10.1016/j.neulet.2016.02.053; Yamatani H, 2013, MENOPAUSE, V20, P437, DOI 10.1097/gme.0b013e318271a640; Zhang YP, 2015, J NUCL ENG RADIAT SC, V1, DOI 10.1115/1.4030364	32	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169266	10.1371/journal.pone.0169266	http://dx.doi.org/10.1371/journal.pone.0169266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199328	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400006
J	Taguchi, Y; Nishida, N				Taguchi, Yuzuru; Nishida, Noriyuki			Secondary-structure prediction revisited: Theoretical beta-sheet propensity and coil propensity represent structures of amyloids and aid in elucidating phenomena involved in interspecies transmission of prions	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; PROTEIN; SCRAPIE; AGGREGATION; PARALLEL; SEQUENCE; FIBRILS; STRAINS; MODELS	Prions are unique infectious agents, consisting solely of abnormally-folded prion protein (PrPSc). However, they possess virus-like features, including strain diversity, the ability to adapt to new hosts and to be altered evolutionarily. Because prions lack genetic material (DNA and RNA), these biological phenomena have been attributed to the structural properties of PrPSc. Therefore, many structural models of the structure of PrPSc have been proposed based on the limited structural information available, regardless of the incompatibility with high-resolution structural analysis. Recently hypothesized models consist solely of beta sheets and intervening loops/ kinks; i.e. parallel in-register beta-sheet and beta-solenoid models. Owing to the relative simplicity of these structural models of PrPSc, we hypothesized that numerical conversion of the primary structures with a relevant algorithm would enable quantitative comparison between PrPs of distinct primary structures. We therefore used the theoretical values of beta-sheet (P beta) and random-coil (Pc) propensity calculated by secondary structure prediction with a neural network, to analyze interspecies transmission of prions. By reviewing experiments in the literature, we ascertained the biological relevance of P beta and Pc and found that these classical parameters surprisingly carry substantial information of amyloid structures. We also demonstrated how these parameters could aid in interpreting and explaining phenomena in interspecies transmissions. Our approach can lead to the development of a versatile tool for investigating not only prions but also other amyloids.	[Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Div Cellular & Mol Biol, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University	Taguchi, Y (corresponding author), Nagasaki Univ, Div Cellular & Mol Biol, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan.	ytaguchi@nagasaki-u.ac.jp			Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	The study was supported by the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hennetin J, 2006, J MOL BIOL, V358, P1094, DOI 10.1016/j.jmb.2006.02.039; Imamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082538; Jiji AC, 2016, ANGEW CHEM INT EDIT, V55, P11562, DOI 10.1002/anie.201606544; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kurt TD, 2015, J CLIN INVEST, V125, P1485, DOI 10.1172/JCI79408; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; LOWENSTEIN DH, 1990, MOL CELL BIOL, V10, P1153, DOI 10.1128/MCB.10.3.1153; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Meade-White KD, 2009, EMERG INFECT DIS, V15, P207, DOI 10.3201/eid1502.081173; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Pirisinu L, 2013, PATHOGENS, V2, P446, DOI 10.3390/pathogens2030446; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Shu YJ, 2011, PRION, V5, P103, DOI 10.4161/pri.5.2.15847; Taguchi Y, 2013, PRION, V7, P91; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	36	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171974	10.1371/journal.pone.0171974	http://dx.doi.org/10.1371/journal.pone.0171974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199368	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400063
J	Choi, JE; Ahn, J; Park, HW; Baek, SY; Kim, S; Moon, IJ				Choi, Ji Eun; Ahn, Jungmin; Park, Hyun Woo; Baek, Sun-Young; Kim, Seonwoo; Moon, Il Joon			Prevalence of minimal hearing loss in South Korea	PLOS ONE			English	Article							SINGLE-SIDED DEAFNESS; OLDER-ADULTS; COCHLEAR IMPLANTATION; UNITED-STATES; IMPAIRMENT; DEMENTIA; DEVICES	This study evaluated the prevalence of minimal hearing loss (MHL) in South Korea based on the 2010 to 2012 Korea National Health and Nutrition Examination Survey. A total of 16,630 representative individuals (older than 12 years) who completed ear examinations and structured questionnaires were analyzed. Only participants who had normal tympanic membranes were included. MHL was categorized into the following three groups: 1) unilateral sensorineural hearing loss (USHL, pure-tone average (PTA) >= 15 dB in the affected ear), 2) bilateral sensorineural hearing loss (BSHL, 15 dB <= PTA < 40 dB in both ears), and 3) high-frequency sensorineural hearing loss (HFSHL, two or more high-frequency thresholds > 25 dB in either ear). To evaluate clinical symptoms, subjective hearing status, tinnitus, and quality of life of each MHL group were compared to those of normal-hearing listeners. The use of hearing aids (HAs) was also investigated in the MHL population. The prevalence of normal hearing and MHL were 58.4% and 37.4%, respectively. In univariate analyses, the prevalence of MHL increased with age. It was significantly increased in males. Regarding clinical symptoms, 13.0% and 92.1% of participants with MHL reported difficulties with hearing and annoying tinnitus, respectively. In multivariate analyses, these proportions were significantly higher in the MHL groups than in normal-hearing listeners. Participants with MHL also showed significantly lower Euro Qol-5D index scores than did normal-hearing listeners. Regarding hearing rehabilitation, among minimally hearing impaired participants with subjective hearing loss, only 0.47% of individuals used HAs. Our results reveal that MHL is common in South Korea. It is associated with significant subjective hearing loss, tinnitus, and poor quality of life. Therefore, clinicians need to pay attention to this special group and provide proper counselling and rehabilitative management.	[Choi, Ji Eun; Ahn, Jungmin; Park, Hyun Woo; Moon, Il Joon] Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Samsung Med Ctr, Seoul, South Korea; [Baek, Sun-Young; Kim, Seonwoo] Sungkyunkwan Univ, Sch Med, Biostat & Clin Epidemiol Ctr, Samsung Med Ctr,Res Inst Future Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, IJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Samsung Med Ctr, Seoul, South Korea.	moonij@skku.edu						Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; [Anonymous], 2018, WHO GLOB EST PREV HE; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Finbow J, 2015, OTOL NEUROTOL, V36, P819, DOI 10.1097/MAO.0000000000000762; Fitzpatrick EM, 2014, EAR HEARING, V35, P10, DOI 10.1097/AUD.0b013e31829e1ed9; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Indeyeva YA, 2015, AM J OTOLARYNG, V36, P810, DOI 10.1016/j.amjoto.2015.06.003; Kochkin S., 2012, HEAR REV, V19, P12; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; LUTMAN M E, 1987, British Journal of Audiology, V21, P45, DOI 10.3109/03005368709077774; Mamo SK, 2016, AM J MED, V129, P245, DOI 10.1016/j.amjmed.2015.09.014; McKay Sarah, 2008, Trends Amplif, V12, P43, DOI 10.1177/1084713807313570; Mertens G, 2015, AUDIOL NEURO-OTOL, V20, P67, DOI 10.1159/000380751; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Newman CW, 1997, ANN OTO RHINOL LARYN, V106, P210, DOI 10.1177/000348949710600305; Peters JPM, 2015, LARYNGOSCOPE, V125, P218, DOI 10.1002/lary.24865; Scherer MJ, 1998, J REHABIL RES DEV, V35, P420; Sereda M, 2015, EAR HEARING, V36, P417, DOI 10.1097/AUD.0000000000000140; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; van Zon A, 2015, OTOL NEUROTOL, V36, P209, DOI 10.1097/MAO.0000000000000681; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	28	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171635	10.1371/journal.pone.0171635	http://dx.doi.org/10.1371/journal.pone.0171635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196098	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900026
J	Giraudo, M; Douville, M; Cottin, G; Houde, M				Giraudo, Maeva; Douville, Melanie; Cottin, Guillaume; Houde, Magali			Transcriptomic, cellular and life-history responses of Daphnia magna chronically exposed to benzotriazoles: Endocrine-disrupting potential and molting effects	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; RNA-SEQ DATA; WATER FLEA; JUVENILE-HORMONE; BISPHENOL-A; ECDYSTEROID BIOSYNTHESIS; GENE-TRANSCRIPTION; ENVIRONMENTAL FATE; AQUATIC ORGANISMS	Benzotriazoles (BZTs) are ubiquitous aquatic contaminants used in a wide range of industrial and domestic applications from aircraft deicers to dishwasher tablets. Acute toxicity has been reported in aquatic organisms for some of the BZTs but their mode of action remains unknown. The objectives of this study were to evaluate the transcriptomic response of D. magna exposed to sublethal doses of 1H-benzotriazole (BTR), 5-methyl-1H-benzotriazole (5MeBTR) and 5-chloro-1H-benzotriazole (5CIBTR) using RNA-sequencing and quantitative real-time PCR. Cellular and life-history endpoints (survival, number of neonates, growth) were also investigated. Significant effects on the molting frequency were observed after 21-d exposure to 5MeBTR and 5CIBTR. No effects on molting frequency were observed for BTR but RNA-seq results indicated that this BZT induced the up-regulation of genes coding for cuticular proteins, which could have compensated the molting disruption. Molting in cladocerans is actively controlled by ecdysteroid hormones. Complementary short-term temporal analysis (4-and 8-d exposure) of the transcription of genes related to molting and hormone-mediated processes indicated that the three compounds had specific modes of action. BTR induced the transcription of genes involved in 20-hydroxyecdysone synthesis, which suggests pro-ecdysteroid properties. 5CIBTR exposure induced protein activity and transcriptional levels of chitinase enzymes, associated with an impact on ecdysteroid signaling pathways, which could explain the decrease in molt frequency. Finally, 5MeBTR seemed to increase molt frequency through epigenetic processes. Overall, results suggested that molting effects observed at the physiological level could be linked to endocrine regulation impacts of BZTs at the molecular level.	[Giraudo, Maeva; Douville, Melanie; Cottin, Guillaume; Houde, Magali] Environm & Climate Change Canada, Aquat Contaminants Res Div, Water Sci & Technol Directorate, Montreal, PQ, Canada; [Cottin, Guillaume] Univ Paris 05, Paris, France	Environment & Climate Change Canada; UDICE-French Research Universities; Universite Paris Cite	Giraudo, M (corresponding author), Environm & Climate Change Canada, Aquat Contaminants Res Div, Water Sci & Technol Directorate, Montreal, PQ, Canada.	maeva.giraudo@gmail.com	Giraudo, Maeva/ABE-4328-2021; Giraudo, Maeva/GVS-6750-2022	Giraudo, Maeva/0000-0003-4296-146X; Houde, Magali/0000-0001-5013-6529	Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program; Environment and Climate Change Canada's Chemical Management Plan; Strategic Technology Application of Genomics in the Environment (STAGE) program	Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program; Environment and Climate Change Canada's Chemical Management Plan; Strategic Technology Application of Genomics in the Environment (STAGE) program	This work was supported by the Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program to MG, http://www.nsercc rsng.gc.ca/Students-Etudiants/PD-NP/ Laboratories-Laboratoires/index_eng.asp, and was funded by grants awarded to MH from Environment and Climate Change Canada's Chemical Management Plan (CMP), http://www. chemicalsubstanceschimiques.gc.ca/plan/indexeng.php, and the Strategic Technology Application of Genomics in the Environment (STAGE) program http://www.ec.gc.ca/scitech/default.asp?lang=En&n=BA7C049C-1. Funders approved the study design.	Alotaibi MD, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2469-4; Alotaibi MD, 2015, ENVIRON SCI-PROC IMP, V17, P448, DOI [10.1039/c4em00484a, 10.1039/C4EM00484A]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Asada M, 2014, MAR ENVIRON RES, V93, P118, DOI 10.1016/j.marenvres.2013.11.005; Asimakopoulos AG, 2013, ENVIRON INT, V59, P274, DOI 10.1016/j.envint.2013.06.007; Baldwin WS, 2001, ENVIRON TOXICOL CHEM, V20, P1564, DOI [10.1897/1551-5028(2001)020&lt;1564:IEIAIO&gt;2.0.CO;2, 10.1002/etc.5620200721]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bozinovic G, 2011, ENVIRON TOXICOL CHEM, V30, P283, DOI 10.1002/etc.403; Briguglio I, 2015, EUR J MED CHEM, V97, P612, DOI 10.1016/j.ejmech.2014.09.089; Campos B, 2013, ENVIRON SCI TECHNOL, V47, P9434, DOI 10.1021/es4012299; Cancilla DA, 2003, B ENVIRON CONTAM TOX, V70, P868, DOI 10.1007/s00128-003-0063-8; Cancilla DA, 2003, ENVIRON TOXICOL CHEM, V22, P134, DOI [10.1002/etc.5620220117, 10.1897/1551-5028(2003)022&lt;0134:SOTEFA&gt;2.0.CO;2]; Cancilla DA, 1998, ENVIRON SCI TECHNOL, V32, P3834, DOI 10.1021/es980489k; Cantwell M.G., 2015, COMPR ANAL CHEM, DOI [10.1016/B978-0-444-63299-9.00016-8, DOI 10.1016/B978-0-444-63299-9.00016-8]; Careghini A, 2015, ENVIRON SCI POLLUT R, V22, P5711, DOI 10.1007/s11356-014-3974-5; Casado J, 2014, J CHROMATOGR A, V1336, P1, DOI 10.1016/j.chroma.2014.01.068; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen Y, 2014, ENVIRON SCI POLLUT R, V21, P234, DOI 10.1007/s11356-013-1692-z; Cheong SPS, 2015, INTEGR COMP BIOL, V55, P878, DOI 10.1093/icb/icv066; Chiaia-Hernandez AC, 2013, ENVIRON SCI TECHNOL, V47, P10667, DOI 10.1021/es401763d; Colbourne JK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-45; Cornell JS, 2000, ENVIRON TOXICOL CHEM, V19, P1465, DOI 10.1002/etc.5620190601; Corsi SR, 2006, ENVIRON SCI TECHNOL, V40, P7409, DOI 10.1021/es0603608; DauphinVillemant C, 1997, MOL CELL ENDOCRINOL, V128, P139, DOI 10.1016/S0303-7207(97)04031-8; David RM, 2011, AQUAT TOXICOL, V104, P192, DOI 10.1016/j.aquatox.2011.04.016; Davies R, 2012, ECOTOXICOLOGY, V21, P1371, DOI 10.1007/s10646-012-0891-6; De Silva AO, 2015, ORGANOPHOSPHORUS FLA; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Durjava MK, 2013, ATLA-ALTERN LAB ANIM, V41, P65, DOI 10.1177/026119291304100108; *ENV CAN, 1990, BIOL TEST METH AC LE; Environment and Climate Change Canada, 2016, EC RISK CALSS ORG SU; Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021; Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P4188, DOI 10.1021/es803702a; Giger W, 2006, ENVIRON SCI TECHNOL, V40, P7186, DOI 10.1021/es061565j; Giraudo M, 2015, CHEMOSPHERE, V132, P159, DOI 10.1016/j.chemosphere.2015.03.028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hannas BR, 2010, MOL CELL ENDOCRINOL, V315, P208, DOI 10.1016/j.mce.2009.07.013; Harris CA, 2007, ENVIRON TOXICOL CHEM, V26, P2367, DOI 10.1897/06-587R.1; Hart DS, 2004, MICROCHEM J, V77, P9, DOI 10.1016/j.microc.2003.08.005; He TT, 2012, ECOTOX ENVIRON SAFE, V80, P327, DOI 10.1016/j.ecoenv.2012.03.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herrero P, 2013, J CHROMATOGR A, V1309, P22, DOI 10.1016/j.chroma.2013.08.018; Herrero P, 2014, TRAC-TREND ANAL CHEM, V62, P46, DOI 10.1016/j.trac.2014.06.017; Hilliou F, 2013, P INT C BIOINF MOD M; Houde M, 2016, ENVIRON POLLUT, V218, P950, DOI 10.1016/j.envpol.2016.08.043; Houde M, 2015, ECOTOX ENVIRON SAFE, V116, P10, DOI 10.1016/j.ecoenv.2015.02.031; Huntscha S, 2014, ENVIRON SCI TECHNOL, V48, P4435, DOI 10.1021/es405694z; Ishak NSM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154636; Janna H, 2011, ENVIRON SCI TECHNOL, V45, P3858, DOI 10.1021/es103267g; Jordao R, 2015, ENVIRON HEALTH PERSP, V123, P813, DOI 10.1289/ehp.1409163; Kato Y, 2007, J ENDOCRINOL, V193, P183, DOI 10.1677/JOE-06-0228; Kim HY, 2012, ECOTOXICOLOGY, V21, P993, DOI 10.1007/s10646-012-0853-z; Kim J, 2011, ECOTOXICOLOGY, V20, P1741, DOI 10.1007/s10646-011-0707-0; Kiss A, 2009, ENVIRON SCI POLLUT R, V16, P702, DOI 10.1007/s11356-009-0179-4; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; KORACH KS, 1988, MOL PHARMACOL, V33, P120; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; LeBlanc GA, 2015, FEBS J, V282, P4080, DOI 10.1111/febs.13393; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu YS, 2011, J CHROMATOGR A, V1218, P5328, DOI 10.1016/j.chroma.2011.05.100; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Miyakawa H, 2014, CURR OPIN INSECT SCI, V1, P81, DOI 10.1016/j.cois.2014.04.006; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Mu XY, 2002, J EXP ZOOL, V292, P287, DOI 10.1002/jez.10020; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; OECD-Organization for Economic Cooperation and Development, 2008, GUID TEST CHEM DAPHN; Orsini L, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.30; Overturf CL, 2015, COMP BIOCHEM PHYS C, V171, P49, DOI 10.1016/j.cbpc.2015.01.006; Palma P, 2009, CHEMOSPHERE, V74, P676, DOI 10.1016/j.chemosphere.2008.10.021; Palma P, 2009, ECOTOX ENVIRON SAFE, V72, P344, DOI 10.1016/j.ecoenv.2008.04.018; Pillard DA, 2001, WATER RES, V35, P557, DOI 10.1016/S0043-1354(00)00268-2; Plahuta M, 2015, ECOTOX ENVIRON SAFE, V117, P81, DOI [10.1016/J.ecoenv.2015.03.031, 10.1016/j.ecoenv.2015.03.031]; Pondeville E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079861; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Reemtsma T, 2006, ENVIRON SCI TECHNOL, V40, P5451, DOI 10.1021/es060908a; Reemtsma T, 2010, WATER RES, V44, P596, DOI 10.1016/j.watres.2009.07.016; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Richardson SD, 2014, ANAL CHEM, V86, P2813, DOI 10.1021/ac500508t; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Rotchell JM, 2003, J TOXICOL ENV HEAL B, V6, P453, DOI 10.1080/10937400306476; Schlotz N, 2012, COMP BIOCHEM PHYS A, V162, P449, DOI 10.1016/j.cbpa.2012.05.004; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Seeland A, 2012, ENVIRON SCI POLLUT R, V19, P1781, DOI 10.1007/s11356-011-0705-z; Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076; Stasinakis AS, 2013, SCI TOTAL ENVIRON, V463, P1067, DOI 10.1016/j.scitotenv.2013.06.087; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Toyota K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1392-9; Toyota K, 2014, J APPL TOXICOL, V34, P537, DOI 10.1002/jat.2922; USEPA, 2011, HIGH PROD VOL HPV CH; van Leerdam JA, 2009, INT J MASS SPECTROM, V282, P99, DOI 10.1016/j.ijms.2009.02.018; Voutsa D, 2006, ENVIRON SCI POLLUT R, V13, P333, DOI 10.1065/espr2006.01.295; Waddy SL, 2002, CAN J FISH AQUAT SCI, V59, P1096, DOI [10.1139/f02-106, 10.1139/F02-106]; Webster TMU, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1254-5; Weiss S, 2005, ANAL CHEM, V77, P7415, DOI 10.1021/ac051203e; Wolschke H, 2011, WATER RES, V45, P6259, DOI 10.1016/j.watres.2011.09.028; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zou E, 1997, B ENVIRON CONTAM TOX, V58, P596, DOI 10.1007/s001289900376; Zou EM, 2004, COMP BIOCHEM PHYS C, V139, P225, DOI 10.1016/j.cca.2004.11.003; Zou EM, 1997, ECOTOX ENVIRON SAFE, V38, P281, DOI 10.1006/eesa.1997.1589	112	33	34	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171763	10.1371/journal.pone.0171763	http://dx.doi.org/10.1371/journal.pone.0171763			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196088	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900032
J	Kim, K; Bloom, MS; Fujimoto, VY; Browne, RW				Kim, Keewan; Bloom, Michael S.; Fujimoto, Victor Y.; Browne, Richard W.			Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens	PLOS ONE			English	Article							LIPOPROTEIN PARTICLE COMPONENTS; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN; BIOLOGICAL VARIATION; OXIDATIVE STRESS; PARAOXONASE ACTIVITY; HDL; POLYMORPHISM; VARIABILITY; GENE	The importance of high-density lipoprotein (HDL) particle components to reproduction is increasingly recognized, including the constituent paraoxonase 1 (PON1). However, the reliability characteristics of PON1 enzymes in ovarian follicular fluid (FF) as biomarkers for clinical and epidemiologic studies have not been described. Therefore, we characterized PON1 enzymes in FF and serum and assessed the impact of the PON1 Q192R polymorphism on associations between enzyme activities in two compartments. We also evaluated associations between HDL particle size and enzyme activities. We collected FF and serum from 171 women undergoing in vitro fertilization. PON1 activities were measured as paraoxonase and arylesterase activities, and HDL particle size was determined by H-1 NMR spectrometry. Reliability indices for PON1 activities were characterized and we evaluated HDL particle sizes as predictors of PON1 enzyme activities. We found that PON1 enzyme activities were correlated between compartments, but higher in serum than in FF. For FF, the index of individuality (II) was low and the coefficient of variation (CV%) was high for paraoxonase activity overall (0.12 and 11.51%, respectively). However, IIs increased (0.33-1.30) and CV%s decreased (5.58%-8.52%) when stratified by PON1 Q192R phenotype. The intraclass correlation coefficient (ICC) for FF paraoxonase activity was high overall (0.89) but decreased when stratified by PON1 Q192R phenotype (0.43-0.75). We found similar, although more modest, patterns for FF arylesterase activity. For enzyme activities in serum, ICCs were close to 1.00 across all phenotypes. Additionally, different HDL particle sizes predicted PON1 enzyme activities according to PON1 Q192R phenotype. Overall, stratification by PON1 Q192R phenotype improved the reliability characteristics of FF PON1 enzymes as biomarkers for use in clinical investigations but diminished usefulness for epidemiologic studies. Thus, we recommend stratification by PON1 Q192R phenotype for clinical but not epidemiologic investigations, when employing FF PON1 enzyme activity biomarkers.	[Kim, Keewan; Bloom, Michael S.] SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY 12222 USA; [Bloom, Michael S.] SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY 12222 USA; [Fujimoto, Victor Y.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Browne, Richard W.] Univ Buffalo State Univ New York, Dept Biotech & Clin Lab Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bloom, MS (corresponding author), SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY 12222 USA.; Bloom, MS (corresponding author), SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY 12222 USA.	mbloom@albany.edu	Bloom, Michael S/A-5743-2010	Bloom, Michael/0000-0002-0028-5494; Kim, Keewan/0000-0002-1892-6739	National Institute on Aging, National Institutes of Health [R21 AG031957-01A2]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through grant R21 AG031957-01A2, provided by the National Institute on Aging, National Institutes of Health (PI VYF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088; Ali SM, 2008, IND HEALTH, V46, P309, DOI 10.2486/indhealth.46.309; Bergmeier C, 2004, CLIN CHEM, V50, P2309, DOI 10.1373/clinchem.2004.034439; Bloom MS, 2014, FERTIL STERIL, V101, P1431, DOI 10.1016/j.fertnstert.2014.01.028; Browne RW, 2008, HUM REPROD, V23, P1884, DOI 10.1093/humrep/den183; Browne RW, 2008, BIOMARKERS, V13, P160, DOI [10.1080/13547500701775563, 10.1080/13547500701775563 ]; Browne RW, 2007, CLIN CHEM, V53, P310, DOI 10.1373/clinchem.2006.074559; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Fujimoto VY, 2010, HUM REPROD UPDATE, V16, P20, DOI 10.1093/humupd/dmp029; Gaidukov L, 2007, J LIPID RES, V48, P1637, DOI 10.1194/jlr.D600045-JLR200; Gugliucci A, 2015, CLIN CHIM ACTA, V439, P5, DOI 10.1016/j.cca.2014.09.016; Gugliucci A, 2013, CLIN CHIM ACTA, V415, P162, DOI 10.1016/j.cca.2012.10.044; Hughes EG, 1996, FERTIL STERIL, V66, P679; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Julious SA, 2004, PHARM STAT, V3, P217, DOI 10.1002/pst.126; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim K, 2016, J ASSIST REPROD GEN, V33, P423, DOI 10.1007/s10815-016-0648-x; Kim K, 2014, FERTIL STERIL, V101, pE44, DOI 10.1016/j.fertnstert.2014.04.019; Kotani K, 2012, J INT MED RES, V40, P1513, DOI 10.1177/147323001204000431; Kuremoto Kenichi, 2003, J Atheroscler Thromb, V10, P85; La Du BN, 1999, CHEM-BIOL INTERACT, V119, P379, DOI 10.1016/S0009-2797(99)00049-6; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Maheshwari A, 2008, HUM REPROD, V23, P538, DOI 10.1093/humrep/dem431; McPherson PAC, 2007, J LIPID RES, V48, P86, DOI 10.1194/jlr.M600094-JLR200; Otocka-Kmiecik A, 2009, POSTEP HIG MED DOSW, V63, P668; Otvos James D, 2002, Clin Lab, V48, P171; Pandey Shilpi, 2010, J Hum Reprod Sci, V3, P62, DOI 10.4103/0974-1208.69332; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Straus III JF, 2004, REPROD ENDOCRINOLOGY, P125; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; VINEIS P, 1993, MOL EPIDEMIOLOGY PRI, P109; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Wang XL, 2003, ARTERIOSCL THROM VAS, V23, P328, DOI 10.1161/01.ATV.0000051702.38086.C1; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172193	10.1371/journal.pone.0172193	http://dx.doi.org/10.1371/journal.pone.0172193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196109	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900060
J	Naito, Y; Senchi, A; Sawada, H; Oboshi, M; Horimatsu, T; Okuno, K; Yasumura, S; Ishihara, M; Masuyama, T				Naito, Yoshiro; Senchi, Aya; Sawada, Hisashi; Oboshi, Makiko; Horimatsu, Tetsuo; Okuno, Keisuke; Yasumura, Seiki; Ishihara, Masaharu; Masuyama, Tohru			Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease	PLOS ONE			English	Article							REMNANT KIDNEY; RAC1 GTPASE; ACCUMULATION; PREVENTS; ANEMIA; GROWTH; MODEL	Background We have previously shown that dietary iron restriction prevents the development of renal damage in a rat model of chronic kidney disease (CKD). However, iron deficiency is associated with appetite loss. In addition, calorie restriction is reported to prevent the development of end-stage renal pathology in CKD rats. Thus, the beneficial effect of iron restriction on renal damage may depend on calorie restriction. Here, we investigate the effect of pair-feeding iron restriction on renal damage in a rat model of CKD. Methods First, to determine the amount of food intake, Sprague-Dawley (SD) rats were randomly given an ad libitum normal diet or an iron-restricted diet, and the food intake was measured. Second, CKD was induced by a 5/6 nephrectomy in SD rats, and CKD rats were given either a pair-feeding normal or iron-restricted diet. Results Food intake was reduced in the iron-restricted diet group compared to the normal diet group of SD rats for 16 weeks (mean food intake; normal diet group and iron-restricted diet group: 25 and 20 g/day, respectively). Based on the initial experiments, CKD rats received either a pair-feeding normal or iron-restricted diet (20 g/day) for 16 weeks. Importantly, pair-feeding iron restriction prevented the development of proteinuria, glomerulosclerosis, and tubulointerstitial damage in CKD rats. Interestingly, pair-feeding iron restriction attenuated renal expression of nuclear mineralocorticoid receptor in CKD rats. Conclusions Pair-feeding iron restriction affected renal damage in a rat model of CKD.	[Naito, Yoshiro; Senchi, Aya; Sawada, Hisashi; Oboshi, Makiko; Horimatsu, Tetsuo; Okuno, Keisuke; Yasumura, Seiki; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Ishihara, Masaharu] Hyogo Coll Med, Div Coronary Heart Dis, Dept Internal Med, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Naito, Y (corresponding author), Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan.	ynaito@hyo-med.ac.jp			JSPS KAKENHI [25460919, 16K09273]; Salt Science Research Foundation [1544, 1641]; Suzuken Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16K09273] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919 and 16K09273) and grants from The Salt Science Research Foundation (No. 1544 and 1641), Suzuken Memorial Foundation, and Takeda Science Foundation (to Y. Naito).	Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Gay HC, 2016, HYPERTENSION, V67, P733, DOI 10.1161/HYPERTENSIONAHA.115.06853; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KOBAYASHI S, 1992, KIDNEY INT, V42, P710, DOI 10.1038/ki.1992.338; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Ni ZM, 1997, KIDNEY INT, V52, P195, DOI 10.1038/ki.1997.319; Oboshi M, 2016, HYPERTENS RES, V39, P832, DOI 10.1038/hr.2016.93; Otis L, 1940, SCIENCE, V91, P146, DOI 10.1126/science.91.2354.146; SALMON HA, 1962, J PHYSIOL-LONDON, V164, P17, DOI 10.1113/jphysiol.1962.sp006999; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Stoltzfus RJ, 2004, J NUTR, V134, P348, DOI 10.1093/jn/134.2.348; TAPP DC, 1989, LAB INVEST, V60, P184; Vassalotti JA, 2016, AM J MED, V129, P153, DOI 10.1016/j.amjmed.2015.08.025	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172157	10.1371/journal.pone.0172157	http://dx.doi.org/10.1371/journal.pone.0172157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196143	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900058
J	Wu, LW; Lin, YY; Kao, TW; Lin, CM; Liaw, FY; Wang, CC; Peng, TC; Chen, WL				Wu, Li-Wei; Lin, Yuan-Yung; Kao, Tung-Wei; Lin, Chien-Ming; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang			Mid-arm muscle circumference as a significant predictor of all-cause mortality in male individuals	PLOS ONE			English	Article							SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; OLDER PERSONS; SARCOPENIA; STRENGTH; MEN; LIMITATIONS; DEFINITION; DISABILITY	Background Emerging evidences indicate that mid-arm muscle circumference (MAMC) is one of the anthropometric indicators that reflect health and nutritional status, but its correlative effectiveness in all-cause mortality prediction of United States individuals remains uncertain. Methods and findings design We investigated the joint association between MAMC and all-cause mortality in the US general population. A population-based longitudinal study of 6,769 participants aged 40 to 90 years in the third National Health and Nutrition Examination Survey (NHANES III) conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. All participants were divided into two groups based on the gender: male and female group; each group was then divided into three subgroups depending on their MAMC level. The tertiles were as follows: T1 (18<27.3), T2 (27.3<29.6), T3 (29.6 <= 40.0) cm in the male group and T1 (15<22.3), T2 (22.3<24.6), T3 (24.6 <= 44.0) cm in the female group. Multivariable Cox regression analyses and Kaplan-Meier survival probabilities were utilized to jointly relate all-cause mortality risk to different MAMC level. For all-cause mortality in male participants, multivariable adjusted hazard ratios (HRs) were 0.83 (95% confidence interval (CI): 0.69-0.98; p = 0.033) for MAMC of 27.3-29.6 cm compared with 18-27.3cm, and 0.76 (95% CI: 0.61-0.95; p = 0.018) for MAMC of 29.6-40 cm compared with 18-27.3 cm. For all-cause mortality in female participants, multivariable adjusted hazard ratios (HRs) were 0.84 (95% confidence interval (CI): 0.69-1.02; p = 0.075) for MAMC of 22.3-24.6 cm compared with 15-22.3 cm, and 0.94 (95% CI: 0.75-1.17; p = 0.583) for MAMC of 24.6-44 cm compared with 15-22.3 cm.	[Wu, Li-Wei; Kao, Tung-Wei; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Lin, Yuan-Yung; Kao, Tung-Wei; Lin, Chien-Ming; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Wu, Li-Wei; Kao, Tung-Wei; Liaw, Fang-Yih; Wang, Chung-Ching; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Wu, Li-Wei; Lin, Yuan-Yung; Lin, Chien-Ming; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Yuan-Yung] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Lin, Chien-Ming] Triserv Gen Hosp, Dept Pediat, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020					Batsis J.A., 2016, CLIN NUTR; Blaak EE, 2000, AM J PHYSIOL-ENDOC M, V279, pE146, DOI 10.1152/ajpendo.2000.279.1.E146; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Blaak EE, 2002, DIABETES, V51, P784, DOI 10.2337/diabetes.51.3.784; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Gosker HR, 2000, AM J CLIN NUTR, V71, P1033; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Hyattsville, 2009, 3 NAT HLTH NUTR EX S; Hyattsville National Center for Health Statistics, 1994, VITAL HLTH STAT, V1, P1; Landi F, 2010, CLIN NUTR, V29, P441, DOI 10.1016/j.clnu.2009.12.006; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Muller MJ, 2014, EUR J CLIN NUTR, V68, P1220, DOI 10.1038/ejcn.2014.169; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Olsen DB, 2005, J PHYSIOL-LONDON, V565, P555, DOI 10.1113/jphysiol.2004.081356; Preis SR, 2013, DIABETES CARE, V36, pE3, DOI 10.2337/dc12-0738; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Roubenoff R, 2000, EUR J CLIN NUTR, V54, pS40, DOI 10.1038/sj.ejcn.1601024; Tian SM, 2016, GERIATR GERONTOL INT, V16, P155, DOI 10.1111/ggi.12579; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Woodrow G, 2009, CURR OPIN CLIN NUTR, V12, P8, DOI 10.1097/MCO.0b013e32831b9c5b; Zeng P, 2015, ARCH GERONTOL GERIAT, V60, P118, DOI 10.1016/j.archger.2014.08.010	28	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171707	10.1371/journal.pone.0171707	http://dx.doi.org/10.1371/journal.pone.0171707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196081	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900029
J	Fortuin-de Smidt, M; de Waal, R; Cohen, K; Technau, KG; Stinson, K; Maartens, G; Boulle, A; Igumbor, EU; Davies, MA				Fortuin-de Smidt, Melony; de Waal, Renee; Cohen, Karen; Technau, Karl-Gunter; Stinson, Kathryn; Maartens, Gary; Boulle, Andrew; Igumbor, Ehimario U.; Davies, Mary-Ann			First-line antiretroviral drug discontinuations in children	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; TOLERABILITY; THERAPY; AFRICA; SAFETY; HAART	Introduction There are a limited number of paediatric antiretroviral drug options. Characterising the long term safety and durability of different antiretrovirals in children is important to optimise management of HIV infected children and to determine the estimated need for alternative drugs in paediatric regimens. We describe first-line antiretroviral therapy (ART) durability and reasons for discontinuations in children at two South African ART programmes, where lopinavir/ ritonavir has been recommended for children <3 years old since 2004, and abacavir replaced stavudine as the preferred nucleoside reverse transcriptase inhibitor in 2010. Methods We included children (<16 years at ART initiation) who initiated >= 3 antiretrovirals between 2004-2014 with >= 1 follow-up visit on ART. We estimated the incidence of first antiretroviral discontinuation using Kaplan-Meier analysis. We determined the reasons for antiretroviral discontinuations using competing risks analysis. We used Cox regression to identify factors associated with treatment-limiting toxicity. Results We included 3579 children with median follow-up duration of 41 months (IQR 14-72). At ART initiation, median age was 44 months (IQR 13-89) and median CD4 percent was 15% (IQR 9-21%). At three and five years on ART, 72% and 26% of children respectively remained on their initial regimen. By five years on ART, the most common reasons for discontinuations were toxicity (32%), treatment failure (18%), treatment simplification (5%), drug interactions (3%), and other or unspecified reasons (18%). The incidences of treatment limiting toxicity were 50.6 (95% CI 46.2-55.4), 1.6 (0.5-4.8), 2.0 (1.2-3.3), and 1.3 (0.6-2.8) per 1000 patient years for stavudine, abacavir, efavirenz and lopinavir/ritonavir respectively. Conclusions While stavudine was associated with a high risk of treatment-limiting toxicity, abacavir, lopinavir/ ritonavir and efavirenz were well-tolerated. This supports the World Health Organization recommendation to replace stavudine with abacavir or zidovudine in paediatric first-line ART regimens in order to improve paediatric first-line ART durability.	[Fortuin-de Smidt, Melony; Cohen, Karen; Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa; [de Waal, Renee; Stinson, Kathryn; Boulle, Andrew; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Technau, Karl-Gunter] Univ Witwatersrand, Dept Paediat & Child Hlth, Empilweni Serv & Res Unit, Johannesburg, South Africa; [Stinson, Kathryn] Med Sans Frontieres, Khayelitsha, South Africa; [Igumbor, Ehimario U.] US Ctr Dis Control & Prevent, Pretoria, South Africa	University of Cape Town; University of Cape Town; University of Witwatersrand	Davies, MA (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa.	karltechnau@gmail.com; andrew.boulle@uct.ac.za; mary-ann.davies@uct.ac.za	Igumbor, Ehimario U/B-2652-2012; Maartens, Gary/S-2788-2019; Boulle, Andrew/C-1413-2008; Cohen, Karen/D-4036-2017	Igumbor, Ehimario U/0000-0002-6313-6031; Maartens, Gary/0000-0003-3080-6606; Boulle, Andrew/0000-0002-7713-8062; Cohen, Karen/0000-0002-1892-4207; de Waal, Renee/0000-0001-6171-2181; Technau, Karl-Gunter/0000-0001-7367-7512	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [GH000371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under terms of Cooperative Agreement Number GH000371. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.	[Anonymous], 2004, NAT ANT TREATM GUID; Bracher L, 2007, SCAND J INFECT DIS, V39, P799, DOI 10.1080/00365540701203493; Brennan AT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18794; Green H, 2007, AIDS, V21, P947, DOI 10.1097/QAD.0b013e3280e087e7; Hewitt RG, 2002, CLIN INFECT DIS, V34, P1137, DOI 10.1086/339751; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kampiire L, 2012, 19 INT AIDS C WASH U; Kline MW, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e47; Kumarasamy N, 2009, J TROP PEDIATRICS, V55, P155, DOI 10.1093/tropej/fmn080; Nahirya-Ntege P, 2011, PEDIATR INFECT DIS J, V30, P535, DOI 10.1097/INF.0b013e3182076864; National Department of Health South Africa, 2005, GUID MAN HIV INF CHI; National Department of Health South Africa and South African National AIDS council, 2010, GUID MAN HIV CHILDR; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Palmer M, 2013, AIDS, V27, P781, DOI 10.1097/QAD.0b013e32835c54b8; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; South African National Department of Health, 2013, S AFR ANT TREATM GUI; Tukei VJ, 2012, JAIDS-J ACQ IMM DEF, V59, P274, DOI 10.1097/QAI.0b013e3182423668; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2010, ANT THER HIV INF INF	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0169762	10.1371/journal.pone.0169762	http://dx.doi.org/10.1371/journal.pone.0169762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192529	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800006
J	Gopinath, B; Moshtaghian, H; Flood, VM; Louie, JCY; Liew, G; Burlutsky, G; Mitchell, P				Gopinath, Bamini; Moshtaghian, Hanieh; Flood, Victoria M.; Louie, Jimmy C. Y.; Liew, Gerald; Burlutsky, George; Mitchell, Paul			Pattern of omega-3 polyunsaturated fatty acid intake and fish consumption and retinal vascular caliber in children and adolescents: A cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIETARY-INTAKE; HYPERCHOLESTEROLEMIC PATIENTS; ATHEROSCLEROSIS RISK; AUSTRALIAN CHILDREN; VESSEL DIAMETERS; FOOD SOURCES; POPULATION; OIL; MORTALITY	We aimed to investigate whether fish and long chain omega-3 polyunsaturated fatty acid (LCn-3 PUFA) consumption changed appreciably during adolescence. We also assessed whether these dietary variables are associated with retinal microvascular signs (possible markers of future cardiovascular disease risk). 633 children had dietary data at ages 12 and 17. Fish and LCn-3 PUFA [eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA)] intake was assessed by a food frequency questionnaire. Retinal vessel caliber was quantified from digital photographs using computer software. Mean energy-adjusted intakes (mg/day) of total LCn-3 PUFA, EPA, and DHA at age 12 were 297.1 +/- 261.1; 102.5 +/- 106.9; and 129.7 +/- 137.7, respectively; and this increased significantly at age 17 to: 347.0 +/- 324.0 (p<0.0001); 122.5 +/- 132.7 (p = 0.0001); and 160.3 +/- 171.4 (p < 0.0001), respectively. Increasing quartiles of LCn-3PUFA intake were associated with widening of mean retinal arteriolar caliber among 17-year old girls similar to 3.9 mu m (multivariable-adjusted P-trend = 0.001). Girls who consumed >= 2 serves of fish/week versus those who did not had similar to 2.1 mu m wider retinal arterioles (p = 0.03). No associations were observed among boys or with retinal venules. Mean dietary intakes of LCn-3 PUFA increased during adolescence, but are still below recommended levels of consumption. These results suggest that LCn-3 PUFA and fish intake might have a beneficial influence.	[Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Westmead Inst, Sydney, NSW, Australia; [Moshtaghian, Hanieh] Univ Wollongong, Sch Med, Fac Sci Med & Hlth, Wollongong, NSW, Australia; [Flood, Victoria M.] St Vincents Hosp, Sydney, NSW, Australia; [Flood, Victoria M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Louie, Jimmy C. Y.] Univ Hong Kong, Sch Biol Sci, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Louie, Jimmy C. Y.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Wollongong; St Vincents Hospital Sydney; University of Sydney; University of Hong Kong; University of Sydney	Gopinath, B (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia.; Gopinath, B (corresponding author), Univ Sydney, Westmead Inst, Sydney, NSW, Australia.	bamini.gopinath@sydney.edu.au	Gopinath, Bamini/K-4286-2019; Liew, Gerald/AAB-6870-2022; Mitchell, Paul/P-1498-2014; Flood, Victoria M/A-8732-2016; Louie, Jimmy Chun Yu/B-6754-2008	Gopinath, Bamini/0000-0003-3573-359X; Flood, Victoria M/0000-0001-5310-7221; Louie, Jimmy Chun Yu/0000-0001-7736-605X	Australian National Health & Medical Research Council [253732, 512530]; Westmead Millennium Institute, University of Sydney; Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute, University of Sydney(University of Sydney); Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The Sydney Myopia Study (Sydney Childhood Eye Study) and Sydney Adolescent Vascular Eye Study were supported by the Australian National Health & Medical Research Council (Grant Nos. 253732, 512530); the Westmead Millennium Institute, University of Sydney; and the Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia.	[Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18; CHIN JPF, 1995, CLIN EXP PHARMACOL P, V22, P71, DOI 10.1111/j.1440-1681.1995.tb01959.x; Clayton EH, 2009, BRIT J NUTR, V101, P1731, DOI 10.1017/S0007114508135887; Commonwealth Scientific Industrial Research Organisation (CSIRO) Preventative Health National Research Flagship and the University of South Australia, 2008, 2007 AUSTR NAT CHILD; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; Flood VM, 2007, ASIA PAC J CLIN NUTR, V16, P322; Food Standards Australia New Zealand, 2011, NUTTAB 2006; Food Standards Australia New Zealand, 2007, AUSNUT 2007; Food Standards Australia New Zealand, 2010, NUTTAB 2010; Goode GK, 1997, CIRCULATION, V96, P2802, DOI 10.1161/01.CIR.96.9.2802; Gopinath B, 2014, NUTR METAB CARDIOVAS; Gopinath B, 2013, NUTR METAB IN PRESS; Gopinath B, 2014, ASIA PAC J CLIN NUTR, V23, P612, DOI 10.6133/apjcn.2014.23.4.05; Gopinath B, 2014, ASIA PAC J CLIN NUTR, V23, P121, DOI 10.6133/apjcn.2014.23.1.13; Gopinath B, 2012, AM J CLIN NUTR, V95, P1215, DOI 10.3945/ajcn.111.031641; Gopinath B, 2012, J PAEDIATR CHILD H, V48, P44, DOI 10.1111/j.1440-1754.2011.02181.x; Gopinath B, 2011, ARTERIOSCL THROM VAS, V31, P1233, DOI 10.1161/ATVBAHA.110.219451; Gopinath B, 2011, AM J CLIN NUTR, V93, P1073, DOI 10.3945/ajcn.110.009977; Gopinath B, 2010, J HYPERTENS, V28, P1406, DOI 10.1097/HJH.0b013e3283395223; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, NEUROLOGY, V66, P1339, DOI 10.1212/01.wnl.0000210533.24338.ea; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kaushik S, 2007, MICROCIRCULATION, P1; Kaushik S, 2009, STROKE, V40, P206, DOI 10.1161/STROKEAHA.108.513812; Keel S, 2016, ACTA OPHTHALMOL; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Mann N. J., 2003, Nutrition & Dietetics, V60, P42; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; McLennan W, 1995, 48070 AUSTR BUR STAT; MCVEIGH GE, 1993, DIABETOLOGIA, V36, P33, DOI 10.1007/BF00399090; MCVEIGH GE, 1994, ARTERIOSCLER THROMB, V14, P1425, DOI 10.1161/01.ATV.14.9.1425; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Murray CS, 2006, ALLERGY, V61, P438, DOI 10.1111/j.1398-9995.2005.00927.x; National Department of Health, 2008, POLICY IMPLEMENTATIO, P1; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rahmawaty S, 2014, NUTRITION, V30, P169, DOI 10.1016/j.nut.2013.07.014; Rahmawaty S, 2013, LIPIDS, V48, P869, DOI 10.1007/s11745-013-3812-4; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Sasongko MB, 2010, MICROCIRCULATION, V17, P21, DOI 10.1111/j.1549-8719.2009.00007.x; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Shaw LJ, 2004, CIRCULATION, V109, pE56, DOI 10.1161/01.CIR.0000116210.70548.2A; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2006, OBESITY, V14, P206, DOI 10.1038/oby.2006.27; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172109	10.1371/journal.pone.0172109	http://dx.doi.org/10.1371/journal.pone.0172109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192538	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800070
J	Johnsen, AS; Sollid, SJM; Vigerust, T; Jystad, M; Rehn, M				Johnsen, Anne Siri; Sollid, Stephen J. M.; Vigerust, Trond; Jystad, Morten; Rehn, Marius			Helicopter emergency medical services in major incident management: A national Norwegian cross-sectional survey	PLOS ONE			English	Article								Objective Helicopter Emergency Medical Services (HEMS) aim to bring a highly specialised crew to the scene of major incidents for triage, treatment and transport. We aim to describe experiences made by HEMS in Norway in the management of major incidents. Design Doctors, rescue paramedics and pilots working in Norwegian HEMS and Search and Rescue Helicopters (SAR) January 1st 2015 were invited to a cross-sectional study on experiences, preparedness and training in major incident management. Results We identified a total of 329 Norwegian crewmembers of which 229 (70%) responded; doctors 101/150, (67%), rescue paramedics 64/78 (82%), pilots 64/101, (63%). HEMS and SAR crewmembers had experience from a median of 2 (interquartile range 0-6) major incidents. Road traffic incidents were the most frequent mechanism and blunt trauma the dominating injury. HEMS mainly contributed with triage, treatment and transport. Communication with other emergency services prior to arrival was described as bad, but good to excellent when cooperating on scene. The respondents called for more interdisciplinary exercises. Conclusion HEMS and SAR crewmembers have limited exposure to major incident management. Interdisciplinary training on frequent scenarios with focus on cooperation and communication is called for.	[Johnsen, Anne Siri; Sollid, Stephen J. M.; Vigerust, Trond; Jystad, Morten; Rehn, Marius] Norwegian Air Ambulance Fdn, Dept Res & Dev, Drobak, Norway; [Johnsen, Anne Siri; Sollid, Stephen J. M.; Rehn, Marius] Univ Stavanger, Dept Hlth Studies, Fac Social Sci, Stavanger, Norway; [Johnsen, Anne Siri; Rehn, Marius] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway; [Sollid, Stephen J. M.] Oslo Univ Hosp, Air Ambulance Dept, Oslo, Norway; [Vigerust, Trond; Jystad, Morten] Norwegian Air Ambulance Ltd, Lorenskog Dombas Base, Lorenskog Dombas, Norway	Universitetet i Stavanger; University of Oslo; University of Oslo	Johnsen, AS (corresponding author), Norwegian Air Ambulance Fdn, Dept Res & Dev, Drobak, Norway.; Johnsen, AS (corresponding author), Univ Stavanger, Dept Hlth Studies, Fac Social Sci, Stavanger, Norway.; Johnsen, AS (corresponding author), Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway.	anne.siri.johnsen@norskluftambulanse.no	Sollid, Stephen J. M./E-7395-2010	Sollid, Stephen/0000-0001-5543-0057	Norwegian Air Ambulance Foundation	Norwegian Air Ambulance Foundation	Norwegian Air Ambulance Foundation funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ROTORS EU, V4, P45; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Braendeland G, 2013, INT J EMERG MANAG, V9, P127, DOI 10.1504/IJEM.2013.055160; Cassuto J, 2003, BURNS, V29, P405, DOI 10.1016/S0305-4179(03)00074-3; Det kongelige justis og politidepartement, REDN FREMT; Eide A.W., 2013, P 10 INT ISCRAM C BA, P94; Fattah S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-5; Guha-Sapir D, 2017, ANN DISASTER STAT RE; Jersin E., 2003, SINTEF RAPPORT STORU; Johnsen AS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010307; Kapucu N., 2005, CONNECT, V26, P33; Lavery GG, 2005, CRIT CARE, V9, P401, DOI 10.1186/cc3502; Leiba A, 2005, PREHOSPITAL DISASTER, V20, P253, DOI 10.1017/S1049023X00002624; Osteras O, 2016, ACTA ANAESTH SCAND, V60, P659, DOI 10.1111/aas.12673; Rimstad R, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0052-9; Romundstad Luis, 2004, Prehosp Disaster Med, V19, P179; Sammut J, 2001, Emerg Med (Fremantle), V13, P174, DOI 10.1046/j.1442-2026.2001.00206.x; Sedia H., 2003, 77 KAMEDO, P1; Sollid SJM, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-3; Urquieta E, 2015, AIR MED J, V33, P309	20	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171436	10.1371/journal.pone.0171436	http://dx.doi.org/10.1371/journal.pone.0171436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192440	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800025
J	Terrenato, I; D'Alicandro, V; Casini, B; Perracchio, L; Rollo, F; De Salvo, L; Di Filippo, S; Di Filippo, F; Pescarmona, E; Maugeri-Sacca, M; Mottolese, M; Buglioni, S				Terrenato, Irene; D'Alicandro, Valerio; Casini, Beatrice; Perracchio, Letizia; Rollo, Francesca; De Salvo, Laura; Di Filippo, Simona; Di Filippo, Franco; Pescarmona, Edoardo; Maugeri-Sacca, Marcello; Mottolese, Marcella; Buglioni, Simonetta			A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; MOLECULAR METHOD; METASTASES; DISSECTION; INVOLVEMENT; DIAGNOSIS; METAANALYSIS; NOMOGRAM; RECEPTOR; BIOPSY	Since 2007, one-step nucleic acid amplification (OSNA) has been used as a diagnostic system for sentinel lymph node (SLN) examination in patients with breast cancer. This study aimed to define a new clinical cut-off of CK19 mRNA copy number based on the calculation of the risk that an axillary lymph node dissection (ALND) will be positive. We analyzed 1529 SLNs from 1140 patients with the OSNA assay and 318 patients with positive SLNs for micrometastasis (250 copies) and macrometastasis (5000 copies) underwent ALND. Axillary non-SLNs were routinely examined. ROC curves and Youden's index were performed in order to identify a new cut-off value. Logistic regression models were performed in order to compare OSNA categorical variables created on the basis of our and traditional cut-off to better identify patients who really need an axillary dissection. 69% and 31% of OSNA positive patients had a negative and positive ALND, respectively. ROC analysis identified a cutoff of 2150 CK19 mRNA copies with 95% sensitivity and 51% specificity. Positive and negative predictive values of this new cut-off were 47% and 96%, respectively. Logistic regression models indicated that the cut-off of 2150 copies better discriminates patients with node negative or positive in comparison with the conventional OSNA cut-off (p<0.0001). This cutoff identifies false positive and false negative cases and true-positive and true negative cases very efficiently, and therefore better identifies which patients really need an ALND and which patients can avoid one. This is why we suggest that the negative cut-off should be raised from 250 to 2150. Furthermore, we propose that for patients with a copy number that ranges between 2150 and 5000, there should be a multidisciplinary discussion concerning the clinical and bio-morphological features of primary breast cancer before any decision is taken on whether to perform an ALND or not.	[Terrenato, Irene] Regina Elena Inst Canc Res, Biostat Unit, Rome, Italy; [D'Alicandro, Valerio; Casini, Beatrice; Perracchio, Letizia; Rollo, Francesca; De Salvo, Laura; Pescarmona, Edoardo; Mottolese, Marcella; Buglioni, Simonetta] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Di Filippo, Simona; Di Filippo, Franco] Regina Elena Inst Canc Res, Dept Surg, Rome, Italy; [Maugeri-Sacca, Marcello] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy; [Maugeri-Sacca, Marcello] Regina Elena Inst Canc Res, Sci Direct, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Buglioni, S (corresponding author), Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.	simonetta.buglioni@ifo.gov.it	D'Alicandro, Valerio/AAA-7751-2020; Terrenato, Irene/B-1308-2017; Maugeri-Saccà, Marcello/K-2350-2014; Rollo, Francesca/I-5249-2018; Rollo, Francesca/AAC-2775-2021	Terrenato, Irene/0000-0002-0187-9323; Maugeri-Saccà, Marcello/0000-0003-2287-9581; Rollo, Francesca/0000-0003-2724-872X; Rollo, Francesca/0000-0003-2724-872X; CASINI, BEATRICE/0000-0002-9038-0179; buglioni, simonetta/0000-0002-5066-1523; Pescarmona, Edoardo/0000-0002-0443-9331				Belda MA, 2012, INT J CANCER, V130, P2377, DOI [10.1002/ijc.26291, DOI 10.1002/IJC.26291]; Bernet L, 2011, HISTOPATHOLOGY, V58, P863, DOI 10.1111/j.1365-2559.2011.03836.x; Buglioni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058823; Castellano I, 2012, ANN SURG, V255, P334, DOI 10.1097/SLA.0b013e31823000ed; Deambrogio C, 2014, J CLIN PATHOL, V67, P702, DOI 10.1136/jclinpath-2014-202384; Di Filippo F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0246-2; Fattaneh A, 2003, PATHOLOGY GENETICS T; Feldman S, 2011, CANCER-AM CANCER SOC, V117, P2599, DOI 10.1002/cncr.25822; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Heilmann T, 2013, J CANCER RES CLIN, V139, P1649, DOI 10.1007/s00432-013-1481-6; Kamath VJ, 2001, ARCH SURG-CHICAGO, V136, P688, DOI 10.1001/archsurg.136.6.688; Khaddage A, 2011, ANTICANCER RES, V31, P585; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Li CZ, 2015, EJSO-EUR J SURG ONC, V41, P958, DOI 10.1016/j.ejso.2015.05.007; Meretoja TJ, 2013, BREAST CANCER RES TR, V138, P817, DOI 10.1007/s10549-013-2468-3; Nos C, 2003, BRIT J SURG, V90, P1354, DOI 10.1002/bjs.4325; Peg V, 2013, BREAST CANCER RES TR, V139, P87, DOI 10.1007/s10549-013-2524-z; Rubio IT, 2014, BREAST CANCER RES TR, V147, P371, DOI 10.1007/s10549-014-3108-2; Sagara Y, 2013, BREAST CANCER-TOKYO, V20, P181, DOI 10.1007/s12282-011-0324-z; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Ugras S, 2014, ANN SURG ONCOL, V21, P3780, DOI 10.1245/s10434-014-3851-y; Visser M, 2008, INT J CANCER, V122, P2562, DOI 10.1002/ijc.23451; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171517	10.1371/journal.pone.0171517	http://dx.doi.org/10.1371/journal.pone.0171517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187209	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300026
J	Alene, KA; Viney, K; McBryde, ES; Clements, ACA				Alene, Kefyalew Addis; Viney, Kerri; McBryde, Emma S.; Clements, Archie C. A.			Spatial patterns of multidrug resistant tuberculosis and relationships to socioeconomic, demographic and household factors in northwest Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION; REGION; PERU; MDR; TB	Background Understanding the geographical distribution of multidrug-resistant tuberculosis (MDR-TB) in high TB burden countries such as Ethiopia is crucial for effective control of TB epidemics in these countries, and thus globally. We present the first spatial analysis of multidrug resistant tuberculosis, and its relationship to socio-economic, demographic and household factors in northwest Ethiopia. Methods An ecological study was conducted using data on patients diagnosed with MDR-TB at the University of Gondar Hospital MDR-TB treatment centre, for the period 2010 to 2015. District level population data were extracted from the Ethiopia National and Regional Census Report. Spatial autocorrelation was explored using Moran's I statistic, Local Indicators of Spatial Association (LISA), and the Getis-Ord statistics. A multivariate Poisson regression model was developed with a conditional autoregressive (CAR) prior structure, and with posterior parameters estimated using a Bayesian Markov chain Monte Carlo (MCMC) simulation approach with Gibbs sampling, in WinBUGS. Results A total of 264 MDR-TB patients were included in the analysis. The overall crude incidence rate of MDR-TB for the six-year period was 3.0 cases per 100,000 population. The highest incidence rate was observed in Metema (21 cases per 100,000 population) and Humera (18 cases per 100,000 population) districts; whereas nine districts had zero cases. Spatial clustering of MDR-TB was observed in districts located in the Ethiopia-Sudan and Ethiopia-Eritrea border regions, where large numbers of seasonal migrants live. Spatial clustering of MDR-TB was positively associated with urbanization (RR: 1.02; 95% CI: 1.01, 1.04) and the percentage of men (RR: 1.58; 95% CI: 1.26, 1.99) in the districts; after accounting for these factors there was no residual spatial clustering. Conclusion Spatial clustering of MDR-TB, fully explained by demographic factors (urbanization and percent male), was detected in the border regions of northwest Ethiopia, in locations where seasonal migrants live and work. Cross-border initiatives including options for mobile TB treatment and follow up are important for the effective control of MDR-TB in the region.	[Alene, Kefyalew Addis; Viney, Kerri; Clements, Archie C. A.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia; [Alene, Kefyalew Addis] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [McBryde, Emma S.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [McBryde, Emma S.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [McBryde, Emma S.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia	Australian National University; University of Gondar; Burnet Institute; University of Melbourne; James Cook University	Alene, KA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia.; Alene, KA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia.	kefyalew.alene@anu.edu.au	Clements, Archie/ABD-1615-2020; Alene, Dr Kefyalew Addis/V-8240-2018; McBryde, Emma/D-2220-2018	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; McBryde, Emma/0000-0002-9570-9172				Agency CS, 2007, 2007 POP HOUS CENS E; Alene KA, 2016, TROPICAL MED INT HLT; [Anonymous], 2015, IMPL END TB STRAT ES; Asfaw W, 2010, NORSK GEOGR TIDSSKR, V64, P58, DOI 10.1080/00291950903557696; Biruck Kebede BA, 2013, GUIDELINES PROGRAMMA; Cain KP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001791; CSA, 2013, POPULATION PROJECTIO; Dara M, 2012, EUR RESPIR J, V40, P1081, DOI 10.1183/09031936.00053012; ESRI, 2015, ARCGIS DESKT REL 10; Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]; Guinand Y., 1999, UNDERDEVELOPED DROUG, P18; Gurjav U, 2015, INT J TUBERC LUNG D, V19, P1376, DOI 10.5588/ijtld.15.0361; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Jagielski T, 2015, EUR J CLIN MICROBIOL, V34, P41, DOI 10.1007/s10096-014-2202-z; Jenkins H, 2014, B EUROPEEN MALADIES, V19; Jenkins HE, 2013, EUR RESPIR J, V42, P1291, DOI 10.1183/09031936.00111812; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Leung ECC, 2012, EUROPEAN RESP J; Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347; Lin H, 2011, EPIDEMIOL INFECT, V139, P1784, DOI 10.1017/S0950268810002797; Lin HH, 2012, EMERG INFECT DIS, V18, P811, DOI 10.3201/eid1805.111467; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lopes ML, 2012, REV PAN AMAZONICA SA, V3, P27; Manjourides J, 2012, TUBERCULOSIS, V92, P273, DOI 10.1016/j.tube.2012.02.003; [MOH Health EFMo], 2013, EXTR 5 YEARS TB TB H, V5; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Rosas S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-442; Shah L, 2014, INT J TUBERC LUNG D, V18, P1307, DOI 10.5588/ijtld.14.0011; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Tang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1789-z; Tesfay K, 2016, INT J MYCOBACTERIOLO; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Ullah I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147529; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, US HIGH BURD COUNTR; World Health Organization, 2013, DEFINITIONS REPORTIN; Zelner JL, 2015, J INFECT DIS; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	40	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171800	10.1371/journal.pone.0171800	http://dx.doi.org/10.1371/journal.pone.0171800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182726	Green Published, Green Accepted, gold			2022-12-27	WOS:000394231800114
J	Alston, CI; Dix, RD				Alston, Christine I.; Dix, Richard D.			Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS) 1 and SOCS3	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IFN-GAMMA; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; NEGATIVE REGULATORS; INTERFERON; VIRUS; ACTIVATION; REPLICATION; PROTEINS	Human cytomegalovirus (HCMV) is a species-specific beta-herpesvirus that infects for life up to 80% of the world's population and causes severe morbidity in at-risk immunocompromised populations. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 are host proteins that act as inducible negative feedback regulators of cytokine signaling and have been implicated in several ocular diseases and viral infections. We recently found in our mouse model of experimental cytomegalovirus retinitis that subretinally-injected murine cytomegalovirus (MCMV) stimulates ocular SOCS1 and SOCS3 during retrovirus-induced immune suppression of murine AIDS (MAIDS), and that infiltrating macrophages are prominent cellular sources of retinal SOCS1 and SOCS3 expression. Herein we investigate possible virologic mechanisms whereby MCMV infection may stimulate SOCS1 and/or SOCS3 expression in cell culture. We report that infection of IC-21 mouse macrophages with MCMV propagated through the salivary glands of BALB/c mice, but not from tissue culture in C57BL/6 fibroblasts, transiently stimulates SOCS1 and SOCS3 mRNA transcripts, but not SOCS5 mRNA. Viral tegument proteins are insufficient for this stimulation, as replication-deficient UV-inactivated MCMV fails to stimulate SOCS1 or SOCS3 in IC-21 macrophages. By contrast, infection of murine embryonic fibroblasts (MEFs) with either productive MCMV or UV-inactivated MCMV significantly stimulates SOCS1 and SOCS3 mRNA expression early after infection. Treatment of MCMV-infected IC-21 mouse macrophages with the antiviral drug ganciclovir significantly decreases MCMV-stimulated SOCS3 expression at 3 days post-infection. These data suggest cell type-specific, different roles for viral immediate early or early gene expression and/or viral tegument proteins in the early stimulation of SOCS1 and SOCS3 during MCMV infection. Furthermore, putative biphasic stimulation of SOCS3 during late MCMV infection of IC-21 mouse macrophages may occur by divergent virologic mechanisms.	[Alston, Christine I.; Dix, Richard D.] Georgia State Univ, Viral Immunol Ctr, Dept Biol, Atlanta, GA 30302 USA; [Alston, Christine I.; Dix, Richard D.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University	Dix, RD (corresponding author), Georgia State Univ, Viral Immunol Ctr, Dept Biol, Atlanta, GA 30302 USA.; Dix, RD (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.	rdix@gsu.edu			NIH [EY010568, EY024630]; NIH/NEI [P30/EY006360]; Emory Eye Center Vision Training Grant [NIH/NEI T32-EY007092]; Research to Prevent Blindness; Fight for Sight; NATIONAL EYE INSTITUTE [P30EY006360, R01EY024630, T32EY007092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Emory Eye Center Vision Training Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY010568 (RDD), NIH Grant EY024630 (RDD), NIH/NEI Core Grant P30/EY006360, Emory Eye Center Vision Training Grant NIH/NEI T32-EY007092, Research to Prevent Blindness, and Fight for Sight.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmed Amina, 2011, Infect Disord Drug Targets, V11, P475; Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blalock EL, 2013, CYTOKINE, V61, P862, DOI 10.1016/j.cyto.2013.01.009; CARDIN RD, 1995, VIROLOGY, V209, P236, DOI 10.1006/viro.1995.1249; Cheng TP, 2010, J VIROL, V84, P2623, DOI 10.1128/JVI.02142-09; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Cousins SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002671; Daley-Bauer LP, 2014, CELL HOST MICROBE, V15, P351, DOI 10.1016/j.chom.2014.02.002; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dix RD, 2004, CURR EYE RES, V29, P173, DOI 10.1080/02713680490504876; DIX RD, 1994, CURR EYE RES, V13, P587, DOI 10.3109/02713689408999892; DUDGEON JA, 1971, ARCH DIS CHILD, V46, P581, DOI 10.1136/adc.46.249.581; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Harter G, 2012, EXPERT OPIN PHARMACO, V13, P623, DOI 10.1517/14656566.2012.658775; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hanson LK, 1999, J VIROL, V73, P5970, DOI 10.1128/JVI.73.7.5970-5980.1999; Hanson LK, 2001, J VIROL, V75, P6292, DOI 10.1128/JVI.75.14.6292-6302.2001; Heiden D, 2007, PLOS MED, V4, P1845, DOI 10.1371/journal.pmed.0040334; HEISE MT, 1995, J VIROL, V69, P904, DOI 10.1128/JVI.69.2.904-909.1995; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; HERMISTON TW, 1987, J VIROL, V61, P3214, DOI 10.1128/JVI.61.10.3214-3221.1987; HOLLAND GN, 1982, AM J OPHTHALMOL, V93, P393, DOI 10.1016/0002-9394(82)90127-1; Holland GN TA, 1996, CYTOMEGALOVIRUS DIS; INADA T, 1985, J GEN VIROL, V66, P871, DOI 10.1099/0022-1317-66-4-871; INADA T, 1985, J GEN VIROL, V66, P879, DOI 10.1099/0022-1317-66-4-879; Jabs DA, 1997, AM J OPHTHALMOL, V124, P227, DOI 10.1016/S0002-9394(14)70789-5; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; Jabs DA, 2011, AM J OPHTHALMOL, V151, P198, DOI 10.1016/j.ajo.2010.10.018; JORDAN MC, 1982, J CLIN INVEST, V70, P762, DOI 10.1172/JCI110672; KEIL GM, 1984, J VIROL, V50, P784, DOI 10.1128/JVI.50.3.784-795.1984; KEIL GM, 1985, J VIROL, V54, P422, DOI 10.1128/JVI.54.2.422-428.1985; KEIL GM, 1987, J VIROL, V61, P526, DOI 10.1128/JVI.61.2.526-533.1987; KELSEY DK, 1976, ANTIMICROB AGENTS CH, V9, P458, DOI 10.1128/AAC.9.3.458; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kropp KA, 2011, J VIROL, V85, P10286, DOI 10.1128/JVI.00373-11; Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0; LOH L, 1980, INFECT IMMUN, V27, P54, DOI 10.1128/IAI.27.1.54-60.1980; Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10; MANNING WC, 1988, VIROLOGY, V167, P477, DOI 10.1016/0042-6822(88)90110-9; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; MAR EC, 1985, J VIROL, V53, P776, DOI 10.1128/JVI.53.3.776-780.1985; MATTHEWS T, 1988, REV INFECT DIS, V10, pS490; MAUEL J, 1971, J EXP MED, V134, P335, DOI 10.1084/jem.134.2.335; MESSERLE M, 1992, J VIROL, V66, P27, DOI 10.1128/JVI.66.1.27-36.1992; MIMS CA, 1978, J GEN VIROL, V41, P143, DOI 10.1099/0022-1317-41-1-143; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Mocarski E.S., 2001, FIELDS VIROLOGY, V2, P2629; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; OSBORN JE, 1971, INFECT IMMUN, V3, P228, DOI 10.1128/IAI.3.2.228-236.1971; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Pomeroy C, 1998, J LAB CLIN MED, V132, P124, DOI 10.1016/S0022-2143(98)90007-5; Popkin DL, 2003, P NATL ACAD SCI USA, V100, P14309, DOI 10.1073/pnas.1835673100; Prichard MN, 2011, VIRUS RES, V157, P212, DOI 10.1016/j.virusres.2010.11.004; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELGRADE MK, 1981, INFECT IMMUN, V33, P840, DOI 10.1128/IAI.33.3.840-847.1981; Sharma N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27685; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SINICKAS VG, 1985, J GEN VIROL, V66, P747, DOI 10.1099/0022-1317-66-4-747; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stewart MW, 2010, CLIN OPHTHALMOL, V4, P285; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Strobl B, 2005, J IMMUNOL, V175, P4000, DOI 10.4049/jimmunol.175.6.4000; Terhune SS, 2004, J VIROL, V78, P10390, DOI 10.1128/JVI.78.19.10390-10398.2004; Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516; TYMS AS, 1987, J GEN VIROL, V68, P1563, DOI 10.1099/0022-1317-68-6-1563; Vadlapudi Aswani D, 2012, Recent Pat Antiinfect Drug Discov, V7, P8; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Watanabe S, 1996, CURR OPIN GENET DEV, V6, P587, DOI 10.1016/S0959-437X(96)80088-8; YAMAGUCHI T, 1988, J GEN VIROL, V69, P2961, DOI 10.1099/0022-1317-69-12-2961; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	86	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171812	10.1371/journal.pone.0171812	http://dx.doi.org/10.1371/journal.pone.0171812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182772	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800117
J	Aras, D; Cakar, Z; Ozkavukcu, S; Can, A; Cinar, O				Aras, Duru; Cakar, Zeynep; Ozkavukcu, Sinan; Can, Alp; Cinar, Ozgur			In Vivo acrylamide exposure may cause severe toxicity to mouse oocytes through its metabolite glycidamide	PLOS ONE			English	Article							REPRODUCTIVE TOXICITY; GERM-CELLS; ENVIRONMENTAL DEGRADATION; MICE; POLYACRYLAMIDES; MUTAGENICITY; GENOTOXICITY; CENTROSOME; SMOKE	High acrylamide (ACR) content in heat-processed carbohydrate-rich foods, as well as roasted products such as coffee, almonds etc., has been found to be as a risk factor for carcinogenicity and genotoxicity by The World Health Organization. Glycidamide (GLY), the epoxide metabolite of ACR, is processed by the cytochrome P-450 enzyme system and has also been found to be a genotoxic agent. The aim of this study was to determine whether ACR and/or GLY have any detrimental effect on the meiotic cell division of oocytes. For this purpose, germinal vesicle-stage mouse oocytes were treated with 0, 100, 500, or 1000 mu M ACR or 0, 25, or 250 mu M GLY in vitro. In vivo experiments were performed after an intraperitoneal injection of 25 mg/kg/day ACR of female BALB/c mice for 7 days. The majority of in vitro ACR-treated oocytes reached the metaphase-II stage following 18 hours of incubation, which was not significantly different from the control group. Maturation of the oocytes derived from in vivo ACR-treated mice was impaired significantly. Oocytes, reaching the M-II stage in the in vivo ACR-treated group, were characterized by a decrease in meiotic spindle mass and an increase in chromosomal disruption. In vitro GLY treatment resulted in the degeneration of all oocytes, indicating that ACR toxicity on female germ cells may occur through its metabolite, GLY. Thus, ACR exposure must be considered, together with its metabolite GLY, when female fertility is concerned.	[Aras, Duru; Cakar, Zeynep; Can, Alp; Cinar, Ozgur] Ankara Univ, Sch Med, Dept Histol & Embryol, Labs Stem Cells & Reprod Biol, Ankara, Turkey; [Ozkavukcu, Sinan] Ankara Univ, Sch Med, Ctr Assisted Reprod, Dept Obstet & Gynecol, Ankara, Turkey	Ankara University; Ankara University	Cinar, O (corresponding author), Ankara Univ, Sch Med, Dept Histol & Embryol, Labs Stem Cells & Reprod Biol, Ankara, Turkey.	ocinar@ankara.edu.tr	cinar, ozgur/ABI-5190-2020; Can, Alp/AAO-5734-2020; Ozkavukcu, Sinan/A-8802-2019; TOSUN, Duru ARAS/L-5783-2018	cinar, ozgur/0000-0003-2901-1910; Ozkavukcu, Sinan/0000-0003-4525-9027; TOSUN, Duru ARAS/0000-0001-8236-4315	Ankara University Scientific Research Council [BAP13B3330012]	Ankara University Scientific Research Council	This study was supported by Ankara University Scientific Research Council BAP13B3330012 to SO, AC, and OC. The funders had no role in study design, data collection and analysis, decisiontopublish, orpreparation of the manuscript.	ALKarim S., 2015, ASIAN PAC J REPROD, V4, P179, DOI [10.1016/j.apjr.2015.05.001, DOI 10.1016/j.apjr.2015.05.001]; Aras D, 2016, MOL HUM REPROD, V22, P57, DOI 10.1093/molehr/gav065; Can A, 2003, MOL HUM REPROD, V9, P749, DOI 10.1093/molehr/gag093; Cinar O, 2015, TOXICOL SCI, V144, P298, DOI 10.1093/toxsci/kfu317; COSTA LG, 1992, NEUROTOXICOLOGY, V13, P219; Dobrovolsky VN, 2016, FOOD CHEM TOXICOL, V87, P120, DOI 10.1016/j.fct.2015.12.006; Doerge DR, 2005, TOXICOL APPL PHARM, V202, P258, DOI 10.1016/j.taap.2004.07.001; Duan XY, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0405-3; Dybing E, 2003, TOXICOL SCI, V75, P7, DOI 10.1093/toxsci/kfg165; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; FAO/WHO, 2002, HLTH IMPL ACR FOOD, V90; Favor J, 2005, MUTAT RES-GEN TOX EN, V580, P21, DOI 10.1016/j.mrgentox.2004.09.010; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Ghanayem BI, 2005, BIOL REPROD, V72, P157, DOI 10.1095/biolreprod.104.033308; Hagmar L, 2001, SCAND J WORK ENV HEA, V27, P219, DOI 10.5271/sjweh.608; HASHIMOTO K, 1981, ARCH TOXICOL, V47, P179, DOI 10.1007/BF00368678; HASHIMOTO K, 1985, MUTAT RES, V158, P129, DOI 10.1016/0165-1218(85)90075-8; HE FS, 1989, SCAND J WORK ENV HEA, V15, P125, DOI 10.5271/sjweh.1878; Hsu HT, 2016, FOOD CHEM, V211, P669, DOI 10.1016/j.foodchem.2016.05.125; Hulas-Stasiak M, 2013, REPROD TOXICOL, V42, P125, DOI 10.1016/j.reprotox.2013.08.007; Liu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135818; Manjanatha MG, 2006, ENVIRON MOL MUTAGEN, V47, P6, DOI 10.1002/em.20157; Mojska H, 2016, ANN AGR ENV MED, V23, P456, DOI 10.5604/12321966.1219187; NICNAS, 2002, ACR PRIOR EX CHEM AS; Nixon BJ, 2012, TOXICOL SCI, V129, P135, DOI 10.1093/toxsci/kfs178; SAKAMOTO J, 1986, ARCH TOXICOL, V59, P201, DOI 10.1007/BF00290538; SHIRAISHI Y, 1978, MUTAT RES, V57, P313, DOI 10.1016/0027-5107(78)90216-6; Sickles DW, 2007, TOXICOL APPL PHARM, V222, P111, DOI 10.1016/j.taap.2007.04.006; Sickles DW, 1996, J NEUROSCI RES, V46, P7, DOI 10.1002/(SICI)1097-4547(19961001)46:1<7::AID-JNR2>3.0.CO;2-P; Smith EA, 1996, ECOTOX ENVIRON SAFE, V35, P121, DOI 10.1006/eesa.1996.0091; Smith EA, 1997, ECOTOX ENVIRON SAFE, V37, P76, DOI 10.1006/eesa.1997.1527; Sobinoff AP, 2013, TOXICOL APPL PHARM, V271, P156, DOI 10.1016/j.taap.2013.05.009; SUMNER SCJ, 1992, CHEM RES TOXICOL, V5, P81, DOI 10.1021/tx00025a014; Tardiff RG, 2010, FOOD CHEM TOXICOL, V48, P658, DOI 10.1016/j.fct.2009.11.048; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Wei QW, 2014, REPROD TOXICOL, V46, P121, DOI 10.1016/j.reprotox.2014.03.007; ZENICK H, 1986, J TOXICOL ENV HEALTH, V17, P457, DOI 10.1080/15287398609530840	37	20	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172026	10.1371/journal.pone.0172026	http://dx.doi.org/10.1371/journal.pone.0172026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182799	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800143
J	Parker, L; Trewin, A; Levinger, I; Shaw, CS; Stepto, NK				Parker, Lewan; Trewin, Adam; Levinger, Itamar; Shaw, Christopher S.; Stepto, Nigel K.			The effect of exercise-intensity on skeletal muscle stress kinase and insulin protein signaling	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; MESSENGER-RNA; AS160 PHOSPHORYLATION; SINGLE BOUT; ACTIVATION; RESISTANCE; EXPRESSION; INTERVAL; P38	Background Stress and mitogen activated protein kinase (SAPK) signaling play an important role in glucose homeostasis and the physiological adaptation to exercise. However, the effects of acute high-intensity interval exercise (HIIE) and sprint interval exercise (SIE) on activation of these signaling pathways are unclear. Methods Eight young and recreationally active adults performed a single cycling session of HIIE (5 x 4 minutes at 75% W-max), SIE (4 x 30 second Wingate sprints), and continuous moderate- intensity exercise work-matched to HIIE (CMIE; 30 minutes at 50% of W-max), separated by a minimum of 1 week. Skeletal muscle SAPK and insulin protein signaling were measured immediately, and 3 hours after exercise. Results SIE elicited greater skeletal muscle NF-kappa B p65 phosphorylation immediately after exercise (SIE: similar to 40%; HIIE: similar to 4%; CMIE; similar to 13%; p < 0.05) compared to HIIE and CMIE. AS160(Ser588) phosphorylation decreased immediately after HIIE (similar to-27%; p < 0.05), and decreased to the greatest extent immediately after SIE (similar to-60%; p < 0.05). Skeletal muscle JNK (similar to 42%; p < 0.05) and p38 MAPK (similar to 171%; p < 0.05) phosphorylation increased, and skeletal muscle Akt(Ser473) phosphorylation (similar to-32%; p < 0.05) decreased, to a similar extent immediately after all exercise protocols. AS160(Ser588) phosphorylation was similar to baseline three hours after SIE (similar to-12%; p > 0.05), remained lower 3 hours after HIIE (similar to-34%; p < 0.05), and decreased 3 hours after CMIE (similar to-33%; p < 0.05). Conclusion Despite consisting of less total work than CMIE and HIIE, SIE proved to be an effective stimulus for the activation of stress protein kinase signaling pathways linked to exercise-mediated adaptation of skeletal muscle. Furthermore, post-exercise AS160(Ser588) phosphorylation decreased in an exercise-intensity and post-exercise time-course dependent manner.	[Parker, Lewan; Trewin, Adam; Levinger, Itamar; Shaw, Christopher S.; Stepto, Nigel K.] Victoria Univ, Coll Sport & Exercise Sci, ISEAL, Melbourne, Vic, Australia; [Shaw, Christopher S.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Stepto, Nigel K.] Monash Univ, MCHRI, Sch Publ Hlth & Preventat Med, Clayton, Vic, Australia; [Stepto, Nigel K.] Monash Hlth, Clayton, Vic, Australia	Victoria University; Deakin University; Monash University	Parker, L (corresponding author), Victoria Univ, Coll Sport & Exercise Sci, ISEAL, Melbourne, Vic, Australia.	lewan.parker@live.vu.edu.au	Trewin, Adam/M-1584-2019	Trewin, Adam/0000-0001-7322-4054; Levinger, Itamar/0000-0001-9194-2033; Stepto, Nigel/0000-0002-0875-6836; Parker, Lewan/0000-0002-5372-1851	Future Leader Fellowship from the National Heart Foundation of Australia [100040]; Australian Governments Collaborative Research Network	Future Leader Fellowship from the National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Governments Collaborative Research Network(Australian Government)	A/Prof Levinger was supported by Future Leader Fellowship (ID: 100040) from the National Heart Foundation of Australia. A/Prof Nigel Stepto was supported by the Australian Governments Collaborative Research Network.; A/Prof Levinger was supported by Future Leader Fellowship (ID: 100040) from the National Heart Foundation of Australia. A/Prof Nigel Stepto was supported by the Australian Governments Collaborative Research Network. The authors wish to thank Dr. Andrew Garnham (Victoria University University) and Dr. Mitchell Anderson for performing the muscle biopsies. Thank you to the participants involved in the research.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Aoi W, 2012, PHYSIOL RES, V61, P81, DOI 10.33549/physiolres.932239; Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Berdichevsky A, 2010, J BIOL CHEM, V285, P21581, DOI 10.1074/jbc.M109.093633; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453; Combes A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12462; Cuevas MJ, 2005, FREE RADICAL RES, V39, P431, DOI 10.1080/10715760500072149; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Fuentes T, 2012, EUR J APPL PHYSIOL, V112, P1917, DOI 10.1007/s00421-011-2164-0; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Henriquez-Olguin C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00282; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Howlett KF, 2007, DIABETES, V56, P1608, DOI 10.2337/db06-1398; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Iwabe M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12162; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Ji LL, 2004, FASEB J, V18, P1499, DOI 10.1096/fj.04-1846com; Kang C, 2009, FREE RADICAL BIO MED, V47, P1394, DOI 10.1016/j.freeradbiomed.2009.08.007; Kramer HF, 1985, J APPL PHYSIOL, V2007, P388, DOI DOI 10.1152/; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Li YJ, 2009, AM J PHYSIOL-CELL PH, V296, pC25, DOI 10.1152/ajpcell.00094.2008; Liubaoerjijin Y, 2016, ACTA DIABETOL, V53, P769, DOI 10.1007/s00592-016-0870-0; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; MohammadTaghvaei N, 2012, CELL SIGNAL, V24, P1964, DOI 10.1016/j.cellsig.2012.04.019; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Parker L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00411; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Schweitzer GG, 2012, J APPL PHYSIOL, V113, P1852, DOI 10.1152/japplphysiol.00619.2012; Sen P, 2005, FEBS LETT, V579, P4402, DOI 10.1016/j.febslet.2005.06.081; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Thompson WR, 2013, ACSMS HEALTH FIT J, V17, P10, DOI 10.1249/FIT.0b013e3182a955e6; Thong FSL, 2003, J APPL PHYSIOL, V94, P2337, DOI 10.1152/japplphysiol.00036.2003; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Vendelbo MH, 2014, J APPL PHYSIOL, V117, P289, DOI 10.1152/japplphysiol.00044.2014; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wadley GD, 2013, AM J PHYSIOL-ENDOC M, V304, pE853, DOI 10.1152/ajpendo.00568.2012; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	66	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171613	10.1371/journal.pone.0171613	http://dx.doi.org/10.1371/journal.pone.0171613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182793	Green Accepted, Green Published, gold			2022-12-27	WOS:000394231800079
J	Sung, JY; Tani, J; Chang, TS; Lin, CSY				Sung, Jia-Ying; Tani, Jowy; Chang, Tsui-San; Lin, Cindy Shin-Yi			Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy	PLOS ONE			English	Article							STRENGTH-DURATION PROPERTIES; GLYCEMIC CONTROL; MOTOR AXONS; EXCITABILITY PROPERTIES; NERVE EXCITABILITY; NA+ CURRENTS; CONDUCTION; ISCHEMIA	This study investigated sensory and motor nerve excitability properties to elucidate the development of diabetic neuropathy. A total of 109 type 2 diabetes patients were recruited, and 106 were analyzed. According to neuropathy severity, patients were categorized into G0, G1, and G2+3 groups using the total neuropathy score-reduced (TNSr). Patients in the G0 group were asymptomatic and had a TNSr score of 0. Sensory and motor nerve excitability data from diabetic patients were compared with data from 33 healthy controls. Clinical assessment, nerve conduction studies, and sensory and motor nerve excitability testing data were analyzed to determine axonal dysfunction in diabetic neuropathy. In the G0 group, sensory excitability testing revealed increased stimulus for the 50% sensory nerve action potential (P<0.05), shortened strength-duration time constant (P<0.01), increased superexcitability (P<0.01), decreased subexcitability (P<0.05), decreased accommodation to depolarizing current (P<0.01), and a trend of decreased accommodation to hyperpolarizing current in threshold electrotonus. All the changes progressed into G1 (TNSr 1-8) and G2+3 (TNSr 9-24) groups. In contrast, motor excitability only had significantly increased stimulus for the 50% compound motor nerve action potential (P<0.01) in the G0 group. This study revealed that the development of axonal dysfunction in sensory axons occurred prior to and in a different fashion from motor axons. Additionally, sensory nerve excitability tests can detect axonal dysfunction even in asymptomatic patients. These insights further our understanding of diabetic neuropathy and enable the early detection of sensory axonal abnormalities, which may provide a basis for neuroprotective therapeutic approaches.	[Sung, Jia-Ying; Tani, Jowy] Taipei Med Univ, Wan Fang Hosp, Dept Neurol, Taipei, Taiwan; [Sung, Jia-Ying; Chang, Tsui-San] Taipei Med Univ, Sch Med, Dept Neurol, Coll Med, Taipei, Taiwan; [Tani, Jowy] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Tani, Jowy; Lin, Cindy Shin-Yi] Natl Hlth Res Inst, Taipei, Taiwan; [Lin, Cindy Shin-Yi] Taipei Med Univ, Coll Med Sci & Technol, Neural Regenerat Med, Taipei, Taiwan; [Lin, Cindy Shin-Yi] Univ New South Wales, Fac Med, Sch Med Sci, Translat Neurosci,Dept Physiol, Sydney, NSW, Australia	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Health Research Institutes - Taiwan; Taipei Medical University; University of New South Wales Sydney	Lin, CSY (corresponding author), Natl Hlth Res Inst, Taipei, Taiwan.	c.lin@unsw.edu.au		Lin, Cindy Shin-Yi/0000-0003-2379-7369				[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BRISMAR T, 1987, ANN NEUROL, V21, P504, DOI 10.1002/ana.410210515; BRISMAR T, 1993, DIABETIC MED, V10, pS110, DOI 10.1111/j.1464-5491.1993.tb00216.x; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Cavaletti G, 2003, NEUROLOGY, V61, P1297, DOI 10.1212/01.WNL.0000092015.03923.19; Cherian PV, 1996, J DIABETES COMPLICAT, V10, P192, DOI 10.1016/1056-8727(95)00084-4; Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dyck PJ, 2011, MUSCLE NERVE, V44, P340, DOI 10.1002/mus.22074; Han SE, 2010, J PHYSIOL-LONDON, V588, P1737, DOI 10.1113/jphysiol.2010.188169; Hoeijmakers JGJ, 2014, TRENDS MOL MED, V20, P544, DOI 10.1016/j.molmed.2014.06.003; Hofmeijer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067113; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kiernan MC, 2001, MUSCLE NERVE, V24, P883; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Kitano Y, 2004, ANN NEUROL, V56, P462, DOI 10.1002/ana.20232; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2008, J PERIPHER NERV SYST, V13, P7, DOI 10.1111/j.1529-8027.2008.00155.x; Krishnan AV, 2005, BRAIN, V128, P1178, DOI 10.1093/brain/awh476; Kuwabara S, 2002, INTERNAL MED, V41, P360, DOI 10.2169/internalmedicine.41.360; Kwai NCG, 2013, DIABETES CARE, V36, P1272, DOI 10.2337/dc12-1310; Lauria G, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0538-5; Lin CSY, 2002, J PHYSIOL-LONDON, V541, P1025, DOI 10.1113/jphysiol.2002.017848; Misawa S, 2006, NEUROLOGY, V66, P1545, DOI 10.1212/01.wnl.0000216260.39452.bf; Misawa S, 2005, CLIN NEUROPHYSIOL, V116, P254, DOI 10.1016/j.clinph.2004.08.003; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Mogyoros I, 1998, BRAIN, V121, P851, DOI 10.1093/brain/121.5.851; Mogyoros I, 1997, BRAIN, V120, P317, DOI 10.1093/brain/120.2.317; Moon HI, 2014, CLIN NEUROPHYSIOL, V125, P844, DOI 10.1016/j.clinph.2013.10.041; Sung JY, 2012, DIABETES, V61, P1592, DOI 10.2337/db11-1509; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Vucic S, 2014, CLIN NEUROPHYSIOL, V125, P657, DOI 10.1016/j.clinph.2013.10.042; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Zenker J, 2013, TRENDS NEUROSCI, V36, P439, DOI 10.1016/j.tins.2013.04.008; Zenker J, 2012, J NEUROSCI, V32, P7493, DOI 10.1523/JNEUROSCI.0719-12.2012	37	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171223	10.1371/journal.pone.0171223	http://dx.doi.org/10.1371/journal.pone.0171223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182728	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800048
J	Nualsri, C; Kongjan, P; Reungsang, A; Imai, T				Nualsri, Chatchawin; Kongjan, Prawit; Reungsang, Alissara; Imai, Tsuyoshi			Effect of biogas sparging on the performance of bio-hydrogen reactor over a long-term operation	PLOS ONE			English	Article							BIOHYDROGEN PRODUCTION; METHANE PRODUCTION; CLOSTRIDIUM-BUTYRICUM; ANAEROBIC-DIGESTION; DARK FERMENTATION; WASTE; HYDROLYSATE; SLUDGE; H-2	This study aimed to enhance hydrogen production from sugarcane syrup by biogas sparging. Two-stage continuous stirred tank reactor (CSTR) and upflow anaerobic sludge blanket (UASB) reactor were used to produce hydrogen and methane, respectively. Biogas produced from the UASB was used to sparge into the CSTR. Results indicated that sparging with biogas increased the hydrogen production rate (HPR) by 35% (from 17.1 to 23.1 L/L.d) resulted from a reduction in the hydrogen partial pressure. A fluctuation of HPR was observed during a long term monitoring because CO2 in the sparging gas and carbon source in the feedstock were consumed by Enterobacter sp. to produce succinic acid without hydrogen production. Mixed gas released from the CSTR after the sparging can be considered as bio-hythane (H-2+CH4). In addition, a continuous sparging biogas into CSTR release a partial pressure in the headspace of the methane reactor. In consequent, the methane production rate is increased.	[Nualsri, Chatchawin; Reungsang, Alissara] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand; [Nualsri, Chatchawin] Phibulsongkram Rajabhat Univ, Fac Food & Agr Technol, Phitsanulok, Thailand; [Kongjan, Prawit] Prince Songkla Univ, Fac Sci & Technol, Dept Sci, Div Chem, Muang, Pattani, Thailand; [Kongjan, Prawit] Prince Songkla Univ, Fac Sci & Technol, Dept Sci, Biomass Convers Energy & Chem Bio MEC Res Unit, Muang, Pattani, Thailand; [Reungsang, Alissara] Khon Kaen Univ, Res Grp Dev Microbial Hydrogen Prod Proc Biomass, Khon Kaen, Thailand; [Imai, Tsuyoshi] Yamaguchi Univ, Grad Sch Sci & Engn, Div Environm Sci & Engn, Yamaguchi, Japan	Khon Kaen University; Pibulsongkram Rajabhat University; Prince of Songkla University; Prince of Songkla University; Khon Kaen University; Yamaguchi University	Reungsang, A (corresponding author), Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand.; Reungsang, A (corresponding author), Khon Kaen Univ, Res Grp Dev Microbial Hydrogen Prod Proc Biomass, Khon Kaen, Thailand.	alissara@kku.ac.th	Reungsang, Alissara/K-6978-2019; Kongjan, Prawit/AAB-1818-2021; Imai, Tsuyoshi/F-2515-2018; Nualsri, Chatchawin/GPP-2772-2022	Reungsang, Alissara/0000-0001-7836-032X; Kongjan, Prawit/0000-0001-5762-3733; Imai, Tsuyoshi/0000-0002-8891-0564; Nualsri, Chatchawin/0000-0002-9271-4187	Graduate School, Khon Kaen University [551T213]; Thailand Research Fund Research Scholar [RTA5980004]; Thailand Research Fund Senior Research Scholar [RTA5980004]	Graduate School, Khon Kaen University; Thailand Research Fund Research Scholar; Thailand Research Fund Senior Research Scholar(Thailand Research Fund (TRF))	This work was supported by Graduate School, Khon Kaen University, URL: gs.kku.ac.th, Recipient: Chatchawin Nualsri (Grant No. 551T213); Thailand Research Fund Research Scholar, URL: www.trf.or.th, Recipient: Alissara Reungsang (Grant No. RTA5980004). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ph.D. scholarship to CN was provided by Graduate School, Khon Kaen University (Grant No. 551T213). Research funds to AR were provided by Thailand Research Fund Senior Research Scholar (Grant No. RTA5980004).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; American Public Health Association A., 1995, STANDARD METHODS EXA; Argun H, 2011, INT J HYDROGEN ENERG, V36, P7443, DOI 10.1016/j.ijhydene.2011.03.116; BATTINO R, 1966, CHEM REV, V66, P395, DOI 10.1021/cr60242a003; Chong ML, 2009, INT J HYDROGEN ENERG, V34, P3277, DOI 10.1016/j.ijhydene.2009.02.010; Chou CH, 2008, INT J HYDROGEN ENERG, V33, P1550, DOI 10.1016/j.ijhydene.2007.09.031; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Endo G., 1982, PROC SOC CIV ENG, V325, P61, DOI DOI 10.2208/JSCEJ1969.1982.325_61; Esquivel-Elizondo S, 2014, APPL BIOCHEM BIOTECH, V173, P1737, DOI 10.1007/s12010-014-0961-8; Fulton J, 2008, United States patent, Patent No. [US 7721682, 7721682]; Hawkes FR, 2007, INT J HYDROGEN ENERG, V32, P172, DOI 10.1016/j.ijhydene.2006.08.014; Junghare M, 2012, INT J HYDROGEN ENERG, V37, P3160, DOI 10.1016/j.ijhydene.2011.11.043; Khanal S. K., 2008, ANAEROBIC BIOTECHNOL; Kim DH, 2006, INT J HYDROGEN ENERG, V31, P2158, DOI 10.1016/j.ijhydene.2006.02.012; Kim DH, 2012, INT J HYDROGEN ENERG, V37, P15563, DOI 10.1016/j.ijhydene.2012.03.071; Kongjan P, 2014, INT J HYDROGEN ENERG, V39, P19343, DOI 10.1016/j.ijhydene.2014.06.057; Kongjan P, 2010, BIOTECHNOL BIOENG, V105, P899, DOI 10.1002/bit.22616; Levin DB, 2004, INT J HYDROGEN ENERG, V29, P173, DOI 10.1016/S0360-3199(03)00094-6; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; Leite WRM, 2016, RENEW ENERG, V86, P1324, DOI 10.1016/j.renene.2015.09.069; Nualsri C, 2016, INT J HYDROGEN ENERG, V41, P17884, DOI 10.1016/j.ijhydene.2016.07.135; Pattra S, 2008, INT J HYDROGEN ENERG, V33, P5256, DOI 10.1016/j.ijhydene.2008.05.008; Pattra S, 2011, INT J HYDROGEN ENERG, V36, P8697, DOI 10.1016/j.ijhydene.2010.05.120; Plangklang P, 2012, INT J HYDROGEN ENERG, V37, P15525, DOI 10.1016/j.ijhydene.2012.02.186; Spirito CM, 2014, CURR OPIN BIOTECH, V27, P115, DOI 10.1016/j.copbio.2014.01.003; Tanisho S, 1998, INT J HYDROGEN ENERG, V23, P559, DOI 10.1016/S0360-3199(97)00117-1; Willquist K, 2012, INT J HYDROGEN ENERG, V37, P17749, DOI 10.1016/j.ijhydene.2012.08.092; Zhang T, 2000, BIOTECHNOL LETT, V22, P399, DOI 10.1023/A:1005680803442	29	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171248	10.1371/journal.pone.0171248	http://dx.doi.org/10.1371/journal.pone.0171248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207755	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500021
J	Wang, ZZ; Hu, BL; Yin, QY				Wang, Zhengzhou; Hu, Bingliang; Yin, Qinye			An improved schlieren method for measurement and automatic reconstruction of the far-field focal spot	PLOS ONE			English	Article							NATIONAL IGNITION FACILITY	The schlieren method of measuring far-field focal spots offers many advantages at the Shenguang III laser facility such as low cost and automatic laser-path collimation. However, current methods of far-field focal spot measurement often suffer from low precision and efficiency when the final focal spot is merged manually, thereby reducing the accuracy of reconstruction. In this paper, we introduce an improved schlieren method to construct the high dynamic-range image of far-field focal spots and improve the reconstruction accuracy and efficiency. First, a detection method based on weak light beam sampling and magnification imaging was designed; images of the main and side lobes of the focused laser irradiance in the far field were obtained using two scientific CCD cameras. Second, using a self correlation template matching algorithm, a circle the same size as the schlieren ball was dug from the main lobe cutting image and used to change the relative region of the main lobe cutting image within a 100x100 pixel region. The position that had the largest correlation coefficient between the side lobe cutting image and the main lobe cutting image when a circle was dug was identified as the best matching point. Finally, the least squares method was used to fit the center of the side lobe schlieren small ball, and the error was less than 1 pixel. The experimental results show that this method enables the accurate, high-dynamic-range measurement of a far-field focal spot and automatic image reconstruction. Because the best matching point is obtained through image processing rather than traditional reconstruction methods based on manual splicing, this method is less sensitive to the efficiency of focal spot reconstruction and thus offers better experimental precision.	[Wang, Zhengzhou] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China; [Wang, Zhengzhou; Yin, Qinye] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhengzhou; Hu, Bingliang] Chinese Acad Sci, Xian Inst Opt & Precis Mech, Xian, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS	Hu, BL (corresponding author), Chinese Acad Sci, Xian Inst Opt & Precis Mech, Xian, Peoples R China.	wangbl_xa@163.com			National Natural Science Foundation of China [11327303, 61405244]; project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light"	This study was supported by the National Natural Science Foundation of China (11327303, 61405244) and by the project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light."	Cheng Juan, 2006, High Power Laser and Particle Beams, V18, P612; Du Xiangwan, 1997, Chinese Journal of Lasers, VA24, P327; Goshtasby AA, 2005, IMAGE VISION COMPUT, V23, P611, DOI 10.1016/j.imavis.2005.02.004; Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276; HE YX, 2012, CHINESE J LASERS PAP, V39, P1; Heestand GM, 2008, APPL OPTICS, V47, P3494, DOI 10.1364/AO.47.003494; Ishino Y, 2016, FLOW TURBUL COMBUST, V96, P819, DOI 10.1007/s10494-015-9658-5; Jain DS, 2016, INT J HEAT MASS TRAN, V98, P697, DOI 10.1016/j.ijheatmasstransfer.2016.03.062; Klimov AI, 2008, IEEE T PLASMA SCI, V36, P661, DOI 10.1109/TPS.2008.917300; Kong Bing, 2002, Infrared Laser Engineering, V31, P275; Lu Y, 2015, J APPL OPT, V36, P104; MANTIUK R, 2006, ACM T APPL PERCEPT, V3, P288; Mehfuz R, 2012, P SOC PHOTO-OPT INS, P8463; Raffel M, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-015-1927-5; Rudiger Foest, 2015, EUR PHYS J-APPL PHYS, V71, P20804; Shao M, 2007, OPTICS OPTOELECTRONI, V5, P1; Tomaszewska A, 2007, WSCG 2007, FULL PAPERS PROCEEDINGS I AND II, P49; Williams WH, 2004, P SOC PHOTO-OPT INS, V5341, P66, DOI 10.1117/12.538476; Xia Yanwei, 2014, ACTA PHOTONICA SINIC, V43; Yang Pengling, 2010, Chinese Journal of Lasers, V37, P521, DOI 10.3788/CJL20103702.0521; [杨作廷 Yang Zuoting], 2013, [光子学报, Acta Photonica Sinica], V42, P742; Zhang Z., 2013, DIGITAL IMAGE PROCES	22	1	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171415	10.1371/journal.pone.0171415	http://dx.doi.org/10.1371/journal.pone.0171415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207758	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500028
J	Albano, PM; Holzinger, D; Salvador, C; Orosa, J; Racelis, S; Leano, M; Sanchez, D; Angeles, LM; Halec, G; Schmitt, M; Ramos, JD; Pawlita, M				Albano, Pia Marie; Holzinger, Dana; Salvador, Christianne; Orosa, Jose, III; Racelis, Sheryl; Leano, Modesty; Sanchez, Danilo, Jr.; Angeles, Lara Mae; Halec, Gordana; Schmitt, Markus; Ramos, John Donnie; Pawlita, Michael			Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; E6/E7 MESSENGER-RNA; OROPHARYNGEAL CANCER; ORAL-CAVITY; VIRAL LOAD; MALIGNANT-TRANSFORMATION; HPV; INFECTION; EPIDEMIOLOGY; EXPRESSION	Background Geographic heterogeneity of human papillomavirus (HPV) involvement in head and neck squamous cell carcinoma (HNSCC) has been observed over the last few years. This trend has not been evaluated in the Philippines. Hence, this study aims to provide for the first time a data on the prevalence of HPV in HNSCC in the northwestern region of the Philippines. Methods Two hundred one (201) biopsy samples (179 formalin fixed paraffin embedded and 22 fresh frozen) from 163 Filipino HNSCC cases (oral cavity = 88; larynx = 60; oropharynx = 15) diagnosed between 2003 to 2013 were initially included in this study. HPV DNA was detected by two methods: (1) BSGP5+/6+-PCR/multiplex human papillomavirus genotyping and (2) TaqMan probes-based real-time qPCR. Presence of HPV type-specific transcripts were also analyzed by reverse transcription-PCR with subsequent hybridization to oligonucleotide probes coupled to Luminex beads. Co-amplification of the beta-globin and ubiquitin C genes served as internal positive controls for DNA and RNA analyses, respectively. Results and conclusions Of the 163, 82 (50.3%) cases had at least one tissue sample that was valid for molecular analysis. Only two of the DNA valid cases (2.4%) were HPV DNA-positive (HPV11 and HPV33). All HPV mRNA assays rendered negative results except for HPV11 transcripts. Results of this study may indicate that there is probably very low prevalence of HPV-associated HNSCC among Filipino adults living in a rural region of the Philippines. This study could serve as a benchmark for designing follow-up studies that would assess possible changes in trends of HNSCC among Filipinos in different ethnic regions of the country, especially urban areas in which the population is expected to adapt Western style sexual behavior. A prospective sampling of fresh frozen tissue is also highly recommended to ensure better molecular analyses.	[Albano, Pia Marie; Holzinger, Dana; Halec, Gordana; Schmitt, Markus; Pawlita, Michael] German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany; [Albano, Pia Marie; Ramos, John Donnie] Univ Santo Tomas, Coll Sci, Dept Biol, Manila, Philippines; [Albano, Pia Marie; Ramos, John Donnie] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines; [Salvador, Christianne; Orosa, Jose, III; Sanchez, Danilo, Jr.] Mariano Marcos Mem Hosp & Med Ctr, Dept ENT Head & Neck Surg, Ilocos Norte, Philippines; [Racelis, Sheryl; Leano, Modesty] Mariano Marcos Mem Hosp & Med Ctr, Dept Pathol & Labs, Ilocos Norte, Philippines; [Angeles, Lara Mae] Univ Santo Tomas Hosp, Dept Clin Pathol, Manila, Philippines	Helmholtz Association; German Cancer Research Center (DKFZ); University of Santo Tomas; University of Santo Tomas; University of Santo Tomas	Albano, PM (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany.; Albano, PM (corresponding author), Univ Santo Tomas, Coll Sci, Dept Biol, Manila, Philippines.; Albano, PM (corresponding author), Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines.	psalbano@ust.edu.ph	Orosa, José A./D-9782-2012; Holzinger, Dana/I-3437-2013; Schmitt, Markus/B-6410-2008	Orosa, José A./0000-0002-8384-908X; Schmitt, Markus/0000-0002-7827-6694; Ramos, John Donnie/0000-0002-1404-4093; Pawlita, Michael/0000-0002-4720-8306	DKFZ; Roche; Qiagen	DKFZ(Helmholtz Association); Roche(Roche Holding); Qiagen	MP and MS have received royalties for patents owned by DKFZ and research support through cooperation contracts of DKFZ with Roche and Qiagen in the field of HPV diagnostics. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alechnowicz K, 2004, TOB CONTROL, V13, P71, DOI 10.1136/tc.2004.009324; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Bahl A, 2014, HEAD NECK-J SCI SPEC, V36, P505, DOI 10.1002/hed.23317; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Boscolo-Rizzo P, 2013, ACTA OTORHINOLARYNGO, V33, P77; Chaturvedi AK, 2012, HEAD NECK PATHOL S1, V6, pS16, DOI [DOI 10.1007/s12105-012-0377-0, 10.1007/s12105-012-0377-0]; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DSouza G, 2014, PLOS ONE, V9, P19; Evans M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-220; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Francoeur Robert T., 2004, CONTINUUM COMPLETE I, P834; Gerein V, 2005, OTOLARYNG HEAD NECK, V132, P392, DOI 10.1016/j.otohns.2004.09.035; Gheit T, 2014, J MED VIROL, V86, P642, DOI 10.1002/jmv.23866; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Hernandez BY, 2014, PLOS ONE, V9, P1; Holzinger D, 2012, CANCER RES, V72, P4993, DOI 10.1158/0008-5472.CAN-11-3934; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Huebbers CU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057207; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; Lee LA, 2008, LARYNGOSCOPE, V118, P50, DOI 10.1097/MLG.0b013e318155a288; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mehanna H, 2010, BMJ-BRIT MED J, V341, P663, DOI DOI 10.1136/BMJ.C4684; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Ndiaye C, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-14; Ngelangel CA, 2002, JPN J CLIN ONCOL, V32, pS52, DOI 10.1093/jjco/hye126; Oga EA, 2016, PLOS ONE, P1; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Rodrigo JP, 2014, INT J CANCER, V134, P487, DOI 10.1002/ijc.28355; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, INT J CANCER, V132, P2395, DOI 10.1002/ijc.27891; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Sudhoff HH, 2011, EUR ARCH OTO-RHINO-L, V268, P1541, DOI 10.1007/s00405-011-1714-8; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; van Monsjou HS, 2013, ORAL ONCOL, V49, P1097, DOI 10.1016/j.oraloncology.2013.09.001; Villa LL, 2006, INT J GYNECOL OBSTET, V94, pS71, DOI 10.1016/S0020-7292(07)60013-7	50	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172240	10.1371/journal.pone.0172240	http://dx.doi.org/10.1371/journal.pone.0172240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199413	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400084
J	D'Elia, L; Cappuccio, FP; Iacone, R; Russo, O; Galletti, F; Strazzullo, P				D'Elia, Lanfranco; Cappuccio, Francesco P.; Iacone, Roberto; Russo, Ornella; Galletti, Ferruccio; Strazzullo, Pasquale			Altered renal sodium handling and risk of incident hypertension: Results of the Olivetti Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSE; ADDUCIN POLYMORPHISM; METABOLIC SYNDROME; MEN; REABSORPTION; ALDOSTERONE; SENSITIVITY; EXCRETION	Renal tubular sodium (Na) handling plays a key role in blood pressure (BP) regulation. Several cross-sectional studies reported a positive association between higher proximal tubule fractional reabsorption of Na and BP, but no prospective investigation has been reported of this possible association. Hence, the purpose of this study was to estimate the predictive role of renal Na handling on the risk of incident hypertension and the changes in BP occurring in the 8-year follow-up observation of a sample of initially normotensive men (The Olivetti Heart Study). The study included 294 untreated normotensive non-diabetic men with normal renal function examined twice (1994-95 and 2002-04). Renal tubular Na handling was estimated by exogenous lithium clearance. Fractional reabsorption of Na in proximal and distal tubules was calculated and included in the analysis. At baseline, there was no association between BP and either proximal or distal fractional reabsorption of Na. At the end of the 8-year follow-up, direct associations were observed between baseline proximal (but not distal) Na fractional reabsorption and the changes occurred in systolic and diastolic BP over time (+2.79 and +1.53 mmHg, respectively, per 1SD difference in proximal Na-FR; p<0.01). Also multivariable analysis showed a direct association between baseline proximal Na fractional reabsorption and risk of incident hypertension, independently of potential confounders (OR: 1.34, 95%Cl: 1.06-1.70). The results of this prospective investigation strongly suggest a causal relationship between an enhanced rate of Na reabsorption in the proximal tubule and the risk of incident hypertension in initially normotensive men.	[D'Elia, Lanfranco; Iacone, Roberto; Russo, Ornella; Galletti, Ferruccio; Strazzullo, Pasquale] Univ Naples Federico II, Dept Clin Med & Surg, ESH Excellence Ctr Hypertens, Sch Med, Naples, Italy; [Cappuccio, Francesco P.] Univ Warwick, Div Hlth Sci, WHO Collaborating Ctr Nutr, Coventry, W Midlands, England	University of Naples Federico II; University of Warwick	D'Elia, L (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, ESH Excellence Ctr Hypertens, Sch Med, Naples, Italy.	lanfranco.delia@unina.it	Iacone, Roberto/M-2867-2016; D'Elia, Lanfranco/U-6499-2017	Iacone, Roberto/0000-0003-3360-3855; Galletti, Ferruccio/0000-0001-7556-0254; D'Elia, Lanfranco/0000-0002-1782-0211				Barba G, 1996, HYPERTENSION, V27, P1160, DOI 10.1161/01.HYP.27.5.1160; Barba G, 2007, J HYPERTENS, V25, P1465, DOI 10.1097/HJH.0b013e3281139ebd; Barbato A, 2004, DIABETOLOGIA, V47, P40, DOI 10.1007/s00125-003-1260-z; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; CAPPUCCIO FP, 1991, EUR J CLIN INVEST, V21, P40, DOI 10.1111/j.1365-2362.1991.tb01356.x; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; D'Elia L, 2014, EUR J PUBLIC HEALTH, V24, P226, DOI 10.1093/eurpub/ckt041; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Glorioso N, 1999, HYPERTENSION, V34, P649, DOI 10.1161/01.HYP.34.4.649; Goldring W, 1941, J CLIN INVEST, V20, P637, DOI 10.1172/JCI101257; GUYTON AC, 1990, HYPERTENSION, V16, P725, DOI 10.1161/01.HYP.16.6.725; HOLLENBERG NK, 1976, AM J MED, V60, P773, DOI 10.1016/0002-9343(76)90891-3; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Luft FC, 2002, SEMIN NEPHROL, V22, P115, DOI 10.1053/snep.2002.30211; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Manunta P, 1999, HYPERTENSION, V33, P694, DOI 10.1161/01.HYP.33.2.694; Meneton P, 2001, SEMIN NEPHROL, V21, P81, DOI 10.1053/snep.2001.21210; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; Royston P, 1992, STATA TECHNICAL B RE, V2, P112; Siani A, 2004, HYPERTENSION, V43, P598, DOI 10.1161/01.HYP.0000117985.57001.b3; Strazzullo P, 2003, HYPERTENSION, V41, P1000, DOI 10.1161/01.HYP.0000066844.63035.3A; Strazzullo P, 2001, J HYPERTENS, V19, P2157, DOI 10.1097/00004872-200112000-00007; STRAZZULLO P, 1988, CLIN SCI, V74, P651, DOI 10.1042/cs0740651; Strazzullo P, 2001, J MOL MED, V79, P574, DOI 10.1007/s001090100257; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; ULICK S, 1977, J CLIN ENDOCR METAB, V44, P799, DOI 10.1210/jcem-44-4-799; WHO, 2012, WORLD HEAL ORGAN, P1	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171973	10.1371/journal.pone.0171973	http://dx.doi.org/10.1371/journal.pone.0171973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196131	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900039
J	DeLellis, P; DiMeglio, A; Garofalo, F; Lo Iudice, F				DeLellis, Pietro; DiMeglio, Anna; Garofalo, Franco; Lo Iudice, Francesco			The evolving cobweb of relations among partially rational investors	PLOS ONE			English	Article							COMPLEX NETWORKS; HERD BEHAVIOR; SOCIAL NETWORKS; MARKET; MODEL; FLUCTUATIONS; DYNAMICS; SYSTEMS	To overcome the limitations of neoclassical economics, researchers have leveraged tools of statistical physics to build novel theories. The idea was to elucidate the macroscopic features of financial markets from the interaction of its microscopic constituents, the investors. In this framework, the model of the financial agents has been kept separate from that of their interaction. Here, instead, we explore the possibility of letting the interaction topology emerge from the model of the agents' behavior. Then, we investigate how the emerging cobweb of relationship affects the overall market dynamics. To this aim, we leverage tools from complex systems analysis and nonlinear dynamics, and model the network of mutual influence as the output of a dynamical system describing the edge evolution. In this work, the driver of the link evolution is the relative reputation between possibly coupled agents. The reputation is built differently depending on the extent of rationality of the investors. The continuous edge activation or deactivation induces the emergence of leaders and of peculiar network structures, typical of real influence networks. The subsequent impact on the market dynamics is investigated through extensive numerical simulations in selected scenarios populated by partially rational investors.	[DeLellis, Pietro; DiMeglio, Anna; Garofalo, Franco; Lo Iudice, Francesco] Univ Naples Federico II, Dept Elect Engn & Informat Technol, Naples, Italy	University of Naples Federico II	DeLellis, P (corresponding author), Univ Naples Federico II, Dept Elect Engn & Informat Technol, Naples, Italy.	pietro.delellis@unina.it	Garofalo, Franco/J-7666-2013; DE LELLIS, Pietro/N-3928-2019	DE LELLIS, Pietro/0000-0002-2656-6454				Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Batista JD, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-50645-1; Bentley RA, 2014, EVOL HUM BEHAV, V35, P257, DOI 10.1016/j.evolhumbehav.2014.02.001; Bentley RA, 2011, BEHAV ECOL SOCIOBIOL, V65, P537, DOI 10.1007/s00265-010-1102-1; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonanno G, 2004, EUR PHYS J B, V38, P363, DOI 10.1140/epjb/e2004-00129-6; Brennan TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050310; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Cont R, 2000, MACROECON DYN, V4, P170; Curty P, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/03/P03013; DeLellis P, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/8/083003; DeLellis P, 2010, APPL MATH COMPUT, V217, P988, DOI 10.1016/j.amc.2010.01.126; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; Ehrhardt GCMA, 2006, PHYS REV E, V74, P1; ERDOS P, 1960, B INT STATIST INST, V38, P343; Estrada E, 2006, EUR PHYS J B, V52, P563, DOI 10.1140/epjb/e2006-00330-7; Farmer JD, 2012, EUR PHYS J-SPEC TOP, V214, P295, DOI 10.1140/epjst/e2012-01696-9; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Galbiati M, 2013, NAT PHYS, V9, P126, DOI 10.1038/nphys2581; Galbiati M, 2011, J ECON DYN CONTROL, V35, P859, DOI 10.1016/j.jedc.2010.11.001; Gilbert N., 2008, AGENT BASED MODELS; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Hall RE, 1995, FLAT TAX, V423; Hanke M, 2010, J ECON BEHAV ORGAN, V74, P58, DOI 10.1016/j.jebo.2010.02.004; Hirshleifer D., 2003, EUR FINANC MANAG, V9, P25, DOI DOI 10.1111/1468-036X.00207; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Holme P, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60657-4; Holme P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04999; Hommes C. H., 2001, Quantitative Finance, V1, P149, DOI 10.1088/1469-7688/1/1/311; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khashanah K, 2016, COMPLEXITY, V21, P530, DOI 10.1002/cplx.21834; Lebaron B, 2006, HANDB ECON, V13, P1187; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; PALMER RG, 1994, PHYSICA D, V75, P264, DOI 10.1016/0167-2789(94)90287-9; Pan YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094998; Pincus S, 2004, P NATL ACAD SCI USA, V101, P13709, DOI 10.1073/pnas.0405168101; Raberto M, 2001, PHYSICA A, V299, P319, DOI 10.1016/S0378-4371(01)00312-0; Rivera MT, 2010, ANNU REV SOCIOL, V36, P91, DOI 10.1146/annurev.soc.34.040507.134743; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Saramaki J, 2015, EUR PHYS J B, V88, DOI [10.1140/epjb/e2015-60106-6, 10.1140/epjb/e2015-60660-9]; Schleussner CF, 2016, SCI REPORTS, V6, P1; Schweitzer F, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026113; Shiller RJ, 2003, J ECON PERSPECT, V17, P83, DOI 10.1257/089533003321164967; Singer HM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026113; Stanley HE, 1996, PHYSICA A, V224, P302, DOI 10.1016/0378-4371(95)00409-2; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; Toth B, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021006; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Uchida H, 2007, J FINANC INTERMED, V16, P555, DOI 10.1016/j.jfi.2007.03.007; Voit J., 2005, STAT MECH FINANCIAL; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	60	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171891	10.1371/journal.pone.0171891	http://dx.doi.org/10.1371/journal.pone.0171891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196144	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900037
J	Rodil, IF; Lucena-Moya, P; Jokinen, H; Ollus, V; Wennhage, H; Villnas, A; Norkko, A				Rodil, Ivan F.; Lucena-Moya, Paloma; Jokinen, Henri; Ollus, Victoria; Wennhage, Hakan; Villnas, Anna; Norkko, Alf			The role of dispersal mode and habitat specialization for metacommunity structure of shallow beach invertebrates	PLOS ONE			English	Article							AQUATIC MACROINVERTEBRATES; DIVERSITY; MARINE; EUTROPHICATION; HETEROGENEITY; CONNECTIVITY; GENERALISTS; ASSEMBLAGES; SPECIALISTS; DURATION	Metacommunity ecology recognizes the interplay between local and regional patterns in contributing to spatial variation in community structure. In aquatic systems, the relative importance of such patterns depends mainly on the potential connectivity of the specific system. Thus, connectivity is expected to increase in relation to the degree of water movement, and to depend on the specific traits of the study organism. We examined the role of environmental and spatial factors in structuring benthic communities from a highly connected shallow beach network using a metacommunity approach. Both factors contributed to a varying degree to the structure of the local communities suggesting that environmental filters and dispersal-related mechanisms played key roles in determining abundance patterns. We categorized benthic taxa according to their dispersal mode (passive vs. active) and habitat specialization (generalist vs. specialist) to understand the relative importance of environment and dispersal related processes for shallow beach metacommunities. Passive dispersers were predicted by a combination of environmental and spatial factors, whereas active dispersers were not spatially structured and responded only to local environmental factors. Generalists were predicted primarily by spatial factors, while specialists were only predicted by local environmental factors. The results suggest that the role of the spatial component in metacommunity organization is greater in open coastal waters, such as shallow beaches, compared to less-connected environmentally controlled aquatic systems. Our results also reveal a strong environmental role in structuring the benthic metacommunity of shallow beaches. Specifically, we highlight the sensitivity of shallow beach macrofauna to environmental factors related to eutrophication proxies.	[Rodil, Ivan F.; Lucena-Moya, Paloma; Jokinen, Henri; Ollus, Victoria; Villnas, Anna; Norkko, Alf] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Rodil, Ivan F.; Norkko, Alf] Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden; [Wennhage, Hakan] Swedish Univ Agr Sci, Havsfiskelab, Uppsala, Sweden	University of Helsinki; Stockholm University; Swedish University of Agricultural Sciences	Rodil, IF (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.; Rodil, IF (corresponding author), Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden.	ivan.rodil@helsinki.fi	Norkko, Alf/A-1856-2012; Norkko, Alf/L-8736-2019; Norkko, Alf/K-2341-2019; Rodil, Iván F./I-5305-2013; Jokinen, Henri/GQY-4490-2022	Norkko, Alf/0000-0002-9741-4458; Norkko, Alf/0000-0002-9741-4458; Rodil, Iván F./0000-0001-6375-1598; Jokinen, Henri/0000-0001-7617-7820; Villnas, Anna/0000-0003-3077-929X; Wennhage, Hakan/0000-0001-9631-5688; Lucena-Moya, Paloma/0000-0002-8095-7552; Ollus, Victoria Marja Sofia/0000-0002-3633-9079	Walter et Andree de Nottbeck Foundation; Svenska Kulturfonden [12/2258, 13/3919, 12/7244-1292]; Maj and Tor Nessling Foundation [2014322]; University of Helsinki; Stockholm University	Walter et Andree de Nottbeck Foundation; Svenska Kulturfonden; Maj and Tor Nessling Foundation; University of Helsinki; Stockholm University	This work was supported by the Walter et Andree de Nottbeck Foundation and Svenska Kulturfonden (grant numbers: 12/2258; 13/3919) as part of the PhD-work of HJ; The Maj and Tor Nessling Foundation (2014322) and Svenska Kulturfonden (12/7244-1292) supported AV; Strategic funding for collaboration between University of Helsinki and Stockholm University supported IFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bekkby T, 2008, MAR GEOD, V31, P117, DOI 10.1080/01490410802053674; Bendtsen J, 2013, ECOL MODEL, V264, P17, DOI 10.1016/j.ecolmodel.2012.06.018; Berglund J, 2003, ESTUAR COAST SHELF S, V56, P1167, DOI 10.1016/S0272-7714(02)00326-8; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bonsdorff E, 1997, ESTUAR COAST SHELF S, V44, P63, DOI 10.1016/S0272-7714(97)80008-X; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bostrom C, 2002, ESTUAR COAST SHELF S, V55, P795, DOI 10.1006/ecss.2001.0943; Canedo-Arguelles M, 2015, J BIOGEOGR, V42, P778, DOI 10.1111/jbi.12457; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Conley DJ, 2011, ENVIRON SCI TECHNOL, V43, P3412; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Fleming-Lehtinen V, 2012, ESTUAR COAST SHELF S, V102, P1, DOI 10.1016/j.ecss.2012.02.015; Gascon S, 2016, OECOLOGIA, V181, P193, DOI 10.1007/s00442-015-3540-y; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Grainger TN, 2016, OIKOS, V125, P1213, DOI 10.1111/oik.03018; Grantham BA, 2003, ECOL APPL, V13, pS108; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Guizien K, 2012, LIMNOL OCEANOGR, V57, P1099, DOI 10.4319/lo.2012.57.4.1099; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Heino J, 2013, ECOL EVOL, V3, P344, DOI 10.1002/ece3.470; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Horsak M, 2015, J BIOGEOGR, V42, P2112, DOI 10.1111/jbi.12569; Jokinen H, 2016, J SEA RES, V107, P67, DOI 10.1016/j.seares.2015.06.002; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Karna OM, 2015, J ANIM ECOL, V84, P1342, DOI 10.1111/1365-2656.12397; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levins R., 1968, EVOLUTION CHANGING E; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norkko A, 2001, MAR ECOL PROG SER, V212, P131, DOI 10.3354/meps212131; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peres-Neto PR, 2012, ECOLOGY, V93, pS14, DOI 10.1890/11-0494.1; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; R Core Team, 2021, R LANGUAGE ENV STAT; Radkova V, 2014, FRESHWATER BIOL, V59, P2256, DOI 10.1111/fwb.12428; Reed DC, 2000, ECOLOGY, V81, P2011; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Snickars M, 2015, MAR BIOL, V162, P141, DOI 10.1007/s00227-014-2579-3; Tornroos A, 2012, ECOL APPL, V22, P2221; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Valanko S, 2015, ECOL EVOL, V5, P5203, DOI 10.1002/ece3.1767; Valanko S, 2010, J EXP MAR BIOL ECOL, V384, P51, DOI 10.1016/j.jembe.2009.12.012; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; van Noordwijk CGE, 2015, ECOLOGY, V96, P518, DOI 10.1890/14-0082.1; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Villnas A, 2013, ECOLOGY, V94, P2275, DOI 10.1890/12-1716.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376	62	18	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172160	10.1371/journal.pone.0172160	http://dx.doi.org/10.1371/journal.pone.0172160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196112	Green Published, gold			2022-12-27	WOS:000394423900059
J	Dai, RJ; Cowan, C; Heid, B; Khan, D; Liang, ZH; Pham, CTN; Ahmed, SA				Dai, Rujuan; Cowan, Catharine; Heid, Bettina; Khan, Deena; Liang, Zhihong; Pham, Christine T. N.; Ahmed, S. Ansar			Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice	PLOS ONE			English	Article							INTERFERON-GAMMA; CELL-DIFFERENTIATION; AUTOIMMUNE-DISEASES; MENSTRUAL-CYCLE; T-LYMPHOCYTES; NITRIC-OXIDE; CATHEPSIN-G; IN-VIVO; B-CELLS; 17-BETA-ESTRADIOL	Estrogen, a natural immunomodulator, regulates the development and function of diverse immune cell types. There is now renewed attention on neutrophils and neutrophil serine proteases (NSPs) such as neutrophil elastase (NE), proteinase 3 (PR3), and cathepsin G (CG) in inflammation and autoimmunity. In this study, we found that although estrogen treatment significantly reduced total splenocytes number, it markedly increased the splenic neutrophil absolute numbers in estrogen-treated C57BL/6 (B6) mice when compared to placebo controls. Concomitantly, the levels of NSPs and myeloperoxidase (MPO) were highly upregulated in the splenocytes from estrogen-treated mice. Despite the critical role of NSPs in the regulation of non-infectious inflammation, by employing NE-/-/PR3(-/-)/CG(-/-) triple knock out mice, we demonstrated that the absence of NSPs affected neither estrogen's ability to increase splenic neutrophils nor the induction of inflammatory mediators (IFN gamma, IL-1 beta, IL-6, TNF alpha, MCP-1, and NO) from ex vivo activated splenocytes. Depletion of neutrophils in vitro in splenocytes with anti-Ly6G antibody also had no obvious effect on NSP expression or LPS-induced IFN gamma and MCP-1. These data suggest that estrogen augments NSPs, which appears to be independent of enhancing ex vivo inflammatory responses. Since estrogen has been implicated in regulating several experimental autoimmune diseases, we extended our observations in estrogen-treated B6 mice to spontaneous autoimmune-prone female MRL-lpr, B6-lpr and NZB/W-F1 mice. There was a remarkable commonality with regards to the increase of neutrophils and concomitant increase of NSPs and MPO in the splenic cells of different strains of autoimmune-prone mice and estrogen-treated B6 mice. Collectively, since NSPs and neutrophils are involved in diverse pro-inflammatory activities, these data suggest a potential pathologic implication of increased neutrophils and NSPs that merits further investigation.	[Dai, Rujuan; Cowan, Catharine; Heid, Bettina; Khan, Deena; Liang, Zhihong; Ahmed, S. Ansar] Virginia Tech, IDRF, Dept Biomed Sci & Pathobiol, VMCVM, Blacksburg, VA 24061 USA; [Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Liang, Zhihong] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Safety & Mol Biol, Beijing, Peoples R China	Virginia Polytechnic Institute & State University; Washington University (WUSTL); China Agricultural University	Ahmed, SA (corresponding author), Virginia Tech, IDRF, Dept Biomed Sci & Pathobiol, VMCVM, Blacksburg, VA 24061 USA.	ansrahmd@vt.edu			National Institutes of Health (NIH) [5 RO1 AI051880]; NIH [AI049261, AI051436]; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the grants from National Institutes of Health (NIH, 5 RO1 AI051880) and Interdepartmental Fund to SAA. The generation of NSP triple knock out mouse model was support by the grants from NIH (AI049261 and AI051436) to CP. The publication fee for this article is supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; AHMED SA, 1989, J IMMUNOL, V142, P2647; Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; BAIN BJ, 1975, BRIT MED J, V2, P473, DOI 10.1136/bmj.2.5969.473; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Blesson CS, 2011, UPDATE MECH HORMONE; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Calippe B, 2008, J IMMUNOL, V180, P7980, DOI 10.4049/jimmunol.180.12.7980; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; CRANDALL TL, 1980, J LAB CLIN MED, V95, P857; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dietsch V, 1996, RECEPT SIGNAL TRANS, V6, P63; GAUNT SD, 1985, VET PATHOL, V22, P403, DOI 10.1177/030098588502200416; Grimaldi CM, 2005, MOL IMMUNOL, V42, P811, DOI 10.1016/j.molimm.2004.05.014; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; JILKA RL, 1995, EXP HEMATOL, V23, P500; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Khan D, 2012, ADV NEUROIMMUNE BIOL, V3, P73, DOI 10.3233/NIB-2012-012039; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Lengi AJ, 2007, J LEUKOCYTE BIOL, V81, P1065, DOI 10.1189/jlb.0606391; MATHUR S, 1979, CLIN IMMUNOL IMMUNOP, V13, P246, DOI 10.1016/0090-1229(79)90069-2; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Robinson DP, 2014, J VIROL, V88, P4711, DOI 10.1128/JVI.02081-13; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Suzuki M, 2011, INT J ENDOCRINOL MET, V9, P347, DOI 10.5812/Kowsar.1726913X.2246; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yan HM, 2016, ARTERIOSCL THROM VAS, V36, P1660, DOI 10.1161/ATVBAHA.116.307786; [No title captured]	45	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172105	10.1371/journal.pone.0172105	http://dx.doi.org/10.1371/journal.pone.0172105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192517	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800068
J	Huang, XB; Tang, WW; Liu, Y; Hu, R; Ouyang, LY; Liu, JX; Li, XJ; Yi, YJ; Wang, TD; Zhao, SP				Huang, Xiao-bo; Tang, Wei-wei; Liu, Ya; Hu, Rong; Ouyang, Ling-yun; Liu, Jian-xiong; Li, Xiu-jun; Yi, Yan-jing; Wang, Tzung-Dau; Zhao, Shui-ping			Prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in southwest China	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; HYPERGLYCEMIA; WOMEN; RISK; MEN	This study aimed to assess the prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in Southwest China. From September 2013 to March 2014, a cross-sectional survey was conducted in 4021 hypertensive patients aged 40 to 79 years living in Chengdu and Chongqing, China. Fasting plasma glucose (FPG) and 2h plasma glucose (2-hPG) in an oral glucose-tolerance test (OGTT) were used for assessments. Whether the patients previously had diabetes (DM) was determined by their own reports. The survey was carried out by the same questionnaire for all respondents. DM prevalence was 32.0% in hypertensive patients aged 40 to 79 years in Southwest China, with the rates of 29.6% and 33.5% in men and women, respectively (P<0.001). DM prevalence increased with age age and body-mass index. DM prevalence rates were 16.9%, 24.7%, 38.2% and 41.9% in hypertensive patients aged 40-49, 50-59, 60-69 and over 70, respectively. DM prevalence were 30.6%, 27.9%, 37.1%, and 37.4%, for BMI<18.5, 18.5-24.9, 25.0-29.9, and >= 30, respectively. Prevalence of unrecognized DM were 20.8% in hypertensive patients aged 40 to 79 years in Southwest China. Using only fasting blood glucose testing without OGTT would have resulted in 65.0% of missed DM diagnosis in these newly diagnosed patients. The prevalence of DM and unrecognized DM were high in hypertensive patients aged 40 to 79 years in Southwest China. These findings indicate that hypertensive patients aged 40 to 79 years should regularly submit to community-based OGTT screening for timely DM diagnosis.	[Huang, Xiao-bo; Zhao, Shui-ping] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China; [Huang, Xiao-bo; Liu, Ya; Liu, Jian-xiong; Yi, Yan-jing] Second Peoples Hosp Chengdu, Dept Cardiol, Chengdu, Sichuan Provinc, Peoples R China; [Tang, Wei-wei] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan Provinc, Peoples R China; [Hu, Rong] Chongqing Med Univ, Div Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China; [Ouyang, Ling-yun] Second Peoples Hosp Chengdu, Dept Endocrinol & Metab, Chengdu, Sichuan Provinc, Peoples R China; [Li, Xiu-jun] Sichuan Univ, Dept Endocrinol & Metab, West China Hosp, Chengdu, Peoples R China; [Wang, Tzung-Dau] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan	Central South University; Sichuan University; Chongqing Medical University; Sichuan University; National Taiwan University; National Taiwan University Hospital	Zhao, SP (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.; Wang, TD (corresponding author), Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	tdwang@ntu.edu.tw; shuipingzhao@126.com	YI, YAN/GUS-2240-2022; li, xiu/GXV-1745-2022	WANG, TZUNG-DAU/0000-0002-7180-3607	Szechwan Province Science and Technology Agency Fund Project, Chengdu [2009FZ 0027]; China and Population and health project of Chengdu Municipal Science and Technology Bureau, Chengdu, China [10YTYB272SF-182]	Szechwan Province Science and Technology Agency Fund Project, Chengdu; China and Population and health project of Chengdu Municipal Science and Technology Bureau, Chengdu, China	This research was supported by the Szechwan Province Science and Technology Agency Fund Project (2009FZ 0027), Chengdu, China and Population and health project of Chengdu Municipal Science and Technology Bureau (10YTYB272SF-182), Chengdu, China.	[Anonymous], IDF CONS WORLDW DEF; [Anonymous], 1998, CLIN GUID ID EV TREA; Arauz-Pacheco C, 2004, DIABETES CARE S1, V27, P65; Bakris George L., 1999, J Clin Hypertens (Greenwich), V1, P141; Bakris George L, 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251.49515.c2, DOI 10.1161/01.HYP.0000107251.49515.C2]; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Garcia-Puig J, 2006, AM J MED, V119, P318, DOI 10.1016/j.amjmed.2005.09.010; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gu P, 2012, CLIN EXP HYPERTENS, V34, P474, DOI 10.3109/10641963.2012.666601; Jiang P, 2015, CLIN EXP RHEUMATOL, V33, P115; Jiang Y.-Y., 2015, SHOCK VIB, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0130400; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Liu J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003798; Liu XX, 2014, ANN NUTR METAB, V65, P324, DOI 10.1159/000365892; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; OUYANG LY, 2009, CHIN J DIABETES MELL, V1, P282; Qin XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042538; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Tseng CC, 2016, JOINT BONE SPINE, V83, P307, DOI 10.1016/j.jbspin.2015.06.017; Ursini F, 2016, JOINT BONE SPINE, V83, P611, DOI 10.1016/j.jbspin.2016.07.006; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; Ursini F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000888; Ursini F, 2010, AUTOIMMUN REV, V9, P536, DOI 10.1016/j.autrev.2009.12.014; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170250	10.1371/journal.pone.0170250	http://dx.doi.org/10.1371/journal.pone.0170250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192474	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800008
J	Rauh, SP; Heymans, MW; Koopman, ADM; Nijpels, G; Stehouwer, CD; Thorand, B; Rathmann, W; Meisinger, C; Peters, A; Gala, TD; Glumer, C; Pedersen, O; Cederberg, H; Kuusisto, J; Laakso, M; Pearson, ER; Franks, PW; Rutters, F; Dekker, JM				Rauh, Simone P.; Heymans, Martijn W.; Koopman, Anitra D. M.; Nijpels, Giel; Stehouwer, Coen D.; Thorand, Barbara; Rathmann, Wolfgang; Meisinger, Christa; Peters, Annette; Gala, Tonia de las Heras; Glumer, Charlotte; Pedersen, Oluf; Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku; Pearson, Ewan R.; Franks, Paul W.; Rutters, Femke; Dekker, Jacqueline M.			Predicting glycated hemoglobin levels in the non-diabetic general population: Development and validation of the DIRECT - DETECT prediction model - a DIRECT study	PLOS ONE			English	Article							INCIDENT DIABETES-MELLITUS; HISPANIC WHITE ADULTS; LIFE-STYLE; INSULIN SENSITIVITY; CAUCASIAN POPULATION; GLUCOSE-TOLERANCE; RISK SCORE; FOLLOW-UP; TYPE-2; TOOL	Aims/hypothesis To develop a prediction model that can predict HbA1 c levels after six years in the non-diabetic general population, including previously used readily available predictors. Methods Data from 5,762 initially non-diabetic subjects from three population-based cohorts (Hoorn Study, Inter99, KORA 54/F4) were combined to predict HbAl c levels at six year follow-up. Using backward selection, age, BMI, waist circumference, use of anti-hypertensive medication, current smoking and parental history of diabetes remained in sex-specific linear regression models. To minimize overfitting of coefficients, we performed internal validation using bootstrapping techniques. Explained variance, discrimination and calibration were assessed using R-2, classification tables (comparing highest/lowest 50% HbA1 c levels) and calibration graphs. The model was externally validated in 2,765 non-diabetic subjects of the population-based cohort METSIM. Results At baseline, mean HbAlc level was 5.6% (38 mmol/mol). After a mean follow-up of six years, mean HbAlc level was 5.7% (39 mmol/mol). Calibration graphs showed that predicted HbA1c levels were somewhat underestimated in the Inter99 cohort and overestimated in the Hoorn and KORA cohorts, indicating that the model's intercept should be adjusted for each cohort to improve predictions. Sensitivity and specificity (95% CI) were 55.7% (53.9, 57.5) and 56.9% (55.1, 58.7) respectively, for women, and 54.6% (52.7, 56.5) and 54.3% (52.4, 56.2) for men. External validation showed similar performance in the METSIM cohort. Conclusions/interpretation In the non-diabetic population, our DIRECT-DETECT prediction model, including readily available predictors, has a relatively low explained variance and moderate discriminative performance, but can help to distinguish between future highest and lowest HbA1c levels. Absolute HbA1c values are cohort-dependent.	[Rauh, Simone P.; Heymans, Martijn W.; Koopman, Anitra D. M.; Rutters, Femke; Dekker, Jacqueline M.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Rauh, Simone P.; Heymans, Martijn W.; Koopman, Anitra D. M.; Nijpels, Giel; Rutters, Femke; Dekker, Jacqueline M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Nijpels, Giel] Vrije Univ Amsterdam, Dept Gen Practice, Med Ctr, Amsterdam, Netherlands; [Stehouwer, Coen D.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Stehouwer, Coen D.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Med Ctr, Maastricht, Netherlands; [Thorand, Barbara; Meisinger, Christa; Peters, Annette; Gala, Tonia de las Heras] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany; [Thorand, Barbara; Peters, Annette] German Ctr Diabet Res DZD, Neuherberg, Germany; [Rathmann, Wolfgang] Heinrich Heine Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Glumer, Charlotte] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Capital Region Of Denmar, Denmark; [Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, Kuopio, Finland; [Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Pearson, Ewan R.] Univ Dundee, Med Res Inst, Ninewells Hosp, Dundee, Scotland; [Pearson, Ewan R.] Univ Dundee, Sch Med, Dundee, Scotland; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Skane Univ Hosp Malmo, Malmo, Sweden; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Franks, Paul W.] Harvard Chan Sch Publ Hlth, Boston, MA USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Novo Nordisk Foundation; University of Copenhagen; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Dundee; University of Dundee; Lund University; Skane University Hospital; Umea University; Harvard University; Harvard T.H. Chan School of Public Health	Rauh, SP (corresponding author), Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands.; Rauh, SP (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands.	simone.rauh@outlook.com	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Rauh, Simone/ABC-4935-2021; Rauh, Simone/AAB-9565-2019; Peters, Annette/A-6117-2011; Franks, Paul/AAA-3300-2020; Stehouwer, Coen/AAB-3435-2021; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014	Pedersen, Oluf/0000-0002-3321-3972; Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Franks, Paul/0000-0002-0520-7604; Heymans, Martijn/0000-0002-3889-0921; Nijpels, Giel/0000-0002-3679-9710; Cederberg, Henna/0000-0003-2901-9373; Stehouwer, Coen/0000-0001-8752-3223; Pearson, Ewan/0000-0001-9237-8585	Innovative Medicines Initiative Joint [115317]; European Union's Seventh Framework Programme (FP7); EFPIA companies; Vrije Universiteit Amsterdam; VU University Medical Center; Dutch Diabetes Research Foundation; Dutch Organization for Scientific Research; Netherlands Heart Foundation; Health Research and Development Council of the Netherlands; Helmholtz Zentrum Munchen-German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center [RA 459/2-1]; German Federal Ministry of Health and the Ministry of Innovation, Science, Research and Technology of the federal state of North Rhine Westfalia; Danish Medical Research Council; Danish Center for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County; Danish Heart Foundation; Danish Diabetes Association; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	Innovative Medicines Initiative Joint; European Union's Seventh Framework Programme (FP7); EFPIA companies; Vrije Universiteit Amsterdam; VU University Medical Center; Dutch Diabetes Research Foundation; Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); Health Research and Development Council of the Netherlands; Helmholtz Zentrum Munchen-German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center; German Federal Ministry of Health and the Ministry of Innovation, Science, Research and Technology of the federal state of North Rhine Westfalia; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Center for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County(Novo Nordisk); Danish Heart Foundation; Danish Diabetes Association; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115317 (DIRECT), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution (http://www.direct-diabetes.org/). The Hoorn Study was supported by Vrije Universiteit Amsterdam, the VU University Medical Center, the Dutch Diabetes Research Foundation, the Dutch Organization for Scientific Research, the Netherlands Heart Foundation, and the Health Research and Development Council of the Netherlands. The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The Diabetes Cohort Study was funded by a German Research Foundation project grant to W.R. (RA 459/2-1) from the German Diabetes Center. The German Diabetes Center is funded by the German Federal Ministry of Health and the Ministry of Innovation, Science, Research and Technology of the federal state of North Rhine Westfalia. The Inter99 Study was supported by the Danish Medical Research Council, the Danish Center for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, the Danish Heart Foundation, the Danish Diabetes Association, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, and the Becket Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bongaerts BWC, 2013, DIABETES CARE, V36, P1141, DOI 10.2337/dc12-0744; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Engberg S, 2009, DIABETES CARE, V32, P606, DOI 10.2337/dc08-1869; Fizel'ova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109772; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2001, REGRESSION MODELING; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Kluppelholz B, 2015, DIABETOLOGIA, V58, P2269, DOI 10.1007/s00125-015-3679-4; Knowler WC., 2009, LANCET, V374, P1677, DOI [10.1016/S0140-6736(09)61457-4, DOI 10.1016/S0140-6736(09)61457-4, 10.1016/B978-0-323-29738-7]; Koivula RW, 2014, DIABETOLOGIA, V57, P1132, DOI 10.1007/s00125-014-3216-x; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Soulimane S, 2011, DIABETIC MED, V28, P1311, DOI 10.1111/j.1464-5491.2011.03403.x; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Steyerberg E., 2009, CLIN PREDICTION MODE; Tuomilehto J, 2009, DIABETES CARE, V32, pS189, DOI 10.2337/dc09-S308; van't Riet E, 2012, EUR J PREV CARDIOL, V19, P23, DOI 10.1097/HJR.0b013e32833b0932; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171816	10.1371/journal.pone.0171816	http://dx.doi.org/10.1371/journal.pone.0171816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187151	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300046
J	Arita, M; Fertala, J; Hou, C; Kostas, J; Steplewski, A; Fertala, A				Arita, Machiko; Fertala, Jolanta; Hou, Cheryl; Kostas, James; Steplewski, Andrzej; Fertala, Andrzej			Prospects and limitations of improving skeletal growth in a mouse model of spondyloepiphyseal dysplasia caused by R992C (p.R1192C) substitution in collagen II	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENESIS IMPERFECTA; MECHANICAL-PROPERTIES; C57B1/6 MICE; BONE-GROWTH; TRANSPLANTATION; EXPRESSION; CARTILAGE; CHILDREN; THERAPEUTICS	Skeletal dysplasias form a group of skeletal disorders caused by mutations in macromolecules of cartilage and bone. The severity of skeletal dysplasias ranges from precocious arthropathy to perinatal lethality. Although the pathomechanisms of these disorders are generally well defined, the feasibility of repairing established aberrant skeletal tissues that developed in the presence of mutant molecules is currently unknown. Here, we employed a validated mouse model of spondyloepiphyseal dysplasia (SED) that enables temporal control of the production of the R992C (p.R1192C) collagen II mutant that causes this disease. Although in our earlier studies we determined that blocking the expression of this mutant at the early prenatal stages prevents a SED phenotype, the utility of blocking the R992C collagen II at the postnatal stages is not known. Here, by switching off the expression of R992C collagen II at various postnatal stages of skeletal development, we determined that significant improvements of cartilage and bone morphology were achieved only when blocking the production of the mutant molecules was initiated in newborn mice. Our study indicates that future therapies of skeletal dysplasias may require defining a specific time window when interventions should be applied to be successful.	[Arita, Machiko; Fertala, Jolanta; Hou, Cheryl; Kostas, James; Steplewski, Andrzej; Fertala, Andrzej] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA	Jefferson University	Fertala, A (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	andrzej.fertala@jefferson.edu						Arita M, 2015, AM J PATHOL, V185, P214, DOI 10.1016/j.ajpath.2014.09.003; Arnold WV, 2013, INT J BIOCHEM CELL B, V45, P1556, DOI 10.1016/j.biocel.2013.05.017; Briggs MD, 2015, EXPERT OPIN ORPHAN D, V3, P1137, DOI 10.1517/21678707.2015.1083853; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Cabral WA, 2002, J BIOL CHEM, V277, P4215, DOI 10.1074/jbc.M109048200; Chambers MG, 2002, OSTEOARTHR CARTILAGE, V10, P51, DOI 10.1053/joca.2001.0481; CHAN D, 1993, J BIOL CHEM, V268, P15238; Chan JKY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00223; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Dawson PA, 2000, NUCLEIC ACIDS RES, V28, P4013, DOI 10.1093/nar/28.20.4013; Farquharson C, 2000, POULTRY SCI, V79, P994, DOI 10.1093/ps/79.7.994; Fertala A, 2001, BIOCHEMISTRY-US, V40, P14422, DOI 10.1021/bi0109109; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gawron K, 2010, BIOCHEM BIOPH RES CO, V396, P213, DOI 10.1016/j.bbrc.2010.04.056; Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; Jensen DA, 2011, HUM MUTAT, V32, P794, DOI 10.1002/humu.21506; Kanazawa H, 2003, J BONE MINER METAB, V21, P307, DOI 10.1007/s00774-003-0425-7; Kveiborg M, 2006, J BONE MINER RES, V21, P1288, DOI 10.1359/JBMR.060502; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Lin XB, 2014, J AM SOC NEPHROL, V25, P687, DOI 10.1681/ASN.2013070798; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Millington-Ward S, 2005, TRENDS MOL MED, V11, P299, DOI 10.1016/j.molmed.2005.04.006; Okada M, 2015, HUM MOL GENET, V24, P299, DOI 10.1093/hmg/ddu444; Peace BE, 2005, MOL THER, V12, P128, DOI 10.1016/j.ymthe.2005.02.015; POOLE CA, 1992, J CELL SCI, V103, P1101; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Posey KL, 2014, J BONE MINER RES, V29, P1258, DOI 10.1002/jbmr.2139; Prein C, 2016, MATRIX BIOL, V50, P1, DOI 10.1016/j.matbio.2015.10.001; Richman C, 2001, J BONE MINER RES, V16, P386, DOI 10.1359/jbmr.2001.16.2.386; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Sloan LA, 2009, CURR OPIN DRUG DISC, V12, P666; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Wang Q, 1996, J CLIN INVEST, V97, P448, DOI 10.1172/JCI118434; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775	40	3	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172068	10.1371/journal.pone.0172068	http://dx.doi.org/10.1371/journal.pone.0172068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182776	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800148
J	Buzanskas, ME; Ventura, RV; Chud, TCS; Bernardes, PA; Santos, DJD; Regitano, LCD; de Alencar, MM; Mudadu, MD; Zanella, R; da Silva, MVGB; Li, CX; Schenkel, FS; Munari, DP				Buzanskas, Marcos Eli; Ventura, Ricardo Vieira; Seleguim Chud, Tatiane Cristina; Bernardes, Priscila Arrigucci; de Abreu Santos, Daniel Jordan; de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello; Mudadu, Mauricio de Alvarenga; Zanella, Ricardo; Gualberto Barbosa da Silva, Marcos Vinicius; Li, Changxi; Schenkel, Flavio Schramm; Munari, Danisio Prado			Study on the introgression of beef breeds in Canchim cattle using single nucleotide polymorphism markers	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GROWTH TRAITS; ASSOCIATION; PREDICTION	The aim of this study was to evaluate the level of introgression of breeds in the Canchim (CA: 62.5% Charolais-37.5% Zebu) and MA genetic group (MA: 65.6% Charolais-34.4% Zebu) cattle using genomic information on Charolais (CH), Nelore (NE), and Indubrasil (IB) breeds. The number of animals used was 395 (CA and MA), 763 (NE), 338 (CH), and 37 (IB). The Bovine50SNP BeadChip from Illumina panel was used to estimate the levels of introgression of breeds considering the Maximum likelihood, Bayesian, and Single Regression method. After genotype quality control, 32,308 SNPs were considered in the analysis. Furthermore, three thresholds to prune out SNPs in linkage disequilibrium higher than 0.10, 0.05, and 0.01 were considered, resulting in 15,286, 7,652, and 1,582 SNPs, respectively. For k = 2, the proportion of taurine and indicine varied from the expected proportion based on pedigree for all methods studied. For k = 3, the Regression method was able to differentiate the animals in three main clusters assigned to each purebred breed, showing more reasonable according to its biological viewpoint. Analyzing the data considering k = 2 seems to be more appropriate for Canchim-MA animals due to its biological interpretation. The usage of 32,308 SNPs in the analyses resulted in similar findings between the estimated and expected breed proportions. Using the Regression approach, a contribution of Indubrasil was observed in Canchim-MA when k = 3 was considered. Genetic parameter estimation could account for this breed composition information as a source of variation in order to improve the accuracy of genetic models. Our findings may help assemble appropriate reference populations for genomic prediction for Canchim-MA in order to improve prediction accuracy. Using the information on the level of introgression in each individual could also be useful in breeding or crossing design to improve individual heterosis in crossbred cattle.	[Buzanskas, Marcos Eli; Seleguim Chud, Tatiane Cristina; Bernardes, Priscila Arrigucci; Munari, Danisio Prado] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Ciencias Exatas, Sao Paulo, Brazil; [Ventura, Ricardo Vieira] BIO, Guelph, ON, Canada; [Ventura, Ricardo Vieira] Univ Sao Paulo, FZEA, Dept Ciencias Basicas, Sao Paulo, Brazil; [de Abreu Santos, Daniel Jordan] Univ Estadual Paulista, Fac Ciencias Agrarias Vet, Sao Paulo, Brazil; [de Almeida Regitano, Luciana Correia; de Alencar, Mauricio Mello] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Mudadu, Mauricio de Alvarenga] Embrapa Agr Informat, Campinas, SP, Brazil; [Zanella, Ricardo] Univ Passo Fundo, Fac Agron Med Vet, Rio De Janeiro, Brazil; [Gualberto Barbosa da Silva, Marcos Vinicius] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil; [Li, Changxi] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Li, Changxi] Lacombe Res & Dev Ctr, Agr & Agri Food Canada, 6000 C&E Trail, Lacombe, AB, Canada; [Schenkel, Flavio Schramm] Univ Guelph, CGIL, Dept Anim & Poultry Sci, Guelph, ON, Canada	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Passo Fundo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Munari, DP (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Ciencias Exatas, Sao Paulo, Brazil.	danisio@fcav.unesp.br	Schenkel, Flavio/ABG-1842-2021; Zanella, Ricardo/AAM-8508-2020; de Alvarenga Mudadu, Maurício/B-6524-2014; Buzanskas, Marcos Eli/C-8147-2012; Munari, Danisio P/C-6384-2012; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; de Almeida Regitano, Luciana Correia/C-7002-2012; Bernardes, Priscila Arrigucci/L-3170-2018; Zanella, Ricardo/A-4644-2011	Zanella, Ricardo/0000-0003-1449-6708; de Alvarenga Mudadu, Maurício/0000-0002-2767-2507; Buzanskas, Marcos Eli/0000-0002-2728-079X; Munari, Danisio P/0000-0001-6915-038X; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Bernardes, Priscila Arrigucci/0000-0003-0864-8621; Zanella, Ricardo/0000-0003-1449-6708; Alencar, Mauricio/0000-0002-6102-663X; Schenkel, Flavio/0000-0001-8700-0633; Jordan de Abreu Santos, Daniel/0000-0002-7062-3372	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [449564/2014-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [02663/09-0]; Sao Paulo Research Foundation [FAPESP - 2012/23638-8]; FAPESP [2013/19335-2, 2015/08939-0, 2015/25096-6, 2015/12396-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - 449564/2014-2 (http//www.cnpq.br/),Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - 02663/09-0 (http.//www.capes.gov.br/), and Sao Paulo Research Foundation - FAPESP - 2012/23638-8 (http://www.fapesp.br/en/). MEB, TCSC, PAB, and DJAS are FAPESP fellows (grants n. 2013/19335-2, 2015/08939-0, 2015/25096-6, and 2015/12396-1). MVGBS, MMA, LCAR, and DPM are CNPq fellows. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alencar MM., 1988, BOVINORAA CANCHIM OR; Alencar MM., 2000, CANCHIM BEEF CATTLE; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexander DH, 2015, ADMIXTURE 1 3 SOFTWA, P1; Andrade PC, 2008, ANIM GENET, V39, P480, DOI 10.1111/j.1365-2052.2008.01755.x; [Anonymous], 2010, INTERBULL B; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Auguie B, 2017, GRIDEXTRA MISCELLANE; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Buzanskas ME, 2010, LIVEST SCI, V132, P107, DOI 10.1016/j.livsci.2010.05.008; Canaza-Cayo AW, 2016, LIVEST SCI; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Chud TCS, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0251-7; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Frkonja A, 2012, ANIM GENET, V43, P696, DOI 10.1111/j.1365-2052.2012.02345.x; Grossi DD, 2015, MOL BIOL REP, V42, P245, DOI 10.1007/s11033-014-3767-4; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Lu Duc, 2012, Frontiers in Genetics, V3, P152, DOI 10.3389/fgene.2012.00152; Mao F, 2013, J ANIM SCI, V91, P2067, DOI 10.2527/jas.2012-5470; Mokry FB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S6; Mokry FB, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-47; Montaldo H. H., 2012, Animal Frontiers, V2, P23, DOI 10.2527/af.2011-0029; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nielsen Rasmus, 2004, Human Genomics, V1, P218; O'Brien AMP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0109-5; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Santiago AA., 1957, ZEBU SUA HIST EVOLUC; SVED J A, 1971, Theoretical Population Biology, V2, P125; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Ventura R, 2016, J ANIM SCI, V94, P1844, DOI 10.2527/jas.2016-0322; Wang Dai, 2009, BMC Proc, V3 Suppl 7, pS109	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171660	10.1371/journal.pone.0171660	http://dx.doi.org/10.1371/journal.pone.0171660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182737	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800086
J	Cervia, LD; Chang, CC; Wang, LL; Yuan, F				Cervia, Lisa D.; Chang, Chun-Chi; Wang, Liangli; Yuan, Fan			Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; DNA-TRANSFECTION; PHOTOCHEMICAL INTERNALIZATION; PROTEIN-DEGRADATION; CATIONIC LIPOSOMES; CELLULAR UPTAKE; SIRNA DELIVERY; PLASMID DNA; IN-VITRO; CELLS	A recent theory suggests that endocytosis is involved in uptake and intracellular transport of electrotransfected plasmid DNA (pDNA). The goal of the current study was to understand if approaches used previously to improve endocytosis of gene delivery vectors could be applied to enhancing electrotransfection efficiency (eTE). Results from the study showed that photochemically induced endosomal escape, which could increase poly-L-lysine (PLL)-mediated gene delivery, decreased eTE. The decrease could not be blocked by treatment of cells with endonuclease inhibitors (aurintricarboxylic acid and zinc ion) or antioxidants (L-glutamine and ascorbic acid). Chemical treatment of cells with an endosomal trafficking inhibitor that blocks endosome progression, bafilomycin A1, resulted in a significant decrease in eTE. However, treatment of cells with lysosomotropic agents (chloroquine and ammonium chloride) had little effects on eTE. These data suggested that endosomes played important roles in protecting and intracellular trafficking of electrotransfected pDNA.	[Cervia, Lisa D.; Chang, Chun-Chi; Wang, Liangli; Yuan, Fan] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Yuan, F (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	fyuan@duke.edu		Cervia, Lisa/0000-0002-8385-4014	National Institutes of Health [GM098520]; National Science Foundation [BES-0828630]; Duke University Pharmacological Sciences Training Program (PSTP) [T32 GM 007105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105, R01GM098520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Duke University Pharmacological Sciences Training Program (PSTP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (GM098520); National Science Foundation (BES-0828630); and Duke University Pharmacological Sciences Training Program (PSTP) (T32 GM 007105).	Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Behr JP, 1997, CHIMIA, V51, P34; BENCHOKROUN Y, 1995, BIOCHEM PHARMACOL, V49, P305, DOI 10.1016/0006-2952(94)00465-X; Berg K, 1999, CANCER RES, V59, P1180; Berg K, 2010, METHODS MOL BIOL, V635, P133, DOI 10.1007/978-1-60761-697-9_10; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chang CC, 2016, CELL MOL BIOENG, V9, P538, DOI 10.1007/s12195-016-0452-9; Chang CC, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.58; Chaumet A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9218; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Cornelis S, 2002, DNA CELL BIOL, V21, P91, DOI 10.1089/104454902753604961; COTTEN M, 1992, P NATL ACAD SCI USA, V89, P6094, DOI 10.1073/pnas.89.13.6094; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; Dalluge R, 2002, BBA-GENE STRUCT EXPR, V1576, P45, DOI 10.1016/S0167-4781(02)00291-9; de Bruin KG, 2008, J CONTROL RELEASE, V130, P175, DOI 10.1016/j.jconrel.2008.06.001; DIJKSTRA J, 1984, BIOCHIM BIOPHYS ACTA, V804, P58, DOI 10.1016/0167-4889(84)90099-5; Donahue DA, 2016, J VIROL, V90, P4199, DOI 10.1128/JVI.03202-15; ELMQUIST S, 1992, MUSCLE NERVE, V15, P876, DOI 10.1002/mus.880150803; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; Erbacher P, 2002, BIOCONJUGATE AM CHEM, V6, P401; Eynard N, 1997, BIOELECTROCH BIOENER, V44, P103, DOI 10.1016/S0302-4598(97)00038-X; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Felgner PL, 1990, ADV DRUG DELIV REV, V5, P163; Forrest ML, 2002, MOL THER, V6, P57, DOI 10.1006/mthe.2002.0631; GILBERTOGONZALEZ R, 1980, BIOCHEMISTRY-US, V19, P4299, DOI 10.1021/bi00559a023; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Goldshtein M, 2016, INT J PHARMACEUT, V515, P46, DOI 10.1016/j.ijpharm.2016.10.009; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HAMMARSKJOLD ML, 1986, GENE, V43, P41, DOI 10.1016/0378-1119(86)90006-5; HASAN MT, 1991, SOMAT CELL MOLEC GEN, V17, P513, DOI 10.1007/BF01233175; Hellum M, 2003, PHOTOCH PHOTOBIO SCI, V2, P407, DOI 10.1039/b211880g; Henshaw JW, 2008, J PHARM SCI-US, V97, P691, DOI 10.1002/jps.21000; Hogset Anders, 2002, Somatic Cell and Molecular Genetics, V27, P97, DOI 10.1023/A:1022979806314; Hyndman L, 2004, J CONTROL RELEASE, V99, P435, DOI 10.1016/j.jconrel.2004.07.023; James MB, 2000, MOL THER, V1, P339, DOI 10.1006/mthe.2000.0054; Jin GW, 2011, POLYMER, V52, P339, DOI 10.1016/j.polymer.2010.10.066; Kamiya H, 2002, BIOCHEM BIOPH RES CO, V298, P591, DOI 10.1016/S0006-291X(02)02485-3; KANEDA Y, 1995, J MOL MED-JMM, V73, P289; Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173; KLUXEN FW, 1993, ANAL BIOCHEM, V208, P352, DOI 10.1006/abio.1993.1060; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; LabatMoleur F, 1996, GENE THER, V3, P1010; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Leonetti JP, 1990, BIOCONJUGATE CHEM, V1, P149, DOI 10.1021/bc00002a010; Li L, 2015, CELL BIOL INT, V39, P531, DOI 10.1002/cbin.10424; Liang W, 2012, MOL REGULATION ENDOC, P1; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; Mao M, MOL THERAPY IN PRESS; Medina-Kauwe LK, 2005, GENE THER, V12, P1734, DOI 10.1038/sj.gt.3302592; Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Miller AM, 2009, ADV DRUG DELIVER REV, V61, P603, DOI 10.1016/j.addr.2009.02.008; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Monk KWC, 1997, BIOPHYS J, V73, P2534, DOI 10.1016/S0006-3495(97)78282-1; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pires P, 1999, BBA-BIOMEMBRANES, V1418, P71, DOI 10.1016/S0005-2736(99)00023-1; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; Prasmickaite L, 2002, BRIT J CANCER, V86, P652, DOI 10.1038/sj.bjc.6600138; Prasmickaite L, 2001, PHOTOCHEM PHOTOBIOL, V73, P388, DOI 10.1562/0031-8655(2001)073<0388:EODPFU>2.0.CO;2; Prasmickaite L, 2000, J GENE MED, V2, P477, DOI 10.1002/1521-2254(200011/12)2:6<477::AID-JGM137>3.0.CO;2-B; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Rosazza C, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2015.59; ROSS DD, 1989, CANCER RES, V49, P3776; Selbo PK, 2010, J CONTROL RELEASE, V148, P2, DOI 10.1016/j.jconrel.2010.06.008; Shiraishi T, 2005, CHEM BIOL, V12, P923, DOI 10.1016/j.chembiol.2005.06.009; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Sonntag F, 2006, J VIROL, V80, P11040, DOI 10.1128/JVI.01056-06; Tachibana R, 2002, PHARMACEUT RES, V19, P377, DOI 10.1023/A:1015162722295; UEDA N, 1992, J CLIN INVEST, V90, P2593, DOI 10.1172/JCI116154; Uherek C, 1998, J BIOL CHEM, V273, P8835, DOI 10.1074/jbc.273.15.8835; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Vaughan EE, 2006, CURR GENE THER, V6, P671, DOI 10.2174/156652306779010688; Wagner E, 2006, ADV POLYM SCI, V192, P135, DOI 10.1007/12_023; Weaver J C, 1995, Methods Mol Biol, V47, P1; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zaharoff DA, 2008, EXP BIOL MED, V233, P94, DOI 10.3181/0704-RM-113; Zelphati O, 1999, HUM GENE THER, V10, P15, DOI 10.1089/10430349950019156; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195; Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c; ZHOU XH, 1994, BBA-BIOMEMBRANES, V1189, P195, DOI 10.1016/0005-2736(94)90066-3	92	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171699	10.1371/journal.pone.0171699	http://dx.doi.org/10.1371/journal.pone.0171699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182739	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800092
J	Jonnalagadda, S; Rodriguez, O; Estrella, B; Sabin, LL; Sempertegui, F; Hamer, DH				Jonnalagadda, Sivani; Rodriguez, Oswaldo; Estrella, Bertha; Sabin, Lora L.; Sempertegui, Fernando; Hamer, Davidson H.			Etiology of severe pneumonia in Ecuadorian children	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; BACTEREMIC PNEUMOCOCCAL PNEUMONIA; MULTIPLEX PCR ASSAY; RISK-FACTORS; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD PNEUMONIA; TRACT INFECTIONS; CLINICAL CHARACTERISTICS; HUMAN METAPNEUMOVIRUS	Background In Latin America, community-acquired pneumonia remains a major cause of morbidity and mortality among children. Few studies have examined the etiology of pneumonia in Ecuador. Methods This observational study was part of a randomized, double blind, placebo-controlled clinical trial conducted among children aged 2-59 months with severe pneumonia in Quito, Ecuador. Nasopharyngeal and blood samples were tested for bacterial and viral etiology by polymerase chain reaction. Risk factors for specific respiratory pathogens were also evaluated. Results Among 406 children tested, 159 (39.2%) had respiratory syncytial virus (RSV), 71 (17.5%) had human metapneumovirus (hMPV), and 62 (15.3%) had adenovirus. Streptococcus pneumoniae was identified in 37 (9.2%) samples and Mycoplasma pneumoniae in three (0.74%) samples. The yearly circulation pattern of RSV (P = 0.0003) overlapped with S. pneumoniae, (P = 0.03) with most cases occurring in the rainy season. In multivariable analysis, risk factors for RSV included younger age (adjusted odds ratio [aOR] = 1.9, P = 0.01) and being underweight (aOR = 1.8, P = 0.04). Maternal education (aOR = 0.82, P = 0.003), pulse oximetry (aOR = 0.93, P = 0.005), and rales (aOR = 0.25, P = 0.007) were associated with influenza A. Younger age (aOR = 3.5, P = 0.007) and elevated baseline respiratory rate were associated with HPIV-3 infection (aOR = 0.94, P = 0.03). Conclusion These results indicate the importance of RSV and influenza, and potentially modifiable risk factors including undernutrition and future use of a RSV vaccine, when an effective vaccine becomes available.	[Jonnalagadda, Sivani; Sabin, Lora L.; Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Rodriguez, Oswaldo; Estrella, Bertha; Sempertegui, Fernando] Crp Ecuatoriana Biotecnol, Quito, Ecuador; [Estrella, Bertha; Sempertegui, Fernando] Univ Cent Ecuador, Escuela Med, Quito, Ecuador; [Sabin, Lora L.; Hamer, Davidson H.] Boston Univ, Sch Publ, Dept Global Hlth, Boston, MA 02215 USA; [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02115 USA; [Hamer, Davidson H.] Tufts Univ, Gerald J & Dorothy R Friedman Sch Nutr Sci & Poli, Boston, MA 02155 USA	Boston University; Universidad Central del Ecuador; Boston University; Boston University; Tufts University	Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.; Hamer, DH (corresponding author), Boston Univ, Sch Publ, Dept Global Hlth, Boston, MA 02215 USA.; Hamer, DH (corresponding author), Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02115 USA.; Hamer, DH (corresponding author), Tufts Univ, Gerald J & Dorothy R Friedman Sch Nutr Sci & Poli, Boston, MA 02155 USA.	dhamer@bu.edu	Hamer, Davidson Howes/J-2020-2019	Hamer, Davidson Howes/0000-0002-4700-1495	Thrasher Research Fund [028257]	Thrasher Research Fund	The Thrasher Research Fund provided financial support for this study (grant number 028257). The sponsors of the study had no role in study design, data collection, data analysis, or manuscript writing.	Ali A, 2013, PLOS ONE, V8; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; [Anonymous], 2016, REGIONAL UPDATE EW 5; [Anonymous], 2016, COUNTRIES REPORTING, P1; Aponte FE, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0262-z; Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Asner SA, 2014, INFLUENZA OTHER RESP, V8, P436, DOI 10.1111/irv.12255; Azab SFAH, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-14; Ramirez JB, 2014, REV PANAM SALUD PUBL, V36, P101; Belshe RB, 2004, J INFECT DIS, V190, P2096, DOI 10.1086/425981; Ben-Shimol S, 2015, CLIN INFECT DIS, V60, P1384, DOI 10.1093/cid/civ023; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Budge PJ, 2014, PEDIATR INFECT DIS J, V33, P443, DOI 10.1097/INF.0000000000000135; Byington CL, 2015, CLIN INFECT DIS, V61, P1217, DOI 10.1093/cid/civ486; Cardinale F, 2013, EARLY HUM DEV S3, V89; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Choudhuri JA, 2006, PEDIATRICS, V117, P349, DOI 10.1542/peds.2004-2795; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; Constenla DO., 2015, POSTINTRODUCTION EC, V38, P388; Lima EJD, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0695-6; De Oliveira LH, 2016, PNEUMOCOCCAL CONJUGA; Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; Esposito S, 2002, CLIN INFECT DIS, V35, P1345, DOI 10.1086/344191; Family PY, 2015, INT EXPERT COMMITTEE, VXXXVII, P1; Floyd J, 2015, NATURE, V528, pS53, DOI 10.1038/nature16043; Geertsen R, 2007, SCAND J INFECT DIS, V39, P769, DOI 10.1080/00365540701367736; Gentile A, 2012, INT J INFECT DIS, V16, pE5, DOI 10.1016/j.ijid.2011.09.013; Gilani Z, 2012, CLIN INFECT DIS, V54, pS102, DOI 10.1093/cid/cir1053; Graham BS, 2016, VACCINE, V34, P3535, DOI 10.1016/j.vaccine.2016.04.083; Grijalva CG, 2014, INT J EPIDEMIOL, V43, P1021, DOI 10.1093/ije/dyt065; Harris AM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-93; Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512; Hindiyeh M, 2001, AM J CLIN PATHOL, V116, P218; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Howard LM, 2015, PEDIATR INFECT DIS J, V34, P1074, DOI 10.1097/INF.0000000000000812; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Khan AJ, 2009, B WORLD HEALTH ORGAN, V87, P193, DOI 10.2471/BLT.07.048264; Kumar S, 2017, ACUTE RESP INFECT DU, V44, P568; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Lee KH, 2016, EVOL MED PUBLIC HLTH, P95, DOI 10.1093/emph/eow007; Lee LH, 2014, VACCINES-BASEL, V2, P112, DOI 10.3390/vaccines2010112; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Loens K, 2003, J CLIN MICROBIOL, V41, P4915, DOI 10.1128/JCM.41.11.4915-4923.2003; Lucia S., 2016, YEAR VACCINE INTRO, V2009; Garcia-Garcia ML, 2012, PEDIATR INFECT DIS J, V31, P808, DOI 10.1097/INF.0b013e3182568c67; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Mazur NI, 2015, LANCET RESP MED, V2600; McCracken JP, 2014, INFLUENZA OTHER RESP, V8, P414, DOI 10.1111/irv.12251; McCulloh RJ, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0521-1; Messacar K, 2013, J CLIN VIROL, V56, P41, DOI 10.1016/j.jcv.2012.09.012; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Moisi JC, 2016, AM J TROP MED HYG, V94, P267, DOI 10.4269/ajtmh.15-0431; Moschovis PP, 2013, PEDIATRICS, V132, pE1156, DOI 10.1542/peds.2013-0761; Munywoki PK, 2015, J INFECT DIS, V212, P1711, DOI 10.1093/infdis/jiv263; Muro F, 2015, TROP MED INT HEALTH, V20, P757, DOI 10.1111/tmi.12492; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nascimento-Carvalho CM, 2012, J MED VIROL, V84, P253, DOI 10.1002/jmv.22268; Nguyen TTX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116679; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Papenburg J, 2012, J INFECT DIS, V206, P178, DOI 10.1093/infdis/jis333; Parrott GL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00513; Paynter S, 2014, PEDIATR INFECT DIS J, V33, P267, DOI 10.1097/INF.0000000000000096; Pediatrica P, 2015, INFLUENZA VACCINE CO, V48; Pio A, 2003, B WORLD HEALTH ORGAN, V81, P298; Principi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135640; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Rodgers GL, 2016, HUM VACC IMMUNOTHER, V12, P417, DOI 10.1080/21645515.2015.1057671; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; SALO P, 1995, J INFECT DIS, V171, P479, DOI 10.1093/infdis/171.2.479; Saso A, 2016, LANCET INFECT DIS, V16, pE153, DOI 10.1016/S1473-3099(16)00119-5; Schlaudecker EP, 2012, PEDIATR INFECT DIS J, V31, P1113, DOI 10.1097/INF.0b013e31826052eb; Schmidt AC, 2012, VACCINES, V5, P515; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Sempertegui F, 2014, AM J CLIN NUTR, V99, P497, DOI 10.3945/ajcn.113.067892; Shi T, 2015, J GLOB HEALTH, V5, P203, DOI 10.7189/jogh.05.020416; Shoma S, 2001, J HEALTH POPUL NUTR, V19, P268; Smith CM, 2014, AM J RESP CRIT CARE, V190, P196, DOI 10.1164/rccm.201311-2110OC; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; WHO, 2015, INT PHARM, P1; Wonodi CB, 2012, CLIN INFECT DIS S2, V54; Wu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130233; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247; Zhang XB, 2014, WORLD J PEDIATR, V10, P360, DOI 10.1007/s12519-014-0513-x	92	41	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171687	10.1371/journal.pone.0171687	http://dx.doi.org/10.1371/journal.pone.0171687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182741	gold, Green Published			2022-12-27	WOS:000394231800089
J	Rexford, A; Zorio, DAR; Miller, BG				Rexford, Alix; Zorio, Diego A. R.; Miller, Brian G.			Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL; PHOSPHORYLATION; INHIBITOR; MUTATIONS; BCL-X(L); COMPLEX; IMAGE; SITE	The glycolytic enzyme glucokinase (GCK) and the pro-apoptotic protein BAD reportedly reside within a five-membered complex that localizes to the mitochondria of mammalian hepatocytes and pancreatic beta-cells. Photochemical crosslinking studies using a synthetic analog of BAD's BH3 domain and in vitro transcription/translation experiments support a direct interaction between BAD and GCK. To investigate the biochemical and biophysical consequences of the BAD: GCK interaction, we developed a method for the production of recombinant human BAD. Consistent with published reports, recombinant BAD displays high affinity for Bcl-xL (K-D = 7 nM), and phosphorylation of BAD at S118, within the BH3 domain, abolishes this interaction. Unexpectedly, we do not detect association of recombinant, full-length BAD with recombinant human pancreatic GCK over a range of protein concentrations using various biochemical methods including size-exclusion chromatography, chemical cross-linking, analytical ultracentrifugation, and isothermal titration calorimetry. Furthermore, fluorescence polarization assays and isothermal titration calorimetry detect no direct interaction between GCK and BAD BH3 peptides. Kinetic characterization of GCK in the presence of high concentrations of recombinant BAD show modest (< 15%) increases in GCK activity, observable only at glucose concentrations well below the K-0.5 value. GCK activity is unaffected by BAD BH3 peptides. These results raise questions as to the mechanism of action of stapled peptide analogs modeled after the BAD BH3 domain, which reportedly enhance the V-max value of GCK and stimulate insulin release in BAD-deficient islets. Based on our results, we postulate that the BAD: GCK interaction, and any resultant regulatory effect(s) upon GCK activity, requires the participation of additional members of the mitochondrial complex.	[Rexford, Alix; Zorio, Diego A. R.; Miller, Brian G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Zorio, Diego A. R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Miller, BG (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	miller@chem.fsu.edu			National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK081358]; National Institute of General Medical Sciences [1R01GM115388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115388] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of Diabetes and Digestive and Kidney Diseases [https://www.niddk.nih.gov/] 5R01DK081358 to BGM; and the National Institute of General Medical Sciences [https://www.nigms. nih.gov/] 1R01GM115388 to BGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bowler JM, 2013, ACS MED CHEM LETT, V4, P15, DOI 10.1021/ml400061x; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cornish-Bowden A, 2004, FRONT DIABETES, V16, P125; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Gimenez-Cassina A, 2014, CELL METAB, V19, P272, DOI 10.1016/j.cmet.2013.12.001; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Hemmer W, 1997, ANAL BIOCHEM, V245, P115, DOI 10.1006/abio.1996.9952; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Kamata K, 2004, STRUCTURE; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; Larion M, 2009, BIOCHEMISTRY-US, V48, P6157, DOI 10.1021/bi9007534; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LIANG Y, 1990, J BIOL CHEM, V265, P16863; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; NEET KE, 1990, BIOCHEMISTRY-US, V29, P770, DOI 10.1021/bi00455a026; Pal P, 2009, BIOCHEMISTRY-US, V48, P814, DOI 10.1021/bi802142q; Paz A, 2010, INSTRUMENTAL ANAL IN; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sambrook J., 2001, MOL CLONING LAB MANU; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Szlyk B, 2014, NAT STRUCT MOL BIOL, V21, P36, DOI 10.1038/nsmb.2717; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Zhang HC, 2002, ANAL BIOCHEM, V307, P70, DOI 10.1016/S0003-2697(02)00028-3	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171587	10.1371/journal.pone.0171587	http://dx.doi.org/10.1371/journal.pone.0171587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182770	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800077
J	Dalenberg, JR; Weitkamp, L; Renken, RJ; Nanetti, L; ter Horst, GJ				Dalenberg, Jelle R.; Weitkamp, Liselore; Renken, Remco J.; Nanetti, Luca; ter Horst, Gert J.			Flavor pleasantness processing in the ventral emotion network	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; BRAIN ACTIVATION; AVERSIVE TASTE; REWARD; FMRI; REPRESENTATION; INTENSITY; AMYGDALA; RESPONSES; CIRCUITS	The ventral emotion network -encompassing the amygdala, insula, ventral striatum, and ventral regions of the prefrontal cortex - has been associated with the identification of emotional significance of perceived external stimuli and the production of affective states. Functional magnetic resonance imaging (fMRI) studies investigating chemosensory stimuli have associated parts of this network with pleasantness coding. In the current study, we independently analyzed two datasets in which we measured brain responses to flavor stimuli in young adult men. In the first dataset, participants evaluated eight regular off the shelf drinking products while participants evaluated six less familiar oral nutritional supplements (ONS) in the second dataset. Participants provided pleasantness ratings 20 seconds after tasting. Using independent component analysis (ICA) and mixed effect models, we identified one brain network in the regular products dataset that was associated with flavor pleasantness. This network was very similar to the ventral emotion network. Although we identified an identical network in the ONS dataset using ICA, we found no linear relation between activation of any network and pleasantness scores within this dataset. Our results indicate that flavor pleasantness is processed in a network encompassing amygdala, ventral prefrontal, insular, striatal and parahippocampal regions for familiar drinking products. For more unfamiliar ONS products the association is not obvious, which could be related to the unfamiliarity of these products.	[Dalenberg, Jelle R.; Weitkamp, Liselore; Renken, Remco J.; ter Horst, Gert J.] Top Inst Food & Nutr, Wageningen, Netherlands; [Dalenberg, Jelle R.; Weitkamp, Liselore; Renken, Remco J.; Nanetti, Luca; ter Horst, Gert J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen	Dalenberg, JR (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Dalenberg, JR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, Groningen, Netherlands.	j.r.dalenberg@umcg.nl		Dalenberg, Jelle R./0000-0001-8580-5358; Renken, Remco Jan/0000-0002-7777-9484	TI Food and Nutrition [SL001]; Danone; FrieslandCampina	TI Food and Nutrition; Danone(Danone Nutricia); FrieslandCampina	Funding was realized by TI Food and Nutrition, project code SL001. http://www.tifn.nl/. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone and FrieslandCampina partly financed the project and did have a role in the study design. More specifically: the choice of stimuli, which were produced by these sponsors. However, Danone and FrieslandCampina had no influence on the authors' research positions, the collection, analysis and presentation of the data or the decision to publish or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bender G, 2009, EUR J NEUROSCI, V30, P327, DOI 10.1111/j.1460-9568.2009.06819.x; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bragulat V, 2010, OBESITY, V18, P1566, DOI 10.1038/oby.2010.57; Bryant M, 2006, BRIT J NUTR, V96, P888, DOI 10.1017/BJN20061931; Buchanan TW, 2003, LEARN MEMORY, V10, P319, DOI 10.1101/lm.62303; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2013, PSYCHOMETRIKA, V78, P243, DOI 10.1007/s11336-012-9291-3; Cerf-Ducastel B, 2012, CHEMOSENS PERCEPT, V5, P100, DOI 10.1007/s12078-011-9109-1; Crouzet SM, 2015, CURR BIOL, V25, P890, DOI 10.1016/j.cub.2015.01.057; Dalenberg JR, 2015, NEUROIMAGE, V119, P210, DOI 10.1016/j.neuroimage.2015.06.062; Dalenberg JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093350; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; de Araujo IE, 2013, CURR BIOL, V23, P878, DOI 10.1016/j.cub.2013.04.001; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Haase L, 2011, APPETITE, V57, P421, DOI 10.1016/j.appet.2011.06.009; Hayes DJ, 2014, NEUROSCI BIOBEHAV R, V45, P350, DOI 10.1016/j.neubiorev.2014.06.018; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Kim D, 2008, NEUROIMAGE, V42, P1560, DOI 10.1016/j.neuroimage.2008.05.065; Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Laird AR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00154; Marciani L, 2006, J NEUROSCI METH, V158, P186, DOI 10.1016/j.jneumeth.2006.05.035; McCutcheon JE, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00137; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.3.CO;2-5; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pinheiro J, 2000, MIXED EFFECTS MODELS; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Rudenga K, 2010, CHEM SENSES, V35, P693, DOI 10.1093/chemse/bjq068; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; Spetter MS, 2010, CHEM SENSES, V35, P831, DOI 10.1093/chemse/bjq093; Stevens MC, 2007, HUM BRAIN MAPP, V28, P394, DOI 10.1002/hbm.20285; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; van den Bosch I, 2014, BEHAV BRAIN RES, V269, P128, DOI 10.1016/j.bbr.2014.04.010; Van Vugt DA, 2010, HUM REPROD UPDATE, V16, P276, DOI 10.1093/humupd/dmp051; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	67	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170310	10.1371/journal.pone.0170310	http://dx.doi.org/10.1371/journal.pone.0170310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207751	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500009
J	Kovalchuk, Y; Stewart, R; Broadbent, M; Hubbard, TJP; Dobson, RJB				Kovalchuk, Yevgeniya; Stewart, Robert; Broadbent, Matthew; Hubbard, Tim J. P.; Dobson, Richard J. B.			Analysis of diagnoses extracted from electronic health records in a large mental health case register	PLOS ONE			English	Article								The UK government has recently recognised the need to improve mental health services in the country. Electronic health records provide a rich source of patient data which could help policymakers to better understand needs of the service users. The main objective of this study is to unveil statistics of diagnoses recorded in the Case Register of the South London and Maudsley NHS Foundation Trust, one of the largest mental health providers in the UK and Europe serving a source population of over 1.2 million people residing in south London. Based on over 500,000 diagnoses recorded in ICD10 codes for a cohort of approximately 200,000 mental health patients, we established frequency rate of each diagnosis (the ratio of the number of patients for whom a diagnosis has ever been recorded to the number of patients in the entire population who have made contact with mental disorders). We also investigated differences in diagnoses prevalence between subgroups of patients stratified by gender and ethnicity. The most common diagnoses in the considered population were (recurrent) depression (ICD10 codes F32-33; 16.4% of patients), reaction to severe stress and adjustment disorders (F43; 7.1%), mental/behavioural disorders due to use of alcohol (F10; 6.9%), and schizophrenia (F20; 5.6%). We also found many diagnoses which were more likely to be recorded in patients of a certain gender or ethnicity. For example, mood (affective) disorders (F31-F39); neurotic, stress-related and somatoform disorders (F40-F48, except F42); and eating disorders (F50) were more likely to be found in records of female patients, while males were more likely to be diagnosed with mental/ behavioural disorders due to psychoactive substance use (F10-F19). Furthermore, mental/ behavioural disorders due to use of alcohol and opioids were more likely to be recorded in patients of white ethnicity, and disorders due to use of cannabinoids in those of black ethnicity.	[Kovalchuk, Yevgeniya] Birmingham City Univ, Fac Comp Engn & Built Environm, Sch Comp & Digital Technol, Birmingham, W Midlands, England; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England; [Stewart, Robert; Broadbent, Matthew; Dobson, Richard J. B.] South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England; [Stewart, Robert; Broadbent, Matthew; Dobson, Richard J. B.] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England; [Hubbard, Tim J. P.] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England; [Dobson, Richard J. B.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England; [Dobson, Richard J. B.] UCL, London Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England; [Dobson, Richard J. B.] Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England	Birmingham City University; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London	Kovalchuk, Y (corresponding author), Birmingham City Univ, Fac Comp Engn & Built Environm, Sch Comp & Digital Technol, Birmingham, W Midlands, England.; Dobson, RJB (corresponding author), South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England.; Dobson, RJB (corresponding author), South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England.; Dobson, RJB (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England.; Dobson, RJB (corresponding author), UCL, London Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England.; Dobson, RJB (corresponding author), Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England.	yevgeniya.kovalchuk@bcu.ac.uk; richard.j.dobson@kcl.ac.uk	Stewart, Robert/B-1667-2010; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; dobson, richard/C-9269-2011	Stewart, Robert/0000-0002-4435-6397; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; dobson, richard/0000-0003-4224-9245	National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and King's College London	National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust and King's College London	This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The NIHR University College London (UCL) Hospitals Biomedical Research Centre and the Farr Institute of Health Informatics Research at UCL Partners provided support for this study in the form of salary for Richard J.B. Dobson. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Alzheimer's Society, DEM UK 2007 REP MAT; [Anonymous], 2011, ATT MENT ILLN; [Anonymous], 2016, MENT HLTH SERV REF; [Anonymous], 2014, ACHIEVING BETTER ACC; [Anonymous], 2011, MENT HLTH POV ETHN F; [Anonymous], 2001, OFFICE NATL STAT PSY; [Anonymous], 2015, PM PLANS 7 DAY NHS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanowicz KM, 2015, DRUG ALCOHOL DEPEN, V148, P85, DOI 10.1016/j.drugalcdep.2014.12.025; Brugha T., 2012, ESTIMATING PREVALENC; Coventry and Warwickshire Partnership NHS Trust, 2020, MED USED MENTAL HLTH; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Hawton K, 2008, CRISIS, V29, P4, DOI 10.1027/0227-5910.29.1.4; Ibrahim ZM, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P831; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Jackson R, P AMIA 2014; Kovalchuk Y, 2013, IEEE CONF WIREL MOB, P297, DOI 10.1109/WiMOB.2013.6673376; Liang SF, 2015, METHOD INFORM MED, V54, P32, DOI 10.3414/ME13-02-0029; McNicoll A Andy, 2015, NEWS MENTAL HLT 0529; National Statistics, 2003, BETT WORS LONG STUD; Patel Rashmi, 2015, Lancet, V385 Suppl 1, pS79, DOI 10.1016/S0140-6736(15)60394-4; Patel R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007504; Patel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126530; Rehman H, 2013, MENTAL HLTH SURVEY E; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Taylor CL, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0451-8; The Mental Health Policy Group, 2012, MENT ILLN LOS OUT NH; The National Mental Health, DEM NEUR INT NETW; Weaks L, 2015, IMPROVING MENTAL HLT; World Health Organization, INT CLASS DIS ICD	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171526	10.1371/journal.pone.0171526	http://dx.doi.org/10.1371/journal.pone.0171526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207753	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000394424500034
J	Neeb, ZT; Hogan, DJ; Katzman, S; Zahler, AM				Neeb, Zachary T.; Hogan, Daniel J.; Katzman, Sol; Zahler, Alan M.			Preferential expression of scores of functionally and evolutionarily diverse DNA and RNA-binding proteins during Oxytricha trifallax macronuclear development	PLOS ONE			English	Article							INTERNAL ELIMINATED SEGMENTS; CILIATE PARAMECIUM-TETRAURELIA; PIWI-INTERACTING RNAS; GENOME-REARRANGEMENT; GENE-EXPRESSION; STYLONYCHIA-LEMNAE; EUPLOTES-CRASSUS; HISTONE H3; TETRAHYMENA-THERMOPHILA; MAXIMUM-LIKELIHOOD	During its sexual reproduction, the stichotrichous ciliate Oxytricha trifallax orchestrates a remarkable transformation of one of the newly formed germline micronuclear genomes. Hundreds of thousands of gene pieces are stitched together, excised from chromosomes, and replicated dozens of times to yield a functional somatic macronuclear genome composed of similar to 16,000 distinct DNA molecules that typically encode a single gene. Little is known about the proteins that carry out this process. We profiled mRNA expression as a function of macronuclear development and identified hundreds of mRNAs preferentially expressed at specific times during the program. We find that a disproportionate number of these mRNAs encode proteins that are involved in DNA and RNA functions. Many mRNAs preferentially expressed during macronuclear development have paralogs that are either expressed constitutively or are expressed at different times during macronuclear development, including many components of the RNA polymerase II machinery and homologous recombination complexes. Hundreds of macronuclear development-specific genes encode proteins that are well-conserved among multicellular eukaryotes, including many with links to germline functions or development. Our work implicates dozens of DNA and RNA-binding proteins with diverse evolutionary trajectories in macronuclear development in O. trifallax. It suggests functional connections between the process of macronuclear development in unicellular ciliates and germline specialization and differentiation in multicellular organisms, and argues that gene duplication is a key source of evolutionary innovation in this process.	[Neeb, Zachary T.; Zahler, Alan M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Neeb, Zachary T.; Zahler, Alan M.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Hogan, Daniel J.] Tocagen Inc, San Diego, CA 92109 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Neeb, Zachary T.] Univ Bern, Inst Cell Biol, Dept Biol, Bern, Switzerland	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Bern	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.; Zahler, AM (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.; Hogan, DJ (corresponding author), Tocagen Inc, San Diego, CA 92109 USA.	hogandj@alumni.stanford.edu; zahler@ucsc.edu		Zahler, Alan/0000-0003-0027-1647; Neeb, Zachary T./0000-0001-8930-3574	National Science Foundation EAGER award [MCB-1324780]; UCSC MCD Graduate Training Grant from National Institute of General Medical Sciences [T32-GM008646]; Div Of Molecular and Cellular Bioscience [1324780] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Science Foundation EAGER award; UCSC MCD Graduate Training Grant from National Institute of General Medical Sciences; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Science Foundation EAGER award, MCB-1324780, to AMZ. ZTN was supported in part by the UCSC MCD Graduate Training Grant, T32-GM008646, from the National Institute of General Medical Sciences. DJH is an employee of Tocagen, Inc., however his work on this project was done on his own time with no financial support or input from Tocagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Aeschlimann SH, 2014, GENOME BIOL EVOL, V6, P1707, DOI 10.1093/gbe/evu139; ALLIS CD, 1982, CELL, V31, P131, DOI 10.1016/0092-8674(82)90412-3; AMMERMAN.D, 1968, CHROMOSOMA, V25, P107, DOI 10.1007/BF00327172; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; BANNON GA, 1984, NUCLEIC ACIDS RES, V12, P1961, DOI 10.1093/nar/12.4.1961; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Bracht JR, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r99; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bulic A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-5; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; Chen X, 2015, GENOME BIOL EVOL, V7, P2859, DOI 10.1093/gbe/evv172; Chen X, 2014, CELL, V158, P1187, DOI 10.1016/j.cell.2014.07.034; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Fetzer CP, 2002, NUCLEIC ACIDS RES, V30, P4380, DOI 10.1093/nar/gkf579; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Forcob S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-4; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GRESLIN AF, 1989, P NATL ACAD SCI USA, V86, P6264, DOI 10.1073/pnas.86.16.6264; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOFFMAN DC, 1995, NUCLEIC ACIDS RES, V23, P1279, DOI 10.1093/nar/23.8.1279; Hoffman DC, 1997, NUCLEIC ACIDS RES, V25, P1883, DOI 10.1093/nar/25.10.1883; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huang H, 1999, MOL CELL BIOL, V19, P3624; Jacobs ME, 1996, J EUKARYOT MICROBIOL, V43, P442, DOI 10.1111/j.1550-7408.1996.tb04503.x; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jahn CL, 1997, P NATL ACAD SCI USA, V94, P1332, DOI 10.1073/pnas.94.4.1332; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khanduja JS, 2016, MOL CELL, V63, P7, DOI 10.1016/j.molcel.2016.06.011; Khurana JS, 2014, GENETICS, V197, P839, DOI 10.1534/genetics.114.163279; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KLOBUTCHER LA, 1984, CELL, V36, P1045, DOI 10.1016/0092-8674(84)90054-0; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; KLOETZEL JA, 1970, J CELL BIOL, V47, P395, DOI 10.1083/jcb.47.2.395; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kraus WL, 2015, MOL CELL, V58, P901, DOI 10.1016/j.molcel.2015.06.014; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LAUTH MR, 1976, CELL, V7, P67, DOI 10.1016/0092-8674(76)90256-7; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; LIPPS HJ, 1974, CHROMOSOMA, V45, P273; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Murti K.G., 1976, P113; MURTI KG, 1973, J CELL SCI, V13, P479; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Paschka AG, 2005, GENE, V359, P81, DOI 10.1016/j.gene.2005.06.024; Postberg J, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-3; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1998, J EUKARYOT MICROBIOL, V45, P575, DOI 10.1111/j.1550-7408.1998.tb04552.x; PRESCOTT DM, 1973, NATURE, V242, P576, DOI 10.1038/242576a0; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Prescott DM, 1997, CURR OPIN GENET DEV, V7, P807, DOI 10.1016/S0959-437X(97)80044-5; PRESCOTT DM, 1971, EXP CELL RES, V67, P124, DOI 10.1016/0014-4827(71)90627-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROTH M, 1985, J CELL BIOL, V101, P79, DOI 10.1083/jcb.101.1.79; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; SWANTON MT, 1980, CHROMOSOMA, V77, P217, DOI 10.1007/BF00329546; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TEICHER DA, 1978, IEEE T BIO-MED ENG, V25, P105, DOI 10.1109/TBME.1978.326318; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tucker SL, 2010, COLD SH Q B, V75, P285, DOI 10.1101/sqb.2010.75.037; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004032; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003659; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wang RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21139; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	109	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170870	10.1371/journal.pone.0170870	http://dx.doi.org/10.1371/journal.pone.0170870			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207760	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500014
J	Woitas, RP; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T				Woitas, Rainer P.; Scharnagl, Hubert; Kleber, Marcus E.; Delgado, Graciela E.; Grammer, Tanja B.; Pichler, Martin; Kraemer, Bernhard K.; Maerz, Winfried; Stojakovic, Tatjana			Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ACUTE KIDNEY INJURY; RENAL-INSUFFICIENCY; PROGNOSTIC UTILITY; CYSTATIN-C; NGAL; PLASMA; DISEASE; ATHEROSCLEROSIS; ACTIVATION	Introduction Neutrophil gelatinase-associated lipocalin (NGAL) is a glycoprotein released by damaged renal tubular cells and mature neutrophils. It is elevated in kidney injury, but also in patients with coronary artery disease (CAD) and myocardial infarction. We investigated the prognostic value of NGAL for total and cardiovascular mortality in patients undergoing coronary angiography without history of renal insufficiency at inclusion into the study. Participants The LURIC study is an ongoing prospective cohort study of patients referred for coronary angiography and is designed to evaluate determinants of cardiovascular health. Results NGAL was determined in plasma of 2997 persons (mean age: 62.7 years; 69.7% men) with a follow up for 10 years. 2358 patients suffered from CAD and 638 did not-these patients served as controls. Stable CAD was found in 1408 and unstable CAD in 950 patients. Death rate from cardiovascular events and all causes was highest in patients within the 4(th) quartile of NGAL (>= 56 ng/ml, p<0.001 vs third quartile), even after adjustment for age and gender. According to multivariable-adjusted Cox analysis adjusting for well-known cardiovascular risk factors, as well as lipid lowering therapy, angiographic CAD, and C-reactive protein we found patients in the highest NGAL quartile being at increased risk for cardiovascular (hazard ratio (HR) 1.33, 95% CI 1.05-1.67, p = 0.016) and all cause mortality (HR 1.29 95% CI 1.07-1.55, p = 0.007) compared to those in the third quartile. The lowest risk was seen in the third quartile of NGAL (41-56 ng/ml) suggesting a U-shaped relationship between NGAL and mortality. Further adjustment for creatinine abrogated the predictive effect of NGAL. However, the 3(rd) and 4(th) quartiles of NGAL were significantly associated with higher neutrophil counts, which were associated with CAD, non-ST elevation and ST-elevation myocardial infarction (p<0.05). Conclusions Plasma NGAL concentrations are mainly derived from neutrophils and do not predict mortality independent of renal function.	[Woitas, Rainer P.] Univ Bonn, Div Nephrol, Dept Internal Med 1, Bonn, Germany; [Scharnagl, Hubert; Maerz, Winfried; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Kleber, Marcus E.; Delgado, Graciela E.; Grammer, Tanja B.; Kraemer, Bernhard K.; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin Nephrol Hypertensiol Endocrinol Diabetol, Mannheim, Germany; [Pichler, Martin] Med Univ Graz, Div Clin Oncol, Dept Internal Med, Graz, Austria; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany	University of Bonn; Medical University of Graz; Ruprecht Karls University Heidelberg; Medical University of Graz; SYNLAB Group	Woitas, RP (corresponding author), Univ Bonn, Div Nephrol, Dept Internal Med 1, Bonn, Germany.	woitas@uni-bonn.de		Pichler, Martin/0000-0002-8701-9462	European Union [LSHM-CT-2004-503485, 201668, 305739]; Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases); German Ministry of Education and Research (Project AtheroSysMed); Synlab Services GmbH	European Union(European Commission); Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases); German Ministry of Education and Research (Project AtheroSysMed); Synlab Services GmbH	LURIC has received funding from the 6th Framework Program (Integrated Project Bloodomics, Grant LSHM-CT-2004-503485) and 7th Framework Program (Integrated Projects AtheroRemo, Grant no. 201668, and RiskyCAD, Project no. 305739) of the European Union, the Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases), and the German Ministry of Education and Research (Project AtheroSysMed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, the funder "Synlab Services GmbH" provided support in the form of salaries for author W.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions section.	Akcay AB, 2012, J INVEST MED, V60, P508, DOI 10.2310/JIM.0b013e31823e9d86; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bachorzewska-Gajewska H, 2007, NEPHROL DIAL TRANSPL, V22, P295, DOI 10.1093/ndt/gfl408; Bolignano D, 2010, EUR J CLIN INVEST, V40, P273, DOI 10.1111/j.1365-2362.2010.02258.x; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bratt T, 1999, BBA-GEN SUBJECTS, V1472, P262, DOI 10.1016/S0304-4165(99)00131-2; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Carling RS, 2008, ANN CLIN BIOCHEM, V45, P575, DOI 10.1258/acb.2008.008029; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Furuya F, 2014, CLIN EXP NEPHROL, V18, P778, DOI 10.1007/s10157-013-0923-4; Gilet A, 2015, EXP CELL RES, V331, P152, DOI 10.1016/j.yexcr.2014.11.004; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Helmersson-Karlqvist J, 2013, ATHEROSCLEROSIS; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Iannaccone M, 2016, EUR HEART J-CARD IMG, V17, P1128, DOI 10.1093/ehjci/jev283; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELDSEN L, 1994, BLOOD, V83, P1640, DOI 10.1182/blood.V83.6.1640.bloodjournal8361640; Kubo T, 2014, J ATHEROSCLER THROMB, V21, P895, DOI 10.5551/jat.25452; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lindberg S, 2014, ARTERIOSCL THROM VAS, V34, P2135, DOI 10.1161/ATVBAHA.114.303950; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; Liu KD, 2015, AM J KIDNEY DIS, V65, P267, DOI 10.1053/j.ajkd.2014.07.025; Mahfouz MH, 2016, BIOMARK INSIGHTS, V11, P31, DOI [10.4137/BMI.S33191, 10.4137/BMIMI.S33191]; Maisel AS, 2011, EUR J HEART FAIL, V13, P846, DOI 10.1093/eurjhf/hfr087; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mann Johannes F E, 2002, Am J Cardiovasc Drugs, V2, P157, DOI 10.2165/00129784-200202030-00003; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Nymo SH, 2012, J INTERN MED, V271, P436, DOI 10.1111/j.1365-2796.2011.02503.x; Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003; Piechota-Polanczyk A, 2015, EUR J VASC ENDOVASC, V49, P549, DOI 10.1016/j.ejvs.2015.02.011; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Quade-Lyssy P, 2013, J LIPID RES, V54, P3052, DOI 10.1194/jlr.M038968; Ronco C, 2013, BLOOD PURIFICAT, V36, P65, DOI 10.1159/000354768; Ronco C, 2013, NAT REV NEPHROL, V9, P198, DOI 10.1038/nrneph.2013.19; Shavit L, 2011, KIDNEY BLOOD PRESS R, V34, P116, DOI 10.1159/000323897; Soylu K, 2014, ANADOLU KARDIYOLOJI; Stone NJ, 2005, AM J CARDIOL, V96, p53E, DOI 10.1016/j.amjcard.2005.06.006; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Winkelmann BR, 2001, PHARMACOGENOMICS, V2, pS7; Woitas RP, 2013, ATHEROSCLEROSIS, V229, P541, DOI 10.1016/j.atherosclerosis.2013.04.027; Zografos T, 2009, AM J CARDIOL, V104, P917, DOI 10.1016/j.amjcard.2009.05.023	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171574	10.1371/journal.pone.0171574	http://dx.doi.org/10.1371/journal.pone.0171574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207778	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500040
J	Zhang, YH; Tang, L; Liu, XJ; Liu, LL; Cao, WX; Zhu, Y				Zhang, Yonghui; Tang, Liang; Liu, Xiaojun; Liu, Leilei; Cao, Weixing; Zhu, Yan			Modeling the leaf angle dynamics in rice plant	PLOS ONE			English	Article							FUNCTIONAL-STRUCTURAL MODEL; ARCHITECTURAL MODEL; LIGHT INTERCEPTION; DENSITY-FUNCTION; WHEAT; RECONSTRUCTION; VISUALIZATION; MORPHOLOGY; RADIATION; AREA	The leaf angle between stem and sheath (SSA) is an important rice morphological trait. The objective of this study was to develop and validate a dynamic SSA model under different nitrogen (N) rates for selected rice cultivars. The time-course data of SSA were collected in three years, and a dynamic SSA model was developed for different main stem leaf ranks under different N rates for two selected rice cultivars. SSA increased with tiller age. The SSA of the same leaf rank increased with increase in N rate. The maximum SSA increased with leaf rank from the first to the third leaf, then decreased from the third to the final leaf. The relationship between the maximum SSA and leaf rank on main stem could be described with a linear piecewise function. The change of SSA with thermal time (TT) was described by a logistic equation. A variety parameter (the maximum SSA of the 3rd leaf on main stem) and a nitrogen factor were introduced to quantify the effect of cultivar and N rate on SSA. The model was validated against data collected from both pot and field experiments. The relative root mean square error (RRMSE) was 11.56% and 14.05%, respectively. The resulting models could be used for virtual rice plant modeling and plant-type design.	[Zhang, Yonghui] Weifang Univ, Comp Engn Sch, Weifang, Peoples R China; [Zhang, Yonghui; Tang, Liang; Liu, Xiaojun; Liu, Leilei; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Weifang University; Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	zhuyannjau@163.com	Tang, Liang/L-2889-2019; Zhu, Yan/AAK-6927-2020	Tang, Liang/0000-0002-3483-0462; Zhu, Yan/0000-0002-8912-3888	National High-Tech R&D Program of China [2013M100404, 2012AA101306]; National Natural Science Foundation of China [31201130, 61471269, 31571566]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Shandong Province [BS2015DX001]; Science and Technology Development Project of Weifang [2016GX019]; Doctoral Foundation of Weifang University of China	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Development Project of Weifang; Doctoral Foundation of Weifang University of China	The work is supported by the National High-Tech R&D Program of China (2013M100404, 2012AA101306), the National Natural Science Foundation of China (Grant No. 31201130, 61471269, 31571566), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Natural Science Foundation of Shandong Province (BS2015DX001), Science and Technology Development Project of Weifang (2016GX019), and the Doctoral Foundation of Weifang University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Buck-Sorlin GH, 2000, AGRONOMIE, V20, P691, DOI 10.1051/agro:2000161; Buck-Sorlin GH, 2005, NEW PHYTOL, V166, P859, DOI 10.1111/j.1469-8137.2005.01324.x; CAMPBELL GS, 1990, AGR FOREST METEOROL, V49, P173, DOI 10.1016/0168-1923(90)90030-A; Ding WL, 2011, RICE SCI, V18, P224, DOI 10.1016/S1672-6308(11)60031-0; Dornbusch T, 2007, VISUAL COMPUT, V23, P569, DOI 10.1007/s00371-007-0119-6; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Evers JB, 2007, ECOL MODEL, V200, P308, DOI 10.1016/j.ecolmodel.2006.07.042; Fournier C, 1998, ANN BOT-LONDON, V81, P233, DOI 10.1006/anbo.1997.0549; Fournier M, 2013, J EXP BOT, V64, P4793, DOI 10.1093/jxb/ert279; FUCHS M, 1984, AGR FOREST METEOROL, V32, P13, DOI 10.1016/0168-1923(84)90024-8; GAO LZ, 1987, AGR FOREST METEOROL, V39, P205, DOI 10.1016/0168-1923(87)90038-4; Guo Y, 2006, ANN BOT-LONDON, V97, P217, DOI 10.1093/aob/mcj033; Hanan JS, 2003, AGR SYST, V75, P47, DOI 10.1016/S0308-521X(01)00114-7; IVANOV N, 1995, AGR FOREST METEOROL, V75, P85, DOI 10.1016/0168-1923(94)02204-W; Kaitaniemi P, 2000, COMPUT ELECTRON AGR, V28, P195, DOI 10.1016/S0168-1699(00)00126-5; Khush GS, 2002, CROP IMPROVEMENT: CHALLENGES IN THE TWENTY-FIRST CENTURY, P17; LuLiHua, 2008, Scientia Agricultura Sinica, V41, P2624; NILSON T, 1971, AGR METEOROL, V8, P25, DOI 10.1016/0002-1571(71)90092-6; Peng S, 1994, BREAKING YIELD BARRI, P5; Ross J., 1981, THE RADIATION REGIME; Ruiz RA, 2008, EUR J AGRON, V29, P144, DOI 10.1016/j.eja.2008.05.003; Shi ChunLin, 2006, Acta Agronomica Sinica, V32, P656; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Tadrist L, 2014, J THEOR BIOL, V341, P9, DOI 10.1016/j.jtbi.2013.09.025; Thomas SC, 2000, AGR FOREST METEOROL, V100, P19, DOI 10.1016/S0168-1923(99)00089-1; Verhoef W., 1998, THEORY RADIATIVE TRA; Wang WM, 2007, AGR FOREST METEOROL, V143, P106, DOI 10.1016/j.agrformet.2006.12.003; Watanabe T, 2005, ANN BOT-LONDON, V95, P1131, DOI 10.1093/aob/mci136; Wit C. T de, 1965, Agricultural Research Report, Centre for Agricultural Publications and Documentation, Wageningen, P57; Xu LF, 2011, ANN BOT-LONDON, V107, P817, DOI 10.1093/aob/mcq264; Xu LiNa, 2012, Acta Agronomica Sinica, V38, P301; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang YH, 2014, J INTEGR AGR, V13, P749, DOI 10.1016/S2095-3119(13)60391-3; Zheng BY, 2008, FUNCT PLANT BIOL, V35, P900, DOI 10.1071/FP08060; Zhu Y, 2009, NJAS-WAGEN J LIFE SC, V57, P73, DOI 10.1016/j.njas.2009.11.001; Zou XC, 2015, AGR FOREST METEOROL, V205, P73, DOI 10.1016/j.agrformet.2015.02.016; Zou XC, 2014, AGR FOREST METEOROL, V184, P137, DOI 10.1016/j.agrformet.2013.09.010	38	7	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171890	10.1371/journal.pone.0171890	http://dx.doi.org/10.1371/journal.pone.0171890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207799	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500057
J	Konstantinova, J; Cotugno, G; Dasgupta, P; Althoefer, K; Nanayakkara, T				Konstantinova, Jelizaveta; Cotugno, Giuseppe; Dasgupta, Prokar; Althoefer, Kaspar; Nanayakkara, Thrishantha			Palpation force modulation strategies to identify hard regions in soft tissue organs	PLOS ONE			English	Article							HAPTIC FEEDBACK; BREAST	This paper presents experimental evidence for the existence of a set of unique force modulation strategies during manual soft tissue palpation to locate hard abnormalities such as tumors. We explore the active probing strategies of defined local areas and outline the role of force control. In addition, we investigate whether the applied force depends on the nonhomogeneity of the soft tissue. Experimental results on manual palpation of soft silicone phantoms show that humans have a well defined force control pattern of probing that is used independently of the non-homogeneity of the soft tissue. We observed that the modulations of lateral forces are distributed around the mean frequency of 22.3 Hz. Furthermore, we found that the applied normal pressure during probing can be modeled using a second order reactive autoregressive model. These mathematical abstractions were implemented and validated for the autonomous palpation for different stiffness parameters using a robotic probe with a rigid spherical indentation tip. The results show that the autonomous robotic palpation strategy abstracted from human demonstrations is capable of not only detecting the embedded nodules, but also enhancing the stiffness perception compared to static indentation of the probe.	[Konstantinova, Jelizaveta; Althoefer, Kaspar] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Cotugno, Giuseppe] Kings Coll London, Dept Informat, London, England; [Dasgupta, Prokar] Kings Coll London, Guys Hosp, AMRC Ctr Transplantat, DTIMB, London, England; [Dasgupta, Prokar] Kings Coll London, Guys Hosp, NIHR BRC, London, England; [Nanayakkara, Thrishantha] Imperial Coll London, Dyson Sch Engn, South Kensington Campus, London, England	University of London; Queen Mary University London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London	Konstantinova, J (corresponding author), Queen Mary Univ London, Sch Engn & Mat Sci, London, England.	j.konstantinova@qmul.ac.uk	Nanayakkara, Thrishantha/AAM-5964-2020; Althoefer, Kaspar/AAA-5984-2022	Nanayakkara, Thrishantha/0000-0002-1882-1232; Konstantinova, Jelizaveta/0000-0002-4499-345X; Dasgupta, Prokar/0000-0001-8690-0445	EPSRC MOTION grant [EP/N03211X/1]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Vattikuti Foundation; Engineering and Physical Sciences Research Council [EP/N03211X/1, EP/N03211X/2] Funding Source: researchfish; EPSRC [EP/N03211X/1, EP/N03211X/2] Funding Source: UKRI	EPSRC MOTION grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Vattikuti Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC MOTION grant (grant number EP/N03211X/1), National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and Vattikuti Foundation.; The research has received funding EPSRC MOTION grant (grant number EP/N03211X/1), the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and Vattikuti Foundation. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Araghi MH, 2009, P SMART MAT STRUCT O, P59; Bourgeois KS, 2005, INFANCY, V8, P233, DOI 10.1207/s15327078in0803_3; Byl K, 2008, THESIS MIT; Eberman L. E., 2010, ATHLETIC TRAIN ED J, V5, P170; Forrest N, 2011, IEEE T HAPTICS, V4, P78, DOI [10.1109/TOH.2010.57, 10.1109/ToH.2010.57]; Greenwald D, 2012, IEEE T HAPTICS, V5, P131, DOI [10.1109/ToH.2011.68, 10.1109/TOH.2011.68]; Greinger TM, 1989, TECH REP; Haines RW, 1944, J ANAT, V78, P44; Hendel T, 2008, ELLIPSE FIT FUNCTION; Jansen SEM, 2013, IEEE T HAPTICS, V6, P464, DOI [10.1109/ToH.2013.22, 10.1109/TOH.2013.22]; Jia M, 2011, SENSORS-BASEL, V11, P1212, DOI 10.3390/s110101212; Konstantinova J., 2013, P HAML S MED ROB JUN, P41; Konstantinova J, 2014, IEEE T BIO-MED ENG, V61, P1651, DOI 10.1109/TBME.2013.2296877; Konstantinova J, 2013, IEEE SYS MAN CYBERN, P4190, DOI 10.1109/SMC.2013.714; Kotranza A, 2012, IEEE T VIS COMPUT GR, V18, P1101, DOI 10.1109/TVCG.2011.132; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Lee E. H., 1960, J APPL MECH, V27, P438; Li M, 2015, MOD DRIV REQ ENG WOR, P1; Liu H, 2010, P I MECH ENG H, V224, P751, DOI 10.1243/09544119JEIM682; Liu HB, 2010, IEEE T BIO-MED ENG, V57, P404, DOI 10.1109/TBME.2009.2032164; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moallem TM, 2010, J ACOUST SOC AM, V127, P3696, DOI 10.1121/1.3397432; Nichols KA, 2016, IEEE T AUTOM SCI ENG, V13, P68, DOI 10.1109/TASE.2015.2499195; Nichols KA, 2015, IEEE T ROBOT, V31, P344, DOI 10.1109/TRO.2015.2402531; Nichols KA, 2013, IEEE INT CONF ROBOT, P4384, DOI 10.1109/ICRA.2013.6631198; Noh Y, 2015, SENSORS J IEEE, VPP, P1; Ohka M, 2012, IEEE INT CONF ROBOT, P1404, DOI 10.1109/ICRA.2012.6224666; Okamura AM, 2009, CURR OPIN UROL, V19, P102, DOI 10.1097/MOU.0b013e32831a478c; Pacchierotti C, 2015, SYSTEMS MAN CYBERN A, V1412, P1; Pacchierotti C, 2016, IEEE T BIO-MED ENG, V63, P278, DOI 10.1109/TBME.2015.2455932; Puangmali P, 2008, IEEE SENS J, V8, P371, DOI 10.1109/JSEN.2008.917481; Romano JM, 2014, IEEE HAPTICS SYM, P49, DOI 10.1109/HAPTICS.2014.6775432; Saddik A. E., 2007, IEEE INSTRUMENTATION, V10, P10, DOI DOI 10.1109/MIM.2007.339540; Sangpradit K, 2009, IEEE INT CONF ROBOT, P2933; Sornkarn N, 2016, IEEE INT CONF ROBOT, P2657, DOI 10.1109/ICRA.2016.7487425; Talasaz A, 2013, IEEE T HAPTICS, V6, P217, DOI [10.1109/ToH.2012.64, 10.1109/TOH.2012.64]; van der Meijden OAJ, 2009, SURG ENDOSC, V23, P1180, DOI 10.1007/s00464-008-0298-x; Viljoen MJ, 1988, NURSING ASSESSMENT H; Volpicello C., 1991, AORN, V54, P1302, DOI DOI 10.1016/S0001-2092(07)66883-5; Wang NH, 2010, IEEE T INF TECHNOL B, V14, P1088, DOI 10.1109/TITB.2010.2041064; Wanninayake IB, 2012, IEEE INT CONF ROBOT, P4648, DOI 10.1109/ICRA.2012.6225127; White RM, 1980, TECH REP; Woodward WA, 2003, J CLIN ONCOL, V21, P3244, DOI 10.1200/JCO.2003.03.052; Xie H, 2013, IEEE INT C INT ROBOT, P2539, DOI 10.1109/IROS.2013.6696714; Yen PL, 2003, IEEE ASME INT C ADV, P1102; Zbyszewski D, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2647, DOI 10.1109/IROS.2009.5354140	46	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171706	10.1371/journal.pone.0171706	http://dx.doi.org/10.1371/journal.pone.0171706			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199349	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400045
J	Toniti, W; Yoshida, T; Tsurumura, T; Irikura, D; Monma, C; Kamata, Y; Tsuge, H				Toniti, Waraphan; Yoshida, Toru; Tsurumura, Toshiharu; Irikura, Daisuke; Monma, Chie; Kamata, Yoichi; Tsuge, Hideaki			Crystal structure and structure-based mutagenesis of actin-specific ADP-ribosylating toxin CPILE-a as novel enterotoxin	PLOS ONE			English	Article							PERFRINGENS IOTA-TOXIN; ADENOSINE-DIPHOSPHATE RIBOSYLATION; PROTEIN-SYNTHESIS; BACTERIAL TOXINS; C3 EXOENZYME; CLOSTRIDIUM; RECOGNITION; MECHANISM; SITE; RIBOSYLTRANSFERASE	Unusual outbreaks of food poisoning in Japan were reported in which Clostridium perfringens was strongly suspected to be the cause based on epidemiological information and fingerprinting of isolates. The isolated strains lack the typical C. perfringens enterotoxin (CPE) but secrete a new enterotoxin consisting of two components: C. perfringens iota-like enterotoxin- a (CPILE-a), which acts as an enzymatic ADP-ribosyltransferase, and CPILE-b, a membrane binding component. Here we present the crystal structures of apo-CPILE-a, NAD(+) -CPILE-a and NADH-CPILE-a. Though CPILE-a structure has high similarity with known iota toxin-a (Ia) with NAD+, it possesses two extra-long protruding loops from G262S269 and E402-K408 that are distinct from Ia. Based on the Ia-actin complex structure, we focused on actin-binding interface regions (I-V) including two protruding loops (PT) and examined how mutations in these regions affect the ADP-ribosylation activity of CPILE-a. Though some site-directed mutagenesis studies have already been conducted on the actin binding site of Ia, in the present study, mutagenesis studies were conducted against both alpha- and beta/gamma-actin in CPILE-a and Ia. Interestingly, CPILE-a ADP-ribosylates both alpha- and beta/gamma-actin, but its sensitivity towards beta/gamma-actin is 36% compared with a-actin. Our results contrast to that only C2-I ADP-ribosylates beta/gamma-actin. We also showed that PT-I and two convex-concave interactions in CPILE-a are important for actin binding. The current study is the first detailed analysis of site-directed mutagenesis in the actin binding region of Ia and CPILE-a against both alpha- and beta/gamma-actin.	[Toniti, Waraphan; Yoshida, Toru; Tsurumura, Toshiharu; Tsuge, Hideaki] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan; [Irikura, Daisuke] Horiba Ltd, Adv R&D Ctr, Kyoto, Japan; [Monma, Chie] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo, Japan; [Kamata, Yoichi] Iwate Univ, Dept Vet Med, Morioka, Iwate, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Horiba Ltd.; Tokyo Metropolitan Institute of Public Health; Iwate University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan.; Tsuge, H (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	Horiba Ltd.;  [16J09051];  [15K08289]	Horiba Ltd.; ; 	This work was funded by a Grant-in-Aid for JSPS Research Fellow (16J09051) and Grant-in-Aid for Scientific Research (C) (15K08289). Horiba Ltd. provided support in the form of salaries for author DI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2015, CURR TOP MICROBIOL, V384, P53, DOI 10.1007/82_2014_382; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Belyy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145708; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HONJO T, 1968, J BIOL CHEM, V243, P3553; HONJO T, 1971, J BIOL CHEM, V246, P4251; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Irikura D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138183; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KATADA T, 1982, J BIOL CHEM, V257, P7210; Kawahara K, 2016, BIOCHEM BIOPH RES CO, V480, P261, DOI 10.1016/j.bbrc.2016.10.042; Knapp O, 2016, BBA-BIOMEMBRANES, V1858, P512, DOI 10.1016/j.bbamem.2015.08.006; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lyras D, 2014, ANAEROBE, V30, P183, DOI 10.1016/j.anaerobe.2014.11.006; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Monma C, 2015, J CLIN MICROBIOL, V53, P859, DOI 10.1128/JCM.02859-14; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2016, CURR TOP MICROBIOL I; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; vanDamme J, 1996, FEBS LETT, V380, P291, DOI 10.1016/0014-5793(96)00052-X; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14	53	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							0171278	10.1371/journal.pone.0171278	http://dx.doi.org/10.1371/journal.pone.0171278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199340	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424400028
J	Kapurubandara, S; Melov, SJ; Shalou, ER; Mukerji, M; Yim, S; Rao, U; Battikhi, Z; Karunaratne, N; Nayyar, R; Alahakoon, TI				Kapurubandara, Supuni; Melov, Sarah J.; Shalou, Evangeline R.; Mukerji, Monika; Yim, Stephen; Rao, Ujvala; Battikhi, Zain; Karunaratne, Nirusha; Nayyar, Roshini; Alahakoon, Thushari I.			A perinatal review of singleton stillbirths in an Australian metropolitan tertiary centre	PLOS ONE			English	Review							RISK; PREGNANCY; DEATHS; COHORT; RATES	It is estimated that everyday 7000 women worldwide have their pregnancy end with a stillbirth, however, research and data collection on stillbirth remains underfunded. This stillbirth case series audit investigates an apparent rise in stillbirths at a Sydney tertiary referral hospital in Australia. A retrospective case series of singleton stillbirths from 2005-2010 was conducted at Westmead Hospital. Stillbirth was defined as per the Perinatal Society of Australia and New Zealand classification as a death of a baby before or during birth, from the 20th week of pregnancy onwards, or a birth weight of 400 grams or more if gestational age is unknown. A total of 215 singleton stillbirths were identified in a cohort of 28 109, a rate of 7.6 per 1000 singleton births. There was a significant increase in annual stillbirth rate at our institution; the rate exceeded both Australian national and state singleton stillbirth rates. After pregnancy terminations over 20 weeks were excluded from the data, there was no statistical change in the stillbirth rate over time. Congenital anomalies (27%) and unexplained antepartum death (15%) remained as major causes; fetal growth restriction (17%) was also identified as an increasingly important cause, particularly in preterm gestations. Termination of pregnancy after 20 weeks was found to be the cause of rising stillbirth rate at our institution. Local and national data collection on stillbirth should be standardised and should include differentiation of termination of pregnancy as a separate entity so as to accurately assess stillbirth to target appropriate research and resource allocation.	[Kapurubandara, Supuni; Melov, Sarah J.; Shalou, Evangeline R.; Mukerji, Monika; Yim, Stephen; Rao, Ujvala; Nayyar, Roshini; Alahakoon, Thushari I.] Westmead Hosp, Westmead Inst Maternal & Fetal Med, Sydney, NSW, Australia; [Kapurubandara, Supuni; Alahakoon, Thushari I.] Univ Sydney, Sydney, NSW, Australia; [Battikhi, Zain] Liverpool Hosp, Sydney, NSW, Australia; [Karunaratne, Nirusha] Nepean Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; Liverpool Hospital; Nepean Hospital	Melov, SJ (corresponding author), Westmead Hosp, Westmead Inst Maternal & Fetal Med, Sydney, NSW, Australia.	Sarah.Melov@health.nsw.gov.au	Melov, Sarah J/AFK-4262-2022	Melov, Sarah J/0000-0002-7569-1016				Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017; [Anonymous], 2012, PERINATAL STAT SERIE; [Anonymous], CLIN PRACT GUID PER; Australian Institute of Health and Welfare, 2015, PERINATAL STAT SERIE, V31; Bartsch E, 2015, J OBSTET GYNAECOL CA, V37, P314, DOI 10.1016/S1701-2163(15)30281-4; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Bythell M, 2008, BJOG-INT J OBSTET GY, V115, P664, DOI 10.1111/j.1471-0528.2008.01668.x; (CMACE) C. f.M.a.C.E, 2011, PER MORT 2009 UK; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Craig ED, 2004, AUST NZ J OBSTET GYN, V44, P441, DOI 10.1111/j.1479-828X.2004.00284.x; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Drysdale H, 2012, MED J AUSTRALIA, V197, P278, DOI 10.5694/mja12.10125; Farrant BM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0904-1; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Flenady V, 2010, AUST NZ J OBSTET GYN, V50, P138, DOI 10.1111/j.1479-828X.2009.01125.x; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, P1; Gardosi J., 2013, BMJ-BRIT MED J, V346, P346; Gynecologists RCOG, 2010, GREEN TOP GUIDELINE, V55, P1; Hamamy H, 2012, J COMMUN GENET, V3, P185, DOI 10.1007/s12687-011-0072-y; Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042; Hilder L, 2014, PERINATAL STAT SERIE, V30; Horton R, 2016, LANCET, V387, P418, DOI 10.1016/S0140-6736(16)00159-8; Joseph KS, 2013, CAN MED ASSOC J, V185, pE345, DOI 10.1503/cmaj.121372; Kapurubandara S, 2016, AUST NZ J OBSTET GYN; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LEISHER SH, 2016, BMC PREGNANCY CHILDB, V16, DOI DOI 10.1186/S12884-016-; Penn N, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0404-0; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Stacey T, 2012, AUST NZ J OBSTET GYN, V52, P242, DOI 10.1111/j.1479-828X.2011.01406.x; Stoltenberg C, 1999, AM J PUBLIC HEALTH, V89, P517, DOI 10.2105/AJPH.89.4.517; Treacy A, 2006, Ir Med J, V99, P22; Tucker A, 2010, ARCH GYNECOL OBSTET, V281, P613, DOI 10.1007/s00404-009-1152-7; Western Sydney Local Health District (WSLHD), 2013, W SYDN LOC HLTH DIST; World Health Organization, 2014, EV NEWB ACT PLAN END	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171829	10.1371/journal.pone.0171829	http://dx.doi.org/10.1371/journal.pone.0171829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192505	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800044
J	Peppoloni, L; Lawrence, EL; Ruffaldi, E; Valero-Cuevas, FJ				Peppoloni, Lorenzo; Lawrence, Emily L.; Ruffaldi, Emanuele; Valero-Cuevas, Francisco J.			Characterization of the disruption of neural control strategies for dynamic fingertip forces from attractor reconstruction	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; PARKINSONS-DISEASE; PHASE-SPACE; LYAPUNOV EXPONENTS; MANIPULATION; DEXTERITY; CLASSIFICATION; INSTABILITIES; COORDINATION; OSCILLATIONS	The Strength-Dexterity (SD) test measures the ability of the pulps of the thumb and index finger to compress a compliant and slender spring prone to buckling at low forces (<3N). We know that factors such as aging and neurodegenerative conditions bring deteriorating physiological changes (e.g., at the level of motor cortex, cerebellum, and basal ganglia), which lead to an overall loss of dexterous ability. However, little is known about how these changes reflect upon the dynamics of the underlying biological system. The spring-hand system exhibits nonlinear dynamical behavior and here we characterize the dynamical behavior of the phase portraits using attractor reconstruction. Thirty participants performed the SD test: 10 young adults, 10 older adults, and 10 older adults with Parkinson's disease (PD). We used delayed embedding of the applied force to reconstruct its attractor. We characterized the distribution of points of the phase portraits by their density (number of distant points and interquartile range) and geometric features (trajectory length and size). We find phase portraits from older adults exhibit more distant points (p = 0.028) than young adults and participants with PD have larger interquartile ranges (p = 0.001), trajectory lengths (p = 0.005), and size (p = 0.003) than their healthy counterparts. The increased size of the phase portraits with healthy aging suggests a change in the dynamical properties of the system, which may represent a weakening of the neural control strategy. In contrast, the distortion of the attractor in PD suggests a fundamental change in the underlying biological system, and disruption of the neural control strategy. This ability to detect differences in the biological mechanisms of dexterity in healthy and pathological aging provides a simple means to assess their disruption in neurodegenerative conditions and justifies further studies to understand the link with the physiological changes.	[Peppoloni, Lorenzo; Ruffaldi, Emanuele] Scuola Super Sant Anna, TeCIP Inst, PERCRO Lab, Via Alamanni 13B, I-56010 Pisa, Italy; [Lawrence, Emily L.; Valero-Cuevas, Francisco J.] Univ Southern Calif, Brain Body Dynam Lab, Dept Biomed Engn, 3710 McClintock Ave, Los Angeles, CA 90089 USA; [Valero-Cuevas, Francisco J.] Univ Southern Calif, Div Biokinesiol & Phys Therapy, 3710 McClintock Ave, Los Angeles, CA 90089 USA	Scuola Superiore Sant'Anna; University of Southern California; University of Southern California	Valero-Cuevas, FJ (corresponding author), Univ Southern Calif, Brain Body Dynam Lab, Dept Biomed Engn, 3710 McClintock Ave, Los Angeles, CA 90089 USA.; Valero-Cuevas, FJ (corresponding author), Univ Southern Calif, Div Biokinesiol & Phys Therapy, 3710 McClintock Ave, Los Angeles, CA 90089 USA.	valero@usc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) [AR050520, AR052345]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052345] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award numbers AR050520 and AR052345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BHATIA N., 2002, STABILITY THEORY DYN, V161; Dayanidhi S, 2014, J GERONTOL A-BIOL; Dayanidhi S, 2013, J NEUROPHYSIOL, V110, P1583, DOI 10.1152/jn.00320.2013; Dayanidhi S, 2013, J NEUROSCI, V33, P15050, DOI 10.1523/JNEUROSCI.1968-13.2013; Duff SV, 2015, J HAND THER, V28, P144, DOI 10.1016/j.jht.2015.01.004; Fedotenkova M., 2013, MATH MODELING LEVEL; Grassberger P., 2004, THEORY CHAOTIC ATTRA, P170, DOI [DOI 10.1007/978-0-387-21830-4_12, 10.1007/978-0-387-21830-4_12]; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Jaszuk M, 2000, SPATIAL DISTRIBUTION; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; JONES LA, 1989, J HAND SURG-AM, V14, P221, DOI 10.1016/0363-5023(89)90010-5; Kantz H., 2004, NONLINEAR TIME SERIE, V7; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Ko NH, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00151; Lawrence EL, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00053; Liao MJ, 1997, J EXP PSYCHOL HUMAN, V23, P1644, DOI 10.1037/0096-1523.23.6.1644; Lightdale-Miric N, 2015, J HAND THER, V28, P158, DOI 10.1016/j.jht.2014.11.003; Lightdale-Miric N, 2015, GAIT POSTURE, V41, P1, DOI 10.1016/j.gaitpost.2014.08.012; Lukos J. R., 2014, HAND FUNCTION, P133; McAuley JH, 2001, J NEUROL NEUROSUR PS, V70, P471, DOI 10.1136/jnnp.70.4.471; Mosier K, 2011, J NEUROPHYSIOL, V105, P1295, DOI 10.1152/jn.00757.2010; Oswal A, 2013, CURR OPIN NEUROL, V26, P662, DOI 10.1097/WCO.0000000000000034; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Perlmutter JS, 2009, CURRENT PROTOCOLS NE, P10; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Povinelli RJ, 2006, IEEE T SIGNAL PROCES, V54, P2178, DOI 10.1109/TSP.2006.873479; ROBERTON MA, 1988, J MOTOR BEHAV, V20, P197, DOI 10.1080/00222895.1988.10735443; Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sharma R, 2015, EXPERT SYST APPL, V42, P1106, DOI 10.1016/j.eswa.2014.08.030; Sherback M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000708; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Snider J, 2014, J NEUROPHYSIOL, V112, P300, DOI 10.1152/jn.00041.2014; Souza JA, 2015, MATH NACHRICHTEN; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; STEWART I., 1997, DOES GOD PLAY DICE N; Takens F., 1985, NUMERICAL DETERMINAT; Talati A, 2005, PERCEPT MOTOR SKILL, V101, P317, DOI 10.2466/PMS.101.5.317-334; TenBroek T., 2007, J BIOMECH, V40, P210, DOI DOI 10.1016/S0021-9290(07)70206-3; Vaillancourt DE, 2001, CLIN NEUROPHYSIOL, V112, P1594, DOI 10.1016/S1388-2457(01)00593-4; Valero-Cuevas FJ, 2003, J BIOMECH, V36, P265, DOI 10.1016/S0021-9290(02)00340-8; Venkadesan M, 2007, J BIOMECH, V40, P1653, DOI 10.1016/j.jbiomech.2007.01.022; Venkadesan M, 2009, PHILOS T R SOC A, V367, P1163, DOI 10.1098/rsta.2008.0261; Welford AT, 1980, REACTION TIMES, P321; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Zhao F., 1993, Annals of Mathematics and Artificial Intelligence, V8, P285, DOI 10.1007/BF01530794; ZHAO F, 1994, ARTIF INTELL, V69, P51, DOI 10.1016/0004-3702(94)90078-7	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172025	10.1371/journal.pone.0172025	http://dx.doi.org/10.1371/journal.pone.0172025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192482	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423800061
J	Suda, K; Rozeboom, L; Yu, H; Ellison, K; Rivard, CJ; Mitsudomi, T; Hirsch, FR				Suda, Kenichi; Rozeboom, Leslie; Yu, Hui; Ellison, Kim; Rivard, Christopher J.; Mitsudomi, Tetsuya; Hirsch, Fred R.			Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status	PLOS ONE			English	Article							SOLID TUMORS; PHASE-I; IDENTIFICATION; RESISTANT; CARCINOMA; GROWTH; LINES; AMPLIFICATION; ESTABLISHMENT; EXPRESSION	Small cell lung cancer (SCLC) is a highly aggressive malignancy with few therapeutic advances in the treatment in recent decades. Based on a recent study that identified the spliceosome as a therapeutic vulnerability in MYC-driven breast cancers, we evaluated the efficacy of a spliceosome inhibitor in SCLC cell lines and analyzed the correlation with MYC status. Among 23 SCLC cell lines examined, eight showed high MYC protein expression (> 80% positive cells) by immunohistochemistry (IHC), while 10 cell lines demonstrated no staining for MYC. The remaining five cell lines showed weak staining (< 40% positive cells). All four cell lines that were previously demonstrated to have MYC gene amplification were positive for MYC by IHC. Four cell lines with high MYC expression and four with low MYC expression were used in further analysis. A spliceosome inhibitor, pladienolide B, showed high efficacy (IC50 < 12nM) in all eight cell lines tested, irrespective of the MYC IHC or MYC gene amplification status. We observed that the four cell lines with higher sensitivity to the spliceosome inhibitor were established from patients with prior chemotherapy. Therefore we chronically treated H1048 cells, that were established from a treatment-naive patient, with cisplatin for 4 weeks, and found that H1048-cisplatin treated cells became more sensitive to pladienolide B. In conclusion, our in vitro results indicate that spliceosome inhibitors would be promising molecular target drugs in SCLC irrespective of the MYC status, especially in the second-line settings after an effective front-line chemotherapy.	[Suda, Kenichi; Rozeboom, Leslie; Yu, Hui; Ellison, Kim; Rivard, Christopher J.; Hirsch, Fred R.] Univ Colorado, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA; [Suda, Kenichi; Mitsudomi, Tetsuya] Kindai Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan	University of Colorado System; University of Colorado Anschutz Medical Campus; Kindai University (Kinki University)	Hirsch, FR (corresponding author), Univ Colorado, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	fred.hirsch@ucdenver.edu			International Association for the Study of Lung Cancer (IASLC) Young Investigator Award	International Association for the Study of Lung Cancer (IASLC) Young Investigator Award	The present study is partly supported by International Association for the Study of Lung Cancer (IASLC) Young Investigator Award to K. Suda (2015-2017), https://www.iasic.org/fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; CARNEY DN, 1985, CANCER RES, V45, P2913; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Hirsch FR, 2016, LANCET, V388, P1012, DOI 10.1016/S0140-6736(16)31473-8; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; HONG WS, 1988, INT J CANCER, V41, P462, DOI 10.1002/ijc.2910410325; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Hwang DH, 2015, HISTOPATHOLOGY, V67, P81, DOI 10.1111/his.12622; Johnson BE, 1996, J CELL BIOCHEM, P210; Kashyap MK, 2015, HAEMATOLOGICA, V100, P945, DOI 10.3324/haematol.2014.122069; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; LONG BH, 1986, CANCER RES, V46, P3809; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Fiorentino FP, 2016, ONCOTARGET, V7, P31014, DOI 10.18632/oncotarget.8826; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sato M, 2015, ONCOTARGET, V6, P3292, DOI 10.18632/oncotarget.3203; Schrodl K, 2009, CELL ONCOL, V31, P301, DOI 10.3233/CLO-2009-0472; Sirichanchuen B, 2012, MOL CELL BIOCHEM, V364, P11, DOI 10.1007/s11010-011-1199-1; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Zhou ZX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-944	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172209	10.1371/journal.pone.0172209	http://dx.doi.org/10.1371/journal.pone.0172209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192473	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800083
J	Song, Y; Shi, M				Song, Yang; Shi, Meng			Associations between empathy and big five personality traits among Chinese undergraduate medical students	PLOS ONE			English	Article							PERSPECTIVE-TAKING; SELF-EFFICACY; GENDER; DECLINE; SATISFACTION; EDUCATION	Background Empathy promotes positive physician-patient communication and is associated with improved patient satisfaction, treatment adherence and clinical outcomes. It has been suggested that personality traits should be taken into consideration in programs designed to enhance empathy in medical education due to the association found between personality and empathy among medical students. However, the associations between empathy and big five personality traits in medical education are still underrepresented in the existing literature and relevant studies have not been conducted among medical students in China, where tensions in the physician-patient relationship have been reported as outstanding problems in the context of China's current medical reform. Thus, the main objective of this study was to examine the associations between empathy and big five personality traits among Chinese medical students. Methods A cross-sectional study was conducted in a medical university in Northeast China in June 2016. Self-reported questionnaires including the Interpersonal Reactivity Index (IRI) and Big Five Inventory (BFI) and demographic characteristics were distributed. A total of 530 clinical medical students became our final subjects. Hierarchical regression analysis was performed to explore the effects of big five personality traits on empathy. Results Results of this study showed that big five personality traits accounted for 19.4%, 18.1%, 30.2% of the variance in three dimensions of empathy, namely, perspective taking, empathic concern and personal distress, respectively. Specifically, agreeableness had a strong positive association with empathic concern (beta = 0.477, P < 0.01), and a moderate association with perspective taking (beta = 0.349, P < 0.01). Neuroticism was strongly associated with personal distress (beta = 0.526, P < 0.01) and modestly associated with perspective taking (beta = 0.149, P < 0.01). Openness to experience had modest associations with perspective taking (beta = 0.150, P < 0.01) and personal distress (beta = -0.160, P < 0.01). Conscientiousness had a modest association with perspective taking (beta = 0.173, P < 0.01). Conclusion This study revealed that big five personality traits were important predictors of self-reported measures of both cognitive and affective empathy among Chinese medical students. Therefore, individualized intervention strategies based on personality traits could be integrated into programs to enhance empathy in medical education.	[Song, Yang; Shi, Meng] China Med Univ, Sch Fundamental Sci, Dept English, Shenyang, Liaoning, Peoples R China	China Medical University	Shi, M (corresponding author), China Med Univ, Sch Fundamental Sci, Dept English, Shenyang, Liaoning, Peoples R China.	mshi@cmu.edu.cn		Shi, Meng/0000-0002-1732-4293	Liaoning Education and Science Program [JG15DB458]; Liaoning Humanities and Social Science Program [LR201605]; Liaoning Higher Education Society [WYZD150058]	Liaoning Education and Science Program; Liaoning Humanities and Social Science Program; Liaoning Higher Education Society	This study was supported by Liaoning Education and Science Program (grant number JG15DB458), Liaoning Humanities and Social Science Program (grant number LR201605) and Liaoning Higher Education Society (grant number WYZD150058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HM, 2002, J GEN INTERN MED, V17, P883, DOI 10.1046/j.1525-1497.2002.10640.x; Austin EJ, 2007, MED EDUC, V41, P684, DOI 10.1111/j.1365-2923.2007.02795.x; Batson C.D., 1991, THE ALTRUISM QUESTIO; Butrus N, 2013, AUST PSYCHOL, V48, P290, DOI 10.1111/j.1742-9544.2012.00081.x; Chen DCR, 2012, MED TEACH, V34, P305, DOI 10.3109/0142159X.2012.644600; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Colliver JA, 2010, ACAD MED, V85, P588, DOI 10.1097/ACM.0b013e3181d281dc; Costa P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089254, 10.1371/journal.pone.0094842]; Costa P, 2013, ADV HEALTH SCI EDUC, V18, P509, DOI 10.1007/s10459-012-9390-z; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1987, J PERS SOC PSYCHOL, V53, P397, DOI 10.1037/0022-3514.53.2.397; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; del Barrio V, 2004, SOC BEHAV PERSONAL, V32, P677; Derksen F, 2013, BRIT J GEN PRACT, V63, DOI [10.3399/bjgpbjgp13X660814, 10.3399/bjgp13X660814]; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dubovi AS, 2016, AM J MENS HEALTH, V10, pN118, DOI 10.1177/1557988315590654; Eisenberg N., 2000, HDB EMOTIONS, P677; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; Eysenck HJ, 1985, PERSONALITY AND INDI; Funder DC, 2001, ANNU REV PSYCHOL, V52, P197, DOI 10.1146/annurev.psych.52.1.197; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061526; Graziano W.G., 1997, HDB PERSONALITY PSYC, P795, DOI DOI 10.1016/B978-012134645-4/50031-7; Graziano WG, 1996, J PERS SOC PSYCHOL, V70, P820, DOI 10.1037/0022-3514.70.4.820; Graziano WG, 1997, J PERS SOC PSYCHOL, V73, P1394, DOI 10.1037/0022-3514.73.6.1394; Graziano WG, 2007, J PERS SOC PSYCHOL, V93, P583, DOI 10.1037/0022-3514.93.4.583; Haas BW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120639; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Hojat M, 2005, PERS INDIV DIFFER, V39, P1205, DOI 10.1016/j.paid.2005.04.007; Hojat M, 2004, MED EDUC, V38, P934, DOI 10.1111/j.1365-2929.2004.01911.x; Hojat M., 2007, EMPATHY IN PATIENT C; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jordan KD, 2016, ADV HEALTH SCI EDUC, V21, P1009, DOI 10.1007/s10459-016-9675-8; Kataoka HU, 2009, ACAD MED, V84, P1192, DOI 10.1097/ACM.0b013e3181b180d4; Kinnersley P, 1999, BRIT J GEN PRACT, V49, P711; Lee Byung Kuk, 2009, Korean J Med Educ, V21, P117, DOI 10.3946/kjme.2009.21.2.117; Lee SA, 2009, PERS INDIV DIFFER, V47, P429, DOI 10.1016/j.paid.2009.04.020; Magalhaes E, 2012, MED TEACH, V34, P807, DOI 10.3109/0142159X.2012.702248; Majzub RM, 2010, PROCD SOC BEHV, V7, P685, DOI 10.1016/j.sbspro.2010.10.093; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; Matthews G, 1998, PERSONALITY TRAITS; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; McCrae RR, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P148; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; McCrae RR, 1996, PSYCHOL BULL, V120, P323, DOI 10.1037/0033-2909.120.3.323; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Melchers MC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00290; Mooradian TA, 2008, MARKET LETT, V19, P79, DOI 10.1007/s11002-008-9032-7; Mooradian TA, 2011, AM J PSYCHOL, V124, P99, DOI 10.5406/amerjpsyc.124.1.0099; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Novojenova R, 1999, SOC BEHAV PERSONAL, V27, P533, DOI 10.2224/sbp.1999.27.5.533; Paro HBMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094133; Quince TA, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0603-7; Quince TA, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-90; Rahimi-Madiseh M, 2010, MED TEACH, V32, pE471, DOI 10.3109/0142159X.2010.509419; Richardson DR, 1998, J PERS, V66, P235, DOI 10.1111/1467-6494.00011; Roberts B.W., 2009, HDB INDIVIDUAL DIFFE, P369, DOI DOI 10.1037/0033-2909.126.1; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Shariat SV, 2013, MED TEACH, V35, pE890, DOI 10.3109/0142159X.2012.714881; Tamayo CA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00096; Toto RL, 2015, ADV HEALTH SCI EDUC, V20, P23, DOI 10.1007/s10459-014-9502-z; Wang Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-61; Wen DL, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-130; Williams B, 2015, Med J Malaysia, V70, P76; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798	69	46	53	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171665	10.1371/journal.pone.0171665	http://dx.doi.org/10.1371/journal.pone.0171665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187194	gold, Green Submitted, Green Published			2022-12-27	WOS:000394244300036
J	Wu, YX; Chen, D; Zhu, SJ; Zhang, LF; Li, LJ				Wu, Yuxiang; Chen, Di; Zhu, Shuijin; Zhang, Lufei; Li, Lingjiao			A New Sythetic Hybrid (A(1)D(5)) between Gossypium herbaceum and G. raimondii and Its Morphological, Cytogenetic, Molecular Characterization	PLOS ONE			English	Article							GENE-EXPRESSION; INTERSPECIFIC HYBRIDIZATION; ALLOTETRAPLOID COTTON; SOMATIC HYBRIDS; GENOME; POLYPLOIDY; EVOLUTION; DIVERSITY; DOMINANCE; HIRSUTUM	The diploid species G. herbaceum (A1) and G. raimondii (D5) are the progenitors of allotetraploid cotton, respectively. However, hybrids between G. herbaceum and G. raimondii haven't been reported. In the present study, hybridization between G. herbaceum and G. raimondii was explored. Morphological, cytogenetic and molecular analyses were used to assess the hybridity. The interspecific hybrid plants were successfully obtained. Most of the morphological characteristics of the hybrids were intermediate between G. herbaceum and G. raimondii. However, the color of glands, anther cases, pollen and corolla, and the state of bracteoles in hybrids were associated with the G. herbaceum. The color of staminal columns and filaments in hybrids were associated with G. raimondii. Cytogenetic analysis confirmed abnormal meiotic behavior existed in hybrids. The hybrids couldn't produce boll -set. Simple sequence repeat results found that besides the fragments inherited from the two parents, some novel bands were amplified in hybrids, indicating that potential mutations and chromosomal recombination occurred between parental genomes during hybridization. These results may provide some novel insights in speciation, genome interaction, and evolution of the tetraploid cotton species.	[Wu, Yuxiang; Zhang, Lufei; Li, Lingjiao] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Wu, Yuxiang; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Chen, Di] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China	Shanxi Agricultural University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	shjzhu@zju.edu.cn			China Agriculture Research System [CARS-18-25]; National Natural Science Foundation of China [31171599, 31301364]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was financially supported by China Agriculture Research System (No. CARS-18-25) and National Natural Science Foundation of China (No. 31171599; No. 31301364).	Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Benbouza H, MOL BREEDING; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; ENDRIZZI JOHN E., 1960, CANADIAN JOUR GENET AND CYTOL, V2, P311; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; HILU KW, 1993, AM J BOT, V80, P1494, DOI 10.2307/2445679; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kashkush K, 2002, GENETICS, V160, P1651; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li B. L., 1987, Acta Genetica Sinica, V14, P121; Liu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123209; Liu S, 2000, J HERED, V91, P326, DOI 10.1093/jhered/91.4.326; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; MURAMOTO H, 1969, CROP SCI, V9, P27, DOI 10.2135/cropsci1969.0011183X000900010009x; Newaskar GS, 2013, PLANT BREEDING, V132, P211, DOI 10.1111/pbr.12031; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Noormohammadi Z., 2013, International Journal of Plant, Animal and Environmental Sciences, V3, P79; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pires JC, 2004, AM J BOT, V91, P1022, DOI 10.3732/ajb.91.7.1022; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Rowe HC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-342; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; Stewart J. M., 1994, CHALLENGING FUTURE, P313; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu YX, 2007, PLANT SYST EVOL, V268, P199, DOI 10.1007/s00606-007-0565-7; Wu YX, 2013, CARYOLOGIA, V66, P368, DOI 10.1080/00087114.2013.857830; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yu XS, 2012, THEOR APPL GENET, V125, P1503, DOI 10.1007/s00122-012-1929-0; Zhang X, 2014, CROP J, V2, P272, DOI 10.1016/j.cj.2014.06.009; Zhang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep18618; Zhu HY, 2009, PLANT SCI, V176, P397, DOI 10.1016/j.plantsci.2008.12.007	47	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0169833	10.1371/journal.pone.0169833	http://dx.doi.org/10.1371/journal.pone.0169833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187145	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300003
J	Kharrazi, A; Rovenskaya, E; Fath, BD				Kharrazi, Ali; Rovenskaya, Elena; Fath, Brian D.			Network structure impacts global commodity trade growth and resilience	PLOS ONE			English	Article							ECOLOGICAL NETWORK; COMPLEX-SYSTEMS	Global commodity trade networks are critical to our collective sustainable development. Their increasing interconnectedness pose two practical questions: (i) Do the current network configurations support their further growth? (ii) How resilient are these networks to economic shocks? We analyze the data of global commodity trade flows from 1996 to 2012 to evaluate the relationship between structural properties of the global commodity trade networks and (a) their dynamic growth, as well as (b) the resilience of their growth with respect to the 2009 global economic shock. Specifically, we explore the role of network efficiency and redundancy using the information theory-based network flow analysis. We find that, while network efficiency is positively correlated with growth, highly efficient systems appear to be less resilient, losing more and gaining less growth following an economic shock. While all examined networks are rather redundant, we find that network redundancy does not hinder their growth. Moreover, systems exhibiting higher levels of redundancy lose less and gain more growth following an economic shock. We suggest that a strategy to support making global trade networks more efficient via, e.g., preferential trade agreements and higher specialization, can promote their further growth; while a strategy to increase the global trade networks' redundancy via e.g., more abundant free-trade agreements, can improve their resilience to global economic shocks.	[Kharrazi, Ali; Rovenskaya, Elena; Fath, Brian D.] Int Inst Appl Syst Anal, Adv Syst Anal Program, Laxenburg, Austria; [Kharrazi, Ali] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Rovenskaya, Elena] Lomonosov Moscow State Univ MSU, Fac Computat Math & Cybernet, Moscow, Russia; [Fath, Brian D.] Towson Univ, Dept Biol, Towson, MD USA	International Institute for Applied Systems Analysis (IIASA); University of Tokyo; Lomonosov Moscow State University; University System of Maryland; Towson University	Kharrazi, A (corresponding author), Int Inst Appl Syst Anal, Adv Syst Anal Program, Laxenburg, Austria.; Kharrazi, A (corresponding author), Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan.	ali@pp.u-tokyo.ac.jp	Rovenskaya, Elena/CAF-1378-2022; Kharrazi, Ali/M-4097-2018	Kharrazi, Ali/0000-0002-5881-2568; Rovenskaya, Elena/0000-0002-2761-3443				Battiston S, 2016, SCIENCE, V351, P818, DOI 10.1126/science.aad0299; Bodini A, 2012, ECOL INDIC, V15, P140, DOI 10.1016/j.ecolind.2011.09.032; Boltzmann L, 1872, WIEN BER, V66, P275, DOI DOI 10.1007/978-3-322-84986-1_3; Bruning J. L., 1968, COMPUTATIONAL HDB ST; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; Fagiolo G, 2008, PHYSICA A, P387; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fang DL, 2015, ENVIRON SCI TECHNOL, V49, P6722, DOI 10.1021/es505388n; Foti NJ, 2013, J ECON DYN CONTROL, V37, P1889, DOI 10.1016/j.jedc.2013.04.009; Garlaschelli D, 2004, PHYS REV LETT, V93; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; He J, 2010, PHYS REV LETT, P105; Hendricks KB, 2009, J OPER MANAG, V27, P233, DOI 10.1016/j.jom.2008.09.001; Huang JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-839; International Monetary Fund, 2009, WORLD EC OUTL APR 20; Kharrazi A, 2013, ECOL ECON, V90, P177, DOI 10.1016/j.ecolecon.2013.03.018; Levin SA, 2015, P NATL ACAD SCI USA, V112, P12543, DOI 10.1073/pnas.1518385112; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Mukherjee J, 2015, ECOL MODEL, V306, P160, DOI 10.1016/j.ecolmodel.2014.10.027; O'Brien G, 2010, ENERG POLICY, V38, P7550, DOI 10.1016/j.enpol.2010.03.033; PUKELSHEIM F, 1994, AM STAT, V48, P88, DOI 10.2307/2684253; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Suweis S, 2015, P NATL ACAD SCI USA, V112, P6902, DOI 10.1073/pnas.1507366112; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; ULANOWICZ RE, 1991, MATH BIOSCI, V103, P45, DOI 10.1016/0025-5564(91)90090-6; Ulanowicz RE, 2009, 3 WINDOW NATURAL LIF; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; UN General Assembly, 2014, OP WORK GROUP GEN AS; von Braun J., 2008, FOOD FINANCIAL CRISE; World Economic Forum, 2017, GLOB RISKS REP 2017	33	21	21	12	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171184	10.1371/journal.pone.0171184	http://dx.doi.org/10.1371/journal.pone.0171184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207790	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000394424500017
J	Klitzman, R				Klitzman, Robert			How much is a child worth? Providers' and patients' views and responses concerning ethical and policy challenges in paying for ART	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; AFFORDABLE CARE; FERTILITY CARE; PREGNANCY; HEALTH; FAMILY; WOMEN	Infertility treatments remain expensive and in many countries are covered by little, if any, insurance, raising critical questions concerning how patients and providers view and make decisions regarding these challenges. In-depth semi-structured interviews of approximately 1 hour were conducted with 37 IVF providers and 10 patients (17 physicians, 10 other providers and 10 patients), and were systematically analyzed. These data suggest current insurance policies and legislation pose critical ethical and logistical challenges for both patients and providers. These individuals face multiple uncertainties about costs and insurance, related to unclear causes of fertility, treatment length, costs and outcomes, and odds that insurers will cover expenses. Insurers frequently decline to agree to reimbursement beforehand, and decide only afterwards, case-by-case, generating stress. Patients and providers thus may not be able to predict how best to allocate limited resources. Providers may advocate for patients, but are usually unsuccessful. Patients may adopt several strategies: e.g., moving/seeking treatment elsewhere, switching or feeling "stuck" in jobs because of insurance, seeking "free" medications, going into debt, or using funds intended for other purposes. Patients do not perceive and respond to resource limitations as fixed phenomena-i.e., patients do not see treatment simply as "affordable" or not. Rather, patients face quandaries of how much to keep spending-how much a child is worth-and are forced to make complex risk/benefit calculations. Couples can disagree, straining relationships. In sum, these data, the first to explore how providers and patients struggle, view, and make decisions regarding limited insurance and resources for infertility, raise several critical ethical and policy issues. These data suggest that individuals have difficulty translating profoundly life-altering, deeply personal quests for meaning and fulfillment into purely economic terms. These findings thus have important implications for future policy, practice, research, and patient and provider education.	[Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA	Columbia University	Klitzman, R (corresponding author), Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA.	rlk2@columbia.edu			National Center for Research Resources (NCRR) [UL1 RR024156]; Greenwall Foundation; John Simon Guggenheim Memorial Foundation	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Greenwall Foundation; John Simon Guggenheim Memorial Foundation	This work was supported by #UL1 RR024156 from the National Center for Research Resources (NCRR): https://www.nih.gov/research-training/research-resources, The Greenwall Foundation: http://www.greenwall.org/, and The John Simon Guggenheim Memorial Foundation: http://www.gf.org/.	Akyuz A, 2009, J REPROD INFANT PSYC, V27, P258, DOI 10.1080/02646830802409652; American Society for Reproductive Medicine, 2017, STAT INF LAWS 2017; [Anonymous], 2015, FERTIL STERIL, V104, P1104, DOI [10.1016/j.fertnstert.2015.07.1139, DOI 10.1016/j.fertnstert.2015.07.1139, DOI 10.1016/J.FERTNSTERT.2015.07.1139]; [Anonymous], 2016, FERTIL STERIL, V106, pe8, DOI [10.1016/j.fertnstert.2016.07.003, DOI 10.1016/J.FERTNSTERT.2016.07.003]; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Cauchi R, 2016, STATE PRESCRIPTION D; Chambers GM, 2013, FERTIL STERIL, V100, P319, DOI 10.1016/j.fertnstert.2013.06.017; Chandra A, 2010, FERTIL STERIL, V93, P725, DOI 10.1016/j.fertnstert.2008.10.049; Cho YI, 2013, EVAL HEALTH PROF, V36, P382, DOI 10.1177/0163278713496425; Creswell J. W., 2013, RES DESIGN QUANTITAT; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; Desjarlais R, 2007, J ROY ANTHROPOL INST, V13, P1044, DOI 10.1111/j.1467-9655.2007.00472_20.x; Devine K, 2014, FERTIL STERIL, V101, P1224, DOI 10.1016/j.fertnstert.2014.01.024; Figueira JR, 2011, INT J MED INFORM, V80, P262, DOI 10.1016/j.ijmedinf.2010.12.001; Fisher PB, 2011, FERTIL STERIL, V96, pS30, DOI 10.1016/j.fertnstert.2011.07.123; FRIEDMAN D, 1994, DEMOGRAPHY, V31, P375, DOI 10.2307/2061749; Geertz C., 1973, INTERPREATION CULTUR; Green EC, 2014, HLTH BELIEF MODEL, P766; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hershberger P, 2007, FERTIL STERIL, V87, P288, DOI 10.1016/j.fertnstert.2006.06.036; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Iaconelli A, 2013, FERTIL STERIL, V100, pS66, DOI 10.1016/j.fertnstert.2013.07.1884; Johnston J, 2015, JAMA PEDIATR, V169, P287, DOI 10.1001/jamapediatrics.2014.3219; Katz P, 2011, FERTIL STERIL, V95, P915, DOI 10.1016/j.fertnstert.2010.11.026; Klitzman RL, 2005, SOC SCI MED, V61, P2396, DOI 10.1016/j.socscimed.2005.04.031; Klitzman R, 2007, AM J MED GENET A, V143A, P1835, DOI 10.1002/ajmg.a.31864; Klitzman Robert, 2016, Reprod Biomed Soc Online, V3, P1, DOI 10.1016/j.rbms.2016.07.001; Klitzman R, 2016, J LAW MED ETHICS, V44, P616, DOI 10.1177/1073110516684804; Klitzman R, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0151-z; Klitzman R, 2013, GENET MED, V15, P888, DOI 10.1038/gim.2013.87; Klitzman R, 2013, CLIN TRIALS, V10, P761, DOI 10.1177/1740774513500080; Klitzman R, 2012, ACAD MED, V87, P975, DOI 10.1097/ACM.0b013e3182578b54; Klitzman RL, 2016, HUM REPROD, V31, P2570, DOI 10.1093/humrep/dew231; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Linkov L, 2011, MULTICRITERIA DECISI, P73, DOI [10.1016/j.ijmedinf.2010.12.001, DOI 10.1016/J.IJMEDINF.2010.12.001]; Marcus D, 2011, HUM FERTIL, V14, P29, DOI 10.3109/14647273.2010.541971; Omurtag K, 2013, FERTIL STERIL, V99, P652, DOI 10.1016/j.fertnstert.2012.10.001; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Prag P, 2015, FAMILIES SOC, V43, P1; Sazonova A, 2013, FERTIL STERIL, V99, P731, DOI 10.1016/j.fertnstert.2012.11.023; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; Smith JF, 2011, FERTIL STERIL, V96, P95, DOI 10.1016/j.fertnstert.2011.04.054; Strauss A., 1990, BASICS QUALITATIVE R; Trump B, 2015, BMJ EVID-BASED MED, V20, P193, DOI DOI 10.1136/EBMED-2015-110274; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Wu AK, 2013, FERTIL STERIL, V99, P2025, DOI 10.1016/j.fertnstert.2013.01.145	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171939	10.1371/journal.pone.0171939	http://dx.doi.org/10.1371/journal.pone.0171939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207807	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500063
J	Ning, PB; Zhou, YL; Gao, LF; Sun, YY; Zhou, WF; Liu, FR; Yao, ZY; Xie, LF; Wang, JH; Gong, CM				Ning, Pengbo; Zhou, Yulu; Gao, Lifang; Sun, Yingying; Zhou, Wenfei; Liu, Furong; Yao, Zhenye; Xie, Lifang; Wang, Junhui; Gong, Chunmei			Unraveling the microRNA of Caragana korshinskii along a precipitation gradient on the Loess Plateau, China, using high-throughput sequencing	PLOS ONE			English	Article							ARABIDOPSIS BAX INHIBITOR-1; RESPONSIVE MICRORNAS; IDENTIFICATION; EXPRESSION; STRESS; PLANT; SOIL; BIOGENESIS; CLEAVAGE; MIR319	Drought remains one of the main factors that negatively affect plant growth and development. Caragana korshinskii is widely distributed on the Loess Plateau, China, where it mediates soil and water loss and helps prevent desertification. However, little is known about the stress response mechanisms of C. korshinskii in water-starved environments. MicroRNAs (miRNAs) have been implicated in the regulation of plant responses to several types of biotic and abiotic stress. Here, we describe the miRNAs of wild C. korshinskii from Huangling, Yulin, and Dalad Banner, which occur along a precipitation gradient. Using next-generation sequencing technology, we obtained a total of 13 710 681, 15 048 945, and 15 198 442 reads for each location, respectively; after filtering and BLAST analysis, 490 conserved miRNAs and 96 novel miRNAs were characterized from the sRNAome data, with key functions determined using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. We also designed stem-loop qRT-PCR to validate the expression patterns of 5 conserved miRNAs (miR390, miR398, miR530, miR2119, and miR5559) that obviously responded to water stress in plants grown both under natural and experimental water stress conditions and found that the expression levels of miR2119 and miR5559 were negatively correlated with their predicted target genes. This study is the first to identify miRNAs from wild C. korshinskii and provides a basis for future studies of miRNA-mediated gene regulation of stress responses in C. korshinskii.	[Ning, Pengbo; Zhou, Yulu; Gao, Lifang; Sun, Yingying; Zhou, Wenfei; Liu, Furong; Yao, Zhenye; Xie, Lifang; Wang, Junhui; Gong, Chunmei] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Ning, Pengbo] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Xidian University	Gong, CM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	gcm228@nwsuaf.edu.cn			National Natural Science Foundation of China [31070538, 31370599]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31070538) and partially supported by the National Natural Science Foundation of China (No. 31370599).; This work was supported by the National Natural Science Foundation of China (No. 31070538) and partially supported by the National Natural Science Foundation of China (No. 31370599). We would like to thank the Guangzhou Gene Denovo Biotechnology Co., Ltd for assisting us with sequencing and technical support.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Gong CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28883; He XB, 2003, AGR ECOSYST ENVIRON, V94, P355, DOI 10.1016/S0167-8809(02)00039-7; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jian SQ, 2014, J HYDROL HYDROMECH, V62, P89, DOI 10.2478/johh-2014-0020; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kohli Deshika, 2014, PLoS One, V9, pe108851, DOI 10.1371/journal.pone.0108851; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudet O, 2008, P NATL ACAD SCI USA, V105, P17193, DOI 10.1073/pnas.0807264105; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu YZ, 2011, FUNCT PLANT BIOL, V38, P44, DOI 10.1071/FP10178; Ma CC, 2008, J ARID ENVIRON, V72, P247, DOI 10.1016/j.jaridenv.2007.05.009; Ma HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025184; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Ning PB, 2016, ECOL EVOL, V6, P3786, DOI 10.1002/ece3.2157; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Patel PK, 2012, AM J PLANT PHYSL, V10, P3932; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Qiu YP, 2004, CHINESE SCI BULL, V49, P2159, DOI 10.1360/982004-183; Qu D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00027; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Turner M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24918; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702	52	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172017	10.1371/journal.pone.0172017	http://dx.doi.org/10.1371/journal.pone.0172017			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207805	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424500073
J	Szucs, A; Marjai, T; Szentesi, A; Farkas, N; Parniczky, A; Nagy, G; Kui, B; Takacs, T; Czako, L; Szepes, Z; Nemeth, BC; Vincze, A; Par, G; Szabo, I; Sarlos, P; Illes, A; Godi, S; Izbeki, F; Gervain, J; Halasz, A; Farkas, G; Leindler, L; Kelemen, D; Papp, R; Szmola, R; Varga, M; Hamvas, J; Novak, J; Bod, B; Sahin-Toth, M; Hegyi, P				Szucs, Akos; Marjai, Tamas; Szentesi, Andrea; Farkas, Nelli; Parniczky, Andrea; Nagy, Gyorgy; Kui, Balazs; Takacs, Tamas; Czako, Laszlo; Szepes, Zoltan; Nemeth, Balazs Csaba; Vincze, Aron; Par, Gabriella; Szabo, Imre; Sarlos, Patricia; Illes, Anita; Godi, Szilard; Izbeki, Ferenc; Gervain, Judit; Halasz, Adrienn; Farkas, Gyula; Leindler, Laszlo; Kelemen, Dezso; Papp, Robert; Szmola, Richard; Varga, Marta; Hamvas, Jozsef; Novak, Janos; Bod, Barnabas; Sahin-Toth, Miklos; Hegyi, Peter		Hungarian Pancreatic Study Grp	Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group	PLOS ONE			English	Article							ALCOHOLIC CHRONIC-PANCREATITIS; COMMON BILE-DUCT; DUODENUM-PRESERVING RESECTION; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; IDIOPATHIC CHRONIC-PANCREATITIS; LONG-TERM; CIGARETTE-SMOKING; LATE-ONSET; ENDOSCOPIC TREATMENT; BEGER PROCEDURE	Introduction Chronic pancreatitis is an inflammatory disease associated with structural and functional damage to the pancreas, causing pain, maldigestion and weight loss and thus worsening the quality of life. Aims and methods Our aim was to find correlations from a multicentre database representing the epidemiological traits, diagnosis and treatment of the disease in Hungary. The Hungarian Pancreatic Study Group collected data prospectively from 2012 to 2014 on patients suffering from chronic pancreatitis. Statistical analysis was performed on different questions. Results Data on 229 patients (74% male and 26% female) were uploaded from 14 centres. Daily alcohol consumption was present in the aetiology of 56% of the patients. 66% of the patients were previously treated for acute exacerbation. One third of the patients had had previous endoscopic or surgical interventions. Pain was present in 69% of the cases, endocrine insufficiency in 33%, diarrhoea in 13% and weight loss in 39%. Diagnosis was confirmed with US (80%), CT scan (52%), MRI-MRCP (6%), ERCP (39%), and EUS (7,4%). A functional test was carried out in 5% of the patients. In 31% of the cases, an endoscopic intervention was performed with the need for re-intervention in 5%. Further elective surgical intervention was necessitated in 44% of endoscopies. 20% of the registered patients were primarily treated with surgery. The biliary complication rate for surgery was significantly smaller (2%) than endoscopy (27%); however, pancreatic complications were higher in the patients treated with surgery. Patients who smoked regularly needed significantly more surgical intervention following endoscopy (66.7% vs. 26.9%, p = 0.002) than non-smokers, and the ratio of surgical intervention alone was also significantly higher (27.3% vs. 10.8%, p = 0.004). The ratio of surgery in patients who smoked and drank was significantly higher (30.09% vs. 12.5%, p = 0.012) than in abstinent and non-smoking patients, similarly to the need for further surgical intervention after endoscopic treatment (71.43% vs. 27.78%, p = 0.004). Conclusions According to the data analysed, the epidemiological data and the aetiological factors in our cohort differ little from European trends. The study highlighted the overuse of ERCP as a diagnostic modality and the low ratio of use of endoscopic ultrasonography. The results proved that alcohol consumption and smoking represent risk factors for the increased need for surgical intervention. Chronic pancreatitis should be treated by multidisciplinary consensus grounded in evidence-based medicine.	[Szucs, Akos; Marjai, Tamas] Semmelweis Univ, Dept Surg 1, Budapest, Hungary; [Szentesi, Andrea; Hegyi, Peter] Univ Pecs, Inst Translat Med, Pecs, Hungary; [Szentesi, Andrea; Kui, Balazs; Takacs, Tamas; Czako, Laszlo; Szepes, Zoltan; Nemeth, Balazs Csaba; Hegyi, Peter] Univ Szeged, Dept Med 1, Szeged, Hungary; [Farkas, Nelli] Univ Pecs, Inst Bioanal, Pecs, Hungary; [Parniczky, Andrea] Heim Pal Childrens Hosp, Budapest, Hungary; [Nagy, Gyorgy] Univ Debrecen, Dept Internal Med 2, Debrecen, Hungary; [Vincze, Aron; Par, Gabriella; Szabo, Imre; Sarlos, Patricia; Illes, Anita] Univ Pecs, Dept Med 1, Div Gastroenterol, Pecs, Hungary; [Godi, Szilard; Hegyi, Peter] Univ Pecs, Dept Med 1, Div Translat Med, Pecs, Hungary; [Izbeki, Ferenc; Gervain, Judit; Halasz, Adrienn] Szent Gyorgy Univ, Teaching Hosp Fejer Cty, Szekesfehervar, Hungary; [Farkas, Gyula; Leindler, Laszlo] Univ Szeged, Dept Surg, Szeged, Hungary; [Kelemen, Dezso; Papp, Robert] Univ Pecs, Dept Surg, Pecs, Hungary; [Szmola, Richard] Natl Inst Oncol, Dept Intervent Gastroenterol, Budapest, Hungary; [Varga, Marta] Dr Rethy Pal Hosp, Bekescsaba, Hungary; [Hamvas, Jozsef] Bajcsy Zsilinszky Hosp, Budapest, Hungary; [Novak, Janos] Pandy Kalman Hosp Bekes Cty, Gyula, Hungary; [Bod, Barnabas] Dr Bugyi Istvan Hosp, Szentes, Hungary; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02215 USA; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary	Semmelweis University; University of Pecs; Szeged University; University of Pecs; University of Debrecen; University of Pecs; University of Pecs; Szeged University; University of Pecs; National Institute of Oncology Hungary; Boston University; Hungarian Academy of Sciences; Szeged University	Hegyi, P (corresponding author), Univ Pecs, Inst Translat Med, Pecs, Hungary.; Hegyi, P (corresponding author), Univ Szeged, Dept Med 1, Szeged, Hungary.; Hegyi, P (corresponding author), Univ Pecs, Dept Med 1, Div Translat Med, Pecs, Hungary.; Hegyi, P (corresponding author), Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary.	hegyi.peter@med.u-szeged.hu	Sarlos, Patricia/V-6890-2017; Vincze, Aron/J-6724-2019; Vincze, Aron/A-7048-2011	Sarlos, Patricia/0000-0002-5086-9455; Vincze, Aron/0000-0003-2217-7686; Vincze, Aron/0000-0003-2217-7686; Farkas, Gyula/0000-0001-7293-7546; Sahin-Toth, Miklos/0000-0003-4513-9922; Nemeth, Balazs/0000-0001-5338-7577; Farkas, Nelli/0000-0002-5349-6527; Leindler MD, Laszlo/0000-0001-9455-1775	Hungarian Scientific Research Fund [K116634]; Hungarian Academy of Sciences [LP2014-10/2014]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (K116634 to PH) and the Momentum Grant of the Hungarian Academy of Sciences (LP2014-10/2014 to PH).	AFROUDAKIS A, 1981, HEPATOLOGY, V1, P65, DOI 10.1002/hep.1840010111; AMMANN RW, 1988, GASTROENTEROLOGY, V95, P1018, DOI 10.1016/0016-5085(88)90178-3; Ammann RW, 2001, INTERNAL MED, V40, P368, DOI 10.2169/internalmedicine.40.368; ANDERSEN BN, 1982, SCAND J GASTROENTERO, V17, P247; Andren-Sandberg Ake, 2004, JOP, V5, P8; Angelopoulos N, 2005, PANCREATOLOGY, V5, P122, DOI 10.1159/000085264; ARANHA GV, 1984, ARCH SURG-CHICAGO, V119, P595; BANK S, 1975, AM J GASTROENTEROL, V64, P13; BEGER HG, 1985, SURGERY, V97, P467; BEGER HG, 1989, ANN SURG, V209, P273, DOI 10.1097/00000658-198903000-00004; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Buchler MW, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-93; BUSCAIL L, 1995, PANCREAS, V10, P251, DOI 10.1097/00006676-199504000-00006; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Cahen DL, 2005, EUR J GASTROEN HEPAT, V17, P103, DOI 10.1097/00042737-200501000-00019; Cataldegirmen G, 2008, BRIT J SURG, V95, P447, DOI 10.1002/bjs.6006; CAVALLINI G, 1994, PANCREAS, V9, P42, DOI 10.1097/00006676-199401000-00006; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Czako L, 2007, J GASTROENTEROL, V42, P113, DOI 10.1007/s00535-006-1919-6; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; DIMAGNO EP, 1973, NEW ENGL J MED, V288, P813, DOI 10.1056/NEJM197304192881603; DiMagno MJ, 2006, CURR OPIN GASTROEN, V22, P487; DiMagno MJ, 2010, CURR OPIN GASTROEN, V26, P490, DOI 10.1097/MOG.0b013e32833d11b2; Dite P, 2003, ENDOSCOPY, V35, P553; Dite P, 2001, EUR J GASTROEN HEPAT, V13, P749; Frey CF, 2003, WORLD J SURG, V27, P1217, DOI 10.1007/s00268-003-7241-z; Frulloni L, 2009, DIGEST LIVER DIS, V41, P311, DOI 10.1016/j.dld.2008.07.316; Glasbrenner B, 2002, EUR J GASTROEN HEPAT, V14, P935, DOI 10.1097/00042737-200209000-00003; Hirota M, 2012, PANCREATOLOGY, V12, P79, DOI 10.1016/j.pan.2012.02.005; Hirota M, 2010, J HEPATO-BIL-PAN SCI, V17, P770, DOI 10.1007/s00534-009-0182-7; Hoffmeister A, 2012, Z GASTROENTEROL, V50, P1176, DOI 10.1055/s-0032-1325479; HOLLERBACH S, 1994, MED KLIN, V89, P7; HUIZINGA WKJ, 1992, ANN ROY COLL SURG, V74, P119; Imoto M, 2000, PANCREAS, V21, P115, DOI 10.1097/00006676-200008000-00002; Isaji S, 2010, J HEPATO-BIL-PAN SCI, V17, P763, DOI 10.1007/s00534-009-0181-8; JAAKKOLA M, 1993, GUT, V34, P1255, DOI 10.1136/gut.34.9.1255; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Kahl S, 2003, AM J GASTROENTEROL, V98, P2448, DOI 10.1016/S0002-9270(03)01700-3; Lakatos G, 2016, J GASTROINTEST LIVER, V25, P219, DOI [10.15403/jgld.2014.1121.252.pcr, 10.15403/jgld.2014.1121.252.per]; Lankisch PG, 2002, PANCREATOLOGY, V2, P469, DOI 10.1159/000064713; Layer P, 2003, PANCREAS, V26, P1, DOI 10.1097/00006676-200301000-00001; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Layer P, 1999, SURG CLIN N AM, V79, P847, DOI 10.1016/S0039-6109(05)70047-5; Levy P, 2006, GASTROEN CLIN BIOL, V30, P838, DOI 10.1016/S0399-8320(06)73330-9; Levy P, 2014, UNITED EUR GASTROENT, V2, P345, DOI 10.1177/2050640614548208; Lohr J M, 2000, Z Gastroenterol, V38, P603, DOI 10.1055/s-2000-7444; LOWENFELS AB, 1994, AM J GASTROENTEROL, V89, P1467; Luaces-Regueira M, 2014, PANCREAS, V43, P275, DOI 10.1097/01.mpa.0000437324.52598.ee; LUETMER PH, 1989, RADIOLOGY, V171, P353, DOI 10.1148/radiology.171.2.2704799; Maisonneuve P, 2005, GUT, V54, P510, DOI 10.1136/gut.2004.039263; Maisonneuve P, 2006, PANCREAS, V33, P163, DOI 10.1097/01.mpa.0000227916.94073.fc; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Mullady DK, 2011, GUT, V60, P77, DOI 10.1136/gut.2010.213835; Nguyen-Tang T, 2010, BEST PRACT RES CL GA, V24, P281, DOI 10.1016/j.bpg.2010.03.002; Pelli Hanna, 2009, Duodecim, V125, P1195; PETROZZA JA, 1985, J CLIN GASTROENTEROL, V7, P447, DOI 10.1097/00004836-198510000-00018; Rebours V, 2012, PANCREAS, V41, P1219, DOI 10.1097/MPA.0b013e31825de97d; Sai JK, 2008, WORLD J GASTROENTERO, V14, P1218, DOI 10.3748/wjg.14.1218; SAND JA, 1995, EUR J SURG, V161, P587; Schneider A, 2007, J GASTROENTEROL, V42, P101, DOI 10.1007/s00535-006-1945-4; Schoenberg MH, 1998, CHIRURG, V69, P633, DOI 10.1007/s001040050467; Siddiqui UD, 2010, J CLIN GASTROENTEROL, V44, P1, DOI 10.1097/MCG.0b013e3181bb87f4; STABILE BE, 1987, SURG GYNECOL OBSTET, V165, P121; STRUM WB, 1995, J CLIN GASTROENTEROL, V20, P37, DOI 10.1097/00004836-199501000-00010; Talamini G, 1996, PANCREAS, V12, P131, DOI 10.1097/00006676-199603000-00004; Tamura R, 2006, RADIOLOGY, V238, P920, DOI 10.1148/radiol.2382041527; Thuluvath PJ, 2003, J CLIN GASTROENTEROL, V36, P159, DOI 10.1097/00004836-200302000-00014; Vijungco JD, 2003, WORLD J SURG, V27, P1258, DOI 10.1007/s00268-003-7246-7; WISLOFF F, 1982, BRIT J SURG, V69, P52, DOI 10.1002/bjs.1800690117; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; YADEGAR J, 1980, ARCH SURG-CHICAGO, V115, P582; Zhou YM, 2015, PANCREATOLOGY, V15, P372, DOI 10.1016/j.pan.2015.05.466	76	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171420	10.1371/journal.pone.0171420	http://dx.doi.org/10.1371/journal.pone.0171420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207747	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500029
J	Villa, G; Chelazzi, C; Morettini, E; Zamidei, L; Valente, S; Caldini, AL; Zagli, G; De Gaudio, AR; Romagnoli, S				Villa, Gianluca; Chelazzi, Cosimo; Morettini, Elena; Zamidei, Lucia; Valente, Serafina; Caldini, A. Lucia; Zagli, Giovanni; De Gaudio, A. Raffaele; Romagnoli, Stefano			Organ dysfunction during continuous veno-venous high cut-off hemodialysis in patients with septic acute kidney injury: A prospective observational study	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; POLYMYXIN-B HEMOPERFUSION; BLOOD PURIFICATION; CYTOKINE REMOVAL; SEVERE SEPSIS; HEMOFILTRATION; SHOCK; HEMOFILTERS; MEMBRANES; MODALITY	Background Continuous veno-venous hemodialysis with high cut-off membranes (HCO-CVVHD) removes inflammatory mediators involved in organ dysfunction during sepsis. The aim of the present study was to assess the variations in SOFA score and identify early predictors of short-term mortality in a cohort of patients with septic shock, treated with HCO-CVVHD for acute kidney injury (AKI). Methods An observational prospective multicenter cohort study was conducted in four mixed medical-surgical ICUs. Thirty-eight patients with septic shock and AKI (KDIGO stage >= 1) treated with HCO-CVVHD have been included in this study. Patients were divided into Survivors and non-Survivors according to mortality observed at 72nd hr of treatment. The variation of SOFA scores and clinical/biochemical parameters were described over time for the entire population and specifically for Survivors and non-Survivors. Similarly, circulating inflammatory mediators (as IL-6, TNF-alpha and IL-10) were described over time. A logistic regression analysis was used to identify the baseline clinical and biochemical parameters associated with 72 hrs-ICU mortality. Results Overall, the mean SOFA score was 12 +/- 3 at baseline, 10.9 +/- 3 at 6hrs, 9.8 +/- 3 at 12hrs, 8.9 +/- 3.3 at 24 hrs, and 8 +/- 3.5 at 48 hrs after HCO-CVVHD initiation; and 6.5 +/- 2.7 at 24 hrs and 6.6 +/- 3 at 48 hrs after HCO-CVVHD discontinuation. In the multivariate regression analysis, baseline serum lactate levels and AKI stage independently correlated with short-term mortality during HCO-CVVHD. A significant reduction was observed in circulating levels of TNF alpha and IL-6 among Survivors. Conclusions SOFA score significantly decreased early after initiation of HCO-CVVHD in patients with septic AKI. Baseline lactate levels and the AKI stage resulted to be associated to 72 hrs-ICU-mortality.	[Villa, Gianluca; Chelazzi, Cosimo; Morettini, Elena; Zagli, Giovanni; De Gaudio, A. Raffaele; Romagnoli, Stefano] Univ Florence, Dept Hlth Sci, Sect Anesthesiol & Intens Care, Florence, Italy; [Villa, Gianluca; Chelazzi, Cosimo; Zagli, Giovanni; De Gaudio, A. Raffaele; Romagnoli, Stefano] Azienda Osped Univ Careggi, Dept Anesthesia & Intens Care, Florence, Italy; [Zamidei, Lucia] Osped Santo Stefano, Anesthesia & Intens Care Unit, Prato, Italy; [Valente, Serafina] Azienda Osped Univ Careggi, Heart & Vessel Dept, Intens Cardiac Coronary Unit, Florence, Italy; [Caldini, A. Lucia] Azienda Osped Univ Careggi, Clin Chem Lab, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Villa, G (corresponding author), Univ Florence, Dept Hlth Sci, Sect Anesthesiol & Intens Care, Florence, Italy.; Villa, G (corresponding author), Azienda Osped Univ Careggi, Dept Anesthesia & Intens Care, Florence, Italy.	gianlucavilla1@gmail.com	Chelazzi, Cosimo/E-5611-2017	Chelazzi, Cosimo/0000-0002-5156-8638; Villa, Gianluca/0000-0003-4274-3593	Department of Health Science of the University of Florence	Department of Health Science of the University of Florence	Baxter has provided a grant to the Department of Health Science of the University of Florence for the cytokine analysis. Ente Cassa di Risparmio di Firenze" and Philip and Irene Toll Gage Foundation have economically supported the feasibility and management of this study through research grants aimed at study coordination, statistical analysis and recruitment of investigators for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Atan R, 2016, INT J ARTIF ORGANS, V39, P479, DOI 10.5301/ijao.5000527; Boschetti-de-Fierro A, 2013, INT J ARTIF ORGANS, V36, P455, DOI 10.5301/ijao.5000220; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Caldini A, 2013, CLIN CHEM LAB MED, V51, pE261, DOI 10.1515/cclm-2013-0257; Carbonell N, 2004, CLIN NEPHROL, V62, P185; Cardinal-Fernandez P, 2013, J CRIT CARE, V28, P365, DOI 10.1016/j.jcrc.2012.11.010; Chelazzi C, 2012, J NEPHROL, V2, P78; Chelazzi C, 2016, BLOOD PURIFICAT, V42, P186, DOI 10.1159/000446978; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Giannoni C, 2013, TRENDS ANAESTH CRIT, V3, P89, DOI 10.1016/j.tacc.2013.01.008; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Honore PM, 2012, BLOOD PURIFICAT, V33, P44, DOI 10.1159/000333837; Honore PM, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-32; Kade G, 2016, MED SCI MONITOR, V22, P4338, DOI 10.12659/MSM.896819; Kim WY, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.005; Mariano F, 2008, CRIT CARE, V12, DOI 10.1186/cc6848; Morgera S, 2003, NEPHRON CLIN PRACT, V94, pC75, DOI 10.1159/000072024; Morgera S, 2003, NEPHROL DIAL TRANSPL, V18, P1361, DOI 10.1093/ndt/gfg115; Morgera S, 2004, AM J KIDNEY DIS, V43, P444, DOI 10.1053/j.ajkd.2003.11.006; Morgera S, 2006, CRIT CARE MED, V34, P2099, DOI 10.1097/01.CCM.0000229147.50592.F9; Neri M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1489-9; Payen DM, 2015, INTENS CARE MED, V41, P975, DOI 10.1007/s00134-015-3751-z; Ricci Z, 2016, MINERVA UROL NEFROL, V68, P78; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; Villa G, 2016, CRIT CARE, V20; Villa G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1551-7; Villa G, 2015, INT J ANTIMICROB AG, V46, P465, DOI 10.1016/j.ijantimicag.2015.06.015; Villa G, 2015, CRIT CARE CLIN, V31, P839, DOI 10.1016/j.ccc.2015.06.015; Villa G, 2014, BLOOD PURIFICAT, V38, P239, DOI 10.1159/000368958; Villa G, 2014, BLOOD PURIFICAT, V38, P167, DOI 10.1159/000369155; Villa G, 2014, BLOOD PURIFICAT, V38, P100, DOI 10.1159/000363496; Zoller M, 2014, CRIT CARE, V18, DOI 10.1186/cc13984	36	28	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172039	10.1371/journal.pone.0172039	http://dx.doi.org/10.1371/journal.pone.0172039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207795	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424500076
J	Iaia, FM; Fiorenza, M; Larghi, L; Alberti, G; Millet, GP; Girard, O				Iaia, F. Marcello; Fiorenza, Matteo; Larghi, Luca; Alberti, Giampietro; Millet, Gregoire P.; Girard, Olivier			Short- or long-rest intervals during repeated sprint training in soccer?	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MUSCLE METABOLISM; OXYGEN-UPTAKE; PLAYERS; EXERCISE; ABILITY; RESPONSES; FOOTBALL; STRENGTH; SPORTS	The present study compared the effects of two repeated-sprint training (RST) programs, differing in duration of the between-sprint rest intervals, on various soccer-related exercise performances. For 5 weeks during the competitive season, twenty-nine young trained male soccer players either replaced two of their habitual fitness conditioning sessions with RST characterized by short (5-15; n = 9) or long (5-30; n = 10) rest intervals, or served as control (n = 10). The 5-15 and 5-30 protocols consisted of 6 repetitions of 30-m (similar to 5 s) straight-line sprints interspersed with 15 s or 30 s of passive recovery, respectively. 5-15 improved 200m sprint time (2.0 +/- 1.5%; p<0.05) and had a likely positive impact on 20-m sprint performance, whereas 5-30 lowered the 20-m sprint time (2.7 +/- 1.6%; p<0.05) but was only possiblyeffective for enhancing the 200-m sprint performance. The distance covered during the Yo-Yo Intermittent Recovery Test Level 2 increased following 5-15 (11.4 +/- 5.0%; p<0.05), which was possibly better than the non-significant 6.5% enhancement observed in 5-30. Improvements in the total time of a repeated-sprint ability test were possibly greater following 5-30 (3.6 +/- 0.9%; p<0.05) compared to 5-15 (2.6 +/- 1.1%; p<0.05). Both RST interventions led to similar beneficial (p<0.05) reductions in the percentage decrement score (similar to 30%) of the repeated-sprint ability test as well as in blood lactate concentration during submaximal exercise (17-18%). No changes occurred in the control group. In soccer players, RST over a 5-week in-season period is an efficient means to simultaneously develop different components of fitness relevant to match performance, with different benefits induced by shorter compared to longer rest intervals.	[Iaia, F. Marcello; Larghi, Luca; Alberti, Giampietro] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Fiorenza, Matteo] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Millet, Gregoire P.; Girard, Olivier] Univ Lausanne, Inst Sport Sci, ISSUL, Lausanne, Switzerland; [Girard, Olivier] Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar	University of Milan; University of Copenhagen; University of Lausanne; Aspetar Orthopaedic & Sports Medicine Hospital	Iaia, FM (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	marcello.iaia@unimi.it	Fiorenza, Matteo/AAA-1887-2020; Iaia, F. Marcello/L-6067-2015; Millet, Gregoire P/F-4104-2012; Alberti, Giampietro/M-4110-2016	Fiorenza, Matteo/0000-0002-8377-0857; Iaia, F. Marcello/0000-0003-0981-6471; Millet, Gregoire P/0000-0001-8081-4423; Alberti, Giampietro/0000-0002-5464-9644; girard, olivier/0000-0002-4797-182X				Al Haddad H, 2015, INT J SPORT PHYSIOL, V10, P888, DOI 10.1123/ijspp.2014-0539; Balsom PD, 1999, ACTA PHYSIOL SCAND, V165, P337, DOI 10.1046/j.1365-201x.1999.00517.x; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Brocherie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144446; Brocherie F, 2015, J STRENGTH COND RES, V29, P226, DOI 10.1519/JSC.0000000000000590; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Buchheit M, 2008, MED SCI SPORT EXER, V40, P362, DOI 10.1249/mss.0b013e31815aa2ee; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Buchheit M, 2012, SPORTS MED, V42, P169, DOI 10.2165/11598230-000000000-00000; Buchheit M, 2010, J STRENGTH COND RES, V24, P2715, DOI 10.1519/JSC.0b013e3181bf0223; Buchheit M, 2010, INT J SPORT PHYSIOL, V5, P152, DOI 10.1123/ijspp.5.2.152; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dawson B, 1998, EUR J APPL PHYSIOL O, V78, P163, DOI 10.1007/s004210050402; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Dupont G, 2005, EUR J APPL PHYSIOL, V95, P27, DOI 10.1007/s00421-005-1382-8; Edge J, 2013, EXP PHYSIOL, V98, P481, DOI 10.1113/expphysiol.2012.067603; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Galvin Harvey M, 2013, Br J Sports Med, V47 Suppl 1, pi74, DOI 10.1136/bjsports-2013-092826; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gatterer H, 2014, J SPORT SCI MED, V13, P731; Glaister M, 2008, J STRENGTH COND RES, V22, P1597, DOI 10.1519/JSC.0b013e318181ab80; Hader K, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-2; Hill-Haas S, 2007, J SPORT SCI, V25, P619, DOI 10.1080/02640410600874849; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Iaia FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138096; Impellizzeri FM, 2005, J SPORT SCI, V23, P583, DOI 10.1080/02640410400021278; McGawley K, 2015, J SCI MED SPORT, V18, P214, DOI 10.1016/j.jsams.2014.02.002; Mohr M, 2007, AM J PHYSIOL-REG I, V292, pR1594, DOI 10.1152/ajpregu.00251.2006; Mohr M, 2016, EUR J APPL PHYSIOL, V116, P179, DOI 10.1007/s00421-015-3245-2; Oliveira RS, 2013, INT J SPORTS MED, V34, P424, DOI 10.1055/s-0032-1323720; Ross A, 2001, SPORTS MED, V31, P409, DOI 10.2165/00007256-200131060-00002; Saraslanidis P, 2011, J SPORT SCI, V29, P1167, DOI 10.1080/02640414.2011.583672; Serpiello FR, 2011, EUR J APPL PHYSIOL, V111, P669, DOI 10.1007/s00421-010-1687-0; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P667, DOI [10.1123/ijspp.2013-0238, 10.1123/IJSPP.2013-0238]; Taylor J, 2015, SPORTS MED, V45, P881, DOI 10.1007/s40279-015-0324-9; Thomassen M, 2010, J APPL PHYSIOL, V108, P898, DOI 10.1152/japplphysiol.01015.2009	42	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171462	10.1371/journal.pone.0171462	http://dx.doi.org/10.1371/journal.pone.0171462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199402	Green Published, gold			2022-12-27	WOS:000394424400032
J	Shimamura, S; Kaneko, T; Ozawa, G; Matsumoto, MN; Koshiishi, T; Takaki, Y; Kato, C; Takai, K; Yoshida, T; Fujikura, K; Barry, JP; Maruyama, T				Shimamura, Shigeru; Kaneko, Takashi; Ozawa, Genki; Matsumoto, Mamiko Nishino; Koshiishi, Takeru; Takaki, Yoshihiro; Kato, Chiaki; Takai, Ken; Yoshida, Takao; Fujikura, Katsunori; Barry, James P.; Maruyama, Tadashi			Loss of genes related to Nucleotide Excision Repair (NER) and implications for reductive genome evolution in symbionts of deep-sea vesicomyid clams	PLOS ONE			English	Article							SOS RESPONSE SYSTEM; ILLEGITIMATE RECOMBINATION; ENDOSYMBIOTIC BACTERIA; HYDROTHERMAL VENT; DNA-REPAIR; GROEL; CONSEQUENCES; PROTEIN; ROLES; UVRA	Intracellular thioautotrophic symbionts of deep-sea vesicomyid clams lack some DNA repair genes and are thought to be undergoing reductive genome evolution (RGE). In this study, we addressed two questions, 1) how these symbionts lost their DNA repair genes and 2) how such losses affect RGE. For the first question, we examined genes associated with nucleotide excision repair (NER; uvrA, uvrB, uvrC, uvrD, uvrD paralog [uvrDp] and mfd) in 12 symbionts of vesicomyid clams belonging to two clades (5 clade I and 7 clade II symbionts). While uvrA, uvrDp and mfd were conserved in all symbionts, uvrB and uvrC were degraded in all clade I symbionts but were apparently intact in clade II symbionts. UvrD was disrupted in two clade II symbionts. Among the intact genes in Ca. Vesicomyosocius okutanii (clade I), expressions of uvrD and mfd were detected by reverse transcription-polymerase chain reaction (RT-PCR), but those of uvrA and uvrDp were not. In contrast, all intact genes were expressed in the symbiont of Calyptogena pacifica (clade II). To assess how gene losses affect RGE (question 2), genetic distances of the examined genes in symbionts from Bathymodiolus septemdierum were shown to be larger in clade I than clade II symbionts. In addition, these genes had lower guanine+ cytosine (GC) content and higher repeat sequence densities in clade I than measured in clade II. Our results suggest that NER genes are currently being lost from the extant lineages of vesicomyid clam symbionts. The loss of NER genes and mutY in these symbionts is likely to promote increases in genetic distance and repeat sequence density as well as reduced GC content in genomic genes, and may have facilitated reductive evolution of the genome.	[Shimamura, Shigeru; Kaneko, Takashi; Ozawa, Genki; Matsumoto, Mamiko Nishino; Koshiishi, Takeru; Kato, Chiaki; Yoshida, Takao; Fujikura, Katsunori] Japan Agcy Marine Earth Sci & Technol, Dept Marine Biodivers Res, 2-15 Natsushima Cho, Yokosuka, Kanagawa, Japan; [Shimamura, Shigeru; Takaki, Yoshihiro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol, Dept Subsurface Geobiol Anal & Res, Natsushima Cho, Yokosuka, Kanagawa, Japan; [Kaneko, Takashi] Tokyo Coll Biotechnol, Ota Ku, Tokyo, Japan; [Ozawa, Genki; Yoshida, Takao; Maruyama, Tadashi] Kitasato Univ, Sch Marine Biosci, Kitasato Minami Ku, Sagamihara, Kanagawa, Japan; [Barry, James P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Submarine Resources, Natsushima Cho, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kitasato University; Monterey Bay Aquarium Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Maruyama, T (corresponding author), Kitasato Univ, Sch Marine Biosci, Kitasato Minami Ku, Sagamihara, Kanagawa, Japan.; Maruyama, T (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Submarine Resources, Natsushima Cho, Yokosuka, Kanagawa, Japan.	tadashim@jamstec.go.jp			Japan Agency for Marine-Earth Science and Technology; Monterey Bay Aquarium Research Institute [901007]	Japan Agency for Marine-Earth Science and Technology; Monterey Bay Aquarium Research Institute	This study was supported partly by the budget of Japan Agency for Marine-Earth Science and Technology and by the Monterey Bay Aquarium Research Institute, project number 901007.	AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; Batut B, 2014, NAT REV MICROBIOL, V12, P841, DOI 10.1038/nrmicro3331; Charmasson S, 2009, J ENVIRON RADIOACTIV, V100, P522, DOI 10.1016/j.jenvrad.2009.02.002; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DOOLITTLE RF, 1986, NATURE, V323, P451, DOI 10.1038/323451a0; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Fares MA, 2005, J EVOLUTION BIOL, V18, P651, DOI 10.1111/j.1420-9101.2004.00861.x; Fiala-Medioni A, 1986, MAR BIOL, V90, P8; Hanada K, 2000, P NATL ACAD SCI USA, V97, P5989, DOI 10.1073/pnas.100101297; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Janion C, 2001, ACTA BIOCHIM POL, V48, P599; Janion C, 2008, INT J BIOL SCI, V4, P338; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura M, 1983, NEUTRAL THEORY MOL E, P396, DOI DOI 10.1101/GR.966203; Kisker C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012591; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Kupper M, 2014, FEMS MICROBIOL LETT, V353, P1, DOI 10.1111/1574-6968.12390; Kuwahara H, 2008, EXTREMOPHILES, V12, P365, DOI 10.1007/s00792-008-0141-2; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Kuwahara H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-285; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Martinez-Cano DJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00742; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Okutani T, 2000, VENUS, V59, P18; Palacios C, 2002, MOL BIOL EVOL, V19, P1575, DOI 10.1093/oxfordjournals.molbev.a004219; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Pruski AM, 2003, AQUAT TOXICOL, V64, P1, DOI 10.1016/S0166-445X(03)00010-9; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart FJ, 2009, MOL BIOL EVOL, V26, P1391, DOI 10.1093/molbev/msp049; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Yanai H, 2011, 4STEPS USEFUL ADD FO; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171274	10.1371/journal.pone.0171274	http://dx.doi.org/10.1371/journal.pone.0171274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199404	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424400027
J	Cao, XZ; Yumul, R; Lazo, OLE; Friedman, J; Durra, O; Zhang, X; White, PF				Cao, Xuezhao; Yumul, Roya; Lazo, Ofelia Loani Elvir; Friedman, Jeremy; Durra, Omar; Zhang, Xiao; White, Paul F.			A novel visual facial anxiety scale for assessing preoperative anxiety	PLOS ONE			English	Article							ANALOG SCALE; RELIABILITY; VALIDATION; PAIN	Background There is currently no widely accepted instrument for measuring preoperative anxiety. The objective of this study was to develop a simple visual facial anxiety scale (VFAS) for assessing acute preoperative anxiety. Methods The initial VFAS was comprised of 11 similarly styled stick-figure reflecting different types of facial expressions (Fig 1). After obtaining IRB approval, a total of 265 participant-healthcare providers (e.g., anesthesiologists, anesthesiology residents, and perioperative nurses) were recruited to participate in this study. The participants were asked to: (1) rank the 11 faces from 0-10 (0 = no anxiety, while 10 = highest anxiety) and then to (2) match one of the 11 facial expression with a numeric verbal rating scale (NVRS) (0 = no anxiety and 10 = highest level of anxiety) and a specific categorical level of anxiety, namely no anxiety, mild, mild-moderate, moderate, moderate-high or highest anxiety. Based on these data, the Spearman correlation and frequencies of the 11 faces in relation to the 11-point numerical anxiety scale and 6 categorical anxiety levels were calculated. The highest frequency of a face assigned to a level of the numerical anxiety scale resulted in a finalized order of faces corresponding to the 11-point numeric rating scale. Results The highest frequency for each of the NVRS anxiety scores were as follow: A0, A1, A2, A3, A4, A5, A7, A6, A8, A9 and A10 (Fig 2). For the six categorical anxiety levels, a total of 260 (98.1%) participants chose the face A0 as representing 'no' anxiety, 250 (94.3%) participants chose the face A0 as representing 'highest' anxiety and 147 (55.5%) participants chose the face A8 as representing 'moderate-high' anxiety. Spearman analysis showed a significant correlation between the faces A3 and A5 assigned to the mild-moderate anxiety category (r = 0.58), but A5 was ultimately chosen due to its higher frequency compared tothe frequency of A3 (30.6% vs 24.9%)(Fig 3). Similarly, the correlation of the faces A7 and A6 was significantly correlated with moderate anxiety (r = 0.87), but A7 remained because of its higher frequency (35.9% vs 22.6%). Using frequency and Spearman correlations, the final order of the faces assigned to the categories none, mild, mild-moderate, moderate, moderate -high and highest anxiety levels was A0, A1, A5, A7, A8 and A10, respectively (Fig 4). Conclusion The proposed VFAS was a valid tool for assessing the severity of acute [state] anxiety, and could be easy to administer in routine clinical practice.	[Cao, Xuezhao; Yumul, Roya; Lazo, Ofelia Loani Elvir; Friedman, Jeremy; Durra, Omar; Zhang, Xiao; White, Paul F.] Cedars Sinai Med Ctr, Dept Anesthesiol, Los Angeles, CA 90048 USA; [Cao, Xuezhao] China Med Univ, Dept Anesthesiol, Hosp 1, Shenyang, Liaoning, Peoples R China; [Yumul, Roya] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [White, Paul F.] White Mt Inst, Dept Anesthesiol, The Sea Ranch, CA 95497 USA	Cedars Sinai Medical Center; China Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	White, PF (corresponding author), Cedars Sinai Med Ctr, Dept Anesthesiol, Los Angeles, CA 90048 USA.; White, PF (corresponding author), White Mt Inst, Dept Anesthesiol, The Sea Ranch, CA 95497 USA.	Paul.White@cshs.org		Zhang, Xiao/0000-0003-4248-1546; Elvir Lazo, Ofelia Loani/0000-0002-2825-5182; yumul, roya/0000-0002-3645-7972				Abend R, 2014, J BEHAV THER EXP PSY, V45, P447, DOI 10.1016/j.jbtep.2014.06.004; [Anonymous], MED RES ARCH; Bulloch B, 2009, ACAD EMERG MED, V16, P465, DOI 10.1111/j.1553-2712.2009.00404.x; Chlan LL, 2004, J ADV NURS, V48, P493, DOI 10.1111/j.1365-2648.2004.03231.x; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Hashimoto Y, 1993, Masui, V42, P611; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Matthias Anne Thushara, 2012, Acta Anaesthesiol Taiwan, V50, P3, DOI 10.1016/j.aat.2012.02.004; McGrath P, 1996, PAIN, V64, P435, DOI 10.1016/0304-3959(95)00171-9; MILLAR K, 1995, BRIT J ANAESTH, V74, P180, DOI 10.1093/bja/74.2.180; Giang NV, 2015, PAIN MANAG NURS, V16, P678, DOI 10.1016/j.pmn.2015.02.002; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tomlinson D, 2010, PEDIATRICS, V126, pE1168, DOI 10.1542/peds.2010-1609	15	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171233	10.1371/journal.pone.0171233	http://dx.doi.org/10.1371/journal.pone.0171233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196099	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900014
J	Rizwan, M; Aslam, M; Asghar, MJ; Abbas, G; Shah, TM; Shimelis, H				Rizwan, Muhammad; Aslam, Muhammad; Asghar, Muhammad Jawad; Abbas, Ghulam; Shah, Tariq Mahmud; Shimelis, Hussein			Pre-breeding of lentil (Lens culinaris Medik.) for herbicide resistance through seed mutagenesis	PLOS ONE			English	Article							ACETOLACTATE SYNTHASE; TOLERANCE; SULFONYLUREA; MUTANTS	Lentil is a poor competitor of weeds and its sensitivity to herbicides is a major hurdle for large scale production. The present study was conducted to select herbicide resistant lentil genotypes through seed mutagenesis. Seeds of three advanced lentil genotypes (LPP 11001, LPP 11100 and LPP 11116) were treated with two different concentrations of ethyl methanesulfonate (EMS; 0.1 and 0.2%), hydrazine hydrate (HH; 0.02 and 0.03%) and sodium azide (SA; 0.01 and 0.02%) to develop M-1 seed. The M-2 was screened against two herbicides including Ally Max 28.6% SG (X = 34.58 g/ha and 1.5X = 51.87 g/ha) and Atlantis 3.6% WG (X = 395.2 g/ha and 1.5X = 592.8 g/ha) using the following three screening methods: post plant emergence (PPE), pre-plant incorporation (PPI) and seed priming (SP). Data were recorded on survival index and survival percentage from each experimental unit of every population. Plants in all populations were categorized following their reaction to herbicides. The newly developed populations showed greater variation for herbicide resistance when compared to their progenitors. Phenotypic traits were significantly reduced in all the screening environments. Overall, 671 herbicide resistant mutants were selected from all testing environments. The seeds from selected plants were re-mutagenized at 150 Gy of gamma radiation and evaluated against higher dose of herbicides. This allowed selection of 134 herbicide resistant mutants. The selected mutants are useful germplasm for herbicide resistance breeding of lentil.	[Rizwan, Muhammad; Asghar, Muhammad Jawad; Abbas, Ghulam; Shah, Tariq Mahmud] Nucl Inst Agr & Biol, Faisalabad, Pakistan; [Aslam, Muhammad] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Shimelis, Hussein] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa	Nuclear Institute for Agriculture & Biology - Pakistan; University of Agriculture Faisalabad; University of Kwazulu Natal	Rizwan, M (corresponding author), Nucl Inst Agr & Biol, Faisalabad, Pakistan.	rzi_rizwan@yahoo.com	Shimelis, Hussein/N-5073-2013; shah, Tariqmahmud mahmud/D-2767-2017	Shimelis, Hussein/0000-0003-2793-8392; 				Alkadhi KA, 2012, INT J NEUROPSYCHOPH, V15, P223, DOI 10.1017/S1461145711000162; ANDERSON PC, 1989, GENOME, V31, P994, DOI 10.1139/g89-173; Barrentine W. L., 1979, Proceedings of the 32nd Annual Meeting of the Southern Weed Science Society., P97; Beckie HJ, 2006, CAN J PLANT SCI, V86, P1243, DOI 10.4141/P05-193; BERNASCONI P, 1995, J BIOL CHEM, V270, P17381, DOI 10.1074/jbc.270.29.17381; CHALEFF RS, 1984, SCIENCE, V223, P1148, DOI 10.1126/science.223.4641.1148; CHALEFF RS, 1984, SCIENCE, V224, P1443, DOI 10.1126/science.224.4656.1443; Chant SR, 2004, THESIS; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Federer WT, 2005, J CROP IMPROV, V14, P29, DOI [10.1300/J411v14n01_04, 10.1300/J411v15n01_07]; Federer WT, 2005, TECHNICAL REPORT SER; FRIESEN GH, 1986, CAN J PLANT SCI, V66, P131, DOI 10.4141/cjps86-017; Gaikwad N. B., 2004, Indian Journal of Genetics & Plant Breeding, V64, P73; Gaur PM, 2013, AGRONOMY-BASEL, V3, P524, DOI 10.3390/agronomy3030524; Malkawi HI, 2003, J AGR SCI, V140, P83, DOI 10.1017/S0021859602002733; Ndungu DK, 2009, THESIS; NEWHOUSE K, 1991, THEOR APPL GENET, V83, P65, DOI 10.1007/BF00229227; NEWHOUSE KE, 1992, PLANT PHYSIOL, V100, P882, DOI 10.1104/pp.100.2.882; Pandolfo CE, 2013, PLANTA DANINHA, V31, P657, DOI 10.1590/S0100-83582013000300017; PINTHUS MJ, 1972, SCIENCE, V177, P715, DOI 10.1126/science.177.4050.715; Rajasekaran K, 1996, PLANT SCI, V119, P115, DOI 10.1016/0168-9452(96)04444-5; Sala CA, 2008, CROP SCI, V48, P1817, DOI 10.2135/cropsci2007.11.0625; Sarker A, 2006, J AGR SCI-CAMBRIDGE, V144, P19, DOI 10.1017/S0021859605005800; SEBASTIAN SA, 1987, CROP SCI, V27, P948, DOI 10.2135/cropsci1987.0011183X002700050025x; Shamima Aktar, 2013, The Agriculturists, V11, P89; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993	26	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171846	10.1371/journal.pone.0171846	http://dx.doi.org/10.1371/journal.pone.0171846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196091	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900035
J	Li, YH; Zhuang, SF; Wu, YP; Ren, HL; Chen, FY; Lin, X; Wang, KJ; Beardall, J; Gao, KS				Li, Yahe; Zhuang, Shufang; Wu, Yaping; Ren, Honglin; Chen, Fangyi; Lin, Xin; Wang, Kejian; Beardall, John; Gao, Kunshan			Ocean acidification modulates expression of genes and physiological performance of a marine diatom	PLOS ONE			English	Article							CARBON CONCENTRATING MECHANISMS; ELEVATED CO2; ANHYDRASE; LIGHT; PHYTOPLANKTON; PH; PHOTOSYNTHESIS; EVOLUTION; RESPONSES; ECOLOGY	Ocean Acidification (OA) is known to affect various aspects of physiological performances of diatoms, but little is known about the underlining molecular mechanisms involved. Here, we show that in the model diatom Phaeodactylum tricornutum, the expression of key genes associated with photosynthetic light harvesting as well as those encoding Rubisco, carbonic anhydrase, NADH dehydrogenase and nitrite reductase, are modulated by OA (1000 mu atm, pH(nbs) 7.83). Growth and photosynthetic carbon fixation were enhanced by elevated CO2. OA treatment decreased the expression of beta-carbonic anhydrase (beta-ca), which functions in balancing intracellular carbonate chemistry and the CO2 concentrating mechanism (CCM). The expression of the genes encoding fucoxanthin chlorophyll a/c protein (lhcf type (fcp)), mitochondrial ATP synthase (mtATP), ribulose-1, 5-bisphosphate carboxylase/oxygenase large subunit gene (rbcl) and NADH dehydrogenase subunit 2 (ndh2), were down-regulated during the first four days (< 8 generations) after the cells were transferred from LC (cells grown under ambient air condition; 390 mu atm; pH(nbs) 8.19) to OA conditions, with no significant difference between LC and HC treatments with the time elapsed. The expression of nitrite reductase (nir) was up-regulated by the OA treatment. Additionally, the genes for these proteins (NiR, FCP, mtATP synthase, beta-CA) showed diel expression patterns. It appeared that the enhanced photosynthetic and growth rates under OA could be attributed to stimulated nitrogen assimilation, increased CO2 availability or saved energy from downregulation of the CCM and consequently lowered cost of protein synthesis versus that of non-nitrogenous cell components.	[Li, Yahe; Zhuang, Shufang; Wu, Yaping; Chen, Fangyi; Lin, Xin; Wang, Kejian; Gao, Kunshan] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Ren, Honglin] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Xiamen University; Jilin University; Monash University	Wang, KJ; Gao, KS (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	wkjian@xmu.edu.cn; ksgao@xmu.edu.cn	Wu, Yaping/C-7996-2014; Beardall, John/L-5262-2019; Wu, Yaping/AAK-2810-2021; gao, kunshan/G-3374-2010; Wang, KJ/G-4609-2010	Beardall, John/0000-0001-7684-446X; Gao, Kunshan/0000-0001-7365-6332	National Natural Science Foundation [41430967, 41120164007, 41206091, 41306096]; State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction) [GASI-03-01-02-04]; NSFC [U1406403]; Strategic Priority Research Program of CAS [XDA11020302]; Fundamental Research Funds for the Central Universities [2013121049]; XMU president program [ZK1050]; Xiamen University; Shandong province [U1406403]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction); NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); XMU president program; Xiamen University(Xiamen University); Shandong province	This study was supported by the National Natural Science Foundation (41430967 and 41120164007 to KG, 41206091 to YW, 41306096 to XL), State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction, GASI-03-01-02-04), the Joint project of NSFC and Shandong province (Grant No. U1406403) and the Strategic Priority Research Program of CAS (Grant No. XDA11020302), the Fundamental Research Funds for the Central Universities (2013121049) and XMU president program (ZK1050). JBs visit was supported by Xiamen University.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Beardall J, 2014, AQUAT BIOL, V22, P5, DOI 10.3354/ab00582; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; BHAYA D, 1993, NUCLEIC ACIDS RES, V21, P4458; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Dubinsky Z, 2010, HYDROBIOLOGIA, V639, P153, DOI 10.1007/s10750-009-0026-0; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; Gao KS, 2007, PHOTOCHEM PHOTOBIOL, V83, P802, DOI 10.1111/j.1751-1097.2007.00154.x; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Giordano M, 2013, PLANT SCI, V211, P92, DOI 10.1016/j.plantsci.2013.07.008; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Harada H, 2005, CAN J BOT, V83, P909, DOI 10.1139/B05-078; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Hennon GMM, 2015, NAT CLIM CHANGE, V5, P761, DOI [10.1038/NCLIMATE2683, 10.1038/nclimate2683]; Hofmann LC, 2013, J EXP BOT, V64, P899, DOI 10.1093/jxb/ers369; Hopkinson BM, 2016, CURR OPIN PLANT BIOL, V31, P51, DOI 10.1016/j.pbi.2016.03.013; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Jin P, 2013, EVOLUTION, V67, P1869, DOI 10.1111/evo.12112; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Lavoie M, 2016, J PHYCOL, V52, P239, DOI 10.1111/jpy.12390; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Li FT, 2016, GLOBAL CHANGE BIOL; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051590; Li YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096173; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milligan AJ, 2009, MAR CHEM, V114, P31, DOI 10.1016/j.marchem.2009.03.003; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Park S, 2010, PLANTA, V231, P349, DOI 10.1007/s00425-009-1044-x; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Portner H, 2011, OCEAN ACIDIFICATION, P154; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Rickaby REM, 2010, CLIM PAST, V6, P771, DOI 10.5194/cp-6-771-2010; Riebesell U, 2010, GUIDE TO BEST PRACTI, P84; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Shi DL, 2015, LIMNOL OCEANOGR, V60, P1805, DOI 10.1002/lno.10134; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Wu HY, 2009, FUNCT PLANT BIOL, V36, P137, DOI 10.1071/FP08172; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002	53	11	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170970	10.1371/journal.pone.0170970	http://dx.doi.org/10.1371/journal.pone.0170970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192486	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800013
J	da Silva, RA; Souza, G; Lemos, LSL; Lopes, UV; Patrocinio, NGRB; Alves, RM; Marcellino, LH; Clement, D; Micheli, F; Gramacho, KP				da Silva, Rangeline Azevedo; Souza, Gustavo; Lima Lemos, Livia Santos; Lopes, Uilson Vanderlei; Ribeiro Braz Patrocinio, Nara Georgia; Alves, Rafael Moyses; Marcellino, Lucilia Helena; Clement, Didier; Micheli, Fabienne; Gramacho, Karina Peres			Genome size, cytogenetic data and transferability of EST-SSRs markers in wild and cultivated species of the genus Theobroma L. (Byttnerioideae, Malvaceae)	PLOS ONE			English	Article							FLOW-CYTOMETRIC ESTIMATION; NUCLEAR-DNA CONTENT; MICROSATELLITE MARKERS; STOICHIOMETRIC ERROR; GENETIC DIVERSITY; WITCHES-BROOM; LINKAGE MAP; CACAO; CHROMOSOMES; CONSEQUENCES	The genus Theobroma comprises several trees species native to the Amazon. Theobroma cacao L. plays a key economic role mainly in the chocolate industry. Both cultivated and wild forms are described within the genus. Variations in genome size and chromosome number have been used for prediction purposes including the frequency of interspecific hybridization or inference about evolutionary relationships. In this study, the nuclear DNA content, karyotype and genetic diversity using functional microsatellites (EST-SSR) of seven Theobroma species were characterized. The nuclear content of DNA for all analyzed Theobroma species was 1C = -0.46 pg. These species presented 2n = 20 with small chromosomes and only one pair of terminal heterochromatic bands positively stained (CMA+/DAPI- bands). The small size of Theobroma ssp. genomes was equivalent to other Byttnerioideae species, suggesting that the basal lineage of Malvaceae have smaller genomes and that there was an expansion of 2C values in the more specialized family clades. A set of 20 EST-SSR primers were characterized for related species of Theobroma, in which 12 loci were polymorphic. The polymorphism information content (PIC) ranged from 0.23 to 0.65, indicating a high level of information per locus. Combined results of flow cytometry, cytogenetic data and EST-SSRs markers will contribute to better describe the species and infer about the evolutionary relationships among Theobroma species. In addition, the importance of a core collection for conservation purposes is highlighted.	[da Silva, Rangeline Azevedo; Ribeiro Braz Patrocinio, Nara Georgia; Micheli, Fabienne] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [da Silva, Rangeline Azevedo; Lima Lemos, Livia Santos; Lopes, Uilson Vanderlei; Ribeiro Braz Patrocinio, Nara Georgia; Clement, Didier; Gramacho, Karina Peres] CEPLAC CEPEC, Cocoa Res Ctr, Itabuna, BA, Brazil; [Souza, Gustavo] Univ Fed Pernambuco, Recife, PE, Brazil; [Alves, Rafael Moyses] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Marcellino, Lucilia Helena] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Clement, Didier; Micheli, Fabienne] UMR AGAP, CIRAD, Montpellier, France; [da Silva, Rangeline Azevedo] Inst Oswaldo Cruz, Inst Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Lima Lemos, Livia Santos] Univ Fed Sul Bahia, Teixeira De Freitas, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal de Pernambuco; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Fundacao Oswaldo Cruz; Universidade Federal do Sul da Bahia	Gramacho, KP (corresponding author), CEPLAC CEPEC, Cocoa Res Ctr, Itabuna, BA, Brazil.	gramachokp@hotmail.com	Azevedo da Silva, Rangeline/X-9939-2018; da Silva, Rangeline Azevedo/R-4604-2018; GRAMACHO, KARINA PERES/AAO-8862-2020; Souza, Luiz Gustavo/C-2307-2019; GRAMACHO, KARINA PERES/J-3868-2014; Micheli, Fabienne/AAL-9895-2021; Marcellino, Lucilia/N-1967-2016	Azevedo da Silva, Rangeline/0000-0001-6903-1137; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Souza, Luiz Gustavo/0000-0002-5700-6097; GRAMACHO, KARINA PERES/0000-0003-4037-1554; CLEMENT, Didier/0000-0002-7602-6472; Marcellino, Lucilia/0000-0002-0430-2490; Micheli, Fabienne/0000-0002-9031-362X	Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq; CAPES	Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Financiadora de Inovacao e Pesquisa (Finep)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Cocoa Reserarch Center (CEPEC/CEPLAC); Brazilian Agricultural Research Corporation (EMBRAPA); Santa Cruz State University, (UESC), Coordination for the Improvement of Higher Education Personnel (CAPES); FINEP/CNPq. The funder provided support in the form of either research material/ or salaries for authors KPG, UVL, RMA, and LHM, and CAPES provided scholarship to RAS, but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Alverson WS, 1999, AM J BOT, V86, P1474, DOI 10.2307/2656928; Alves RM, 2006, MOL ECOL NOTES, V6, P1219, DOI 10.1111/j.1471-8286.2006.01496.x; Alves RM, 2013, REV BRAS FRUTIC, V35, P818, DOI 10.1590/S0100-29452013000300019; [Anonymous], 1996, 5000 CNRS UMR; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Ayala-Navarrete L, 2007, THEOR APPL GENET, V116, P63, DOI 10.1007/s00122-007-0647-5; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; Bayer C, 1999, BOT J LINN SOC, V129, P267, DOI 10.1006/bojl.1998.0226; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bennett Michael D., 2005, P89, DOI 10.1016/B978-012301463-4/50004-8; Benor S, 2011, GENOME, V54, P575, DOI [10.1139/G11-021, 10.1139/g11-021]; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Costa MP, 2016, J DAIRY RES, V83, P493, DOI 10.1017/S0022029916000674; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Cuatrecasas J., 1964, CONTRIB US NAT MUS, V35, P379, DOI DOI 10.1016/0165-5728(95)00055-7; Dantas LG, 2010, GENET MOL BIOL, V33, P94, DOI 10.1590/S1415-47572009005000103; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Efraim P., 2006, Brazilian Journal of Food Technology, V9, P229; Oliveira GAF, 2013, BRAZ ARCH BIOL TECHN, V56, P785, DOI 10.1590/S1516-89132013000500009; Faleiro FG, 2005, MARACUJA GERMOPLASMA; Felix LP, 2010, BOT J LINN SOC, V163, P234, DOI 10.1111/j.1095-8339.2010.01059.x; FIGUEIRA A, 1992, J AM SOC HORTIC SCI, V117, P673, DOI 10.21273/JASHS.117.4.673; FLAVELL RB, 1988, J MOL BIOL, V204, P523, DOI 10.1016/0022-2836(88)90352-X; Galbraith DW, 2002, CURRENT PROTOCOLS CY, V76, P1; Galvao KSC, 2015, GENET MOL RES, V14, P7344, DOI 10.4238/2015.July.3.10; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; GLICENSTEIN LJ, 1989, J HERED, V80, P464, DOI 10.1093/oxfordjournals.jhered.a110899; Gramacho KP, 2009, OBTENC LITES GENOTIP, V196, P1106, DOI [10.1111/j.1365-294X.2007.03089, DOI 10.1111/J.1365-294X.2007.03089.X]; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; GREILHUBER J, 1986, CAN J GENET CYTOL, V28, P409, DOI 10.1139/g86-060; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Greilhuber J, 1988, P 3 CHROM C KEW 1 4, P39; GRIME JP, 1982, NATURE, V299, P151, DOI 10.1038/299151a0; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Hagras AAA, 2005, BREEDING SCI, V55, P335, DOI 10.1270/jsbbs.55.335; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; JMO, 1948, EST CROM GEN THEOBR; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kawara S, 1999, J DERMATOL SCI, V21, P23, DOI 10.1016/S0923-1811(99)00009-2; Kerr WE, 1980, ACTA AMAZONICA, V10; Lannes Suzana Caetano da Silva, 2002, Rev. Bras. Cienc. Farm., V38, P463, DOI 10.1590/S1516-93322002000400009; Lemos LSL, THESIS; Lemos LSL, 2007, THESIS; Lima LS, 2008, MOL BREEDING, V22, P315, DOI 10.1007/s11032-008-9174-6; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Loureiro J, 2010, PRESLIA, V82, P3; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Machado RCR, 1998, P 10 INT COC RES C P, P151; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Marinho RC, 2014, PLANT BIOLOGY, V16, P508, DOI 10.1111/plb.12135; Marita JM, 2001, CROP SCI, V41, P1305, DOI 10.2135/cropsci2001.4141305x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Noirot M, 2005, ANN BOT-LONDON, V95, P111, DOI 10.1093/aob/mci006; Noirot M, 2003, ANN BOT-LONDON, V92, P259, DOI 10.1093/aob/mcg139; Noirot M, 2000, ANN BOT-LONDON, V86, P309, DOI 10.1006/anbo.2000.1187; Ochatt SJ, 2008, CYTOM PART A, V73A, P581, DOI 10.1002/cyto.a.20562; Ogutu C, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1014-y; Pellicer J, 2010, PLANT BIOLOGY, V12, P820, DOI 10.1111/j.1438-8677.2009.00268.x; Teixeira PJPL, 2014, PLANT CELL, V26, P4245, DOI 10.1105/tpc.114.130807; Pinent M, 2016, J SCI FOOD AGR, V96, P178, DOI 10.1002/jsfa.7079; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Roiaini M, 2016, INT FOOD RES J, V23, P47; Rowland LJ, 2003, HORTSCIENCE, V38, P1428, DOI 10.21273/HORTSCI.38.7.1428; SAMAD M A, 1992, Cytologia (Tokyo), V57, P21, DOI 10.1508/cytologia.57.21; Santos L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154519; Santos R. M. F., 2014, African Journal of Biotechnology, V13, P814; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Sarkar D, 2011, CARYOLOGIA, V64, P147, DOI 10.1080/00087114.2002.10589776; SAS Institute, 2008, SAS STAT US GUID; Silva CRS, 2005, PLANT SYST EVOL, V250, P93, DOI 10.1007/s00606-004-0223-2; Silva FCO, 1998, GENET MOL BIOL, V21, P205; Sullivan AR, 2013, PLANT MOL BIOL REP, V31, P231, DOI 10.1007/s11105-012-0495-6; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Ul Haq S, 2016, GENET RES INT, V2016, DOI 10.1155/2016/7052323; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venturieri Giorgini Augusto, 2004, Acta Amaz., V34, P507, DOI 10.1590/S0044-59672004000400004; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Silva SDVM, 2010, PESQUI AGROPECU BRAS, V45, P680, DOI 10.1590/S0100-204X2010000700007; WARREN AM, 1991, GENET RES, V58, P225, DOI 10.1017/S0016672300029979; Whitlock BA, 1999, SYST BOT, V24, P128, DOI 10.2307/2419544; Wollgast J, 2000, FOOD RES INT, V33, P423, DOI 10.1016/S0963-9969(00)00068-5; ZHANG MF, 2014, PLOS MED, V11, DOI DOI 10.1371/JOURNAL.PONE.0094881; Zhou R, 2015, GENET MOL RES, V14, P13184, DOI 10.4238/2015.October.26.14	92	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0170799	10.1371/journal.pone.0170799	http://dx.doi.org/10.1371/journal.pone.0170799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187131	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300008
J	Ng, ST; Tey, NP; Asadullah, MN				Ng, Sor Tho; Tey, Nai Peng; Asadullah, M. Niaz			What matters for life satisfaction among the oldest-old? Evidence from China	PLOS ONE			English	Article							QUALITY-OF-LIFE; LIVING ARRANGEMENTS; SINGLE-ITEM; SOCIAL SUPPORT; RECENT TRENDS; HEALTH; HAPPINESS; DISABILITY; PEOPLE; SCALES	Objective The world population is aging rapidly and the well-being of older people is of great interest. Therefore, this study investigates the determinants of life satisfaction among the oldest-old (i.e. individuals aged 80 or over) in China. Materials and methods We use the 2011/2012 Chinese Longitudinal Healthy Longevity Survey data (n= 6530) for this paper. Logistic regression is used to analyse the effects of socio-demographic, economic, health, instrumental activities of daily living, family and community factors on life satisfaction and depression among the oldest-old in China. Results Our analysis confirms the significance of many factors affecting life satisfaction among the oldest-old in China. Factors that are correlated with life satisfaction include respondent's sex, education, place of residence, self-rated health status, cognitive ability (using mini mental state examination), regular physical examination, perceived relative economic status, access to social security provisions, commercialized insurances, living arrangements, and number of social services available in the community (p<0.05 for all these variables). Although life satisfaction is negatively associated with instrumental activities of daily living (beta =-0.068, 95%CI =-.093-.043), and depression (beta =-0.463, 95%Cl =-.644-.282), the overall effect of self-rated health status is positive (p<0.001). This confirms the primacy of health as the determinant of well-being among the oldest-old. Conclusions Majority of the oldest-old in China rated their life satisfaction as good or very good. Our findings show that health and economic status are by far the most significant predictors of life satisfaction. Our finding on the primacy of health and relative income as determinants of well-being among the oldest-old, and the greater influence of self-rated health status over objective health measures is consistent with the findings of many past studies. Our results suggest that efforts should be directed at enhancing family support as well as health and social service provisions in the community to improve life satisfaction of older people.	[Ng, Sor Tho; Tey, Nai Peng; Asadullah, M. Niaz] Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia; [Asadullah, M. Niaz] Univ Reading, Dept Econ, Reading, Berks, England; [Asadullah, M. Niaz] Univ Oxford, Ctr Skills Knowledge & Organisat Performance, Oxford, England; [Asadullah, M. Niaz] IZA Inst Labor Econ, Bonn, Germany; [Asadullah, M. Niaz] Univ Manchester, Sch Environm Educ & Dev, Manchester, Lancs, England	Universiti Malaya; University of Reading; University of Oxford; IZA Institute Labor Economics; University of Manchester	Ng, ST (corresponding author), Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia.	ngst@um.edu.my	Asadullah, M Niaz/H-6768-2013; TEY, NAI PENG/B-5270-2010; Ng, Sor Tho/B-9233-2010	Asadullah, M Niaz/0000-0001-8047-5548; TEY, NAI PENG/0000-0003-3707-5033; Ng, Sor Tho/0000-0001-9251-2377	Population Studies Unit, Faculty of Economics & Administration, University of Malaya [IF002-2014]	Population Studies Unit, Faculty of Economics & Administration, University of Malaya	This research is supported by Population Studies Unit, Faculty of Economics & Administration, University of Malaya, IF002-2014 (University of Malaya). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini V, 2012, SOC INDIC RES, V105, P293, DOI 10.1007/s11205-011-9882-x; Angner E, 2011, J ECON PSYCHOL, V32, P357, DOI 10.1016/j.joep.2011.01.002; Asadullah MN, 2016, CHINA ECON REV; Asadullah MN, 2012, J ECON PSYCHOL, V33, P940, DOI 10.1016/j.joep.2012.05.003; Asian Development Bank, 2010, POP AG LONG TERM HLT; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Brown P. H., 2009, J SOCIO-ECON, V38, P310, DOI DOI 10.1016/J.SOCEC.2008.07.014; Camfield L, 2014, WORLD DEV, V59, P212, DOI 10.1016/j.worlddev.2014.01.018; Carlsson F, 2009, OXFORD ECON PAP, V61, P52, DOI 10.1093/oep/gpn015; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Chen ZH, 2008, J HAPPINESS STUD, V9, P589, DOI 10.1007/s10902-008-9092-7; Chi I, 2001, INT J AGING HUM DEV, V52, P231, DOI 10.2190/V5K8-CNMG-G2UP-37QV; Chou KL, 2003, AGING MENT HEALTH, V7, P224, DOI 10.1080/136031000101210; Chou KL, 1999, AGING MENT HEALTH, V3, P328, DOI 10.1080/13607869956109; Cigolle C, 2016, J GERONTOL B-PSYCHOL; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Corazzini L, 2012, J ECON BEHAV ORGAN, V81, P715, DOI 10.1016/j.jebo.2010.12.016; de Boer AGEM, 2004, QUAL LIFE RES, V13, P311, DOI 10.1023/B:QURE.0000018499.64574.1f; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Deaton A, 2013, AM ECON REV, V103, P591, DOI 10.1257/aer.103.3.591; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.68.4.653; Diener E, 2013, SOC INDIC RES, V112, P497, DOI 10.1007/s11205-012-0076-y; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; Dobson AJ, INTRO GEN LINEAR MOD; Easterlin RA, 2012, P NATL ACAD SCI USA, V109, P9775, DOI 10.1073/pnas.1205672109; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Flores G, 2015, J HEALTH ECON, V44, P150, DOI 10.1016/j.jhealeco.2015.09.003; Fong H, 2015, CHINESE J GERONTOL, V35, P208; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Graham C, 2015, WORLD DEV, V68, P163, DOI 10.1016/j.worlddev.2014.11.018; Gwozdz W, 2010, SOC INDIC RES, V97, P397, DOI 10.1007/s11205-009-9508-8; Hlavac M, 2011, SUBJECTIVE LIFE SATI; Hu H, 2012, CHINA SOFT SCI, V11, P41; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Jagodzinski W, 2010, SOC INDIC RES, V97, P85, DOI 10.1007/s11205-009-9555-1; Knight J, 2014, CSAE WORKING PAPER S; KRAUSE N, 1993, J GERONTOL, V48, pP282, DOI 10.1093/geronj/48.6.P282; Layard R, 2013, IZA J LABOR POLICY, V2, DOI 10.1186/2193-9004-2-2; LEMON BW, 1972, J GERONTOL, V27, P511, DOI 10.1093/geronj/27.4.511; Li D., 2008, CHIN J GERONTOL, V19, P1943; Li D., 2008, HLTH LONGEVITY CHINA, P347, DOI [10.1007/978-1-4020-6752-5_21, DOI 10.1007/978-1-4020-6752-5_21]; [李德明 LI DeMing], 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P1193; Li H, 2014, DOES MONEY BUY HAPPI; Li LW, 2007, PSYCHOL AGING, V22, P386, DOI 10.1037/0882-7974.22.2.386; Li Q, 2005, 2005011 MPIDR WP; Liu J, 2015, SCI RES AGING, V3, P69; Liu LJ, 2008, QUAL LIFE RES, V17, P823, DOI 10.1007/s11136-008-9370-1; Lou VWQ, 2010, SOC INDIC RES, V95, P377, DOI 10.1007/s11205-009-9526-6; Luo W., 2011, POPUL RES, V35, P51; Michael YL, 2001, AM J EPIDEMIOL, V153, P123, DOI 10.1093/aje/153.2.123; Mudege NN, 2009, J AGING STUD, V23, P245, DOI 10.1016/j.jaging.2007.12.021; Perez-Truglia R, 2015, J ECON PSYCHOL, V49, P74, DOI 10.1016/j.joep.2015.05.002; Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313; Ravallion M, 2010, J ECON BEHAV ORGAN, V73, P171, DOI 10.1016/j.jebo.2009.08.008; Ren Q, 2015, CHINESE SOCIOL REV, V47, P255, DOI 10.1080/21620555.2015.1032162; Rocco, 2016, 10022 IZA; Rodriguez A, 2008, SOC INDIC RES, V86, P163, DOI 10.1007/s11205-007-9101-y; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; Rowe JW, 1998, SUCCESSFUL AGING; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Silverstein M, 2002, RES AGING, V24, P528, DOI 10.1177/0164027502245003; State Council Information Office (SCIO) of the People's Republic of China, 2006, WHIT PAP SEN CIT CHI; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Steptoe A, 2012, ARCH INTERN MED, V172, P273, DOI 10.1001/archinternmed.2011.1028; Tey NP, 2016, MATURITAS, V94, P39, DOI 10.1016/j.maturitas.2016.08.016; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Tomioka K, 2016, AGE AGEING; Wang DW, 2009, AGEING SOC, V29, P1141, DOI 10.1017/S0144686X09008629; Wang JF, 2014, AGING MENT HEALTH, V18, P232, DOI 10.1080/13607863.2013.837143; Wang Y, 2014, CHINA EC STUD, V5, P19; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Zeng Y, 2002, POPUL DEV REV, V28, P251; Zeng Y, 2003, CHINA REV, V3, P95, DOI [DOI 10.1007/S42379-018-0010-3, 10.1007/978-90-481-8906-9_14]; Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677; Zhang L., 2015, OPEN J SOCIAL SCI, V3, P150, DOI [DOI 10.4236/JSS.2015.33024, 10.4236/jss.2015.33024]; Zhang M, 2016, INVESTIGATION ELDERL; Zhang W, 2014, SCI RES AGING, V2, P59; Zhou M, 2008, HLTH LONGEVITY CHINA, P357, DOI DOI 10.1007/978-1-4020-6752-5_22; Zhou YC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0136-4; 庞宝华, 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P798; 李德明, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2513	85	71	75	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171799	10.1371/journal.pone.0171799	http://dx.doi.org/10.1371/journal.pone.0171799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187153	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000394244300044
J	Pittet, V; Vaucher, C; Froehlich, F; Burnand, B; Michetti, P; Maillard, MH				Pittet, Valerie; Vaucher, Carla; Froehlich, Florian; Burnand, Bernard; Michetti, Pierre; Maillard, Michel H.		Swiss IBD Cohort Study Grp	Patient self-reported concerns in inflammatory bowel diseases: A gender specific subjective quality-of-life indicator	PLOS ONE			English	Article							HEALTH-STATUS; PART II; WORRIES; WOMEN; INFORMATION; PHYSICIANS; SEXUALITY; FATIGUE; IBD	Background Patient-reported disease perceptions are important components to be considered within a holistic model of quality of care. Gender may have an influence on these perceptions. We aimed to explore gender-specific concerns of patients included in a national bilingual inflammatory bowel disease cohort. Methods Following a qualitative study, we built a questionnaire comprising 37 items of concern. Answers were collected on a visual analog scale ranging from 0 to 100. Principal axis factor analysis was used to explore concern domains. Linear multiple regressions were conducted to assess associations with patient characteristics. Results Of 1102 patients who replied to the survey, 54% were female and 54% had Crohn's disease. We identified six domains of concern: socialization and stigmatization, disease-related constraints and uncertainty, symptoms and their impact on body and mind, loss of body control (including sexuality), disease transmission, and long-term impact of the disease. Cancer concerns were among the highest scored by all patients (median 61.8). Severity of symptoms was the only factor associated with concerns, unrelated to dimension and gender (p<0.015). In women, being >40 years decreased disease-related constraints and uncertainty concerns, and being at home or unemployed increased them. Treatments were associated with increased socialization and stigmatization and with increased disease-related constraints and uncertainty concerns in men. Overall, psychosomatic characteristics were highly associated with concerns for both men and women. Depending on the concern dimensions, increased levels of concern were associated with the highest signs of anxiety in women or depression in men, as well as lower health-related quality of life in men. Conclusions Patients have numerous concerns related to their illness that need to be reassessed regularly. Concerns differ between men and women, suggesting that information and communication about the disease should take gender differences and subjective perceptions of quality of life into consideration.	[Pittet, Valerie; Vaucher, Carla; Burnand, Bernard] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Froehlich, Florian; Maillard, Michel H.] Univ Lausanne Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Froehlich, Florian] Univ Basel Hosp, Div Gastroenterol & Hepatol, Basel, Switzerland; [Michetti, Pierre] Clin Source Beaulieu, Crohn & Colitis Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Pittet, V (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Valerie.pittet@chuv.ch		Braegger, Christian/0000-0001-8069-9875; Pittet, Valerie/0000-0003-2208-966X	Swiss National Science Foundation (SNSF) [33CS30-148422, 32473B-138498]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The study was supported by the Swiss National Science Foundation (SNSF) grants No 33CS30-148422 (Swiss IBD cohort study) and 32473B-138498 (Appropriateness of care in IBD) to VP.	Aghamohammadi-Kalkhoran M, 2014, J HLTH PSYCHOL; Anderson KL, 1999, J ADV NURS, V29, P298, DOI 10.1046/j.1365-2648.1999.00889.x; Barbour R., 2007, DOING FOCUS GROUPS; Berroa E, 2015, INFLAMM BOWEL DIS, V21, pE22, DOI 10.1097/MIB.0000000000000539; Borum ML, 2010, INFLAMM BOWEL DIS, V16, P181, DOI 10.1002/ibd.20955; Borum ML, 2009, INFLAMM BOWEL DIS, V15, P1773, DOI 10.1002/ibd.20871; Camara RJA, 2011, INFLAMM BOWEL DIS, V17, P1277, DOI 10.1002/ibd.21481; Fernandez JC, 2010, PSICOTHEMA, V22, P208; Casati J, 2000, DIGEST DIS SCI, V45, P26, DOI 10.1023/A:1005492806777; de Rooy EC, 2001, AM J GASTROENTEROL, V96, P1816, DOI 10.1016/S0002-9270(01)02440-6; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DROSSMAN DA, 1991, PSYCHOSOM MED, V53, P701, DOI 10.1097/00006842-199111000-00010; DROSSMAN DA, 1991, DIGEST DIS SCI, V36, P1746, DOI 10.1007/BF01296620; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fletcher PC, 2008, CLIN NURSE SPEC, V22, P278, DOI 10.1097/01.NUR.0000325382.99717.ac; Fletcher PC, 2008, CLIN NURSE SPEC, V22, P184, DOI 10.1097/01.NUR.0000311707.32566.c8; Hair JF, 1998, MULTIVAR DATA ANAL, VXX, P730; Hauser G, 2011, COLLEGIUM ANTROPOL, V35, P203; Hjortswang H, 1998, AM J GASTROENTEROL, V93, P2203, DOI 10.1111/j.1572-0241.1998.00537.x; Jamieson AE, 2007, CLIN NURSE SPEC, V21, P152, DOI 10.1097/01.NUR.0000270015.97457.9c; Jelsness-Jorgensen LP, 2012, J PSYCHOSOM RES, V73, P469, DOI 10.1016/j.jpsychores.2012.08.009; Jelsness-Jorgensen LP, 2012, WORLD J GASTROENTERO, V18, P445, DOI 10.3748/wjg.v18.i5.445; Jelsness-Jorgensen LP, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/492034; Lagro-Janssen Toine, 2008, Eur J Gen Pract, V14 Suppl 1, P33, DOI 10.1080/13814780802436127; Levenstein S, 2001, AM J GASTROENTEROL, V96, P1822, DOI 10.1016/S0002-9270(01)02441-8; Maunder R, 1999, CAN J GASTROENTEROL, V13, P728, DOI 10.1155/1999/701645; MOSER G, 1995, EUR J GASTROEN HEPAT, V7, P853; Muller KR, 2010, INFLAMM BOWEL DIS, V16, P657, DOI 10.1002/ibd.21090; Multone E, 2015, SCAND J GASTROENTERO, P1; Mussell M, 2004, EUR J GASTROEN HEPAT, V16, P1273, DOI 10.1097/00042737-200412000-00007; Okoro Ngozi Ivunanya, 2009, Expert Rev Gastroenterol Hepatol, V3, P145, DOI 10.1586/egh.09.1; Reddy S I, 2001, J Am Osteopath Assoc, V101, pS17; Stjernman H, 2010, SCAND J GASTROENTERO, V45, P696, DOI 10.3109/00365521003734141; Trachter AB, 2002, INFLAMM BOWEL DIS, V8, P413, DOI 10.1097/00054725-200211000-00006; Vaucher C, 2016, SCAND J GASTROENTERO, P1	36	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171864	10.1371/journal.pone.0171864	http://dx.doi.org/10.1371/journal.pone.0171864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187201	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300054
J	Dabi, Y; Nedellec, S; Bonneau, C; Trouchard, B; Rouzier, R; Benachi, A				Dabi, Yohann; Nedellec, Sophie; Bonneau, Claire; Trouchard, Blandine; Rouzier, Roman; Benachi, Alexandra			Clinical validation of a model predicting the risk of preterm delivery	PLOS ONE			English	Article							BIRTH; MORTALITY; GESTATION; IMPACT	Objectives To validate a model predicting the risk of threatened preterm delivery and to establish the optimal threshold for this risk scoring system. Materials and methods Two cohorts were studied: one of singleton pregnancies without preterm premature rupture of membranes (PPROM) and no cervical cerclage (cohort 1) and one of twin pregnancies without PPROM and no cervical cerclage (cohort 2). Patients were included from January 1 st 2013 until December 31 st 2013 by the Regional Perinatal Network of Ile de France with patients transferred because of threatened preterm delivery at 22 to 32 weeks of gestation. The individual probability of delivery within 48 hours of admission was calculated using the nomogram for every patient. Discrimination and calibration of the nomogram as well as the optimal threshold were determined using R studio. Results The nomogram accurately predicted obstetric outcome. Discrimination and calibration were excellent, with an area under the curve (AUC) of 0.88 (95% CI 0.86-0.90) for cohort 1 and 0.73 (95% CI 0.66-0.80) for cohort 2. The optimal threshold would be 15% for cohort 1 and 10% for cohort 2. Using these thresholds, the performance characteristics of the nomogram were: sensitivity 80% (cohort 1) and 69% (cohort 2), negative predictive value 94.8% (cohort 1) and 91.3% (cohort 2). Use of the nomogram would avoid 253 unnecessary transfers in cohort 1. Conclusions The nomogram was efficient and clinically relevant in our high risk population. A threshold set at 15% would help minimize the risk of preterm deliveries in singleton pregnancies and should reduce unnecessary, costly and stressful in utero transfer.	[Dabi, Yohann; Nedellec, Sophie; Trouchard, Blandine; Benachi, Alexandra] Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Gynecol Obstet, Clamart, France; [Dabi, Yohann; Nedellec, Sophie; Trouchard, Blandine; Benachi, Alexandra] Hop Antoine Beclere, Cellule Transfert Utero Ile France, Clamart, France; [Bonneau, Claire; Rouzier, Roman] Inst Curie, Serv Chirurg, St Cloud, France; [Rouzier, Roman] Univ Versailles, Risques Clin & Securite Sante Femmes & Sante Per, EA 7285, St Quentin En Yvelines, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Dabi, Y (corresponding author), Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Gynecol Obstet, Clamart, France.; Dabi, Y (corresponding author), Hop Antoine Beclere, Cellule Transfert Utero Ile France, Clamart, France.	yohann.dabi@gmail.com	Bonneau, Claire/GON-5289-2022; Rouzier, Roman/G-2953-2018	Bonneau, Claire/0000-0001-6251-286X; Dabi, Yohann/0000-0002-9353-6036; Rouzier, Roman/0000-0002-8167-6808				Allouche M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.030; Davey MA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004902.pub4; Eastham James A, 2002, Semin Urol Oncol, V20, P108, DOI 10.1053/suro.2002.32936; Gilbert WM, 2006, BJOG-INT J OBSTET GY, V113, P4, DOI 10.1111/j.1471-0528.2006.01117.x; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Honest H, 2004, J Obstet Gynaecol, V24, P343, DOI 10.1080/01443610410001685439; Kattan MW, 2004, CANCER-AM CANCER SOC, V101, P2509, DOI 10.1002/cncr.20635; Mailath-Pokorny M, 2015, EUR J OBSTET GYN R B, V186, P42, DOI 10.1016/j.ejogrb.2014.12.010; PAPIERNIK E, 1974, J PERINAT MED, V2, P30, DOI 10.1515/jpme.1974.2.1.30; Parant O, 2008, BJOG-INT J OBSTET GY, V115, P1538, DOI 10.1111/j.1471-0528.2008.01929.x; Petrou S, 2006, EARLY HUM DEV, V82, P77, DOI 10.1016/j.earlhumdev.2006.01.002; Petrou S, 2003, PEDIATRICS, V112, P1290, DOI 10.1542/peds.112.6.1290; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; Shlossman PA, 1997, AM J PERINAT, V14, P449, DOI 10.1055/s-2007-994178; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Towers CV, 2000, OBSTET GYNECOL, V95, P291, DOI 10.1016/S0029-7844(99)00528-1	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171801	10.1371/journal.pone.0171801	http://dx.doi.org/10.1371/journal.pone.0171801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182768	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800115
J	Hughes, J; Huo, X; Falk, L; Hurford, A; Lan, KQ; Coburn, B; Morris, A; Wu, JH				Hughes, Josie; Huo, Xi; Falk, Lindsey; Hurford, Amy; Lan, Kunquan; Coburn, Bryan; Morris, Andrew; Wu, Jianhong			Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA ACQUISITION; CLOSTRIDIUM-DIFFICILE INFECTION; ANTIBIOTIC-RESISTANCE; RISK-FACTORS; CLINICAL-OUTCOMES; DISEASES SOCIETY; SEVERE SEPSIS; ICU	Sequential antimicrobial de-escalation aims to minimize resistance to high-value broad-spectrum empiric antimicrobials by switching to alternative drugs when testing confirms susceptibility. Though widely practiced, the effects de-escalation are not well understood. Definitions of interventions and outcomes differ among studies. We use mathematical models of the transmission and evolution of Pseudomonas aeruginosa in an intensive care unit to assess the effect of de-escalation on a broad range of outcomes, and clarify expectations. In these models, de-escalation reduces the use of high-value drugs and preserves the effectiveness of empiric therapy, while also selecting for multidrug-resistant strains and leaving patients vulnerable to colonization and superinfection. The net effect of de-escalation in our models is to increase infection prevalence while also increasing the probability of effective treatment. Changes in mortality are small, and can be either positive or negative. The clinical significance of small changes in outcomes such as infection prevalence and death may exceed more easily detectable changes in drug use and resistance. Integrating harms and benefits into ranked outcomes for each patient may provide a way forward in the analysis of these tradeoffs. Our models provide a conceptual framework for the collection and interpretation of evidence needed to inform antimicrobial stewardship.	[Hughes, Josie; Huo, Xi; Wu, Jianhong] York Univ, Ctr Dis Modelling, Toronto, ON, Canada; [Huo, Xi; Lan, Kunquan] Ryerson Univ, Dept Math, Toronto, ON, Canada; [Falk, Lindsey] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Hurford, Amy] Mem Univ Newfoundland, Dept Math & Stat, St John, NF, Canada; [Coburn, Bryan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Coburn, Bryan; Morris, Andrew] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Coburn, Bryan; Morris, Andrew] Univ Hlth Network, Toronto, ON, Canada; [Morris, Andrew] Univ Toronto, Dept Med, Toronto, ON, Canada; [Falk, Lindsey] Hlth Qual Ontario, Toronto, ON, Canada	York University - Canada; Toronto Metropolitan University; University of Toronto; Memorial University Newfoundland; Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Wu, JH (corresponding author), York Univ, Ctr Dis Modelling, Toronto, ON, Canada.; Morris, A (corresponding author), Sinai Hlth Syst, Dept Med, Toronto, ON, Canada.; Morris, A (corresponding author), Univ Hlth Network, Toronto, ON, Canada.; Morris, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	Andrew.Morris@sinaihealthsystem.ca; wujh@yorku.ca	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Coburn, Bryan/0000-0003-0150-4510; Hughes, Josie/0000-0001-7875-9015				Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; Alyaseen SA, 2005, ANTIMICROB AGENTS CH, V49, P2543, DOI 10.1128/AAC.49.6.2543-2545.2005; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2001, PATHOL BIOL, V49, P620, DOI [10.1016/S0369-8114(01)00219-X, DOI 10.1016/S0369-8114(01)00219-X]; [Anonymous], 2016, CLIN INFECT DIS, DOI DOI 10.1093/cid/civ1199; Boyer A, 2011, CRIT CARE, V15, DOI 10.1186/cc10026; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105454; Carnell R, 2016, LHS LATIN HYPERCUBE; Cobos-Trigueros N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0916-7; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Eagye KJ, 2009, SEMIN RESP CRIT CARE, V30, P116, DOI 10.1055/s-0028-1119815; Evans SR, 2015, CLIN INFECT DIS, V61, P800, DOI 10.1093/cid/civ495; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; Garnacho-Montero J, 2015, CURR OPIN INFECT DIS, V28, P193, DOI 10.1097/QCO.0000000000000141; Gehring R, 2010, J THEOR BIOL, V262, P97, DOI 10.1016/j.jtbi.2009.09.002; Geli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029838; Giantsou E, 2007, INTENS CARE MED, V33, P1533, DOI 10.1007/s00134-007-0619-x; Haber M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-254; Harper EB, 2011, ECOL APPL, V21, P1225, DOI 10.1890/10-0506.1; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hughes JS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012040; Hurford A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138216; Hurford A, 2012, EPIDEMICS-NETH, V4, P203, DOI 10.1016/j.epidem.2012.12.001; Jin-Hee Kim, 2012, International Journal of Photoenergy, DOI 10.1155/2012/957847; Kaye KS, 2012, J HOSP MED, V7, pS13, DOI 10.1002/jhm.983; Khasawneh FA, 2014, INFECTION, V42, P829, DOI 10.1007/s15010-014-0639-8; Kollef MH, 2006, CHEST, V129, P1210, DOI 10.1378/chest.129.5.1210; Kouyos RD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0566; Kouyos RD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001094; Lambert ML, 2011, LANCET INFECT DIS, V11, P30, DOI 10.1016/S1473-3099(10)70258-9; Leone M, 2014, INTENS CARE MED, V40, P1399, DOI 10.1007/s00134-014-3411-8; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mokart D, 2014, INTENS CARE MED, V40, P41, DOI 10.1007/s00134-013-3148-9; Morita Y, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00422; Morris Andrew M, 2014, Curr Treat Options Infect Dis, V6, P101; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Obolski U, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004340; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Paskovaty A, 2015, INTENS CARE MED, V41, P2022, DOI 10.1007/s00134-015-4016-6; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Perron GG, 2012, APPL ENVIRON MICROB, V78, P6137, DOI 10.1128/AEM.01078-12; Poole K, 2014, CAN J MICROBIOL, V60, P783, DOI 10.1139/cjm-2014-0666; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Pujol G., 2015, SENSITIVITY SENSITIV; RADBERG G, 1990, ANTIMICROB AGENTS CH, V34, P2142, DOI 10.1128/AAC.34.11.2142; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; Schwaber MJ, 2004, NAT REV MICROBIOL, V2, P979, DOI 10.1038/nrmicro1047; Shime N, 2013, INFECTION, V41, P203, DOI 10.1007/s15010-012-0388-5; Silva BNG, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007934.pub3; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102; Spicknall IH, 2013, AM J EPIDEMIOL, V178, P508, DOI 10.1093/aje/kwt017; Talaminos A, 2016, EPIDEMIOL INFECT, P1; Therneau T, 2015, RPART RECURSIVE PART; Thuong M, 2003, J HOSP INFECT, V53, P274, DOI 10.1053/jhin.2002.1370; Timsit JF, 2014, INTENS CARE MED, V40, P1580, DOI 10.1007/s00134-014-3485-3; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; U.S. Food and Drug Administration, 2016, FDA STRENGTH KIDN WA; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Venier AG, 2014, J HOSP INFECT, V88, P103, DOI 10.1016/j.jhin.2014.06.018; WHO, 2011, WHO LIB CAT PUBL DAT; Wolkewitz M, 2008, STAT MED, V27, P6522, DOI 10.1002/sim.3419; Wolkewitz M, 2014, CRIT CARE, V18, DOI 10.1186/cc13821; Wolter DJ, 2007, ANTIMICROB AGENTS CH, V51, P2997, DOI 10.1128/AAC.00111-07; zur Wiesch PA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004225; [No title captured]	75	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171218	10.1371/journal.pone.0171218	http://dx.doi.org/10.1371/journal.pone.0171218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182774	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800046
J	Kenmogne, LC; Roy, J; Maltais, R; Rouleau, M; Neveu, B; Pouliot, F; Poirier, D				Kenmogne, Lucie Carolle; Roy, Jenny; Maltais, Rene; Rouleau, Melanie; Neveu, Bertrand; Pouliot, Frederic; Poirier, Donald			Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17 beta-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models	PLOS ONE			English	Article							ANDROGEN RECEPTOR; DIFFERENTIAL EXPRESSION; DIHYDROTESTOSTERONE; TESTOSTERONE; TARGET; GENE; ANDROSTANEDIOL; AMPLIFICATION; METABOLITES; MUTATIONS	In the fight against androgen-sensitive prostate cancer, the enzyme 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3) is an attractive therapeutic target considering its key role in the formation of androgenic steroids. In this study, we attempted to assess the in vivo efficacy of the compound RM-532-105, an androsterone derivative developed as an inhibitor of 17 beta-HSD3, in the prostate cancer model of androgen-sensitive LAPC-4 cells xenografted in nude mice. RM-532-105 did not inhibit the tumor growth induced by 4-androstene-3,17-dione (4-dione); rather, the levels of the androgens testosterone (T) and dihydrotestosterone (DHT) increased within the tumors. In plasma, however, DHT levels increased but T levels did not. In troubleshooting experiments, the non-androgenic potential of RM-532-105 was confirmed by two different assays (LAPC-4 proliferation and androgen receptor transcriptional activity assays). The enzyme 5 alpha-reductase was also revealed to be the predominant enzyme metabolizing 4-dione in LAPC-4 cells, yielding 5 alpha-androstane-3,17-dione and not T. Other 17 beta-HSDs than 17 beta-HSD3 seem responsible in the androgen synthesis. From experiments with LAPC-4 cells, we fortuitously came across the interesting finding that 17 beta-HSD3 inhibitor RM-532-105 is concentrated inside tumors.	[Kenmogne, Lucie Carolle; Roy, Jenny; Maltais, Rene; Poirier, Donald] CHU Quebec, Res Ctr, CHUL, Lab Med Chem,T4, Quebec City, PQ, Canada; [Rouleau, Melanie; Neveu, Bertrand; Pouliot, Frederic] CHU Quebec, Res Ctr, Axe Canc, Quebec City, PQ, Canada; [Pouliot, Frederic] Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada; [Poirier, Donald] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Poirier, D (corresponding author), CHU Quebec, Res Ctr, CHUL, Lab Med Chem,T4, Quebec City, PQ, Canada.; Poirier, D (corresponding author), Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada.	donald.poirier@crchul.ulaval.ca		Rouleau, Melanie/0000-0003-4154-3127; Pouliot, Frederic/0000-0002-6651-1079; Neveu, Bertrand/0000-0002-6505-6692	Canadian Institute of Health Research (POP-Phase I)	Canadian Institute of Health Research (POP-Phase I)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (POP-Phase I). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chouinard S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703370200; Das K, 2010, ENDOCR-RELAT CANCER, V17, P757, DOI 10.1677/ERC-10-0022; Djigoue GB, 2015, BIOORGAN MED CHEM, V23, P5433, DOI 10.1016/j.bmc.2015.07.049; Endo S, 2016, BIOCHEM BIOPH RES CO, V472, P231, DOI 10.1016/j.bbrc.2016.01.190; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Hara T, 2003, CANCER RES, V63, P149; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Jain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33968; Kaisary AV, 1996, BRIT J HOSP MED, V55, P359; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knuuttila M, 2014, AM J PATHOL, V184, P2163, DOI 10.1016/j.ajpath.2014.04.010; Koh E, 2002, PROSTATE, V53, P154, DOI 10.1002/pros.10139; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Labrie F, 2011, NAT REV UROL, V8, P73, DOI 10.1038/nrurol.2010.231; Laplante Y, 2008, STEROIDS, V73, P266, DOI 10.1016/j.steroids.2007.10.009; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Maltais R, 2002, J MED CHEM, V45, P640, DOI 10.1021/jm010286y; Maltais R, 2011, BIOORGAN MED CHEM, V19, P4652, DOI 10.1016/j.bmc.2011.06.003; Mohler JL, 2011, CLIN CANCER RES, V17, P5844, DOI 10.1158/1078-0432.CCR-11-0644; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mostaghel EA, 2013, TRANSL ANDROL UROL, V2, P212, DOI 10.3978/j.issn.2223-4683.2013.09.16; Neumann F, 1982, CLIN ONCOLOGY, V1, P41; Neveu B, 2016, ONCOTARGET, V7, P1300, DOI 10.18632/oncotarget.6360; Ngatcha BT, 2005, J MED CHEM, V48, P5257, DOI 10.1021/jm058179h; Penning TM, 2015, J STEROID BIOCHEM, V153, P105, DOI 10.1016/j.jsbmb.2015.05.010; Pouliot F, 2013, MOL THER, V21, P554, DOI 10.1038/mt.2012.259; RADWANSKI E, 1989, J CLIN PHARMACOL, V29, P554, DOI 10.1002/j.1552-4604.1989.tb03381.x; Roy J, 2014, J STEROID BIOCHEM, V141, P44, DOI 10.1016/j.jsbmb.2013.12.019; Sato M, 2005, CLIN CANCER RES, V11, P3743, DOI 10.1158/1078-0432.CCR-04-1990; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sobel RE, 2005, J UROLOGY, V173, P360, DOI 10.1097/01.ju.0000149989.01263.dc; Statistics CCSsACoC, 2015, CAN CANC STAT 2015; Taplin ME, 1999, CANCER RES, V59, P2511; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; Yin YRD, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00159	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171871	10.1371/journal.pone.0171871	http://dx.doi.org/10.1371/journal.pone.0171871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182747	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800129
J	Sinsch, U; Dehling, JM				Sinsch, Ulrich; Dehling, Jonas Maximilian			Tropical anurans mature early and die young: Evidence from eight Afromontane Hyperolius species and a meta-analysis	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; AGE STRUCTURE; EUPHLYCTIS-CYANOPHLYCTIS; ALTITUDINAL VARIATION; NATTERJACK TOADS; BUFO-CALAMITA; CASTANEUS AHL; BODY-SIZE; GROWTH; FROGS	Age-and size-related life-history traits of anuran amphibians are thought to vary systematically with latitude and altitude. Because the available data base is strongly biased towards temperate-zone species, we provide new estimates on eight afrotropical Reed Frog species. A meta-analysis of the demographic traits in 44 tropical anuran species aims to test for the predicted clinal variation and to contrast results with variation detected in temperate-zone species. The small-sized reed frogs reach sexual maturity during the first or second year of life, but longevity does not exceed three to four years. Latitudinal effects on demographic life-history traits are not detectable in tropical anurans, and altitudinal effects are limited to a slight size reduction at higher elevations. Common features of anuran life-history in the tropics are early sexual maturation at small size and low longevity resulting in low lifetime fecundity. This pattern contrasts with that found in temperate-zone anurans which mature later at larger size and grow considerably older yielding greater lifetime fecundity than in the tropics. Latitudinal and altitudinal contraction of the yearly activity period shape the evolution of life-history traits in the temperate region, while trait variation in the tropics seems to be driven by distinct, not yet identified selective forces.	[Sinsch, Ulrich; Dehling, Jonas Maximilian] Univ Koblenz Landau, Dept Biol, Zool Grp, Koblenz, Germany	University of Koblenz & Landau	Sinsch, U (corresponding author), Univ Koblenz Landau, Dept Biol, Zool Grp, Koblenz, Germany.	sinsch@uni-koblenz.de	Sinsch, Ulrich/K-1832-2012	Sinsch, Ulrich/0000-0001-8735-8723				Andreone F, 2002, J ZOOL, V257, P425, DOI 10.1017/S0952836902001036; Andreone Franco, 2011, Alytes (Paris), V27, P73; Banks Brian, 1993, Amphibia-Reptilia, V14, P155, DOI 10.1163/156853893X00327; Castanet J., 1993, BONE, P245; Castanet J., 1990, ZOOLOGIE, V11, P191, DOI DOI 10.1046/J.1472-4642.2003.00012.X; Davies SJ, 2015, COMP BIOCHEM PHYS A, V189, P11, DOI 10.1016/j.cbpa.2015.06.033; Dehling JM, 2012, ZOOTAXA, P52; Esteban M, 2000, HERPETOL J, V10, P19; Fa J, IUCN RED LIST THREAT; FRANCILLON H, 1984, REV ECOL-TERRE VIE, V39, P209; Gramapurohit NP, 2009, CURR SCI INDIA, V97, P1243; Guarino F.M., 2008, CONSERVATION STRATEG, VXLV, P265; Guarino FM, 2014, HERPETOL J, V24, P167; HODL W, 1990, FORTS ZOOL, V38, P41; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Jovanovic O, 2010, AMPHIBIA-REPTILIA, V31, P553, DOI 10.1163/017353710X518414; Khonsue W, 2000, ZOOL SCI, V17, P253, DOI 10.2108/zsj.17.253; KLEINENBERG S E, 1969, Zoologicheskii Zhurnal, V48, P1090; Kusrini Mirza Dikari, 2006, Herpetological Review, V37, P423; Lehr E, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.546.6044; Lin Ya-Ling, 2002, Acta Zoologica Taiwanica, V13, P21; Lindquist Erik, 2012, Phyllomedusa, V11, P117; Mahapatra Pravati K., 2008, HERPETOZOA, V21, P31; Miaud C, 2000, HERPETOLOGICA, V56, P135; Morrison C, 2004, HERPETOLOGICA, V60, P34, DOI 10.1655/02-68; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Olalla-Tarraga MA, 2007, GLOBAL ECOL BIOGEOGR, V16, P606, DOI 10.1111/j.1466-8238.2007.00309.x; Oromi N, 2012, ZOOLOGY, V115, P30, DOI 10.1016/j.zool.2011.08.003; Pancharatna Katti, 2009, Journal of Advanced Zoology, V30, P60; Patrelle C, 2012, POLAR BIOL, V35, P1505, DOI 10.1007/s00300-012-1190-7; Pereira G, 2012, HERPETOL J, V22, P145; SABATER-PI J, 1985, Amphibia-Reptilia, V6, P143, DOI 10.1163/156853885X00047; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Sinsch U, 2015, J ZOOL, V297, P32, DOI 10.1111/jzo.12243; Sinsch U, 2010, J ZOOL, V281, P272, DOI 10.1111/j.1469-7998.2010.00702.x; Sinsch U, 2001, STUD NEOTROP FAUNA E, V36, P95, DOI 10.1076/snfe.36.2.95.2134; Sinsch U, 2007, HERPETOL J, V17, P129; Sinsch U, 2015, HERPETOL J, V25, P5; Sinsch U, 2012, AFR ZOOL, V47, P60, DOI 10.3377/004.047.0122; Sinsch U, 2011, AFR ZOOL, V46, P320, DOI 10.3377/004.046.0211; Sinsch Ulrich, 1995, Alytes (Paris), V13, P14; SMIRINA E M, 1972, Zoologicheskii Zhurnal, V51, P1529; Tessa Giulia, 2007, Acta Herpetologica, V2, P139; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Zhang LX, 2012, BIOL J LINN SOC, V106, P623, DOI 10.1111/j.1095-8312.2012.01876.x	46	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171666	10.1371/journal.pone.0171666	http://dx.doi.org/10.1371/journal.pone.0171666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182738	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800087
J	Stott, SRW; Hayat, S; Carnwath, T; Garas, S; Sleeman, JP; Barker, RA				Stott, Simon R. W.; Hayat, Shaista; Carnwath, Tom; Garas, Shaady; Sleeman, Jonathan P.; Barker, Roger A.			CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEAT-STABLE ANTIGEN; VENTRAL TEGMENTAL AREA; CENTRAL-NERVOUS-SYSTEM; SUBSTANTIA-NIGRA; RAT MODEL; MULTIPLE-SCLEROSIS; NEURITE OUTGROWTH; GENE-EXPRESSION; ALPHA-SYNUCLEIN	Parkinson's disease (PD) is a progressive neurodegenerative condition that is characterised by the loss of specific populations of neurons in the brain. The mechanisms underlying this selective cell death are unknown but by using laser capture microdissection, the glycoprotein, CD24 has been identified as a potential marker of the populations of cells that are affected in PD. Using in situ hybridization and immunohistochemistry on sections of mouse brain, we confirmed that CD24 is robustly expressed by many of these subsets of cells. To determine if CD24 may have a functional role in PD, we modelled the dopamine cell loss of PD in Cd24 mutant mice using striatal delivery of the neurotoxin 6-OHDA. We found that Cd24 mutant mice have an anatomically normal dopamine system and that this glycoprotein does not modulate the lesion effects of 6-OHDA delivered into the striatum. We then undertook in situ hybridization studies on sections of human brain and found-as in the mouse brain-that CD24 is expressed by many of the subsets of the cells that are vulnerable in PD, but not those of the midbrain dopamine system. Finally, we sought to determine if CD24 is required for the neuroprotective effect of Glial cell-derived neurotrophic factor (GDNF) on the dopaminergic nigrostriatal pathway. Our results indicate that in the absence of CD24, there is a reduction in the protective effects of GDNF on the dopaminergic fibres in the striatum, but no difference in the survival of the cell bodies in the midbrain. While we found no obvious role for CD24 in the normal development and maintenance of the dopaminergic nigrostriatal system in mice, it may have a role in mediating the neuroprotective aspects of GDNF in this system.	[Stott, Simon R. W.; Hayat, Shaista; Carnwath, Tom; Garas, Shaady; Barker, Roger A.] John Van Geest Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge, England; [Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Sleeman, Jonathan P.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Barker, Roger A.] Wellcome Trust MRC Stem Cell Inst, Cambridge, England	University of Cambridge; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Stott, SRW (corresponding author), John Van Geest Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge, England.	ss2060@cam.ac.uk	Sleeman, Jonathan P/H-2515-2013	Sleeman, Jonathan P/0000-0003-1718-7687; Barker, Roger Alistair/0000-0001-8843-7730; Stott, Simon/0000-0002-5741-4664	Parkinson's UK Innovation grant; Cure Parkinsons's trust grant; DDPDGENES (FP7-HEALTH) [278871]; DDPDGENES; Klinikum Mannheim gGmbH; NIHR Biomedical Research Centre; UKRMP PSP hub; Parkinson's UK; Cambridge Brain Bank - NIHR Cambridge Biomedical Research Centre; charity registered in England; charity registered in Wales [258197]; charity registered in Scotland [SC037554]; Medical Research Council [MC_PC_12009] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10011] Funding Source: researchfish; Parkinson&quot;s UK [K-1011] Funding Source: researchfish	Parkinson's UK Innovation grant; Cure Parkinsons's trust grant; DDPDGENES (FP7-HEALTH); DDPDGENES; Klinikum Mannheim gGmbH; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); UKRMP PSP hub; Parkinson's UK(Parkinson's UK); Cambridge Brain Bank - NIHR Cambridge Biomedical Research Centre; charity registered in England; charity registered in Wales; charity registered in Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	SRWS was funded by a Parkinson's UK Innovation grant (https://www.parkinsons.org.uk/); Cure Parkinsons's trust grant (https://www.cureparkinsons.org.uk/); and DDPDGENES (FP7-HEALTH #278871; http://cordis.europa.eu/project/rcn/101801_en.html). SH was also funded by DDPDGENES. TC & SG received no specific funding for this work (summer interns). JPS was funded by the Klinikum Mannheim gGmbH. RAB was funded by the NIHR Biomedical Research Centre and also receives funding from the UKRMP PSP hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Leigh-Anne McDuffus, Dr Julia Jones and Dr Will Howat at the Histopathology/ISH facility, Cambridge Research Institute for the scanning of DAB stained slides and technical support with the in situ hybridization work. The authors would like to thank Dr Kieren Allinson of the Cambridge Brain Bank for help with the neuroanatomy of human brain sections. Tissue samples, associated clinical and neuropathological data were supplied by the Parkinson's UK Brain Bank, funded by Parkinson's UK, a charity registered in England and Wales (258197) and in Scotland (SC037554), and by the Cambridge Brain Bank which is supported by the NIHR Cambridge Biomedical Research Centre. The authors would also like to thank Prof Anders Bjorklund (Lund University) for supplying the AAV-GDNF virus used in this study. And finally, the authors would like to thank Dr Wei-Li Kuan for constructive feedback on the manuscript.	Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; BRAAK H, 1994, ACTA NEUROPATHOL, V88, P493, DOI 10.1007/BF00296485; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Breysse N, 2007, J NEUROSCI, V27, P5849, DOI 10.1523/JNEUROSCI.0626-07.2007; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DANIEL SE, 1992, LANCET, V340, P186, DOI 10.1016/0140-6736(92)93275-R; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Del Tredici K, 2012, MOVEMENT DISORD, V27, P597, DOI 10.1002/mds.24921; Diaz-Gallo LM, 2011, HUM IMMUNOL, V72, P969, DOI 10.1016/j.humimm.2011.05.028; Engler H, 2009, BRAIN BEHAV IMMUN, V23, P518, DOI 10.1016/j.bbi.2009.01.018; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062456; GOTO S, 1991, ANN NEUROL, V30, P192, DOI 10.1002/ana.410300211; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; JAVOYAGID F, 1980, NEUROLOGY, V30, P1326, DOI 10.1212/WNL.30.12.1326; JELLINGER K, 1988, J NEUROL NEUROSUR PS, V51, P540, DOI 10.1136/jnnp.51.4.540; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103; Kirik D, 2001, J NEUROSCI, V21, P2889, DOI 10.1523/JNEUROSCI.21-08-02889.2001; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kollaee A, 2011, INT J NEUROSCI, V121, P684, DOI 10.3109/00207454.2011.610529; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Liu JQ, 2007, J IMMUNOL, V178, P6227, DOI 10.4049/jimmunol.178.10.6227; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; McClung CA, 2005, J NEUROSCI, V25, P6005, DOI 10.1523/JNEUROSCI.0062-05.2005; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Reyes S, 2013, NEUROBIOL AGING, V34, P873, DOI 10.1016/j.neurobiolaging.2012.07.019; Sanchez E, 2007, ARTHRITIS RHEUM, V56, P3080, DOI 10.1002/art.22871; Schack LM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1319578; Shewan D, 1996, J NEUROSCI, V16, P2624; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Stott SRW, 2013, J NEUROSCI, V33, P8022, DOI 10.1523/JNEUROSCI.4774-12.2013; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wu Y, 1998, J EXP MED, V187, P1151, DOI 10.1084/jem.187.7.1151; Zhou QM, 2003, P NATL ACAD SCI USA, V100, P15041, DOI 10.1073/pnas.2533866100	56	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171748	10.1371/journal.pone.0171748	http://dx.doi.org/10.1371/journal.pone.0171748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182766	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800098
J	Kallemeijn, WW; Scheij, S; Hoogendoorn, S; Witte, MD; Chao, DHM; van Roomen, CPAA; Ottenhoff, R; Overkleeft, HS; Boot, RG; Aerts, JMFG				Kallemeijn, Wouter W.; Scheij, Saskia; Hoogendoorn, Sascha; Witte, Martin D.; Chao, Daniela Herrera Moro; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Overkleeft, Herman S.; Boot, Rolf G.; Aerts, Johannes M. F. G.			Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; TYPE-1 GAUCHER-DISEASE; MANNOSE-TERMINAL GLUCOCEREBROSIDASE; PLACENTAL BETA-GLUCOCEREBROSIDASE; LIVER ENDOTHELIAL-CELLS; RAT-LIVER; VELAGLUCERASE ALPHA; RECOMBINANT GLUCOCEREBROSIDASE; STORAGE DISEASES; IN-VIVO	Deficiency of glucocerebrosidase (GBA) causes Gaucher disease (GD). In the common non-neuronopathic GD type I variant, glucosylceramide accumulates primarily in the lysosomes of visceral macrophages. Supplementing storage cells with lacking enzyme is accomplished via chronic intravenous administration of recombinant GBA containing mannose-terminated N-linked glycans, mediating the selective uptake by macrophages expressing mannose-binding lectin(s). Two recombinant GBA preparations with distinct Nlinked glycans are registered in Europe for treatment of type I GD: imiglucerase (Genzyme), contains predominantly Man(mannose-binding lectins. Differences among cells from different donors (n = 12) were noted, but the same trends were always observed. Our study suggests that further insight in targeting and efficacy of enzyme therapy of individual Gaucher patients could be obtained by the use of recombinant GBA, trace-labeled with an ABP, preferably equipped with an infrared fluorophore or other reporter tag suitable for in vivo imaging.3) glycans, and velaglucerase (Shire PLC) Man(9) glycans. Activity-based probes (ABPs) enable fluorescent labeling of recombinant GBA preparations through their covalent attachment to the catalytic nucleophile E340 of GBA. We comparatively studied binding and uptake of ABP-labeled imiglucerase and velaglucerase in isolated dendritic cells, cultured human macrophages and living mice, through simultaneous detection of different GBAs by paired measurements. Uptake of ABP-labeled rGBAs by dendritic cells was comparable, as well as the bio-distribution following equimolar intravenous administration to mice. ABP-labeled rGBAs were recovered largely in liver, white-blood cells, bone marrow and spleen. Lungs, brain and skin, affected tissues in severe GD types II and III, were only poorly supplemented. Small, but significant differences were noted in binding and uptake of rGBAs in cultured human macrophages, in the absence and presence of mannan. Mannan-competed binding and uptake were largest for velaglucerase, when determined with single enzymes or as equimolar mixtures of both enzymes. Vice versa, imiglucerase showed more prominent binding and uptake not competed by mannan. Uptake of recombinant GBAs by cultured macrophages seems to involve multiple receptors, including several mannose-binding lectins. Differences among cells from different donors (n = 12) were noted, but the same trends were always observed. Our study suggests that further insight in targeting and efficacy of enzyme therapy of individual Gaucher patients could be obtained by the use of recombinant GBA, trace-labeled with an ABP, preferably equipped with an infrared fluorophore or other reporter tag suitable for in vivo imaging.	[Kallemeijn, Wouter W.; Boot, Rolf G.; Aerts, Johannes M. F. G.] Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands; [Kallemeijn, Wouter W.; Scheij, Saskia; Chao, Daniela Herrera Moro; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Hoogendoorn, Sascha; Witte, Martin D.] Leiden Univ, Leiden Inst Chem, Dept Bioorgan Synth, Leiden, Netherlands; [Hoogendoorn, Sascha] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Witte, Martin D.] Univ Groningen, Stratingh Inst Chem, Dept Bioorgan Chem, Groningen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Stanford University; University of Groningen	Aerts, JMFG (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands.; Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Aerts, Johannes/A-1028-2009; Kallemeijn, W. W./P-2768-2019	Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, W. W./0000-0002-3660-2930; Herrera Moro Chao, Daniela/0000-0001-8406-1377; Overkleeft, Herman/0000-0001-6976-7005; Hoogendoorn, Sascha/0000-0002-1155-8697; Boot, Rolf/0000-0002-7031-3390	Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism"); European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING)	Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism"); European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING)	This work was supported by the Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism") and the European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING) to HS Overkleeft and JMFG Aerts.	AERTS JMFG, 1986, ANAL BIOCHEM, V154, P655, DOI 10.1016/0003-2697(86)90043-6; Aerts JMFG, 2010, NAT REV DRUG DISCOV, V9, P837, DOI 10.1038/nrd3311; Aviezer D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004792; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Ben Bdira F, 2016, BIOCHEMISTRY-US, V55, P4823, DOI 10.1021/acs.biochem.6b00363; Ben Turkia H, 2013, AM J HEMATOL, V88, P179, DOI 10.1002/ajh.23382; Berger J, 2012, BRIT J HAEMATOL, V157, P274, DOI 10.1111/j.1365-2141.2011.08989.x; BEUTLER E, 1988, BLOOD REV, V2, P59, DOI 10.1016/0268-960X(88)90009-4; Bijsterbosch MK, 1996, EUR J BIOCHEM, V237, P344, DOI 10.1111/j.1432-1033.1996.00344.x; Bleijlevens B, 2008, ANAL BIOCHEM, V372, P52, DOI 10.1016/j.ab.2007.09.033; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; BRADY RO, 1975, FED PROC, V34, P1310; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1974, NEW ENGL J MED, V291, P989, DOI 10.1056/NEJM197411072911901; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; Cox TM, 1997, BAILLIERE CLIN HAEM, V10, P657, DOI 10.1016/S0950-3536(97)80033-9; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; DEMARSH QB, 1957, BLOOD, V12, P324, DOI 10.1182/blood.V12.4.324.324; DOEBBER TW, 1982, J BIOL CHEM, V257, P2193; ESSNER E, 1960, J BIOPHYS BIOCHEM CY, V7, P329, DOI 10.1083/jcb.7.2.329; EZEKOWITZ RAB, 1988, J CELL SCI, P121; Friedman BA, 1999, BLOOD, V93, P2807; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 1998, BLOOD REV, V12, P115, DOI 10.1016/S0268-960X(98)90023-6; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P5696; Hijnen NM, 2012, CONTRAST MEDIA MOL I, V7, P214, DOI 10.1002/cmmi.485; Hollak CEM, 2010, BLOOD CELL MOL DIS, V44, P41, DOI 10.1016/j.bcmd.2009.09.006; Hopwood JJ, 2006, NAT REV DRUG DISCOV, V5, P101, DOI 10.1038/nrd1962; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; IHLER GM, 1973, P NATL ACAD SCI USA, V70, P2663, DOI 10.1073/pnas.70.9.2663; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; LENNARTZ MR, 1987, J BIOL CHEM, V262, P9942; Machaczka M, 2011, J INHERIT METAB DIS, V34, P233, DOI 10.1007/s10545-010-9241-0; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; MAGNUSSON S, 1993, BIOCHEM J, V291, P749, DOI 10.1042/bj2910749; Malini E, 2015, FASEB J, V29, P3839, DOI 10.1096/fj.15-271148; Mandlebaum FS, 1912, J EXP MED, V16, P797, DOI 10.1084/jem.16.6.797; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; Morales LE, 1996, ANN PHARMACOTHER, V30, P381, DOI 10.1177/106002809603000411; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; MURRAY GJ, 1995, J HISTOCHEM CYTOCHEM, V43, P149, DOI 10.1177/43.2.7822772; MURRAY GJ, 1995, J CELL BIOCHEM, V57, P208, DOI 10.1002/jcb.240570205; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; Phenix CP, 2010, P NATL ACAD SCI USA, V107, P10842, DOI 10.1073/pnas.1003247107; PHILIPPART M, 1965, J NEUROPATH EXP NEUR, V24, P290, DOI 10.1097/00005072-196504000-00009; Piepenhagen PA, 2010, MICROSC RES TECHNIQ, V73, P694, DOI 10.1002/jemt.20810; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; SATO Y, 1993, J CLIN INVEST, V91, P1909, DOI 10.1172/JCI116409; STANG E, 1990, EUR J CELL BIOL, V52, P67; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; TAKASAKI S, 1984, J BIOL CHEM, V259, P112; Tekoah  Y., 2013, BIOSCI REP, V33; TRAYNOR K, 2012, AM J HEALTH SYST PH, V69, P1009; van den Berg LM, 2012, ANN NY ACAD SCI, V1253, P149, DOI 10.1111/j.1749-6632.2011.06392.x; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van Dussen L, 2012, HAEMATOL-HEMATOL J, V97, P1850, DOI 10.3324/haematol.2011.059071; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Zeng DX, 2013, J NUCL MED, V54, P829, DOI 10.2967/jnumed.112.115550; Zhang XS, 2011, J INHERIT METAB DIS, V34, P795, DOI 10.1007/s10545-011-9285-9; Zhu YX, 2004, J PHARMACOL EXP THER, V308, P705, DOI 10.1124/jpet.103.060236; ZIMRAN A, 1995, LANCET, V345, P1479, DOI 10.1016/S0140-6736(95)91038-7; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955; Zimran A, 2010, BLOOD, V115, P4651, DOI 10.1182/blood-2010-02-268649	78	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170268	10.1371/journal.pone.0170268	http://dx.doi.org/10.1371/journal.pone.0170268			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207759	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500008
J	Witzel, TC; Lora, W; Lees, S; Desmond, N				Witzel, T. Charles; Lora, Wezzie; Lees, Shelley; Desmond, Nicola			Uptake contexts and perceived impacts of HIV testing and counselling among adults in East and Southern Africa: A meta-ethnographic review	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; QUALITATIVE RESEARCH; HEALTH-CARE; UGANDA; RISK; TRANSMISSION; EXPERIENCES; INTERVIEWS; DISCLOSURE; COSTS	Introduction HIV testing and counselling (HTC) interventions are key to controlling the HIV epidemic in East and Southern Africa where HTC is primarily delivered through voluntary counselling and testing (VCT), provider initiated testing and counselling (PITC), and home-based counselling and testing (HBVCT). Decision making processes around uptake of HTC models must be taken into account when designing new interventions. Counselling in HTC aims to reduce post-test risk taking behaviour and to link individuals to care but its efficacy is unclear. This meta-ethnography aims to understand the contexts of HTC uptake in East and Southern Africa and to analyse the perceived impacts of counselling-based interventions in relation to sexual behaviour and linkage to care. Methods We conducted a systematic literature review of studies investigating HTC in East and Southern Africa from 2003-April 2014. The search and additional snowballing identified 20 studies that fit our selection criteria. These studies were synthesised through a thematic framework analysis. Results Twenty qualitative and mixed-methods studies examining impacts of HTC models in East and Southern Africa were meta-synthesised. VCT decisions were made individually while HBVCT decisions were located in family and community units. PITC was associated with coercion from healthcare providers. Low quality counselling components and multiple-intersecting barriers faced by individuals mean that counselling in HTC was not perceived to be effective in reducing post-test risk behaviour and had limited perceived effect in facilitating linkage to care. Conclusion HBVCT is associated with minimal stigma and should be considered as an area of priority. Counselling components in HTC interventions were effective in transmitting information about HIV and sexual risk, but were perceived as ineffective in addressing the broader personal circumstances preventing sexual behaviour change and modulating access to care.	[Witzel, T. Charles] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Sigma Res, London, England; [Lora, Wezzie; Desmond, Nicola] Univ Liverpool Liverpool Sch Trop Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Lees, Shelley] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England; [Desmond, Nicola] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine	Witzel, TC (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Sigma Res, London, England.	Charles.witzel@lshtm.ac.uk	Desmond, Nicola/GYQ-8574-2022; Desmond, Nicola/ABA-6504-2020	Desmond, Nicola/0000-0002-2874-8569; Witzel, T Charles/0000-0003-4262-261X	Wellcome Trust [099051/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [099051/Z/12/Z].	[Anonymous], 2013, UNAIDS GETTING TO ZE; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bond VA, 2010, AIDS CARE, V22, P6, DOI 10.1080/09540121003720994; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Emusu D, 2009, AIDS CARE, V21, P1363, DOI 10.1080/09540120902883077; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Groves AK, 2010, AIDS CARE, V22, P538, DOI 10.1080/09540120903311508; Jurgensen M, 2013, SOC SCI MED, V97, P210, DOI 10.1016/j.socscimed.2013.07.033; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Koo DJ, 2006, AM J PUBLIC HEALTH, V96, P962, DOI 10.2105/AJPH.2006.089235; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; Lifshay J, 2009, AIDS CARE, V21, P715, DOI 10.1080/09540120802511844; Lubega M, 2013, PATIENT PREFER ADHER, V7, P447, DOI 10.2147/PPA.S19327; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Musheke M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-97; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Noblit G., 1988, METAETHNOGRAPHY SYNT; Nyanzi-Wakholi B, 2009, AIDS CARE, V21, P903, DOI 10.1080/09540120802657498; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Obermeyer CM, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-6; Rohleder P, 2005, AIDS CARE, V17, P397, DOI 10.1080/09540120512331314376; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Sarna A, 2009, CULT HEALTH SEX, V11, P783, DOI 10.1080/13691050903033423; Sethosa E, 2005, Curationis, V28, P29; Shamu S, 2012, PLOS ONE, V7; Sikasote J, 2011, SEX TRANSM INFECT, V87, P433, DOI 10.1136/sti.2010.047738; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; Taegtmeyer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064527; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; WHO, 2014, CONSOLIDATED GUIDELI; World Health Organisation, 2016, GUIDELINES ON SELF T; World Health Organization, 2012, SERVICE DELIVERY APP; World Health Organization, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2012, PLANNING IMPLEMENTIN	45	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170588	10.1371/journal.pone.0170588	http://dx.doi.org/10.1371/journal.pone.0170588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207802	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000394424500012
J	Yin, ZY; Zou, FNA; Li, H; Cheng, Y; Zhang, JL; Li, BF				Yin Zongyi; Zou Funian; Li Hao; Cheng Ying; Zhang Jialin; Li Baifeng			A rapid, efficient, and economic device and method for the isolation and purification of mouse islet cells	PLOS ONE			English	Article							TRANSPLANTATION	Rapid, efficient, and economic method for the isolation and purification of islets has been pursued by numerous islet-related researchers. In this study, we compared the advantages and disadvantages of our developed patented method with those of commonly used conventional methods (Ficoll-400, 1077, and handpicking methods). Cell viability was assayed using Trypan blue, cell purity and yield were assayed using diphenylthiocarbazone, and islet function was assayed using acridine orange/ethidium bromide staining and enzyme-linked immunosorbent assay-glucose stimulation testing 4 days after cultivation. The results showed that our islet isolation and purification method required 12 +/- 3 min, which was significantly shorter than the time required in Ficoll-400, 1077, and HPU groups (34 +/- 3, 41 +/- 4, and 30 +/- 4 min, respectively; P < 0.05). There was no significant difference in islet viability among the four groups. The islet purity, function, yield, and cost of our method were superior to those of the Ficoll-400 and 1077 methods, but inferior to the handpicking method. However, the handpicking method may cause wrist injury and visual impairment in researchers during large-scale islet isolation (>1000 islets). In summary, the MCT method is a rapid, efficient, and economic method for isolating and purifying murine islet cell clumps. This method overcomes some of the shortcomings of conventional methods, showing a relatively higher quality and yield of islets within a shorter duration at a lower cost. Therefore, the current method provides researchers with an alternative option for islet isolation and should be widely generalized.	[Yin Zongyi; Zou Funian; Li Hao; Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China; [Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Natl Key Lab Gen Surg, Shenyang, Peoples R China; [Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Multiple Organ Transplantat Inst, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Li, BF (corresponding author), China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China.; Li, BF (corresponding author), China Med Univ, Hosp 1, Natl Key Lab Gen Surg, Shenyang, Peoples R China.; Li, BF (corresponding author), China Med Univ, Hosp 1, Multiple Organ Transplantat Inst, Shenyang, Peoples R China.	bfli@cmu.edu.cn			National Nature and Science Funding of China [81370882]; Natural Science Foundation of Liaoning Province [2013021058]	National Nature and Science Funding of China; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Nature and Science Funding of China [grant numbers: 81370882] http://www.nsfc.gov.cn/, and the Natural Science Foundation of Liaoning Province (grant numbers: 2013021058) http://kjih. Ininfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn AJ, 2015, EXPERT REV CLIN IMMU, V11, P59, DOI 10.1586/1744666X.2015.978291; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Li Baifeng, 2016, China Patent, Patent No. [ZL201620214060.8 [P], 201620214060]; Min T, 2010, TRANSPL P, V42, P1825, DOI 10.1016/j.transproceed.2010.01.068; Mohammadi Ayenehdeh J, 2016, IRAN BIOMED J; MOSKALEW.S, 1965, GEN COMP ENDOCR, V5, P342, DOI 10.1016/0016-6480(65)90059-6; Moskalewski S, 1997, Ann Transplant, V2, P6; O'Dowd JF, 2009, METHODS MOL BIOL, V560, P37, DOI 10.1007/978-1-59745-448-3_3; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	11	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171618	10.1371/journal.pone.0171618	http://dx.doi.org/10.1371/journal.pone.0171618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207765	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500043
J	Zhang, MD; Qin, YY; Zuo, B; Gong, W; Zhang, SL; Gong, YR; Quan, ZW; Chu, BF				Zhang, Mingdi; Qin, Yiyu; Zuo, Bin; Gong, Wei; Zhang, Shenglai; Gong, Yurong; Quan, Zhiwei; Chu, Bingfeng			Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression	PLOS ONE			English	Article							CANCER; PROTOONCOGENE; METASTASIS; MUTATIONS; PATHWAY; DECADES; NRARP; EMT	Papillary thyroid cancer (PTC) is one of the endocrine cancers with high clinical and genetic heterogeneity. NOTCH signaling and its downstream NOTCH-Regulated Ankyrin Repeat Protein (NRARP) have been implicated in oncogenesis of many cancers, but the roles in PTCs are less studied. In this study, we show that NRARP is frequently over-expressed in thyroid carcinoma. The over-activation of NRARP is highly and positively correlated with NOTCH genes. Moreover, we find that the expression of NRARP is highly associated with several epithelial mesenchymal transition (EMT) markers and contributes to poor survival outcomes. Therefore, these results indicate that NRARP is an important clinical biomarker in thyroid carcinoma and it promotes EMT induction as well as the progression of PTCs via NOTCH signaling activation.	[Zhang, Mingdi; Gong, Wei; Zhang, Shenglai; Gong, Yurong; Quan, Zhiwei; Chu, Bingfeng] Shanghai Jiao Tong Univ, Dept Gen Surg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Qin, Yiyu] Yancheng Inst Hlth Sci, Clin Coll, Yancheng, Jiangsu, Peoples R China; [Zuo, Bin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Orthoped Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Quan, ZW; Chu, BF (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China.	zhiwquan@163.com; kcb105@126.com			Shanghai Jiao Tong University School of Medicine scientific research fund project [13XJ22003]; National Natural Science Foundation of Youth Science Foundation of China [81602549, 81501914]; National Natural Science Foundation of China [81272747, 81572297]	Shanghai Jiao Tong University School of Medicine scientific research fund project; National Natural Science Foundation of Youth Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Shanghai Jiao Tong University School of Medicine scientific research fund project (No. 13XJ22003) to BFC and National Natural Science Foundation of Youth Science Foundation of China (No.81602549) to MDZ, National Natural Science Foundation of Youth Science Foundation of China (No.81501914) to BZ and National Natural Science Foundation of China (No.81272747, No.81572297) to ZWQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Choi D, 2016, CANCER RES, V76, P582, DOI 10.1158/0008-5472.CAN-15-1199; Costa V, 2015, ONCOTARGET, V6, P11242, DOI 10.18632/oncotarget.3593; Fazio C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20670; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Imaoka T, 2014, ANTICANCER RES, V34, P2165; Jung CK, 2014, J CLIN ENDOCR METAB, V99, pE276, DOI 10.1210/jc.2013-2503; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Montemayor-Garcia C, 2013, ENDOCR PATHOL, V24, P206, DOI 10.1007/s12022-013-9272-9; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; PIEROTTI MA, 1995, J ENDOCRINOL INVEST, V18, P130, DOI 10.1007/BF03349721; Preca BT, 2015, INT J CANCER, V137, P2566, DOI 10.1002/ijc.29642; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Therneau T.M., 2000, MODELING SURVIVAL DA; Wang X, 2014, LEUKEMIA, V28, P894, DOI 10.1038/leu.2013.233; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Yamashita AS, 2013, TRANSL ONCOL, V6, P197, DOI 10.1593/tlo.12442; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0167782	10.1371/journal.pone.0167782	http://dx.doi.org/10.1371/journal.pone.0167782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207739	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500001
J	Auer, MK; Liedl, A; Fuss, J; Nieder, T; Briken, P; Stalla, GK; Hildebrandt, T; Biedermann, SV; Sievers, C				Auer, Matthias K.; Liedl, Anita; Fuss, Johannes; Nieder, Timo; Briken, Peer; Stalla, Guenter K.; Hildebrandt, Thomas; Biedermann, Sarah V.; Sievers, Caroline			High impact of sleeping problems on quality of life in transgender individuals: A crosssectional multicenter study	PLOS ONE			English	Article							SOCIAL SUPPORT; GENERAL-POPULATION; HORMONAL-THERAPY; GENDER IDENTITY; SEXUAL HEALTH; PAIN; FEMALE; DISCRIMINATION; ASSOCIATIONS; TRANSSEXUALS	Introduction Studies in the general population suggest that determinants of QoL are often sex-dependent. Sex-dependent analyses of QoL in transgender populations have not been performed so far. Aim To identify sex-specific and potentially modifiable determinants of QoL in transgender patients Methods In this cross-sectional multicentre study including 82 transwomen (TW) and 72 transmen (TM) at different treatment stages, we investigated potential determinants for QoL focusing on the impact of mood (BDI, STAI-X), sleep quality (PSQI), chronic pain (GPQ), body image (FBeK) and social support (SSS). Main outcome measure Health-related quality of life measured with the Short Form (36) Health Survey (SF-36). Results The age-adjusted SF-36 total score and its subscales did not significantly differ between TM and TW. Using a multivariate regression analysis approach, we identified common but also sex-dependent determinants for QoL (Adjusted R-2 = 0.228; 0.650 respectively). Accounting for general characteristics such as age, BMI and treatment status, sleep quality according to the PSQI was an independent and strong determinant of QoL in both sexes (beta =-0.451, p = 0.003 TM; beta =-0.320; p = 0.0029 TW). Chronic pain was a significant independent predictor of QoL in TM (beta =-0.298; p = 0.042) but not in TW. In contrast, anxiety (beta =-0.451; p< 0.001) being unemployed (beta =-0.206; p = 0.020) and insecurity about the own appearance (FBeK) (beta =-0.261; p = 0.01) were independent predictors of QoL in TW. The rate of those reporting high sleep disturbances (PSQI >= 5) was high with 79.2% in TW and 81.2% in TM. Accordingly, age-adjusted QoL was also significantly lower in those reporting poor sleep in both sexes. Conclusions Sleep strongly affected QoL in both genders, while other factors, like pain and body image, seem to be gender specific in transgender individuals.	[Auer, Matthias K.; Liedl, Anita; Stalla, Guenter K.; Sievers, Caroline] Max Planck Inst Psychiat, Res Grp Clin Neuroendocrinol, Munich, Germany; [Fuss, Johannes; Nieder, Timo; Briken, Peer] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany; [Hildebrandt, Thomas] Erlangen Univ Hosp, Dept Gynecol & Obstet, Erlangen, Germany; [Biedermann, Sarah V.] Univ Med Ctr Hamburg Eppendorf, Ctr Psychosocial Med, Clin Psychiat & Psychotherapy, Hamburg, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Auer, MK (corresponding author), Max Planck Inst Psychiat, Res Grp Clin Neuroendocrinol, Munich, Germany.	mauer@psych.mpg.de	Auer, Matthias/AAI-5449-2021; Fuss, Johannes/AAI-6580-2021	Nieder, Timo/0000-0003-3052-5169				Ainsworth TA, 2010, QUAL LIFE RES, V19, P1019, DOI 10.1007/s11136-010-9668-7; Aloisi AM, 2007, PAIN, V132, pS60, DOI 10.1016/j.pain.2007.02.006; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Auer MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078469; Basar K, 2016, J SEX MED, V13, P1133, DOI 10.1016/j.jsxm.2016.04.071; Baum A., 1984, HDB PSYCHOL HLTH; Bellach Ellert M., 2000, BUNDESGESUNDHEITSBL, V43, P210, DOI DOI 10.1007/S001030050036]; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Bockting W, 2016, CURR OPIN ENDOCRINOL, V23, P188, DOI 10.1097/MED.0000000000000232; BOWSHER D, 1991, Pain Clinic, V4, P223; Buysse D J, 1989, Psychiatry Res, V28, P193; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Chatterjee B, 2014, SLEEP MED, V15, P1547, DOI 10.1016/j.sleep.2014.06.023; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Davey A, 2014, J SEX MED, V11, P2976, DOI 10.1111/jsm.12681; de Torres JP, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-72; Dimopoulou C, 2014, EUR J ENDOCRINOL, V171, P581, DOI 10.1530/EJE-14-0375; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; ERLIK Y, 1981, JAMA-J AM MED ASSOC, V245, P1741, DOI 10.1001/jama.245.17.1741; Franzen Peter L, 2008, Dialogues Clin Neurosci, V10, P473; Fuss J, 2013, J PSYCHIATR RES, V47, P2015, DOI 10.1016/j.jpsychires.2013.08.023; Fydrich T, 2007, FRAGEBOGEN SOZIALEN; Geraedts VJ, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00229; Gomez-Gil E, 2014, QUAL LIFE RES, V23, P671, DOI 10.1007/s11136-013-0497-3; Gorin-Lazard A, 2013, J NERV MENT DIS, V201, P996, DOI 10.1097/NMD.0000000000000046; Gorin-Lazard A, 2012, J SEX MED, V9, P531, DOI 10.1111/j.1743-6109.2011.02564.x; Hajek A, 2015, QUAL LIFE RES, P1; Hajek A, 2016, QUAL LIFE RES, V25, P1159, DOI 10.1007/s11136-015-1166-5; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Heylens G, 2014, BRIT J PSYCHIAT, V204, P151, DOI 10.1192/bjp.bp.112.121954; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; Imbimbo C, 2009, J SEX MED, V6, P2736, DOI 10.1111/j.1743-6109.2009.01379.x; Kim JS, 2015, ASIAN NURS RES, V9, P96, DOI 10.1016/j.anr.2014.12.001; Kunzel HE, 2011, PSYCHONEUROENDOCRINO, V36, P1005, DOI 10.1016/j.psyneuen.2010.12.014; Kuhn A, 2009, FERTIL STERIL, V92, P1685, DOI 10.1016/j.fertnstert.2008.08.126; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lacruz ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007919; Larios SE, 2009, ETHNIC DIS, V19, P65; Leistner SM, 2015, EUR J ENDOCRINOL, V172, P733, DOI 10.1530/EJE-14-0941; LeResche L, 2000, PROG PAIN RES MANAG, V17, P233; LITTLE BC, 1974, J NERV MENT DIS, V159, P256, DOI 10.1097/00005053-197410000-00004; Malchaire J, 2001, INT ARCH OCC ENV HEA, V74, P79, DOI 10.1007/s004200000212; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Manber R, 1999, SLEEP, V22, P540; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Morley S, 2011, PAIN, V152, pS99, DOI 10.1016/j.pain.2010.10.042; Motmans J, 2012, J SEX MED, V9, P743, DOI 10.1111/j.1743-6109.2011.02569.x; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Newfield E, 2006, QUAL LIFE RES, V15, P1447, DOI 10.1007/s11136-006-0002-3; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Spielberger CD, 1994, STATE TRAIT ANXIETY; Strauss B, 1996, HOGREFE VERLAG PSYCH; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Taziaux M, 2016, J CLIN ENDOCR METAB, V101, P2380, DOI 10.1210/jc.2015-4175; TERRY DJ, 1995, ANXIETY STRESS COPIN, V8, P1, DOI 10.1080/10615809508249360; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Wierckx K, 2011, J SEX MED, V8, P3379, DOI 10.1111/j.1743-6109.2011.02348.x; Yang XS, 2016, J AFFECT DISORDERS, V203, P22, DOI 10.1016/j.jad.2016.05.051; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	63	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171640	10.1371/journal.pone.0171640	http://dx.doi.org/10.1371/journal.pone.0171640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199359	Green Published, gold			2022-12-27	WOS:000394424400038
J	Wu, Y; Liu, F; Adi, D; Yang, YN; Xie, X; Li, XM; Ma, X; Fu, ZY; Huang, Y; Chen, BD; Shan, CF; Ma, YT				Wu, Yun; Liu, Fen; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Chen, Bang-Dang; Shan, Chun-Fang; Ma, Yi-Tong			Association between carotid atherosclerosis and different subtypes of hypertension in adult populations: A multiethnic study in Xinjiang, China	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK; CORONARY; PLAQUE; PROGRESSION; PREVALENCE; PREDICTION; IMPACT	Background Ethnic differences in non-invasive measurements of carotid atherosclerosis are being increasingly reported, but the association between carotid atherosclerosis and different subtypes of hypertension in adult populations is not fully understood in different ethnicities. We aimed to investigate the association of carotid atherosclerosis with different subtypes of hypertension in different ethnicities in Xinjiang, a northwestern province in China. Methods A total of 14,618 participants (5,757 Hans, 4,767 Uygurs, and 4,094 Kazakhs) from 26 villages of seven cities in Xinjiang were randomly selected from the Cardiovascular Risk Survey conducted during 2007 and 2010. A standard questionnaire, a physical examination and biochemical tests were employed. Results The mean common carotid intima-media thickness (CIMT) for the 14,618 participants was 0.86 +/- 0.003 mm. The CIMT gradually increased with age. Men (0.92 +/- 0.005 mm) had a higher CIMT than women (0.81 +/- 0.004 mm). The Uygur participants (0.82 +/- 0.006 mm) had a lower CIMT than the Han (0.88 +/- 0.005 mm) and Kazakh participants (0.88 +/- 0.005 mm). The overall prevalences of carotid intimal thickening and carotid plaques were 12.4% and 9.7%, respectively. The prevalence of CIMT varied for the different subtypes of hypertension. Multivariate logistic regression analysis showed different risk factors for abnormal CIMT in different ethnicities. The associations between abnormal CIMT and the different subtypes of hypertension within different ethnic backgrounds were also different. The risk factors for abnormal CIMT included systolic- diastolic hypertension (SDH) in Han participants (OR: 1.323, 95% CI: 1.100 -1.590), SDH ( OR: 1.426, 95% CI: 1.160 - 1.753) and isolated-systolic hypertension (ISH) (OR: 1.844, 95% CI: 1.470 - 2.313) in Uygur participants, and isolateddiastolic hypertension (IDH) (OR: 1.536, 95% CI: 1.170 - 2.016) in Kazakh participants. Conclusion There was an ethnic difference in the prevalence of abnormal CIMT in Xinjiang, a northwestern province in China. The associations between abnormal CIMT and the subtypes of hypertension varied among the different ethnic groups. Among the studied populations, Han participants with SDH, Uygur participants with SDH and ISH, and Kazakh with IDH were more likely to suffer carotid atherosclerosis than those with other subtypes of hypertension. Participants with different ethnic backgrounds had different sets of risk factors for abnormal CIMT.	[Wu, Yun; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China; [Wu, Yun] Xinjiang Med Univ, Dept Gen Practice, Affiliated Hosp 1, Urumqi, Peoples R China; [Liu, Fen; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Chen, Bang-Dang; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Xinjiang Key Lab Cardiovasc Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Xinjiang Key Lab Cardiovasc Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China.	myt_xj@sina.com	xie, xiang/AAG-2128-2021	Wu, Yun/0000-0002-2692-9067	Key Laboratory of Xinjiang Uygur Autonomous Region [2014KL011]	Key Laboratory of Xinjiang Uygur Autonomous Region	This work was funded by the special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region (grant#2014KL011).	Arima H, 2012, HYPERTENSION, V59, P1118, DOI 10.1161/HYPERTENSIONAHA.111.187252; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Bots ML, 2014, HYPERTENSION, V63, P1173, DOI 10.1161/HYPERTENSIONAHA.113.02683; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Huang LC, 2016, J ATHEROSCLER THROMB, V23, P940, DOI 10.5551/jat.32177; Ikeda N, 2015, ULTRASOUND MED BIOL, V41, P1247, DOI 10.1016/j.ultrasmedbio.2014.12.024; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Li W, 2016, J HYPERTENS, V34, P39, DOI 10.1097/HJH.0000000000000745; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu AY, 2015, INT J CLIN EXP MED, V8, P21932; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145325; Lu M, 2004, J HYPERTENS, V22, P1699, DOI 10.1097/00004872-200409000-00013; Manios E, 2015, BLOOD PRESS MONIT, V20, P64, DOI 10.1097/MBP.0000000000000093; Manolio TA, 2008, ATHEROSCLEROSIS, V197, P132, DOI 10.1016/j.atherosclerosis.2007.02.030; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Polak JF, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001492; Usman A, 2015, J ATHEROSCLER THROMB, V22, P739, DOI 10.5551/jat.30460; Wang MY, 2015, HYPERTENSION, V65, P698, DOI 10.1161/HYPERTENSIONAHA.114.03618; Xie W, 2014, HYPERTENS RES, V37, P960, DOI 10.1038/hr.2014.93; Xie WX, 2011, J AM SOC ECHOCARDIOG, V24, P729, DOI 10.1016/j.echo.2011.02.011; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zielinski T, 2007, AM J HYPERTENS, V20, P1058, DOI 10.1016/j.amjhyper.2007.05.011	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171791	10.1371/journal.pone.0171791	http://dx.doi.org/10.1371/journal.pone.0171791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199358	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400049
J	Montesi, M; Panseri, S; Dapporto, M; Tampieri, A; Sprio, S				Montesi, Monica; Panseri, Silvia; Dapporto, Massimiliano; Tampieri, Anna; Sprio, Simone			Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; STRONTIUM RANELATE; IN-VITRO; NONVERTEBRAL FRACTURES; PHOSPHATE CEMENTS; DIFFERENTIATION; PROLIFERATION; RESORPTION; WOMEN; OSTEOPOROSIS	Strontium-substituted apatitic bone cements enriched with sodium alginate were developed as a potential modulator of bone cells fate. The biological impact of the bone cement were investigated in vitro through the study of the effect of the nanostructured apatitic composition and the doping of strontium on mesenchymal stem cells, pre-osteoblasts and osteoclasts behaviours. Up to 14 days of culture the bone cells viability, proliferation, morphology and gene expression profiles were evaluated. The results showed that different concentrations of strontium were able to evoke a cell-specific response, in fact an inductive effect on mesenchymal stem cells differentiation and pre-osteoblasts proliferation and an inhibitory effect on osteoclasts activity were observed. Moreover, the apatitic structure of the cements provided a biomimetic environment suitable for bone cells growth. Therefore, the combination of biological features of this bone cement makes it as promising biomaterials for tissue regeneration.	[Montesi, Monica; Panseri, Silvia; Dapporto, Massimiliano; Tampieri, Anna; Sprio, Simone] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR)	Montesi, M (corresponding author), CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy.	monica.montesi@istec.cnr.it	Dapporto, Massimiliano/O-3740-2019; Panseri, Silvia/AAW-2856-2020; Montesi, Monica/J-8861-2018	Dapporto, Massimiliano/0000-0002-8783-4061; Panseri, Silvia/0000-0002-8099-7132; Sprio, Simone/0000-0003-1526-7915; Montesi, Monica/0000-0002-9192-8554; Panseri, Sara/0000-0001-6970-2009	European Union's Seventh Framework Programme (FP7) [NMP3-SL-2010-SMALL-3-246373]; European Union's Seventh Framework Programme (FP7), OPHIS [246373]	European Union's Seventh Framework Programme (FP7); European Union's Seventh Framework Programme (FP7), OPHIS	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement NMP3-SL-2010-SMALL-3-246373 (2010-2013), Composite Phenotypic triggers for bone and cartilage repair "OPHIS". AT is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 246373, OPHIS.	Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8; Bohner M, 2000, Injury, V31 Suppl 4, P37; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Cianferotti L, 2015, OSTEOPOROSIS INT, V26, P2055, DOI 10.1007/s00198-015-3203-1; Cohen-Solal M, 2002, NEPHROL DIAL TRANSPL, V17, P30, DOI 10.1093/ndt/17.suppl_2.30; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; De Santis R, 2003, J MATER SCI-MATER M, V14, P583, DOI 10.1023/A:1024014822277; Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x; Ginebra MP, 2009, WOODHEAD PUBL MATER, P271, DOI 10.1533/9781845696610.2.271; Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kammerlander C, 2013, BEST PRACT RES CL RH, V27, P757, DOI 10.1016/j.berh.2014.02.005; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Kuang GM, 2015, J BIOMED MATER RES A, V103, P1613, DOI 10.1002/jbm.a.35298; Kumar S, 2010, BONE, V46, P534, DOI 10.1016/j.bone.2009.09.028; Li YF, 2012, BIOCHEM BIOPH RES CO, V418, P725, DOI 10.1016/j.bbrc.2012.01.088; Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048; Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Maenz S, 2014, J MECH BEHAV BIOMED, V39, P328, DOI 10.1016/j.jmbbm.2014.07.028; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Montesi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132633; Nardone V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/871863; Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026; Nouda S, 2009, SPINE, V34, P2613, DOI 10.1097/BRS.0b013e3181abc150; Oral A, 2013, EUR J PHYS REHAB MED, V49, P565; Pan HB, 2009, ACTA BIOMATER, V5, P1678, DOI 10.1016/j.actbio.2008.11.032; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; Rizzoli R, 2010, RHEUMATOL INT, V30, P1341, DOI 10.1007/s00296-010-1542-y; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Schumacher M, 2016, ACTA BIOMATER, V37, P184, DOI 10.1016/j.actbio.2016.04.016; Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027; Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014; Schumacher M, 2015, J MATER CHEM B, V3, P4626, DOI 10.1039/c5tb00654f; Seeman E, 2006, J BONE MINER RES, V21, P1113, DOI 10.1359/JBMR.060404; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25; Sprio S, 2016, MATERIALS, V9, DOI 10.3390/ma9090763; Vaananen HK, 2000, J CELL SCI, V113, P377; Wade SW, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0182-3; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang W, 2013, BIOMATERIALS, V34, P631, DOI 10.1016/j.biomaterials.2012.10.021; Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646; Zhang YD, 2015, ACS APPL MATER INTER, V7, P2393, DOI 10.1021/am507008z; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104527; Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120	54	28	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172100	10.1371/journal.pone.0172100	http://dx.doi.org/10.1371/journal.pone.0172100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196118	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900050
J	Osinski, J; Karbowski, A				Osinski, Jerzy; Karbowski, Adam			Delaying rewards has greater effect on altruism when the beneficiary is socially distant	PLOS ONE			English	Article							PSYCHOLOGICAL DISTANCE; CHOICE	Based on the assumption that social distance and time are dimensions of psychological distance important for altruistic choices it was predicted that enhancement of altruism due to delaying rewards when choosing between a reward for oneself and for another person would be more pronounced the greater the social distance between the subject and another person. In order to test this hypothesis, social discounting using hypothetical monetary rewards and manipulation of social distance and reward delay was measured in a group of 161 college students. The results indicate that delaying rewards increasingly enhances preference for altruistic choices as the social distance between subject and beneficiary grows.	[Osinski, Jerzy] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Karbowski, Adam] Warsaw Sch Econ, Warsaw, Poland	University of Warsaw; Warsaw School of Economics	Osinski, J (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	tomek@psych.uw.edu.pl		Osinski, Jerzy/0000-0001-9612-6799; Karbowski, Adam/0000-0002-8725-1616	Faculty of Psychology, University of Warsaw [BST 164640]; Collegium of World Economy, Warsaw School of Economics [BMN2015]; National Science Centre, Poland [2015/19/B/HS6/01633]	Faculty of Psychology, University of Warsaw; Collegium of World Economy, Warsaw School of Economics; National Science Centre, Poland(National Science Centre, Poland)	The research was supported by a grant BST 164640 from the Faculty of Psychology, University of Warsaw, JO and by a grant BMN2015 from the Collegium of World Economy, Warsaw School of Economics, AK. The preparation of the manuscript was supported by a grant BMN2015 from the Collegium of World Economy, Warsaw School of Economics, AK and by a grant 2015/19/B/HS6/01633 from the National Science Centre, Poland, JO.	Bickel WK, 2012, PSYCHOPHARMACOLOGY, V224, P109, DOI 10.1007/s00213-012-2745-6; Charlton SR, 2013, J BEHAV DECIS MAKING, V26, P118, DOI 10.1002/bdm.766; Green L, 2005, J EXP PSYCHOL LEARN, V31, P1121, DOI 10.1037/0278-7393.31.5.1121; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; Kim H, 2013, PERS SOC PSYCHOL B, V39, P1005, DOI 10.1177/0146167213488214; Maglio SJ, 2013, J EXP PSYCHOL GEN, V142, P644, DOI 10.1037/a0030258; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Osinski J, 2015, BEHAV PROCESS, V115, P61, DOI 10.1016/j.beproc.2015.02.010; Ostaszewski P, 2011, EUR PSYCHOL, V16, P220, DOI 10.1027/1016-9040/a000054; Pronin E, 2008, PERS SOC PSYCHOL B, V34, P224, DOI 10.1177/0146167207310023; Rachlin H., 2010, IMPULSIVITY THEORY S, P411, DOI [10.1037/12069-015, DOI 10.1037/12069-015]; Rachlin H, 2008, J BEHAV DECIS MAKING, V21, P29, DOI 10.1002/bdm.567; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Yi R, 2011, BEHAV PROCESS, V86, P160, DOI 10.1016/j.beproc.2010.09.003	16	4	4	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170387	10.1371/journal.pone.0170387	http://dx.doi.org/10.1371/journal.pone.0170387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196125	Green Published, gold			2022-12-27	WOS:000394423900006
J	Owen, LA; Morrison, MA; Hoffman, RO; Yoder, BA; DeAngelis, MM				Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; Yoder, Bradley A.; DeAngelis, Margaret M.			Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease	PLOS ONE			English	Article							POSTNATAL WEIGHT-GAIN; BIRTH-WEIGHT; RETROLENTAL FIBROPLASIA; GESTATIONAL-AGE; INFANTS; PREVALENCE	Background Retinopathy of prematurity (ROP) is a blinding morbidity of preterm infants. Our current screening criteria have remained unchanged since their inception and lack the ability to identify those at greatest risk. Objectives We sought to comprehensively analyze numerous proposed maternal, infant, and environmental ROP risk variables in a robustly phenotyped population using logistic regression to determine the most predictive model for ROP development and severity. We further sought to determine the statistical interaction between significant ROP risk variables, which has not previously been done in the field of ROP. We hypothesize that our comprehensive analysis will allow for better identification of risk variables that independently correlate with ROP disease. Going forward, this may allow for improved infant risk stratification along a time continuum from prenatal to postnatal development, making prevention more feasible. Methods We performed a retrospective cohort analysis of preterm infants referred for ROP screening in one neonatal intensive care unit from 2010-2015. The primary outcome measure was presence of ROP. Secondary outcome measures were ROP requiring treatment and severe ROP not clearly meeting current treatment criteria. Univariate, stepwise regression and statistical interaction analyses of 57 proposed ROP risk variables was performed to identify variables which were significantly associated with each outcome measure. Results We identified 457 infants meeting our inclusion criteria. Within this cohort, numerous factors showed a significant individual association with our ROP outcome measures; however, stepwise regression analysis found the most predictive model for overall ROP risk included estimated gestational age, birth weight, the need for any surgery, and maternal magnesium prophylaxis. The corresponding Area Under the Curve (AUC) for this model was 0.8641, while the traditional model of gestational age and birth weight predicted ROP disease less well with an AUC of 0.8489. Development of severe ROP was best predicted by estimated gestational age (week), the need for any surgery and increased probability of death or moderate-severe BPD at 7 days. Finally, the model most predictive for type 1 ROP included estimated gestational age (week) and the presence of severe chronic lung disease. No significant statistical interaction was found between variables. Conclusions Our work is unique as we report comprehensive analysis of the greatest number of proposed ROP risk variables to date in a robustly phenotyped population. We describe novel risk models for our ROP outcome measures and demonstrate independence of these variables using statistical modeling not previously applied to ROP. This may better allow for individual infant risk stratification and importantly mitigation of future risk.	[Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; DeAngelis, Margaret M.] Univ Utah, Sch Med, John Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA; [Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; Yoder, Bradley A.; DeAngelis, Margaret M.] Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Owen, LA; DeAngelis, MM (corresponding author), Univ Utah, Sch Med, John Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA.; Owen, LA; DeAngelis, MM (corresponding author), Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA.	leah.owen@hsc.utah.edu; Margaret.deangelis@utah.edu		Owen, Leah/0000-0003-3802-3868	Unrestricted Grant from Research to Prevent Blindness; National Eye Institute Core grant [EY014800]; NATIONAL EYE INSTITUTE [P30EY014800] Funding Source: NIH RePORTER	Unrestricted Grant from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute Core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by an Unrestricted Grant from Research to Prevent Blindness to the John Moran Eye Center and a National Eye Institute (EY014800) Core grant to the John Moran Eye Center.	Alizadeh Yousef, 2015, J Ophthalmic Vis Res, V10, P424, DOI 10.4103/2008-322X.176907; Binenbaum G, 2012, ARCH OPHTHALMOL-CHIC, V130, P1560, DOI 10.1001/archophthalmol.2012.2524; Brown D R, 1990, J Pediatr Ophthalmol Strabismus, V27, P268; Cao JH, 2016, J AAPOS, V20, P19, DOI 10.1016/j.jaapos.2015.10.017; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; DeAngelis MM, 2004, ARCH OPHTHALMOL-CHIC, V122, P575, DOI 10.1001/archopht.122.4.575; Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Fortes JB, 2009, REV PANAM SALUD PUBL, V26, P216; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gergely K, 2010, BRATISL MED J, V111, P514; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert Clare, 2008, Community Eye Health, V21, P46; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; GUNN TR, 1980, PEDIATRICS, V65, P1096; Hakeem AHAA, 2012, MIDDLE EAST AFR J OP, V19, P289, DOI 10.4103/0974-9233.97927; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Holmstrom G, 1998, ACTA OPHTHALMOL SCAN, V76, P204, DOI 10.1034/j.1600-0420.1998.760216.x; Holmstrom G, 1996, ACTA OBSTET GYN SCAN, V75, P628, DOI 10.3109/00016349609054687; Hutchinson AK, 2016, OPHTHALMOLOGY, V123, P804, DOI 10.1016/j.ophtha.2015.11.003; Karna Padmani, 2005, BMC Pediatr, V5, P18, DOI 10.1186/1471-2431-5-18; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LECHNER D, 1977, PEDIATRICS, V59, P916; Liu PM, 2005, AM J PERINAT, V22, P115, DOI 10.1055/s-2005-837276; Lundgren P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109460; Owen Leah A, 2014, J Ophthalmic Vis Res, V9, P94; Painter S. L., 2014, BR J OPHTHALMOL; PUROHIT DM, 1985, PEDIATRICS, V76, P339; SCHAFFER DB, 1993, OPHTHALMOLOGY, V100, P230; Shin DL, 2014, J AAPOS, V18, P124, DOI 10.1016/j.jaapos.2013.12.003; SHOHAT M, 1983, PEDIATRICS, V72, P159; Slidsborg C, 2016, OPHTHALMOLOGY, V123, P796, DOI 10.1016/j.ophtha.2015.12.019; TERRY TL, 1945, ARCH OPHTHALMOL-CHIC, V33, P203, DOI 10.1001/archopht.1945.00890150047006; Woo SJ, 2011, EYE, V25, P1478, DOI 10.1038/eye.2011.208; Yanovitch TL, 2006, J AAPOS, V10, P128, DOI 10.1016/j.jaapos.2005.08.005; Ying GS, 2015, JAMA OPHTHALMOL, V133, P304, DOI 10.1001/jamaophthalmol.2014.5185; Zin A, 2013, CLIN PERINATOL, V40, P185, DOI 10.1016/j.clp.2013.02.001	40	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171467	10.1371/journal.pone.0171467	http://dx.doi.org/10.1371/journal.pone.0171467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196114	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423900023
J	Wang, K; Jin, S; Fan, DD; Wang, MS; Xing, NAZ; Niu, YN				Wang, Kai; Jin, Song; Fan, Dongdong; Wang, Mingshuai; Xing, Nianzeng; Niu, Yinong			Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-jun gene	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; HYPERPLASIA; PROLIFERATION; CROSSTALK; ESTROGEN; ANDROGEN; CANCER; MEN	This study aimed to identify the role of mouse fibroblast-mediated c-Jun and IGF-1 signaling in the therapeutic effect of finasteride on benign prostatic epithelial cells. BPH-1 cells, alone or with fibroblasts (c-Jun+I+ or c-Jun-I-), were implanted subcutaneously in male nude mice who were then treated with finasteride. The degrees of cell proliferation, apoptosis, and sizes of the xenografts were determined. BPH-1 cells were grown alone or co-cultured with mouse fibroblasts in the presence of finasteride and the level of IGF-1 secreted into the medium by the fibroblasts was determined. The proliferation-associated signaling pathway in BPH-1 cells was also evaluated. Fibroblasts and c-Jun promoted xenograft growth, stimulated Ki-67 expression, and inhibited BPH-1 apoptosis. Finasteride did not induce the shrinkage of xenografts in the combined-grafted groups despite repressing Ki-67 expression and inducing cell apoptosis. The addition of c-Jurft-fibroblasts did not promote xenograft growth. In the absence of c-Jun and fibroblasts, finasteride did not alter xenograft growth, Ki-67 expression, or cell apoptosis. The in vitro results demonstrated that when BPH-1 cells were grown in monoculture, treatment with finasteride did not induce cell death and stimulated the expression of pro-proliferative signaling molecules, while in the presence of fibroblasts containing c-Jun, finasteride treatment repressed epithelial cell proliferation, the level of IGF-1 in the medium, and the activation of downstream pro-proliferative signaling pathways. Taken together, our results suggest that fibroblasts, c-Jun, and IGF-1 play key roles in mediating stromal-epithelial interactions that are required for the therapeutic effects of finasteride in benign prostate epithelial cells.	[Wang, Kai; Jin, Song; Fan, Dongdong; Wang, Mingshuai; Xing, Nianzeng; Niu, Yinong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China; [Wang, Kai] Weifang Hosp Tradit Chinese Med, Dept Urol, Weifang, Peoples R China	Capital Medical University	Niu, YN (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China.	18601020160@163.com	Yinong, Niu/J-9086-2019	Xing, Nianzeng/0000-0002-2696-5279	National Natural Science Foundation of China [30973015]; Beijing Natural Science Foundation at Beijing Chaoyang Hospital, Capital Medical University [7122074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation at Beijing Chaoyang Hospital, Capital Medical University	This study was supported by funding from the National Natural Science Foundation of China (No. 30973015) and the Beijing Natural Science Foundation (No. 7122074) at Beijing Chaoyang Hospital, Capital Medical University to Yinong Niu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne CW, 2003, EUR J CANCER, V39, P1004, DOI 10.1016/S0959-8049(03)00071-6; Carrasquillo RJ, 2014, CURR OPIN ENDOCRINOL, V21, P488, DOI 10.1097/MED.0000000000000110; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Cunha GR, 2011, DIFFERENTIATION, V82, P168, DOI 10.1016/j.diff.2011.04.002; GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701; Hennenberg M, 2015, LIFE SCI, V123, P18, DOI 10.1016/j.lfs.2014.12.006; Kang DI, 2013, KOREAN J UROL, V54, P213, DOI 10.4111/kju.2013.54.4.213; Kim JH, 2016, PROSTATE, V76, P1431, DOI 10.1002/pros.23227; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; Niu Y, 2011, REDUCED LEVELS 5 RED, P1317; Niu YN, 2009, ASIAN J ANDROL, V11, P28, DOI 10.1038/aja.2008.39; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Shao R, 2014, PROSTATE, V74, P970, DOI 10.1002/pros.22814; Song LM, 2016, BOSNIAN J BASIC MED, V16, P201, DOI 10.17305/bjbms.2016.1209; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Wadsworth TL, 2004, ENDOCRINOLOGY, V145, P3205, DOI 10.1210/en.2003-1716; Wang K, 2014, ASIAN J ANDROL, V16, P274, DOI 10.4103/1008-682X.123664; Webber JP, 2016, ONCOTARGET, V7, P20124, DOI 10.18632/oncotarget.7716; Yang XL, 2010, INT J MOL MED, V26, P17, DOI 10.3892/ijmm_00000429	20	8	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172233	10.1371/journal.pone.0172233	http://dx.doi.org/10.1371/journal.pone.0172233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196103	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900062
J	Kamfwa, K; Zhao, DY; Kelly, JD; Cichy, KA				Kamfwa, Kelvin; Zhao, Dongyan; Kelly, James D.; Cichy, Karen A.			Transcriptome analysis of two recombinant inbred lines of common bean contrasting for symbiotic nitrogen fixation	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; LOTUS-JAPONICUS; PURINE BIOSYNTHESIS; EXPRESSION ANALYSIS; NODULE DEVELOPMENT; NODULATION; LEGUME; GENE; RHIZOBIUM; TRANSPORT	Common bean (Phaseolus vulgaris L.) fixes atmospheric nitrogen (N-2) through symbiotic nitrogen fixation (SNF) at levels lower than other grain legume crops. An understanding of the genes and molecular mechanisms underlying SNF will enable more effective strategies for the genetic improvement of SNF traits in common bean. In this study, transcriptome profiling was used to identify genes and molecular mechanisms underlying SNF differences between two common bean recombinant inbred lines that differed in their N-fixing abilities. Differential gene expression and functional enrichment analyses were performed on leaves, nodules and roots of the two lines when grown under N-fixing and non-fixing conditions. Receptor kinases, transmembrane transporters, and transcription factors were among the differentially expressed genes identified under N-fixing conditions, but not under non-fixing conditions. Genes up-regulated in the stronger nitrogen fixer, SA36, included those involved in molecular functions such as purine nucleoside binding, oxidoreductase and transmembrane receptor activities in nodules, and transport activity in roots. Transcription factors identified in this study are candidates for future work aimed at understanding the functional role of these genes in SNF. Information generated in this study will support the development of gene-based markers to accelerate genetic improvement of SNF in common bean.	[Kamfwa, Kelvin] Univ Zambia, Dept Plant Sci, Lusaka, Zambia; [Zhao, Dongyan; Cichy, Karen A.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Kelly, James D.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Cichy, Karen A.] USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI USA	University of Zambia; Michigan State University; Michigan State University; United States Department of Agriculture (USDA)	Cichy, KA (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.; Cichy, KA (corresponding author), USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI USA.	karen.cichy@ars.usda.gov		Zhao, Dongyan/0000-0002-2080-8416; Cichy, Karen/0000-0002-4311-0774	USDA-ARS; Feed the Future Innovation Lab for Collaborative Research on Grain Legumes; Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005-00]; Norman Borlaug Commemorative Research Initiative (US Agency for International Development)	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Feed the Future Innovation Lab for Collaborative Research on Grain Legumes(United States Agency for International Development (USAID)); Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID)); Norman Borlaug Commemorative Research Initiative (US Agency for International Development)(United States Agency for International Development (USAID))	Research was supported by the USDA-ARS and was also made possible through support provided by the Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Cooperative Agreement No. EDH-A-00-07-00005-00, and this work was supported by funding from the Norman Borlaug Commemorative Research Initiative (US Agency for International Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akibode CS, 2012, GLOBAL REGIONAL TREN; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1970, HDB RHIZOBIA; APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; Chiasson DM, 2014, P NATL ACAD SCI USA, V111, P4814, DOI 10.1073/pnas.1312801111; Chungopast S, 2014, PLANT BIOTECHNOL, V31; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; DAY DA, 1991, PLANT PHYSIOL BIOCH, V29, P185; Denance N, 2014, PLANT CELL PHYSIOL, V55, P469, DOI 10.1093/pcp/pct198; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Godiard L, 2011, NEW PHYTOL, V191, P391, DOI 10.1111/j.1469-8137.2011.03718.x; Graham P., 2009, NITROGEN FIXATION CR, P171; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; GRAHAM PH, 1981, FIELD CROP RES, V4, P93, DOI 10.1016/0378-4290(81)90060-5; GRAHAM PH, 1994, CAN J MICROBIOL, V40, P198, DOI 10.1139/m94-033; Gresshoff PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-201; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI DOI 10.1093/nar/gkh066; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Institute S, 2011, SAS VERS 9 3; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Kusolwa PM, 2016, J PLANT REGIST, V10, P149, DOI 10.3198/jpr2015.10.0064crg; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Long SR, 2015, NATURE, V523, P298, DOI 10.1038/nature14632; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Noor SNM, 2015, BIOLOGICAL NITROGEN FIXATION, VOLS 1 AND 2, P683; Nova-Franco B, 2015, PLANT PHYSIOL, V168, P273, DOI 10.1104/pp.114.255547; O'Rourke JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-866; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Sinharoy S, 2013, BIOL NITROGEN FIXATI, V2, P823; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Vincent JM, 1970, IBP HDB; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	58	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172141	10.1371/journal.pone.0172141	http://dx.doi.org/10.1371/journal.pone.0172141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192540	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800077
J	Wu, B; Hu, YN; Huo, PJ; Zhang, Q; Chen, X; Zhang, ZW				Wu, Bin; Hu, Yani; Huo, Pengjie; Zhang, Qian; Chen, Xin; Zhang, Zongwen			Transcriptome analysis of hexaploid hulless oat in response to salinity stress	PLOS ONE			English	Article							PLANT SALT-TOLERANCE; RNA-SEQ; ANNOTATION; SODIUM; WHEAT; L.; MECHANISMS; GENERATION; POTASSIUM; PROTEINS	Background Oat is a cereal crop of global importance used for food, feed, and forage. Understanding salinity stress tolerance mechanisms in plants is an important step towards generating crop varieties that can cope with environmental stresses. To date, little is known about the salt tolerance of oat at the molecular level. To better understand the molecular mechanisms underlying salt tolerance in oat, we investigated the transcriptomes of control and salt-treated oat using RNA-Seq. Results Using Illumina HiSeq 4000 platform, we generated 72,291,032 and 356,891,432 reads from non-stressed control and salt-stressed oat, respectively. Assembly of 64 Gb raw sequence data yielded 128,414 putative unique transcripts with an average length of 1,189 bp. Analysis of the assembled unigenes from the salt stressed and control libraries indicated that about 65,000 unigenes were differentially expressed at different stages. Functional annotation showed that ABC transporters, plant hormone signal transduction, plant-pathogen interactions, starch and sucrose metabolism, arginine and proline metabolism, and other secondary metabolite pathways were enriched under salt stress. Based on the RPKM values of assembled unigenes, 24 differentially expressed genes under salt stress were selected for quantitative RT-PCR validation, which successfully confirmed the results of RNA-Seq. Furthermore, we identified 18,039 simple sequence repeats, which may help further elucidate salt tolerance mechanisms in oat. Conclusions Our global survey of transcriptome profiles of oat plants in response to salt stress provides useful insights into the molecular mechanisms underlying salt tolerance in this crop. These findings also represent a rich resource for further analysis of salt tolerance and for breeding oat with improved salt tolerance through the use of salt-related genes.	[Wu, Bin; Hu, Yani; Huo, Pengjie; Zhang, Qian; Chen, Xin; Zhang, Zongwen] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, ZW (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	zongwenzh@sina.com			Chinese Agricultural Research System [CARS-08-A-3]; Chinese Ministry of Agriculture; National Natural Science Foundation of China [30800699]	Chinese Agricultural Research System; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Agricultural Research System (grant number CARS-08-A-3) Chinese Ministry of Agriculture (http://www.moa.gov.cn/), and the National Natural Science Foundation of China (grant number 30800699) (http //www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashraf M, 2000, FIELD CROP RES, V66, P115, DOI 10.1016/S0378-4290(00)00064-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; [陈新 Chen Xin], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2038; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; Han LP, 2013, ECOL ENG, V61, P274, DOI 10.1016/j.ecoleng.2013.09.034; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; KINGSBURY RW, 1986, PLANT PHYSIOL, V80, P651, DOI 10.1104/pp.80.3.651; Kristensen M, 2011, EUR J CLIN NUTR, V65, P1053, DOI 10.1038/ejcn.2011.102; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reyes JL, 2010, METHODS MOL BIOL, V639, P239, DOI 10.1007/978-1-60761-702-0_14; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhling KH, 2003, PLANT SOIL, V253, P219, DOI 10.1023/A:1024517919764; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Ren CZ, 2013, CHINA OATS; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; [王波 Wang Bo], 2006, [生态环境, Ecology and Environment], V15, P625; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Yan XK, 2005, PEDOSPHERE, V15, P84; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	44	38	41	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171451	10.1371/journal.pone.0171451	http://dx.doi.org/10.1371/journal.pone.0171451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192458	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800027
J	Benoit, J; Norton, LA; Manger, PR; Rubidge, BS				Benoit, Julien; Norton, Luke A.; Manger, Paul R.; Rubidge, Bruce S.			Reappraisal of the envenoming capacity of Euchambersia mirabilis (Therapsida, Therocephalia) using mu CT-scanning techniques	PLOS ONE			English	Article							TOOTH REPLACEMENT; VENOM; PATTERNS; MORPHOLOGY; MAMMALS; ORGANS; GLAND	Euchambersia mirabilis is an iconic species of Permo-Triassic therapsid because of its unusually large external maxillary fossa linked through a sulcus to a ridged canine. This anatomy led to the commonly accepted conclusion that the large fossa accommodated a venom gland. However, this hypothesis remains untested so far. Here, we conducted a mu CT scan assisted reappraisal of the envenoming capacity of Euchambersia, with a special focus on the anatomy of the maxillary fossa and canines. This study shows that the fossa, presumably for the venom-producing gland, is directly linked to the maxillary canal, which carries the trigeminal nerve (responsible for the sensitivity of the face). The peculiar anatomy of the maxillary canal suggests important reorganisation in the somatosensory system and that a ganglion could possibly have been present in the maxillary fossa instead of a venom gland. Nevertheless, the venom gland hypothesis is still preferred since we describe, for the first time, the complete crown morphology of the incisiform teeth of Euchambersia, which strongly suggests that the complete dentition was ridged. Therefore Euchambersia manifests evidence of all characteristics of venomous animals: a venom gland (in the maxillary fossa), a mechanism to deliver the venom (the maxillary canal and/or the sulcus located ventrally to the fossa); and an apparatus with which to inflict a wound for venom delivery (the ridged dentition).	[Benoit, Julien; Norton, Luke A.; Rubidge, Bruce S.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa; [Benoit, Julien; Manger, Paul R.] Univ Witwatersrand, Sch Anat Sci, Johannesburg, Gauteng, South Africa; [Benoit, Julien; Norton, Luke A.; Rubidge, Bruce S.] Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Benoit, J (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Anat Sci, Johannesburg, Gauteng, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa.	julien.benoit@wits.ac.za	Norton, Luke/R-2446-2017; Rubidge, Bruce/AAE-7021-2019	Norton, Luke/0000-0002-9434-9267; Rubidge, Bruce/0000-0003-2477-1873; Benoit, Julien/0000-0001-5378-3940	PAST; Scatterlings projects; NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences	PAST; Scatterlings projects; NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences	This research was conducted with financial support from PAST and its Scatterlings projects; the NRF African Origins Platform; and the DST-NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader TG, 2011, LIFE SCI J, V8, P650; Barone R., 1999, ANATOMIE COMP MAMMIF, V1; BELLAIRS AD, 1949, J ANAT, V83, P116; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Benoit J, 2005, SCI NAT, V102, P69; Benoit J, 2016, B SOC GEOL FR, V187, P217, DOI 10.2113/gssgfbull.187.4-5.217; Benoit J, 2016, ACTA PALAEONTOL POL, V61, P777, DOI 10.4202/app.00219.2015; Boonstra L. D., 1962, Annals of the South African Museum, V46, P57; BOONSTRA LIEUWE D., 1934, ANN S AFRICAN MUS, V31, P215; BRINK A. S., 1986, HDB GEOLOGICAL SURVE, V10, P1; Broom, 1932, MAMMAL LIKE REPTILES; BROOM R., 1931, REC ALBANY MUS [GRAHAMSTOWN], V4, P161; Edmund A.G., 1962, Contributions of the Royal Ontario Museum (Life Sci), V56, P1; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Faurie S., 1974, Annals S Afr Mus, V65, P337; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; Folinsbee KE, 2007, J VERTEBR PALEONTOL, V27, P547, DOI 10.1671/0272-4634(2007)27[547:CGMFAR]2.0.CO;2; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Gans C., 1978, P1; Godefroit Pascal, 1997, Palaeovertebrata (Montpellier), V26, P1; Gong EP, 2011, PALAEONTOL Z, V85, P109, DOI 10.1007/s12542-010-0076-7; Gong EP, 2010, P NATL ACAD SCI USA, V107, P766, DOI 10.1073/pnas.0912360107; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; GRINE F E, 1979, Palaeontologia Africana, V22, P35; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Holloway RL, 2014, P NATL ACAD SCI USA, V111, P13022, DOI 10.1073/pnas.1402905111; HOPSON JAMES A., 1964, PROC ZOOL SOC LONDON, V142, P625; Hotton N. III, 1991, P598; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Huttenlocker AK, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.969400; Ivakhnenko MF, 2008, PALEONTOL J+, V42, P409, DOI 10.1134/S0031030108040102; Kemp T.S, 1982, MAMMAL LIKE REPTILES; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1956, PHILOS T ROY SOC B, V240, P95, DOI 10.1098/rstb.1956.0013; KIESER JA, 1993, J MORPHOL, V218, P195, DOI 10.1002/jmor.1052180208; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Lebrun R., 2014, 12 ANN M EAVP TOR IT; Lehman JP, 1961, TRAITE PALEONTOL, V6, P224; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; Ligabue-Braun R, 2012, TOXICON, V59, P680, DOI 10.1016/j.toxicon.2012.02.012; Macpherson C. B., 1968, ETHNIC GROUPS BOUND, V1968, P9; Mebs D., 2002, VENOMOUS POISONOUS A; Mendrez C., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P379; Mitchell JS, 2010, NATURWISSENSCHAFTEN, V97, P1117, DOI 10.1007/s00114-010-0729-0; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; NOPCSA FRANCIS, 1933, ANN AND MAG NAT HIST, V12, P125; Norton L, 2009, J VERTEBR PALEONTOL, V29, p156A; Orr CM, 2007, J VERTEBR PALEONTOL, V27, P541, DOI 10.1671/0272-4634(2007)27[541:TCMATI]2.0.CO;2; POOLE D. F. G., 1961, PROC ZOOL SOC LONDON, V136, P131; Quay W.B., 1979, P245; Rehorek SJ, 2005, CHEM SIGNAL, V10, P152, DOI 10.1007/0-387-25160-X_19; Rehorek SJ, 2010, ANAT REC, V293, P1433, DOI 10.1002/ar.21046; Rodriguez-de la Rosa Ruben A., 2000, Journal of Vertebrate Paleontology, V20, p64A; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Romer A.S., 1945, VERTEBRATE PALEONTOL; Romer AS, 1961, INT C EV LOW NONSP 1, V1, P9; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Sawin H. J., 1941, BULL MUS COMP ZOOL HARVARD UNIV, V88, P407; Sigogneau D., 1970, CAHIERS PALEONTOLOGI; Sigogneau-Russell D., 1989, ENCY PALEOHERPET 17B, P1; Sues HD, 1996, J VERTEBR PALEONTOL, V16, P571, DOI 10.1080/02724634.1996.10011340; SUES HD, 1991, NATURE, V351, P141, DOI 10.1038/351141a0; Szaniawski H, 2009, ACTA PALAEONTOL POL, V54, P669, DOI 10.4202/app.2009.0045; Tatarinov LP., 1976, MORPHOLOGICAL EVOLUT; VAETH RH, 1985, J HERPETOL, V19, P20, DOI 10.2307/1564416; Van Den Heever J., 1987, THESIS; Van den Heever J.A., 1994, Universiteit van Stellenbosch Annale, V1, P1; VANVALEN L, 1960, EVOLUTION, V14, P304, DOI 10.1111/j.1558-5646.1960.tb03092.x; Vjuschkov BP, 1964, FUNDAMENTALS PALEONT, P275; von During M., 1979, P407; Weinstein S. A., 2009, HDB VENOMS TOXINS RE, P76; Young Bruce A., 1996, Amphibia-Reptilia, V17, P261, DOI 10.1163/156853896X00432	74	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172047	10.1371/journal.pone.0172047	http://dx.doi.org/10.1371/journal.pone.0172047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187210	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300074
J	Conte, F; Fiscon, G; Chiara, M; Colombo, T; Farina, L; Paci, P				Conte, Federica; Fiscon, Giulia; Chiara, Matteo; Colombo, Teresa; Farina, Lorenzo; Paci, Paola			Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer	PLOS ONE			English	Article							COMPETING ENDOGENOUS RNA; MESSENGER-RNAS; MICRORNA SPONGES; TUMOR-SUPPRESSOR; REPRESSORS ZEB1; CIRCULAR RNAS; HUMAN GENOME; EXPRESSION; TRANSCRIPTS; LNCRNA	Recent findings have identified competing endogenous RNAs (ceRNAs) as the drivers in many disease conditions, including cancers. The ceRNAs indirectly regulate each other by reducing the amount of microRNAs (miRNAs) available to target messenger RNAs (mRNAs). The ceRNA interactions mediated by miRNAs are modulated by a titration mechanism, i. e. large changes in the ceRNA expression levels either overcome, or relieve, the miRNA repression on competing RNAs; similarly, a very large miRNA overexpression may abolish competition. The ceRNAs are also called miRNA "decoys" or miRNA "sponges" and encompass different RNAs competing with each other to attract miRNAs for interactions: mRNA, long non-coding RNAs (lncRNAs), pseudogenes, or circular RNAs. Recently, we developed a computational method for identifying ceRNA-ceRNA interactions in breast invasive carcinoma. We were interested in unveiling which lncRNAs could exert the ceRNA activity. We found a drastic rewiring in the cross-talks between ceRNAs from the physiological to the pathological condition. The main actor of this dysregulated lncRNA-associated ceRNA network was the lncRNA PVT1, which revealed a net biding preference towards the miR-200 family members in normal breast tissues. Despite its up-regulation in breast cancer tissues, mimicked by the miR-200 family members, PVT1 stops working as ceRNA in the cancerous state. The specific conditions required for a ceRNA landscape to occur are still far from being determined. Here, we emphasized the importance of the relative concentration of the ceRNAs, and their related miRNAs. In particular, we focused on the withdrawal in breast cancer tissues of the PVT1 ceRNA activity and performed a gene expression and sequence analysis of its multiple isoforms. We found that the PVT1 isoform harbouring the binding site for a representative miRNA of the miR-200 family shows a drastic decrease in its relative concentration with respect to the miRNA abundance in breast cancer tissues, providing a plausibility argument to the breakdown of the sponge program orchestrated by the oncogene PVT1.	[Conte, Federica; Fiscon, Giulia; Colombo, Teresa; Paci, Paola] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Chiara, Matteo] Univ Milan, Dept Biosci, Milan, Italy; [Farina, Lorenzo] Univ Sapienza, Dept Comp Control & Management Engn, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University of Milan; Sapienza University Rome	Paci, P (corresponding author), CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy.	paola.paci@iasi.cnr.it	Colombo, Teresa/P-2959-2018; FISCON, GIULIA/J-3442-2019	Colombo, Teresa/0000-0003-2415-7507; FISCON, GIULIA/0000-0002-3354-8203; Paci, Paola/0000-0002-9393-2047; Conte, Federica/0000-0003-0427-1476; CHIARA, MATTEO/0000-0003-3983-4961; Farina, Lorenzo/0000-0001-8314-6029	Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN; National Research Council of Italy (CNR); Italian Ministry of Education, University and Research (MIUR)	Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN; National Research Council of Italy (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was financially support by The Epigenomics Flagship Project (Progetto Bandiera Epigenomica) EPIGEN funded by Italian Ministry of Education, University and Research (MIUR) and the National Research Council of Italy (CNR), URL: http://www.epigen.it/.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooksbank C, 2014, NUCLEIC ACIDS RES, V42, pD18, DOI 10.1093/nar/gkt1206; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chang HY, 2013, BLOOD, V122; Chapman MH, 2012, J HEPATOL, V56, P877, DOI 10.1016/j.jhep.2011.10.022; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Cong NN, 2013, ONCOL REP, V29, P1579, DOI 10.3892/or.2013.2267; Cui D, 2016, TUMOR BIOL, V37, P4127, DOI 10.1007/s13277-015-4261-x; Dey BK, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/21541272.2014.944014; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ergun S, 2015, TUMOR BIOL, V36, P3129, DOI 10.1007/s13277-015-3346-x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiscon G, 2016, JOURNAL OF GENETICS, V3; Fiscon G, 2015, CURR BIOINFORM, V10, P242, DOI 10.2174/1574893609666140820224651; Fiscon G, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S6-S1; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; GRAHAM M, 1985, NATURE, V314, P740, DOI 10.1038/314740a0; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guo LL, 2015, WORLD J GASTROENTERO, V21, P11680, DOI 10.3748/wjg.v21.i41.11680; Hamilton MJ, 2015, AIMS BIOPHYS, V2, P794, DOI 10.3934/biophy.2015.4.794; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansji H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00379; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Iden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156274; Jackson JE, 2005, A USERS GUIDE TO PRI, V587; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kagami H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14577; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Knowling S, 2011, BIOCHIMIE, V93, P1922, DOI 10.1016/j.biochi.2011.07.031; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Larriba E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040452; LEMAY G, 1984, P NATL ACAD SCI-BIOL, V81, P38, DOI 10.1073/pnas.81.1.38; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Li XL, 2013, MED RES REV, V33, P517, DOI 10.1002/med.21254; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Liu FT, 2016, MINERVA MED, V107, P77; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Memczak S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141214; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Morlando M, 2014, CHEMMEDCHEM, V9, P505, DOI 10.1002/cmdc.201300569; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Paci P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-83; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Posa I., 2016, ONCOTARGET; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2016, CELL CYCLE, V15, P881, DOI 10.1080/15384101.2016.1149660; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Shi Q, 2016, J CELL PHYSIOL, V231, P751, DOI 10.1002/jcp.25174; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Sosinska P, 2015, MUTAT RES-REV MUTAT, V766, P58, DOI 10.1016/j.mrrev.2015.08.002; Tan JY, 2016, BIOESSAYS, V38, P295, DOI 10.1002/bies.201500148; Tang JY, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/943539; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; VILLENEUVE L, 1986, MOL CELL BIOL, V6, P1834, DOI 10.1128/MCB.6.5.1834; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, CARCINOGENESIS, V34, P1773, DOI 10.1093/carcin/bgt139; Wang P, 2015, NUCLEIC ACIDS RES, V43, P3478, DOI 10.1093/nar/gkv233; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Xie J, 2015, J BIOMATER TISS ENG, V5, P872, DOI 10.1166/jbt.2015.1389; Yang C, 2016, ONCOTARGET, V7, P13479, DOI 10.18632/oncotarget.7266; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zhou M., 2016, ONCOTARGET; Zhou QY, 2016, TUMOR BIOL, V37, P3105, DOI 10.1007/s13277-015-4149-9; Zhou XY, 2015, CELL PHYSIOL BIOCHEM, V36, P1440, DOI 10.1159/000430309; Zhuang CL, 2015, ONCOTARGET, V6, P41194, DOI 10.18632/oncotarget.5880; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm4079	125	85	87	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171661	10.1371/journal.pone.0171661	http://dx.doi.org/10.1371/journal.pone.0171661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187158	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300035
J	Gullo, S; Galavotti, C; Kuhlmann, AS; Msiska, T; Hastings, P; Marti, CN				Gullo, Sara; Galavotti, Christine; Kuhlmann, Anne Sebert; Msiska, Thumbiko; Hastings, Phil; Marti, C. Nathan			Effects of a social accountability approach, CARE's Community Score Card, on reproductive health-related outcomes in Malawi: A cluster-randomized controlled evaluation	PLOS ONE			English	Article							TRANSPARENCY; WORKERS; IMPACT	Background Social accountability approaches, which emphasize mutual responsibility and accountability by community members, health care workers, and local health officials for improving health outcomes in the community, are increasingly being employed in low-resource settings. We evaluated the effects of a social accountability approach, CARE's Community Score Card (CSC), on reproductive health outcomes in Ntcheu district, Malawi using a cluster-randomized control design. Methods We matched 10 pairs of communities, randomly assigning one from each pair to intervention and control arms. We conducted two independent cross-sectional surveys of women who had given birth in the last 12 months, at baseline and at two years post-baseline. Using difference -in-difference (DiD) and local average treatment effect (LATE) estimates, we evaluated the effects on outcomes including modern contraceptive use, antenatal and postnatal care service utilization, and service satisfaction. We also evaluated changes in indicators developed by community members and service providers in the intervention areas. Results DID analyses showed significantly greater improvements in the proportion of women receiving a home visit during pregnancy (B = 0.20, P <.01), receiving a postnatal visit (B = 0.06, P =.01), and overall service satisfaction (B = 0.16, P <.001) in intervention compared to control areas. LATE analyses estimated significant effects of the CSC intervention on home visits by health workers (114% higher in intervention compared to control) (B = 1.14, P<.001) and current use of modern contraceptives (57% higher) (B = 0.57, P <.01). All 13 community-and provider-developed indicators improved, with 6 of them showing significant improvements. Conclusions By facilitating the relationship between community members, health service providers, and local government officials, the CSC contributed to important improvements in reproductive health-related outcomes. Further, the CSC builds mutual accountability, and ensures that solutions to problems are locally-relevant, locally-supported and feasible to implement.	[Gullo, Sara; Galavotti, Christine] CARE USA, Atlanta, GA 30303 USA; [Kuhlmann, Anne Sebert] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Msiska, Thumbiko] CARE Malawi, Lilongwe, Malawi; [Hastings, Phil; Marti, C. Nathan] Far Harbor LLC, Austin, TX USA	Saint Louis University	Gullo, S (corresponding author), CARE USA, Atlanta, GA 30303 USA.	sgullo@care.org			Sall Family Foundation	Sall Family Foundation(European Commission)	The Sall Family Foundation funded this work through a grant to CARE USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Funder provided support in the form of research materials and salaries for authors SG, CG and TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Far Harbor, LLC, a public health research firm, was contracted by CARE USA to conduct data analysis and assist in the preparation of the manuscript.	ANGRIST JD, 2006, J EXPT CRIMINOLOGY, V0002; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, ECONOMIST; [Anonymous], 2012, EFFECTIVE ARE COMMUN; Berman P, 2012, FORMAL HLTH SYSTEM S; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Bjorkman-Nyqvist M, 2013, WORKING PAPER; Boydell V, 2014, WORKING PAPER; CARE Malawi, 2013, COMM SCOR CARD CSC G; ERT1, 2012, ERT1 FINAL REPORT EV; Fox JA, 2015, WORLD DEV, V72, P346, DOI 10.1016/j.worlddev.2015.03.011; Gaventa J, 2013, DEV POLICY REV, V31, pS3, DOI 10.1111/dpr.12017; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Goncalves S, 2013, WORLD DEV, V53, P94, DOI 10.1016/j.worlddev.2013.01.009; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Independent Expert Review Group (iERG) on Information and Accountability for Women's and Children's Health, 2013, EV WOM EV CHILD STRE; Joshi A, 2013, DEV POLICY REV, V31, pS29, DOI 10.1111/dpr.12018; Kilpatrick S, 2009, HEALTH PLACE, V15, P284, DOI 10.1016/j.healthplace.2008.05.008; Kok MC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1402-x; Kruk ME, 2008, HEALTH POLICY, V85, P263, DOI 10.1016/j.healthpol.2007.09.003; Lechner Michael, 2011, Foundations and Trends in Econometrics, V4, P165, DOI 10.1561/0800000014; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Rutstein S. O., 2004, DHS COMP REPORTS; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Touchton M, 2014, COMP POLIT STUD, V47, P1442, DOI 10.1177/0010414013512601; Tucker J.L., 2001, MANAG SERV QUAL, V11, P272, DOI [DOI 10.1108/EUM0000000005611, 10.1108/EUM0000000005611]; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; UNICEF, 1995, MULT IND SURV HDB; United Nations Secretary-General BanKi-moon, 2010, GLOB STRAT WOM CHILD; United Nations' Children's Fund (UNICEF), 2015, STAT WORLDS CHILDR 2; Vice President Khumbo Kachali on behalf of the Government of Malawi, 2012, VICE PRESIDENT K KAC; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Bank, 2003, WORLD DEV REPORT 200, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X, 10.1596/0-8213-5468-X]; World Health Organization (WHO), 2015, MAL COUNTR STAT PROF	35	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171316	10.1371/journal.pone.0171316	http://dx.doi.org/10.1371/journal.pone.0171316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187159	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300017
J	Baah-Acheamfour, M; Bourque, CPA; Meng, FR; Swift, DE				Baah-Acheamfour, Mark; Bourque, Charles P. -A.; Meng, Fan-Rui; Swift, D. Edwin			Incorporating interspecific competition into species-distribution mapping by upward scaling of small-scale model projections to the landscape	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; ACADIAN FOREST; NOVA-SCOTIA; DYNAMICS; IMPACTS; KAPPA	There are a number of overarching questions and debate in the scientific community concerning the importance of biotic interactions in species distribution models at large spatial scales. In this paper, we present a framework for revising the potential distribution of tree species native to the Western Ecoregion of Nova Scotia, Canada, by integrating the long-term effects of interspecific competition into an existing abiotic-factor-based definition of potential species distribution (PSD). The PSD model is developed by combining spatially explicit data of individualistic species' response to normalized incident photosynthetically active radiation, soil water content, and growing degree days. A revised PSD model adds biomass output simulated over a 100-year timeframe with a robust forest gap model and scaled up to the landscape using a forestland classification technique. To demonstrate the method, we applied the calculation to the natural range of 16 target tree species as found in 1,240 provincial forest-inventory plots. The revised PSD model, with the long-term effects of interspecific competition accounted for, predicted that eastern hemlock (Tsuga canadensis), American beech (Fagus grandifolia), white birch (Betula papyrifera), red oak (Quercus rubra), sugar maple (Acer saccharum), and trembling aspen (Populus tremuloides) would experience a significant decline in their original distribution compared with balsam fir (Abies balsamea), black spruce (Picea mariana), red spruce (Picea rubens), red maple (Acer rubrum L.), and yellow birch (Betula alleghaniensis). True model accuracy improved from 64.2% with original PSD evaluations to 81.7% with revised PSD. Kappa statistics slightly increased from 0.26 (fair) to 0.41 (moderate) for original and revised PSDs, respectively.	[Baah-Acheamfour, Mark] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Bourque, Charles P. -A.; Meng, Fan-Rui] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada; [Swift, D. Edwin] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Canadian Wood Fibre Ctr, Fredericton, NB, Canada	University of Alberta; University of New Brunswick; Natural Resources Canada; Canadian Forest Service	Bourque, CPA (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada.	cbourque@unb.ca			Natural Sciences and Engineering Research Council of Canada Discovery Grant; Natural Science and Engineering Council of Canada in the form of an Discovery Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Council of Canada in the form of an Discovery Grant	Funding for this work was provided by a Natural Sciences and Engineering Research Council of Canada Discovery Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for funding provided by the Natural Science and Engineering Council of Canada in the form of an Discovery Grant to Dr. Charles P.-A. Bourque under the direction of the Faculty of Forestry and Environmental Management, University of New Brunswick, New Brunswick, Canada. We are also grateful to the Nova Scotia Department of Natural Resources for providing forest-inventory data in order that we may assess the accuracy of the predicted PSD surfaces against independent field-based information.	Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Baah-Acheamfour M, 2017, DRYAD DIGITAL REPOSI; Baah-Acheamfour M, 2013, CAN J FOREST RES, V43, P517, DOI 10.1139/cjfr-2012-0476; BETTS MG, 2002, FOREST CHRON, V18, P123; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Bourque CPA, 2008, FOREST CHRON, V84, P553, DOI 10.5558/tfc84553-4; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; BURNS RM, 1990, SILVICS N AM, V2, P1; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Environment Canada, 2012, NAT CLIM DAT INF ARC; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hassan QK, 2009, REMOTE SENS-BASEL, V1, P393, DOI 10.3390/rs1030393; Kaye TN, 2009, 22 S CURR THREAT CAL; Kienast F., 2007, LANDSC SER, P1; Kohyama T, 2005, ECOL RES, V20, P305, DOI 10.1007/s11284-005-0046-9; Kozlowski TT, 1968, WATER DEFICITS PLANT, VI; Loo J, 2003, FOREST CHRON, V79, P462, DOI 10.5558/tfc79462-3; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Nova Scotia Department of Natural Resources (NS DNR), 2012, 201201 NS DNR; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rowe JS, 1972, DEP ENV CANADA PUBL, V1300; Shugart H.H., 1984, THEORY FOREST DYNAMI; SVENNING JC, 2014, ECOGRAPHY, V37, P1198, DOI DOI 10.1111/J.1600-0587.2013.00574.X; Urban D. L., 1990, VERSATILE MODEL SIMU; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350	41	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171487	10.1371/journal.pone.0171487	http://dx.doi.org/10.1371/journal.pone.0171487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207782	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500031
J	Gotschy, A; Bauer, WR; Winter, P; Nordbeck, P; Rommel, E; Jakob, PM; Herold, V				Gotschy, Alexander; Bauer, Wolfgang R.; Winter, Patrick; Nordbeck, Peter; Rommel, Eberhard; Jakob, Peter M.; Herold, Volker			Local versus global aortic pulse wave velocity in early atherosclerosis: An animal study in ApoEi(-/-) mice using ultrahigh field MRI	PLOS ONE			English	Article							E-DEFICIENT MOUSE; IN-VIVO; ARTERIAL STIFFNESS; APOLIPOPROTEIN-E; KNOCKOUT MICE; 17.6 TESLA; DISEASE; LESIONS; EVENTS; MODELS	Increased aortic stiffness is known to be associated with atherosclerosis and has a predictive value for cardiovascular events. This study aims to investigate the local distribution of early arterial stiffening due to initial atherosclerotic lesions. Therefore, global and local pulse wave velocity (PWV) were measured in ApoE(-/-) and wild type (WT) mice using ultrahigh field MRI. For quantification of global aortic stiffness, a new multi-point transit-time (TT) method was implemented and validated to determine the global PWV in the murine aorta. Local aortic stiffness was measured by assessing the local PWV in the upper abdominal aorta, using the flow/area (QA) method. Significant differences between age matched ApoE(-/-) and WT mice were determined for global and local PWV measurements (global PWV: ApoE(-/-) : 2.7 +/- 0.2m/s vs WT: 2.1 +/- 0.2m/s, P<0.03; local PWV: ApoE(-/-) : 2.9 0.2m/s vs WT: 2.2 0.2m/s, P<0.03). Within the WT mouse group, the global PWV correlated well with the local PWV in the upper abdominal aorta (R-2 = 0.75, P<0.01), implying a widely uniform arterial elasticity. In ApoE/-animals, however, no significant correlation between individual local and global PWV was present (R-2 = 0.07, P = 0.53), implying a heterogeneous distribution of vascular stiffening in early atherosclerosis. The assessment of global PWV using the new multi-point TT measurement technique was validated against a pressure wire measurement in a vessel phantom and showed excellent agreement. The experimental results demonstrate that vascular stiffening caused by early atherosclerosis is unequally distributed over the length of large vessels. This finding implies that assessing heterogeneity of arterial stiffness by multiple local measurements of PWV might be more sensitive than global PWV to identify early atherosclerotic lesions.	[Gotschy, Alexander; Winter, Patrick; Rommel, Eberhard; Jakob, Peter M.; Herold, Volker] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Gotschy, Alexander] Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland; [Gotschy, Alexander] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Gotschy, Alexander] ETH, Zurich, Switzerland; [Bauer, Wolfgang R.; Nordbeck, Peter] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Gotschy, Alexander; Nordbeck, Peter; Jakob, Peter M.] Univ Wurzburg, Deutsch Zentrum Herzinsuffizienz, Comprehens Heart Failure Ctr, Wurzburg, Germany	University of Wurzburg; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; University of Wurzburg	Gotschy, A (corresponding author), Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany.; Gotschy, A (corresponding author), Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland.; Gotschy, A (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.; Gotschy, A (corresponding author), ETH, Zurich, Switzerland.	alexander.gotschy@usz.ch	Nordbeck, Peter/D-4771-2018	Nordbeck, Peter/0000-0002-2560-4068; Bauer, Wolfgang/0000-0002-4652-7313	German Research Foundation [SFB 688]; Federal Ministry of Education and Research [BM BF01 E01504]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (www.dfg.de) research grant SFB 688 (TP B5, Z) to WRB and the Federal Ministry of Education and Research (www.bmbf.de) research grant BM BF01 E01504 to WRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Briley-Saebo KC, 2012, J AM COLL CARDIOL, V59, P616, DOI 10.1016/j.jacc.2011.10.881; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230; Fayad ZA, 1998, CIRCULATION, V98, P1541, DOI 10.1161/01.CIR.98.15.1541; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Itskovich VV, 2003, MAGNET RESON MED, V49, P381, DOI 10.1002/mrm.10360; Klug G, 2011, METHODS MOL BIOL, V771, P407, DOI 10.1007/978-1-61779-219-9_21; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Makowski MR, 2012, ATHEROSCLEROSIS, V222, P43, DOI 10.1016/j.atherosclerosis.2012.01.008; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Ohyama Y, 2016, EUR HEART J-CARD IMG, V17, P1044, DOI 10.1093/ehjci/jev332; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Teixeira R, 2016, EUR HEART J-CARD IMG, V17, P233, DOI 10.1093/ehjci/jev287; Vulliemoz S, 2002, MAGNET RESON MED, V47, P649, DOI 10.1002/mrm.10100; Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04; Zhao XD, 2009, J MAGN RESON IMAGING, V30, P286, DOI 10.1002/jmri.21846	28	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171603	10.1371/journal.pone.0171603	http://dx.doi.org/10.1371/journal.pone.0171603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207773	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500042
J	Sergeant, K; Printz, B; Gutsch, A; Behr, M; Renaut, J; Hausman, JF				Sergeant, Kjell; Printz, Bruno; Gutsch, Annelie; Behr, Marc; Renaut, Jenny; Hausman, Jean-Francois			Didehydrophenylalanine, an abundant modification in the beta subunit of plant polygalacturonases	PLOS ONE			English	Article							CELL-WALL; CONFORMATIONAL-CHANGES; PROTEOMIC ANALYSIS; PROTEIN; DOMAIN; BINDING; PECTIN; ATLAS; PHOSPHORYLATION; IDENTIFICATION	The structure and the activity of proteins are often regulated by transient or stable post-translational modifications (PTM). Different from well-known, abundant modifications such as phosphorylation and glycosylation some modifications are limited to one or a few proteins across a broad range of related species. Although few examples of the latter type are known, the evolutionary conservation of these modifications and the enzymes responsible for their synthesis suggest an important physiological role. Here, the first observation of a new, fold-directing PTM is described. During the analysis of alfalfa cell wall proteins a -2Da mass shift was observed on phenylalanine residues in the repeated tetrapeptide FxxY of the beta-subunit of polygalacturonase. This modular protein is known to be involved in developmental and stress-responsive processes. The presence of this modification was confirmed using in-house and external datasets acquired by different commonly used techniques in proteome studies. Based on these analyses it was found that all identified phenylalanine residues in the sequence FxxY of this protein were modified to a, alpha,beta-didehydro-Phe (Delta Phe). Besides showing the reproducible identification of Delta Phe in different species arguments that substantiate the fold-determining role of Delta Phe are given.	[Sergeant, Kjell; Printz, Bruno; Gutsch, Annelie; Behr, Marc; Renaut, Jenny; Hausman, Jean-Francois] LIST, Environm Res & Innovat ERIN Dept, Esch Sur Alzette, Luxembourg; [Printz, Bruno; Behr, Marc] Catholic Univ Louvain, Earth & Life Inst Agron, Grp Rech Physiol Vegetale Louvain la Neuve, Louvain La Neuve, Belgium; [Gutsch, Annelie] Univ Hasselt, Ctr Environm Sci, Environm Biol, Diepenbeek, Belgium	Luxembourg Institute of Science & Technology; Universite Catholique Louvain; Hasselt University	Sergeant, K (corresponding author), LIST, Environm Res & Innovat ERIN Dept, Esch Sur Alzette, Luxembourg.	kjell.sergeant@list.lu	sergeant, kjell/M-9789-2015; Behr, Marc/J-5582-2019; Hausman, Jean-Francois/AAB-6208-2020	sergeant, kjell/0000-0003-2071-3510; Hausman, Jean-Francois/0000-0001-6103-7817; Behr, Marc/0000-0002-5907-9185; Renaut, Jenny/0000-0002-0450-3866	National Research Fund (FNR) Luxembourg: FNR Project CANCAN [C13/SR/5774202]; FNR Project CADWALL [INTER/FWO/13/14]	National Research Fund (FNR) Luxembourg: FNR Project CANCAN(Luxembourg National Research Fund); FNR Project CADWALL(Luxembourg National Research Fund)	The authors thank for financial support obtained through the National Research Fund (FNR) Luxembourg: FNR Project CANCAN C13/SR/5774202 and FNR Project CADWALL INTER/FWO/13/14.	Abdallah C, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-37; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Buczek AM, 2011, MAGN RESON CHEM, V49, P343, DOI 10.1002/mrc.2753; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Chun JP, 1997, PHYSIOL PLANTARUM, V101, P283, DOI 10.1034/j.1399-3054.1997.1010205.x; Crisma M, 1999, J AM CHEM SOC, V121, P3272, DOI 10.1021/ja9842114; De Vijlder T, 2015, J CHROMATOGR B, V974, P48, DOI 10.1016/j.jchromb.2014.10.024; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; DELLAPENNA D, 1990, PLANT PHYSIOL, V94, P1882, DOI 10.1104/pp.94.4.1882; Ding XP, 2009, PLANTA, V230, P149, DOI 10.1007/s00425-009-0929-z; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ENGLISH ML, 1978, BIOCHEM BIOPH RES CO, V85, P780, DOI 10.1016/0006-291X(78)91229-9; Fermani S, 2012, J BIOL CHEM, V287, P21372, DOI 10.1074/jbc.M112.350355; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Francin-Allami M, 2015, PROTEOMICS, V15, P2296, DOI 10.1002/pmic.201400485; Gavrilov Y, 2015, J PHYS CHEM LETT, V6, P3572, DOI 10.1021/acs.jpclett.5b01588; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Gupta M, 2011, BIOPOLYMERS, V95, P161, DOI 10.1002/bip.21561; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Herbert B, 2003, PROTEOMICS, V3, P826, DOI 10.1002/pmic.200300414; Liu HH, 2014, PLANT CELL ENVIRON, V37, P1144, DOI 10.1111/pce.12223; Maathuis FJM, 2008, PLANT SIGNAL BEHAV, V3, P1011, DOI 10.4161/psb.6721; McLachlin DT, 2003, ANAL CHEM, V75, P6826, DOI 10.1021/ac034989u; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Miernyk JA, 2013, J PROTEOMICS, V89, P265, DOI 10.1016/j.jprot.2013.05.013; Nguyen-Kim H, 2015, PROTEOMICS; O'Connor SE, 1998, CHEM BIOL, V5, P427, DOI 10.1016/S1074-5521(98)90159-4; O'Rourke JA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1718-7; Park J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00412; Printz B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00237; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P8433, DOI 10.1073/pnas.92.18.8433; Siodlak D, 2015, AMINO ACIDS, V47, P1, DOI 10.1007/s00726-014-1846-4; Spadoni S, 2006, PLANT PHYSIOL, V141, P557, DOI 10.1104/pp.106.076950; Sultana N, 2015, PLANT CELL ENVIRON, V38, P375, DOI 10.1111/pce.12267; Twomey D, 2002, ANTON LEEUW INT J G, V82, P165, DOI 10.1023/A:1020660321724; VANNESS BG, 1980, J BIOL CHEM, V255, P710; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Verdonk JC, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00279; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; Walley JW, 2016, SCIENCE, V353, P814, DOI 10.1126/science.aag1125; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wei H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00315; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuyama PM, 2015, MOL GENET GENOMICS; ZHENG LS, 1992, PLANT CELL, V4, P1147, DOI 10.1105/tpc.4.9.1147	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171990	10.1371/journal.pone.0171990	http://dx.doi.org/10.1371/journal.pone.0171990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207764	gold, Green Published			2022-12-27	WOS:000394424500068
J	Stefanko, A; Thiede, C; Ehninger, G; Simons, K; Grzybek, M				Stefanko, Adam; Thiede, Christian; Ehninger, Gerhard; Simons, Kai; Grzybek, Michal			Lipidomic approach for stratification of acute myeloid leukemia patients	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; THROUGHPUT SHOTGUN LIPIDOMICS; ACUTE MYELOGENOUS LEUKEMIA; MASS-SPECTROMETRY; BREAST-CANCER; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOLIPID METABOLISM; MULTIDRUG-RESISTANCE; CELL-PROLIFERATION; SIGNALING PATHWAYS	The pathogenesis and progression of many tumors, including hematologic malignancies is highly dependent on enhanced lipogenesis. De novo fatty-acid synthesis permits accelerated proliferation of tumor cells by providing membrane components but these may also alter physicochemical properties of lipid bilayers, which can impact signaling or even increase drug resistance in cancer cells. Cancer type-specific lipid profiles would permit us to monitor and interpret actual effects of lipid changes, potential fingerprints of individual tumors to be explored as diagnostic markers. We have used the shotgun MS approach to identify lipid patterns in different types of acute myeloid leukemia (AML) patients that either show no karyotype change or belong to t(8; 21) or inv 16 types. Differences in lipidomes of t(8; 21) and inv(16) patients, as compared to AML patients without karyotype change, presented mostly as substantial modulation of ceramide/sphingolipid synthesis. Furthermore, between the t(8; 21) and all other patients we observed significant changes in physicochemical membrane properties. These were related to a marked alteration in lipid saturation levels. The discovered differences in lipid profiles of various AML types improve our understanding of the pathobiochemical pathways involved and may serve in the development of diagnostic tools.	[Stefanko, Adam; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Thiede, Christian; Ehninger, Gerhard] Univ Hosp TU Dresden, Med Clin & Polyclin 1, Dresden, Germany; [Simons, Kai] Lipotype GmbH, Dresden, Germany; [Grzybek, Michal] Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Clin Carl Gustav Carus, Dresden, Germany; [Grzybek, Michal] German Ctr Diabet Res DZD eV, Neuherberg, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Grzybek, M (corresponding author), Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Clin Carl Gustav Carus, Dresden, Germany.; Grzybek, M (corresponding author), German Ctr Diabet Res DZD eV, Neuherberg, Germany.	Michal.Grzybek@tu-dresden.de	; Grzybek, Michal/D-3802-2017	Simons, Kai/0000-0002-9231-9996; Grzybek, Michal/0000-0003-2083-0506; Thiede, Christian/0000-0003-1241-2048	German Federal Ministry of Education and Research grant	German Federal Ministry of Education and Research grant	The results of this research have been achieved using the German Federal Ministry of Education and Research grant to the German Center for Diabetes Research (DZD e.V.) (M.G.).	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Alo PL, 1999, TUMORI, V85, P35, DOI 10.1177/030089169908500108; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Campanella R, 1992, J Neurosurg Sci, V36, P11; Casalou C, 2011, MOL CANCER RES, V9, P215, DOI 10.1158/1541-7786.MCR-10-0155; Corominas-Faja B, 2014, ONCOTARGET, V5, P8306, DOI 10.18632/oncotarget.2059; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Funaki NO, 2001, ONCOL REP, V8, P527; Gosse G, 2015, LEUKEMIA RES, V39, P709, DOI 10.1016/j.leukres.2015.03.017; Gouaze V, 2005, CANCER RES, V65, P3861, DOI 10.1158/0008-5472.CAN-04-2329; Greer AH, 2013, J CELL PHYSIOL, V228, P2350, DOI 10.1002/jcp.24406; Hatzimichael E, 2013, AM J BLOOD RES, V3, P29; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; HORAN KL, 1994, FREE RADICAL BIO MED, V17, P587, DOI 10.1016/0891-5849(94)90098-1; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Luczak M, 2012, J PROTEOMICS, V75, P5734, DOI 10.1016/j.jprot.2012.07.030; Luck SC, 2011, LEUKEMIA, V25, P1728, DOI 10.1038/leu.2011.154; Mardis ER, 2014, SEMIN HEMATOL, V51, P250, DOI 10.1053/j.seminhematol.2014.08.003; Marien E, 2015, INT J CANCER, V137, P1539, DOI 10.1002/ijc.29517; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; MEDES G, 1953, CANCER RES, V13, P27; Miljan EA, 2002, SCIENCE, V2002, P10; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Pullarkat V, 2015, CRIT REV ONCOL HEMAT, V95, P38, DOI 10.1016/j.critrevonc.2015.01.005; Ratajczak MZ, 2015, LEUKEMIA, V29, P1452, DOI 10.1038/leu.2015.66; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Southam AD, 2015, CANCER RES, V75, P2530, DOI 10.1158/0008-5472.CAN-15-0202; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Tarasov K, 2014, MOL BIOSYST, V10, P1364, DOI 10.1039/c3mb70599d; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao W, 2016, CANC RES; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	72	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0168781	10.1371/journal.pone.0168781	http://dx.doi.org/10.1371/journal.pone.0168781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207743	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500002
J	Azzollini, J; Pesenti, C; Ferrari, L; Fontana, L; Calvello, M; Peissel, B; Portera, G; Tabano, S; Carcangiu, ML; Riva, P; Miozzo, M; Manoukian, S				Azzollini, Jacopo; Pesenti, Chiara; Ferrari, Luca; Fontana, Laura; Calvello, Mariarosaria; Peissel, Bernard; Portera, Giorgio; Tabano, Silvia; Carcangiu, Maria Luisa; Riva, Paola; Miozzo, Monica; Manoukian, Siranoush			Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies	PLOS ONE			English	Article							BREAST-CANCER RISK; NATURAL GENE-THERAPY; POSITIVE FAMILIES; DETECTION RATES; FANCONI-ANEMIA; NEGATIVE WOMEN; WOMAN; PATIENT; DELETION; CARRIERS	In BRCA1/2 families, early-onset breast cancer (BrCa) cases may be also observed among non-carrier relatives. These women are considered phenocopies and raise difficult counselling issues concerning the selection of the index case and the residual risks estimate in negative family members. Few studies investigated the presence of potential genetic susceptibility factors in phenocopies, mainly focussing on BrCa-associated single-nucleotide polymorphisms. We hypothesized that, as for other Mendelian diseases, a revertant somatic mosaicism, resulting from spontaneous correction of a pathogenic mutation, might occur also in BRCA pedigrees. A putative low-level mosaicism in phenocopies, which has never been investigated, might be the causal factor undetected by standard diagnostic testing. We selected 16 non-carriers BrCa-affected from 15 BRCA1/2 families, and investigated the presence of mosaicism through MALDI-TOF mass spectrometry. The analyses were performed on available tumour samples (7 cases), blood leukocytes, buccal mucosa and urine samples (2 cases) or on blood only (7 cases). In one family (n. 8), real-time PCR was also performed to analyse the phenocopy and her healthy parents. On the 16 phenocopies we did not detect the family mutations neither in the tumour, expected to display the highest mutation frequency, nor in the other analysed tissues. In family 8, all the genotyping assays did not detect mosaicism in the phenocopy or her healthy parents, supporting the hypothesis of a de novo occurrence of the BRCA2 mutation identified in the proband. These results suggest that somatic mosaicism is not likely to be a common phenomenon in BRCA1/2 families. As our families fulfilled high-risk selection criteria, other genetic factors might be responsible for most of these cases and have a significant impact on risk assessment in BRCA1/2 families. Finally, we found a de novo BRCA2 mutation, suggesting that, although rare, this event should be taken into account in the evaluation of high-risk families.	[Azzollini, Jacopo; Calvello, Mariarosaria; Peissel, Bernard; Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Med Genet Unit, Milan, Italy; [Pesenti, Chiara; Fontana, Laura; Tabano, Silvia; Miozzo, Monica] Univ Milan, Dept Pathophysiol & Transplantat, Div Pathol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Ferrari, Luca; Portera, Giorgio; Riva, Paola] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Carcangiu, Maria Luisa] Fdn IRCCS Ist Nazl Tumori, Pathol Unit, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Miozzo, M (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Div Pathol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.	monica.miozzo@unimi.it	Pesenti, Chiara/AEO-4195-2022; Fontana, Laura/AAB-9869-2019; Azzollini, Jacopo/E-7134-2017; Riva, Paola/K-7871-2016; Peissel, Bernard/E-8187-2017; manoukian, siranoush/E-7132-2017; Calvello, Mariarosaria/AAM-8866-2020; Miozzo, Monica Rosa/AAC-6401-2022; Pesenti, Chiara/P-2031-2017	Fontana, Laura/0000-0001-9517-6997; Azzollini, Jacopo/0000-0002-9364-9778; Riva, Paola/0000-0001-6481-8467; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; Miozzo, Monica Rosa/0000-0002-6523-4575; Pesenti, Chiara/0000-0002-7277-1205; Ferrari, Luca/0000-0003-0103-2170	Fondazione IRCCS Istituto Nazionale dei Tumori	Fondazione IRCCS Istituto Nazionale dei Tumori	The study was financed by funds from Italian citizens who allocated the 5 x 1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale dei Tumori, according to Italian laws (INT-Institutional strategic projects "5 x 1000") to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financed by funds from Italian citizens who allocated the 5 x 1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale dei Tumori, according to Italian laws (INT-Institutional strategic projects "5 x 1000") and to the initiative "Prove Aperte" (Filarmonica della Scala of Milan in collaboration with Unicredit Foundation) to SM. We thank Dr. Daniela Zaffaroni for her support as data manager in the study.	Azzollini J, 2016, EUR J INTERN MED, V32, P65, DOI 10.1016/j.ejim.2016.03.010; Diez O, 2010, BREAST CANCER RES TR, V121, P221, DOI 10.1007/s10549-009-0494-y; Edwards E, 2009, FAM CANCER, V8, P479, DOI 10.1007/s10689-009-9270-8; Evans DGR, 2013, CANCER EPIDEM BIOMAR, V22, P2269, DOI 10.1158/1055-9965.EPI-13-0316-T; Fischer C, 2012, CLIN GENET, V82, P478, DOI 10.1111/j.1399-0004.2011.01788.x; Friedman E, 2015, BRIT J CANCER, V112, P765, DOI 10.1038/bjc.2015.14; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Gronwald J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048462; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Hadiji-Abbes N, 2015, PATHOL BIOL, V63, P185, DOI 10.1016/j.patbio.2015.07.009; Hansen TVO, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-58; Harvey SL, 2011, BREAST CANCER RES TR, V130, P1057, DOI 10.1007/s10549-011-1733-6; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Korde LA, 2011, BREAST CANCER RES TR, V125, P169, DOI 10.1007/s10549-010-0923-y; Kurian AW, 2011, J CLIN ONCOL, V29, P4505, DOI 10.1200/JCO.2010.34.4440; Kwiatkowski F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127363; Kwong A, 2011, FAM CANCER, V10, P233, DOI 10.1007/s10689-011-9429-y; Lai-Cheong JE, 2011, TRENDS MOL MED, V17, P140, DOI 10.1016/j.molmed.2010.11.003; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Mankad A, 2006, BLOOD, V107, P3084, DOI 10.1182/blood-2005-07-2638; Marshall M, 2009, CLIN GENET, V76, P427, DOI 10.1111/j.1399-0004.2009.01246.x; Nielsen HR, 2016, FAM CANC; Pearce M, 2010, NATURE METHODS APPL; Robson M, 2002, J MED GENET, V39, P126, DOI 10.1136/jmg.39.2.126; Rowan E, 2007, J MED GENET, V44; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Spurdle AB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0474-y; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503; van der Luijt RB, 2001, J MED GENET, V38, P102, DOI 10.1136/jmg.38.2.102; Wada T, 2008, CURR OPIN ALLERGY CL, V8, P510, DOI 10.1097/ACI.0b013e328314b651	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171663	10.1371/journal.pone.0171663	http://dx.doi.org/10.1371/journal.pone.0171663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199346	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400041
J	Chauvenet, ALM; Kuempel, CD; McGowan, J; Beger, M; Possingham, HP				Chauvenet, Alienor L. M.; Kuempel, Caitlin D.; McGowan, Jennifer; Beger, Maria; Possingham, Hugh P.			Methods for calculating Protection Equality for conservation planning	PLOS ONE			English	Article							DIVERSITY; BIODIVERSITY; COMMUNITIES; ECOREGIONS	Protected Areas (PAs) are a central part of biodiversity conservation strategies around the world. Today, PAs cover c15% of the Earth's land mass and c3% of the global oceans. These numbers are expected to grow rapidly to meet the Convention on Biological Diversity's Aichi Biodiversity target 11, which aims to see 17% and 10% of terrestrial and marine biomes protected, respectively, by 2020. This target also requires countries to ensure that PAs protect an "ecologically representative" sample of their biodiversity. At present, there is no clear definition of what desirable ecological representation looks like, or guidelines of how to standardize its assessment as the PA estate grows. We propose a systematic approach to measure ecological representation in PA networks using the Protection Equality (PE) metric, which measures how equally ecological features, such as habitats, within a country's borders are protected. We present an R package and two Protection Equality (PE) measures; proportional to area PE, and fixed area PE, which measure the representativeness of a country's PA network. We illustrate the PE metrics with two case studies: coral reef protection across countries and ecoregions in the Coral Triangle, and representation of ecoregions of six of the largest countries in the world. Our results provide repeatable transparency to the issue of representation in PA networks and provide a starting point for further discussion, evaluation and testing of representation metrics. They also highlight clear shortcomings in current PA networks, particularly where they are biased towards certain assemblage types or habitats. Our proposed metrics should be used to report on measuring progress towards the representation component of Aichi Target 11. The PE metrics can be used to measure the representation of any kind of ecological feature including: species, ecoregions, processes or habitats.	[Chauvenet, Alienor L. M.; Kuempel, Caitlin D.; McGowan, Jennifer; Beger, Maria; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia; [Chauvenet, Alienor L. M.; Kuempel, Caitlin D.; McGowan, Jennifer; Beger, Maria; Possingham, Hugh P.] Univ Queensland, ARC Ctr Excellence Environm Decis, St Lucia, Qld, Australia; [Beger, Maria] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Possingham, Hugh P.] Nature Conservancy, South Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Leeds; Nature Conservancy	Chauvenet, ALM (corresponding author), Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia.; Chauvenet, ALM (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, St Lucia, Qld, Australia.	a.chauvenet@uq.edu.au	POSSINGHAM, HUGH/R-8310-2019; Chauvenet, Alienor/L-9135-2015; Possingham, Hugh/B-1337-2008; Beger, Maria/F-9049-2013; Beger, Maria/ABC-5975-2022; Kuempel, Caitlin D./AAV-8807-2020	POSSINGHAM, HUGH/0000-0001-7755-996X; Chauvenet, Alienor/0000-0002-3743-7375; Possingham, Hugh/0000-0001-7755-996X; Beger, Maria/0000-0003-1363-3571; Beger, Maria/0000-0003-1363-3571; Kuempel, Caitlin D./0000-0003-1609-9706	ARC Laureate Fellowship [FL130100090]; Early Career Research Award [CE110001014]	ARC Laureate Fellowship(Australian Research Council); Early Career Research Award	ALMC, CDK, JM, and HPP were supported by an ARC Laureate Fellowship (FL130100090). MB was supported by an Early Career Research Award to the ARC Centre of Excellence for Environmental Decisions (CE110001014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1978, AM SOCIOL REV, V43, P865, DOI 10.2307/2094626; Ay JS, 2013, J ENVIRON MANAGE, V129, P190, DOI 10.1016/j.jenvman.2013.07.012; Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Beger M, 2015, NATURE COMMUNICATION, V14, P6; Beger M, 2014, IDENTIFYING CONSERVA; BUBB P, 2009, COVERAGE PROTECTED A; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Chauvenet ALM, 2017, PROTECTEQUAL VERSION; Convention Biological Diversity, 2013, CONVENTION BIOL DIVE; Coral Triangle Initiative Secretariat, 2009, REG PLAN ACT COR TRI; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Harch BD, 1997, J MICROBIOL METH, V30, P91, DOI 10.1016/S0167-7012(97)00048-1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Kalaba F, 2013, POPUL ENVIRON, V35, P159, DOI 10.1007/s11111-013-0189-5; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Klein CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17539; Kuempel CD, 2016, CONSERVATION LETT; L'Roe J, 2014, ECOL ECON, V97, P1, DOI 10.1016/j.ecolecon.2013.10.017; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Thomas V., 2001, MEASURING ED INEQUAL; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Visconti P, 2013, CONSERV BIOL, V27, P1000, DOI 10.1111/cobi.12095; Watson JE, 2015, CONSERVATION BIOL J; WEINER J, 1984, OECOLOGIA, V61, P334, DOI 10.1007/BF00379630; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Yao L, 2014, ECOL INDIC, V47, P123, DOI 10.1016/j.ecolind.2014.07.009	32	21	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171591	10.1371/journal.pone.0171591	http://dx.doi.org/10.1371/journal.pone.0171591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199341	Green Published, gold			2022-12-27	WOS:000394424400035
J	Foster, E; Hawkins, A; Barton, KL; Stamp, E; Matthews, JNS; Adamson, AJ				Foster, Emma; Hawkins, Adrian; Barton, Karen L.; Stamp, Elaine; Matthews, John N. S.; Adamson, Ashley J.			Development of food photographs for use with children aged 18 months to 16 years: Comparison against weighed food diaries - The Young Person's Food Atlas (UK)	PLOS ONE			English	Article							PORTION SIZE; ACCURACY; SYSTEM	Traditional dietary assessment methods, used in the UK, such as weighed food diaries impose a large participant burden, often resulting in difficulty recruiting representative samples and underreporting of energy intakes. One approach to reducing the burden placed on the participant is to use portion size assessment tools to obtain an estimate of the amount of food consumed, removing the need to weigh all foods. An age range specific food atlas was developed for use in assessing children's dietary intakes. The foods selected and portion sizes depicted were derived from intakes recorded during the UK National Diet and Nutrition Surveys of children aged 1.5 to 16 years. Estimates of food portion sizes using the food atlas were compared against 4-day weighed intakes along with in-school/nursery observations, by the research team. Interviews were conducted with parents the day after completion of the diary, and for children aged 4 to 16 years, also with the child. Mean estimates of portion size consumed were within 7% of the weight of food recorded in the weighed food diary. The limits of agreement were wide indicating high variability of estimates at the individual level but the precision increased with increasing age. For children 11 years and over, agreement with weighed food diaries, was as good as that of their parents in terms of total weight of food consumed and of intake of energy and key nutrients. The age appropriate food photographs offer an alternative to weighed intakes for dietary assessment with children.	[Foster, Emma; Hawkins, Adrian; Stamp, Elaine; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Barton, Karen L.] Abertay Univ, Sch Sci Engn & Technol, Div Food & Drink, Dundee, Scotland; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; University of Abertay Dundee; Newcastle University - UK	Foster, E (corresponding author), Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	Emma.Foster@ncl.ac.uk		Adamson, Ashley/0000-0003-3735-2846; Barton, Karen/0000-0003-2074-005X	Food Standards Agency [N08027]; National Institutes for Health Research, Research Professorship; Medical Research Council [MR/K02325X/1B] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001, PDA/03/07/022] Funding Source: researchfish	Food Standards Agency; National Institutes for Health Research, Research Professorship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Food Standards Agency (project number N08027) funded the research, EF was PI on this project, EF, AH, KB, ES and JNSM all received funding as members of the project team. www.food.gov.uk. AJA is funded by a National Institutes for Health Research, Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski T, 2002, J AM DIET ASSOC, V102, P380, DOI 10.1016/S0002-8223(02)90088-X; Bates CJ, 2000, NATL DIET NUTR SURVE; Berg C, 1998, EUR J CLIN NUTR, V52, P663, DOI 10.1038/sj.ejcn.1600620; Black AE, 1996, P NUTR SOC, V56, p121A; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Foster E, 2008, BRIT J NUTR, V99, P175, DOI 10.1017/S000711450779390X; Foster E, 2008, BRIT J NUTR, V99, P185, DOI 10.1017/S0007114507791882; Foster E, 2014, J HUM NUTR DIET, V27, P18, DOI 10.1111/jhn.12127; Foster E, 2006, PUBLIC HEALTH NUTR, V9, P509, DOI 10.1079/PHN2005872; Frobisher C, 2003, J HUM NUTR DIET, V16, P181, DOI 10.1046/j.1365-277X.2003.00434.x; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Government CaL, 2007, IND DEPR 2007; Gregory J., 1995, NATIONAL DIET AND NU; Hernandez T, 2006, J FOOD COMPOS ANAL, V19, pS14, DOI 10.1016/j.jfca.2006.02.010; Holmes B, 2008, PUBLIC HEALTH NUTR, V11, P444, DOI 10.1017/S1368980007000559; Korkalo L, 2013, PUBLIC HEALTH NUTR, V16, P1558, DOI 10.1017/S1368980012003655; LIVINGSTONE MBE, 1990, BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Macmillan N. A., 1991, DETECTION THEORY USE; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; Nelson M, 1996, BRIT J NUTR, V76, P31, DOI 10.1079/BJN19960007; Nelson M, 1997, PHOTOGRAPHIC ATLAS F; Piaget J, 1974, THE CHILDS CONCEPTIO; Robinson F, 1997, J HUM NUTR DIET, V10, P117, DOI 10.1046/j.1365-277X.1997.00043.x; Shaffer D.R., 1999, DEV PSYCHOL CHILDHOO; Subar AF, 2010, J AM DIET ASSOC, V110, P55, DOI 10.1016/j.jada.2009.10.007; THANE CW, 2006, PUBLIC HLTH NUTR, V0009; Timon CM, 2011, P NUTR SOC, V70, pE51, DOI 10.1017/S0029665111000917; Turconi G, 2005, EUR J CLIN NUTR, V59, P923, DOI 10.1038/sj.ejcn.1602162; Vereecken CA, 2008, INT J OBESITY, V32, pS26, DOI 10.1038/ijo.2008.180	30	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169084	10.1371/journal.pone.0169084	http://dx.doi.org/10.1371/journal.pone.0169084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199319	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400005
J	Rodriguez-Martin, D; Sama, A; Perez-Lopez, C; Catala, A; Arostegui, JMM; Cabestany, J; Bayes, A; Alcaine, S; Mestre, B; Prats, A; Crespo, MC; Counihan, TJ; Browne, P; Quinlan, LR; OLaighin, G; Sweeney, D; Lewy, H; Azuri, J; Vainstein, G; Annicchiarico, R; Costa, A; Rodriguez-Molinero, A				Rodriguez-Martin, Daniel; Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan; Bayes, Angels; Alcaine, Sheila; Mestre, Berta; Prats, Anna; Cruz Crespo, M.; Counihan, Timothy J.; Browne, Patrick; Quinlan, Leo R.; OLaighin, Gearoido; Sweeney, Dean; Lewy, Hadas; Azuri, Joseph; Vainstein, Gabriel; Annicchiarico, Roberta; Costa, Alberto; Rodriguez-Molinero, Alejandro			Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; PHYSICAL-ACTIVITY; SYSTEM; MOTOR; IDENTIFICATION; QUESTIONNAIRE; ABNORMALITIES; FREQUENCY; SYMPTOM; SENSOR	Among Parkinson's disease (PD) symptoms, freezing of gait (FoG) is one of the most debilitating. To assess FoG, current clinical practice mostly employs repeated evaluations over weeks and months based on questionnaires, which may not accurately map the severity of this symptom. The use of a non-invasive system to monitor the activities of daily living (ADL) and the PD symptoms experienced by patients throughout the day could provide a more accurate and objective evaluation of FoG in order to better understand the evolution of the disease and allow for a more informed decision-making process in making adjustments to the patient's treatment plan. This paper presents a new algorithm to detect FoG with a machine learning approach based on Support Vector Machines (SVM) and a single tri-axial accelerometer worn at the waist. The method is evaluated through the acceleration signals in an outpatient setting gathered from 21 PD patients at their home and evaluated under two different conditions: first, a generic model is tested by using a leave-one-out approach and, second, a personalised model that also uses part of the dataset from each patient. Results show a significant improvement in the accuracy of the personalised model compared to the generic model, showing enhancement in the specificity and sensitivity geometric mean (GM) of 7.2%. Furthermore, the SVM approach adopted has been compared to the most comprehensive FoG detection method currently in use (referred to as MBFA in this paper). Results of our novel generic method provide an enhancement of 11.2% in the GM compared to the MBFA generic model and, in the case of the personalised model, a 10% of improvement with respect to the MBFA personalised model. Thus, our results show that a machine learning approach can be used to monitor FoG during the daily life of PD patients and, furthermore, personalised models for FoG detection can be used to improve monitoring accuracy.	[Rodriguez-Martin, Daniel; Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan] Univ Politecn Cataluna, BarcelonaTech UPC, Tech Res Ctr Dependency Care & Autonomous Living, Vilanova I La Geltru, Spain; [Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan; Rodriguez-Molinero, Alejandro] Sense4Care, Barcelona, Spain; [Bayes, Angels; Alcaine, Sheila; Mestre, Berta; Prats, Anna; Cruz Crespo, M.] Unidad Parkinson Trastornos Movimiento UParkinson, Barcelona, Spain; [Counihan, Timothy J.; Browne, Patrick] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [Quinlan, Leo R.; OLaighin, Gearoido; Sweeney, Dean; Rodriguez-Molinero, Alejandro] Natl Univ Ireland Galway, Dept Elect & Elect Engn, Galway, Ireland; [Lewy, Hadas; Azuri, Joseph; Vainstein, Gabriel] Maccabi Healthcare Serv, Tel Aviv, Israel; [Azuri, Joseph] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Annicchiarico, Roberta; Costa, Alberto] IRCCS Fdn Santa Lucia, Rome, Italy; [Rodriguez-Molinero, Alejandro] Consorci Sanitari Garraf, Clin Res Unit, Vilanova I La Geltru, Spain	Universitat Politecnica de Catalunya; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Tel Aviv University; Sackler Faculty of Medicine; IRCCS Santa Lucia	Rodriguez-Martin, D (corresponding author), Univ Politecn Cataluna, BarcelonaTech UPC, Tech Res Ctr Dependency Care & Autonomous Living, Vilanova I La Geltru, Spain.	daniel.rodriguez-martin@upc.edu	Cabestany, Joan/F-2281-2015; CATALA, Andreu/G-4038-2015; Quinlan, Leo R/N-4117-2014; Pérez López, Carlos/GSM-9311-2022; ÓLaighin, Gearóid/A-5239-2009; Costa, Alberto/AAA-7038-2019; ÓLaighin, Gearóid/AAC-2198-2019; Azuri, Joseph/ABD-5871-2021; Bayés, Àngels/AAB-3873-2019	Cabestany, Joan/0000-0002-6926-3322; Quinlan, Leo R/0000-0002-4011-6732; ÓLaighin, Gearóid/0000-0002-1885-814X; Azuri, Joseph/0000-0003-1049-9848; Catala, Andreu/0000-0001-8775-1955; Sweeney, Dean/0000-0002-9834-923X; Rodriguez Martin, Daniel/0000-0002-2598-6772; Rodriguez-Molinero, Alejandro/0000-0002-9678-2654; Prats, Anna/0000-0002-3586-4525	La Fundacio La Marato de [TV3 20140431]; European Community [ICT-287677]	La Fundacio La Marato de; European Community(European Commission)	This project has been performed within the framework of the "Freezing in Parkinsons Disease: Improving Quality of Life with an Automatic Control System" (MASPARK) project which is funded by La Fundacio La Marato de TV3 20140431 [http://www.tv3.cat/marato/es/projectes_financats_2013]. This work also forms part of the framework of the FP7 project "Personal Health Device for the Remote and Autonomous Management of Parkinsons Disease" (REMPARK) ICT-287677, which is funded by the European Community [http://www.rempark.eu/].; Part of this project has been performed within the framework of the MASPARK project which is funded by La Fundacio La Marato de TV3 20140431. This work also forms part of the framework of the FP7 project REMPARK ICT-287677, which is funded by the European Community. The authors, thus, would like to acknowledge the contributions of their colleagues from MASPARK and REMPARK consortium.	Aarsland D, 2007, J NEUROL NEUROSUR PS, V78, P36, DOI 10.1136/jnnp.2005.083113; Ahlrichs C, 2016, MED BIOL ENG COMPUT, V54, P223, DOI 10.1007/s11517-015-1395-3; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Amboni M, 2010, MOVEMENT DISORD, V25, P800, DOI 10.1002/mds.23033; [Anonymous], 2011, FP7ICT20117287677; Arias P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009675; Bachlin M., DAPHNET PROJECT DYNA; Bachlin M., 2009, P 4 INT ICST C BOD A; Bachlin M, 2010, METHOD INFORM MED, V49, P88, DOI 10.3414/ME09-02-0003; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Boni A, 2007, IEEE T INSTRUM MEAS, V56, P39, DOI 10.1109/TIM.2006.887319; Cabestany J, 2013, 20 INT C MIX DES INT; Cole BT, 2011, IEEE ENG MED BIO, P5649, DOI 10.1109/IEMBS.2011.6091367; Coste CA, 2014, SENSORS-BASEL, V14, P6819, DOI 10.3390/s140406819; Delval A, 2010, MOVEMENT DISORD, V25, P1684, DOI 10.1002/mds.23159; European Parkinson's Disease Association Working Group on Parkinson's Disease (World Health Organization), 2015, PREV PARK DIS; FAHN S, 1995, ADV NEUROL, V67, P53; Geebelen D, 2012, IEEE T NEUR NET LEAR, V23, P682, DOI 10.1109/TNNLS.2012.2186314; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Han JH, 2003, P ANN INT IEEE EMBS, V25, P1863; Handojoseno AMA, 2012, IEEE ENG MED BIO, P69, DOI 10.1109/EMBC.2012.6345873; Hausdorff JM, 2003, PHYSICA A, V321, P565, DOI 10.1016/S0378-4371(02)01744-2; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jovanov E, 2009, IEEE ENG MED BIO, P5151, DOI 10.1109/IEMBS.2009.5334257; Khan AM, 2008, IEEE ENG MED BIO, P5172, DOI 10.1109/IEMBS.2008.4650379; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Lieberman A, 2006, J NEUROL SCI, V248, P219, DOI 10.1016/j.jns.2006.05.023; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Maidan I, 2015, J NEUROL, V262, P899, DOI 10.1007/s00415-015-7650-6; Maidan I, 2010, MOVEMENT DISORD, V25, P2346, DOI 10.1002/mds.23280; Mancini M, 2012, IEEE ENG MED BIO, P1198, DOI 10.1109/EMBC.2012.6346151; MASPARK, 2015, FREEZING PARKINSONS; Mathie MJ, 2001, P ANN INT IEEE EMBS, V23, P3654, DOI 10.1109/IEMBS.2001.1019627; Mazilu Sinziana, 2013, Machine Learning and Data Mining in Pattern Recognition. 9th International Conference, MLDM 2013. Proceedings: LNCS 7988, P144, DOI 10.1007/978-3-642-39712-7_11; Mazilu S., 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P123, DOI 10.4108/icst.pervasivehealth.2012.248680; Mazilu S, 2015, IEEE J BIOMED HEALTH, V6, P1; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moore ST, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-19; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Niazmand K, 2011, BIOMED CIRC SYST C, P201, DOI 10.1109/BioCAS.2011.6107762; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 1998, DISABIL REHABIL, V20, P142, DOI 10.3109/09638289809166074; Nilsson MH, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-85; Nonnekes J, 2014, J NEUROL, V261, P1763, DOI 10.1007/s00415-014-7422-8; Papapetropoulos S, 2012, CNS NEUROSCI THER, V18, P380, DOI 10.1111/j.1755-5949.2011.00253.x; Perez-Lopez C, 2016, ARTIF INTELL MED, V67, P47, DOI 10.1016/j.artmed.2016.01.001; Perez-Lopez C, 2015, LECT NOTES COMPUT SC, V9094, P461, DOI 10.1007/978-3-319-19258-1_38; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rodriguez-Martin D., 2015, RECENT ADV AMBIENT A, P3; Rodriguez-Martin D, 2014, ENVIRON TECHNOL, P1; Rodriguez-Martin D, 2015, NEUROCOMPUTING, V164, P144, DOI 10.1016/j.neucom.2014.09.084; Rodriguez-Martin D, 2013, SENSORS-BASEL, V13, P14079, DOI 10.3390/s131014079; Rodriguez-Martin D, 2013, EXPERT SYST APPL, V40, P7203, DOI 10.1016/j.eswa.2013.07.028; Sama A., 2013, EUR S ART NEUR NETW; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Stamatakis J, 2011, IEEE ENG MED BIO, P7900, DOI 10.1109/IEMBS.2011.6091948; Takac B, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2539; Tay A, 2015, 2015 10 AS CONTR C A, P1, DOI [10.1109/ASCC.2015.7244608, DOI 10.1109/ASCC.2015.7244608]; Tripoliti EE, 2013, COMPUT METH PROG BIO, V110, P12, DOI 10.1016/j.cmpb.2012.10.016; Vapnik V., 2013, NATURE STAT LAERNING; Weiss A, 2015, J NEURAL TRANSM, V122, P403, DOI 10.1007/s00702-014-1279-y; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zabaleta H., 2008, GERONTECHNOLOGY, V7, P4, DOI DOI 10.4017/GT.2008.07.02.184.00; Zach H, 2015, PARKINSONISM RELAT D, V21, P1362, DOI 10.1016/j.parkreldis.2015.09.051; Zhao Y., 2012, 2012 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI), P192, DOI 10.1109/BH1.2012.6211542; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	73	88	90	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171764	10.1371/journal.pone.0171764	http://dx.doi.org/10.1371/journal.pone.0171764			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199357	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400048
J	Gliszczynska, A; Niezgoda, N; Gladkowski, W; Switalska, M; Wietrzyk, J				Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Switalska, Marta; Wietrzyk, Joanna			Isoprenoid-phospholipid conjugates as potential therapeutic agents: Synthesis, characterization and antiproliferative studies	PLOS ONE			English	Article							HL-60 LEUKEMIA-CELLS; PANCREATIC-CANCER; D-LIMONENE; PERILLYL ALCOHOL; PRODRUG; FARNESOL; GROWTH; RATS; CHEMOPREVENTION; INHIBITION	The aim of this research was to extend application field of isoprenoid compounds by their introduction into phospholipid structure as the transport vehicle. The series of novel isoprenoid phospholipids were synthesized in high yields (24-97%), their structures were fully characterized and its anticancer activity was investigated in vitro towards several cell lines of different origin. Most of synthesized compounds showed a significantly higher antiproliferative effect on tested cell lines than free terpene acids. The most active phosphatidylcholine analogue, containing 2,3-dihydro-3-vinylfarnesoic acids instead of fatty acids in both sn-1 and sn-2 position, inhibits the proliferation of colon cancer cells at 13.6 mu M.	[Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Switalska, Marta; Wietrzyk, Joanna] Polish Acad Sci, Dept Expt Oncol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Gliszczynska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	anna.gliszczynska@wp.pl	Gładkowski, Witold/A-5750-2017; Niezgoda, Natalia/HHN-1650-2022; Wietrzyk, Joanna/O-4392-2018; Gliszczyńska, Anna/A-2601-2017	Gładkowski, Witold/0000-0002-3271-779X; Niezgoda, Natalia/0000-0002-1154-9707; Wietrzyk, Joanna/0000-0003-4980-6606; Gliszczyńska, Anna/0000-0002-0218-6369; Switalska, Marta/0000-0001-7920-2251	National Science Center of Poland [2013/09/D/NZ9/02457]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	National Science Center of Poland(National Science Centre, Poland); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This project was financed by National Science Center of Poland no. 2013/09/D/NZ9/02457. Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl).	Alexander RL, 2005, CURR PHARM DESIGN, V11, P1079, DOI 10.2174/1381612053507602; Biodrowska K, 2012, PRZEM CHEM, V91, P692; Burke YD, 2002, ANTICANCER RES, V22, P3127; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Casado V, 2013, FOOD BIOPROD PROCESS, V91, P599, DOI 10.1016/j.fbp.2013.02.002; CROWELL PL, 1994, CRIT REV ONCOGENESIS, V5, P1; Deepika R, 2003, PROSTATE, V57, P14, DOI 10.1002/pros.10269; DEVERRE JR, 1989, J PHARM PHARMACOL, V41, P191, DOI 10.1111/j.2042-7158.1989.tb06428.x; GARZONABURBEH A, 1986, J MED CHEM, V29, P687, DOI 10.1021/jm00155a018; Gliszczynska A, 2014, RSC ADV, V4, P39248, DOI 10.1039/c4ra03939d; Gliszczynska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157278; Gliszczynska A, 2011, PRZEM CHEM, V90, P759; Gliszczynska A, 2011, NAT PROD COMMUN, V6, P367; HAAG JD, 1992, CANCER RES, V52, P4021; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; He L, 1997, J NUTR, V127, P668, DOI 10.1093/jn/127.5.668; Howard HB, 2004, CANCER CHEMOTH PHARM, V54, P368, DOI 10.1007/s00280-004-0788-z; Howard HB, 2008, CANCER CHEMOTH PHARM, V62, P149, DOI 10.1007/s00280-007-0585-6; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Kaki SS, 2014, EUR J LIPID SCI TECH, V116, P1347, DOI 10.1002/ejlt.201400202; KUMAR R, 1978, J PHARM PHARMACOL, V30, P754, DOI 10.1111/j.2042-7158.1978.tb13386.x; Kurz M, 2000, CHEM PHYS LIPIDS, V107, P143, DOI 10.1016/S0009-3084(00)00167-5; Lambert DM, 2000, EUR J PHARM SCI, V11, pS15, DOI 10.1016/S0928-0987(00)00161-5; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; LIDBETTER PS, 1986, SYNTHETIC COMMUN, V16, P1529, DOI 10.1080/00397918608056406; MALTZMAN TH, 1989, CARCINOGENESIS, V10, P781, DOI 10.1093/carcin/10.4.781; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; PARIS GY, 1980, J MED CHEM, V23, P9, DOI 10.1021/jm00175a003; SCRIBA GKE, 1995, J PHARM SCI, V84, P300, DOI 10.1002/jps.2600840307; Smith-Warner S. A., 1999, NUTR ONCOLOGY, P153; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Smuga DA, 2010, STEROIDS, V75, P1146, DOI 10.1016/j.steroids.2010.08.001; STARK MJ, 1995, CANCER LETT, V96, P15, DOI 10.1016/0304-3835(95)03912-G; SUGIHARA J, 1988, J PHARMACOBIO-DYNAM, V11, P555, DOI 10.1248/bpb1978.11.555; Tatman D, 2002, CANCER LETT, V175, P129, DOI 10.1016/S0304-3835(01)00723-6; Wang T, 2008, OILY PRESS LIPID LIB; WATTENBERG LW, 1991, CARCINOGENESIS, V12, P115, DOI 10.1093/carcin/12.1.115; Yamamoto Y, 2008, BIOORG MED CHEM LETT, V18, P4044, DOI 10.1016/j.bmcl.2008.05.113; Yamamoto Y, 2008, J AM OIL CHEM SOC, V85, P313, DOI 10.1007/s11746-008-1206-1; Yamamoto Y, 2011, NEW BIOTECHNOL, V28, P1, DOI 10.1016/j.nbt.2010.06.014; YU SG, 1995, J NUTR, V125, P2763	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172238	10.1371/journal.pone.0172238	http://dx.doi.org/10.1371/journal.pone.0172238			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196124	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900063
J	Ji, YJ; Kong, XF; Li, HW; Zhu, Q; Guo, QP; Yin, YL				Ji, Yujiao; Kong, Xiangfeng; Li, Huawei; Zhu, Qian; Guo, Qiuping; Yin, Yulong			Effects of dietary nutrient levels on microbial community composition and diversity in the ileal contents of pregnant Huanjiang mini-pigs	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; LUMINAL CONTENT; METABOLISM; ILEUM; SUPPLEMENTATION; BACTEROIDES; EXPRESSION; NUTRITION; SEQUENCES	The mammalian gut microbiota influences various metabolic and physiological processes. Substantial metabolic changes occur during a healthy pregnancy that may be related to microbiota composition dynamics. However, the effect of diet on intestinal microbiota composition and diversity during pregnancy remains unclear. We examined the ileal contents of Huanjiang mini-pigs at two pregnancy stages to determine the effects of dietary nutrient levels on such microbial communities. Animals received either a higher-nutrient (HN) diet formulated to meet US National Research Council requirements or a lower-nutrient (LN) diet that met the Chinese National Feeding Standard recommendations. On day 45 or 75 of pregnancy, sows were euthanized and their ileal contents sampled. Experimental diet and pregnancy stage did not affect ileal bacterial richness or diversity, as determined by Chao1 and ACE species richness measures and Shannon and Simpson indices, respectively. The phyla Firmicutes and Proteobacteria, accounting for 69.99-85.44% and 5.82-15.17% of the total reads, respectively, predominated regardless of diet. At the genus level, diet significantly affected the abundance of Lactobacillus species, which was greater in pigs given HN feed (P < 0.05), but had little impact on that of Megasphaera species (P = 0.096). Pregnancy stage had a minimal effect on Proteobacteria numbers (P = 0.053). The number of bacteria of the phylum Firmicutes and genus Lactobacillus decreased, while that of the phylum Proteobacteria, family Enterobacteriaceae, and genus Bacteroides increased between days 45 and 75 of pregnancy. Of the short-chain fatty acids (SCFAs) measured, only propionate levels changed significantly, with higher concentrations observed on day 45 than on day 75. Our findings indicate that Firmicutes and Proteobacteria dominate pregnant sow ileal bacterial profiles. Excepting a tendency for the number of Proteobacteria to increase as pregnancy progressed, pregnancy stage and diet had little effect on ileal microbiotic composition and diversity and luminal SCFA concentrations.	[Ji, Yujiao; Kong, Xiangfeng; Li, Huawei; Zhu, Qian; Guo, Qiuping; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Kong, Xiangfeng; Yin, Yulong] Huanjiang Observat & Res Stn Karst Ecosysterms, Res Ctr Mini Pig, Huanjiang, Guangxi, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Kong, XF; Yin, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.; Kong, XF; Yin, YL (corresponding author), Huanjiang Observat & Res Stn Karst Ecosysterms, Res Ctr Mini Pig, Huanjiang, Guangxi, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn			Chinese Academy of Sciences; National Nature Science Foundation of China [31270044, 31572421]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAC17130102, 2014BAD08B06]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2013T2S0014]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	The present work was jointly supported by grants from the "Western Light" key Program for Talent Cultivation from Chinese Academy of Sciences, National Nature Science Foundation of China (31270044, 31572421), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAC17130102, 2014BAD08B06), and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (F. Blachier, 2013T2S0014).	Ai J, 2010, BIORESOURCE TECHNOL, V101, P215, DOI 10.1016/j.biortech.2009.07.090; Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010; Basson A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00290; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Booijink CCGM, 2009, AN DIV FUNCT HUM SMA; Boudry G, 2013, J NUTR, V143, P1225, DOI 10.3945/jn.113.175828; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Dai ZL, 2015, MOL HUM REPROD, V21, P389, DOI 10.1093/molehr/gav003; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egshatyan L, 2016, ENDOCR CONNECT, V5, P1, DOI 10.1530/EC-15-0094; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Jindal R, 1996, J ANIM SCI, V74, P620; Johnston L, 1999, FEEDSTUFFS, V10, P12; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Kim J, 2015, ARCH MICROBIOL, V197, P753, DOI 10.1007/s00203-015-1108-1; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Kong XF, 2007, ASIAN AUSTRAL J ANIM, V20, P1453, DOI 10.5713/ajas.2007.1453; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lan A, 2015, J NUTR BIOCHEM, V26, P91, DOI 10.1016/j.jnutbio.2014.09.007; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138277; Liu YY, 2015, BRIT J NUTR, V113, P1069, DOI 10.1017/S0007114514004310; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; National Research Council (NRC), 1998, INSIDE NRC, V10th, P1; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Nielsen S, 2007, J PEDIATR GASTR NUTR, V44, P613, DOI 10.1097/MPG.0b013e3180406a11; Pedersen R, 2013, GUT MICROBES, V4, P371, DOI 10.4161/gmic.26108; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; SALYERS AA, 1984, ANNU REV MICROBIOL, V38, P293, DOI 10.1146/annurev.mi.38.100184.001453; Sera N, 2005, J NUTR BIOCHEM, V16, P50, DOI 10.1016/j.jnutbio.2004.09.005; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELDON WC, 1994, J ANIM SCI, V72, P387, DOI 10.2527/1994.722387x; Zhou LP, 2016, ANAEROBE, V38, P61, DOI 10.1016/j.anaerobe.2015.12.009; Zhou XL, 2012, J ANIM SCI, V90, P37, DOI 10.2527/jas.50269; Zhou XL, 2014, NUTR RES, V34, P780, DOI 10.1016/j.nutres.2014.08.008; Zhu Qian, 2016, Chinese Journal of Animal Nutrition, V28, P1534	61	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172086	10.1371/journal.pone.0172086	http://dx.doi.org/10.1371/journal.pone.0172086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196137	Green Submitted, gold, Green Published			2022-12-27	WOS:000394423900049
J	Kallistova, A; Horacek, I; Slouf, M; Skala, R; Fridrichova, M				Kallistova, Anna; Horacek, Ivan; Slouf, Miroslav; Skala, Roman; Fridrichova, Michaela			Mammalian enamel maturation: Crystallographic changes prior to tooth eruption	PLOS ONE			English	Article							RESOLUTION ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; DENTAL ENAMEL; VERTEBRATE DENTITION; RAT ENAMEL; PROTEIN; EVOLUTION; CRYSTALS; SHAPE; AMELOBLASTIN	Using the distal molar of a minipig as a model, we studied changes in the microstructural characteristics of apatite crystallites during enamel maturation (16-23 months of postnatal age), and their effects upon the mechanical properties of the enamel coat. The slow rate of tooth development in a pig model enabled us to reveal essential heterochronies in particular components of the maturation process. The maturation changes began along the enamel dentine junction (EDJ) of the trigonid, spreading subsequently to the outer layers of the enamel coat to appear at the surface zone with a 2-month delay. Correspondingly, at the distal part of the tooth the timing of maturation processes is delayed by 3-5 month compared to the mesial part of the tooth. The early stage of enamel maturation (16-20 months), when the enamel coat is composed almost exclusively of radial prismatic enamel, is characterized by a gradual increase in crystallite thickness (by a mean monthly increment of 3.8 nm); and an increase in the prism width and thickness of crystals composed of elementary crystallites. The late stage of maturation (the last two months prior to tooth eruption), marked with the rapid appearance of the interprismatic matrix (IPM) during which the crystals densely infill spaces between prisms, is characterized by an abrupt decrease in microstrain and abrupt changes in the micromechanical properties of the enamel: a rapid increase in its ability to resist long-term load and its considerable hardening. The results suggest that in terms of crystallization dynamics the processes characterizing the early and late stage of mammalian enamel maturation represent distinct entities. In regards to common features with enamel formation in the tribosphenic molar we argue that the separation of these processes could be a common apomorphy of mammalian amelogenetic dynamics in general.	[Kallistova, Anna; Skala, Roman] Charles Univ Prague, Inst Geochem Mineral & Mineral Resources, Fac Sci, Albertov 6, Prague, Czech Republic; [Kallistova, Anna; Skala, Roman; Fridrichova, Michaela] CAS, Inst Geol, Vvi, Rozvojova 269, Prague 6, Czech Republic; [Horacek, Ivan] Charles Univ Prague, Dept Zool, Fac Sci, Vinicna 7, Prague, Czech Republic; [Slouf, Miroslav] Inst Macromol Chem CAS Vvi, Heyrovskeho Namesti 2, Prague 6, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Fac Sci, Vinicna 7, Prague, Czech Republic.	horacek@natur.cuni.cz	Skala, Roman/C-4442-2008; Fridrichova, Michaela/GVS-4377-2022; Fridrichova, Michaela/A-7017-2013; Horacek, Ivan/V-9741-2017; Slouf, Miroslav/F-6311-2012; Kallistova, Anna/I-8773-2014	Skala, Roman/0000-0002-5168-1585; Fridrichova, Michaela/0000-0002-3636-723X; Horacek, Ivan/0000-0002-8356-5554; Slouf, Miroslav/0000-0003-1528-802X; Kallistova, Anna/0000-0003-1320-0071	Charles University Grant Agency [742213]; University Student Project [SVV260197]; research plan of the Institute of Geology of the CAS, v.v.i. [RVO67985831]; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I) [POLYMAT LO1507]	Charles University Grant Agency; University Student Project; research plan of the Institute of Geology of the CAS, v.v.i.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I)	This work was supported by Charles University Grant Agency, project No. 742213, University Student Project No. SVV260197, and the research plan of the Institute of Geology of the CAS, v.v.i. RVO67985831. The work at the Institute of Macromolecular Chemistry was supported by the Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I), project POLYMAT LO1507.	Baxa M, 2013, J HUNTINGTONS DIS, V2, P47, DOI 10.3233/JHD-130001; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; BOYDE A, 1989, TEETH, P309; Clemens WA, 1997, TOOTH ENAMEL MICROSTRUCTURE, P85; COOPER WEG, 1968, ARCH ORAL BIOL, V13, P27, DOI 10.1016/0003-9969(68)90035-6; CUISINIER FJG, 1992, CALCIFIED TISSUE INT, V51, P259, DOI 10.1007/BF00334485; CUISINIER FJG, 1990, J BIOL BUCCALE, V18, P149; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Davis BM, 2011, J MAMM EVOL, V18, P227, DOI 10.1007/s10914-011-9168-8; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Duverger O, 2014, J CLIN INVEST, V124, P5219, DOI 10.1172/JCI78272; ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704; Enamel I., 2010, J MORPHOL, V271, P1204, DOI [10.1002/jmor.10867, DOI 10.1002/JMOR.10867]; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Ganss B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00371; Gasse B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0329-x; GLIMCHER MJ, 1964, BIOCHEM J, V93, P202, DOI 10.1042/bj0930202; Horacek I, 2012, CAM STUD MORPHOL MOL, P410; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Iijima M, 2001, J CRYST GROWTH, V222, P615, DOI 10.1016/S0022-0248(00)00984-2; Instruments C., 2013, INDENTATION SOFTWARE, P135; Jernvall J, 1995, ACTA ZOOLOGICA FENNI; Kallistova A, 2015, J APPL CRYSTALLOGR, V48, P763, DOI 10.1107/S1600576715005208; Kallonen A, 2014, B INT ASS PALEODONTO, V8, P103; Kawasaki K, 2008, J DENT RES, V87, P520, DOI 10.1177/154405910808700608; Kirkham J, 1998, CONNECT TISSUE RES, V38, P91, DOI 10.3109/03008209809017025; KLUG HP, 1974, XRAY DIFFRACTION PRO, P618; Koenigswald W. von, 1997, TOOTH ENAMEL MICROST, P267; Lester K S, 1987, Adv Dent Res, V1, P181; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P421; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Margolis HC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00339; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Nanci A., 2008, 10 CATES ORAL HISTOL; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Osborn HF., 1907, EVOLUTION MAMMALIAN, V1; Planska D, 2015, ACTA HISTOCHEM CYTOC, V48, P15, DOI 10.1267/ahc.14020; Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x; Robinson C, 2003, CONNECT TISSUE RES, V44, P65, DOI 10.1080/03008200390152115; ROBINSON C, 1975, ARCH ORAL BIOL, V20, P29, DOI 10.1016/0003-9969(75)90149-1; ROBINSON C, 1995, INT J DEV BIOL, V39, P145; Robinson C, 1982, J DENT RES, P1490; Robinson C, 2006, EUR J ORAL SCI, V114, P99, DOI 10.1111/j.1600-0722.2006.00275.x; Robinson C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00388; Rodriguez-Carvajal J., 2001, NEWSL, V26, P12; Sander PM, 1997, TOOTH ENAMEL MICROSTRUCTURE, P41; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Slouf M, 2015, POLYM TEST, V41, P191, DOI 10.1016/j.polymertesting.2014.12.003; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; TONGE CH, 1973, J ANAT, V115, P1; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wang F, 2014, ORAL DIS, V20, P367, DOI 10.1111/odi.12126; WARSHAWSKY H, 1981, ANAT RECORD, V200, P371, DOI 10.1002/ar.1092000402; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040	69	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171424	10.1371/journal.pone.0171424	http://dx.doi.org/10.1371/journal.pone.0171424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196135	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900019
J	Rousseau, C; Oulhote, Y; Ruiz-Casares, M; Cleveland, J; Greenaway, C				Rousseau, Cecile; Oulhote, Youssef; Ruiz-Casares, Monica; Cleveland, Janet; Greenaway, Christina			Encouraging understanding or increasing prejudices: A cross-sectional survey of institutional influence on health personnel attitudes about refugee claimants' access to health care	PLOS ONE			English	Article							POSITIVE INTERGROUP CONTACT; NEGATIVE CONTACT; PREGNANT-WOMEN; PERCEPTIONS; RACISM; BIAS; INTENTIONS; INSURANCE; CHILDREN; IMPACT	Background This paper investigates the personal, professional and institutional predictors of health institution personnel's attitudes regarding access to healthcare for refugee claimants in Canada. Methods In Montreal, the staff of five hospitals and two primary care centres (n = 1772) completed an online questionnaire documenting demographics, occupation, exposure to refugee claimant patients, and attitudes regarding healthcare access for refugee claimants. We used structural equations modeling to investigate the associations between professional and institutional factors with latent functions of positive and negative attitudes toward refugee's access to healthcare. Results Younger participants, social workers, participants from primary care centres, and from 1st migrant generation had the lowest scores of negative attitudes. Respondents who experienced contact with refugees had lower scores of negative attitudes (B = -14% standard deviation [SD]; 95% CI: -24, -4%). However, direct contact with refugees increased scores of negative attitudes in the institution with the most negative attitudes by 36% SD (95% CI: 1, 71%). Interpretation Findings suggest that institutions influence individuals' attitudes about refugee claimants' access to health care and that, in an institutional context of negative attitudes, contact with refugees may further confirm negative perceptions about this vulnerable group.	[Rousseau, Cecile; Ruiz-Casares, Monica] McGill Univ, Dept Social & Cultural Psychiat, Montreal, PQ, Canada; [Oulhote, Youssef] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Cleveland, Janet] Univ Inst Regard Cultural Communities, Res Ctr, CIUSSS Ctr Ouest Ile Montreal, Montreal, PQ, Canada; [Greenaway, Christina] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	McGill University; Harvard University; Harvard T.H. Chan School of Public Health; McGill University	Rousseau, C (corresponding author), McGill Univ, Dept Social & Cultural Psychiat, Montreal, PQ, Canada.	cecile.rousseau@mcgill.ca		oulhote, youssef/0000-0002-2323-1982	Canadian Institutes of Health Research [MOP-130451]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by a grant from the Canadian Institutes of Health Research, MOP-130451, to CR, CG, MR-C and JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 2007, LANCET, V370, P2; [Anonymous], 2012, J STAT SOFTW, V48, P37; Arya N, 2012, CAN MED ASSOC J, V184, P1875, DOI 10.1503/cmaj.120938; Barlow FK, 2012, PERS SOC PSYCHOL B, V38, P1629, DOI 10.1177/0146167212457953; Beatson J, 2016, REFUGEE, V32; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brach C, 2003, PEDIATRICS, V112, pE499; Burgess DJ, 2010, J GEN INTERN MED, V25, pS169, DOI 10.1007/s11606-009-1221-4; Came H, 2014, SOC SCI MED, V106, P214, DOI 10.1016/j.socscimed.2014.01.055; Christ O, 2014, P NATL ACAD SCI USA, V111, P3996, DOI 10.1073/pnas.1320901111; Christ O, 2010, PERS SOC PSYCHOL B, V36, P1662, DOI 10.1177/0146167210386969; Cole P, 2009, CAMB Q HEALTHC ETHIC, V18, P70, DOI 10.1017/S0963180108090117; Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006; Fernando S., 2008, MENTAL HLTH MULTIETH; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Glaser J., 2014, POL INS BEH BRAIN SC, V1, P88, DOI [10.1177/, DOI 10.1177/2372732214550403]; Graf S, 2014, EUR J SOC PSYCHOL, V44, P536, DOI 10.1002/ejsp.2052; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haider AH, 2011, JAMA-J AM MED ASSOC, V306, P942, DOI 10.1001/jama.2011.1248; Hunt Paul, 2008, Health Hum Rights, V10, P81; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kronick R, 2015, J REFUGEE STUDIES; Michaelsen JJ, 2004, SCAND J PUBLIC HEALT, V32, P287, DOI 10.1080/14034940310022223; Paolini S, 2014, EUR J SOC PSYCHOL, V44, P548, DOI 10.1002/ejsp.2029; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Plaut V. C., 2014, POLICY INSIGHTS BEHA, V1, P72, DOI DOI 10.1177/2372732214550164; R Core Team, 2021, R LANGUAGE ENV STAT; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Ruiz-Casares M, 2013, MATERN CHILD HLTH J, V17, P292, DOI 10.1007/s10995-012-0973-3; Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773; Sinclair S, 2014, POLICY INSIGHTS BEHA, V1, P81; Steele LS, 2002, CAN J PUBLIC HEALTH, V93, P118, DOI 10.1007/BF03404551; Stepanikova I, 2008, HEALTH SERV RES, V43, P915, DOI 10.1111/j.1475-6773.2007.00816.x; Teal CR, 2010, J GEN INTERN MED, V25, pS115, DOI 10.1007/s11606-009-1243-y; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Vanthuyne K, 2013, SOC SCI MED, V93, P78, DOI 10.1016/j.socscimed.2013.06.008; Willen SS, 2011, MED ANTHROPOL Q, V25, P303, DOI 10.1111/j.1548-1387.2011.01163.x	38	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170910	10.1371/journal.pone.0170910	http://dx.doi.org/10.1371/journal.pone.0170910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196129	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900008
J	Meng, FY; Sun, Y; Shen, YG; Pan, HF; Tang, JH; Wang, BB; Wu, CH; Ye, DQ				Meng, Fan-Ya; Sun, Yong; Shen, Yong-Gang; Pan, Hai-Feng; Tang, Ji-Hai; Wang, Bin-Bing; Wu, Chang-Hao; Ye, Dong-Qing			Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China	PLOS ONE			English	Article							EVENT FOLLOWING IMMUNIZATION; CASE-DEFINITION; DATA-COLLECTION; FEBRILE SEIZURES; GUIDELINES; ELIMINATION; CHILDREN; AGE; FEVER	The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live attenuated measles vaccine, live attenuated measles and rubella combined vaccine, live attenuated measles and mumps combined vaccine, live attenuated Measles, Mumps and Rubella Combined Vaccine) in Anhui Province, China. From 2009 to 2014, 9.9 million doses of measles-containing vaccines were administrated and 1893 AEFIs were found (191.4 per million doses), of which, 33 serious AEFIs (3.3 per million vaccine doses) were reported. 59.4% (1124 cases) were male cases, and 85.1% (1611 cases) occurred in persons aged < 1 year. 93.3% (1766 cases) occurred at the first dose of vaccination and 95.9% (1815 cases) were found within 3 days after vaccination. This study presents up-to-date data and suggests that the measles-containing vaccines used in Anhui Province of China are safe.	[Meng, Fan-Ya; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Meng, Fan-Ya; Pan, Hai-Feng; Ye, Dong-Qing] Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China; [Meng, Fan-Ya; Sun, Yong; Shen, Yong-Gang; Tang, Ji-Hai; Wang, Bin-Bing] Anhui Ctr Dis Control & Prevent, Dept Immunizat & Prevent, Hefei, Anhui, Peoples R China; [Wu, Chang-Hao] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England	Anhui Medical University; University of Surrey	Ye, DQ (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.; Ye, DQ (corresponding author), Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China.	ydqahmu@gmail.com	Yue, Yuhang/AAW-9279-2021	Ye, Dongqing/0000-0001-6604-9614; Pan, Hai-Feng/0000-0001-8218-5747	Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease [CXNLX-1401]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I025379/1, BB/P004695/1]; National Institute of Aging (NIA) [1R01AG049321-01A1]; Royal Society; NSFC [IE151259]; BBSRC [BB/I025379/1, BB/P004695/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P004695/1, BB/I025379/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG049321] Funding Source: NIH RePORTER	Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Royal Society(Royal Society of London); NSFC(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease (CXNLX-1401) for data collection. CW gratefully acknowledges support from Biotechnology and Biological Sciences Research Council (BBSRC) (BB/I025379/1, BB/P004695/1) for analysis, National Institute of Aging (NIA, 1R01AG049321-01A1) for decision to publish, The Royal Society and NSFC (IE151259) for preparation of the manuscript. http://www.nsfc.gov.cn/. http://www.governmentfunding.org.uk/default.aspx.	Beigel J, 2007, VACCINE, V25, P5697, DOI 10.1016/j.vaccine.2007.02.066; Beijing Tiantan of Biological Products, MEASL RUB COMB VACC; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Gidudu J, 2011, VACCINE, V29, P1053, DOI 10.1016/j.vaccine.2010.11.065; Gidudu J, 2008, VACCINE, V26, P6800, DOI 10.1016/j.vaccine.2008.10.006; Jones JF, 2007, VACCINE, V25, P5685, DOI 10.1016/j.vaccine.2007.02.065; Klein NP, 2015, PEDIATRICS, V135, pE321, DOI 10.1542/peds.2014-1822; Klein NP, 2012, PEDIATRICS, V129, P809, DOI 10.1542/peds.2011-3198; Li J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-986; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Liu SJ, 2013, HUM VACC IMMUNOTHER, V9, P1296, DOI 10.4161/hv.24032; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Macartney KK, 2015, VACCINE, V33, P1412, DOI 10.1016/j.vaccine.2014.10.071; Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007; Naim HY, 2015, HUM VACC IMMUNOTHER, V11, P21, DOI 10.4161/hv.34298; National Health and Family Planning Commission of the People's Republic of China, CHIN INF SYST DIS CO; National Health and Family Planning Commission of the People's Republic of China, 2010, NAT GUID SURV ADV EV; Rowhani-Rahbar A, 2013, JAMA PEDIATR, V167, P1111, DOI 10.1001/jamapediatrics.2013.2745; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Rumke HC, 2011, VACCINE, V29, P3842, DOI 10.1016/j.vaccine.2011.02.067; Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060; Shanghai Institute of Biological Products, MEASL VACC LIV; Shanghai Institute of Biological Products, MEASL MUMPS RUB COMB; Shanghai Institute of Biological Products, MEASL MUMPS COMB VAC; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; van den Ent MMVX, 2011, J INFECT DIS, V204, pS18, DOI 10.1093/infdis/jir081; Wang XY, 2014, CHINESE J STRUC CHEM, V33, P33; WHO, 2015, IMM SAF SURV GUID IM; Wise RP, 2007, VACCINE, V25, P5717, DOI 10.1016/j.vaccine.2007.02.067; Wu W., 2013, CHINA VACCINES IMMUN, V19, P97; Wu WD, 2011, CHINESE J VACCINES I, V2, P99; Wu WD, 2012, CHINESE J VACCINES I, V5, P385; Wu Wei, 2014, POWER MEASUREMENT IN, V1, P12; Ye JK, 2015, CHIN J VAC IMMUN, V2, P200; Ye JK, 2016, CHINESE J VACCINES I, V2, P125; Zuo SY, 2015, VACCINE, V33, P2050, DOI 10.1016/j.vaccine.2015.02.078	38	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172108	10.1371/journal.pone.0172108	http://dx.doi.org/10.1371/journal.pone.0172108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192490	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800069
J	Budinich, M; Bourdon, J; Larhlimi, A; Eveillard, D				Budinich, Marko; Bourdon, Jeremie; Larhlimi, Abdelhalim; Eveillard, Damien			A multi-objective constraint-based approach for modeling genome-scale microbial ecosystems	PLOS ONE			English	Article							COMMUNITY ECOLOGY; SYSTEMS; THERMODYNAMICS; RECONSTRUCTION; OPTIMIZATION; FIXATION; ENTROPY; BALANCE; BIOLOGY; CYCLE	Interplay within microbial communities impacts ecosystems on several scales, and elucidation of the consequent effects is a difficult task in ecology. In particular, the integration of genome-scale data within quantitative models of microbial ecosystems remains elusive. This study advocates the use of constraint-based modeling to build predictive models from recent high-resolution-omics datasets. Following recent studies that have demonstrated the accuracy of constraint-based models (CBMs) for simulating single-strain metabolic networks, we sought to study microbial ecosystems as a combination of single-strain metabolic networks that exchange nutrients. This study presents two multi-objective extensions of CBMs for modeling communities: multi-objective flux balance analysis (MO-FBA) and multi objective flux variability analysis (MO-FVA). Both methods were applied to a hot spring mat model ecosystem. As a result, multiple trade-offs between nutrients and growth rates, as well as thermodynamically favorable relative abundances at community level, were emphasized. We expect this approach to be used for integrating genomic information in microbial ecosystems. Following models will provide insights about behaviors (including diversity) that take place at the ecosystem scale.	[Budinich, Marko; Bourdon, Jeremie; Larhlimi, Abdelhalim; Eveillard, Damien] Univ Nantes, Computat Biol Grp, LINA UMR CNRS 6241, EMN, Nantes, France	IMT - Institut Mines-Telecom; IMT Atlantique; Nantes Universite	Budinich, M (corresponding author), Univ Nantes, Computat Biol Grp, LINA UMR CNRS 6241, EMN, Nantes, France.	marko.budinich@univ-nantes.fr	eveillard, damien/AAQ-2363-2020	eveillard, damien/0000-0002-8162-7360; Bourdon, Jeremie/0000-0001-6674-8626; Larhlimi, Abdelhalim/0000-0002-1709-2648; Budinich, Marko/0000-0003-3541-0547	CNRS; Region Pays de la Loire funding (GRIOTE project); ANR (IMPEKAB) [ANR-15-CE02-001-03]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Pays de la Loire funding (GRIOTE project)(Region Pays de la Loire); ANR (IMPEKAB)(French National Research Agency (ANR))	MB is supported by CNRS and Region Pays de la Loire funding (GRIOTE project, http://griote.univ-nantes.fr/). This study is supported by ANR (IMPEKAB, ANR-15-CE02-001-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 2006, APPLICATIONS OF MATH; ANDERSON KL, 1987, APPL ENVIRON MICROB, V53, P2343, DOI 10.1128/AEM.53.10.2343-2352.1987; Aoki I, 1998, J PHYS SOC JPN, V67, P2132, DOI 10.1143/JPSJ.67.2132; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Benson HP, 1998, J GLOBAL OPTIM, V13, P1, DOI 10.1023/A:1008215702611; Biggs MB, 2015, WIRES SYST BIOL MED, V7, P317, DOI 10.1002/wsbm.1308; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bordron P, 2016, MICROBIOLOGYOPEN, V5, P106, DOI 10.1002/mbo3.315; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Czyzyk J, 1998, IEEE COMPUT SCI ENG, V5, P68, DOI 10.1109/99.714603; Dantzig GB, 1983, MATH PROGRAMMING STA, P78, DOI [10.1007/978- 3- 642- 68874- 4, DOI 10.1007/978-3-642-68874-4]; Dillon JG, 2007, APPL ENVIRON MICROB, V73, P5218, DOI 10.1128/AEM.00357-07; Dolan E, 2001, TECHNICAL MEMORANDUM; Ehrgott M, 2005, MULTICRITERIA OPTIMI; Ehrgott M, 2005, INT SER OPER RES MAN, V78, P667, DOI 10.1007/0-387-23081-5_17; Ehrgott M, 2012, J GLOBAL OPTIM, V52, P757, DOI 10.1007/s10898-011-9709-y; Ehrgott M, 2011, J GLOBAL OPTIM, V50, P397, DOI 10.1007/s10898-010-9588-7; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Fleming RMT, 2010, J THEOR BIOL, V264, P683, DOI 10.1016/j.jtbi.2010.02.044; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Gropp W., 1997, APPROXIMATION THEORY, P167; Gurobi Optimization I, 2015, GUROBI OPTIMIZER REF; Hamel AH, 2014, J GLOBAL OPTIM, V59, P811, DOI 10.1007/s10898-013-0098-2; Hanemaaijer M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Kim YM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00209; Klatt CG, 2013, ISME J, V7, P1775, DOI 10.1038/ismej.2013.52; Klitgord N, 2009, GENOME INFORM SER, V22, P41; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Koch S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0429-x; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Kschischo M, 2010, EUR PHYS J-SPEC TOP, V187, P255, DOI 10.1140/epjst/e2010-01290-3; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lin BL, 2000, ECOL MODEL, V135, P89, DOI 10.1016/S0304-3800(00)00372-0; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lohne A, 2015, BENSOLVE VLP SOLVER; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Martyushev LM, 2006, PHYS REP, V426, P1, DOI 10.1016/j.physrep.2005.12.001; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Nash SG, 2000, J COMPUT APPL MATH, V124, P45, DOI 10.1016/S0377-0427(00)00426-X; Oberhardt Matthew A., 2009, V500, P61, DOI 10.1007/978-1-59745-525-1_3; Perez-Garcia O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00673; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rodriguez J, 2006, BIOTECHNOL BIOENG, V93, P592, DOI 10.1002/bit.20765; Rullkotter J., 2006, MARINE GEOCHEMISTRY, P125, DOI DOI 10.1007/3-540-32144-6_4; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Segata N, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.22; STADLER W, 1979, J OPTIMIZ THEORY APP, V29, P1, DOI 10.1007/BF00932634; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Taffs R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-114; Tawarmalani M, 2005, MATH PROGRAM, V103, P225, DOI 10.1007/s10107-005-0581-8; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Waldor MK, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002050; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363; Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307	69	36	38	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171744	10.1371/journal.pone.0171744	http://dx.doi.org/10.1371/journal.pone.0171744			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187207	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300042
J	Pfistermeister, B; Tumena, T; Gassmann, KG; Maas, R; Fromm, MF				Pfistermeister, Barbara; Tuemena, Thomas; Gassmann, Karl-Guenter; Maas, Renke; Fromm, Martin F.			Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients	PLOS ONE			English	Article							MINI-MENTAL-STATE; POTENTIALLY INAPPROPRIATE MEDICATIONS; GIB-DAT; IMPLEMENTATION; DEMENTIA; IMPACT; DRUGS; RISK; IMPAIRMENT; BAVARIA	Purpose Previous studies suggest an association between use of anticholinergic drugs in elderly patients and cognitive impairment. However, there are still limited data on the association of anticholinergic drug use and cognitive impairment as well as contribution of individual drugs to anticholinergic load using large, well-documented patient cohorts treated in geriatric units from Europe. Methods We investigated 797,440 prescriptions to 89,579 hospitalized patients treated in geriatric units within the GiB-DAT database. Data of all patients discharged between 1 January 2013 and 30 June 2015 was included. The Anticholinergic Cognitive Burden (ACB) scale was used to classify anticholinergic drugs as definite (score 2 or 3) and possible anticholinergics (score 1). Cognitive function was determined using Mini-Mental State Examination (MMSE) and the standardized scale for dementia (4D+S). Results In two multivariable logistic regression models age, sex, number of drugs and ACB total scores were identified as variables independently associated with cognitive impairment as measured by MMSE (odds ratio per ACB unit 1.114, 95% CI 1.099-1.130) or the diagnosis dementia (odds ratio 1.159 per ACB unit, 95% CI 1.144-1.173, both p < 0.0001). High anticholinergic load was associated with patients with severe cognitive impairment (p < 0.05 for all pairwise comparisons). ACB score 3 anticholinergic drugs contributed 77.9% to the cumulative amount of ACB points in patients with an anticholinergic load of 3 and higher. Conclusions Using a cross-sectional study design, a significant positive association between anticholinergic drug load and cognitive impairment in European patients treated in specialised geriatric units was found. The most frequently used definitve anticholinergic drugs were quetiapine, amitriptyline and carbamazepine.	[Pfistermeister, Barbara; Maas, Renke; Fromm, Martin F.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Fahrstr 17, Erlangen, Germany; [Tuemena, Thomas; Gassmann, Karl-Guenter] GiB DAT Database, Nurnberg, Germany; [Gassmann, Karl-Guenter] Waldkrankenhaus St Marien gGmbH, Internal Med 3, Geriatr Ctr Erlangen, Erlangen, Germany	University of Erlangen Nuremberg	Fromm, MF (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Fahrstr 17, Erlangen, Germany.	martin.fromm@fau.de						Aging Brain Care, ANT COGN BURD SCAL 2; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Block CK, 2015, ARCH CLIN NEUROPSYCH, V30, P105, DOI 10.1093/arclin/acu073; Boudreau DM, 2011, J AM GERIATR SOC, V59, P2069, DOI 10.1111/j.1532-5415.2011.03654.x; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Cai XY, 2013, ALZHEIMERS DEMENT, V9, P377, DOI 10.1016/j.jalz.2012.02.005; Callegari E, 2011, BRIT J CLIN PHARMACO, V72, P235, DOI 10.1111/j.1365-2125.2011.03961.x; Campbell NL, 2010, NEUROLOGY, V75, P152, DOI 10.1212/WNL.0b013e3181e7f2ab; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chancellor M, 2012, CNS NEUROSCI THER, V18, P167, DOI 10.1111/j.1755-5949.2011.00248.x; Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000; Duran CE, 2013, EUR J CLIN PHARMACOL, V69, P1485, DOI 10.1007/s00228-013-1499-3; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox C, 2011, AGE AGEING, V40, P730, DOI 10.1093/ageing/afr102; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Fromm MF, 2013, EUR J CLIN PHARMACOL, V69, P975, DOI 10.1007/s00228-012-1425-0; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gassmann KG, 2012, Z GERONTOL GERIATR, V45, P455, DOI 10.1007/s00391-012-0382-7; Gnjidic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083224; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Jessen F, 2010, EUR ARCH PSY CLIN N, V260, pS111, DOI 10.1007/s00406-010-0156-4; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Lechevallier-Michel N, 2005, BRIT J CLIN PHARMACO, V59, P143, DOI 10.1111/j.1365-2125.2004.02232.x; Lopez M, 2005, ASSESSMENT, V12, P137, DOI 10.1177/1073191105275412; Mate KE, 2015, DRUG AGING, V32, P159, DOI 10.1007/s40266-014-0230-0; Mayer T, 2015, EUR J CLIN PHARMACOL, V71, P1299, DOI 10.1007/s00228-015-1932-x; Mintzer J, 2000, J ROY SOC MED, V93, P457, DOI 10.1177/014107680009300903; Schachtele S, 2015, E HLTH 2015, P116; Schachtele S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155649; Schachtele S, 2014, DTSCH ARZTEBL INT, V111, P255, DOI 10.3238/arztebl.2014.0255; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trogner J, 2006, Z GERONTOL GERIATR, V39, P126, DOI 10.1007/s00391-006-0338-x; Trogner J, 2006, Z GERONTOL GERIATR, V39, P134, DOI 10.1007/s00391-006-0339-9; Tune LE, 2001, J CLIN PSYCHIAT, V62, P11; WHO Collaborating Centre for Drug Statistics Methodology, ATC STRUCT PRINC; Yeh YC, 2013, GERIATR GERONTOL INT, V13, P694, DOI 10.1111/ggi.12000	38	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171353	10.1371/journal.pone.0171353	http://dx.doi.org/10.1371/journal.pone.0171353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187171	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300021
J	Lima, DCD; do Vale, CR; Veras, JH; Bernardes, A; Perez, CN; Chen-Chen, L				da Silva Lima, Debora Cristina; do Vale, Camila Regina; Veras, Jefferson Hollanda; Bernardes, Aline; Perez, Caridad Noda; Chen-Chen, Lee			Absence of genotoxic effects of the chalcone (E)-1-(2-hydroxyphenyl)-3-(4-methylphenyl)-prop-2-en-1-one) and its potential chemoprevention against DNA damage using in vitro and in vivo assays	PLOS ONE			English	Article							COMET ASSAY; MICRONUCLEUS TEST; ANTIOXIDANT PROPERTIES; SODIUM-AZIDE; MUTAGENICITY; HYDROXYCHALCONES; DERIVATIVES; INHIBITORS; CRYSTAL; LEADS	The chalcone (E)-1-(2-hydroxyphenyl)-3-(4-methylphenyl)-prop-2-en-1-one), or 2HMC, displays antileishmanial, antimalarial, and antioxidant activities. The aim of this study was to investigate the cytotoxic, genotoxic, mutagenic, and protective effects of 2HMC using the Ames mutagenicity test, the mouse bone marrow micronucleus test, and the comet assay in mice. In the assessment using the Ames test, 2HMC did not increase the number of His + revertants in Salmonella typhimurium strains, demonstrating lack of mutagenicity. 2HMC showed no significant increase in micronucleated polychromatic erythrocyte frequency (MNPCE) in the micronucleus test, or in DNA strand breaks using the comet assay, evidencing absence of genotoxicity. Regarding cytotoxicity, 2HMC exhibited moderate cytotoxicity in mouse bone marrow cells by micronucleus test. 2HMC showed antimutagenic action in co-administration with the positive controls, sodium azide (SA) and 4-nitroquinoline-1-oxide (4NQO), in the Ames test. Co-administered and mainly pre-administered with cyclophosphamide (CPA), 2HMC caused a decrease in the frequency of MNPCE using the micronucleus test and in DNA strand breaks using the comet assay. Thus, 2HMC exhibited antimutagenic and antigenotoxic effects, displaying a DNA-protective effect against CPA, SA, and 4NQO carcinogens. In conclusion, 2HMC presented antimutagenic, antigenotoxic and moderate cytotoxic effects; therefore it is a promising molecule for cancer prevention.	[da Silva Lima, Debora Cristina; do Vale, Camila Regina; Veras, Jefferson Hollanda; Chen-Chen, Lee] Univ Fed Goias, Inst Biol Sci, Dept Genet, Goiania, Go, Brazil; [Bernardes, Aline; Perez, Caridad Noda] Univ Fed Goias, Inst Chem, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Chen-Chen, L (corresponding author), Univ Fed Goias, Inst Biol Sci, Dept Genet, Goiania, Go, Brazil.	chenleego@yahoo.com.br	Noda-Perez, Caridad/AAO-1659-2021; Perez, Caridad C. Noda Noda/M-6704-2013; Chen-Chen, Lee/Q-9797-2019; Véras, Jefferson Hollanda/B-5181-2013; Chen, Lee Chen/B-1668-2013	Noda-Perez, Caridad/0000-0003-0586-0774; Perez, Caridad C. Noda Noda/0000-0003-0586-0774; Chen-Chen, Lee/0000-0002-0386-247X; Véras, Jefferson Hollanda/0000-0001-9959-6411; Chen, Lee Chen/0000-0002-0386-247X	Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under auspices of the Federal University of Goias (UFG)	Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under auspices of the Federal University of Goias (UFG)	This study was financially supported by the Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the auspices of the Federal University of Goias (UFG).	Al-Qurainy F., 2009, World Applied Sciences Journal, V6, P1589; Augustyniak M, 2014, CHEMOSPHERE, V96, P180, DOI 10.1016/j.chemosphere.2013.10.033; Balsera B, 2014, EUR J MED CHEM, V86, P724, DOI 10.1016/j.ejmech.2014.09.039; Batagin-Neto A, 2014, MED CHEM RES, V23, P580, DOI 10.1007/s00044-013-0667-4; Bukhari SNA, 2012, MINI-REV MED CHEM, V12, P1394; Chakraborty P., 2009, J CANC MOL, V4, P183; CHENG XY, 1988, ENVIRON EXP BOT, V28, P281, DOI 10.1016/0098-8472(88)90051-2; Corcuera LA, 2015, FOOD CHEM TOXICOL, V76, P116, DOI 10.1016/j.fct.2014.12.003; Das S, 2014, BIOORG MED CHEM LETT, V24, P5050, DOI 10.1016/j.bmcl.2014.09.028; de Lima JP, 2015, FOOD RES INT, V75, P216, DOI 10.1016/j.foodres.2015.05.045; Detsi A, 2009, BIOORGAN MED CHEM, V17, P8073, DOI 10.1016/j.bmc.2009.10.002; Echeverria C, 2009, INT J MOL SCI, V10, P221, DOI 10.3390/ijms10010221; Fedato RP, 2014, J APPL TOXICOL, V34, P33, DOI 10.1002/jat.2823; Goodarzi M, 2014, EUR J PHARM SCI, V51, P189, DOI 10.1016/j.ejps.2013.09.019; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; HALES BF, 1982, CANCER RES, V42, P3016; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kim IY, 2006, ECOTOX ENVIRON SAFE, V64, P288, DOI 10.1016/j.ecoenv.2005.05.019; Kozlowski D, 2007, J PHYS CHEM A, V111, P1138, DOI 10.1021/jp066496+; KRAMER A, 1993, MUTAT RES, V290, P165, DOI 10.1016/0027-5107(93)90156-A; Lapchak PA, 2013, TRANSL STROKE RES, V4, P328, DOI 10.1007/s12975-012-0200-y; Lee RF, 2013, MAR POLLUT BULL, V77, P355, DOI 10.1016/j.marpolbul.2013.06.017; Leon-Mejia G, 2011, SCI TOTAL ENVIRON, V409, P686, DOI 10.1016/j.scitotenv.2010.10.049; Liu M, 2003, BIOORGAN MED CHEM, V11, P2729, DOI 10.1016/S0968-0896(03)00233-5; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Maronpot RR, 2015, FOOD CHEM TOXICOL, V77, P111, DOI 10.1016/j.fct.2014.12.021; Martinez-Cifuentes M, 2015, RSC ADV, V5, P1; Mersch-Sundermann V, 2004, TOXICOLOGY, V198, P329, DOI 10.1016/j.tox.2004.02.009; Mondal R, 2011, TETRAHEDRON LETT, V52, P5020, DOI 10.1016/j.tetlet.2011.07.072; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Mostahar S, 2006, INDIAN J CHEM B, V45, P1478; Muthukumar M, 2008, SPECTROCHIM ACTA A, V70, P1222, DOI 10.1016/j.saa.2007.10.043; Noroozi M, 1998, AM J CLIN NUTR, V67, P1210, DOI 10.1093/ajcn/67.6.1210; Parmar AR, 2014, REPROD TOXICOL, V49, P171, DOI 10.1016/j.reprotox.2014.08.004; Patel M. M., 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P187; Qian H, 2013, IND ENG CHEM RES, V52, P13272, DOI 10.1021/ie401557j; Qin CX, 2008, J MED CHEM, V51, P1874, DOI 10.1021/jm070352h; Qu Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/603415; Raghav N, 2014, EUR J PHARM SCI, V60, P55, DOI 10.1016/j.ejps.2014.04.006; RASHID KA, 1986, MUTAT RES, V169, P71, DOI 10.1016/0165-1218(86)90086-8; Resende FA, 2015, REGUL TOXICOL PHARM, V72, P506, DOI 10.1016/j.yrtph.2015.05.014; Ross L, 2009, PHENOLS ANTIOXIDANTS, P1; Rossi M, 2013, BIOCHIMIE, V95, P1954, DOI 10.1016/j.biochi.2013.07.002; Rothfuss A, 2011, MUTAT RES-GEN TOX EN, V723, P108, DOI 10.1016/j.mrgentox.2010.12.005; Sakirolla R, 2012, MONATSH CHEM, V143, P797, DOI 10.1007/s00706-011-0663-7; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Serifi O, 2013, J PHYS ORG CHEM, V26, P226, DOI 10.1002/poc.3071; Serpeloni JM, 2013, HUM EXP TOXICOL, V32, P828, DOI 10.1177/0960327112468911; Sghaier MB, 2011, S AFR J BOT, V77, P730, DOI 10.1016/j.sajb.2011.03.014; Shoja M, 1999, Z KRIST-NEW CRYST ST, V214, P235; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stoyanov EV, 2002, BIOORG MED CHEM LETT, V12, P2685, DOI 10.1016/S0960-894X(02)00553-X; Tran TD, 2009, BIOORG MED CHEM LETT, V19, P1650, DOI 10.1016/j.bmcl.2009.02.001; TORIGOE T, 1983, BIOCHEM BIOPH RES CO, V112, P833, DOI 10.1016/0006-291X(83)91693-5; Trivedi PP, 2010, MUTAT RES-GEN TOX EN, V703, P115, DOI 10.1016/j.mrgentox.2010.08.005; Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P19, DOI 10.1016/j.mrgentox.2015.03.001; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Vinod V, 2011, J ETHNOPHARMACOL, V134, P931, DOI 10.1016/j.jep.2011.02.003; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wang GR, 2015, FOOD CHEM, V171, P89, DOI 10.1016/j.foodchem.2014.08.106; Wang H, 2005, TOXICOLOGY, V207, P303, DOI 10.1016/j.tox.2004.10.005; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E; Xue YS, 2013, J PHYS ORG CHEM, V26, P240, DOI 10.1002/poc.3074; Xue YS, 2012, COMPUT THEOR CHEM, V982, P74, DOI 10.1016/j.comptc.2011.12.020; YAMAMOTO K, 1992, PLANTA MED, V58, P389, DOI 10.1055/s-2006-961498	66	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171224	10.1371/journal.pone.0171224	http://dx.doi.org/10.1371/journal.pone.0171224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207781	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500019
J	Mern, DS; Tschugg, A; Hartmann, S; Thome, C				Mern, Demissew Shenegelegn; Tschugg, Anja; Hartmann, Sebastian; Thome, Claudius			Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: A new therapeutic approach for intervertebral disc disorders	PLOS ONE			English	Article							EFFICIENT TRANSDUCTION; GENE-TRANSFER; THROMBOSPONDIN-1 REPEATS; ANIMAL-MODELS; IN-VITRO; VECTORS; EXPRESSION; FAMILY; METALLOPROTEINASES; COTRANSFECTION	Inhibition of intervertebral disc (IVD) degeneration, which is often accompanied by painful inflammatory and immunopathological processes, is challenging. Current IVD gene therapeutic approaches are based on adenoviral gene delivery systems, which are limited by immune reactions to their viral proteins. Their applications in IVDs near to sensitive neural structure could provoke toxicity and immunological side-effects with neurological deficits. Self-complementary adeno-associated virus (scAAV) vectors, which do not express any viral gene and are not linked with any known disease in humans, are attractive therapeutic gene delivery vectors in degenerative IVDs. However, scAAV-based silencing of catabolic or inflammatory factor has not yet been investigated in human IVD cells. Therefore, we used scAAV6, the most suitable serotype for transduction of human nucleus pulposus (NP) cells, to knockdown the major catabolic gene (ADAMTS4) of IVD degeneration. IVD degeneration grades were determined by preoperative magnetic resonance imaging. Lumbar NP tissues of degeneration grade III were removed from 12 patients by nucleotomy. NP cells were isolated and cultured with low-glucose. Titre of recombinant scAAV6 vectors targeting ADAMTS4, transduction efficiencies, transduction units, cell viabilities and expression levels of target genes were analysed using quantitative PCR, fluorescence microscopy, fluorescence -activated cell sorting, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assays, quantitative reverse transcription PCR, western blot and enzyme-linked immunosorbent assays during 48 days of post-transduction. Transduction efficiencies between 98.2% and 37.4% and transduction units between 611 and 245 TU/cell were verified during 48 days of post-transduction (p<0.001). scAAV6-mediated knockdown of ADAMTS4 with maximum 87.7% and minimum 40.1% was confirmed on day 8 and 48 with enhanced the level of aggrecan 48.5% and 30.2% respectively (p<0.001). scAAV6-mediated knockdown of ADAMTS4 showed no impact on cell viability and expression levels of other inflammatory catabolic proteins. Thus, our results are promising and may help to design long-term and less immunogenic gene therapeutic approaches in IVD disorders, which usually need prolonged therapeutic period between weeks and months.	[Mern, Demissew Shenegelegn; Tschugg, Anja; Hartmann, Sebastian; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Medical University of Innsbruck	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.	demissew.shenegelegn@i-med.ac.at		Shenegelegn Mern, Demissew/0000-0001-5893-981X	Innsbruck Medical University	Innsbruck Medical University	The study is funded by Innsbruck Medical University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chen SF, 2005, HUM GENE THER, V16, P235, DOI 10.1089/hum.2005.16.235; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Kaneyama S, 2008, J ORTHOP SCI, V13, P130, DOI 10.1007/s00776-007-1204-4; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lattermann C, 2005, SPINE, V30, P497, DOI 10.1097/01.brs.0000154764.62072.44; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9; Lozier JN, 2002, HUM GENE THER, V13, P113, DOI 10.1089/10430340152712665; Mazzolini G, 2001, GENE THER, V8, P259, DOI 10.1038/sj.gt.3301387; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Mern DS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0799-4; Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7; Nemunaitis J, 2001, GENE THER, V8, P746, DOI 10.1038/sj.gt.3301424; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ren S, 2013, INT J MOL MED, V32, P1063, DOI 10.3892/ijmm.2013.1497; Ren XF, 2015, GENET MOL RES, V14, P3736, DOI 10.4238/2015.April.22.1; Rothe D, 2010, OLIGONUCLEOTIDES, V20, P191, DOI 10.1089/oli.2010.0236; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Wagner A, 2013, HUM GENE THER METHOD, V24, P355, DOI 10.1089/hgtb.2013.095; Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088; Xi YM, 2013, GENET MOL RES, V12, P4895, DOI 10.4238/2013.February.28.11; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	49	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172181	10.1371/journal.pone.0172181	http://dx.doi.org/10.1371/journal.pone.0172181			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207788	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500094
J	Vidal, M				Vidal, Manuel			Hearing flashes and seeing beeps: Timing audiovisual events	PLOS ONE			English	Article							TEMPORAL VENTRILOQUISM; PERCEPTUAL LATENCY; RECALIBRATION; DURATION; SOUND; SIMULTANEITY; VISION; INTEGRATION; TIME; DISCRIMINATION	Many events from daily life are audiovisual (AV). Handclaps produce both visual and acoustic signals that are transmitted in air and processed by our sensory systems at different speeds, reaching the brain multisensory integration areas at different moments. Signals must somehow be associated in time to correctly perceive synchrony. This project aims at quantifying the mutual temporal attraction between senses and characterizing the different interaction modes depending on the offset. In every trial participants saw four beep-flash pairs regularly spaced in time, followed after a variable delay by a fifth event in the test modality (auditory or visual). A large range of AV offsets was tested. The task was to judge whether the last event came before/after what was expected given the perceived rhythm, while attending only to the test modality. Flashes were perceptually shifted in time toward beeps, the attraction being stronger for lagging than leading beeps. Conversely, beeps were not shifted toward flashes, indicating a nearly total auditory capture. The subjective timing of the visual component resulting from the AV interaction could easily be forward but not backward in time, an intuitive constraint stemming from minimum visual processing delays. Finally, matching auditory and visual time-sensitivity with beeps embedded in pink noise produced very similar mutual attractions of beeps and flashes. Breaking the natural auditory preference for timing allowed vision to take over as well, showing that this preference is not hardwired.	[Vidal, Manuel] Aix Marseille Univ, CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vidal, M (corresponding author), Aix Marseille Univ, CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France.	manuel.vidal@univ-amu.fr		Vidal, Manuel/0000-0002-8504-1500				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Di Luca M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28563; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; HALPERN AR, 1982, PERCEPT PSYCHOPHYS, V31, P86, DOI 10.3758/BF03206204; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Hartcher-O'Brien J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089339; Hartcher-O'Brien J, 2011, J EXP PSYCHOL HUMAN, V37, P1383, DOI 10.1037/a0024234; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Horr NK, 2015, ATTEN PERCEPT PSYCHO, V77, P592, DOI 10.3758/s13414-014-0787-z; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Keetels M, 2012, NEURAL BASEMULTISE; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kuling IA, 2013, ATTEN PERCEPT PSYCHO, V75, P1583, DOI 10.3758/s13414-013-0511-4; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Linares D, 2014, I-PERCEPTION, V5, P559, DOI 10.1068/i0675; Machulla TK, 2012, EXP BRAIN RES, V217, P89, DOI 10.1007/s00221-011-2976-5; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Ortega L, 2014, ATTEN PERCEPT PSYCHO, V76, P1485, DOI 10.3758/s13414-014-0663-x; POPPEL E, 1990, NATURWISSENSCHAFTEN, V77, P89, DOI 10.1007/BF01131783; Poppel E., 1988, MINDWORKS TIME CONSC; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Ten Hoopen G, 2011, ATTEN PERCEPT PSYCHO, V73, P2249, DOI 10.3758/s13414-011-0171-1; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Yarrow K, 2011, CONSCIOUS COGN, V20, P1518, DOI 10.1016/j.concog.2011.07.003	39	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172028	10.1371/journal.pone.0172028	http://dx.doi.org/10.1371/journal.pone.0172028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207786	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424500075
J	Wei, BF; Wei, W; Zhao, BX; Guo, XX; Liu, S				Wei, Biaofang; Wei, Wei; Zhao, Baoxiang; Guo, Xiaxia; Liu, Song			Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in nontraumatic osteonecrosis of femoral head	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES; IDENTIFICATION; EXPRESSION; MICRORNAS; GROWTH; RISK	Background and aim The biological functions of non-coding RNAs (ncRNAs) have been widely identified in many human diseases. In the present study, the relationship between long non-coding RNA HOTAIR and microRNA-17-5p (miR-17-5p) and their roles in osteogenic differentiation and proliferation in non-traumatic osteonecrosis of femoral head (ONFH) were investigated. Methods The expression levels of HOTAIR and miR-17-5p in the mesenchymal stem cells (MSCs) derived from patients with non-traumatic ONFH and osteoarthritis (OA) were examined by real-time PCR. BMP-2 induced human MSCs from bone marrow (hMSC-BM) were used for osteogenic differentiation. Results It was observed that the expression level of miR-17-5p was lower and the level of HOTAIR was higher in samples of non-traumatic ONFH compared with OA. HOTAIR downregulation induced by si-HOTAIR led to the increase of miR-17-5p expression and the decrease of miR-17-5p target gene SMAD7 expression. The values of osteogenic differentiation markers, including RUNX2 and COL1A1 mRNA expression and ALP activity, were also elevated by si-HOTAIR. However, the increase of these values was canceled by miR-17-5p inhibitor or SMAD7 upregulation. Conclusion HOTAIR played a role in regulating osteogenic differentiation and proliferation through modulating miR-17-5p and its target gene SMAD7 in non-traumatic ONFH.	[Wei, Biaofang; Zhao, Baoxiang; Guo, Xiaxia; Liu, Song] Linyi Peoples Hosp, Dept Orthopaed, Linyi, Shandong, Peoples R China; [Wei, Wei] Guangzhou Univ Chinese Med, Sch Clin Med 1, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine	Wei, BF (corresponding author), Linyi Peoples Hosp, Dept Orthopaed, Linyi, Shandong, Peoples R China.	weibiaofang@126.com			Science and Technology Development Plan of Shandong Province [2014GSF119022]	Science and Technology Development Plan of Shandong Province	The work was funded by the Science and Technology Development Plan of Shandong Province (Grant Number: 2014GSF119022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrion K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096577; Fang T, 2016, EXPERIMENTAL CELL RE; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Ji X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030349; Jia J, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.43; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lee JS, 2006, J ORTHOP RES, V24, P604, DOI 10.1002/jor.20078; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Liu S, 2016, CURR NEUROVASC RES, V13, P115, DOI 10.2174/1567202613666160316155228; Miao CG, 2013, CELL SIGNAL, V25, P1118, DOI 10.1016/j.cellsig.2013.01.024; Qu Y, 2016, ONCOTARGET; Svoboda M, 2014, CARCINOGENESIS, V35, P1510, DOI 10.1093/carcin/bgu055; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Wang W, 2016, ONCOL REP, V35, P1473, DOI 10.3892/or.2016.4542; Wei Q, 2012, IUBMB LIFE, V64, P697, DOI 10.1002/iub.1051; Wu Q, 2014, FEBS LETT, V588, P2055, DOI 10.1016/j.febslet.2014.04.036; Wu XJ, 2015, GENE, V565, P22, DOI 10.1016/j.gene.2015.03.072; Wu YS, 2014, TUMOR BIOL, V35, P9531, DOI 10.1007/s13277-014-2523-7; Xing D, 2014, ORTHOP SURG, V6, P288, DOI 10.1111/os.12147; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang L, 2015, MABS, V8, P205; Zhou Q, 2016, ONCOTARGET, V7, P19928, DOI 10.18632/oncotarget.7957	25	107	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169097	10.1371/journal.pone.0169097	http://dx.doi.org/10.1371/journal.pone.0169097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207735	Green Submitted, Green Published, gold			2022-12-27	WOS:000394424500003
J	Heaney, M; Gray, RD; Taylor, AH				Heaney, Megan; Gray, Russell D.; Taylor, Alex H.			Keas Perform Similarly to Chimpanzees and Elephants when Solving Collaborative Tasks	PLOS ONE			English	Article							NESTOR-NOTABILIS; CORVUS-FRUGILEGUS; HUMAN COOPERATION; CALEDONIAN CROWS; PAN-TROGLODYTES; EVOLUTION; COGNITION; BEHAVIOR; PARTNER; PREFER	Cooperation between individuals is one of the defining features of our species. While other animals, such as chimpanzees, elephants, coral trout and rooks also exhibit cooperative behaviours, it is not clear if they think about cooperation in the same way as humans do. In this study we presented the kea, a parrot endemic to New Zealand, with a series of tasks designed to assess cooperative cognition. We found that keas were capable of working together, even when they had to wait for their partner for up to 65 seconds. The keas also waited for a partner only when a partner was actually needed to gain food. This is the first demonstration that any non-human animal can wait for over a minute for a cooperative partner, and the first conclusive evidence that any bird species can successful track when a cooperative partner is required, and when not. The keas did not attend to whether their partner could actually access the apparatus themselves, which may have been due to issues with task demands, but one kea did show a clear preference for working together with other individuals, rather than alone. This preference has been shown to be present in humans but absent in chimpanzees. Together these results provide the first evidence that a bird species can perform at a similar level to chimpanzees and elephants across a range of collaborative tasks. This raises the possibility that aspects of the cooperative cognition seen in the primate lineage have evolved convergently in birds.	[Heaney, Megan; Gray, Russell D.; Taylor, Alex H.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Gray, Russell D.] Max Planck Inst Sci Human Hist, Jena, Germany; [Gray, Russell D.] Australian Natl Univ, Res Sch Social Sci, Canberra, ACT, Australia	University of Auckland; Australian National University	Taylor, AH (corresponding author), Univ Auckland, Sch Psychol, Auckland, New Zealand.	alexander.taylor@auckland.ac.nz	Taylor, Alex H/D-6428-2012	Taylor, Alex/0000-0003-3492-7667	University of Auckland Doctoral Scholarship; Rutherford Discovery Fellowship	University of Auckland Doctoral Scholarship; Rutherford Discovery Fellowship	This work was supported by a University of Auckland Doctoral Scholarship (MH) and a Rutherford Discovery Fellowship (AHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Boyd R, 2009, PHILOS T R SOC B, V364, P3281, DOI 10.1098/rstb.2009.0134; Brownell CA, 2006, CHILD DEV, V77, P803, DOI 10.1111/j.1467-8624.2006.00904.x; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Diamond J, 2004, BEHAVIOUR, V141, P777, DOI 10.1163/1568539042265680; DIAMOND J, 1991, ETHOLOGY, V88, P128; Diamond J., 1998, KEA BIRD PARADOX EVO; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Henrich J., 2007, WHY HUMANS COOPERATE; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Jelbert SA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0871; Kabadayi C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160104; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Massen JJ, 2015, SCI REPORTS; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Rekers Y, 2011, CURR BIOL, V21, P1756, DOI 10.1016/j.cub.2011.08.066; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seed AM, 2011, NATURE, V472, P424, DOI 10.1038/472424a; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Tebbich S, 1996, ANIM BEHAV, V52, P1, DOI 10.1006/anbe.1996.0147; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	30	29	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169799	10.1371/journal.pone.0169799	http://dx.doi.org/10.1371/journal.pone.0169799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199322	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400010
J	Di Giminiani, R; Visca, C				Di Giminiani, Riccardo; Visca, Christiano			Explosive strength and endurance adaptations in young elite soccer players during two soccer seasons	PLOS ONE			English	Article							LEG EXTENSOR MUSCLES; JUMP PERFORMANCE; YOUTH SOCCER; MATCH-PLAY; FIBER COMPOSITION; MECHANICAL POWER; RUNNING SPEED; HEART-RATE; AGE-GROUP; EXERCISE	The purpose of the present study was to investigate the explosive strength and endurance adaptations in young elite soccer players who underwent a supervised training program for a period of two years. Nineteen players, with seven years of training experience (age: 13.3 0.1 years; body weight: 57.9 4.9 kg; height: 168.9 4.7 cm; BMI: 20.1 1.1 kg/m(2)), voluntarily participated in the present study. The testing sessions were performed at the beginning of the preparation period in the first (T1), second (T2), and third year (T3). The following performance variables were measured: explosive strength [squat-jump (SJ) and countermovement -jump (CMJ)], pre-stretch augmentation (CMJ-SJ), leg stiffness [hopping test (HT)], short sprint performance [15 m (SSP15) and 30 m (SSP30)], aerobic endurance [test of Leger (VO2max)], maximal heart rate [at the last step of Leger (HR)], and speed-strength endurance [continuous counter-movement-jumps (CCMJ)]. A significant main effect on the VO2Max (+5.72%; F(2.45) = 3.822; p= 0.029; ES = 1.00), HR (-1.70%; F-(2.54) = 3.472; p = 0.038; ES = 0.97), CCMJ (+7.64%; F-(2.54) = 5.438; p = 0.007; ES = 1.15), SJ (+10.26%; F-(2.54) = 15.254; p = 0.0001; ES = 1.53), CMJ (+7.36; F-(2.54) = 8.270; p= 0.001; ES = 1.33), HT (+8.34%; F-(2.45) = 3.297; p= 0.046; ES = 1.01), SSP15 (-3.50%; F-(2.44) = 12.760; p = 0.0001; ES = 1.53), and SSP30 (-4.44%; F-(2.44) = 5.797; p= 0.006; ES = 1.16) was observed in the two soccer seasons. These results highlight that, in long-term training, the monitoring of the adaptive responses in relation to the training load may provide a guideline to optimize the trainability of some performance variables in young elite soccer players (13-15 years). In the present study, we cannot exclude the influence of growth and maturation on some performance variables; therefore, the monitored adaptive responses should be considered as the possible results of an interaction between the applied training load and maturation.	[Di Giminiani, Riccardo; Visca, Christiano] Univ Aquila, Lab Biomech Musculoskeletal Syst & Motion Anal, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	University of L'Aquila	Di Giminiani, R (corresponding author), Univ Aquila, Lab Biomech Musculoskeletal Syst & Motion Anal, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	riccardo.digiminiani@univaq.it	Di Giminiani, Riccardo/AAB-1207-2020	Di Giminiani, Riccardo/0000-0003-3574-3114				Baar K, 2006, MED SCI SPORT EXER, V38, P1939, DOI 10.1249/01.mss.0000233799.62153.19; Baker D, 1999, J STRENGTH COND RES, V13, P230; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; BAXTERJONES A, 1993, J APPL PHYSIOL, V75, P1160, DOI 10.1152/jappl.1993.75.3.1160; BERG KE, 1985, MED SCI SPORT EXER, V17, P656, DOI 10.1249/00005768-198512000-00006; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P129, DOI 10.1007/BF00952545; BOSCO C, 1980, EUR J APPL PHYSIOL O, V45, P209, DOI 10.1007/BF00421329; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Buchheit M, 2010, J STRENGTH COND RES, V24, P2715, DOI 10.1519/JSC.0b013e3181bf0223; Capranica L, 2001, J SPORT SCI, V19, P379, DOI 10.1080/026404101300149339; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Christou M, 2006, J STRENGTH COND RES, V20, P783, DOI 10.1519/00124278-200611000-00010; COLLIANDER EB, 1988, EUR J APPL PHYSIOL O, V58, P81, DOI 10.1007/BF00636607; Comfort P, 2014, J STRENGTH COND RES, V28, P173, DOI 10.1519/JSC.0b013e318291b8c7; Comfort P, 2012, J STRENGTH COND RES, V26, P937, DOI 10.1519/JSC.0b013e31822e5889; Dalleau G, 2004, INT J SPORTS MED, V25, P170, DOI 10.1005/s-2003-45252; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Hebestreit H., 2007, YOUNG ATHLETE, P3, DOI DOI 10.1002/9780470696255.CH1; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hobara H, 2009, J BIOMECH, V42, P1768, DOI 10.1016/j.jbiomech.2009.04.047; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jastrzebski Z, 2013, J STRENGTH COND RES, V27, P916, DOI 10.1519/JSC.0b013e31825c327a; Kraemer WJ., 2007, OPTIMIZING STRENGTH; Kraemer WJ., 1989, PEDIATR EXERC SCI, V1, P336, DOI [10.1123/pes.1.4.336, DOI 10.1123/PES.1.4.336]; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; KUNO SY, 1995, EUR J APPL PHYSIOL O, V70, P301, DOI 10.1007/BF00865026; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Makhlouf I, 2015, J STRENGTH COND RES; Marques MC, 2013, J HUM KINET, V39, P157, DOI 10.2478/hukin-2013-0078; McMillan K, 2005, BRIT J SPORT MED, V39, P273, DOI 10.1136/bjsm.2004.012526; Mirkov DM, 2010, J STRENGTH COND RES, V24, P2677, DOI 10.1519/JSC.0b013e3181e27245; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1884, DOI 10.1519/JSC.0000000000000836; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1784, DOI 10.1519/JSC.0000000000000827; Ramirez-Campillo R, 2014, J STRENGTH COND RES, V28, P1335, DOI 10.1519/JSC.0000000000000284; Riddell MC, 2008, J APPL PHYSIOL, V105, P725, DOI 10.1152/japplphysiol.00031.2008; Stolen T, 2005, SPORTS MED, V35, P501; Stoyer J, 2004, MED SCI SPORTS EXERC, V36, P168, DOI [10.1249/01.MSS.0000106187.05259.96, DOI 10.1249/01.MSS.0000106187.05259.96]; TIHANYI J, 1982, EUR J APPL PHYSIOL, V48, P331, DOI 10.1007/BF00430223; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Vesterinen V, 2014, J STRENGTH COND RES, V28, P902, DOI 10.1519/JSC.0000000000000349; Walshe AD, 1996, EUR J APPL PHYSIOL O, V73, P332, DOI 10.1007/BF02425495; Walter G, 1999, J PHYSIOL-LONDON, V519, P901, DOI 10.1111/j.1469-7793.1999.0901n.x; WASHINGTON RL, 1994, CIRCULATION, V90, P2166, DOI 10.1161/01.CIR.90.4.2166; Williams CA, 2011, INT J SPORT PHYSIOL, V6, P264, DOI 10.1123/ijspp.6.2.264	50	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171734	10.1371/journal.pone.0171734	http://dx.doi.org/10.1371/journal.pone.0171734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192512	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800039
J	Rojo, JU; Melkus, MW; Kottapalli, KR; Okiya, OE; Sudduth, J; Zhang, WD; Molehin, AJ; Carter, D; Siddiqui, AA				Rojo, Juan U.; Melkus, Michael W.; Kottapalli, Kameswara Rao; Okiya, Oscar E.; Sudduth, Justin; Zhang, Weidong; Molehin, Adebayo J.; Carter, Darrick; Siddiqui, Afzal A.			Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; PROTECTIVE IMMUNITY; SYSTEMS BIOLOGY; DENDRITIC CELLS; DNA VACCINE; MANSONI; RESPONSES; INFECTION; RECEPTOR; IMMUNOGENICITY	Schistosomiasis is a neglected parasitic disease of major public health concern as it affects over 250 million people in developing countries. Currently there is no licensed vaccine available against schistosomiasis. The Schistosoma mansoni calpain protein, Sm-p80, is a leading vaccine candidate now ready to move to clinical trials. In order to better assess Sm-p80 vaccine immunogenicity; here we used a systems biology approach employing RNA-sequencing to identify gene signatures and epistatic interactions following Sm-p80 vaccination in mouse and baboon models that may predict vaccine efficacy. Recombinant Sm-p80 + CpG-oligodeoxynucleotide (ODN) vaccine formulation induced both cellular and humoral immunity genes with a predominant TH1 response as well as TH2 and TH17 gene signatures. Early gene responses and gene -network interactions in mice immunized with rSm-p80 + ODN appear to be initiated through TLR4 signaling. CSFgenes, S100A alarmin genes and TNFRSF genes appear to be a signature of vaccine immunogenicity/efficacy as identified by their participation in gene network interactions in both mice and baboons. These gene families may provide a basis for predicting desirable outcomes for vaccines against schistosomiasis leading to a better understanding of the immune system response to vaccination.	[Rojo, Juan U.; Okiya, Oscar E.; Sudduth, Justin; Zhang, Weidong; Molehin, Adebayo J.; Siddiqui, Afzal A.] Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Lubbock, TX 79409 USA; [Melkus, Michael W.] Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Amarillo, TX USA; [Kottapalli, Kameswara Rao] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Zhang, Weidong; Molehin, Adebayo J.; Siddiqui, Afzal A.] Texas Tech Univ, Dept Internal Med, Sch Med, Lubbock, TX 79409 USA; [Carter, Darrick] PAI Life Sci, Seattle, WA USA; [Carter, Darrick] Infect Dis Res Inst, Seattle, WA USA; [Carter, Darrick] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; University of Washington; University of Washington Seattle	Siddiqui, AA (corresponding author), Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Lubbock, TX 79409 USA.; Siddiqui, AA (corresponding author), Texas Tech Univ, Dept Internal Med, Sch Med, Lubbock, TX 79409 USA.	Afzal.Siddiqui@ttuhsc.edu	Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Rojo, Juan Ulises/0000-0002-3769-0047	NIH [R43A1103983, R44A1103983]; Bill and Melinda Gates Foundation [OPP1097535]; South Plains Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South Plains Foundation	This work was supported by NIH grants [R43A1103983, R44A1103983]; Bill and Melinda Gates Foundation Grant [OPP1097535]; and the South Plains Foundation. The funder provided support in the form of salaries for authors [JUR, MWM, OEO, JS, WZ, AJM, DC, and MS], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The collaboration with PAI Life Sciences in this study includes data analysis and preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmad G, 2009, PARASITE IMMUNOL, V31, P156, DOI 10.1111/j.1365-3024.2008.01091.x; Ahmad G, 2011, J INFECT DIS, V204, P1437, DOI 10.1093/infdis/jir545; Ahmad G, 2009, PARASITOL RES, V105, P1767, DOI 10.1007/s00436-009-1646-z; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Boissier J, 2015, LANCET INFECT DIS, V15, P757, DOI 10.1016/S1473-3099(15)00084-5; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Burland T G, 2000, Methods Mol Biol, V132, P71; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Karmakar S, 2014, VACCINE, V32, P1296, DOI 10.1016/j.vaccine.2013.12.057; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Merrifield M, 2016, VACCINE, V34, P2988, DOI 10.1016/j.vaccine.2016.03.079; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nyindo M, 1999, PARASITOL TODAY, V15, P478, DOI 10.1016/S0169-4758(99)01569-0; Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Podesta R. B. KS, 1987, P UCLA S MOL CELL BI; Pulendran B, 2004, EUR J IMMUNOL, V34, P66, DOI 10.1002/eji.200324567; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ricciardi A, 2015, HUM VACC IMMUNOTHER, V11, P2504, DOI 10.1080/21645515.2015.1059981; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santini-Oliveira M, 2016, VACCINE, V34, P586, DOI 10.1016/j.vaccine.2015.10.027; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIDDIQUI AA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P37, DOI 10.1016/0925-4439(93)90087-H; Siddiqui AA, 2003, INFECT IMMUN, V71, P3844, DOI 10.1128/IAI.71.7.3844-3851.2003; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; [WHO WHO], 2015, SHIST PCT DAT; World Health Organization, 2013, GLOB VACC ACT PLAN M; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zepp F, 2016, METHODS MOL BIOL, V1403, P57, DOI 10.1007/978-1-4939-3387-7_3; Zhang W, 2010, PARASITE IMMUNOL, V32, P252, DOI 10.1111/j.1365-3024.2009.01181.x; Zhang WD, 2014, PARASITOL RES, V113, P2239, DOI 10.1007/s00436-014-3879-8; Zhang WD, 2011, ACTA TROP, V118, P142, DOI 10.1016/j.actatropica.2011.01.010	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171677	10.1371/journal.pone.0171677	http://dx.doi.org/10.1371/journal.pone.0171677			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192534	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423800038
J	Khan, AR; Park, GS; Asaf, S; Hong, SJ; Jung, BK; Shin, JH				Khan, Abdur Rahim; Park, Gun-Seok; Asaf, Sajjad; Hong, Sung-Jun; Jung, Byung Kwon; Shin, Jae-Ho			Complete genome analysis of Serratia marcescens RSC-14: A plant growth-promoting bacterium that alleviates cadmium stress in host plants	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; SOLANUM-NIGRUM; LIPID-PEROXIDATION; INDUCTION; CUCUMBER; RHIZOBACTERIA; DIVERSITY; WILT; COMMUNITIES; ENDOPHYTES	Serratia marcescens RSC-14 is a Gram-negative bacterium that was previously isolated from the surface-sterilized roots of the Cd-hyperaccumulator Solanum nigrum. The strain stimulates plant growth and alleviates Cd stress in host plants. To investigate the genetic basis for these traits, the complete genome of RSC-14 was obtained by single-molecule real-time sequencing. The genome of S. marcescens RSC-14 comprised a 5.12-Mbp-long circular chromosome containing 4,593 predicted protein-coding genes, 22 rRNA genes, 88 tRNA genes, and 41 pseudogenes. It contained genes with potential functions in plant growth promotion, including genes involved in indole-3-acetic acid (IAA) biosynthesis, acetoin synthesis, and phosphate solubilization. Moreover, annotation using NCBI and Rapid Annotation using Subsystem Technology identified several genes that encode antioxidant enzymes as well as genes involved in antioxidant production, supporting the observed resistance towards heavy metals, such as Cd. The presence of IAA pathway-related genes and oxidative stress-responsive enzyme genes may explain the plant growth-promoting potential and Cd tolerance, respectively. This is the first report of a complete genome sequence of Cd-tolerant S. marcescens and its plant growth promotion pathway. The whole-genome analysis of this strain clarified the genetic basis underlying its phenotypic and biochemical characteristics, underpinning the beneficial interactions between RSC-14 and plants.	[Khan, Abdur Rahim; Park, Gun-Seok; Asaf, Sajjad; Hong, Sung-Jun; Jung, Byung Kwon; Shin, Jae-Ho] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea; [Khan, Abdur Rahim] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Kyungpook National University; University of California System; University of California Berkeley	Shin, JH (corresponding author), Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea.	jhshin@knu.ac.kr	Khan, Abdur Rahim/N-5836-2015; khan, abdur Rahim/B-6034-2015; Asaf, Sajjad/ABA-3647-2021	Khan, Abdur Rahim/0000-0001-5370-6216; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01057187]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2015R1D1A1A01057187).	Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Arcand MM, 2006, AN ACAD BRAS CIENC, V78, P791, DOI 10.1590/S0001-37652006000400013; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Aylward FO, 2013, GENOME ANNOUNC, V1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bagchi D, 1997, FREE RADICAL BIO MED, V22, P471, DOI 10.1016/S0891-5849(96)00352-8; Behera BC, 2014, BIOCATAL AGR BIOTECH, V3, P97, DOI 10.1016/j.bcab.2013.09.008; Berendsen RL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1632-z; BERGAN T, 1983, CURR MICROBIOL, V8, P7, DOI 10.1007/BF01567306; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Chakraborty U, 2010, J PLANT INTERACT, V5, P261, DOI 10.1080/17429140903551738; Chen L, 2014, SOIL BIOL BIOCHEM, V68, P300, DOI 10.1016/j.soilbio.2013.10.021; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chung WC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00126-13; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; D'Alessandro M, 2014, PLANT CELL ENVIRON, V37, P813, DOI 10.1111/pce.12220; De Maayer P, 2010, J BACTERIOL, V192, P2936, DOI 10.1128/JB.00060-10; dos Santos MF, 2010, J PROTEOMICS, V73, P917, DOI 10.1016/j.jprot.2009.12.005; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Furnkranz M, 2012, MICROB ECOL, V63, P418, DOI 10.1007/s00248-011-9942-4; Guo JH, 2004, BIOL CONTROL, V29, P66, DOI 10.1016/S1049-9644(03)00124-5; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Holguin G, 2001, MICROBIAL ECOL, V41, P281, DOI 10.1007/s002480000040; Hussein KA, 2015, J KOREAN SOC APPL BI, V58, P847, DOI 10.1007/s13765-015-0114-y; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kahlke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-179; Khan AR, 2015, ENVIRON SCI POLLUT R, V22, P14032, DOI 10.1007/s11356-015-4647-8; Kisa D, 2016, APPL BIOL CHEM, V59, P813, DOI 10.1007/s13765-016-0229-9; Li PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123061; LIU L, 1995, PHYTOPATHOLOGY, V85, P843, DOI 10.1094/Phyto-85-843; LIU L, 1995, PHYTOPATHOLOGY, V85, P695, DOI 10.1094/Phyto-85-695; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Luo SL, 2011, APPL MICROBIOL BIOT, V89, P1637, DOI 10.1007/s00253-010-2927-2; MANCA D, 1994, ARCH TOXICOL, V68, P364, DOI 10.1007/s002040050083; Muller H, 2008, BIOCONTROL, V53, P905, DOI 10.1007/s10526-007-9111-3; Neupane S, 2012, STAND GENOMIC SCI, V7, P22, DOI 10.4056/sigs.2966299; Neupane S, 2012, STAND GENOMIC SCI, V6, P165, DOI 10.4056/sigs.2705996; Nicholson WL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00548-13; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Ping LY, 2004, TRENDS PLANT SCI, V9, P263, DOI 10.1016/j.tplants.2004.04.008; Raupach GS, 1996, PLANT DIS, V80, P891, DOI 10.1094/PD-80-0891; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Ryu CM, 2013, PLANT PATHOLOGY J, V29, P182, DOI [10.5423/PPJ.SI.11.2012.0173, 10.5423/PPJ.SI.11.2012.0173.R2]; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Singh RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155026; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Taghavi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115455; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Tahtamouni M. E. W., 2006, The Plant Pathology Journal, V22, P107; Ulrich K, 2008, FEMS MICROBIOL ECOL, V63, P169, DOI 10.1111/j.1574-6941.2007.00419.x; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wan Y, 2012, CHEMOSPHERE, V89, P743, DOI 10.1016/j.chemosphere.2012.07.005; Wei G, 1996, PHYTOPATHOLOGY, V86, P221, DOI 10.1094/Phyto-86-221; WEI G, 1991, Phytopathology, V81, P1508, DOI 10.1094/Phyto-81-1508; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Yamagishi T, 2001, WATER RES, V35, P3089, DOI 10.1016/S0043-1354(01)00032-X; Zehnder G, 1997, J ECON ENTOMOL, V90, P391, DOI 10.1093/jee/90.2.391; Zhang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19257	68	38	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171534	10.1371/journal.pone.0171534	http://dx.doi.org/10.1371/journal.pone.0171534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187139	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300027
J	Olchowy, C; Cebulski, K; Lasecki, M; Chaber, R; Olchowy, A; Kalwak, K; Zaleska-Dorobisz, U				Olchowy, Cyprian; Cebulski, Kamil; Lasecki, Mateusz; Chaber, Radoslaw; Olchowy, Anna; Kalwak, Krzysztof; Zaleska-Dorobisz, Urszula			The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review	PLOS ONE			English	Review							T1-WEIGHTED MR-IMAGES; HIGH-SIGNAL INTENSITY; HYPERINTENSE DENTATE NUCLEUS; GLOBUS-PALLIDUS; PROGRESSIVE INCREASE; MULTIPLE-SCLEROSIS; RENAL-FUNCTION; GADODIAMIDE; DIMEGLUMINE; TOXICITY	Background and purpose Gadolinium based contrast agents (GBCAs) are widely used in magnetic resonance imaging, but recently, high signal intensity in the cerebellum structures was reported after repeated administrations of contrast-enhanced magnetic resonance images. The aim of this systematic review was to investigate the association between increased signal intensity in the dentate nucleus and globus pallidus in the brain and repeated administrations of GBCAs. Additionally, we focused on possible short- and long-term consequences of gadolinium use in those patients. Methods Systematic review of retrospective investigations in PubMed and Medline was performed in July 2016. Primary outcomes included the presence of increased signal intensity within the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in patients following administrations of GBCAs. Two independent reviewers were responsible for search and data extraction. Results 25 publications satisfied inclusion criteria (19 magnetic resonance images analyses, 3 case reports; 3 autopsy studies). Magnetic resonance images of 1247 patients with increased signal intensity on unenhanced T1-weighted MR images were analyzed as well as tissue specimens from 27 patients. Signal intensity correlated positively with the exposure to GBCAs and was greater after serial administrations of linear nonionic than cyclic contrast agents. Gadolinium was detected in all tissue examinations. Conclusions High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted magnetic resonance images were associated with previous administration of GBCAs. Signal intensity correlated negatively with stability of contrast agents. Clinical significance of gadolinium deposition in the brain remains unclear. There is a strong need for further research to identify type of gadolinium deposited in the brain as well as to gather knowledge about long-term consequences.	[Olchowy, Cyprian; Lasecki, Mateusz; Zaleska-Dorobisz, Urszula] Wroclaw Med Univ, Dept Gen & Pediat Radiol, Wroclaw, Poland; [Cebulski, Kamil; Olchowy, Anna] Wroclaw Med Univ, Dept Gen & Pediat Radiol, Radiol Students Sci Club, Wroclaw, Poland; [Chaber, Radoslaw] Univ Rzeszow, Fac Med, Div Hematol Canc Prevent & Propaedeut Rare Dis, Rzeszow, Poland; [Kalwak, Krzysztof] Wroclaw Med Univ, Dept Pediat Hematol Oncol & BMT, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; University of Rzeszow; Wroclaw Medical University	Olchowy, C (corresponding author), Wroclaw Med Univ, Dept Gen & Pediat Radiol, Wroclaw, Poland.	cyprian.olchowy@gmail.com	Chaber, Radoslaw/AAY-5993-2020; Chaber, Radosław/ABB-9222-2020; Kalwak, Krzysztof/U-1724-2019; Cebulski, Kamil/T-7657-2018	Chaber, Radoslaw/0000-0002-6862-9142; Kalwak, Krzysztof/0000-0003-1174-5799; Olchowy, Cyprian/0000-0002-6559-3973; Zaleska-Dorobisz, Urszula/0000-0001-5035-485X; Cebulski, Kamil/0000-0002-3643-8106; Lasecki, Mateusz/0000-0002-5879-5366				Adin ME, 2015, AM J NEURORADIOL, V36, P1859, DOI 10.3174/ajnr.A4378; Agris J, 2016, EUR RADIOL, V26, P816, DOI 10.1007/s00330-015-4019-2; [Anonymous], 2016, CONTR MED GUID VERS, V05, P15; Barbieri S, 2016, CONTRAST MEDIA MOL I, V11, P245, DOI 10.1002/cmmi.1683; Birka M, 2015, ANAL CHEM, V87, P3321, DOI 10.1021/ac504488k; Burke LMB, 2016, MAGN RESON IMAGING, V34, P1078, DOI 10.1016/j.mri.2016.05.005; Cabot Richard C, 2010, N Engl J Med, V363, P2445, DOI 10.1056/NEJMcpc1004361; Cao Y, 2016, INVEST RADIOL; Cao Y, 2016, AM J ROENTGENOL, V206, P414, DOI 10.2214/AJR.15.15327; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Edward M, 2008, J PATHOL, V214, P584, DOI 10.1002/path.2311; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Flood TF, 2016, RADIOLOGY; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hu HH, 2016, PEDIAT RADIOL; Joffe P, 1998, ACAD RADIOL, V5, P491, DOI 10.1016/S1076-6332(98)80191-8; Kanda T, 2016, JPN J RADIOL, V34, P3, DOI 10.1007/s11604-015-0503-5; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kasahara S, 2011, RADIOLOGY, V258, P222, DOI 10.1148/radiol.10100508; Khadilkar S, 2016, CLIN RADIOL, V71, P107, DOI 10.1016/j.crad.2015.09.010; Klawiter Eric C, 2013, Continuum (Minneap Minn), V19, P1058, DOI 10.1212/01.CON.0000433283.00221.37; Kromrey ML, 2016, EUR RADIOL; Lai PH, 1999, AM J ROENTGENOL, V172, P1109, DOI 10.2214/ajr.172.4.10587157; Laurent S, 2006, CONTRAST MEDIA MOL I, V1, P128, DOI 10.1002/cmmi.100; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Miller JH, 2015, PEDIATRICS, V136, pE1637, DOI 10.1542/peds.2015-2222; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; Port M, 2008, BIOMETALS, V21, P469, DOI 10.1007/s10534-008-9135-x; Quattrocchi CC, 2015, INVEST RADIOL, V50, P470, DOI 10.1097/RLI.0000000000000154; Radbruch A, 2016, INVEST RADIOL, V51, P683, DOI 10.1097/RLI.0000000000000308; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2016, EUR RADIOL; Ramalho J, 2016, AJNR AM J NEURORADIO; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Roberts DR, 2016, BRAIN DEV-JPN, V38, P331, DOI 10.1016/j.braindev.2015.08.009; Roccatagliata L, 2009, RADIOLOGY, V251, P503, DOI 10.1148/radiol.2511081269; Rogosnitzky M, 2016, BIOMETALS, V29, P365, DOI 10.1007/s10534-016-9931-7; Sanyal S, 2011, NEPHROL DIAL TRANSPL, V26, P3616, DOI 10.1093/ndt/gfr085; Stojanov DA, 2016, EUR RADIOL, V26, P807, DOI 10.1007/s00330-015-3879-9; Suzuki S, 2000, ACTA NEUROCHIR, V142, P801, DOI 10.1007/s007010070095; Tanaka M, 2016, EUR NEUROL, V75, P195, DOI 10.1159/000445431; Tedeschi E, 2016, EUR RADIOL; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206	46	120	120	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171704	10.1371/journal.pone.0171704	http://dx.doi.org/10.1371/journal.pone.0171704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187173	Green Published, gold, Green Submitted			2022-12-27	WOS:000394244300038
J	Tan, DY; Xu, J; Shao, SH; Fu, YY; Sun, F; Zhang, YZ; Hu, YY; Walline, J; Zhu, HD; Yu, XZ				Tan, Dingyu; Xu, Jun; Shao, Shihuan; Fu, Yangyang; Sun, Feng; Zhang, Yazhi; Hu, Yingying; Walline, Joseph; Zhu, Huadong; Yu, Xuezhong			Comparison of different inspiratory triggering settings in automated ventilators during cardiopulmonary resuscitation in a porcine model	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; EMERGENCY CARDIOVASCULAR CARE; ASSOCIATION GUIDELINES UPDATE; HOSPITAL CARDIAC-ARREST; CONVENTIONAL BAG VALVE; BASIC LIFE-SUPPORT; CHEST-COMPRESSION; TRANSPORT VENTILATOR; HYPERVENTILATION; OXYGEN	Background Mechanical ventilation via automated in-hospital ventilators is quite common during cardiopulmonary resuscitation. It is not known whether different inspiratory triggering sensitivity settings of ordinary ventilators have different effects on actual ventilation, gas exchange and hemodynamics during resuscitation. Methods 18 pigs enrolled in this study were anaesthetized and intubated. Continuous chest compressions and mechanical ventilation (volume-controlled mode, 100% O-2, respiratory rate 10/min, and tidal volumes 10ml/kg) were performed after 3 minutes of ventricular fibrillation. Group trig-4, trig-10 and trig-20 (six pigs each) were characterized by triggering sensitivities of 4, 10 and 20 (cmH(2)O for pressure-triggering and Umin for flow-triggering), respectively. Additionally, each pig in each group was mechanically ventilated using three types of inspiratory triggering (pressure-triggering, flow-triggering and turned-off triggering) of 5 minutes duration each, and each animal matched with one of six random assortments of the three different triggering settings. Blood gas samples, respiratory and hemodynamic parameters for each period were all collected and analyzed. Results In each group, significantly lower actual respiratory rate, minute ventilation volume, mean airway pressure, arterial pH, PaO2, and higher end-tidal carbon dioxide, aortic blood pressure, coronary perfusion pressure, PaCO2 and venous oxygen saturation were observed in the ventilation periods with a turned-off triggering setting compared to those with pressure or flow-triggering (all P<0.05), except when compared with pressure-triggering of 20 cmH2O (respiratory rate 10.5[10/11.3]/min vs 12.5[10.8/13.3]/min, P = 0.07; coronary perfusion pressure 30.3[24.5/31.6] mmHg vs 27.4[23.7/29] mmHg, P = 0.173; venous oxygen saturation 46.5[32/56.8]% vs 41.5[33.5148.5]%, P = 0.575). Conclusions Ventilation with pressure- or flow-triggering tends to induce hyperventilation and deteriorating gas exchange and hemodynamics during CPR. A turned-off patient triggering or a pressure-triggering of 20 cmH(2)O is preferred for ventilation when an ordinary inpatient hospital ventilator is used during resuscitation.	[Tan, Dingyu; Xu, Jun; Shao, Shihuan; Fu, Yangyang; Sun, Feng; Zhang, Yazhi; Hu, Yingying; Zhu, Huadong; Yu, Xuezhong] Chinese Acad Med Sci, Dept Emergency, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Walline, Joseph] St Louis Univ Hosp, Div Emergency Med, Dept Surg, St Louis, MO USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Saint Louis University	Zhu, HD; Yu, XZ (corresponding author), Chinese Acad Med Sci, Dept Emergency, Peking Union Med Coll Hosp, Beijing, Peoples R China.	zhuhuadong1970@126.com; yxzpumch@126.com	Hu, Ying/GQZ-8100-2022; Walline, Joseph/K-6667-2019; Walline, Joseph/A-4001-2019	Walline, Joseph/0000-0001-9582-1044; Walline, Joseph/0000-0001-9582-1044; Zhu, Huadong/0000-0002-1592-3188	National Health and Family Planning Commission of the People's Republic of China [201502019]; Peking Union Medical College Foundation for Graduate Innovation [201510020101]	National Health and Family Planning Commission of the People's Republic of China; Peking Union Medical College Foundation for Graduate Innovation	This work was supported by National Health and Family Planning Commission of the People's Republic of China (Special scientific research funds for health industry 201502019) (XY) and Peking Union Medical College Foundation for Graduate Innovation (201510020101) (DT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Bertrand C, 2006, INTENS CARE MED, V32, P843, DOI 10.1007/s00134-006-0137-2; Brooks SC, 2015, CIRCULATION, V132, pS436, DOI 10.1161/CIR.0000000000000260; Cavus E, 2008, RESUSCITATION, V79, P118, DOI 10.1016/j.resuscitation.2008.04.015; Chalkias A, 2017, RESUSCITATION, V110, P101, DOI 10.1016/j.resuscitation.2016.10.023; Chalkias A, 2015, EUR HEART J-ACUTE CA, V4, P24, DOI 10.1177/2048872613516923; Chardoli M, 2012, CHIN J TRAUMATOL, V15, P284, DOI 10.3760/cma.j.issn.1008-1275.2012.05.005; Cheifetz IM, 1998, CRIT CARE MED, V26, P710, DOI 10.1097/00003246-199804000-00020; Dimitriou G, 1998, ACTA PAEDIATR, V87, P1256; Gazmuri RJ, 2012, RESUSCITATION, V83, P259, DOI 10.1016/j.resuscitation.2011.07.034; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Hurst V, 2007, RESUSCITATION, V73, P123, DOI 10.1016/j.resuscitation.2006.07.027; IDRIS AH, 1994, CRIT CARE MED, V22, P1827; JOHANNIGMAN JA, 1995, ACAD EMERG MED, V2, P719, DOI 10.1111/j.1553-2712.1995.tb03624.x; Kill C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127759; Kill C, 2014, CRIT CARE MED, V42, pE89, DOI 10.1097/CCM.0b013e3182a63fa0; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kleinsasser A, 2002, CIRCULATION, V106, P373, DOI 10.1161/01.CIR.0000021428.94652.04; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Lurie KG, 2008, RESP CARE, V53, P862; Mallat J, 2014, EUR J ANAESTH, V31, P371, DOI 10.1097/EJA.0000000000000064; McInnes AD, 2011, RESUSCITATION, V82, P1025, DOI 10.1016/j.resuscitation.2011.03.020; Nikolla D, 2015, AM J EMERG MED; O'Neill JF, 2007, RESUSCITATION, V73, P82, DOI 10.1016/j.resuscitation.2006.09.012; ORNATO JP, 1990, ANN EMERG MED, V19, P1104, DOI 10.1016/S0196-0644(05)81512-4; Park SO, 2013, RESUSCITATION, V84, P298, DOI 10.1016/j.resuscitation.2012.07.028; Pitts S, 2004, LANCET, V364, P313, DOI 10.1016/S0140-6736(04)16740-8; RIVERS EP, 1992, ANN EMERG MED, V21, P1094, DOI 10.1016/S0196-0644(05)80650-X; Salas N, 2007, RESUSCITATION, V74, P94, DOI 10.1016/j.resuscitation.2006.01.023; Sassoon C S, 1992, Respir Care, V37, P1056; SASSOON CSH, 1995, INTENS CARE MED, V21, P159, DOI 10.1007/BF01726540; Weiss SJ, 2005, SOUTH MED J, V98, P970, DOI 10.1097/01.smj.0000182177.01436.70	34	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171869	10.1371/journal.pone.0171869	http://dx.doi.org/10.1371/journal.pone.0171869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187154	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300055
J	Kyaw, NTT; Harries, AD; Kumar, AMV; Oo, MM; Kyaw, KWY; Win, T; Aung, TK; Min, AC; Oo, HN				Kyaw, Nang Thu Thu; Harries, Anthony D.; Kumar, Ajay M. V.; Oo, Myo Minn; Kyaw, Khine Wut Yee; Win, Than; Aung, Thet Ko; Min, Aung Chan; Oo, Htun Nyunt			High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on firstline ART in Myanmar, 2005-2015	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; OUTCOMES; CHALLENGES; MANAGEMENT; PREDICTORS	Background The number of people living with HIV on antiretroviral treatment (ART) in Myanmar has been increasing rapidly in recent years. This study aimed to estimate rates of virological failure on first-line ART and switching to second-line ART due to treatment failure at the Integrated HIV Care program (IHC). Methods Routinely collected data of all adolescent and adult patients living with HIV who were initiated on first-line ART at IHC between 2005 and 2015 were retrospectively analyzed. The cumulative hazard of virological failure on first-line ART and switching to second-line ART were estimated. Crude and adjusted hazard ratios were calculated using the Cox regression model to identify risk factors associated with the two outcomes. Results Of 23,248 adults and adolescents, 7,888 (34%) were tested for HIV viral load. The incidence rate of virological failure among those tested was 3.2 per 100 person-years follow-up and the rate of switching to second-line ART among all patients was 1.4 per 100 person-years follow-up. Factors associated with virological failure included: being adolescent; being lost to follow-up at least once; having WHO stage 3 and 4 at ART initiation; and having taken first-line ART elsewhere before coming to IHC. Of the 1032 patients who met virological failure criteria, 762 (74%) switched to second-line ART. Conclusions We found high rates of virological failure among one third of patients in the cohort who were tested for viral load. Of those failing virologically on first-line ART, about one quarter were not switched to second-line ART. Routine viral load monitoring, especially for those identified as having a higher risk of treatment failure, should be considered in this setting to detect all patients failing on first-line ART. Strategies also need to be put in place to prevent treatment failure and to treat more of those patients who are actually failing.	[Kyaw, Nang Thu Thu; Oo, Myo Minn; Kyaw, Khine Wut Yee; Aung, Thet Ko; Min, Aung Chan] Int Union TB & Lung Dis, Mandalay, Myanmar; [Harries, Anthony D.; Kumar, Ajay M. V.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Kumar, Ajay M. V.] Union Southeast Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Win, Than] Natl HIV AIDS Program, Mandalay, Myanmar; [Oo, Htun Nyunt] Natl HIV AIDS Program, Nay Pyi Taw, Myanmar	University of London; London School of Hygiene & Tropical Medicine	Kyaw, NTT (corresponding author), Int Union TB & Lung Dis, Mandalay, Myanmar.	nangthu82@gmail.com	Oo, Myo Minn/P-3720-2018; Kyaw, Khine Wut Yee/K-4130-2019	Oo, Myo Minn/0000-0003-4089-016X; Kyaw, Khine Wut Yee/0000-0003-0709-484X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Union and The Department for International Development (DFID), UK	Union and The Department for International Development (DFID), UK	This study was funded by The Union and The Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bila DCA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130580; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; [Anonymous], 2003, Paediatr Child Health, V8, P577; [Anonymous], 2009, STAT STAT SOFTW VERS; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Crawford TN, 2014, AIDS CARE, V26, P1393, DOI 10.1080/09540121.2014.920076; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Jespersen S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20243; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Kanapathipillai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086122; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2016, NAT STRAT PLAN HIV A; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Renaud-Thery F, ADULT ANTIRETROVIRAL; Ruperez M, 2015, J ANTIMICROB CHEMOTH, V70, P2639, DOI 10.1093/jac/dkv143; Shet A, 2016, CURR HIV RES, V14, P71, DOI 10.2174/1570162X13666150825123750; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; Trotter AB, 2013, AIDS REV, V15, P162; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Health Organization, 2013, CONSOLIDATED GUIDELI	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171780	10.1371/journal.pone.0171780	http://dx.doi.org/10.1371/journal.pone.0171780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182786	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000394231800109
J	Liu, C; Dong, JY; Yue, LL; Liu, SH; Wan, Y; Liu, H; Tan, WY; Guo, QQ; Zhang, D				Liu, Chao; Dong, Jian Yong; Yue, Lin Lin; Liu, Shao Hua; Wan, Yi; Liu, Hong; Tan, Wan Ye; Guo, Qian Qian; Zhang, Dong			Rapamycin/sodium hyaluronate binding on nano-hydroxyapatite coated titanium surface improves MC3T3-E1 osteogenesis	PLOS ONE			English	Article							OSTEOBLAST; DRUG; DIFFERENTIATION; APOPTOSIS	Endosseous titanium (Ti) implant failure due to poor biocompatibility of implant surface remains a major problem for osseointegration. Improving the topography of Ti surface may enhance osseointegration, however, the mechanism remains unknown. To investigate the effect of modified Ti surface on osteogenesis, we loaded rapamycin (RA) onto nano-hydroxyapatite (HAp) coated Ti surface which was acid-etched, alkali-heated and HAp coated sequentially. Sodium hyaluronate (SH) was employed as an intermediate layer for the load of RA, and a steady release rate of RA was maintained. Cell vitality of MC3T3-E1 was assessed by MTT. Osteogenesis of MC3T3-E1 on this modified Ti surface was evaluated by alkaline phosphatase (ALP) activity, mineralization and related osteogenesis genes osteocalcin (OCN), osteopontin (OPN), Collagen-I and Runx2. The result revealed that RA/SH-loaded nano-HAp Ti surface was innocent for cell vitality and even more beneficial for cell osteogenesis in vitro. Furthermore, osteogenesis of MC3T3-E1 showed significant association with the mammalian target of rapamycin (mTOR) phosphorylation by RA, which required further study about the mechanism. The approach to this modified Ti surface presented in this paper has high research value for the development of Ti-based implant.	[Liu, Chao; Liu, Shao Hua; Tan, Wan Ye; Zhang, Dong] Shandong Univ, Qilu Hosp, Dept Oral & Maxillofacial Surg, Jinan, Peoples R China; [Liu, Chao; Liu, Shao Hua; Tan, Wan Ye; Zhang, Dong] Shandong Univ, Qilu Hosp, Inst Dent Med, Jinan, Peoples R China; [Dong, Jian Yong; Yue, Lin Lin; Guo, Qian Qian] Shandong Univ, Sch Stomotol, Jinan, Peoples R China; [Wan, Yi] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Manufacture, Minist Educ, Jinan, Peoples R China; [Liu, Hong] Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, D (corresponding author), Shandong Univ, Qilu Hosp, Dept Oral & Maxillofacial Surg, Jinan, Peoples R China.; Zhang, D (corresponding author), Shandong Univ, Qilu Hosp, Inst Dent Med, Jinan, Peoples R China.	qiluzhangdong@163.com	Liu, Hong/D-7288-2019	Liu, Hong/0000-0003-1640-9620; Dong, Jianyong/0000-0002-1147-176X	Natural Science Foundation of Shandong Provience, China [BS2015SW028]	Natural Science Foundation of Shandong Provience, China	This work was supported by the Natural Science Foundation of Shandong Provience, China (BS2015SW028), http://ww.sdnsf.gov.cn/portal/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Shandong Province, China (BS2015SW028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d; Cai KY, 2010, ACTA BIOMATER, V6, P2314, DOI 10.1016/j.actbio.2009.11.034; Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019; Darcy A, 2012, BONE, V50, P1294, DOI 10.1016/j.bone.2012.03.001; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Fukuda A, 2005, J BONE MINER RES, V20, P2245, DOI 10.1359/JBMR.050816; Hao XH, 2015, ACS NANO, V9, P9614, DOI 10.1021/nn507485j; Huang Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/6/065007; Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041; Jiang PL, 2015, ACS APPL MATER INTER, V7, P14384, DOI 10.1021/acsami.5b03172; Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009; Kim HM, 1997, J BIOMED MATER RES, V38, P121; Kirmanidou Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2908570; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lai W, 2016, MAT SCI ENG C-MATER, V62, P166, DOI 10.1016/j.msec.2016.01.055; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Li GL, 2016, ACS APPL MATER INTER, V8, P3840, DOI 10.1021/acsami.5b10633; Liu C, 2014, ANN HEMATOL, V93, P1177, DOI 10.1007/s00277-014-2024-1; Luo Y, 2010, J CONTROL RELEASE, V147, P278, DOI 10.1016/j.jconrel.2010.07.108; Mainardes RM, 2004, CURR DRUG TARGETS, V5, P449, DOI 10.2174/1389450043345407; Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Svanborg LM, 2014, INT J DENT, V2014, DOI 10.1155/2014/197581; Tan WY, 2013, ULTRASON SONOCHEM, V20, P216, DOI 10.1016/j.ultsonch.2012.07.020; Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746; Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624; Wu JM, 2006, J AM CERAM SOC, V89, P2660, DOI 10.1111/j.1551-2916.2006.01104.x; Xuereb M, 2015, INT J PROSTHODONT, V28, P51, DOI 10.11607/ijp.4124; Zhao YY, 2015, J SHANDONG U HLTH SC, V53, P41	32	9	9	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171693	10.1371/journal.pone.0171693	http://dx.doi.org/10.1371/journal.pone.0171693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182765	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800091
J	Wu, LP; Pang, YL; Qin, GQ; Xi, GN; Wu, SN; Wang, XP; Chen, TS				Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Wang, Xiaoping; Chen, Tongsheng			Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives	PLOS ONE			English	Article							MEDIATED INTRINSIC PATHWAY; DIHYDROARTEMISININ INDUCES APOPTOSIS; MITOCHONDRIAL AMPLIFICATION LOOP; LUNG ADENOCARCINOMA CELLS; TRAIL-INDUCED APOPTOSIS; BREAST-CANCER CELLS; T-LEUKEMIA-CELLS; HEPATOCELLULAR-CARCINOMA; IN-VITRO; CURRENT MANAGEMENT	Dihydroartemisinin (DHA) and artesunate (ARS), two artemisinin derivatives, have efficacious anticancer activities against human hepatocarcinoma (HCC) cells. This study aims to study the anticancer action of the combination treatment of DHA/ARS and farnesylthiosalicylic acid (FTS), a Ras inhibitor, in HCC cells (Huh-7 and HepG2 cell lines). FTS pretreatment significantly enhanced DHA/ARS-induced phosphatidylserine (PS) externalization, Bak/Bax activation, mitochondrial membrane depolarization, cytochrome c release, and caspase-8 and -9 activations, characteristics of the extrinsic and intrinsic apoptosis. Pretreatment with Z-IETD-FMK (caspase-8 inhibitor) potently prevented the cytotoxicity of the combination treatment of DHA/ARS and FTS, and pretreatment with Z-VAD-FMK (pan-caspase inhibitor) significantly inhibited the loss of Delta psi m induced by DHA/ARS treatment or the combination treatment of DHA/ARS and FTS in HCC cells. Furthermore, silencing Bak/Bax modestly but significantly inhibited the cytotoxicity of the combination treatment of DHA/ARS and FTS. Interestingly, pretreatment with an antioxidant N-Acetyle-Cysteine (NAC) significantly prevented the cytotoxicity of the combination treatment of DHA and FTS instead of the combination treatment of ARS and FTS, suggesting that reactive oxygen species (ROS) played a key role in the anticancer action of the combination treatment of DHA and FTS. Similar to FTS, DHA/ARS also significantly prevented Ras activation. Collectively, our data demonstrate that FTS potently sensitizes Huh-7 and HepG2 cells to artemisinin derivatives via accelerating the extrinsic and intrinsic apoptotic pathways.	[Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Chen, Tongsheng] South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Wu, Liping; Pang, Yilin; Qin, Guiqi; Xi, Gaina; Wu, Shengnan; Chen, Tongsheng] South China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoping] Jinan Univ, Dept Pain Management, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; Jinan University	Chen, TS (corresponding author), South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.; Chen, TS (corresponding author), South China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China.; Wang, XP (corresponding author), Jinan Univ, Dept Pain Management, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	txp2938@jnu.edu.cn; chentsh@scnu.edu.cn			National Natural Science Foundation of China [61527825, 81471699, 61308111]; Guangdong Province Science and Technology Plan Project [20146090901060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Plan Project	This work was supported by the National Natural Science Foundation of China (61527825, 81471699 and 61308111), the Guangdong Province Science and Technology Plan Project (20146090901060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayev A, 2016, J CELL PHYSL, P1; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Carlisi D, 2015, J CELL PHYSIOL, V230, P1276, DOI 10.1002/jcp.24863; Chang FM, 2003, INT J ONCOL, V22, P469; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Charette N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.200; Charette N, 2010, MOL CANCER, V9, P1; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Conrad DM, 2008, INT J ONCOL, V32, P1325; Crespo-Ortiz MP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/247597; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Gana-Weisz M, 2002, CLIN CANCER RES, V8, P555; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Gao WJ, 2013, APOPTOSIS, V18, P1201, DOI 10.1007/s10495-013-0857-z; Goldberg L, 2008, MOL CANCER THER, V7, P3609, DOI 10.1158/1535-7163.MCT-08-0488; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Guo W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.276; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; He Q, 2014, CANCER BIOL THER, V9, P819; Hippe D, 2008, INFECT IMMUN, V76, P2905, DOI 10.1128/IAI.01546-07; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jiang C, 2001, CANCER RES, V61, P3062; Jiang W, 2013, ASIAN PAC J CANCER P, V14, P4615, DOI 10.7314/APJCP.2013.14.8.4615; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klein J, 2013, INT J RADIAT ONCOL, V87, P22, DOI 10.1016/j.ijrobp.2012.08.043; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laheru D, 2012, INVEST NEW DRUG, V30, P2391, DOI 10.1007/s10637-012-9818-6; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Li LN, 2007, INT J CANCER, V121, P1360, DOI 10.1002/ijc.22804; Li Y, 2014, LEUKEMIA LYMPHOMA, V55, P1366, DOI 10.3109/10428194.2013.829573; Liu Y, 2013, ASIAN PAC J CANCER P, V14, P5243, DOI 10.7314/APJCP.2013.14.9.5243; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Marquardt JU, 2014, CANCER CELL, V25, P550, DOI 10.1016/j.ccr.2014.04.002; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mologni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051449; Onuki R, 2002, P NATL ACAD SCI USA, V99, P14716, DOI 10.1073/pnas.232177599; Pang YL, 2016, EXP CELL RES, V347, P251, DOI 10.1016/j.yexcr.2016.06.012; Perelman A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.171; Qin GQ, 2015, EXP CELL RES, V336, P308, DOI 10.1016/j.yexcr.2015.07.004; Qin GQ, 2015, APOPTOSIS, V20, P1072, DOI 10.1007/s10495-015-1132-2; Rampone B, 2010, CURR ONCOL REP, V12, P186, DOI 10.1007/s11912-010-0094-3; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Takikawa Y, 2001, GASTROENTEROLOGY, V120, P1810, DOI 10.1053/gast.2001.24835; Thanaketpaisarn O, 2011, INT J ONCOL, V39, P279, DOI 10.3892/ijo.2011.1017; Tian X, 2002, SCI B, V47, P480; Wang Chun-Hsiang, 2015, Asian Pac J Cancer Prev, V16, P3595; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolfson E, 2015, BIOL CELL, V107, P130, DOI 10.1111/boc.201400087; Wu GS, 2013, PHARMACOL REP, V65, P453, DOI 10.1016/S1734-1140(13)71021-1; Yang SH, 2006, APOPTOSIS, V11, P1987, DOI 10.1007/s10495-006-0084-y; Yu HN, 2013, MICROSC MICROANAL, V19, P171, DOI 10.1017/S1431927612014079; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zhang J, 2015, J MICROSC-OXFORD, V257, P104, DOI 10.1111/jmi.12189; Zhang J, 2016, MICRON, V88, P7, DOI 10.1016/j.micron.2016.04.005; Zhang QY, 2014, WORLD J GASTROENTERO, V20, P10082, DOI 10.3748/wjg.v20.i29.10082; Zhao CB, 2014, CELL SIGNAL, V26, P2223, DOI 10.1016/j.cellsig.2014.07.001; Zhao CB, 2014, APOPTOSIS, V19, P668, DOI 10.1007/s10495-013-0953-0; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	73	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171840	10.1371/journal.pone.0171840	http://dx.doi.org/10.1371/journal.pone.0171840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182780	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800123
J	Di Gregorio, J; Sferra, R; Speca, S; Vetuschi, A; Dubuquoy, C; Desreumaux, P; Pompili, S; Cristiano, L; Gaudio, E; Flati, V; Latella, G				Di Gregorio, Jacopo; Sferra, Roberta; Speca, Silvia; Vetuschi, Antonella; Dubuquoy, Caroline; Desreumaux, Pierre; Pompili, Simona; Cristiano, Loredana; Gaudio, Eugenio; Flati, Vincenzo; Latella, Giovanni			Role of glycogen synthase kinase-3 beta and PPAR-gamma on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BETA-CATENIN; INTESTINAL FIBROSIS; MECHANISMS; PATHWAY; DYSFUNCTION; INHIBITION; EXPRESSION; COLLAGEN; AGONIST	Background Intestinal fibrosis is characterized by abnormal production and deposition of extracellular matrix (ECM) proteins by activated myofibroblasts. The main progenitor cells of activated myofibroblasts are the fibroblasts and the epithelial cells, the latter through the epithelial-mesenchymal transition (EMT). Aim To evaluate the action of the new PPAR-gamma modulator, GED-0507-34 Levo (GED) on the expression of EMT associated and regulatory proteins such as TGF-beta, Smad3, E-cadherin, Snail, ZEB1, beta-catenin, and GSK-3 beta, in a mouse model of DSS-induced intestinal fibrosis. Methods Chronic colitis and fibrosis were induced by oral administration of 2.5% DSS (w/v) for 6 weeks. GW9662 (GW), a selective PPAR-gamma inhibitor, was also administered by intraperitoneal injection at the dose of 1 mg/kg/day combined with GED treatment. All drugs were administered at the beginning of the second cycle of DSS (day 12). 65 mice were randomly divided into five groups (H2O as controls n = 10, H2O+GED n = 10, DSS n = 15, DSS+GED n = 15, DSS+GED+GW n = 15). The colon was excised for macroscopic examination and histological and morphometric analyses. The level of expression of molecules involved in EMT and fibrosis, like TGF-beta, Smad3, E-cadherin, Snail, ZEB1, beta-catenin, GSK-3 beta and PPAR-gamma, was assessed by immunohistochemistry, immunofluorescence, western blot and Real Time PCR. Results GED improved the DSS-induced chronic colitis and fibrosis. GED was able to reduce the expression of the main fibrosis markers (alpha-SMA, collagen I-III and fibronectin) as well as the pivotal pro-fibrotic molecules IL-13, TGF-beta and Smad3, while it increased the anti-fibrotic PPAR-gamma. All these GED effects were nullified by co-administration of GW with GED. Furthermore, GED was able to normalize the expression levels of E-cadherin and beta-catenin and upregulated GSK-3 beta, that are all known to be involved both in EMT and fibrosis. Conclusions The DSS-induced intestinal fibrosis was improved by the new PPAR-gamma modulator GED-0507-34 Levo through the modulation of EMT mediators and pro-fibrotic molecules and through GSK-3 beta induction.	[Di Gregorio, Jacopo; Sferra, Roberta; Vetuschi, Antonella; Pompili, Simona; Flati, Vincenzo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Speca, Silvia; Desreumaux, Pierre] Univ Lille, Lille Inflammat Res Int Ctr, U995, F-59000 Lille, France; [Speca, Silvia; Dubuquoy, Caroline; Desreumaux, Pierre] IBD, Lille, France; [Desreumaux, Pierre] CHR Lille, Serv Malad Appareil Digestif & Nutr, Hop Claude Huriez, Lille, France; [Cristiano, Loredana] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Gaudio, Eugenio] Univ Roma La Sapienza, Dept Human Anat, Rome, Italy; [Latella, Giovanni] Univ Aquila, Dept Life Hlth & Environm Sci, Gastroenterol Unit, Laquila, Italy	University of L'Aquila; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of L'Aquila; Sapienza University Rome; University of L'Aquila	Vetuschi, A (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy.	antonella.vetuschi@univaq.it	Desreumaux, Pierre F/R-6877-2018; Pompili, Simona/AAL-2988-2021; Speca, Silvia/S-8547-2016; FLATI, VINCENZO/R-6231-2018	Desreumaux, Pierre F/0000-0002-6127-5281; Pompili, Simona/0000-0001-8628-1517; Speca, Silvia/0000-0001-8494-3329; FLATI, VINCENZO/0000-0003-1014-297X; Latella, Giovanni/0000-0001-6341-5711	University of L'Aquila, L'Aquila, Italy; Inserm, Lille, France [U995]; Nogra Pharma Ltd, Dublin, Ireland; Intestinal Biotech Development of Lille, France; Digest Science foundation; association F. Aupetit, Lille, France	University of L'Aquila, L'Aquila, Italy; Inserm, Lille, France; Nogra Pharma Ltd, Dublin, Ireland; Intestinal Biotech Development of Lille, France; Digest Science foundation; association F. Aupetit, Lille, France	This study was supported by the University of L'Aquila, L'Aquila, Italy; the Inserm U995, Lille, France; Nogra Pharma Ltd, Dublin, Ireland; the Intestinal Biotech Development of Lille, France; the Digest Science foundation and the association F. Aupetit, Lille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Awuah PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039771; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bauer K, 2009, CARCINOGENESIS, V30, P1781, DOI 10.1093/carcin/bgp175; Bertin B, 2013, CURR DRUG TARGETS, V14, P1501, DOI 10.2174/13894501113149990162; Bettenworth D, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-5; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi SS, 2009, HEPATOLOGY; Dantas AT, 2015, PPAR RES, V2015, DOI 10.1155/2015/124624; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Drygiannakis I, 2013, J CROHNS COLITIS, V7, P286, DOI 10.1016/j.crohns.2012.04.008; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; Glaser S, 2010, DIG LIV DIS; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Jeon KI, 2014, AM J PATHOL, V184, P1429, DOI 10.1016/j.ajpath.2014.01.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kumar V, 2014, PHARM RES-DORDR, V31, P1158, DOI 10.1007/s11095-013-1239-5; Kweon SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156111; Lakatos G, 2012, DIGEST DIS, V30, P289, DOI 10.1159/000336995; Lan AP, 2014, CELL PHYSIOL BIOCHEM, V34, P368, DOI 10.1159/000363006; Latella G, 2013, EUR REV MED PHARMACO, V17, P1283; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Latella G, 2014, J CROHNS COLITIS; Latella G, 2015, SCAND J GASTROENTERO, V50, P53, DOI 10.3109/00365521.2014.968863; Lee YH, 2013, CELL MOL LIFE SCI, V70, P3959, DOI 10.1007/s00018-013-1363-8; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Li QH, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/26/265101; Liu H, 2013, ACTA PHARMACOL SIN, V34, P26; Liu JQ, 2012, J DERMATOL SCI, V65, P38, DOI 10.1016/j.jdermsci.2011.09.012; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Lu J, 2014, EUR J PHARMACOL, V737, P133, DOI 10.1016/j.ejphar.2014.05.008; Miao CG, 2013, BIOCHIMIE, V95, P2326, DOI 10.1016/j.biochi.2013.09.003; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Pirat C, 2012, J MED CHEM, V55, P4027, DOI 10.1021/jm101360s; Qian JJ, 2012, PHARMACOL RES, V66, P219, DOI 10.1016/j.phrs.2012.06.003; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Rieder F, 2013, DIGEST DIS, V31, P186, DOI 10.1159/000353364; Rieder F, 2012, J CROHNS COLITIS, V6, P373, DOI 10.1016/j.crohns.2011.11.009; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Segel MJ, 2003, AM J PHYSIOL-LUNG C, V285, pL1255, DOI 10.1152/ajplung.00303.2002; Shim CY, 2014, J DIABETES INVEST, V5, P362, DOI 10.1111/jdi.12153; Shimshoni E, 2015, GUT, V64, P367, DOI 10.1136/gutjnl-2014-308048; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Speca S, 2012, WORLD J GASTROENTERO, V18, P3635, DOI 10.3748/wjg.v18.i28.3635; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Wei J, 2012, ARTHRITIS RHEUM-US, V64, P2734, DOI 10.1002/art.34424; Wei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013778; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yanagid A, 2011, BBA-MOL BASIS DIS, V1812, P1403, DOI 10.1016/j.bbadis.2011.06.015; Yang MC, 2014, AM J CANCER RES, V4, P751; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhu HY, 2015, BIOCHEM BIOPH RES CO, V459, P49, DOI 10.1016/j.bbrc.2015.02.061; Zhu M, 2011, AM J RESP CELL MOL, V45, P111, DOI 10.1165/rcmb.2009-0445OC	62	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171093	10.1371/journal.pone.0171093	http://dx.doi.org/10.1371/journal.pone.0171093			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207769	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424500015
J	de Queiroz, KB; Honorato-Sampaio, K; Rossoni, JV; Leal, DA; Pinto, ABG; Kappes-Becker, L; Evangelista, EA; Guerra-Sa, R				de Queiroz, Karina Barbosa; Honorato-Sampaio, Kinulpe; Rossoni Junior, Joamyr Victor; Leal, Diego Andrade; Pinto, Angelica Barbosa G.; Kappes-Becker, Lenice; Evangelista, Elisio Alberto; Guerra-Sa, Renata			Physical activity prevents alterations in mitochondrial ultrastructure and glucometabolic parameters in a high-sugar diet model	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; OXIDATIVE STRESS; GENE-EXPRESSION; ADIPOSE-TISSUE; MESSENGER-RNA; UP-REGULATION; EXERCISE	Endurance exercise is a remarkable intervention for the treatment of many diseases. Mitochondria) changes on skeletal muscle are likely important for many of the benefits provided by exercise. In this study, we aimed to evaluate the effects that a regular physical activity (swimming withoutworkload) has on mitochondrial morphological alterations and glucometabolic parameters induced by a high-sugar diet (HSD). Weaned male Wistar rats fed with a standard diet or a HSD (68% carbohydrate) were subjected to 60 minutes of regular physical activity by swimming (without workload) for four- (20 sessions) or eight-week (40 sessions) periods. After training, animals were euthanized and the sera, adipose tissues, and skeletal muscles were collected for further analysis. The HSD increased body weight after an 8 week period; it also increased the fat pads and the adipose index, resulting in glucose intolerance and insulin resistance (IR). Transmission electron microscopy showed an increase in alterations of mitochondrial ultrastructure in the gastrocnemius muscle, as well as a decrease in superoxide dismutase (SOD) activity, and an increase in protein carbonylation. Regular physical activity partially reverted these alterations in rats fed a HSD, preventing mitochondrial morphological alterations and IR. Moreover, we observed a decrease in Pgcla expression (qPCR analysis) in STD-EXE group and a less pronounced reduction in HSD-EXE group after an 8-week period. Thus, regular physical activity (swimming without workload) in rats fed a HSD can prevent mitochondrial dysfunction and IR, highlighting the crucial role for physical activity on metabolic homeostasis.	[de Queiroz, Karina Barbosa; Leal, Diego Andrade; Evangelista, Elisio Alberto; Guerra-Sa, Renata] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim & Biol Mol, Ouro Preto, MG, Brazil; [Honorato-Sampaio, Kinulpe] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Campus JK, Diamantina, MG, Brazil; [Rossoni Junior, Joamyr Victor] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim Metab, Ouro Preto, MG, Brazil; [Pinto, Angelica Barbosa G.; Kappes-Becker, Lenice] Univ Fed Ouro Preto, Ctr Esportes, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	de Queiroz, KB (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim & Biol Mol, Ouro Preto, MG, Brazil.	karinabq@gmail.com	de Queiroz, Karina Barbosa/S-9628-2017; Honorato-Sampaio, Kinulpe/AAX-3742-2021	de Queiroz, Karina Barbosa/0000-0002-8171-435X; Honorato-Sampaio, Kinulpe/0000-0002-8154-9606; Rossoni Junior, Joamyr Victor/0000-0002-1882-4249	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Barbieri E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/917085; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bhatt BA, 2006, AM J PHYSIOL-REG I, V290, pR233, DOI 10.1152/ajpregu.00097.2005; Bluher S, 2014, METABOLISM; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Chan CYY, 2013, EUR J NUTR, V52, P1721, DOI 10.1007/s00394-012-0475-5; Chu L, 2011, EUR J APPL PHYSIOL, V111, P3135, DOI 10.1007/s00421-011-1940-1; de Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI 10.1007/s11011-008-9101-x; de Queiroz KB, 2014, MOL NUTR FOOD RES, V58, P2331, DOI 10.1002/mnfr.201400241; de Queiroz KB, 2014, LIPIDS, V49, P85, DOI 10.1007/s11745-013-3854-7; de Queiroz KB, 2012, NUTR RES, V32, P709, DOI 10.1016/j.nutres.2012.06.020; de Souza MO, 2010, NUTRITION, V26, P804, DOI 10.1016/j.nut.2009.09.007; Evangelista FS, 2003, BRAZ J MED BIOL RES, V36, P1751, DOI 10.1590/S0100-879X2003001200018; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878; Gatineau E, 2015, J NUTR, V145, P923, DOI 10.3945/jn.114.205583; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gomez-Cabrera MC, 2006, BRIT J NUTR, V96, pS31, DOI 10.1079/BJN20061696; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guran T, 2011, MINERVA PEDIATR, V63, P483; Hackman CL, 2014, ADOLESC HEALTH MED T, V5, P101, DOI 10.2147/AHMT.S56207; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Joslowski G, 2012, INT J OBES LOND; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kregel KC, 2006, EXERCISE PROTOCOLS U, P35; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/H11-076, 10.1139/h11-076]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mittendorfer B, 2003, NUTR RES REV, V16, P97, DOI 10.1079/NRR200357; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Morton TL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00080; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; PITTS GC, 1984, AM J PHYSIOL, V246, pR495, DOI 10.1152/ajpregu.1984.246.4.R495; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Skledar MT, 2015, CENT EUR J PUBL HEAL, V23, P26, DOI 10.21101/cejph.a3956; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stephen A, 2012, EUR J CLIN NUTR, V66, P765, DOI 10.1038/ejcn.2012.27; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Ustunel I, 1997, ACTA ANAT, V158, P279; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiao T, 2015, EUR REV MED PHARMACO, V19, P1779; YAMADA T, 1975, J LAB CLIN MED, V86, P38; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; YANG XL, 1995, ANAT RECORD, V241, P255, DOI 10.1002/ar.1092410212	80	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172103	10.1371/journal.pone.0172103	http://dx.doi.org/10.1371/journal.pone.0172103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199417	Green Published, gold, Green Submitted			2022-12-27	WOS:000394424400072
J	Issa, H; Huc-Claustre, E; Reddad, T; Bottino, NB; Tropis, M; Houssin, C; Daffe, M; Bayan, N; Dautin, N				Issa, Hanane; Huc-Claustre, Emilie; Reddad, Thamila; Bottino, Nolwenn Bonade; Tropis, Maryelle; Houssin, Christine; Daffe, Mamadou; Bayan, Nicolas; Dautin, Nathalie			Click-chemistry approach to study mycoloylated proteins: Evidence for PorB and PorC porins mycoloylation in Corynebacterium glutamicum	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; CELL-WALL CHANNEL; MYCOBACTERIUM-TUBERCULOSIS; FORMING PROTEIN; BETA-BARREL; IDENTIFICATION; GENE; PALMITOYLATION; EXPRESSION; LOCALIZATION	Protein mycoloylation is a recently identified, new form of protein acylation. This post -translational modification consists in the covalent attachment of mycolic acids residues to serine. Mycolic acids are long chain, alpha-branched, beta-hydroxylated fatty acids that are exclusively found in the cell envelope of Corynebacteriales, a bacterial order that includes important genera such as Mycobacterium, Nocardia or Corynebacterium. So far, only 3 mycoloylated proteins have been identified: PorA, PorH and ProtX from C. glutamicum. Whereas the identity and function of ProtX is unknown, PorH and PorA associate to form a membrane channel, the activity of which is dependent upon PorA mycoloylation. However, the exact role of mycoloylation and the generality of this phenomenon are still unknown. In particular, the identity of other mycoloylated proteins, if any, needs to be determined together with establishing whether such modification occurs in Corynebacteriales genera other than Corynebacterium. Here, we tested whether a metabolic labeling and click -chemistry approach could be used to detect mycoloylated proteins. Using a fatty acid alkyne analogue, we could indeed label PorA, PorH and ProtX and determine ProtX mycoloylation site. Importantly, we also show that two other porins from C. glutamicum, PorB and PorC are mycoloylated.	[Issa, Hanane; Reddad, Thamila; Bottino, Nolwenn Bonade; Houssin, Christine; Bayan, Nicolas; Dautin, Nathalie] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France; [Issa, Hanane] Holy Spirit Univ Kaslik USEK, Jounieh, Mt Lebanon, Lebanon; [Huc-Claustre, Emilie; Tropis, Maryelle; Daffe, Mamadou] Inst Pharmacol & Struct Biol, UMR 5089, Paris, France; [Huc-Claustre, Emilie] Canc Res Ctr Toulouse, Toulouse, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dautin, N (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France.	nathalie.dautin@i2bc.paris-saclay.fr	Bayan, Nicolas/AAI-5034-2020; Claustre, Emilie Huc/M-6693-2016	Claustre, Emilie Huc/0000-0002-8856-207X; Bayan, Nicolas/0000-0001-7760-0811	Centre National de la Recherche Scientifique; Paris-Sud University; USEK-Lebanese CNRS doctoral fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Paris-Sud University; USEK-Lebanese CNRS doctoral fellowship	This work was supported by the Centre National de la Recherche Scientifique and the Paris-Sud University. HI is supported by a USEK-Lebanese CNRS doctoral fellowship.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; Baumgart M, 2011, J BACTERIOL, V193, P6864, DOI 10.1128/JB.05465-11; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Buddelmeijer N, 2015, FEMS MICROBIOL REV, V39, P246, DOI 10.1093/femsre/fuu006; Charlton TM, 2015, CHEM BIOL, V22, P1562, DOI 10.1016/j.chembiol.2015.10.006; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Costa-Riu N, 2003, J BACTERIOL, V185, P4779, DOI 10.1128/JB.185.16.4779-4786.2003; Daffe AM, 2015, TUBERCULOSIS EDIN S1, pS155; Dautin N, 2016, BIOCH BIOPHYS ACTA; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Foley HN, 2016, ANGEW CHEM INT EDIT, V55, P2053, DOI 10.1002/anie.201509216; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Houston S, 2011, INFECT IMMUN, V79, P1386, DOI 10.1128/IAI.01083-10; Huc E, 2013, J BACTERIOL, V195, P4121, DOI 10.1128/JB.00285-13; Huc E, 2010, J BIOL CHEM, V285, P21908, DOI 10.1074/jbc.C110.133033; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Huysmans GHM, 2016, BIOCHEM SOC T, V44, P845, DOI 10.1042/BST20160003; JOLIFF G, 1992, MOL MICROBIOL, V6, P2349, DOI 10.1111/j.1365-2958.1992.tb01410.x; Kavunja HW, 2016, CHEM COMMUN, V52, P13795, DOI 10.1039/c6cc07143k; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mohiman N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046225; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Rangan KJ, 2010, J AM CHEM SOC, V132, P10628, DOI 10.1021/ja101387b; Rath P, 2013, FEBS LETT, V587, P3687, DOI 10.1016/j.febslet.2013.09.032; Rath P, 2011, J BIOL CHEM, V286, P32525, DOI 10.1074/jbc.M111.276956; Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x; Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Siegrist MS, 2015, FEMS MICROBIOL REV, V39, P184, DOI 10.1093/femsre/fuu012; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Tate EW, 2015, CURR OPIN CHEM BIOL, V24, P48, DOI 10.1016/j.cbpa.2014.10.016; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; van der Woude AD, 2013, J BACTERIOL, V195, P2050, DOI 10.1128/JB.02236-12; Walsh C, 2006, POSTTRANSLATIONAL MO, Vxxi; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Yang YS, 2011, PROTEINS, V79, P645, DOI 10.1002/prot.22912; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	65	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171955	10.1371/journal.pone.0171955	http://dx.doi.org/10.1371/journal.pone.0171955			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199365	Green Submitted, gold, Green Published			2022-12-27	WOS:000394424400060
J	Pruszynski, CA; Hribar, LJ; Mickle, R; Leal, AL				Pruszynski, Catherine A.; Hribar, Lawrence J.; Mickle, Robert; Leal, Andrea L.			A Large Scale Biorational Approach Using Bacillus thuringiensis israeliensis (Strain AM65-52) for Managing Aedes aegypti Populations to Prevent Dengue, Chikungunya and Zika Transmission	PLOS ONE			English	Article							VAR. ISRAELENSIS; KEY-WEST; DIPTERA-CULICIDAE; ALBOPICTUS; MOSQUITO; SUSCEPTIBILITY; INVERTEBRATES; FORMULATIONS; RESIDENTS; FLORIDA	Background Aedes aegypti is a container-inhabiting mosquito and a vector of dengue, chikungunya, and Zika viruses. In 2009 several cases of autochthonous dengue transmission were reported in Key West, Florida, USA prompting a comprehensive response to control A. aegypti. In Key West, larvae of this mosquito develop in containers around human habitations which can be numerous and labor intensive to find and treat. Aerial applications of larvicide covering large areas in a short time can be an efficient and economical method to control A. aegypti. Bacillus thuringiensis israelensis (Bti) is a bacterial larvicide which is highly target specific and appropriate for wide area spraying over urban areas, but to date, there are no studies that evaluate aerial spraying of Bti to control container mosquitoes like A. aegypti. Methodology This paper examines the effectiveness of aerial larvicide applications using VectoBac (R) WG, a commercially available Bti formulation, for A. aegypti control in an urban setting in the USA. Droplet characteristics and spray drop deposition were evaluated in Key West, Florida, USA. The mortality of A. aegypti in containers placed under canopy in an urban environment was also evaluated. Efficacy of multiple larvicide applications on adult female A. aegypti population reduction was compared between an untreated control and treatment site. Conclusions Droplet characteristics showed that small droplets can penetrate through dense canopy to reach small containers. VectoBac WG droplets reached small containers under heavy canopy in sufficient amounts to cause >55% mortality on all application days and >90% mortality on 3 of 5 application days while controls had <5% mortality. Aerial applications of dVectoBac WG caused significant decrease in adult female populations throughout the summer and during the 38 th week (last application) the difference in adult female numbers between untreated and treated sites was >50%. Aerial larvicide applications using VectoBac WG can cover wide areas in a short period of time and can be effective in controlling A. aegypti and reducing A. aegypti-borne transmission in urban areas similar to Key West, Florida, USA.	[Pruszynski, Catherine A.; Hribar, Lawrence J.; Leal, Andrea L.] Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA; [Mickle, Robert] REMSpC Spray Consulting, Welsh Dr, Ayr, ON, Canada		Pruszynski, CA (corresponding author), Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA.	cpruz@keysmosquito.org			Florida Keys Mosquito Control District; Monroe County property taxes	Florida Keys Mosquito Control District; Monroe County property taxes	The authors received no specific funding for this work. Author Robert Mickle is the owner of the commercial company "REMSpC Spray Consulting" and was paid a consulting fee by the government agency, Florida Keys Mosquito Control District, for his evaluation of the droplet analysis evaluated for this experiment. The Florida Keys Mosquito Control District is an independent taxing district in Monroe County, Florida. The FKMCD budget is funded by a percentage of Monroe County property taxes. The funders (tax-payers of Monroe Co.) did not play a role in the study design, collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702; Aldemir A, 2009, J AM MOSQUITO CONTR, V25, P113, DOI 10.2987/08-5836.1; [Anonymous], 2016, ZIK VIR CAS COUNTS U; Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Attar N., 2016, NAT REV MICROBIOL, V2016, P14; Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Becker N, 2003, J AM MOSQUITO CONTR, V19, P63; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Boisvert M, 2005, UTILIZATION BACILLUS, P87; Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2; Caquet T, 2011, ECOTOX ENVIRON SAFE, V74, P1122, DOI 10.1016/j.ecoenv.2011.04.028; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dunford JC, 2014, J AM MOSQUITO CONTR, V30, P191, DOI 10.2987/14-6400R.1; Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Glare TR, 1998, ENV HLTH IMPACTS BAC, P81; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Guide Who, 1994, WHO GUIDEL DRINK QUA, P1; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hribar Lawrence J., 2011, Studia Dipterologica, V17, P237; Huber Karine, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P81; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Key West Chamber of Commerce, 2015, KEY W MONR COUNT DEM; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lagadic L, 2014, J APPL ECOL, V51, P102, DOI 10.1111/1365-2664.12165; Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071; Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601; Lee YW, 2006, J AM MOSQUITO CONTR, V22, P97, DOI 10.2987/8756-971X(2006)22[97:SOLAFA]2.0.CO;2; Mao T, 1997, AICHE J, V43, P2169, DOI 10.1002/aic.690430903; Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665; Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Reece AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004521; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y; Rodriguez MM, 2004, J MEDIAL ENTOMOL, V38, P623; Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1; Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296; To Setha, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P261; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Vilarinhos PTR, 2004, J AM MOSQUITO CONTR, V20, P311; WHO, 1999, IPCS ENV HLTH CRIT 2; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035; World Health Organization, 2016, ZIK FACT SHEET; World Health Organization, 2015, CHIK FACT SHEET; World Health Organization, 2016, WHOPES REC COMP FORM	53	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170079	10.1371/journal.pone.0170079	http://dx.doi.org/10.1371/journal.pone.0170079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199323	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424400013
J	Ruocco, N; Costantini, S; Zupo, V; Romano, G; Ianora, A; Fontana, A; Costantini, M				Ruocco, Nadia; Costantini, Susan; Zupo, Valerio; Romano, Giovanna; Ianora, Adrianna; Fontana, Angelo; Costantini, Maria			High-quality RNA extraction from the sea urchin Paracentrotus lividus embryos	PLOS ONE			English	Article							MOLECULAR ECOLOGY; STRESS; PRESERVATION; TRANSCRIPTOMES; CELOMOCYTES; ECHINODERMS; RESPONSES; TISSUES; DNA	The sea urchin Paracentrotus lividus (Lamarck, 1816) is a keystone herbivore in the Mediterranean Sea due to its ability to transform macroalgal-dominated communities into barren areas characterized by increased cover of bare substrates and encrusting coralline algae, reduced biodiversity and altered ecosystem functions. P. lividus is also an excellent animal model for toxicology, physiology and biology investigations having been used for more than a century as a model for embryological studies with synchronously developing embryos which are easy to manipulate and analyze for morphological aberrations. Despite its importance for the scientific community, the complete genome is still not fully annotated. To date, only a few molecular tools are available and a few Next Generation Sequencing (NGS) studies have been performed. Here we aimed at setting-up an RNA extraction method to obtain high quality and sufficient quantity of RNA for NGS from P. lividus embryos at the pluteus stage. We compared five different RNA extraction protocols from four different pools of plutei (500, 1000, 2500 and 5000 embryos): TRIzol, and four widely-used Silica Membrane kits, GenElute TM Mammalian Total RNA Miniprep Kit, RNAqueous Micro Kit, RNeasy Micro Kit and Aurum TM Total RNA Mini Kit. The quantity of RNA isolated was evaluated using NanoDrop. The quality, considering the purity, was measured as A260/A280 and A260/230 ratios. The integrity was measured by RNA Integrity Number (RIN). Our results demonstrated that the most efficient procedures were GenElute, RNeasy and Aurum, producing a sufficient quantity of RNA for NGS. The Bioanalyzer profiles and RIN values revealed that the most efficient methods guaranteeing for RNA integrity were RNeasy and Aurum combined with an initial preservation in RNAlater. This research represents the first attempt to standardize a method for high-quality RNA extraction from sea urchin embryos at the pluteus stage, providing a new resource for this established model marine organism.	[Ruocco, Nadia; Costantini, Maria] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Ruocco, Nadia] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, Via Cinthia, Naples, Italy; [Ruocco, Nadia; Fontana, Angelo] CNR, Inst Biomol Chem, Bioorgan Chem Unit, Via Campi Flegrei 34, Naples, Italy; [Costantini, Susan] Fdn G Pascale, Ist Nazl Tumori, CROM, Naples, Italy; [Zupo, Valerio] Ctr Villa Dohrn Ischia Benth Ecol, Dept Integrat Marine Ecol, Stn Zool Anton Dohrn, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Costantini, M (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.; Fontana, A (corresponding author), CNR, Inst Biomol Chem, Bioorgan Chem Unit, Via Campi Flegrei 34, Naples, Italy.	afontana@icb.cnr.it; maria.costantini@szn.it	Ianora, Adrianna/O-3408-2019; Fontana, Angelo/AAO-2741-2021; Costantini, Susan/J-9914-2018; Costantini, Maria/AGH-4080-2022; Ruocco, Nadia/HGA-2143-2022; Fontana, Angelo/C-3354-2012; Romano, Giovanna/F-4561-2015	Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Romano, Giovanna/0000-0002-4898-7153; Costantini, Susan/0000-0002-7538-4657	PhD (PhD in Biology, University of Naples Federico II) fellowship; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples	PhD (PhD in Biology, University of Naples Federico II) fellowship; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples	Nadia Ruocco has been supported by a PhD (PhD in Biology, University of Naples Federico II) fellowship co-funded by the Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RL, 2013, MOL ECOL, V22, P2605, DOI 10.1111/mec.12319; Asai S, 2015, MAR GENOM, V24, P115, DOI 10.1016/j.margen.2014.12.004; Bellas J, 2008, AQUAT TOXICOL, V88, P308, DOI 10.1016/j.aquatox.2008.05.011; Bonaventura R, 2011, CELL STRESS CHAPERON, V16, P681, DOI 10.1007/s12192-011-0277-3; Bosnjak I, 2011, WATER AIR SOIL POLL, V217, P627, DOI 10.1007/s11270-010-0615-6; Boudouresque CF, 2007, DEV AQUAC FISH SCI, V37, P243; Boudouresque Charles F., 2001, Developments in Aquaculture and Fisheries Science, V32, P177; Dinnel P.A., 1988, P611; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; Hillyard G, 2012, POLAR BIOL, V35, P633, DOI 10.1007/s00300-011-1088-9; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Kobayashi N, 2005, CHEMOSPHERE, V61, P1198, DOI 10.1016/j.chemosphere.2005.02.071; Kominami T, 2004, DEV GROWTH DIFFER, V46, P309; Lawrence JM, 2007, SEA URCHINS BIOLOGY; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Morale A, 1998, CHEMOSPHERE, V37, P3001, DOI 10.1016/S0045-6535(98)00341-5; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Paredes E, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4010007; Perez-Portela R, 2013, MOL ECOL RESOUR, V13, P884, DOI 10.1111/1755-0998.12122; Pinsino A, 2008, CELL BIOL TOXICOL, V24, P541, DOI 10.1007/s10565-008-9055-0; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; Ruocco N, 2016, AQUAT TOXICOL, V176, P128, DOI 10.1016/j.aquatox.2016.04.012; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCONZO G, 1995, PHARMAZIE, V50, P616; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simister RL, 2011, J EXP MAR BIOL ECOL, V397, P38, DOI 10.1016/j.jembe.2010.11.004; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wangensteen OS, 2011, MAR ECOL PROG SER, V441, P117, DOI 10.3354/meps09359; Zito F, 2005, PROG MOLEC, V39, P7	44	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172171	10.1371/journal.pone.0172171	http://dx.doi.org/10.1371/journal.pone.0172171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199408	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400079
J	Wisowski, G; Kozma, EM; Bielecki, T; Pudelko, A; Olczyk, K				Wisowski, Grzegorz; Kozma, Ewa M.; Bielecki, Tomasz; Pudelko, Adam; Olczyk, Krystyna			Dermatan sulfate is a player in the transglutaminase 2 interaction network	PLOS ONE			English	Article							FIBROSIS-AFFECTED FASCIA; HEPARIN-BINDING-SITE; TISSUE TRANSGLUTAMINASE; CELL-ADHESION; CHONDROITIN SULFATE; MATRIX-DEPOSITION; GROWTH; FIBRONECTIN; BIGLYCAN; PROTEOGLYCANS	Transglutaminase 2 (TG2) is a multifunctional protein that is primarily engaged in cell adhesion/signaling or shows Ca2+ -dependent transglutaminase activity in the extracellular space of tissues. This latter action leads to the cross-linking of the extracellular matrix (ECM) proteins. The enhanced extracellular expression of TG2 is associated with processes such as wound healing, fibrosis or vascular remodeling that are also characterized by a high deposition of dermatan sulfate (DS) proteoglycans in the ECM. However, it is unknown whether DS may bind to TG2 or affect its function. Using the plasmon surface resonance method, we showed that DS chains, especially those of biglycan, are good binding partners for TG2. The interaction has some requirements as to the DS structure. The competitive effect of heparin on DS binding to TG2 suggests that both glycosaminoglycans occupy the same binding site(s) on the protein molecule. An occurrence of the DS-TG2 interaction was confirmed by the co-immunoprecipitation of this protein with native decorin that is a DS-bearing proteoglycan rather than with the decorin core protein. Moreover, in vivo DS is responsible for both TG2 binding and the regulation of the location of this protein in the ECM as can be suggested from an increased extraction of TG2 from the human fascia only when an enzymatic degradation of the tissue DS was conducted in the presence of the anti-collagen type I antiserum. In addition, DS with a low affinity for TG2 exerted an inhibitory effect on the protein transamidating activity most probably via the control of the accessibility of a substrate. Our data show that DS can affect several aspects of TG2 biology in both physiological and pathological conditions.	[Wisowski, Grzegorz; Kozma, Ewa M.; Pudelko, Adam; Olczyk, Krystyna] Med Univ Silesia, Div Lab Med Sosnowiec, Sch Pharm, Dept Clin Chem & Lab Diagnost, Katowice, Poland; [Bielecki, Tomasz] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept & Clin Orthoped & Trauma Surg, Katowice, Poland	Medical University Silesia; Medical University Silesia	Wisowski, G (corresponding author), Med Univ Silesia, Div Lab Med Sosnowiec, Sch Pharm, Dept Clin Chem & Lab Diagnost, Katowice, Poland.	vis@sum.edu.pl		Kozma, Ewa Maria/0000-0002-4502-0828; Pudelko, Adam/0000-0003-4558-8437; Wisowski, Grzegorz/0000-0001-8781-0011; Olczyk, Krystyna/0000-0002-5833-2628	Medical University of Silesia in Katowice [KNW-1-030/K/3/0]	Medical University of Silesia in Katowice	Grant of Medical University of Silesia in Katowice, number KNW-1-030/K/3/0; http://www.sum.edu.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chou CY, 2011, J BIOL CHEM, V286, P27825, DOI 10.1074/jbc.M111.226340; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dolynchuk Kenneth N., 1996, Wound Repair and Regeneration, V4, P16, DOI 10.1046/j.1524-475X.1996.40105.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GENTILE V, 1991, J BIOL CHEM, V266, P478; Huelsz-Prince G, 2013, J VASC RES, V50, P383, DOI 10.1159/000354222; Jandu SK, 2013, AMINO ACIDS, V44, P261, DOI 10.1007/s00726-011-1090-0; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; JUPRELLESORET M, 1988, BIOCHEM J, V250, P421, DOI 10.1042/bj2500421; Kozma EM, 2005, J BIOCHEM, V137, P463, DOI 10.1093/jb/mvi054; Kozma EM, 2014, EXP BIOL MED, V239, P1575, DOI 10.1177/1535370214538590; Kozma EM, 2011, GLYCOBIOLOGY, V21, P1301, DOI 10.1093/glycob/cwr065; Kozma EM, 2009, BIOCHIMIE, V91, P1394, DOI 10.1016/j.biochi.2009.07.010; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; van den Akker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023067; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhao WJ, 2012, BIOSCIENCE REP, V32, P71, DOI 10.1042/BSR20110077	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172263	10.1371/journal.pone.0172263	http://dx.doi.org/10.1371/journal.pone.0172263			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199387	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400086
J	Atee, HA; Ahmad, R; Noor, NM; Rahma, AMS; Aljeroudi, Y				Atee, Hayfaa Abdulzahra; Ahmad, Robiah; Noor, Norliza Mohd; Rahma, Abdul Monem S.; Aljeroudi, Yazan			Extreme learning machine based optimal embedding location finder for image steganography	PLOS ONE			English	Article							NEURAL-NETWORKS; ALGORITHM; CAPACITY; STEGANALYSIS; SCHEME	In image steganography, determining the optimum location for embedding the secret message precisely with minimum distortion of the host medium remains a challenging issue. Yet, an effective approach for the selection of the best embedding location with least deformation is far from being achieved. To attain this goal, we propose a novel approach for image steganography with high-performance, where extreme learning machine (ELM) algorithm is modified to create a supervised mathematical model. This ELM is first trained on a part of an image or any host medium before being tested in the regression mode. This allowed us to choose the optimal location for embedding the message with best values of the predicted evaluation metrics. Contrast, homogeneity, and other texture features are used for training on a new metric. Furthermore, the developed ELM is exploited for counter over-fitting while training. The performance of the proposed steganography approach is evaluated by computing the correlation, structural similarity (SSIM) index, fusion matrices, and mean square error (MSE). The modified ELM is found to outperform the existing approaches in terms of imperceptibility. Excellent features of the experimental results demonstrate that the proposed steganographic approach is greatly proficient for preserving the visual information of an image. An improvement in the imperceptibility as much as 28% is achieved compared to the existing state of the art methods.	[Atee, Hayfaa Abdulzahra] Fdn Tech Educ, Higher Educ & Sci Res, Baghdad, Iraq; [Atee, Hayfaa Abdulzahra; Ahmad, Robiah; Noor, Norliza Mohd] UTM Kuala Lumpur, UTM Razak Sch Engn & Adv Technol, Dept Engn, Kuala Lumpur, Malaysia; [Rahma, Abdul Monem S.] Univ Technol Baghdad, Dept Comp Sci, Baghdad, Iraq; [Aljeroudi, Yazan] Int Islamic Univ Malaysia, Dept Mech Engn, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; University of Technology- Iraq; International Islamic University Malaysia	Atee, HA (corresponding author), Fdn Tech Educ, Higher Educ & Sci Res, Baghdad, Iraq.; Atee, HA (corresponding author), UTM Kuala Lumpur, UTM Razak Sch Engn & Adv Technol, Dept Engn, Kuala Lumpur, Malaysia.	haifaa_atee@yahoo.com	aljeroudi, yazan/AAU-8971-2021; AHMAD, ROBIAH/J-2107-2019; Noor, Norliza Mohd/AAF-5733-2020; Atee, Hayfaa A./AAX-4633-2020; Rahma, Abdul Monem Salih/AAR-4753-2021; Atee, Hayfaa/G-6826-2019	AHMAD, ROBIAH/0000-0001-6461-9564; Rahma, Abdul Monem Salih/0000-0001-6323-9148; Atee, Hayfaa/0000-0001-5647-9215				Al-Jbara HAG, 2012, AIP CONF PROC, V1482, P20, DOI 10.1063/1.4757431; Almohammad A, 2010, THESIS; Atawneh S, 2013, IETE TECH REV, V30, P344, DOI 10.4103/0256-4602.116724; Banerjee I, 2013, PROC TECH, V10, P157, DOI 10.1016/j.protcy.2013.12.348; Barni M, 2011, IEEE SIGNAL PROCESS, V28, P142, DOI DOI 10.1109/MSP.2011.941841; Cheddad A, 2010, SIGNAL PROCESS, V90, P727, DOI 10.1016/j.sigpro.2009.08.010; Cho SG, 2013, J VIS COMMUN IMAGE R, V24, P846, DOI 10.1016/j.jvcir.2013.05.007; Paulson LD, 2006, COMPUTER, V39, P25, DOI 10.1109/MC.2006.273; Deng ZH, 2014, IEEE T NEUR NET LEAR, V25, P664, DOI 10.1109/TNNLS.2013.2280171; Dwd Q, 2015, CONTR C ASCC 2015 10; El-Alfy EM, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P160, DOI 10.1109/CIDM.2013.6597231; El-Emam NN, 2013, J SYST SOFTWARE, V86, P1465, DOI 10.1016/j.jss.2012.12.006; Elshoura SM, 2013, SIGNAL PROCESS-IMAGE, V28, P531, DOI 10.1016/j.image.2012.12.005; Filler T, 2011, IEEE T INF FOREN SEC, V6, P920, DOI 10.1109/TIFS.2011.2134094; Filler T, 2011, PROC SPIE, V7880, DOI 10.1117/12.872192; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hassaan, 2008, P IEEE SWARM INT S, P1; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Husien S, 2015, NEURAL COMPUT APPL, V26, P111, DOI 10.1007/s00521-014-1702-1; Iranpour M, 2015, MULTIMED TOOLS APPL, V74, P11429, DOI 10.1007/s11042-014-2237-2; Islam S, 2014, 10 INT C ICIC TAIYUA, P803; Kanan HR, 2014, EXPERT SYST APPL, V41, P6123, DOI 10.1016/j.eswa.2014.04.022; Ker A, 2008, ESECURITY FORENSICS; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Luo JH, 2014, IEEE T NEUR NET LEAR, V25, P836, DOI 10.1109/TNNLS.2013.2281839; Luo WQ, 2010, IEEE T INF FOREN SEC, V5, P201, DOI 10.1109/TIFS.2010.2041812; Ma XY, 2009, L N INST COMP SCI SO, V18, P152; Najafi HL, 2010, INT J INTELL COMPUT, V3, P391, DOI 10.1108/17563781011066693; Oplatkova Zuzana Kominkova, 2013, International Journal of Innovative Computing and Applications, V5, P184; Pathak P, 2014, DIGIT INVEST, V11, P67, DOI 10.1016/j.diin.2013.12.002; Pevny T., 2010, USING HIGH DIMENSION, P161; Prabakaran G., 2012, 2012 International Conference on Computing, Electronics and Electrical Technologies (ICCEET 2012), P1096, DOI 10.1109/ICCEET.2012.6203811; Pratt MA, 2008, INT J INTELL COMPUT, V1, P549, DOI 10.1108/17563780810919122; Qi M, 2010, J NETW COMPUT APPL, V33, P247, DOI 10.1016/j.jnca.2009.12.004; Roy R, 2015, PROCEDIA COMPUT SCI, V60, P468, DOI 10.1016/j.procs.2015.08.168; Tsai DS, 2009, INFORM SCIENCES, V179, P3247, DOI 10.1016/j.ins.2009.05.020; Wang ST, 2015, APPL SOFT COMPUT, V37, P125, DOI 10.1016/j.asoc.2015.07.040; Wu HC, 2009, J SYST SOFTWARE, V82, P1966, DOI 10.1016/j.jss.2009.06.056; Zhang F, 2008, INFORM SCIENCES, V178, P2950, DOI 10.1016/j.ins.2008.03.011	39	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170329	10.1371/journal.pone.0170329	http://dx.doi.org/10.1371/journal.pone.0170329			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196080	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423900005
J	Hoffman, O; Burns, N; Vadasz, I; Eltzschig, HK; Edwards, MG; Vohwinkel, CU				Hoffman, Olivia; Burns, Nana; Vadasz, Istvan; Eltzschig, Holger K.; Edwards, Michael G.; Vohwinkel, Christine U.			Detrimental ELAVL-1/HuR-dependent GSK3 beta mRNA stabilization impairs resolution in acute respiratory distress syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; BINDING PROTEIN; EXPRESSION; PROTECTION; CLEARANCE; HUR; INFLAMMATION; INHIBITION; ACTIVATION; MECHANISMS	A hallmark of acute respiratory distress syndrome (ARDS) is accumulation of protein-rich edema in the distal airspaces and its removal is critical for patient survival. Previous studies have shown a detrimental role of Glycogen Synthase Kinase (GSK) 3 beta during ARDS via inhibition of alveolar epithelial protein transport. We hypothesized that post-transcriptional regulation of GSK3 beta could play a functional role in ARDS resolution. To address this hypothesis, we performed an in silico analysis to identify regulatory genes whose expression correlation to GSK3 beta messenger RNA utilizing two lung cancer cell line array datasets. Among potential regulatory partners of GSK3 beta, these studies identified the RNA-binding protein ELAVL-1/HuR (Embryonic Lethal, Abnormal Vision, Drosophila-Like) as a central component in a likely GSK3 beta signaling network. ELAVL-1/HuR is a RNA-binding protein that selectively binds to AU-rich elements of mRNA and enhances its stability thereby increasing target gene expression. Subsequent studies with siRNA suppression of ELAVL-1/HuR demonstrated deceased GSK3 beta mRNA and protein expression and improved clearance of FITC-albumin in A549 cells. Conversely, stabilization of ELAVL-1/HuR with the proteasome inhibitor MG-132 resulted in induction of GSK3 beta at mRNA and protein level and attenuated FITC-albumin clearance. Utilizing ventilator-induced lung injury or intra-tracheal installation of hydrochloric acid to induce ARDS in mice, we observed increased mRNA and protein expression of ELAVL-1/HuR and GSK3 beta. Together, our findings indicate a previously unknown interaction between GSK3 beta and ELAV-1 during ARDS, and suggest the inhibition of the ELAV-1- GSK3 beta pathways as a novel ARDS treatment approach.	[Hoffman, Olivia; Vohwinkel, Christine U.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Burns, Nana; Edwards, Michael G.; Vohwinkel, Christine U.] Univ Colorado, Cardio Vasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Div Pediat Crit Care,Dev Lung Biol,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Burns, Nana; Edwards, Michael G.; Vohwinkel, Christine U.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA; [Vadasz, Istvan] Justus Liebig Univ, Dept Internal Med, Univ Giessen & Marburg Lung Ctr, Giessen, Germany; [Vadasz, Istvan] German Ctr Lung Res, Giessen, Germany; [Eltzschig, Holger K.] Univ Colorado, Sch Med, Dept Anesthesiol, Organ Protect Program, Aurora, CO USA; [Hoffman, Olivia] Harvard Univ, Boston Childrens Hosp, Div Crit Med, Dept Anesthesiol, Boston, MA 02115 USA; [Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA; [Edwards, Michael G.] Bioinfo Solut, Parker, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Justus Liebig University Giessen; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Health Science Center Houston	Vohwinkel, CU (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Cardio Vasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Div Pediat Crit Care,Dev Lung Biol,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	Christine.vohwinkel@ucdenver.edu	Vadasz, Istvan/AAO-8288-2021	Vohwinkel, Christine/0000-0001-8959-157X; Vadasz, Istvan/0000-0003-1370-9783	Department of Pediatrics, University of Colorado School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	Department of Pediatrics, University of Colorado School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded through start-up funding given to CV by the Department of Pediatrics, University of Colorado School of Medicine.	Abdallah Claude, 2014, J Anaesthesiol Clin Pharmacol, V30, P7, DOI 10.4103/0970-9185.125685; Agrawal MS, 2009, INDIAN J UROL, V25, P474, DOI 10.4103/0970-1591.57917; BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589; Buchackert Y, 2012, J PHYSIOL-LONDON, V590, P5167, DOI 10.1113/jphysiol.2012.233403; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cerutti A, 2015, J AM COLL SURGEONS, V221, pS41, DOI 10.1016/j.jamcollsurg.2015.07.085; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Giaginis C, 2015, CLIN SIGNIFICANCE HU; Giaginis C, 2015, TUMOR BIOL, V36, P315, DOI 10.1007/s13277-014-2637-y; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hastings RH, 2004, AM J PHYSIOL-LUNG C, V286, pL679, DOI 10.1152/ajplung.00205.2003; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hoegl S, 2015, J IMMUNOL, V195, P1815, DOI 10.4049/jimmunol.1401957; Hudy MH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-88; Hummler SC, 2013, AM J RESP CELL MOL, V48, P578, DOI 10.1165/rcmb.2012-0383OC; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neumann P, 2013, PULM PHARMACOL THER, V26, P685, DOI 10.1016/j.pupt.2013.06.001; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sklepkiewicz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018883; Tanaka A, 2012, AM J RESP CELL MOL, V46, P507, DOI 10.1165/rcmb.2009-0415OC; Thangavel J, 2015, J CELL SCI, V128, P3094, DOI 10.1242/jcs.170258; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Wada A, 2009, FRONT BIOSCI-LANDMRK, V14, P1558, DOI 10.2741/3324; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; Wu T, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0247-8; Xing B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128068; Yogosawa S, 1999, BIOCHEM BIOPH RES CO, V266, P123, DOI 10.1006/bbrc.1999.1773; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172116	10.1371/journal.pone.0172116	http://dx.doi.org/10.1371/journal.pone.0172116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196122	gold, Green Published			2022-12-27	WOS:000394423900051
J	Babu, BK; Mathur, RK; Kumar, PN; Ramajayam, D; Ravichandran, G; Venu, MVB; Babu, SS				Babu, B. Kalyana; Mathur, R. K.; Kumar, P. Naveen; Ramajayam, D.; Ravichandran, G.; Venu, M. V. B.; Babu, S. Sparjan			Development, identification and validation of CAPS marker for SHELL trait which governs dura, pisifera and tenera fruit forms in oil palm (Elaeis guineensis Jacq.)	PLOS ONE			English	Article							OVULE DEVELOPMENT; LINKAGE MAP; CARPEL; LOCI; SNP	The oil palm fruit forms (dura, pisifera and tenera) governed by the shell thickness gene (Sh) plays a major role in identification of fruit type and also influences palm oil yield. Identification of desired fruit type is a major asset to the breeders and oil palm workers for applications in breeding, seed certification and to reduce time, space and money spent on identification of fruit form. In the present study, we developed Sh gene specific primer pairs and bulk segregant analysis was done using 300 genomic and 8 genic SSR markers. We identified one cleaved amplified polymorphic site (CAPS) marker for differentiation of oil palm fruit type which produced two alleles (280 and 250bp) in dura genotypes, three alleles in tenera genotypes (550, 280, and 250bp) and one allele in pisifera genotypes (550bp). The shell allele sequencing results showed that two SNPs were present, of which SNP2 contributed for variation of fruit forms. The nucleotide 'A' was present in only dura genotypes, where as 'T' was present only in pisifera genotypes, which in turn led to the change of amino acid lysine to aspargine. The identified CAPS marker was validated on 300 dura, 25 pisifera and 80 tenera genotypes, 80 dura/pisifera cross progenies and 60 lines of tenera/tenera cross progeny. Association mapping of marker data with phenotypic data of eight oil yield related traits resulted in identification of seven significant QTLs by GLM approach, four by MLM approach at a significant threshold (P) level of 0.001. Significant QTLs were identified for fruit to bunch and oil to bunch traits, which explained R2 of 12.9% and 11.5% respectively. The CAPS marker used in the present study facilitate selection and timely distribution of desirable high yielding tenera sprouts to the farmers instead of waiting for 4-5 years. This saves a lot of land, time and money which will be a major breakthrough to the oil palm community.	[Babu, B. Kalyana; Mathur, R. K.; Kumar, P. Naveen; Ramajayam, D.; Ravichandran, G.; Venu, M. V. B.; Babu, S. Sparjan] ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India; [Babu, S. Sparjan] KL Univ, Guntur, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oil Palm Research; Koneru Lakshmaiah Education Foundation (K L Deemed to be University)	Babu, BK (corresponding author), ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India.	kalyan_biotek@yahoo.co.in	Kumar, Naveen/GZK-9881-2022; Devarajan, Ramajayam/J-1236-2019; D, SAMUEL SPARJAN BABU/N-8120-2017	Kumar, Naveen/0000-0003-2529-8344; D, SAMUEL SPARJAN BABU/0000-0002-8158-1411	Department of Science and Technology (DST), New Delhi, India; DST	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	The authors thankful to Department of Science and Technology (DST), New Delhi, India for partial support of the project. The author MVB thankful to DST for providing fellowship.	Bakoume C, 2014, GENET RESOUR CROP EV, V62, P349; Basiron Y, 2000, ADV OIL PALM RES, V1, P1; Beirnaert A, 1941, CONGO BELGE SER SCI, V27, P1; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Corley R., 2003, OIL PALM; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; HARTLEY C, 1988, OIL PALM, P47; Jeennor S, 2014, TREE GENET GENOMES, V10, P1, DOI 10.1007/s11295-013-0655-3; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Rance KA, 2001, THEOR APPL GENET, V103, P1302, DOI 10.1007/s122-001-8204-z; Reyes Paola A., 2015, Agron. colomb., V33, P5, DOI 10.15446/agron.colomb.v33n1.47988; Ritter E, 2016, EUPHYTICA, V207, P367, DOI 10.1007/s10681-015-1553-6; Sathish D. K., 2007, Indian Journal of Biotechnology, V6, P354; Singh R, 2013, NATURE; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Ting NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-309; USDA, 2014, OILS WORLD MARK TRAD; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936	23	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171933	10.1371/journal.pone.0171933	http://dx.doi.org/10.1371/journal.pone.0171933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192462	gold, Green Submitted, Green Published			2022-12-27	WOS:000394423800053
J	Hohl, CM; Partovi, N; Ghement, I; Wickham, ME; McGrail, K; Reddekopp, LN; Sobolev, B				Hohl, Corinne M.; Partovi, Nilu; Ghement, Isabella; Wickham, Maeve E.; McGrail, Kimberlyn; Reddekopp, Lisa N.; Sobolev, Boris			Impact of early in-hospital medication review by clinical pharmacists on health services utilization	PLOS ONE			English	Review							ADVERSE DRUG EVENTS; RANDOMIZED-CONTROLLED-TRIAL; EMERGENCY-DEPARTMENT; ELDERLY-PATIENTS; RECOGNITION; PREVENTABILITY; INTERVENTION; INPATIENTS; CRITERIA; CARE	Background Adverse drug events are a leading cause of emergency department visits and unplanned admissions, and prolong hospital stays. Medication review interventions aim to identify adverse drug events and optimize medication use. Previous evaluations of in-hospital medication reviews have focused on interventions at discharge, with an unclear effect on health outcomes. We assessed the effect of early in-hospital pharmacist-led medication review on the health outcomes of high-risk patients. Methods We used a quasi-randomized design to evaluate a quality improvement project in three hospitals in British Columbia, Canada. We incorporated a clinical decision rule into emergency department triage pathways, allowing nurses to identify patients at high-risk for adverse drug events. After randomly selecting the first eligible patient for participation, clinical pharmacists systematically allocated subsequent high-risk patients to medication review or usual care. Medication review included obtaining a best possible medication history and reviewing the patient's medications for appropriateness and adverse drug events. The primary outcome was the number of days spent in-hospital over 30 days, and was ascertained using administrative data. We used median and inverse propensity score weighted logistic regression modeling to determine the effect of pharmacist-led medication review on downstream health services use. Results Of 10,807 high-risk patients, 6,416 received early pharmacist-led medication review and 4,391 usual care. Their baseline characteristics were balanced. The median number of hospital days was reduced by 0.48 days (95% confidence intervals [CI] = 0.00 to 0.96; p = 0.058) in the medication review group compared to usual care, representing an 8% reduction in the median length of stay. Among patients under 80 years of age, the median number of hospital days was reduced by 0.60 days (95% CI = 0.06 to 1.17; p = 0.03), representing 11% reduction in the median length of stay. There was no significant effect on emergency department revisits, admissions, readmissions, or mortality. Limitations We were limited by our inability to conduct a randomized controlled trial, but used quasi-random patient allocation methods and propensity score modeling to ensure balance between treatment groups, and administrative data to ensure blinded outcomes ascertainment. We were unable to account for alternate level of care days, and therefore, may have underestimated the treatment effect in frail elderly patients who are likely to remain in hospital while awaiting long-term care. Conclusions Early pharmacist-led medication review was associated with reduced hospital-bed utilization compared to usual care among high-risk patients under 80 years of age, but not among those who were older. The results of our evaluation suggest that medication review by pharmacists in the emergency department may impact the length of hospital stay in select patient populations.	[Hohl, Corinne M.; Wickham, Maeve E.; Sobolev, Boris] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Hohl, Corinne M.; Wickham, Maeve E.; Sobolev, Boris] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Hohl, Corinne M.] Vancouver Gen Hosp, Emergency Dept, Vancouver, BC, Canada; [Partovi, Nilu] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC, Canada; [Partovi, Nilu] Vancouver Gen Hosp, Clin Pharm Serv, Vancouver, BC, Canada; [Ghement, Isabella] Ghement Stat Consulting Co Ltd, Richmond, ON, Canada; [McGrail, Kimberlyn; Sobolev, Boris] Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Reddekopp, Lisa N.] Vancouver Coastal Hlth, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Hohl, CM (corresponding author), Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada.; Hohl, CM (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.; Hohl, CM (corresponding author), Vancouver Gen Hosp, Emergency Dept, Vancouver, BC, Canada.	chohl@mail.ubc.ca	Hohl, Corinne M/AAY-3325-2021	Hohl, Corinne M/0000-0002-9210-7838	British Columbia Ministry of Health; Vancouver Coastal Health; Canadian Institutes of Health Research; Ghement Statistical Consulting Company Ltd	British Columbia Ministry of Health; Vancouver Coastal Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ghement Statistical Consulting Company Ltd	The British Columbia Ministry of Health and Vancouver Coastal Health funded this quality improvement program. None of the sponsors had any role in the evaluation design, data collection or processing, statistical analysis or preparation of the manuscript. Dr. Hohl is supported by a New Investigator grant from the Canadian Institutes of Health Research. Isabella Ghement is affiliated to Ghement Statistical Consulting Company Ltd. Ghement Statistical Consulting Company Ltd provided support in the form of salary for author IG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bladh L, 2011, BMJ QUAL SAF, V20, P738, DOI 10.1136/bmjqs.2009.039693; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Christensen M, 2013, COCHRANE DB SYST REV, P2; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Dalleur O, 2014, DRUG AGING, V31, P291, DOI 10.1007/s40266-014-0157-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Farris KB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-406; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Hohl CM, 2005, ACAD EMERG MED, V12, P197, DOI 10.1197/j.aem.2004.08.056; Hohl CM, 2009, CJEM, V11, P274; Hohl CM, 2015, BRIT J CLIN PHARMACO, V80, P51, DOI 10.1111/bcp.12585; Hohl Corinne M, 2015, CMAJ Open, V3, pE103, DOI 10.9778/cmajo.20140010; Hohl CM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-473; Hohl CM, 2012, ACAD EMERG MED, V19, P640, DOI 10.1111/j.1553-2712.2012.01379.x; Hohl CM, 2011, ANN EMERG MED, V58, P270, DOI 10.1016/j.annemergmed.2011.01.003; Hohl CM, 2010, ANN EMERG MED, V55, P493, DOI 10.1016/j.annemergmed.2009.10.008; Klopotowska JE, 2013, EUR J CLIN PHARMACOL, V69, P75, DOI 10.1007/s00228-012-1316-4; Lisby M, 2015, J PATIENT SAF; Lisby M, 2010, BASIC CLIN PHARMACOL, V106, P422, DOI 10.1111/j.1742-7843.2009.00511.x; Makowsky Mark J, 2009, Med Care, V47, P642, DOI 10.1097/MLR.0b013e3181926032; Manos Daria, 2002, CJEM, V4, P16; PATEL H., 2007, BMC CLIN PHARM, V7, P1; Rodriguez-Monguio R, 2003, PHARMACOECONOMICS, V21, P623, DOI 10.2165/00019053-200321090-00002; Roulet L, 2014, J EMERG MED, V46, P857, DOI 10.1016/j.jemermed.2013.11.124; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scullin C, 2007, J EVAL CLIN PRACT, V13, P781, DOI 10.1111/j.1365-2753.2006.00753.x; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Tegeder I, 1999, BRIT J CLIN PHARMACO, V47, P557; World Health Organization, 2008, GLOB PRIOR RES PAT S; Zed PJ, 2008, CAN MED ASSOC J, V178, P1563, DOI 10.1503/cmaj.071594	35	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							0170495	10.1371/journal.pone.0170495	http://dx.doi.org/10.1371/journal.pone.0170495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192477	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800010
J	Tejada, CAO; Triaca, LM; da Costa, FK; Hellwig, F				Oviedo Tejada, Cesar Augusto; Triaca, Livia Madeira; da Costa, Flavia Katrein; Hellwig, Franciele			The sociodemographic, behavioral, reproductive, and health factors associated with fertility in Brazil	PLOS ONE			English	Article								High fertility rates among disadvantaged subgroups are a public health problem because fertility levels significantly affect socioeconomic conditions and a population's welfare. This paper aims to analyze the sociodemographic, behavioral, and reproductive factors associated with fertility rates among Brazilian women aged between 15-49 years. A Poisson regression was used to analyze data from the 2006 PNDS (Pesquisa Nacional de Demografia e Saude da Crianga e da Mulher), which evaluates socioeconomic, demographic, geographic, reproductive, behavioral, and chronic disease variables. The results show that the following characteristics are positively associated with an increase in the number of children born: being aged 20-24, residing in the North, being nonwhite, not being in paid employment, having lower education levels, having lower socioeconomic status, being in a stable union, having the first sexual intercourse before the age of 16 and having the first child before the age of 20. Thus, it is important to implement efficient family planning policies targeting these subgroups in order to improve life conditions, reduce inequalities and avoid the adverse outcomes of high fertility.	[Oviedo Tejada, Cesar Augusto; Triaca, Livia Madeira; da Costa, Flavia Katrein] Univ Fed Pelotas, Posgrad Program Econ, Pelotas, RS, Brazil; [Hellwig, Franciele] Univ Fed Pelotas, Posgrad Program Epidemiol, Pelotas, RS, Brazil; [Triaca, Livia Madeira] Pontificia Univ Catolica Rio Grande do Sul, Posgrad Program Econ, Porto Alegre, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Pontificia Universidade Catolica Do Rio Grande Do Sul	Triaca, LM (corresponding author), Univ Fed Pelotas, Posgrad Program Econ, Pelotas, RS, Brazil.; Triaca, LM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Posgrad Program Econ, Porto Alegre, RS, Brazil.	liviamtriaca@gmail.com	Tejada, Cesar Augusto Oviedo/AAN-9108-2020; Hellwig, Franciele/AAC-4924-2019; Triaca, Lívia/AAN-9118-2020	Hellwig, Franciele/0000-0002-2509-9866; Triaca, Livia/0000-0001-7192-6554				Alves JED, 2013, PROGRAMA BOLSA FAMIL, P502; Alves JED, 2008, TRANSICAO DEMOGRAFIC, P13; Angeles L, 2010, J POPUL ECON, V23, P99, DOI 10.1007/s00148-009-0255-6; [Anonymous], 2014, ENC DEM SAL FAM ENDE; Basu AM, 2002, WORLD DEV, V30, P1779, DOI 10.1016/S0305-750X(02)00072-4; BECKER GS, 1976, J POLIT ECON, V84, pS143, DOI 10.1086/260536; Berquo A E, 2004, ANAIS 14 ENCONTRO NA, P1; Berquo A E, 2008, PESQUISA NACL DEMOGR; Berquó Elza, 2006, Novos estud. CEBRAP, P11; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Casternile JB, 2010, DETERMINANTS CONSEQU; Chackiel Juan, 2004, Pap. poblac, V10, P9; Comision Economica para America Latina y el Caribe, 2008, FEC AM LAT DESC AC H; Coutinho Raquel Zanatta, 2015, Rev. bras. estud. popul., V32, P395, DOI 10.1590/S0102-30982015000000023; De Carvalho AA, 2016, REV LATINOAMERICANA; Duarte CM, 2006, REV PANAM SALUD PUBL, V19, P236, DOI 10.1590/S1020-49892006000400003; Ethiopian Society of Population Studies, 2008, LEV TRENDS DET LIF D; Gomes MMF, 2012, 18 ENC NAC EST POP, P1; Hashmi AR, 2013, SINGAP ECON REV, V58, DOI 10.1142/S0217590813500239; Klawon E, 2001, POPUL RES POLICY REV, V20, P423, DOI 10.1023/A:1013337201896; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Llerena F, 2007, DETERMINANTS FERTILI; LUNDQUIST J, 2014, DEMOGRAPHY STUDY HUM; Madalozzo R, 2012, PLOS ONE, P7; MARTIN TC, 1995, STUD FAMILY PLANN, V26, P187, DOI 10.2307/2137845; Mendes MF, 2006, EDUCACAO FECUNDIDADE, P23; Nelson JO, 2013, FERTILITY BOLSA FAMI; Oliveira Isabel Tiago de, 2008, Anál. Social, P29; Simões Patrícia, 2012, Rev. Bras. Econ., V66, P445, DOI 10.1590/S0034-71402012000400004; StataCorp, 2011, STAT STAT SOFTW REL; Testa MR., 2014, ADV LIFE COURSE RES; Tuman JP, 2007, GLOB HEAL GOV, V1, P1; Wang WR, 1997, J POPUL ECON, V10, P273, DOI 10.1007/s001480050043; Weinberger M. B., 1987, International Family Planning Perspectives, V13, P35, DOI 10.2307/2947826	34	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171888	10.1371/journal.pone.0171888	http://dx.doi.org/10.1371/journal.pone.0171888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9KV	28187167	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300057
J	Owada, G; Mihara, T; Inagawa, G; Asakura, A; Goto, T; Ka, K				Owada, Gen; Mihara, Takahiro; Inagawa, Gaku; Asakura, Ayako; Goto, Takahisa; Ka, Koui			A comparison of the Airtraq (R), McGrath (R), and Macintosh laryngoscopes for difficult paediatric intubation: A manikin study	PLOS ONE			English	Article							TRACHEAL INTUBATION; MANAGEMENT; PERSONNEL; TRIAL	Background The efficacy of devices for difficult intubation in paediatric patients, especially with a Cormack-Lehane grade 4 view, has yet to be established. We compared intubating parameters among three devices (the Airtraq (R), McGrath (R), and Macintosh laryngoscopes). Methods This study is a randomised cross-over trial. Participants were 20 anaesthetists. Each device was tested three times using a paediatric manikin with a Cormack-Lehane grade 4 view. The order to use each device was randomised by a computer-generated random sequence. The primary endpoint was the rate of successful intubation. Secondary endpoints included the time taken to intubate, percentage of glottic opening score, and severity of potential dental trauma. Results The successful intubation rates of the Airtraq (R), McGrath (R), and Macintosh laryngoscopes were 100%, 72%, and 45%, respectively. The risk ratio of the success rates of Airtraq (R) compared with McGrath (R) and Macintosh laryngoscopes were 1.40 (95% CI; 1.19-1.64, P < 0.001) and 2.22 (95% CI; 1.68-2.94, P < 0.001), respectively. The modified Cormack-Lehane grade and percentage of the glottic opening score were better for the Airtraq (R) than for the other devices. The dental trauma score was lower for the Airtraq (R) than for the other devices. There were no significant differences in the intubation time among the groups. Conclusions The Airtraq (R) had higher success rate, had better visibility, and was associated with less dental trauma than the other devices in a difficult paediatric intubation model with a Cormack-Lehane grade 4 view.	[Owada, Gen; Mihara, Takahiro; Ka, Koui] Kanagawa Childrens Med Ctr, Dept Anaesthesiol, Yokohama, Kanagawa, Japan; [Mihara, Takahiro; Asakura, Ayako; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anaesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan; [Inagawa, Gaku] Yokohama Municipal Citizens Hosp, Dept Anaesthesiol, Yokohama, Kanagawa, Japan	Yokohama City University	Mihara, T (corresponding author), Kanagawa Childrens Med Ctr, Dept Anaesthesiol, Yokohama, Kanagawa, Japan.; Mihara, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Anaesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan.	miharaxxxtotoro@yahoo.co.jp	Mihara, Takahiro/AAH-8487-2020	Mihara, Takahiro/0000-0003-0613-511X				Burdett E, 2011, BRIT J ANAESTH, V107, P983, DOI 10.1093/bja/aer295; Isada Tetsuro, 2005, Japanese Journal of Anesthesiology, V54, P490; Komiya K, 2009, ANAESTHESIA, V64, P425, DOI 10.1111/j.1365-2044.2008.05795.x; Levitan RM, 1998, ACAD EMERG MED, V5, P919, DOI 10.1111/j.1553-2712.1998.tb02823.x; Liu LJ, 2010, ANESTH ANALG, V110, P1049, DOI 10.1213/ANE.0b013e3181d2aad7; Maharaj CH, 2008, ANAESTHESIA, V63, P182, DOI 10.1111/j.1365-2044.2007.05316.x; Maharaj CH, 2006, ANAESTHESIA, V61, P1093, DOI 10.1111/j.1365-2044.2006.04819.x; Maharaj CH, 2006, ANAESTHESIA, V61, P671, DOI 10.1111/j.1365-2044.2006.04653.x; Maharaj CH, 2006, ANAESTHESIA, V61, P469, DOI 10.1111/j.1365-2044.2006.04547.x; Nishinarita R, 2015, J ANESTH, V29, P450, DOI 10.1007/s00540-014-1955-y; Petrini F, 2005, Minerva Anestesiol, V71, P617; Ray DC, 2009, ANAESTHESIA, V64, P1207, DOI 10.1111/j.1365-2044.2009.06061.x; Savoldelli GL, 2008, ANAESTHESIA, V63, P1358, DOI 10.1111/j.1365-2044.2008.05653.x; Savoldelli GL, 2009, EUR J ANAESTH, V26, P554, DOI 10.1097/EJA.0b013e3283269ff4; Schebesta K, 2012, ANESTHESIOLOGY, V116, P1204, DOI 10.1097/ALN.0b013e318254cf41; Vlatten A, 2012, J PEDIATR INTENSIVE, V1, P71, DOI 10.3233/PIC-2012-013; Xue FS, 2011, J CLIN ANESTH, V23, P667, DOI 10.1016/j.jclinane.2010.12.027; Yentis SM, 1998, ANAESTHESIA, V53, P1041, DOI 10.1046/j.1365-2044.1998.00605.x	18	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171889	10.1371/journal.pone.0171889	http://dx.doi.org/10.1371/journal.pone.0171889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187213	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300058
J	Tunc-Ozdemir, M; Jones, AM				Tunc-Ozdemir, Meral; Jones, Alan M.			Ligand-induced dynamics of heterotrimeric G protein-coupled receptor-like kinase complexes	PLOS ONE			English	Article							NADPH OXIDASE RBOHD; ALPHA-SUBUNIT; BETA-SUBUNIT; ARABIDOPSIS; MEMBRANE; PHOSPHORYLATION; MECHANISMS; RESISTANCE; TRANSIENT; INTERACT	Background Arabidopsis, 7-transmembrane Regulator of G signaling protein 1 (AtRGS1) modulates canonical G protein signaling by promoting the inactive state of heterotrimeric G protein complex on the plasma membrane. It is known that plant leucine-rich repeat receptor like kinases (LRR RLKs) phosphorylate AtRGS1 in vitro but little is known about the in vivo interaction, molecular dynamics, or the cellular consequences of this interaction. Methods Therefore, a subset of the known RLKs that phosphorylate AtRGS1 were selected for elucidation, namely, BAK1, BIR1, FLS2. Several microscopies for both static and dynamic protein -protein interactions were used to follow in vivo interactions between the RLKs and AtRGS1 after the presentation of the Pathogen-associated Molecular Pattern, Flagellin 22 (FIg22). These microscopies included Forster Resonance Energy Transfer, Bimolecular Fluoresence Complementation, and Cross Number and Brightness Fluorescence Correlation Spectroscopy. In addition, reactive oxygen species and calcium changes in living cells were quantitated using luminometry and R-GECO1 microscopy. Results The LRR RLKs BAK1 and BIR1, interact with AtRGS1 at the plasma membrane. The RLK ligand f1g22 sets BAK1 in motion toward AtRGS1 and BIR1 away, both returning to the baseline orientations by 10 minutes. The C-terminal tail of AtRGS1 is important for the interaction with BAK1 and for the tempo of the AtRGS1/BIR1 dynamics. This window of time corresponds to the f1g22-induced transient production of reactive oxygen species and calcium release which are both attenuated in the rgs1 and the bak1 null mutants. Conclusions A temporal model of these interactions is proposed. flg22 binding induces nearly instantaneous dimerization between FLS2 and BAK1. Phosphorylated BAK1 interacts with and enables AtRGS1 to move away from BIR1 and AtRGS1 becomes phosphorylated leading to its endocytosis thus leading to de-repression by permitting AtGPA1 to exchange GDP for GTP. Finally, the G protein complex becomes dissociated thus AGB1 interacts with its effector proteins leading to changes in reactive oxygen species and calcium.	[Tunc-Ozdemir, Meral; Jones, Alan M.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Jones, Alan M.] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jones, AM (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Jones, AM (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27514 USA.	alan_jones@unc.edu			NIGMS [R01GM065989]; NSF [MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-05er15671]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the NIGMS (R01GM065989) and NSF (MCB-0718202) to AMJ and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through the grant DE-FG02-05er15671 to AMJ.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Booker F, 2012, PLANT CELL ENVIRON, V35, P668, DOI 10.1111/j.1365-3040.2011.02443.x; Chakravorty D, 2015, PLANT PHYSIOL; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen YN, 2012, PLANT J, V69, P266, DOI 10.1111/j.1365-313X.2011.04788.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Choudhury SR, 2015, PLANT CELL, V27, P3260, DOI 10.1105/tpc.15.00517; Chung EH, 2014, CELL HOST MICROBE, V16, P484, DOI 10.1016/j.chom.2014.09.004; Clark NM, 2016, ELIFE, P5; Colaneri AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-129; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Drechsel G, 2011, J EXP BOT, V62, P775, DOI 10.1093/jxb/erq313; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Ishida T, 2014, EMBO REP, V15, P1202, DOI 10.15252/embr.201438660; Ishikawa A, 2009, BIOSCI BIOTECH BIOCH, V73, P47, DOI 10.1271/bbb.80449; Jiang K, 2012, PLANT PHYSIOL, V159, P975, DOI 10.1104/pp.112.196337; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Keinath NF, 2015, MOL PLANT, V8, P1188, DOI 10.1016/j.molp.2015.05.006; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Liang X, 2016, ELIFE, P5; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lorek J, 2013, MOL PLANT MICROBE IN, V26, P991, DOI 10.1094/MPMI-03-13-0077-R; Maruta N, 2015, PLANT PHYSIOL, V167, P1004, DOI 10.1104/pp.114.255703; Aranda-Sicilia MN, 2015, J PLANT PHYSIOL, V188, P44, DOI 10.1016/j.jplph.2015.09.005; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Serna L, 2005, NEW PHYTOL, V165, P947, DOI 10.1111/j.1469-8137.2004.01278.x; Shamloul M, 2014, JOVE-J VIS EXP, DOI 10.3791/51204; Spallek T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004035; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Torres MA, 2013, MOL PLANT MICROBE IN; Tunc-Ozdemir M, 2016, METHODS MOL BIOL; Tunc-Ozdemir M, 2016, J BIOL CHEM; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Xu DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116385; Yu TY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005933; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; 이상협, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P8, DOI 10.7746/jkros.2013.8.1.008	52	30	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171854	10.1371/journal.pone.0171854	http://dx.doi.org/10.1371/journal.pone.0171854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187200	gold, Green Published, Green Submitted			2022-12-27	WOS:000394244300052
J	Zagatto, AM; Miyagi, WE; Sousa, FAD; Gobatto, CA				Zagatto, Alessandro Moura; Miyagi, Willian Eiji; de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre			Relationship between anaerobic capacity estimated using a single effort and 30-s tethered running outcomes	PLOS ONE			English	Article							ACCUMULATED OXYGEN DEFICIT; TABLE-TENNIS; SPRINT TEST; POWER; MAOD; ENERGETICS; RELIABILITY; METABOLISM; EXHAUSTION; TIME	The purpose of the current study was to investigate the relationship between alternative anaerobic capacity method (MAOD(ALT)) and a 30-s all-out tethered running test. Fourteen male recreational endurance runners underwent a graded exercise test, a supramaximal exhaustive effort and a 30-s all-out test on different days, interspaced by 48h. After verification of data normality (Shapiro-Wilk test), the Pearson's correlation test was used to verify the association between the anaerobic estimates from the MAOD(ALT) and the 30-s all-out tethered running outputs. Absolute MAOD(ALT) was correlated with mean power (r = 0.58; P = 0.03), total work (r = 0.57; P = 0.03), and mean force (r = 0.79; P = 0.001). In addition, energy from the glycolytic pathway (E[La-]) was correlated with mean power (r = 0.58; P = 0.03). Significant correlations were also found at each 5s interval between absolute MAOD(ALT) and force values (r between 0.75 and 0.84), and between force values and E[La-] (r between 0.73 to 0.80). In conclusion, the associations between absolute MAOD(ALT) and the mechanical outputs from the 30-s all-out tethered running test evidenced the importance of the anaerobic capacity for maintaining force during the course of time in short efforts.	[Zagatto, Alessandro Moura; Miyagi, Willian Eiji] Sao Paulo State Univ Unesp, Sch Sci, Lab Physiol & Sports Performance LAFIDE, Bauru, SP, Brazil; [Zagatto, Alessandro Moura; Miyagi, Willian Eiji] Sao Paulo State Univ Unesp, Postgrad Program Movement Sci, Rio Claro, SP, Brazil; [de Barros Sousa, Filipe Antonio; Gobatto, Claudio Alexandre] Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Campinas	Zagatto, AM (corresponding author), Sao Paulo State Univ Unesp, Sch Sci, Lab Physiol & Sports Performance LAFIDE, Bauru, SP, Brazil.; Zagatto, AM (corresponding author), Sao Paulo State Univ Unesp, Postgrad Program Movement Sci, Rio Claro, SP, Brazil.	azagatto@yahoo.com.br	Sousa, Filipe A B/H-2444-2017; Gobatto, Claudio A/E-7388-2014; Zagatto, Alessandro M/F-9969-2012; Gobatto, Claudio/O-7257-2015	Zagatto, Alessandro M/0000-0003-1065-4158; Sousa, Filipe Antonio/0000-0001-8252-725X; Gobatto, Claudio/0000-0002-1441-7582	FAPESP [2013/129408]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by a grant from FAPESP process numbers 2013/129408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade VL, 2015, INT J SPORTS MED, V36, P1156, DOI 10.1055/s-0035-1555935; Astorino TA, 2011, J SPORT MED PHYS FIT, V51, P11; Bangsbo J, 1996, Can J Appl Physiol, V21, P350; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bertuzzi R, 2015, BRAZ J MED BIOL RES, V48, P261, DOI [10.1590/1414-431X20144043, 10.1590/1414-431x20144043]; Bertuzzi RCM, 2010, INT J SPORTS MED, V31, P477, DOI 10.1055/s-0030-1253375; Billat VL, 1999, EUR J APPL PHYSIOL O, V80, P159, DOI 10.1007/s004210050573; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; De Poli RDB, 2016, INT J SPORT NUTR EXE, V26, P549, DOI 10.1123/ijsnem.2016-0038; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheetham M E, 1985, Br J Sports Med, V19, P81; di Prampero P E, 1981, Rev Physiol Biochem Pharmacol, V89, P143; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fitzsimons M., 1993, AUST J SCI MED SPORT, V25, P82; Gama MCT, 2016, INT J SPORT IN PRESS; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lima MCS, 2011, INT J SPORTS MED, V32, P529, DOI 10.1055/s-0031-1273689; Mangine GT, 2014, J STRENGTH COND RES, V28, P1812, DOI 10.1519/JSC.0000000000000316; Margaria R, 1933, AM J PHYSIOL, V106, P689, DOI 10.1152/ajplegacy.1933.106.3.689; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; Milioni F, 2017, INT J SPORT IN PRESS; Milioni F, 2016, APPL PHYSIOL NUTR ME, V41, P498, DOI 10.1139/apnm-2015-0435; Minahan C, 2007, INT J SPORTS MED, V28, P836, DOI 10.1055/s-2007-964976; Morin JB, 2010, J BIOMECH, V43, P1970, DOI 10.1016/j.jbiomech.2010.03.012; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Noordhof DA, 2010, SPORTS MED, V40, P285, DOI 10.2165/11530390-000000000-00000; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; Padulo Johnny, 2014, Muscles Ligaments Tendons J, V4, P159; Papoti M, 2017, SCI REPORTS; Pereira VH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10489; Brisola GMP, 2015, APPL PHYSIOL NUTR ME, V40, P931, DOI 10.1139/apnm-2015-0036; Rowntree D, 2000, STAT TEARS INTRO NON; SCOTT CB, 1991, MED SCI SPORT EXER, V23, P618; Sousa FAB, 2015, MED SCI SPORT EXER, V47, P12, DOI 10.1249/01.mss.0000476425.05454.de; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; VANDEWALLE H, 1985, EUR J APPL PHYSIOL, V54, P222, DOI 10.1007/BF02335934; Zagatto A, 2011, SCAND J MED SCI SPOR, V21, pE222, DOI 10.1111/j.1600-0838.2010.01258.x; Zagatto AM, 2016, INT J SPORTS MED, V37, P700, DOI 10.1055/s-0042-104413; Zagatto AM, 2012, INT J SPORTS MED, V33, P613, DOI 10.1055/s-0032-1304648; Zagatto A. M., 2017, J SPORTS SC IN PRESS; Zagatto AM, 2009, J STRENGTH COND RES, V23, P1820, DOI 10.1519/JSC.0b013e3181b3df32; Zagatto AM, 2016, INT J SPORT PHYSIOL, V11, P1012, DOI 10.1123/ijspp.2015-0746; Zemkova E., 2004, KINESIOLOGY, V36, P165	46	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0172032	10.1371/journal.pone.0172032	http://dx.doi.org/10.1371/journal.pone.0172032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182775	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800145
J	Kim, SH; Shin, DW; Yun, JM; Lee, JE; Lim, JS; Cho, BL; Kwon, HM; Park, JH				Kim, Sang Hyuck; Shin, Dong Wook; Yun, Jae Moon; Lee, Ji Eun; Lim, Jae-Sung; Cho, Be Long; Kwon, Hyung-Min; Park, Jin-Ho			Kidney dysfunction and cerebral microbleeds in neurologically healthy adults	PLOS ONE			English	Article							SMALL VESSEL DISEASE; INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; RENAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; STROKE; ASSOCIATIONS; GUIDELINES; PREDICTOR	Introduction Cerebral microbleed (CMB) is a potent risk factor for overt cerebrovascular disease. Although some studies indicated the possible role of renal dysfunction as a risk factor of CMB, the findings could not be generalized. This study aimed to investigate the association between renal dysfunction and cerebral microbleed (CMB) in neurologically healthy adults. Materials and methods A total of 2,518 subjects who underwent brain MRI as part of health screening were involved in the study. CMBs were defined as well-demarcated focal areas of low signal intensity with associated blooming on the T2-weighted MRI measuring less than 5 mm in diameter. The glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease formula. Kidney function was classified as normal (>90), mild (60 to 89.9), moderate (30 to 59.9), and severe (<30 mL/min/1.73 m(2)) renal dysfunction according to the GFR. Results The mean age of the participants was 57.5 +/- 8.3 years (ranged 40 to 79), and 1,367 subjects (54.3%) were male. The mean GFR level was 81.5 +/- 15.5, and the prevalence of CMB was 4.1% (n = 103). Subjects with CMB demonstrated a higher proportion of moderate-to-severe renal dysfunction than those without CMB (15.5% vs. 5.0%, p < 0.001). In the multivariate logistic regression analysis, moderate-to-severe renal dysfunction showed a significant association with CMB (adjusted odd ratio = 2.63; p = 0.008). Furthermore, a decrease in the GFR level was associated with an increasing trend of the presence of CMB (p for trend = 0.031) and number of CMB lesions (p for trend = 0.003). Conclusions Renal dysfunction was significantly associated with the presence of CMB in neurologically healthy adults. More studies are needed to evaluate if treatment of kidney disease and risk factor modification may prevent further progress of CMB.	[Kim, Sang Hyuck; Shin, Dong Wook; Yun, Jae Moon; Lee, Ji Eun; Cho, Be Long; Park, Jin-Ho] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lim, Jae-Sung] Hallym Univ, Dept Neurol, Sacred Heart Hosp, Anyang, South Korea; [Kwon, Hyung-Min] Seoul Natl Univ, Dept Neurol, Seoul Municipal Govt Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU)	Park, JH (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea.; Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul Municipal Govt Boramae Med Ctr, Seoul, South Korea.	hmkwon@snu.ac.kr; kkolzzi0@gmail.com	Lim, Jae-Sung/D-5555-2012; Cho, Belong/GLU-3443-2022	Lim, Jae-Sung/0000-0001-6157-2908; Cho, Belong/0000-0001-9558-689X; Kim, Sang Hyuck/0000-0002-4851-396X; Kwon, Hyung-Min/0000-0002-6101-7127	Hanmi Pharmaceutical Company [06-2015-0810]	Hanmi Pharmaceutical Company	This study was supported in part by Hanmi Pharmaceutical Company (Grant No. 06-2015-0810, www.hanmi.co.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoudad S, 2015, CIRCULATION, V132, P509, DOI 10.1161/CIRCULATIONAHA.115.016261; Akoudad S, 2015, INT J STROKE, V10, P603, DOI 10.1111/ijs.12465; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Charidimou A, 2014, INT J STROKE, V9, P457, DOI 10.1111/ijs.12280; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Darweesh SKL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000359; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregg NM, 2015, JAMA NEUROL, V72, P1021, DOI 10.1001/jamaneurol.2015.1359; Hanyu H, 2003, J NEUROL, V250, P1496, DOI 10.1007/s00415-003-0245-7; Horstmann S, 2015, EUR J NEUROL, V22, P1355, DOI 10.1111/ene.12608; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Kim BJ, 2015, J STROKE, V17, P101, DOI 10.5853/jos.2015.17.2.101; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kim CK, 2012, J NEUROL SCI, V319, P56, DOI 10.1016/j.jns.2012.05.017; Kim SG, 2007, J CLIN ONCOL, V25, P5267, DOI 10.1200/JCO.2007.11.9651; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Kwon HM, 2016, CEREBROVASC DIS, V42, P90, DOI 10.1159/000445300; Laible M, 2015, J NEUROL, V262, P2312, DOI 10.1007/s00415-015-7840-2; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lim JS, 2015, JAMA NEUROL, V72, P301, DOI 10.1001/jamaneurol.2014.3958; Luchsinger JA, 2009, NEUROLOGY, V73, P450, DOI 10.1212/WNL.0b013e3181b1636a; Naganuma T, 2015, STROKE, V46, P2107, DOI 10.1161/STROKEAHA.115.009324; Naka H, 2013, J STROKE CEREBROVASC, V22, P834, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.001; Nakata Y, 2002, ANN NY ACAD SCI, V977, P169, DOI 10.1111/j.1749-6632.2002.tb04813.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Saji N, 2015, J STROKE CEREBROVASC, V24, P2572, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.010; Shima H, 2009, NEPHROL DIAL TRANSPL, V25, P1554; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31, DOI 10.1007/s002340100649; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Vernooij MW, 2012, INT J STROKE, V7, P565, DOI 10.1111/j.1747-4949.2012.00886.x; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172210	10.1371/journal.pone.0172210	http://dx.doi.org/10.1371/journal.pone.0172210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207801	gold, Green Submitted, Green Published			2022-12-27	WOS:000394424500099
J	Klotz, P; Gottig, S; Leidner, U; Semmler, T; Scheufen, S; Ewers, C				Klotz, Peter; Goettig, Stephan; Leidner, Ursula; Semmler, Torsten; Scheufen, Sandra; Ewers, Christa			Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PSEUDOMONAS-AERUGINOSA; GALLERIA-MELLONELLA; ESCHERICHIA-COLI; GENOME SEQUENCE; BAUMANNII; IDENTIFICATION; EMERGENCE; STRAIN; RADIORESISTENS	The objective of this study was to characterize bla(OXA-23) harbouring Acinetobacter indicus-like strains from cattle including genomic and phylogenetic analyses, antimicrobial susceptibility testing and evaluation of pathogenicity in vitro and in vivo. Nasal and rectal swabs (n = 45) from cattle in Germany were screened for carbapenem-non-susceptible Acinetobacter spp. Thereby, two carbapenem resistant Acinetobacter spp. from the nasal cavities of two calves could be isolated. MALDI-TOF mass spectrometry and 16S rDNA sequencing identified these isolates as A. indicus-like. A phylogenetic tree based on partial rpoB sequences indicated closest relation of the two bovine isolates to the A. indicus type strain A648(T) and human clinical A. indicus isolates, while whole genome comparison revealed considerable intraspecies diversity. High mimimum inhibitory concentrations were observed for carbapenems and other antibiotics including fluoroquinolones and gentamicin. Whole genome sequencing and PCR mapping revealed that both isolates harboured bla(OXA-23) localized on the chromosome and surrounded by interrupted Tn2008 transposon structures. Since the pathogenic potential of A. indicus is unknown, pathogenicity was assessed employing the Galleria (G.) mellonella infection model and an in vitro cytotoxicity assay using A549 human lung epithelial cells. Pathogenicity in vivo (G. mellonella killing assay) and in vitro (cytotoxicity assay) of the two A. indicus-like isolates was lower compared to A. baumannii ATCC 17978 and similar to A. lwoffii ATCC 15309. The reduced pathogenicity of A. indicus compared to A. baumannii correlated with the absence of important virulence genes encoding like phospholipase C1+C2, acinetobactin outer membrane protein BauA, RND-type efflux system proteins AdeRS and AdeAB or the trimeric autotransporter adhesin Ata. The emergence of carbapenem-resistant A. indicus-like strains from cattle carrying bla(OXA-23) on transposable elements and revealing genetic relatedness to isolates from human clinical sources requires further investigations regarding the pathogenic potential, genomic characteristics, zoonotic risk and putative additional sources of this new Acinetobacter species.	[Klotz, Peter; Leidner, Ursula; Scheufen, Sandra; Ewers, Christa] Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany; [Goettig, Stephan] Hosp Johann Wolfgang von Goethe Univ, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Semmler, Torsten] Robert Koch Inst, Berlin, Germany	Justus Liebig University Giessen; Robert Koch Institute	Ewers, C (corresponding author), Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany.	christa.ewers@vetmed.uni-giessen.de	Ewers, Christa/AAL-9186-2020; Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Ewers, Christa/0000-0001-6167-1340	Engemann Family Foundation; German Research Foundation [DFG FOR 2251]	Engemann Family Foundation; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Engemann Family Foundation providing a grant to P.K. and by the German Research Foundation (DFG FOR 2251 Adaption and Persistence of the Emerging Pathogen Acinetobacter baumannii) to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; Al Bayssari C, 2015, J ANTIMICROB CHEMOTH, V70, P950, DOI 10.1093/jac/dku469; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bonnin RA, 2014, INT J ANTIMICROB AG, V44, P345, DOI 10.1016/j.ijantimicag.2014.05.022; CLSI, 2016, M100 PERF STAND ANT, V26; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Ewers C, 2017, INT J ANTIMICROB AG, V49, P37, DOI 10.1016/j.ijantimicag.2016.09.033; Ewers C, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0119-z; Fiester SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167068; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Gruber TM, 2015, J ANTIMICROB CHEMOTH, V70, P1026, DOI 10.1093/jac/dku482; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P2682, DOI 10.1093/jac/dkt233; Heindorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101033; Higgins PG, 2013, J ANTIMICROB CHEMOTH, V68, P720, DOI 10.1093/jac/dks446; Higgins PG, 2010, J CLIN MICROBIOL, V48, P4592, DOI 10.1128/JCM.01765-10; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krizova L, 2015, INT J SYST EVOL MICR, V65, P3905, DOI 10.1099/ijsem.0.000511; Liu D, 2016, VET MICROBIOL, V186, P126, DOI 10.1016/j.vetmic.2016.02.018; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; Malhotra J, 2012, INT J SYST EVOL MICR, V62, P2883, DOI 10.1099/ijs.0.037721-0; Malhotra J, 2012, J BACTERIOL, V194, P5156, DOI 10.1128/JB.01194-12; Marra A, 2012, ANTIMICROB AGENTS CH, V56, P4671, DOI 10.1128/AAC.00276-12; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nguyen VH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-329; Nigro SJ, 2016, J ANTIMICROBIAL CHEM; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Pomba C, 2014, ANTIMICROB AGENTS CH, V58, P1267, DOI 10.1128/AAC.02527-13; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Repizo GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138265; Richmond GE, 2016, MBIO, V7, DOI 10.1128/mBio.00430-16; Schumann G, 2002, CLIN CHEM LAB MED, V40, P643, DOI 10.1515/CCLM.2002.111; Segal H, 2007, ANTIMICROB AGENTS CH, V51, P3040, DOI 10.1128/AAC.00594-07; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tipton KA, 2016, MICROBIOLOGYOPEN; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wang XH, 2011, DIAGN MICR INFEC DIS, V69, P218, DOI 10.1016/j.diagmicrobio.2010.10.018; Weidensdorfer M, 2016, INFECT IMMUN, V84, P711, DOI 10.1128/IAI.01502-15; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171986	10.1371/journal.pone.0171986	http://dx.doi.org/10.1371/journal.pone.0171986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207789	Green Published, gold			2022-12-27	WOS:000394424500067
J	Phillips, DR; Clark, KD				Phillips, Dennis R.; Clark, Kevin D.			Bombyx mori and Aedes aegypti form multi-functional immune complexes that integrate pattern recognition, melanization, coagulants, and hemocyte recruitment	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; PROPHENOLOXIDASE PROPO ACTIVATION; DOPACHROME CONVERSION ENZYME; LECTIN-DOMAIN PROTEINS; MANDUCA-SEXTA; APOLIPOPHORIN-III; SERINE PROTEASES; FOREIGN TARGETS; SURFACE CHARACTERISTICS; INSECT APOLIPOPROTEIN	The innate immune system of insects responds to wounding and pathogens by mobilizing multiple pathways that provide both systemic and localized protection. Key localized responses in hemolymph include melanization, coagulation, and hemocyte encapsulation, which synergistically seal wounds and envelop and destroy pathogens. To be effective, these pathways require a targeted deposition of their components to provide protection without compromising the host. Extensive research has identified a large number of the effectors that comprise these responses, but questions remain regarding their post-translational processing, function, and targeting. Here, we used mass spectrometry to demonstrate the integration of pathogen recognition proteins, coagulants, and melanization components into stable, high-mass, multi-functional Immune Complexes (ICs) in Bombyx mori and Aedes aegypti. Essential proteins common to both include phenoloxidases, apolipophorins, serine protease homologs, and a serine protease that promotes hemocyte recruitment through cytokine activation. Pattern recognition proteins included C-type Lectins in B. mori, while A. aegypti contained a protein homologous to Plasmodium-resistant LRIM1 from Anopheles gambiae. We also found that the B. mori IC is stabilized by extensive transglutaminase-catalyzed cross-linking of multiple components. The melanization inhibitor Egf1.0, from the parasitoid wasp Microplitis demolitor, blocked inclusion of specific components into the IC and also inhibited transglutaminase activity. Our results show how coagulants, melanization components, and hemocytes can be recruited to a wound surface or pathogen, provide insight into the mechanism by which a parasitoid evades this immune response, and suggest that insects as diverse as Lepidoptera and Diptera utilize similar defensive mechanisms.	[Phillips, Dennis R.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Clark, Kevin D.] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Clark, KD (corresponding author), Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA.	kclark@uga.edu	Clark, Kevin/GQA-9811-2022	Clark, Kevin/0000-0002-7392-2730	National Science Foundation [IOS-1121006]	National Science Foundation(National Science Foundation (NSF))	Support was generously provided by a grant from the National Science Foundation (IOS-1121006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agianian B, 2007, DEV COMP IMMUNOL, V31, P879, DOI 10.1016/j.dci.2006.12.006; Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001; BARWIG B, 1985, J COMP PHYSIOL B, V155, P135, DOI 10.1007/BF00685206; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Beresford PJ, 1997, DEV COMP IMMUNOL, V21, P253, DOI 10.1016/S0145-305X(97)00011-6; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bryant WB, 2016, DEV COMP IMMUNOL, V55, P119, DOI 10.1016/j.dci.2015.10.020; Cerenius L, 2013, J EXP BIOL, V216, P4313, DOI 10.1242/jeb.085191; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chang HJ, 2012, DEV COMP IMMUNOL, V36, P274, DOI 10.1016/j.dci.2011.04.009; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; Clark KD, 2015, INSECT BIOCHEM MOLEC, V58, P66, DOI 10.1016/j.ibmb.2015.01.002; Clark KD, 2013, J BIOL CHEM, V288, P14476, DOI 10.1074/jbc.M113.459222; Clark KD, 2010, INSECT BIOCHEM MOLEC, V40, P460, DOI 10.1016/j.ibmb.2010.04.005; COLE KD, 1987, J BIOL CHEM, V262, P11794; Dettloff M, 2001, CELL TISSUE RES, V306, P449, DOI 10.1007/s00441-001-0468-9; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Gold KS, 2015, SEMIN IMMUNOL, V27, P357, DOI 10.1016/j.smim.2016.03.010; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Gorman MJ, 1998, J INSECT PHYSIOL, V44, P947, DOI 10.1016/S0022-1910(98)00056-0; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; He Y, 2016, MOL CELL PROTEOMICS, V15, P1176, DOI 10.1074/mcp.M115.054296; Huang CY, 2005, INSECT MOL BIOL, V14, P675, DOI 10.1111/j.1365-2583.2005.00597.x; Iatrou K, 2005, J BIOTECHNOL, V120, P237, DOI 10.1016/j.jbiotec.2005.06.037; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; Jiang H, 1999, INSECT MOL BIOL, V8, P39, DOI 10.1046/j.1365-2583.1999.810039.x; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Kamareddine L, 2016, J INNATE IMMUN, V8, P314, DOI 10.1159/000443883; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanaya T, 2000, J GEN VIROL, V81, P1135, DOI 10.1099/0022-1317-81-4-1135; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; Lavine MD, 2001, J INSECT PHYSIOL, V47, P965, DOI 10.1016/S0022-1910(01)00071-3; Lesch C, 2007, DEV COMP IMMUNOL, V31, P1255, DOI 10.1016/j.dci.2007.03.012; Lombardo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003145; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Matsumoto H, 2012, INSECT BIOCHEM MOLEC, V42, P446, DOI 10.1016/j.ibmb.2012.03.001; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Pech LL, 1996, J CELL SCI, V109, P2053; Pinto SB, 2009, P NATL ACAD SCI USA, V106, P21270, DOI 10.1073/pnas.0909463106; Poopathi S, 2014, APPL BIOCHEM BIOTECH, V172, P2299, DOI 10.1007/s12010-013-0681-5; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Rao XJ, 2015, DEV COMP IMMUNOL, V53, P328, DOI 10.1016/j.dci.2015.07.005; Rao XJ, 2015, INSECT BIOCHEM MOLEC, V62, P75, DOI 10.1016/j.ibmb.2014.12.006; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Shi XF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev057; Sideri M, 2008, IMMUNOLOGY, V123, P528, DOI 10.1111/j.1365-2567.2007.02722.x; Sigle LT, 2016, DEV COMP IMMUNOL, V55, P90, DOI 10.1016/j.dci.2015.10.018; Soliman DE, 2016, J MED ENTOMOL, V53, P262, DOI 10.1093/jme/tjv245; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Sun Q, 2007, INSECT SCI, V14, P5, DOI 10.1111/j.1744-7919.2007.00121.x; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Ujita M, 2002, BIOSCI BIOTECH BIOCH, V66, P2264, DOI 10.1271/bbb.66.2264; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wiesner A, 1997, J INSECT PHYSIOL, V43, P383, DOI 10.1016/S0022-1910(96)00113-8; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118911; Yang F, 2016, INSECT BIOCHEM MOLEC, V76, P1, DOI 10.1016/j.ibmb.2016.06.009; Yokoyama H, 2013, J LIPID RES, V54, P2379, DOI 10.1194/jlr.M037093; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zdybicka-Barabas A, 2013, BBA-BIOMEMBRANES, V1828, P1449, DOI 10.1016/j.bbamem.2013.02.004; Zhang Y, 2012, FUNCT INTEGR GENOMIC, V12, P705, DOI 10.1007/s10142-012-0281-4; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	100	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171447	10.1371/journal.pone.0171447	http://dx.doi.org/10.1371/journal.pone.0171447			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199361	Green Published, Green Submitted, gold			2022-12-27	WOS:000394424400030
J	Zhang, R; Dong, S; Ma, WW; Cai, XP; Le, ZY; Xiao, R; Zhou, Q; Yu, HL				Zhang, Ran; Dong, Shan; Ma, Wei-wei; Cai, Xue-ping; Le, Zhi-yin; Xiao, Rong; Zhou, Qi; Yu, Huan-ling			Modulation of cholesterol transport by maternal hypercholesterolemia in human full term placenta	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GESTATIONAL DIABETES-MELLITUS; PLASMA-CHOLESTEROL; TROPHOBLAST CELLS; LIPID-METABOLISM; PREGNANT-WOMEN; SR-BI; EXPRESSION; RECEPTOR; FETUS	The significance of maternal cholesterol transporting to the fetus under normal as well as pathological circumstances is less understood. The objective of this study was to observe the effects of maternal hypercholesterolemia on placental cholesterol transportation. Human full-time placenta, maternal and venous cord blood were sampled at delivery from the pregnant women with serum total cholesterol (TC) concentrations at third trimester higher than 7.25 mM (n = 19) and the pregnant women with normal TC concentrations (n = 19). Serum lipids and expression of genes related to cholesterol transportation were measured by western blot or real-time PCR. The results indicated that serum TC, high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) levels were significantly increased, in pregnancies, but decreased in cord blood in hypercholesterolemic group compared to the matched control group. All the subjects were no-drinking, nonsmoker, and gestational disease free. The mRNA expression of lipoprotein receptors, including LDLR and VLDLR were significantly increased, while the protein expression of PCSK9 was significantly increased in hypercholesterolemic placenta. In conclusion, maternal hypercholesterolemia might decrease the transportation of cholesterol from mother to fetus because of the high levels of PCSK9 protein expression.	[Zhang, Ran; Dong, Shan; Ma, Wei-wei; Cai, Xue-ping; Le, Zhi-yin; Xiao, Rong; Yu, Huan-ling] Capital Med Univ, Beijing Key Lab Environm Toxicol, Sch Publ Hlth, Beijing, Peoples R China; [Zhou, Qi] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Xiao, R; Yu, HL (corresponding author), Capital Med Univ, Beijing Key Lab Environm Toxicol, Sch Publ Hlth, Beijing, Peoples R China.; Zhou, Q (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China.	xiaor22@ccmu.edu.cn; lk602@sina.com; yuhlzjl@ccmu.edu.cn			National Natural Science Foundation of China [81273070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81273070) HLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035027; Aye ILMH, 2010, BBA-MOL CELL BIOL L, V1801, P1013, DOI 10.1016/j.bbalip.2010.05.015; Baardman ME, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102442; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; Busso D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/280497; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Daoud G, 2005, BBA-MOL CELL BIOL L, V1687, P181, DOI 10.1016/j.bbalip.2004.11.017; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dube E, 2007, BIOL REPROD, V76, P1034, DOI 10.1095/biolreprod.106.059246; Dube E, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105619; Ethier-Chiasson M, 2007, BIOCHEM BIOPH RES CO, V359, P8, DOI 10.1016/j.bbrc.2007.05.002; FURUHASHI M, 1989, MOL ENDOCRINOL, V3, P1252, DOI 10.1210/mend-3-8-1252; Grozdanov PN, 2013, BIOCH CELL BIOL, V84, P80; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Jan MR, 2012, HYPERTENS PREGNANCY, V31, P292, DOI 10.3109/10641955.2010.507843; Jurevics HA, 1997, J LIPID RES, V38, P723; Kushtagi P, 2009, INT J GYNECOL OBSTET, V106, P258, DOI 10.1016/j.ijgo.2009.03.004; Leiva A, 2015, PLACENTA, V36, P895, DOI 10.1016/j.placenta.2015.05.012; Liguori A, 2007, BJOG-INT J OBSTET GY, V114, P1547, DOI 10.1111/j.1471-0528.2007.01510.x; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Marseille-Tremblay C, 2008, MOL REPROD DEV, V75, P1054, DOI 10.1002/mrd.20842; MAZURKIEWICZ JC, 1994, J CLIN PATHOL, V47, P728, DOI 10.1136/jcp.47.8.728; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Narverud I, 2013, THROMB RES, V131, P178, DOI 10.1016/j.thromres.2012.11.008; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; PIECHOTA W, 1992, EUR J OBSTET GYN R B, V45, P27, DOI 10.1016/0028-2243(92)90190-A; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Tabatabaei Mozhgan, 2011, J Prenat Med, V5, P35; Vuorio AF, 2002, J LAB CLIN MED, V140, P35, DOI 10.1067/mlc.2002.125214; Wadsack C, 2003, PLACENTA, V24, P131, DOI 10.1053/plac.2002.0912; WITTMAACK FM, 1995, ENDOCRINOLOGY, V136, P340, DOI 10.1210/en.136.1.340; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Yoshida S, 2005, J LIPID RES, V46, P2168, DOI 10.1194/jlr.M500096-JLR200	39	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171934	10.1371/journal.pone.0171934	http://dx.doi.org/10.1371/journal.pone.0171934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199412	gold, Green Published, Green Submitted			2022-12-27	WOS:000394424400059
J	Tian, JS; Hu, L				Tian, Jiansheng; Hu, Li			Anchorage performance of a high-pressure pre-tightening resin anchor with a compressed grouting body	PLOS ONE			English	Article							SUPPORT DESIGN; ROADWAY; TECHNOLOGY; STRESS; ROCK; DEEP	Supports for deep mine roadways located in soft surrounding rock face several problems: difficulty in applying pre-tightening force, low bearing capacity, and poor initial support. To solve these problems, this study proposes a high-pressure pre-tightening resin anchor with a compressed grouting body for use in soft and fractured rock surrounding a deep roadway. Using model experiments, we analyzed the anchorage performance of the proposed anchor and a conventional tensile-type anchor for three different values of the elastic modulus of the surrounding rock. The results showed that regardless of the surrounding rock type, the peak micro-strain (642-541) and displacement (6.09-6.5 mm) at the pull-out end of the proposed anchor were always smaller than the peak micro-strain (1433-1105) and displacement (8.77-9.2 mm) at the pull-out end of the conventional anchor. Furthermore, as the anchor's pre-tightening force increased from 20 kN to 120 kN, the anchor's strain remained concentrated over a length of 0.4 m from the bearing end. Compared with conventional tensile-type anchors, the proposed high-pressure pre-tightening resin anchor with a compressed grouting body has a higher ultimate bearing capacity, allows the grouting length to be decreased to 0.4 m, and provides initial support resistance.	[Tian, Jiansheng] China Univ Min & Technol, Sch Mech & Civil Engn, Xuzhou, Peoples R China; [Hu, Li] PowerChina Roadbridge Grp Co Ltd, Beijing, Peoples R China	China University of Mining & Technology	Hu, L (corresponding author), PowerChina Roadbridge Grp Co Ltd, Beijing, Peoples R China.	hulichi@yeah.net						Guo ZB, 2012, INT J MIN SCI TECHNO, V22, P665, DOI 10.1016/j.ijmst.2012.08.012; Huang Y.G., 2014, ELECTRON J GEOTECH E, V19, P6319; Kang H., 2014, INT J COAL SCI TECHN, V1, P261, DOI 10.1007/s40789-014-0043-0; Kang H. P., 2011, COAL MINING TECHNOLO, V16, P25; Kang HP., 2013, J MIN STRATA CONTROL, V18, P1, DOI [10.13532/j.cnki.cn11-3677/td.2013.03.004, DOI 10.13532/J.CNKI.CN11-3677/TD.2013.03.004]; Li H, 2013, APPL MECH MATER, V353-356, P1675, DOI 10.4028/www.scientific.net/AMM.353-356.1675; Li SC, 2016, J CENT SOUTH UNIV, V23, P440, DOI 10.1007/s11771-016-3089-x; Liu Q.S., 2014, J MIN SAF ENG, V31, P333; Meng Q, 2016, INT J MIN SCI TECHNO; Meng QB, 2015, INT J MIN SCI TECHNO, V25, P113, DOI 10.1016/j.ijmst.2014.11.010; Pengfei J, 2016, PHYS NUMERICAL SIMUL, V22, P55; Xie SR, 2015, INT J MIN SCI TECHNO, V25, P429, DOI 10.1016/j.ijmst.2015.03.016; Yan H, 2015, J CENT SOUTH UNIV, V22, P4385, DOI 10.1007/s11771-015-2987-7; Yang RS., 2014, COAL SCI TECHNOL, V42, P1; Yang XJ, 2013, INT J MIN SCI TECHNO, V23, P307, DOI 10.1016/j.ijmst.2013.04.002; Zhang K, 2015, ROCK MECH ROCK ENG, V48, P333, DOI 10.1007/s00603-014-0546-4	16	4	4	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171653	10.1371/journal.pone.0171653	http://dx.doi.org/10.1371/journal.pone.0171653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196084	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900027
J	Veto, B; Bojcsuk, D; Bacquet, C; Kiss, J; Sipeki, S; Martin, L; Buday, L; Balint, BL; Aranyi, T				Veto, Borbala; Bojcsuk, Dora; Bacquet, Caroline; Kiss, Judit; Sipeki, Szabolcs; Martin, Ludovic; Buday, Laszlo; Balint, Balint L.; Aranyi, Tamas			The transcriptional activity of hepatocyte nuclear factor 4 alpha is inhibited via phosphorylation by ERK1/2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FARNESOID X RECEPTOR; FACTOR 4-ALPHA; GENE-EXPRESSION; BINDING DOMAIN; FACTOR-4-ALPHA PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; PSEUDOXANTHOMA ELASTICUM; LIGAND-BINDING; TARGET GENES	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) nuclear receptor is a master regulator of hepatocyte development, nutrient transport and metabolism. HNF4 alpha is regulated both at the transcriptional and post-transcriptional levels by different mechanisms. Several kinases (PKA, PKC, AMPK) were shown to phosphorylate and decrease the activity of HNF4 alpha. Activation of the ERK1/2 signalling pathway, inducing proliferation and survival, inhibits the expression of HNF4a. However, based on our previous results we hypothesized that HNF4 alpha is also regulated at the post-transcriptional level by ERK1/2. Here we show that ERK1/2 is capable of directly phosphorylating HNF4 alpha in vitro at several phosphorylation sites including residues previously shown to be targeted by other kinases, as well. Furthermore, we also demonstrate that phosphorylation of HNF4 alpha leads to a reduced trans-activational capacity of the nuclear receptor in luciferase reporter gene assay. We confirm the functional relevance of these findings by demonstrating with ChIP-qPCR experiments that 30-minute activation of ERK1/2 leads to reduced chromatin binding of HNF4 alpha. Accordingly, we have observed decreasing but not disappearing binding of HNF4 alpha to the target genes. In addition, 24-hour activation of the pathway further decreased HNF4 alpha chromatin binding to specific loci in ChIP-qPCR experiments, which confirms the previous reports on the decreased expression of the HNF4 alpha gene due to ERK1/2 activation. Our data suggest that the ERK1/2 pathway plays an important role in the regulation of HNF4 alpha-dependent hepatic gene expression.	[Veto, Borbala; Bacquet, Caroline; Kiss, Judit; Buday, Laszlo; Aranyi, Tamas] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Veto, Borbala] Semmelweis Univ, Doctoral Sch Mol Med, Budapest, Hungary; [Bojcsuk, Dora; Balint, Balint L.] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Martin, Ludovic; Aranyi, Tamas] Univ Angers, CNRS UMR 6214, INSERM U1083, Angers, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; University of Debrecen; Semmelweis University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Aranyi, T (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	aranyi.tamas@ttk.mta.hu	Aranyi, Tamas/AAJ-9629-2021	Aranyi, Tamas/0000-0002-2087-6275; Balint, Balint/0000-0002-6163-7190; Bojcsuk, Dora/0000-0001-5091-7237; , Caroline/0000-0002-1954-1806	MedinProt Program of the Hungarian Academy of Sciences; Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project"; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund) [K100638, K104227, NN 110115]	MedinProt Program of the Hungarian Academy of Sciences; Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project"; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The work was supported by grants from the MedinProt Program of the Hungarian Academy of Sciences (LB and TA). BLB is a Szodoray Fellow of the University of Debrecen, Medical Faculty, in which his research was funded by an Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project". This work was also supported by the Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund) through grants K100638, K104227, and NN 110115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarenstrup L, 2002, CELL BIOL INT, V26, P615, DOI 10.1006/cbir.2002.0896; Aranyi Tamas, 2013, Frontiers in Genetics, V4, P27, DOI 10.3389/fgene.2013.00027; Barta E., 2011, EMBNET J, V17; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Caron S, 2013, MOL CELL BIOL, V33, P2202, DOI 10.1128/MCB.01004-12; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Drewes T, 1996, MOL CELL BIOL, V16, P925; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2007, J BIOCHEM, V141, P635, DOI 10.1093/jb/mvm066; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Illes A, 2006, CELL SIGNAL, V18, P830, DOI 10.1016/j.cellsig.2005.07.012; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lin CY, 2016, ONCOTARGET, V7, P11067, DOI 10.18632/oncotarget.7093; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Malik S, 2003, FRONT BIOSCI, V8, pD360, DOI 10.2741/1005; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratajewski M, 2012, J INVEST DERMATOL, V132, P2709, DOI 10.1038/jid.2012.218; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Song YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13409; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Varadi A, 2011, CURR DRUG TARGETS, V12, P671, DOI 10.2174/138945011795378612; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang ZY, 2011, BIOCHEMISTRY-US, V50, P5292, DOI 10.1021/bi200540w; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu ZM, 2007, J BIOL CHEM, V282, P24607, DOI 10.1074/jbc.M611481200; Xue TC, 2014, ONCOL REP, V32, P2387, DOI 10.3892/or.2014.3501; Yokoyama A, 2011, BIOCHEM BIOPH RES CO, V410, P749, DOI 10.1016/j.bbrc.2011.06.033	57	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172020	10.1371/journal.pone.0172020	http://dx.doi.org/10.1371/journal.pone.0172020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196117	Green Published, gold, Green Accepted			2022-12-27	WOS:000394423900044
J	Welsch, C; Efinger, M; von Wagner, M; Herrmann, E; Zeuzem, S; Welzel, TM; Lange, CM				Welsch, Christoph; Efinger, Mira; von Wagner, Michael; Herrmann, Eva; Zeuzem, Stefan; Welzel, Tania M.; Lange, Christian M.			Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response	PLOS ONE			English	Article							AMINOTRANSFERASE LEVELS; FIBROSIS PROGRESSION; STEATOSIS; CIRRHOSIS; CURE	Background Novel direct-acting antiviral DAA combination therapies tremendously improved sustained virologic response (SVR) rates in patients with chronic HCV infection. SVR is typically accompanied by normalization of liver enzymes, however, hepatic inflammation, i. e. persistently elevated aminotransferase levels may persist despite HCV eradication. Aim: To investigate prevalence and risk factors for ongoing hepatic inflammation after SVR in two large patient cohorts. Methods This post-hoc analysis was based on prospectively collected demographic and clinical data from 834 patients with SVR after HCV treatment with either PegIFN-or DAA-based treatment regimens from the PRAMA trial (n = 341) or patients treated at our outpatient clinic (n = 493). Results We observed an unexpected high prevalence of post-SVR inflammation, including patients who received novel IFN-free DAA-based therapies. Up to 10% of patients had ongoing elevation of aminotransferase levels and another 25% showed aminotransferase activity above the so-called healthy range. Several baseline factors were independently associated with post-SVR aminotransferase elevation. Among those, particularly male gender, advanced liver disease and markers for liver steatosis were strongly predictive for persistent ALT elevation. The use of IFN-based antiviral treatment was independently correlated with postSVR inflammation, further supporting the overall benefit of IFN-free combination regimens. Conclusion This is the first comprehensive study on a large patient cohort investigating the prevalence and risk factors for ongoing liver inflammation after eradication of HCV. Our data show a high proportion of patients with ongoing hepatic inflammation despite HCV eradication with potential implications for the management of approximately one third of all patients upon SVR.	[Welsch, Christoph; Efinger, Mira; von Wagner, Michael; Zeuzem, Stefan; Welzel, Tania M.; Lange, Christian M.] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ, Inst Biostat & Math Modelling, Fac Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Welsch, C (corresponding author), JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	christoph.welsch@kgu.de	Welsch, Christoph/AAF-6785-2020; Zeuzem, Stefan/AAE-7435-2019	Welsch, Christoph/0000-0002-1823-4863; 	research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP; Deutsche Forschungsgemeinschaft [WE4388/6-1, LA2806/2-1]	research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, and the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP). Grant support from the Deutsche Forschungsgemeinschaft is acknowledged for C. W. (WE4388/6-1) and C. M. L. (LA2806/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascione Antonio, 2007, Dig Liver Dis, V39 Suppl 1, pS4, DOI 10.1016/S1590-8658(07)80003-X; Bataller R, 2012, P NATL ACAD SCI USA, V109, P14293, DOI 10.1073/pnas.1212048109; Bugianesi E, 2004, DIGEST LIVER DIS, V36, P165, DOI 10.1016/j.dld.2003.12.008; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; Farci P, 2012, P NATL ACAD SCI USA, V109, P14562, DOI 10.1073/pnas.1210592109; Gentile I, 2015, EXPERT OPIN DRUG SAF, V14, P1631, DOI 10.1517/14740338.2015.1084287; Hill AM, 2014, HEPATOLOGY, V60, p218A; Innes HA, 2015, HEPATOLOGY, V62, P355, DOI 10.1002/hep.27766; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lonardo A, 2006, J VIRAL HEPATITIS, V13, P73, DOI 10.1111/j.1365-2893.2005.00669.x; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Schlevogt B, 2016, J HEPATOL, V64, pS750, DOI 10.1016/S0168-8278(16)01461-6; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	21	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171755	10.1371/journal.pone.0171755	http://dx.doi.org/10.1371/journal.pone.0171755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196130	Green Submitted, Green Published, gold			2022-12-27	WOS:000394423900031
J	Zhai, HH; Shi, YQ; Chen, X; Wang, J; Lu, YY; Zhang, FM; Liu, ZX; Lei, T; Fan, DM				Zhai, Huihong; Shi, Yongquan; Chen, Xiong; Wang, Jun; Lu, Yuanyuan; Zhang, Faming; Liu, Zhengxiong; Lei, Ting; Fan, Daiming			CacyBP/SIP promotes the proliferation of colon cancer cells	PLOS ONE			English	Article							CALCYCLIN-BINDING-PROTEIN; TUMOR PROMOTER; GASTRIN; TRANSLOCATION; DEGRADATION; PROTEOLYSIS; P27(KIP1); PATHWAY; GROWTH; MECHANISMS	CacyBP/SIP is a component of the ubiquitin pathway and is overexpressed in several transformed tumor tissues, including colon cancer, which is one of the most common cancers worldwide. It is unknown whether CacyBP/SIP promotes the proliferation of colon cancer cells. This study examined the expression level, subcellular localization, and binding activity of CacyBP/SIP in human colon cancer cells in the presence and absence of the hormone gastrin. We found that CacyBP/SIP was expressed in a high percentage of colon cancer cells, but not in normal colonic surface epithelium. CacyBP/SIP promoted the cell proliferation of colon cancer cells under both basal and gastrin stimulated conditions as shown by knockdown studies. Gastrin stimulation triggered the translocation of CacyBP/SIP to the nucleus, and enhanced interaction between CacyBP/SIP and SKP1, a key component of ubiquitination pathway which further mediated the proteasome-dependent degradation of p27(kip1) protein. The gastrin induced reduction in p27(kip1) was prevented when cells were treated with the proteasome inhibitor MG132. These results suggest that CacyBP/SIP may be promoting growth of colon cancer cells by enhancing ubiquitin-mediated degradation of p27(kip1).	[Zhai, Huihong; Shi, Yongquan; Chen, Xiong; Wang, Jun; Lu, Yuanyuan; Zhang, Faming; Liu, Zhengxiong; Lei, Ting; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Zhai, Huihong] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China	Air Force Military Medical University; Capital Medical University	Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China.	daimingfan@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020	Zhai, Hui-Hong/0000-0002-8452-6311	National Natural Science Foundation of China [30860321]; National Key Technologies RD Program [2015BAI13B09]; Science Foundation of Ningxia [NZ0897]; Research Fund of Ningxia Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Science Foundation of Ningxia; Research Fund of Ningxia Medical University	This work was funded by the National Natural Science Foundation of China (No. 30860321), National Key Technologies R&D Program (No.2015BAI13B09), the Science Foundation of Ningxia (NZ0897) and the Research Fund of Ningxia Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BERTRAND V, 1994, INT J CANCER, V56, P427, DOI 10.1002/ijc.2910560324; Birt DF, 2014, TOXICOL PATHOL, V42, P182, DOI 10.1177/0192623313506791; Calvert PM, 2002, ANN INTERN MED, V137, P603, DOI 10.7326/0003-4819-137-7-200210010-00012; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Fan DN, 2008, SHIJIE HUAREN XIAOHU, V16, P3953, DOI [10.3969/j.issn.1009-3079.2008.35.005, DOI 10.3969/J.ISSN.1009-3079.2008.35.005]; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Garcia-Ibarbia C, 2013, GENE, V532, P165, DOI 10.1016/j.gene.2013.09.080; GRANA X, 1995, ONCOGENE, V11, P211; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kilanczyk E, 2015, J NEUROSCI RES, V93, P75, DOI 10.1002/jnr.23466; Liu DF, 1999, J CLIN LAB ANAL, V13, P291, DOI 10.1002/(SICI)1098-2825(1999)13:6<291::AID-JCLA7>3.0.CO;2-K; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; SEVA C, 1994, REGUL PEPTIDES, V52, P31, DOI 10.1016/0167-0115(94)90018-3; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Singh SP, 1998, CANCER RES, V58, P1730; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Thorburn CM, 1998, GASTROENTEROLOGY, V115, P275, DOI 10.1016/S0016-5085(98)70193-3; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wan ES, 2015, MOL REPROD DEV, V82, P377, DOI 10.1002/mrd.22483; WATSON SA, 1989, INT J CANCER, V43, P692, DOI 10.1002/ijc.2910430425; Watson SA, 2001, CANCER RES, V61, P625; Wu J, 2003, J BIOCHEM MOL BIOL, V36, P354; Xie FL, 2012, SHANDONG YIXUE ZAZHI, V52, P1, DOI [10.3969/j.issn.1002-266X.2012.23.001, DOI 10.3969/J.ISSN.1002-266X.2012.23.001]; [谢福利 Xie Fuli], 2012, [基础医学与临床, Basic & Clinical Medicine], V32, P1312; [谢福利 Xie Fuli], 2012, [重庆医学, Chongqing Medicine], V41, P3020; Yew PR, 2001, J CELL PHYSIOL, V187, P1, DOI 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O; Zhai H-H., 2014, WORLD CHINESE J DIGE, V22, P1328; Zhai HH, 2006, HYBRIDOMA, V25, P91, DOI 10.1089/hyb.2006.25.91; Zhai HH, 2014, WORLD J GASTROENTERO, V20, P10062, DOI 10.3748/wjg.v20.i29.10062; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0169959	10.1371/journal.pone.0169959	http://dx.doi.org/10.1371/journal.pone.0169959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196083	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423900003
J	Gianotti, N; Cozzi-Lepri, A; Antinori, A; Castagna, A; De Luca, A; Celesia, BM; Galli, M; Mussini, C; Pinnetti, C; Spagnuolo, V; Monforte, AD; Ceccherini-Silberstein, F; Andreoni, M				Gianotti, Nicola; Cozzi-Lepri, Alessandro; Antinori, Andrea; Castagna, Antonella; De Luca, Andrea; Celesia, Benedetto Maurizio; Galli, Massimo; Mussini, Cristina; Pinnetti, Carmela; Spagnuolo, Vincenzo; Monforte, Antonella d'Arminio; Ceccherini-Silberstein, Francesca; Andreoni, Massimo		Lcono Fdn Study & Mono PI r	Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients	PLOS ONE			English	Article							PROTEASE INHIBITOR MONOTHERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; EFFECTIVE ANTIRETROVIRAL THERAPY; LOPINAVIR-RITONAVIR MONOTHERAPY; GLOMERULAR-FILTRATION-RATE; MYOCARDIAL-INFARCTION; MONET TRIAL; INCOMPLETE REVERSIBILITY; HIV-1-INFECTED PATIENTS; COHORT COLLABORATION	Objective The primary objective of this study was to estimate the incidence of treatment failure (TF) to protease inhibitor monotherapies (Pl/r-MT) with lopinavir/ritonavir (LPV/r) or darunavir/ritonavir (DRV/r). Design A multicenter cohort of HIV-infected patients with viral load (VL) <50 copies/mL, who underwent a switch from any triple combination therapy to Pl/r-MT with either LPV/r or DRV/r. Methods VL was assessed in each center according to local procedures. Residual viremia was defined by any HIV-RNA value detectable below 50 copies/mL by a Real-Time PCR method. Standard survival analysis was used to estimate the rate of TF (defined by virological failure or interruption of monotherapy or reintroduction of combination therapy). A multi variable Cox regression analysis with automatic stepwise procedures was used to identify factors independently associated with TF among nadir and baseline CD4+ counts, residual viremia, time spent with <50 HIV-RNA copies/mL before switch, history of virological failure, HCV co-infection, being on a Pl/r and hemoglobin concentrations at baseline. Results Six hundred ninety patients fulfilled the inclusion criteria and were included in this analysis. Their median follow-up was 20 (10-37) months. By month 36, TF occurred in 176 (30.2%; 95% Cl:25.9-34.5) patients. Only CD4+ nadir counts (adjusted hazard ratio [aHR] = 2.03 [95% CI: 1.35, 3.07] for counts <100 vs. >100 cells/pL) and residual viremia (aHR = 1.48 [95% CI: 1.01-2.17] vs. undetectable VL) were independently associated to TF. Conclusions Residual viremia and nadir CD4+ counts <100 cells/pL should be regarded as the main factors to be taken into account before considering switching to a Pl/r-MT.	[Gianotti, Nicola; Castagna, Antonella; Spagnuolo, Vincenzo] Hosp San Raffaele, Milan, Italy; [Cozzi-Lepri, Alessandro] UCL, London, England; [Antinori, Andrea; Pinnetti, Carmela] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Castagna, Antonella] Univ Vita Salute San Raffaele, Milan, Italy; [De Luca, Andrea] Univ Siena, Siena, Italy; [Celesia, Benedetto Maurizio] Univ Catania, Catania, Italy; [Galli, Massimo] Luigi Sacco Hosp, Milan, Italy; [Mussini, Cristina] Univ Modena, Modena, Italy; [Monforte, Antonella d'Arminio] San Paolo Hosp, Milan, Italy; [Ceccherini-Silberstein, Francesca; Andreoni, Massimo] Univ Roma Tor Vergata, Rome, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; IRCCS Lazzaro Spallanzani; Vita-Salute San Raffaele University; University of Siena; University of Catania; University of Milan; Luigi Sacco Hospital; Universita di Modena e Reggio Emilia; San Paolo-Polo Universitaria Hospital; University of Rome Tor Vergata	Gianotti, N (corresponding author), Hosp San Raffaele, Milan, Italy.	nicola.gianotti@hsr.it	Castagna, Antonella/K-3280-2018; Antinori, Andrea/K-7125-2016; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; Ceccherini-Silberstein, Francesca/K-4762-2016; Mussini, Cristina/K-8672-2016; De Luca, Andrea/G-8810-2011; celesia, benedetto maurizio/E-4562-2017; GALLI, MASSIMO/L-7282-2017	Castagna, Antonella/0000-0002-8338-9714; Antinori, Andrea/0000-0003-2121-4684; Mussini, Cristina/0000-0002-6615-4198; De Luca, Andrea/0000-0002-9561-9193; Spagnuolo, Vincenzo/0000-0002-9656-7217; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; celesia, benedetto maurizio/0000-0002-6919-1955; GALLI, MASSIMO/0000-0001-8887-6215; Segala, Daniela/0000-0001-6133-0386; Gianotti, Nicola/0000-0002-7182-5080	Abbvie; BMS; Gilead; Jannsen; MSD; ViiV, Italy	Abbvie(AbbVie); BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Jannsen; MSD; ViiV, Italy	ICONA Foundation is sponsored by unrestricted educational grants of Abbvie, BMS, Gilead, Jannsen, MSD, ViiV, Italy. The funders of the ICONA Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 20 CROI 2013; Antinori A, 2016, NEW MICROBIOL, V39, P93; Antinori A, 2015, AIDS, V29, P1811, DOI 10.1097/QAD.0000000000000778; Arribas JR, 2016, HIV MED, V17, P358, DOI 10.1111/hiv.12348; Arribas JR, 2012, HIV MED, V13, P398, DOI 10.1111/j.1468-1293.2012.00989.x; Arribas J, 2013, INT J STD AIDS, V24, P679, DOI 10.1177/0956462413486461; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Burgard M, 2009, AIDS, V23, P2165, DOI 10.1097/QAD.0b013e32833032d4; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Curran A, 2014, J ANTIMICROB CHEMOTH, V69, P1390, DOI 10.1093/jac/dkt517; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Geretti AM, 2013, HIV CLIN TRIALS, V14, P45, DOI [10.1410/hct1401-45, 10.1310/hct1401-45]; Gianotti N, 2015, CLIN MICROBIOL INFEC, V21; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Gutierrez-Valencia A, 2014, ANTIVIR THER, V19, P443, DOI 10.3851/IMP2722; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Jose S, 2014, J INFECT DIS, V210, P363, DOI 10.1093/infdis/jiu107; Kahlert C, 2016, INFECTION, V44, P329, DOI 10.1007/s15010-015-0866-7; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Monforte AD, 2014, ANTIVIR THER, V19, P319, DOI 10.3851/IMP2687; Parisi SG, 2012, J CLIN MICROBIOL, V50, P258, DOI 10.1128/JCM.06022-11; Parisi SG, 2015, CLIN MICROBIOL INFEC, P21; Paton NI, 2015, LANCET HIV, V2, pE417, DOI 10.1016/S2352-3018(15)00176-9; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Pulido F, 2012, AIDS REV, V14, P124; Pulido F, 2009, ANTIVIR THER, V14, P195; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sabin CA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0588-4; Santos JR, 2015, J ANTIMICROB CHEMOTH, V70, P1124, DOI 10.1093/jac/dku509; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Stohr W, 2016, AIDS, V30, P2617, DOI 10.1097/QAD.0000000000001206; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171611	10.1371/journal.pone.0171611	http://dx.doi.org/10.1371/journal.pone.0171611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192453	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800032
J	Keum, J; Nam, H				Keum, Jongsoo; Nam, Hojung			SELF-BLM: Prediction of drug-target interactions via self-training SVM	PLOS ONE			English	Article							WEB SERVER; MI-DRAGON; PROTEIN; INHIBITORS; IDENTIFICATION; INFORMATION; ALGORITHM; DATABASE; NETWORK; KERNELS	Predicting drug-target interactions is important for the development of novel drugs and the repositioning of drugs. To predict such interactions, there are a number of methods based on drug and target protein similarity. Although these methods, such as the bipartite local model (BLM), show promise, they often categorize unknown interactions as negative interaction. Therefore, these methods are not ideal for finding potential drug-target interactions that have not yet been validated as positive interactions. Thus, here we propose a method that integrates machine learning techniques, such as self-training support vector machine (SVM) and BLM, to develop a self-training bipartite local model (SELF-BLM) that facilitates the identification of potential interactions. The method first categorizes unlabeled interactions and negative interactions among unknown interactions using a clustering method. Then, using the BLM method and self-training SVM, the unlabeled interactions are self-trained and final local classification models are constructed. When applied to four classes of proteins that include enzymes, G-protein coupled receptors (GPCRs), ion channels, and nuclear receptors, SELF-BLM showed the best performance for predicting not only known interactions but also potential interactions in three protein classes compare to other related studies. The implemented software and supporting data are available at https://github.com/GIST-CSBL/SELF-BLM.	[Keum, Jongsoo; Nam, Hojung] Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, 123 Cheomdangwgi Ro, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Nam, H (corresponding author), Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, 123 Cheomdangwgi Ro, Gwangju, South Korea.	hjnam@gist.ac.kr	Nam, Hojung/AAR-4065-2020	Nam, Hojung/0000-0002-5109-9114	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2014M3A9C4066449]; National Research Foundation of Korea grant - the Korea government (MSIP) [NRF-2015R1C1A1A01051578]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea grant - the Korea government (MSIP)(National Research Foundation of Korea)	This work was supported by the Bio-Synergy Research Project (NRF-2014M3A9C4066449, http://nrf.re.kr/) of the Ministry of Science, ICT and Future Planning through the National Research Foundation, and supported by the National Research Foundation of Korea grant funded by the Korea government (MSIP) (NRF-2015R1C1A1A01051578, http://nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X, 2016, BRIEF BIOINFORM, V17, P696, DOI 10.1093/bib/bbv066; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Ding H, 2014, BRIEF BIOINFORM, V15, P734, DOI 10.1093/bib/bbt056; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gonzalez-Diaz H, 2011, J THEOR BIOL, V276, P229, DOI 10.1016/j.jtbi.2011.01.010; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nickel J, 2014, NUCLEIC ACIDS RES, V42, pW26, DOI 10.1093/nar/gku477; Perlman L, 2011, J COMPUT BIOL, V18, P133, DOI 10.1089/cmb.2010.0213; Prado-Prado F, 2012, CURR TOP MED CHEM, V12, P1843; Prado-Prado F, 2011, EUR J MED CHEM, V46, P5838, DOI 10.1016/j.ejmech.2011.09.045; Romero-Duran FJ, 2016, NEUROPHARMACOLOGY, V103, P270, DOI 10.1016/j.neuropharm.2015.12.019; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wang YC, 2016, BIOINFORMATICS, V32, P226, DOI 10.1093/bioinformatics/btv528; Wang YC, 2011, COMPUT BIOL CHEM, V35, P353, DOI 10.1016/j.compbiolchem.2011.10.003; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yoo M, 2015, BIOINFORMATICS, V31, P3069, DOI 10.1093/bioinformatics/btv313; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57	33	43	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171839	10.1371/journal.pone.0171839	http://dx.doi.org/10.1371/journal.pone.0171839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192537	gold, Green Published			2022-12-27	WOS:000394423800045
J	Lieder, B; Hoi, JK; Holik, AK; Geissler, K; Hans, J; Friedl, B; Liszt, K; Krammer, GE; Ley, JP; Somoza, V				Lieder, Barbara; Hoi, Julia Katharina; Holik, Ann-Katrin; Geissler, Katrin; Hans, Joachim; Friedl, Barbara; Liszt, Kathrin; Krammer, Gerhard E.; Ley, Jakob P.; Somoza, Veronika			The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells	PLOS ONE			English	Article							SUGAR ABSORPTION; SH-SY5Y CELLS; GLUT2; EXPRESSION; 5-HYDROXYTRYPTAMINE; MECHANISMS; TRANSPORT; RECEPTOR; PATHWAY	Flavanoids and related polyphenols, among them hesperitin, have been shown to modulate cellular glucose transport by targeting SGLT-1 and GLUT-2 transport proteins. We aimed to investigate whether homoeriodictyol, which is structurally related to hesperitin, affects glucose uptake in differentiated Caco-2 cells as a model for the intestinal barrier. The results revealed that, in contrast to other polyphenols, the flavanon homoeriodictyol promotes glucose uptake by 29.0 3.83% at a concentration of 100 pM. The glucose uptake stimulating effect was sensitive to phloridzin, but not to phloretin, indicating an involvement of the sodium-coupled glucose transporter SGLT-1, but not of sodium-independent glucose transporters (GLUT). In addition, in contrast to the increased extracellular serotonin levels by stimulation with 500 mM D-(+)-glucose, treatment with 100 pM homoeriodictyol decreased serotonin release by 48.8 7.57% in Caco-2 cells via a phloridzin-sensitive signaling pathway. Extracellular serotonin levels were also reduced by 57.1 5.43% after application of 0.01 pM homoeriodictyol to human neural SH-SY5Y cells. In conclusion, we demonstrate that homoeriodictyol affects both the glucose metabolism and the serotonin system in Caco-2 cells via a SGLT-1-meditated pathway. Furthermore, the results presented here support the usage of Caco-2 cells as a model for peripheral serotonin release. Further investigations may address the value of homoeriodictyol in the treatment of anorexia and malnutrition through the targeting of SGLT-1.	[Lieder, Barbara; Hoi, Julia Katharina; Friedl, Barbara; Liszt, Kathrin; Somoza, Veronika] Univ Vienna, Fac Chem, Christian Doppler Lab Bioact Aroma Cpds, Vienna, Austria; [Lieder, Barbara; Holik, Ann-Katrin; Somoza, Veronika] Univ Vienna, Fac Chem, Dept Nutr & Physiol Chem, Vienna, Austria; [Geissler, Katrin; Hans, Joachim; Krammer, Gerhard E.; Ley, Jakob P.] Symrise AG, Muhlenfeldstr 1, Holzminden, Germany	University of Vienna; University of Vienna; Symrise	Lieder, B (corresponding author), Univ Vienna, Fac Chem, Christian Doppler Lab Bioact Aroma Cpds, Vienna, Austria.; Lieder, B (corresponding author), Univ Vienna, Fac Chem, Dept Nutr & Physiol Chem, Vienna, Austria.	barbara.lieder@univie.ac.at	Somoza, Veronika/D-4141-2013	Somoza, Veronika/0000-0003-2456-9245; Hoi, Julia Katharina/0000-0003-3201-5365; Liszt, Kathrin/0000-0003-2507-0630; Lieder, Barbara/0000-0002-0527-8330	Austrian Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; Sym rise AG	Austrian Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; Sym rise AG	The financial support by the Austrian Federal Ministry of Economy, Family and Youth and the Austrian National Foundation for Research, Technology and Development and the Sym rise AG is gratefully acknowledged. KG contributed to the glucose uptake experiments, JH, JPL and GEK contributed to the study design and preparation of the manuscript.	Alzaid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078932; Doihara H, 2009, MOL CELL BIOCHEM, V331, P239, DOI 10.1007/s11010-009-0165-7; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Grefner N. M., 2010, Cell and Tissue Biology, V4, P354, DOI 10.1134/S1990519X10040085; Grefner N.M., 2012, CELL TISSUE BIOL, V6, P335, DOI [10.1134/S1990519X12040062., DOI 10.1134/S1990519X12040062]; Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563; Holik AK, 2013, FOOD FUNCT, V4, P1111, DOI 10.1039/c3fo60097a; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kim MS, 2001, GASTROENTEROLOGY, V121, P1400, DOI 10.1053/gast.2001.29567; Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; Riedel A, 2014, J NUTR BIOCHEM, V25, P750, DOI 10.1016/j.jnutbio.2014.03.002; Rohm B, 2015, FOOD FUNCT, V6, P173, DOI 10.1039/c4fo00435c; Rohm B, 2013, MOL NUTR FOOD RES, V57, P2008, DOI 10.1002/mnfr.201200846; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Yanai H, 2010, DIABETES METAB SYNDR, V3, P1; Yang Y, 2013, CELL BIOCHEM FUNCT, V31, P374, DOI 10.1002/cbf.2905; Young RL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00023; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010	26	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171580	10.1371/journal.pone.0171580	http://dx.doi.org/10.1371/journal.pone.0171580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192456	Green Published, gold, Green Submitted			2022-12-27	WOS:000394423800031
J	Miller, MA; Crane, BT				Miller, Mark Andrew; Crane, Benjamin Thomas			Roll vection in migraine and controls using inertial nulling and certainty estimate techniques	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; VISUAL-VESTIBULAR INTERACTIONS; ROOM TILT ILLUSION; OPTIC-FLOW; CORTICAL HYPEREXCITABILITY; ABSOLUTE IDENTIFICATION; MAGNITUDE ESTIMATION; VELOCITY STORAGE; CIRCULAR VECTION; VERTICAL AXIS	Vection is an illusory perception of self-motion that occurs when a visual motion is presented in the majority of the visual field. We used certainty estimate (CE) and inertial nulling (IN) techniques to study the effect of visual stimuli on roll perception in 10 migraine and 9 control subjects. A visual roll stimulus was presented for 1 to 8s. For the IN method, an inertial stimulus was delivered during the final 1s of the visual stimulus during which subjects judged the direction of perceived motion. The inertial motion was varied to find the point of subjective equality (PSE) at which both responses were equally likely to be reported. For the CE trials, the same durations of visual motion were used but without inertial motion and subjects rated their certainty of motion on a scale of 0 - 100. The overall difference in PSE between 1s and 8s subjects is significant (p = 0.03). Migraineurs had a ten fold larger effect in IN studies in the 8s than 1s (p = 0.01), but controls did not have a significant difference (p = 0.72). Unlike the control population, in migraineurs the perception of roll increased significantly with the duration of the visual stimulus. There was a large variation between subjects with both the CE and IN measures. The CE measure was poorly correlated with IN measures but demonstrated a similar trend with larger variation between subjects.	[Miller, Mark Andrew] Univ Rochester, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA.	Benjamin_Crane@urmc.rochester.edu		Crane, Benjamin/0000-0002-8327-1257	NIDCD [K23 DC011298, R01 DC013580]; Triological Career Scientist Award; University of Rochester School of Medicine Office of Medical Education Research Grant	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Career Scientist Award; University of Rochester School of Medicine Office of Medical Education Research Grant	This work was supported by NIDCD K23 DC011298, R01 DC013580, and a Triological Career Scientist Award (to Benjamin Crane), as well as a University of Rochester School of Medicine Office of Medical Education Research Grant (to Mark Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Arjona A, 2002, NEUROLOGIA, V17, P338; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Crane BT, 2014, JARO-J ASSOC RES OTO, V15, P87, DOI 10.1007/s10162-013-0423-y; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, EXP BRAIN RES, V223, P89, DOI 10.1007/s00221-012-3243-0; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; Dominguez JML, 2007, NEUROLOGIA, V22, P58; Drummond PD, 2005, HEADACHE, V45, P653, DOI 10.1111/j.1526-4610.2005.05132.x; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; GUEDRY FE, 1974, HDB SENSORY PHYSIO 2, V6, P3; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Haigh SM, 2012, CEPHALALGIA, V32, P236, DOI 10.1177/0333102411433301; HUANG J, 1981, EXP BRAIN RES, V41, P172; HUANG JK, 1988, AVIAT SPACE ENVIR MD, V59, P611; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; KENYON RV, 1993, IEEE T SYST MAN CYB, V23, P183, DOI 10.1109/21.214776; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; KRANTZ DH, 1972, J MATH PSYCHOL, V9, P168, DOI 10.1016/0022-2496(72)90025-9; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lewis RF, 2011, LARYNGOSCOPE, V121, P1124, DOI 10.1002/lary.21723; Matthews WJ, 2009, Q J EXP PSYCHOL, V62, P2014, DOI 10.1080/17470210802649285; McKendrick AM, 2006, CEPHALALGIA, V26, P1131, DOI 10.1111/j.1468-2982.2006.01182.x; MELCHER GA, 1981, PERCEPT PSYCHOPHYS, V30, P552, DOI 10.3758/BF03202009; Miller MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135335; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Pouget A, 2016, NAT NEUROSCI, V19, P366, DOI 10.1038/nn.4240; PREVIC FH, 1993, PERCEPT PSYCHOPHYS, V54, P93, DOI 10.3758/BF03206941; REINHARDTRUTLAND AH, 1991, PERCEPTION, V20, P337, DOI 10.1068/p200337; Rey MCB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00162; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Shepherd AJ, 2016, CEPHALALGIA; Singh P, 2016, INVEST OPHTH VIS SCI, V57, P1228, DOI 10.1167/iovs.15-17692; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; Yong NA, 2007, J NEUROPHYSIOL, V97, P1100, DOI 10.1152/jn.00694.2006; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159; Zupan LH, 2008, EXP BRAIN RES, V191, P505, DOI 10.1007/s00221-008-1540-4	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171332	10.1371/journal.pone.0171332	http://dx.doi.org/10.1371/journal.pone.0171332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192443	gold, Green Published, Green Submitted			2022-12-27	WOS:000394423800020
J	Qian, J; Mummalaneni, S; Phan, THT; Heck, GL; DeSimone, JA; West, D; Mahavadi, S; Hojati, D; Murthy, KS; Rhyu, MR; Spielman, AI; Ozdener, MH; Lyall, V				Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Rhyu, Mee-Ra; Spielman, Andrew I.; Ozdener, Mehmet Hakan; Lyall, Vijay			Cyclic-AMP regulates postnatal development of neural and behavioral responses to NaCl in rats	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; TYMPANI NERVE RESPONSES; TASTE CELLS; SODIUM-CHANNEL; AMILORIDE INHIBITION; GUSTATORY RESPONSES; MEDIATED REGULATION; ENAC; CAMP; VASOPRESSIN	During postnatal development rats demonstrate an age-dependent increase in NaCl chorda tympani (CT) responses and the number of functional apical amiloride-sensitive epithelial Na+ channels (ENaCs) in salt sensing fungiform (FF) taste receptor cells (TRCs). Currently, the intracellular signals that regulate the postnatal development of salt taste have not been identified. We investigated the effect of cAMP, a downstream signal for arginine vasopressin (AVP) action, on the postnatal development of NaCl responses in 19-23 day old rats. ENaC-dependent NaCl CT responses were monitored after lingual application of 8-chlorophenylthio-cAMP (8-CPT-cAMP) under open-circuit conditions and under +/- 60 mV lingual voltage clamp. Behavioral responses were tested using 2 bottle/24h NaCl preference tests. The effect of [deamino-Cys(1), D-Arg(8)]-vasopressin (dDAVP, a specific V2R agonist) was investigated on ENaC subunit trafficking in rat FF TRCs and on cAMP generation in cultured adult human FF taste cells (HBO cells). Our results show that in 19-23 day old rats, the ENaC-dependent maximum NaCl CT response was a saturating sigmoidal function of 8-CPT-cAMP concentration. 8-CPT-cAMP increased the voltage-sensitivity of the NaCl CT response and the apical Na+ response conductance. Intravenous injections of dDAVP increased ENaC expression and gamma-ENaC trafficking from cytosolic compartment to the apical compartment in rat FF TRCs. In HBO cells dDAVP increased intracellular cAMP and cAMP increased trafficking of gamma- and delta-ENaC from cytosolic compartment to the apical compartment 10 min post-cAMP treatment. Control 19-23 day old rats were indifferent to NaCl, but showed clear preference for appetitive NaCl concentrations after 8-CPT-cAMP treatment. Relative to adult rats, 14 day old rats demonstrated significantly less V2R antibody binding in circumvallate TRCs. We conclude that an age-dependent increase in V2R expression produces an AVP-induced incremental increase in cAMP that modulates the postnatal increase in TRC ENaC and the neural and behavioral responses to NaCl.	[Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Qian, Jie; Mummalaneni, Shobha; Phan, Tam-Hao T.; Heck, Gerard L.; DeSimone, John A.; West, David; Mahavadi, Sunila; Hojati, Deanna; Murthy, Karnam S.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Rhyu, Mee-Ra] Korea Food Res Inst, Sungnam Si, Gyeonggi Do, South Korea; [Spielman, Andrew I.] NYU, Coll Dent, New York, NY USA; [Ozdener, Mehmet Hakan] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Virginia Commonwealth University; Korea Food Research Institute (KFRI); New York University; Monell Chemical Senses Center	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Biophys, Med Coll Virginia Campus, Richmond, VA 23284 USA.	vijay.lyall@vcuhealth.org	Ozdener, Mehmet Hakan/I-4097-2019; Spielman, Andrew I./ABG-1150-2021	Spielman, Andrew I./0000-0002-7052-3689	NIDDKD [DK-28300]; NIDCD [DC-011569]; KFRI [E094101, E0111501]; NCI [P30 CA16059]; National Cancer Institute [P30 CA16059];  [NIDCD-011569];  [DK28300];  [KFRI E094101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	NIDDKD; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); KFRI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by funds from NIDDKD grant (DK-28300); NIDCD grant (DC-011569), KFRI grant (E094101 and E0111501), and NCI grant (P30 CA16059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants NIDCD-011569 (VL), DK28300 (KSM), and KFRI E094101, E0111501 (MR). Imaging cytometry was supported in part by National Cancer Institute Grant P30 CA16059. We also thank Dr Li Ya Qiao for use of her fluorescence microscope.	Abaffy T, 2003, AM J PHYSIOL-CELL PH, V284, pC1420, DOI 10.1152/ajpcell.00556.2002; Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; Baquero AF, 2011, AM J PHYSIOL-CELL PH, V300, pC860, DOI 10.1152/ajpcell.00318.2010; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Blanchard A, 2011, CLIN J AM SOC NEPHRO, V6, P753, DOI 10.2215/CJN.06540810; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076553; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Coleman J, 2011, J NEUROPHYSIOL, V106, P2606, DOI 10.1152/jn.00196.2010; COWART BJ, 1981, PSYCHOL BULL, V90, P43, DOI 10.1037/0033-2909.90.1.43; Denton DA, 1967, HANDBOOK PHYSIOLOG 6, V1, P433; DeSimone J. A., 2015, THESIS, P667; DeSimone JA, 2001, J NEUROPHYSIOL, V86, P2638, DOI 10.1152/jn.2001.86.5.2638; DeSimone JA, 2008, SENSES COMPREHENSIVE, V4, P281; DeSimone JA, 2015, CHEM SENSES, V40, P401, DOI 10.1093/chemse/bjv022; DeSimone JA, 2011, CHEM SENSES, V36, P389, DOI 10.1093/chemse/bjq148; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; FERRELL MF, 1981, J COMP NEUROL, V198, P37, DOI 10.1002/cne.901980105; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Guggino WB, 2000, P NATL ACAD SCI USA, V97, P9827, DOI 10.1073/pnas.97.18.9827; Hager H, 2001, AM J PHYSIOL-RENAL, V280, pF1093, DOI 10.1152/ajprenal.2001.280.6.F1093; Halpern BP, 1998, CHEM SENSES, V23, P501, DOI 10.1093/chemse/23.5.501; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hendricks SJ, 2000, J NEUROPHYSIOL, V84, P1531, DOI 10.1152/jn.2000.84.3.1531; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; HILL DL, 1983, J NEUROPHYSIOL, V50, P879, DOI 10.1152/jn.1983.50.4.879; HILL DL, 1987, J NEUROPHYSIOL, V57, P481, DOI 10.1152/jn.1987.57.2.481; HILL DL, 1982, J NEUROSCI, V2, P782; HILL DL, 1985, DEV BRAIN RES, V20, P310, DOI 10.1016/0165-3806(85)90121-X; HILL DL, 1980, BRAIN RES, V197, P27, DOI 10.1016/0006-8993(80)90432-1; Hochheimer A, 2014, CHEM SENSES, V39, P359, DOI 10.1093/chemse/bju009; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kossel AH, 1997, J NEUROSCI, V17, P9634; KREISBERG JI, 1984, KIDNEY INT, V25, P874, DOI 10.1038/ki.1984.104; KREISBERG JI, 1986, IN VITRO CELL DEV B, V22, P392, DOI 10.1007/BF02623528; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; LAWRENCE TS, 1979, J CELL BIOL, V80, P21, DOI 10.1083/jcb.80.1.21; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lindemann B, 1998, ANN NY ACAD SCI, V855, P116, DOI 10.1111/j.1749-6632.1998.tb10553.x; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2002, J NEUROPHYSIOL, V87, P399, DOI 10.1152/jn.00331.2001; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Mennella J. A., 2004, FETAL NEONATAL PHYSL, V2, P1819; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Mummalaneni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098049; NINOMIYA Y, 1988, BRAIN RES, V451, P319, DOI 10.1016/0006-8993(88)90777-9; Ozdener H, 2012, JOVE-J VIS EXP, DOI 10.3791/3730; Pittman DW, 2002, CHEM SENSES, V27, P333, DOI 10.1093/chemse/27.4.333; Pittman DW, 2002, PHYSIOL BEHAV, V77, P277, DOI 10.1016/S0031-9384(02)00852-1; RABITO CA, 1980, IN VITRO CELL DEV B, V16, P461, DOI 10.1007/BF02626458; Robins GG, 2013, J PHYSIOL BIOCHEM, V69, P419, DOI 10.1007/s13105-012-0223-6; Sauter D, 2006, KIDNEY INT, V69, P1024, DOI 10.1038/sj.ki.5000211; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Shigemura N, 2008, AM J PHYSIOL-REG I, V294, pR66, DOI 10.1152/ajpregu.00420.2007; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; SOLLARS SI, 1994, BEHAV NEUROSCI, V108, P981, DOI 10.1037/0735-7044.108.5.981; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Spector AC, 1996, J NEUROSCI, V16, P8115; Stahler F, 2008, CHEMOSENS PERCEPT, V1, P78, DOI 10.1007/s12078-008-9006-4; Stewart RE, 1996, AM J PHYSIOL-REG I, V270, pR704, DOI 10.1152/ajpregu.1996.270.4.R704; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; Stockand JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00304; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; VALENTICH JD, 1979, J CELL PHYSIOL, V100, P291, DOI 10.1002/jcp.1041000210; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watson KJ, 2007, CHEM SENSES, V32, P411, DOI 10.1093/chemse/bjm006; YE Q, 1991, SCIENCE, V254, P724, DOI 10.1126/science.1948054; YE Q, 1993, J NEUROPHYSIOL, V70, P1713, DOI 10.1152/jn.1993.70.4.1713; Yu SJ, 2012, EXP NEUROL, V238, P209, DOI 10.1016/j.expneurol.2012.08.007; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG728, DOI 10.1152/ajpgi.00138.2006	82	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171335	10.1371/journal.pone.0171335	http://dx.doi.org/10.1371/journal.pone.0171335			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192441	Green Published, Green Submitted, gold			2022-12-27	WOS:000394423800021
J	Cova, I; Pomati, S; Maggiore, L; Forcella, M; Cucumo, V; Ghiretti, R; Grande, G; Muzio, F; Mariani, C				Cova, Ilaria; Pomati, Simone; Maggiore, Laura; Forcella, Marica; Cucumo, Valentina; Ghiretti, Roberta; Grande, Giulia; Muzio, Fulvio; Mariani, Claudio			Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ELDERLY-PATIENTS; MASS INDEX; DEMENTIA; RECOMMENDATIONS; BIOIMPEDANCE; VALIDATION	Aims Analysis of nutritional status and body composition in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). Methods A cross-sectional study was performed in a University-Hospital setting, recruiting 59 patients with AD, 34 subjects with MCI and 58 elderly healthy controls (HC). Nutritional status was assessed by anthropometric parameters (body mass index; calf, upper arm and waist circumferences), Mini Nutritional Assessment (MNA) and body composition by bioelectrical impedance vector analysis (BIVA). Variables were analyzed by analysis of variance and subjects were grouped by cognitive status and gender. Results Sociodemographic variables did not differ among the three groups (AD, MCI and HC), except for females' age, which was therefore used as covariate in a general linear multivariate model. MNA score was significantly lower in AD patients than in HC; MCI subjects achieved intermediate scores. AD patients (both sexes) had significantly (p<0.05) higher height-normalized impedance values and lower phase angles (body cell mass) compared with HC; a higher ratio of impedance to height was found in men with MCI with respect to HC. With BIVA method, MCI subjects showed a significant displacement on the RXc graph on the right side indicating lower soft tissues (Hotelling's T-2 test: men = 10.6; women = 7.9;p < 0,05) just like AD patients (Hotelling's T-2 test: men = 18.2; women = 16.9; p<0,001). Conclusion Bioelectrical parameters significantly differ from MCI and AD to HC; MCI showed an intermediate pattern between AD and HC. Longitudinal studies are required to investigate if BIVA could reflect early AD-changes in body composition in subjects with MCI.	[Cova, Ilaria; Pomati, Simone; Maggiore, Laura; Forcella, Marica; Cucumo, Valentina; Ghiretti, Roberta; Grande, Giulia; Mariani, Claudio] Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Ctr Res & Treatment Cognit Dysfunct, Inst Clin Neurol,Dept Clin Sci, Milan, Italy; [Muzio, Fulvio] Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Dietet & Clin Nutr Unit, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Cova, I (corresponding author), Luigi Sacco Univ Hosp, ASST Fatebenefratelli Sacco, Ctr Res & Treatment Cognit Dysfunct, Inst Clin Neurol,Dept Clin Sci, Milan, Italy.	ilaria.cova@unimi.it	Grande, Giulia/K-4276-2018; Cova, Ilaria/K-9454-2016; Pomati, Simone/AAP-5414-2021	Cova, Ilaria/0000-0001-7831-6791; Pomati, Simone/0000-0001-8930-6361				Al-Gindan YY, 2014, AM J CLIN NUTR, V100, P1041, DOI 10.3945/ajcn.113.070466; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1994, AM J CLIN NUTR, V64, p387S; Buffa R, 2014, EXP GERONTOL, V58, P30, DOI 10.1016/j.exger.2014.07.005; Buffa R, 2010, J NUTR HEALTH AGING, V14, P823, DOI 10.1007/s12603-010-0115-9; Martin MAC, 2015, NUTRITION, V31, P155, DOI 10.1016/j.nut.2014.06.006; Cova I, 2016, DEMENT GERIATR COGN, V41, P172, DOI 10.1159/000444216; Cova I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151710; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grande G, 2016, J ALZHEIMERS DIS, V51, P57, DOI 10.3233/JAD-150786; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Kawakami R, 2015, GERIATR GERONTOL INT, V15, P969, DOI 10.1111/ggi.12377; Lohman T. G., 1998, ANTROPOMETRIC STANDA; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morris JK, 2014, BBA-MOL BASIS DIS, V1842, P1340, DOI 10.1016/j.bbadis.2014.04.012; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Piccoli A, BIVA SOFTWARE; RENVALL MJ, 1993, J AM DIET ASSOC, V93, P47, DOI 10.1016/0002-8223(93)92130-P; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Saragat B, 2012, J NUTR HEALTH AGING, V16, P231, DOI 10.1007/s12603-011-0347-3; Schmand B, 1997, BRIT J PSYCHIAT, V171, P373, DOI 10.1192/bjp.171.4.373; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Withers RT, 1999, AM J HUM BIOL, V11, P175, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;175::AID-AJHB5&gt;3.0.CO;2-C; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0171331	10.1371/journal.pone.0171331	http://dx.doi.org/10.1371/journal.pone.0171331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187148	Green Published, Green Submitted, gold			2022-12-27	WOS:000394244300019
J	Su, WJ; Wang, LJ; Lei, J; Chai, SS; Liu, Y; Yang, YY; Yang, XS; Jiao, CH				Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Liu, Yi; Yang, Yuanyuan; Yang, Xinsun; Jiao, Chunhai			Genome-wide assessment of population structure and genetic diversity and development of a core germplasm set for sweet potato based on specific length amplified fragment (SLAF) sequencing	PLOS ONE			English	Article							BATATAS L. LAM.; SSR MARKERS; LINKAGE MAP; COLLECTION; AFLP; CONSTRUCTION; STRATEGIES; RESOURCES; DISTANCE; AMERICA	Sweet potato, Ipomoea batatas (L.) Lam., is an important food crop that is cultivated worldwide. However, no genome-wide assessment of the genetic diversity of sweet potato has been reported to date. In the present study, the population structure and genetic diversity of 197 sweet potato accessions most of which were from China were assessed using 62,363 SNPs. A model-based structure analysis divided the accessions into three groups: group 1, group 2 and group 3. The genetic relationships among the accessions were evaluated using a phylogenetic tree, which clustered all the accessions into three major groups. A principal component analysis (PCA) showed that the accessions were distributed according to their population structure. The mean genetic distance among accessions ranged from 0.290 for group 1 to 0.311 for group 3, and the mean polymorphic information content (PIC) ranged from 0.232 for group 1 to 0.251 for group 3. The mean minor allele frequency (MAF) ranged from 0.207 for group 1 to 0.222 for group 3. Analysis of molecular variance (AMOVA) showed that the maximum diversity was within accessions (89.569%). Using CoreHunter software, a core set of 39 accessions was obtained, which accounted for approximately 19.8% of the total collection. The core germplasm set of sweet potato developed will be a valuable resource for future sweet potato improvement strategies.	[Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Yang, Yuanyuan; Yang, Xinsun] Hubei Acad Agr Sci, Food Crops Inst, Wuhan, Peoples R China; [Su, Wenjin] China Agr Univ, Minist Educ, Lab Crop Heterosis & Utilizat, Beijing Key Lab Crop Genet Improvement, Beijing, Peoples R China; [Liu, Yi] Yangtze Univ, Coll Agr, Jingzhou, Peoples R China; [Jiao, Chunhai] Hubei Acad Agr Sci, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences; China Agricultural University; Yangtze University; Hubei Academy of Agricultural Sciences	Yang, XS (corresponding author), Hubei Acad Agr Sci, Food Crops Inst, Wuhan, Peoples R China.; Jiao, CH (corresponding author), Hubei Acad Agr Sci, Wuhan, Peoples R China.	yangxins013@163.com; jiaoch@hotmail.com		Yang, Xinsun/0000-0003-3942-1112	Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America [2013-Z61]; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences [2007-620-001-03]; China Agriculture Research System [CARS-11-C-15]; Characteristic Discipline of Hubei Academy of Agricultural Sciences [2015TSXK06]; National Natural Science Foundation of China Grant [31301377]; Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia [2016ABA087]	Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences; China Agriculture Research System; Characteristic Discipline of Hubei Academy of Agricultural Sciences; National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia	This work was supported by Hubei Engineering and Technology Research Center of Sweet Potato, Introduction and Utilization of Sweet Potato Germplasm Resources from America (2013-Z61), Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences (2007-620-001-03), China Agriculture Research System (CARS-11-C-15), Characteristic Discipline of Hubei Academy of Agricultural Sciences (2015TSXK06), National Natural Science Foundation of China Grant (31301377), Innovation and Application of Major Crops Germplasm Resources Introduced from Africa and Southeast Asia (2016ABA087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Austin DF, 1987, 1 SWEET POT PLANN C, P27; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Department of Science Technology and Education of Ministry of Agriculture of China Department of Education Science and Culture of Ministry of Finance of China, 2010, AGR IND DEV REP CHIN; Dunteman G.H, 1989, PRINCIPAL COMPONENTS, P69; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fajardo S, 2002, GENET RESOUR CROP EV, V49, P463; Fang BP, 2004, GUANGDONG AGR SCI, V1, P1; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gichuki ST, 2003, GENET RESOUR CROP EV, V50, P429, DOI 10.1023/A:1023998522845; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HE GH, 1995, GENOME, V38, P938, DOI 10.1139/g95-123; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Jarret R. L., 1994, Genetic Resources and Crop Evolution, V41, P165, DOI 10.1007/BF00051633; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Liu DG, 2012, J INTEGR AGR, V11, P1424; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Lopez-Sese AI, 2002, EUPHYTICA, V127, P41, DOI 10.1023/A:1019904224170; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Moulin MM, 2012, ACTA SCI-AGRON, V34, P139, DOI 10.4025/actasciagron.v34i2.12616; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Skroch PW, 1998, CROP SCI, V38, P488, DOI 10.2135/cropsci1998.0011183X003800020036x; [苏文瑾 Su Wenjin], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P27; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; van Treuren R, 2006, GENET RESOUR CROP EV, V53, P43, DOI 10.1007/s10722-004-0585-x; Veasey EA, 2008, GENET MOL BIOL, V31, P725, DOI 10.1590/S1415-47572008000400020; Wen WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032626; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yang XS, 2015, J INTEGR AGR, V14, P633, DOI 10.1016/S2095-3119(14)60794-2; Yonezawa K., 1995, P35; Zhang DP, 2000, GENET RESOUR CROP EV, V47, P659, DOI 10.1023/A:1026520507223; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhao N, 2013, MOL BREEDING, V32, P807, DOI 10.1007/s11032-013-9908-y	56	26	30	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2017	12	2							e0172066	10.1371/journal.pone.0172066	http://dx.doi.org/10.1371/journal.pone.0172066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9KV	28187178	Green Submitted, Green Published, gold			2022-12-27	WOS:000394244300077
